Citrus Sinensis ID: 005577
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 690 | 2.2.26 [Sep-21-2011] | |||||||
| Q86HW6 | 798 | Probable serine/threonine | yes | no | 0.401 | 0.347 | 0.445 | 3e-63 | |
| Q54VV7 | 1126 | Probable serine/threonine | no | no | 0.402 | 0.246 | 0.406 | 9e-61 | |
| F1SPM8 | 968 | AP2-associated protein ki | yes | no | 0.392 | 0.279 | 0.431 | 3e-60 | |
| Q2M2I8 | 961 | AP2-associated protein ki | yes | no | 0.392 | 0.281 | 0.428 | 6e-60 | |
| F1MH24 | 957 | AP2-associated protein ki | yes | no | 0.392 | 0.283 | 0.428 | 9e-60 | |
| Q3UHJ0 | 959 | AP2-associated protein ki | yes | no | 0.392 | 0.282 | 0.420 | 1e-58 | |
| P0C1X8 | 962 | AP2-associated protein ki | yes | no | 0.391 | 0.280 | 0.417 | 9e-57 | |
| O14976 | 1311 | Cyclin-G-associated kinas | no | no | 0.398 | 0.209 | 0.406 | 2e-56 | |
| P97874 | 1305 | Cyclin-G-associated kinas | yes | no | 0.447 | 0.236 | 0.375 | 5e-56 | |
| Q99KY4 | 1305 | Cyclin-G-associated kinas | no | no | 0.447 | 0.236 | 0.375 | 2e-55 |
| >sp|Q86HW6|Y6461_DICDI Probable serine/threonine-protein kinase DDB_G0276461 OS=Dictyostelium discoideum GN=DDB_G0276461 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 243 bits (620), Expect = 3e-63, Method: Compositional matrix adjust.
Identities = 128/287 (44%), Positives = 179/287 (62%), Gaps = 10/287 (3%)
Query: 14 GLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKE 73
G G+ D+ ++ ++AEGGF VY RD + YA+K M + E LE+ E
Sbjct: 41 GRVGQVYDINGRRVTEVKLVAEGGFGFVYLVRD--DYNNMYALKRMFIQERERLEAMKNE 98
Query: 74 ISVMKSLKGHPNVVTLYAHTILDLGRTKE--ALLVME-CCDKSLVNVLENRGA-GYFEEK 129
I VM+ L+ +PN+V L I + T+E L++ME C S+++++ RG EE+
Sbjct: 99 IDVMQKLRNNPNIVKLEGFKINENRNTRETEVLMLMEYCSGGSVLDIMNARGEFTRLEER 158
Query: 130 QVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS-DGLWKLCDFGSTSTNHKRFEKL 188
++LAIF DVCN V AMH Q PPIAHRDLK EN+L +KLCDFGS++ K F
Sbjct: 159 EILAIFSDVCNGVLAMHQQQPPIAHRDLKIENVLYCEHSNRYKLCDFGSSTI--KTFNTA 216
Query: 189 EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK 248
E G ED+I TT YRAPEM DL+R ++I+EKVD+WALGCLLF++ ++ + FDG S
Sbjct: 217 TERGKAEDDINMFTTLFYRAPEMVDLYRGQIIDEKVDVWALGCLLFKMAFYVDPFDGGS- 275
Query: 249 LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295
LQI+N NY+IP++ KYS++ LI+ +L A P RP I + +NE
Sbjct: 276 LQIINNNYKIPDNSKYSNNFHKLIQFILVADPTQRPSINDLLNYLNE 322
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q54VV7|Y0111_DICDI Probable serine/threonine-protein kinase DDB_G0280111 OS=Dictyostelium discoideum GN=DDB_G0280111 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 235 bits (599), Expect = 9e-61, Method: Compositional matrix adjust.
Identities = 115/283 (40%), Positives = 177/283 (62%), Gaps = 5/283 (1%)
Query: 16 EGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEIS 75
+G+++ +G+ ++ IAEGGFS V+ +D+ + SK YA+K ++ DE+ L+ EIS
Sbjct: 5 QGKTLKIGSYHLNFVKQIAEGGFSYVFLVKDS-NTSKHYALKRILIRDEDELKGVKHEIS 63
Query: 76 VMKSLKGHPNVV-TLYAHTILDLGRTKEALLVMECCDKSLVNVLENR--GAGYFEEKQVL 132
+MK L H N+V L H + D T+ +L+ C LV +++ R F ++++L
Sbjct: 64 IMKRLTKHKNIVKILDYHKVSDKNNTEMFILMEYCSGGHLVEIMQKRLSSGSKFTDQEIL 123
Query: 133 AIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD-GLWKLCDFGSTSTNHKRFEKLEEM 191
IF+D+C +V MHSQ P I HRDLK EN+LL + G++KLCDFGS + R + EM
Sbjct: 124 KIFQDICESVAYMHSQQPLIIHRDLKVENVLLDEESGIYKLCDFGSATEEITRMKNKTEM 183
Query: 192 GIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI 251
ED+I +HTT YRAPE+ D +R +INEK+DIWALGCLL+++ ++ F+ L I
Sbjct: 184 QNAEDDISRHTTLQYRAPEIVDFYRSPVINEKIDIWALGCLLYKLLFYVTPFEDSGSLGI 243
Query: 252 LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294
LN NY IP + +S+ + LI+ ML P +RP+I ++ ++N
Sbjct: 244 LNSNYTIPPNHTHSNDLISLIKIMLNPDPINRPNIFEITNQLN 286
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|F1SPM8|AAK1_PIG AP2-associated protein kinase 1 OS=Sus scrofa GN=AAK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 233 bits (595), Expect = 3e-60, Method: Compositional matrix adjust.
Identities = 120/278 (43%), Positives = 171/278 (61%), Gaps = 7/278 (2%)
Query: 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISV 76
GR +G ++ V V+AEGGF+ V+ R + M + A+K M N+E L+ +EI +
Sbjct: 36 GRVFGIGRQQVTVDEVLAEGGFAIVFLVRTSNGM--KCALKRMFVNNEHDLQVCKREIQI 93
Query: 77 MKSLKGHPNVVTLYAHTILDL--GRTKEALLVMECC-DKSLVNVLENRGAGYFEEKQVLA 133
M+ L GH N+V +I ++ G E L++M+ C +VN++ R F E +VL
Sbjct: 94 MRDLSGHKNIVGYIDSSINNVSSGDVWEVLILMDFCRGGQVVNLMNQRLQTGFTESEVLQ 153
Query: 134 IFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGI 193
IF D C AV +H PI HRDLK EN+LL G + LCDFGS +TN + + E +
Sbjct: 154 IFCDTCEAVARLHQCKTPIIHRDLKVENILLHDRGHYVLCDFGS-ATNKFQNPQTEGVNA 212
Query: 194 EEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN 253
ED I+K+TT +YRAPEM +L+ ++I K DIWALGCLL+++CYF F GES++ I +
Sbjct: 213 VEDEIKKYTTLSYRAPEMVNLYSGKIITTKADIWALGCLLYKLCYFTLPF-GESQVAICD 271
Query: 254 GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291
GN+ IP++ +YS + LIR ML+ PD RPDI QV F
Sbjct: 272 GNFTIPDNSRYSQDMHCLIRYMLEPDPDKRPDIYQVSF 309
|
Regulates clathrin-mediated endocytosis by phosphorylating the AP2M1/mu2 subunit of the adaptor protein complex 2 (AP-2) which ensures high affinity binding of AP-2 to cargo membrane proteins during the initial stages of endocytosis. Regulates phosphorylation of other AP-2 subunits as well as AP-2 localization and AP-2-mediated internalization of ligand complexes. Phosphorylates NUMB and regulates its cellular localization, promoting NUMB localization to endosomes. Binds to and stabilizes the activated form of NOTCH1, increases its localization in endosomes and regulates its transcriptional activity. Sus scrofa (taxid: 9823) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2M2I8|AAK1_HUMAN AP2-associated protein kinase 1 OS=Homo sapiens GN=AAK1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 232 bits (592), Expect = 6e-60, Method: Compositional matrix adjust.
Identities = 119/278 (42%), Positives = 171/278 (61%), Gaps = 7/278 (2%)
Query: 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISV 76
GR +G ++ V V+AEGGF+ V+ R + M + A+K M N+E L+ +EI +
Sbjct: 36 GRVFGIGRQQVTVDEVLAEGGFAIVFLVRTSNGM--KCALKRMFVNNEHDLQVCKREIQI 93
Query: 77 MKSLKGHPNVVTLYAHTILDL--GRTKEALLVMECC-DKSLVNVLENRGAGYFEEKQVLA 133
M+ L GH N+V +I ++ G E L++M+ C +VN++ R F E +VL
Sbjct: 94 MRDLSGHKNIVGYIDSSINNVSSGDVWEVLILMDFCRGGQVVNLMNQRLQTGFTENEVLQ 153
Query: 134 IFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGI 193
IF D C AV +H PI HRDLK EN+LL G + LCDFGS +TN + + E +
Sbjct: 154 IFCDTCEAVARLHQCKTPIIHRDLKVENILLHDRGHYVLCDFGS-ATNKFQNPQTEGVNA 212
Query: 194 EEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN 253
ED I+K+TT +YRAPEM +L+ ++I K DIWALGCLL+++CYF F GES++ I +
Sbjct: 213 VEDEIKKYTTLSYRAPEMVNLYSGKIITTKADIWALGCLLYKLCYFTLPF-GESQVAICD 271
Query: 254 GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291
GN+ IP++ +YS + LIR ML+ PD RPDI QV +
Sbjct: 272 GNFTIPDNSRYSQDMHCLIRYMLEPDPDKRPDIYQVSY 309
|
Regulates clathrin-mediated endocytosis by phosphorylating the AP2M1/mu2 subunit of the adaptor protein complex 2 (AP-2) which ensures high affinity binding of AP-2 to cargo membrane proteins during the initial stages of endocytosis. Isoform 1 and isoform 2 display similar levels of kinase activity towards AP2M1. Regulates phosphorylation of other AP-2 subunits as well as AP-2 localization and AP-2-mediated internalization of ligand complexes. Phosphorylates NUMB and regulates its cellular localization, promoting NUMB localization to endosomes. Binds to and stabilizes the activated form of NOTCH1, increases its localization in endosomes and regulates its transcriptional activity. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|F1MH24|AAK1_BOVIN AP2-associated protein kinase 1 OS=Bos taurus GN=AAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 232 bits (591), Expect = 9e-60, Method: Compositional matrix adjust.
Identities = 119/278 (42%), Positives = 170/278 (61%), Gaps = 7/278 (2%)
Query: 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISV 76
GR +G ++ V V+AEGGF+ V+ R + M + A+K M N+E L+ +EI +
Sbjct: 36 GRVFGIGRQQVTVDEVLAEGGFAIVFLVRTSNGM--KCALKRMFVNNEHDLQVCKREIQI 93
Query: 77 MKSLKGHPNVVTLYAHTI--LDLGRTKEALLVMECC-DKSLVNVLENRGAGYFEEKQVLA 133
M+ L GH N+V +I + G E L++M+ C +VN++ R F E +VL
Sbjct: 94 MRDLSGHKNIVGYIDSSINSVSSGDVWEVLILMDFCRGGQVVNLMNQRLQTGFTENEVLQ 153
Query: 134 IFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGI 193
IF D C AV +H PI HRDLK EN+LL G + LCDFGS +TN + + E +
Sbjct: 154 IFCDTCEAVARLHQCKTPIIHRDLKVENILLHDRGHYVLCDFGS-ATNKFQNPQTEGVNA 212
Query: 194 EEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN 253
ED I+K+TT +YRAPEM +L+ ++I K DIWALGCLL+++CYF F GES++ I +
Sbjct: 213 VEDEIKKYTTLSYRAPEMVNLYSGKVITTKADIWALGCLLYKLCYFTLPF-GESQVAICD 271
Query: 254 GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291
GN+ IP++ +YS + LIR ML+ PD RPDI QV +
Sbjct: 272 GNFTIPDNSRYSQDMHCLIRYMLEPDPDKRPDIYQVSY 309
|
Regulates clathrin-mediated endocytosis by phosphorylating the AP2M1/mu2 subunit of the adaptor protein complex 2 (AP-2) which ensures high affinity binding of AP-2 to cargo membrane proteins during the initial stages of endocytosis. Regulates phosphorylation of other AP-2 subunits as well as AP-2 localization and AP-2-mediated internalization of ligand complexes. Phosphorylates NUMB and regulates its cellular localization, promoting NUMB localization to endosomes. Binds to and stabilizes the activated form of NOTCH1, increases its localization in endosomes and regulates its transcriptional activity. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3UHJ0|AAK1_MOUSE AP2-associated protein kinase 1 OS=Mus musculus GN=Aak1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 228 bits (581), Expect = 1e-58, Method: Compositional matrix adjust.
Identities = 117/278 (42%), Positives = 171/278 (61%), Gaps = 7/278 (2%)
Query: 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISV 76
GR +G ++ V V+AEGGF+ V+ R + + + A+K M N+E L+ +EI +
Sbjct: 36 GRVFGIGRQQVTVDEVLAEGGFALVFLVRTSNGV--KCALKRMFVNNEHDLQVCKREIQI 93
Query: 77 MKSLKGHPNVVTLYAHTILDL--GRTKEALLVMECC-DKSLVNVLENRGAGYFEEKQVLA 133
M+ L GH N+V +I ++ G E L++M+ C +VN++ R F E +VL
Sbjct: 94 MRDLSGHKNIVGYIDSSINNVSSGDVWEVLILMDFCRGGQVVNLMNQRLQTGFTENEVLQ 153
Query: 134 IFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGI 193
IF D C AV +H PI HRDLK EN+LL G + LCDFGS +TN + + E +
Sbjct: 154 IFCDTCEAVARLHQCKTPIIHRDLKVENILLHDRGHYVLCDFGS-ATNKFQNPQAEGVNA 212
Query: 194 EEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN 253
ED I+K+TT +YRAPEM +L+ ++I K DIWALGCLL+++CYF F GES++ I +
Sbjct: 213 VEDEIKKYTTLSYRAPEMVNLYSGKIITTKADIWALGCLLYKLCYFTLPF-GESQVAICD 271
Query: 254 GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291
G++ IP++ +YS + LIR ML+ PD RPDI QV +
Sbjct: 272 GSFTIPDNSRYSQDMHCLIRYMLEPDPDKRPDIYQVSY 309
|
Regulates clathrin-mediated endocytosis by phosphorylating the AP2M1/mu2 subunit of the adaptor protein complex 2 (AP-2) which ensures high affinity binding of AP-2 to cargo membrane proteins during the initial stages of endocytosis. Isoform 1 and isoform 2 display similar levels of kinase activity towards AP2M1. Regulates phosphorylation of other AP-2 subunits as well as AP-2 localization and AP-2-mediated internalization of ligand complexes. Phosphorylates NUMB and regulates its cellular localization, promoting NUMB localization to endosomes. Binds to and stabilizes the activated form of NOTCH1, increases its localization in endosomes and regulates its transcriptional activity. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0C1X8|AAK1_RAT AP2-associated protein kinase 1 OS=Rattus norvegicus GN=Aak1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 222 bits (565), Expect = 9e-57, Method: Compositional matrix adjust.
Identities = 116/278 (41%), Positives = 170/278 (61%), Gaps = 8/278 (2%)
Query: 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISV 76
GR +G ++ V V+AEGGF+ V+ R + + + A+K M N+E L+ +EI +
Sbjct: 36 GRVFGIGRQQVTVDEVLAEGGFALVFLVRTSNGV--KCALKRMFVNNEHDLQVCKREIQI 93
Query: 77 MKSLKGHPNVVTLYAHTILDL--GRTKEALLVMECC-DKSLVNVLENRGAGYFEEKQVLA 133
M+ L GH N+V +I ++ G E L++M+ C +VN++ R F E +VL
Sbjct: 94 MRDLSGHKNIVGYIDSSINNVSSGDVWEVLILMDFCRGGQVVNLMNQRLQTGFTENEVLQ 153
Query: 134 IFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGI 193
IF D C AV +H PI HRDLK EN+LL G + LCDFGS +TN + + E +
Sbjct: 154 IFCDTCEAVARLHQCKTPIIHRDLKVENILLHDRGHYVLCDFGS-ATNKFQNPQAEGVNA 212
Query: 194 EEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN 253
ED I+K+TT +YRAPEM +L+ ++I K DIWALGCLL+++CYF F GES++ I +
Sbjct: 213 VEDEIKKYTTLSYRAPEMVNLYSGKIITTKADIWALGCLLYKLCYFTLPF-GESQVAICD 271
Query: 254 GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291
G++ IP++ +YS + LI ML+ PD RPDI QV +
Sbjct: 272 GSFTIPDNSRYSQDMHCLIY-MLEPDPDKRPDIYQVSY 308
|
Regulates clathrin-mediated endocytosis by phosphorylating the AP2M1/mu2 subunit of the adaptor protein complex 2 (AP-2) which ensures high affinity binding of AP-2 to cargo membrane proteins during the initial stages of endocytosis. Regulates phosphorylation of other AP-2 subunits as well as AP-2 localization and AP-2-mediated internalization of ligand complexes. Phosphorylates NUMB and regulates its cellular localization, promoting NUMB localization to endosomes. Binds to and stabilizes the activated form of NOTCH1, increases its localization in endosomes and regulates its transcriptional activity. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O14976|GAK_HUMAN Cyclin-G-associated kinase OS=Homo sapiens GN=GAK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 221 bits (562), Expect = 2e-56, Method: Compositional matrix adjust.
Identities = 118/290 (40%), Positives = 174/290 (60%), Gaps = 15/290 (5%)
Query: 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISV 76
G+++++G L++ VR V+AEGGF+ VY A+D + ++YA+K ++ N+EE + ++E+
Sbjct: 30 GQTVELGELRLRVRRVLAEGGFAFVYEAQD-VGSGREYALKRLLSNEEEKNRAIIQEVCF 88
Query: 77 MKSLKGHPNVVTLYAHTIL-----DLGRTKEALLVMECCDKSLVNVL---ENRGAGYFEE 128
MK L GHPN+V + + D G+ E LL+ E C LV L E+RG
Sbjct: 89 MKKLSGHPNIVQFCSAASIGKEESDTGQA-EFLLLTELCKGQLVEFLKKMESRGP--LSC 145
Query: 129 KQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST--NHKRFE 186
VL IF C AV MH Q PPI HRDLK ENLLL + G KLCDFGS +T ++ +
Sbjct: 146 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 205
Query: 187 -KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDG 245
+ + E+ I ++TTP YR PE+ DL+ I EK DIWALGC+L+ +C+ ++ F+
Sbjct: 206 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 265
Query: 246 ESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295
+KL+I+NG Y IP + LIR MLQ +P++R I +V ++ E
Sbjct: 266 GAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 315
|
Associates with cyclin G and CDK5. Seems to act as an auxilin homolog that is involved in the uncoating of clathrin-coated vesicles by Hsc70 in non-neuronal cells. Expression oscillates slightly during the cell cycle, peaking at G1. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P97874|GAK_RAT Cyclin-G-associated kinase OS=Rattus norvegicus GN=Gak PE=2 SV=1 | Back alignment and function description |
|---|
Score = 219 bits (558), Expect = 5e-56, Method: Compositional matrix adjust.
Identities = 122/325 (37%), Positives = 188/325 (57%), Gaps = 16/325 (4%)
Query: 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISV 76
G+++++G L++ VR V+AEGGF+ VY A+D + ++YA+K ++ N+EE + ++E+
Sbjct: 30 GQTVELGELRLRVRRVLAEGGFAFVYEAQD-LGSGREYALKRLLSNEEEKNRAIIQEVCF 88
Query: 77 MKSLKGHPNVVTLYAHTIL-----DLGRTKEALLVMECCDKSLVNVLEN-RGAGYFEEKQ 130
+K L GHPN+V + + D G+ E LL+ E C LV L G
Sbjct: 89 LKKLSGHPNIVQFCSAASIGKEESDTGQA-EFLLLTELCKGQLVEFLRRVECKGPLSCDS 147
Query: 131 VLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST--NHKRFE-K 187
+L IF C AV MH Q PPI HRDLK ENLLL + G KLCDFGS +T ++ +
Sbjct: 148 ILKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 207
Query: 188 LEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES 247
++ + E+ I ++TTP YR PE+ DL+ I EK DIWALGC+L+ +C+ ++ F+ +
Sbjct: 208 AQKRAMVEEEITRNTTPMYRTPEIVDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 267
Query: 248 KLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGLQKSLPD 307
KL+I+NG Y IP + + DLIR ML+ +P++R I +V ++ E + +++
Sbjct: 268 KLRIVNGKYSIPVNDTRYTVFHDLIRGMLKVNPEERLSIAEVVRQLQE---IAAARNVNP 324
Query: 308 RPPETQSAVANEGM--SKPMNRSPP 330
+ P T+ N G S P PP
Sbjct: 325 KAPITELLEQNGGYGNSGPSRAQPP 349
|
Associates with cyclin G and CDK5. Seems to act as an auxilin homolog that is involved in the uncoating of clathrin-coated vesicles by Hsc70 in non-neuronal cells. Expression oscillates slightly during the cell cycle, peaking at G1. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q99KY4|GAK_MOUSE Cyclin-G-associated kinase OS=Mus musculus GN=Gak PE=1 SV=2 | Back alignment and function description |
|---|
Score = 217 bits (553), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 122/325 (37%), Positives = 188/325 (57%), Gaps = 16/325 (4%)
Query: 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISV 76
G+++++G L++ VR V+AEGGF+ VY A+D + ++YA+K ++ N+EE + ++E+
Sbjct: 30 GQTVELGELRLRVRRVLAEGGFAFVYEAQD-LGSGREYALKRLLSNEEEKNRAIIQEVCF 88
Query: 77 MKSLKGHPNVVTLYAHTIL-----DLGRTKEALLVMECCDKSLVNVLEN-RGAGYFEEKQ 130
+K L GHPN+V + + D G+ E LL+ E C LV L+ G
Sbjct: 89 LKKLSGHPNIVQFCSAASIGKEESDTGQA-EFLLLTELCKGQLVEFLKRVECKGPLSCDS 147
Query: 131 VLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST--NHKRFE-K 187
+L IF C AV MH Q PPI HRDLK ENLLL + G KLCDFGS +T ++ +
Sbjct: 148 ILKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 207
Query: 188 LEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES 247
++ + E+ I ++TTP YR PE+ DL+ I EK DIWALGC+L+ +C+ ++ F+ +
Sbjct: 208 AQKRAMVEEEITRNTTPMYRTPEIVDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 267
Query: 248 KLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGLQKSLPD 307
KL+I+NG Y IP + + DLIR ML+ +P +R I +V ++ E + +++
Sbjct: 268 KLRIVNGKYSIPVNDTRYTVFHDLIRAMLKVNPVERLSIAEVVRQLQE---IAAARNVNP 324
Query: 308 RPPETQSAVANEGM--SKPMNRSPP 330
+ P T+ N G S P PP
Sbjct: 325 KAPITELLEQNGGYGNSGPSRAQPP 349
|
Associates with cyclin G and CDK5. Seems to act as an auxilin homolog that is involved in the uncoating of clathrin-coated vesicles by Hsc70 in non-neuronal cells. Expression oscillates slightly during the cell cycle, peaking at G1. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 690 | ||||||
| 225450356 | 697 | PREDICTED: uncharacterized protein LOC10 | 0.995 | 0.985 | 0.721 | 0.0 | |
| 449463803 | 676 | PREDICTED: uncharacterized protein LOC10 | 0.966 | 0.986 | 0.653 | 0.0 | |
| 356525620 | 662 | PREDICTED: uncharacterized protein LOC10 | 0.949 | 0.989 | 0.651 | 0.0 | |
| 356557118 | 660 | PREDICTED: uncharacterized protein LOC10 | 0.927 | 0.969 | 0.621 | 0.0 | |
| 255542175 | 622 | serine/threonine protein kinase, putativ | 0.891 | 0.988 | 0.628 | 0.0 | |
| 30685467 | 670 | AP2-associated kinase [Arabidopsis thali | 0.936 | 0.964 | 0.606 | 0.0 | |
| 297826731 | 660 | hypothetical protein ARALYDRAFT_482227 [ | 0.926 | 0.968 | 0.597 | 0.0 | |
| 18403106 | 650 | AP2-associated kinase [Arabidopsis thali | 0.918 | 0.975 | 0.603 | 0.0 | |
| 18176324 | 650 | putative serine/threonine protein kinase | 0.918 | 0.975 | 0.601 | 0.0 | |
| 50726471 | 667 | cyclin G-associated kinase-like protein | 0.944 | 0.977 | 0.554 | 0.0 |
| >gi|225450356|ref|XP_002274890.1| PREDICTED: uncharacterized protein LOC100258075 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 951 bits (2457), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 505/700 (72%), Positives = 576/700 (82%), Gaps = 13/700 (1%)
Query: 1 MWRFKPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMI 60
MWRFKPFM KE GLEGRSIDVGN+K++VRN IAEGGFSCVY ARDAI+ SKQYA+KH+I
Sbjct: 1 MWRFKPFMPKEQAGLEGRSIDVGNVKVYVRNAIAEGGFSCVYLARDAINSSKQYALKHII 60
Query: 61 CNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLEN 120
CNDEESL+ KEI VMK L+GHPNVVTL+AHTILD+GRTKEALLVME C+KSLVNVLE+
Sbjct: 61 CNDEESLDLVKKEILVMKVLRGHPNVVTLHAHTILDMGRTKEALLVMEFCEKSLVNVLES 120
Query: 121 RGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180
RGAGYFEEKQVL+IFRDVCNAVFAMH QSPPIAHRDLKAENLLLG DGLWKLCDFGSTST
Sbjct: 121 RGAGYFEEKQVLSIFRDVCNAVFAMHCQSPPIAHRDLKAENLLLGPDGLWKLCDFGSTST 180
Query: 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK 240
NHKRFEK EEMGIEEDNIRK+TTPAYRAPEMWDL RRELINEKVDIWALGCLLFRICYFK
Sbjct: 181 NHKRFEKPEEMGIEEDNIRKYTTPAYRAPEMWDLLRRELINEKVDIWALGCLLFRICYFK 240
Query: 241 NAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVG 300
+AFDGESKLQILNGNYRIPE PKYSS+VTDLIRDMLQASPD+RPDITQVWFRVNEQLP
Sbjct: 241 SAFDGESKLQILNGNYRIPELPKYSSNVTDLIRDMLQASPDNRPDITQVWFRVNEQLPAA 300
Query: 301 LQKSLPDRPPETQSAVAN--EGMSKPMNRSPPMPQRSPPPPPSSVDPTRNISQPSTTPAV 358
LQKSLPDRPP + A+ EG SKP N++ P+P+RSPPPPPSS +PTRN S PS T
Sbjct: 301 LQKSLPDRPPGMNQSAADGHEGFSKPSNKASPVPRRSPPPPPSSREPTRNPSPPSLTTRA 360
Query: 359 SGGGGVLGAFWSTQHAKDSIVAEDQSRSKFYEEPSIYSTSGHSRSQSDNHPV--NPSTVE 416
GGGG LGAFWS+QHAKDS + ED S KF EE + +STSG R + +NH N S +
Sbjct: 361 GGGGGSLGAFWSSQHAKDSAI-EDNSGPKFDEETTSHSTSG-DRYRPENHYYSKNSSPPK 418
Query: 417 EENIQNHAIRRNVHGKSHKPEDGPSKDIKMNFFQKDTDTRIERPKTLKTESTATFQDEAF 476
E NIQ RRN + K E+ PSKD ++ FFQ+D++ ERPK K ESTA+FQ++AF
Sbjct: 419 EANIQTRG-RRNAQANTFKSEEVPSKDFEIRFFQEDSNRGTERPKASKGESTASFQNDAF 477
Query: 477 NSFVAEFDTNKLNSAISSNKSEKEEALQNEVERLKGQLKQTNLEKAEITSKFEKLSAICR 536
N+FVAEFDT+KL S ++NKS KEE L+ E ERLK QLKQ NLEK+EITSKFEKLSAICR
Sbjct: 478 NTFVAEFDTSKLGSGSNANKSAKEEELEAETERLKEQLKQANLEKSEITSKFEKLSAICR 537
Query: 537 SQRQEIQELKQALAARLPSPNKDAAINQTSPGNESFATPPR-EKIEGTIWEL-KSEWGTP 594
SQRQEIQELKQALAAR PSPN+DA+ NQTS G +S ATPP EKIEGT+WEL + + +P
Sbjct: 538 SQRQEIQELKQALAARTPSPNRDASKNQTSTGLQSAATPPHGEKIEGTVWELQQGKSDSP 597
Query: 595 SPESKSWQAFAEDPKPQQ----QNTAQSVRTRNGHLNKHTAQSTSGFDSWGFGTESFTAI 650
+P+SK WQAF ++ K Q NT++SVRTRNGH NK ++TSG ++WGFGTESFTA
Sbjct: 598 APDSKPWQAFPDELKQHQPLSRDNTSKSVRTRNGHHNKPATEATSGPETWGFGTESFTAT 657
Query: 651 PAANSQRSKPITEGNSSQSIGRSKTTENQPSAQPAGWAGF 690
PAA+S S+P GN++Q G SK E++P+ QPAGWAGF
Sbjct: 658 PAASSSFSRPTVGGNNAQLFGDSKRIESKPATQPAGWAGF 697
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463803|ref|XP_004149621.1| PREDICTED: uncharacterized protein LOC101211119 [Cucumis sativus] gi|449527069|ref|XP_004170535.1| PREDICTED: uncharacterized LOC101211119 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 860 bits (2221), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/699 (65%), Positives = 530/699 (75%), Gaps = 32/699 (4%)
Query: 1 MWRFKPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMI 60
MWRFKPFM KEP+GLEGRSIDVGNLKIHVRNVIAEGGFSCVY A+DA+H+SKQYA+KH+I
Sbjct: 1 MWRFKPFMHKEPSGLEGRSIDVGNLKIHVRNVIAEGGFSCVYLAKDAVHISKQYALKHII 60
Query: 61 CNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLEN 120
CNDEESLE MKE+SVMKSL+GHPNVVTLYAHTI+D+GRTKEALLVME C+KSLVNVLE+
Sbjct: 61 CNDEESLELVMKEVSVMKSLRGHPNVVTLYAHTIIDMGRTKEALLVMEFCEKSLVNVLES 120
Query: 121 RGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180
RGAGYF+E QVL IFRDVCNAVFAMH SPP+AHRDLKAENLLLGSDG WKLCDFGSTST
Sbjct: 121 RGAGYFDESQVLLIFRDVCNAVFAMHCHSPPVAHRDLKAENLLLGSDGHWKLCDFGSTST 180
Query: 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK 240
NHKRFEK EEMGIEEDNIRK+TTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK
Sbjct: 181 NHKRFEKPEEMGIEEDNIRKYTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK 240
Query: 241 NAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVG 300
+AFDGESKLQILNGNYRIPE PKYSSSV DLIRDMLQASP+DRPDITQVWFR N LPVG
Sbjct: 241 SAFDGESKLQILNGNYRIPELPKYSSSVIDLIRDMLQASPNDRPDITQVWFRANNLLPVG 300
Query: 301 LQKSLPDRPPETQSAVANEGMSKPMNR---SPPMPQRSPPPPPSSVDPTRNISQPSTTPA 357
QKSLPD+PP+ S +EG S P+N+ P PP SS T N+S+P+
Sbjct: 301 SQKSLPDQPPDMPSTDKHEGTSNPVNKLSPMPRRSPPPPPSVKSSSQATSNMSKPAGG-G 359
Query: 358 VSGGGGVLGAFWSTQHAKDSIVAEDQSRSKFYEEPSIYSTSGHSRSQSDNHPVNPSTVEE 417
GGGG LGAFWSTQHA D+ V ED +R +F EE + STS H R+ +NH
Sbjct: 360 GGGGGGPLGAFWSTQHASDT-VNEDTNRIRFDEESTSRSTSKHDRNGPNNH--------- 409
Query: 418 ENIQNHAIRRNVHGKSHK--PEDGPSKDIKMNFFQKDTDTRIERPKTLKTESTATFQDEA 475
+ +A +V+ K +K + G +D +++FFQ + + K KT S A FQD+A
Sbjct: 410 -STHKNASPGDVNQKGNKTVTDSGSFRDFELSFFQNEMEHGSSGSKASKTGS-ANFQDKA 467
Query: 476 FNSFVAEFDTNKLNSAISSNKSEKEEALQNEVERLKGQLKQTNLEKAEITSKFEKLSAIC 535
FN+FVAEFDT K +S +++NK KE AL+ EVE+LK QLK N+EK+EITSKFEKLSAIC
Sbjct: 468 FNNFVAEFDTGKFSSDVTNNKPGKEVALEAEVEKLKEQLKHANVEKSEITSKFEKLSAIC 527
Query: 536 RSQRQEIQELKQALAARLPSPNKDAAINQTSPGNESFATPPREKIEGTIWELKSEWGTPS 595
RSQRQEIQELKQALAAR PSPNK NQ S + A P +K + T TPS
Sbjct: 528 RSQRQEIQELKQALAARSPSPNKLEMKNQNSREAQPSAVPRLQKADVT---------TPS 578
Query: 596 PESKSWQAFAEDPKPQQQNT----AQSVRTRNGHLNKHTAQSTSGFDSWGFGTESFTAIP 651
P++K+WQAFAE+ QQ T +S+RTR+ + + ++T GF+SWGFG ESFTA+
Sbjct: 579 PDAKAWQAFAEESPNQQPVTPEKGVKSMRTRSVQRKQASPENT-GFESWGFGAESFTAVS 637
Query: 652 AANSQRSKPITEGNSSQSIGRSKTTENQPSAQPAGWAGF 690
A +S +S E NSSQ G + N S+QPAGWAGF
Sbjct: 638 AGSSNKSGLTGERNSSQRTGGGEPKSNDISSQPAGWAGF 676
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356525620|ref|XP_003531422.1| PREDICTED: uncharacterized protein LOC100808507 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 841 bits (2173), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/697 (65%), Positives = 531/697 (76%), Gaps = 42/697 (6%)
Query: 1 MWRFKPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMI 60
MWRFKPF KE TGLEGR+IDVGNLKIHV IAEGGFSCVY ARDA+HMSKQYA+KHMI
Sbjct: 1 MWRFKPFSHKEQTGLEGRTIDVGNLKIHVIKAIAEGGFSCVYLARDAVHMSKQYALKHMI 60
Query: 61 CNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLEN 120
CNDEESL KEISVMK L GHPNVVTL+AH I D+GRTKEA LVME C++SLVNVLE+
Sbjct: 61 CNDEESLGLVKKEISVMKVLAGHPNVVTLHAHAIFDMGRTKEAFLVMEFCERSLVNVLES 120
Query: 121 RGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180
RGAGYF+EKQVL IFRDVCNAV AMH QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST
Sbjct: 121 RGAGYFDEKQVLLIFRDVCNAVLAMHCQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180
Query: 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK 240
NHKRFEK EEMGIEEDNIRK+TTPAYRAPEMWDLF RE+INEKVDIWALGCLLFRICYFK
Sbjct: 181 NHKRFEKPEEMGIEEDNIRKYTTPAYRAPEMWDLFLREVINEKVDIWALGCLLFRICYFK 240
Query: 241 NAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVG 300
+AFDGESKLQ+LNGNYRIPE PKY+S VTDLIRDMLQA PD+RPDITQVWFRVNEQLP+
Sbjct: 241 SAFDGESKLQVLNGNYRIPELPKYNSPVTDLIRDMLQARPDNRPDITQVWFRVNEQLPIN 300
Query: 301 LQKSLPDRPPETQSAVANEGMSKPMNRSPPMPQRSPPPPPSSVDPTRNISQPSTTPAVSG 360
LQKSLPDRPPE S+ +EG+S P NRSPPMP+R+PPPPPSS +P + QPS G
Sbjct: 301 LQKSLPDRPPELPSSNDHEGVSMPSNRSPPMPRRNPPPPPSSGEP-KTSPQPSPASRGGG 359
Query: 361 GGGVLGAFWSTQHAKDSIVAEDQSRSKFYEEPSIYSTS---GHSRSQSDNHPVNPSTVEE 417
GG LGAFWSTQHAK+S+VAED+S+ F EEPS + S R ++D P N +
Sbjct: 360 SGGALGAFWSTQHAKESLVAEDKSKPIFDEEPSSHHFSLKHDRIRPENDQLPKNDGPNKV 419
Query: 418 ENIQNHAIRRNVHGKSHKPEDGPSKDIKMNFFQKDTDTRIERPKTLKTESTATFQDEAFN 477
N Q H ++ + HGK KP+ PSKD ++N F+ D D R+ EST FQ++AFN
Sbjct: 420 VNTQTHTVKSSTHGKLPKPDTAPSKDFELNLFE-DKD-RV-------GESTTNFQNQAFN 470
Query: 478 SFVAEFDTNKLNSAISSNKSEKEEALQNEVERLKGQLKQTNLEKAEITSKFEKLSAICRS 537
+FVAEFD KLN + +NK E+E+AL+ EVE LK +LK+ NLEKAEITSK+EKLSAICRS
Sbjct: 471 TFVAEFDATKLNPGL-NNKPEREQALEAEVEILKEKLKEANLEKAEITSKYEKLSAICRS 529
Query: 538 QRQEIQELKQALAARLPSPNKDAAINQTSPGNESFATPPREKIEGTIWELKSEWGTPSPE 597
QRQE+Q+LKQALAAR PSP+++ + SP + S +
Sbjct: 530 QRQELQDLKQALAARTPSPSREGL--KISPA------------------VTSSASASASS 569
Query: 598 SKSWQAFAEDPKPQQ----QNTAQSVRTRNGHLNKHTAQSTSGFDSWGFGTESFTAIPAA 653
KSWQAF E+P+ Q+ +NT++SVR +NG NK + FDSWGFGT+SF+A+PA
Sbjct: 570 DKSWQAFPEEPQQQRSLSAENTSKSVRVKNGQQNKQPVPLATDFDSWGFGTDSFSAVPAG 629
Query: 654 NSQRSKPITEGNSSQSIGRSKTTENQPSAQPAGWAGF 690
+ Q +P + G SQ+ G + N+ ++QPAGWAGF
Sbjct: 630 SPQMQRPSSAGTKSQAFGEA----NKSTSQPAGWAGF 662
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356557118|ref|XP_003546865.1| PREDICTED: uncharacterized protein LOC100780879 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 835 bits (2156), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 441/710 (62%), Positives = 517/710 (72%), Gaps = 70/710 (9%)
Query: 1 MWRFKPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMI 60
MWRFKPF KE TGLEGR+IDV NLKI++ IAEGGFSCVY ARDA+HMSKQYA+KHMI
Sbjct: 1 MWRFKPFSHKEQTGLEGRTIDVSNLKINIIKAIAEGGFSCVYLARDAVHMSKQYALKHMI 60
Query: 61 CNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLEN 120
CNDEESL KEISVMK L GHPNVVTL+AH I+D+GRTKEA +VME C++SLVNVLE+
Sbjct: 61 CNDEESLGLVKKEISVMKMLAGHPNVVTLHAHAIVDMGRTKEAFVVMEFCERSLVNVLES 120
Query: 121 RGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180
RGAGYF+EKQVL IFRDVCNAV AMH QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST
Sbjct: 121 RGAGYFDEKQVLLIFRDVCNAVLAMHCQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180
Query: 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK 240
NHKRFEK EEMGIEEDNIRK+TTPAYRAPEMWDLF RE+INEKVDIWALGCLLFRICYFK
Sbjct: 181 NHKRFEKPEEMGIEEDNIRKYTTPAYRAPEMWDLFLREVINEKVDIWALGCLLFRICYFK 240
Query: 241 NAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVG 300
+AFDGESKLQ+LNGNYRIPE PKY+S VTDLIR+MLQA PDDRPDITQVWFRVNEQLP+
Sbjct: 241 SAFDGESKLQVLNGNYRIPELPKYTSPVTDLIREMLQARPDDRPDITQVWFRVNEQLPIN 300
Query: 301 LQKSLPDRPPETQSAVANEGMSKPMNRSPPM-------------PQRSPPPPPSSVDPTR 347
LQKSLPDRPPE+ S+ +EG+S P NRSPPM P+ SP PPP+S
Sbjct: 301 LQKSLPDRPPESPSSNNHEGVSMPSNRSPPMPRRNPPPPPSSGEPKTSPQPPPASRGGGS 360
Query: 348 NISQPSTTPAVSGGGGVLGAFWSTQHAKDSIVAEDQSRSKFYEEPSIYSTS-GHSRSQSD 406
+ GAFWSTQHAK+S+VAED+S+ F EEPS + S H R +
Sbjct: 361 GGAL--------------GAFWSTQHAKESLVAEDKSKPIFDEEPSSHHISPKHDRILPE 406
Query: 407 NH--PVNPSTVEEENIQNHAIRRNVHGKSHKPEDGPSKDIKMNFFQKDTDTRIERPKTLK 464
N P N + N Q H ++ + HGK HKP+ PSKD ++N F KD D R+
Sbjct: 407 NEQLPKNVGPNKVVNTQTHTVKSSTHGKLHKPDTVPSKDFEINLF-KDKD-RVR------ 458
Query: 465 TESTATFQDEAFNSFVAEFDTNKLNSAISSNKSEKEEALQNEVERLKGQLKQTNLEKAEI 524
EST FQ++AFN+FVAEFDT LNS + SNK E+E+AL+ EVE+LK QLK+ NLEKAEI
Sbjct: 459 -ESTTNFQNQAFNTFVAEFDTTNLNSGL-SNKPEREQALEAEVEKLKEQLKEANLEKAEI 516
Query: 525 TSKFEKLSAICRSQRQEIQELKQALAARLPSPNKDAAINQTSPGNESFATPPREKIEGTI 584
TSK+EKLSAICRSQRQE+Q+LKQAL AR PSP +D G
Sbjct: 517 TSKYEKLSAICRSQRQELQDLKQALTARTPSPIRD----------------------GLK 554
Query: 585 WELKSEWGTPSPESKSWQAFAEDPKPQQ----QNTAQSVRTRNGHLNKHTAQSTSGFDSW 640
+ +KSW AF E+P+ Q+ +NT++SVR +NG NK + FDSW
Sbjct: 555 TSPAVTSSASASANKSWHAFPEEPQQQKSFSAENTSKSVRVKNGQQNKQPVALATDFDSW 614
Query: 641 GFGTESFTAIPAANSQRSKPITEGNSSQSIGRSKTTENQPSAQPAGWAGF 690
GFG++SF+A+PA + +P + G SQ+ G + N+ ++QPAGWAGF
Sbjct: 615 GFGSDSFSAVPAGSPHMQRPSSAGTKSQAFGEA----NKSTSQPAGWAGF 660
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542175|ref|XP_002512151.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223548695|gb|EEF50185.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 809 bits (2089), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/697 (62%), Positives = 502/697 (72%), Gaps = 82/697 (11%)
Query: 1 MWRFKPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMI 60
MWRFK F QKEP GLEGR IDVGNLKIHVRN IAEGGFSCVY A DA+H SKQYA+KHMI
Sbjct: 1 MWRFKSFTQKEPVGLEGRYIDVGNLKIHVRNAIAEGGFSCVYLALDAMHASKQYALKHMI 60
Query: 61 CNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLEN 120
CNDEESLE A+KEI+VMKS +GHPN+V L AH ILD GRTKEALLVME C+KSLV+VL++
Sbjct: 61 CNDEESLELALKEINVMKSFQGHPNIVALCAHAILDKGRTKEALLVMEFCEKSLVSVLDS 120
Query: 121 RGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180
RGAGYFEEKQVL+IFRD CNAVFAMHSQSPPIAHRDLKAENLLLG DG WKLCDFGSTS
Sbjct: 121 RGAGYFEEKQVLSIFRDACNAVFAMHSQSPPIAHRDLKAENLLLGPDGSWKLCDFGSTSI 180
Query: 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK 240
NHKRFEK E+MGIEEDNIRK+TTPAYRAPEMWDL RR+ I+EKVDIWALGCLLFRICYFK
Sbjct: 181 NHKRFEKPEDMGIEEDNIRKYTTPAYRAPEMWDLLRRDRISEKVDIWALGCLLFRICYFK 240
Query: 241 NAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVG 300
NAFDGESKLQILNGNYRIP+ PKYS VTDLIRDMLQASPDDRPDITQVWFRVNEQLPV
Sbjct: 241 NAFDGESKLQILNGNYRIPDLPKYSMPVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVN 300
Query: 301 LQKSLPDRPPETQSAVANEGMSKPMNRSPPMPQRSPPPPPSSVDPTRNISQPSTTPAVSG 360
LQKSLPD PE +S +E S+P NR P + G
Sbjct: 301 LQKSLPDGLPEMKSTSVHEVTSRPANR--------------PPPMPNRSPPPPPSSGGVG 346
Query: 361 GGGVLGAFWSTQHAKDSIVAEDQSRSKFYEEPSIYSTSGHSRSQSDNHPVNP--STVEEE 418
GGG LGAFWS+QHA+DS V E++S+SKF +E S Y+ S +SQS+NH ++ S V++E
Sbjct: 347 GGGQLGAFWSSQHARDSFV-EEKSKSKFDDESS-YNPSRQDKSQSENHTLSKTYSPVKDE 404
Query: 419 NIQNHAIRRNVHGKSHKPEDGPSKDIKMNFFQKDTDTRIERPKTLKTESTATFQDEAFNS 478
N Q HA RR VHGKSH +D KD +
Sbjct: 405 NSQAHATRRIVHGKSHVSQDDSYKDFE--------------------------------- 431
Query: 479 FVAEFDTNKLNSAISSNKSEKEEALQNEVERLKGQLKQTNLEKAEITSKFEKLSAICRSQ 538
LNS + + KS +EE L++E+ERLK QLKQ N+EKAE+TSK+EKLSAICRSQ
Sbjct: 432 --------XLNSRVGNIKSAREEELESEIERLKDQLKQANMEKAEMTSKYEKLSAICRSQ 483
Query: 539 RQEIQELKQALAARLPSPNKDAAINQTSPGNESFATPPREKIEGTIWELKSEWGTPSPES 598
RQEIQELKQ +AAR PSPNK A +T P + ++G +S+W PSP+
Sbjct: 484 RQEIQELKQVVAARTPSPNKYQASPKTQPSTNT--------LQG-----ESDWSIPSPDQ 530
Query: 599 KSWQAFAEDPKPQQQ-----NTAQSVRTRNGHLNKHTAQSTSGFDSWGFGTESFTAIPAA 653
K W AFA+D KPQQQ N+ QSVRTRN + K A+S +SWGFG +SFTA PAA
Sbjct: 531 KPWHAFADDSKPQQQPPSKGNSPQSVRTRNANQRKQ-AES----ESWGFGADSFTAAPAA 585
Query: 654 NSQRSKPITEGNSSQSIGRSKTTENQPSAQPAGWAGF 690
++Q S+PI EGNSSQ +K E+Q + QPAGWAGF
Sbjct: 586 STQTSRPINEGNSSQHFSGTKIMESQAATQPAGWAGF 622
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30685467|ref|NP_850199.1| AP2-associated kinase [Arabidopsis thaliana] gi|24762201|gb|AAN64167.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|330253658|gb|AEC08752.1| AP2-associated kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2039), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 433/714 (60%), Positives = 508/714 (71%), Gaps = 68/714 (9%)
Query: 1 MWRFKPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMI 60
MW+FKPF QKEP GLEGR +++GNLK+ VRNVIAEGGFS VY A+D H SKQYA+KHMI
Sbjct: 1 MWKFKPFAQKEPAGLEGRFLEIGNLKVQVRNVIAEGGFSSVYLAQDVNHASKQYALKHMI 60
Query: 61 CNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK-EALLVMECCDKSLVNVLE 119
CNDEESLE MKEISV+KSLKGHPNVVTLYAH ILD+GR K EALL M+ C KSLV+VLE
Sbjct: 61 CNDEESLELVMKEISVLKSLKGHPNVVTLYAHGILDMGRNKKEALLAMDFCGKSLVDVLE 120
Query: 120 NRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179
NRGAGYFEEKQ L IFRDVCNAVFAMH QSP IAHRDLKAENLLL SDG WKLCDFGS S
Sbjct: 121 NRGAGYFEEKQALTIFRDVCNAVFAMHCQSPRIAHRDLKAENLLLSSDGQWKLCDFGSVS 180
Query: 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF 239
TNHK FE+ EEMGIEEDNIRK+TTP YRAPEMWDLFRRE+I+EKVDIWALGCLLFRICYF
Sbjct: 181 TNHKIFERAEEMGIEEDNIRKYTTPTYRAPEMWDLFRREMISEKVDIWALGCLLFRICYF 240
Query: 240 KNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPV 299
KNAFDGESKLQILNGNYRIPESPKYS +TDLI++MLQASPD+RPDITQ+WFRVNEQLP
Sbjct: 241 KNAFDGESKLQILNGNYRIPESPKYSVFITDLIKEMLQASPDERPDITQIWFRVNEQLPA 300
Query: 300 GLQKSLPDRPPETQSAVANEGMSKPMNRSPPMPQRSPPPPPSSVDPTRNISQPSTTPAVS 359
LQKSLPDRPPE QS ++G SK + S P R+ P + S
Sbjct: 301 NLQKSLPDRPPEMQSTGVHDGSSKSATK-------------PSPAPRRSPPPPPPSSGES 347
Query: 360 GGGGVLGAFWSTQHAKDSIVAEDQSRSKFYEEPSIYSTSGHSRSQSDNH-PVNPSTVEEE 418
GG LGAFW+TQHAK S+V+ED ++EP+ +TS R + D+H P PS V E
Sbjct: 348 DSGGPLGAFWATQHAKTSVVSEDNKNMPKFDEPN-SNTSKSERVRVDSHQPKKPSPVRGE 406
Query: 419 NIQNHAIRRNVHGKSHKPEDGPSKDIKMNFFQKDTDTRIERPKTLKTESTATFQDEAFNS 478
I+RN KD++ QK+T T +D+AFNS
Sbjct: 407 ---ARGIQRN-------------KDLETTISQKNT------TPAAANNMTRVSKDDAFNS 444
Query: 479 FVAEFDTNKLNSAISSNKSEKEEALQNEVERLKGQLKQTNLEKAEITSKFEKLSAICRSQ 538
FVA+FDT K ++ NK KEEAL+ E++RLK +LKQT EKAEIT+KFEKLSAICRSQ
Sbjct: 445 FVADFDTTKFDNG---NKPGKEEALEAEIQRLKDELKQTKSEKAEITAKFEKLSAICRSQ 501
Query: 539 RQEIQELKQAL--AARLPSPNKDAAINQTSPGNESF-ATPPREKIEGTIWEL---KSEWG 592
RQE+Q+LKQ L + PSP++D++ NQ SPG S +TP R+K+EGT+WEL +S W
Sbjct: 502 RQELQDLKQTLASKSASPSPSRDSSQNQPSPGMHSMSSTPSRDKMEGTMWELQQDRSNWS 561
Query: 593 TPSPESKSWQAFAEDPKPQQQNTA--------QSVRTRNGHLNKHTAQSTSGFDSWGFGT 644
T S ++ SWQ F+++ KP ++ + QSVRTR+ +A T GF+ WGF T
Sbjct: 562 TGSSDTNSWQPFSDEAKPVMESASKGNNNTINQSVRTRS---KPASAAGTQGFEPWGFET 618
Query: 645 ESF-------TAIPAANSQRSKPITEGNS-SQSIGRSKTTENQPSAQPAGWAGF 690
ESF A A+ +QRS + GNS SQ G SK ENQ +AQPAGWAGF
Sbjct: 619 ESFRAAATSAAATSASGTQRS--MGSGNSTSQRYGNSKMRENQKTAQPAGWAGF 670
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297826731|ref|XP_002881248.1| hypothetical protein ARALYDRAFT_482227 [Arabidopsis lyrata subsp. lyrata] gi|297327087|gb|EFH57507.1| hypothetical protein ARALYDRAFT_482227 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 785 bits (2027), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/711 (59%), Positives = 507/711 (71%), Gaps = 72/711 (10%)
Query: 1 MWRFKPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMI 60
MW+FKPF QKEP GLEGR +++GNLK+ VRNVIAEGGFS VY A+D H SKQYA+KH+I
Sbjct: 1 MWKFKPFTQKEPAGLEGRFLEIGNLKVQVRNVIAEGGFSSVYLAQDVNHASKQYALKHII 60
Query: 61 CNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK-EALLVMECCDKSLVNVLE 119
CNDEESLE MKEISV+KSLKGHPNVVTLYAH ILD+GR K EALL M+ C KSLV+VLE
Sbjct: 61 CNDEESLELVMKEISVLKSLKGHPNVVTLYAHGILDMGRNKKEALLAMDFCGKSLVDVLE 120
Query: 120 NRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179
NRGAGYFEEKQ L IFRDVCNAVFAMH Q+P IAHRDLKAENLLL SDG WKLCDFGS S
Sbjct: 121 NRGAGYFEEKQALTIFRDVCNAVFAMHCQTPRIAHRDLKAENLLLSSDGQWKLCDFGSVS 180
Query: 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF 239
NHK FE+ EEMGIEEDNIRK+TTP YRAPEMWDLFRRE+I+EKVDIWALGCLLFRICYF
Sbjct: 181 KNHKIFERAEEMGIEEDNIRKYTTPTYRAPEMWDLFRREMISEKVDIWALGCLLFRICYF 240
Query: 240 KNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPV 299
KNAFDGESKLQILNGNYRIPESPKYS+ VTDLI++MLQASPD+RPDITQ+WFRVNEQLP
Sbjct: 241 KNAFDGESKLQILNGNYRIPESPKYSAFVTDLIKEMLQASPDERPDITQIWFRVNEQLPA 300
Query: 300 GLQKSLPDRPPETQSAVANEGMSKPMNRSPPMPQRSPPPPPSSVDPTRNISQPSTTPAVS 359
LQKSLPDRPPE QS ++G SK N+ SS P R+ P + S
Sbjct: 301 NLQKSLPDRPPEMQSTGVHDGSSKSANK-------------SSPVPRRSPPPPPPSSGES 347
Query: 360 GGGGVLGAFWSTQHAKDSIVAEDQSRSKFYEEPSIYSTSGHSRSQSDNHPVNPSTVEEEN 419
GG LGAFW+TQHAK S+++ED ++EP+ +T HP PS V
Sbjct: 348 DSGGPLGAFWATQHAKTSVLSEDNKSMPKFDEPNSNTTKSERVRVDSQHPKKPSPV---- 403
Query: 420 IQNHAIRRNVHGKSHKPEDGPSKDIKMNFFQKDTDTRIERPKTLKTESTATFQDEAFNSF 479
R V G + + + P+ T+ R T +D+AFNSF
Sbjct: 404 ------RGEVRGMNSQKDTTPAA----------TNNR-----------TRVSKDDAFNSF 436
Query: 480 VAEFDTNKLNSAISSNKSEKEEALQNEVERLKGQLKQTNLEKAEITSKFEKLSAICRSQR 539
VA+FDT KL++ NK KEEAL+ E+ERLK +LK+TN EKAEIT+KFEKLSAICRSQR
Sbjct: 437 VADFDTTKLDNG---NKPGKEEALEAEIERLKDELKKTNSEKAEITAKFEKLSAICRSQR 493
Query: 540 QEIQELKQAL--AARLPSPNKDAAINQTSPGNESF-ATPPREKIEGTIWEL---KSEWGT 593
QE+Q+LKQ+L + PSP++D++ +Q SPG S +TP R+KIEGT+WEL +S W T
Sbjct: 494 QELQDLKQSLASKSASPSPSRDSSQSQPSPGMHSMSSTPSRDKIEGTMWELQQDRSNWST 553
Query: 594 PSPESKSWQAFAEDPKPQQQNTA--------QSVRTRNGHLNKHTAQSTSGFDSWGFGTE 645
S ++ SWQ F+++ KP ++ + QSVRTR+ +A T GF++WGF TE
Sbjct: 554 GSSDTNSWQPFSDEAKPVMESASKGNNNTINQSVRTRS---KPASAAGTQGFEAWGFETE 610
Query: 646 SF------TAIPAANSQRSKPITEGNSSQSIGRSKTTENQPSAQPAGWAGF 690
SF +A A+ +QRS + N+SQ G SK +NQ +AQPAGWAGF
Sbjct: 611 SFRAAATSSATTASATQRSMG-SGNNTSQRYGNSKMRDNQKTAQPAGWAGF 660
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18403106|ref|NP_565756.1| AP2-associated kinase [Arabidopsis thaliana] gi|20196989|gb|AAB91980.2| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|20197066|gb|AAM14904.1| putative serine threonine protein kinase [Arabidopsis thaliana] gi|21618258|gb|AAM67308.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|23297401|gb|AAN12961.1| putative serine/threonine kinase [Arabidopsis thaliana] gi|330253657|gb|AEC08751.1| AP2-associated kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 781 bits (2016), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/706 (60%), Positives = 500/706 (70%), Gaps = 72/706 (10%)
Query: 1 MWRFKPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMI 60
MW+FKPF QKEP GLEGR +++GNLK+ VRNVIAEGGFS VY A+D H SKQYA+KHMI
Sbjct: 1 MWKFKPFAQKEPAGLEGRFLEIGNLKVQVRNVIAEGGFSSVYLAQDVNHASKQYALKHMI 60
Query: 61 CNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK-EALLVMECCDKSLVNVLE 119
CNDEESLE MKEISV+KSLKGHPNVVTLYAH ILD+GR K EALL M+ C KSLV+VLE
Sbjct: 61 CNDEESLELVMKEISVLKSLKGHPNVVTLYAHGILDMGRNKKEALLAMDFCGKSLVDVLE 120
Query: 120 NRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179
NRGAGYFEEKQ L IFRDVCNAVFAMH QSP IAHRDLKAENLLL SDG WKLCDFGS S
Sbjct: 121 NRGAGYFEEKQALTIFRDVCNAVFAMHCQSPRIAHRDLKAENLLLSSDGQWKLCDFGSVS 180
Query: 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF 239
TNHK FE+ EEMGIEEDNIRK+TTP YRAPEMWDLFRRE+I+EKVDIWALGCLLFRICYF
Sbjct: 181 TNHKIFERAEEMGIEEDNIRKYTTPTYRAPEMWDLFRREMISEKVDIWALGCLLFRICYF 240
Query: 240 KNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPV 299
KNAFDGESKLQILNGNYRIPESPKYS +TDLI++MLQASPD+RPDITQ+WFRVNEQLP
Sbjct: 241 KNAFDGESKLQILNGNYRIPESPKYSVFITDLIKEMLQASPDERPDITQIWFRVNEQLPA 300
Query: 300 GLQKSLPDRPPETQSAVANEGMSKPMNRSPPMPQRSPPPPPSSVDPTRNISQPSTTPAVS 359
LQKSLPDRPPE QS ++G SK + S P R+ P + S
Sbjct: 301 NLQKSLPDRPPEMQSTGVHDGSSKSATK-------------PSPAPRRSPPPPPPSSGES 347
Query: 360 GGGGVLGAFWSTQHAKDSIVAEDQSRSKFYEEPSIYSTSGHSRSQSDNH-PVNPSTVEEE 418
GG LGAFW+TQHAK S+V+ED ++EP+ +TS R + D+H P PS V E
Sbjct: 348 DSGGPLGAFWATQHAKTSVVSEDNKNMPKFDEPN-SNTSKSERVRVDSHQPKKPSPVRGE 406
Query: 419 NIQNHAIRRNVHGKSHKPEDGPSKDIKMNFFQKDTDTRIERPKTLKTESTATFQDEAFNS 478
I+RN KD++ QK+T T +D+AFNS
Sbjct: 407 ---ARGIQRN-------------KDLETTISQKNT------TPAAANNMTRVSKDDAFNS 444
Query: 479 FVAEFDTNKLNSAISSNKSEKEEALQNEVERLKGQLKQTNLEKAEITSKFEKLSAICRSQ 538
FVA+FDT K ++ NK KEEAL+ E++RLK +LKQT EKAEIT+KFEKLSAICRSQ
Sbjct: 445 FVADFDTTKFDNG---NKPGKEEALEAEIQRLKDELKQTKSEKAEITAKFEKLSAICRSQ 501
Query: 539 RQEIQELKQAL--AARLPSPNKDAAINQTSPGNESF-ATPPREKIEGTIWEL---KSEWG 592
RQE+Q+LKQ L + PSP++D++ NQ SPG S +TP R+K+EGT+WEL +S W
Sbjct: 502 RQELQDLKQTLASKSASPSPSRDSSQNQPSPGMHSMSSTPSRDKMEGTMWELQQDRSNWS 561
Query: 593 TPSPESKSWQAFAEDPKPQQQNTAQSVRTRNGHLNKHTAQSTSGFDSWGFGTESF----- 647
T S ++ SWQ F+++ KP + + ++ T GF+ WGF TESF
Sbjct: 562 TGSSDTNSWQPFSDEAKP---------------VMESASKGTQGFEPWGFETESFRAAAT 606
Query: 648 --TAIPAANSQRSKPITEGNS-SQSIGRSKTTENQPSAQPAGWAGF 690
A A+ +QRS + GNS SQ G SK ENQ +AQPAGWAGF
Sbjct: 607 SAAATSASGTQRS--MGSGNSTSQRYGNSKMRENQKTAQPAGWAGF 650
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18176324|gb|AAL60023.1| putative serine/threonine protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 780 bits (2014), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/706 (60%), Positives = 500/706 (70%), Gaps = 72/706 (10%)
Query: 1 MWRFKPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMI 60
MW+FKPF QKEP GLEGR +++GNLK+ VRNVIAEGGFS VY A+D H SKQYA+KHMI
Sbjct: 1 MWKFKPFAQKEPAGLEGRFLEIGNLKVQVRNVIAEGGFSSVYLAQDVNHASKQYALKHMI 60
Query: 61 CNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK-EALLVMECCDKSLVNVLE 119
CNDEESLE MKEISV+KSLKGHPNVVTLYAH ILD+GR K EALL M+ C KSLV+VLE
Sbjct: 61 CNDEESLELVMKEISVLKSLKGHPNVVTLYAHGILDMGRNKKEALLAMDFCGKSLVDVLE 120
Query: 120 NRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179
NRGAGYFEEKQ L IFRDVCNAVFAMH QSP IAHRDLKAENLLL SDG WKLCDFGS S
Sbjct: 121 NRGAGYFEEKQALTIFRDVCNAVFAMHCQSPRIAHRDLKAENLLLSSDGQWKLCDFGSVS 180
Query: 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF 239
TNHK FE+ EEMGIEEDNIRK+TTP YRAPEMWDLFRRE+I+EKVDIWALGCLLFRICYF
Sbjct: 181 TNHKIFERAEEMGIEEDNIRKYTTPTYRAPEMWDLFRREMISEKVDIWALGCLLFRICYF 240
Query: 240 KNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPV 299
KNAFDGESKLQILNGNYRIPESPKYS +TDLI++MLQASPD+RPD+TQ+WFRVNEQLP
Sbjct: 241 KNAFDGESKLQILNGNYRIPESPKYSVFITDLIKEMLQASPDERPDVTQIWFRVNEQLPA 300
Query: 300 GLQKSLPDRPPETQSAVANEGMSKPMNRSPPMPQRSPPPPPSSVDPTRNISQPSTTPAVS 359
LQKSLPDRPPE QS ++G SK + S P R+ P + S
Sbjct: 301 NLQKSLPDRPPEMQSTGVHDGSSKSATK-------------PSPAPRRSPPPPPPSSGES 347
Query: 360 GGGGVLGAFWSTQHAKDSIVAEDQSRSKFYEEPSIYSTSGHSRSQSDNH-PVNPSTVEEE 418
GG LGAFW+TQHAK S+V+ED ++EP+ +TS R + D+H P PS V E
Sbjct: 348 DSGGPLGAFWATQHAKTSVVSEDNKNMPKFDEPN-SNTSKSERVRVDSHQPKKPSPVRGE 406
Query: 419 NIQNHAIRRNVHGKSHKPEDGPSKDIKMNFFQKDTDTRIERPKTLKTESTATFQDEAFNS 478
I+RN KD++ QK+T T +D+AFNS
Sbjct: 407 ---ARGIQRN-------------KDLETTISQKNT------TPAAANNMTRVSKDDAFNS 444
Query: 479 FVAEFDTNKLNSAISSNKSEKEEALQNEVERLKGQLKQTNLEKAEITSKFEKLSAICRSQ 538
FVA+FDT K ++ NK KEEAL+ E++RLK +LKQT EKAEIT+KFEKLSAICRSQ
Sbjct: 445 FVADFDTTKFDNG---NKPGKEEALEAEIQRLKDELKQTKSEKAEITAKFEKLSAICRSQ 501
Query: 539 RQEIQELKQAL--AARLPSPNKDAAINQTSPGNESF-ATPPREKIEGTIWEL---KSEWG 592
RQE+Q+LKQ L + PSP++D++ NQ SPG S +TP R+K+EGT+WEL +S W
Sbjct: 502 RQELQDLKQTLASKSASPSPSRDSSQNQPSPGMHSMSSTPSRDKMEGTMWELQQDRSNWS 561
Query: 593 TPSPESKSWQAFAEDPKPQQQNTAQSVRTRNGHLNKHTAQSTSGFDSWGFGTESF----- 647
T S ++ SWQ F+++ KP + + ++ T GF+ WGF TESF
Sbjct: 562 TGSSDTNSWQPFSDEAKP---------------VMESASKGTQGFEPWGFETESFRAAAT 606
Query: 648 --TAIPAANSQRSKPITEGNS-SQSIGRSKTTENQPSAQPAGWAGF 690
A A+ +QRS + GNS SQ G SK ENQ +AQPAGWAGF
Sbjct: 607 SAAATSASGTQRS--MGSGNSTSQRYGNSKMRENQKTAQPAGWAGF 650
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|50726471|dbj|BAD34080.1| cyclin G-associated kinase-like protein [Oryza sativa Japonica Group] gi|215704301|dbj|BAG93141.1| unnamed protein product [Oryza sativa Japonica Group] gi|218191079|gb|EEC73506.1| hypothetical protein OsI_07872 [Oryza sativa Indica Group] gi|222623150|gb|EEE57282.1| hypothetical protein OsJ_07336 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 691 bits (1784), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/705 (55%), Positives = 477/705 (67%), Gaps = 53/705 (7%)
Query: 1 MWRFKPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMI 60
MWRF PF K GLEGR+IDVGN+KI VRN IA+GGFSCVY A DA+H SKQYAMKH+I
Sbjct: 1 MWRFNPFGGKVQNGLEGRTIDVGNIKITVRNAIAQGGFSCVYLASDAMHPSKQYAMKHII 60
Query: 61 CNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLEN 120
CND E L+ M+EI VM LKGHPNVVTL AH + D+GRTKEALLVME C+KSLV+ +E+
Sbjct: 61 CNDSELLDLVMEEIQVMNLLKGHPNVVTLVAHDVFDMGRTKEALLVMEFCEKSLVSAMES 120
Query: 121 RGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180
RG GY+EEK+ L I RDVCNAVFAMH QSPPIAHRDLKAEN+LLG DG WKLCDFGSTST
Sbjct: 121 RGTGYYEEKKALLILRDVCNAVFAMHGQSPPIAHRDLKAENVLLGLDGAWKLCDFGSTST 180
Query: 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK 240
NHK F++ EEMGIEED IRKHTTPAYRAPEMWDL+RRE+I+EKVDIWALGCLL+RICYFK
Sbjct: 181 NHKCFDRPEEMGIEEDIIRKHTTPAYRAPEMWDLYRREVISEKVDIWALGCLLYRICYFK 240
Query: 241 NAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVG 300
+AFDGESKLQILNGNYRIPE PKYS++VT LI+DML+ASP+DRPD+TQVWFRVNE LP+
Sbjct: 241 SAFDGESKLQILNGNYRIPEQPKYSAAVTKLIKDMLEASPNDRPDVTQVWFRVNELLPLE 300
Query: 301 LQKSLPDRPPETQS-AVANEGMSKPMNRSPPMPQRSPPPPPSSVDPTRNISQPSTTPAVS 359
LQK+LPD S ++ +EG K R+ MP+R+ P + + +
Sbjct: 301 LQKNLPDGASSGISMSLQDEGAYK---RTHVMPRRN-----PPPPPIEQSNSSLSHGSSK 352
Query: 360 GGGGVLGAFWSTQHAKDSIVAEDQSRSKFYEEPSIYS-TSGHSRSQSDNHPVNPSTVEEE 418
G LGAFW+TQHA+ S VA D S F EEP S +S H++S+ D P
Sbjct: 353 AGDAPLGAFWATQHAQGSQVA-DNRNSLFDEEPIKPSPSSKHNQSRGDISISAPG----- 406
Query: 419 NIQNHAIRRNVHGKSHKPEDG-PSKDIKMNFFQKDTDTRI--ERPKTLKT-ESTATFQDE 474
+ HG+S + G PS + N +T + E +LKT ES + +
Sbjct: 407 ---------DRHGRSGQAVRGTPSNSVSNNGLASGANTNLFMESQSSLKTKESQPKSEKD 457
Query: 475 AFNSFVAEFDTNKLNSAISSNKSEKEEALQNEVERLKGQLKQTNLEKAEITSKFEKLSAI 534
FNSFVA+F+ N L+S +N + KE L+ EV LK QLK+T+ EKAE+T+KFEKLSAI
Sbjct: 458 PFNSFVADFEANNLHSG--TNVASKESELEAEVSNLKEQLKKTSSEKAEMTAKFEKLSAI 515
Query: 535 CRSQRQEIQELKQALAARLPSPNKDAA-INQTSPGNESFATPPREKIEGTIWELKSEW-- 591
CRSQRQEIQELK+ LA P +K ++ + + P +EKIEGT+WEL+
Sbjct: 516 CRSQRQEIQELKRTLAETTPPSSKVSSRLPDSGPQR-------KEKIEGTVWELEQGMLA 568
Query: 592 -GTPSPESKSWQAFAEDPKPQQQNTAQSV-RTRNGHLN-KHTAQSTSGFDSWGFGTESFT 648
PS E+K+WQAF DPK Q V + NG N A S D WGFG +SF
Sbjct: 569 NSLPSSEAKTWQAFP-DPKSQPAQVRPKVDHSTNGAQNLARNANSRQSPDGWGFGPDSFR 627
Query: 649 AIPAAN-SQRSKPITEGNSSQ--SIGRSKTTENQPSAQPAGWAGF 690
P + +Q ++P +G+SSQ S G +K E QP+GWAGF
Sbjct: 628 TSPGSTAAQINRPTAQGSSSQRFSSGAAKKVE-----QPSGWAGF 667
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 690 | ||||||
| TAIR|locus:2046462 | 670 | AT2G32850 [Arabidopsis thalian | 0.730 | 0.752 | 0.608 | 1.1e-158 | |
| DICTYBASE|DDB_G0276461 | 798 | DDB_G0276461 "NAK family prote | 0.933 | 0.807 | 0.279 | 6.4e-60 | |
| UNIPROTKB|J9NX04 | 801 | AAK1 "Uncharacterized protein" | 0.433 | 0.373 | 0.410 | 2.1e-59 | |
| DICTYBASE|DDB_G0280111 | 1126 | DDB_G0280111 "NAK family prote | 0.402 | 0.246 | 0.406 | 4.7e-59 | |
| UNIPROTKB|Q2M2I8 | 961 | AAK1 "AP2-associated protein k | 0.433 | 0.311 | 0.410 | 2.3e-57 | |
| UNIPROTKB|E9PG46 | 674 | AAK1 "AP2-associated protein k | 0.433 | 0.443 | 0.410 | 8.8e-57 | |
| ZFIN|ZDB-GENE-091118-25 | 1055 | aak1 "AP2 associated kinase 1" | 0.389 | 0.254 | 0.407 | 1.7e-56 | |
| UNIPROTKB|I3L548 | 959 | AAK1 "AP2-associated protein k | 0.433 | 0.311 | 0.413 | 5.3e-56 | |
| UNIPROTKB|F1SPM8 | 968 | AAK1 "AP2-associated protein k | 0.433 | 0.308 | 0.413 | 5.8e-56 | |
| UNIPROTKB|E1C584 | 742 | E1C584 "Uncharacterized protei | 0.443 | 0.412 | 0.404 | 6.1e-56 |
| TAIR|locus:2046462 AT2G32850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1546 (549.3 bits), Expect = 1.1e-158, P = 1.1e-158
Identities = 325/534 (60%), Positives = 373/534 (69%)
Query: 1 MWRFKPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMI 60
MW+FKPF QKEP GLEGR +++GNLK+ VRNVIAEGGFS VY A+D H SKQYA+KHMI
Sbjct: 1 MWKFKPFAQKEPAGLEGRFLEIGNLKVQVRNVIAEGGFSSVYLAQDVNHASKQYALKHMI 60
Query: 61 CNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK-EALLVMECCDKSLVNVLE 119
CNDEESLE MKEISV+KSLKGHPNVVTLYAH ILD+GR K EALL M+ C KSLV+VLE
Sbjct: 61 CNDEESLELVMKEISVLKSLKGHPNVVTLYAHGILDMGRNKKEALLAMDFCGKSLVDVLE 120
Query: 120 NRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179
NRGAGYFEEKQ L IFRDVCNAVFAMH QSP IAHRDLKAENLLL SDG WKLCDFGS S
Sbjct: 121 NRGAGYFEEKQALTIFRDVCNAVFAMHCQSPRIAHRDLKAENLLLSSDGQWKLCDFGSVS 180
Query: 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF 239
TNHK FE+ EEMGIEEDNIRK+TTP YRAPEMWDLFRRE+I+EKVDIWALGCLLFRICYF
Sbjct: 181 TNHKIFERAEEMGIEEDNIRKYTTPTYRAPEMWDLFRREMISEKVDIWALGCLLFRICYF 240
Query: 240 KNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPV 299
KNAFDGESKLQILNGNYRIPESPKYS +TDLI++MLQASPD+RPDITQ+WFRVNEQLP
Sbjct: 241 KNAFDGESKLQILNGNYRIPESPKYSVFITDLIKEMLQASPDERPDITQIWFRVNEQLPA 300
Query: 300 GLQKSLPDRPPETQSAVANEGMSKXXXXXXXXXXXXXXXXXXXVDPTRNISQPSTTPAVS 359
LQKSLPDRPPE QS ++G SK P R+ P + S
Sbjct: 301 NLQKSLPDRPPEMQSTGVHDGSSKSATKPSPA-------------PRRSPPPPPPSSGES 347
Query: 360 GGGGVLGAFWSTQHAKDSIVAEDQSRSKFYEEPSIYSTSGHSRSQSDNH-PVNPSTV--E 416
GG LGAFW+TQHAK S+V+ED ++EP+ +TS R + D+H P PS V E
Sbjct: 348 DSGGPLGAFWATQHAKTSVVSEDNKNMPKFDEPNS-NTSKSERVRVDSHQPKKPSPVRGE 406
Query: 417 EENIQ-NHAIRRNVHGKSHKPEDGP-----SKDIKMNFFQKDTDT-RIERPKTLKTESTA 469
IQ N + + K+ P SKD N F D DT + + E
Sbjct: 407 ARGIQRNKDLETTISQKNTTPAAANNMTRVSKDDAFNSFVADFDTTKFDNGNKPGKEEAL 466
Query: 470 TFQDEAFNSFVAEFDTNKLNSAISSNKSEKEEAL-QNEVERLKGQLKQTNLEKA 522
+ + E K A + K EK A+ +++ + L+ LKQT K+
Sbjct: 467 EAEIQRLKD---ELKQTKSEKAEITAKFEKLSAICRSQRQELQ-DLKQTLASKS 516
|
|
| DICTYBASE|DDB_G0276461 DDB_G0276461 "NAK family protein kinase DDB_G0276461" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 614 (221.2 bits), Expect = 6.4e-60, P = 6.4e-60
Identities = 190/680 (27%), Positives = 304/680 (44%)
Query: 14 GLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKE 73
G G+ D+ ++ ++AEGGF VY RD + YA+K M + E LE+ E
Sbjct: 41 GRVGQVYDINGRRVTEVKLVAEGGFGFVYLVRD--DYNNMYALKRMFIQERERLEAMKNE 98
Query: 74 ISVMKSLKGHPNVVTLYAHTILDLGRTKEA--LLVMECCDK-SLVNVLENRGA-GYFEEK 129
I VM+ L+ +PN+V L I + T+E L++ME C S+++++ RG EE+
Sbjct: 99 IDVMQKLRNNPNIVKLEGFKINENRNTRETEVLMLMEYCSGGSVLDIMNARGEFTRLEER 158
Query: 130 QVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS-DGLWKLCDFGSTSTNHKRFEKL 188
++LAIF DVCN V AMH Q PPIAHRDLK EN+L +KLCDFGS++ K F
Sbjct: 159 EILAIFSDVCNGVLAMHQQQPPIAHRDLKIENVLYCEHSNRYKLCDFGSSTI--KTFNTA 216
Query: 189 EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK 248
E G ED+I TT YRAPEM DL+R ++I+EKVD+WALGCLLF++ ++ + FDG S
Sbjct: 217 TERGKAEDDINMFTTLFYRAPEMVDLYRGQIIDEKVDVWALGCLLFKMAFYVDPFDGGS- 275
Query: 249 LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGLQKSLPDR 308
LQI+N NY+IP++ KYS++ LI+ +L A P RP I + +NE + ++ L
Sbjct: 276 LQIINNNYKIPDNSKYSNNFHKLIQFILVADPTQRPSINDLLNYLNE-IRGSSRRGLQTF 334
Query: 309 PPETQSAVANEGMSKXXXXXXXXXXXXXXXXXXXVDPTRNISQPSTTPAVSGGGGVLGAF 368
++ N + P R S ++TP +
Sbjct: 335 SSNNNNSNNNSNNNSNNNSNNNSVNNSSNSINR---PIRTSSSSNSTPNFNSPN-TNNNN 390
Query: 369 WSTQHAKDSIVAEDQSRSKFYEEPSIYSTSGHSRSQSDNHPVNPSTVEEENIQNHAIRRN 428
++ + + + + +I+ G + S ++ N +V NI N++ N
Sbjct: 391 YNNNNNNSKNYGNTPNSTPPNAKKNIFDILGDDTTSSTSNSNNSPSVSRNNINNNSNNFN 450
Query: 429 VHGKSHKPEDGPSKDIKMNFFQKDTDTRIERPKTLKTESTATFQDEAFNSFVAEFDT--N 486
+ ++ + + + N +T+ + + E++ + + + N
Sbjct: 451 NNNNNNNNNNNNNNNNNNNNNNNNTNNNNSNNNNYNNNNNKFDEFESWGNTPLQHPSPSN 510
Query: 487 KLNSAISSNKSEKEEALQNEVERLKGQLKQTNLEKAEITSKFEKLSAICRSQRQEIQELK 546
++ I +N + + QN+ G + E S S
Sbjct: 511 SNSNVIINNTNSSGKNNQNKSNSGNGNFFDNDFEFEGFVSPTTNGSTNFEVNTTNTNVSL 570
Query: 547 QALAARLPSPNKDAAINQTSPGNESFATPPREKIEGTIWELKSEWGTPSPESKSWQAFAE 606
+ S N + N T+ N S + GT L + P+S+ +F
Sbjct: 571 NSSTHSSSSFNNSSNNNNTN--NSSVSVGSSINNSGT--RLMNNSSGSLPQSRQ-SSFNS 625
Query: 607 DPKPQQQNTAQSVRTRNGHLNKHTAQSTSGFDSWGFGTESFTAIPAA-----NSQRSKPI 661
P+ QQQ S T +G N TS F++ T S +I ++ NS S +
Sbjct: 626 TPQQQQQQFNSS--TNSGSYNN----LTSSFNNLNISTSSSASISSSGGVSNNSDNSWNV 679
Query: 662 T---EGNSSQSIGRSKTTEN 678
T ++ S G K N
Sbjct: 680 TLTPSQSNKNSTGNLKPLNN 699
|
|
| UNIPROTKB|J9NX04 AAK1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 563 (203.2 bits), Expect = 2.1e-59, Sum P(3) = 2.1e-59
Identities = 128/312 (41%), Positives = 188/312 (60%)
Query: 13 TGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMK 72
+G GR +G ++ V V+AEGGF+ V+ R + M + A+K M N+E L+ +
Sbjct: 32 SGYIGRVFGIGRQQVTVDEVLAEGGFAIVFLVRTSNGM--KCALKRMFVNNEHDLQVCKR 89
Query: 73 EISVMKSLKGHPNVVTLYAHTILDL--GRTKEALLVMECC-DKSLVNVLENRGAGYFEEK 129
EI +M+ L GH N+V +I ++ G E L++M+ C +VN++ R F E
Sbjct: 90 EIQIMRDLSGHKNIVGYIDSSINNVSSGDVWEVLILMDFCRGGQVVNLMNQRLQTGFTEN 149
Query: 130 QVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLE 189
+VL IF D C AV +H PI HRDLK EN+LL G + LCDFGS +TN + + E
Sbjct: 150 EVLQIFCDTCEAVARLHQCKTPIIHRDLKVENILLHDRGHYVLCDFGS-ATNKFQNPQTE 208
Query: 190 EMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL 249
+ ED I+K+TT +YRAPEM +L+ ++I K DIWALGCLL+++CYF F GES++
Sbjct: 209 GVNAVEDEIKKYTTLSYRAPEMVNLYSGKIITTKADIWALGCLLYKLCYFTLPF-GESQV 267
Query: 250 QILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV-WFR---VNEQLPV-GLQKS 304
I +GN+ IP++ +YS + LIR ML+ PD RPDI QV +F + ++ P+ +Q S
Sbjct: 268 AICDGNFTIPDNSRYSQDMHCLIRYMLEPDPDKRPDIYQVSYFSFKLLKKECPIPNVQNS 327
Query: 305 -LPDRPPETQSA 315
+P + PE A
Sbjct: 328 PIPAKLPEPVKA 339
|
|
| DICTYBASE|DDB_G0280111 DDB_G0280111 "NAK family protein kinase DDB_G0280111" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 578 (208.5 bits), Expect = 4.7e-59, Sum P(3) = 4.7e-59
Identities = 115/283 (40%), Positives = 179/283 (63%)
Query: 16 EGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEIS 75
+G+++ +G+ ++ IAEGGFS V+ +D+ + SK YA+K ++ DE+ L+ EIS
Sbjct: 5 QGKTLKIGSYHLNFVKQIAEGGFSYVFLVKDS-NTSKHYALKRILIRDEDELKGVKHEIS 63
Query: 76 VMKSLKGHPNVVTLYA-HTILDLGRTKEALLVMECCDKSLVNVLENR-GAGY-FEEKQVL 132
+MK L H N+V + H + D T+ +L+ C LV +++ R +G F ++++L
Sbjct: 64 IMKRLTKHKNIVKILDYHKVSDKNNTEMFILMEYCSGGHLVEIMQKRLSSGSKFTDQEIL 123
Query: 133 AIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD-GLWKLCDFGSTSTNHKRFEKLEEM 191
IF+D+C +V MHSQ P I HRDLK EN+LL + G++KLCDFGS + R + EM
Sbjct: 124 KIFQDICESVAYMHSQQPLIIHRDLKVENVLLDEESGIYKLCDFGSATEEITRMKNKTEM 183
Query: 192 GIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI 251
ED+I +HTT YRAPE+ D +R +INEK+DIWALGCLL+++ ++ F+ L I
Sbjct: 184 QNAEDDISRHTTLQYRAPEIVDFYRSPVINEKIDIWALGCLLYKLLFYVTPFEDSGSLGI 243
Query: 252 LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294
LN NY IP + +S+ + LI+ ML P +RP+I ++ ++N
Sbjct: 244 LNSNYTIPPNHTHSNDLISLIKIMLNPDPINRPNIFEITNQLN 286
|
|
| UNIPROTKB|Q2M2I8 AAK1 "AP2-associated protein kinase 1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 563 (203.2 bits), Expect = 2.3e-57, Sum P(3) = 2.3e-57
Identities = 128/312 (41%), Positives = 188/312 (60%)
Query: 13 TGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMK 72
+G GR +G ++ V V+AEGGF+ V+ R + M + A+K M N+E L+ +
Sbjct: 32 SGYIGRVFGIGRQQVTVDEVLAEGGFAIVFLVRTSNGM--KCALKRMFVNNEHDLQVCKR 89
Query: 73 EISVMKSLKGHPNVVTLYAHTILDL--GRTKEALLVMECC-DKSLVNVLENRGAGYFEEK 129
EI +M+ L GH N+V +I ++ G E L++M+ C +VN++ R F E
Sbjct: 90 EIQIMRDLSGHKNIVGYIDSSINNVSSGDVWEVLILMDFCRGGQVVNLMNQRLQTGFTEN 149
Query: 130 QVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLE 189
+VL IF D C AV +H PI HRDLK EN+LL G + LCDFGS +TN + + E
Sbjct: 150 EVLQIFCDTCEAVARLHQCKTPIIHRDLKVENILLHDRGHYVLCDFGS-ATNKFQNPQTE 208
Query: 190 EMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL 249
+ ED I+K+TT +YRAPEM +L+ ++I K DIWALGCLL+++CYF F GES++
Sbjct: 209 GVNAVEDEIKKYTTLSYRAPEMVNLYSGKIITTKADIWALGCLLYKLCYFTLPF-GESQV 267
Query: 250 QILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV-WFR---VNEQLPV-GLQKS 304
I +GN+ IP++ +YS + LIR ML+ PD RPDI QV +F + ++ P+ +Q S
Sbjct: 268 AICDGNFTIPDNSRYSQDMHCLIRYMLEPDPDKRPDIYQVSYFSFKLLKKECPIPNVQNS 327
Query: 305 -LPDRPPETQSA 315
+P + PE A
Sbjct: 328 PIPAKLPEPVKA 339
|
|
| UNIPROTKB|E9PG46 AAK1 "AP2-associated protein kinase 1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 563 (203.2 bits), Expect = 8.8e-57, Sum P(2) = 8.8e-57
Identities = 128/312 (41%), Positives = 188/312 (60%)
Query: 13 TGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMK 72
+G GR +G ++ V V+AEGGF+ V+ R + M + A+K M N+E L+ +
Sbjct: 32 SGYIGRVFGIGRQQVTVDEVLAEGGFAIVFLVRTSNGM--KCALKRMFVNNEHDLQVCKR 89
Query: 73 EISVMKSLKGHPNVVTLYAHTILDL--GRTKEALLVMECC-DKSLVNVLENRGAGYFEEK 129
EI +M+ L GH N+V +I ++ G E L++M+ C +VN++ R F E
Sbjct: 90 EIQIMRDLSGHKNIVGYIDSSINNVSSGDVWEVLILMDFCRGGQVVNLMNQRLQTGFTEN 149
Query: 130 QVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLE 189
+VL IF D C AV +H PI HRDLK EN+LL G + LCDFGS +TN + + E
Sbjct: 150 EVLQIFCDTCEAVARLHQCKTPIIHRDLKVENILLHDRGHYVLCDFGS-ATNKFQNPQTE 208
Query: 190 EMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL 249
+ ED I+K+TT +YRAPEM +L+ ++I K DIWALGCLL+++CYF F GES++
Sbjct: 209 GVNAVEDEIKKYTTLSYRAPEMVNLYSGKIITTKADIWALGCLLYKLCYFTLPF-GESQV 267
Query: 250 QILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV-WFR---VNEQLPV-GLQKS 304
I +GN+ IP++ +YS + LIR ML+ PD RPDI QV +F + ++ P+ +Q S
Sbjct: 268 AICDGNFTIPDNSRYSQDMHCLIRYMLEPDPDKRPDIYQVSYFSFKLLKKECPIPNVQNS 327
Query: 305 -LPDRPPETQSA 315
+P + PE A
Sbjct: 328 PIPAKLPEPVKA 339
|
|
| ZFIN|ZDB-GENE-091118-25 aak1 "AP2 associated kinase 1" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 538 (194.4 bits), Expect = 1.7e-56, Sum P(4) = 1.7e-56
Identities = 114/280 (40%), Positives = 168/280 (60%)
Query: 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISV 76
GR+ VG ++ V +AEGGF+ V+ R + + A+K M N+E L+ +EI +
Sbjct: 37 GRNFTVGRHQVTVEETLAEGGFAIVFLVRT--NQGVRCALKRMYVNNEHDLQVCKREIQI 94
Query: 77 MKSLKGHPNVVTLYAHTILDLGRTK--EALLVMECC-DKSLVNVLENRGAGYFEEKQVLA 133
M+ L GH N+V +I +G E ++M+ C +VN++ R F E++ L
Sbjct: 95 MRDLNGHKNIVGFLDSSITAVGGGDVWEVFILMDFCRGGQVVNLMNQRLQTGFSEQEALQ 154
Query: 134 IFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGI 193
IF D C AV +H PI HRDLK EN+LL G + LCDFGS + +F+ + G+
Sbjct: 155 IFCDTCEAVARLHQYKTPIIHRDLKVENILLHDRGHYVLCDFGSATM---KFQNPQSEGV 211
Query: 194 E--EDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI 251
ED I+K+TT +YRAPEM +L+ ++I K DIWA+GCLL+++C+F F GES++ I
Sbjct: 212 TAVEDEIKKYTTLSYRAPEMVNLYNGKIITTKADIWAMGCLLYKLCFFTLPF-GESQVAI 270
Query: 252 LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291
+GN+ IP++ +YS + LIR ML+ PD RPDI QV F
Sbjct: 271 CDGNFTIPDNSRYSQDMHRLIRYMLEPDPDKRPDIYQVSF 310
|
|
| UNIPROTKB|I3L548 AAK1 "AP2-associated protein kinase 1" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 565 (203.9 bits), Expect = 5.3e-56, Sum P(2) = 5.3e-56
Identities = 129/312 (41%), Positives = 187/312 (59%)
Query: 13 TGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMK 72
+G GR +G ++ V V+AEGGF+ V+ R + M + A+K M N+E L+ +
Sbjct: 32 SGYIGRVFGIGRQQVTVDEVLAEGGFAIVFLVRTSNGM--KCALKRMFVNNEHDLQVCKR 89
Query: 73 EISVMKSLKGHPNVVTLYAHTILDL--GRTKEALLVMECC-DKSLVNVLENRGAGYFEEK 129
EI +M+ L GH N+V +I ++ G E L++M+ C +VN++ R F E
Sbjct: 90 EIQIMRDLSGHKNIVGYIDSSINNVSSGDVWEVLILMDFCRGGQVVNLMNQRLQTGFTES 149
Query: 130 QVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLE 189
+VL IF D C AV +H PI HRDLK EN+LL G + LCDFGS +TN + + E
Sbjct: 150 EVLQIFCDTCEAVARLHQCKTPIIHRDLKVENILLHDRGHYVLCDFGS-ATNKFQNPQTE 208
Query: 190 EMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL 249
+ ED I+K+TT +YRAPEM +L+ ++I K DIWALGCLL+++CYF F GES++
Sbjct: 209 GVNAVEDEIKKYTTLSYRAPEMVNLYSGKIITTKADIWALGCLLYKLCYFTLPF-GESQV 267
Query: 250 QILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF----RVNEQLPV-GLQKS 304
I +GN+ IP++ +YS + LIR ML+ PD RPDI QV F + ++ PV +Q S
Sbjct: 268 AICDGNFTIPDNSRYSQDMHCLIRYMLEPDPDKRPDIYQVSFFSFKLLKKECPVPNVQNS 327
Query: 305 -LPDRPPETQSA 315
+P + PE A
Sbjct: 328 PIPAKLPEPVKA 339
|
|
| UNIPROTKB|F1SPM8 AAK1 "AP2-associated protein kinase 1" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 565 (203.9 bits), Expect = 5.8e-56, Sum P(2) = 5.8e-56
Identities = 129/312 (41%), Positives = 187/312 (59%)
Query: 13 TGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMK 72
+G GR +G ++ V V+AEGGF+ V+ R + M + A+K M N+E L+ +
Sbjct: 32 SGYIGRVFGIGRQQVTVDEVLAEGGFAIVFLVRTSNGM--KCALKRMFVNNEHDLQVCKR 89
Query: 73 EISVMKSLKGHPNVVTLYAHTILDL--GRTKEALLVMECC-DKSLVNVLENRGAGYFEEK 129
EI +M+ L GH N+V +I ++ G E L++M+ C +VN++ R F E
Sbjct: 90 EIQIMRDLSGHKNIVGYIDSSINNVSSGDVWEVLILMDFCRGGQVVNLMNQRLQTGFTES 149
Query: 130 QVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLE 189
+VL IF D C AV +H PI HRDLK EN+LL G + LCDFGS +TN + + E
Sbjct: 150 EVLQIFCDTCEAVARLHQCKTPIIHRDLKVENILLHDRGHYVLCDFGS-ATNKFQNPQTE 208
Query: 190 EMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL 249
+ ED I+K+TT +YRAPEM +L+ ++I K DIWALGCLL+++CYF F GES++
Sbjct: 209 GVNAVEDEIKKYTTLSYRAPEMVNLYSGKIITTKADIWALGCLLYKLCYFTLPF-GESQV 267
Query: 250 QILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF----RVNEQLPV-GLQKS 304
I +GN+ IP++ +YS + LIR ML+ PD RPDI QV F + ++ PV +Q S
Sbjct: 268 AICDGNFTIPDNSRYSQDMHCLIRYMLEPDPDKRPDIYQVSFFSFKLLKKECPVPNVQNS 327
Query: 305 -LPDRPPETQSA 315
+P + PE A
Sbjct: 328 PIPAKLPEPVKA 339
|
|
| UNIPROTKB|E1C584 E1C584 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 6.1e-56, Sum P(2) = 6.1e-56
Identities = 131/324 (40%), Positives = 188/324 (58%)
Query: 13 TGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMK 72
+G GR +G ++ V V+AEGGF+ V+ R M + A+K M N+E L+ +
Sbjct: 32 SGYIGRVFGIGRRQVTVDEVLAEGGFAIVFLVRTNNGM--KCALKRMYVNNEYDLQVCKR 89
Query: 73 EISVMKSLKGHPNVVTLYAHTI--LDLGRTKEALLVMECC-DKSLVNVLENRGAGYFEEK 129
EI +M+ L GH N+V +I + G E L++M+ C +VN++ R F E
Sbjct: 90 EIQIMRDLSGHKNIVGYIDSSINSVSSGDVWEVLILMDFCRGGQVVNLMNQRLQTGFTEN 149
Query: 130 QVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLE 189
+VL IF D C AV +H PI HRDLK EN+LL G + LCDFGS +TN + + E
Sbjct: 150 EVLQIFCDTCEAVARLHQCKTPIIHRDLKVENILLHDRGHYVLCDFGS-ATNKFQNPQTE 208
Query: 190 EMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL 249
+ E+ I+K+TT +YRAPEM +L+ +LI K DIWALGCLL+++CYF F GES++
Sbjct: 209 GVNAVEEEIKKYTTLSYRAPEMVNLYSGKLITTKADIWALGCLLYKLCYFTLPF-GESQV 267
Query: 250 QILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV-WFR---VNEQLPV-GLQKS 304
I +GN+ IP++ ++S + LIR ML+ PD RPDI QV +F ++ PV +Q S
Sbjct: 268 AICDGNFTIPDNSRHSQDMHCLIRYMLEPDPDKRPDIYQVSYFAFKLAKKECPVQNVQNS 327
Query: 305 -----LPDRPPETQSAVANEGMSK 323
LPD P + A A + K
Sbjct: 328 PIPAKLPD-PVKASEAAAKKSQPK 350
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 690 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-57 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-55 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-45 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-35 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-33 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-31 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-31 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-30 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-29 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-29 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-26 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-26 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-25 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-24 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-24 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-24 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-23 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-22 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-22 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-21 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-19 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-16 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-15 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-15 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-14 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-13 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-08 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-08 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-06 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-06 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-04 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-04 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 8e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.001 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.001 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 0.001 | |
| TIGR00934 | 800 | TIGR00934, 2a38euk, potassium uptake protein, Trk | 0.001 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 0.002 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 0.002 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 0.002 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.003 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 0.004 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 2e-57
Identities = 85/280 (30%), Positives = 126/280 (45%), Gaps = 43/280 (15%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC-NDEESLESAMKEISVMKSLKGHPNV 86
+ + EG F VY ARD K A+K + ++ E ++EI ++K LK HPN+
Sbjct: 2 EILEKLGEGSFGKVYLARD-KKTGKLVAIKVIKKKKIKKDRERILREIKILKKLK-HPNI 59
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
V LY D+ ++ L LVME C+ L ++L+ RG E + R + +A+
Sbjct: 60 VRLY-----DVFEDEDKLYLVMEYCEGGDLFDLLKKRG--RLSEDEARFYLRQILSALEY 112
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT-- 202
+HS+ I HRDLK EN+LL DG KL DFG + + T
Sbjct: 113 LHSKG--IVHRDLKPENILLDEDGHVKLADFGLAR-------------QLDPGEKLTTFV 157
Query: 203 -TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL-----QILNGNY 256
TP Y APE + + + VDIW+LG +L+ + K F G+ +L +I
Sbjct: 158 GTPEYMAPE---VLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKP 214
Query: 257 RIPE-SPKYSSSVTDLIRDMLQASPDDRPDITQV----WF 291
P S DLIR +L P+ R + +F
Sbjct: 215 PFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 188 bits (481), Expect = 4e-55
Identities = 88/274 (32%), Positives = 136/274 (49%), Gaps = 38/274 (13%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNV 86
+ I +G F VY R K Y +K + + E+ E A+ E+ ++K L HPN+
Sbjct: 4 IIKQIGKGSFGKVYLVRR-KSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNI 61
Query: 87 VTLYAHTILDLGRTKEALL-VMECCD-KSLVNVLENRGA--GYFEEKQVLAIFRDVCNAV 142
+ Y K L VME D L ++ + F E+Q+L F +C A+
Sbjct: 62 IKYYESFE-----EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 143 FAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT 202
+HS+ I HRD+K +N+ L S+GL KL DFG + K ++ T
Sbjct: 117 KYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGIS----KVLSSTVDLA--------KT 162
Query: 203 ---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK----LQILNGN 255
TP Y +PE+ + + N K DIW+LGC+L+ +C K+ F+GE+ L+IL G
Sbjct: 163 VVGTPYYLSPELC---QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ 219
Query: 256 YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
Y P +YSS + +L+ +LQ P++RP I Q+
Sbjct: 220 YP-PIPSQYSSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 9e-49
Identities = 87/261 (33%), Positives = 119/261 (45%), Gaps = 54/261 (20%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEES-LESAMKEISVMKSLKGHPNVVTLYA 91
+ EGGF VY ARD K+ A+K + D S LE ++EI ++K L HPN+V LY
Sbjct: 1 LGEGGFGTVYLARD-KKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVKLYG 58
Query: 92 HTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSP 150
+ LVME C+ SL ++L+ G E ++L I + + +HS
Sbjct: 59 VFEDE----NHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSN-- 111
Query: 151 PIAHRDLKAENLLLGSD-GLWKLCDFG-STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRA 208
I HRDLK EN+LL SD G KL DFG S + +G TPAY A
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG----------TPAYMA 161
Query: 209 PEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESPKYSSSV 268
PE+ L + +EK DIW+LG +L+ + K
Sbjct: 162 PEV--LLGKGYYSEKSDIWSLGVILYELPELK---------------------------- 191
Query: 269 TDLIRDMLQASPDDRPDITQV 289
DLIR MLQ P+ RP ++
Sbjct: 192 -DLIRKMLQKDPEKRPSAKEI 211
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-45
Identities = 83/279 (29%), Positives = 116/279 (41%), Gaps = 43/279 (15%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEES---LESAMKEISVMKSLKGHPNVVT 88
+ G F VY A+ K A+K + E ++A +EI +++ L HPN+V
Sbjct: 6 KLGSGSFGTVYKAKH-KGTGKIVAVKI-LKKRSEKSKKDQTARREIRILRRLS-HPNIVR 62
Query: 89 LYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH 146
L D K+ L LVME C+ L + L G E + I + + +H
Sbjct: 63 LI-----DAFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLH 115
Query: 147 SQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEM-GIEEDNIRKHTTPA 205
S I HRDLK EN+LL +G+ K+ DFG K L G TP
Sbjct: 116 SNG--IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVG----------TPW 163
Query: 206 YRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL-------QILNGNYRI 258
Y APE+ L KVD+W+LG +L+ + K F GE+ L +IL
Sbjct: 164 YMAPEV--LLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEF 221
Query: 259 PESPKY--SSSVTDLIRDMLQASPDDRPDITQV----WF 291
E S DLI+ L P RP ++ WF
Sbjct: 222 DEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 73/231 (31%), Positives = 118/231 (51%), Gaps = 36/231 (15%)
Query: 73 EISVMKSLKGHPNVVTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLEN--RGAGYFEE 128
E+++++ LK HPN+V Y I+D R+ + L +VME C+ L +++ + Y EE
Sbjct: 49 EVNILRELK-HPNIVRYY-DRIID--RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEE 104
Query: 129 KQVLAIFRDVCNAVFAMHSQSPP---IAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185
+ + I + A++ H++S P + HRDLK N+ L ++ KL DFG
Sbjct: 105 EFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG--------- 155
Query: 186 EKLEEMGIEEDNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNA 242
L ++ + D+ T TP Y +PE +EK DIW+LGCL++ +C
Sbjct: 156 --LAKI-LGHDSSFAKTYVGTPYYMSPE---QLNHMSYDEKSDIWSLGCLIYELCALSPP 209
Query: 243 FDGESKLQ----ILNGNY-RIPESPKYSSSVTDLIRDMLQASPDDRPDITQ 288
F ++LQ I G + RIP +YSS + ++I+ ML PD RP +
Sbjct: 210 FTARNQLQLASKIKEGKFRRIP--YRYSSELNEVIKSMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 85/295 (28%), Positives = 129/295 (43%), Gaps = 65/295 (22%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESL-ESAMKEISVMKSLKGHPNVVTLY 90
+ EG + VY ARD + A+K + + N+EE + +A++EIS++K LK HPN+V L
Sbjct: 7 LGEGTYGVVYKARD-KKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK-HPNIVKL- 63
Query: 91 AHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS 149
LD+ T+ L LV E CD L L+ R + +I + + HS
Sbjct: 64 ----LDVIHTERKLYLVFEYCDMDLKKYLDKRPGP-LSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 150 PPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGIEEDNIRKHT----TP 204
I HRDLK +N+L+ DG+ KL DFG + + +R +T T
Sbjct: 119 --ILHRDLKPQNILINRDGVLKLADFGLARAFGIP--------------LRTYTHEVVTL 162
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL-------QIL----- 252
YRAPE+ L + + VDIW++GC+ + K F G+S++ QIL
Sbjct: 163 WYRAPEI--LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTE 220
Query: 253 ----------NGNYRIPESPK---------YSSSVTDLIRDMLQASPDDRPDITQ 288
+ P+ P DL+ MLQ +P R +
Sbjct: 221 ESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKE 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 75/265 (28%), Positives = 114/265 (43%), Gaps = 32/265 (12%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYA 91
I +GGF VY AR K+ A+K + +E E + EI ++K K HPN+V Y
Sbjct: 7 KIGKGGFGEVYKARHKR-TGKEVAIKVIKLESKEKKEKIINEIQILKKCK-HPNIVKYYG 64
Query: 92 HTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSP 150
+ E +VME C SL ++L++ E Q+ + +++ + +HS
Sbjct: 65 SYLKK----DELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG- 118
Query: 151 PIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT--TPAYRA 208
I HRD+KA N+LL SDG KL DFG + + R TP + A
Sbjct: 119 -IIHRDIKAANILLTSDGEVKLIDFGLS----AQLSDT--------KARNTMVGTPYWMA 165
Query: 209 PEMWDLFRRELINEKVDIWALGCLLF-----RICYFKNAFDGESKLQILNGNYRIPESPK 263
PE+ + + K DIW+LG + Y + NG + K
Sbjct: 166 PEVI---NGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEK 222
Query: 264 YSSSVTDLIRDMLQASPDDRPDITQ 288
+S D ++ LQ +P+ RP Q
Sbjct: 223 WSDEFKDFLKKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 76/275 (27%), Positives = 122/275 (44%), Gaps = 39/275 (14%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICND-----EESLESAMKEISVMKSLKGHPNV 86
+I EG FS V A++ +K+YA+K I + E+ ++ E V+ L GHP +
Sbjct: 8 IIGEGSFSTVVLAKE-KETNKEYAIK--ILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
+ LY +T D +E L V+E L+ + G+ +EK ++ A+
Sbjct: 65 IKLY-YTFQD----EENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEY 117
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS----TSTNHKRFEKLEEMGIEEDNIRK 200
+HS+ I HRDLK EN+LL D K+ DFG+ + K + I+ +
Sbjct: 118 LHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 201 HT-------TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ--- 250
T Y +PE+ + + D+WALGC+++++ K F G ++
Sbjct: 176 RRRFASFVGTAEYVSPEL---LNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ 232
Query: 251 -ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
IL Y P P + DLI +L P DR
Sbjct: 233 KILKLEYSFP--PNFPPDAKDLIEKLLVLDPQDRL 265
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 79/266 (29%), Positives = 128/266 (48%), Gaps = 36/266 (13%)
Query: 35 EGGFSCVYSARDAIHMSKQYAMKHM---ICNDEESLESAMKEISVMKSLKGHPNVVTLYA 91
+G + VY + + ++ YA+K + + +E E A+ EI ++ S+ HPN+++ Y
Sbjct: 10 KGSYGSVYKVK-RLSDNQFYALKEVDLGSMSQKER-EDAVNEIRILASVN-HPNIIS-YK 65
Query: 92 HTILDLGRTKEALLVMECCDKS-LVNVLENRGAGY--FEEKQVLAIFRDVCNAVFAMHSQ 148
LD + +VME L + R E+++ IF + + A+H Q
Sbjct: 66 EAFLDGNKL---CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122
Query: 149 SPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRA 208
I HRDLK+ N+LL ++ L K+ D G + K K ++G TP Y A
Sbjct: 123 K--ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK-TQIG----------TPHYMA 169
Query: 209 PEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES----KLQILNGNY-RIPESPK 263
PE+W + + K DIW+LGCLL+ + F F+ S + ++ G Y IP P
Sbjct: 170 PEVW---KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP--PI 224
Query: 264 YSSSVTDLIRDMLQASPDDRPDITQV 289
YS + + IR MLQ P RP+ ++
Sbjct: 225 YSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-31
Identities = 83/353 (23%), Positives = 129/353 (36%), Gaps = 34/353 (9%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC---NDEESLESAMKEISVMKSLKGHP 84
+ + EG F VY ARD K A+K + + + +E ++EI ++ SL P
Sbjct: 3 RILRKLGEGSFGEVYLARD----RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 85 NVVTLYAHTILDLGRTKEALLVMECCD-KSLVNVLENRG-AGYFEEKQVLAIFRDVCNAV 142
N+V LY + LVME D SL ++L+ G G E + L I + +A+
Sbjct: 59 NIVKLYDFFQDE----GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 143 FAMHSQSPPIAHRDLKAENLLLGSDGLW-KLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH 201
+HS+ I HRD+K EN+LL DG KL DFG + ++
Sbjct: 115 EYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV--- 169
Query: 202 TTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRI--- 258
TP Y APE+ + DIW+LG L+ + F+GE + +I
Sbjct: 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229
Query: 259 ------------PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGLQKSLP 306
S + +DL++ +L P +R + + L
Sbjct: 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLS 289
Query: 307 DRPPETQSAVANEGMSKPMNRSPPMPQRSPPPPPSSVDPTRNISQPSTTPAVS 359
D SA + + N S+ VS
Sbjct: 290 DLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVS 342
|
Length = 384 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 74/233 (31%), Positives = 110/233 (47%), Gaps = 27/233 (11%)
Query: 63 DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENR 121
E+ A+ EI ++ SL HPN++ Y H + D L+ ME + +L + + +
Sbjct: 39 SEKERRDALNEIVIL-SLLQHPNIIAYYNHFMDD----NTLLIEMEYANGGTLYDKIVRQ 93
Query: 122 GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181
FEE+ VL + +AV +H I HRD+K N+ L GL KL DFG +
Sbjct: 94 KGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKIL 151
Query: 182 HKRFEKLEE-MGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK 240
+ E +G TP Y +PE+ + N K DIWALGC+L+ + K
Sbjct: 152 GSEYSMAETVVG----------TPYYMSPEL---CQGVKYNFKSDIWALGCVLYELLTLK 198
Query: 241 NAFDGESKL----QILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
FD + L +I+ GNY P YSS + L+ +LQ P+ RP +V
Sbjct: 199 RTFDATNPLNLVVKIVQGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 78/290 (26%), Positives = 116/290 (40%), Gaps = 64/290 (22%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMI--CNDEESLESAMKEISVMKSLKGH 83
+ ++ G F VY A D + A+K + + EE LE+ +EI ++ SL+ H
Sbjct: 1 EWTRGELLGRGSFGSVYLALD-KDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-H 58
Query: 84 PNVVTLYAHTILDLGRTKEAL-LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNA 141
PN+V Y + K L + +E SL ++L+ G E + R +
Sbjct: 59 PNIVRYYGS---ERDEEKNTLNIFLEYVSGGSLSSLLKKFGK--LPEPVIRKYTRQILEG 113
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH 201
+ +HS I HRD+K N+L+ SDG+ KL DFG + KR IE
Sbjct: 114 LAYLHSNG--IVHRDIKGANILVDSDGVVKLADFG-CA---KRLG-----DIETGEGTGS 162
Query: 202 T--TPAYRAPEMWDLFRRELINEKVDIWALGC--------------------LLFRICYF 239
TP + APE + R E DIW+LGC L++I
Sbjct: 163 VRGTPYWMAPE---VIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI--- 216
Query: 240 KNAFDGESKLQILNGNYRIPESPKY-SSSVTDLIRDMLQASPDDRPDITQ 288
GE PE P++ S D +R L+ P RP +
Sbjct: 217 --GSSGE-----------PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 78/295 (26%), Positives = 120/295 (40%), Gaps = 62/295 (21%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAM--KEISVMKSLKGHPNVVTLY 90
+ +G F VY AR+ + A+K M S E M +E+ ++ L HPN+V L
Sbjct: 7 LGDGTFGSVYLARN-KETGELVAIKKMK-KKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 91 AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSP 150
+ E V E + +L ++++R F E + +I + + +H
Sbjct: 65 -EVFRE---NDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG- 119
Query: 151 PIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT----TPAY 206
HRDLK ENLL+ + K+ DFG + E + +T T Y
Sbjct: 120 -FFHRDLKPENLLVSGPEVVKIADFG--------------LAREIRSRPPYTDYVSTRWY 164
Query: 207 RAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL-------QIL------- 252
RAPE+ L R + VDIWALGC++ + + F G S++ +L
Sbjct: 165 RAPEI--LLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD 222
Query: 253 --NG-------NYRIPES---------PKYSSSVTDLIRDMLQASPDDRPDITQV 289
G +R P+ P S DLI+DML+ P RP +Q
Sbjct: 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQA 277
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 79/265 (29%), Positives = 113/265 (42%), Gaps = 44/265 (16%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHPNVV 87
+ +G F V R K YAMK +I E E + E +++ + HP +V
Sbjct: 1 LGKGSFGKVLLVRK-KDTGKLYAMKVLKKKKIIKRKEV--EHTLTERNILSRIN-HPFIV 56
Query: 88 TLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
L+ +T+E L LV+E L + L G F E++ ++ A+ +
Sbjct: 57 KLHY-AF----QTEEKLYLVLEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYL 109
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT--- 202
HS I +RDLK EN+LL +DG KL DFG K + R +T
Sbjct: 110 HSLG--IIYRDLKPENILLDADGHIKLTDFGLA----KELSS--------EGSRTNTFCG 155
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNYRI 258
TP Y APE+ + + VD W+LG LL+ + K F E + + IL R
Sbjct: 156 TPEYLAPEV---LLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF 212
Query: 259 PESPKYSSSVTDLIRDMLQASPDDR 283
PE S DLI +LQ P R
Sbjct: 213 PEFL--SPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 81/274 (29%), Positives = 130/274 (47%), Gaps = 33/274 (12%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMS----KQYAMKHMICNDEESLESAMKEISVMKSLK 81
+ + I EG F +Y A+ K+ + M ++E+ + KE+ ++ +K
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEA---SKKEVILLAKMK 57
Query: 82 GHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAG-YFEEKQVLAIFRDVCN 140
HPN+VT +A +VME CD + NR G F E Q+L+ F +
Sbjct: 58 -HPNIVTFFA----SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL 112
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDGL-WKLCDFGSTSTNHKRFEKLEEMGIEEDNIR 199
+ +H + I HRD+K++N+ L +G+ KL DFG + E L +
Sbjct: 113 GLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-LAYTCV------ 163
Query: 200 KHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES----KLQILNGN 255
TP Y +PE + + N K DIW+LGC+L+ +C K+ F+G + L+I G
Sbjct: 164 --GTPYYLSPE---ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY 218
Query: 256 YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
+ P SP +S + LI + + SP DRP IT +
Sbjct: 219 FA-PISPNFSRDLRSLISQLFKVSPRDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 83/264 (31%), Positives = 130/264 (49%), Gaps = 28/264 (10%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHM-ICN-DEESLESAMKEISVMKSLKGHPNVVTLY 90
I EG F + KQY +K + I + E + KE++V+ ++K HPN+V Y
Sbjct: 8 IGEGSFGKAILVKSKED-GKQYVIKEINISKMSPKEREESRKEVAVLSNMK-HPNIVQ-Y 64
Query: 91 AHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS 149
+ + G +VM+ C+ L + + F E Q+L F +C A+ +H +
Sbjct: 65 QESFEENGNL---YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121
Query: 150 PPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAP 209
I HRD+K++N+ L DG KL DFG + E L I TP Y +P
Sbjct: 122 --ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-LARTCI--------GTPYYLSP 170
Query: 210 EMWDLFRRELINEKVDIWALGCLLFRICYFKNAFD-GESK---LQILNGNYRIPESPKYS 265
E+ + N K DIWALGC+L+ +C K+AF+ G K L+I+ G+Y P S YS
Sbjct: 171 EICE---NRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP-PVSSHYS 226
Query: 266 SSVTDLIRDMLQASPDDRPDITQV 289
+ +L+ + + +P DRP + +
Sbjct: 227 YDLRNLVSQLFKRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 81/299 (27%), Positives = 125/299 (41%), Gaps = 54/299 (18%)
Query: 10 KEPTGLEGRSIDVGNLKIHVRN--VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESL 67
+E + G+ + +N I EG VY A D K+ A+K M + +
Sbjct: 2 EELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATD-RATGKEVAIKKMRLRKQ-NK 59
Query: 68 ESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYF 126
E + EI +MK K HPN+V Y ++ E +VME D SL +++
Sbjct: 60 ELIINEILIMKDCK-HPNIVDYYDSYLVG----DELWVVMEYMDGGSLTDIITQNFV-RM 113
Query: 127 EEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS----TSTNH 182
E Q+ + R+V + +HSQ + HRD+K++N+LL DG KL DFG T
Sbjct: 114 NEPQIAYVCREVLQGLEYLHSQ--NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171
Query: 183 KRFEKLEEMGIEEDNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC-- 237
KR ++ TP + APE + +R+ KVDIW+LG + +
Sbjct: 172 KR----------------NSVVGTPYWMAPE---VIKRKDYGPKVDIWSLGIMCIEMAEG 212
Query: 238 ---YFKNAFDGESKLQIL-----NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQ 288
Y + E L+ L G + K+S D + L P+ RP +
Sbjct: 213 EPPYLR-----EPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEE 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 80/273 (29%), Positives = 126/273 (46%), Gaps = 44/273 (16%)
Query: 32 VIAEGGFSCVYSAR----DAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVV 87
V+ G F V+ R + + KQ ++ M DE +A E V+K L HPN++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDER--LAAQNECQVLKLLS-HPNII 62
Query: 88 TLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH 146
Y + + D K ++VME +L ++ R +E +L F + A+ +H
Sbjct: 63 EYYENFLED----KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118
Query: 147 SQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---- 202
++ I HRDLK +N+LL HK K+ + GI + K
Sbjct: 119 TKL--ILHRDLKTQNILL---------------DKHKMVVKIGDFGISKILSSKSKAYTV 161
Query: 203 --TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES----KLQILNGNY 256
TP Y +PE L + N+K DIWALGC+L+ + K AF+ + L+I++G +
Sbjct: 162 VGTPCYISPE---LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF 218
Query: 257 RIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
P S +YS + LI ML P RP ++Q+
Sbjct: 219 A-PISDRYSPDLRQLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 80/286 (27%), Positives = 128/286 (44%), Gaps = 46/286 (16%)
Query: 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISV 76
+GN KI + I +G FS VY A + + A+K M+ D ++ + +KEI +
Sbjct: 1 LGNFKIEKK--IGKGQFSVVYKAICLLD-GRVVALKKVQIFEMM--DAKARQDCLKEIDL 55
Query: 77 MKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCD----KSLVNVLENRGAGYFEEKQVL 132
+K L HPNV+ A I + E +V+E D ++ + + E+ +
Sbjct: 56 LKQLD-HPNVIKYLASFIEN----NELNIVLELADAGDLSRMIKHFKKQKR-LIPERTIW 109
Query: 133 AIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMG 192
F +C+A+ MHS+ I HRD+K N+ + + G+ KL D G RF
Sbjct: 110 KYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGL-----GRF------- 155
Query: 193 IEEDNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK- 248
H+ TP Y +PE N K DIW+LGCLL+ + ++ F G+
Sbjct: 156 FSSKTTAAHSLVGTPYYMSPE---RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 212
Query: 249 -----LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
+I +Y + YS + DL+ + P+ RPDI+ V
Sbjct: 213 LYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 76/282 (26%), Positives = 118/282 (41%), Gaps = 48/282 (17%)
Query: 31 NVIAEGGFSCVYSA--RDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNV 86
+ EG F VY + + + A+K + D EE + +KE VMK L GHPNV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVK-TLKEDASEEERKDFLKEARVMKKL-GHPNV 58
Query: 87 VTLYAHTILDLGRTKEALLVMECCDK-SLVNVL-ENRGAGYFEE------KQVLAIFRDV 138
V L + + LV+E + L++ L ++R E K +L+ +
Sbjct: 59 VRLLGVCTEE----EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 139 CNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNI 198
+ + S+ HRDL A N L+G D + K+ DFG L ++D
Sbjct: 115 AKGMEYLASK--KFVHRDLAARNCLVGEDLVVKISDFG-----------LSRDVYDDDYY 161
Query: 199 RKHTT---PAYR--APEMWDLFRRELINEKVDIWALGCLLFRIC------YFKNAFDGES 247
RK T P R APE + + K D+W+ G LL+ I Y E
Sbjct: 162 RKKTGGKLPI-RWMAPES---LKDGIFTSKSDVWSFGVLLWEIFTLGATPY--PGLSNEE 215
Query: 248 KLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
L+ L YR+P+ + +L+ Q P+DRP +++
Sbjct: 216 VLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 74/272 (27%), Positives = 119/272 (43%), Gaps = 37/272 (13%)
Query: 36 GGFSCVYSARDAIHMSKQYAMKHMICND----------EESLESAMKEISVMKSLKGHPN 85
G F CVY R + A+K + ++ ++S+ + E++++K HPN
Sbjct: 11 GAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPN 70
Query: 86 VVTLYAHTILDLGRTKEALLVMECCD----KSLVNVLENRGAGYFEEKQVLAIFRDVCNA 141
+V Y T L+ R +VM+ + N L+ + F E+++ IF + A
Sbjct: 71 IVR-YYKTFLENDRL---YIVMDLIEGAPLGEHFNSLKEKK-QRFTEERIWNIFVQMVLA 125
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH 201
+ +H + I HRDL N++LG D + DFG + + KL
Sbjct: 126 LRYLHKEKR-IVHRDLTPNNIMLGEDDKVTITDFG-LAKQKQPESKLTS---------VV 174
Query: 202 TTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL----QILNGNYR 257
T Y PE + + E EK D+WA GC+L+++C + F + L +I+ Y
Sbjct: 175 GTILYSCPE---IVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231
Query: 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
YS VTD+I L + RPDI QV
Sbjct: 232 PLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 74/292 (25%), Positives = 127/292 (43%), Gaps = 64/292 (21%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGH 83
+ ++I G F VY + + A+K + EE+L+S M+EI ++K+LK H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLN-LETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK-H 58
Query: 84 PNVVTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNA 141
PN+V T ++L +++E + SL +++ G F E V V
Sbjct: 59 PNIVKYIGSI-----ETSDSLYIILEYAENGSLRQIIKKFGP--FPESLVAVYVYQVLQG 111
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH 201
+ +H Q + HRD+KA N+L DG+ KL DFG + KL ++ ++ ++
Sbjct: 112 LAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVAT-------KLNDVSKDDASVV-- 160
Query: 202 TTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN------ 255
TP + APE+ ++ + DIW+LGC + +++L GN
Sbjct: 161 GTPYWMAPEVIEM---SGASTASDIWSLGCTV---------------IELLTGNPPYYDL 202
Query: 256 ------YRI--PESPKYSSSVTDLIRDML----QASPDDRPDITQ----VWF 291
+RI + P ++ ++D L Q P+ RP Q W
Sbjct: 203 NPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 78/281 (27%), Positives = 126/281 (44%), Gaps = 35/281 (12%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLE--SAMKEISVMKSLKGHPNVVTLY 90
I EG FS V A+ K YA+K M +SLE + ++EI ++ L HPN++ L
Sbjct: 7 IGEGTFSEVLKAQS-RKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRL- 63
Query: 91 AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSP 150
+L +T LV E D +L +++ R EK+V + + ++ MH
Sbjct: 64 -IEVLFDRKTGRLALVFELMDMNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNG- 120
Query: 151 PIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPE 210
I HRD+K EN+L+ D L KL DFGS + + E + +T YRAPE
Sbjct: 121 -IFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTEYI----------STRWYRAPE 168
Query: 211 MWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESPKYSSSVTD 270
L K+DIWA+GC+ F I F G ++L + + + +P +
Sbjct: 169 C--LLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTP-----DAE 221
Query: 271 LIRDMLQASPDDRPDITQVWFRVNEQLPVGLQKSLPDRPPE 311
+++ ++ + + + GL+K LP+ E
Sbjct: 222 VLKKFRKS--------RHMNYNFPSKKGTGLRKLLPNASAE 254
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 76/273 (27%), Positives = 118/273 (43%), Gaps = 38/273 (13%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLE--SAMKEISVMKSLKGHPNV 86
+ N I +G F V+ + YAMK + + E A+ E V+ L +
Sbjct: 4 ILNKIGKGSFGVVFKVVRKAD-KRVYAMKQIDLSKMNRREREEAIDEARVLAKLD-SSYI 61
Query: 87 VTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
+ Y + LD G+ +VME + L +L+ + E QV F + + +
Sbjct: 62 IRYY-ESFLDKGKLN---IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL 117
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-----STSTNHKRFEKLEEMGIEEDNIRK 200
HS+ I HRD+K+ NL L + K+ D G S +TN +G
Sbjct: 118 HSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN----TIVG-------- 163
Query: 201 HTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK----LQILNGNY 256
TP Y +PE+ + + NEK D+WALG +L+ C K+ FD ++ L+I+ G +
Sbjct: 164 --TPYYLSPELCE---DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF 218
Query: 257 RIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
P S YS + LI L RPD Q+
Sbjct: 219 P-PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQL 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 70/231 (30%), Positives = 114/231 (49%), Gaps = 32/231 (13%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE-ESLE-SAMKEISVMKSLKGHPNVVT 88
N I EG + VY ARD + A+K + ++E + + S+++EI+++ +L+ HPN+V
Sbjct: 13 NRIGEGTYGIVYRARDTT-SGEIVALKKVRMDNERDGIPISSLREITLLLNLR-HPNIVE 70
Query: 89 LYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
L ++ G+ +++ LVME C++ L ++L+N F E QV + + + +H
Sbjct: 71 L-KEVVV--GKHLDSIFLVMEYCEQDLASLLDNMPTP-FSESQVKCLMLQLLRGLQYLHE 126
Query: 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPA-- 205
I HRDLK NLLL G K+ DFG T K TP
Sbjct: 127 NF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYG--------------LPAKPMTPKVV 170
Query: 206 ---YRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN 253
YRAPE+ L +D+WA+GC+L + K G+S+++ L+
Sbjct: 171 TLWYRAPEL--LLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 66/237 (27%), Positives = 103/237 (43%), Gaps = 33/237 (13%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLESAM-KEISVMKSLK--GH 83
I EG + VY ARD + A+K + + EE + + +EI+++K L+ H
Sbjct: 2 EELAEIGEGAYGTVYKARDLNT-GRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 84 PNVVTLY--AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNA 141
PN+V L H R + LV E D+ L L + + + R +
Sbjct: 61 PNIVRLLDVCHGP-RTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH 201
V +HS I HRDLK +N+L+ SDG K+ DFG + + EM +
Sbjct: 120 VDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLA----RIYS--FEMAL-------- 163
Query: 202 TTPA-----YRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN 253
T YRAPE+ L + VD+W++GC+ + + F G S+ L+
Sbjct: 164 -TSVVVTLWYRAPEV--LLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 80/286 (27%), Positives = 124/286 (43%), Gaps = 41/286 (14%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESL-ESAMKEISVMKSLKGHPNVVTLY 90
I EG V+ A+D + A+K + + E + A++EI +++ + HP VV L
Sbjct: 8 IGEGAHGIVFKAKD-RETGETVALKKVALRRLEGGIPNQALREIKALQACQ-HPYVVKLL 65
Query: 91 AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSP 150
G +LVME L VL + E QV + R + V MH+
Sbjct: 66 DVFPHGSG----FVLVMEYMPSDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMHANG- 119
Query: 151 PIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH--TTPAYRA 208
I HRDLK NLL+ +DG+ K+ DFG EE + H T YRA
Sbjct: 120 -IMHRDLKPANLLISADGVLKIADFGLARL----------FSEEEPRLYSHQVATRWYRA 168
Query: 209 PEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESPKYSS-- 266
PE+ L+ + VD+WA+GC+ + F GE+ ++ L +R +P +
Sbjct: 169 PEL--LYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWP 226
Query: 267 SVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGLQKSLPDRPPET 312
+T L PD ++ F ++ P+ L++ PD PE
Sbjct: 227 GLTSL------------PDYNKITFPESK--PIPLEEIFPDASPEA 258
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 78/287 (27%), Positives = 125/287 (43%), Gaps = 46/287 (16%)
Query: 33 IAEGGFSCVYSARDAIHMSKQ-YAMKHMICNDEESLE--SAMKEISVMKSLKGHPNVVTL 89
I EG + VY ARD ++ + A+K + E +A++EI ++K L HPN++ L
Sbjct: 7 IGEGTYGVVYKARDK--LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN-HPNIIKL 63
Query: 90 YAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQ 148
LD+ R K L LV E D L ++++R G E + + + + HS
Sbjct: 64 -----LDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHSH 117
Query: 149 SPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRA 208
I HRDLK ENLL+ ++G+ KL DFG + T YRA
Sbjct: 118 G--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH---------YVVTRWYRA 166
Query: 209 PEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESPKYSSSV 268
PE+ L + + VDIW++GC+ + + F G+S++ L +R +P
Sbjct: 167 PEL--LLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPD----- 219
Query: 269 TDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLPDRPPE 311
P+ P T + F ++ + L K P+ P+
Sbjct: 220 -----------PEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQ 255
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 70/272 (25%), Positives = 123/272 (45%), Gaps = 36/272 (13%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEE--SLESAMKEISVMKSLKGHPN 85
N I G F VY+A + + + A+K + D + +++ E+ V++ LK HPN
Sbjct: 3 QRGNKIGGGTFGKVYTAVN-LDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-HPN 60
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIF-RDVCNAVF 143
+V Y +++ R K + ME C +L +LE+ G ++ V+ ++ + +
Sbjct: 61 LVKYYG---VEVHREK-VYIFMEYCSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLA 113
Query: 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT- 202
+HS I HRD+K N+ L +G+ KL DFG + E +
Sbjct: 114 YLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV-------QSLA 164
Query: 203 -TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDG-ESKLQILNGNYR--- 257
TPAY APE+ + + DIW+LGC++ + K + +++ QI+ +
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM---FHVGA 221
Query: 258 -----IPESPKYSSSVTDLIRDMLQASPDDRP 284
IP+S + S D + L++ P RP
Sbjct: 222 GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 78/264 (29%), Positives = 118/264 (44%), Gaps = 28/264 (10%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTL 89
I++G + V+ A+ YA+K + D + ++ + E ++ + P VV L
Sbjct: 1 ISKGAYGRVFLAKKKS-TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKL 58
Query: 90 YAHTILDLGRTKEAL-LVMECC---DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
Y K+ L LVME D L ++LEN G +E ++ A+ +
Sbjct: 59 YYSFQ-----GKKNLYLVMEYLPGGD--LASLLEN--VGSLDEDVARIYIAEIVLALEYL 109
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPA 205
HS I HRDLK +N+L+ S+G KL DFG + R + +ED R TP
Sbjct: 110 HSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK-RIVGTPD 166
Query: 206 YRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK----LQILNGNYRIPES 261
Y APE + + ++ VD W+LGC+L+ F GE+ ILNG PE
Sbjct: 167 YIAPE---VILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED 223
Query: 262 PKYSSSVTDLIRDMLQASPDDRPD 285
+ S DLI +L P+ R
Sbjct: 224 VEVSDEAIDLISKLLVPDPEKRLG 247
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 71/271 (26%), Positives = 112/271 (41%), Gaps = 45/271 (16%)
Query: 32 VIAEGGFSCVYSARDAIHMS--KQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTL 89
+ EG + VY A IH + A+K + EE L+ +KEIS++K P +V
Sbjct: 10 KLGEGSYGSVYKA---IHKETGQVVAIK--VVPVEEDLQEIIKEISILKQCD-SPYIVKY 63
Query: 90 YAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS 149
Y + + +VME C V+ + E+++ AI + +HS
Sbjct: 64 YGSYFKN----TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 150 PPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRA 208
HRD+KA N+LL +G KL DFG S ++ +G TP + A
Sbjct: 120 --KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIG----------TPFWMA 167
Query: 209 PEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGE---SKLQILNGNYRIPESP--- 262
PE + + N K DIW+LG + +G+ S + + + IP P
Sbjct: 168 PE---VIQEIGYNNKADIWSLGITAIEM------AEGKPPYSDIHPMRAIFMIPNKPPPT 218
Query: 263 -----KYSSSVTDLIRDMLQASPDDRPDITQ 288
K+S D ++ L P++RP Q
Sbjct: 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 1e-22
Identities = 80/276 (28%), Positives = 130/276 (47%), Gaps = 33/276 (11%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMS--KQYAMKHM-ICNDEESLESAMKEISVMKSLKG 82
+ +V V+ EG F A H++ ++YAMK + + ++E + KE ++ +K
Sbjct: 1 QYNVLRVVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK- 56
Query: 83 HPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNA 141
HPN+V + + G +VME CD L+ ++ + F E +L F +C
Sbjct: 57 HPNIVA-FKESFEADGHL---YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG 112
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST-NHKRFEKLEEMGIEEDNIRK 200
V +H + + HRD+K++N+ L +G KL DFGS +G
Sbjct: 113 VQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVG-------- 162
Query: 201 HTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES----KLQILNGNY 256
TP Y PE+W+ N K DIW+LGC+L+ +C K+ F S L++ G+Y
Sbjct: 163 --TPYYVPPEIWENMP---YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY 217
Query: 257 RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292
+ P YS + LI+ M + +P RP T + R
Sbjct: 218 K-PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 78/268 (29%), Positives = 120/268 (44%), Gaps = 36/268 (13%)
Query: 35 EGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTI 94
+G F VY A+ A K + EE LE M EI ++ K HPN+V LY
Sbjct: 15 DGAFGKVYKAQHK-ETGLFAAAKIIQIESEEELEDFMVEIDILSECK-HPNIVGLYEAYF 72
Query: 95 LDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAH 154
+ K +L+ C +L +++ G E Q+ + R + A+ +HS + H
Sbjct: 73 YE---NKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSHK--VIH 126
Query: 155 RDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---TPAYRAPE- 210
RDLKA N+LL DG KL DFG ++ N +K + T TP + APE
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK------------RDTFIGTPYWMAPEV 174
Query: 211 -MWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESP------- 262
+ F+ + K DIW+LG L + + + +++L +I +S
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL---LKILKSEPPTLDQP 231
Query: 263 -KYSSSVTDLIRDMLQASPDDRPDITQV 289
K+SSS D ++ L PDDRP ++
Sbjct: 232 SKWSSSFNDFLKSCLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 74/298 (24%), Positives = 120/298 (40%), Gaps = 64/298 (21%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLE----SAMKEISVMKSLKGHPNVVT 88
I EG + VY AR+ + A+K + +E+ E +A++EI +++ L+ HPN+V
Sbjct: 7 IGEGTYGQVYKARNKKTG-ELVALKKIRMENEK--EGFPITAIREIKLLQKLR-HPNIVR 62
Query: 89 LYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQ 148
L I+ +V E D L +L++ F E Q+ + + + +HS
Sbjct: 63 L--KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV-KFTESQIKCYMKQLLEGLQYLHSN 119
Query: 149 SPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT----TP 204
I HRD+K N+L+ +DG+ KL DFG R + N +T T
Sbjct: 120 G--ILHRDIKGSNILINNDGVLKLADFGLA-----RP-------YTKRNSADYTNRVITL 165
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN----------- 253
YR PE+ L +VD+W++GC+L + K F G ++L+ L
Sbjct: 166 WYRPPEL--LLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD 223
Query: 254 ------------GNYRIPESPK----------YSSSVTDLIRDMLQASPDDRPDITQV 289
N + + K S DL+ +L P R Q
Sbjct: 224 ENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 64/279 (22%), Positives = 111/279 (39%), Gaps = 41/279 (14%)
Query: 27 IHVRNVIAEGGFSCVYSAR-DAIHMSKQY--AMKHMICND--EESLESAMKEISVMKSLK 81
+ + + EG F VY K+ A+K + D E+ +E ++E +M+ L
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVK-TLKEDASEQQIEEFLREARIMRKLD 59
Query: 82 GHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCN 140
HPN+V L + + ++VME L++ L +L+ +
Sbjct: 60 -HPNIVKLLGVCTEE----EPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR 114
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG------STSTNHKRFEKLEEMGIE 194
+ + S+ HRDL A N L+G + + K+ DFG + KL
Sbjct: 115 GMEYLESK--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL------ 166
Query: 195 EDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF-KNAFDGESKLQILN 253
IR + APE + K D+W+ G LL+ I + + G S ++L
Sbjct: 167 --PIR------WMAPESLKEGK---FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLE 215
Query: 254 ---GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
YR+P+ P + L+ P+DRP +++
Sbjct: 216 YLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 68/239 (28%), Positives = 112/239 (46%), Gaps = 44/239 (18%)
Query: 32 VIAEGGFSCVYSARD-------AIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHP 84
V+ EG + V R+ AI K++ +DE+ ++A++E+ V++ L+ H
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAI---KKFKESE---DDEDVKKTALREVKVLRQLR-HE 60
Query: 85 NVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143
N+V L + R K L LV E +++L+ +LE G + I++ + A+
Sbjct: 61 NIVNL-----KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ-LLQAIA 114
Query: 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT- 202
HS + I HRD+K EN+L+ G+ KLCDFG F + + T
Sbjct: 115 YCHSHN--IIHRDIKPENILVSESGVLKLCDFG--------FARA----LRARPASPLTD 160
Query: 203 ---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRI 258
T YRAPE+ L + VD+WA+GC++ + + F G+S + L Y I
Sbjct: 161 YVATRWYRAPEL--LVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL---YLI 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 1e-21
Identities = 68/274 (24%), Positives = 112/274 (40%), Gaps = 42/274 (15%)
Query: 32 VIAEGGFSCVYSAR-DAIHMSKQY--AMKHMICND--EESLESAMKEISVMKSLKGHPNV 86
+ EG F VY + K+ A+K + D E+ +E ++E +M+ L HPNV
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVK-TLKEDASEQQIEEFLREARIMRKLD-HPNV 63
Query: 87 VTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
V L + + +VME + L++ L +L+ + + +
Sbjct: 64 VKLLGVCTEE----EPLYIVMEYMEGGDLLSYLRKNR-PKLSLSDLLSFALQIARGMEYL 118
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFG------STSTNHKRFEKLEEMGIEEDNIR 199
S+ HRDL A N L+G + + K+ DFG KR KL IR
Sbjct: 119 ESK--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--------PIR 168
Query: 200 KHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF-KNAFDGESKLQILNG---N 255
+ APE + K D+W+ G LL+ I + + G S ++L
Sbjct: 169 ------WMAPESLKEGK---FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG 219
Query: 256 YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
YR+P+ P + DL+ P+DRP +++
Sbjct: 220 YRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSEL 253
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 72/283 (25%), Positives = 117/283 (41%), Gaps = 53/283 (18%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYA 91
VI EG + VY AR + A+K ++ E+ E +E ++++ HPN+ T Y
Sbjct: 13 VIGEGTYGKVYKARHK-KTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 92 HTIL--DLGRTKEALLVMECCD----KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
I G + LVME C LV L +G +E+ + I R+ + +
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG-KRLKEEWIAYILRETLRGLAYL 129
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFG----STSTNHKRFEKLEEMGIEEDNIRKH 201
H + HRD+K +N+LL + KL DFG ST +R +
Sbjct: 130 HENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR----------------N 171
Query: 202 T---TPAYRAPE--MWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGE---SKLQILN 253
T TP + APE D + + D+W+LG I + A DG+ + +
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG-----ITAIELA-DGKPPLCDMHPMR 225
Query: 254 GNYRIPESP--------KYSSSVTDLIRDMLQASPDDRPDITQ 288
++IP +P +S D I + L + + RP + +
Sbjct: 226 ALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEE 268
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (233), Expect = 3e-21
Identities = 66/283 (23%), Positives = 107/283 (37%), Gaps = 49/283 (17%)
Query: 27 IHVRNVIAEGGFSCVYSAR-----------DAIHMSKQYAMKHMICNDEESLESAMKEIS 75
+ + + EG F VY A+ K+ A EE E ++E S
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGAS-------EEEREEFLEEAS 53
Query: 76 VMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAI 134
+MK L HPN+V L + +V E L++ L G K +L +
Sbjct: 54 IMKKLS-HPNIVRLLGVCTQG----EPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQM 107
Query: 135 FRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIE 194
+ + + S+ HRDL A N L+ + + K+ DFG L E
Sbjct: 108 ALQIAKGMEYLESK--NFVHRDLAARNCLVTENLVVKISDFG-----------LSRDIYE 154
Query: 195 EDNIRKHTT----PAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF-KNAFDGESKL 249
+D RK + APE + K D+W+ G LL+ I + + G S
Sbjct: 155 DDYYRKRGGGKLPIKWMAPESLK-DGK--FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE 211
Query: 250 QILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
++L YR+P + +L+ P+DRP +++
Sbjct: 212 EVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSEL 254
|
Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 71/271 (26%), Positives = 118/271 (43%), Gaps = 34/271 (12%)
Query: 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHM---ICNDEESLESAMKEISVMKSLKGHPNV 86
VI G + VY+A + +++ A+K + C S++ KE+ M S HPNV
Sbjct: 6 IEVIGVGATAVVYAAI-CLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAM-SQCNHPNV 61
Query: 87 VTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENR-GAGYFEEKQVLAIFRDVCNAVFA 144
V Y ++ E LVM SL++++++ G +E + + ++V +
Sbjct: 62 VKYYTSFVVG----DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT-- 202
+HS HRD+KA N+LLG DG K+ DFG +++ L + G +RK
Sbjct: 118 LHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSAS-------LADGGDRTRKVRKTFVG 168
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY----FKNAFDGESKLQILNGNY-R 257
TP + APE+ + + + K DIW+ G + + + + L +
Sbjct: 169 TPCWMAPEV--MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPS 226
Query: 258 IPE---SPKYSSSVTDLIRDMLQASPDDRPD 285
+ KYS S +I LQ P RP
Sbjct: 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 9e-21
Identities = 80/292 (27%), Positives = 125/292 (42%), Gaps = 57/292 (19%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESL--ESAMKEISVMKSLKGHPNVVTLY 90
I EG + V+ R+ + A+K + ++++ + + A++EI ++K LK HPN+V L
Sbjct: 9 IGEGSYGVVFKCRN-RETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK-HPNLVNL- 65
Query: 91 AHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS 149
+++ R K L LV E CD +++N LE G E + I AV H +
Sbjct: 66 ----IEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 150 PPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAP 209
HRD+K EN+L+ G KLCDFG F ++ G +D T YRAP
Sbjct: 121 --CIHRDVKPENILITKQGQIKLCDFG--------FARILT-GPGDDYTDYVATRWYRAP 169
Query: 210 EMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL------------------QI 251
E+ L VD+WA+GC+ + + + G+S + QI
Sbjct: 170 EL--LVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227
Query: 252 LNGN-----YRIPES----------PKYSSSVTDLIRDMLQASPDDRPDITQ 288
+ N IPE P SS ++ LQ P +R +
Sbjct: 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEE 279
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 6e-20
Identities = 82/320 (25%), Positives = 130/320 (40%), Gaps = 83/320 (25%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLE-----SAMKEISVMKSLKGHPNVV 87
+ EG ++ VY ARD + A+K + + + + +A++EI +++ LK HPN++
Sbjct: 8 LGEGTYAVVYKARDK-ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNII 65
Query: 88 TLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH 146
L LD+ K + LV E + L V++++ + + + + +H
Sbjct: 66 GL-----LDVFGHKSNINLVFEFMETDLEKVIKDK-SIVLTPADIKSYMLMTLRGLEYLH 119
Query: 147 SQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---- 202
S I HRDLK NLL+ SDG+ KL DFG + F RK T
Sbjct: 120 SNW--ILHRDLKPNNLLIASDGVLKLADFGLA----RSFG---------SPNRKMTHQVV 164
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGC----LLFRICYFKNAFDGESKLQILN----- 253
T YRAPE+ LF VD+W++GC LL R+ + G+S + L
Sbjct: 165 TRWYRAPEL--LFGARHYGVGVDMWSVGCIFAELLLRVPF----LPGDSDIDQLGKIFEA 218
Query: 254 ----------GNYRIP------ESPKY---------SSSVTDLIRDMLQASPDDRPDITQ 288
G +P P S DL++ +L +P+ R Q
Sbjct: 219 LGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ 278
Query: 289 V----WFRVN------EQLP 298
+F + QLP
Sbjct: 279 ALEHPYFSNDPAPTPPSQLP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 7e-20
Identities = 71/250 (28%), Positives = 113/250 (45%), Gaps = 34/250 (13%)
Query: 51 SKQYAMKHMICNDEESLE--SAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVME 108
KQY +K + + E +A +E ++ LK HPN+V Y + G +VM
Sbjct: 25 GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK-HPNIVA-YRESWE--GEDGLLYIVMG 80
Query: 109 CCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD 167
C+ L + L+ + E QV+ F + A+ +H + I HRDLK +N+ L
Sbjct: 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRT 138
Query: 168 GLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---TPAYRAPEMWDLFRRELINEKV 224
+ K+ D G +E T TP Y +PE LF + N K
Sbjct: 139 NIIKVGDLGIARV------------LENQCDMASTLIGTPYYMSPE---LFSNKPYNYKS 183
Query: 225 DIWALGCLLFRICYFKNAFDGESK----LQILNGNYRIPESPK-YSSSVTDLIRDMLQAS 279
D+WALGC ++ + K+AF+ + +I+ G ++P PK YS + +LI ML
Sbjct: 184 DVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG--KLPPMPKDYSPELGELIATMLSKR 241
Query: 280 PDDRPDITQV 289
P+ RP + +
Sbjct: 242 PEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 8e-20
Identities = 80/253 (31%), Positives = 113/253 (44%), Gaps = 54/253 (21%)
Query: 70 AMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEE 128
AM+EI ++K L+ H N+V L +++ R K+ L LV E D ++++ LE G +E
Sbjct: 47 AMREIRMLKQLR-HENLVNL-----IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDE 99
Query: 129 KQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL 188
+V + + HS + I HRD+K EN+L+ G+ KLCDFG T L
Sbjct: 100 SRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFART-------L 150
Query: 189 EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK 248
G E T YRAPE+ L VDIWA+GCL+ + + F G+S
Sbjct: 151 AAPG--EVYTDYVATRWYRAPEL--LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD 206
Query: 249 LQILN------GNY-----------------RIPES----------PKYSSSVTDLIRDM 275
+ L GN R+PE PK S V DL +
Sbjct: 207 IDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQC 266
Query: 276 LQASPDDRPDITQ 288
L+ PDDRP +Q
Sbjct: 267 LRIDPDDRPSSSQ 279
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 69/270 (25%), Positives = 116/270 (42%), Gaps = 51/270 (18%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEES---LESAMKEISVMKSLKGHPNVVT 88
I +G F VY A D ++ A+K + + EE+ +E +EI + + P +
Sbjct: 8 CIGKGSFGEVYKAID-KRTNQVVAIK--VIDLEEAEDEIEDIQQEIQFLSQCRS-PYITK 63
Query: 89 LYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
Y L +K + +ME C S +++L+ G +E + I R+V + +H
Sbjct: 64 YYGSF---LKGSKLWI-IMEYCGGGSCLDLLK---PGKLDETYIAFILREVLLGLEYLHE 116
Query: 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---TP 204
+ HRD+KA N+LL +G KL DFG + + +++T TP
Sbjct: 117 EGK--IHRDIKAANILLSEEGDVKLADFGVSGQ------------LTSTMSKRNTFVGTP 162
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGE---SKLQILNGNYRIPES 261
+ APE + ++ +EK DIW+LG + GE S L + + IP++
Sbjct: 163 FWMAPE---VIKQSGYDEKADIWSLGITAIEL------AKGEPPLSDLHPMRVLFLIPKN 213
Query: 262 P-------KYSSSVTDLIRDMLQASPDDRP 284
K+S D + L P +RP
Sbjct: 214 NPPSLEGNKFSKPFKDFVSLCLNKDPKERP 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 78/289 (26%), Positives = 116/289 (40%), Gaps = 50/289 (17%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKG 82
V VI G F V+ RD + YAMK MI ++ + A ++I
Sbjct: 4 EVIKVIGRGAFGEVWLVRD-KDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD--- 59
Query: 83 HPNVVTLYAHTILDLGRTKEAL-LVME-CCDKSLVNVLENRGAGYFEEKQVLAIFRDVCN 140
P +V LY + D +E L LVME L+N+L + F E+ ++
Sbjct: 60 SPWIVKLYY-SFQD----EEHLYLVMEYMPGGDLMNLLIRKDV--FPEETARFYIAELVL 112
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS---TNHKRFEKLEEMGIEE-- 195
A+ ++H HRD+K +N+L+ +DG KL DFG R L +
Sbjct: 113 ALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 196 DNIRKHT---------------TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK 240
DN+ TP Y APE + R + D W+LG +L+ + Y
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPE---VLRGTPYGLECDWWSLGVILYEMLYGF 227
Query: 241 NAFDGESKLQ----ILNGN--YRIPESPKYSSSVTDLIRDMLQASPDDR 283
F ++ + I+N R P P S DLI +L P+DR
Sbjct: 228 PPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCD-PEDR 275
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 78/272 (28%), Positives = 120/272 (44%), Gaps = 55/272 (20%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHPNVV 87
+ GGF V + ++ +A+K H++ ++ E E +++ HP +V
Sbjct: 1 LGVGGFGRVELVKVKSK-NRTFALKCVKKRHIVETGQQ--EHIFSEKEILEECN-HPFIV 56
Query: 88 TLYAHTILDLGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH 146
LY T D K ++ME C L +L R G F+E V A +H
Sbjct: 57 KLYR-TFKD---KKYIYMLMEYCLGGELWTIL--RDRGLFDEYTARFYIACVVLAFEYLH 110
Query: 147 SQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---T 203
++ I +RDLK ENLLL S+G KL DFG +KL + + T T
Sbjct: 111 NRG--IIYRDLKPENLLLDSNGYVKLVDFGFA-------KKL------KSGQKTWTFCGT 155
Query: 204 PAYRAPEMWDLFRRELINEK-----VDIWALGCLLFRICYFKNAFDGESKLQ------IL 252
P Y AP E+I K VD W+LG LL+ + + F + + IL
Sbjct: 156 PEYVAP--------EIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL 207
Query: 253 NGNYRIPESPKY-SSSVTDLIRDMLQASPDDR 283
GN ++ E P Y + DLI+ +L+ +P++R
Sbjct: 208 KGNGKL-EFPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLY 90
I G + VY ARD I + A+K + + E +EIS++K + HPN+V Y
Sbjct: 9 QRIGSGTYGDVYKARD-IATGELVAIKVIKLEPGDDFEIIQQEISMLKECR-HPNIVA-Y 65
Query: 91 AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSP 150
+ L R + +VME C + + G E Q+ + R+ + +H
Sbjct: 66 FGSYL---RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG- 121
Query: 151 PIAHRDLKAENLLLGSDGLWKLCDFGS----TSTNHKR--FEKLEEMGIEEDNIRKHTTP 204
HRD+K N+LL DG KL DFG T+T KR F +G TP
Sbjct: 122 -KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF-----IG----------TP 165
Query: 205 AYRAPEMWDLFRRELINEKVDIWALG 230
+ APE+ + R+ + K DIWALG
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALG 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 67/241 (27%), Positives = 113/241 (46%), Gaps = 52/241 (21%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLE----SAMKEISVMKSLKGHPNV 86
N I EG + VY ARD + A+K + E+ E ++++EI+++ L+ HPN+
Sbjct: 11 NRIEEGTYGVVYRARD-KKTGEIVALKKLKM--EKEKEGFPITSLREINILLKLQ-HPNI 66
Query: 87 VTLYAHTILDLGRTKEAL---------LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRD 137
VT+ KE + +VME + L +++E F + +V +
Sbjct: 67 VTV-----------KEVVVGSNLDKIYMVMEYVEHDLKSLMET-MKQPFLQSEVKCLMLQ 114
Query: 138 VCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIE-ED 196
+ + V +H I HRDLK NLLL + G+ K+CDFG + E
Sbjct: 115 LLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFG--------------LAREYGS 158
Query: 197 NIRKHT----TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL 252
++ +T T YRAPE+ L + + +D+W++GC+ + K F G+S++ L
Sbjct: 159 PLKPYTQLVVTLWYRAPEL--LLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL 216
Query: 253 N 253
N
Sbjct: 217 N 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 69/269 (25%), Positives = 115/269 (42%), Gaps = 33/269 (12%)
Query: 27 IHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNV 86
+ + I +G F V + ++ A+K + +D + ++ + E SVM +L+ HPN+
Sbjct: 8 LKLGATIGKGEFGDVMLG---DYRGQKVAVK-CLKDDSTAAQAFLAEASVMTTLR-HPNL 62
Query: 87 VTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
V L +L +V E K SLV+ L +RG Q L DVC + +
Sbjct: 63 VQLLG-VVLQ---GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPA 205
++ HRDL A N+L+ D + K+ DFG K G + + T
Sbjct: 119 EEKN--FVHRDLAARNVLVSEDLVAKVSDFGLA--------KEASQGQDSGKLPVKWT-- 166
Query: 206 YRAPEMWDLFRRELINEKVDIWALGCLLFRICYF-KNAFDGESKLQILN---GNYRIPES 261
APE R + + K D+W+ G LL+ I F + + ++ YR+ E+
Sbjct: 167 --APEA---LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM-EA 220
Query: 262 P-KYSSSVTDLIRDMLQASPDDRPDITQV 289
P V +++D + P RP Q+
Sbjct: 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 68/273 (24%), Positives = 109/273 (39%), Gaps = 50/273 (18%)
Query: 29 VRNVIAEGGFS--CVYSARDAIHMSKQYAMKHMI---CNDEESLESAMKEISVMKSLKGH 83
+ VI +G F C+ RD K +AMK+M C ++ S+ + + E +++ L H
Sbjct: 4 LLRVIGKGAFGKVCIVQKRDT---KKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-H 59
Query: 84 PNVVTL--------YAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIF 135
P +V L + ++DL + D L L + F E+QV
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDL---------LLGGD--LRYHLSQKVK--FSEEQVKFWI 106
Query: 136 RDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEE 195
++ A+ +HS+ I HRD+K +N+LL G + DF + G
Sbjct: 107 CEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSG--- 161
Query: 196 DNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL---QIL 252
TP Y APE+ R+ + VD W+LG + K + G S+ QI
Sbjct: 162 -------TPGYMAPEV---LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211
Query: 253 NG-NYRIPESPK-YSSSVTDLIRDMLQASPDDR 283
P +S+ D I +L+ P R
Sbjct: 212 AKQETADVLYPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-18
Identities = 80/272 (29%), Positives = 120/272 (44%), Gaps = 36/272 (13%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLY 90
I G FS VY A + K I + D ++ +KEI ++K L HPNV+ Y
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYY 68
Query: 91 AHTILDLGRTKEALLVMECCDK-SLVNVLEN--RGAGYFEEKQVLAIFRDVCNAVFAMHS 147
A I D E +V+E D L ++++ + EK V F +C+A+ MHS
Sbjct: 69 ASFIED----NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS 124
Query: 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---TP 204
+ + HRD+K N+ + + G+ KL D G RF H+ TP
Sbjct: 125 RR--VMHRDIKPANVFITATGVVKLGDLGL-----GRF-------FSSKTTAAHSLVGTP 170
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK------LQILNGNYRI 258
Y +PE N K DIW+LGCLL+ + ++ F G+ +I +Y
Sbjct: 171 YYMSPER---IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 227
Query: 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQVW 290
S YS + L+ + P+ RPDIT V+
Sbjct: 228 LPSDHYSEELRQLVNMCINPDPEKRPDITYVY 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 9e-18
Identities = 70/270 (25%), Positives = 114/270 (42%), Gaps = 37/270 (13%)
Query: 32 VIAEGGFSCVYSARD----AIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNV 86
+ G FS Y ARD + KQ ++ EE +E+ KEI +M L HP++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHI 65
Query: 87 VTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH 146
+ + T D + L V S+ ++L GA F+E ++ + + +H
Sbjct: 66 IRMLGATCED---SHFNLFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLSYLH 120
Query: 147 SQSPPIAHRDLKAENLLLGSDG-LWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT--T 203
I HRD+K NLL+ S G ++ DFG+ + +L G + T
Sbjct: 121 ENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAA-------RLAAKGTGAGEFQGQLLGT 171
Query: 204 PAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK---NAFDGESKLQIL------NG 254
A+ APE + R E D+W++GC++ + K NA + L ++
Sbjct: 172 IAFMAPE---VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT 228
Query: 255 NYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
IPE S + D+ L+ P+DRP
Sbjct: 229 APSIPEH--LSPGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 66/260 (25%), Positives = 117/260 (45%), Gaps = 35/260 (13%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAH 92
I EG V A D +Q A+K M ++ E E+ +M+ + HPN+V +Y+
Sbjct: 27 IGEGSTGIVCIATD-KSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HPNIVEMYSS 84
Query: 93 TILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPP 151
++ E +VME + +L +++ E+Q+ + V A+ +H+Q
Sbjct: 85 YLVG----DELWVVMEFLEGGALTDIVT---HTRMNEEQIATVCLAVLKALSFLHAQG-- 135
Query: 152 IAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---TPAYRA 208
+ HRD+K++++LL SDG KL DFG + + ++ R+ + TP + A
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQ------------VSKEVPRRKSLVGTPYWMA 183
Query: 209 PEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL-----NGNYRIPESPK 263
PE + R +VDIW+LG ++ + + + E LQ + N ++ K
Sbjct: 184 PE---VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHK 240
Query: 264 YSSSVTDLIRDMLQASPDDR 283
S + + ML P R
Sbjct: 241 VSPRLRSFLDRMLVRDPAQR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-17
Identities = 56/164 (34%), Positives = 88/164 (53%), Gaps = 19/164 (11%)
Query: 126 FEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185
F E + +F V AV +HS+ + HRD+K+ N+LL S+GL KL DFG F
Sbjct: 140 FREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLGDFG--------F 189
Query: 186 EKLEEMGIEEDNIRKHT-TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFD 244
K+ + +D R TP Y APE+W RR+ ++K D+++LG LL+ + K FD
Sbjct: 190 SKMYAATVSDDVGRTFCGTPYYVAPEIW---RRKPYSKKADMFSLGVLLYELLTLKRPFD 246
Query: 245 GESKLQILN----GNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
GE+ ++++ G Y P P S + +++ +L + P RP
Sbjct: 247 GENMEEVMHKTLAGRYD-PLPPSISPEMQEIVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 83/290 (28%), Positives = 128/290 (44%), Gaps = 54/290 (18%)
Query: 22 VGNLKIHVRNVIAEGGFSCVYSA-----RDAIHMSKQYAMKHMICNDEESLESAMKEISV 76
+ N +I + I G FS VY A R + + K + M D ++ + +KEI +
Sbjct: 1 LANFQIEKK--IGRGQFSEVYRATCLLDRKPVALKKVQIFEMM---DAKARQDCVKEIDL 55
Query: 77 MKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFE-------EK 129
+K L HPNV+ I D E +V+E D ++ + YF+ E+
Sbjct: 56 LKQLN-HPNVIKYLDSFIED----NELNIVLELADAGDLSQM----IKYFKKQKRLIPER 106
Query: 130 QVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLE 189
V F +C+AV MHS+ + HRD+K N+ + + G+ KL D G RF
Sbjct: 107 TVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGL-----GRF---- 155
Query: 190 EMGIEEDNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGE 246
H+ TP Y +PE N K DIW+LGCLL+ + ++ F G+
Sbjct: 156 ---FSSKTTAAHSLVGTPYYMSPER---IHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
Query: 247 SKLQILNGNYRI-----PESPK--YSSSVTDLIRDMLQASPDDRPDITQV 289
K+ + + +I P P YS + +L+ + PD RPDI V
Sbjct: 210 -KMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 56/226 (24%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDE-ESLE-SAMKEISVMKSLKGHPNVVTLY 90
I +G F V+ AR + A+K ++ +E E +A++EI +++ LK H NVV L
Sbjct: 20 IGQGTFGEVFKARH-KKTKQIVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLI 77
Query: 91 AHTILDLGRTKEA---------LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNA 141
++ RTK LV E C+ L +L N+ F ++ + + + N
Sbjct: 78 -----EICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK-FTLSEIKKVMKMLLNG 131
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-----STSTNHKRFEKLEEMGIEED 196
++ +H I HRD+KA N+L+ DG+ KL DFG S S N K
Sbjct: 132 LYYIHRNK--ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP------------ 177
Query: 197 NIRKHT----TPAYRAPEMWDLFRRELINEK-----VDIWALGCLL 233
++T T YR PE+ L+ E+ +D+W GC++
Sbjct: 178 --NRYTNRVVTLWYRPPEL-------LLGERDYGPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 78/270 (28%), Positives = 112/270 (41%), Gaps = 55/270 (20%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHM-----ICNDEESLESAMKEISVMKSLKGHPNV 86
+ G F V R K YA+K + + + E + E +++S++ HP +
Sbjct: 8 TLGTGSFGRVMLVRH-KGSGKYYALKILSKAKIVKLKQV--EHVLNEKRILQSIR-HPFL 63
Query: 87 VTLYAHTILDLGRTKEAL---LVME-CCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAV 142
V LY ++ LVME L + L R +G F E V A+
Sbjct: 64 VNLYGSF-------QDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPVARFYAAQVVLAL 114
Query: 143 FAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT 202
+HS I +RDLK ENLLL SDG K+ DFG F K ++ T
Sbjct: 115 EYLHSLD--IVYRDLKPENLLLDSDGYIKITDFG--------FAKR---------VKGRT 155
Query: 203 -----TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILN 253
TP Y APE+ + + VD WALG L++ + F ++ +Q IL
Sbjct: 156 YTLCGTPEYLAPEI---ILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE 212
Query: 254 GNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
G R P +S DLIR++LQ R
Sbjct: 213 GKVRFP--SFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 80/278 (28%), Positives = 126/278 (45%), Gaps = 38/278 (13%)
Query: 18 RSI-DVGNLKIHVRNV--IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEI 74
R+I VG+ K I +G VY+A D + ++ A+K M + E + EI
Sbjct: 9 RTIVSVGDPKKKYTRFEKIGQGASGTVYTAID-VATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 75 SVMKSLKGHPNVVTLYAHTILDLGRTKEALLVME-CCDKSLVNVLENRGAGYFEEKQVLA 133
VM+ K HPN+V Y + L E +VME SL +V+ +E Q+ A
Sbjct: 68 LVMRENK-HPNIVN-YLDSYL---VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAA 119
Query: 134 IFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGI 193
+ R+ A+ +HS + HRD+K++N+LLG DG KL DFG + I
Sbjct: 120 VCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQ------------I 165
Query: 194 EEDNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ 250
+ ++ T TP + APE + R+ KVDIW+LG + + + + E+ L+
Sbjct: 166 TPEQSKRSTMVGTPYWMAPE---VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222
Query: 251 IL-----NGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
L NG + K S+ D + L+ + R
Sbjct: 223 ALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 72/238 (30%), Positives = 115/238 (48%), Gaps = 32/238 (13%)
Query: 33 IAEGGFSCVYSARDAIHMSKQY-AMKHM-ICNDEESLES-AMKEISVMKSLKGHPNVVTL 89
I EG + VY R+ + Q AMK + + ++EE + S A++EIS++K L+ HPN+V L
Sbjct: 8 IGEGTYGVVYKGRN--KKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ-HPNIVCL 64
Query: 90 YAHTILDLGRTKEALLVMECCDKSLVNVLENRGAG-YFEEKQVLAIFRDVCNAVFAMHSQ 148
++ R L+ E L L++ G Y + + V + + + HS+
Sbjct: 65 -QDVLMQESRL---YLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 149 SPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT----TP 204
+ HRDLK +NLL+ + G+ KL DFG GI +R +T T
Sbjct: 121 R--VLHRDLKPQNLLIDNKGVIKLADFGLARA----------FGIP---VRVYTHEVVTL 165
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESP 262
YRAPE+ L + VDIW++G + + K F G+S++ L +RI +P
Sbjct: 166 WYRAPEV--LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTP 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 76/282 (26%), Positives = 120/282 (42%), Gaps = 38/282 (13%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLES-AMKEISVMKSLKGHPNVVTLYA 91
+ EG ++ VY R+ + A+K + + EE S A++EIS+MK LK H N+V L+
Sbjct: 8 LGEGTYATVYKGRNR-TTGEIVALKEIHLDAEEGTPSTAIREISLMKELK-HENIVRLH- 64
Query: 92 HTILDLGRTKEAL-LVMECCDKSLVNVLENRGA-GYFEEKQVLAIFRDVCNAVFAMHSQS 149
D+ T+ L LV E DK L ++ G G + V + + + H
Sbjct: 65 ----DVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120
Query: 150 PPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT-TPAYRA 208
+ HRDLK +NLL+ G KL DFG GI + T YRA
Sbjct: 121 --VLHRDLKPQNLLINKRGELKLADFGLARA----------FGIPVNTFSNEVVTLWYRA 168
Query: 209 PEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESPKYSSSV 268
P++ L + +DIW++GC++ + + F G + L +RI +P
Sbjct: 169 PDV--LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTP------ 220
Query: 269 TDLIRDMLQASPDDRPDITQVWFRVNEQLPVGLQKSLPDRPP 310
T+ + P+ +P + P LQ+ P P
Sbjct: 221 TESTWPGISQLPEYKPTFPRY-------PPQDLQQLFPHADP 255
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 68/294 (23%), Positives = 125/294 (42%), Gaps = 43/294 (14%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGH--PNV 86
+I G + VY + + + A+K I N ++ + +E++++ L+ PN+
Sbjct: 8 LIGRGAYGAVYRGKH-VPTGRVVALK--IINLDTPDDDVSDIQREVALLSQLRQSQPPNI 64
Query: 87 VTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH 146
Y + ++ME + V L AG EK + I R+V A+ +H
Sbjct: 65 TKYYGSYLKG----PRLWIIMEYAEGGSVRTLMK--AGPIAEKYISVIIREVLVALKYIH 118
Query: 147 SQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGIEEDNIRKHTTPA 205
+ HRD+KA N+L+ + G KLCDFG + N ++ +G TP
Sbjct: 119 KV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVG----------TPY 166
Query: 206 YRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPES--PK 263
+ APE+ + + + K DIW+LG ++ + + + + IP+S P+
Sbjct: 167 WMAPEV--ITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM---MLIPKSKPPR 221
Query: 264 -----YSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLPDR 308
YS + + + L P +R ++ W + + + PV + K L R
Sbjct: 222 LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSILKELISR 275
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 7e-17
Identities = 70/246 (28%), Positives = 110/246 (44%), Gaps = 35/246 (14%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLE-SAMKEISVMKSLKGHPNVVT 88
I EG + VY ARD + A+K + + N++E +A++EI +++ L H N+V
Sbjct: 13 GQIGEGTYGQVYKARDK-DTGELVALKKVRLDNEKEGFPITAIREIKILRQLN-HRNIVN 70
Query: 89 LYAHTI-------LDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCN 140
L I LD + K A LV E D L+ +LE+ G +F E + + + +
Sbjct: 71 L--KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES-GLVHFSEDHIKSFMKQLLE 127
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRK 200
+ H ++ HRD+K N+LL + G KL DFG + + R
Sbjct: 128 GLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARLYNS------------EESRP 173
Query: 201 HT----TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY 256
+T T YR PE+ L E +D+W+ GC+L + K F +L L
Sbjct: 174 YTNKVITLWYRPPEL--LLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231
Query: 257 RIPESP 262
R+ SP
Sbjct: 232 RLCGSP 237
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLE--SAMKEISVMKSLKGHPNVVTL- 89
+ EG F VY AR I + A+K ++ ++E+ +A++EI ++K LK HPNVV L
Sbjct: 16 LGEGTFGEVYKARQ-IKTGRVVALKKILMHNEKDGFPITALREIKILKKLK-HPNVVPLI 73
Query: 90 ---YAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH 146
+ +V D L +LEN E Q+ + + +H
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV-KLTESQIKCYMLQLLEGINYLH 132
Query: 147 SQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---- 202
I HRD+KA N+L+ + G+ K+ DFG + G RK+T
Sbjct: 133 ENH--ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG--GTRKYTNLVV 188
Query: 203 TPAYRAPEMWDLFRRELINEK-----VDIWALGCLL 233
T YR PE+ L+ E+ VDIW +GC+
Sbjct: 189 TRWYRPPEL-------LLGERRYTTAVDIWGIGCVF 217
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 2e-16
Identities = 67/262 (25%), Positives = 102/262 (38%), Gaps = 70/262 (26%)
Query: 72 KEISVMKSLKGHPNVVTLYAHTILDLGRT---KEALLVMECCDKSLVNVLENRGAGYFEE 128
+EI ++ L HPN+V L L++ + K+ LV E + L V+ A E+
Sbjct: 55 REIMFLQELGDHPNIVKL-----LNVIKAENDKDIYLVFEYMETDLHAVIR---ANILED 106
Query: 129 KQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL 188
I + A+ +HS + + HRDLK N+LL SD KL DFG + L
Sbjct: 107 VHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARS-------L 157
Query: 189 EEMGIEEDNIRKHTTPA---------YRAPEMWDLFRRELINEKVDIWALGCLLFRICYF 239
E+ +N P YRAPE+ L + VD+W++GC+L +
Sbjct: 158 SELEENPEN------PVLTDYVATRWYRAPEI--LLGSTRYTKGVDMWSVGCILGEMLLG 209
Query: 240 KNAFDGESKL---------------------------QILNGNYRIPES------PKYSS 266
K F G S L +L+ P PK S
Sbjct: 210 KPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASD 269
Query: 267 SVTDLIRDMLQASPDDRPDITQ 288
DL++ +L +P+ R +
Sbjct: 270 DALDLLKKLLVFNPNKRLTAEE 291
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 73/307 (23%), Positives = 124/307 (40%), Gaps = 63/307 (20%)
Query: 27 IHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHM----ICNDEESLE----------SAMK 72
I + EG + V A D + K A+K + I ND + ++
Sbjct: 11 IQKGAHLGEGTYGKVEKAYDTL-TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 73 EISVMKSLKGHPNVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQV 131
E+ +M +K H N++ L +D+ + + LVM+ L V++ + E QV
Sbjct: 70 ELKIMNEIK-HENIMGL-----VDVYVEGDFINLVMDIMASDLKKVVDRKI--RLTESQV 121
Query: 132 LAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNH----KRFE 186
I + N + +H HRDL N+ + S G+ K+ DFG + +
Sbjct: 122 KCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGE 246
K E M E+ K T YRAPE+ L E + VD+W++GC+ + K F GE
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPEL--LMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237
Query: 247 SKLQILNGNYRI---------PES---PKY------------------SSSVTDLIRDML 276
+++ L + + P++ P Y S DL++ +L
Sbjct: 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLL 297
Query: 277 QASPDDR 283
+ +P +R
Sbjct: 298 KLNPLER 304
|
Length = 335 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 65/230 (28%), Positives = 108/230 (46%), Gaps = 29/230 (12%)
Query: 66 SLESAMK-EISVMKSLKGHPNVVTLYAHTILDLGRTKEAL-LVME-CCDKSLVNVLENRG 122
+ A++ EI +K L H N+V L T+E L + +E S+ + L R
Sbjct: 50 DMVKALRSEIETLKDLD-HLNIVQY-----LGFETTEEYLSIFLEYVPGGSIGSCL--RT 101
Query: 123 AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182
G FEE+ V V + +HS+ I HRDLKA+NLL+ +DG+ K+ DFG + +
Sbjct: 102 YGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSD 159
Query: 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNA 242
++ + M ++ + + APE+ + + + KVDIW+LGC++ + +
Sbjct: 160 DIYDNDQNMSMQ-------GSVFWMAPEVIHSYSQGY-SAKVDIWSLGCVVLEMFAGRRP 211
Query: 243 FDGESKLQILN--GNYR----IPE--SPKYSSSVTDLIRDMLQASPDDRP 284
+ E + + GN R IP S S D + +PD+RP
Sbjct: 212 WSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 79/270 (29%), Positives = 115/270 (42%), Gaps = 49/270 (18%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLES---AMKEISVMKSLKGHPNVVTL 89
I G F VY ARD + ++ A+K M + ++S E +KE+ ++ L+ HPN +
Sbjct: 23 IGHGSFGAVYFARD-VRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEY 80
Query: 90 YAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS 149
+ R A LVME C S ++LE +E ++ AI + +HS
Sbjct: 81 KGCYL----REHTAWLVMEYCLGSASDILEVHKKP-LQEVEIAAICHGALQGLAYLHSHE 135
Query: 150 PPIAHRDLKAENLLLGSDGLWKLCDFGSTS--TNHKRFEKLEEMGIEEDNIRKHTTPAYR 207
HRD+KA N+LL G KL DFGS S + F +G TP +
Sbjct: 136 --RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF-----VG----------TPYWM 178
Query: 208 APEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN-----YRIP--E 260
APE+ + KVD+W+LG + E K + N N Y I +
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIEL--------AERKPPLFNMNAMSALYHIAQND 230
Query: 261 SPKYSSS-----VTDLIRDMLQASPDDRPD 285
SP SS+ + + LQ P DRP
Sbjct: 231 SPTLSSNDWSDYFRNFVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 78/289 (26%), Positives = 122/289 (42%), Gaps = 62/289 (21%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDE-ESLES-AMKEISVMKSLKGHPNVVTLY 90
I EG + VY AR+ + + A+K + + E E + S A++EIS++K L HPN+V L
Sbjct: 8 IGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKL- 64
Query: 91 AHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS 149
LD+ T+ L LV E + L ++ + + + + HS
Sbjct: 65 ----LDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 150 PPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT----TPA 205
+ HRDLK +NLL+ ++G KL DFG G+ +R +T T
Sbjct: 121 --VLHRDLKPQNLLINTEGAIKLADFGLARA----------FGVP---VRTYTHEVVTLW 165
Query: 206 YRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYR-------- 257
YRAPE+ L + + VDIW+LGC+ + + F G+S++ L +R
Sbjct: 166 YRAPEI--LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 223
Query: 258 ----IPESPKYSSSV-------------------TDLIRDMLQASPDDR 283
+ P Y S DL+ ML P+ R
Sbjct: 224 VWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKR 272
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 59/230 (25%), Positives = 105/230 (45%), Gaps = 26/230 (11%)
Query: 33 IAEGGFSCVYSARDA-IHMSKQYAMKHM--ICNDEESLESAMKEISVMKSLKGHPNVVTL 89
+ +G + V SAR+A + A+K + + + + + A++E+ +++ +GH N+ L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 90 YAHTILDLGRTKEALLVMECCDKSLVNV------LENRGAGYFEEKQVLAIFRDVCNAVF 143
Y I+ G E L E + L + L + F I++ +C +
Sbjct: 68 YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSF-------IYQILCGLKY 120
Query: 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTT 203
+HS + + HRDLK NLL+ +D K+CDFG + + E T
Sbjct: 121 -IHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE-----YVAT 172
Query: 204 PAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN 253
YRAPE+ F+ + +D+W++GC+L + K F G+ + LN
Sbjct: 173 RWYRAPEIMLSFQS--YTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLN 220
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 32/208 (15%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESL-ESAMKEISVMKSLKGHPNVVTLY 90
I EG + V+ A++ + A+K + + +D+E + SA++EI ++K LK H N+V LY
Sbjct: 8 IGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLY 65
Query: 91 AHTILD-LGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS 149
D L K+ LV E CD+ L ++ G + + V + + + HS +
Sbjct: 66 -----DVLHSDKKLTLVFEYCDQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN 119
Query: 150 PPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT----TPA 205
+ HRDLK +NLL+ +G KL DFG GI +R ++ T
Sbjct: 120 --VLHRDLKPQNLLINKNGELKLADFGLARA----------FGIP---VRCYSAEVVTLW 164
Query: 206 YRAPEMWDLFRRELINEKVDIWALGCLL 233
YR P++ LF +L + +D+W+ GC+
Sbjct: 165 YRPPDV--LFGAKLYSTSIDMWSAGCIF 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 31/222 (13%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDE-ESLES-AMKEISVMKSLKGHPNVVTLY 90
I EG + VY ARD + A+K + E E + S A++EIS++K L HPN+V L
Sbjct: 7 IGEGTYGVVYKARD-KLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN-HPNIVRLL 64
Query: 91 AHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS 149
D+ ++ L LV E D L +++ + + + + + HS
Sbjct: 65 -----DVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR 119
Query: 150 PPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT----TPA 205
+ HRDLK +NLL+ +G KL DFG G+ +R +T T
Sbjct: 120 --VLHRDLKPQNLLIDREGALKLADFGLARA----------FGVP---VRTYTHEVVTLW 164
Query: 206 YRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES 247
YRAPE+ L + VDIW++GC+ + + F G+S
Sbjct: 165 YRAPEI--LLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 62/285 (21%), Positives = 123/285 (43%), Gaps = 45/285 (15%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESA---MKEISVMKSLKGHPNVVT 88
I G + V SA D K+ A+K I + + A ++E+ +++ K H N++
Sbjct: 12 NIGSGAYGVVCSAIDTRS-GKKVAIKK-IPHAFDVPTLAKRTLRELKILRHFK-HDNIIA 68
Query: 89 LYAHTILDLGRTKEAL-----LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143
I D+ R A +VM+ + L +++ + E+ + + +
Sbjct: 69 -----IRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQP--LTEEHIRYFLYQLLRGLK 121
Query: 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG------STSTNHKRFEKLEEMGIEEDN 197
+HS + + HRDLK NLL+ D ++ DFG S+ T HK F
Sbjct: 122 YIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF------------ 167
Query: 198 IRKH-TTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES---KLQILN 253
+ ++ T YRAPE+ L +D+W++GC+ + + F G++ +L+++
Sbjct: 168 MTEYVATRWYRAPEL--LLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLIL 225
Query: 254 GNYRIPESPKYSSSVTDLIRDMLQASPDDRP-DITQVWFRVNEQL 297
P + +D +R +Q P +P ++++ + + +
Sbjct: 226 SVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEA 270
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 77/299 (25%), Positives = 137/299 (45%), Gaps = 42/299 (14%)
Query: 20 IDVGNLKIHVRNV--IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVM 77
+D G+ + + N I EG V AR+ H +Q A+K M ++ E E+ +M
Sbjct: 14 VDQGDPRSLLENYIKIGEGSTGIVCIAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIM 72
Query: 78 KSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFR 136
+ + H NVV +Y ++ +E ++ME +L +++ E+Q+ +
Sbjct: 73 RDYQ-HQNVVEMYKSYLVG----EELWVLMEFLQGGALTDIVSQT---RLNEEQIATVCE 124
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEED 196
V A+ +HSQ + HRD+K++++LL DG KL DFG + K K + +
Sbjct: 125 SVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL----- 177
Query: 197 NIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY 256
TP + APE + R +VDIW+LG ++ + + + +S +Q +
Sbjct: 178 ----VGTPYWMAPE---VISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK--- 227
Query: 257 RIPESP----KYSSSVTDLIRD----MLQASPDDRPDITQVWFRVNEQLPVGLQKSLPD 307
R+ +SP K + ++ ++RD ML P +R ++ P LQ LP+
Sbjct: 228 RLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELL-----DHPFLLQTGLPE 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 70/271 (25%), Positives = 105/271 (38%), Gaps = 39/271 (14%)
Query: 41 VYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97
V+ R K +A+K + + ++ + E ++ +L HP + TLYA
Sbjct: 17 VFLVRL-KGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYAS----F 70
Query: 98 GRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRD 156
LVM+ C L +L+ + E+ +V A+ +H I +RD
Sbjct: 71 QTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRD 128
Query: 157 LKAENLLLGSDGLWKLCDF----------------GSTSTNHKRFEKLE-EMGIEEDNIR 199
LK EN+LL G L DF + + E EE + R
Sbjct: 129 LKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFR 188
Query: 200 KHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----IL 252
++ T Y APE + + VD W LG LL+ + Y F G ++ + IL
Sbjct: 189 SNSFVGTEEYIAPE---VISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245
Query: 253 NGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
P SP SSS DLIR +L P R
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 76/270 (28%), Positives = 120/270 (44%), Gaps = 36/270 (13%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAH 92
+ +G F VY A++ A K + EE LE M EI ++ + HP +V L
Sbjct: 20 LGDGAFGKVYKAKNK-ETGALAAAKVIETKSEEELEDYMVEIEILATCN-HPYIVKLLGA 77
Query: 93 TILDLGRTKEALLVMECCDKSLVN--VLE-NRGAGYFEEKQVLAIFRDVCNAVFAMHSQS 149
D + +++E C V+ +LE +RG E Q+ I R + A+ +HS
Sbjct: 78 FYWD----GKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVICRQMLEALQYLHSMK 130
Query: 150 PPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAP 209
I HRDLKA N+LL DG KL DFG ++ N K ++ + TP + AP
Sbjct: 131 --IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF---------IGTPYWMAP 179
Query: 210 E--MWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPES------ 261
E M + + + K DIW+LG L + + + +++L +I +S
Sbjct: 180 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL---LKIAKSEPPTLS 236
Query: 262 --PKYSSSVTDLIRDMLQASPDDRPDITQV 289
K+S D ++ L P+ RP Q+
Sbjct: 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQL 266
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 69/272 (25%), Positives = 107/272 (39%), Gaps = 36/272 (13%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAM-KEISVMKSLKGHPNVV 87
V+ +G VY R K YA+K + + +E + +E+ ++S + P VV
Sbjct: 5 RVKVLGQGSSGVVYKVRH-KPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE-SPYVV 62
Query: 88 TLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH 146
Y G +V+E D SL ++L+ G E + I R + + +H
Sbjct: 63 KCY-GAFYKEGEIS---IVLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYLH 116
Query: 147 SQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGIEEDNIRKHTTPA 205
++ I HRD+K NLL+ S G K+ DFG S + + +G T
Sbjct: 117 TKRH-IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVG----------TVT 165
Query: 206 YRAPEMWDLFRRELINEKVDIWALG-----CLLFRICYFKNAFDG--ESKLQILNGNYRI 258
Y +PE + E + DIW+LG C L + + E I +G
Sbjct: 166 YMSPER---IQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP--P 220
Query: 259 PESPK--YSSSVTDLIRDMLQASPDDRPDITQ 288
P P +S D I LQ P RP +
Sbjct: 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-14
Identities = 80/307 (26%), Positives = 129/307 (42%), Gaps = 45/307 (14%)
Query: 51 SKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMEC- 109
++ K ++ NDE A E+ + + H +V + D + LL+ME
Sbjct: 93 KEKVVAKFVMLNDERQAAYARSELHCLAACD-HFGIVKHFD----DFKSDDKLLLIMEYG 147
Query: 110 ----CDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLG 165
+K + L+ F+E +V +F + A+ +HS+ + HRDLK+ N+ L
Sbjct: 148 SGGDLNKQIKQRLKEHLP--FQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM 203
Query: 166 SDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT-TPAYRAPEMWDLFRRELINEKV 224
G+ KL DFG F K + D TP Y APE+W+ R+ ++K
Sbjct: 204 PTGIIKLGDFG--------FSKQYSDSVSLDVASSFCGTPYYLAPELWE---RKRYSKKA 252
Query: 225 DIWALGCLLFRICYFKNAFDGESK----LQILNGNYRIPESPKYSSSVTDLIRDMLQASP 280
D+W+LG +L+ + F G S+ Q+L G Y P SS + L+ +L +P
Sbjct: 253 DMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNP 311
Query: 281 DDRPDITQVWFRVNEQLPVGLQKSLPDRPPETQSAVANEGMSKPMNRSPPMPQ----RSP 336
RP Q+ L K + + Q V + P +R + Q
Sbjct: 312 ALRPTTQQL-------LHTEFLKYVANL---FQDIVRHSETISPHDREEILRQLQESGER 361
Query: 337 PPPPSSV 343
PPPSS+
Sbjct: 362 APPPSSI 368
|
Length = 478 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 77/271 (28%), Positives = 107/271 (39%), Gaps = 55/271 (20%)
Query: 33 IAEGGFSCVYSARD-------AIHMSKQYAM--KHMICNDEESLESAMKEISVMKSLKGH 83
I++G F VY A+ AI + K+ M K+ + N E ++M
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTN-------VKAERAIMMIQGES 56
Query: 84 PNVVTLYAHTILDLGRTKEAL-LVMECCD----KSLVNVLENRGAGYFEEKQVLAIFRDV 138
P V LY ++K+ L LVME + SL+ L G E +V
Sbjct: 57 PYVAKLYYSF-----QSKDYLYLVMEYLNGGDCASLIKTL-----GGLPEDWAKQYIAEV 106
Query: 139 CNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNI 198
V +H + I HRD+K ENLL+ G KL DFG L G+E N
Sbjct: 107 VLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFG-----------LSRNGLE--NK 151
Query: 199 RKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNG 254
+ TP Y APE ++ D W+LGC++F + F E+ IL+
Sbjct: 152 KFVGTPDYLAPET---ILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR 208
Query: 255 NYRIPESPKYSSS--VTDLIRDMLQASPDDR 283
PE K S DLI +L P R
Sbjct: 209 RINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 81/267 (30%), Positives = 116/267 (43%), Gaps = 45/267 (16%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLES---AMKEISVMKSLKGHPNVVTL 89
I G F VY ARD + S+ A+K M + ++S E +KE+ ++ L+ HPN +
Sbjct: 23 IGHGSFGAVYFARD-VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ- 79
Query: 90 YAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS 149
Y L R A LVME C S ++LE +E ++ A+ + +HS +
Sbjct: 80 YRGCYL---REHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLHSHN 135
Query: 150 PPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAP 209
+ HRD+KA N+LL GL KL DFGS S M + TP + AP
Sbjct: 136 --MIHRDVKAGNILLSEPGLVKLGDFGSASI----------MAPANXFV---GTPYWMAP 180
Query: 210 EMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN-----YRIP--ESP 262
E+ + KVD+W+LG + E K + N N Y I ESP
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL--------AERKPPLFNMNAMSALYHIAQNESP 232
Query: 263 -----KYSSSVTDLIRDMLQASPDDRP 284
+S + + LQ P DRP
Sbjct: 233 ALQSGHWSEYFRNFVDSCLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-14
Identities = 75/261 (28%), Positives = 121/261 (46%), Gaps = 37/261 (14%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVT-LYA 91
I +G VY+A D I ++ A+K M + E + EI VM+ K +PN+V L +
Sbjct: 27 IGQGASGTVYTAID-IATGQEVAIKQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDS 84
Query: 92 HTILDLGRTKEALLVME-CCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSP 150
+ + D E +VME SL +V+ +E Q+ A+ R+ A+ +HS
Sbjct: 85 YLVGD-----ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQ- 135
Query: 151 PIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---TPAYR 207
+ HRD+K++N+LLG DG KL DFG + I + ++ T TP +
Sbjct: 136 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQ------------ITPEQSKRSTMVGTPYWM 182
Query: 208 APEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL-----NGNYRIPESP 262
APE + R+ KVDIW+LG + + + + E+ L+ L NG +
Sbjct: 183 APE---VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE 239
Query: 263 KYSSSVTDLIRDMLQASPDDR 283
+ S+ D + L+ D R
Sbjct: 240 RLSAVFRDFLNRCLEMDVDRR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 71/259 (27%), Positives = 119/259 (45%), Gaps = 33/259 (12%)
Query: 33 IAEG--GFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLY 90
I EG G C+ + + H KQ A+K M ++ E E+ +M+ H NVV +Y
Sbjct: 30 IGEGSTGIVCIATEK---HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH-HENVVDMY 85
Query: 91 AHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS 149
++ E +VME + +L +++ + E+Q+ + V A+ +H+Q
Sbjct: 86 NSYLVG----DELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQG 138
Query: 150 PPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAP 209
+ HRD+K++++LL SDG KL DFG + K K + + TP + AP
Sbjct: 139 --VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL---------VGTPYWMAP 187
Query: 210 EMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL-----NGNYRIPESPKY 264
E + R +VDIW+LG ++ + + + E LQ + N R+ +S K
Sbjct: 188 E---VISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKV 244
Query: 265 SSSVTDLIRDMLQASPDDR 283
SS + + ML P R
Sbjct: 245 SSVLRGFLDLMLVREPSQR 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 74/264 (28%), Positives = 119/264 (45%), Gaps = 34/264 (12%)
Query: 33 IAEGGFSCVYSARD--AIHMSKQYAMKHMICNDEESLES--AMKEISVMKSLKGHPNVVT 88
+ +G F VY +D A+ + +K + + E+ A +E ++ L HP +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVK 66
Query: 89 LYAHTILDLGRTKEALLVMECCDKSL-VNVLENRGAG-YFEEKQVLAIFRDVCNAVFAMH 146
+A L R ++ C + L + E + G E QV F + V MH
Sbjct: 67 FHASF---LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 147 SQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAY 206
+ I HRDLKA+N+ L + L K+ DFG + R MG + TP Y
Sbjct: 124 QRR--ILHRDLKAKNIFL-KNNLLKIGDFGVS-----RLL----MGSCDLATTFTGTPYY 171
Query: 207 RAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESP---- 262
+PE + + + K DIW+LGC+L+ +C +AF+G++ L ++ RI E P
Sbjct: 172 MSPEA---LKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV---LRIVEGPTPSL 225
Query: 263 --KYSSSVTDLIRDMLQASPDDRP 284
YS + +++ ML P RP
Sbjct: 226 PETYSRQLNSIMQSMLNKDPSLRP 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 71/259 (27%), Positives = 107/259 (41%), Gaps = 47/259 (18%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESL---ESAMKEISVMKSLKGHPNVVTL 89
+ G F V+ RD I YA+K M + L + E V+K + HP ++ L
Sbjct: 9 VGTGTFGRVHLVRDRIS-EHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRL 66
Query: 90 YAHTILDLGRTKEAL-LVME-CCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
+ + L ++ME L + L R +G F L ++ A+ +HS
Sbjct: 67 FWTE-----HDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLHS 119
Query: 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT----- 202
+ I +RDLK EN+LL +G KL DFG F K +R T
Sbjct: 120 KE--IVYRDLKPENILLDKEGHIKLTDFG--------FAK---------KLRDRTWTLCG 160
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL----QILNGNYRI 258
TP Y APE + + + N+ VD WALG L++ + F ++ +IL G
Sbjct: 161 TPEYLAPE---VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEF 217
Query: 259 PESPKYSSSVTDLIRDMLQ 277
P DLI+ +L
Sbjct: 218 PRH--LDLYAKDLIKKLLV 234
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 65/229 (28%), Positives = 106/229 (46%), Gaps = 22/229 (9%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGH 83
K V V+ EG + V R + A+K ++ EE E+ ++E+ ++++LK
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHK-ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK-Q 59
Query: 84 PNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143
N+V L R + LV E +K+++ +LE G EK I++ + A+
Sbjct: 60 ENIVELKEA----FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQ-LIKAIH 114
Query: 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTT 203
H I HRD+K ENLL+ + + KLCDFG F + G + T
Sbjct: 115 WCHKND--IVHRDIKPENLLISHNDVLKLCDFG--------FARNLSEGSNANYTEYVAT 164
Query: 204 PAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL 252
YR+PE L + VD+W++GC+L + + F GES++ L
Sbjct: 165 RWYRSPE---LLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 73/258 (28%), Positives = 117/258 (45%), Gaps = 31/258 (12%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVT-LYA 91
I +G VY+A D + ++ A++ M + E + EI VM+ K +PN+V L +
Sbjct: 28 IGQGASGTVYTAMD-VATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDS 85
Query: 92 HTILDLGRTKEALLVME-CCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSP 150
+ + D E +VME SL +V+ +E Q+ A+ R+ A+ +HS
Sbjct: 86 YLVGD-----ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ- 136
Query: 151 PIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPE 210
+ HRD+K++N+LLG DG KL DFG + K M TP + APE
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---------VGTPYWMAPE 186
Query: 211 MWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL-----NGNYRIPESPKYS 265
+ R+ KVDIW+LG + + + + E+ L+ L NG + K S
Sbjct: 187 ---VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243
Query: 266 SSVTDLIRDMLQASPDDR 283
+ D + L + R
Sbjct: 244 AIFRDFLNRCLDMDVEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 65/265 (24%), Positives = 110/265 (41%), Gaps = 41/265 (15%)
Query: 32 VIAEGGFSCVYSAR----DAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVV 87
V+ +G F V A D ++ K +K + ++ +E M E V+ HP +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVK--VLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 88 TLYAHTILDLGRTKEAL-LVMECCDKS--LVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
L++ +TK+ L VME + + ++ + F+E + A F +
Sbjct: 60 QLHS-----CFQTKDRLFFVMEYVNGGDLMFHIQRSG---RFDEPR--ARFYAAEIVLGL 109
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH--T 202
I +RDLK +N+LL S+G K+ DFG + + GI
Sbjct: 110 QFLHERGIIYRDLKLDNVLLDSEGHIKIADFG-----------MCKEGILGGVTTSTFCG 158
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNYRI 258
TP Y APE + + VD WALG LL+ + ++ F+G+ + + IL R
Sbjct: 159 TPDYIAPE---ILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY 215
Query: 259 PESPKYSSSVTDLIRDMLQASPDDR 283
P S +++ L +P+ R
Sbjct: 216 PRW--LSKEAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 1e-13
Identities = 71/260 (27%), Positives = 118/260 (45%), Gaps = 35/260 (13%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAH 92
I +G V++A D + ++ A+K + + E + EI VMK LK +PN+V
Sbjct: 27 IGQGASGTVFTAID-VATGQEVAIKQINLQKQPKKELIINEILVMKELK-NPNIVNFLDS 84
Query: 93 TILDLGRTKEALLVME-CCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPP 151
++ E +VME SL +V+ +E Q+ A+ R+ A+ +H+
Sbjct: 85 FLVG----DELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ-- 135
Query: 152 IAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---TPAYRA 208
+ HRD+K++N+LLG DG KL DFG + I + ++ T TP + A
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQ------------ITPEQSKRSTMVGTPYWMA 183
Query: 209 PEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL-----NGNYRIPESPK 263
PE + R+ KVDIW+LG + + + + E+ L+ L NG + K
Sbjct: 184 PE---VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240
Query: 264 YSSSVTDLIRDMLQASPDDR 283
S D + L+ + R
Sbjct: 241 LSPIFRDFLNRCLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 67/246 (27%), Positives = 119/246 (48%), Gaps = 30/246 (12%)
Query: 23 GNLKIHVR-NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLE-SAMKEISVMKSL 80
G L+ +++ + + EG ++ VY R + A+K + EE +A++E+S++K L
Sbjct: 3 GKLETYIKLDKLGEGTYATVYKGRSKL-TDNLVALKEIRLEHEEGAPCTAIREVSLLKDL 61
Query: 81 KGHPNVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVC 139
K H N+VTL+ D+ T+++L LV E DK L L++ G L +F+ +
Sbjct: 62 K-HANIVTLH-----DIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQ-LL 114
Query: 140 NAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG---STSTNHKRFEKLEEMGIEED 196
+ H + + HRDLK +NLL+ G KL DFG + S K +
Sbjct: 115 RGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN--------- 163
Query: 197 NIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY 256
+ T YR P++ L + ++D+W +GC+ + + + F G + + L+ +
Sbjct: 164 ---EVVTLWYRPPDI--LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF 218
Query: 257 RIPESP 262
RI +P
Sbjct: 219 RILGTP 224
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 2e-13
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 41/220 (18%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESA---MKEISVMKSLKGHPN 85
+ I G + V SA D ++ A+K I N + L A ++EI +++ L+ H N
Sbjct: 4 LLKPIGSGAYGVVCSAVDKR-TGRKVAIK-KISNVFDDLIDAKRILREIKLLRHLR-HEN 60
Query: 86 VVTLYAHTIL---DLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAV 142
++ L IL + +V E + L V+++ + + + +
Sbjct: 61 IIGL--LDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQ--PLTDDHIQYFLYQILRGL 116
Query: 143 FAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH- 201
+HS + + HRDLK N+L+ S+ K+CDFG R G++ D K
Sbjct: 117 KYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLA-----R-------GVDPDEDEKGF 162
Query: 202 -----TTPAYRAPE---MWDLFRRELINEKVDIWALGCLL 233
T YRAPE + + +DIW++GC+
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRY-----TKAIDIWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 70/259 (27%), Positives = 114/259 (44%), Gaps = 35/259 (13%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYA 91
+I EG F V + ++ A+K++ C + + ++ ++E +VM L H N+V L
Sbjct: 13 IIGEGEFGAVLQGE---YTGQKVAVKNIKC--DVTAQAFLEETAVMTKLH-HKNLVRLLG 66
Query: 92 HTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSP 150
IL G +VME K +LVN L RG Q+L DV + + +S
Sbjct: 67 -VILHNG----LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM--EYLESK 119
Query: 151 PIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPE 210
+ HRDL A N+L+ DG+ K+ DFG ++ MG++ + T APE
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFG--------LARVGSMGVDNSKLPVKWT----APE 167
Query: 211 MWDLFRRELINEKVDIWALGCLLFRICYFKNA-----FDGESKLQILNGNYRIPESPKYS 265
+ + + K D+W+ G LL+ + + A E K + G YR+
Sbjct: 168 A---LKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YRMEPPEGCP 223
Query: 266 SSVTDLIRDMLQASPDDRP 284
+ V L+ + P RP
Sbjct: 224 ADVYVLMTSCWETEPKKRP 242
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 72/299 (24%), Positives = 114/299 (38%), Gaps = 78/299 (26%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLE-SAMKEISVMKSLKGHPNVVTLY 90
+ EG ++ VY R + + A+K + EE +A++E S++K LK H N+VTL+
Sbjct: 12 KLGEGSYATVYKGR-SKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK-HANIVTLH 69
Query: 91 AHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFR-----DVCNAVFA 144
D+ TK+ L LV E D L +++ G G L +F+ C
Sbjct: 70 -----DIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC----- 119
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-----STSTNHKRFEKLEEMGIEEDNIR 199
H + + HRDLK +NLL+ G KL DFG S + E +
Sbjct: 120 -HQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV----------- 165
Query: 200 KHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDG----ESKLQIL--- 252
T YR P++ L + +D+W +GC+ + + + F G E +L +
Sbjct: 166 ---TLWYRPPDV--LLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRV 220
Query: 253 --------------NGNYRIPESPKYS--------------SSVTDLIRDMLQASPDDR 283
N ++ P Y +L LQ P R
Sbjct: 221 LGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKR 279
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 68/265 (25%), Positives = 116/265 (43%), Gaps = 26/265 (9%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAH 92
+ +G F VY A++ A K + EE LE M EI ++ S HPN+V L
Sbjct: 13 LGDGAFGKVYKAQNK-ETGVLAAAKVIDTKSEEELEDYMVEIDILASCD-HPNIVKL--- 67
Query: 93 TILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPP 151
LD + L +++E C V+ + E Q+ + + A+ +H
Sbjct: 68 --LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK-- 123
Query: 152 IAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPE- 210
I HRDLKA N+L DG KL DFG ++ N + ++ + TP + APE
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF---------IGTPYWMAPEV 174
Query: 211 -MWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL-----NGNYRIPESPKY 264
M + + + K D+W+LG L + + + +++L + + + ++
Sbjct: 175 VMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 234
Query: 265 SSSVTDLIRDMLQASPDDRPDITQV 289
SS D ++ L+ + D R TQ+
Sbjct: 235 SSEFKDFLKKCLEKNVDARWTTTQL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 79/267 (29%), Positives = 114/267 (42%), Gaps = 45/267 (16%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLES---AMKEISVMKSLKGHPNVVTL 89
I G F VY ARD ++ A+K M + ++S E +KE+ ++ +K HPN +
Sbjct: 33 IGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIE- 89
Query: 90 YAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS 149
Y L R A LVME C S ++LE +E ++ AI + +HS +
Sbjct: 90 YKGCYL---REHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAITHGALQGLAYLHSHN 145
Query: 150 PPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAP 209
+ HRD+KA N+LL G KL DFGS S + TP + AP
Sbjct: 146 --MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-------------GTPYWMAP 190
Query: 210 EMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN-----YRIP--ESP 262
E+ + KVD+W+LG + E K + N N Y I ESP
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIEL--------AERKPPLFNMNAMSALYHIAQNESP 242
Query: 263 -----KYSSSVTDLIRDMLQASPDDRP 284
++S + + LQ P DRP
Sbjct: 243 TLQSNEWSDYFRNFVDSCLQKIPQDRP 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 76/279 (27%), Positives = 113/279 (40%), Gaps = 58/279 (20%)
Query: 32 VIAEGGFSCVYSARDAI--HMSKQYAMKHM----ICNDEESLESAMKEISVMKSLKGHPN 85
V+ G + V+ R K YAMK + I ++ E E V+++++ P
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 86 VVTL-YA-------HTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRD 137
+VTL YA H ILD E L L R +F E +V +
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGE-----------LFTHLYQRE--HFTESEVRVYIAE 113
Query: 138 VCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDN 197
+ A+ +H I +RD+K EN+LL S+G L DFG L + + E+
Sbjct: 114 IVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFG-----------LSKEFLAEEE 160
Query: 198 IRKHT---TPAYRAPEMWDLFRRELI--NEKVDIWALGCLLFRICYFKNAF--DGESKLQ 250
R ++ T Y APE + R ++ VD W+LG L F + + F DGE Q
Sbjct: 161 ERAYSFCGTIEYMAPE---VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ 217
Query: 251 ------ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
IL P S+ D I+ +L+ P R
Sbjct: 218 SEISRRILKSKPPFP--KTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 20/225 (8%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLE-SAMKEISVMKSLKG--HPNVVT 88
I EG + V+ ARD + + A+K + + EE + S ++E++V++ L+ HPNVV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 89 LY-AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
L+ T+ R + LV E D+ L L+ + + + + + +HS
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128
Query: 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYR 207
+ HRDLK +N+L+ S G KL DFG F+ + T YR
Sbjct: 129 HR--VVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVV--------VTLWYR 176
Query: 208 APEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL 252
APE + + VD+W++GC+ + K F G S + L
Sbjct: 177 APE---VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 65/274 (23%), Positives = 119/274 (43%), Gaps = 48/274 (17%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLESAMK----EISVMKSLKGHPNVV 87
+ G F VY + +A+K + + +D ++ + A+K EI+++ L+ HPN+V
Sbjct: 8 LGSGSFGSVYEGL-NLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIV 65
Query: 88 TLYAHTILDLGRTKEALLV-MECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
R ++ L + +E SL +L+ G+ F E + R + + +
Sbjct: 66 QYLGTE-----REEDNLYIFLELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEYL 118
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEM----GIEEDNIRKH 201
H ++ HRD+K N+L+ ++G+ KL DFG K+ + G
Sbjct: 119 HDRN--TVHRDIKGANILVDTNGVVKLADFGMA----KQVVEFSFAKSFKG--------- 163
Query: 202 TTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRI--- 258
+P + APE+ + ++ DIW+LGC + + K + S+L+ + ++I
Sbjct: 164 -SPYWMAPEV--IAQQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRS 217
Query: 259 ---PESPKY-SSSVTDLIRDMLQASPDDRPDITQ 288
P P + S D I LQ P RP +
Sbjct: 218 KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 67/262 (25%), Positives = 113/262 (43%), Gaps = 31/262 (11%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAH 92
I G + VY AR+ ++ + A+K + E +EI +MK K H N+V +
Sbjct: 17 IGSGTYGDVYKARN-VNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK-HSNIVAYFGS 74
Query: 93 TILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPP 151
+ R + + ME C SL ++ G E Q+ + R+ ++ +HS+
Sbjct: 75 YL----RRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSKGK- 127
Query: 152 IAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH--TTPAYRAP 209
HRD+K N+LL +G KL DFG ++ K RK TP + AP
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVSAQITATIAK-----------RKSFIGTPYWMAP 175
Query: 210 EMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL----NGNYRIP---ESP 262
E+ + R+ N+ DIWA+G + + ++ L N++ P +
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKM 235
Query: 263 KYSSSVTDLIRDMLQASPDDRP 284
K+S+S ++ L +P RP
Sbjct: 236 KWSNSFHHFVKMALTKNPKKRP 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 64/254 (25%), Positives = 108/254 (42%), Gaps = 55/254 (21%)
Query: 47 AIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLV 106
AI M ++ AM ++++ +E E VM L HPN+V LY + + +V
Sbjct: 32 AIKMIREGAM-----SEDDFIE----EAKVMMKLS-HPNLVQLYGVCT----KQRPIFIV 77
Query: 107 ME-CCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLG 165
E + L+N L R G + +L + DVC A+ + S HRDL A N L+G
Sbjct: 78 TEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVG 134
Query: 166 SDGLWKLCDFG---------STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFR 216
D + K+ DFG TS+ +F ++ + PE++D R
Sbjct: 135 EDNVVKVSDFGLARYVLDDQYTSSQGTKFP-----------VK------WAPPEVFDYSR 177
Query: 217 RELINEKVDIWALGCLLFRICYF---KNAFDGESKLQILNG---NYRIPESPKYSSSVTD 270
+ K D+W+ G L++ + F K ++ S +++ YR+ + V
Sbjct: 178 ---FSSKSDVWSFGVLMWEV--FSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYT 232
Query: 271 LIRDMLQASPDDRP 284
++ P+DRP
Sbjct: 233 IMYSCWHEKPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 73/262 (27%), Positives = 114/262 (43%), Gaps = 35/262 (13%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDE---ESLESAMKEISVMKSLKGHPNVVTL 89
I G F VY A ++ H ++ A+K M + + E + +KE+ ++ LK HPN +
Sbjct: 29 IGHGSFGAVYFATNS-HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIE- 85
Query: 90 YAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS 149
Y L + A LVME C S ++LE +E ++ AI + +HS +
Sbjct: 86 YKGCYL---KEHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAITHGALQGLAYLHSHN 141
Query: 150 PPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAP 209
+ HRD+KA N+LL G KL DFGS S + + TP + AP
Sbjct: 142 --MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-------------GTPYWMAP 186
Query: 210 EMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIP--ESP----- 262
E+ + KVD+W+LG + K + + L Y I +SP
Sbjct: 187 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIAQNDSPTLQSN 243
Query: 263 KYSSSVTDLIRDMLQASPDDRP 284
+++ S + LQ P +RP
Sbjct: 244 EWTDSFRGFVDYCLQKIPQERP 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 69/276 (25%), Positives = 117/276 (42%), Gaps = 39/276 (14%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICND------EESLESAMKEISVMKSLKGHP 84
V+ +G + VY + + A+K + + E+ E +E+ ++KSLK H
Sbjct: 6 EVLGKGAYGTVYCG--LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HV 62
Query: 85 NVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
N+V Y T LD + ME ++ + NR G E + + + V
Sbjct: 63 NIVQ-YLGTCLDDNTIS---IFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAY 117
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRK-HTT 203
+H+ + HRD+K N++L +G+ KL DFG +R + G + ++ H T
Sbjct: 118 LHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCA----RRLAWVGLHGTHSNMLKSMHGT 171
Query: 204 PAYRAPEMWDLFRRELINE-----KVDIWALGCLLFRICYFKNAFDGESKLQ----ILNG 254
P + AP E+INE K DIW++GC +F + K +L I
Sbjct: 172 PYWMAP--------EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH 223
Query: 255 NYRIPESP-KYSSSVTDLIRDMLQASPDDRPDITQV 289
+P P +S++ D + L +RP Q+
Sbjct: 224 RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQL 259
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 66/246 (26%), Positives = 116/246 (47%), Gaps = 30/246 (12%)
Query: 23 GNLKIHVR-NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLE-SAMKEISVMKSL 80
G L+ +V+ + + EG ++ V+ R + A+K + EE +A++E+S++K+L
Sbjct: 2 GKLETYVKLDKLGEGTYATVFKGRSKL-TENLVALKEIRLEHEEGAPCTAIREVSLLKNL 60
Query: 81 KGHPNVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVC 139
K H N+VTL+ D+ T+ L LV E D L L+N G + +F+ +
Sbjct: 61 K-HANIVTLH-----DIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLR 114
Query: 140 NAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG---STSTNHKRFEKLEEMGIEED 196
+ + I HRDLK +NLL+ G KL DFG + S K +
Sbjct: 115 GLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN--------- 162
Query: 197 NIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY 256
+ T YR P++ L + +D+W +GC+L+ + + F G + + L+ +
Sbjct: 163 ---EVVTLWYRPPDV--LLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF 217
Query: 257 RIPESP 262
R+ +P
Sbjct: 218 RLLGTP 223
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 79/294 (26%), Positives = 123/294 (41%), Gaps = 49/294 (16%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKH-MICNDEESLES-AMKEISVMKSLKGHPNVVTLY 90
I EG + VY ARD + K A+K + DEE + A++EIS+++ L +V L
Sbjct: 9 IGEGTYGKVYKARD-KNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 91 A--HTILDLGRTKEALLVMECCDKSLVNVLENRGAGY---FEEKQVLAIFRDVCNAVFAM 145
H G+ LV E D L +++ G G K + + + V
Sbjct: 68 DVEHVEEKNGKP-SLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 146 HSQSPPIAHRDLKAENLLLGSD-GLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT-- 202
H + HRDLK +NLL+ GL K+ D G + F ++ +T
Sbjct: 127 HKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLG----RAFSI---------PVKSYTHE 171
Query: 203 --TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPE 260
T YRAPE+ L + VDIW++GC+ + + F G+S+LQ L +++
Sbjct: 172 IVTLWYRAPEV--LLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229
Query: 261 SPKYSS--SVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGLQKSLPDRPPET 312
+P V+ L RD W + P L +++PD PE
Sbjct: 230 TPTEQVWPGVSKL-RD---------------WHEFPQWKPQDLSRAVPDLSPEG 267
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 75/270 (27%), Positives = 118/270 (43%), Gaps = 44/270 (16%)
Query: 30 RNVIAEGGFSCVYSAR--DAIHMSKQYAMK----HMICNDEESLESAMKEISVMKSLKGH 83
V+ +GG+ V+ R K +AMK I +++ E ++++++K H
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-H 59
Query: 84 PNVVTL-YAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCN 140
P +V L YA +T L L++E L LE G F E ++
Sbjct: 60 PFIVDLIYAF------QTGGKLYLILEYLSGGELFMHLEREGI--FMEDTACFYLSEISL 111
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRK 200
A+ +H Q I +RDLK EN+LL + G KL DFG L + I E +
Sbjct: 112 ALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFG-----------LCKESIHEGTV-T 157
Query: 201 HT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILN 253
HT T Y APE + R + VD W+LG L++ + F E++ + IL
Sbjct: 158 HTFCGTIEYMAPE---ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
Query: 254 GNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
G +P P + DL++ +L+ +P R
Sbjct: 215 GKLNLP--PYLTPEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 58/234 (24%), Positives = 101/234 (43%), Gaps = 36/234 (15%)
Query: 36 GGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLY----- 90
G V+SA D+ K+ A+K ++ D +S++ A++EI +++ L H N+V +Y
Sbjct: 16 GSNGLVFSAVDS-DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD-HDNIVKVYEVLGP 73
Query: 91 -----AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
+ L +V E + L NVLE G E+ + + +
Sbjct: 74 SGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ---GPLSEEHARLFMYQLLRGLKYI 130
Query: 146 HSQSPPIAHRDLKAENLLLGSDGL-WKLCDFG-----STSTNHKRFEKLEEMGIEEDNIR 199
HS + + HRDLK N+ + ++ L K+ DFG +HK + G+
Sbjct: 131 HSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYL---SEGL------ 179
Query: 200 KHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN 253
T YR+P + L + +D+WA GC+ + K F G +L+ +
Sbjct: 180 --VTKWYRSPRL--LLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 33/273 (12%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMI--------CNDEESLESAMK-EISVMKSLKG 82
+I G F VY +A + A+K + + + S+ A+ EI+++K L+
Sbjct: 7 LIGSGSFGSVYLGMNASS-GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ- 64
Query: 83 HPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAV 142
H N+V Y + LD + + S+ +L N GA FEE V R + +
Sbjct: 65 HENIVQ-YLGSSLD--ADHLNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGL 119
Query: 143 FAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT 202
+H++ I HRD+K N+L+ + G K+ DFG K E
Sbjct: 120 NYLHNRG--IIHRDIKGANILVDNKGGIKISDFG--------ISKKLEANSLSTKTNGA- 168
Query: 203 TPAYRAPEMW---DLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN--GNYR 257
P+ + W ++ ++ K DIW+LGCL+ + K+ F ++LQ + G
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA 228
Query: 258 IPESPKY-SSSVTDLIRDMLQASPDDRPDITQV 289
PE P SS D + + + RP ++
Sbjct: 229 SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAEL 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 21/221 (9%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLE-SAMKEISVMKSLKG--HPNVVT 88
I G + VY ARD H A+K + + +E+ L S ++E++++K L+ HPN+V
Sbjct: 8 IGVGAYGTVYKARD-PHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 89 LY-AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
L R + LV E D+ L L+ + + + R + +H+
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYR 207
I HRDLK EN+L+ S G KL DFG ++ + + T YR
Sbjct: 127 NC--IVHRDLKPENILVTSGGQVKLADFG--------LARIYSCQMALTPVV--VTLWYR 174
Query: 208 APEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK 248
APE + + VD+W++GC+ + K F G S+
Sbjct: 175 APE---VLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 33/224 (14%)
Query: 71 MKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEK 129
+ E +MK L+ HP ++ LYA L+ + +V E SL+ L+ +
Sbjct: 49 LAEAQIMKKLR-HPKLIQLYAVCTLE----EPIYIVTELMKYGSLLEYLQGGAGRALKLP 103
Query: 130 QVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLE 189
Q++ + V + + + +Q+ HRDL A N+L+G + + K+ DFG
Sbjct: 104 QLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLAR---------- 151
Query: 190 EMGIEEDNIRKHTTPA-----YRAPEMWDLFRRELINEKVDIWALGCLLFRI-CYFKNAF 243
+ +++I + A + APE L+ R I K D+W+ G LL I Y + +
Sbjct: 152 ---VIKEDIYEAREGAKFPIKWTAPEA-ALYNRFSI--KSDVWSFGILLTEIVTYGRMPY 205
Query: 244 DGESKLQIL---NGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
G + ++L + YR+P P + D++ D + PDDRP
Sbjct: 206 PGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRP 249
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 63/246 (25%), Positives = 113/246 (45%), Gaps = 30/246 (12%)
Query: 23 GNLKIHVR-NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLE-SAMKEISVMKSL 80
G ++ +++ + EG ++ V+ R + A+K + EE +A++E+S++K L
Sbjct: 3 GKMETYIKLEKLGEGTYATVFKGRSKL-TENLVALKEIRLEHEEGAPCTAIREVSLLKDL 61
Query: 81 KGHPNVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVC 139
K H N+VTL+ D+ T ++L LV E DK L +++ G V +
Sbjct: 62 K-HANIVTLH-----DIVHTDKSLTLVFEYLDKDLKQYMDDCGN-IMSMHNVKIFLYQIL 114
Query: 140 NAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG---STSTNHKRFEKLEEMGIEED 196
+ H + + HRDLK +NLL+ G KL DFG + S K +
Sbjct: 115 RGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN--------- 163
Query: 197 NIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY 256
+ T YR P++ L + ++D+W +GC+ F + + F G + L+ +
Sbjct: 164 ---EVVTLWYRPPDV--LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218
Query: 257 RIPESP 262
R+ +P
Sbjct: 219 RLLGTP 224
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 57/227 (25%), Positives = 100/227 (44%), Gaps = 25/227 (11%)
Query: 65 ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCD-KSLVNVLENRGA 123
+ ++ +KE ++M SL H N++ LY + T ++V E SL++ L
Sbjct: 38 DIMDDFLKEAAIMHSLD-HENLIRLYG-----VVLTHPLMMVTELAPLGSLLDRLRKDAL 91
Query: 124 GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183
G+F + + N + + S+ HRDL A N+LL SD K+ DFG +
Sbjct: 92 GHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLM----R 145
Query: 184 RFEKLEEMGIEEDNIRKHTTP-AYRAPEMWDLFRRELINEKVDIWALGCLLFRI-CYFKN 241
+ E+ + E++++ P A+ APE R + D+W G L+ + Y +
Sbjct: 146 ALPQNEDHYVMEEHLK---VPFAWCAPES---LRTRTFSHASDVWMFGVTLWEMFTYGEE 199
Query: 242 AFDGESKLQIL---NGNYRIPESPKYSSS-VTDLIRDMLQASPDDRP 284
+ G S QIL + E P+ + +++ +P DRP
Sbjct: 200 PWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRP 246
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 61/264 (23%), Positives = 112/264 (42%), Gaps = 30/264 (11%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVT 88
+ + G F V+ + + A+K + +D + KE+ +K L+ H ++++
Sbjct: 10 LERKLGSGYFGEVWEGLWKNRV--RVAIKILKSDDLLKQQDFQKEVQALKRLR-HKHLIS 66
Query: 89 LYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
L+A + +G ++ E +K SL+ L + ++ + V + +
Sbjct: 67 LFA--VCSVGEP--VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTP-AY 206
Q+ HRDL A N+L+G D + K+ DFG R K E++ + D P +
Sbjct: 123 QN--SIHRDLAARNILVGEDLVCKVADFGLA-----RLIK-EDVYLSSD----KKIPYKW 170
Query: 207 RAPEMWDLFRRELINEKVDIWALGCLLFRI-----CYFKNAFDGESKLQILNGNYRIPES 261
APE + K D+W+ G LL+ + + + E QI G YR+P
Sbjct: 171 TAPEA---ASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPCP 226
Query: 262 PKYSSSVTDLIRDMLQASPDDRPD 285
K + ++ + A P+DRP
Sbjct: 227 AKCPQEIYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 67/274 (24%), Positives = 124/274 (45%), Gaps = 35/274 (12%)
Query: 20 IDVGNLKIHVRNVIAEG----GFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEIS 75
+D G+ + ++ N I G G C+ + + + K A+K M ++ E E+
Sbjct: 13 VDPGDPRTYLDNFIKIGEGSTGIVCIATVKSS---GKLVAVKKMDLRKQQRRELLFNEVV 69
Query: 76 VMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAI 134
+M+ + H NVV +Y ++ E +VME + +L +++ + E+Q+ A+
Sbjct: 70 IMRDYQ-HENVVEMYNSYLVG----DELWVVMEFLEGGALTDIVTHT---RMNEEQIAAV 121
Query: 135 FRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIE 194
V A+ +H+Q + HRD+K++++LL DG KL DFG + K + + +
Sbjct: 122 CLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL--- 176
Query: 195 EDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL-- 252
TP + APE L R +VDIW+LG ++ + + + E L+ +
Sbjct: 177 ------VGTPYWMAPE---LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM 227
Query: 253 ---NGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
N ++ K S S+ + +L P R
Sbjct: 228 IRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 68/238 (28%), Positives = 107/238 (44%), Gaps = 32/238 (13%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLY 90
I EG + VY ARD ++ A+K + DE +A++EIS++K ++ H N+V L
Sbjct: 10 IGEGTYGVVYKARDR-VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQ 67
Query: 91 AHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS 149
D+ +++ L LV E D L +++ + + + + HS
Sbjct: 68 -----DVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR 122
Query: 150 PPIAHRDLKAENLLLG-SDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT----TP 204
+ HRDLK +NLL+ KL DFG GI +R T T
Sbjct: 123 --VLHRDLKPQNLLIDRRTNALKLADFGLARA----------FGIP---VRTFTHEVVTL 167
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESP 262
YRAPE+ L + VDIW++GC+ + K F G+S++ L +RI +P
Sbjct: 168 WYRAPEI--LLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTP 223
|
Length = 294 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 76/319 (23%), Positives = 117/319 (36%), Gaps = 98/319 (30%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMK-------HMICNDEESLESAMKEISVMKSLK 81
+ I EG + V SA K A+K C + ++EI +++ K
Sbjct: 9 NLSYIGEGAYGMVCSATHKPTGVK-VAIKKISPFEHQTFC------QRTLREIKILRRFK 61
Query: 82 GHPNVVTLYAHTILDLGRT------KEALLVMECCDKSLVNV-----LENRGAGYFEEKQ 130
H N++ ILD+ R + +V E + L + L N YF
Sbjct: 62 -HENIIG-----ILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYF---- 111
Query: 131 VLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG---STSTNHKRFEK 187
+ I R + +HS + + HRDLK NLLL ++ K+CDFG H
Sbjct: 112 LYQILR----GLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165
Query: 188 LEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEK-----VDIWALGCLLFRICYFKNA 242
L E T YRAPE+ ++N K +DIW++GC+L + +
Sbjct: 166 LTEY---------VATRWYRAPEI-------MLNSKGYTKAIDIWSVGCILAEMLSNRPL 209
Query: 243 FDGESKLQILN----------------------GNY--------RIPES---PKYSSSVT 269
F G+ L LN NY ++P + P
Sbjct: 210 FPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKAL 269
Query: 270 DLIRDMLQASPDDRPDITQ 288
DL+ ML +P R + +
Sbjct: 270 DLLDKMLTFNPHKRITVEE 288
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 35/226 (15%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLE-SAMKEISVMKSLKGHPNVVTLYA 91
+ EG ++ VY + ++ K A+K + +EE +A++E S++K LK H N+V L+
Sbjct: 13 LGEGSYATVYKGKSKVN-GKLVALKVIRLQEEEGTPFTAIREASLLKGLK-HANIVLLH- 69
Query: 92 HTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSP 150
D+ TKE L LV E L ++ G E L +F+ + + +H +
Sbjct: 70 ----DIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQ-LLRGLSYIHQRY- 123
Query: 151 PIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT------TP 204
I HRDLK +NLL+ G KL DFG ++ HT T
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLARAK---------------SVPSHTYSNEVVTL 167
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ 250
YR P++ L + +D+W +GC+ + AF G +Q
Sbjct: 168 WYRPPDV--LLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 81/283 (28%), Positives = 128/283 (45%), Gaps = 60/283 (21%)
Query: 32 VIAEGGFSCVYSARDAIHMS--KQYAMKHMICNDEESLESAMKEISVMK---SLKGHPNV 86
+I+ G + VY R H +++AMK I L + ++++ V + + +P V
Sbjct: 8 LISNGAYGAVYLVR---HKETRQRFAMKK-INKQNLILRNQIQQVFVERDILTFAENPFV 63
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGA-------GYFEEKQVLAIFRD 137
V+++ TK L +VME + +L+N GA YF E VLA+
Sbjct: 64 VSMFCSF-----ETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAET-VLALEY- 116
Query: 138 VCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-------STSTNHKRFEKLEE 190
+H+ I HRDLK +NLL+ S G KL DFG S +TN L E
Sbjct: 117 -------LHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN------LYE 161
Query: 191 MGIEEDN---IRKHT--TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDG 245
IE+D + K TP Y APE + R+ + VD WA+G +L+ F G
Sbjct: 162 GHIEKDTREFLDKQVCGTPEYIAPE---VILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
Query: 246 ESK----LQILNGNYRIPESPK-YSSSVTDLIRDMLQASPDDR 283
++ Q+++ + PE + + DLI +L+ +P +R
Sbjct: 219 DTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYA 91
V+ G + VY R + + A+K M ++E E EI+++K H N+ T Y
Sbjct: 23 VVGNGTYGQVYKGRH-VKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYG 80
Query: 92 HTILD--LGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQ 148
I G + LVME C S+ ++++N +E + I R++ + +H+
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140
Query: 149 SPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---TPA 205
+ HRD+K +N+LL + KL DFG ++ ++ R++T TP
Sbjct: 141 K--VIHRDIKGQNVLLTENAEVKLVDFGVSAQ------------LDRTVGRRNTFIGTPY 186
Query: 206 YRAPEM--WDLFRRELINEKVDIWALG 230
+ APE+ D + + DIW+LG
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLG 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 71/281 (25%), Positives = 122/281 (43%), Gaps = 50/281 (17%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHM--ICNDEESLESAMKEISVMKSLKGHPNVVTLY 90
I +G + V+ + + SK A+K + I + +E +E+ E +++K+L HPNVV Y
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKA-AVKILDPIHDIDEEIEA---EYNILKALSDHPNVVKFY 81
Query: 91 A-HTILDLGRTKEALLVMECCD----KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
+ D+ + LV+E C+ LV RG EE + I + + +
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE-RMEEPIIAYILHEALMGLQHL 140
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS----TSTNHKRFEKLEEMGIEEDNIRKH 201
H HRD+K N+LL ++G KL DFG TST +R +
Sbjct: 141 HVNK--TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV------------- 185
Query: 202 TTPAYRAPEMWDLFRR--ELINEKVDIWALGCLLFRICYFKNAFDGE---SKLQILNGNY 256
TP + APE+ ++ + + D+W+LG + DG+ + L + +
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELG------DGDPPLADLHPMRALF 239
Query: 257 RIPESPK--------YSSSVTDLIRDMLQASPDDRPDITQV 289
+IP +P +S+ D IR L + RP ++ +
Sbjct: 240 KIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 38/265 (14%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHM---ICNDEESLESAMKEISVMKSLKGHPN 85
V++++ G F V R+ YAMK M + +E++ +E ++ S+ P
Sbjct: 5 VKSLVGRGHFGEVQVVREKA-TGDIYAMKVMKKSVLLAQETVSFFEEERDIL-SISNSPW 62
Query: 86 VVTL-YAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143
+ L YA + K+ L LVME + L NR F+E ++ A+
Sbjct: 63 IPQLQYAF------QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIH 116
Query: 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST---STNHKRFEKLEEMGIEEDNIRK 200
++H HRD+K EN+L+ G KL DFGS + N KL +G
Sbjct: 117 SVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKL-PVG-------- 165
Query: 201 HTTPAYRAPEMW---DLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG--N 255
TP Y APE+ + + + D W+LG + + + Y ++ F + + N N
Sbjct: 166 --TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN 223
Query: 256 Y----RIPESPKYSSSVTDLIRDML 276
+ + PE PK SS DLI+ +L
Sbjct: 224 FQRFLKFPEDPKVSSDFLDLIQSLL 248
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 70/269 (26%), Positives = 121/269 (44%), Gaps = 28/269 (10%)
Query: 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTL 89
R V+ +G + VY+ARD + + A+K + D ++ +EI++ LK H N+V
Sbjct: 13 RVVLGKGTYGIVYAARD-LSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLK-HRNIVQ- 69
Query: 90 YAHTILDLGRTKEALLVME-CCDKSLVNVLENRGAGYFEEKQVLAIF-RDVCNAVFAMHS 147
Y + + G K + ME SL +L ++ + +Q + + + + + +H
Sbjct: 70 YLGSDSENGFFK---IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126
Query: 148 QSPPIAHRDLKAENLLLGS-DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT-TPA 205
I HRD+K +N+L+ + G+ K+ DFG++ KR + T T
Sbjct: 127 NQ--IVHRDIKGDNVLVNTYSGVVKISDFGTS----KRLAGINPC------TETFTGTLQ 174
Query: 206 YRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFD--GESKLQILN-GNYRI-PES 261
Y APE+ D R DIW+LGC + + K F GE + + G ++I PE
Sbjct: 175 YMAPEVIDKGPRGY-GAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI 233
Query: 262 PK-YSSSVTDLIRDMLQASPDDRPDITQV 289
P+ S+ + I + PD R +
Sbjct: 234 PESLSAEAKNFILRCFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 67/274 (24%), Positives = 116/274 (42%), Gaps = 36/274 (13%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLESAMKEISVMKSLKGHPNVVTLY 90
++ G + VY R + + A+K M + DEE E +EI+++K H N+ T Y
Sbjct: 13 LVGNGTYGQVYKGRH-VKTGQLAAIKVMDVTGDEE--EEIKQEINMLKKYSHHRNIATYY 69
Query: 91 AHTILD--LGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
I G + LVME C S+ ++++N +E+ + I R++ + +H
Sbjct: 70 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ 129
Query: 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---TP 204
+ HRD+K +N+LL + KL DFG ++ ++ R++T TP
Sbjct: 130 HK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQ------------LDRTVGRRNTFIGTP 175
Query: 205 AYRAPEM--WDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESP 262
+ APE+ D + K D+W+LG + ++ L + IP +P
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---FLIPRNP 232
Query: 263 -------KYSSSVTDLIRDMLQASPDDRPDITQV 289
K+S I L + RP Q+
Sbjct: 233 APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 31/228 (13%)
Query: 66 SLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVME-CCDKSLVNVLENRGAG 124
S E+ ++E +MK L+ H +V LYA + +V E SL++ L++
Sbjct: 44 SPEAFLQEAQIMKKLR-HDKLVQLYAV----CSEEEPIYIVTEYMSKGSLLDFLKSGEGK 98
Query: 125 YFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKR 184
Q++ + + + + S++ HRDL A N+L+G + + K+ DFG
Sbjct: 99 KLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFG-------- 148
Query: 185 FEKLEEMGIEEDNIRKHTTPAY----RAPEMWDLFRRELINEKVDIWALGCLLFRI-CYF 239
L + IE+D + APE + R I K D+W+ G LL I Y
Sbjct: 149 ---LARL-IEDDEYTAREGAKFPIKWTAPEA-ANYGRFTI--KSDVWSFGILLTEIVTYG 201
Query: 240 KNAFDGESK---LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
+ + G + L+ + YR+P P + DL+ P++RP
Sbjct: 202 RVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-09
Identities = 66/235 (28%), Positives = 110/235 (46%), Gaps = 24/235 (10%)
Query: 73 EISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLEN--RGAGYFEEK 129
E++VM+ LK H N+V Y L+ K +L ME CD L ++ + G EE
Sbjct: 62 EVNVMRELK-HKNIVR-YIDRFLNKANQKLYIL-MEFCDAGDLSRNIQKCYKMFGKIEEH 118
Query: 130 QVLAIFRDVCNAVFAMHS-----QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK- 183
++ I R + +A+ H+ + HRDLK +N+ L S G+ + + + N
Sbjct: 119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL-STGIRHIGKITAQANNLNG 177
Query: 184 -------RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI 236
F + +GIE TP Y +PE+ L + ++K D+WALGC+++ +
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELL-LHETKSYDDKSDMWALGCIIYEL 236
Query: 237 CYFKNAFDGESKL-QILNGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQ 288
C K F + Q+++ R P+ P S + LI+++L S +RP Q
Sbjct: 237 CSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQ 291
|
Length = 1021 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 56/192 (29%), Positives = 88/192 (45%), Gaps = 24/192 (12%)
Query: 49 HMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVME 108
+ + A+K I ND + ++ + E SVM L+ H N+V L + + G +V E
Sbjct: 27 YRGNKVAVK-CIKNDATA-QAFLAEASVMTQLR-HSNLVQLLGVIVEEKG---GLYIVTE 80
Query: 109 CCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD 167
K SLV+ L +RG +L DVC A+ + + + HRDL A N+L+ D
Sbjct: 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSED 138
Query: 168 GLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIW 227
+ K+ DFG T +E +D + + APE R + + K D+W
Sbjct: 139 NVAKVSDFGLT----------KEASSTQDTGKLPVK--WTAPEA---LREKKFSTKSDVW 183
Query: 228 ALGCLLFRICYF 239
+ G LL+ I F
Sbjct: 184 SFGILLWEIYSF 195
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 49/167 (29%), Positives = 72/167 (43%), Gaps = 24/167 (14%)
Query: 124 GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183
G F E + ++ A+ +H I +RDLK EN+LL + G LCDFG + N
Sbjct: 91 GRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLT 148
Query: 184 RFEKLEEMGIEEDNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK 240
DN +T T Y APE+ L + + VD W+LG L+F +C
Sbjct: 149 ------------DNKTTNTFCGTTEYLAPEV--LLDEKGYTKHVDFWSLGVLVFEMCCGW 194
Query: 241 NAFDGESKLQ----ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
+ F E Q I G R P++ S ++ +L +P R
Sbjct: 195 SPFYAEDTQQMYRNIAFGKVRFPKN-VLSDEGRQFVKGLLNRNPQHR 240
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 72/266 (27%), Positives = 109/266 (40%), Gaps = 55/266 (20%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVM-KSLKGHPN 85
VI +G F V A+ K YA+K ++ E+ M E +V+ K++K HP
Sbjct: 2 VIGKGSFGKVLLAKHKAD-GKFYAVKVLQKKAILKKKEQK--HIMAERNVLLKNVK-HPF 57
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAG----------YFEEKQVLAIF 135
+V L+ +T + L VL+ G F E +
Sbjct: 58 LVGLHYSF-----QTADKLYF----------VLDYVNGGELFFHLQRERSFPEPRARFYA 102
Query: 136 RDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEE 195
++ +A+ +HS + I +RDLK EN+LL S G L DFG E + +
Sbjct: 103 AEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCK---------EGIEHSK 151
Query: 196 DNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY----FKNAFDGESKLQI 251
TP Y APE + R++ + VD W LG +L+ + Y F + E I
Sbjct: 152 TTSTFCGTPEYLAPE---VLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
Query: 252 LNGNYRIPESPKYSSSVTDLIRDMLQ 277
LN R+ P S S L+ +LQ
Sbjct: 209 LNKPLRLK--PNISVSARHLLEGLLQ 232
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 68/270 (25%), Positives = 116/270 (42%), Gaps = 47/270 (17%)
Query: 32 VIAEGGF----SCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVV 87
V+ +GGF +C A ++ K+ K + E++ A+ E +++ + VV
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM--ALNEKQILEKVNS-RFVV 63
Query: 88 TL-YAHTILDLGRTKEALLVMECCDKSLVN------VLENRGAGYFEEKQVLAIFRDVCN 140
+L YA+ TK+AL C +L+N + N G F+E++ + ++
Sbjct: 64 SLAYAY------ETKDAL----CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC 113
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRK 200
+ +H + I +RDLK EN+LL G ++ D G L E + IR
Sbjct: 114 GLEDLHRER--IVYRDLKPENILLDDYGHIRISDLG-----------LAVEIPEGETIRG 160
Query: 201 HT-TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDG-ESKLQILNGNYRI 258
T Y APE + + E D W LGCL++ + K+ F + K++ R+
Sbjct: 161 RVGTVGYMAPE---VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV 217
Query: 259 PE-----SPKYSSSVTDLIRDMLQASPDDR 283
E S K+S + + R +L P R
Sbjct: 218 KEDQEEYSEKFSEAARSICRQLLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 69/273 (25%), Positives = 111/273 (40%), Gaps = 55/273 (20%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLES------AMKEISVMKSLKGHPNV 86
+ +GGF V + + K YA K D++ L+ A+ E + +
Sbjct: 1 LGKGGFGEVCACQVK-ATGKMYACK---KLDKKRLKKRKGEQMALNE-KKILEKVSSRFI 55
Query: 87 VTL-YAHTILDLGRTKEAL-LVMECCDKSLVN------VLENRGAGYFEEKQVLAIFRDV 138
V+L YA TK+ L LVM +L+N + N G F E + + +
Sbjct: 56 VSLAYAF------ETKDDLCLVM-----TLMNGGDLKYHIYNVGEPGFPEARAIFYAAQI 104
Query: 139 CNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNI 198
+ +H + I +RDLK EN+LL G ++ D G E+ +
Sbjct: 105 ICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAV----------ELKGGKKIK 152
Query: 199 RKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAF--------DGESKLQ 250
+ TP Y APE + + E+ + VD +ALGC L+ + ++ F E K +
Sbjct: 153 GRAGTPGYMAPE---VLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR 209
Query: 251 ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
L P+ K+S DL +LQ P+ R
Sbjct: 210 TLEMAVEYPD--KFSPEAKDLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 74/301 (24%), Positives = 117/301 (38%), Gaps = 58/301 (19%)
Query: 27 IHVRNVIAEGGFSCVYSAR---DAIHMS------KQYAMKHMICNDEESLESAMKEISVM 77
I ++VI EG F V AR D + M K+YA K +D E+ V+
Sbjct: 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK----DDHRDFAG---ELEVL 61
Query: 78 KSLKGHPNVVTL--------YAHTILDL---GRTKEALLVMECCDKSLVNVLENRGAGYF 126
L HPN++ L Y + ++ G + L + + N A
Sbjct: 62 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121
Query: 127 EEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186
+Q+L DV + + SQ I HRDL A N+L+G + + K+ DFG + +
Sbjct: 122 SSQQLLHFAADVARGMDYL-SQKQFI-HRDLAARNILVGENYVAKIADFGLSRGQEVYVK 179
Query: 187 K------LEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK 240
K + M IE N +TT + D+W+ G LL+ I
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNS-------------------DVWSYGVLLWEIVSLG 220
Query: 241 NA-FDGESKLQI---LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296
+ G + ++ L YR+ + V DL+R + P +RP Q+ +N
Sbjct: 221 GTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280
Query: 297 L 297
L
Sbjct: 281 L 281
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 29/235 (12%)
Query: 55 AMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALL-VMECCDKS 113
A+K + +++ +E M E V+ HP + L+ +TKE L VME +
Sbjct: 27 ALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVMEYLNGG 81
Query: 114 LVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLC 173
+ + + +G F+E + ++ + +H + I +RDLK +N+LL DG K+
Sbjct: 82 DL-MFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIA 138
Query: 174 DFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLL 233
DFG N K TP Y APE + + + NE VD W+ G LL
Sbjct: 139 DFGMCKENMNGEGKASTFC---------GTPDYIAPE---ILKGQKYNESVDWWSFGVLL 186
Query: 234 FRICYFKNAFDGESKLQ----ILNGNYRIPESPKY-SSSVTDLIRDMLQASPDDR 283
+ + ++ F GE + + ILN P P++ S D + + + P R
Sbjct: 187 YEMLIGQSPFHGEDEDELFDSILNDR---PHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 62/245 (25%), Positives = 98/245 (40%), Gaps = 39/245 (15%)
Query: 63 DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR-TKEA--LLVME-CCDKSLVNVL 118
D +E +KE +VMK +K HPN+V L LG T+E ++ E +L++ L
Sbjct: 42 DTMEVEEFLKEAAVMKEIK-HPNLVQL-------LGVCTREPPFYIITEFMTYGNLLDYL 93
Query: 119 ENRGAGYFEEKQVLAIFRDVCNAVFAM-HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS 177
+E + + AM + + HRDL A N L+G + L K+ DFG
Sbjct: 94 RECNR---QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 150
Query: 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAY----RAPEMWDLFRRELINEKVDIWALGCLL 233
+ R + D H + APE + + K D+WA G LL
Sbjct: 151 S-----RL-------MTGDTYTAHAGAKFPIKWTAPESLAYNK---FSIKSDVWAFGVLL 195
Query: 234 FRICYFKNA----FDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
+ I + + D ++L YR+ V +L+R Q +P DRP ++
Sbjct: 196 WEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEI 255
Query: 290 WFRVN 294
Sbjct: 256 HQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 65/277 (23%), Positives = 117/277 (42%), Gaps = 47/277 (16%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLY 90
N+I G F VY A I S++ A+K ++ + + +E+ +MK+L H N++ L
Sbjct: 72 NIIGNGSFGVVYEAI-CIDTSEKVAIKKVL----QDPQYKNRELLIMKNLN-HINIIFLK 125
Query: 91 AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIF------RDVCNAVFA 144
+ + + E + + + + + Y L +F +C A+
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185
Query: 145 MHSQSPPIAHRDLKAENLLLGSDG-LWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTT 203
+HS+ I HRDLK +NLL+ + KLCDFGS + + + ++ +
Sbjct: 186 IHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSA----------KNLLAGQRSVSYICS 233
Query: 204 PAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES---------------- 247
YRAPE+ + +D+W+LGC++ + F G+S
Sbjct: 234 RFYRAPEL--MLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291
Query: 248 --KLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDD 282
+L+ +N NY + P DL + + +PDD
Sbjct: 292 EDQLKEMNPNYADIKFPDVKPK--DLKKVFPKGTPDD 326
|
Length = 440 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 65/263 (24%), Positives = 112/263 (42%), Gaps = 33/263 (12%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAH 92
+ G + VY AR+ +H + A+K + + +EI ++K K H N+V +
Sbjct: 17 VGSGTYGDVYKARN-LHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK-HCNIVAYFGS 74
Query: 93 TILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPI 152
L R K + + C SL ++ G E Q+ + R+ + +HS+
Sbjct: 75 Y---LSREKLWICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLAYLHSKGK-- 127
Query: 153 AHRDLKAENLLLGSDGLWKLCDFGS----TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRA 208
HRD+K N+LL +G KL DFG T+T KR + TP + A
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-------------GTPYWMA 174
Query: 209 PEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL----NGNYRIP---ES 261
PE+ + + N+ DIWA+G + + ++ L N++ P +
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDK 234
Query: 262 PKYSSSVTDLIRDMLQASPDDRP 284
K+SS+ + ++ L +P RP
Sbjct: 235 TKWSSTFHNFVKISLTKNPKKRP 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 8e-09
Identities = 63/259 (24%), Positives = 111/259 (42%), Gaps = 37/259 (14%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMI--CNDEESLESAMKEISVMKSLKGHPNVVTLY 90
I G V +A DA+ + + A+K + ++ + A +E+ +MK + H N+++L
Sbjct: 25 IGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLL 82
Query: 91 AHTILDLGRTKEAL----LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH 146
+ ++ E LVME D +L V++ E+ +++ +C H
Sbjct: 83 --NVFTPQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI---KH 134
Query: 147 SQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAY 206
S I HRDLK N+++ SD K+ DFG T F + T Y
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV----------VTRYY 184
Query: 207 RAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPES----- 261
RAPE + E VDIW++GC++ + K F G + N ++ E
Sbjct: 185 RAPE---VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN---KVIEQLGTPC 238
Query: 262 PKYSSSVTDLIRDMLQASP 280
P++ + +R+ ++ P
Sbjct: 239 PEFMKKLQPTVRNYVENRP 257
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLE-SAMKEISVMKSLKGHPNVVTLYA 91
+ EG ++ VY I+ + A+K + EE + +A++E S++K LK H N+V L+
Sbjct: 13 LGEGSYATVYKGISRIN-GQLVALKVISMKTEEGVPFTAIREASLLKGLK-HANIVLLH- 69
Query: 92 HTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSP 150
D+ TKE L V E L + G L +F+ + + +H Q
Sbjct: 70 ----DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQ-LLRGLAYIHGQH- 123
Query: 151 PIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPE 210
I HRDLK +NLL+ G KL DFG R + + + + T YR P+
Sbjct: 124 -ILHRDLKPQNLLISYLGELKLADFGLA-----RAKSIPSQTYSSEVV----TLWYRPPD 173
Query: 211 MWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES 247
+ L + +DIW GC+ + + AF G S
Sbjct: 174 V--LLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 66/259 (25%), Positives = 112/259 (43%), Gaps = 32/259 (12%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYA 91
I +G F V+ D K A+K + + E+ +E +EI+V+ P V Y
Sbjct: 12 IGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYG 69
Query: 92 HTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPP 151
+ D TK +++ S +++LE G +E Q+ I R++ + +HS+
Sbjct: 70 SYLKD---TKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEKK- 122
Query: 152 IAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEM 211
HRD+KA N+LL G KL DFG +L + I+ + TP + APE
Sbjct: 123 -IHRDIKAANVLLSEHGEVKLADFGVAG-------QLTDTQIKRNTFVG--TPFWMAPE- 171
Query: 212 WDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESP------KYS 265
+ ++ + K DIW+LG + + S+L + + IP++ YS
Sbjct: 172 --VIKQSAYDSKADIWSLGITAIELAKGEPP---HSELHPMKVLFLIPKNNPPTLEGNYS 226
Query: 266 SSVTDLIRDMLQASPDDRP 284
+ + + L P RP
Sbjct: 227 KPLKEFVEACLNKEPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 53/231 (22%), Positives = 87/231 (37%), Gaps = 37/231 (16%)
Query: 71 MKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQ 130
++E+ ++ P +V Y + + ME D ++ + G E+
Sbjct: 47 LRELDILHKCN-SPYIVGFYGAFY----NNGDISICMEYMDGGSLDKILKEVQGRIPERI 101
Query: 131 VLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STS-TNHKRFEKL 188
+ I V + +H + I HRD+K N+L+ S G KLCDFG S N
Sbjct: 102 LGKIAVAVLKGLTYLHEKHK-IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN------- 153
Query: 189 EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALG-----CLLFRICYFKNAF 243
+ + + T +Y APE + + K DIW+LG R Y
Sbjct: 154 ---SLAKTFV---GTSSYMAPER---IQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND 204
Query: 244 DGESKLQILNGNYRIPESP------KYSSSVTDLIRDMLQASPDDRPDITQ 288
+ ++L Y + E P K+S D + L P +RP +
Sbjct: 205 PPDGIFELL--QYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 36/111 (32%), Positives = 52/111 (46%), Gaps = 25/111 (22%)
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRK 200
AV A+H HRDLK EN L+ + G KL DFG L + +
Sbjct: 113 AVDALHELG--YIHRDLKPENFLIDASGHIKLTDFG-----------LSKGIVT----YA 155
Query: 201 HT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFR-ICYFKNAFDGES 247
++ +P Y APE+ R + + VD W+LGC+L+ +C F F G +
Sbjct: 156 NSVVGSPDYMAPEV---LRGKGYDFTVDYWSLGCMLYEFLCGF-PPFSGST 202
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 72/274 (26%), Positives = 102/274 (37%), Gaps = 57/274 (20%)
Query: 36 GGFSC--VYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGH--PNVVTLY 90
G +C VY R A+K M +E + + ++ V+ LK H P +V Y
Sbjct: 24 GSGTCGQVYKMR-FKKTGHVMAVKQMRRTGNKEENKRILMDLDVV--LKSHDCPYIVKCY 80
Query: 91 AHTILDLGRTKEALLVME----CCDKSLVNVLENRGAGYFEE----KQVLAIFRDVCNAV 142
+ I D + + ME C DK L R G E K +AI V
Sbjct: 81 GYFITDS----DVFICMELMSTCLDK-----LLKRIQGPIPEDILGKMTVAI-------V 124
Query: 143 FAMH--SQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRK 200
A+H + + HRD+K N+LL + G KLCDFG + R ++ R
Sbjct: 125 KALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG----RL--VDSKA----KTRS 174
Query: 201 HTTPAYRAPEMWDLFRRELINEKVDI----WALGCLLFRIC-----YFKNAFDGESKLQI 251
AY APE D N K DI W+LG L + Y + E +I
Sbjct: 175 AGCAAYMAPERIDP---PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231
Query: 252 LNGNY-RIPESPKYSSSVTDLIRDMLQASPDDRP 284
L +P + +S + L RP
Sbjct: 232 LQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 10/105 (9%)
Query: 149 SPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRA 208
S I HRD+K NLL+ S+ + K+CDFG ++EE + ++ T YRA
Sbjct: 121 SAGILHRDIKPGNLLVNSNCVLKICDFG--------LARVEEPDESKHMTQEVVTQYYRA 172
Query: 209 PEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN 253
PE+ L VDIW++GC+ + + F +S +Q L+
Sbjct: 173 PEI--LMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD 215
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 81/326 (24%), Positives = 134/326 (41%), Gaps = 71/326 (21%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESA---MKEISVMKSLKGHPN 85
++ VI +G + V SA D H ++ A+K I + E + A ++EI +++ L+ HP+
Sbjct: 4 IQEVIGKGSYGVVCSAIDT-HTGEKVAIKK-INDVFEHVSDATRILREIKLLRLLR-HPD 60
Query: 86 VVTLYAHTILDLGRT--KEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143
+V + H +L R K+ +V E + L V++ E Q + A+
Sbjct: 61 IVEI-KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFF--LYQLLRALK 117
Query: 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTT 203
+H+ + + HRDLK +N+L +D K+CDFG F D + T
Sbjct: 118 YIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVA---FNDTPTAIFWTDYV---AT 169
Query: 204 PAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESPK 263
YRAPE+ F + +DIW++GC+ + K F G++ + L
Sbjct: 170 RWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL----------- 217
Query: 264 YSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGLQKSLPDRPPETQSAVANEGMSK 323
DLI D+L +P PET S V NE +
Sbjct: 218 ------DLITDLL-GTP----------------------------SPETISRVRNEKARR 242
Query: 324 ---PMNRSPPMP--QRSPPPPPSSVD 344
M + P+P Q+ P P ++
Sbjct: 243 YLSSMRKKQPVPFSQKFPNADPLALR 268
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 45/147 (30%), Positives = 68/147 (46%), Gaps = 24/147 (16%)
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEED 196
+V +A+ +HS + I +RDLK EN+LL S G L DFG L + G+E +
Sbjct: 104 EVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFG-----------LCKEGVEPE 150
Query: 197 NIRKH--TTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ---- 250
TP Y APE + R+E + VD W LG +L+ + Y F Q
Sbjct: 151 ETTSTFCGTPEYLAPE---VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDN 207
Query: 251 ILNGNYRIPESPKYSSSVTDLIRDMLQ 277
IL+ ++P + + DL+ +L
Sbjct: 208 ILHKPLQLP--GGKTVAACDLLVGLLH 232
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 64/256 (25%), Positives = 115/256 (44%), Gaps = 31/256 (12%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMK------EISVMKSLKGHPN 85
++ G F VY DA ++ A+K + D +S E++ + EI ++K+L+ H
Sbjct: 9 LLGRGAFGEVYLCYDA-DTGRELAVKQ-VPFDPDSQETSKEVNALECEIQLLKNLR-HDR 65
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
+V Y + D K ++ V S+ + L+ GA E R + V +
Sbjct: 66 IVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYL 122
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT-TP 204
HS I HRD+K N+L S G KL DFG++ ++++ + + I+ T TP
Sbjct: 123 HSNM--IVHRDIKGANILRDSAGNVKLGDFGAS-------KRIQTICMSGTGIKSVTGTP 173
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRI---PES 261
+ +PE + E K D+W++ C + + K + ++ + + ++I P
Sbjct: 174 YWMSPE---VISGEGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTK 227
Query: 262 PKYSSSVTDLIRDMLQ 277
P V+D RD L+
Sbjct: 228 PMLPDGVSDACRDFLK 243
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 65/265 (24%), Positives = 114/265 (43%), Gaps = 37/265 (13%)
Query: 32 VIAEGGF----SCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVV 87
V+ +GGF +C A ++ K+ K + ES+ A+ E +++ + V
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESM--ALNEKQILEKVNSQFVVN 64
Query: 88 TLYAHTILDLGRTKEAL-LVMECCDKSLVNV-LENRGAGYFEEKQVLAIFRDVCNAVFAM 145
YA+ TK+AL LV+ + + + N G FEE++ L ++ + +
Sbjct: 65 LAYAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT-TP 204
H ++ +RDLK EN+LL G ++ D G L E ++IR T
Sbjct: 119 HREN--TVYRDLKPENILLDDYGHIRISDLG-----------LAVKIPEGESIRGRVGTV 165
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDG-ESKLQILNGNYRIPE--- 260
Y APE + + D W LGCL++ + ++ F G + K++ + R+ E
Sbjct: 166 GYMAPE---VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE 222
Query: 261 --SPKYSSSVTDLIRDMLQASPDDR 283
S K+S + + +L P R
Sbjct: 223 VYSAKFSEEAKSICKMLLTKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 67/288 (23%), Positives = 108/288 (37%), Gaps = 54/288 (18%)
Query: 33 IAEGGFSCVYSARDAIHMSKQ-------YAMKHMICNDEESLESAMKEISVMKSLKGHPN 85
+ EG F V A +A+ + M +++ L + E+ +MK + H N
Sbjct: 20 LGEGAFGQVVKA-EAVGLDNPNETSTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHKN 77
Query: 86 VVTLYAHTILDLGR-TKEALL--VMECCDK-SLVNVLENRGAGYFEEKQVLAI------- 134
++ L LG T+E L V+E +L + L R
Sbjct: 78 IINL-------LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 135 FRDVCNAVFAM-----HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLE 189
+D+ + + + S HRDL A N+L+ D + K+ DFG H
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH------- 183
Query: 190 EMGIEEDNIRKHTTPAYRAPEMW----DLFRRELINEKVDIWALGCLLFRICYFKNA-FD 244
D RK T R P W LF R + + D+W+ G LL+ I + +
Sbjct: 184 ----HIDYYRKTTNG--RLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYP 236
Query: 245 G---ESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
G E ++L YR+ + + + L+RD P RP Q+
Sbjct: 237 GIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQL 284
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 65/270 (24%), Positives = 104/270 (38%), Gaps = 40/270 (14%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMIC-NDEESLESAMKEISVMKSLKGHPNVVTLYA 91
I G F V A+K + DE+ + + ++ V+ P +V Y
Sbjct: 12 IGRGAFGTVNKMLHK-PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 92 HTILDLGRTKEALLVMECCDKSLVN---VLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQ 148
R + + ME D SL + E+ + I A+ + +
Sbjct: 71 ALF----REGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE 126
Query: 149 SPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPA--- 205
I HRD+K N+LL +G KLCDFG + G D+I K T A
Sbjct: 127 LK-IIHRDVKPSNILLDRNGNIKLCDFGIS-------------GQLVDSIAK-TRDAGCR 171
Query: 206 -YRAPEMWDLFRRELINEKVDIWALGCLLFRIC-----Y--FKNAFDGESKLQILNGNY- 256
Y APE D R+ + + D+W+LG L+ + Y + + FD + Q++ G+
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLT--QVVKGDPP 229
Query: 257 RIPESPK--YSSSVTDLIRDMLQASPDDRP 284
+ S + +S S + I L RP
Sbjct: 230 ILSNSEEREFSPSFVNFINLCLIKDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 65/256 (25%), Positives = 117/256 (45%), Gaps = 31/256 (12%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMK------EISVMKSLKGHPN 85
++ +G F VY DA ++ A+K + D ES E++ + EI ++K+L H
Sbjct: 9 LLGQGAFGRVYLCYDA-DTGRELAVKQ-VQFDPESPETSKEVNALECEIQLLKNLL-HER 65
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
+V Y + D ++ + S+ + L++ GA E R + V +
Sbjct: 66 IVQYYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYL 122
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT-TP 204
HS I HRD+K N+L S G KL DFG++ ++L+ + + ++ T TP
Sbjct: 123 HSNM--IVHRDIKGANILRDSVGNVKLGDFGAS-------KRLQTICLSGTGMKSVTGTP 173
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRI---PES 261
+ +PE + E K DIW++GC + + K + ++ + + ++I P +
Sbjct: 174 YWMSPE---VISGEGYGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN 227
Query: 262 PKYSSSVTDLIRDMLQ 277
P V+D RD L+
Sbjct: 228 PVLPPHVSDHCRDFLK 243
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 70/266 (26%), Positives = 112/266 (42%), Gaps = 49/266 (18%)
Query: 32 VIAEGGFSCVYSARDAI--HMSKQYAMKHM----ICNDEESLESAMKEISVMKSLKGHPN 85
V+ G + V+ R K YAMK + + +++E E +V++ ++ P
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 86 VVTL-YA-------HTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRD 137
+VTL YA H ILD E + L R F E +V +
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGE-----------MFTHLYQRD--NFSEDEVRFYSGE 113
Query: 138 VCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDN 197
+ A+ +H I +RD+K EN+LL S+G L DFG + K F + E+
Sbjct: 114 IILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLS----KEF-------LSEEK 160
Query: 198 IRKHT---TPAYRAPEMWDLFRRELINEK-VDIWALGCLLFRICYFKNAF--DGESKLQI 251
R ++ T Y APE + R + + K VD W+LG L+F + + F +GE Q
Sbjct: 161 ERTYSFCGTIEYMAPE---IIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217
Query: 252 LNGNYRIPESPKYSSSVTDLIRDMLQ 277
+ P + S + +D+L
Sbjct: 218 EVSRRILKCDPPFPSFIGPEAQDLLH 243
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 45/166 (27%), Positives = 73/166 (43%), Gaps = 24/166 (14%)
Query: 124 GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183
G F+E + ++ +F +HS+ I +RDLK +N++L ++G K+ DFG N
Sbjct: 96 GKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKEN-- 151
Query: 184 RFEKLEEMGIEEDNIRKH--TTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKN 241
I + TP Y APE + + + VD WA G LL+ + +
Sbjct: 152 ---------IFGGKTTRTFCGTPDYIAPE---IIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
Query: 242 AFDGESKLQ----ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
FDGE + + I+ N P+S S + + +L P R
Sbjct: 200 PFDGEDEDELFQSIMEHNVSYPKS--LSKEAVSICKGLLTKHPAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 63/262 (24%), Positives = 110/262 (41%), Gaps = 38/262 (14%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYA 91
I +G F VY D + A+K + + E+ +E +EI+V+ P + Y
Sbjct: 12 IGKGSFGEVYKGIDN-RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYITRYYG 69
Query: 92 HTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPP 151
+ + + ++ME + L+ G EE + I R++ + +HS+
Sbjct: 70 SYL----KGTKLWIIMEYLGGG--SALDLLKPGPLEETYIATILREILKGLDYLHSERK- 122
Query: 152 IAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---TPAYRA 208
HRD+KA N+LL G KL DFG + + I+++T TP + A
Sbjct: 123 -IHRDIKAANVLLSEQGDVKLADFGVAGQ------------LTDTQIKRNTFVGTPFWMA 169
Query: 209 PEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPE-SP----- 262
PE + ++ + K DIW+LG + + +++L + IP+ SP
Sbjct: 170 PE---VIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FLIPKNSPPTLEG 223
Query: 263 KYSSSVTDLIRDMLQASPDDRP 284
+YS + + L P RP
Sbjct: 224 QYSKPFKEFVEACLNKDPRFRP 245
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 25/225 (11%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMI--CNDEESLESAMKEISVMKSLKGHPNVVTLY 90
I G V +A DAI + + A+K + ++ + A +E+ +MK + H N++ L
Sbjct: 32 IGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLL 89
Query: 91 A--HTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQ 148
L ++ +VME D +L V++ E+ +++ +C H
Sbjct: 90 NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI---KHLH 143
Query: 149 SPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRA 208
S I HRDLK N+++ SD K+ DFG T F + T YRA
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV----------VTRYYRA 193
Query: 209 PEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN 253
PE + E VDIW++GC++ + F G + N
Sbjct: 194 PE---VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 65/265 (24%), Positives = 108/265 (40%), Gaps = 35/265 (13%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLESAMK----EISVMKSLKGHPNVV 87
+ +G F VY D ++ A+K + D + + EI ++K+L+ H +V
Sbjct: 10 LGQGAFGRVYLCYDV-DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIV 67
Query: 88 TLYAHTILDLGRTKEALLV-ME-CCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
Y R E L + ME S+ + L+ GA E R + V +
Sbjct: 68 QYYG-----CLRDDETLSIFMEYMPGGSVKDQLKAYGA--LTETVTRKYTRQILEGVEYL 120
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPA 205
HS I HRD+K N+L S G KL DFG++ KR + + G ++ TP
Sbjct: 121 HSNM--IVHRDIKGANILRDSAGNVKLGDFGAS----KRLQTICSSGTGMKSV--TGTPY 172
Query: 206 YRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK---NAFDGES---KLQILNGNYRIP 259
+ +PE + E K D+W++GC + + K F+ + K+ N ++P
Sbjct: 173 WMSPE---VISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLP 229
Query: 260 ESPKYSSSVTDLIRDMLQASPDDRP 284
S + +R + RP
Sbjct: 230 --SHVSPDARNFLRRTFVENAKKRP 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 46/170 (27%), Positives = 68/170 (40%), Gaps = 44/170 (25%)
Query: 154 HRDLKAENLLLGSDGLWKLCDFG-------------STSTNHKR---FEKLEEMG----- 192
HRD+K +N+L+ DG KL DFG +H R E EE
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 193 ----IEEDNIRKHT---------TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF 239
+E R+H TP Y APE + R + D W++G +L+ +
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPE---VLLRTGYTQLCDWWSVGVILYEMLVG 240
Query: 240 KNAF----DGESKLQILN--GNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
+ F E++L+++N IP K S +DLI L +DR
Sbjct: 241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDR 289
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 55/230 (23%), Positives = 100/230 (43%), Gaps = 36/230 (15%)
Query: 64 EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGA 123
E+ +E +EI+V+ VT Y + L + + ++ME + L+ A
Sbjct: 43 EDEIEDIQQEITVLSQCDS--PYVTKYYGSYL---KGTKLWIIMEYLGGG--SALDLLRA 95
Query: 124 GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183
G F+E Q+ + +++ + +HS+ HRD+KA N+LL G KL DFG
Sbjct: 96 GPFDEFQIATMLKEILKGLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQ--- 150
Query: 184 RFEKLEEMGIEEDNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK 240
+ + I+++T TP + APE + ++ + K DIW+LG + +
Sbjct: 151 ---------LTDTQIKRNTFVGTPFWMAPE---VIQQSAYDSKADIWSLGITAIELAKGE 198
Query: 241 NAFDGESKLQILNGNYRIPESP------KYSSSVTDLIRDMLQASPDDRP 284
+++L + IP++ ++S + I L P RP
Sbjct: 199 PPNSDMHPMRVL---FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 41/143 (28%), Positives = 62/143 (43%), Gaps = 23/143 (16%)
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTP 204
+HS+ I +RDLK ENLLL + G K+ DFG F K + + TP
Sbjct: 134 LHSKD--IIYRDLKPENLLLDNKGHVKVTDFG--------FAK----KVPDRTFTLCGTP 179
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL----QILNGNYRIPE 260
Y APE + + + + VD W +G LL+ F ++ +IL G + P
Sbjct: 180 EYLAPE---VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN 236
Query: 261 SPKYSSSVTDLIRDMLQASPDDR 283
+ DL++ +LQ R
Sbjct: 237 W--FDGRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 67/268 (25%), Positives = 115/268 (42%), Gaps = 47/268 (17%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICND----EESLESAMKEISVMKSLKGHPNVV 87
V+ +G F V AR + YA+K ++ D ++ +E M E ++ + HP +
Sbjct: 2 VLGKGSFGKVMLAR-LKESGRLYAVK-VLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 88 TLYAHTILDLGRTKEALL-VMECCDKS--LVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
LY +T + L VME + + ++ ++R F+E + ++ +A+
Sbjct: 60 QLYC-----CFQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEITSALMF 111
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEE--DNIRKHT 202
+H + I +RDLK +N+LL +G KL DFG M E + T
Sbjct: 112 LHDKG--IIYRDLKLDNVLLDHEGHCKLADFG--------------MCKEGIFNGKTTST 155
Query: 203 ---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGN 255
TP Y APE + + L VD WA+G LL+ + F+ E++ ILN
Sbjct: 156 FCGTPDYIAPE---ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 212
Query: 256 YRIPESPKYSSSVTDLIRDMLQASPDDR 283
P + D+++ + +P R
Sbjct: 213 VVYPTWLSQDA--VDILKAFMTKNPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 34/229 (14%)
Query: 66 SLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAG 124
S E ++E VM L HP +V LY + K +V E + L+N L R G
Sbjct: 42 SEEDFIEEAKVMMKLS-HPKLVQLYGVCT----QQKPLYIVTEFMENGCLLNYLRQR-QG 95
Query: 125 YFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKR 184
+ +L++ +DVC + + S HRDL A N L+ S G+ K+ DFG T R
Sbjct: 96 KLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMT-----R 148
Query: 185 FEKLEEMGIEEDNIRKHTTPAYRAPEMW---DLFRRELINEKVDIWALGCLLFRICYF-- 239
+ ++++ ++ + P W ++F + K D+W+ G L++ + F
Sbjct: 149 YV------LDDEYT---SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEV--FTE 197
Query: 240 -KNAFDGESKLQI---LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
K F+ +S ++ ++ +R+ S +V +++ P+ RP
Sbjct: 198 GKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRP 246
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 70/301 (23%), Positives = 115/301 (38%), Gaps = 58/301 (19%)
Query: 27 IHVRNVIAEGGFSCVYSA---RDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGH 83
I +VI EG F V A +D + M+ M ++ + + A E+ V+ L H
Sbjct: 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFA-GELEVLCKLGHH 62
Query: 84 PNVVTL---------------YA--HTILDLGRTKEALLVMECCDKSLVNVLENRGAGYF 126
PN++ L YA +LD R L D + E+ A
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLET----DPAFAK--EHGTASTL 116
Query: 127 EEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186
+Q+L DV + + + HRDL A N+L+G + K+ DFG + +
Sbjct: 117 TSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK 174
Query: 187 K------LEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK 240
K + M IE N +TT K D+W+ G LL+ I
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTT-------------------KSDVWSFGVLLWEIVSLG 215
Query: 241 NA-FDGESKLQI---LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296
+ G + ++ L YR+ + V +L+R + P +RP Q+ +++
Sbjct: 216 GTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275
Query: 297 L 297
L
Sbjct: 276 L 276
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 65/269 (24%), Positives = 99/269 (36%), Gaps = 40/269 (14%)
Query: 72 KEISVMKSLKGHPNVVTLYAHTILDLGRTKEALL--VMECCD-KSLVNVLENRGAGYFEE 128
+E ++ L HPN+V L LD G LL V E ++L VL GA E
Sbjct: 27 RETALCARLY-HPNIVAL-----LDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGE 80
Query: 129 KQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGL---WKLCDFGSTSTNHKRF 185
L + V +A+ H+Q I HRDLK +N+++ G+ K+ DFG T
Sbjct: 81 TGRLML--QVLDALACAHNQG--IVHRDLKPQNIMVSQTGVRPHAKVLDFG-IGTLLPGV 135
Query: 186 EKLEEMGIEEDNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNA 242
+ + R TP Y APE R E + D++A G + +
Sbjct: 136 RDADVATL----TRTTEVLGTPTYCAPEQ---LRGEPVTPNSDLYAWGLIFLECLTGQRV 188
Query: 243 FDGESKLQILNGNYR--------IPESPKYSSSVTDLIRDMLQASPDDRP-DITQVWFRV 293
G S +IL Y+ +P + ++R L P R + R
Sbjct: 189 VQGASVAEIL---YQQLSPVDVSLPPWIA-GHPLGQVLRKALNKDPRQRAASAPALAERF 244
Query: 294 NEQLPVGLQKSLPDRPPETQSAVANEGMS 322
L L + A+A ++
Sbjct: 245 RALELCALVGILRMGEGAGREAIAAPLVA 273
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 65/269 (24%), Positives = 114/269 (42%), Gaps = 38/269 (14%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK--GHPNVVTLY 90
I +G F VY + A+K C + K + + LK HPN+V L
Sbjct: 3 IGKGNFGDVYKGVLKGNTE--VAVK--TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 91 AHTILDLGRTKEALLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS 149
+ + + +VME SL+ L + K++L + D + + +S
Sbjct: 59 GVCV----QKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGM--EYLES 111
Query: 150 PPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTP-AYRA 208
HRDL A N L+G + + K+ DFG + + EE GI + P + A
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMS--------REEEGGIYTVSDGLKQIPIKWTA 163
Query: 209 PEMWDLFRRELINEKVDIWALGCLLFRI-----CYFKNAFDGESKLQILNGNYRIPESPK 263
PE + R + D+W+ G LL+ + + +++ +I +G YR+P +P+
Sbjct: 164 PEALNYGR---YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-YRMP-APQ 218
Query: 264 YSSSVTDLIRDMLQ---ASPDDRPDITQV 289
++ R MLQ P++RP +++
Sbjct: 219 --LCPEEIYRLMLQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 66/270 (24%), Positives = 111/270 (41%), Gaps = 47/270 (17%)
Query: 32 VIAEGGF----SCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVV 87
V+ +GGF +C A ++ K+ K + ES+ A+ E +++ + V
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM--ALNEKQILEKVNSRFVVS 64
Query: 88 TLYAHTILDLGRTKEALLVMECCDKSLVN------VLENRGAGYFEEKQVLAIFRDVCNA 141
YA+ TK+AL C +L+N + + G FEE + + ++C
Sbjct: 65 LAYAY------ETKDAL----CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH 201
+ +H + I +RDLK EN+LL G ++ D G + + E K
Sbjct: 115 LEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLA------------VHVPEGQTIKG 160
Query: 202 T--TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK------LQILN 253
T Y APE + + E D WALGCLL+ + ++ F K ++ L
Sbjct: 161 RVGTVGYMAPE---VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV 217
Query: 254 GNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
+ S K+S L + +L P +R
Sbjct: 218 KEVQEEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 75/310 (24%), Positives = 124/310 (40%), Gaps = 50/310 (16%)
Query: 1 MWRFKPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHM- 59
++ + M GLE +I I +G + VY + S A+K +
Sbjct: 4 LFPYNSSM----LGLESLGDPTDTWEI--IETIGKGTYGKVYKVTNKKDGS-LAAVKILD 56
Query: 60 -ICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTI-LDLGRTKEALLVMECCD----KS 113
I + +E +E+ E ++++SL HPNVV Y D + LV+E C+
Sbjct: 57 PISDVDEEIEA---EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTE 113
Query: 114 LVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLC 173
LV L G +E + I + +H+ I HRD+K N+LL ++G KL
Sbjct: 114 LVKGLLICGQ-RLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLV 170
Query: 174 DFG-STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRR--ELINEKVDIWALG 230
DFG S R + +G TP + APE+ ++ + + D+W+LG
Sbjct: 171 DFGVSAQLTSTRLRRNTSVG----------TPFWMAPEVIACEQQYDYSYDARCDVWSLG 220
Query: 231 CLLFRICYFKNAFDGESKL---QILNGNYRIPESP--------KYSSSVTDLIRDMLQAS 279
+ DG+ L + ++IP +P K+ S I L
Sbjct: 221 ITAIELG------DGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKD 274
Query: 280 PDDRPDITQV 289
+ RP +T +
Sbjct: 275 FEARPSVTHL 284
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 72/277 (25%), Positives = 109/277 (39%), Gaps = 56/277 (20%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHM---ICNDEESLESAMKEISVMKSLKGHPNVVT 88
VI G ++ V + YAMK + + ND+E ++ E V ++ HP +V
Sbjct: 2 VIGRGSYAKVLLVE-LKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 89 LYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIF--RDVCNAVFAMH 146
L H+ V+E + R EE A F ++ A+ +H
Sbjct: 61 L--HSCFQ--TESRLFFVIEFVSGGDLMFHMQRQRKLPEEH---ARFYSAEISLALNFLH 113
Query: 147 SQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---- 202
+ I +RDLK +N+LL ++G KL D+G ++ IR
Sbjct: 114 ERG--IIYRDLKLDNVLLDAEGHIKLTDYGMC----------------KEGIRPGDTTST 155
Query: 203 ---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFD--GESKLQ------- 250
TP Y APE + R E VD WALG L+F + ++ FD G S
Sbjct: 156 FCGTPNYIAPE---ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY 212
Query: 251 ----ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
IL RIP S S + +++ L P +R
Sbjct: 213 LFQVILEKQIRIPRS--LSVKASSVLKGFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 70/267 (26%), Positives = 110/267 (41%), Gaps = 38/267 (14%)
Query: 32 VIAEGGFSCVYSAR----DAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVV 87
VI G ++ V R D I+ K +K + +D+E ++ E V + +P +V
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMK--VVKKELVHDDEDIDWVQTEKHVFEQASSNPFLV 59
Query: 88 TLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
L++ T LV+E + + R EE ++C A+ +H
Sbjct: 60 GLHSC----FQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYA-AEICIALNFLHE 114
Query: 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYR 207
+ I +RDLK +N+LL +DG KL D+G E +G + TP Y
Sbjct: 115 RG--IIYRDLKLDNVLLDADGHIKLTDYGMCK---------EGLGPGDTTSTFCGTPNYI 163
Query: 208 APEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFD----------GESKLQ-ILNGNY 256
APE + R E VD WALG L+F + ++ FD + Q IL
Sbjct: 164 APE---ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI 220
Query: 257 RIPESPKYSSSVTDLIRDMLQASPDDR 283
RIP S + +++ L P +R
Sbjct: 221 RIPRF--LSVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 36/216 (16%)
Query: 33 IAEGGFSCVYSA-RDAIHMSKQYAMKHMICNDEESLE----SAMKEISVMKSLKGHPNVV 87
I G + VY A R K+YA+K D+E SA +EI++++ LK H NVV
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIK-KFKGDKEQYTGISQSACREIALLRELK-HENVV 65
Query: 88 TLYAHTILDLGRTKEALLVMECCDKSLVNVLE---NRGAGYFEEKQVLAIFRDVCNAVFA 144
+L L+ K L+ + + L +++ V ++ + N V
Sbjct: 66 SL-VEVFLEHA-DKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLW----KLCDFGSTSTNHKRFEKLEEMGIEEDNIRK 200
+HS + HRDLK N+L+ +G K+ D G + + L + D +
Sbjct: 124 LHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL----ADLDPVV- 176
Query: 201 HTTPAYRAPEMWDLFRRELINEK-----VDIWALGC 231
T YRAPE+ L+ + +DIWA+GC
Sbjct: 177 -VTIWYRAPEL-------LLGARHYTKAIDIWAIGC 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 26/167 (15%)
Query: 124 GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183
G F+E Q + ++ +F +H + I +RDLK +N++L S+G K+ DFG
Sbjct: 96 GKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCK---- 149
Query: 184 RFEKLEEMGIEEDNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK 240
E M D + T TP Y APE + + + VD WA G LL+ + +
Sbjct: 150 -----EHM---VDGVTTRTFCGTPDYIAPE---IIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
Query: 241 NAFDGESKLQ----ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
FDGE + + I+ N P+S S + + ++ P R
Sbjct: 199 PPFDGEDEDELFQSIMEHNVSYPKS--LSKEAVSICKGLMTKHPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 73/303 (24%), Positives = 110/303 (36%), Gaps = 70/303 (23%)
Query: 31 NVIAEGGFSCVYSA---------RDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK 81
+VI EG F V A AI K+YA K +D E+ V+ L
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK----DDHRDFAG---ELEVLCKLG 53
Query: 82 GHPNVVTL---------------YA--HTILDLGRTKEALLVMECCDKSLVNVLENRGAG 124
HPN++ L YA +LD R L D + N A
Sbjct: 54 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET----DPAFAI--ANSTAS 107
Query: 125 YFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKR 184
+Q+L DV + + + HRDL A N+L+G + + K+ DFG +
Sbjct: 108 TLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQEVY 165
Query: 185 FEK------LEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY 238
+K + M IE N +TT D+W+ G LL+ I
Sbjct: 166 VKKTMGRLPVRWMAIESLNYSVYTT-------------------NSDVWSYGVLLWEIVS 206
Query: 239 FKNA-FDGESKLQI---LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294
+ G + ++ L YR+ + V DL+R + P +RP Q+ +N
Sbjct: 207 LGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 266
Query: 295 EQL 297
L
Sbjct: 267 RML 269
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 30/227 (13%)
Query: 66 SLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGY 125
S E ++E VM L HP +V LY LV E + ++ G
Sbjct: 42 SEEDFIEEAQVMMKLS-HPKLVQLYGVCT----ERSPICLVFEFMEHGCLSDYLRAQRGK 96
Query: 126 FEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185
F ++ +L + DVC + + S + + HRDL A N L+G + + K+ DFG T RF
Sbjct: 97 FSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMT-----RF 149
Query: 186 EKLEEMGIEEDNIRKHTTPAYRAPEMW---DLFRRELINEKVDIWALGCLLFRI-----C 237
+ +D T + P W ++F + K D+W+ G L++ +
Sbjct: 150 -------VLDDQYTSSTGTKF--PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKT 200
Query: 238 YFKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
++N + E ++ +N +R+ + S SV +L++ + P+DRP
Sbjct: 201 PYENRSNSEV-VETINAGFRLYKPRLASQSVYELMQHCWKERPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 11/105 (10%)
Query: 149 SPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRA 208
S + HRDLK NLLL ++ K+CDFG T ++ + + E + T YRA
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV---------TRWYRA 176
Query: 209 PEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN 253
PE+ L +D+W++GC+ + K F G+ + L
Sbjct: 177 PEL--LLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLK 219
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 65/235 (27%), Positives = 99/235 (42%), Gaps = 44/235 (18%)
Query: 71 MKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCD-KSLVNVLEN---RGAGYF 126
++E+ + KS K P +V Y + + + + ME C+ SL ++ + RG G
Sbjct: 47 LRELEINKSCK-SPYIVKYYGAFLDE--SSSSIGIAMEYCEGGSLDSIYKKVKKRG-GRI 102
Query: 127 EEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186
EK + I V + +HS+ I HRD+K N+LL G KLCDFG +
Sbjct: 103 GEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSG------- 153
Query: 187 KLEEMGIEEDNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAF 243
E N T T Y APE + + + D+W+LG L + + F
Sbjct: 154 -------ELVNSLAGTFTGTSFYMAPER---IQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
Query: 244 --DGESKLQ-------ILNG-NYRIPESP----KYSSSVTDLIRDMLQASPDDRP 284
+GE L I+N N + + P K+S D I+ L+ P RP
Sbjct: 204 PPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 26/167 (15%)
Query: 124 GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183
G F+E + ++ +F +HS+ I +RDLK +N++L S+G K+ DFG N
Sbjct: 96 GRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153
Query: 184 RFEKLEEMGIEEDNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK 240
D + T TP Y APE + + + VD WA G LL+ + +
Sbjct: 154 ------------DGVTTKTFCGTPDYIAPE---IIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
Query: 241 NAFDGESKLQ----ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
F+GE + + I+ N P+S S + + ++ P R
Sbjct: 199 APFEGEDEDELFQSIMEHNVAYPKS--MSKEAVAICKGLMTKHPGKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 59/282 (20%), Positives = 116/282 (41%), Gaps = 35/282 (12%)
Query: 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQY--AMKHM-ICNDEESLESAMKEISV 76
ID +KI VI G F V S R + ++ A+K + E+ + E S+
Sbjct: 1 IDASCIKIE--KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASI 58
Query: 77 MKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFR 136
M HPN++ L ++K ++V E + ++ + G F Q++ + R
Sbjct: 59 MGQFD-HPNIIHLEGVVT----KSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR 113
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEED 196
+ + + + HRDL A N+L+ S+ + K+ DFG + +E+D
Sbjct: 114 GIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRV------------LEDD 159
Query: 197 NIRKHTTPAYRAPEMWD-----LFRRELINEKVDIWALGCLLFRICYFKN----AFDGES 247
+TT + P W +R+ D+W+ G +++ + + +
Sbjct: 160 PEAAYTTRGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWEMSNQD 217
Query: 248 KLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
++ + YR+P +++ L+ D Q ++RP Q+
Sbjct: 218 VIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQI 259
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 64/255 (25%), Positives = 116/255 (45%), Gaps = 31/255 (12%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMK------EISVMKSLKGHPN 85
++ +G F VY D + ++ A K + D ES E++ + EI ++K+L+ H
Sbjct: 9 LLGQGAFGRVYLCYD-VDTGRELAAKQ-VQFDPESPETSKEVSALECEIQLLKNLQ-HER 65
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
+V Y + D + + S+ + L+ GA E R + + +
Sbjct: 66 IVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA--LTESVTRKYTRQILEGMSYL 122
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT-TP 204
HS I HRD+K N+L S G KL DFG++ ++L+ + + IR T TP
Sbjct: 123 HSNM--IVHRDIKGANILRDSAGNVKLGDFGAS-------KRLQTICMSGTGIRSVTGTP 173
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRI---PES 261
+ +PE + E K D+W+LGC + + K + ++ + + ++I P +
Sbjct: 174 YWMSPE---VISGEGYGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTN 227
Query: 262 PKYSSSVTDLIRDML 276
P+ S +++ RD L
Sbjct: 228 PQLPSHISEHARDFL 242
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 62/253 (24%), Positives = 98/253 (38%), Gaps = 41/253 (16%)
Query: 51 SKQYAMKHMICNDEESLESA-MKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA--LLVM 107
+ A+K + + + ++E SVM L HP +V L +G K +LVM
Sbjct: 23 EVEVAVKTLKQEHIAAGKKEFLREASVMAQLD-HPCIVRL-------IGVCKGEPLMLVM 74
Query: 108 ECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS-QSPPIAHRDLKAENLLLG 165
E L+ L+ R E V + M +S HRDL A N+LL
Sbjct: 75 ELAPLGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV 129
Query: 166 SDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELIN---- 221
+ K+ DFG + +G D R T A R P W + E IN
Sbjct: 130 NRHQAKISDFGMSRA----------LGAGSDYYRATT--AGRWPLKW--YAPECINYGKF 175
Query: 222 -EKVDIWALGCLLFRICYFKNAFDGESK----LQILNGNYRIPESPKYSSSVTDLIRDML 276
K D+W+ G L+ + GE K + +L R+P + + ++
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCW 235
Query: 277 QASPDDRPDITQV 289
+ P+DRP +++
Sbjct: 236 KYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 57/242 (23%), Positives = 99/242 (40%), Gaps = 34/242 (14%)
Query: 68 ESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVME-CCDKSLVNVLENRGAGYF 126
E+ M E+ +M L H N+V L + L++ E CC L+N L + +
Sbjct: 83 EALMSELKIMSHLGNHENIVNLLGACTI----GGPILVITEYCCYGDLLNFLRRKRESFL 138
Query: 127 EEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186
+ +L+ V + + S++ HRDL A N+LL + K+CDFG
Sbjct: 139 TLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLARD------ 190
Query: 187 KLEEMGIEEDN--IRKHTTPAYRAPEMW----DLFRRELINEKVDIWALGCLLFRICYFK 240
I D+ + K R P W +F + + D+W+ G LL+ I
Sbjct: 191 ------IMNDSNYVVKGNA---RLPVKWMAPESIF-NCVYTFESDVWSYGILLWEIFSLG 240
Query: 241 -NAFDG----ESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295
N + G +++ YR+ + + + D+++ A P RP Q+ + +
Sbjct: 241 SNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300
Query: 296 QL 297
QL
Sbjct: 301 QL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-07
Identities = 36/124 (29%), Positives = 59/124 (47%), Gaps = 14/124 (11%)
Query: 129 KQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL 188
L+IF +C + +HS+ + HRDLK +N+LLG G + D+G+ E L
Sbjct: 113 GAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDL 170
Query: 189 EEMGIEEDNIRKHT---------TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF 239
++ ++E NI + TP Y APE +E DI+ALG +L+++
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPER---LLGVPASESTDIYALGVILYQMLTL 227
Query: 240 KNAF 243
+
Sbjct: 228 SFPY 231
|
Length = 932 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 36 GGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAM-KEISVMKSLKGHPNVVTLYAHTI 94
G F V SARD + K M L +E+ ++K L+ H N+++L +
Sbjct: 21 GAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR-HENIISL---SD 76
Query: 95 LDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIF-RDVCNAVFAMHSQSPPIA 153
+ + ++ V E L +L +R EKQ + F + + +HS +
Sbjct: 77 IFISPLEDIYFVTELLGTDLHRLLTSRPL----EKQFIQYFLYQILRGLKYVHSAG--VV 130
Query: 154 HRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH-TTPAYRAPEMW 212
HRDLK N+L+ + K+CDFG I++ + + +T YRAPE+
Sbjct: 131 HRDLKPSNILINENCDLKICDFGLAR-------------IQDPQMTGYVSTRYYRAPEIM 177
Query: 213 DLFRRELINEKVDIWALGCLLFRICYFKNAFDGE 246
+++ + +VDIW+ GC+ + K F G+
Sbjct: 178 LTWQK--YDVEVDIWSAGCIFAEMLEGKPLFPGK 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 36/230 (15%)
Query: 66 SLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAG 124
S E+ ++E VMK L+ H +V LYA + + +V E K SL++ L+
Sbjct: 44 SPEAFLQEAQVMKKLR-HEKLVQLYA-----VVSEEPIYIVTEYMSKGSLLDFLKGEMGK 97
Query: 125 YFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKR 184
Y Q++ + + + + + + HRDL+A N+L+G + + K+ DFG
Sbjct: 98 YLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLAR----- 150
Query: 185 FEKLEEMGIEEDNIRKHTTPA-----YRAPEMWDLFRRELINEKVDIWALGCLLFRICY- 238
+ EDN A + APE L+ R I K D+W+ G LL +
Sbjct: 151 --------LIEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI--KSDVWSFGILLTELTTK 199
Query: 239 ----FKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
+ + E Q+ G YR+P P+ S+ DL+ + P++RP
Sbjct: 200 GRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 62/251 (24%), Positives = 108/251 (43%), Gaps = 45/251 (17%)
Query: 49 HMSKQYAMK-----HMICNDE-ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102
+ YA+K +I DE ESL K I + + HP +V L+A +T++
Sbjct: 22 KTGELYAIKALKKGDIIARDEVESLMCE-KRIFETANSERHPFLVNLFA-----CFQTED 75
Query: 103 -ALLVMECCD--KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKA 159
VME ++++ + F E + + V + +H I +RDLK
Sbjct: 76 HVCFVMEYAAGGDLMMHIHTDV----FSEPRAVFYAACVVLGLQYLHENK--IVYRDLKL 129
Query: 160 ENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---TPAYRAPEMWDLFR 216
+NLLL ++G K+ DFG E MG + R T TP + APE +
Sbjct: 130 DNLLLDTEGFVKIADFGLCK---------EGMGFGD---RTSTFCGTPEFLAPE---VLT 174
Query: 217 RELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESPKY----SSSVTDLI 272
VD W LG L++ + ++ F G+ + ++ + + + +Y S ++
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS--IVNDEVRYPRFLSREAISIM 232
Query: 273 RDMLQASPDDR 283
R +L+ +P+ R
Sbjct: 233 RRLLRRNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 54/236 (22%), Positives = 102/236 (43%), Gaps = 25/236 (10%)
Query: 61 CNDEESLESAMKEISVMKSLK--GHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVL 118
C ++ E +K +S + LK HPN+V L I + + +VME
Sbjct: 27 CKEDLPQELKIKFLSEARILKQYDHPNIVKL----IGVCTQRQPIYIVMELVPGGDFLSF 82
Query: 119 ENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178
+ + KQ++ D + + S++ HRDL A N L+G + + K+ DFG +
Sbjct: 83 LRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMS 140
Query: 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFR--- 235
+ E+ GI + K + APE + R + + D+W+ G LL+
Sbjct: 141 --------RQEDDGIYSSSGLKQIPIKWTAPEALNYGR---YSSESDVWSYGILLWETFS 189
Query: 236 --ICYFKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
+C + + +++ Q+ G YR+ K V +++ P++RP +++
Sbjct: 190 LGVCPYPGMTNQQAREQVEKG-YRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEED 196
++ +A+ +HS+ + +RD+K ENL+L DG K+ DFG L + GI +
Sbjct: 103 EIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFG-----------LCKEGISDG 149
Query: 197 NIRKH--TTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAF---DGESKL-Q 250
K TP Y APE + VD W LG +++ + + F D E
Sbjct: 150 ATMKTFCGTPEYLAPE---VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 206
Query: 251 ILNGNYRIPE--SPKYSSSVTDLIR----DMLQASPDDRPDITQVWFRVNEQLPVGLQKS 304
IL R P SP+ S + L++ L P D ++ + F ++ +QK
Sbjct: 207 ILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKK 266
Query: 305 L-PDRPPETQSAV-----ANEGMSKPMNRSPP 330
L P P+ S V +E ++ + +PP
Sbjct: 267 LLPPFKPQVTSEVDTRYFDDEFTAQSITITPP 298
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 49/175 (28%), Positives = 72/175 (41%), Gaps = 40/175 (22%)
Query: 70 AMKEISVMKSLKGHPNVVTLYAHTILD--LGRTKEALLVMECCDKSLVNV----LENRGA 123
A +E+ +MK + H N++ L L ++ LVME D +L V L++
Sbjct: 62 AYRELVLMKLVN-HKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERM 120
Query: 124 GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183
Y + + I H S I HRDLK N+++ SD K+ DFG T
Sbjct: 121 SYLLYQMLCGI----------KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170
Query: 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELI-----NEKVDIWALGCLL 233
F + T YRAP E+I E VDIW++GC++
Sbjct: 171 SFMMTPYV----------VTRYYRAP--------EVILGMGYKENVDIWSVGCIM 207
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 43/198 (21%)
Query: 47 AIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE--AL 104
AI M K+ +M S + ++E VM L H +V LY TK+
Sbjct: 32 AIKMIKEGSM---------SEDEFIEEAKVMMKLS-HEKLVQLYGVC------TKQRPIY 75
Query: 105 LVME-CCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLL 163
+V E + L+N L G F+ Q+L + +DVC + + S+ HRDL A N L
Sbjct: 76 IVTEYMSNGCLLNYLREHGKR-FQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCL 132
Query: 164 LGSDGLWKLCDFGSTSTNHKRF----EKLEEMGIEEDNIRKHTTPA-YRAPEMWDLFRRE 218
+ G K+ DFG + R+ E +G + P + PE+ +
Sbjct: 133 VDDQGCVKVSDFGLS-----RYVLDDEYTSSVGSK--------FPVRWSPPEVLLYSK-- 177
Query: 219 LINEKVDIWALGCLLFRI 236
+ K D+WA G L++ +
Sbjct: 178 -FSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 28/217 (12%)
Query: 70 AMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL----LVMECCDKSLVNVLENRGAGY 125
A +E+ ++K + H N+++L + ++ E LVME D +L V+
Sbjct: 67 AYRELVLLKCVN-HKNIISLL--NVFTPQKSLEEFQDVYLVMELMDANLCQVIH---MEL 120
Query: 126 FEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185
E+ +++ +C H S I HRDLK N+++ SD K+ DFG T F
Sbjct: 121 DHERMSYLLYQMLCGI---KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF 177
Query: 186 EKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDG 245
+ T YRAPE+ + E VDIW++GC++ + F G
Sbjct: 178 MMTPYV----------VTRYYRAPEVILGMGYK---ENVDIWSVGCIMGELVKGSVIFQG 224
Query: 246 ESKLQILNGNYRIPESP--KYSSSVTDLIRDMLQASP 280
+ N +P ++ + + +R+ ++ P
Sbjct: 225 TDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRP 261
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 67/258 (25%), Positives = 115/258 (44%), Gaps = 32/258 (12%)
Query: 32 VIAEGGFSCVYSAR--DAIHMSKQYAMKHM----ICNDEESLESAMKEISVMKSLKGHPN 85
V+ G + V+ R K YAMK + I ++ E E V++ ++ P
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
+VTL+ D TK L++ L L R F+E++V ++ A+ +
Sbjct: 67 LVTLHYAFQTD---TKLHLILDYINGGELFTHLSQRER--FKEQEVQIYSGEIVLALEHL 121
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT--- 202
H I +RD+K EN+LL S+G L DFG + K F E++ R ++
Sbjct: 122 HKLG--IIYRDIKLENILLDSNGHVVLTDFGLS----KEF-------HEDEVERAYSFCG 168
Query: 203 TPAYRAPEMWDLFRRELINEK-VDIWALGCLLFRICYFKNAF--DGESKLQILNGNYRIP 259
T Y AP++ + + ++K VD W++G L++ + + F DGE Q +
Sbjct: 169 TIEYMAPDI--VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK 226
Query: 260 ESPKYSSSVTDLIRDMLQ 277
P Y ++ L +D++Q
Sbjct: 227 SEPPYPQEMSALAKDIIQ 244
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 74/325 (22%), Positives = 129/325 (39%), Gaps = 50/325 (15%)
Query: 32 VIAEGGFSCVYSA---RDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVT 88
VI +G F V A D + + K ++ N +E + M E +V+ HP +V
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ-KHIMAERNVLLKNVKHPFLVG 60
Query: 89 LYAHTILDLGRTKEALLVMECCD--KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH 146
L+ T++ V++ + + ++ R F E + ++ +A+ +H
Sbjct: 61 LH----YSFQTTEKLYFVLDFVNGGELFFHLQRERS---FPEPRARFYAAEIASALGYLH 113
Query: 147 SQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAY 206
S + I +RDLK EN+LL S G L DFG E + + TP Y
Sbjct: 114 SIN--IVYRDLKPENILLDSQGHVVLTDFGLCK---------EGIAQSDTTTTFCGTPEY 162
Query: 207 RAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESPKYSS 266
APE + R++ + VD W LG +L+ + Y +P P Y
Sbjct: 163 LAPE---VIRKQPYDNTVDWWCLGAVLYEML------------------YGLP--PFYCR 199
Query: 267 SVTDLIRDMLQASPDDRPDI-TQVWFRVNEQLPVGLQKSLPDRPPETQSAVANEGMSKPM 325
V ++ ++L RP W + E L Q+ L + E + + +
Sbjct: 200 DVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAK--EDFLEIQEHPFFESL 257
Query: 326 NRSPPMPQRSPPPPPSSVDPTRNIS 350
+ + ++ PPP +V+ +IS
Sbjct: 258 SWTDLEQKKIPPPFNPNVEGPDDIS 282
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 44/165 (26%), Positives = 65/165 (39%), Gaps = 39/165 (23%)
Query: 154 HRDLKAENLLLGSDGLWKLCDFG-------STSTNHKRFEKLEEMGIEEDNIRK------ 200
HRD+K +NLLL + G KL DFG S T R D I K
Sbjct: 124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKR 183
Query: 201 --HT--------------TPAYRAPEMWDLFRRELINEKVDIWALGCLLFR--ICY--FK 240
T TP Y APE +F + N++ D W+LG +++ + Y F
Sbjct: 184 KAETWKRNRRALAYSTVGTPDYIAPE---VFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240
Query: 241 NAFDGESKLQILN--GNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
+ E+ +I+N + P+ S DLI+ + + R
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERR 284
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 1e-06
Identities = 54/223 (24%), Positives = 87/223 (39%), Gaps = 52/223 (23%)
Query: 73 EISVMKSLKGHPNVVTLY-AHTILDLGRTKEALLVM---ECCDKSLVNVLENRGAGYFEE 128
E V + +K +PN + LY + T L K +L+M + D L ++L+ G E
Sbjct: 58 EPMVHQLMKDNPNFIKLYYSVTTL-----KGHVLIMDYIKDGD--LFDLLKKEGK--LSE 108
Query: 129 KQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWK--LCDFGSTSTNHKRFE 186
+V I R + A+ +H + I H D+K EN+L + LCD+G
Sbjct: 109 AEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLY-DRAKDRIYLCDYGLCK------- 158
Query: 187 KLEEMGIEEDNIRKHT------TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-- 238
T T Y +PE + + D WA+G L + +
Sbjct: 159 ------------IIGTPSCYDGTLDYFSPEK---IKGHNYDVSFDWWAVGVLTYELLTGK 203
Query: 239 --FKNAFDGESKLQILNGNY--RIPESPKYSSSVTDLIRDMLQ 277
FK D E L+ L ++P S + D ++ ML+
Sbjct: 204 HPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLK 246
|
Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 68/269 (25%), Positives = 105/269 (39%), Gaps = 40/269 (14%)
Query: 32 VIAEGGFSCVYSAR----DAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVV 87
VI G ++ V R + I+ K +K + ND+E ++ E V + HP +V
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMK--VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59
Query: 88 TLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
L++ V+E + + R EE ++ A+ +H
Sbjct: 60 GLHSC----FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLHE 114
Query: 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYR 207
+ I +RDLK +N+LL S+G KL D+G + + TP Y
Sbjct: 115 RG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---------GTPNYI 163
Query: 208 APEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFD--GESK-----------LQILNG 254
APE + R E VD WALG L+F + ++ FD G S IL
Sbjct: 164 APE---ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 220
Query: 255 NYRIPESPKYSSSVTDLIRDMLQASPDDR 283
RIP S S +++ L P +R
Sbjct: 221 QIRIPRS--LSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 66/282 (23%), Positives = 113/282 (40%), Gaps = 48/282 (17%)
Query: 32 VIAEGGFSCVYSARDAIHMSK-----QYAMK-HMICNDEESLESAMKEISVMKSLKGHPN 85
I EG F VY ++MS A+K C E ++E +M+ HP+
Sbjct: 13 CIGEGQFGDVY---QGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD-HPH 68
Query: 86 VVTLYAHTILDLGRTKE--ALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAV 142
+V L +G E +VME L + L+ +L ++ + A+
Sbjct: 69 IVKL-------IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQ-LSTAL 120
Query: 143 FAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT 202
+ S+ HRD+ A N+L+ S KL DFG + R+ +E+++ K +
Sbjct: 121 AYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLS-----RY-------LEDESYYKAS 166
Query: 203 TPA----YRAPEMWDLFRRELINEKVDIWALGCLLFRICYF-KNAFDG----ESKLQILN 253
+ APE + FRR D+W G ++ I F G + +I N
Sbjct: 167 KGKLPIKWMAPESIN-FRR--FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN 223
Query: 254 GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295
G R+P P ++ L+ P RP T++ ++++
Sbjct: 224 GE-RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 43/143 (30%), Positives = 70/143 (48%), Gaps = 23/143 (16%)
Query: 138 VCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDN 197
VC F +HS+ I +RDLK +N++L DG K+ DFG N + DN
Sbjct: 106 VCGLQF-LHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKEN-----------VFGDN 151
Query: 198 IRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG 254
R T TP Y APE+ + VD W+ G LL+ + ++ F G+ + ++
Sbjct: 152 -RASTFCGTPDYIAPEILQGLKYTF---SVDWWSFGVLLYEMLIGQSPFHGDDEDELFE- 206
Query: 255 NYRIPESPKYSSSVTDLIRDMLQ 277
+ R+ ++P Y +T +D+L+
Sbjct: 207 SIRV-DTPHYPRWITKESKDILE 228
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 64/283 (22%), Positives = 102/283 (36%), Gaps = 50/283 (17%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAM------KHMICNDEESLESAMKEISVMKSLKGHP 84
+ EG F V R H +E+ +EI ++++L H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS--GEEQHRSDFEREIEILRTLD-HE 66
Query: 85 NVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143
N+V + + + L+ME SL + L+ R K++L +C +
Sbjct: 67 NIVKYKG--VCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMD 123
Query: 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS--TNHKRFEKLEEMGIEEDNIRKH 201
+ SQ HRDL A N+L+ S+ L K+ DFG K + ++E G E I
Sbjct: 124 YLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG--ESPIF-- 177
Query: 202 TTPAYRAPE--MWDLFRRELINEKVDIWALGCLLFRI---------------CYFKNAFD 244
+ APE F D+W+ G L+ + A
Sbjct: 178 ----WYAPECLRTSKFSS-----ASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQG 228
Query: 245 GESKLQILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
++L R+P P V DL++ +A P DRP
Sbjct: 229 QMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRP 271
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 61/285 (21%), Positives = 121/285 (42%), Gaps = 39/285 (13%)
Query: 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQY--AMKHMICN-DEESLESAMKEISV 76
IDV +KI VI G F V R + ++ A+K + E+ + E S+
Sbjct: 1 IDVSCVKIE--EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 58
Query: 77 MKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFR 136
M HPN++ L + +++ +++ E + ++ + G F Q++ + R
Sbjct: 59 MGQFD-HPNIIHLEGV----VTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR 113
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEED 196
+ + + + HRDL A N+L+ S+ + K+ DFG + RF +E+D
Sbjct: 114 GIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLS-----RF-------LEDD 159
Query: 197 NIRKHTTPA--------YRAPEMWDLFRRELINEKVDIWALGCLLFRICYF-KNAFDGES 247
T + + APE +R+ D+W+ G +++ + + + + S
Sbjct: 160 TSDPTYTSSLGGKIPIRWTAPEAIA-YRK--FTSASDVWSYGIVMWEVMSYGERPYWDMS 216
Query: 248 KLQILNG---NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
++N +YR+P +++ L+ D Q + RP Q+
Sbjct: 217 NQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQI 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 44/242 (18%)
Query: 71 MKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA---LLVMECCD-KSLVNVL-ENRG--A 123
++E+ + L HPNV+ LG+ E+ LLV+E C L N L NRG A
Sbjct: 43 LQEVQPYRELN-HPNVLQC-------LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVA 94
Query: 124 GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183
++ + + +V + + +H H DL N L +D K+ D+G
Sbjct: 95 QMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLA----- 147
Query: 184 RFEKLEEMGIEEDNIRKHTTP-AYRAPEMWDLFRREL----INEKVDIWALGCLLFRICY 238
E+ E + H P + APE+ ++ ++L +K +IW+LG ++ +
Sbjct: 148 -LEQYPEDYYITKD--CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL-- 202
Query: 239 FKNA---FDGESKLQILNGNYR-----IPESPKYSSSVTDLIRDMLQ---ASPDDRPDIT 287
F A + S Q+L R +P+ P+ +D +++Q P+ RP
Sbjct: 203 FTAADQPYPDLSDEQVLKQVVREQDIKLPK-PQLDLKYSDRWYEVMQFCWLDPETRPTAE 261
Query: 288 QV 289
+V
Sbjct: 262 EV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 67/259 (25%), Positives = 102/259 (39%), Gaps = 66/259 (25%)
Query: 70 AMKEISVMKSLKGHPNVVTLY----AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGY 125
A +E++++K ++ H NV+ L + D ++ LVM L + G
Sbjct: 61 AYRELTLLKHMQ-HENVIGLLDVFTSAVSGD--EFQDFYLVMPYMQTDLQKI---MGHPL 114
Query: 126 FEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185
E+K +++ +C + +HS I HRDLK NL + D K+ DFG R
Sbjct: 115 SEDKVQYLVYQMLCGLKY-IHSAG--IIHRDLKPGNLAVNEDCELKILDFGLA-----RH 166
Query: 186 EKLEEMGIEEDNIRKHTTPAYRAPEM---WDLFRRELINEKVDIWALGCLLFRICYFKNA 242
E G T YRAPE+ W + N+ VDIW++GC++ + K
Sbjct: 167 ADAEMTGYV-------VTRWYRAPEVILNWMHY-----NQTVDIWSVGCIMAEMLTGKTL 214
Query: 243 FDGESKL----QILN------------------GNY-----RIPES------PKYSSSVT 269
F G+ L QIL +Y + P PK S
Sbjct: 215 FKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAV 274
Query: 270 DLIRDMLQASPDDRPDITQ 288
DL+ ML+ D R T+
Sbjct: 275 DLLEKMLELDVDKRLTATE 293
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 66/273 (24%), Positives = 119/273 (43%), Gaps = 46/273 (16%)
Query: 28 HVRNVIAEGGF----SCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGH 83
H R V+ +GGF +C A ++ K+ K + E++ A+ E +++ +
Sbjct: 4 HYR-VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM--ALNEKRILEKVNSR 60
Query: 84 PNVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNV-LENRGAGYFEEKQVLAIFRDVCNA 141
V YA+ TK+AL LV+ + + + N G F+E++ + ++C
Sbjct: 61 FVVSLAYAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG 114
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH 201
+ + + I +RDLK EN+LL G ++ D G L E + +R
Sbjct: 115 LEDLQRER--IVYRDLKPENILLDDRGHIRISDLG-----------LAVQIPEGETVRGR 161
Query: 202 T-TPAYRAPEMWDLFRRELINEKV----DIWALGCLLFRICYFKNAFDG-ESKLQILNGN 255
T Y APE+ + NEK D W LGCL++ + ++ F + +++ +
Sbjct: 162 VGTVGYMAPEV-------INNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD 214
Query: 256 YRIPE-----SPKYSSSVTDLIRDMLQASPDDR 283
R+ E S K+S + R +L +P +R
Sbjct: 215 RRVKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 34/199 (17%)
Query: 57 KHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALL-VMECCDKSLV 115
K +I D++ ++ M E ++ HP + L+ +TK+ L VME V
Sbjct: 30 KDVILQDDD-VDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVME-----YV 78
Query: 116 N----VLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWK 171
N + + + + F+E + +V A+ +H + +RDLK +N+LL ++G K
Sbjct: 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCK 136
Query: 172 LCDFGSTSTNHKRFEKLEEMGIEEDNIRKH--TTPAYRAPEMWDLFRRELINEKVDIWAL 229
L DFG + + GI TP Y APE + + VD WAL
Sbjct: 137 LADFG-----------MCKEGILNGVTTTTFCGTPDYIAPE---ILQELEYGPSVDWWAL 182
Query: 230 GCLLFRICYFKNAFDGESK 248
G L++ + + F+ +++
Sbjct: 183 GVLMYEMMAGQPPFEADNE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 62/266 (23%), Positives = 109/266 (40%), Gaps = 49/266 (18%)
Query: 55 AMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECC-DKS 113
A+K + + E L +EI ++KSL+ H N+V Y GR + LVME S
Sbjct: 37 AVKKLQHSTAEHLRDFEREIEILKSLQ-HDNIVK-YKGVCYSAGR-RNLRLVMEYLPYGS 93
Query: 114 LVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLC 173
L + L+ + +++L +C + + S+ HRDL N+L+ S+ K+
Sbjct: 94 LRDYLQKHRE-RLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIG 150
Query: 174 DFGSTST--NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKV-----DI 226
DFG T K + K+ E G +P W + E + E D+
Sbjct: 151 DFGLTKVLPQDKEYYKVREPG--------------ESPIFW--YAPESLTESKFSVASDV 194
Query: 227 WALGCLLFRI-------CYFKNAF---DGESK---------LQILNGNYRIPESPKYSSS 267
W+ G +L+ + C F G K +++L N R+P P +
Sbjct: 195 WSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAE 254
Query: 268 VTDLIRDMLQASPDDRPDITQVWFRV 293
+ ++++ P RP +++ +V
Sbjct: 255 IYAIMKECWNNDPSQRPSFSELALQV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 45/153 (29%), Positives = 68/153 (44%), Gaps = 24/153 (15%)
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEED 196
++ +A+ +HS + I +RDLK EN+LL S G L DFG N IE +
Sbjct: 104 EIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKEN-----------IEHN 150
Query: 197 NIRKH--TTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY----FKNAFDGESKLQ 250
TP Y APE + ++ + VD W LG +L+ + Y F + E
Sbjct: 151 GTTSTFCGTPEYLAPE---VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN 207
Query: 251 ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
ILN ++ P ++S L+ +LQ R
Sbjct: 208 ILNKPLQL--KPNITNSARHLLEGLLQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 16/147 (10%)
Query: 138 VCNAVFAMHS-QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEED 196
+ V A+HS HRD+K +N+LL +G +L DFGS K+ + G +
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCL-------KMNQDGTVQS 160
Query: 197 NIRKHTTPAYRAPEMWDLFRREL--INEKVDIWALGCLLFRICYFKNAFDGESKLQ---- 250
++ TP Y +PE+ + + D W+LG ++ + Y + F ES ++
Sbjct: 161 SVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 219
Query: 251 ILNGNYRIPESPKYSSSVTDLIRDMLQ 277
I+N R + P + + V++ +D++Q
Sbjct: 220 IMNHEERF-QFPSHITDVSEEAKDLIQ 245
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 51/229 (22%), Positives = 101/229 (44%), Gaps = 33/229 (14%)
Query: 66 SLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAG 124
S+++ ++E ++MK+L+ H +V LYA + + + ++ E K SL++ L++ G
Sbjct: 44 SVQAFLEEANLMKTLQ-HDKLVRLYAV----VTKEEPIYIITEYMAKGSLLDFLKSDEGG 98
Query: 125 YFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKR 184
+++ + + + ++ HRDL+A N+L+ + K+ DFG
Sbjct: 99 KVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARV---- 152
Query: 185 FEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINE-----KVDIWALGCLLFRI-CY 238
IE++ + P W E IN K D+W+ G LL+ I Y
Sbjct: 153 --------IEDNEYTAREGAKF--PIKWT--APEAINFGSFTIKSDVWSFGILLYEIVTY 200
Query: 239 FKNAFDGESKLQILNG---NYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
K + G S +++ YR+P + D+++ + ++RP
Sbjct: 201 GKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERP 249
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 38/214 (17%)
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEED 196
++ +A+ +HS + +RDLK ENL+L DG K+ DFG L + GI +
Sbjct: 103 EIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFG-----------LCKEGISDG 149
Query: 197 NIRKH--TTPAYRAPEMWDLFRRELINEKVDIWALGCLLF-----RICYFKNAFDGESKL 249
K TP Y APE+ + VD W LG +++ R+ ++ + +L
Sbjct: 150 ATMKTFCGTPEYLAPEVLE---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206
Query: 250 QILNGNYRIPE--SPKYSSSVTDLI----RDMLQASPDDRPDITQVWF--RVNEQLPVGL 301
IL R P SP+ S + L+ + L P+D +I + F +N Q V
Sbjct: 207 -ILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ-DVVQ 264
Query: 302 QKSLPDRPPETQSAV-----ANEGMSKPMNRSPP 330
+K P P+ S E ++ + +PP
Sbjct: 265 KKLEPPFKPQVTSETDTRYFDEEFTAQSITITPP 298
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 27/178 (15%)
Query: 126 FEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185
F E + ++ +A+ +HS+ + +RDLK ENL+L DG K+ DFG
Sbjct: 92 FSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFG--------- 141
Query: 186 EKLEEMGIEEDNIRKH--TTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAF 243
L + GI++ K TP Y APE + VD W LG +++ + + F
Sbjct: 142 --LCKEGIKDGATMKTFCGTPEYLAPE---VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196
Query: 244 ---DGESKLQ-ILNGNYRIPE--SPKYSSSVTDLIR----DMLQASPDDRPDITQVWF 291
D E + IL R P SP+ S ++ L++ L PDD +I Q F
Sbjct: 197 YNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 17/139 (12%)
Query: 138 VCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDN 197
+C F +HS+ I +RDLK +N+LL +DG K+ DFG E M +
Sbjct: 106 ICGLQF-LHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCK---------ENMLGDAKT 153
Query: 198 IRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYR 257
TP Y APE + + N VD W+ G LL+ + ++ F G + ++ + R
Sbjct: 154 CTFCGTPDYIAPE---ILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ-SIR 209
Query: 258 IPESPKYSSSVTDLIRDML 276
+ ++P Y +T +D+L
Sbjct: 210 M-DNPCYPRWLTREAKDIL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 40/120 (33%), Positives = 53/120 (44%), Gaps = 38/120 (31%)
Query: 124 GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183
G F Q++ IF + QS I +RDLK ENLLL DG K+ DFG
Sbjct: 133 GCFYAAQIVLIFE---------YLQSLNIVYRDLKPENLLLDKDGFIKMTDFG------- 176
Query: 184 RFEKLEEMGIEEDNIRKHT---TPAYRAPEMWDLFRRELIN----EKVDIWALGCLLFRI 236
F K+ + R +T TP Y APE+ L+N + D W LG ++ I
Sbjct: 177 -FAKVVDT-------RTYTLCGTPEYIAPEI-------LLNVGHGKAADWWTLGIFIYEI 221
|
Length = 340 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 50/213 (23%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 33 IAEGGFSCVYSARDAIHM-SKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYA 91
+ G + VY A+ K+YA+K + SA +EI++++ LK HPNV+ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELK-HPNVIAL-- 63
Query: 92 HTILDLGRTKEALLVMECCDKSLVNVLE-------NRGAGYFEEKQVLAIFRDVCNAVFA 144
+ ++ L+ + + L ++++ N+ V ++ + + +
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 145 MHSQSPPIAHRDLKAENLLLGSDG----LWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRK 200
+H+ + HRDLK N+L+ +G K+ D G + + L ++ D +
Sbjct: 124 LHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL----DPVV- 176
Query: 201 HTTPAYRAPEMWDLFRRELINEKVDIWALGCLL 233
T YRAPE+ L + +DIWA+GC+
Sbjct: 177 -VTFWYRAPEL--LLGARHYTKAIDIWAIGCIF 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 67/286 (23%), Positives = 114/286 (39%), Gaps = 48/286 (16%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMK------HMICND--EESLESAMKEISVMKSLKGHP 84
+ EG F V A +AI + K+ + M+ +D E+ L + E+ +MK + H
Sbjct: 26 LGEGCFGQVVMA-EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 84
Query: 85 NVVTLYAHTILD-----------LGRTKEALLV-----MECCDKSLVNVLENRGAGYFEE 128
N++ L D G +E L ME C E
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ-----LSF 139
Query: 129 KQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEK 187
K +++ V + + S+ HRDL A N+L+ D + K+ DFG + +H + K
Sbjct: 140 KDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 188 LEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNA-FDG- 245
G + APE LF R + + D+W+ G LL+ I + + G
Sbjct: 198 KTTNG--------RLPVKWMAPEA--LFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246
Query: 246 --ESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
E ++L +R+ + ++ + ++RD A P RP Q+
Sbjct: 247 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 41/151 (27%), Positives = 65/151 (43%), Gaps = 32/151 (21%)
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT--- 202
H I +RDLK EN+LL +DG ++ D G + +E + + T
Sbjct: 112 HLHQRRIIYRDLKPENVLLDNDGNVRISDLG--------------LAVELKDGQSKTKGY 157
Query: 203 --TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAF--------DGESKLQIL 252
TP + APE L + E + VD +ALG L+ + + F + E K +IL
Sbjct: 158 AGTPGFMAPE---LLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL 214
Query: 253 NGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
N + P+ K+S + +L P+ R
Sbjct: 215 NDSVTYPD--KFSPASKSFCEALLAKDPEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 42/136 (30%), Positives = 55/136 (40%), Gaps = 18/136 (13%)
Query: 152 IAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEM 211
+ +RDLK EN+LL G LCDFG N K +K TP Y APE
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC---------GTPEYLAPE- 163
Query: 212 WDLFRRELINEKVDIWALGCLLFRICY----FKNAFDGESKLQILNGNYRIPESPKYSSS 267
L + VD W LG LL+ + F + E +IL R P+ +
Sbjct: 164 --LLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG--FDRD 219
Query: 268 VTDLIRDMLQASPDDR 283
DL+ +L P R
Sbjct: 220 AKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 76/282 (26%), Positives = 116/282 (41%), Gaps = 64/282 (22%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQ--YAMKHMICNDE--ESLESAM--KEISVMKSLK 81
V VI G F V R H S + YAMK ++ E + +SA +E +M
Sbjct: 46 DVIKVIGRGAFGEVQLVR---HKSSKQVYAMK-LLSKFEMIKRSDSAFFWEERDIM---- 97
Query: 82 GHPN---VVTL-YAHTILDLGRTKEALLVMECC-DKSLVNVLENRGAGYFEEKQVLAIF- 135
H N +V L YA K +VME LVN++ N ++ + A F
Sbjct: 98 AHANSEWIVQLHYA-----FQDDKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFY 147
Query: 136 -RDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIE 194
+V A+ A+HS HRD+K +N+LL G KL DFG+ K++ G+
Sbjct: 148 TAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCM-------KMDANGM- 197
Query: 195 EDNIRKHT---TPAYRAPEMW------DLFRRELINEKVDIWALGCLLFRICYFKNAFDG 245
+R T TP Y +PE+ + RE D W++G L+ + F
Sbjct: 198 ---VRCDTAVGTPDYISPEVLKSQGGDGYYGRE-----CDWWSVGVFLYEMLVGDTPFYA 249
Query: 246 ESKL----QILN--GNYRIPESPKYSSSVTDLIRDMLQASPD 281
+S + +I++ + P+ + S DLI L
Sbjct: 250 DSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREV 291
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 61/250 (24%), Positives = 108/250 (43%), Gaps = 45/250 (18%)
Query: 64 EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR-TKEALL--VMECCDK-SLVNVLE 119
++ L + E+ +MK + H N++ L LG T+E L ++E K +L L
Sbjct: 58 DKDLADLISEMELMKLIGKHKNIINL-------LGVCTQEGPLYVIVEYAAKGNLREFLR 110
Query: 120 NR---GAGY-FEEKQV---LAIFRDVCNAVFAM-----HSQSPPIAHRDLKAENLLLGSD 167
R G Y F+ +V F+D+ + + + + +S HRDL A N+L+ D
Sbjct: 111 ARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED 170
Query: 168 GLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMW----DLFRRELINEK 223
+ K+ DFG G+ + + K T+ R P W LF R + +
Sbjct: 171 NVMKIADFGLAR------------GVHDIDYYKKTSNG-RLPVKWMAPEALFDR-VYTHQ 216
Query: 224 VDIWALGCLLFRICYFKNA-FDG---ESKLQILNGNYRIPESPKYSSSVTDLIRDMLQAS 279
D+W+ G L++ I + + G E ++L +R+ + + + L+R+ A
Sbjct: 217 SDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAV 276
Query: 280 PDDRPDITQV 289
P RP Q+
Sbjct: 277 PTQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 33 IAEGGFSCVYSA-RDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYA 91
+ G + VY A R + YA+K + SA +EI++++ LK HPNV++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELK-HPNVISL-- 63
Query: 92 HTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEK-------QVLAIFRDVCNAVFA 144
+ ++ L+ + + L ++++ A +K V ++ + + +
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 145 MHSQSPPIAHRDLKAENLLLGSDG----LWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRK 200
+H+ + HRDLK N+L+ +G K+ D G + + L ++ D +
Sbjct: 124 LHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL----DPVV- 176
Query: 201 HTTPAYRAPEMWDLFRRELINEKVDIWALGCLL 233
T YRAPE+ L + +DIWA+GC+
Sbjct: 177 -VTFWYRAPEL--LLGARHYTKAIDIWAIGCIF 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 36/228 (15%)
Query: 68 ESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYF 126
E+ ++E +MK L+ H +V LYA + + +V E K SL++ L+ Y
Sbjct: 46 EAFLQEAQIMKKLR-HDKLVPLYA-----VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYL 99
Query: 127 EEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186
+ Q++ + + + + + + HRDL+A N+L+G + + K+ DFG
Sbjct: 100 KLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLAR------- 150
Query: 187 KLEEMGIEEDNIRKHTTPA-----YRAPEMWDLFRRELINEKVDIWALGCLLFRICY--- 238
+ EDN A + APE L+ R I K D+W+ G LL +
Sbjct: 151 ------LIEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI--KSDVWSFGILLTELVTKGR 201
Query: 239 --FKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
+ + E Q+ G YR+P S+ +L++ + PD+RP
Sbjct: 202 VPYPGMVNREVLEQVERG-YRMPCPQGCPESLHELMKLCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 55/222 (24%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQY-AMKHMICNDEESLESAM------KEISVMKSLKGH 83
+ + G + V SA D + + A+K + +SA+ +E+ ++K + H
Sbjct: 21 SPVGSGAYGQVCSAFDT--KTGRKVAIKKL----SRPFQSAIHAKRTYRELRLLKHMD-H 73
Query: 84 PNVVTLYAHTILDLGRTKEAL-------LVMECCDKSLVNVLENRGAGYFEEKQVLAIFR 136
NV+ L LD+ +L LV L N+++ + + + +
Sbjct: 74 ENVIGL-----LDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ---KLSDDHIQFLVY 125
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGIEE 195
+ + +HS I HRDLK N+ + D K+ DFG + T+ EM
Sbjct: 126 QILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDD-------EM---- 172
Query: 196 DNIRKHT----TPAYRAPEMWDLFRRELINEKVDIWALGCLL 233
T T YRAPE+ + N+ VDIW++GC++
Sbjct: 173 ------TGYVATRWYRAPEI--MLNWMHYNQTVDIWSVGCIM 206
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 41/172 (23%), Positives = 73/172 (42%), Gaps = 17/172 (9%)
Query: 63 DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVME-CCDKSLVNVLENR 121
+E L+ +EI + L+ HPN++ I+D E +V S ++L+
Sbjct: 39 SKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVD----SELYVVSPLMAYGSCEDLLKTH 93
Query: 122 GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181
E + I +DV NA+ +HS+ HR +KA ++LL DG L +
Sbjct: 94 FPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGL---RYS 148
Query: 182 HKRFEKLEEMGIEEDNIRKHTTPAY-RAPEMWDLFRRELI--NEKVDIWALG 230
+ + + D + +PE+ ++ L NEK DI+++G
Sbjct: 149 VSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV---LQQNLQGYNEKSDIYSVG 197
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 44/151 (29%), Positives = 63/151 (41%), Gaps = 36/151 (23%)
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEK-------LEEMGIEEDNI 198
H S I +RDLK EN+LL +G KL DFG + + +K +E M E N
Sbjct: 113 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 199 RKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDG----ESKLQILNG 254
R HT A D W+ G L+F + F G E+ IL
Sbjct: 173 RGHTQSA-------------------DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA 213
Query: 255 NYRIPE--SPKYSSSVTDLIRDMLQASPDDR 283
+P+ SP+ S L+R + + +P +R
Sbjct: 214 KLGMPQFLSPEAQS----LLRALFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 72/265 (27%), Positives = 115/265 (43%), Gaps = 42/265 (15%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHM-----ICNDEESLESAMKEISVMKSLKGHPNV 86
++ +G F V R+ K YAMK + I DE + + E V+K+ + HP +
Sbjct: 2 LLGKGTFGKVILVREKAS-GKYYAMKILKKEVIIAKDE--VAHTLTESRVLKNTR-HPFL 57
Query: 87 VTL-YAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
+L Y+ +TK+ L VME + + +R F E + ++ +A+
Sbjct: 58 TSLKYSF------QTKDRLCFVMEYVNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDY 110
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH--T 202
+HS I +RDLK ENL+L DG K+ DFG L + GI + K
Sbjct: 111 LHSGK--IVYRDLKLENLMLDKDGHIKITDFG-----------LCKEGITDAATMKTFCG 157
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAF---DGESKLQ-ILNGNYRI 258
TP Y APE + VD W LG +++ + + F D E + IL + +
Sbjct: 158 TPEYLAPE---VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKF 214
Query: 259 PESPKYSSSVTDLIRDMLQASPDDR 283
P + S+ L+ +L P+ R
Sbjct: 215 PRT--LSADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 73/272 (26%), Positives = 113/272 (41%), Gaps = 64/272 (23%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQ--YAMK-----HMICNDEESLESAMKEISVMKSLK 81
V VI G F V R H S Q YAMK MI + + ++I +
Sbjct: 47 VVKVIGRGAFGEVQLVR---HKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDI---MAFA 100
Query: 82 GHPNVVTLYAHTILDLGRTKEALLVMECC-DKSLVNVLEN-----RGAGYFEEKQVLAIF 135
P VV L+ K +VME LVN++ N + A ++ + VLA+
Sbjct: 101 NSPWVVQLFCA----FQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLAL- 155
Query: 136 RDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEE 195
+A+ +M + HRD+K +N+LL G KL DFG+ K++E G+
Sbjct: 156 ----DAIHSMG-----LIHRDVKPDNMLLDKHGHLKLADFGTCM-------KMDETGM-- 197
Query: 196 DNIRKHT---TPAYRAPEMWD------LFRRELINEKVDIWALGCLLFRIC-----YFKN 241
+R T TP Y +PE+ + RE D W++G LF + ++ +
Sbjct: 198 --VRCDTAVGTPDYISPEVLKSQGGDGYYGRE-----CDWWSVGVFLFEMLVGDTPFYAD 250
Query: 242 AFDGE-SKLQILNGNYRIPESPKYSSSVTDLI 272
+ G SK+ + PE + S +LI
Sbjct: 251 SLVGTYSKIMDHKNSLNFPEDVEISKHAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 36/146 (24%), Positives = 62/146 (42%), Gaps = 20/146 (13%)
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTP 204
+H S I +RD+K EN+LL G +L D G E+ + ++ T
Sbjct: 109 LHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAV----------ELKDGKTITQRAGTN 158
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICY----FKNAFDGESKLQILNGNYRIP- 259
Y APE + + E + VD +A+GC ++ + FK+ + +K ++
Sbjct: 159 GYMAPE---ILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV 215
Query: 260 --ESPKYSSSVTDLIRDMLQASPDDR 283
E ++ D+ R L P+DR
Sbjct: 216 KFEHQNFTEESKDICRLFLAKKPEDR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 33/120 (27%), Positives = 57/120 (47%), Gaps = 10/120 (8%)
Query: 154 HRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWD 213
HRD+K +N+L+ +G +L DFGS KL E G + ++ TP Y +PE+
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFGSCL-------KLMEDGTVQSSVAV-GTPDYISPEILQ 176
Query: 214 LFR--RELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESPKYSSSVTDL 271
+ + D W+LG ++ + Y + F ES ++ E ++ + VTD+
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 43/152 (28%), Positives = 64/152 (42%), Gaps = 30/152 (19%)
Query: 152 IAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPE- 210
I HRD+K N+L+ +G KLCDFG S N + + NI +Y APE
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFG-VSGNL-------VASLAKTNI---GCQSYMAPER 172
Query: 211 --MWDLFRRELINEKVDIWALG-----CLLFRICY----FKNAFDGESKLQ-ILNGN-YR 257
+ + D+W+LG L R Y + N F ++L I++G+
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF---AQLSAIVDGDPPT 229
Query: 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
+P YS D + L P+ RP Q+
Sbjct: 230 LP--SGYSDDAQDFVAKCLNKIPNRRPTYAQL 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 47/158 (29%), Positives = 73/158 (46%), Gaps = 18/158 (11%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLY 90
I+ G F VY R + SK YA+K + D +++ ++ +L P +V LY
Sbjct: 12 ISRGAFGKVYLGRKK-NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY 70
Query: 91 AHTILDLGRTKEALLVMECCD----KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH 146
L LVME KSL+++ GYF+E+ + +V A+ +H
Sbjct: 71 ----YSLQSANNVYLVMEYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLH 121
Query: 147 SQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKR 184
I HRDLK +N+L+ ++G KL DFG + R
Sbjct: 122 RHG--IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR 157
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 67/290 (23%), Positives = 119/290 (41%), Gaps = 52/290 (17%)
Query: 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQY---AMK--HMICNDEESLESAMKEI 74
ID + I VI G F V R + K+ A+K +D++ L+ + E
Sbjct: 1 IDPSYVTIE--KVIGGGEFGEVCRGRLKLP-GKKEIDVAIKTLKAGSSDKQRLD-FLTEA 56
Query: 75 SVMKSLKGHPNVVTLYAHTILDLGRTKEALLVME-----CCDKSLVNVLENRGAGYFEEK 129
S+M HPN++ L + +++ +++ E DK L EN G F
Sbjct: 57 SIMGQFD-HPNIIRLEGV----VTKSRPVMIITEYMENGSLDKFL---RENDG--KFTVG 106
Query: 130 QVLAIFRDVCNAVFAMHSQSP-PIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL 188
Q++ + R + M S HRDL A N+L+ S+ + K+ DFG + +R E
Sbjct: 107 QLVGMLRGI---ASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS----RRLEDS 159
Query: 189 EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKV-----DIWALGCLLFRICYFKN-- 241
E +TT + P W E I + D+W+ G +++ + +
Sbjct: 160 EA---------TYTTKGGKIPIRWT--APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
Query: 242 --AFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
+ ++ + YR+P S++ L+ D Q ++RP +Q+
Sbjct: 209 YWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 18/149 (12%)
Query: 31 NVIAEGGFSCVYSARDAIH--MSKQYAMKHMICNDEESLESAM-KEISVMKSLKGHPNVV 87
N I G VY H + YA+K + N E+++ + +EI +++ + HPNVV
Sbjct: 80 NRIGSGAGGTVYKVI---HRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN-HPNVV 135
Query: 88 TLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
H + D E +++E D LE +E+ + + R + + + +H
Sbjct: 136 K--CHDMFD--HNGEIQVLLEFMDGG---SLEGTHIA--DEQFLADVARQILSGIAYLHR 186
Query: 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFG 176
+ I HRD+K NLL+ S K+ DFG
Sbjct: 187 RH--IVHRDIKPSNLLINSAKNVKIADFG 213
|
Length = 353 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 50/204 (24%)
Query: 124 GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG------- 176
G F E ++ AV ++H HRD+K +N+L+ DG KL DFG
Sbjct: 96 GIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153
Query: 177 ------STSTNHKRFEKLE---EMG-------------IEEDNIRKHT---------TPA 205
S +H R + ++ E G +E R+H TP
Sbjct: 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPN 213
Query: 206 YRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDG----ESKLQILN--GNYRIP 259
Y APE + R + D W++G +L+ + + F E++++++N + IP
Sbjct: 214 YIAPE---VLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIP 270
Query: 260 ESPKYSSSVTDLIRDMLQASPDDR 283
K S +DLI + + P+DR
Sbjct: 271 PQAKLSPEASDLIIKLCRG-PEDR 293
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 43/141 (30%), Positives = 65/141 (46%), Gaps = 22/141 (15%)
Query: 154 HRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPE--- 210
HRD+K +N+LL +G +L DFGS +L G + N+ TP Y +PE
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFGSCL-------RLLADGTVQSNVAV-GTPDYISPEILQ 176
Query: 211 -MWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNYRI---PESP 262
M D R + D W+LG ++ + Y + F ES ++ I+N P+
Sbjct: 177 AMEDGKGR--YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVT 234
Query: 263 KYSSSVTDLIRDMLQASPDDR 283
S DLIR ++ SP+ R
Sbjct: 235 DVSEEAKDLIRRLI-CSPETR 254
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 32/118 (27%), Positives = 48/118 (40%), Gaps = 16/118 (13%)
Query: 130 QVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLE 189
Q L I + + + +H+Q I HRD+K EN+ + + D G+ L
Sbjct: 158 QALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG 215
Query: 190 EMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFR-ICYFKNAFDGE 246
G E N APE + R+ N K DIW+ G +LF + Y F+
Sbjct: 216 LAGTVETN----------APE---VLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDP 260
|
Length = 357 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 37/136 (27%), Positives = 56/136 (41%), Gaps = 17/136 (12%)
Query: 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYR 207
S I HRDLK NL + D K+ DFG R E G T YR
Sbjct: 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYV-------ATRWYR 184
Query: 208 APEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRI---PESPKY 264
APE+ + N+ VDIW++GC++ + + F G + L R+ P +
Sbjct: 185 APEI--MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 242
Query: 265 SSSVTDLIRDMLQASP 280
++ R+ +Q+
Sbjct: 243 KKISSESARNYIQSLT 258
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 37/118 (31%), Positives = 56/118 (47%), Gaps = 9/118 (7%)
Query: 62 NDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCD-KSLVNVLEN 120
+++ KEI+++K+L H N+V Y + G K L+ME SL + L
Sbjct: 45 CGQQNTSGWKKEINILKTLY-HENIVK-YKGCCSEQG-GKGLQLIMEYVPLGSLRDYLPK 101
Query: 121 RGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178
Q+L + +C + +HSQ HRDL A N+LL +D L K+ DFG
Sbjct: 102 HKLNL---AQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLA 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 74/272 (27%), Positives = 113/272 (41%), Gaps = 63/272 (23%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEI-----SVMKSLKGH--- 83
+I GGF VY R A K YAMK C D++ ++ E +M SL
Sbjct: 1 IIGRGGFGEVYGCRKA-DTGKMYAMK---CLDKKRIKMKQGETLALNERIMLSLVSTGDC 56
Query: 84 PNVVTL-YA-HT------ILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIF 135
P +V + YA HT ILDL M D L L G F EK++
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDL---------MNGGD--LHYHLSQHGV--FSEKEMRFYA 103
Query: 136 RDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEE 195
++ + MH++ + +RDLK N+LL G ++ D G K+
Sbjct: 104 TEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----------- 150
Query: 196 DNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAF---DGESKL 249
+ H T Y APE+ L + + D ++LGC+LF++ + F + K
Sbjct: 151 ---KPHASVGTHGYMAPEV--LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205
Query: 250 QI----LNGNYRIPESPKYSSSVTDLIRDMLQ 277
+I L N +P+S +S + L+ +LQ
Sbjct: 206 EIDRMTLTVNVELPDS--FSPELKSLLEGLLQ 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 44/174 (25%), Positives = 71/174 (40%), Gaps = 48/174 (27%)
Query: 154 HRDLKAENLLLGSDGLWKLCDFGSTS-------------TNHKRFEKLEE---------- 190
HRD+K +N+L+ DG KL DFG + +H R + +E
Sbjct: 124 HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNC 183
Query: 191 ------MGIEEDNIRKHT---------TPAYRAPEMWDLFRRELINEKVDIWALGCLLFR 235
+E+ ++H TP Y APE + R+ + D W++G +LF
Sbjct: 184 RCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPE---VLLRKGYTQLCDWWSVGVILFE 240
Query: 236 ICYFKNAF----DGESKLQILN--GNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
+ + F E++L+++N IP K S DLI L S ++R
Sbjct: 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITK-LCCSAEER 293
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 36/230 (15%)
Query: 66 SLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGA 123
S+E+ + E +VMK+L+ H +V L+A TKE + ++ E K SL++ L++
Sbjct: 44 SVEAFLAEANVMKTLQ-HDKLVKLHAVV------TKEPIYIITEFMAKGSLLDFLKSDEG 96
Query: 124 GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183
+++ + + + ++ HRDL+A N+L+ + + K+ DFG
Sbjct: 97 SKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLAR---- 150
Query: 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINE-----KVDIWALGCLLFRI-C 237
+ EDN A + P W E IN K D+W+ G LL I
Sbjct: 151 ---------VIEDNEYTAREGA-KFPIKWT--APEAINFGSFTIKSDVWSFGILLMEIVT 198
Query: 238 YFKNAFDGESKLQI---LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
Y + + G S ++ L YR+P + +++ + P++RP
Sbjct: 199 YGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 52/200 (26%), Positives = 83/200 (41%), Gaps = 32/200 (16%)
Query: 70 AMKEISVMKSLKGHPNVVTLY----AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGY 125
A +E+ ++K +K H NV+ L LD R + LVM L ++++
Sbjct: 61 AYRELRLLKHMK-HENVIGLLDVFTPDLSLD--RFHDFYLVMPFMGTDLGKLMKHEKLS- 116
Query: 126 FEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185
E ++ + + + +H+ I HRDLK NL + D K+ DFG R
Sbjct: 117 --EDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLA-----RQ 167
Query: 186 EKLEEMGIEEDNIRKHTTPAYRAPEM---WDLFRRELINEKVDIWALGCLLFRICYFKNA 242
E G T YRAPE+ W + + VDIW++GC++ + K
Sbjct: 168 TDSEMTGYV-------VTRWYRAPEVILNWMHY-----TQTVDIWSVGCIMAEMLTGKPL 215
Query: 243 FDGESKLQILNGNYRIPESP 262
F G L L ++ +P
Sbjct: 216 FKGHDHLDQLMEIMKVTGTP 235
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 38/141 (26%), Positives = 58/141 (41%), Gaps = 22/141 (15%)
Query: 152 IAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEM 211
+ HRDL A N+L+ K+ DFG + + EED+ K + R P
Sbjct: 148 LVHRDLAARNVLVAEGRKMKISDFGLSRDVY-----------EEDSYVKRSKG--RIPVK 194
Query: 212 W----DLFRRELINEKVDIWALGCLLFRICYF-KNAFDG---ESKLQILNGNYRIPESPK 263
W LF + + D+W+ G LL+ I N + G E +L YR+
Sbjct: 195 WMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPEN 253
Query: 264 YSSSVTDLIRDMLQASPDDRP 284
S + +L+ + PD RP
Sbjct: 254 CSEEMYNLMLTCWKQEPDKRP 274
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 52/188 (27%), Positives = 75/188 (39%), Gaps = 34/188 (18%)
Query: 131 VLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST----STNHKRFE 186
+LAI R V A+ +H I HRD+KAEN+ + G L DFG+ N ++
Sbjct: 184 ILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC------YFK 240
T A APE L R+ VDIW+ G +LF + + K
Sbjct: 242 GWA------------GTIATNAPE---LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286
Query: 241 NAFDGES------KLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294
+ DG+ KL I E P + + D I L +P +W +
Sbjct: 287 DGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLY 346
Query: 295 EQLPVGLQ 302
E LP+ L+
Sbjct: 347 E-LPIDLE 353
|
Length = 391 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 69/287 (24%), Positives = 115/287 (40%), Gaps = 50/287 (17%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMK------HMICND--EESLESAMKEISVMKSLKGHP 84
+ EG F V A +AI + K K M+ +D ++ L + E+ +MK + H
Sbjct: 20 LGEGCFGQVVMA-EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHK 78
Query: 85 NVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENR---GAGY------FEEKQVLAIF 135
N++ L D +LV +L L R G Y E+Q+ F
Sbjct: 79 NIINLLGACTQD---GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQL--TF 133
Query: 136 RDVCNAVFAM-----HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEE 190
+D+ + + + + S HRDL A N+L+ D + K+ DFG H
Sbjct: 134 KDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNI------ 187
Query: 191 MGIEEDNIRKHTTPAYRAPEMW----DLFRRELINEKVDIWALGCLLFRICYFKNA-FDG 245
D +K T R P W LF R + + D+W+ G LL+ I + + G
Sbjct: 188 -----DYYKKTTNG--RLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPG 239
Query: 246 ---ESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
E ++L +R+ + + + ++R+ A P RP Q+
Sbjct: 240 IPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 57/247 (23%), Positives = 93/247 (37%), Gaps = 42/247 (17%)
Query: 62 NDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENR 121
+ + KEI ++++L H N+V D G + L+ME + R
Sbjct: 45 SGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYLPR 101
Query: 122 GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181
KQ L +C + + S+ HRDL A N+L+ S+ K+ DFG T
Sbjct: 102 NKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLT--- 156
Query: 182 HKRFEKLEEMGIEEDNIRKHTTPAY-RAPEMWDLFRRELINEKV----DIWALGCLLFRI 236
K E +E +D++ +P + APE LI K D+W+ G L+ +
Sbjct: 157 -KAIETDKEYYTVKDDL---DSPVFWYAPEC-------LIQSKFYIASDVWSFGVTLYEL 205
Query: 237 CYFKNA----------FDGESKLQ--------ILNGNYRIPESPKYSSSVTDLIRDMLQA 278
+ ++ G + Q +L R+P P V L+R +
Sbjct: 206 LTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEF 265
Query: 279 SPDDRPD 285
P R
Sbjct: 266 QPSKRTT 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 40/151 (26%), Positives = 59/151 (39%), Gaps = 35/151 (23%)
Query: 152 IAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---TPAYRA 208
I HRD+K N+L+ S G KLCDFG + E N T T Y +
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSG--------------ELINSIADTFVGTSTYMS 170
Query: 209 PEMWDLFRRELINEKVDIWALGCLLFRICYFKNAF-------DGE-SKLQILNGNYRIPE 260
PE + K D+W+LG + + K F DG+ + IL+ +I +
Sbjct: 171 PER---IQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ 227
Query: 261 SP-------KYSSSVTDLIRDMLQASPDDRP 284
P + + D + L P +RP
Sbjct: 228 EPPPRLPSSDFPEDLRDFVDACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 57/231 (24%), Positives = 98/231 (42%), Gaps = 38/231 (16%)
Query: 66 SLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAG 124
S ES ++E +MK L+ H +V LYA + + +V E K SL++ L++
Sbjct: 44 SPESFLEEAQIMKKLR-HDKLVQLYA-----VVSEEPIYIVTEYMSKGSLLDFLKDGEGR 97
Query: 125 YFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKR 184
+ ++ + V + + + HRDL++ N+L+G + K+ DFG
Sbjct: 98 ALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLAR----- 150
Query: 185 FEKLEEMGIEEDNIRKHTTPA-----YRAPEMWDLFRRELINEKVDIWALGCLLF----- 234
+ EDN A + APE L+ R I K D+W+ G LL
Sbjct: 151 --------LIEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI--KSDVWSFGILLTELVTK 199
Query: 235 -RICYFKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
R+ Y + L+ + YR+P S+ +L+ + P++RP
Sbjct: 200 GRVPY--PGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 32/106 (30%), Positives = 47/106 (44%), Gaps = 13/106 (12%)
Query: 129 KQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL 188
KQ AI + + AV +H + + HRD+K EN+ L DG L DFG+ K E
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324
Query: 189 EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLF 234
+ + T A +PE+ + E DIW+ G +L
Sbjct: 325 DYGWV--------GTVATNSPEI---LAGDGYCEITDIWSCGLILL 359
|
Length = 501 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 40/228 (17%)
Query: 83 HPNVVTLYAHTILDLGRTKEA---LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVC 139
HPN++ LG+ EA LLV E C+ + ++ + Q+L + R C
Sbjct: 54 HPNILQC-------LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMAC 106
Query: 140 N---AVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEED 196
V MH + H DL N L SD K+ D+G + +K E IE +
Sbjct: 107 EIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK------EDYIETE 158
Query: 197 NIRKHTTPAYRAPEMWDLFRRELI----NEKVDIWALGCLLFRICYFKNA---FDGESKL 249
+ K + APE+ F LI + ++WALG L+ + F+NA + S
Sbjct: 159 D-DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL--FENAAQPYSHLSDR 215
Query: 250 QILN-----GNYRIPESPKYSSSVTDLIRDMLQ---ASPDDRPDITQV 289
++LN ++ + P+ ++ ++LQ SP+ R +V
Sbjct: 216 EVLNHVIKDQQVKLFK-PQLELPYSERWYEVLQFCWLSPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 72/278 (25%), Positives = 110/278 (39%), Gaps = 63/278 (22%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEI-----SVMKSLKGH--- 83
+I GGF VY R A K YAMK C D++ ++ E +M SL
Sbjct: 1 IIGRGGFGEVYGCRKA-DTGKMYAMK---CLDKKRIKMKQGETLALNERIMLSLVSTGDC 56
Query: 84 PNVVTL-YA-HT------ILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIF 135
P +V + YA HT ILDL M D L L G F E ++
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDL---------MNGGD--LHYHLSQHGV--FSEAEMRFYA 103
Query: 136 RDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEE 195
++ + MH++ + +RDLK N+LL G ++ D G K+
Sbjct: 104 AEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----------- 150
Query: 196 DNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDG------- 245
+ H T Y APE+ L + + D ++LGC+LF++ + F
Sbjct: 151 ---KPHASVGTHGYMAPEV--LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205
Query: 246 ESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
E L +P+S +S + L+ +LQ + R
Sbjct: 206 EIDRMTLTMAVELPDS--FSPELRSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 30/88 (34%), Positives = 42/88 (47%), Gaps = 20/88 (22%)
Query: 154 HRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWD 213
HRDL A N+LL + + K+CDFG +K + D +RK + R P W
Sbjct: 197 HRDLAARNILLSENNVVKICDFGLARDIYK----------DPDYVRKGSA---RLPLKW- 242
Query: 214 LFRRELINEKV-----DIWALGCLLFRI 236
E I +KV D+W+ G LL+ I
Sbjct: 243 -MAPESIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 51/242 (21%), Positives = 103/242 (42%), Gaps = 34/242 (14%)
Query: 62 NDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVN--VLE 119
ND + ++E +VM+ L +P +V + + + + +LVME + +N + +
Sbjct: 35 NDPALKDELLREANVMQQLD-NPYIVRM-----IGICEAESWMLVMELAELGPLNKFLQK 88
Query: 120 NRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179
N+ + EK + + V + + + HRDL A N+LL + K+ DFG +
Sbjct: 89 NK---HVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLS- 142
Query: 180 TNHKRFEKLEEMGIEEDNIRKHTTP----AYRAPEMWDLFRRELINEKVDIWALGCLLFR 235
+ +G +E+ + T + APE + ++ + K D+W+ G L++
Sbjct: 143 ---------KALGADENYYKAKTHGKWPVKWYAPECMNYYK---FSSKSDVWSFGVLMWE 190
Query: 236 -ICYFKNAF---DGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291
Y + + G Q++ R+ + + DL++ D+RP V
Sbjct: 191 AFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250
Query: 292 RV 293
R+
Sbjct: 251 RL 252
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 39/148 (26%), Positives = 61/148 (41%), Gaps = 29/148 (19%)
Query: 154 HRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWD 213
HRDL A N+LL + + K+CDFG +K + D +RK R P W
Sbjct: 202 HRDLAARNILLSENNVVKICDFGLARDIYK----------DPDYVRKGDA---RLPLKW- 247
Query: 214 LFRRELINEKV-----DIWALGCLLFRIC------YFKNAFDGESKLQILNGNYRIPESP 262
E I ++V D+W+ G LL+ I Y D E ++ G +P
Sbjct: 248 -MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--RAP 304
Query: 263 KYSSS-VTDLIRDMLQASPDDRPDITQV 289
Y++ + + D P RP +++
Sbjct: 305 DYTTPEMYQTMLDCWHGEPSQRPTFSEL 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 39/222 (17%)
Query: 84 PNVVTLYAHTILDLGRTKEALLVMECCDKSL----VNVLENRGAGYFEEKQVLA-IFRDV 138
P VT Y L R + + ME D SL V + G + +L I +
Sbjct: 60 PYTVTFYGA----LFREGDVWICMEVMDTSLDKFYKKVYDK---GLTIPEDILGKIAVSI 112
Query: 139 CNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNI 198
A+ +HS+ I HRD+K N+L+ +G KLCDFG + G D++
Sbjct: 113 VKALEYLHSKLSVI-HRDVKPSNVLINRNGQVKLCDFGIS-------------GYLVDSV 158
Query: 199 RKHTTPA----YRAPEMWDLFRREL-INEKVDIWALGCLLFRICYFKNAFDG-----ESK 248
K T A Y APE + + + K D+W+LG + + + +D +
Sbjct: 159 AK-TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL 217
Query: 249 LQILNG-NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
Q++ + ++P K+S D + L+ + +RP+ ++
Sbjct: 218 KQVVEEPSPQLPAE-KFSPEFQDFVNKCLKKNYKERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 42/175 (24%), Positives = 67/175 (38%), Gaps = 47/175 (26%)
Query: 113 SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKL 172
SL ++LE RG E+++ A+ + HR K+ N+LL DGL KL
Sbjct: 2 SLADILEVRGRP-LNEEEIWAVCLQCL--------GALRELHRQAKSGNILLTWDGLLKL 52
Query: 173 CDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCL 232
GS + K E P + APE + + + EK DI++LG
Sbjct: 53 --DGSVA------FKTPEQSRP--------DPYFMAPE---VIQGQSYTEKADIYSLGIT 93
Query: 233 LFRICYFKNAFDGESKLQILNGNYRIPES--PKYSSSVTDLIRDMLQASPDDRPD 285
L+ +Y +P + + S+ + L+ M P DR +
Sbjct: 94 LYEA-----------------LDYELPYNEERELSAILEILLNGMPADDPRDRSN 131
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 29/156 (18%)
Query: 154 HRDLKAENLLLGSDGLWKLCDFG-----STSTNHKRFEKLEEMGIEEDNIRKHTTPA-YR 207
HRDL A N+LL + K+CDFG +N+ + + N R P +
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLARDIRNDSNY----------VVKGNAR---LPVKWM 283
Query: 208 APEMWDLFRRELINEKVDIWALGCLLFRICYFKNA-FDG---ESKL-QILNGNYRIPESP 262
APE +F E D+W+ G LL+ I ++ + G +SK +++ YR+ SP
Sbjct: 284 APE--SIFNCVYTFES-DVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM-LSP 339
Query: 263 KYS-SSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297
+ + S + D+++ A P RP Q+ + +QL
Sbjct: 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 27/87 (31%), Positives = 41/87 (47%), Gaps = 18/87 (20%)
Query: 154 HRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMW- 212
HRDL A N+LL + + K+CDFG +K + D +RK R P W
Sbjct: 196 HRDLAARNILLSENNVVKICDFGLARDIYK----------DPDYVRKGDA---RLPLKWM 242
Query: 213 ---DLFRRELINEKVDIWALGCLLFRI 236
+F + + + D+W+ G LL+ I
Sbjct: 243 APESIFDK-VYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 33/222 (14%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESA---MKEISVMKSLKGHPNVVTL 89
+ G + V SA D + ++ A+K + +SL A +E+ ++K +K H NV+ L
Sbjct: 23 VGSGAYGSVCSAYDT-RLRQKVAVKKL-SRPFQSLIHARRTYRELRLLKHMK-HENVIGL 79
Query: 90 Y-----AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
A +I + E LV L N+++ + ++ V + + +
Sbjct: 80 LDVFTPATSIENF---NEVYLVTNLMGADLNNIVKCQK---LSDEHVQFLIYQLLRGLKY 133
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTP 204
+HS I HRDLK N+ + D ++ DFG +++ T
Sbjct: 134 IHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQA------------DDEMTGYVATR 179
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGE 246
YRAPE+ + N+ VDIW++GC++ + K F G
Sbjct: 180 WYRAPEI--MLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 55/244 (22%), Positives = 101/244 (41%), Gaps = 33/244 (13%)
Query: 64 EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRG 122
E+ L + E+ +MK + H N++ L D +++E K +L L R
Sbjct: 61 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD----GPLYVIVEYASKGNLREYLRARR 116
Query: 123 AGYFEEKQVLA-------IFRDVCNAVFAM-----HSQSPPIAHRDLKAENLLLGSDGLW 170
E +A F+D+ + + + + S HRDL A N+L+ + +
Sbjct: 117 PPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVM 176
Query: 171 KLCDFG-STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWAL 229
K+ DFG + N+ + K G + APE LF R + + D+W+
Sbjct: 177 KIADFGLARDVNNIDYYKKTTNG--------RLPVKWMAPEA--LFDR-VYTHQSDVWSF 225
Query: 230 GCLLFRICYFKNA-FDG---ESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPD 285
G L++ I + + G E ++L +R+ + ++ + ++RD A P RP
Sbjct: 226 GVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPT 285
Query: 286 ITQV 289
Q+
Sbjct: 286 FKQL 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|130009 TIGR00934, 2a38euk, potassium uptake protein, Trk family | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 24/173 (13%), Positives = 45/173 (26%), Gaps = 4/173 (2%)
Query: 275 MLQASPDDRPDITQVWFRVNEQLPVGLQKSLPDRP-PETQSAVANEGMSKPMNRSPPMPQ 333
MLQ + + + R +E+ +Q+ + RP + + ++S
Sbjct: 242 MLQGIHERIREKSSANSRSDERSSESIQEQVERRPSTSDIERNSQSLTRRYDDKSFDKAV 301
Query: 334 RSPPPPPSSVDPTRNISQPSTTPAVSGGGGVLGAFWSTQHAKDSIVAEDQSRSKFYEEPS 393
R ++ + W H K KF +
Sbjct: 302 RLRRSKTIDRAEACDLEELDRAKDFEKM---TYDNWKAHHRKKKNFRPRGWNLKFRKASR 358
Query: 394 IYSTSGHSRSQSDNHPVNPSTVEEENIQNHAIRRNVHGKSHKPEDGPSKDIKM 446
S + + NH S+ E + + K ED K
Sbjct: 359 FPKDSDRNYEDNGNHLSASSSFGSEEPSLSSEENLYPTYNKKREDSRHTLSKT 411
|
The proteins of the Trk family are derived from Gram-negative and Gram-positive bacteria, yeast and wheat. The proteins of E. coli K12 TrkH and TrkG as well as several yeast proteins have been functionally characterized.The E. coli TrkH and TrkG proteins are complexed to two peripheral membrane proteins, TrkA, an NAD-binding protein, and TrkE, an ATP-binding protein. This complex forms the potassium uptake system. This family is specific for the eukaryotic Trk system [Transport and binding proteins, Cations and iron carrying compounds]. Length = 800 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 66/303 (21%), Positives = 114/303 (37%), Gaps = 63/303 (20%)
Query: 27 IHVRNVIAEGGFSCVYSAR-------DAIHMSKQYAMKHMICNDEESLESAMKEISVMKS 79
I ++ + EG F V+ + + +K ND + +E ++ +
Sbjct: 7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTN 64
Query: 80 LKGHPNVVTLYAHTILDLGRTKEALLV---MECCDKSLVNVLENRG------------AG 124
H N+V Y ++V ME D L L + G G
Sbjct: 65 F-QHENIVKFYGV----CTEGDPPIMVFEYMEHGD--LNKFLRSHGPDAAFLKSPDSPMG 117
Query: 125 YFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST----ST 180
Q+L I + + + + SQ HRDL N L+G D + K+ DFG + +T
Sbjct: 118 ELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTT 175
Query: 181 NHKRFEKLEEMGIEEDNIRKHTTPAYR--APE--MWDLFRRELINEKVDIWALGCLLFRI 236
++ R + HT R PE M+ F E D+W+ G +L+ I
Sbjct: 176 DYYR-------------VGGHTMLPIRWMPPESIMYRKFTTE-----SDVWSFGVVLWEI 217
Query: 237 -CYFKNAFDGESKLQILN--GNYRIPESPKY-SSSVTDLIRDMLQASPDDRPDITQVWFR 292
Y K + G S +++ R+ + P+ S V D++ + P R +I + R
Sbjct: 218 FTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHER 277
Query: 293 VNE 295
+ +
Sbjct: 278 LQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 40/232 (17%)
Query: 66 SLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLV----MECCDKSLVNVLENR 121
S E+ + E ++MK L+ HP +V LYA T+E + + ME + SLV+ L+
Sbjct: 44 SPEAFLAEANLMKQLQ-HPRLVRLYAVV------TQEPIYIITEYME--NGSLVDFLKTP 94
Query: 122 GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181
+++ + + + + ++ HRDL+A N+L+ K+ DFG
Sbjct: 95 EGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLA--- 149
Query: 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINE-----KVDIWALGCLLFRI 236
R + E E + P W E IN K D+W+ G LL I
Sbjct: 150 --RLIEDNEYTARE---------GAKFPIKWT--APEAINYGTFTIKSDVWSFGILLTEI 196
Query: 237 C-YFKNAFDGESK---LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
Y + + G + +Q L YR+P + +L+R + P++RP
Sbjct: 197 VTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 37/175 (21%), Positives = 66/175 (37%), Gaps = 50/175 (28%)
Query: 154 HRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT----------- 202
HRD+K +N+L+ G KL DFG ++ HK+ + + + K+
Sbjct: 124 HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDS 183
Query: 203 ---------------------------TPAYRAPEMWDLFRRELINEKVDIWALGCLLFR 235
TP Y APE +F ++ ++ D W+LG ++F
Sbjct: 184 INLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE---IFLQQGYGQECDWWSLGAIMFE 240
Query: 236 ICYF-------KNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
C +N+ + K+ P+ S DLIR ++ + ++R
Sbjct: 241 -CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI-TNAENR 293
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 53/217 (24%), Positives = 84/217 (38%), Gaps = 33/217 (15%)
Query: 31 NVIAEGGFSCVYSAR--DAIHMSKQYAMKHMI-CNDEESLESAMKEISVMKSLKGHPNVV 87
VI +G F CVY D+ A+K + D E +E +KE +MK HPNV+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS-HPNVL 59
Query: 88 TLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEE-----KQVLAIFRDVCNAV 142
+L + G L M L N + + E K ++ V +
Sbjct: 60 SLLGICLPSEGSPLVVLPYM--KHGDLRNFIRS------ETHNPTVKDLIGFGLQVAKGM 111
Query: 143 FAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT 202
+ S+ HRDL A N +L K+ DFG + + E ++ HT
Sbjct: 112 EYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDK---------EYYSVHNHT 160
Query: 203 TPAYRAPEMW---DLFRRELINEKVDIWALGCLLFRI 236
+ P W + + + K D+W+ G LL+ +
Sbjct: 161 --GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 195
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 15/25 (60%), Positives = 18/25 (72%)
Query: 152 IAHRDLKAENLLLGSDGLWKLCDFG 176
I HRD+K N+L+ S G KLCDFG
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFG 145
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 75/313 (23%), Positives = 124/313 (39%), Gaps = 55/313 (17%)
Query: 21 DVGNLKIHVRNVIAEGGFSCVYS--ARDAIHMSKQYAMKHMICNDEESLESAMK---EIS 75
+V KI + + +G F VY ARD I + + N+ SL ++ E S
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 76 VMKSLKGHPNVVTLYAHTILDLG---RTKEALLVMECCD----KSLVNVLE-----NRGA 123
VMK H H + LG + + L+VME KS + L N G
Sbjct: 62 VMKGFTCH--------HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 113
Query: 124 GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183
++++ + ++ + + ++++ HRDL A N ++ D K+ DFG T +
Sbjct: 114 PPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIY- 170
Query: 184 RFEKLEEMGIEEDNIRKHTTP----AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF 239
E D RK + APE + + D+W+ G +L+ I
Sbjct: 171 ----------ETDYYRKGGKGLLPVRWMAPES---LKDGVFTTSSDMWSFGVVLWEITSL 217
Query: 240 -KNAFDGESKLQIL----NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294
+ + G S Q+L +G Y + + VTDL+R Q +P RP + +
Sbjct: 218 AEQPYQGLSNEQVLKFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRP----TFLEIV 272
Query: 295 EQLPVGLQKSLPD 307
L L S P+
Sbjct: 273 NLLKDDLHPSFPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 52/244 (21%), Positives = 89/244 (36%), Gaps = 38/244 (15%)
Query: 63 DEESLESAMKEISVMKSLKGHPNVVTLYA-------HTIL----DLGRTKEALLVMECCD 111
+E+L+S + M H NVV L H ++ DLG K+ L
Sbjct: 47 KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRA----T 102
Query: 112 KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWK 171
KS L+ KQ +A+ + + + + HRDL A N L+ S K
Sbjct: 103 KSKDEKLKPPP---LSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVK 157
Query: 172 LCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPA-YRAPEMWDLFRRELINEKVDIWALG 230
+ + + E +R P + APE + + + K D+W+ G
Sbjct: 158 VSLLSLSKDVYNS---------EYYKLRNALIPLRWLAPEA---VQEDDFSTKSDVWSFG 205
Query: 231 CLLFRICY-----FKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPD 285
L++ + F D E ++ G +P S + L+ +P DRP
Sbjct: 206 VLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPS 265
Query: 286 ITQV 289
+++
Sbjct: 266 FSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 44/183 (24%), Positives = 77/183 (42%), Gaps = 27/183 (14%)
Query: 130 QVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST----STNHKRF 185
Q+L I + + + + SQ HRDL N L+G++ L K+ DFG + ST++ R
Sbjct: 124 QMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR- 180
Query: 186 EKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI-CYFKNAFD 244
+ HT R + R+ E D+W+ G +L+ I Y K +
Sbjct: 181 ------------VGGHTMLPIRWMPPESIMYRKFTTES-DVWSFGVILWEIFTYGKQPWF 227
Query: 245 GESKLQILN--GNYRIPESPKY-SSSVTDLIRDMLQASPDDR---PDITQVWFRVNEQLP 298
S +++ R+ E P+ V D++ Q P R +I ++ + + P
Sbjct: 228 QLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287
Query: 299 VGL 301
+ L
Sbjct: 288 IYL 290
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 690 | |||
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.58 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.22 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.13 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.12 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.11 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.02 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.01 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.0 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.91 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.81 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.72 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.7 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.69 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.5 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.5 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.36 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.29 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.27 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.24 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.16 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.14 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.02 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.99 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.92 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.81 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.81 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.72 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.7 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.68 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.67 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.64 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.64 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.47 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.34 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.18 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.14 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.07 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.07 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.05 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.0 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.96 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.83 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.76 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.68 | |
| PLN02236 | 344 | choline kinase | 96.62 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.55 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.55 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.28 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.24 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.13 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.09 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.82 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.67 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.65 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.59 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.51 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 95.32 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 94.61 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.28 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 93.74 |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-58 Score=522.55 Aligned_cols=641 Identities=31% Similarity=0.448 Sum_probs=414.4
Q ss_pred CCCCCCCccCCCCCCCceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhc
Q 005577 2 WRFKPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK 81 (690)
Q Consensus 2 ~~~~~~~~~~~~~~~g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~ 81 (690)
|+.+..-...+.++.|+.++|+..+++|.+.|.+|||+.||+|.+. ..++.||+|++...++..++.+.+||.+|++|.
T Consensus 14 ~~~~~~~~~~~~~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~-~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~ 92 (738)
T KOG1989|consen 14 GSSKGSSPQSENYFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDV-KGGKKYALKRMYVNDEEALNAVKREIDIMKLLS 92 (738)
T ss_pred CCCCCCCcccccCCCceEEEECCEEEEEEEEEccCCcEEEEEEEec-CCCceeeeeeeecCCHHHHHHHHHHHHHHHHhc
Confidence 4555566667899999999999999999999999999999999995 445999999999999999999999999999999
Q ss_pred CCCCceEEEE-EEEeecCCC--ceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCC
Q 005577 82 GHPNVVTLYA-HTILDLGRT--KEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDL 157 (690)
Q Consensus 82 ~HPNIVkL~~-~~~~~~~~~--~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDL 157 (690)
+|+|||.+++ +.......+ -+++|+||||. |+|++++..+....|++.+++.|+.++|+||.+||...++||||||
T Consensus 93 gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDL 172 (738)
T KOG1989|consen 93 GHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDL 172 (738)
T ss_pred CCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhh
Confidence 9999999999 444433333 46789999997 7999999988766799999999999999999999999999999999
Q ss_pred CCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHH
Q 005577 158 KAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC 237 (690)
Q Consensus 158 KP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELl 237 (690)
|-+||||+.+|..||||||.|+...............+.......|+.|+|||+++.+++..+++|+|||+|||+||.||
T Consensus 173 KiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLC 252 (738)
T KOG1989|consen 173 KIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLC 252 (738)
T ss_pred hhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHH
Confidence 99999999999999999999876554443333333444555667899999999999999999999999999999999999
Q ss_pred hCCCCCCCchHHHHHhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhcCcccccCCCCCCCccccccc
Q 005577 238 YFKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGLQKSLPDRPPETQSAVA 317 (690)
Q Consensus 238 tG~~PF~~~~~~~il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l~~~l~~~~p~~~p~~~~~~~ 317 (690)
++..||+......|+++.|.+|..+.++..+.+||+.||+.||++||++.+++..+.++....... ++.. .......
T Consensus 253 y~t~PFe~sg~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~--~~~~-~~~~s~~ 329 (738)
T KOG1989|consen 253 YFTTPFEESGKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPI--PDIY-LKKLSSL 329 (738)
T ss_pred HhCCCcCcCcceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCc--cccc-cchhccc
Confidence 999999999999999999999999999999999999999999999999999988776654322111 1110 0000000
Q ss_pred ccCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCccccccccccccCcch-hhhcccCCcccCCCCC
Q 005577 318 NEGMSKPMN--RSPPMPQRSPPPPPSSVDPTRNISQPSTTPAVSGGGGVLGAFWSTQHAKDSI-VAEDQSRSKFYEEPSI 394 (690)
Q Consensus 318 ~~~~~~p~~--~~pp~p~~~~pp~p~~~~p~~~~s~p~~~~~~a~g~~~lga~ws~~~~~~~~-~~~~~~~~~~~~~~~~ 394 (690)
......+.. ...++|...+ ...+..| ++.+|..+...... ...+............
T Consensus 330 ~~~~~~~~~~~~~~~~p~~~~--~~~~~~p-------------------~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~ 388 (738)
T KOG1989|consen 330 EANLTSPIQELSSGSPPRSSP--SSSSYSP-------------------LGLPSALSPSKNAVLPQTNPMPSGSSFPNSS 388 (738)
T ss_pred ccccCcchhhccCCCCCCCCC--CCCCCCc-------------------cccCCCCCCCcCCcccccCCCCccccCCCCC
Confidence 000000000 0000000000 0000000 11111111111000 0000000000000000
Q ss_pred CCCCC--cccCCCCCCCC--CCCc-hhhhccccccccccCCCCCCCCCCCCCCccccccccccccccccCcCCccccCcc
Q 005577 395 YSTSG--HSRSQSDNHPV--NPST-VEEENIQNHAIRRNVHGKSHKPEDGPSKDIKMNFFQKDTDTRIERPKTLKTESTA 469 (690)
Q Consensus 395 ~~~~~--~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 469 (690)
.+.++ ....+...|.+ -|.+ ...++. ......+....... +.+.. -+++.. ..-..
T Consensus 389 ~t~~~~~~~~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~-------------~~~~~~-~~~~~ 449 (738)
T KOG1989|consen 389 PTSGTSVAPRLRPGSHTVPTVPSTTERLPNQ--GEQQKKPLSQTQSP---PRGTP-------------PAQSFS-GQTDR 449 (738)
T ss_pred CCCCCCCCCccccCcccCCCCCcccccCccc--cccccCCCcccccc---CCCCC-------------cccccc-ccccc
Confidence 00000 00011111111 0111 000000 00001110000000 00000 000000 01111
Q ss_pred cccccccc--------hhhhccccccccccccCCchhHHHHHHHHHHH------------HHHHHHHhhhhhhhHhhhhh
Q 005577 470 TFQDEAFN--------SFVAEFDTNKLNSAISSNKSEKEEALQNEVER------------LKGQLKQTNLEKAEITSKFE 529 (690)
Q Consensus 470 ~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~ 529 (690)
+...++|| .|++.||.++.... +...+.+.+.+|... +..++|...-..+..+..|+
T Consensus 450 ~s~~~~~n~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 526 (738)
T KOG1989|consen 450 VSNEDAANDWFDFLSQPFIAPFDKTLTDDS---KSPLPSENLSAEIGADLLSSQSDIATSESKQLKRSQTSQARRVSAFN 526 (738)
T ss_pred cchhhhcccccccccCccccccccccccCC---cccchhhhhhhhhhhhhhhhhhhHHHhhhhhccCCcccccccccccc
Confidence 22245565 48888888886655 445556666666544 36778888888999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHhcCCC--CCcccccccCCCCCC--------------------------------CCCCC
Q 005577 530 KLSAICRSQRQEIQELKQALAARLPS--PNKDAAINQTSPGNE--------------------------------SFATP 575 (690)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~--------------------------------~~~~~ 575 (690)
.++.+|.+++..+|.+++++.....+ ++.....+...+... -+..+
T Consensus 527 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~s~s~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~ 606 (738)
T KOG1989|consen 527 PLSSTQPSSKSSLQVLRPVEQPSSRNNSSSGSAPNGIPSPSSSNSSLSSVSSSSFPKSNQDTHRKYLSDVNRRAEKFLRV 606 (738)
T ss_pred cccccccccccccccCCccccccccCcccccccCCCCCCCCCCcccccccccccccccchhhhhcccccccccccccccc
Confidence 99999999999999999988766533 222222111111000 11233
Q ss_pred ccccccccccccccc---CCCCCCCCCccccCcCCCCccccc-----cc-cccccccccccccc---ccCCCCCCCCCCC
Q 005577 576 PREKIEGTIWELKSE---WGTPSPESKSWQAFAEDPKPQQQN-----TA-QSVRTRNGHLNKHT---AQSTSGFDSWGFG 643 (690)
Q Consensus 576 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~-----~~-~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 643 (690)
.....++..|++.+. |.+.+++..+|..+-++.+..+.- .. ..-++ +--+.... ......++.|+++
T Consensus 607 ~~~~~~~~~~~~~~~~~~~~q~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 685 (738)
T KOG1989|consen 607 NSDSTSGSSQHPQGQRTASTQGSSQPVSSPPAQDNSKELMTLASKGNNNSEQGTK-ESVQQRSKNASGAGKSPVEPWSSK 685 (738)
T ss_pred CccccccchhhhhhcccccccccccccccCcccccccccccCCcccCCccccccc-cccccchhhhhccCCCCCCCCCcc
Confidence 445667888888764 788889999999998887777652 11 00111 00000000 1222478889999
Q ss_pred CCcccccCccCCCCCC------CCCCCCCcccccCCccCCCCCCCCCCCCCCC
Q 005577 644 TESFTAIPAANSQRSK------PITEGNSSQSIGRSKTTENQPSAQPAGWAGF 690 (690)
Q Consensus 644 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (690)
.+++.++.-.++.... ...+....+++.+++.....+..+|.+|+.+
T Consensus 686 ~~~~~~~~~~s~s~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~ 738 (738)
T KOG1989|consen 686 DKSTRGAARSSASKSAGGTERKFGTGEFDSSRYVDSGLSGNIKSIQPVGPPKL 738 (738)
T ss_pred cccccccccccccccccccccccCCCCCChhhhcccCCCccccccCCCCCCCC
Confidence 9999887766433322 3444555778888888888888899999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=408.98 Aligned_cols=246 Identities=29% Similarity=0.498 Sum_probs=213.0
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
...+|...++||+|||+.||++++. .+++.||+|++.+. .....+.+.+||+|.+.|. |||||++|++|. +
T Consensus 16 ~~~~Y~~g~~LGkGgFA~cYe~~~~-~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FE----D 89 (592)
T KOG0575|consen 16 RSKRYKRGRFLGKGGFARCYEARDL-DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFE----D 89 (592)
T ss_pred CcceeeeeeeeccCcceEEEEEEEc-CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEee----c
Confidence 4468999999999999999999994 68999999999653 4556788999999999995 999999999854 6
Q ss_pred CceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 100 TKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
.+++|||+|+|. ++|.+++.++. .|+|.+++.|++||+.||.|||+++ |||||||..||||+++.+|||+|||||
T Consensus 90 s~nVYivLELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 90 SNNVYIVLELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLA 165 (592)
T ss_pred CCceEEEEEecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEeccccee
Confidence 789999999996 56666666444 4999999999999999999999999 999999999999999999999999999
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH----Hhc
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI----LNG 254 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~i----l~~ 254 (690)
..+... .+...+.||||.|+||||+ .+...+..+||||+|||||.||+|++||+.....+. ...
T Consensus 166 t~le~~---------~Erk~TlCGTPNYIAPEVl---~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~ 233 (592)
T KOG0575|consen 166 TQLEYD---------GERKKTLCGTPNYIAPEVL---NKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN 233 (592)
T ss_pred eeecCc---------ccccceecCCCcccChhHh---ccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc
Confidence 765432 2344567999999999984 467789999999999999999999999998766544 445
Q ss_pred cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 255 NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 255 ~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
.|.+|. .++.+..+||..||..||.+||++.+|+.+
T Consensus 234 ~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 234 EYSMPS--HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred Cccccc--ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 566655 789999999999999999999999999754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=395.88 Aligned_cols=249 Identities=31% Similarity=0.423 Sum_probs=206.8
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-------HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEe
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-------EESLESAMKEISVMKSLKGHPNVVTLYAHTIL 95 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-------~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~ 95 (690)
.+..|.+.+.||+|+||.|-+|..+ ++++.||||++.... ........+|++||++|. |||||+++++|.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~-~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~f~- 246 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEK-KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDFFE- 246 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEc-ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeeeee-
Confidence 5678999999999999999999986 789999999996531 112334679999999995 999999999865
Q ss_pred ecCCCceEEEEEecC-CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCC---CCee
Q 005577 96 DLGRTKEALLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD---GLWK 171 (690)
Q Consensus 96 ~~~~~~~~~LVmEy~-~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~d---g~vK 171 (690)
.....||||||+ +|.|++.+..++ ++.++....+++||+.||.|||++| |+||||||+||||..+ ..+|
T Consensus 247 ---~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llK 319 (475)
T KOG0615|consen 247 ---VPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLK 319 (475)
T ss_pred ---cCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEE
Confidence 446779999999 568999998775 4999999999999999999999999 9999999999999766 6799
Q ss_pred eeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch----
Q 005577 172 LCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES---- 247 (690)
Q Consensus 172 L~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~---- 247 (690)
|+|||+|+..+. ..-..+.||||.|.||||+..-....+..++||||||||||-+|+|.+||.+..
T Consensus 320 ItDFGlAK~~g~----------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s 389 (475)
T KOG0615|consen 320 ITDFGLAKVSGE----------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS 389 (475)
T ss_pred ecccchhhcccc----------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc
Confidence 999999987532 122345799999999999643333345568999999999999999999997642
Q ss_pred -HHHHHhccCCCC--CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 248 -KLQILNGNYRIP--ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 248 -~~~il~~~~~~~--~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
..++..+.|.+. ....++++..+||.+||..||++||++.|++.
T Consensus 390 l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 390 LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 345666666543 34678999999999999999999999999854
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=386.88 Aligned_cols=247 Identities=25% Similarity=0.373 Sum_probs=206.3
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
..+++..+.||+|..|+||+++|+ .+++.+|+|++..+ +++...++++|+++++.+ +|||||++|+.|..+ +..
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk-~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~---~~~ 152 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHK-PTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSN---GEE 152 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEc-CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeC---Cce
Confidence 347888999999999999999996 78999999999554 566778999999999999 699999999998754 116
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS-QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs-~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
.+|+||||+|+.++.+.... +.++|..+-.|+.+|++||.|||. ++ ||||||||+||||+..|.|||||||.+..+
T Consensus 153 isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 99999999765444444433 459999999999999999999996 77 999999999999999999999999988765
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----hHHHHHhccC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGE-----SKLQILNGNY 256 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~-----~~~~il~~~~ 256 (690)
... ...+.+||..|||||. +.+..|+.++||||||++++||++|+.||... ...+++..+.
T Consensus 230 vnS-----------~a~tfvGT~~YMsPER---i~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv 295 (364)
T KOG0581|consen 230 VNS-----------IANTFVGTSAYMSPER---ISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV 295 (364)
T ss_pred hhh-----------hcccccccccccChhh---hcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh
Confidence 332 2345789999999995 67889999999999999999999999999764 4455444433
Q ss_pred CC---CCCC-CCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 257 RI---PESP-KYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 257 ~~---~~~~-~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
.. ..+. .+++++++||..||++||.+||++.|++.+
T Consensus 296 ~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 296 DEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred cCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 21 1223 499999999999999999999999999643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=384.15 Aligned_cols=242 Identities=29% Similarity=0.452 Sum_probs=206.6
Q ss_pred eecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec
Q 005577 21 DVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97 (690)
Q Consensus 21 ei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~ 97 (690)
.+.-.+|+++++||+|+||.||+++.. .+++.||+|++.+. .....+....|..||..++ ||+||+|+.. +
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~-dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ys----F 94 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKK-DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYS----F 94 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEc-ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEe----c
Confidence 355679999999999999999999986 88999999999654 3345678889999999995 9999999765 4
Q ss_pred CCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccC
Q 005577 98 GRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176 (690)
Q Consensus 98 ~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFG 176 (690)
++...+|||+||+. |.|...|.+.+. |+|+.+.-++.+|+.||.|||++| ||||||||+|||||.+|+++|+|||
T Consensus 95 Qt~~kLylVld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 95 QTEEKLYLVLDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccc
Confidence 56789999999995 578888876654 999999999999999999999999 9999999999999999999999999
Q ss_pred CCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC
Q 005577 177 STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY 256 (690)
Q Consensus 177 lA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~ 256 (690)
|++..... .....+.|||+.|||||+ +.+..|+.++|+|||||++|||++|.+||.+.+...+...+.
T Consensus 171 L~k~~~~~---------~~~t~tfcGT~eYmAPEi---l~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~ 238 (357)
T KOG0598|consen 171 LCKEDLKD---------GDATRTFCGTPEYMAPEI---LLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKIL 238 (357)
T ss_pred cchhcccC---------CCccccccCCccccChHH---HhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHh
Confidence 99753221 122334799999999997 567789999999999999999999999999988776655444
Q ss_pred CC--CCCCC-CCHHHHHHHHHHhhhCCCCCC
Q 005577 257 RI--PESPK-YSSSVTDLIRDMLQASPDDRP 284 (690)
Q Consensus 257 ~~--~~~~~-~s~~l~~LI~~~L~~dP~~RP 284 (690)
.. +..+. ++.+.++||.++|.+||.+|.
T Consensus 239 ~~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 239 KGKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred cCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 32 23344 899999999999999999996
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=383.57 Aligned_cols=245 Identities=27% Similarity=0.448 Sum_probs=207.3
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.+|.+.+.||.|+||+||+|+++ ..+..||||.+.+. ....++.+..|+.+|+.|+ |||||+|++++. ..+.
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~-~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~----~~~~ 83 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHK-KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK-HPNIVRLLDCIE----DDDF 83 (429)
T ss_pred ccceehhhccCcceEEEEEeEec-cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC-CcceeeEEEEEe----cCCe
Confidence 58888999999999999999997 56699999999776 6777888999999999996 999999999865 3478
Q ss_pred EEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCC------CCeeeecc
Q 005577 103 ALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD------GLWKLCDF 175 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~d------g~vKL~DF 175 (690)
+|||||||+ |+|.++|.+++. ++++.++.++.||+.||++||+++ ||||||||+||||+.. -.+||+||
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 999999996 677888877764 999999999999999999999999 9999999999999765 35899999
Q ss_pred CCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN 255 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~ 255 (690)
|+|+.+.... -..+.+|+|.||||||+ ....|+.|+|+||+|+|||+|++|+.||+..+..+++...
T Consensus 160 GfAR~L~~~~----------~a~tlcGSplYMAPEV~---~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~ 226 (429)
T KOG0595|consen 160 GFARFLQPGS----------MAETLCGSPLYMAPEVI---MSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI 226 (429)
T ss_pred chhhhCCchh----------HHHHhhCCccccCHHHH---HhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence 9999876321 12346899999999984 4577999999999999999999999999988877765421
Q ss_pred ----CCCCC-CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 256 ----YRIPE-SPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 256 ----~~~~~-~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
..++. +..++..+.+|+...|++++.+|.++.+.+.+
T Consensus 227 ~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 227 KKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred hccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 11222 23467778899999999999999998877544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=380.95 Aligned_cols=254 Identities=31% Similarity=0.549 Sum_probs=207.7
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.+|+|.++||+|.||+||++.+. .+++.+|.|.+... +....+....|+.+|++|. |||||++|++.+.+ +...
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~-~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~--~~ev 94 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCL-LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIE--DNEV 94 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeec-cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhc--cchh
Confidence 47899999999999999999985 78999999998644 4556788899999999995 99999999864322 3444
Q ss_pred EEEEEecCC-CcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCC--CcccCCCCCCcEEeCCCCCeeeeccCC
Q 005577 103 ALLVMECCD-KSLVNVLENR--GAGYFEEKQVLAIFRDVCNAVFAMHSQSP--PIAHRDLKAENLLLGSDGLWKLCDFGS 177 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~--~~~~lse~~~~~i~~qIa~aL~yLHs~g~--~IVHRDLKP~NILLd~dg~vKL~DFGl 177 (690)
++||||||+ |+|.+.+... ....++|..+|.++.|+|.||..+|..-+ .|+||||||.||+|+.+|.|||+|||+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 899999996 5666666542 34579999999999999999999999433 399999999999999999999999999
Q ss_pred CCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh----
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN---- 253 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~---- 253 (690)
++.+..... -....+|||.||+||+ +....|+.++|||||||++||||..+.||.+.+...+..
T Consensus 175 ~r~l~s~~t---------fA~S~VGTPyYMSPE~---i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q 242 (375)
T KOG0591|consen 175 GRFLSSKTT---------FAHSLVGTPYYMSPER---IHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ 242 (375)
T ss_pred HhHhcchhH---------HHHhhcCCCcccCHHH---HhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc
Confidence 987654321 1234689999999996 678899999999999999999999999999987765543
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 254 GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 254 ~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
+.+..-....++..+..||..|+..||+.||+...++..+.
T Consensus 243 gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 243 GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 33321222468999999999999999999999655555443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=375.33 Aligned_cols=247 Identities=31% Similarity=0.495 Sum_probs=210.3
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.+|+.+.++|+|+||+||+++++ .+++.||||++... ++.-.+-.+||+++|++|+ |+|+|.|+.+|. ....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk-~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFr----rkrk 75 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNK-DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLK-HENLVNLIEVFR----RKRK 75 (396)
T ss_pred cHHhhhhccccCcceEEEEeccC-CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHH----hcce
Confidence 47888999999999999999997 78999999999654 3444566789999999997 999999998854 5688
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
++||+|||+.++++.|.....| ++...+..|+.|++.|+.|+|.++ +|||||||+||||+.+|.+||||||+|+.+.
T Consensus 76 lhLVFE~~dhTvL~eLe~~p~G-~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 76 LHLVFEYCDHTVLHELERYPNG-VPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLS 152 (396)
T ss_pred eEEEeeecchHHHHHHHhccCC-CCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhc
Confidence 9999999999999999887654 899999999999999999999999 9999999999999999999999999998876
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc--------
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG-------- 254 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~-------- 254 (690)
...+.++ ..+.|.+|.|||. .+....|+..+||||+||++.||++|.+.|.+.+..+.+.-
T Consensus 153 ~pgd~YT---------DYVATRWYRaPEL--LvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L 221 (396)
T KOG0593|consen 153 APGDNYT---------DYVATRWYRAPEL--LVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNL 221 (396)
T ss_pred CCcchhh---------hhhhhhhccChhh--hcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHccc
Confidence 4333322 2356999999997 45568899999999999999999999999999887654311
Q ss_pred ---------------cCCCCCC----------CCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 255 ---------------NYRIPES----------PKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 255 ---------------~~~~~~~----------~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
..++|.+ +.++..+.+|+..||..||++|++..+++.
T Consensus 222 ~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 222 IPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1122322 466788999999999999999999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=391.19 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=215.6
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|...+.||+|+|++||+|++. .+++.||||++.+. .+..+.-+.+|-.+|.+|.+||.||+||..|. +..
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~-~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ----D~~ 147 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREK-ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ----DEE 147 (604)
T ss_pred hhcchhheeccccceeEEEeeec-CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEee----ccc
Confidence 58999999999999999999986 78999999998543 23344556779999999988999999997643 568
Q ss_pred eEEEEEecC-CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~-~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
.+|+|+||+ +|.|+++|.+.+. |++..++.++.+|+.||+|||++| ||||||||+|||||.||++||+|||.|+.
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeecccccc
Confidence 899999999 5889999988865 999999999999999999999999 99999999999999999999999999988
Q ss_pred ccccchhhhhcc----ccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC
Q 005577 181 NHKRFEKLEEMG----IEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY 256 (690)
Q Consensus 181 ~~~~~~~~~~~~----~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~ 256 (690)
+........... ...+...++||..|.+||+ +.....++.+|||+||||||.|+.|.+||.+.+...+...+.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPEl---L~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~ 300 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPEL---LNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ 300 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHH---hcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH
Confidence 765443321111 1112256899999999996 667889999999999999999999999999988876655443
Q ss_pred --CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHH
Q 005577 257 --RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVW 290 (690)
Q Consensus 257 --~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil 290 (690)
....++++++.+++||.++|..||.+|+++.+|-
T Consensus 301 ~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk 336 (604)
T KOG0592|consen 301 ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIK 336 (604)
T ss_pred HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHh
Confidence 3345678999999999999999999999998884
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=385.48 Aligned_cols=262 Identities=24% Similarity=0.370 Sum_probs=214.3
Q ss_pred ceEeecCceEEEEEEeeecCceEEEEEEEcccCCeE-EEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEE
Q 005577 18 RSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQ-YAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTI 94 (690)
Q Consensus 18 ~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~-vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~ 94 (690)
..+.+....+.+...||.|+||+||+|.+. +.. ||||++...+ ....+.|.+|+.+|.+|+ |||||+++|+|.
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~---g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~f~G~~~ 109 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWR---GTDVVAVKIISDPDFDDESRKAFRREASLLSRLR-HPNIVQFYGACT 109 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeC---CceeEEEEEecchhcChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEc
Confidence 445566677777888999999999999984 555 9999986542 333679999999999995 999999999986
Q ss_pred eecCCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCC-Ceee
Q 005577 95 LDLGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG-LWKL 172 (690)
Q Consensus 95 ~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg-~vKL 172 (690)
.. ...++|||||+. |+|.+++.......|+...++.|+.+|+.||.|||++++ ||||||||+||||+.++ ++||
T Consensus 110 ~~---~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI 185 (362)
T KOG0192|consen 110 SP---PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKI 185 (362)
T ss_pred CC---CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEE
Confidence 32 116899999995 667777766434569999999999999999999999986 89999999999999998 9999
Q ss_pred eccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH-
Q 005577 173 CDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI- 251 (690)
Q Consensus 173 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~i- 251 (690)
||||+++...... .......||+.|||||++... ...|+.++|||||||+||||+||+.||.+....++
T Consensus 186 ~DFGlsr~~~~~~---------~~~~~~~GT~~wMAPEv~~~~-~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~ 255 (362)
T KOG0192|consen 186 ADFGLSREKVISK---------TSMTSVAGTYRWMAPEVLRGE-KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA 255 (362)
T ss_pred CCCccceeecccc---------ccccCCCCCccccChhhhcCC-CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9999997654321 111124689999999974322 56899999999999999999999999998876443
Q ss_pred ---HhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 252 ---LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 252 ---l~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
.....+...+..+++.+..||.+||..||..||++.+|+..+....
T Consensus 256 ~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 256 SAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 4455565556669999999999999999999999999988877554
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=357.08 Aligned_cols=279 Identities=30% Similarity=0.572 Sum_probs=235.1
Q ss_pred CceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEee
Q 005577 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 17 g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~ 96 (690)
+.++-|.+.||++.+.||+|||+-||++... .+++.||+|++.+...+..+..++|++..+++ +||||++++++.+.+
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~-s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGL-STGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLRE 90 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeeccc-CcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHh
Confidence 6688899999999999999999999999974 78899999999999988999999999999999 599999999987766
Q ss_pred cCCC-ceEEEEEecC-CCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeee
Q 005577 97 LGRT-KEALLVMECC-DKSLVNVLENRG--AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKL 172 (690)
Q Consensus 97 ~~~~-~~~~LVmEy~-~gsLl~~L~~~~--~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL 172 (690)
..++ ...||++.|. .|+|++.+.... ...+++.+++.|+.+||+||.+||...+++.||||||.|||+.+++.++|
T Consensus 91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence 4433 3579999998 688999887754 33799999999999999999999999999999999999999999999999
Q ss_pred eccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch-----
Q 005577 173 CDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES----- 247 (690)
Q Consensus 173 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~----- 247 (690)
.|||.++...-....-...-.-.+......|..|.|||.|..-.+...++++|||||||+||.|+.|..||+...
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS 250 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS 250 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence 999998765433322111110011112245899999999877777789999999999999999999999996422
Q ss_pred -HHHHHhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 248 -KLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 248 -~~~il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
.+.+.+..+.+|....+++.+.+||+.||+.||.+||++.+++.++..++
T Consensus 251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 23456677888888889999999999999999999999999998877653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=385.73 Aligned_cols=250 Identities=27% Similarity=0.471 Sum_probs=210.8
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHH--HHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLE--SAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e--~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
...||.++++||.|.||.||+|+.. ..+..||||.|...-.. ++ --+||+..|++|..|||||+|++++.. ..
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~-~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d---~~ 82 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSK-ETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRD---ND 82 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeec-CCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhc---cC
Confidence 4579999999999999999999875 78899999998654222 22 246899999999559999999988542 23
Q ss_pred ceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 101 KEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 101 ~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
..+|+|||||+.+|++++..| ...|++..++.|+.||+.||+|+|.+| +.||||||+|||+.....+||+|||+||.
T Consensus 83 ~~L~fVfE~Md~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 83 RILYFVFEFMDCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred ceEeeeHHhhhhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEecccccccc
Confidence 389999999999999999988 568999999999999999999999999 99999999999999999999999999988
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc------
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG------ 254 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~------ 254 (690)
+..... ....+.|.+|+|||+ +++.+.|+.++||||+|||++|+.+.++.|.|.+..+.+..
T Consensus 160 v~SkpP----------YTeYVSTRWYRAPEv--LLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLG 227 (538)
T KOG0661|consen 160 VRSKPP----------YTEYVSTRWYRAPEV--LLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLG 227 (538)
T ss_pred cccCCC----------cchhhhcccccchHH--hhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhC
Confidence 654322 223467999999999 68899999999999999999999999999999877654311
Q ss_pred -----------------cCCCCC---------CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 255 -----------------NYRIPE---------SPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 255 -----------------~~~~~~---------~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
.++++. .+.++.++.+||.+||..||.+|||+.+++.+
T Consensus 228 tP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 228 TPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 122222 13578999999999999999999999998754
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=386.01 Aligned_cols=263 Identities=23% Similarity=0.379 Sum_probs=222.3
Q ss_pred CCCCceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEE
Q 005577 14 GLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHT 93 (690)
Q Consensus 14 ~~~g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~ 93 (690)
++....+++....+++.+.||+|-||+||+|.+. ....||+|.+.... ...+.|++|+.+|++|+ |+|||+||++|
T Consensus 195 ~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~--~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~-H~~lV~l~gV~ 270 (468)
T KOG0197|consen 195 DLARDPWEIPREELKLIRELGSGQFGEVWLGKWN--GSTKVAVKTIKEGS-MSPEAFLREAQIMKKLR-HEKLVKLYGVC 270 (468)
T ss_pred ccccCCeeecHHHHHHHHHhcCCccceEEEEEEc--CCCcccceEEeccc-cChhHHHHHHHHHHhCc-ccCeEEEEEEE
Confidence 3334556777788888999999999999999984 45589999986642 23467889999999996 99999999998
Q ss_pred EeecCCCceEEEEEecC-CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeee
Q 005577 94 ILDLGRTKEALLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKL 172 (690)
Q Consensus 94 ~~~~~~~~~~~LVmEy~-~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL 172 (690)
..+ ..+||||||| .|+|+++|.......+...+.+.|+.|||.|++||++++ +|||||.+.||||+.+..+||
T Consensus 271 ~~~----~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKI 344 (468)
T KOG0197|consen 271 TKQ----EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKI 344 (468)
T ss_pred ecC----CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEE
Confidence 633 4799999999 589999999866677999999999999999999999999 999999999999999999999
Q ss_pred eccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH
Q 005577 173 CDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI 251 (690)
Q Consensus 173 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i 251 (690)
+|||||+.+.+........ ..-.+.|.|||. +..+.++.++|||||||+||||+| |+.||.+.+..++
T Consensus 345 sDFGLAr~~~d~~Y~~~~~--------~kfPIkWtAPEa---~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev 413 (468)
T KOG0197|consen 345 SDFGLARLIGDDEYTASEG--------GKFPIKWTAPEA---LNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV 413 (468)
T ss_pred cccccccccCCCceeecCC--------CCCCceecCHHH---HhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH
Confidence 9999998543322111111 122678999996 666789999999999999999998 9999998876554
Q ss_pred ---HhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 252 ---LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 252 ---l~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
+...++++.+..||+.+.+||..||..+|++|||+..+...+.+..
T Consensus 414 ~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 414 LELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred HHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 6788999999999999999999999999999999998887776543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=381.33 Aligned_cols=256 Identities=26% Similarity=0.437 Sum_probs=214.2
Q ss_pred eEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEee
Q 005577 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 19 ~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~ 96 (690)
+.......|+.+++||+|.||.||+|++. .+++.||+|++.... ++...-..|||.||++| +||||++|.+.....
T Consensus 111 w~~r~~~~feki~kIGeGTyg~VYkAr~~-~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 111 WGPRRADSFEKIEKIGEGTYGQVYKARDL-ETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSK 188 (560)
T ss_pred ccccchHHHHHHHHhcCcchhheeEeeec-ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEec
Confidence 34455678899999999999999999995 789999999997654 56677788999999999 599999999875533
Q ss_pred cCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccC
Q 005577 97 LGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFG 176 (690)
....+|||+|||+.+|.-++...+- .|++.++..|+.||+.||+|+|.+| |+|||||.+|||||.+|.+||+|||
T Consensus 189 --~~~siYlVFeYMdhDL~GLl~~p~v-kft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFG 263 (560)
T KOG0600|consen 189 --LSGSIYLVFEYMDHDLSGLLSSPGV-KFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFG 263 (560)
T ss_pred --CCceEEEEEecccchhhhhhcCCCc-ccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEecccc
Confidence 3568999999999999988876442 4999999999999999999999999 9999999999999999999999999
Q ss_pred CCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC
Q 005577 177 STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY 256 (690)
Q Consensus 177 lA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~ 256 (690)
||+.+...... .....+-|++|.|||. ++....|+.++|+||.||||.||++|++.|.+....+.+..++
T Consensus 264 LAr~y~~~~~~--------~~T~rVvTLWYRpPEL--LLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIf 333 (560)
T KOG0600|consen 264 LARFYTPSGSA--------PYTSRVVTLWYRPPEL--LLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIF 333 (560)
T ss_pred ceeeccCCCCc--------ccccceEEeeccChHH--hcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHH
Confidence 99865433211 1233466999999997 5667889999999999999999999999999988776654332
Q ss_pred CC--------------CC-----------------CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 RI--------------PE-----------------SPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 ~~--------------~~-----------------~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
++ |. ...++....+|+..||..||.+|.|+.+++.
T Consensus 334 klcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 334 KLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred HHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11 10 0246888999999999999999999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=382.15 Aligned_cols=245 Identities=30% Similarity=0.496 Sum_probs=214.1
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
++|.|.+.||+|.||+||+|+.+ .+.+.||||.+.+. .+..+..+.+|++|++.|+ |||||.++++|. ...+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK-~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfE----t~~~ 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRK-YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK-HPNIVEMLESFE----TSAH 75 (808)
T ss_pred cchhHHHHhcCCccceeeecccc-cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC-CcchhhHHHhhc----ccce
Confidence 47889999999999999999975 78899999998543 4556788999999999996 999999998854 5689
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
+++|.|||.|+|..+|...+. |+|+.+..|+.+++.||.|||+++ |+|||+||.||||+..|.+||||||+|+...
T Consensus 76 ~~vVte~a~g~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 76 LWVVTEYAVGDLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMS 151 (808)
T ss_pred EEEEehhhhhhHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcc
Confidence 999999999999999987765 999999999999999999999999 9999999999999999999999999998754
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCCCC--C
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIP--E 260 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~~~--~ 260 (690)
..... ..+..|||.|||||+ ..+..|+..+|+||||||||||++|++||...+..+++..+..-+ .
T Consensus 152 ~~t~v---------ltsikGtPlYmAPEl---v~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~ 219 (808)
T KOG0597|consen 152 TNTSV---------LTSIKGTPLYMAPEL---VEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP 219 (808)
T ss_pred cCcee---------eeeccCcccccCHHH---HcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC
Confidence 32211 223579999999995 678999999999999999999999999999988887766555433 2
Q ss_pred CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 261 SPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 261 ~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
+...+..+..||..+|.+||..|.+..+++.
T Consensus 220 p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 220 PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 3478999999999999999999999999854
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=353.61 Aligned_cols=234 Identities=29% Similarity=0.430 Sum_probs=204.8
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
-.+|+.++.||.|+||.|.++++. .++..||+|++.+. +...++...+|.++|+.+. ||+||+|++.|. +.
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k-~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~----d~ 116 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREK-HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFK----DN 116 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEc-cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeec----cC
Confidence 358889999999999999999996 57899999999664 3456778889999999996 999999998865 56
Q ss_pred ceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 101 KEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 101 ~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
..+||||||++ |.|..+|++.++ |++..++.++.||+.||+|||+++ ||+|||||+|||||.+|.+||+|||+|+
T Consensus 117 ~~lymvmeyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK 192 (355)
T KOG0616|consen 117 SNLYMVMEYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAK 192 (355)
T ss_pred CeEEEEEeccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceE
Confidence 89999999995 578888877655 999999999999999999999999 9999999999999999999999999997
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH----hcc
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL----NGN 255 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il----~~~ 255 (690)
.+.. ...+.||||.|+|||+ +..+.|+.++|+|||||++|||+.|.+||...+..++. .+.
T Consensus 193 ~v~~------------rT~TlCGTPeYLAPEi---i~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~ 257 (355)
T KOG0616|consen 193 RVSG------------RTWTLCGTPEYLAPEI---IQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK 257 (355)
T ss_pred EecC------------cEEEecCCccccChHH---hhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc
Confidence 6432 2445799999999997 56788999999999999999999999999988876654 444
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhCCCCCC
Q 005577 256 YRIPESPKYSSSVTDLIRDMLQASPDDRP 284 (690)
Q Consensus 256 ~~~~~~~~~s~~l~~LI~~~L~~dP~~RP 284 (690)
+++ +..++.++++||..+|+.|-.+|.
T Consensus 258 v~f--P~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 258 VKF--PSYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred ccC--CcccCHHHHHHHHHHHhhhhHhhh
Confidence 444 457899999999999999999993
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=373.41 Aligned_cols=248 Identities=28% Similarity=0.466 Sum_probs=204.9
Q ss_pred eecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC----CH-HHHHHHHHHHHHHHhhcCCCCceEEEEEEEe
Q 005577 21 DVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN----DE-ESLESAMKEISVMKSLKGHPNVVTLYAHTIL 95 (690)
Q Consensus 21 ei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~----~~-e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~ 95 (690)
.....+|.+.+.||+|+||.|++|.+. .++..||+|++... .. ...+.+.+|+.+|+.++.||||+++++++..
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~-~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHR-LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeec-cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 456679999999999999999999985 57799999966442 11 2345566899999999669999999998653
Q ss_pred ecCCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCC-CCeeee
Q 005577 96 DLGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD-GLWKLC 173 (690)
Q Consensus 96 ~~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~d-g~vKL~ 173 (690)
...+|||||||. |.|++.+..+ +++.|.++..+|+||+.||+|||++| |+||||||+||||+.+ +++||+
T Consensus 92 ----~~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~ 163 (370)
T KOG0583|consen 92 ----PTKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLS 163 (370)
T ss_pred ----CCeEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEe
Confidence 356999999996 5899999884 45999999999999999999999999 9999999999999999 999999
Q ss_pred ccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 005577 174 DFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRE-LINEKVDIWALGCLLFRICYFKNAFDGESKLQIL 252 (690)
Q Consensus 174 DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~-~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il 252 (690)
|||++..... ......+.+||+.|+|||++. ... +-+.++||||+||+||.|++|+.||+......+.
T Consensus 164 DFG~s~~~~~---------~~~~l~t~cGsp~Y~aPEvl~--~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~ 232 (370)
T KOG0583|consen 164 DFGLSAISPG---------EDGLLKTFCGSPAYAAPEVLS--GKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY 232 (370)
T ss_pred ccccccccCC---------CCCcccCCCCCcccCCHHHhC--CCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH
Confidence 9999976421 112234568999999999843 223 3358999999999999999999999987654443
Q ss_pred ----hccCCCCCCCCC-CHHHHHHHHHHhhhCCCCCCCHHHHH
Q 005577 253 ----NGNYRIPESPKY-SSSVTDLIRDMLQASPDDRPDITQVW 290 (690)
Q Consensus 253 ----~~~~~~~~~~~~-s~~l~~LI~~~L~~dP~~RPt~~eil 290 (690)
.+.+.++ ..+ +.++..||.+||..||.+|+++.+|+
T Consensus 233 ~ki~~~~~~~p--~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 233 RKIRKGEFKIP--SYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHHhcCCccCC--CCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 3344444 345 99999999999999999999999996
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=363.74 Aligned_cols=260 Identities=25% Similarity=0.355 Sum_probs=217.3
Q ss_pred ceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEee
Q 005577 18 RSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 18 ~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~ 96 (690)
..+.+....|++...||.|.-++||+|++. ..+..||||++... ....++.+.+|+..|..+ +|||||++|..|+.+
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~-p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCI-PTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVVD 96 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeec-ccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEec
Confidence 344566789999999999999999999996 56799999999543 233478899999999999 599999999998865
Q ss_pred cCCCceEEEEEecC-CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeecc
Q 005577 97 LGRTKEALLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDF 175 (690)
Q Consensus 97 ~~~~~~~~LVmEy~-~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DF 175 (690)
..+|+||.|| .|++++++...-...|+|..+..|+++++.||.|||.+| .||||||+.||||+.+|.|||+||
T Consensus 97 ----~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadF 170 (516)
T KOG0582|consen 97 ----SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADF 170 (516)
T ss_pred ----ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCc
Confidence 7899999999 578999998877777999999999999999999999999 999999999999999999999999
Q ss_pred CCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN 255 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~ 255 (690)
|.+..+.... .+.. .+..+.+||+.|||||++.+ ....|+.|+|||||||+..||++|..||....+.+++...
T Consensus 171 gvsa~l~~~G---~R~~--~rf~tfvgtp~wmAPEvl~q-~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t 244 (516)
T KOG0582|consen 171 GVSASLFDSG---DRQV--TRFNTFVGTPCWMAPEVLMQ-QLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT 244 (516)
T ss_pred eeeeeecccC---ceee--EeeccccCcccccChHHhhh-cccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 9765543322 1111 11145689999999999422 2345999999999999999999999999999888876554
Q ss_pred CCCCCC------------CCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 256 YRIPES------------PKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 256 ~~~~~~------------~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
+....+ ..++..++.+|..||++||.+||++.+++.
T Consensus 245 Lqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 245 LQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred hcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 433322 356788999999999999999999999964
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=363.88 Aligned_cols=263 Identities=20% Similarity=0.327 Sum_probs=207.4
Q ss_pred EeecCceEEEEEEeeecCceEEEEEEEc----ccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEE
Q 005577 20 IDVGNLKIHVRNVIAEGGFSCVYSARDA----IHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTI 94 (690)
Q Consensus 20 iei~~~ry~v~~~LG~GgFG~VylA~d~----~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~ 94 (690)
+.+...+|++.++||+|+||.||+|.+. ...++.||||++... .......+++|+.+|..+.+|||||++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 4677789999999999999999999752 234568999998653 23445678999999999966999999999864
Q ss_pred eecCCCceEEEEEecCC-CcHHHHHHHhC---------------------------------------------------
Q 005577 95 LDLGRTKEALLVMECCD-KSLVNVLENRG--------------------------------------------------- 122 (690)
Q Consensus 95 ~~~~~~~~~~LVmEy~~-gsLl~~L~~~~--------------------------------------------------- 122 (690)
. ....+|+|||||. |+|.+++....
T Consensus 82 ~---~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (338)
T cd05102 82 K---PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN 158 (338)
T ss_pred C---CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence 2 2456899999995 67777776432
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccc
Q 005577 123 ---------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGI 193 (690)
Q Consensus 123 ---------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~ 193 (690)
...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~----- 231 (338)
T cd05102 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----- 231 (338)
T ss_pred cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchh-----
Confidence 124788899999999999999999999 9999999999999999999999999987543211110
Q ss_pred cccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH----HHHHhccCCCCCCCCCCHHH
Q 005577 194 EEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESK----LQILNGNYRIPESPKYSSSV 268 (690)
Q Consensus 194 ~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~----~~il~~~~~~~~~~~~s~~l 268 (690)
......+++.|||||+ +.+..++.++|||||||+||||++ |..||.+... ...+........+..+++.+
T Consensus 232 --~~~~~~~~~~y~aPE~---~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 306 (338)
T cd05102 232 --RKGSARLPLKWMAPES---IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEI 306 (338)
T ss_pred --cccCCCCCccccCcHH---hhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHH
Confidence 1112345788999996 456778999999999999999997 9999986432 12233333334456789999
Q ss_pred HHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 269 TDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 269 ~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
.+||.+||+.||.+||++.+++..+...+
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=365.55 Aligned_cols=256 Identities=25% Similarity=0.385 Sum_probs=204.5
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
..++...+.||+|.||.||++.+. +++..+|||.+...+....+.+.+|+.+|.+|+ |||||++|+..... +...+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~-~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~--~~~~~ 91 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNK-KTGELMAVKSVELEDSPTSESLEREIRILSRLN-HPNIVQYYGSSSSR--ENDEY 91 (313)
T ss_pred cchhhhhccccCccceEEEEEEec-CCCcceeeeeeecccchhHHHHHHHHHHHHhCC-CCCEEeeCCccccc--cCeee
Confidence 356888999999999999999985 558999999987665444777899999999997 99999999863222 11368
Q ss_pred EEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCC-CCCeeeeccCCCCcc
Q 005577 104 LLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS-DGLWKLCDFGSTSTN 181 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~-dg~vKL~DFGlA~~~ 181 (690)
+|+|||+. |+|.+++.+.+. .|++..++.+.+||+.||.|||++| ||||||||+||||+. ++.+||+|||++...
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 89999995 678888877664 6999999999999999999999999 999999999999999 799999999998765
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc-hH----HHHHhccC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGE-SK----LQILNGNY 256 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~-~~----~~il~~~~ 256 (690)
.... ..........||+.|||||++.. +.....++|||||||++.||+||+.||... .. ..+.....
T Consensus 169 ~~~~------~~~~~~~~~~Gtp~~maPEvi~~--g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~ 240 (313)
T KOG0198|consen 169 ESKG------TKSDSELSVQGTPNYMAPEVIRN--GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDS 240 (313)
T ss_pred cccc------ccccccccccCCccccCchhhcC--CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCC
Confidence 4200 01112234679999999998432 333446999999999999999999999862 22 22222222
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 257 RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 257 ~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
....+..++.+.++||.+||.+||++|||+.++|.+..
T Consensus 241 ~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 241 LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 23445678999999999999999999999999987643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=371.66 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=208.9
Q ss_pred CceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcCCCCceEEEEEE
Q 005577 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHT 93 (690)
Q Consensus 17 g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~ 93 (690)
-++..++-.+|+++++||+|+||.||+|+.+ .++..||+|++.+.+ ...++.++.|-.+|... ++|+||+||..
T Consensus 133 ~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk-~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYs- 209 (550)
T KOG0605|consen 133 LRRTRLSLDDFELLKVIGKGAFGEVRLARKK-DTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYS- 209 (550)
T ss_pred hccccCCcccchhheeeccccceeEEEEEEc-cCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEE-
Confidence 3445567789999999999999999999986 789999999997653 34567788899999996 69999999976
Q ss_pred EeecCCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeee
Q 005577 94 ILDLGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKL 172 (690)
Q Consensus 94 ~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL 172 (690)
|++..++||||||++ |++..+|.+.+. |+++.+..++.+++.|++.||..| +|||||||+|+|||..|++||
T Consensus 210 ---FQD~~~LYLiMEylPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKL 282 (550)
T KOG0605|consen 210 ---FQDKEYLYLIMEYLPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKL 282 (550)
T ss_pred ---ecCCCeeEEEEEecCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEee
Confidence 446789999999995 567777776654 999999999999999999999999 999999999999999999999
Q ss_pred eccCCCCcccccchh------------hhhc---ccc-----------------------ccccccCCCCcccCccchhh
Q 005577 173 CDFGSTSTNHKRFEK------------LEEM---GIE-----------------------EDNIRKHTTPAYRAPEMWDL 214 (690)
Q Consensus 173 ~DFGlA~~~~~~~~~------------~~~~---~~~-----------------------~~~~~~~GT~~YmAPEvl~~ 214 (690)
+||||+..+...... +... ... .-....+|||.||||||
T Consensus 283 SDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEV--- 359 (550)
T KOG0605|consen 283 SDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEV--- 359 (550)
T ss_pred ccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHH---
Confidence 999998544331100 0000 000 01123579999999998
Q ss_pred hhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh----c--cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCC
Q 005577 215 FRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN----G--NYRIPESPKYSSSVTDLIRDMLQASPDDRPD 285 (690)
Q Consensus 215 ~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~----~--~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt 285 (690)
+.+..|+..+|+||||||+||||.|.+||.++++.+... . .+..|....++++..+||.+||. ||++|..
T Consensus 360 ll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 360 LLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 556779999999999999999999999999988766543 2 35566667889999999999999 9999976
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=380.54 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=214.2
Q ss_pred CCCCCceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEE
Q 005577 13 TGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTL 89 (690)
Q Consensus 13 ~~~~g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL 89 (690)
.....+...+.-.+|++.++||+|.||.|++|... .+++.||||++.+. ..+.++..+.|.+|+....+||.|+.|
T Consensus 356 ~~~~~~~~~~~l~~F~~l~vLGkGsFGkV~lae~k-~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L 434 (694)
T KOG0694|consen 356 PEFPPRRGPLTLDDFRLLAVLGRGSFGKVLLAELK-GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNL 434 (694)
T ss_pred ccCCCCCCcccccceEEEEEeccCcCceEEEEEEc-CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeec
Confidence 33444445566789999999999999999999986 67889999999765 345678899999999999889999999
Q ss_pred EEEEEeecCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCC
Q 005577 90 YAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGL 169 (690)
Q Consensus 90 ~~~~~~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~ 169 (690)
|+.|. ...++|+||||+.|+.+-.+ ...+.|++..++-|+..|+.||.|||.+| |||||||.+|||||.+|.
T Consensus 435 ~~~fQ----T~~~l~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh 506 (694)
T KOG0694|consen 435 FSCFQ----TKEHLFFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGH 506 (694)
T ss_pred ccccc----cCCeEEEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCc
Confidence 98854 56899999999987763333 33345999999999999999999999999 999999999999999999
Q ss_pred eeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 005577 170 WKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL 249 (690)
Q Consensus 170 vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~ 249 (690)
+||+|||+++.. ++......+.+|||.|||||+ +.+..|+.++|+|||||+|||||.|..||.+++..
T Consensus 507 ~kiADFGlcKe~---------m~~g~~TsTfCGTpey~aPEi---l~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe 574 (694)
T KOG0694|consen 507 VKIADFGLCKEG---------MGQGDRTSTFCGTPEFLAPEV---LTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE 574 (694)
T ss_pred EEeccccccccc---------CCCCCccccccCChhhcChhh---hccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 999999999753 223345567899999999997 56788999999999999999999999999999988
Q ss_pred HHHhccCCC--CCCCCCCHHHHHHHHHHhhhCCCCCCCH
Q 005577 250 QILNGNYRI--PESPKYSSSVTDLIRDMLQASPDDRPDI 286 (690)
Q Consensus 250 ~il~~~~~~--~~~~~~s~~l~~LI~~~L~~dP~~RPt~ 286 (690)
++...+... ..+..++.+...+|+++|.++|++|..+
T Consensus 575 e~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 EVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 776654432 2345789999999999999999999865
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=368.58 Aligned_cols=256 Identities=31% Similarity=0.466 Sum_probs=206.5
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--------------HHHHHHHHHHHHHHHhhcCCCCceEEE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--------------EESLESAMKEISVMKSLKGHPNVVTLY 90 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--------------~e~~e~~~~Ei~iL~~L~~HPNIVkL~ 90 (690)
+.|++.+.||+|.||.|-+|++. ..++.||||++.+.. ...+++..+||.||++|. |||||+|+
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~-~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV~Li 174 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDE-VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVVKLI 174 (576)
T ss_pred hheehhhhhcCCccceEEEEeec-CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCeeEEE
Confidence 68999999999999999999996 679999999985421 112468899999999996 99999998
Q ss_pred EEEEeecCCCceEEEEEecCCCcHHHHHHHhCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCC
Q 005577 91 AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGY-FEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGL 169 (690)
Q Consensus 91 ~~~~~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~-lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~ 169 (690)
.+ .+......+|||+|||..+-..+.- ..+. |++.+++.|+++++.||+|||.+| ||||||||+|+||+.+|+
T Consensus 175 Ev--LDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EV--LDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred Ee--ecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCCc
Confidence 76 4556677899999999755444332 2334 899999999999999999999999 999999999999999999
Q ss_pred eeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhh-cCCCCchhhHHHHHHHHHHHHhCCCCCCCchH
Q 005577 170 WKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFR-RELINEKVDIWALGCLLFRICYFKNAFDGESK 248 (690)
Q Consensus 170 vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~-~~~~s~ksDVwSLGviLyELltG~~PF~~~~~ 248 (690)
|||+|||.+...... ...+......+.+|||.|||||.+..-. ....+.+.|||||||+||-|+.|+.||-++..
T Consensus 249 VKIsDFGVs~~~~~~----~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQG----SDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred EEeeccceeeecccC----CccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 999999988643211 0111112223358999999999743211 23456789999999999999999999998877
Q ss_pred HH----HHhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 249 LQ----ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 249 ~~----il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
.+ |++..+.+|..+.+.+.+++||.+||++||+.|.++.+|..+
T Consensus 325 ~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 325 LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 65 455666777778889999999999999999999999988543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=357.75 Aligned_cols=260 Identities=24% Similarity=0.401 Sum_probs=214.2
Q ss_pred CceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEee--cCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEE
Q 005577 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMI--CNDEESLESAMKEISVMKSLKGHPNVVTLYAHTI 94 (690)
Q Consensus 17 g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~--~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~ 94 (690)
+..+++ ..+|...+.||.|+||.|+.|.++ .+++.||||++. ..+.-..++.+||+++|+.++ |+||+.+++++.
T Consensus 15 ~~~~~i-~~~y~~~~~iG~GAyGvVcsA~~~-~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~ 91 (359)
T KOG0660|consen 15 GELFEI-PRYYVLIEPIGRGAYGVVCSAKDK-RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFR 91 (359)
T ss_pred eeEEec-cceecccccccCcceeeEEEEEEc-CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc-CCCcceEEeecc
Confidence 344444 345555899999999999999997 678999999997 556677889999999999997 999999999876
Q ss_pred e-ecCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeee
Q 005577 95 L-DLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLC 173 (690)
Q Consensus 95 ~-~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~ 173 (690)
- .....+.+|+|+|+|+.+|.+.+..... |+++.+..++.||+.||.|+|+.+ |+||||||.|||++.+..+|||
T Consensus 92 p~~~~~f~DvYiV~elMetDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~ 167 (359)
T KOG0660|consen 92 PPSRDKFNDVYLVFELMETDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKIC 167 (359)
T ss_pred cccccccceeEEehhHHhhHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEec
Confidence 5 2345678999999998888888876554 999999999999999999999999 9999999999999999999999
Q ss_pred ccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh
Q 005577 174 DFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN 253 (690)
Q Consensus 174 DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~ 253 (690)
|||+|+..... .........+-|.+|.|||+ .+....|+.++||||+||||.||++|++.|.|.+....+.
T Consensus 168 DFGLAR~~~~~-------~~~~~mTeYVaTRWYRAPEl--ll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~ 238 (359)
T KOG0660|consen 168 DFGLARYLDKF-------FEDGFMTEYVATRWYRAPEL--LLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQ 238 (359)
T ss_pred cccceeecccc-------CcccchhcceeeeeecCHHH--HhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHH
Confidence 99999987543 01112233466999999998 4677889999999999999999999999999876543321
Q ss_pred cc---------------------------CCCCC------CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 254 GN---------------------------YRIPE------SPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 254 ~~---------------------------~~~~~------~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
.. ...+. .++.++...+|+.+||..||.+|+|+.|.+.+
T Consensus 239 lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 239 LILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11 01111 24678999999999999999999999998754
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=353.17 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=210.2
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
..|+.++.|++|.||.||+|+|+ .+++.||+|++.... ...--..+|||.+|.+++ |||||.+-.+.+ ..+.+.
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk-~t~eIVALKr~kmekek~GFPItsLREIniLl~~~-H~NIV~vkEVVv--G~~~d~ 151 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDK-KTDEIVALKRLKMEKEKEGFPITSLREINILLKAR-HPNIVEVKEVVV--GSNMDK 151 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccC-CcceeEEeeecccccccCCCcchhHHHHHHHHhcC-CCCeeeeEEEEe--ccccce
Confidence 47899999999999999999996 789999999986442 222345689999999996 999999988765 335567
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
+|||||||+.+|..++.... .+|...++..++.|++.||+|||.+. |+|||||++|+|+...|.+||+|||+|+.+.
T Consensus 152 iy~VMe~~EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 152 IYIVMEYVEHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eeeeHHHHHhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhc
Confidence 99999999999999888766 46999999999999999999999999 9999999999999999999999999999877
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCCC----
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRI---- 258 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~~---- 258 (690)
.....++. .+-|.+|.|||. ++....|+.++|+||+|||+.||+++++.|.|.+..+.+..+++.
T Consensus 229 sp~k~~T~---------lVVTLWYRaPEL--LLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtP 297 (419)
T KOG0663|consen 229 SPLKPYTP---------LVVTLWYRAPEL--LLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTP 297 (419)
T ss_pred CCcccCcc---------eEEEeeecCHHH--hcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCC
Confidence 66444333 356999999998 466778999999999999999999999999998877655433211
Q ss_pred -------------------CCC-----------CCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 259 -------------------PES-----------PKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 259 -------------------~~~-----------~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
+.. ..+++.-.+|+..+|..||.+|.|+.+.+.+
T Consensus 298 te~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 298 SEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 000 0145888999999999999999999998643
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=343.65 Aligned_cols=248 Identities=29% Similarity=0.443 Sum_probs=209.0
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHH--HHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEE--SLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e--~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.+|...++||+|.||+||+|+|. .+++.||||++...+.. --...+||++.|+.++ |+||+.|.++|. ....
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~-~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~-h~nIi~LiD~F~----~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDT-ETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK-HPNIIELIDVFP----HKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEec-CCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc-Ccchhhhhhhcc----CCCc
Confidence 47888999999999999999996 78999999999765322 1346789999999996 999999999865 4577
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
+.||+|||+.+|...++.+. -.|+..++..|+.+++.||+|||.+. |+||||||.|+||+.+|.+||+|||+|+.+.
T Consensus 76 l~lVfEfm~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 76 LSLVFEFMPTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFG 152 (318)
T ss_pred eEEEEEeccccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccC
Confidence 89999999999999887765 46999999999999999999999999 9999999999999999999999999998865
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCCC----
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRI---- 258 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~~---- 258 (690)
....... ..+-|.+|.|||. .+....|+..+||||.|||+.||+.|.+.|.|.+..+.+..+++.
T Consensus 153 ~p~~~~~---------~~V~TRWYRAPEL--LfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP 221 (318)
T KOG0659|consen 153 SPNRIQT---------HQVVTRWYRAPEL--LFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTP 221 (318)
T ss_pred CCCcccc---------cceeeeeccChHH--hccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCC
Confidence 5433221 1256999999997 466778999999999999999999999999999887765432211
Q ss_pred --------------------CC------CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 259 --------------------PE------SPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 259 --------------------~~------~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
|. .+..+.++.+|+..||..||.+|+++.|++.+
T Consensus 222 ~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 222 TPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 12457888999999999999999999998754
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=375.67 Aligned_cols=246 Identities=28% Similarity=0.420 Sum_probs=212.2
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
.+|....+||+|+-|.||.|+.. ..++.||||.+........+.+++|+.+|+.++ |+|||.+++.+... ..++
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~-~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~----deLW 346 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKI-STKQEVAIKRMDLRKQPKKELLLNEILVMRDLH-HPNIVNFLDSYLVG----DELW 346 (550)
T ss_pred hhhcchhhhccccccceeeeeec-cCCceEEEEEEEeccCCchhhhHHHHHHHHhcc-chHHHHHHHHhccc----ceeE
Confidence 47888899999999999999985 678899999998777666788999999999996 99999999887654 7899
Q ss_pred EEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccccc
Q 005577 105 LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKR 184 (690)
Q Consensus 105 LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~ 184 (690)
+|||||+|+.+..+..... |+|.++..|++++|.||+|||.+| |||||||.+||||+.+|.+||+|||++..+...
T Consensus 347 VVMEym~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred EEEeecCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 9999997654544444333 999999999999999999999999 999999999999999999999999998665432
Q ss_pred chhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH-----hccCCCC
Q 005577 185 FEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL-----NGNYRIP 259 (690)
Q Consensus 185 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il-----~~~~~~~ 259 (690)
.. ...+.+|||.|||||+ .....|++++||||||++++||+-|.+||-.+.+++.+ ++...+.
T Consensus 423 ~~---------KR~TmVGTPYWMAPEV---vtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk 490 (550)
T KOG0578|consen 423 QS---------KRSTMVGTPYWMAPEV---VTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLK 490 (550)
T ss_pred cC---------ccccccCCCCccchhh---hhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcC
Confidence 21 2345689999999997 56788999999999999999999999999887776543 3455667
Q ss_pred CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 260 ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 260 ~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
.+..+++.+++||.+||+.|+++|+++.+||.+
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 778999999999999999999999999999754
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=373.88 Aligned_cols=243 Identities=28% Similarity=0.446 Sum_probs=208.9
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
+-|++.+.||.|+-|.|-+|++. .+|+.+|||++.+. .......+.+|+.||+.|. ||||++||+++ ++..
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~-~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVw----e~~~ 85 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHA-ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVW----ENKQ 85 (786)
T ss_pred cceeccccccCCCCceehhhhcc-cccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeee----ccCc
Confidence 35888999999999999999997 78999999999654 2334567789999999995 99999999984 4678
Q ss_pred eEEEEEecC-CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~-~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
++|||+||+ +|.|+++|..++. |++.++.++++||+.||.|+|..+ |+||||||+|+|||..+++||+|||+|..
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsL 161 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASL 161 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeec
Confidence 999999999 5789999998865 999999999999999999999999 99999999999999999999999999964
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH----hcc
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRE-LINEKVDIWALGCLLFRICYFKNAFDGESKLQIL----NGN 255 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~-~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il----~~~ 255 (690)
-... .-..+.||+|.|.|||+ +.+. +-+.++||||.|||||.||+|+.||++++...++ .+.
T Consensus 162 e~~g----------klLeTSCGSPHYA~PEI---V~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~ 228 (786)
T KOG0588|consen 162 EVPG----------KLLETSCGSPHYAAPEI---VSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV 228 (786)
T ss_pred ccCC----------ccccccCCCcccCCchh---hcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc
Confidence 2211 11234689999999997 4444 4567999999999999999999999988775544 455
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 256 YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 256 ~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
+.+| ..++.++.+||.+||..||.+|.|..+|+.+
T Consensus 229 f~MP--s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 229 FEMP--SNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ccCC--CcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 6666 5899999999999999999999999999765
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=346.02 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=200.6
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhc--CCCCceEEEEEEEeec-CC
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLK--GHPNVVTLYAHTILDL-GR 99 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~--~HPNIVkL~~~~~~~~-~~ 99 (690)
.+|++.+.||+|+||.||+|++....++.||+|++.... ......+.+|+.+++.+. +||||+++++++.... ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 378999999999999999999854457889999886432 223345667888877764 5999999999876432 23
Q ss_pred CceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 100 TKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 100 ~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
...+++||||++++|.+++.......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 45689999999999999987765556899999999999999999999999 9999999999999999999999999986
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC---
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--- 256 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--- 256 (690)
..... .......||+.|+|||+ +.+..++.++|||||||++|+|++|+.||.+....+.+....
T Consensus 159 ~~~~~----------~~~~~~~~~~~y~aPE~---~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~ 225 (290)
T cd07862 159 IYSFQ----------MALTSVVVTLWYRAPEV---LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225 (290)
T ss_pred eccCC----------cccccccccccccChHH---HhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence 53221 11223468999999996 445678999999999999999999999998765543321110
Q ss_pred C------C--------------------CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 R------I--------------------PESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 ~------~--------------------~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
. . ...+.++..+.+||.+||+.||++||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 0 001357788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=351.56 Aligned_cols=253 Identities=23% Similarity=0.382 Sum_probs=199.4
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec-CCCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL-GRTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~-~~~~~ 102 (690)
+|++.++||+|+||.||+|++. ..++.||||++... ......++++|+.+|+.|+ |||||++++++.... .....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDT-HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEEC-CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCce
Confidence 6999999999999999999985 67889999988542 2334567889999999995 999999998875432 22346
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
+|+|||||+++|.+.+.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELMESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecCCCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 89999999999998887654 4999999999999999999999999 9999999999999999999999999986532
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh---------
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN--------- 253 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~--------- 253 (690)
..... .......+||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+......+.
T Consensus 155 ~~~~~------~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 227 (338)
T cd07859 155 NDTPT------AIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTP 227 (338)
T ss_pred cccCc------cccccCCCCCCCcCCHHHHhc-cccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence 21100 011123468999999997431 12568899999999999999999999997754322110
Q ss_pred ------------------cc---CCC---CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 254 ------------------GN---YRI---PESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 254 ------------------~~---~~~---~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.. ... ...+.+++.+.++|.+||..||++||++.+++.
T Consensus 228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00 000 012356788999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=354.58 Aligned_cols=242 Identities=24% Similarity=0.363 Sum_probs=200.2
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|++.+.||+|+||.||+|++. ..++.||||++... .....+.+.+|+.+|+.+. |||||++++++. ..+
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~----~~~ 91 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHK-GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQ----DEN 91 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEE----cCC
Confidence 57999999999999999999985 56889999998643 2344567889999999995 999999998865 347
Q ss_pred eEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
.+|+||||+. |+|.+.+...+ .+++..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+++.
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 8999999995 57777776654 4899999999999999999999999 99999999999999999999999999865
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--CC
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RI 258 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~~ 258 (690)
.... .....||+.|+|||+ +.+..++.++|||||||++|+|++|..||.+........... ..
T Consensus 168 ~~~~------------~~~~~gt~~y~aPE~---~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 232 (329)
T PTZ00263 168 VPDR------------TFTLCGTPEYLAPEV---IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL 232 (329)
T ss_pred cCCC------------cceecCChhhcCHHH---HcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc
Confidence 4221 123468999999996 456678999999999999999999999998876654433221 22
Q ss_pred CCCCCCCHHHHHHHHHHhhhCCCCCCC-----HHHHHH
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRPD-----ITQVWF 291 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~~L~~dP~~RPt-----~~eil~ 291 (690)
..+..++..+.+||.+||+.||.+|++ +.+++.
T Consensus 233 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 334458899999999999999999997 566643
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=346.45 Aligned_cols=247 Identities=25% Similarity=0.396 Sum_probs=198.6
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
.+|++.++||.|+||.||+|++. .+++.||+|++.... ......+.+|+.+++.|. ||||+++++++. .....
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~----~~~~~ 78 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK-HANIVTLHDIIH----TERCL 78 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEEC-CCCCEEEEEEecccccCCcchhHHHHHHHHHhCC-CCCEeeEEEEEc----CCCeE
Confidence 57999999999999999999985 578899999886432 223456778999999995 999999998864 34678
Q ss_pred EEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 104 LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
|+||||++++|.+.+...+ ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 79 TLVFEYLDSDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred EEEEeCCCcCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 9999999999988887654 34899999999999999999999999 99999999999999999999999999865321
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC-------
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY------- 256 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~------- 256 (690)
.. .......+++.|+|||++ .....++.++|||||||++|+|++|+.||.+....+.+....
T Consensus 156 ~~---------~~~~~~~~~~~y~aPE~~--~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 224 (288)
T cd07871 156 PT---------KTYSNEVVTLWYRPPDVL--LGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPT 224 (288)
T ss_pred CC---------ccccCceecccccChHHh--cCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 11 011224679999999973 234568999999999999999999999998765443221100
Q ss_pred ----------------CCC---------CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 ----------------RIP---------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 ----------------~~~---------~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
..+ ..+.++.++.+||.+||..||.+|||+.|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 225 EETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 11356789999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=342.85 Aligned_cols=247 Identities=28% Similarity=0.447 Sum_probs=198.9
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
++|++.+.||+|+||.||+|++. ..++.||+|++... .....+.+.+|+.+++.+. ||||+++++++. ....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~----~~~~ 74 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHK-ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK-QENIVELKEAFR----RRGK 74 (287)
T ss_pred CCceEEEEecccCCEEEEEEEEC-CCCcEEEEEEEecccccccchhhHHHHHHHHHhCC-CccccchhhhEe----cCCE
Confidence 37999999999999999999985 57889999998654 2334567889999999995 999999998864 3468
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
+||||||+.++++..+.... ..+++..++.++.||+.||.|||..+ |+||||||+||||+.++.+||+|||++....
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 75 LYLVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLS 151 (287)
T ss_pred EEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence 89999999988888776543 35899999999999999999999999 9999999999999999999999999987542
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc-------
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN------- 255 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~------- 255 (690)
.... .......|++.|+|||+ +.+..++.++|||||||++|+|++|+.||.+....+.+...
T Consensus 152 ~~~~--------~~~~~~~~~~~y~aPE~---~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 220 (287)
T cd07848 152 EGSN--------ANYTEYVATRWYRSPEL---LLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPL 220 (287)
T ss_pred cccc--------ccccccccccccCCcHH---HcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCC
Confidence 2110 11123468999999996 44567899999999999999999999999876543221100
Q ss_pred ----------------CCCCC-----------CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 256 ----------------YRIPE-----------SPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 256 ----------------~~~~~-----------~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
...+. ...++..+.+||.+||++||++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 221 PAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 1136788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=366.42 Aligned_cols=266 Identities=21% Similarity=0.342 Sum_probs=219.4
Q ss_pred CCCCCceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEE
Q 005577 13 TGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLY 90 (690)
Q Consensus 13 ~~~~g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~ 90 (690)
.-....+|+|....+.+...||+|.||+||+|++- -.||||++... ..+.++.|.+|+.+|++-+ |-||+-+.
T Consensus 380 ~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh----GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR-H~NIlLFM 454 (678)
T KOG0193|consen 380 ASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH----GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTR-HENILLFM 454 (678)
T ss_pred CCccccccccCHHHhhccceeccccccceeecccc----cceEEEEEecCCCCHHHHHHHHHHHHHHhhcc-hhhheeee
Confidence 34445778888899999999999999999999983 36999999765 4668899999999999997 99999999
Q ss_pred EEEEeecCCCceEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCC
Q 005577 91 AHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGL 169 (690)
Q Consensus 91 ~~~~~~~~~~~~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~ 169 (690)
|+|.. ..+.||+.+|+| +|+.+|..... .|.....+.|++||+.|+.|||.++ |||||||..||||.+++.
T Consensus 455 G~~~~-----p~~AIiTqwCeGsSLY~hlHv~et-kfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~k 526 (678)
T KOG0193|consen 455 GACMN-----PPLAIITQWCEGSSLYTHLHVQET-KFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLK 526 (678)
T ss_pred hhhcC-----CceeeeehhccCchhhhhccchhh-hhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCc
Confidence 99752 344899999977 67777765543 4899999999999999999999999 999999999999999999
Q ss_pred eeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 005577 170 WKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL 249 (690)
Q Consensus 170 vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~ 249 (690)
|||+||||+..-. .. .-........|...|||||++.......|++.+||||||||+|||++|..||......
T Consensus 527 VkIgDFGLatvk~-----~w--~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d 599 (678)
T KOG0193|consen 527 VKIGDFGLATVKT-----RW--SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD 599 (678)
T ss_pred EEEecccceeeee-----ee--ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh
Confidence 9999999985421 11 1112223456789999999876555668999999999999999999999999977777
Q ss_pred HHHhc---cCCCCC----CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhcC
Q 005577 250 QILNG---NYRIPE----SPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLP 298 (690)
Q Consensus 250 ~il~~---~~~~~~----~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l~ 298 (690)
+++-. .|-.+. ..+++.++++|+..||.+++++||.+.+|+..+..+++
T Consensus 600 qIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 600 QIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred heEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 76543 322232 24678899999999999999999999999998887665
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=346.78 Aligned_cols=241 Identities=26% Similarity=0.361 Sum_probs=199.0
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
+|++.+.||+|+||.||+|.+. ..++.||+|++.... ....+.+.+|+.+|+.+. ||||+++++++. +...
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~----~~~~ 75 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDR-ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEH----DQRF 75 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEc-CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhc----cCCe
Confidence 6889999999999999999985 568899999986532 234567889999999995 999999987753 4578
Q ss_pred EEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
+|+||||+. |+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+++..
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~ 151 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKL 151 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence 999999995 57878776654 4899999999999999999999999 999999999999999999999999998653
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--CCC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RIP 259 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~~~ 259 (690)
.. .....+||+.|+|||+ +.+..++.++|||||||++|+|++|+.||.+.....+..... ...
T Consensus 152 ~~------------~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 216 (291)
T cd05612 152 RD------------RTWTLCGTPEYLAPEV---IQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLE 216 (291)
T ss_pred cC------------CcccccCChhhcCHHH---HcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcC
Confidence 21 1123468999999996 456678999999999999999999999998876654433221 223
Q ss_pred CCCCCCHHHHHHHHHHhhhCCCCCCC-----HHHHHH
Q 005577 260 ESPKYSSSVTDLIRDMLQASPDDRPD-----ITQVWF 291 (690)
Q Consensus 260 ~~~~~s~~l~~LI~~~L~~dP~~RPt-----~~eil~ 291 (690)
.+..++..+.+||.+||+.||.+|++ +.+++.
T Consensus 217 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 217 FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 34567899999999999999999995 777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=345.04 Aligned_cols=248 Identities=24% Similarity=0.379 Sum_probs=196.2
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH-HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE-ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~-e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
..+|++.+.||+|+||.||+|++. ..++.||||++..... .....+.+|+.+|+.+. |||||++++++. ....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~----~~~~ 77 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSK-VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK-HANIVLLHDIIH----TKET 77 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEEC-CCCCEEEEEEeccccccccchhHHHHHHHHhhCC-CCCcCeEEEEEe----cCCe
Confidence 368999999999999999999985 5688999999865432 22346778999999995 999999998865 3467
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
.|+||||+.++|.+.+.... +.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 78 ~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 78 LTLVFEYVHTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred EEEEEECCCcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 89999999999998887653 45899999999999999999999999 9999999999999999999999999886432
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH-HHHhcc---C--
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL-QILNGN---Y-- 256 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~-~il~~~---~-- 256 (690)
... .......||+.|+|||++ .....++.++|||||||++|+|++|..||.+.... ..+... .
T Consensus 155 ~~~---------~~~~~~~~~~~y~aPE~~--~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 223 (303)
T cd07869 155 VPS---------HTYSNEVVTLWYRPPDVL--LGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGT 223 (303)
T ss_pred CCC---------ccCCCCcccCCCCChHHH--cCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCC
Confidence 111 111224679999999973 23356888999999999999999999999864321 111100 0
Q ss_pred --------------------CC--C-------CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 --------------------RI--P-------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 --------------------~~--~-------~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.. + ....++..+.+||.+||+.||.+||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 224 PNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred CChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 0 00124578899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=350.91 Aligned_cols=262 Identities=27% Similarity=0.367 Sum_probs=213.2
Q ss_pred CceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcCCCCceEEEEEE
Q 005577 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHT 93 (690)
Q Consensus 17 g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~ 93 (690)
-+...++-.+|++++.||.|.-|+||+++.. ..+..+|||+|.+.. ...+.++..|-+||..+ +||.++.||++|
T Consensus 69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~-~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~f 146 (459)
T KOG0610|consen 69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELR-GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASF 146 (459)
T ss_pred cCCCccCHHHHHHHHHcCCCCceeEEEEEec-CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhhee
Confidence 3455666778999999999999999999986 566899999996653 33456777899999999 699999999986
Q ss_pred EeecCCCceEEEEEecCCCc-HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeee
Q 005577 94 ILDLGRTKEALLVMECCDKS-LVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKL 172 (690)
Q Consensus 94 ~~~~~~~~~~~LVmEy~~gs-Ll~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL 172 (690)
. ..+..|||||||.|+ |..++.++..++|++..++.|+.+|+.||+|||..| ||+|||||+||||.++|+|.|
T Consensus 147 e----t~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIML 220 (459)
T KOG0610|consen 147 E----TDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIML 220 (459)
T ss_pred e----ccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEe
Confidence 5 457899999999655 555555555678999999999999999999999999 999999999999999999999
Q ss_pred eccCCCCcccccch--------------------------h---h-h-----------------hccccccccccCCCCc
Q 005577 173 CDFGSTSTNHKRFE--------------------------K---L-E-----------------EMGIEEDNIRKHTTPA 205 (690)
Q Consensus 173 ~DFGlA~~~~~~~~--------------------------~---~-~-----------------~~~~~~~~~~~~GT~~ 205 (690)
+||.|+........ . . . ...........+||-.
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 99998643211000 0 0 0 0111233456789999
Q ss_pred ccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH----HHhccCCCCCCCCCCHHHHHHHHHHhhhCCC
Q 005577 206 YRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNYRIPESPKYSSSVTDLIRDMLQASPD 281 (690)
Q Consensus 206 YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~----il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~ 281 (690)
|+|||| +++...+.++|+|.|||+|||||+|.-||.|.+..+ ++.....++..+.++..+++||+++|.+||.
T Consensus 301 YlAPEv---I~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 301 YLAPEV---IRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred ccccee---eecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 999997 678889999999999999999999999999876544 5556667777788899999999999999999
Q ss_pred CCCC----HHHH
Q 005577 282 DRPD----ITQV 289 (690)
Q Consensus 282 ~RPt----~~ei 289 (690)
+|.. ++||
T Consensus 378 kRlg~~rGA~eI 389 (459)
T KOG0610|consen 378 KRLGSKRGAAEI 389 (459)
T ss_pred hhhccccchHHh
Confidence 9987 6666
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=351.97 Aligned_cols=239 Identities=24% Similarity=0.353 Sum_probs=194.4
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
++||+|+||.||+|++. ..++.||||++... .......+++|+.+|+.+. ||||+++++++. ..+.+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~----~~~~~~lv~ 74 (323)
T cd05571 1 KLLGKGTFGKVILVREK-ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQ----THDRLCFVM 74 (323)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEE----cCCEEEEEE
Confidence 36999999999999985 67899999998643 2344567889999999995 999999998764 357899999
Q ss_pred ecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccch
Q 005577 108 ECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 108 Ey~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~ 186 (690)
||+. |+|.+.+.... .+++..+..++.||+.||.|||++| ||||||||+||||+.++.+||+|||+++.....
T Consensus 75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-- 148 (323)
T cd05571 75 EYANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-- 148 (323)
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--
Confidence 9996 56667766543 4899999999999999999999999 999999999999999999999999998642111
Q ss_pred hhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--CCCCCCCC
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RIPESPKY 264 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~~~~~~~~ 264 (690)
.......+||+.|||||+ +.+..++.++|||||||++|||++|+.||.+.....+..... ....+..+
T Consensus 149 -------~~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 218 (323)
T cd05571 149 -------GATMKTFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL 218 (323)
T ss_pred -------CCcccceecCccccChhh---hcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 011223468999999996 456778999999999999999999999998766544332211 22334578
Q ss_pred CHHHHHHHHHHhhhCCCCCC-----CHHHHHH
Q 005577 265 SSSVTDLIRDMLQASPDDRP-----DITQVWF 291 (690)
Q Consensus 265 s~~l~~LI~~~L~~dP~~RP-----t~~eil~ 291 (690)
+..+.+||.+||++||++|| ++.+++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 99999999999999999999 7888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.77 Aligned_cols=248 Identities=24% Similarity=0.335 Sum_probs=195.6
Q ss_pred eEEEEEEeeecCceEEEEEEEcc--cCCeEEEEEEeecC----CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAI--HMSKQYAMKHMICN----DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~--~~~k~vAvK~i~~~----~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
+|++.+.||+|+||.||++++.. ..++.||+|++... .....+.+.+|+.+|+.+++||||+++++++. .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ----T 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe----c
Confidence 48899999999999999998742 36789999998642 23345677889999999977999999988754 4
Q ss_pred CceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 100 TKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
.+.+||||||+. |+|.+.+..+. .+++.+++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 77 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 77 EAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 467899999995 57778776654 4999999999999999999999999 999999999999999999999999998
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch----HHHHHhc
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES----KLQILNG 254 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~----~~~il~~ 254 (690)
+...... .......+||+.|||||++. ....++.++||||||||||+|++|+.||.... ...+...
T Consensus 153 ~~~~~~~--------~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 222 (332)
T cd05614 153 KEFLSEE--------KERTYSFCGTIEYMAPEIIR--GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR 222 (332)
T ss_pred ccccccC--------CCccccccCCccccCHHHhc--CCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH
Confidence 6532211 01112346899999999732 22357889999999999999999999996422 1222211
Q ss_pred --cCCCCCCCCCCHHHHHHHHHHhhhCCCCCC-----CHHHHHH
Q 005577 255 --NYRIPESPKYSSSVTDLIRDMLQASPDDRP-----DITQVWF 291 (690)
Q Consensus 255 --~~~~~~~~~~s~~l~~LI~~~L~~dP~~RP-----t~~eil~ 291 (690)
....+.+..++..+.+||.+||+.||++|| ++.+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 223 ILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 122233456899999999999999999999 6667753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=341.16 Aligned_cols=257 Identities=16% Similarity=0.231 Sum_probs=204.2
Q ss_pred eEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEe
Q 005577 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTIL 95 (690)
Q Consensus 19 ~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~ 95 (690)
.|+..+.+..-...||+|++|.||+|.+ .++.||||.+.... ....+.+.+|+.+|+++. |||||++++++..
T Consensus 14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~ 89 (283)
T PHA02988 14 CIESDDIDKYTSVLIKENDQNSIYKGIF---NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIID 89 (283)
T ss_pred ecCHHHcCCCCCeEEeeCCceEEEEEEE---CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEe
Confidence 3333333333336799999999999987 58899999986542 233577889999999995 9999999998765
Q ss_pred ecCCCceEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCcccCCCCCCcEEeCCCCCeeee
Q 005577 96 DLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQ-SPPIAHRDLKAENLLLGSDGLWKLC 173 (690)
Q Consensus 96 ~~~~~~~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~-g~~IVHRDLKP~NILLd~dg~vKL~ 173 (690)
.......+++|||||.| +|.+++.... .+++...+.++.+++.||.|||.. + ++||||||+|||++.++.+||+
T Consensus 90 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~ 165 (283)
T PHA02988 90 IVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKII 165 (283)
T ss_pred cccCCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEc
Confidence 33344678999999964 6777776543 489999999999999999999985 7 8999999999999999999999
Q ss_pred ccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH-
Q 005577 174 DFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL- 252 (690)
Q Consensus 174 DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il- 252 (690)
|||+++..... .....|++.|+|||++.. ....++.++|||||||++|||++|+.||.+....++.
T Consensus 166 dfg~~~~~~~~------------~~~~~~~~~y~aPE~~~~-~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~ 232 (283)
T PHA02988 166 CHGLEKILSSP------------PFKNVNFMVYFSYKMLND-IFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD 232 (283)
T ss_pred ccchHhhhccc------------cccccCcccccCHHHhhh-ccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 99988643211 112467899999997421 1257899999999999999999999999887654432
Q ss_pred ---hccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhh
Q 005577 253 ---NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 253 ---~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~ 296 (690)
....+.+.+..++..+.+||.+||+.||++||++.+++..+...
T Consensus 233 ~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 233 LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred HHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 23344444457899999999999999999999999998877643
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=333.24 Aligned_cols=256 Identities=16% Similarity=0.312 Sum_probs=204.8
Q ss_pred eecCceEEEEEEeeecCceEEEEEEEcc--cCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec
Q 005577 21 DVGNLKIHVRNVIAEGGFSCVYSARDAI--HMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97 (690)
Q Consensus 21 ei~~~ry~v~~~LG~GgFG~VylA~d~~--~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~ 97 (690)
++.+.+|++.+.||+|+||.||+|.+.. ..+..||+|.+... .......+.+|+.+|+.+. |||||++++++.
T Consensus 1 ~i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--- 76 (266)
T cd05064 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD-HSNIVRLEGVIT--- 76 (266)
T ss_pred CCchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEe---
Confidence 3567899999999999999999997642 34568999988654 3344567889999999994 999999999865
Q ss_pred CCCceEEEEEecCCCc-HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccC
Q 005577 98 GRTKEALLVMECCDKS-LVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176 (690)
Q Consensus 98 ~~~~~~~LVmEy~~gs-Ll~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFG 176 (690)
.....||||||++++ |.+++... ...+++..++.++.||+.||.|||.++ |+||||||+||||+.++.++|+|||
T Consensus 77 -~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg 152 (266)
T cd05064 77 -RGNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFR 152 (266)
T ss_pred -cCCCcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCc
Confidence 346789999999765 55555543 345899999999999999999999999 9999999999999999999999999
Q ss_pred CCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---H
Q 005577 177 STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---L 252 (690)
Q Consensus 177 lA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i---l 252 (690)
.+........ .......++..|+|||+ +.+..++.++|||||||++|||++ |..||.+.....+ +
T Consensus 153 ~~~~~~~~~~--------~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~ 221 (266)
T cd05064 153 RLQEDKSEAI--------YTTMSGKSPVLWAAPEA---IQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221 (266)
T ss_pred ccccccccch--------hcccCCCCceeecCHHH---HhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence 7754321100 01112245678999996 456778999999999999999775 9999987665443 3
Q ss_pred hccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhh
Q 005577 253 NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 253 ~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~ 295 (690)
......+.+..++..+.+++.+||+.+|.+||++.+|+..+..
T Consensus 222 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 222 EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 3444555667889999999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=354.01 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=198.2
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|++.+.||+|+||.||+|.+. ..++.||||++... .......+.+|+.+|+.+ +|||||++++++. +..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~----~~~ 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKK-DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQ----DAQ 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEE----cCC
Confidence 36899999999999999999985 67899999998653 234456788899999999 5999999998865 457
Q ss_pred eEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
.+|||||||. |+|.+++.... .+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||+++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 75 YLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred eeEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeecccccc
Confidence 8999999995 67777776543 4899999999999999999999999 99999999999999999999999999864
Q ss_pred ccccchh-----hhhc--cc-------------------------------cccccccCCCCcccCccchhhhhcCCCCc
Q 005577 181 NHKRFEK-----LEEM--GI-------------------------------EEDNIRKHTTPAYRAPEMWDLFRRELINE 222 (690)
Q Consensus 181 ~~~~~~~-----~~~~--~~-------------------------------~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ 222 (690)
....... .... .. .......+||+.|+|||+ +.+..++.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~---~~~~~~~~ 227 (377)
T cd05629 151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEI---FLQQGYGQ 227 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHH---HccCCCCC
Confidence 3211000 0000 00 000012469999999997 45667899
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc------cCCCCCCCCCCHHHHHHHHHHhhhCCCCC---CCHHHHHHH
Q 005577 223 KVDIWALGCLLFRICYFKNAFDGESKLQILNG------NYRIPESPKYSSSVTDLIRDMLQASPDDR---PDITQVWFR 292 (690)
Q Consensus 223 ksDVwSLGviLyELltG~~PF~~~~~~~il~~------~~~~~~~~~~s~~l~~LI~~~L~~dP~~R---Pt~~eil~~ 292 (690)
++||||||||||||++|..||.+......... ....+....++..+.+||.+||. +|.+| +++.+++.+
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 228 ECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred ceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999999999999999987665443322 22233334678999999999997 77765 588888643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=361.30 Aligned_cols=249 Identities=29% Similarity=0.466 Sum_probs=211.8
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
..|.++++||+|+||.+++++++ ...+.|++|.+... .....+..++|+.++++++ |||||.+++.|+.+ +..
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk-~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~---~~~ 78 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHK-SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLL-HPNIVEYKDSFEED---GQL 78 (426)
T ss_pred chhhhhhhcCccccchhhhhhhc-cCCceEEEEEEeccccCchhhHHHHHHHHHHHhcc-CCCeeeeccchhcC---Cce
Confidence 57899999999999999999986 56778999998654 3344557889999999996 99999999997633 334
Q ss_pred EEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
+||||+||+| ++.+.|.......|+++.++.|+.||+.||.|||++. |+|||||+.|||++.++.|||+|||+|+.+
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhc
Confidence 9999999965 5666666655567999999999999999999999888 999999999999999999999999999876
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC---CC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY---RI 258 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~---~~ 258 (690)
..... ...+.+|||.||+||+ +.+..|+.++|||||||++|||++-+.+|.+.+...++..+. -.
T Consensus 157 ~~~~~---------~a~tvvGTp~YmcPEi---l~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~ 224 (426)
T KOG0589|consen 157 NPEDS---------LASTVVGTPYYMCPEI---LSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYS 224 (426)
T ss_pred CCchh---------hhheecCCCcccCHHH---hCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCC
Confidence 54321 2334689999999996 668899999999999999999999999999988766654433 23
Q ss_pred CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
+.+..++.+++.||..||.++|..||++.+++.+
T Consensus 225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 5567899999999999999999999999999865
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=352.98 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=200.1
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|++.+.||+|+||+||+|++. ..++.||||++... .......+.+|+.+|..+. ||||+++++++. ...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~----~~~ 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKK-DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQ----DEN 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEE----cCC
Confidence 36899999999999999999985 57889999999653 2344567788999999995 999999998865 457
Q ss_pred eEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
.+|||||||. |+|.+++...+ .+++..+..|+.||+.||.|||+++ |+||||||+||||+.+|.+||+|||++..
T Consensus 75 ~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 150 (364)
T cd05599 75 YLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTG 150 (364)
T ss_pred eEEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeeccccee
Confidence 8999999995 56777776544 4999999999999999999999999 99999999999999999999999999865
Q ss_pred ccccchhhhh--c---------------------------cccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHH
Q 005577 181 NHKRFEKLEE--M---------------------------GIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGC 231 (690)
Q Consensus 181 ~~~~~~~~~~--~---------------------------~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGv 231 (690)
+......... . .........+||+.|||||+ +.+..++.++|||||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwSlG~ 227 (364)
T cd05599 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV---FLQTGYNKECDWWSLGV 227 (364)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHH---HcCCCCCCeeeeecchh
Confidence 4221100000 0 00001123469999999996 45667899999999999
Q ss_pred HHHHHHhCCCCCCCchHHHHHhc------cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCC---HHHHHH
Q 005577 232 LLFRICYFKNAFDGESKLQILNG------NYRIPESPKYSSSVTDLIRDMLQASPDDRPD---ITQVWF 291 (690)
Q Consensus 232 iLyELltG~~PF~~~~~~~il~~------~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt---~~eil~ 291 (690)
++|+|++|..||.+......... .+..+....+++.+.+||.+||. +|.+|++ +.+++.
T Consensus 228 il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 228 IMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99999999999988765544322 12233334678999999999996 9999998 888754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=350.74 Aligned_cols=248 Identities=21% Similarity=0.260 Sum_probs=202.1
Q ss_pred eEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEe
Q 005577 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTIL 95 (690)
Q Consensus 19 ~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~ 95 (690)
...+...+|++.+.||+|+||.||+|.+.......||+|++... .....+.+.+|+.+|+.+. |||||++++++.
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~- 101 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFK- 101 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEE-
Confidence 34455678999999999999999999875344578999988643 3344667889999999995 999999999865
Q ss_pred ecCCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeec
Q 005577 96 DLGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCD 174 (690)
Q Consensus 96 ~~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~D 174 (690)
..+.+||||||+. |+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||||+.+|.+||+|
T Consensus 102 ---~~~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~D 174 (340)
T PTZ00426 102 ---DESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTD 174 (340)
T ss_pred ---eCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEec
Confidence 3468999999995 57777776554 4999999999999999999999999 99999999999999999999999
Q ss_pred cCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc
Q 005577 175 FGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG 254 (690)
Q Consensus 175 FGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~ 254 (690)
||++..... .....+||+.|||||+ +.+..++.++|||||||++|+|++|..||.+.+...+...
T Consensus 175 FG~a~~~~~------------~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~ 239 (340)
T PTZ00426 175 FGFAKVVDT------------RTYTLCGTPEYIAPEI---LLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK 239 (340)
T ss_pred CCCCeecCC------------CcceecCChhhcCHHH---HhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999865321 1123468999999997 4456789999999999999999999999988766443322
Q ss_pred cCC--CCCCCCCCHHHHHHHHHHhhhCCCCCC-----CHHHHH
Q 005577 255 NYR--IPESPKYSSSVTDLIRDMLQASPDDRP-----DITQVW 290 (690)
Q Consensus 255 ~~~--~~~~~~~s~~l~~LI~~~L~~dP~~RP-----t~~eil 290 (690)
... ...+..++..+.++|.+||+.||.+|+ ++.+++
T Consensus 240 i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~ 282 (340)
T PTZ00426 240 ILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVK 282 (340)
T ss_pred HhcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHH
Confidence 221 123456889999999999999999996 677764
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=343.09 Aligned_cols=247 Identities=19% Similarity=0.258 Sum_probs=200.2
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
+...+|++.+.||+|+||.||++++. ..+..||+|++... .....+.+.+|+++|+.+. |||||++++++.. .
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~----~ 75 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYS----D 75 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEEC-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEE----C
Confidence 56789999999999999999999985 57888999998654 3455678999999999995 9999999998653 4
Q ss_pred ceEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 101 KEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQ-SPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 101 ~~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~-g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
+.+++||||++| +|.+++.... .+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 151 (331)
T cd06649 76 GEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS 151 (331)
T ss_pred CEEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccc
Confidence 678999999965 6777765543 489999999999999999999986 5 999999999999999999999999998
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh---c-
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN---G- 254 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~---~- 254 (690)
...... ......||+.|+|||+ +.+..++.++|||||||++|+|++|+.||......++.. .
T Consensus 152 ~~~~~~-----------~~~~~~g~~~y~aPE~---~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~ 217 (331)
T cd06649 152 GQLIDS-----------MANSFVGTRSYMSPER---LQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRP 217 (331)
T ss_pred cccccc-----------ccccCCCCcCcCCHhH---hcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccc
Confidence 654221 1123468999999996 456678999999999999999999999997644322210 0
Q ss_pred ----------------------------------------------cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHH
Q 005577 255 ----------------------------------------------NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQ 288 (690)
Q Consensus 255 ----------------------------------------------~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~e 288 (690)
.........++.++.+||.+||++||++||++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~e 297 (331)
T cd06649 218 VVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKM 297 (331)
T ss_pred ccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHH
Confidence 0000011246889999999999999999999999
Q ss_pred HHHH
Q 005577 289 VWFR 292 (690)
Q Consensus 289 il~~ 292 (690)
++.+
T Consensus 298 ll~h 301 (331)
T cd06649 298 LMNH 301 (331)
T ss_pred HhcC
Confidence 9654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=361.34 Aligned_cols=252 Identities=24% Similarity=0.371 Sum_probs=206.5
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
....|.+.+.||+|+||.||+|.+....+..|++|.+...+......+.+|+.+|+.+. |||||++++++.. .+.
T Consensus 65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~----~~~ 139 (478)
T PTZ00267 65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACD-HFGIVKHFDDFKS----DDK 139 (478)
T ss_pred cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEE----CCE
Confidence 45569999999999999999998864446788999887776666677888999999995 9999999998753 478
Q ss_pred EEEEEecCC-CcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 103 ALLVMECCD-KSLVNVLENR--GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~--~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
+||||||+. |+|.+.+..+ ....+++.++..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSK 217 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCce
Confidence 999999995 6777776543 2345899999999999999999999999 9999999999999999999999999987
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC---
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--- 256 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--- 256 (690)
....... .......+||+.|||||+ +.+..++.++|||||||++|+|++|+.||.+.....++....
T Consensus 218 ~~~~~~~-------~~~~~~~~gt~~y~aPE~---~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~ 287 (478)
T PTZ00267 218 QYSDSVS-------LDVASSFCGTPYYLAPEL---WERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK 287 (478)
T ss_pred ecCCccc-------cccccccCCCccccCHhH---hCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 5432111 011223568999999996 456779999999999999999999999998876655443321
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 ~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
..+.+..++..+.+||.+||.+||++||++.+++.
T Consensus 288 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 288 YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 12334568899999999999999999999999864
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=348.00 Aligned_cols=241 Identities=29% Similarity=0.521 Sum_probs=207.6
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
..||++.+.||+|.||.|-+|++. ..++.||||.+.+. ++..+-.+.+||+||..| |||||+.+|.+| ++.
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~-~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVF----ENk 125 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEH-KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVF----ENK 125 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhc-cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhh----cCC
Confidence 468999999999999999999885 68999999988653 667778899999999999 699999999985 356
Q ss_pred ceEEEEEecC-CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 101 KEALLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 101 ~~~~LVmEy~-~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
...+|||||. .|.|++++..++. |++.+++.||+||++|+.|+|.++ ++|||||.+|||||.++++||+|||++.
T Consensus 126 dKIvivMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSN 201 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSN 201 (668)
T ss_pred ceEEEEEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhh
Confidence 7899999999 5789999988876 999999999999999999999999 9999999999999999999999999986
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh----c
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELI-NEKVDIWALGCLLFRICYFKNAFDGESKLQILN----G 254 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~-s~ksDVwSLGviLyELltG~~PF~~~~~~~il~----~ 254 (690)
.+... .-..++||+|.|.+||+ ..+..| ++.+|.|||||+||.|+.|..||+|.+...++. +
T Consensus 202 ly~~~----------kfLqTFCGSPLYASPEI---vNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G 268 (668)
T KOG0611|consen 202 LYADK----------KFLQTFCGSPLYASPEI---VNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG 268 (668)
T ss_pred hhccc----------cHHHHhcCCcccCCccc---cCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc
Confidence 65432 11235789999999997 445544 678999999999999999999999987655444 4
Q ss_pred cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHH
Q 005577 255 NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVW 290 (690)
Q Consensus 255 ~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil 290 (690)
.|+.| .-+....-||+.||..+|++|.|+.+|.
T Consensus 269 aYrEP---~~PSdA~gLIRwmLmVNP~RRATieDiA 301 (668)
T KOG0611|consen 269 AYREP---ETPSDASGLIRWMLMVNPERRATIEDIA 301 (668)
T ss_pred cccCC---CCCchHHHHHHHHHhcCcccchhHHHHh
Confidence 44433 4567889999999999999999999983
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=337.23 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=195.5
Q ss_pred EEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 27 IHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 27 y~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
|++.+.||+|+||.||+|.+. .+++.||+|++.... ......+.+|+.+|+.+. |+||+++++++. ..+.+
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~----~~~~~ 75 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYE----TKDAL 75 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEe-cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEc----cCCeE
Confidence 788999999999999999985 578999999886432 223456788999999994 999999998764 34679
Q ss_pred EEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
|+|||||.+ +|...+.......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIP 153 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence 999999964 6666665544446899999999999999999999999 9999999999999999999999999986532
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH----HHHh--ccC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL----QILN--GNY 256 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~----~il~--~~~ 256 (690)
.. .......||+.|||||+ +.+..++.++|||||||+||+|++|+.||.+.... .+.. ...
T Consensus 154 ~~----------~~~~~~~g~~~y~aPE~---~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 220 (285)
T cd05631 154 EG----------ETVRGRVGTVGYMAPEV---INNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED 220 (285)
T ss_pred CC----------CeecCCCCCCCccCHhh---hcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc
Confidence 11 01123468999999996 45677899999999999999999999999864321 1111 112
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhCCCCCCC-----HHHHHH
Q 005577 257 RIPESPKYSSSVTDLIRDMLQASPDDRPD-----ITQVWF 291 (690)
Q Consensus 257 ~~~~~~~~s~~l~~LI~~~L~~dP~~RPt-----~~eil~ 291 (690)
....+..++..+.+||.+||..||.+||+ +.+++.
T Consensus 221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 22334568999999999999999999997 677653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=346.40 Aligned_cols=243 Identities=23% Similarity=0.342 Sum_probs=199.9
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|++.+.||+|+||.||+|++. ..++.||||++... .......+.+|+.+|..+. ||||+++++++. ...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~----~~~ 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKK-DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQ----DDE 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEE----cCC
Confidence 36899999999999999999985 56889999998643 2234567889999999995 999999998864 357
Q ss_pred eEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
.+||||||+. |+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~ 150 (333)
T cd05600 75 YLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKG 150 (333)
T ss_pred EEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence 8999999995 57777775543 4899999999999999999999999 99999999999999999999999999865
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc-----
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN----- 255 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~----- 255 (690)
... .....+||+.|+|||+ +.+..++.++|||||||++|||++|..||.+....+.....
T Consensus 151 ~~~------------~~~~~~gt~~y~aPE~---~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 215 (333)
T cd05600 151 IVT------------YANSVVGSPDYMAPEV---LRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE 215 (333)
T ss_pred ccc------------ccCCcccCccccChhH---hcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc
Confidence 432 1123468999999996 45668999999999999999999999999887654432211
Q ss_pred -CCCCCC----CCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 256 -YRIPES----PKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 256 -~~~~~~----~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
...+.. ..++.++.+||.+||..+|.+||++.+++.+
T Consensus 216 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 216 TLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 111111 2568999999999999999999999998653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=335.98 Aligned_cols=250 Identities=27% Similarity=0.408 Sum_probs=198.0
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhc--CCCCceEEEEEEEeec-CCC
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLK--GHPNVVTLYAHTILDL-GRT 100 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~--~HPNIVkL~~~~~~~~-~~~ 100 (690)
+|++.+.||+|+||+||+|++. .+++.||+|.+.... ......+.+|+.+++.|. +||||+++++++.... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEEC-CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 5899999999999999999985 678899999886432 122234567777777664 5999999999875432 223
Q ss_pred ceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 101 KEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 101 ~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
..+++||||+.++|..++.......+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 80 TKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred ceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 5689999999999998887765556999999999999999999999999 99999999999999999999999999865
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC----
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY---- 256 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~---- 256 (690)
..... ......||+.|+|||+ +.+..++.++|||||||++|+|++|+.||.+....+.+....
T Consensus 158 ~~~~~----------~~~~~~~~~~y~aPE~---~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~ 224 (288)
T cd07863 158 YSCQM----------ALTPVVVTLWYRAPEV---LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 224 (288)
T ss_pred ccCcc----------cCCCccccccccCchH---hhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC
Confidence 42211 1112467999999996 445678999999999999999999999997765433221100
Q ss_pred -----------CC--------------CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 -----------RI--------------PESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 -----------~~--------------~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.. ...+.++..+.+||.+||+.||++||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 225 LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 011357888999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=359.24 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=195.8
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec----C
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL----G 98 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~----~ 98 (690)
...+|++.++||+|+||.||+|.+. ..++.||||++.... ....+|+.+|+.+. |||||++++++.... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICI-DTSEKVAIKKVLQDP----QYKNRELLIMKNLN-HINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEecCc----chHHHHHHHHHhcC-CCCCcceeeeEeecccccCC
Confidence 4568999999999999999999985 578899999885432 22347999999995 999999988765432 1
Q ss_pred CCceEEEEEecCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCC-Ceeeecc
Q 005577 99 RTKEALLVMECCDKSLVNVLENR--GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG-LWKLCDF 175 (690)
Q Consensus 99 ~~~~~~LVmEy~~gsLl~~L~~~--~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg-~vKL~DF 175 (690)
....+++||||+++++.+.+... ....+++..++.|+.||+.||.|||+++ ||||||||+||||+.++ .+||+||
T Consensus 138 ~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeecc
Confidence 22356799999999988777542 3346999999999999999999999999 99999999999998665 6999999
Q ss_pred CCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN 255 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~ 255 (690)
|+++.+... .......||+.|||||++ .....|+.++|||||||+||||++|..||.+....+.+...
T Consensus 216 Gla~~~~~~----------~~~~~~~~t~~y~aPE~~--~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 283 (440)
T PTZ00036 216 GSAKNLLAG----------QRSVSYICSRFYRAPELM--LGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283 (440)
T ss_pred ccchhccCC----------CCcccCCCCcCccCHHHh--cCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 999754321 111234679999999973 33456899999999999999999999999876543221110
Q ss_pred ---------------------CCCC----------CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 256 ---------------------YRIP----------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 256 ---------------------~~~~----------~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
+.++ .+...+.++.+||.+||.+||.+||++.+++.+
T Consensus 284 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 284 IQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0011 122467899999999999999999999998643
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=346.20 Aligned_cols=239 Identities=23% Similarity=0.350 Sum_probs=192.9
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
+.||+|+||.||++++. ..++.||+|++... .......+.+|+.+|+.+. ||||+++++++. ....+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~----~~~~~~lv~ 74 (323)
T cd05595 1 KLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQ----THDRLCFVM 74 (323)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEe----cCCEEEEEE
Confidence 36999999999999985 57899999998643 3345567788999999995 999999998865 346899999
Q ss_pred ecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccch
Q 005577 108 ECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 108 Ey~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~ 186 (690)
||+. |+|...+.... .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.......
T Consensus 75 E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~- 149 (323)
T cd05595 75 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 149 (323)
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-
Confidence 9996 46666665443 4899999999999999999999999 9999999999999999999999999876421110
Q ss_pred hhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--CCCCCCCC
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RIPESPKY 264 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~~~~~~~~ 264 (690)
.......||+.|||||+ +.+..++.++|||||||++|+|++|+.||...+......... ....+..+
T Consensus 150 --------~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 218 (323)
T cd05595 150 --------ATMKTFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL 218 (323)
T ss_pred --------CccccccCCcCcCCccc---ccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence 11123468999999996 456778999999999999999999999998765544332221 22234578
Q ss_pred CHHHHHHHHHHhhhCCCCCC-----CHHHHHH
Q 005577 265 SSSVTDLIRDMLQASPDDRP-----DITQVWF 291 (690)
Q Consensus 265 s~~l~~LI~~~L~~dP~~RP-----t~~eil~ 291 (690)
++.+.+||.+||..||.+|+ ++.+++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 99999999999999999998 7777754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=347.68 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=197.6
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|++.+.||+|+||+||+|++. ..++.||||++... .......+.+|+.++..+ +|||||++++++. +..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~----~~~ 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKK-DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQ----DKL 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEe----cCC
Confidence 36899999999999999999985 57889999998653 233456778899999999 5999999998864 456
Q ss_pred eEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
.+|||||||. |+|.+++...+ .+++..++.++.||+.||.|||++| ||||||||+||||+.+|.+||+|||+++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~ 150 (363)
T cd05628 75 NLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTG 150 (363)
T ss_pred eEEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCccc
Confidence 8999999996 57777776544 4999999999999999999999999 99999999999999999999999999875
Q ss_pred ccccchhhh---------------hc-----------cccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHH
Q 005577 181 NHKRFEKLE---------------EM-----------GIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLF 234 (690)
Q Consensus 181 ~~~~~~~~~---------------~~-----------~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLy 234 (690)
......... .. .........+||+.|+|||+ +.+..++.++|||||||+||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~---~~~~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEV---FMQTGYNKLCDWWSLGVIMY 227 (363)
T ss_pred ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHH---HcCCCCCCchhhhhhHHHHH
Confidence 432110000 00 00000123579999999996 45677899999999999999
Q ss_pred HHHhCCCCCCCchHHHHHhc------cCCCCCCCCCCHHHHHHHHHHhhhCCC---CCCCHHHHHH
Q 005577 235 RICYFKNAFDGESKLQILNG------NYRIPESPKYSSSVTDLIRDMLQASPD---DRPDITQVWF 291 (690)
Q Consensus 235 ELltG~~PF~~~~~~~il~~------~~~~~~~~~~s~~l~~LI~~~L~~dP~---~RPt~~eil~ 291 (690)
||++|+.||.+......... ....+....+++++.+||.+|+. +|. .||++.+|+.
T Consensus 228 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 228 EMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT 292 (363)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC
Confidence 99999999987665543322 22334444678999999999775 444 4588898854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=347.74 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=197.7
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec--CC
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL--GR 99 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~--~~ 99 (690)
-.+|++.+.||+|+||.||+|.+. ..++.||||++... +......+.+|+.+++.+. ||||+++++++.... ..
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDT-VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEc-CCCceeEEEEecccccchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCccc
Confidence 368999999999999999999985 57889999998543 3445677889999999995 999999999875332 12
Q ss_pred CceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 100 TKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 100 ~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
...+|+||||++++|...+.. .+++..+..++.||+.||.|||++| |+||||||+||||+.+|.+||+|||+++
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred cceeEEEEeCCCcCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 245799999999998887643 2889999999999999999999999 9999999999999999999999999986
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh------
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN------ 253 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~------ 253 (690)
...... ......||+.|+|||+ +.+..++.++|||||||++|+|++|+.||.+.+......
T Consensus 172 ~~~~~~----------~~~~~~~t~~y~aPE~---~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 238 (359)
T cd07876 172 TACTNF----------MMTPYVVTRYYRAPEV---ILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQL 238 (359)
T ss_pred ccccCc----------cCCCCcccCCCCCchh---ccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 532211 1123467999999997 456678999999999999999999999998654322110
Q ss_pred --------------------ccCCCC------------------CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 254 --------------------GNYRIP------------------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 254 --------------------~~~~~~------------------~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
.....+ .....+..+.+||.+||..||++||++.|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 239 GTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred CCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 011246788999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=351.51 Aligned_cols=263 Identities=20% Similarity=0.321 Sum_probs=207.5
Q ss_pred eEeecCceEEEEEEeeecCceEEEEEEEcc----cCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEE
Q 005577 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDAI----HMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHT 93 (690)
Q Consensus 19 ~iei~~~ry~v~~~LG~GgFG~VylA~d~~----~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~ 93 (690)
.|.+...+|++.+.||+|+||.||+|.+.. ...+.||||++... ..+..+.+.+|+.+|+.+.+|+|||+++++|
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 345667789999999999999999998631 23457999998654 3445677889999999995699999999986
Q ss_pred EeecCCCceEEEEEecCC-CcHHHHHHHhC--------------------------------------------------
Q 005577 94 ILDLGRTKEALLVMECCD-KSLVNVLENRG-------------------------------------------------- 122 (690)
Q Consensus 94 ~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~-------------------------------------------------- 122 (690)
. ....+|+|||||. |+|.+++....
T Consensus 112 ~----~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (374)
T cd05106 112 T----HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV 187 (374)
T ss_pred c----CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence 5 3467899999995 67877775421
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccccc
Q 005577 123 ------------------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKR 184 (690)
Q Consensus 123 ------------------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~ 184 (690)
...+++.+++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~ 265 (374)
T cd05106 188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265 (374)
T ss_pred cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCC
Confidence 124788899999999999999999999 999999999999999999999999998654321
Q ss_pred chhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH----HHHHhccCCCC
Q 005577 185 FEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESK----LQILNGNYRIP 259 (690)
Q Consensus 185 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~----~~il~~~~~~~ 259 (690)
... .......+++.|||||+ +.+..++.++|||||||++|+|++ |+.||..... ..++...+...
T Consensus 266 ~~~-------~~~~~~~~~~~y~aPE~---~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~ 335 (374)
T cd05106 266 SNY-------VVKGNARLPVKWMAPES---IFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS 335 (374)
T ss_pred cce-------eeccCCCCccceeCHHH---hcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc
Confidence 110 00111235678999996 456679999999999999999997 9999976443 23334444444
Q ss_pred CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 260 ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 260 ~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
.+..+++++.++|.+||+.||.+||++.+++..+.+.+
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 45567899999999999999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=352.22 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=198.1
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
+|++.+.||+|+||.||+|++. ..++.||||++.... ......+.+|+.+|+.+. ||||+++++++. +.+.
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~----~~~~ 75 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKV-DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQ----DKDN 75 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEE----cCCE
Confidence 6899999999999999999985 568999999985432 234566788999999995 999999998864 4578
Q ss_pred EEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
+|||||||. |+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++..+
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 999999995 57777776543 4899999999999999999999999 999999999999999999999999997532
Q ss_pred cccchh----------------------------------hhhccccccccccCCCCcccCccchhhhhcCCCCchhhHH
Q 005577 182 HKRFEK----------------------------------LEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIW 227 (690)
Q Consensus 182 ~~~~~~----------------------------------~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVw 227 (690)
...... .............+||+.|||||+ +.+..++.++|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~---~~~~~~~~~~Diw 228 (376)
T cd05598 152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEV---LLRTGYTQLCDWW 228 (376)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHH---HcCCCCCcceeee
Confidence 100000 000000011123579999999996 4567789999999
Q ss_pred HHHHHHHHHHhCCCCCCCchHHHHHhc------cCCCCCCCCCCHHHHHHHHHHhhhCCCCCC---CHHHHHH
Q 005577 228 ALGCLLFRICYFKNAFDGESKLQILNG------NYRIPESPKYSSSVTDLIRDMLQASPDDRP---DITQVWF 291 (690)
Q Consensus 228 SLGviLyELltG~~PF~~~~~~~il~~------~~~~~~~~~~s~~l~~LI~~~L~~dP~~RP---t~~eil~ 291 (690)
|||||||+|++|+.||.+......... .+..+....++..+.++|.+|+ .+|.+|+ ++.+++.
T Consensus 229 SlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 229 SVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 999999999999999988765443221 2233334568999999999976 5999999 8888854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=342.59 Aligned_cols=240 Identities=24% Similarity=0.384 Sum_probs=194.8
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
+|++.+.||+|+||.||+|++. ..++.||||++... .....+.+..|++++..+..|++|+++++++. ..+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~----~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ----TMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE----cCCE
Confidence 4889999999999999999985 56789999998643 33456778889999999964566888887754 3467
Q ss_pred EEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
+||||||+. |+|...+.... .+++..++.++.||+.||.|||.++ |+||||||+||||+.+|.+||+|||++...
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 999999995 56777776544 4899999999999999999999999 999999999999999999999999988542
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--CCC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RIP 259 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~~~ 259 (690)
... .......+||+.|+|||+ +.+..++.++|||||||++|+|++|+.||.+.....++.... ...
T Consensus 152 ~~~---------~~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 219 (324)
T cd05587 152 IFG---------GKTTRTFCGTPDYIAPEI---IAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS 219 (324)
T ss_pred CCC---------CCceeeecCCccccChhh---hcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 111 011123468999999996 456678999999999999999999999998876655443322 223
Q ss_pred CCCCCCHHHHHHHHHHhhhCCCCCCCH
Q 005577 260 ESPKYSSSVTDLIRDMLQASPDDRPDI 286 (690)
Q Consensus 260 ~~~~~s~~l~~LI~~~L~~dP~~RPt~ 286 (690)
.+..++..+.+||.+||.+||.+|++.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 345789999999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=356.34 Aligned_cols=247 Identities=25% Similarity=0.404 Sum_probs=207.6
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
...|+...+||+|.||.||+|.+. .+++.||+|++... ....++++.+|+.+|..++ ++||.++|+.++. +..
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~-~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~-~~~it~yygsyl~----g~~ 85 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDN-KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCD-SPNITEYYGSYLK----GTK 85 (467)
T ss_pred ccccccchhccccccceeeeeeec-cccceEEEEEechhhcchhhHHHHHHHHHHHhcC-cchHHhhhhheee----ccc
Confidence 456778899999999999999996 78999999999654 4556788999999999995 9999999998764 477
Q ss_pred EEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
++|+||||+ |++++.|.... .+.+..+..++++++.||.|||.++ .+|||||+.||||..+|.|||+|||++..+
T Consensus 86 LwiiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql 161 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQL 161 (467)
T ss_pred HHHHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeee
Confidence 899999996 46666665433 2589999999999999999999999 999999999999999999999999998654
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCCCCCC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPES 261 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~~~~~ 261 (690)
.... ....+.+|||.||||||+ ....|+.++||||||+++|||++|.+|+....+..++..+.+..++
T Consensus 162 ~~~~---------~rr~tfvGTPfwMAPEVI---~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP 229 (467)
T KOG0201|consen 162 TNTV---------KRRKTFVGTPFWMAPEVI---KQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPP 229 (467)
T ss_pred echh---------hccccccccccccchhhh---ccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCC
Confidence 3321 112457899999999984 4667999999999999999999999999988886665444332222
Q ss_pred ---CCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 262 ---PKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 262 ---~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
..+++.+++||..||.+||+.||++.+++.+
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 3789999999999999999999999999754
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=345.87 Aligned_cols=239 Identities=25% Similarity=0.356 Sum_probs=194.6
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
++||+|+||.||++++. ..++.||+|++... .......+.+|+.+|+.+. ||||+++++++. ....+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~----~~~~~~lv~ 74 (328)
T cd05593 1 KLLGKGTFGKVILVREK-ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQ----TKDRLCFVM 74 (328)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEE----cCCEEEEEE
Confidence 36999999999999985 67899999998643 3345677889999999995 999999988764 357899999
Q ss_pred ecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccch
Q 005577 108 ECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 108 Ey~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~ 186 (690)
||+. |+|...+.... .+++.+++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 75 Ey~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~- 149 (328)
T cd05593 75 EYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA- 149 (328)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-
Confidence 9996 46666665543 4899999999999999999999999 9999999999999999999999999986422110
Q ss_pred hhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--CCCCCCCC
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RIPESPKY 264 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~~~~~~~~ 264 (690)
......+||+.|+|||+ +.+..++.++|||||||++|+|++|+.||.+.....+..... ....+..+
T Consensus 150 --------~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 218 (328)
T cd05593 150 --------ATMKTFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTL 218 (328)
T ss_pred --------cccccccCCcCccChhh---hcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCC
Confidence 11123468999999996 456678999999999999999999999998766555443322 22334578
Q ss_pred CHHHHHHHHHHhhhCCCCCC-----CHHHHHH
Q 005577 265 SSSVTDLIRDMLQASPDDRP-----DITQVWF 291 (690)
Q Consensus 265 s~~l~~LI~~~L~~dP~~RP-----t~~eil~ 291 (690)
+..+.+||.+||.+||.+|+ ++.+++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 99999999999999999997 7888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=335.03 Aligned_cols=256 Identities=17% Similarity=0.229 Sum_probs=198.8
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcc---------------cCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCC
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAI---------------HMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPN 85 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~---------------~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPN 85 (690)
+...+|++.++||+|+||.||+|.+.. ..+..||+|.+... .......+.+|+.+|.++. |||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLK-DPN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcC-CCC
Confidence 345789999999999999999997531 12347999988654 3445677899999999995 999
Q ss_pred ceEEEEEEEeecCCCceEEEEEecCC-CcHHHHHHHhCC-----------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 005577 86 VVTLYAHTILDLGRTKEALLVMECCD-KSLVNVLENRGA-----------------GYFEEKQVLAIFRDVCNAVFAMHS 147 (690)
Q Consensus 86 IVkL~~~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~-----------------~~lse~~~~~i~~qIa~aL~yLHs 147 (690)
||++++++.. .+..||||||+. |+|.+++..... ..+++..++.++.||+.||.|||+
T Consensus 81 iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 81 IIRLLGVCVD----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred eeEEEEEEec----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 9999998753 367899999995 577777754321 236778899999999999999999
Q ss_pred CCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHH
Q 005577 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIW 227 (690)
Q Consensus 148 ~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVw 227 (690)
.+ |+||||||+||||+.++.+||+|||+++.+..... ........++..|||||+ +..+.++.++|||
T Consensus 157 ~~--ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~ 224 (304)
T cd05096 157 LN--FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-------YRIQGRAVLPIRWMAWEC---ILMGKFTTASDVW 224 (304)
T ss_pred CC--ccccCcchhheEEcCCccEEECCCccceecccCce-------eEecCcCCCCccccCHHH---HhcCCCCchhhhH
Confidence 99 99999999999999999999999999865422110 011122345789999996 4456799999999
Q ss_pred HHHHHHHHHHh--CCCCCCCchHHHHHhc----------cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 228 ALGCLLFRICY--FKNAFDGESKLQILNG----------NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 228 SLGviLyELlt--G~~PF~~~~~~~il~~----------~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
||||++|+|++ +..||......+++.. ......++.++..+.+||.+||+.||.+||++.+|...+.
T Consensus 225 slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 225 AFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 99999999986 5678876554433211 1112234578899999999999999999999999976553
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=352.29 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=197.3
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
+|++.++||+|+||+||+|++. ..++.||||++.... ......+.+|+.+|+.+ +|||||++++++. ....
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~----~~~~ 75 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKV-DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQ----DKDN 75 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEEC-CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEE----eCCE
Confidence 6899999999999999999985 678899999986532 34456788999999999 4999999998865 3468
Q ss_pred EEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
+|||||||. |+|.+.+...+ .+++..+..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||++...
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 999999996 56777776543 4899999999999999999999999 999999999999999999999999997543
Q ss_pred cccchhh--------------------------------------hhccccccccccCCCCcccCccchhhhhcCCCCch
Q 005577 182 HKRFEKL--------------------------------------EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEK 223 (690)
Q Consensus 182 ~~~~~~~--------------------------------------~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~k 223 (690)
....... ............+||+.|||||+ +.+..++.+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~---~~~~~~~~~ 228 (382)
T cd05625 152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEV---LLRTGYTQL 228 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHH---hcCCCCCCe
Confidence 2100000 00000001123478999999997 456678999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCchHHHHH----hc--cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCC---HHHHH
Q 005577 224 VDIWALGCLLFRICYFKNAFDGESKLQIL----NG--NYRIPESPKYSSSVTDLIRDMLQASPDDRPD---ITQVW 290 (690)
Q Consensus 224 sDVwSLGviLyELltG~~PF~~~~~~~il----~~--~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt---~~eil 290 (690)
+||||||||||||++|+.||.+....... .. ....+....+++++.++|.+|+ .+|.+|++ +.+++
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 229 CDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred eeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 99999999999999999999876654332 21 2233444578999999999976 59999997 77664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=349.71 Aligned_cols=274 Identities=22% Similarity=0.332 Sum_probs=210.6
Q ss_pred CCccCCCCCCC-ceEeecCceEEEEEEeeecCceEEEEEEEc----ccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhh
Q 005577 7 FMQKEPTGLEG-RSIDVGNLKIHVRNVIAEGGFSCVYSARDA----IHMSKQYAMKHMICN-DEESLESAMKEISVMKSL 80 (690)
Q Consensus 7 ~~~~~~~~~~g-~~iei~~~ry~v~~~LG~GgFG~VylA~d~----~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L 80 (690)
||..++.-+.. ..+++...+|++.+.||+|+||.||+|.+. ...+..||||++... .....+.+.+|+.+|..+
T Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l 95 (375)
T cd05104 16 YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 95 (375)
T ss_pred EEEecCCCCCCccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHh
Confidence 33344444432 224556678999999999999999999742 234668999988643 234456788999999999
Q ss_pred cCCCCceEEEEEEEeecCCCceEEEEEecCC-CcHHHHHHHhC-------------------------------------
Q 005577 81 KGHPNVVTLYAHTILDLGRTKEALLVMECCD-KSLVNVLENRG------------------------------------- 122 (690)
Q Consensus 81 ~~HPNIVkL~~~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~------------------------------------- 122 (690)
.+|||||+++++|. .....|+|||||. |+|.+++....
T Consensus 96 ~~HpnIv~l~~~~~----~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (375)
T cd05104 96 GNHINIVNLLGACT----VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDM 171 (375)
T ss_pred cCCcceeeeeeeec----cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhc
Confidence 66999999999864 3467899999995 67877775432
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCC
Q 005577 123 ------------------------------------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS 166 (690)
Q Consensus 123 ------------------------------------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~ 166 (690)
...+++..++.|+.||+.||.|||+++ |+||||||+|||++.
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~ 249 (375)
T cd05104 172 KPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTH 249 (375)
T ss_pred CCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEEC
Confidence 124788899999999999999999999 999999999999999
Q ss_pred CCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 005577 167 DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDG 245 (690)
Q Consensus 167 dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~ 245 (690)
++.+||+|||+++........ .......++..|||||+ +.+..++.++|||||||++|+|++ |..||..
T Consensus 250 ~~~~kl~DfG~a~~~~~~~~~-------~~~~~~~~~~~y~aPE~---~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~ 319 (375)
T cd05104 250 GRITKICDFGLARDIRNDSNY-------VVKGNARLPVKWMAPES---IFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319 (375)
T ss_pred CCcEEEecCccceeccCcccc-------cccCCCCCCcceeChhH---hcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999998654322110 00111235678999996 456779999999999999999997 8899976
Q ss_pred chH----HHHHhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhh
Q 005577 246 ESK----LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 246 ~~~----~~il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~ 296 (690)
... ...+....+...+...+.++.+||.+||+.||++||++.+|+..+...
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 320 MPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 432 234444444444456789999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=341.57 Aligned_cols=236 Identities=25% Similarity=0.386 Sum_probs=188.8
Q ss_pred EEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHH---hhcCCCCceEEEEEEEeecCCC
Q 005577 27 IHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMK---SLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 27 y~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~---~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
|++.+.||+|+||.||+|.+. ..++.||||++... .....+.+.+|++++. .+ +||||+++++++. ..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~----~~ 74 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYK-KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQ----TE 74 (324)
T ss_pred CeEEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEE----cC
Confidence 678999999999999999985 57889999998643 2334556677776664 45 5999999999865 35
Q ss_pred ceEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 101 KEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 101 ~~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
+.+||||||+.| +|...+ .. +.+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++
T Consensus 75 ~~~~lv~E~~~~~~L~~~~-~~--~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05589 75 DHVCFVMEYAAGGDLMMHI-HT--DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCK 149 (324)
T ss_pred CEEEEEEcCCCCCcHHHHh-hc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCc
Confidence 789999999976 454444 32 34999999999999999999999999 9999999999999999999999999886
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--C
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--R 257 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~ 257 (690)
..... .......+|++.|||||+ +.+..++.++|||||||++|+|++|+.||.+....++..... .
T Consensus 150 ~~~~~---------~~~~~~~~g~~~y~aPE~---~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~ 217 (324)
T cd05589 150 EGMGF---------GDRTSTFCGTPEFLAPEV---LTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE 217 (324)
T ss_pred cCCCC---------CCcccccccCccccCHhH---hcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 42211 111223568999999996 456678999999999999999999999998876655433221 1
Q ss_pred CCCCCCCCHHHHHHHHHHhhhCCCCCCC
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPD 285 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~~L~~dP~~RPt 285 (690)
...+..++..+.+||.+||..||.+||+
T Consensus 218 ~~~p~~~~~~~~~li~~~L~~dP~~R~~ 245 (324)
T cd05589 218 VRYPRFLSREAISIMRRLLRRNPERRLG 245 (324)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCC
Confidence 2234568999999999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=358.89 Aligned_cols=253 Identities=22% Similarity=0.331 Sum_probs=196.7
Q ss_pred CCceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhc-----CCCCceEEE
Q 005577 16 EGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK-----GHPNVVTLY 90 (690)
Q Consensus 16 ~g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~-----~HPNIVkL~ 90 (690)
.|..+++...+|++.++||+|+||.||+|.+. ..++.||||++.... .....+..|+.+++.++ +|.+|++++
T Consensus 120 ~~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~-~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 120 LGEDIDVSTQRFKILSLLGEGTFGKVVEAWDR-KRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred cCCccccCCCcEEEEEEEEeccCEEEEEEEEc-CCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 46667778889999999999999999999985 568899999985432 22344566787877774 245688888
Q ss_pred EEEEeecCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCcccCCCCCCcEEeCCCC-
Q 005577 91 AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS-QSPPIAHRDLKAENLLLGSDG- 168 (690)
Q Consensus 91 ~~~~~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs-~g~~IVHRDLKP~NILLd~dg- 168 (690)
+++.. ...++|||||+++++|++++..++ .+++..++.|+.||+.||.|||. .| ||||||||+||||+.++
T Consensus 198 ~~~~~---~~~~~~iv~~~~g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~ 270 (467)
T PTZ00284 198 RYFQN---ETGHMCIVMPKYGPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDT 270 (467)
T ss_pred EEEEc---CCceEEEEEeccCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCc
Confidence 87642 345789999999999999987764 49999999999999999999998 48 99999999999998765
Q ss_pred ---------------CeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHH
Q 005577 169 ---------------LWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLL 233 (690)
Q Consensus 169 ---------------~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviL 233 (690)
.+||+|||++..... .....+||+.|||||+ +.+..|+.++|||||||||
T Consensus 271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~------------~~~~~~gt~~Y~APE~---~~~~~~~~~~DiwSlGvil 335 (467)
T PTZ00284 271 VVDPVTNRALPPDPCRVRICDLGGCCDERH------------SRTAIVSTRHYRSPEV---VLGLGWMYSTDMWSMGCII 335 (467)
T ss_pred ccccccccccCCCCceEEECCCCccccCcc------------ccccccCCccccCcHH---hhcCCCCcHHHHHHHHHHH
Confidence 499999998753211 1123578999999997 4567799999999999999
Q ss_pred HHHHhCCCCCCCchHHHHHhcc---C-CCC-------------------------C---------------CCCCCHHHH
Q 005577 234 FRICYFKNAFDGESKLQILNGN---Y-RIP-------------------------E---------------SPKYSSSVT 269 (690)
Q Consensus 234 yELltG~~PF~~~~~~~il~~~---~-~~~-------------------------~---------------~~~~s~~l~ 269 (690)
|||++|+.||.+....+.+... . .++ . .....+.+.
T Consensus 336 ~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (467)
T PTZ00284 336 YELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLC 415 (467)
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHH
Confidence 9999999999876543321100 0 000 0 001135677
Q ss_pred HHHHHHhhhCCCCCCCHHHHHHH
Q 005577 270 DLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 270 ~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
+||.+||.+||.+||++.|++.+
T Consensus 416 dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 416 DLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHHHHhCCcChhhCCCHHHHhcC
Confidence 99999999999999999999753
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=338.92 Aligned_cols=247 Identities=24% Similarity=0.395 Sum_probs=198.0
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
.+|++.+.||+|+||.||+|++. ..++.||+|.+.... ......+.+|+.+++.+. ||||+++++++.. .+..
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~----~~~~ 79 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIVHT----DKSL 79 (309)
T ss_pred CceEEEEEecccCCEEEEEEEec-CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCC-CCCcceEEEEEee----CCeE
Confidence 57999999999999999999985 567889999886442 223346778999999995 9999999998653 4678
Q ss_pred EEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 104 LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
|+||||++++|.+.+...+ ..+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++....
T Consensus 80 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 80 TLVFEYLDKDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred EEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 9999999999988887654 34899999999999999999999999 99999999999999999999999999864322
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC-------
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY------- 256 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~------- 256 (690)
... ......+++.|+|||++ .....++.++|||||||++|+|++|+.||.+.+..+.+....
T Consensus 157 ~~~---------~~~~~~~~~~y~aPE~~--~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 225 (309)
T cd07872 157 PTK---------TYSNEVVTLWYRPPDVL--LGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPT 225 (309)
T ss_pred Ccc---------ccccccccccccCCHHH--hCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 110 11123578999999973 234568899999999999999999999998765433211100
Q ss_pred ----------------CC---------CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 ----------------RI---------PESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 ----------------~~---------~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.. ...+.++.++.+||.+||..||.+||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 226 EETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00 011357889999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=341.80 Aligned_cols=236 Identities=24% Similarity=0.361 Sum_probs=192.6
Q ss_pred eeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEec
Q 005577 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMEC 109 (690)
Q Consensus 33 LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy 109 (690)
||+|+||.||+|++. .+++.||+|++... .......+.+|+.+|+.+ +|||||++++++. ..+..||||||
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~----~~~~~~lv~e~ 74 (312)
T cd05585 1 IGKGSFGKVMQVRKR-DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQ----SPEKLYLVLAF 74 (312)
T ss_pred CCcCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEe----cCCeEEEEEcC
Confidence 799999999999985 57889999998643 344567788999999999 5999999988764 34789999999
Q ss_pred CC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhh
Q 005577 110 CD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL 188 (690)
Q Consensus 110 ~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~ 188 (690)
+. |+|.+.+...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 75 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--- 147 (312)
T cd05585 75 INGGELFHHLQREG--RFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--- 147 (312)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCC---
Confidence 95 56777776543 4999999999999999999999999 9999999999999999999999999986432111
Q ss_pred hhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--CCCCCCCCCH
Q 005577 189 EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RIPESPKYSS 266 (690)
Q Consensus 189 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~~~~~~~~s~ 266 (690)
......+||+.|+|||+ +.+..++.++|||||||++|+|++|+.||.+.....+..... ....+..+++
T Consensus 148 ------~~~~~~~gt~~y~aPE~---~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (312)
T cd05585 148 ------DKTNTFCGTPEYLAPEL---LLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDR 218 (312)
T ss_pred ------CccccccCCcccCCHHH---HcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCH
Confidence 11123468999999996 456778999999999999999999999998876655443322 2233457899
Q ss_pred HHHHHHHHHhhhCCCCCCC---HHHHH
Q 005577 267 SVTDLIRDMLQASPDDRPD---ITQVW 290 (690)
Q Consensus 267 ~l~~LI~~~L~~dP~~RPt---~~eil 290 (690)
.+.+||.+||..||.+||+ +.+++
T Consensus 219 ~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 219 DAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 9999999999999999986 45554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=342.97 Aligned_cols=236 Identities=25% Similarity=0.409 Sum_probs=192.4
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
++||+|+||.||+|++. ..++.||||++... .....+.+..|+.++..+.+||||+++++++. ....+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~----~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLK-ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ----TPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE----cCCEEEEEE
Confidence 36999999999999985 56889999998643 23456677889999988867999999998864 357899999
Q ss_pred ecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccch
Q 005577 108 ECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 108 Ey~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~ 186 (690)
|||.| +|...+.... .+++..++.++.||+.||.|||.++ |+||||||+|||++.++.+||+|||+++......
T Consensus 76 Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~- 150 (320)
T cd05590 76 EFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG- 150 (320)
T ss_pred cCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-
Confidence 99965 6666665543 4999999999999999999999999 9999999999999999999999999886421110
Q ss_pred hhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCC--CCCCCCC
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYR--IPESPKY 264 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~--~~~~~~~ 264 (690)
.......||+.|||||+ +.+..++.++|||||||++|+|++|+.||.+.....++..... ...+..+
T Consensus 151 --------~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 219 (320)
T cd05590 151 --------KTTSTFCGTPDYIAPEI---LQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL 219 (320)
T ss_pred --------CcccccccCccccCHHH---HcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence 11123468999999996 4567789999999999999999999999988776555433322 2234468
Q ss_pred CHHHHHHHHHHhhhCCCCCCCHH
Q 005577 265 SSSVTDLIRDMLQASPDDRPDIT 287 (690)
Q Consensus 265 s~~l~~LI~~~L~~dP~~RPt~~ 287 (690)
+..+.+||.+||++||.+||++.
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 220 SQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CHHHHHHHHHHcccCHHHCCCCC
Confidence 99999999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=346.21 Aligned_cols=253 Identities=27% Similarity=0.408 Sum_probs=203.2
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|++.+.||+|+||.||+|++. ..++.||||++... .......+.+|+.+|..+. ||||+++++++. +.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~----~~~ 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDK-DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQ----DEE 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEEC-CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhhee----cCC
Confidence 36899999999999999999985 57899999998643 2234567888999999995 999999998754 457
Q ss_pred eEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
.+|+||||+. ++|.+++... +.+++..++.++.||+.||.|||.+| |+||||||+||||+.++.+||+|||++..
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 150 (350)
T cd05573 75 HLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKK 150 (350)
T ss_pred eEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence 8999999995 5777777765 35999999999999999999999999 99999999999999999999999999876
Q ss_pred ccccchhhh--------------------hccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCC
Q 005577 181 NHKRFEKLE--------------------EMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK 240 (690)
Q Consensus 181 ~~~~~~~~~--------------------~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~ 240 (690)
......... ............||+.|+|||+ +.+..++.++||||||||||+|++|+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwSlG~il~ell~g~ 227 (350)
T cd05573 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEV---LRGTPYGLECDWWSLGVILYEMLYGF 227 (350)
T ss_pred CcccCcccccccccccccccccccccccccccccccccccccCccccCHHH---HcCCCCCCceeeEecchhhhhhccCC
Confidence 433210000 0000011223568999999996 45668999999999999999999999
Q ss_pred CCCCCchHHHHH----h--ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCC-HHHHHH
Q 005577 241 NAFDGESKLQIL----N--GNYRIPESPKYSSSVTDLIRDMLQASPDDRPD-ITQVWF 291 (690)
Q Consensus 241 ~PF~~~~~~~il----~--~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt-~~eil~ 291 (690)
.||......... . .....+....+++.+.+||.+||. ||.+||+ +.+++.
T Consensus 228 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 228 PPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred CCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 999877654432 2 233445555679999999999997 9999999 998864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.26 Aligned_cols=253 Identities=22% Similarity=0.290 Sum_probs=197.8
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.|++.+.||+|+||+||+|++. ..++.||||++... .......+.+|+.+|+.+. |||||++++++. +...
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~----~~~~ 75 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKV-DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQ----DKDN 75 (381)
T ss_pred CceEEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEe----cCCE
Confidence 5889999999999999999985 67889999998653 3345677889999999995 999999998865 3568
Q ss_pred EEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
+|||||||. |+|.+++.... .+++..+..++.||+.||.|||..| ||||||||+||||+.++.+||+|||+++..
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 999999995 57777776544 4899999999999999999999999 999999999999999999999999997543
Q ss_pred cccchh-h---------------------------------h----hccccccccccCCCCcccCccchhhhhcCCCCch
Q 005577 182 HKRFEK-L---------------------------------E----EMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEK 223 (690)
Q Consensus 182 ~~~~~~-~---------------------------------~----~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~k 223 (690)
...... . . ...........+||+.|||||+ +.+..++.+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~---~~~~~~~~~ 228 (381)
T cd05626 152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEV---LLRKGYTQL 228 (381)
T ss_pred ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHH---HcCCCCCCc
Confidence 111000 0 0 0000001123579999999996 445678999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCchHHHH----Hh--ccCCCCCCCCCCHHHHHHHHHHhh--hCCCCCCCHHHHHH
Q 005577 224 VDIWALGCLLFRICYFKNAFDGESKLQI----LN--GNYRIPESPKYSSSVTDLIRDMLQ--ASPDDRPDITQVWF 291 (690)
Q Consensus 224 sDVwSLGviLyELltG~~PF~~~~~~~i----l~--~~~~~~~~~~~s~~l~~LI~~~L~--~dP~~RPt~~eil~ 291 (690)
+||||||||+|||++|..||........ +. .....+....+++++.+||.+||. .++..|+++.+++.
T Consensus 229 ~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 229 CDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred cceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999999999999999987654332 22 223344445689999999999654 45556999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.77 Aligned_cols=240 Identities=24% Similarity=0.375 Sum_probs=195.4
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
+|++.+.||+|+||.||+|++. ..++.||||++... .....+.+..|..++..+..|++|+++++++. ..+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~----~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ----TMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe----cCCE
Confidence 4889999999999999999985 57789999998653 23345567788888888867899999988754 3468
Q ss_pred EEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
+||||||+. |+|...+.... .+++..++.++.||+.||.|||.++ |+||||||+||||+.++.+||+|||+++..
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~ 151 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 151 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceec
Confidence 999999995 57777776544 4899999999999999999999999 999999999999999999999999998642
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--CCC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RIP 259 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~~~ 259 (690)
.... ......+||+.|+|||+ +.+..++.++|||||||++|+|++|+.||.+.....++.... ...
T Consensus 152 ~~~~---------~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~ 219 (323)
T cd05616 152 MWDG---------VTTKTFCGTPDYIAPEI---IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 219 (323)
T ss_pred CCCC---------CccccCCCChhhcCHHH---hcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 2110 11123468999999996 456778999999999999999999999998876655433222 222
Q ss_pred CCCCCCHHHHHHHHHHhhhCCCCCCCH
Q 005577 260 ESPKYSSSVTDLIRDMLQASPDDRPDI 286 (690)
Q Consensus 260 ~~~~~s~~l~~LI~~~L~~dP~~RPt~ 286 (690)
.+..++.++.+||.+||++||.+|++.
T Consensus 220 ~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=339.94 Aligned_cols=248 Identities=21% Similarity=0.286 Sum_probs=199.5
Q ss_pred eecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 21 DVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 21 ei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
++...+|++.+.||+|+||.||+|.+. ..+..+|+|++... .......+.+|+++|+.+. |||||+++++|..
T Consensus 1 ~l~~~~y~~~~~lg~g~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~---- 74 (333)
T cd06650 1 ELKDDDFEKISELGAGNGGVVFKVSHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYS---- 74 (333)
T ss_pred CcchhhhheeccccCCCCEEEEEEEEC-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC-CCcccceeEEEEE----
Confidence 466789999999999999999999985 56888999988654 4455677899999999995 9999999998763
Q ss_pred CceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCcccCCCCCCcEEeCCCCCeeeeccCC
Q 005577 100 TKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQ-SPPIAHRDLKAENLLLGSDGLWKLCDFGS 177 (690)
Q Consensus 100 ~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~-g~~IVHRDLKP~NILLd~dg~vKL~DFGl 177 (690)
.+.+||||||+. ++|.+++.... .+++..+..++.+|+.||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~ 150 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGV 150 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCc
Confidence 468999999995 57777776544 489999999999999999999975 6 99999999999999999999999998
Q ss_pred CCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc---
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG--- 254 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~--- 254 (690)
+...... ......|++.|+|||+ +.+..++.++|||||||++|+|++|+.||.......+...
T Consensus 151 ~~~~~~~-----------~~~~~~~~~~y~aPE~---~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~ 216 (333)
T cd06650 151 SGQLIDS-----------MANSFVGTRSYMSPER---LQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGC 216 (333)
T ss_pred chhhhhh-----------ccccCCCCccccCHHH---hcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcC
Confidence 8643211 1112468999999996 4566789999999999999999999999976443222100
Q ss_pred ---------------------------------------------cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHH
Q 005577 255 ---------------------------------------------NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289 (690)
Q Consensus 255 ---------------------------------------------~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~ei 289 (690)
.........++.++.+||.+||++||++||++.++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~el 296 (333)
T cd06650 217 PVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQL 296 (333)
T ss_pred cccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHH
Confidence 00000011357889999999999999999999999
Q ss_pred HHH
Q 005577 290 WFR 292 (690)
Q Consensus 290 l~~ 292 (690)
+.+
T Consensus 297 l~h 299 (333)
T cd06650 297 MVH 299 (333)
T ss_pred hhC
Confidence 653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=349.96 Aligned_cols=243 Identities=22% Similarity=0.317 Sum_probs=193.3
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
+...+|.+.+.||+|+||.||+|.+. ..++.||||... ...+.+|+.+|+.|. |||||++++++.. ..
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~-~~~~~vaiK~~~------~~~~~~E~~il~~l~-HpnIv~~~~~~~~----~~ 156 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDN-KTCEHVVIKAGQ------RGGTATEAHILRAIN-HPSIIQLKGTFTY----NK 156 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEEC-CCCCEEEEechh------hhhhHHHHHHHHhCC-CCCCCCEeEEEEE----CC
Confidence 45568999999999999999999996 678899999643 245678999999995 9999999998753 46
Q ss_pred eEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 102 EALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 102 ~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
..|+|||++.++|+..+.... .+++.+++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 157 ~~~lv~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 157 FTCLILPRYKTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred eeEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 789999999999998887654 4899999999999999999999999 999999999999999999999999998643
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch--------H--H-H
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES--------K--L-Q 250 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~--------~--~-~ 250 (690)
.... .......+||+.|+|||+ +.+..++.++||||||||||||++|..||-... . . .
T Consensus 233 ~~~~--------~~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~ 301 (391)
T PHA03212 233 VDIN--------ANKYYGWAGTIATNAPEL---LARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL 301 (391)
T ss_pred cccc--------ccccccccCccCCCChhh---hcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHH
Confidence 2110 011123578999999996 456679999999999999999999997763211 0 0 0
Q ss_pred HHh--------------------------ccCCCCC-------CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 251 ILN--------------------------GNYRIPE-------SPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 251 il~--------------------------~~~~~~~-------~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
++. .....+. ...++.++.+||.+||+.||.+||++.|++.
T Consensus 302 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 302 IIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 0000000 0134678999999999999999999999974
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=325.26 Aligned_cols=256 Identities=24% Similarity=0.369 Sum_probs=209.3
Q ss_pred eecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 21 DVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 21 ei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
++....|.+.+.||+|+||.||+|.+. ..++.|++|++.... .....+.+|+++|+.+. ||||+++++++. ..
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~ 74 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIK-HPNLVQLLGVCT----RE 74 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEe-cCCceEEEEEecCCc-hHHHHHHHHHHHHHhCC-CCChhheEEEEc----CC
Confidence 456678999999999999999999985 568899999876543 34567889999999995 999999999865 34
Q ss_pred ceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 101 KEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 101 ~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
..+++||||+. ++|.+++.......+++..++.++.||+.||.|||.++ |+||||||+|||++.++.+||+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 75 PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCcccc
Confidence 67899999995 67888776655556899999999999999999999999 9999999999999999999999999986
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---Hhcc
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LNGN 255 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i---l~~~ 255 (690)
....... .......+++.|+|||+ +.+..++.++|||||||++|+|++ |..||.+...... +...
T Consensus 153 ~~~~~~~--------~~~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 221 (263)
T cd05052 153 LMTGDTY--------TAHAGAKFPIKWTAPES---LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG 221 (263)
T ss_pred cccccee--------eccCCCCCccccCCHHH---hccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC
Confidence 5432110 01111234678999996 456778999999999999999998 9999987654433 3444
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhh
Q 005577 256 YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 256 ~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~ 296 (690)
+....+..++..+.++|.+||..||++||++.+++..++..
T Consensus 222 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 55555677899999999999999999999999998877653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=349.09 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=198.7
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecC-CCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLG-RTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~-~~~~ 102 (690)
+|++.+.||+|+||.||+|.+. ..++.||||++... +.....++.+|+.+|+.++ ||||+++++++..... ....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDP-RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEEC-CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccce
Confidence 4678899999999999999985 57889999988543 3445677889999999995 9999999998653321 1126
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
.|+||||+.++|...+.... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 79 ~~lv~e~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 79 IYVVTELMQSDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEEEeeccccCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 89999999999988876543 4999999999999999999999999 9999999999999999999999999986532
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc-------
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN------- 255 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~------- 255 (690)
.... .......+++.|+|||++ .....++.++||||||||+|||++|+.||.+....+.+...
T Consensus 155 ~~~~--------~~~~~~~~~~~y~aPE~~--~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~ 224 (372)
T cd07853 155 PDES--------KHMTQEVVTQYYRAPEIL--MGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP 224 (372)
T ss_pred cCcc--------ccCCCCCcCCCcCCHHHH--cCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 2110 111223578999999973 23345789999999999999999999999876543322110
Q ss_pred --------------------CCC-------CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 256 --------------------YRI-------PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 256 --------------------~~~-------~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
... .....+++++.+||.+||+.||.+||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 225 SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 011 1123467899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=340.48 Aligned_cols=238 Identities=25% Similarity=0.397 Sum_probs=191.3
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
++||+|+||.||+|++. ..++.||||++... .....+.+..|..++..+.+||||+++++++. ....+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~----~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELK-GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ----TKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE----cCCEEEEEE
Confidence 36999999999999985 56889999998643 23345566778888877657999999998864 346899999
Q ss_pred ecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccch
Q 005577 108 ECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 108 Ey~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~ 186 (690)
||+. |+|...+.... .+++..+..|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 76 e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~- 150 (316)
T cd05592 76 EYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE- 150 (316)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-
Confidence 9995 56766665543 4999999999999999999999999 9999999999999999999999999986432111
Q ss_pred hhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--CCCCCCCC
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RIPESPKY 264 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~~~~~~~~ 264 (690)
......+||+.|+|||+ +.+..++.++|||||||++|+|++|+.||.+....+++.... ....+..+
T Consensus 151 --------~~~~~~~gt~~y~aPE~---~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 219 (316)
T cd05592 151 --------GKASTFCGTPDYIAPEI---LKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWI 219 (316)
T ss_pred --------CccccccCCccccCHHH---HcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 11123468999999996 456678999999999999999999999998876655443222 22234568
Q ss_pred CHHHHHHHHHHhhhCCCCCCCHHHH
Q 005577 265 SSSVTDLIRDMLQASPDDRPDITQV 289 (690)
Q Consensus 265 s~~l~~LI~~~L~~dP~~RPt~~ei 289 (690)
+..+.+||.+||..||.+||++.+.
T Consensus 220 ~~~~~~ll~~~l~~~P~~R~~~~~~ 244 (316)
T cd05592 220 SKEAKDCLSKLFERDPTKRLGVDGD 244 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHH
Confidence 8999999999999999999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=358.62 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=210.5
Q ss_pred ceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEe
Q 005577 18 RSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTIL 95 (690)
Q Consensus 18 ~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~ 95 (690)
.++.....+|++.++||+|+||+||+|++. ..++.||||++... .......+.+|+.+|..+. |+||++++..+..
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~ 102 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRV-SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAK 102 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEc-CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCC-CCcEEEeecceec
Confidence 455566789999999999999999999985 57899999998654 4555677889999999995 9999999877653
Q ss_pred ecCC----CceEEEEEecCC-CcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCC
Q 005577 96 DLGR----TKEALLVMECCD-KSLVNVLENRG--AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG 168 (690)
Q Consensus 96 ~~~~----~~~~~LVmEy~~-gsLl~~L~~~~--~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg 168 (690)
.... ...+++||||+. |+|.+.+..+. ...+++..++.++.||+.||.|||+++ ||||||||+||||+.++
T Consensus 103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNG 180 (496)
T ss_pred ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCC
Confidence 3211 114689999995 67888776532 346999999999999999999999999 99999999999999999
Q ss_pred CeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH
Q 005577 169 LWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK 248 (690)
Q Consensus 169 ~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~ 248 (690)
.+||+|||+++.+..... .......+||+.|||||+ +.+..++.++|||||||+||||++|+.||.+...
T Consensus 181 ~vkL~DFGls~~~~~~~~-------~~~~~~~~Gt~~Y~aPE~---~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~ 250 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVS-------DDVGRTFCGTPYYVAPEI---WRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM 250 (496)
T ss_pred CEEEEecccCeecccccc-------ccccccccCCcceeCHHH---hCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 999999999875432111 111223578999999996 4567799999999999999999999999998776
Q ss_pred HHHHhccC---CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 249 LQILNGNY---RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 249 ~~il~~~~---~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
..++.... ..+.++.+++.+.+||.+||..||.+||++.+++.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 251 EEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 55443222 223456789999999999999999999999998653
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=355.33 Aligned_cols=244 Identities=23% Similarity=0.398 Sum_probs=208.2
Q ss_pred ceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec
Q 005577 18 RSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97 (690)
Q Consensus 18 ~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~ 97 (690)
..|+|--..+.-++-||.|+.|.||+|+. .++.||||++. +.-..+|+.|++|+ ||||+.+.|+|..
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl---~netVAVKKV~-------elkETdIKHLRkLk-H~NII~FkGVCtq-- 183 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRL---HNETVAVKKVR-------ELKETDIKHLRKLK-HPNIITFKGVCTQ-- 183 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeec---cCceehhHHHh-------hhhhhhHHHHHhcc-CcceeeEeeeecC--
Confidence 34555556666788899999999999986 57899999863 22345788999996 9999999999863
Q ss_pred CCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccC
Q 005577 98 GRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176 (690)
Q Consensus 98 ~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFG 176 (690)
...+|||||||. |-|+..|+.... +.....+.|..+|+.|+.|||.+. |||||||.-||||..+..|||+|||
T Consensus 184 --sPcyCIiMEfCa~GqL~~VLka~~~--itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 184 --SPCYCIIMEFCAQGQLYEVLKAGRP--ITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred --CceeEEeeeccccccHHHHHhccCc--cCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEecccc
Confidence 478999999994 788888877654 889999999999999999999999 9999999999999999999999999
Q ss_pred CCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh---
Q 005577 177 STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN--- 253 (690)
Q Consensus 177 lA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~--- 253 (690)
-++..... .....++||..|||||| ++....++|+|||||||||||||||..||.+-+...|+-
T Consensus 258 TS~e~~~~----------STkMSFaGTVaWMAPEv---IrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG 324 (904)
T KOG4721|consen 258 TSKELSDK----------STKMSFAGTVAWMAPEV---IRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG 324 (904)
T ss_pred chHhhhhh----------hhhhhhhhhHhhhCHHH---hhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEecc
Confidence 87654322 12234689999999997 788999999999999999999999999998877666553
Q ss_pred -ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 254 -GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 254 -~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
..+.++.+..+++.++-||+.||.-.|.+||++.+|+.++
T Consensus 325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 4567788889999999999999999999999999997664
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=342.59 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=198.4
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec--CC
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL--GR 99 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~--~~ 99 (690)
..+|++.+.||+|+||.||+|.+. ..++.||||++... +......+.+|+.+++.+. ||||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEec-CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhC-CCchhceeeeeeccccccc
Confidence 368999999999999999999985 57889999998643 3445677889999999995 999999999875432 23
Q ss_pred CceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 100 TKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 100 ~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
...+|+||||+++++.+.+.. .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred cceeEEEhhhhcccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCcccc
Confidence 346899999999998887753 2889999999999999999999999 9999999999999999999999999987
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc-----
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG----- 254 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~----- 254 (690)
...... ......||+.|+|||+ +.+..++.++|||||||++|+|++|+.||.+......+..
T Consensus 168 ~~~~~~----------~~~~~~~t~~y~aPE~---~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (355)
T cd07874 168 TAGTSF----------MMTPYVVTRYYRAPEV---ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234 (355)
T ss_pred cCCCcc----------ccCCccccCCccCHHH---HcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 543211 1122468999999996 4566789999999999999999999999987553221110
Q ss_pred ---------------------cCC-----C-------------CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 255 ---------------------NYR-----I-------------PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 255 ---------------------~~~-----~-------------~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
... . ......+..+.+||.+||..||.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 0 0011235678999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=323.96 Aligned_cols=255 Identities=21% Similarity=0.358 Sum_probs=207.5
Q ss_pred EeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 20 iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
|+|...+|++.++||+|+||.||+|.+. .+..|++|.+.... ...+.+.+|+.+++.+. |+||+++++++. .
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~--~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~ 72 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYN--NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQ-HDKLVRLYAVVT----K 72 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEec--CCceEEEEEccCCc-hhHHHHHHHHHHHHhCC-CCCeeeEEEEEc----C
Confidence 3567789999999999999999999873 56779999876543 23578889999999995 999999998753 4
Q ss_pred CceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 100 TKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
.+..|+||||+. ++|.+++.......+++..++.++.||+.||.|||..+ ++||||||+|||++.++.++|+|||++
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~ 150 (261)
T cd05072 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLA 150 (261)
T ss_pred CCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccc
Confidence 567899999995 68888887655556899999999999999999999999 999999999999999999999999998
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---Hhc
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LNG 254 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i---l~~ 254 (690)
........ .......++..|+|||+ +....++.++|||||||++|+|++ |..||........ +..
T Consensus 151 ~~~~~~~~--------~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~ 219 (261)
T cd05072 151 RVIEDNEY--------TAREGAKFPIKWTAPEA---INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219 (261)
T ss_pred eecCCCce--------eccCCCccceecCCHHH---hccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc
Confidence 76432110 00112245678999996 455678899999999999999998 9999977654433 333
Q ss_pred cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhh
Q 005577 255 NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 255 ~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~ 295 (690)
.+..+....++.++.++|.+||..+|++||++.++...++.
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 220 GYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 44555556789999999999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=340.80 Aligned_cols=239 Identities=22% Similarity=0.353 Sum_probs=193.4
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
++||+|+||.||+|++. ..++.||||++... .....+.+..|++++..+.+||||+++++++. ..+.+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~----~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ----TKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE----cCCeEEEEE
Confidence 36999999999999985 56789999998653 23455677889999988767999999998865 346799999
Q ss_pred ecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccch
Q 005577 108 ECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 108 Ey~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~ 186 (690)
||+. |+|...+.... .+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++......
T Consensus 76 E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~- 150 (321)
T cd05591 76 EYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG- 150 (321)
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCC-
Confidence 9996 46666665543 4899999999999999999999999 9999999999999999999999999886422110
Q ss_pred hhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCC--CCCCCCC
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYR--IPESPKY 264 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~--~~~~~~~ 264 (690)
.......||+.|+|||+ +.+..++.++|||||||++|+|++|+.||.+.....++..... ...+..+
T Consensus 151 --------~~~~~~~gt~~y~aPE~---~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 219 (321)
T cd05591 151 --------VTTTTFCGTPDYIAPEI---LQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWL 219 (321)
T ss_pred --------ccccccccCccccCHHH---HcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 11123468999999996 4566789999999999999999999999998776555433222 2223457
Q ss_pred CHHHHHHHHHHhhhCCCCCC-------CHHHHH
Q 005577 265 SSSVTDLIRDMLQASPDDRP-------DITQVW 290 (690)
Q Consensus 265 s~~l~~LI~~~L~~dP~~RP-------t~~eil 290 (690)
+.++.+||.+||.+||++|+ ++.+++
T Consensus 220 ~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~ 252 (321)
T cd05591 220 SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIK 252 (321)
T ss_pred CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHh
Confidence 89999999999999999999 666664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=347.59 Aligned_cols=265 Identities=21% Similarity=0.313 Sum_probs=210.2
Q ss_pred CceEeecCceEEEEEEeeecCceEEEEEEEcc----cCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEE
Q 005577 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAI----HMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYA 91 (690)
Q Consensus 17 g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~----~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~ 91 (690)
+..+++...+|++.++||+|+||.||+|.+.. .....||||++... .....+.+++|+.+|+.|..|||||++++
T Consensus 29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 35667888999999999999999999998631 22457999998643 34445788999999999956999999999
Q ss_pred EEEeecCCCceEEEEEecCC-CcHHHHHHHhC------------------------------------------------
Q 005577 92 HTILDLGRTKEALLVMECCD-KSLVNVLENRG------------------------------------------------ 122 (690)
Q Consensus 92 ~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~------------------------------------------------ 122 (690)
++. .....|||||||. |+|.++|....
T Consensus 109 ~~~----~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (400)
T cd05105 109 ACT----KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQAD 184 (400)
T ss_pred EEc----cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccc
Confidence 874 3467899999995 67777765421
Q ss_pred ----------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCC
Q 005577 123 ----------------------------------------------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRD 156 (690)
Q Consensus 123 ----------------------------------------------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRD 156 (690)
...+++.+++.++.||+.||.|||.++ |+|||
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~d 262 (400)
T cd05105 185 TTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRD 262 (400)
T ss_pred ccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCC
Confidence 124788889999999999999999999 99999
Q ss_pred CCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHH
Q 005577 157 LKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI 236 (690)
Q Consensus 157 LKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyEL 236 (690)
|||+|||++.++.+||+|||+++........ .......+++.|||||+ +.+..++.++|||||||++|+|
T Consensus 263 ikp~Nill~~~~~~kL~DfGla~~~~~~~~~-------~~~~~~~~~~~y~aPE~---~~~~~~~~~~DiwSlGvil~el 332 (400)
T cd05105 263 LAARNVLLAQGKIVKICDFGLARDIMHDSNY-------VSKGSTFLPVKWMAPES---IFDNLYTTLSDVWSYGILLWEI 332 (400)
T ss_pred CChHhEEEeCCCEEEEEeCCcceeccccccc-------cccCCcCCCcceEChhh---hcCCCCCchhhHHHHHHHHHHH
Confidence 9999999999999999999998754321110 11112356788999996 4566789999999999999999
Q ss_pred Hh-CCCCCCCchH----HHHHhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 237 CY-FKNAFDGESK----LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 237 lt-G~~PF~~~~~----~~il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
++ |..||..... ...+....+.+.+..++..+.++|.+||+.||++||++.+|...+...+
T Consensus 333 lt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 333 FSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 97 9999976432 2233344455556678999999999999999999999999988877654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=342.41 Aligned_cols=247 Identities=25% Similarity=0.357 Sum_probs=197.6
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec--CC
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL--GR 99 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~--~~ 99 (690)
..+|++.+.||+|+||.||+|.+. ..++.||||++... +......+.+|+.+++.+. ||||+++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEEC-CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcC-CCCccccceeecccccccc
Confidence 468999999999999999999985 56889999998643 3445677889999999995 999999998764321 23
Q ss_pred CceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 100 TKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 100 ~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
...+|+||||++++|...+.. .+++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 346899999999999887753 2788999999999999999999999 9999999999999999999999999987
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCC--
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYR-- 257 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~-- 257 (690)
...... ......||+.|+|||+ +.+..++.++|||||||+||+|++|+.||.+.+....+.....
T Consensus 175 ~~~~~~----------~~~~~~~t~~y~aPE~---~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 241 (364)
T cd07875 175 TAGTSF----------MMTPYVVTRYYRAPEV---ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241 (364)
T ss_pred ccCCCC----------cccCCcccCCcCCHHH---HhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 543211 1122468999999996 4567789999999999999999999999987654332211100
Q ss_pred ---------------------CC---------------------CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 ---------------------IP---------------------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 ---------------------~~---------------------~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.+ .....+..+.+||.+||+.||.+||++.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 242 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred CCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 00113467899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=341.01 Aligned_cols=247 Identities=27% Similarity=0.442 Sum_probs=201.1
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC-CceE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR-TKEA 103 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~-~~~~ 103 (690)
..|+..+++|.|+||.||+|... .+.+.||||++..+.. --.+|+.+|+.+ +|||||+|.-+|....+. .-++
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~-e~~~~vAIKKv~~d~r----~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLR-ETEEEVAIKKVLQDKR----YKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEc-CCCceeEEEEecCCCC----cCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHH
Confidence 47888999999999999999985 5689999999865432 224699999988 599999998777655444 1244
Q ss_pred EEEEecCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCC-CCeeeeccCCCCc
Q 005577 104 LLVMECCDKSLVNVLENR--GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD-GLWKLCDFGSTST 180 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~--~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~d-g~vKL~DFGlA~~ 180 (690)
.||||||+.+|.+.+... ....++.-.+.-+..||++||.|||..| |+||||||.|||+|.+ |.+||||||.|+.
T Consensus 98 nlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 98 NLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 589999999999998852 2345889999999999999999999999 9999999999999987 9999999999987
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCCC--
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRI-- 258 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~~-- 258 (690)
+... +.+.....|..|+|||. .+....|+.+.||||.|||+.||+-|++.|.|++..+++..+.++
T Consensus 176 L~~~----------epniSYicSRyYRaPEL--ifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG 243 (364)
T KOG0658|consen 176 LVKG----------EPNISYICSRYYRAPEL--IFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLG 243 (364)
T ss_pred eccC----------CCceeEEEeccccCHHH--HcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhC
Confidence 6432 22334566999999997 466788999999999999999999999999998765443211100
Q ss_pred -------------------C----------CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 259 -------------------P----------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 259 -------------------~----------~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
+ .....++++.+|+.++|..+|.+|.++.|++.
T Consensus 244 ~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 244 TPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0 12357899999999999999999999999864
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=341.50 Aligned_cols=263 Identities=20% Similarity=0.325 Sum_probs=207.4
Q ss_pred EeecCceEEEEEEeeecCceEEEEEEEc----ccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEE
Q 005577 20 IDVGNLKIHVRNVIAEGGFSCVYSARDA----IHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTI 94 (690)
Q Consensus 20 iei~~~ry~v~~~LG~GgFG~VylA~d~----~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~ 94 (690)
|.+...+|++.++||+|+||.||+|.+. ..+++.||+|++... .......+.+|+.++.++.+|+||++++++|.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 4567789999999999999999999752 124578999988643 23445678899999999966999999999875
Q ss_pred eecCCCceEEEEEecCC-CcHHHHHHHhC---------------------------------------------------
Q 005577 95 LDLGRTKEALLVMECCD-KSLVNVLENRG--------------------------------------------------- 122 (690)
Q Consensus 95 ~~~~~~~~~~LVmEy~~-gsLl~~L~~~~--------------------------------------------------- 122 (690)
. ....+++||||+. ++|.+.+....
T Consensus 82 ~---~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (337)
T cd05054 82 K---PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEE 158 (337)
T ss_pred c---CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhccc
Confidence 3 3457889999996 56766665321
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhhhhcccc
Q 005577 123 --------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIE 194 (690)
Q Consensus 123 --------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~ 194 (690)
...+++..++.++.||+.||.|||.++ |+||||||+||||+.++.++|+|||+++.+.......
T Consensus 159 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~------ 230 (337)
T cd05054 159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------ 230 (337)
T ss_pred chhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchh------
Confidence 125789999999999999999999999 9999999999999999999999999987643221111
Q ss_pred ccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH----HHHHhccCCCCCCCCCCHHHH
Q 005577 195 EDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESK----LQILNGNYRIPESPKYSSSVT 269 (690)
Q Consensus 195 ~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~----~~il~~~~~~~~~~~~s~~l~ 269 (690)
......++..|||||+ +.+..++.++|||||||+||+|++ |..||.+... ...+........+..+++.+.
T Consensus 231 -~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (337)
T cd05054 231 -RKGDARLPLKWMAPES---IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIY 306 (337)
T ss_pred -hccCCCCCccccCcHH---hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHH
Confidence 1112345778999996 456779999999999999999997 9999976332 123333333344456789999
Q ss_pred HHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 270 DLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 270 ~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
+++.+||+.+|++||++.+++..+...+
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999887655
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=343.09 Aligned_cols=239 Identities=23% Similarity=0.351 Sum_probs=192.4
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
+.||+|+||.||++.+. ..++.||+|++... .......+.+|++++..+. ||||+++++++. ....+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~----~~~~~~lv~ 74 (325)
T cd05594 1 KLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQ----THDRLCFVM 74 (325)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEE----cCCEEEEEE
Confidence 36999999999999985 57889999998643 2344567788999999995 999999988764 346899999
Q ss_pred ecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccc
Q 005577 108 ECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS-QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185 (690)
Q Consensus 108 Ey~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs-~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~ 185 (690)
||+.| +|...+.... .+++..++.++.||+.||.|||+ .| |+||||||+||||+.+|.+||+|||+++......
T Consensus 75 E~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~ 150 (325)
T cd05594 75 EYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 150 (325)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC
Confidence 99965 5666665443 48999999999999999999997 78 9999999999999999999999999886422110
Q ss_pred hhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc--CCCCCCCC
Q 005577 186 EKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN--YRIPESPK 263 (690)
Q Consensus 186 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~--~~~~~~~~ 263 (690)
.......||+.|||||+ +.+..++.++|||||||+||+|++|+.||.+.....+.... .....+..
T Consensus 151 ---------~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~ 218 (325)
T cd05594 151 ---------ATMKTFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT 218 (325)
T ss_pred ---------cccccccCCcccCCHHH---HccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 11123468999999996 45677899999999999999999999999876654433322 12233456
Q ss_pred CCHHHHHHHHHHhhhCCCCCC-----CHHHHHH
Q 005577 264 YSSSVTDLIRDMLQASPDDRP-----DITQVWF 291 (690)
Q Consensus 264 ~s~~l~~LI~~~L~~dP~~RP-----t~~eil~ 291 (690)
+++++.+||.+||+.||.+|+ ++.+++.
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 899999999999999999997 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=339.10 Aligned_cols=253 Identities=28% Similarity=0.443 Sum_probs=205.2
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH-H-HHHHHHHHHHHHHhhcCCCC-ceEEEEEEEeec--CC
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE-E-SLESAMKEISVMKSLKGHPN-VVTLYAHTILDL--GR 99 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~-e-~~e~~~~Ei~iL~~L~~HPN-IVkL~~~~~~~~--~~ 99 (690)
..|...++||+|.||+||+|++. .+++.||+|++....+ + .-...++|+.+|+.|+ |+| ||.|++++..+. +.
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~-~~g~~VALKkirl~~~~EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSK-RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEe-cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecccccc
Confidence 45666778999999999999996 6789999999976533 2 3356789999999996 999 999999876432 12
Q ss_pred CceEEEEEecCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCC
Q 005577 100 TKEALLVMECCDKSLVNVLENRGA--GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS 177 (690)
Q Consensus 100 ~~~~~LVmEy~~gsLl~~L~~~~~--~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGl 177 (690)
...+++|+||++-+|..++..... ..++...+..+++||+.||+|||+++ |+||||||+||||+.+|.+||+|||+
T Consensus 89 ~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 89 IGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred cceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccch
Confidence 237899999999999999987663 35888999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCC
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYR 257 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~ 257 (690)
|+...-.... ....++|.+|.|||+ .+....|+..+||||+|||++||++++..|.+.+..+.+..+++
T Consensus 167 Ara~~ip~~~---------yt~evvTlWYRaPEv--LlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~ 235 (323)
T KOG0594|consen 167 ARAFSIPMRT---------YTPEVVTLWYRAPEV--LLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFR 235 (323)
T ss_pred HHHhcCCccc---------ccccEEEeeccCHHH--hcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 9864322221 233567999999998 45556799999999999999999999999999887765433221
Q ss_pred C----------------------CC----------CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 258 I----------------------PE----------SPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 258 ~----------------------~~----------~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
. +. .+...+...+++..||+.+|.+|.++..++.+
T Consensus 236 ~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 236 LLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1 00 01233588899999999999999999988654
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=356.18 Aligned_cols=246 Identities=26% Similarity=0.368 Sum_probs=205.4
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCC-----CCceEEEEEEEeecC
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGH-----PNVVTLYAHTILDLG 98 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~H-----PNIVkL~~~~~~~~~ 98 (690)
..||.|.++||+|.||.|.+|.|. .+++.||||++. +......+...|+.+|..|+.| -|||++|++|.+
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~-~T~e~VAIKIiK-N~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--- 259 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDH-KTGEIVAIKIIK-NKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--- 259 (586)
T ss_pred EEEEEEEEEecccccceeEEEEec-CCCcEEEEEeec-cChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc---
Confidence 349999999999999999999995 789999999874 5566677888899999999734 489999999875
Q ss_pred CCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCC--CeeeeccC
Q 005577 99 RTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG--LWKLCDFG 176 (690)
Q Consensus 99 ~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg--~vKL~DFG 176 (690)
.+++|||+|.++-+|+++|..+.-.+|+...++.|+.||+.||.+||..+ |||+||||+||||..-+ .|||+|||
T Consensus 260 -r~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 260 -RNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred -ccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecc
Confidence 48999999999999999999988778999999999999999999999999 99999999999997654 69999999
Q ss_pred CCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC
Q 005577 177 STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY 256 (690)
Q Consensus 177 lA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~ 256 (690)
+++....... +.+-+..|+|||| +.+..|+.+.||||||||++||++|.+.|.|++..+++..+.
T Consensus 337 SSc~~~q~vy------------tYiQSRfYRAPEV---ILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~ 401 (586)
T KOG0667|consen 337 SSCFESQRVY------------TYIQSRFYRAPEV---ILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARII 401 (586)
T ss_pred cccccCCcce------------eeeeccccccchh---hccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHH
Confidence 9987543321 2345889999998 567889999999999999999999999999988765432100
Q ss_pred ----------------------------C----------------------------CC-CC-------C-CCCHHHHHH
Q 005577 257 ----------------------------R----------------------------IP-ES-------P-KYSSSVTDL 271 (690)
Q Consensus 257 ----------------------------~----------------------------~~-~~-------~-~~s~~l~~L 271 (690)
+ .| .. . .....+.+|
T Consensus 402 e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~df 481 (586)
T KOG0667|consen 402 EVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDF 481 (586)
T ss_pred HHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHH
Confidence 0 00 00 0 112567899
Q ss_pred HHHHhhhCCCCCCCHHHHHHH
Q 005577 272 IRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 272 I~~~L~~dP~~RPt~~eil~~ 292 (690)
|.+||..||.+|+|..+.+.+
T Consensus 482 lk~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 482 LKRCLEWDPAERITPAQALNH 502 (586)
T ss_pred HHHHhccCchhcCCHHHHhcC
Confidence 999999999999999998654
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=344.09 Aligned_cols=247 Identities=21% Similarity=0.276 Sum_probs=194.2
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
-.+|++.+.||+|+||.||+|.+. ..++.||||++... .......+.+|+.+|+.+. |+|||++++++. ..+.
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~----~~~~ 146 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHR-PTGRLYALKVIYGNHEDTVRRQICREIEILRDVN-HPNVVKCHDMFD----HNGE 146 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEEC-CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCC-CCCcceeeeEec----cCCe
Confidence 457888999999999999999985 56889999998654 3445577889999999995 999999998864 4578
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
+|+|||||.++.+.. ...+.+..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.+.
T Consensus 147 ~~lv~e~~~~~~L~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 147 IQVLLEFMDGGSLEG-----THIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILA 219 (353)
T ss_pred EEEEEecCCCCcccc-----cccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence 899999997654321 123677888999999999999999999 9999999999999999999999999987543
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhh--hcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH---HHHH---hc
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLF--RRELINEKVDIWALGCLLFRICYFKNAFDGESK---LQIL---NG 254 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~--~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~---~~il---~~ 254 (690)
.... ......||+.|+|||++... .+...+.++|||||||++|||++|+.||..... ..++ ..
T Consensus 220 ~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 290 (353)
T PLN00034 220 QTMD---------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM 290 (353)
T ss_pred cccc---------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc
Confidence 2111 11234689999999975311 223456789999999999999999999974221 1111 11
Q ss_pred cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 255 NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 255 ~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
.........++..+.+||.+||..||++||++.+++.+
T Consensus 291 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22223345789999999999999999999999999753
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=323.14 Aligned_cols=246 Identities=26% Similarity=0.391 Sum_probs=208.8
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH---HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE---ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~---e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|++.+.||+|-||.||+|+.. ++.-.||+|++.+..- ..-.++.+|++|-..|+ ||||+++|++|. +..
T Consensus 22 ~dfeigr~LgkgkFG~vYlarek-ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fh----d~~ 95 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREK-KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFH----DSK 95 (281)
T ss_pred hhccccccccCCccccEeEeeec-cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhhee----ccc
Confidence 58899999999999999999986 6788999999965421 22356778999999996 999999999976 457
Q ss_pred eEEEEEecC-CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~-~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
..||++||. .|.++..|.......|++..+..++.|++.||.|+|.++ ||||||||+|+|++.+|.+||+|||-+..
T Consensus 96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceee
Confidence 899999999 589999998766667999999999999999999999999 99999999999999999999999997754
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--CC
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RI 258 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~~ 258 (690)
.. .....+.|||..|.+||+ ..+..++..+|+|++|+++||++.|.+||......+...... +.
T Consensus 174 ~p-----------~~kR~tlcgt~dyl~pEm---v~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~ 239 (281)
T KOG0580|consen 174 AP-----------SNKRKTLCGTLDYLPPEM---VEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL 239 (281)
T ss_pred cC-----------CCCceeeecccccCCHhh---cCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc
Confidence 22 122345689999999996 567789999999999999999999999998776544433322 33
Q ss_pred CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
..+..++..+.+||.+||.++|.+|.+..+++.+
T Consensus 240 ~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 3447899999999999999999999999998653
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=346.06 Aligned_cols=254 Identities=24% Similarity=0.285 Sum_probs=201.7
Q ss_pred EeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEee
Q 005577 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 20 iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~ 96 (690)
..+...+|++.++||+|+||.||+|++. ..++.||+|++... .......+.+|+.+|+.+ +||||+++++++.
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~-- 113 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHK-SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQ-- 113 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEe--
Confidence 3455678999999999999999999985 57889999998642 223345577899999999 5999999998754
Q ss_pred cCCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeecc
Q 005577 97 LGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDF 175 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DF 175 (690)
....+|||||||. |+|.+++.. . .+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 114 --~~~~~~lv~Ey~~gg~L~~~l~~-~--~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~Df 186 (370)
T cd05596 114 --DDKYLYMVMEYMPGGDLVNLMSN-Y--DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADF 186 (370)
T ss_pred --cCCEEEEEEcCCCCCcHHHHHHh-c--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEec
Confidence 4578999999996 566666643 2 3899999999999999999999999 999999999999999999999999
Q ss_pred CCCCcccccchhhhhccccccccccCCCCcccCccchhhhh-cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFR-RELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG 254 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~-~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~ 254 (690)
|++........ ......+||+.|||||++.... ...++.++|||||||+||||++|+.||.+.........
T Consensus 187 G~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~ 258 (370)
T cd05596 187 GTCMKMDANGM--------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 258 (370)
T ss_pred cceeeccCCCc--------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH
Confidence 99865422110 0112346899999999743211 23588999999999999999999999988765433222
Q ss_pred ------cCCCCCCCCCCHHHHHHHHHHhhhCCCC--CCCHHHHHHH
Q 005577 255 ------NYRIPESPKYSSSVTDLIRDMLQASPDD--RPDITQVWFR 292 (690)
Q Consensus 255 ------~~~~~~~~~~s~~l~~LI~~~L~~dP~~--RPt~~eil~~ 292 (690)
.+..+....++..+.+||.+||..+|.+ |+++.+++.+
T Consensus 259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 259 IMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1333444568999999999999999988 9999998643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=339.05 Aligned_cols=240 Identities=26% Similarity=0.415 Sum_probs=192.2
Q ss_pred EEeeecCceEEEEEEEcc--cCCeEEEEEEeecC----CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 31 NVIAEGGFSCVYSARDAI--HMSKQYAMKHMICN----DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~--~~~k~vAvK~i~~~----~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
++||+|+||.||++++.. ..++.||||++... +......+.+|+.+|+.+. ||||+++++++. ..+.+|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~----~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQ----TGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEe----cCCeEE
Confidence 679999999999998642 46789999998643 2233456778999999995 999999998865 346799
Q ss_pred EEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 105 LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 105 LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
+||||+.| +|.+.+...+ .+.+..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 77 LILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred EEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 99999965 6777766543 4899999999999999999999999 99999999999999999999999998864211
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--CCCCC
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RIPES 261 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~~~~~ 261 (690)
. ........||+.|+|||+ +.+..++.++|||||||++|||++|+.||.+......+.... ....+
T Consensus 153 ~---------~~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~ 220 (323)
T cd05584 153 E---------GTVTHTFCGTIEYMAPEI---LMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP 220 (323)
T ss_pred C---------CCcccccCCCccccChhh---ccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 1 011123468999999996 445668899999999999999999999998876554433221 22334
Q ss_pred CCCCHHHHHHHHHHhhhCCCCCC-----CHHHHHH
Q 005577 262 PKYSSSVTDLIRDMLQASPDDRP-----DITQVWF 291 (690)
Q Consensus 262 ~~~s~~l~~LI~~~L~~dP~~RP-----t~~eil~ 291 (690)
+.+++.+.+||.+||++||++|| ++.+++.
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 57899999999999999999999 6777643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=333.51 Aligned_cols=256 Identities=17% Similarity=0.284 Sum_probs=206.1
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcccCCe----EEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEee
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSK----QYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~~~k----~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~ 96 (690)
+...+|++.+.||+|+||.||+|.+. ..++ .||||++... .....+.+.+|+.+++.+. ||||+++++++..
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~- 80 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWI-PEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLT- 80 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEe-cCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcC-
Confidence 45678999999999999999999864 2233 4899988644 3455678889999999995 9999999998752
Q ss_pred cCCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeecc
Q 005577 97 LGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDF 175 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DF 175 (690)
...++|+||+. |+|.+.+.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 81 ----~~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~Df 153 (316)
T cd05108 81 ----STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDF 153 (316)
T ss_pred ----CCceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEccc
Confidence 34679999985 67888877643 34889999999999999999999999 999999999999999999999999
Q ss_pred CCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH---H
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQ---I 251 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~---i 251 (690)
|+++......... ......++..|+|||+ +.+..++.++|||||||++|||++ |..||.+....+ +
T Consensus 154 G~a~~~~~~~~~~-------~~~~~~~~~~y~apE~---~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~ 223 (316)
T cd05108 154 GLAKLLGADEKEY-------HAEGGKVPIKWMALES---ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 223 (316)
T ss_pred cccccccCCCcce-------eccCCccceeecChHH---hccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 9997643221111 0111234678999996 456778999999999999999987 999998765433 3
Q ss_pred HhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 252 LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 252 l~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
+......+.++.++..+.++|.+||..+|.+||++.+++..+....
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 224 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred HhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 4455555666788999999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=341.48 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=199.8
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|.+.+.||+|+||.||+|++. ..++.||||++... ..+....+.+|+.+++.+ +||||+++++++. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~----~~~ 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREK-ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQ----DKD 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEe----cCC
Confidence 36899999999999999999986 57889999998653 233456678899999998 5999999988754 346
Q ss_pred eEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
.+||||||+. |+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||++..
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~ 151 (330)
T cd05601 75 NLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAAR 151 (330)
T ss_pred eEEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeE
Confidence 7999999995 5677776654 245999999999999999999999999 99999999999999999999999999865
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhh---cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc---
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFR---RELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG--- 254 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~---~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~--- 254 (690)
+...... ......||+.|+|||++.... ...++.++||||||||+|+|++|+.||........+..
T Consensus 152 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~ 223 (330)
T cd05601 152 LTANKMV--------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN 223 (330)
T ss_pred CCCCCce--------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHc
Confidence 4321110 112246899999999743211 45678999999999999999999999987665443322
Q ss_pred ---cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 255 ---NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 255 ---~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
....+..+.++..+.+||..||. +|.+||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 224 FQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 12334455789999999999998 9999999999853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=337.93 Aligned_cols=237 Identities=22% Similarity=0.360 Sum_probs=190.9
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
++||+|+||.||+|++. .+++.||+|++... .......+..|..++..+.+||||+++++++. ..+.+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~----~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ----TKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE----eCCEEEEEE
Confidence 46999999999999986 57889999998653 12345667788888887667999999998865 347899999
Q ss_pred ecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccch
Q 005577 108 ECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 108 Ey~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~ 186 (690)
||+. |+|...+.... .+++.++..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 76 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 149 (316)
T cd05620 76 EFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-- 149 (316)
T ss_pred CCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccC--
Confidence 9996 56777766543 4899999999999999999999999 999999999999999999999999988642110
Q ss_pred hhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--CCCCCCCC
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RIPESPKY 264 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~~~~~~~~ 264 (690)
.......+||+.|+|||+ +.+..++.++|||||||++|+|++|+.||.+.....+..... ....+..+
T Consensus 150 -------~~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 219 (316)
T cd05620 150 -------DNRASTFCGTPDYIAPEI---LQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWI 219 (316)
T ss_pred -------CCceeccCCCcCccCHHH---HcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCC
Confidence 011223568999999996 456678999999999999999999999998776655443221 12223457
Q ss_pred CHHHHHHHHHHhhhCCCCCCCHHH
Q 005577 265 SSSVTDLIRDMLQASPDDRPDITQ 288 (690)
Q Consensus 265 s~~l~~LI~~~L~~dP~~RPt~~e 288 (690)
+.++.+||.+||+.||.+||++.+
T Consensus 220 ~~~~~~li~~~l~~dP~~R~~~~~ 243 (316)
T cd05620 220 TKESKDILEKLFERDPTRRLGVVG 243 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChH
Confidence 899999999999999999999853
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=352.52 Aligned_cols=245 Identities=29% Similarity=0.411 Sum_probs=208.9
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeec---CCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC---NDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~---~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.|.=++.||.|+||.||-|+|. .+...||||++.. ...+.+.++++|+++|++|+ |||+|.+-+++..+ ..
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~-~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre----~T 100 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLRE----HT 100 (948)
T ss_pred HHHHHHHhcCCccceeEEeecc-CccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeecc----ch
Confidence 4555678999999999999996 7889999999964 35677899999999999996 99999999887643 56
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
.+||||||-|+-.+++.-.. ++|.+.++..|+.+.+.||.|||+.+ .||||||..||||++.|.|||+|||.|....
T Consensus 101 aWLVMEYClGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 101 AWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHHHHHHHhccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcC
Confidence 78999999998888776654 35999999999999999999999999 9999999999999999999999999885432
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH----hccCCC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL----NGNYRI 258 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il----~~~~~~ 258 (690)
....++|||.||||||+..+..+.|+-++|||||||++.||.-.++|+-+.+....+ .+....
T Consensus 178 -------------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPt 244 (948)
T KOG0577|consen 178 -------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT 244 (948)
T ss_pred -------------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCC
Confidence 334579999999999987777889999999999999999999999998776654332 222222
Q ss_pred CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
-..+..+..++.||..||++-|.+|||..+++.+
T Consensus 245 Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 245 LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 2345788999999999999999999999998754
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.98 Aligned_cols=254 Identities=23% Similarity=0.400 Sum_probs=206.7
Q ss_pred eecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 21 DVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 21 ei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
++...+|++.+.||+|+||.||+|.+. .++.||+|.+.... ...+.+.+|+.+++++. ||||+++++++. ..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~ 73 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWN--NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLR-HPKLIQLYAVCT----LE 73 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEec--CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCC-CCCccceeEEEe----cC
Confidence 567788999999999999999999873 56789999886543 23466889999999995 999999998864 34
Q ss_pred ceEEEEEecC-CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 101 KEALLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 101 ~~~~LVmEy~-~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
+..|+||||+ +++|.+++.......+++..+..++.||+.||.|||.++ |+||||||+|||++.++.+||+|||++.
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 151 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLAR 151 (261)
T ss_pred CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEE
Confidence 6789999999 678888887655445899999999999999999999999 9999999999999999999999999886
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---Hhcc
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LNGN 255 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i---l~~~ 255 (690)
....... .......++..|+|||+ ..+..++.++|||||||++|+|++ |+.||.+.....+ +...
T Consensus 152 ~~~~~~~--------~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05068 152 VIKEDIY--------EAREGAKFPIKWTAPEA---ALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG 220 (261)
T ss_pred EccCCcc--------cccCCCcCceeccCccc---cccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 5432110 00011123468999996 456678999999999999999999 9999987665433 2334
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhh
Q 005577 256 YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 256 ~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~ 295 (690)
+..+....++..+.++|.+||..+|.+||++.++...+++
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 221 YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 4445556789999999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=351.75 Aligned_cols=265 Identities=24% Similarity=0.439 Sum_probs=220.9
Q ss_pred CCCCCceEeecCceEEEEEEeeecCceEEEEEEEcccCC--eE-EEEEEeec---CCHHHHHHHHHHHHHHHhhcCCCCc
Q 005577 13 TGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMS--KQ-YAMKHMIC---NDEESLESAMKEISVMKSLKGHPNV 86 (690)
Q Consensus 13 ~~~~g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~--k~-vAvK~i~~---~~~e~~e~~~~Ei~iL~~L~~HPNI 86 (690)
.+..-+.|++.-.++.+.++||+|+||+||+|......+ .. ||||.... ...+.+..+++|+++|+.| +||||
T Consensus 145 ~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NV 223 (474)
T KOG0194|consen 145 RPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNV 223 (474)
T ss_pred ccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCE
Confidence 445567788888899999999999999999998864433 23 89998874 3477889999999999999 59999
Q ss_pred eEEEEEEEeecCCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeC
Q 005577 87 VTLYAHTILDLGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLG 165 (690)
Q Consensus 87 VkL~~~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd 165 (690)
|++||++.. ...+|||||+|. |+|.++|..... .++..+.+.++.+.+.||+|||.++ +|||||-.+|||++
T Consensus 224 Vr~yGVa~~----~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~ 296 (474)
T KOG0194|consen 224 VRFYGVAVL----EEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYS 296 (474)
T ss_pred EEEEEEEcC----CCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheec
Confidence 999999764 477999999995 588888887653 5999999999999999999999999 99999999999999
Q ss_pred CCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 005577 166 SDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFD 244 (690)
Q Consensus 166 ~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~ 244 (690)
.++.+||+|||+++.-.... .......-...|+|||. +..+.|++++|||||||++||+++ |..||.
T Consensus 297 ~~~~vKISDFGLs~~~~~~~---------~~~~~~klPirWLAPEt---l~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~ 364 (474)
T KOG0194|consen 297 KKGVVKISDFGLSRAGSQYV---------MKKFLKKLPIRWLAPET---LNTGIFSFKTDVWSFGVLLWEIFENGAEPYP 364 (474)
T ss_pred CCCeEEeCccccccCCccee---------eccccccCcceecChhh---hccCccccccchhheeeeEEeeeccCCCCCC
Confidence 99999999999986532100 00000123678999996 455689999999999999999998 888999
Q ss_pred CchHHHH----HhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 245 GESKLQI----LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 245 ~~~~~~i----l~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
+....++ +...++.+.+...+..+..++.+||..+|++||++.++...+....
T Consensus 365 g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 365 GMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred CCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 9876554 4667788888889999999999999999999999999988776554
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=366.96 Aligned_cols=263 Identities=22% Similarity=0.339 Sum_probs=218.4
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcccCCe----EEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEee
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSK----QYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~~~k----~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~ 96 (690)
+.....++.+.||+|.||+||.|......+. .||||.+... +.+....|++|+.+|+.+ +|||||+++|+++.
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~- 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLD- 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecC-
Confidence 5688999999999999999999987533343 4899988654 567789999999999999 59999999999873
Q ss_pred cCCCceEEEEEecC-CCcHHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCe
Q 005577 97 LGRTKEALLVMECC-DKSLVNVLENRG-----AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLW 170 (690)
Q Consensus 97 ~~~~~~~~LVmEy~-~gsLl~~L~~~~-----~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~v 170 (690)
....+|++||| +|+|+.+|++.. ...|...+++.|+.+|+.|+.||++++ +|||||...||||+....|
T Consensus 767 ---~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~V 841 (1025)
T KOG1095|consen 767 ---SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVV 841 (1025)
T ss_pred ---CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcE
Confidence 46789999999 578999998752 235899999999999999999999999 9999999999999999999
Q ss_pred eeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 005577 171 KLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKL 249 (690)
Q Consensus 171 KL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~ 249 (690)
||+|||||+.+.... +........-...|||||. +..+.++.++|||||||+|||+++ |..||.+.+..
T Consensus 842 KIaDFGlArDiy~~~-------yyr~~~~a~lPvkWm~PEs---l~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~ 911 (1025)
T KOG1095|consen 842 KIADFGLARDIYDKD-------YYRKHGEAMLPVKWMPPES---LKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF 911 (1025)
T ss_pred EEcccchhHhhhhch-------heeccCccccceecCCHHH---HhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH
Confidence 999999998433211 1111111233678999995 667889999999999999999998 89999987766
Q ss_pred HHHh---ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhcCccc
Q 005577 250 QILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGL 301 (690)
Q Consensus 250 ~il~---~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l~~~l 301 (690)
+++. ..-+++.+..|++.+.+||..||+.+|++||++..|+.++...+...+
T Consensus 912 ~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 912 EVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred HHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 6543 233888999999999999999999999999999999987766554443
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=335.99 Aligned_cols=239 Identities=24% Similarity=0.382 Sum_probs=193.7
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
++||+|+||.||+|++. ..++.||||++... .......+.+|+.++..+.+||||+++++++. ..+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~----~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ----TKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE----cCCEEEEEE
Confidence 36999999999999985 56789999998653 23446677889999998867999999999864 346899999
Q ss_pred ecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccch
Q 005577 108 ECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 108 Ey~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~ 186 (690)
||+. |+|...+.... .+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-- 149 (318)
T cd05570 76 EYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-- 149 (318)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcC--
Confidence 9996 56666665543 4999999999999999999999999 999999999999999999999999988542111
Q ss_pred hhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--CCCCCCCC
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RIPESPKY 264 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~~~~~~~~ 264 (690)
.......+||+.|+|||+ +.+..++.++|||||||++|+|++|+.||.+.....+..... ....+..+
T Consensus 150 -------~~~~~~~~g~~~y~aPE~---~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 219 (318)
T cd05570 150 -------GVTTSTFCGTPDYIAPEI---LSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWL 219 (318)
T ss_pred -------CCcccceecCccccCHHH---hcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcC
Confidence 011123468999999996 456778999999999999999999999998776655433221 22234568
Q ss_pred CHHHHHHHHHHhhhCCCCCCCH-----HHHH
Q 005577 265 SSSVTDLIRDMLQASPDDRPDI-----TQVW 290 (690)
Q Consensus 265 s~~l~~LI~~~L~~dP~~RPt~-----~eil 290 (690)
+..+.+||.+||..||.+||++ .+++
T Consensus 220 ~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll 250 (318)
T cd05570 220 SKEAKSILKSFLTKNPEKRLGCLPTGEQDIK 250 (318)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHh
Confidence 9999999999999999999998 6664
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=336.89 Aligned_cols=232 Identities=26% Similarity=0.391 Sum_probs=187.5
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
++||+|+||.||+|++. ..++.||||++... +......+.+|+.++..+.+|||||++++++. ..+.+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~----~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELK-KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ----TESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE----cCCEEEEEE
Confidence 36999999999999985 57889999998653 34455678889999999977999999998865 347899999
Q ss_pred ecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccch
Q 005577 108 ECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 108 Ey~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~ 186 (690)
|||.| +|...+...+ .+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.....
T Consensus 76 e~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 149 (329)
T cd05588 76 EFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-- 149 (329)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccC--
Confidence 99964 6666665543 4999999999999999999999999 999999999999999999999999988642111
Q ss_pred hhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch--------H----H-HHHh
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES--------K----L-QILN 253 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~--------~----~-~il~ 253 (690)
.......+||+.|+|||+ +.+..++.++|||||||++|+|++|+.||+... . . .+..
T Consensus 150 -------~~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 219 (329)
T cd05588 150 -------GDTTSTFCGTPNYIAPEI---LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE 219 (329)
T ss_pred -------CCccccccCCccccCHHH---HcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc
Confidence 011223578999999996 456778999999999999999999999996311 1 1 1222
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCC
Q 005577 254 GNYRIPESPKYSSSVTDLIRDMLQASPDDRPD 285 (690)
Q Consensus 254 ~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt 285 (690)
.... .+..++..+.+||.+||..||.+|++
T Consensus 220 ~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~ 249 (329)
T cd05588 220 KQIR--IPRSLSVKASSVLKGFLNKDPKERLG 249 (329)
T ss_pred CCCC--CCCCCCHHHHHHHHHHhccCHHHcCC
Confidence 2222 34568999999999999999999997
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=357.05 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=200.3
Q ss_pred EeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec
Q 005577 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97 (690)
Q Consensus 20 iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~ 97 (690)
.++.-.+|++.+.||+|+||+||+|.+. ..++.||+|++... .......++.|+.+|..|. |||||+++++|...
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk-~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de- 84 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHK-RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNK- 84 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEEC-CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEec-
Confidence 3444569999999999999999999996 57889999988643 3445678899999999995 99999999987633
Q ss_pred CCCceEEEEEecCC-CcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCcccCCCCCCcEEeCC---
Q 005577 98 GRTKEALLVMECCD-KSLVNVLENRG--AGYFEEKQVLAIFRDVCNAVFAMHSQS-----PPIAHRDLKAENLLLGS--- 166 (690)
Q Consensus 98 ~~~~~~~LVmEy~~-gsLl~~L~~~~--~~~lse~~~~~i~~qIa~aL~yLHs~g-----~~IVHRDLKP~NILLd~--- 166 (690)
....+|||||||. |+|.++|.... .+.|++..++.|+.||+.||.|||..+ .+||||||||+||||+.
T Consensus 85 -~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 85 -ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred -CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 3457899999996 57877776532 245999999999999999999999843 23999999999999964
Q ss_pred --------------CCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHH
Q 005577 167 --------------DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCL 232 (690)
Q Consensus 167 --------------dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGvi 232 (690)
.+.+||+|||++..+... ......+||+.|+|||++. .....++.++||||||||
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~----------s~~~s~vGTp~YmAPEvL~-ge~~~~s~KSDVWSLG~I 232 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIE----------SMAHSCVGTPYYWSPELLL-HETKSYDDKSDMWALGCI 232 (1021)
T ss_pred ccccccccccccCCCCceEEccCCcccccccc----------ccccccCCCccccCHHHHh-ccCCCCCchhHHHHHHHH
Confidence 235899999998654221 1112346899999999742 123458899999999999
Q ss_pred HHHHHhCCCCCCCchHHH-HH---hccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 233 LFRICYFKNAFDGESKLQ-IL---NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 233 LyELltG~~PF~~~~~~~-il---~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
||+|++|..||....... ++ .....+ ....++..+.+||..||..+|.+||++.+++.
T Consensus 233 LYELLTGk~PF~~~~~~~qli~~lk~~p~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 233 IYELCSGKTPFHKANNFSQLISELKRGPDL-PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHHCCCCCCcCCcHHHHHHHHhcCCCC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 999999999997654322 22 222221 22457899999999999999999999999874
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=324.56 Aligned_cols=254 Identities=20% Similarity=0.298 Sum_probs=203.1
Q ss_pred ceEEEEEEeeecCceEEEEEEEccc----CCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIH----MSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~----~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
.+|++.+.||+|+||.||+|.+... ..+.|++|.+... .......+.+|+.+|..+. ||||+++++++. .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~----~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCT----K 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcC-CcccceEEEEEc----C
Confidence 4788999999999999999987421 2367999988654 3445667889999999995 999999998864 3
Q ss_pred CceEEEEEecCC-CcHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEe
Q 005577 100 TKEALLVMECCD-KSLVNVLENRGA--------------GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLL 164 (690)
Q Consensus 100 ~~~~~LVmEy~~-gsLl~~L~~~~~--------------~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILL 164 (690)
....|+||||+. ++|.+++..... ..+++..++.++.||+.||.|||.++ |+||||||+|||+
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~ 157 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV 157 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEE
Confidence 467899999995 678887765421 45888999999999999999999999 9999999999999
Q ss_pred CCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 005577 165 GSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAF 243 (690)
Q Consensus 165 d~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF 243 (690)
+.++.++|+|||+++....... ........+++.|+|||+ +.+..++.++|||||||++|||++ |..||
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~---~~~~~~~~~sDv~slG~il~el~~~g~~p~ 227 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADY-------YRVQSKSLLPVRWMPPEA---ILYGKFTTESDIWSFGVVLWEIFSYGLQPY 227 (283)
T ss_pred cCCCcEEECCCcceeecccccc-------ccccCCCcccccccCHHH---hccCcCchhhhHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999865322110 011122356889999996 445678999999999999999998 99999
Q ss_pred CCchHHHHHh---ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhh
Q 005577 244 DGESKLQILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 244 ~~~~~~~il~---~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~ 295 (690)
.+....++.. .....+.+..++..+.+|+.+||+.||.+||++.+|+.++..
T Consensus 228 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 228 YGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 8765544432 233334456789999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=323.54 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=199.8
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.+.+|++.+.||+|+||.||+|.+. ..++.||+|++..........+.+|+.+++.+. ||||+++++++.. ...
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~----~~~ 80 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNL-HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK-HCNIVAYFGSYLS----REK 80 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEEC-CCCeEEEEEEEecCccchHHHHHHHHHHHHhcC-CCCeeeeeEEEEe----CCE
Confidence 4568999999999999999999985 578899999987655555567888999999995 9999999998753 467
Q ss_pred EEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
+|+||||+++ +|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKI 156 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceee
Confidence 8999999975 6666665443 4899999999999999999999999 999999999999999999999999998654
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH----hccCC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL----NGNYR 257 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il----~~~~~ 257 (690)
..... ......|++.|+|||++.......++.++|||||||++|+|++|..||......... ...+.
T Consensus 157 ~~~~~---------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd06646 157 TATIA---------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ 227 (267)
T ss_pred ccccc---------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCC
Confidence 22110 111235789999999743223455788999999999999999999999654433221 11111
Q ss_pred C---CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 258 I---PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 258 ~---~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
. .....++..+.+||.+||..+|++||++.+++..
T Consensus 228 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 228 PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 1 1223568899999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=335.80 Aligned_cols=241 Identities=24% Similarity=0.373 Sum_probs=194.7
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
+|++.+.||+|+||.||+|++. .+++.||||++... .....+.+..|+.++..+..|++|+++++++. ..+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~----~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ----TVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe----cCCE
Confidence 4778899999999999999985 57889999998643 23445677889999998866788888987754 3467
Q ss_pred EEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
+||||||+. |+|...+...+ .+++.+++.|+.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~ 151 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEH 151 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEecccccccc
Confidence 999999996 56777765543 4999999999999999999999999 999999999999999999999999998643
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--CCC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RIP 259 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~~~ 259 (690)
.... .......||+.|+|||+ +.+..++.++|||||||++|+|++|+.||.+.....++.... ...
T Consensus 152 ~~~~---------~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 219 (323)
T cd05615 152 MVDG---------VTTRTFCGTPDYIAPEI---IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS 219 (323)
T ss_pred CCCC---------ccccCccCCccccCHHH---HcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 2110 01123468999999996 456678999999999999999999999998876654433322 222
Q ss_pred CCCCCCHHHHHHHHHHhhhCCCCCCCHH
Q 005577 260 ESPKYSSSVTDLIRDMLQASPDDRPDIT 287 (690)
Q Consensus 260 ~~~~~s~~l~~LI~~~L~~dP~~RPt~~ 287 (690)
.+..++..+.++|.+||+++|.+|++..
T Consensus 220 ~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 220 YPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 3456899999999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=335.38 Aligned_cols=238 Identities=23% Similarity=0.378 Sum_probs=190.7
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
+.||+|+||.||+|++. ..++.||||++... .......+..|..++..+.+||||+++++++. ....+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~----~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ----TKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE----eCCEEEEEE
Confidence 36999999999999985 56889999998653 12345567778888887657999999998865 346799999
Q ss_pred ecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccch
Q 005577 108 ECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 108 Ey~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~ 186 (690)
||+. |+|...+.... .+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 76 ey~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 149 (316)
T cd05619 76 EYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-- 149 (316)
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCC--
Confidence 9995 57777776543 4899999999999999999999999 999999999999999999999999988642111
Q ss_pred hhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--CCCCCCCC
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RIPESPKY 264 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~~~~~~~~ 264 (690)
........||+.|+|||+ +.+..++.++|||||||++|+|++|+.||.+.....+..... ....+..+
T Consensus 150 -------~~~~~~~~gt~~y~aPE~---~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 219 (316)
T cd05619 150 -------DAKTCTFCGTPDYIAPEI---LLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWL 219 (316)
T ss_pred -------CCceeeecCCccccCHHH---HcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccC
Confidence 011123468999999996 456678999999999999999999999998776554433211 11223458
Q ss_pred CHHHHHHHHHHhhhCCCCCCCHH-HH
Q 005577 265 SSSVTDLIRDMLQASPDDRPDIT-QV 289 (690)
Q Consensus 265 s~~l~~LI~~~L~~dP~~RPt~~-ei 289 (690)
+..+.+||.+||+.||.+||++. ++
T Consensus 220 ~~~~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 220 TREAKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred CHHHHHHHHHHhccCHhhcCCChHHH
Confidence 89999999999999999999997 44
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=337.59 Aligned_cols=236 Identities=27% Similarity=0.389 Sum_probs=187.8
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHH-HHhhcCCCCceEEEEEEEeecCCCceEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISV-MKSLKGHPNVVTLYAHTILDLGRTKEALLV 106 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~i-L~~L~~HPNIVkL~~~~~~~~~~~~~~~LV 106 (690)
++||+|+||+||+|++. ..++.||||++... .......++.|..+ ++.+ +|||||++++++. ..+.+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~----~~~~~~lv 74 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK-ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQ----TADKLYFV 74 (323)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEE----eCCEEEEE
Confidence 36999999999999985 67899999998643 22233455666654 4667 5999999998764 34788999
Q ss_pred EecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccc
Q 005577 107 MECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185 (690)
Q Consensus 107 mEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~ 185 (690)
|||+.| +|...+.... .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++......
T Consensus 75 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~- 149 (323)
T cd05575 75 LDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH- 149 (323)
T ss_pred EcCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-
Confidence 999964 6666665543 4899999999999999999999999 999999999999999999999999988642111
Q ss_pred hhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--CCCCCCC
Q 005577 186 EKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RIPESPK 263 (690)
Q Consensus 186 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~~~~~~~ 263 (690)
.......+||+.|||||+ +.+..++.++|||||||++|+|++|..||.+....++..... .....+.
T Consensus 150 --------~~~~~~~~gt~~y~aPE~---~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 218 (323)
T cd05575 150 --------SKTTSTFCGTPEYLAPEV---LRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPN 218 (323)
T ss_pred --------CCccccccCChhhcChhh---hcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 111223468999999996 456778999999999999999999999998876655433222 2233457
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCHHH
Q 005577 264 YSSSVTDLIRDMLQASPDDRPDITQ 288 (690)
Q Consensus 264 ~s~~l~~LI~~~L~~dP~~RPt~~e 288 (690)
++..+.+||.+||++||.+||++.+
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 219 ISVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred CCHHHHHHHHHHhhcCHHhCCCCCC
Confidence 8999999999999999999999853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=343.28 Aligned_cols=256 Identities=25% Similarity=0.312 Sum_probs=200.5
Q ss_pred ceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEE
Q 005577 18 RSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTI 94 (690)
Q Consensus 18 ~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~ 94 (690)
+.+.+...+|++.+.||+|+||.||+|++. ..++.||+|++... .......+.+|+.+++.+. ||||+++++++.
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~ 113 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQ 113 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEEC-CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEE
Confidence 345666789999999999999999999986 67889999998542 2233456778999999995 999999998864
Q ss_pred eecCCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeee
Q 005577 95 LDLGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLC 173 (690)
Q Consensus 95 ~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~ 173 (690)
....+|+|||||. |+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+
T Consensus 114 ----~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~ 184 (371)
T cd05622 114 ----DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLA 184 (371)
T ss_pred ----cCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEE
Confidence 3578999999996 5666666432 3899999999999999999999999 9999999999999999999999
Q ss_pred ccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhh-cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 005577 174 DFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFR-RELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL 252 (690)
Q Consensus 174 DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~-~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il 252 (690)
|||+++....... ......+||+.|||||++.... ...++.++|||||||+||+|++|..||.+.+.....
T Consensus 185 DfG~a~~~~~~~~--------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~ 256 (371)
T cd05622 185 DFGTCMKMNKEGM--------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY 256 (371)
T ss_pred eCCceeEcCcCCc--------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999865432110 0112357899999999753221 134789999999999999999999999887654332
Q ss_pred h----cc--CCCCCCCCCCHHHHHHHHHHhhhCCCC--CCCHHHHHHH
Q 005577 253 N----GN--YRIPESPKYSSSVTDLIRDMLQASPDD--RPDITQVWFR 292 (690)
Q Consensus 253 ~----~~--~~~~~~~~~s~~l~~LI~~~L~~dP~~--RPt~~eil~~ 292 (690)
. .. ...+....++..+.+||..||..++.+ |+++.+++.+
T Consensus 257 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 257 SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 2 21 334444578999999999999844433 6788888654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=326.69 Aligned_cols=266 Identities=21% Similarity=0.331 Sum_probs=210.9
Q ss_pred CceEeecCceEEEEEEeeecCceEEEEEEEcc------cCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEE
Q 005577 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAI------HMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTL 89 (690)
Q Consensus 17 g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~------~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL 89 (690)
..++++...+|.+.+.||+|+||.||+|++.. .....||+|.+... .......+.+|+.+++.+.+||||+++
T Consensus 10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 34567777899999999999999999998631 12346999988754 344567788999999999669999999
Q ss_pred EEEEEeecCCCceEEEEEecCC-CcHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCccc
Q 005577 90 YAHTILDLGRTKEALLVMECCD-KSLVNVLENRGA--------------GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAH 154 (690)
Q Consensus 90 ~~~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~--------------~~lse~~~~~i~~qIa~aL~yLHs~g~~IVH 154 (690)
++++. .....|+||||+. |+|.+++..+.. ..+++.+++.++.||+.||.|||++| |+|
T Consensus 90 ~~~~~----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H 163 (307)
T cd05098 90 LGACT----QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIH 163 (307)
T ss_pred EEEEe----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--ccc
Confidence 99865 3467899999996 578888876432 24888999999999999999999999 999
Q ss_pred CCCCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHH
Q 005577 155 RDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLF 234 (690)
Q Consensus 155 RDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLy 234 (690)
|||||+|||++.++.+||+|||+++........ .......+++.|||||+ +.+..++.++|||||||++|
T Consensus 164 ~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~-------~~~~~~~~~~~y~aPE~---~~~~~~~~~~DvwslG~~l~ 233 (307)
T cd05098 164 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYY-------KKTTNGRLPVKWMAPEA---LFDRIYTHQSDVWSFGVLLW 233 (307)
T ss_pred ccccHHheEEcCCCcEEECCCcccccccccchh-------hccccCCCccceeChHH---hccCCCCcHHHHHHHHHHHH
Confidence 999999999999999999999998654321100 00111234578999996 45667899999999999999
Q ss_pred HHHh-CCCCCCCchHHHH---HhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhcC
Q 005577 235 RICY-FKNAFDGESKLQI---LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLP 298 (690)
Q Consensus 235 ELlt-G~~PF~~~~~~~i---l~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l~ 298 (690)
+|++ |..||.+....++ +........+..++.++.+||.+||..+|.+||++.+++..+.+.+.
T Consensus 234 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 234 EIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHcCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 9998 8899987655443 33444445556789999999999999999999999999988877653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=343.91 Aligned_cols=255 Identities=25% Similarity=0.314 Sum_probs=200.0
Q ss_pred eEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEe
Q 005577 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTIL 95 (690)
Q Consensus 19 ~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~ 95 (690)
.+.+...+|++.+.||+|+||.||+|++. ..++.||+|++... .......+.+|+.+++.+. ||||+++++++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~- 113 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHK-SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQ- 113 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEE-
Confidence 34556689999999999999999999985 57889999998542 2233456778999999994 999999998864
Q ss_pred ecCCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeec
Q 005577 96 DLGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCD 174 (690)
Q Consensus 96 ~~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~D 174 (690)
....+|+|||||. |+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|
T Consensus 114 ---~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~D 185 (370)
T cd05621 114 ---DDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLAD 185 (370)
T ss_pred ---cCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEe
Confidence 4578999999996 5677766433 3899999999999999999999999 99999999999999999999999
Q ss_pred cCCCCcccccchhhhhccccccccccCCCCcccCccchhhhh-cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh
Q 005577 175 FGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFR-RELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN 253 (690)
Q Consensus 175 FGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~-~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~ 253 (690)
||++....... .......+||+.|||||++.... ...++.++|||||||+||+|++|+.||.+.+......
T Consensus 186 FG~a~~~~~~~--------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~ 257 (370)
T cd05621 186 FGTCMKMDETG--------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS 257 (370)
T ss_pred cccceecccCC--------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99986542110 01112357899999999753221 1347889999999999999999999998776543322
Q ss_pred ----c--cCCCCCCCCCCHHHHHHHHHHhhhCCCC--CCCHHHHHHH
Q 005577 254 ----G--NYRIPESPKYSSSVTDLIRDMLQASPDD--RPDITQVWFR 292 (690)
Q Consensus 254 ----~--~~~~~~~~~~s~~l~~LI~~~L~~dP~~--RPt~~eil~~ 292 (690)
. .+..+....++..+.++|..||..++.+ |+++.+++.+
T Consensus 258 ~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 258 KIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 2 2233444467999999999999855543 8899988653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=337.99 Aligned_cols=242 Identities=26% Similarity=0.392 Sum_probs=190.1
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHH-HHhhcCCCCceEEEEEEEeecCCCceEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISV-MKSLKGHPNVVTLYAHTILDLGRTKEALLV 106 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~i-L~~L~~HPNIVkL~~~~~~~~~~~~~~~LV 106 (690)
+.||+|+||+||+|++. ..++.||+|++.... ......++.|..+ ++.+ +||||+++++++. ..+.+|+|
T Consensus 1 ~~lg~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~----~~~~~~lv 74 (325)
T cd05602 1 KVIGKGSFGKVLLARHK-AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQ----TADKLYFV 74 (325)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEE----cCCeEEEE
Confidence 36999999999999985 567889999986432 2223344555544 5667 5999999998764 34679999
Q ss_pred EecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccc
Q 005577 107 MECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185 (690)
Q Consensus 107 mEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~ 185 (690)
|||+.| +|...+.... .+.+..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++.....
T Consensus 75 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~- 149 (325)
T cd05602 75 LDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH- 149 (325)
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccC-
Confidence 999965 6666665543 4889999999999999999999999 999999999999999999999999998643211
Q ss_pred hhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--CCCCCCC
Q 005577 186 EKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RIPESPK 263 (690)
Q Consensus 186 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~~~~~~~ 263 (690)
.......+||+.|||||+ +.+..++.++|||||||++|+|++|..||.+......+.... .....+.
T Consensus 150 --------~~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 218 (325)
T cd05602 150 --------NGTTSTFCGTPEYLAPEV---LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN 218 (325)
T ss_pred --------CCCcccccCCccccCHHH---HcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCC
Confidence 111223568999999996 456778999999999999999999999998876655443322 2233457
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 264 YSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 264 ~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
++..+.++|.+||++||.+|+++.+.+..+.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 219 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 8999999999999999999999876544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.40 Aligned_cols=247 Identities=26% Similarity=0.407 Sum_probs=197.9
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
.+|++.+.||.|+||.||+|++. ..++.||+|.+.... ......+.+|+.+++.|. ||||+++++++. ..+.+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~----~~~~~ 79 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSK-LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIH----TEKSL 79 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEc-CCCcEEEEEEEecccccCchhHHHHHHHHHHhcC-CCCcceEEEEEe----cCCeE
Confidence 57999999999999999999985 567899999886442 223456778999999995 999999999865 34678
Q ss_pred EEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 104 LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
|+||||++++|...+.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 80 TLVFEYLDKDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred EEEEeccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 9999999999988887654 35899999999999999999999999 99999999999999999999999998864322
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc--------
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN-------- 255 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~-------- 255 (690)
... ......+++.|+|||++ .....++.++|||||||++|+|++|+.||.+.+....+...
T Consensus 157 ~~~---------~~~~~~~~~~y~~PE~~--~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 225 (301)
T cd07873 157 PTK---------TYSNEVVTLWYRPPDIL--LGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT 225 (301)
T ss_pred CCC---------cccccceeecccCcHHH--hCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 110 01123568899999973 33456788999999999999999999999876543221100
Q ss_pred ---------------CCCC---------CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 256 ---------------YRIP---------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 256 ---------------~~~~---------~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
+..+ ..+.++..+.+||.+||..||.+||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 226 EETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0001 01357889999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=333.27 Aligned_cols=235 Identities=27% Similarity=0.374 Sum_probs=186.5
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHH-HHHhhcCCCCceEEEEEEEeecCCCceEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEIS-VMKSLKGHPNVVTLYAHTILDLGRTKEALLV 106 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~-iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LV 106 (690)
++||+|+||.||+|++. ..++.||+|++... .......++.|+. +++.+ +|||||++++++. ..+..|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~----~~~~~~lv 74 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK-SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQ----TAEKLYFV 74 (321)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEE----cCCEEEEE
Confidence 36999999999999985 57889999998643 2223445556665 56667 5999999998764 45789999
Q ss_pred EecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccc
Q 005577 107 MECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185 (690)
Q Consensus 107 mEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~ 185 (690)
||||.| +|...+.... .+++..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+++.....
T Consensus 75 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 149 (321)
T cd05603 75 LDYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP- 149 (321)
T ss_pred EcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCC-
Confidence 999965 6666665443 4899999999999999999999999 999999999999999999999999988642111
Q ss_pred hhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--CCCCCCC
Q 005577 186 EKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RIPESPK 263 (690)
Q Consensus 186 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~~~~~~~ 263 (690)
.......+||+.|+|||+ +.+..++.++|||||||++|+|++|..||.+.+...+..... ....++.
T Consensus 150 --------~~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 218 (321)
T cd05603 150 --------EETTSTFCGTPEYLAPEV---LRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGG 218 (321)
T ss_pred --------CCccccccCCcccCCHHH---hcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 011223468999999996 456678999999999999999999999998876554433322 2233457
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCHH
Q 005577 264 YSSSVTDLIRDMLQASPDDRPDIT 287 (690)
Q Consensus 264 ~s~~l~~LI~~~L~~dP~~RPt~~ 287 (690)
.+..+.++|.+||++||.+|++..
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCHHHHHHHHHHccCCHhhcCCCC
Confidence 889999999999999999999865
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=324.39 Aligned_cols=247 Identities=27% Similarity=0.420 Sum_probs=196.8
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
+|++.+.||+|+||.||+|.+. ..++.||||++.... ......+.+|+.+++.+. ||||+++++++. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~~~~ 74 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNK-KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ-HPNIVCLQDVLM----QESRL 74 (285)
T ss_pred CceEeeEecccCceEEEEEEEC-CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcC-CCCEeeeEEEEe----eCCeE
Confidence 4889999999999999999985 568899999886432 223466788999999995 999999999865 34688
Q ss_pred EEEEecCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCDKSLVNVLENRGA-GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~-~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
|+||||+.++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++....
T Consensus 75 ~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 75 YLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred EEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 99999999999888765432 46899999999999999999999999 9999999999999999999999999886432
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc-------
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN------- 255 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~------- 255 (690)
.... ......+++.|+|||++ .....++.++|||||||++|+|++|+.||.+......+...
T Consensus 153 ~~~~---------~~~~~~~~~~y~aPE~~--~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~ 221 (285)
T cd07861 153 IPVR---------VYTHEVVTLWYRAPEVL--LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTP 221 (285)
T ss_pred CCcc---------cccCCcccccccChHHh--cCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 2110 11123568899999973 23345788999999999999999999999876543221100
Q ss_pred -------------CC-----------CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 256 -------------YR-----------IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 256 -------------~~-----------~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
+. ......+++++.+||.+||..||.+||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 222 TEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred ChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 0012357899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=338.89 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=196.2
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec--CC
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDL--GR 99 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~--~~ 99 (690)
..+|++.+.||.|+||.||+|.+. ..++.||||++.... ......+.+|+.+|+.+. ||||+++++++.... ..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDT-RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEEC-CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcC-CCchhhhhhhhcccccccc
Confidence 368999999999999999999985 578899999986532 234566788999999995 999999998764321 12
Q ss_pred CceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 100 TKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 100 ~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
....|++|++++++|.+.+.. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 92 ~~~~~~~~~~~~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 92 FNEVYLVTNLMGADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred cCcEEEEeecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCccce
Confidence 346799999998888776643 24999999999999999999999999 9999999999999999999999999986
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC---
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--- 256 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--- 256 (690)
..... .....||+.|+|||++ .....++.++|||||||++|+|++|+.||.+....+.+....
T Consensus 167 ~~~~~------------~~~~~~t~~y~aPE~~--~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07878 167 QADDE------------MTGYVATRWYRAPEIM--LNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV 232 (343)
T ss_pred ecCCC------------cCCccccccccCchHh--cCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence 54321 1234689999999973 233568899999999999999999999998754432221100
Q ss_pred ---------------------CCCC---------CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 ---------------------RIPE---------SPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 ---------------------~~~~---------~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.++. ...+++.+.+||.+||..||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 233 GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 1235677899999999999999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=361.20 Aligned_cols=264 Identities=20% Similarity=0.295 Sum_probs=218.6
Q ss_pred CceEeecCceEEEEEEeeecCceEEEEEEEc----ccCCeEEEEEEeecCCHH-HHHHHHHHHHHHHhhcCCCCceEEEE
Q 005577 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDA----IHMSKQYAMKHMICNDEE-SLESAMKEISVMKSLKGHPNVVTLYA 91 (690)
Q Consensus 17 g~~iei~~~ry~v~~~LG~GgFG~VylA~d~----~~~~k~vAvK~i~~~~~e-~~e~~~~Ei~iL~~L~~HPNIVkL~~ 91 (690)
....++...++.+.+.||+|+||.||+|+.. ......||||.+...... ...+|.||+++|..| +|||||+|+|
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlG 556 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLG 556 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEE
Confidence 3445667778888999999999999999752 133467999999766544 789999999999999 5999999999
Q ss_pred EEEeecCCCceEEEEEecC-CCcHHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCC
Q 005577 92 HTILDLGRTKEALLVMECC-DKSLVNVLENRGA------------GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLK 158 (690)
Q Consensus 92 ~~~~~~~~~~~~~LVmEy~-~gsLl~~L~~~~~------------~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLK 158 (690)
+|. +++.+|+|+||| .|+|.++|+.+.+ ..|+..+.+.|+.||+.||.||-++. +|||||.
T Consensus 557 VC~----~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLA 630 (774)
T KOG1026|consen 557 VCR----EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLA 630 (774)
T ss_pred EEc----cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchh
Confidence 987 457899999999 5899999987532 23889999999999999999999999 9999999
Q ss_pred CCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh
Q 005577 159 AENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY 238 (690)
Q Consensus 159 P~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt 238 (690)
..|+||.++..|||+||||++.+...... +. .....-.++||+||. +..+.|+.++|||||||||||+++
T Consensus 631 TRNCLVge~l~VKIsDfGLsRdiYssDYY--k~-----~~~t~lPIRWMppEs---Ily~kFTteSDVWs~GVvLWEIFs 700 (774)
T KOG1026|consen 631 TRNCLVGENLVVKISDFGLSRDIYSSDYY--KV-----RGNTLLPIRWMPPES---ILYGKFTTESDVWSFGVVLWEIFS 700 (774)
T ss_pred hhhceeccceEEEecccccchhhhhhhhh--cc-----cCCceeeeecCCHHH---hhcCcccchhhhhhhhhhhhhhhc
Confidence 99999999999999999999875443111 11 111234789999995 666789999999999999999987
Q ss_pred -CCCCCCCchHHHHHh---ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 239 -FKNAFDGESKLQILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 239 -G~~PF~~~~~~~il~---~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
|+.||.+.+..++++ ...-++.+.++|.++++||..||+.+|.+||++.+|-.+|....
T Consensus 701 yG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 701 YGKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred cccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 899999877666543 33337778899999999999999999999999999988776543
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=341.01 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=196.7
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
+|++.+.||+|+||.||+|.+. ..++.||||++... ..+....+.+|+.+|..+ +||||+++++.+. ..+.
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~----~~~~ 75 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKK-DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQ----DKRN 75 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEE----cCCE
Confidence 6889999999999999999985 57889999998643 234456778899999999 5999999998754 4578
Q ss_pred EEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
+|||||||. |+|.+++.... .+++..++.++.||+.||.|||++| ||||||||+||||+.+|.+||+|||++..+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 999999996 56777776554 4899999999999999999999999 999999999999999999999999998654
Q ss_pred cccchhhh---------------hc-----------cccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHH
Q 005577 182 HKRFEKLE---------------EM-----------GIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFR 235 (690)
Q Consensus 182 ~~~~~~~~---------------~~-----------~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyE 235 (690)
........ .+ .........+||+.|||||+ +.+..++.++|||||||++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~---~~~~~~~~~~DiwSlGvilye 228 (360)
T cd05627 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEV---FMQTGYNKLCDWWSLGVIMYE 228 (360)
T ss_pred ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHH---HcCCCCCCcceeccccceeee
Confidence 22110000 00 00001123579999999996 456778999999999999999
Q ss_pred HHhCCCCCCCchHHHHHhc------cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCC---HHHHH
Q 005577 236 ICYFKNAFDGESKLQILNG------NYRIPESPKYSSSVTDLIRDMLQASPDDRPD---ITQVW 290 (690)
Q Consensus 236 LltG~~PF~~~~~~~il~~------~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt---~~eil 290 (690)
|++|+.||.+......... ....+....++..+.+||.+|+ .||.+|++ +.+++
T Consensus 229 l~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 291 (360)
T cd05627 229 MLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIK 291 (360)
T ss_pred cccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence 9999999987766544322 1223333457899999999987 49999985 45553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.92 Aligned_cols=254 Identities=22% Similarity=0.362 Sum_probs=203.4
Q ss_pred eecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 21 DVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 21 ei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
.+...+|++.++||+|+||.||+|.+. ....|++|++..... ..+.+.+|+.+++.+. ||||+++++++. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-----~ 72 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLR-HEKLVQLYAVVS-----E 72 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEec--CCceEEEEecccCcc-CHHHHHHHHHHHHhCC-CCCcceEEEEEC-----C
Confidence 456788999999999999999999874 345699998864332 2356889999999995 999999988642 3
Q ss_pred ceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 101 KEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 101 ~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
...|+||||+. |+|.+++.......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~ 150 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLAR 150 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCcee
Confidence 45789999996 57878876544445899999999999999999999999 9999999999999999999999999986
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHh---cc
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQILN---GN 255 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il~---~~ 255 (690)
........ ......++..|+|||+ ..+..++.++|||||||++|+|++ |..||.+.....+.. ..
T Consensus 151 ~~~~~~~~--------~~~~~~~~~~y~~PE~---~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~ 219 (262)
T cd05071 151 LIEDNEYT--------ARQGAKFPIKWTAPEA---ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 219 (262)
T ss_pred eccccccc--------cccCCcccceecCHhH---hccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC
Confidence 54321100 0011235678999996 456678999999999999999999 888998765544332 23
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhh
Q 005577 256 YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 256 ~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~ 296 (690)
...+....++..+.+||.+||++||++||++.+++..+.+.
T Consensus 220 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 220 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 33444567899999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=341.47 Aligned_cols=246 Identities=31% Similarity=0.480 Sum_probs=209.0
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH---HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE---ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~---e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
....|.+.+.||.|.||.||++++. .+++.||+|++.+... ...+.+.+|+.||+.|..|||||.++++|. .
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~-~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e----~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREK-STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE----D 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEec-CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE----c
Confidence 3568999999999999999999986 5699999999965432 345788999999999977999999999865 3
Q ss_pred CceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCC----CCeeeec
Q 005577 100 TKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD----GLWKLCD 174 (690)
Q Consensus 100 ~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~d----g~vKL~D 174 (690)
...+|||||+|. |.|++.+... .+++.++..++.||+.++.|||..| ||||||||+|+|+... +.+|++|
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEee
Confidence 468999999995 6888988877 3999999999999999999999999 9999999999999543 4799999
Q ss_pred cCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH----
Q 005577 175 FGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ---- 250 (690)
Q Consensus 175 FGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~---- 250 (690)
||++..... .......+||+.|+|||+ +....|+..+||||+||++|.|++|..||.+.+...
T Consensus 183 FGla~~~~~----------~~~~~~~~Gtp~y~APEv---l~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~ 249 (382)
T KOG0032|consen 183 FGLAKFIKP----------GERLHTIVGTPEYVAPEV---LGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA 249 (382)
T ss_pred CCCceEccC----------CceEeeecCCccccCchh---hcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH
Confidence 999976433 112334689999999997 455789999999999999999999999999877543
Q ss_pred HHhccCC--CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 251 ILNGNYR--IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 251 il~~~~~--~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
++...+. .+..+.++..+.++|++||..||.+|+++.+++.
T Consensus 250 i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 250 ILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 4444443 3445788999999999999999999999999876
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=335.09 Aligned_cols=233 Identities=26% Similarity=0.383 Sum_probs=186.9
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
++||+|+||.||+|++. ..++.||+|++... +......+.+|+.++.++.+|||||++++++. ..+.+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~----~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK-KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ----TESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE----eCCEEEEEE
Confidence 46999999999999985 56889999998653 34456677889999988867999999999865 346899999
Q ss_pred ecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccch
Q 005577 108 ECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 108 Ey~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~ 186 (690)
||+.+ +|...+.... .+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 76 E~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~- 150 (329)
T cd05618 76 EYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 150 (329)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-
Confidence 99965 5666655443 4999999999999999999999999 9999999999999999999999999986421110
Q ss_pred hhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch---------H---H-HHHh
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES---------K---L-QILN 253 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~---------~---~-~il~ 253 (690)
......+||+.|+|||+ +.+..++.++|||||||++|+|++|+.||.... . . .+..
T Consensus 151 --------~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 219 (329)
T cd05618 151 --------DTTSTFCGTPNYIAPEI---LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 219 (329)
T ss_pred --------CccccccCCccccCHHH---HcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc
Confidence 11123578999999996 456778999999999999999999999995210 0 1 1122
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCH
Q 005577 254 GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDI 286 (690)
Q Consensus 254 ~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~ 286 (690)
... ..+..++..+.+||.+||..||.+||++
T Consensus 220 ~~~--~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 220 KQI--RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCC--CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 222 3345789999999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=337.22 Aligned_cols=240 Identities=25% Similarity=0.374 Sum_probs=189.7
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHH-HHhhcCCCCceEEEEEEEeecCCCceEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISV-MKSLKGHPNVVTLYAHTILDLGRTKEALLV 106 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~i-L~~L~~HPNIVkL~~~~~~~~~~~~~~~LV 106 (690)
++||+|+||.||+|++. ..++.||||++... +......++.|..+ ++.+ +||||+++++++. ..+.+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~----~~~~~~lv 74 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK-LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQ----TTEKLYFV 74 (325)
T ss_pred CceeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEe----cCCEEEEE
Confidence 36999999999999985 67889999998643 22334556666655 5556 5999999998764 34789999
Q ss_pred EecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccc
Q 005577 107 MECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185 (690)
Q Consensus 107 mEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~ 185 (690)
|||+.| +|...+.... .+++..++.++.||+.||.|||++| |+||||||+||||+.+|.+||+|||+++.....
T Consensus 75 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~- 149 (325)
T cd05604 75 LDFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ- 149 (325)
T ss_pred EcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-
Confidence 999965 6666665443 4999999999999999999999999 999999999999999999999999998642111
Q ss_pred hhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--CCCCCCC
Q 005577 186 EKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RIPESPK 263 (690)
Q Consensus 186 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~~~~~~~ 263 (690)
.......+||+.|||||+ +.+..++.++|||||||++|+|++|..||......++..... .....+.
T Consensus 150 --------~~~~~~~~gt~~y~aPE~---~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~ 218 (325)
T cd05604 150 --------SDTTTTFCGTPEYLAPEV---IRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPG 218 (325)
T ss_pred --------CCCcccccCChhhCCHHH---HcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCC
Confidence 111223568999999996 456778999999999999999999999998876655443322 2223457
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 264 YSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 264 ~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
++..+.++|.+||.++|.+||++.+.+..
T Consensus 219 ~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 219 ASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 89999999999999999999988644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=336.38 Aligned_cols=237 Identities=24% Similarity=0.355 Sum_probs=191.6
Q ss_pred EEeeecCceEEEEEEEcc--cCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEE
Q 005577 31 NVIAEGGFSCVYSARDAI--HMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLV 106 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~--~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LV 106 (690)
+.||+|+||.||++++.. ..++.||+|++.... ......+.+|+.+|++|. |||||++++++. ....+|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~----~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN-HPFIVKLHYAFQ----TEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCC-CCCcccEEEEEE----cCCEEEEE
Confidence 579999999999998742 467899999986532 223456778999999995 999999998865 34689999
Q ss_pred EecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccc
Q 005577 107 MECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185 (690)
Q Consensus 107 mEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~ 185 (690)
|||+. |+|.+.+.... .+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 77 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 77 LDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 99995 67777776543 4899999999999999999999999 9999999999999999999999999986532210
Q ss_pred hhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--CCCCCCC
Q 005577 186 EKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RIPESPK 263 (690)
Q Consensus 186 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--~~~~~~~ 263 (690)
.......||+.|+|||+ +.+..++.++|||||||++|+|++|+.||.+......+.... ....+..
T Consensus 153 ---------~~~~~~~g~~~y~aPE~---~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~ 220 (318)
T cd05582 153 ---------KKAYSFCGTVEYMAPEV---VNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF 220 (318)
T ss_pred ---------CceecccCChhhcCHHH---HcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 11123468999999996 455678899999999999999999999998876655443322 2223456
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCHHH
Q 005577 264 YSSSVTDLIRDMLQASPDDRPDITQ 288 (690)
Q Consensus 264 ~s~~l~~LI~~~L~~dP~~RPt~~e 288 (690)
++..+.+||.+||+.||.+||++.+
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 8999999999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=323.11 Aligned_cols=263 Identities=22% Similarity=0.356 Sum_probs=209.7
Q ss_pred eEeecCceEEEEEEeeecCceEEEEEEEcc----cCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEE
Q 005577 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDAI----HMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHT 93 (690)
Q Consensus 19 ~iei~~~ry~v~~~LG~GgFG~VylA~d~~----~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~ 93 (690)
.+++...+|++.+.||+|+||.||++.+.. .....+|+|.+... .......+.+|+.+++.+.+|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 466778899999999999999999998742 23468999988654 3445567889999999995699999999986
Q ss_pred EeecCCCceEEEEEecCC-CcHHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCC
Q 005577 94 ILDLGRTKEALLVMECCD-KSLVNVLENR--------------GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLK 158 (690)
Q Consensus 94 ~~~~~~~~~~~LVmEy~~-gsLl~~L~~~--------------~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLK 158 (690)
. ....+++||||+. |+|..++..+ ....+++..++.++.||+.||.|||+++ |+|||||
T Consensus 86 ~----~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlk 159 (293)
T cd05053 86 T----QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLA 159 (293)
T ss_pred c----CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccc
Confidence 4 3467899999995 6777777542 1245899999999999999999999999 9999999
Q ss_pred CCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh
Q 005577 159 AENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY 238 (690)
Q Consensus 159 P~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt 238 (690)
|+|||++.++.+||+|||+++.+..... ........++..|+|||+ +.+..++.++|||||||++|+|++
T Consensus 160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~il~el~~ 229 (293)
T cd05053 160 ARNVLVTEDHVMKIADFGLARDIHHIDY-------YRKTTNGRLPVKWMAPEA---LFDRVYTHQSDVWSFGVLLWEIFT 229 (293)
T ss_pred eeeEEEcCCCeEEeCccccccccccccc-------eeccCCCCCCccccCHHH---hccCCcCcccceeehhhHHHHHhc
Confidence 9999999999999999999875432110 001111234678999996 456678999999999999999997
Q ss_pred -CCCCCCCchHHHH---HhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 239 -FKNAFDGESKLQI---LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 239 -G~~PF~~~~~~~i---l~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
|..||.+....++ +........+..++..+.+||.+||..||++||++.+++..+...+
T Consensus 230 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 230 LGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 9999987654443 3334444455678899999999999999999999999998887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.87 Aligned_cols=245 Identities=23% Similarity=0.300 Sum_probs=196.0
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.|++.++||+|+||.||++.+. .+++.||+|++.... ......+.+|+.+++.| +||||+++++++. ....
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~----~~~~ 74 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYE----TKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEc-CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeec----CCCe
Confidence 4889999999999999999985 568899999986532 22345677899999999 5999999998864 3467
Q ss_pred EEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
+|+||||+. |+|...+.......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05605 75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEI 152 (285)
T ss_pred EEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence 999999996 56666666554456999999999999999999999999 999999999999999999999999988653
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH----HHhcc--
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGN-- 255 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~----il~~~-- 255 (690)
.... ......|++.|+|||+ +.+..++.++|||||||++|+|++|..||.+..... +....
T Consensus 153 ~~~~----------~~~~~~~~~~y~aPE~---~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~ 219 (285)
T cd05605 153 PEGE----------TIRGRVGTVGYMAPEV---VKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE 219 (285)
T ss_pred CCCC----------ccccccCCCCccCcHH---hcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh
Confidence 2110 1112468999999996 456678999999999999999999999998754321 11111
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhCCCCCC-----CHHHHHH
Q 005577 256 YRIPESPKYSSSVTDLIRDMLQASPDDRP-----DITQVWF 291 (690)
Q Consensus 256 ~~~~~~~~~s~~l~~LI~~~L~~dP~~RP-----t~~eil~ 291 (690)
.....+..++..+.+||.+||..||.+|| ++.+++.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 220 DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 12223356899999999999999999999 6777743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=319.62 Aligned_cols=258 Identities=20% Similarity=0.291 Sum_probs=202.4
Q ss_pred EeecCceEEEEEEeeecCceEEEEEEEcc----cCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEE
Q 005577 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAI----HMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTI 94 (690)
Q Consensus 20 iei~~~ry~v~~~LG~GgFG~VylA~d~~----~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~ 94 (690)
|++...+|++.+.||+|+||.||+|.+.. ..+..||||++... .......+.+|+.+++.+. ||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~ 79 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVVS 79 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEc
Confidence 45678899999999999999999998631 23567999988543 2334567889999999995 999999998864
Q ss_pred eecCCCceEEEEEecCC-CcHHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeC
Q 005577 95 LDLGRTKEALLVMECCD-KSLVNVLENRGA--------GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLG 165 (690)
Q Consensus 95 ~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~--------~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd 165 (690)
.....++||||+. ++|.+++..... ..++...++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 80 ----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~ 153 (277)
T cd05062 80 ----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA 153 (277)
T ss_pred ----CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEc
Confidence 4567899999996 577777754321 23577889999999999999999999 99999999999999
Q ss_pred CCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 005577 166 SDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFD 244 (690)
Q Consensus 166 ~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~ 244 (690)
.++.++|+|||+++....... ........+++.|||||+ +.+..++.++|||||||++|||++ |..||.
T Consensus 154 ~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~~l~el~~~~~~p~~ 223 (277)
T cd05062 154 EDFTVKIGDFGMTRDIYETDY-------YRKGGKGLLPVRWMSPES---LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 223 (277)
T ss_pred CCCCEEECCCCCccccCCcce-------eecCCCCccCHhhcChhH---hhcCCcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999865432111 001112345788999996 456778999999999999999998 788998
Q ss_pred CchHHHHHh---ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 245 GESKLQILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 245 ~~~~~~il~---~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
+......+. .......+..++..+.++|.+||+.||++||++.+++..+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 224 GMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 766544332 22222334568899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=327.11 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=205.3
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
.....|.+.+.||+|.|+.||++.+. .+++.+|+|++..+ .....+.+.+|++|.+.|+ |||||+|.+. ...
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~-~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~Lq-HP~IvrL~~t----i~~ 81 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDS----IQE 81 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhc-cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcC-CCcEeehhhh----hcc
Confidence 34568889999999999999999885 68889999987433 3335788889999999996 9999999875 334
Q ss_pred CceEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCC---CCeeeecc
Q 005577 100 TKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD---GLWKLCDF 175 (690)
Q Consensus 100 ~~~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~d---g~vKL~DF 175 (690)
....|||+|+|.| .|...|..+. .++|..+-.+++||+.+|.|+|.++ |||||+||+|+||-.. --+||+||
T Consensus 82 ~~~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~F 157 (355)
T KOG0033|consen 82 ESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADF 157 (355)
T ss_pred cceeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeeccc
Confidence 5778999999965 6777777763 4899999999999999999999999 9999999999999543 35999999
Q ss_pred CCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH----H
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----I 251 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~----i 251 (690)
|+|..+... .. ....+|||.|||||+ ++...|+..+|||+.|||||-||.|.+||.+++..+ +
T Consensus 158 GvAi~l~~g---~~-------~~G~~GtP~fmaPEv---vrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I 224 (355)
T KOG0033|consen 158 GLAIEVNDG---EA-------WHGFAGTPGYLSPEV---LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQI 224 (355)
T ss_pred ceEEEeCCc---cc-------cccccCCCcccCHHH---hhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 999765421 11 123579999999997 678899999999999999999999999999966554 4
Q ss_pred HhccCCCC--CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 252 LNGNYRIP--ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 252 l~~~~~~~--~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
+.+.+.++ ..+.++++.++||++||..||.+|.|+.|.+.
T Consensus 225 ~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 225 KAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred hccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 44555444 46789999999999999999999999999853
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=316.81 Aligned_cols=255 Identities=20% Similarity=0.374 Sum_probs=204.3
Q ss_pred CceEEEEEEeeecCceEEEEEEEccc--CCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIH--MSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~--~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
-.+|++.+.||+|+||.||+|.+... ....|+||.+... .......+.+|+.+++.+. ||||+++++.+. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~ 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD-HPNIIRLEGVVT----KS 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCC-CCCcceEeEEEe----cC
Confidence 45789999999999999999988532 2457999988654 3445667889999999995 999999998764 34
Q ss_pred ceEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 101 KEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 101 ~~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
+..|+||||+.+ +|.+++.... +.+++..++.++.||+.||.|||+++ |+||||||+||||+.++.++|+|||+++
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhh
Confidence 678999999964 6777765533 46899999999999999999999999 9999999999999999999999999987
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---Hhcc
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LNGN 255 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i---l~~~ 255 (690)
.......... .....+++.|+|||. +.+..++.++|||||||++|+|++ |..||.......+ +...
T Consensus 155 ~~~~~~~~~~-------~~~~~~~~~y~~Pe~---~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~ 224 (266)
T cd05033 155 RLEDSEATYT-------TKGGKIPIRWTAPEA---IAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG 224 (266)
T ss_pred ccccccccee-------ccCCCCCccccChhh---hccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC
Confidence 6531111100 011234678999996 455678999999999999999997 9999976554433 2333
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhh
Q 005577 256 YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 256 ~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~ 296 (690)
+..+.+..++..+.+|+.+||+.+|++||++.+++..+...
T Consensus 225 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 44455567899999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=320.90 Aligned_cols=254 Identities=20% Similarity=0.356 Sum_probs=210.5
Q ss_pred eecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 21 DVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 21 ei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
+....+|++.++||.|+||.||+|.+. .++.+++|++..........+.+|+.+|+.+. ||||+++++++. ..
T Consensus 2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~--~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~----~~ 74 (261)
T cd05148 2 ERPREEFTLERKLGSGYFGEVWEGLWK--NRVRVAIKILKSDDLLKQQDFQKEVQALKRLR-HKHLISLFAVCS----VG 74 (261)
T ss_pred cCcHHHHHHhhhhccCCCccEEEeEec--CCCcEEEEeccccchhhHHHHHHHHHHHhcCC-CcchhheeeeEe----cC
Confidence 445678999999999999999999985 38889999998776666778899999999995 999999998864 34
Q ss_pred ceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 101 KEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 101 ~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
...++||||++ ++|.+++.......+++..++.++.||+.||.|||.+| |+||||||+||||+.++.+||+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~ 152 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLAR 152 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchh
Confidence 67899999996 58888887655556899999999999999999999999 9999999999999999999999999886
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---Hhcc
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LNGN 255 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i---l~~~ 255 (690)
........ .....++..|++||+ +.+..++.++|||||||++|+|++ |+.||.+.....+ +...
T Consensus 153 ~~~~~~~~---------~~~~~~~~~~~~PE~---~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05148 153 LIKEDVYL---------SSDKKIPYKWTAPEA---ASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG 220 (261)
T ss_pred hcCCcccc---------ccCCCCceEecCHHH---HccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC
Confidence 54321110 012245778999996 455678899999999999999998 8999987654433 3344
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhh
Q 005577 256 YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 256 ~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~ 295 (690)
++.+.+..++..+.++|.+||..||.+||++.++...|..
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 221 YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 4555667889999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=315.73 Aligned_cols=248 Identities=23% Similarity=0.379 Sum_probs=202.6
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
+...+|++.+.||+|+||.||++.. .+..|++|.+.... ..+.+.+|+.+++.+. |+||+++++++.. ...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~---~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~---~~~ 73 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDA--TAQAFLAEASVMTQLR-HSNLVQLLGVIVE---EKG 73 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEE---cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCC-CCCeeeEEEEEEc---CCC
Confidence 4456889999999999999999976 47789999875432 3467889999999995 9999999987542 345
Q ss_pred eEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
..|+||||++ ++|.+++..+....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~ 151 (256)
T cd05082 74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKE 151 (256)
T ss_pred ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCcccee
Confidence 7899999996 58888887665556899999999999999999999999 99999999999999999999999998864
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---HhccC
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LNGNY 256 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i---l~~~~ 256 (690)
.... .....++..|+|||+ ..+..++.++|||||||++|+|++ |+.||.......+ +...+
T Consensus 152 ~~~~------------~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~ 216 (256)
T cd05082 152 ASST------------QDTGKLPVKWTAPEA---LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 216 (256)
T ss_pred cccc------------CCCCccceeecCHHH---HccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC
Confidence 3211 011234668999996 456678999999999999999997 9999987655443 23333
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhh
Q 005577 257 RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 257 ~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~ 295 (690)
.......++..+.++|.+||..+|++||++.+++..+..
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 444456789999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=325.35 Aligned_cols=262 Identities=22% Similarity=0.353 Sum_probs=208.9
Q ss_pred eEeecCceEEEEEEeeecCceEEEEEEEc----ccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEE
Q 005577 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDA----IHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHT 93 (690)
Q Consensus 19 ~iei~~~ry~v~~~LG~GgFG~VylA~d~----~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~ 93 (690)
.+.+...+|.+.+.||+|+||.||+|.+. ......||+|++... .....+.+.+|+.+++++.+||||+++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 35677789999999999999999999752 124567999988654 3445677889999999996699999999986
Q ss_pred EeecCCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeee
Q 005577 94 ILDLGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKL 172 (690)
Q Consensus 94 ~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL 172 (690)
.. .+.+|+||||+. |+|.+++.......+++.+++.++.+|+.||.|||+++ |+|+||||+|||++.++.++|
T Consensus 109 ~~----~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 109 TI----GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred ec----CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEE
Confidence 53 467899999995 67888776544445899999999999999999999999 999999999999999999999
Q ss_pred eccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH--
Q 005577 173 CDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKL-- 249 (690)
Q Consensus 173 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~-- 249 (690)
+|||+++........ .......+++.|+|||+ +.+..++.++|||||||++|+|++ |..||......
T Consensus 183 ~dfg~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~---~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~ 252 (302)
T cd05055 183 CDFGLARDIMNDSNY-------VVKGNARLPVKWMAPES---IFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK 252 (302)
T ss_pred CCCcccccccCCCce-------eecCCCCcccccCCHhh---hccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH
Confidence 999998654321110 00112245788999996 456678999999999999999998 99999764432
Q ss_pred --HHHhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhh
Q 005577 250 --QILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 250 --~il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~ 296 (690)
..+...+....+...+..+.+||.+||..+|++||++.+++..+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 253 FYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 23333444444556789999999999999999999999998877653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=333.75 Aligned_cols=263 Identities=19% Similarity=0.311 Sum_probs=205.8
Q ss_pred EeecCceEEEEEEeeecCceEEEEEEEc----ccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEE
Q 005577 20 IDVGNLKIHVRNVIAEGGFSCVYSARDA----IHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTI 94 (690)
Q Consensus 20 iei~~~ry~v~~~LG~GgFG~VylA~d~----~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~ 94 (690)
|++...+|++.+.||+|+||.||+|.+. ...++.||||++... .......+++|+.+|.++.+|||||++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 5567789999999999999999999752 245788999998654 33445678899999999976999999998764
Q ss_pred eecCCCceEEEEEecCC-CcHHHHHHHhC---------------------------------------------------
Q 005577 95 LDLGRTKEALLVMECCD-KSLVNVLENRG--------------------------------------------------- 122 (690)
Q Consensus 95 ~~~~~~~~~~LVmEy~~-gsLl~~L~~~~--------------------------------------------------- 122 (690)
. ....+|+|||||+ |+|.+++....
T Consensus 82 ~---~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (343)
T cd05103 82 K---PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSL 158 (343)
T ss_pred c---CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcc
Confidence 3 3456889999995 57777765421
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhh
Q 005577 123 --------------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL 188 (690)
Q Consensus 123 --------------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~ 188 (690)
...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 236 (343)
T cd05103 159 SDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 236 (343)
T ss_pred ccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchh
Confidence 123678888999999999999999999 9999999999999999999999999986542211110
Q ss_pred hhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH----HHHHhccCCCCCCCC
Q 005577 189 EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESK----LQILNGNYRIPESPK 263 (690)
Q Consensus 189 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~----~~il~~~~~~~~~~~ 263 (690)
......+++.|+|||+ +.+..++.++|||||||++|+|++ |..||..... ...+....+.+.+..
T Consensus 237 -------~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (343)
T cd05103 237 -------RKGDARLPLKWMAPET---IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 306 (343)
T ss_pred -------hcCCCCCCcceECcHH---hcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCC
Confidence 0111235678999996 456678999999999999999996 9999976432 222333333344445
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 264 YSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 264 ~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
+++.+.++|.+||+.||++||++.+|+.++...+
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 7889999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=322.14 Aligned_cols=256 Identities=21% Similarity=0.312 Sum_probs=203.3
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcc----cCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEee
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAI----HMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~----~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~ 96 (690)
+...+|.+.+.||+|+||.||+|.+.. ...+.||||++.... .+..+.+.+|+++|+.+. ||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~- 79 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ-HENIVKFYGVCTE- 79 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcC-CCCchheeeEEec-
Confidence 345678999999999999999998631 235789999986543 335678899999999995 9999999998653
Q ss_pred cCCCceEEEEEecCC-CcHHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEE
Q 005577 97 LGRTKEALLVMECCD-KSLVNVLENRG------------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLL 163 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~-gsLl~~L~~~~------------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NIL 163 (690)
....|+||||+. ++|.+++...+ ...+++..+..++.||+.||.|||.++ |+||||||+|||
T Consensus 80 ---~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nil 154 (280)
T cd05049 80 ---GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCL 154 (280)
T ss_pred ---CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEE
Confidence 367899999995 67777776542 134788999999999999999999999 999999999999
Q ss_pred eCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCC
Q 005577 164 LGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNA 242 (690)
Q Consensus 164 Ld~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~P 242 (690)
++.++.+||+|||+++....... ........+++.|+|||+ +.+..++.++|||||||++|+|++ |..|
T Consensus 155 i~~~~~~kl~d~g~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~il~e~~~~g~~p 224 (280)
T cd05049 155 VGYDLVVKIGDFGMSRDVYTTDY-------YRVGGHTMLPIRWMPPES---IMYRKFTTESDVWSFGVVLWEIFTYGKQP 224 (280)
T ss_pred EcCCCeEEECCcccceecccCcc-------eecCCCCcccceecChhh---hccCCcchhhhHHHHHHHHHHHHhcCCCC
Confidence 99999999999999865322110 001112345788999996 456779999999999999999998 9999
Q ss_pred CCCchHHHHHh---ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 243 FDGESKLQILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 243 F~~~~~~~il~---~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
|.+......+. .......+..++..+.++|.+||+.||++||++.+++..+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 225 WYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 97655444332 22222334578999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=317.13 Aligned_cols=253 Identities=21% Similarity=0.350 Sum_probs=206.0
Q ss_pred EeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 20 iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
++|.+.+|++.++||+|+||.||+|.+ ..++.||+|.+..... ..+.+.+|+.+++++. |+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~--~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~-h~~i~~~~~~~~----- 71 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYY--NGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQ-HPRLVRLYAVVT----- 71 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeec--CCCceEEEEEecCCCC-cHHHHHHHHHHHHhcC-CcCeeeEEEEEc-----
Confidence 467789999999999999999999986 3678899998865432 2467889999999995 999999998742
Q ss_pred CceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 100 TKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
....|+||||+. ++|.+.+.......+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~ 149 (260)
T cd05067 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLA 149 (260)
T ss_pred cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcce
Confidence 346899999995 67888876655556899999999999999999999999 999999999999999999999999988
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---Hhc
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LNG 254 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i---l~~ 254 (690)
......... ......++..|+|||+ +....++.++|||||||++|+|++ |+.||.+.....+ +..
T Consensus 150 ~~~~~~~~~--------~~~~~~~~~~y~~pe~---~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 218 (260)
T cd05067 150 RLIEDNEYT--------AREGAKFPIKWTAPEA---INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER 218 (260)
T ss_pred eecCCCCcc--------cccCCcccccccCHHH---hccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHc
Confidence 654311100 0111245678999996 445678899999999999999998 9999987655443 334
Q ss_pred cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 255 NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 255 ~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
....+.+..++.++.++|.+||..+|++||++.+++..+.
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 219 GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence 4455555678899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.94 Aligned_cols=247 Identities=24% Similarity=0.394 Sum_probs=186.4
Q ss_pred EEEeeecCceEEEEEEEcc-cCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEe
Q 005577 30 RNVIAEGGFSCVYSARDAI-HMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVME 108 (690)
Q Consensus 30 ~~~LG~GgFG~VylA~d~~-~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmE 108 (690)
.++||+|+||+||+|++.. ..++.||+|.+.... ....+.+|+.+|+.+. |||||++++++... ....+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELK-HPNVISLQKVFLSH--ADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcC-CCCCcceeeeEecC--CCcEEEEEEe
Confidence 3579999999999998642 356789999885432 1245678999999995 99999999886532 3457899999
Q ss_pred cCCCcHHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEe----CCCCCeeeeccCC
Q 005577 109 CCDKSLVNVLENRG-------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLL----GSDGLWKLCDFGS 177 (690)
Q Consensus 109 y~~gsLl~~L~~~~-------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILL----d~dg~vKL~DFGl 177 (690)
|++++|..++.... ...+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 81 YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred ccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 99999988876431 124899999999999999999999999 9999999999999 4567899999999
Q ss_pred CCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH---------
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK--------- 248 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~--------- 248 (690)
++......... .......||+.|||||++ .....++.++|||||||++|+|++|+.||.+...
T Consensus 159 a~~~~~~~~~~------~~~~~~~~t~~y~aPE~~--~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~ 230 (317)
T cd07868 159 ARLFNSPLKPL------ADLDPVVVTFWYRAPELL--LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 230 (317)
T ss_pred eeccCCCCccc------cccCCccccccccCCHHH--cCCCCcCchhhHHHHHHHHHHHHhCCCCccCCccccccccccc
Confidence 97643321111 111234689999999973 2335689999999999999999999999964321
Q ss_pred ---H-HHHhc-----------cCCCC-------------------------CCCCCCHHHHHHHHHHhhhCCCCCCCHHH
Q 005577 249 ---L-QILNG-----------NYRIP-------------------------ESPKYSSSVTDLIRDMLQASPDDRPDITQ 288 (690)
Q Consensus 249 ---~-~il~~-----------~~~~~-------------------------~~~~~s~~l~~LI~~~L~~dP~~RPt~~e 288 (690)
. .++.. ....+ .....+..+.+||.+||+.||.+|||+.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e 310 (317)
T cd07868 231 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 310 (317)
T ss_pred HHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHH
Confidence 0 00000 00000 00123567889999999999999999999
Q ss_pred HHH
Q 005577 289 VWF 291 (690)
Q Consensus 289 il~ 291 (690)
++.
T Consensus 311 ~l~ 313 (317)
T cd07868 311 AMQ 313 (317)
T ss_pred Hhc
Confidence 874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=322.18 Aligned_cols=259 Identities=20% Similarity=0.294 Sum_probs=206.5
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcc----cCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAI----HMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~----~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~ 97 (690)
|....|.+.+.||+|+||.||++.+.. .....|++|.+..........+.+|+.+|+++. ||||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--- 77 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ-HEHIVKFYGVCV--- 77 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEe---
Confidence 456789999999999999999998521 234668999887766666778999999999995 999999999865
Q ss_pred CCCceEEEEEecCC-CcHHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeC
Q 005577 98 GRTKEALLVMECCD-KSLVNVLENRG-----------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLG 165 (690)
Q Consensus 98 ~~~~~~~LVmEy~~-gsLl~~L~~~~-----------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd 165 (690)
....+|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||.+| |+||||||+|||++
T Consensus 78 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~ 154 (288)
T cd05093 78 -EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG 154 (288)
T ss_pred -cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc
Confidence 3467899999996 67777776432 124899999999999999999999999 99999999999999
Q ss_pred CCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 005577 166 SDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFD 244 (690)
Q Consensus 166 ~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~ 244 (690)
.++.+||+|||+++....... ........+++.|+|||+ +.+..++.++|||||||++|+|++ |..||.
T Consensus 155 ~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~---~~~~~~~~~sDiwslG~il~~l~t~g~~p~~ 224 (288)
T cd05093 155 ENLLVKIGDFGMSRDVYSTDY-------YRVGGHTMLPIRWMPPES---IMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 224 (288)
T ss_pred cCCcEEeccCCccccccCCce-------eecCCCCCccccccCHHH---hccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999875432110 011112345788999996 456778999999999999999998 999998
Q ss_pred CchHHHHHh---ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 245 GESKLQILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 245 ~~~~~~il~---~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
......++. ..........++..+.+||.+||+.||.+||++.+++..+....
T Consensus 225 ~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 225 QLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred CCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 765544322 22222334468899999999999999999999999987776543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=339.16 Aligned_cols=243 Identities=27% Similarity=0.454 Sum_probs=204.6
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.-|.+.+.||+|-|.+|-+|++. .+|..||||++.+. +.-....+++|+++|+.+. |||||+||.+ ......
T Consensus 18 GLYDLekTlG~GHFAVVKLArHV-FTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQ-HpNiVRLYEV----iDTQTK 91 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHV-FTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ-HPNIVRLYEV----IDTQTK 91 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhh-cccceeEEEEecccccchhhhhHHHHHHHHHHHhc-CcCeeeeeeh----hcccce
Confidence 57999999999999999999995 89999999999765 3444567899999999995 9999999987 224567
Q ss_pred EEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEe-CCCCCeeeeccCCCCc
Q 005577 103 ALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLL-GSDGLWKLCDFGSTST 180 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILL-d~dg~vKL~DFGlA~~ 180 (690)
+|||+|+-+ |+|+++|.++..+ +.|+.+..||.||+.|+.|+|... ||||||||+||.+ ..-|.|||.|||++..
T Consensus 92 lyLiLELGD~GDl~DyImKHe~G-l~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEG-LNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNK 168 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhcc-ccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeecccccc
Confidence 999999996 5899999988754 999999999999999999999999 9999999999877 4568999999998865
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH----HHhccC
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNY 256 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~----il~~~~ 256 (690)
+... ....+.||++.|-|||+ ++...+--+++||||||||||.|++|+.||...+..+ ++...|
T Consensus 169 f~PG----------~kL~TsCGSLAYSAPEI--LLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY 236 (864)
T KOG4717|consen 169 FQPG----------KKLTTSCGSLAYSAPEI--LLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY 236 (864)
T ss_pred CCCc----------chhhcccchhhccCchh--hhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc
Confidence 4321 22335689999999998 3455555678999999999999999999998665544 344455
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHH
Q 005577 257 RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVW 290 (690)
Q Consensus 257 ~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil 290 (690)
.+| ..++.++++||..||..||.+|.+..+|.
T Consensus 237 tvP--shvS~eCrdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 237 TVP--SHVSKECRDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred cCc--hhhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence 544 47899999999999999999999999984
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=319.79 Aligned_cols=253 Identities=19% Similarity=0.290 Sum_probs=200.9
Q ss_pred ceEEEEEEeeecCceEEEEEEEc---ccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDA---IHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~---~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
.+|++.+.||+|+||.||+|.+. ...++.|++|.+... .......+.+|+.+++.+. ||||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~----~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH-HPNIVCLLGVVT----QE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEe----cC
Confidence 56888999999999999999852 134578999988643 3455677889999999995 999999998864 34
Q ss_pred ceEEEEEecCC-CcHHHHHHHhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEe
Q 005577 101 KEALLVMECCD-KSLVNVLENRG---------------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLL 164 (690)
Q Consensus 101 ~~~~LVmEy~~-gsLl~~L~~~~---------------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILL 164 (690)
...|+||||+. ++|.+++..+. ...+++.+++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili 157 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEE
Confidence 67899999996 57777775332 123788999999999999999999999 9999999999999
Q ss_pred CCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 005577 165 GSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAF 243 (690)
Q Consensus 165 d~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF 243 (690)
+.++.+||+|||+++....... ........++..|+|||+ +.+..++.++|||||||++|||++ |..||
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~slG~il~el~~~g~~p~ 227 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADY-------YRVQPKSLLPIRWMPPEA---IMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227 (283)
T ss_pred cCCCcEEeccccccccccCCcc-------eecccCCCccceecChHH---hccCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 9999999999999875432110 001112345778999996 445678999999999999999998 99999
Q ss_pred CCchHHHH---HhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 244 DGESKLQI---LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 244 ~~~~~~~i---l~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
.+.....+ +......+.+..++..+.++|.+||+.||.+||++.+|..++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 228 YGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred CCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 77654333 3333334445678999999999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=317.48 Aligned_cols=252 Identities=21% Similarity=0.334 Sum_probs=202.1
Q ss_pred eecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 21 DVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 21 ei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
++...+|++.+.||+|+||.||+|.+. .+..|++|.+..... ..+.+.+|+.+++++. |+||+++++++. .
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-----~ 72 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN--GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLR-HDKLVQLYAVVS-----E 72 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec--CCceeEEEEecCCCC-CHHHHHHHHHHHHhcC-CCceEEEEeEEC-----C
Confidence 466778999999999999999999874 566799998865432 2356889999999995 999999998752 2
Q ss_pred ceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 101 KEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 101 ~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
...|+||||+. ++|.+++.......+++..++.++.+|+.||.|||+++ |+||||||+|||++.++.++|+|||++.
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~ 150 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLAR 150 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeee
Confidence 45789999996 57878776654445899999999999999999999999 9999999999999999999999999986
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH---hcc
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQIL---NGN 255 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il---~~~ 255 (690)
........ ......++..|+|||+ +.+..++.++|||||||++|+|++ |..||.+.....+. ...
T Consensus 151 ~~~~~~~~--------~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05070 151 LIEDNEYT--------ARQGAKFPIKWTAPEA---ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG 219 (260)
T ss_pred eccCcccc--------cccCCCCCccccChHH---HhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 54221100 0111234678999996 455678999999999999999999 89999876554433 333
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 256 YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 256 ~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
...+.+..++..+.+||.+||.++|.+||++.++...+.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 258 (260)
T cd05070 220 YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258 (260)
T ss_pred CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 444455678899999999999999999999999876554
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=322.89 Aligned_cols=249 Identities=26% Similarity=0.378 Sum_probs=199.9
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALL 105 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~L 105 (690)
-|++.+.||+|+||.||+|.+. ..+..+++|.+........+.+.+|+.+++.+. ||||+++++++.. .+..|+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~----~~~~~~ 79 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNK-ETGVLAAAKVIDTKSEEELEDYMVEIDILASCD-HPNIVKLLDAFYY----ENNLWI 79 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEEC-CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEee----CCEEEE
Confidence 3678899999999999999985 567889999987777777788999999999995 9999999998753 467899
Q ss_pred EEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccc
Q 005577 106 VMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185 (690)
Q Consensus 106 VmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~ 185 (690)
||||+.++.+..+..+....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 99999765554443333345999999999999999999999999 9999999999999999999999999986532211
Q ss_pred hhhhhccccccccccCCCCcccCccchhh--hhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc-----CCC
Q 005577 186 EKLEEMGIEEDNIRKHTTPAYRAPEMWDL--FRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN-----YRI 258 (690)
Q Consensus 186 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~--~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~-----~~~ 258 (690)
. ......+++.|+|||++.. ..+..++.++|||||||++|+|++|+.||........+... ...
T Consensus 158 ~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd06643 158 Q---------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL 228 (282)
T ss_pred c---------ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC
Confidence 1 1112457899999997421 13456788999999999999999999999876554432211 122
Q ss_pred CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
..+..++..+.+||.+||+.||.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 234468899999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=314.20 Aligned_cols=247 Identities=29% Similarity=0.522 Sum_probs=202.3
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
+|++.+.||.|+||.||++.+. ..++.|++|.+... .....+.+.+|+.+++.+. |+||+++++++. ....+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHV-NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK-HPNIVAFKESFE----ADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEc-CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCC-CCCcceEEEEEE----ECCEEE
Confidence 5889999999999999999985 57889999988543 3445677889999999995 999999998865 347899
Q ss_pred EEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 105 LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 105 LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
+||||+. ++|.+++.......+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++.....
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 9999995 57878776654456899999999999999999999999 99999999999999999999999998865422
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh---ccCCCCC
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN---GNYRIPE 260 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~---~~~~~~~ 260 (690)
... ......|++.|+|||+ +.+..++.++|||||||++|+|++|..||.......... .....+.
T Consensus 153 ~~~---------~~~~~~~~~~~~aPE~---~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 220 (255)
T cd08219 153 PGA---------YACTYVGTPYYVPPEI---WENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL 220 (255)
T ss_pred ccc---------ccccccCCccccCHHH---HccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC
Confidence 110 1112457899999996 445668999999999999999999999998766543322 2222233
Q ss_pred CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 261 SPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 261 ~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
+..++..+.+||.+||+.||++||++.+++.+
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 45688999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=324.23 Aligned_cols=265 Identities=20% Similarity=0.312 Sum_probs=210.8
Q ss_pred ceEeecCceEEEEEEeeecCceEEEEEEEc------ccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEE
Q 005577 18 RSIDVGNLKIHVRNVIAEGGFSCVYSARDA------IHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLY 90 (690)
Q Consensus 18 ~~iei~~~ry~v~~~LG~GgFG~VylA~d~------~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~ 90 (690)
..+++...+|++.+.||+|+||.||+|++. ......|++|.+... .......+.+|+.+++.+.+||||++++
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchhee
Confidence 456788999999999999999999999752 123457899988643 3445678889999999996699999999
Q ss_pred EEEEeecCCCceEEEEEecCC-CcHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccC
Q 005577 91 AHTILDLGRTKEALLVMECCD-KSLVNVLENRGA--------------GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHR 155 (690)
Q Consensus 91 ~~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~--------------~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHR 155 (690)
+++. .....|+||||+. |+|.+++..+.. ..++...++.++.||+.||.|||++| |+||
T Consensus 88 ~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~ 161 (304)
T cd05101 88 GACT----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHR 161 (304)
T ss_pred EEEe----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeec
Confidence 9865 3467899999995 577777765421 24778889999999999999999999 9999
Q ss_pred CCCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHH
Q 005577 156 DLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFR 235 (690)
Q Consensus 156 DLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyE 235 (690)
||||+|||++.++.+||+|||+++........ .......+++.|+|||+ +.+..++.++|||||||++|+
T Consensus 162 dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~~l~e 231 (304)
T cd05101 162 DLAARNVLVTENNVMKIADFGLARDVNNIDYY-------KKTTNGRLPVKWMAPEA---LFDRVYTHQSDVWSFGVLMWE 231 (304)
T ss_pred ccccceEEEcCCCcEEECCCccceeccccccc-------ccccCCCCCceeeCchh---hccCCCCchhhHHHHHHHHHH
Confidence 99999999999999999999998754321110 01112345778999996 445678999999999999999
Q ss_pred HHh-CCCCCCCchHHHHH---hccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhcC
Q 005577 236 ICY-FKNAFDGESKLQIL---NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLP 298 (690)
Q Consensus 236 Llt-G~~PF~~~~~~~il---~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l~ 298 (690)
|++ |..||.+....++. ....+...+..++..+.+||.+||..+|.+||++.+++..+.+.+.
T Consensus 232 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 232 IFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 998 88899876655443 3333444456789999999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.74 Aligned_cols=256 Identities=23% Similarity=0.327 Sum_probs=202.0
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC--C
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR--T 100 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~--~ 100 (690)
...+|++.+.||+|+||.||+|.+. ..++.||+|++.... .....+.+|+.++..+.+|+||+++++++...... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEc-CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3567889999999999999999985 678899999986543 23456788999999986699999999987654221 2
Q ss_pred ceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 101 KEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 101 ~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
..+|+||||+. ++|.+++.......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCce
Confidence 46899999996 57777776644456899999999999999999999999 9999999999999999999999999986
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhh--hcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh----
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLF--RRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN---- 253 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~--~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~---- 253 (690)
...... .......|++.|+|||++... .+..++.++|||||||++|+|++|..||..........
T Consensus 160 ~~~~~~---------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~ 230 (272)
T cd06637 160 QLDRTV---------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 230 (272)
T ss_pred eccccc---------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc
Confidence 532211 112234689999999974321 13468889999999999999999999997654433221
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 254 GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 254 ~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
..........++..+.+||.+||..+|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11222223467899999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=323.18 Aligned_cols=251 Identities=27% Similarity=0.405 Sum_probs=201.5
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
+..|++.+.||.|+||.||+|++. ..++.|++|.+...+....+.+.+|+.+++.+. ||||+++++++.. .+.+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----~~~~ 84 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNK-ETGALAAAKVIETKSEEELEDYMVEIEILATCN-HPYIVKLLGAFYW----DGKL 84 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEEC-CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEe----CCeE
Confidence 467999999999999999999985 568899999998877777888999999999995 9999999998753 3678
Q ss_pred EEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 104 LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
|+||||+.|+++..+.......+++..++.++.||+.+|.|||..+ |+||||||+|||++.++.++|+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 9999999766554443333345899999999999999999999999 99999999999999999999999998754321
Q ss_pred cchhhhhccccccccccCCCCcccCccchhh--hhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC-----
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDL--FRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY----- 256 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~--~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~----- 256 (690)
.. .......+++.|+|||++.. .....++.++|||||||++|+|++|..||........+....
T Consensus 163 ~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 233 (292)
T cd06644 163 TL---------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP 233 (292)
T ss_pred cc---------cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc
Confidence 11 01112357889999997421 123457889999999999999999999997765443322211
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 ~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
....+..++..+.+||.+||..+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 12223467889999999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=352.82 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=211.7
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
+..|.|+..||.|+||.||+|..+ .++-..|.|+|.....+.+++++-||.||..+ +||+||+||+.+.++ +.+
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nk-et~~lAAaKvIetkseEELEDylVEIeILa~C-dHP~ivkLl~ayy~e----nkL 104 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNK-ETKLLAAAKVIETKSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFE----NKL 104 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcc-cchhhhhhhhhcccchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhcc----Cce
Confidence 345778889999999999999886 56666788888888888999999999999999 599999999887654 789
Q ss_pred EEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 104 LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
+|+.|||+|+-.+.+.-.-...|.+.++..+++|+|.||.|||+++ |||||||..|||++-+|.++|+|||.+..+..
T Consensus 105 wiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 105 WILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred EEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchh
Confidence 9999999888777665544456999999999999999999999999 99999999999999999999999998754322
Q ss_pred cchhhhhccccccccccCCCCcccCccchh--hhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCC----
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWD--LFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYR---- 257 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~--~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~---- 257 (690)
.. .....++|||.||||||+. .+...+|++++||||||++|.||..+.+|....++..++..+-.
T Consensus 183 t~---------qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePP 253 (1187)
T KOG0579|consen 183 TR---------QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP 253 (1187)
T ss_pred HH---------hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCC
Confidence 11 1122468999999999853 34567899999999999999999999999998888877644332
Q ss_pred -CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 -IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 -~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
+-.+...+..+.+|+.+||.+||..||++++++.
T Consensus 254 TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 254 TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 2234567899999999999999999999999964
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=316.89 Aligned_cols=256 Identities=19% Similarity=0.316 Sum_probs=200.1
Q ss_pred EEEEEEeeecCceEEEEEEEcccCC--eEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecC--CC
Q 005577 27 IHVRNVIAEGGFSCVYSARDAIHMS--KQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLG--RT 100 (690)
Q Consensus 27 y~v~~~LG~GgFG~VylA~d~~~~~--k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~--~~ 100 (690)
|.+.++||+|+||.||+|.+. ..+ ..||+|.+... .....+.+.+|+.+|+.+ +||||+++++++..... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~-~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLN-QDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEc-cCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCC
Confidence 356789999999999999875 233 36899987543 455577889999999999 49999999998754322 22
Q ss_pred ceEEEEEecCC-CcHHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeecc
Q 005577 101 KEALLVMECCD-KSLVNVLENR----GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDF 175 (690)
Q Consensus 101 ~~~~LVmEy~~-gsLl~~L~~~----~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DF 175 (690)
...++||||+. |+|.+++... ....+++..++.++.||+.||.|||.++ |+||||||+|||++.++.+||+||
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCC
Confidence 35789999995 6777666432 2234899999999999999999999999 999999999999999999999999
Q ss_pred CCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI--- 251 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i--- 251 (690)
|+++........ .......+++.|++||+ ..+..++.++|||||||++|+|++ |..||.+.....+
T Consensus 157 g~~~~~~~~~~~-------~~~~~~~~~~~~~~pe~---~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 226 (272)
T cd05075 157 GLSKKIYNGDYY-------RQGRIAKMPVKWIAIES---LADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY 226 (272)
T ss_pred CcccccCcccce-------ecCCcccCCcccCCHHH---ccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 998764321100 01112245778999996 556678999999999999999999 8999987655443
Q ss_pred HhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhh
Q 005577 252 LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 252 l~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~ 296 (690)
+......+..+.++..+.++|.+||+.||++||++.+++..+...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 227 LRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 223333344567889999999999999999999999999887753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=318.14 Aligned_cols=258 Identities=21% Similarity=0.296 Sum_probs=204.9
Q ss_pred EeecCceEEEEEEeeecCceEEEEEEEcc----cCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEE
Q 005577 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAI----HMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTI 94 (690)
Q Consensus 20 iei~~~ry~v~~~LG~GgFG~VylA~d~~----~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~ 94 (690)
+++...+|++.+.||+|+||.||+|.+.. ...+.|++|.+.... ......+.+|+.+|+.+ +||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEc
Confidence 35677899999999999999999998742 234789999986543 34456788999999999 5999999999865
Q ss_pred eecCCCceEEEEEecCC-CcHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeC
Q 005577 95 LDLGRTKEALLVMECCD-KSLVNVLENRG--------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLG 165 (690)
Q Consensus 95 ~~~~~~~~~~LVmEy~~-gsLl~~L~~~~--------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd 165 (690)
.....|+||||+. |+|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 80 ----~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~ 153 (277)
T cd05032 80 ----TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVA 153 (277)
T ss_pred ----CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEc
Confidence 3467899999995 67887776532 123688899999999999999999999 99999999999999
Q ss_pred CCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 005577 166 SDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFD 244 (690)
Q Consensus 166 ~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~ 244 (690)
.++.+||+|||+++....... ........++..|+|||+ +.+..++.++|||||||++|+|++ |..||.
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 223 (277)
T cd05032 154 EDLTVKIGDFGMTRDIYETDY-------YRKGGKGLLPVRWMAPES---LKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223 (277)
T ss_pred CCCCEEECCcccchhhccCcc-------cccCCCCCccccccCHHH---HhcCCCCcccchHHHHHHHHHhhccCCCCCc
Confidence 999999999999865432110 011122346789999996 456678999999999999999998 999998
Q ss_pred CchHHHHH---hccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 245 GESKLQIL---NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 245 ~~~~~~il---~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
+....... ........+..++..+.++|.+||+.+|++||++.+++..+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 224 GLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 76554432 222233345567999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=314.25 Aligned_cols=250 Identities=27% Similarity=0.444 Sum_probs=199.7
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
..+|++.+.||.|+||.||+|.+. ..++.+++|++..........+.+|+.+++.+. ||||+++++++. ....+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~----~~~~~ 75 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDI-ATGELVAIKVIKLEPGDDFEIIQQEISMLKECR-HPNIVAYFGSYL----RRDKL 75 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEec-CCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCC-CCChhceEEEEE----eCCEE
Confidence 357999999999999999999985 567889999998776667788999999999995 999999998865 34679
Q ss_pred EEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
|+||||+++ +|.+++... ...+++.+++.++.||+.||.|||..+ |+|+||||+||+++.++.+||+|||++....
T Consensus 76 ~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred EEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhh
Confidence 999999976 555555443 345999999999999999999999999 9999999999999999999999999886532
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH----hccCC-
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL----NGNYR- 257 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il----~~~~~- 257 (690)
.... ......++..|+|||++.......++.++|||||||++|+|++|+.||......... ...+.
T Consensus 153 ~~~~---------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 223 (262)
T cd06613 153 ATIA---------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP 223 (262)
T ss_pred hhhh---------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Confidence 2110 111235788999999743222237889999999999999999999999876543321 12111
Q ss_pred --CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 --IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 --~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
......++..+.++|.+||..+|.+||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1123356788999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=318.93 Aligned_cols=258 Identities=21% Similarity=0.371 Sum_probs=203.0
Q ss_pred cCceEEEEEEeeecCceEEEEEEEc---ccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDA---IHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~---~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
...+|++.+.||+|+||.||++... ...++.|++|.+........+.+.+|+++|+.+. |||||++++++... .
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~ 78 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA--G 78 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccC--C
Confidence 3568999999999999999999742 2467889999987777777788999999999995 99999999876532 3
Q ss_pred CceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 100 TKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
...+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||.+| |+||||||+||||+.++.+||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCccc
Confidence 456899999995 67777775543 34899999999999999999999999 999999999999999999999999998
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH----------
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK---------- 248 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~---------- 248 (690)
+.......... ......++..|+|||+ +.+..++.++|||||||++|||++|..++.....
T Consensus 156 ~~~~~~~~~~~------~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd05081 156 KVLPQDKEYYK------VREPGESPIFWYAPES---LTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDK 226 (284)
T ss_pred ccccCCCccee------ecCCCCCceEeeCHHH---hccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccc
Confidence 76432211000 0001123456999996 4566789999999999999999998766543211
Q ss_pred ---------HHHHhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhh
Q 005577 249 ---------LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 249 ---------~~il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~ 295 (690)
...+......+....++..+.+||.+||..+|++||++.+++..+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 227 QGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred ccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 11223333444556788999999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=314.99 Aligned_cols=247 Identities=24% Similarity=0.395 Sum_probs=196.8
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
.+|++.+.||+|+||.||++.+. ....+|+|.+.... ...+.+.+|+.+|+.+. ||||+++++++. .....|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~--~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~~~~~ 75 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR--AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLS-HPKLVQLYGVCT----QQKPLY 75 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec--cCceEEEEecccCC-ccHHHHHHHHHHHHHCC-CCCceeEEEEEc----cCCCEE
Confidence 56888999999999999999874 45679999875432 22457888999999995 999999998864 346789
Q ss_pred EEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 105 LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 105 LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
+||||+. |+|.+.+.... +.+++..++.++.||+.||.|||.++ |+||||||+||+++.++.+||+|||+++....
T Consensus 76 iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 76 IVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD 152 (256)
T ss_pred EEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence 9999996 56777765433 35899999999999999999999999 99999999999999999999999998865422
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHhc---cCCCC
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQILNG---NYRIP 259 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il~~---~~~~~ 259 (690)
... .......++..|+|||+ +.+..++.++|||||||++|+|++ |+.||......+.+.. ..+..
T Consensus 153 ~~~--------~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~ 221 (256)
T cd05114 153 DEY--------TSSSGAKFPVKWSPPEV---FNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY 221 (256)
T ss_pred Cce--------eccCCCCCchhhCChhh---cccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC
Confidence 110 00111234678999997 445678899999999999999999 8999987665544322 22333
Q ss_pred CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 260 ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 260 ~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
.+...+..+.+||.+||+.+|.+||++.+++..+
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 3455788999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=320.78 Aligned_cols=250 Identities=28% Similarity=0.406 Sum_probs=209.9
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--------CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEe
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--------DEESLESAMKEISVMKSLKGHPNVVTLYAHTIL 95 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--------~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~ 95 (690)
...|.-.+.||.|..++|-++.+. .+++.+|+|++... -.+-++...+|+.||+++.+||||++|.+++.
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k-~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye- 93 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHK-ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE- 93 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhc-ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc-
Confidence 347888899999999999999886 68899999998542 12345667789999999999999999998854
Q ss_pred ecCCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeec
Q 005577 96 DLGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCD 174 (690)
Q Consensus 96 ~~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~D 174 (690)
....+++|+|.|. |.|.++|...-. +++++.+.|++||+.|++|||.++ ||||||||+|||++++.++||+|
T Consensus 94 ---s~sF~FlVFdl~prGELFDyLts~Vt--lSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 94 ---SDAFVFLVFDLMPRGELFDYLTSKVT--LSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred ---CcchhhhhhhhcccchHHHHhhhhee--ecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEec
Confidence 4467889999995 889999987765 999999999999999999999999 99999999999999999999999
Q ss_pred cCCCCcccccchhhhhccccccccccCCCCcccCccchhhh---hcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 005577 175 FGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLF---RRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI 251 (690)
Q Consensus 175 FGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~---~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~i 251 (690)
||+++.+... .++. ..||||+|+|||.+.+. ....|+..+|+|++|||+|.||.|.+||......-+
T Consensus 167 FGFa~~l~~G-ekLr---------elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM 236 (411)
T KOG0599|consen 167 FGFACQLEPG-EKLR---------ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM 236 (411)
T ss_pred cceeeccCCc-hhHH---------HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH
Confidence 9999876542 2333 24799999999986433 235688999999999999999999999976554332
Q ss_pred ----HhccC--CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 252 ----LNGNY--RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 252 ----l~~~~--~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
+.+.+ +.+...+++...++||.+||+.||.+|.|+.|++.+
T Consensus 237 LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 237 LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 34444 456678999999999999999999999999998653
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=340.66 Aligned_cols=254 Identities=26% Similarity=0.402 Sum_probs=195.5
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc-
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK- 101 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~- 101 (690)
.-..|.-.++||+||||.||+|... .+..||||++.........+|.+|+.+|.+++ |||||+|+|||... +
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~--~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~----~~ 145 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLS--DGTVVAVKRLSSNSGQGEREFLNEVEILSRLR-HPNLVKLLGYCLEG----GE 145 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEEC--CCCEEEEEEecCCCCcchhHHHHHHHHHhcCC-CcCcccEEEEEecC----Cc
Confidence 3456777789999999999999873 55899999876554321344999999999997 99999999999743 4
Q ss_pred eEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 102 EALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSP-PIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~-~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
..+||+|||. |+|.+.|.......|+|...+.|+.+++.||+|||.... +|||||||+.|||||.++.+||+|||+|+
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK 225 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence 5899999995 788888877553269999999999999999999999753 79999999999999999999999999996
Q ss_pred cccccchhhhhcccccccccc-CCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch------HHH--
Q 005577 180 TNHKRFEKLEEMGIEEDNIRK-HTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES------KLQ-- 250 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~-~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~------~~~-- 250 (690)
..... . ...... .||.+|+|||. ...+.++.++|||||||+|+||++|+.+.+... ..+
T Consensus 226 ~~~~~-~--------~~~~~~~~gt~gY~~PEy---~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~ 293 (361)
T KOG1187|consen 226 LGPEG-D--------TSVSTTVMGTFGYLAPEY---ASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA 293 (361)
T ss_pred cCCcc-c--------cceeeecCCCCccCChhh---hccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence 53220 0 000111 68999999995 556789999999999999999999998877421 111
Q ss_pred --HHhc-cC-CCCC---C-CCCC-----HHHHHHHHHHhhhCCCCCCCHHHHHHHHhh
Q 005577 251 --ILNG-NY-RIPE---S-PKYS-----SSVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 251 --il~~-~~-~~~~---~-~~~s-----~~l~~LI~~~L~~dP~~RPt~~eil~~l~~ 295 (690)
.+.. .+ .+.. . ..++ ..+..+..+|++.+|.+||++.+++..+..
T Consensus 294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~ 351 (361)
T KOG1187|consen 294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG 351 (361)
T ss_pred HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence 1111 11 0000 0 1233 224567899999999999999999777643
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=322.22 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=200.8
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCC--eEEEEEEeec-CCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMS--KQYAMKHMIC-NDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~--k~vAvK~i~~-~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|++.++||+|+||.||+|.+. ..+ ..+++|.+.. ......+.+.+|+.++.++.+||||+++++++. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~----~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIK-KDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE----NRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEec-CCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc----cCC
Confidence 47899999999999999999875 233 3468887764 344456778999999999966999999999864 345
Q ss_pred eEEEEEecCC-CcHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCC
Q 005577 102 EALLVMECCD-KSLVNVLENRG--------------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS 166 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~--------------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~ 166 (690)
.+|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~ 154 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGE 154 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECC
Confidence 7899999995 67888886532 124889999999999999999999999 999999999999999
Q ss_pred CCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 005577 167 DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDG 245 (690)
Q Consensus 167 dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~ 245 (690)
++.+||+|||++........ ......+..|+|||+ ..+..++.++|||||||++|+|++ |..||..
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~---~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~ 221 (297)
T cd05089 155 NLASKIADFGLSRGEEVYVK----------KTMGRLPVRWMAIES---LNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG 221 (297)
T ss_pred CCeEEECCcCCCccccceec----------cCCCCcCccccCchh---hccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999998854221100 001123567999996 455678999999999999999997 9999987
Q ss_pred chHHHHHh---ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 246 ESKLQILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 246 ~~~~~il~---~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
.....+.. ..+....+..++..+.+||.+||..+|.+||++.+++..+...+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 222 MTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred CCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 66544332 23334445578999999999999999999999999988776554
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=317.74 Aligned_cols=265 Identities=22% Similarity=0.317 Sum_probs=204.4
Q ss_pred CCCceEee-----cCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEE
Q 005577 15 LEGRSIDV-----GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTL 89 (690)
Q Consensus 15 ~~g~~iei-----~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL 89 (690)
+.|+.|.+ ...+|++.+.||+|+||.||+|.+. ..++.|++|++.... .....+.+|+.+++.+.+||||+++
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~ 80 (286)
T cd06638 3 LSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNK-KNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKF 80 (286)
T ss_pred CCCceEEeecCCCcccceeeeeeeccCCCcEEEEEEEC-CCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeee
Confidence 45555555 5679999999999999999999985 568899999875432 2235677899999999669999999
Q ss_pred EEEEEeec-CCCceEEEEEecCC-CcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeC
Q 005577 90 YAHTILDL-GRTKEALLVMECCD-KSLVNVLENR--GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLG 165 (690)
Q Consensus 90 ~~~~~~~~-~~~~~~~LVmEy~~-gsLl~~L~~~--~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd 165 (690)
++++.... ...+.+|+||||++ ++|.+++... ....+++..++.++.||+.||.|||..+ |+||||||+|||++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~ 158 (286)
T cd06638 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLT 158 (286)
T ss_pred eeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEEC
Confidence 99875322 34567899999996 4666665432 2245899999999999999999999999 99999999999999
Q ss_pred CCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhh--hcCCCCchhhHHHHHHHHHHHHhCCCCC
Q 005577 166 SDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLF--RRELINEKVDIWALGCLLFRICYFKNAF 243 (690)
Q Consensus 166 ~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~--~~~~~s~ksDVwSLGviLyELltG~~PF 243 (690)
.++.++|+|||+++...... .......|++.|+|||++... .+..++.++|||||||++|+|++|+.||
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~ 229 (286)
T cd06638 159 TEGGVKLVDFGVSAQLTSTR---------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229 (286)
T ss_pred CCCCEEEccCCceeecccCC---------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCC
Confidence 99999999999886542210 011123589999999975311 2345788999999999999999999999
Q ss_pred CCchHHHHHhccC-----CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 244 DGESKLQILNGNY-----RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 244 ~~~~~~~il~~~~-----~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
........+.... ....+..++..+.+||.+||+.||++||++.+++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 230 ADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 8765443322211 111233467899999999999999999999999754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=331.17 Aligned_cols=235 Identities=26% Similarity=0.381 Sum_probs=187.6
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
++||+|+||.||+|++. ..++.||+|++... +....+.+.+|+.++.++.+||||+++++++. ..+.+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~----~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK-KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ----TTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE----eCCEEEEEE
Confidence 46999999999999985 67889999999653 34456678899999999977999999998764 346899999
Q ss_pred ecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccch
Q 005577 108 ECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 108 Ey~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~ 186 (690)
||+. |+|...+.... .+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 76 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-- 149 (327)
T cd05617 76 EYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-- 149 (327)
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCC--
Confidence 9996 56666665443 4999999999999999999999999 999999999999999999999999988642111
Q ss_pred hhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch------HHH-HHh--ccCC
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES------KLQ-ILN--GNYR 257 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~------~~~-il~--~~~~ 257 (690)
.......+||+.|+|||+ +.+..++.++|||||||+||+|++|..||.... ... +.. ....
T Consensus 150 -------~~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 219 (327)
T cd05617 150 -------GDTTSTFCGTPNYIAPEI---LRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP 219 (327)
T ss_pred -------CCceecccCCcccCCHHH---HCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC
Confidence 011123568999999996 456778999999999999999999999995311 111 111 1112
Q ss_pred CCCCCCCCHHHHHHHHHHhhhCCCCCCCH
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPDI 286 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~~L~~dP~~RPt~ 286 (690)
...+..++..+.++|.+||..||.+|+++
T Consensus 220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 220 IRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 23345688999999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.64 Aligned_cols=250 Identities=25% Similarity=0.415 Sum_probs=199.6
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
...+|++.+.||+|+||.||+|.+. ..++.|++|++..........+.+|+.+++.+ +||||+++++++.. .+.
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~----~~~ 80 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNV-NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLR----RDK 80 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEc-CCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe----CCE
Confidence 3457888999999999999999985 57889999998776655667788999999999 49999999998653 467
Q ss_pred EEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
+|+||||+++ +|.+++...+ .+++.+++.++.||+.||.|||..| |+||||||+|||++.++.++|+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 81 LWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQI 156 (267)
T ss_pred EEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence 8999999965 6777665544 4999999999999999999999999 999999999999999999999999988543
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH----hccCC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL----NGNYR 257 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il----~~~~~ 257 (690)
.... .......|++.|+|||++.......++.++|||||||++|+|++|..||........+ .....
T Consensus 157 ~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd06645 157 TATI---------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ 227 (267)
T ss_pred cCcc---------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC
Confidence 2211 1112246899999999743223456889999999999999999999998654332211 11121
Q ss_pred CC---CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 IP---ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 ~~---~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.+ ....++..+.++|.+||+.+|++||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 228 PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11 12357889999999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.77 Aligned_cols=259 Identities=20% Similarity=0.274 Sum_probs=206.7
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcc----cCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAI----HMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~----~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~ 97 (690)
+...+|.+.+.||+|+||.||+|.+.. .....+++|.+..........+.+|+.+++.+. ||||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--- 77 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ-HEHIVKFYGVCG--- 77 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCC-CCCcceEEEEEc---
Confidence 345679999999999999999998531 245678999887666666678889999999995 999999999865
Q ss_pred CCCceEEEEEecCC-CcHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcE
Q 005577 98 GRTKEALLVMECCD-KSLVNVLENRG--------------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENL 162 (690)
Q Consensus 98 ~~~~~~~LVmEy~~-gsLl~~L~~~~--------------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NI 162 (690)
.....++||||+. ++|.+++.... .+.+++..++.++.||+.||.|||.++ |+||||||+||
T Consensus 78 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Ni 154 (291)
T cd05094 78 -DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNC 154 (291)
T ss_pred -cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceE
Confidence 3467899999995 67777776532 134889999999999999999999999 99999999999
Q ss_pred EeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCC
Q 005577 163 LLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKN 241 (690)
Q Consensus 163 LLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~ 241 (690)
|++.++.++|+|||+++....... ........++..|+|||+ +.+..++.++|||||||++|+|++ |+.
T Consensus 155 l~~~~~~~~l~dfg~a~~~~~~~~-------~~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~il~el~t~g~~ 224 (291)
T cd05094 155 LVGANLLVKIGDFGMSRDVYSTDY-------YRVGGHTMLPIRWMPPES---IMYRKFTTESDVWSFGVILWEIFTYGKQ 224 (291)
T ss_pred EEccCCcEEECCCCcccccCCCce-------eecCCCCCcceeecChHH---hccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999865432110 011122346788999996 456778999999999999999998 999
Q ss_pred CCCCchHHHHHh---ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 242 AFDGESKLQILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 242 PF~~~~~~~il~---~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
||.......++. ..........++..+.++|.+||+.+|.+||++.+++..+....
T Consensus 225 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 225 PWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred CCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 997765544332 22222334567899999999999999999999999998887653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=314.49 Aligned_cols=252 Identities=21% Similarity=0.349 Sum_probs=202.3
Q ss_pred eecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 21 DVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 21 ei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
++...+|++...||+|+||.||+|.+. .+..+++|.+.... ...+.+.+|+.+++.+. ||||+++++++. .
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-----~ 72 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWN--GTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLR-HDKLVPLYAVVS-----E 72 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEc--CCceEEEEEcccCC-ccHHHHHHHHHHHHhCC-CCCeeeEEEEEc-----C
Confidence 456678999999999999999999874 44569999875433 23466888999999995 999999988752 3
Q ss_pred ceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 101 KEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 101 ~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
...|+||||+. ++|.+++.......+++..++.++.||+.||.|||..+ |+||||||+|||++.++.++|+|||+++
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccce
Confidence 45789999996 57888887655455899999999999999999999999 9999999999999999999999999986
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---Hhcc
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LNGN 255 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i---l~~~ 255 (690)
....... .......++..|+|||+ ..+..++.++|||||||++|+|++ |..||.+...... +...
T Consensus 151 ~~~~~~~--------~~~~~~~~~~~y~~Pe~---~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05069 151 LIEDNEY--------TARQGAKFPIKWTAPEA---ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG 219 (260)
T ss_pred EccCCcc--------cccCCCccchhhCCHHH---hccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 5422110 00111235678999995 455678999999999999999999 9999987654433 2333
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 256 YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 256 ~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
+..+.+..++..+.++|.+||.+||.+||++.+++..+.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 258 (260)
T cd05069 220 YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258 (260)
T ss_pred CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 444445678999999999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=315.31 Aligned_cols=256 Identities=23% Similarity=0.356 Sum_probs=202.0
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec--CCC
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL--GRT 100 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~--~~~ 100 (690)
..++|++.+.||.|+||.||+|.+. ..++.|++|++..... ..+.+.+|+.+++++.+|+||+++++++.... ...
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHK-KTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEEC-CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4579999999999999999999985 5678899998876544 34678899999999967999999999876543 235
Q ss_pred ceEEEEEecCCC-cHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCC
Q 005577 101 KEALLVMECCDK-SLVNVLENRG--AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS 177 (690)
Q Consensus 101 ~~~~LVmEy~~g-sLl~~L~~~~--~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGl 177 (690)
..+|+||||+.+ +|.+++.... ...+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCcc
Confidence 568999999975 6666665433 356999999999999999999999999 99999999999999999999999998
Q ss_pred CCcccccchhhhhccccccccccCCCCcccCccchhhh--hcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLF--RRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN 255 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~--~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~ 255 (690)
+........ ......|++.|+|||++... ....++.++|||||||+||+|++|+.||........+...
T Consensus 160 ~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 230 (275)
T cd06608 160 SAQLDSTLG---------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230 (275)
T ss_pred ceecccchh---------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh
Confidence 865432111 11124578999999975321 1345788999999999999999999999765433322221
Q ss_pred C-----CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 256 Y-----RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 256 ~-----~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
. .......++..+.+||.+||..||++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 11222347889999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=317.01 Aligned_cols=261 Identities=13% Similarity=0.233 Sum_probs=209.7
Q ss_pred EeecCceEEEEEEeeecCceEEEEEEEccc---CCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEe
Q 005577 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIH---MSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTIL 95 (690)
Q Consensus 20 iei~~~ry~v~~~LG~GgFG~VylA~d~~~---~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~ 95 (690)
|.+...+|++.++||+|+||.||+|.+... ....|++|++... .....+.+.+|+.+|+.| +||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~ 79 (280)
T cd05043 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIE 79 (280)
T ss_pred CccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec
Confidence 467889999999999999999999998531 2678999988654 445567888999999999 59999999998653
Q ss_pred ecCCCceEEEEEecCC-CcHHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCC
Q 005577 96 DLGRTKEALLVMECCD-KSLVNVLENRGA------GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG 168 (690)
Q Consensus 96 ~~~~~~~~~LVmEy~~-gsLl~~L~~~~~------~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg 168 (690)
+ ....+++++|+. ++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 80 ~---~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~ 154 (280)
T cd05043 80 D---GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEEL 154 (280)
T ss_pred C---CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCC
Confidence 2 456789999996 677777765322 35899999999999999999999999 99999999999999999
Q ss_pred CeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 005577 169 LWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGES 247 (690)
Q Consensus 169 ~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~ 247 (690)
.+||+|||+++.+....... ......++..|+|||+ +.+..++.++|||||||++|++++ |+.||....
T Consensus 155 ~~kl~d~g~~~~~~~~~~~~-------~~~~~~~~~~y~apE~---~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 224 (280)
T cd05043 155 QVKITDNALSRDLFPMDYHC-------LGDNENRPVKWMALES---LVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID 224 (280)
T ss_pred cEEECCCCCcccccCCceEE-------eCCCCCcchhccCHHH---HhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC
Confidence 99999999987542211000 0111245778999996 455678999999999999999998 999998765
Q ss_pred HHHHH---hccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhh
Q 005577 248 KLQIL---NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 248 ~~~il---~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~ 296 (690)
..++. ...........+++.+.++|.+||..||++||++.+++..+...
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 225 PFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 54432 33444455567899999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=336.31 Aligned_cols=233 Identities=26% Similarity=0.417 Sum_probs=184.7
Q ss_pred eeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhc--CCCCceEEEEEEEeecCCCceEEEEE
Q 005577 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLK--GHPNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 33 LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~--~HPNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
||+|+||+||+|++. ..++.||||++... .......+..|..++..+. +||||+++++++. ....+||||
T Consensus 1 lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~----~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKK-DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ----TDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe----cCCeEEEEE
Confidence 799999999999985 57889999998643 2233445666777777664 6999999998764 347899999
Q ss_pred ecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccch
Q 005577 108 ECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 108 Ey~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~ 186 (690)
||+. |+|...+.... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 76 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~- 150 (330)
T cd05586 76 DYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDN- 150 (330)
T ss_pred cCCCCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-
Confidence 9995 56777776543 4999999999999999999999999 9999999999999999999999999986432110
Q ss_pred hhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc----cCCCCCCC
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG----NYRIPESP 262 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~----~~~~~~~~ 262 (690)
......+||+.|||||++ .....++.++|||||||++|+|++|+.||.+....++... ...++ ..
T Consensus 151 --------~~~~~~~gt~~y~aPE~~--~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~ 219 (330)
T cd05586 151 --------KTTNTFCGTTEYLAPEVL--LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP-KN 219 (330)
T ss_pred --------CCccCccCCccccCHHHH--cCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC-Cc
Confidence 111235689999999973 2334578999999999999999999999988765544332 22222 23
Q ss_pred CCCHHHHHHHHHHhhhCCCCCCCH
Q 005577 263 KYSSSVTDLIRDMLQASPDDRPDI 286 (690)
Q Consensus 263 ~~s~~l~~LI~~~L~~dP~~RPt~ 286 (690)
.++..+.+||.+||..||.+||+.
T Consensus 220 ~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 220 VLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred cCCHHHHHHHHHHcCCCHHHCCCC
Confidence 578999999999999999999853
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.88 Aligned_cols=246 Identities=27% Similarity=0.395 Sum_probs=201.7
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
+|.+.+.||+|+||.||+|.+. ..++.|++|.+... .......+.+|+.+++.+. ||||+++++++. ..+..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~~~~ 74 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRK-ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD-SSYIIRYYESFL----DKGKL 74 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEc-CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcC-CCCeehheeeec----cCCEE
Confidence 4788999999999999999985 56889999988643 3455678889999999995 999999999865 34688
Q ss_pred EEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
|+||||+. ++|.+++.......+++..++.++.+|+.||.|||..+ |+||||||+|||++.++.++|+|||++....
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~ 152 (256)
T cd08529 75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS 152 (256)
T ss_pred EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceecc
Confidence 99999995 57878777654456999999999999999999999999 9999999999999999999999999886543
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc---CCCC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN---YRIP 259 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~---~~~~ 259 (690)
.... ......|++.|+|||+ ..+..++.++|||||||++|+|++|+.||............ ...+
T Consensus 153 ~~~~---------~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 220 (256)
T cd08529 153 DNTN---------FANTIVGTPYYLSPEL---CEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP 220 (256)
T ss_pred Cccc---------hhhccccCccccCHHH---hcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 2110 1112357899999996 45667889999999999999999999999877654433221 1222
Q ss_pred CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 260 ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 260 ~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
....++..+.++|.+||+.+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 23367899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=331.17 Aligned_cols=251 Identities=21% Similarity=0.295 Sum_probs=194.9
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|++.+.||+|+||.||++++. ..++.||||++... .....+.+.+|+.++..+ +|+||+++++++. ..+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~----~~~ 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMK-NTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQ----DEN 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEe----cCC
Confidence 37899999999999999999985 56889999998642 223455678899999998 5999999998765 457
Q ss_pred eEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
.+||||||+. |+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++..
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 151 (331)
T cd05597 75 NLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLR 151 (331)
T ss_pred eEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceee
Confidence 8999999995 57777775533 35899999999999999999999999 99999999999999999999999998854
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhh--cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc---
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFR--RELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN--- 255 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~--~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~--- 255 (690)
+..... ......+||+.|||||++.... ...++.++|||||||++|+|++|+.||.+....+.....
T Consensus 152 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~ 223 (331)
T cd05597 152 LLADGT--------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223 (331)
T ss_pred cCCCCC--------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 322110 0111236899999999753211 245788999999999999999999999876654432211
Q ss_pred ---CCCC-CCCCCCHHHHHHHHHHhhhCCCC--CCCHHHHHHH
Q 005577 256 ---YRIP-ESPKYSSSVTDLIRDMLQASPDD--RPDITQVWFR 292 (690)
Q Consensus 256 ---~~~~-~~~~~s~~l~~LI~~~L~~dP~~--RPt~~eil~~ 292 (690)
+..+ ....++..+.+||.+||..++.+ |+++.+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 224 KEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1222 22357999999999998764443 7888888653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=317.27 Aligned_cols=255 Identities=18% Similarity=0.259 Sum_probs=202.6
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcccCCe----EEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEee
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSK----QYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~~~k----~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~ 96 (690)
+...+|++.++||+|+||+||+|.+. ..+. .||+|++... .......+.+|+.++..+. ||||+++++++.
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~-- 79 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWI-PDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG-SPYVCRLLGICL-- 79 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEe-cCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcC-CCCCceEEEEEc--
Confidence 34578999999999999999999864 2333 4899988654 3445667889999999995 999999998874
Q ss_pred cCCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeecc
Q 005577 97 LGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDF 175 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DF 175 (690)
....+++|||+. |+|.+.+.... +.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 80 ---~~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~df 153 (279)
T cd05109 80 ---TSTVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDF 153 (279)
T ss_pred ---CCCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCC
Confidence 235679999995 67887776533 45899999999999999999999999 999999999999999999999999
Q ss_pred CCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH---HH
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKL---QI 251 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~---~i 251 (690)
|+++......... ......+++.|+|||+ ..+..++.++|||||||++|||++ |..||...... ..
T Consensus 154 G~~~~~~~~~~~~-------~~~~~~~~~~y~~PE~---~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~ 223 (279)
T cd05109 154 GLARLLDIDETEY-------HADGGKVPIKWMALES---ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL 223 (279)
T ss_pred Cceeeccccccee-------ecCCCccchhhCCHHH---hccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 9987543211100 0111234678999996 455678999999999999999998 89999765443 23
Q ss_pred HhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhh
Q 005577 252 LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 252 l~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~ 296 (690)
+......+....++..+.++|.+||..||++||++.+++..+...
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 224 LEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred HHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 344444455667899999999999999999999999998776654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.21 Aligned_cols=256 Identities=23% Similarity=0.356 Sum_probs=202.2
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEccc----CCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEee
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIH----MSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~----~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~ 96 (690)
+....|.+.+.||+|+||.||+|.+... ....|++|.+.... ......+.+|+.+++.+. |+||+++++++.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~-- 79 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN-HQNIVRLIGVSF-- 79 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEc--
Confidence 4567899999999999999999988521 46789999876443 444567899999999995 999999998864
Q ss_pred cCCCceEEEEEecCC-CcHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCC--
Q 005577 97 LGRTKEALLVMECCD-KSLVNVLENRGA-----GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG-- 168 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~-gsLl~~L~~~~~-----~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg-- 168 (690)
+....|+||||+. ++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 80 --~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~ 155 (277)
T cd05036 80 --ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPG 155 (277)
T ss_pred --cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCC
Confidence 3456799999995 677777765432 24899999999999999999999999 99999999999998765
Q ss_pred -CeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCc
Q 005577 169 -LWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGE 246 (690)
Q Consensus 169 -~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~ 246 (690)
.+||+|||+++...... .........++..|+|||+ +.+..++.++|||||||++|+|++ |..||.+.
T Consensus 156 ~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~~~~y~aPE~---~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~ 225 (277)
T cd05036 156 RVAKIADFGMARDIYRAS-------YYRKGGRAMLPIKWMPPEA---FLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225 (277)
T ss_pred cceEeccCccccccCCcc-------ceecCCCCCccHhhCCHHH---HhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 59999999987642111 0011112234568999996 456679999999999999999996 99999876
Q ss_pred hHHHH---HhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 247 SKLQI---LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 247 ~~~~i---l~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
....+ +....+...+..++..+.++|.+||+.+|++||++.+++.++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 226 TNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 54333 3333344445678999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.48 Aligned_cols=258 Identities=21% Similarity=0.332 Sum_probs=202.5
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcccC--CeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecC
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHM--SKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLG 98 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~~--~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~ 98 (690)
|...+|+..+.||+|+||.||+|.+.... ...+++|.+... .....+.+.+|+.+++.+. ||||+++++++.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~---- 76 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS-HHNIIRLEGVVT---- 76 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEc----
Confidence 55678999999999999999999975222 237899988654 3445677889999999995 999999998864
Q ss_pred CCceEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCC
Q 005577 99 RTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS 177 (690)
Q Consensus 99 ~~~~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGl 177 (690)
.....|+||||+.+ +|.+++... .+.+++.+++.++.|++.||.|||..+ |+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~ 153 (268)
T cd05063 77 KFKPAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGL 153 (268)
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCcc
Confidence 34678999999975 555555443 356899999999999999999999999 99999999999999999999999998
Q ss_pred CCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---Hh
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LN 253 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i---l~ 253 (690)
+.......... ........++.|+|||+ +.+..++.++|||||||++|+|++ |..||.......+ +.
T Consensus 154 ~~~~~~~~~~~------~~~~~~~~~~~y~~PE~---~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~ 224 (268)
T cd05063 154 SRVLEDDPEGT------YTTSGGKIPIRWTAPEA---IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN 224 (268)
T ss_pred ceecccccccc------eeccCCCcCceecCHHH---hhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh
Confidence 86543211100 00011123567999996 445678999999999999999997 9999976554433 22
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhh
Q 005577 254 GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 254 ~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~ 296 (690)
.....+....++..+.+++.+||+.+|++||++.+++..+.+.
T Consensus 225 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 225 DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 3334455557899999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=337.83 Aligned_cols=246 Identities=21% Similarity=0.284 Sum_probs=193.7
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcc-cCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAI-HMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~-~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
...+|++.+.||+|+||.||+|.... ..++.|++|.+... ....+|+.+|+.|. |||||++++++. ...
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~-h~~iv~~~~~~~----~~~ 159 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTIS-HRAIINLIHAYR----WKS 159 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcC-CCCccceeeeEe----eCC
Confidence 35689999999999999999997532 34578999987543 23457999999995 999999998865 346
Q ss_pred eEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 102 EALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 102 ~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
.+|+||||+.++|.+++... ..+++.+++.|+.||+.||.|||.+| ||||||||+||||+.++.++|+|||+++..
T Consensus 160 ~~~lv~e~~~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 160 TVCMVMPKYKCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EEEEEehhcCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 78999999999999988543 35999999999999999999999999 999999999999999999999999998654
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-------HHHHhc
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK-------LQILNG 254 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~-------~~il~~ 254 (690)
...... .......||+.|+|||+ +.+..++.++|||||||+||||++|+.||.+... ..++..
T Consensus 236 ~~~~~~-------~~~~~~~gt~~y~aPE~---~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~ 305 (392)
T PHA03207 236 DAHPDT-------PQCYGWSGTLETNSPEL---LALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC 305 (392)
T ss_pred Cccccc-------ccccccccccCccCHhH---hcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH
Confidence 322111 11123568999999996 4566789999999999999999999999965321 011100
Q ss_pred -------------------------cCCCCC-------CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 255 -------------------------NYRIPE-------SPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 255 -------------------------~~~~~~-------~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
..+.+. ...++.++.+||.+||..||++||++.+++.+
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 01356788999999999999999999999754
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=318.11 Aligned_cols=250 Identities=21% Similarity=0.318 Sum_probs=194.6
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
.+|++.+.||+|+||.||+|.+. .+++.||||++.... ......+..|+.++.+..+|||||++++++. .....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~----~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHV-PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF----REGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEc-CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe----cCCcE
Confidence 36899999999999999999985 578999999886542 2333456667776555557999999999875 34678
Q ss_pred EEEEecCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 104 LLVMECCDKSLVNVLENR--GAGYFEEKQVLAIFRDVCNAVFAMHSQ-SPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~--~~~~lse~~~~~i~~qIa~aL~yLHs~-g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
|+||||++|+|.+++... ....+++..++.++.||+.||.|||++ + |+||||||+|||++.++.+||+|||++..
T Consensus 76 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~ 153 (283)
T cd06617 76 WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGY 153 (283)
T ss_pred EEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 999999999988877653 234699999999999999999999997 8 99999999999999999999999999865
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCch-HHH----HHhc
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRR-ELINEKVDIWALGCLLFRICYFKNAFDGES-KLQ----ILNG 254 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~-~~~s~ksDVwSLGviLyELltG~~PF~~~~-~~~----il~~ 254 (690)
..... ......|+..|+|||++..... ..++.++|||||||++|+|++|+.||.... ..+ ++..
T Consensus 154 ~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 223 (283)
T cd06617 154 LVDSV----------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE 223 (283)
T ss_pred ccccc----------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc
Confidence 42211 1112357889999997532111 457889999999999999999999997421 111 2222
Q ss_pred cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 255 NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 255 ~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.........++.++.++|.+||..+|++||++.+++.
T Consensus 224 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111122357899999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=321.27 Aligned_cols=239 Identities=22% Similarity=0.307 Sum_probs=187.7
Q ss_pred eeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEec
Q 005577 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMEC 109 (690)
Q Consensus 33 LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy 109 (690)
||+|+||+||++.+. .+++.||+|++.... ....+.+..|+.+|+.+ +||||+++++++. ....+||||||
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~----~~~~~~lv~e~ 74 (280)
T cd05608 1 LGKGGFGEVSACQMR-ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQ----TKTDLCLVMTI 74 (280)
T ss_pred CCCCCceeEEEEEEc-cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEc----CCCeEEEEEeC
Confidence 799999999999985 578899999986532 23446678899999999 5999999988754 34678999999
Q ss_pred CCC-cHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccch
Q 005577 110 CDK-SLVNVLENR--GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 110 ~~g-sLl~~L~~~--~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~ 186 (690)
+.| +|...+... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..+....
T Consensus 75 ~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~- 151 (280)
T cd05608 75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ- 151 (280)
T ss_pred CCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCC-
Confidence 965 565555432 2345899999999999999999999999 9999999999999999999999999986532211
Q ss_pred hhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH----HHHHhccC--CCCC
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK----LQILNGNY--RIPE 260 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~----~~il~~~~--~~~~ 260 (690)
.......||+.|+|||+ +.+..++.++|||||||++|+|++|+.||..... ..+..... ....
T Consensus 152 --------~~~~~~~g~~~y~aPE~---~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 220 (280)
T cd05608 152 --------SKTKGYAGTPGFMAPEL---LQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTY 220 (280)
T ss_pred --------ccccccCCCcCccCHHH---hcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCC
Confidence 01112468999999996 4567789999999999999999999999975431 12222221 1223
Q ss_pred CCCCCHHHHHHHHHHhhhCCCCCC-----CHHHHHH
Q 005577 261 SPKYSSSVTDLIRDMLQASPDDRP-----DITQVWF 291 (690)
Q Consensus 261 ~~~~s~~l~~LI~~~L~~dP~~RP-----t~~eil~ 291 (690)
+..++..+.+||.+||+.||++|| ++.+++.
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 456899999999999999999999 5566643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.89 Aligned_cols=254 Identities=22% Similarity=0.356 Sum_probs=206.3
Q ss_pred EeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 20 iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
+++...+|++.++||+|+||.||+|.+. .++.|+||.+..... ....+.+|+.+++.+. |+||+++++++. .
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~--~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~ 72 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWN--GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLR-HDKLVQLYAVCS----E 72 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEc--CCceEEEEEecCCcc-CHHHHHHHHHHHhhCC-CCCEeeeeeeee----c
Confidence 4678899999999999999999999874 567899998865432 3467889999999995 999999998854 3
Q ss_pred CceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 100 TKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
....++||||+. ++|.+.+.......+++..++.++.+|+.||.|||.++ |+|+||||+||||+.++.++|+|||++
T Consensus 73 ~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~ 150 (261)
T cd05034 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLA 150 (261)
T ss_pred CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccc
Confidence 467899999996 57888887655446899999999999999999999999 999999999999999999999999988
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH---hc
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQIL---NG 254 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il---~~ 254 (690)
......... ......++..|+|||. +.+..++.++|||||||++|+|++ |+.||.+......+ ..
T Consensus 151 ~~~~~~~~~--------~~~~~~~~~~y~~PE~---~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~ 219 (261)
T cd05034 151 RLIEDDEYT--------AREGAKFPIKWTAPEA---ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219 (261)
T ss_pred eeccchhhh--------hhhccCCCccccCHHH---hccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 654321100 0011234678999996 456678999999999999999998 99999876544333 33
Q ss_pred cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 255 NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 255 ~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
.+..+.+..++..+.++|.+||..+|++||++.++...+.
T Consensus 220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 220 GYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 4445556678999999999999999999999999976554
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=321.63 Aligned_cols=257 Identities=18% Similarity=0.234 Sum_probs=201.8
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcc----cCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEee
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAI----HMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~----~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~ 96 (690)
|.-.+|++.+.||+|+||.||+|.+.. ..++.||||++.... ....+.+.+|+.++..+. |||||++++++.
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~-- 78 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVT-- 78 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc--
Confidence 344578889999999999999998732 235789999986543 334567888999999995 999999998864
Q ss_pred cCCCceEEEEEecCC-CcHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCc
Q 005577 97 LGRTKEALLVMECCD-KSLVNVLENRG--------------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAEN 161 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~-gsLl~~L~~~~--------------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~N 161 (690)
.....++++||+. ++|.+++..+. ...+++..++.++.||+.||.|||++| |+||||||+|
T Consensus 79 --~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~N 154 (283)
T cd05091 79 --KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRN 154 (283)
T ss_pred --CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhh
Confidence 3456899999996 56666664321 124788899999999999999999999 9999999999
Q ss_pred EEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CC
Q 005577 162 LLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FK 240 (690)
Q Consensus 162 ILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~ 240 (690)
||++.++.+||+|||+++....... ........+++.|+|||+ +.++.++.++|||||||++|||++ |.
T Consensus 155 il~~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~slG~~l~el~~~g~ 224 (283)
T cd05091 155 VLVFDKLNVKISDLGLFREVYAADY-------YKLMGNSLLPIRWMSPEA---IMYGKFSIDSDIWSYGVVLWEVFSYGL 224 (283)
T ss_pred eEecCCCceEecccccccccccchh-------eeeccCccCCccccCHHH---HhcCCCCcchhHHHHHHHHHHHHcCCC
Confidence 9999999999999999875432110 011112345789999996 455678999999999999999998 88
Q ss_pred CCCCCchHHHHHhc---cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhh
Q 005577 241 NAFDGESKLQILNG---NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 241 ~PF~~~~~~~il~~---~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~ 295 (690)
.||.+....+++.. ....+.+..++..+.+||.+||+.+|.+||++.+|+.+++.
T Consensus 225 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 225 QPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 89987665544332 22233456789999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=316.38 Aligned_cols=250 Identities=29% Similarity=0.462 Sum_probs=196.8
Q ss_pred EEEEEEeeecCceEEEEEEEc---ccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 27 IHVRNVIAEGGFSCVYSARDA---IHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 27 y~v~~~LG~GgFG~VylA~d~---~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
+.+.+.||.|.||.||+|.+. ...+..|+||.+... ..+..+.+++|+++|+++ +||||+++++++. ..+.
T Consensus 1 ~~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~----~~~~ 75 (259)
T PF07714_consen 1 IKLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCI----ENEP 75 (259)
T ss_dssp EEEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEE----SSSS
T ss_pred CEEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-ccccccccccccc----cccc
Confidence 467899999999999999885 124578999998543 455688999999999999 5999999999987 3456
Q ss_pred EEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
.++|||||. |+|.++|.......+++..++.|+.||+.||.|||+++ |+|+||++.||||+.++.+||+|||++...
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccc
Confidence 899999996 68889998874556999999999999999999999999 999999999999999999999999988654
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---HhccCC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LNGNYR 257 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i---l~~~~~ 257 (690)
..... ........+...|+|||+ +....++.++||||||+++|||++ |+.||......++ +....+
T Consensus 154 ~~~~~-------~~~~~~~~~~~~~~aPE~---~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~ 223 (259)
T PF07714_consen 154 SEKSK-------YKNDSSQQLPLRYLAPEV---LKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR 223 (259)
T ss_dssp TTSSS-------EEESTTSESGGGGS-HHH---HHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE
T ss_pred ccccc-------cccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 11100 011112245778999996 455668999999999999999999 7899987655543 334445
Q ss_pred CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
.+.+..++..+.++|..||..||++||++.+++..|
T Consensus 224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 555667899999999999999999999999998754
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=314.45 Aligned_cols=244 Identities=30% Similarity=0.498 Sum_probs=196.7
Q ss_pred EEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHH--HHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 27 IHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLE--SAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 27 y~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e--~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
|++.+.||+|+||+||++++. ..++.||+|++......... ...+|+.+++.+ +||||+++++++.. ....+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~----~~~~~ 74 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNK-KNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQD----DNYLY 74 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEET-TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEE----SSEEE
T ss_pred CEEeEEEEeCCCEEEEEEEEC-CCCeEEEEEEeccccccccccchhhhhhhccccc-cccccccccccccc----ccccc
Confidence 889999999999999999996 67889999999877654433 345699999999 59999999998764 57889
Q ss_pred EEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 105 LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 105 LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
+||||+.+ +|.+++..... +++..++.++.||+.||.+||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 75 ~v~~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~ 150 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQKNKP--LSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSE 150 (260)
T ss_dssp EEEEEETTEBHHHHHHHHSS--BBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTS
T ss_pred cccccccccccccccccccc--cccccccccccccccccccccccc--cccccccccccccccccccccccccccccccc
Confidence 99999987 88888874443 899999999999999999999999 99999999999999999999999998854211
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc---hHHHHHhccCC---
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGE---SKLQILNGNYR--- 257 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~---~~~~il~~~~~--- 257 (690)
.........++..|+|||++. .+..++.++||||||+++|+|++|..||... .....+.....
T Consensus 151 ---------~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~ 219 (260)
T PF00069_consen 151 ---------NNENFNPFVGTPEYMAPEVLQ--QGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL 219 (260)
T ss_dssp ---------TTSEBSSSSSSGGGSCHHHHT--TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH
T ss_pred ---------ccccccccccccccccccccc--ccccccccccccccccccccccccccccccccchhhhhhhhhcccccc
Confidence 011122346799999999632 2677899999999999999999999999876 22222221111
Q ss_pred ---CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 ---IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 ---~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
..........+.++|.+||+.||++||++.+++.
T Consensus 220 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 220 PSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111123489999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=340.46 Aligned_cols=259 Identities=26% Similarity=0.411 Sum_probs=205.8
Q ss_pred CceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEee--cCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEE
Q 005577 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMI--CNDEESLESAMKEISVMKSLKGHPNVVTLYAHTI 94 (690)
Q Consensus 17 g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~--~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~ 94 (690)
.-.|.|.+..|++.++||.||-+.||++... ....||+|++. ..|...+.-|.+|+..|.+|++|.+||+||+|-+
T Consensus 353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s--~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNS--DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred CeeEEECcchhhHHHhhcCCCcceeeeeecC--CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 3568899999999999999999999999863 55678888763 4577888999999999999999999999999966
Q ss_pred eecCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeec
Q 005577 95 LDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCD 174 (690)
Q Consensus 95 ~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~D 174 (690)
. ...+||||||-+.+|-..|..+... ++...++.|..|++.++.++|.+| |||.||||.|.||- .|.+||+|
T Consensus 431 ~----d~~lYmvmE~Gd~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LKLID 502 (677)
T KOG0596|consen 431 T----DGYLYMVMECGDIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLKLID 502 (677)
T ss_pred c----CceEEEEeecccccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEEeee
Confidence 4 4789999999999999988876542 444588899999999999999999 99999999999985 57799999
Q ss_pred cCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcC--------CCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 005577 175 FGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRE--------LINEKVDIWALGCLLFRICYFKNAFDGE 246 (690)
Q Consensus 175 FGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~--------~~s~ksDVwSLGviLyELltG~~PF~~~ 246 (690)
||+|..+..+.... .....+||+.||+||.+...... .++.++||||||||||+|+.|+.||...
T Consensus 503 FGIA~aI~~DTTsI-------~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~ 575 (677)
T KOG0596|consen 503 FGIANAIQPDTTSI-------VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI 575 (677)
T ss_pred echhcccCccccce-------eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence 99998765543322 22246899999999975432211 3678999999999999999999999764
Q ss_pred hH-HH----HHhccCCCCCCCC-CCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 247 SK-LQ----ILNGNYRIPESPK-YSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 247 ~~-~~----il~~~~~~~~~~~-~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
.. .. +..-...++.+.. -..++.++|+.||++||++||++.+++.+
T Consensus 576 ~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 576 INQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 32 11 1121122222211 12349999999999999999999999753
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=311.80 Aligned_cols=244 Identities=21% Similarity=0.345 Sum_probs=193.6
Q ss_pred EeeecCceEEEEEEEcccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEecC
Q 005577 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECC 110 (690)
Q Consensus 32 ~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy~ 110 (690)
.||+|+||.||+|.+. ..++.||+|.+... ..+....+.+|+++|+.+ +||||+++++++. .....||||||+
T Consensus 2 ~lg~g~~g~vy~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~----~~~~~~lv~e~~ 75 (252)
T cd05084 2 RIGRGNFGEVFSGRLR-ADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCT----QKQPIYIVMELV 75 (252)
T ss_pred ccCcccCccEEEEEEe-cCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEc----CCCCeEEEEeec
Confidence 6899999999999985 56889999987543 345567889999999999 5999999999865 346789999999
Q ss_pred C-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhhh
Q 005577 111 D-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLE 189 (690)
Q Consensus 111 ~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~ 189 (690)
. ++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 76 ~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-- 150 (252)
T cd05084 76 QGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA-- 150 (252)
T ss_pred cCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCccccccccc--
Confidence 5 46776665443 35899999999999999999999999 999999999999999999999999998653221000
Q ss_pred hccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---HhccCCCCCCCCCC
Q 005577 190 EMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LNGNYRIPESPKYS 265 (690)
Q Consensus 190 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i---l~~~~~~~~~~~~s 265 (690)
.......++..|+|||+ +.++.++.++|||||||++|+|++ |..||........ +......+.+..++
T Consensus 151 -----~~~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (252)
T cd05084 151 -----STGGMKQIPVKWTAPEA---LNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCP 222 (252)
T ss_pred -----ccCCCCCCceeecCchh---hcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCC
Confidence 00001123457999996 456678999999999999999997 8899976544332 22333444556789
Q ss_pred HHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 266 SSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 266 ~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
..+.+||.+||+.+|++||++.+++..+.
T Consensus 223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 223 DAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 99999999999999999999999986653
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=318.08 Aligned_cols=256 Identities=21% Similarity=0.292 Sum_probs=204.0
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEc----ccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDA----IHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~----~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~ 97 (690)
+...+|++.++||+|+||.||++... ...+..+++|.+........+.+.+|+++++.+ +|+||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~--- 77 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVCT--- 77 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEEe---
Confidence 45678999999999999999999752 124567899988776667778899999999999 5999999998865
Q ss_pred CCCceEEEEEecCC-CcHHHHHHHhCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEE
Q 005577 98 GRTKEALLVMECCD-KSLVNVLENRGA-------------GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLL 163 (690)
Q Consensus 98 ~~~~~~~LVmEy~~-gsLl~~L~~~~~-------------~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NIL 163 (690)
.....|+||||+. ++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 78 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil 154 (280)
T cd05092 78 -EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCL 154 (280)
T ss_pred -cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEE
Confidence 3466899999995 577777765432 24889999999999999999999999 999999999999
Q ss_pred eCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCC
Q 005577 164 LGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNA 242 (690)
Q Consensus 164 Ld~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~P 242 (690)
++.++.+||+|||+++....... ........+++.|+|||+ +.+..++.++|||||||++|+|++ |..|
T Consensus 155 ~~~~~~~kL~dfg~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~il~el~~~g~~p 224 (280)
T cd05092 155 VGQGLVVKIGDFGMSRDIYSTDY-------YRVGGRTMLPIRWMPPES---ILYRKFTTESDIWSFGVVLWEIFTYGKQP 224 (280)
T ss_pred EcCCCCEEECCCCceeEcCCCce-------eecCCCccccccccCHHH---hccCCcCchhhHHHHHHHHHHHHcCCCCC
Confidence 99999999999998864322110 001112345788999996 456678999999999999999998 9999
Q ss_pred CCCchHHHHH---hccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 243 FDGESKLQIL---NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 243 F~~~~~~~il---~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
|........+ ........+..+++.+.+||.+||+.||.+||++.+|+..+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 225 WYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 9765543332 222233444578999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.82 Aligned_cols=255 Identities=23% Similarity=0.294 Sum_probs=196.5
Q ss_pred ceE-EEEEEeeecCceEEEEEEEc---ccCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 25 LKI-HVRNVIAEGGFSCVYSARDA---IHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 25 ~ry-~v~~~LG~GgFG~VylA~d~---~~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
.|| ++.+.||+|+||+||++... ...+..||+|.+.... ......+.+|+.+|+.+. ||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQ--G 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC--C
Confidence 344 88999999999999987532 2456789999986543 344567889999999994 99999999886532 3
Q ss_pred CceEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 100 TKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
...+|+||||+.+ +|.+++.. . .+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~-~--~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPK-H--KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHH-c--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecccc
Confidence 4568999999965 56666644 2 3899999999999999999999999 999999999999999999999999998
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--H-------
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK--L------- 249 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~--~------- 249 (690)
+......... .......++..|+|||+ +.+..++.++|||||||++|+|++|..||..... .
T Consensus 155 ~~~~~~~~~~------~~~~~~~~~~~~~~PE~---~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 225 (283)
T cd05080 155 KAVPEGHEYY------RVREDGDSPVFWYAVEC---LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQ 225 (283)
T ss_pred cccCCcchhh------ccCCCCCCCceeeCHhH---hcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccc
Confidence 7543221110 00111235677999996 4456789999999999999999999999854221 0
Q ss_pred ---------HHHhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhh
Q 005577 250 ---------QILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 250 ---------~il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~ 296 (690)
+.+......+.+..++..+.+++.+||+.+|++||++.+++..+...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 226 GQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111222333456789999999999999999999999998877653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=310.29 Aligned_cols=247 Identities=24% Similarity=0.404 Sum_probs=205.5
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
+...+|++.+.||.|+||.||+|.+ .++.|++|.+..... ...++.+|+.+++.+. |+||+++++++. ...
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~---~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~~~----~~~ 73 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDY---RGQKVAVKCLKDDST-AAQAFLAEASVMTTLR-HPNLVQLLGVVL----QGN 73 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEe---cCcEEEEEEeccchh-HHHHHHHHHHHHHhcC-CcceeeeEEEEc----CCC
Confidence 4567899999999999999999987 478899999876544 5678899999999995 999999998864 246
Q ss_pred eEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
..|+||||+. ++|.+++.......+++..++.++.|++.||.|||.++ |+||||||+|||++.++.+||+|||+++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~ 151 (256)
T cd05039 74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKE 151 (256)
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEcccccccc
Confidence 7899999996 58888887665456999999999999999999999999 99999999999999999999999999875
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH---hccC
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQIL---NGNY 256 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il---~~~~ 256 (690)
..... ....++..|+|||+ +....++.++|||||||++|+|++ |..||.......+. ...+
T Consensus 152 ~~~~~------------~~~~~~~~~~ape~---~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 216 (256)
T cd05039 152 ASQGQ------------DSGKLPVKWTAPEA---LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY 216 (256)
T ss_pred ccccc------------ccCCCcccccCchh---hcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Confidence 42111 01234668999996 445678899999999999999997 99999876654433 2333
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 257 RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 257 ~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
+...+..+++.+.++|.+||..+|++||++.+++..+.
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 254 (256)
T cd05039 217 RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254 (256)
T ss_pred CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHh
Confidence 44445578999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=313.87 Aligned_cols=256 Identities=20% Similarity=0.363 Sum_probs=201.5
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccC--CeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHM--SKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~--~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
..|++.+.||+|+||.||+|.+.... ...|+||++... +......+..|+.+++.+. ||||+++++++. ...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~----~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVT----KSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CcCcceEEEEEC----CCC
Confidence 46889999999999999999875221 246999988654 4556678999999999995 999999998854 446
Q ss_pred eEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
..++||||+.+ +|.+++... .+.+++.+++.++.|++.||.|||++| ++||||||+|||++.++.+||+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccc
Confidence 78999999975 566665543 345899999999999999999999999 99999999999999999999999998865
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH---hccC
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQIL---NGNY 256 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il---~~~~ 256 (690)
............ ......+..|+|||+ +.+..++.++|||||||++|||++ |..||.......+. ....
T Consensus 156 ~~~~~~~~~~~~----~~~~~~~~~y~~PE~---~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~ 228 (269)
T cd05065 156 LEDDTSDPTYTS----SLGGKIPIRWTAPEA---IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY 228 (269)
T ss_pred cccCcccccccc----ccCCCcceeecCHhH---hccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC
Confidence 432211100000 000112457999996 456678999999999999999886 99999776554433 3344
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhh
Q 005577 257 RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 257 ~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~ 295 (690)
..+.+..++..+.+++.+||..+|.+||++.+++..+..
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 229 RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 556667889999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.02 Aligned_cols=245 Identities=28% Similarity=0.419 Sum_probs=200.1
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
..+|++.+.||+|+||.||+|.+. ..++.|++|.+........+.+.+|+.+++.+. ||||+++++++.. ....
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~----~~~~ 92 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYLV----GDEL 92 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEEC-CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCC-CCCEeeEEEEEEe----CCEE
Confidence 359999999999999999999985 578899999987766556678889999999994 9999999998653 4689
Q ss_pred EEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
|+||||+. ++|.+++.. . .+++.+++.++.||+.||.|||..| |+||||||+|||++.++.+||+|||++....
T Consensus 93 ~lv~e~~~~~~L~~~~~~-~--~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE-T--CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred EEeecccCCCCHHHHHHh-c--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 99999996 467666643 2 4899999999999999999999999 9999999999999999999999999876432
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh-----ccCC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN-----GNYR 257 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~-----~~~~ 257 (690)
... .......|++.|+|||+ +.+..++.++|||||||++|+|++|+.||.......... ....
T Consensus 168 ~~~---------~~~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (296)
T cd06654 168 PEQ---------SKRSTMVGTPYWMAPEV---VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE 235 (296)
T ss_pred ccc---------cccCcccCCccccCHHH---HcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCC
Confidence 110 01112367899999996 445678899999999999999999999998765432211 1112
Q ss_pred CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
...+..++..+.+||.+||..+|++||++.+++.
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 2334568899999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=321.91 Aligned_cols=246 Identities=27% Similarity=0.441 Sum_probs=194.0
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
+|++.+.||+|+||.||+|++. ..++.|++|.+.... ......+.+|+.+++.+. ||||+++++++. +...+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~-~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~----~~~~~ 74 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLYDVLH----SDKKL 74 (284)
T ss_pred CceeEEEecccCCeEEEEEEEC-CCCcEEEEEEeecccccccCccchhHHHHHHHhcC-CCCeeeHHHHhc----cCCce
Confidence 5889999999999999999985 578899999886432 223356778999999995 999999998854 45678
Q ss_pred EEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 104 LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
|+||||++++|.+.+.... +.+++..++.++.||+.||.|||.++ |+||||||+|||++.++.+||+|||+++....
T Consensus 75 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 75 TLVFEYCDQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 9999999999988876543 45999999999999999999999999 99999999999999999999999998865322
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCC-CCchHHHHHhcc-------
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAF-DGESKLQILNGN------- 255 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF-~~~~~~~il~~~------- 255 (690)
... ......+++.|+|||++ .....++.++|||||||++|+|++|..|| .+.+....+...
T Consensus 152 ~~~---------~~~~~~~~~~y~aPE~~--~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
T cd07839 152 PVR---------CYSAEVVTLWYRPPDVL--FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 220 (284)
T ss_pred CCC---------CcCCCccccCCcChHHH--hCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 111 01123568899999973 23345789999999999999999998885 333322111100
Q ss_pred -----------CC-------------CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 256 -----------YR-------------IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 256 -----------~~-------------~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.. ....+.++.++.+||.+||+.||.+||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 221 TEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 0112357889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.62 Aligned_cols=255 Identities=20% Similarity=0.349 Sum_probs=202.8
Q ss_pred eEEEEEEeeecCceEEEEEEEcc----cCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAI----HMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~----~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
+|++.+.||+|+||.||+|.+.. .....+++|.+.... ......+.+|+.+|+.+. |||||++++.+. ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~----~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN-HPHVIKLYGACS----QD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEe----cC
Confidence 47889999999999999998742 123578888876543 345678899999999995 999999998865 34
Q ss_pred ceEEEEEecCC-CcHHHHHHHhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCC
Q 005577 101 KEALLVMECCD-KSLVNVLENRG----------------------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDL 157 (690)
Q Consensus 101 ~~~~LVmEy~~-gsLl~~L~~~~----------------------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDL 157 (690)
...|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||.++ |+||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~di 153 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDL 153 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhh
Confidence 66899999996 56777665321 124788999999999999999999999 999999
Q ss_pred CCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHH
Q 005577 158 KAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC 237 (690)
Q Consensus 158 KP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELl 237 (690)
||+||||+.++.+||+|||+++......... ......++..|+|||+ ..+..++.++|||||||++|+|+
T Consensus 154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~y~apE~---~~~~~~~~~~Di~slG~~l~el~ 223 (290)
T cd05045 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYV-------KRSKGRIPVKWMAIES---LFDHIYTTQSDVWSFGVLLWEIV 223 (290)
T ss_pred hhheEEEcCCCcEEeccccccccccCccchh-------cccCCCCCccccCHHH---HccCCcchHhHHHHHHHHHHHHH
Confidence 9999999999999999999987543221110 1112345778999996 45667899999999999999999
Q ss_pred h-CCCCCCCchHHHH---HhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 238 Y-FKNAFDGESKLQI---LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 238 t-G~~PF~~~~~~~i---l~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
+ |..||.+.....+ +...+..+.+..++..+.++|..||+.+|.+||++.+++..+...+
T Consensus 224 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 224 TLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred hcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 8 9999987665443 3334455556678999999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=322.48 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=200.3
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCe--EEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSK--QYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k--~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
-.+|++.+.||+|+||.||+|.+. ..+. .+++|.+... .......+.+|+.++.++.+||||+++++++. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~-~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~----~~ 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIK-KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE----HR 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEc-cCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC----CC
Confidence 357888999999999999999985 3443 4577766543 34456778899999999966999999999864 34
Q ss_pred ceEEEEEecCC-CcHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeC
Q 005577 101 KEALLVMECCD-KSLVNVLENRG--------------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLG 165 (690)
Q Consensus 101 ~~~~LVmEy~~-gsLl~~L~~~~--------------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd 165 (690)
+.+|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+|||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~ 158 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG 158 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEec
Confidence 67899999995 67888776542 125889999999999999999999999 99999999999999
Q ss_pred CCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 005577 166 SDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFD 244 (690)
Q Consensus 166 ~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~ 244 (690)
.++.+||+|||++....... ......++..|+|||+ +.+..++.++|||||||++|+|++ |..||.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 225 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVYV----------KKTMGRLPVRWMAIES---LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 225 (303)
T ss_pred CCCcEEeCccccCcccchhh----------hcccCCCcccccCHHH---HhccCCcccccchhhhhHHHHHHhcCCCCcc
Confidence 99999999999885321100 0011124668999996 455678899999999999999998 999997
Q ss_pred CchHHHHH---hccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 245 GESKLQIL---NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 245 ~~~~~~il---~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
+....+.. ...+....+..++..+.+||.+||+.+|++||++.+++..+...+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 226 GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred cCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 66544433 223333344567899999999999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=320.63 Aligned_cols=251 Identities=29% Similarity=0.457 Sum_probs=202.9
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
..+|++.+.||.|+||.||+|.+. ..++.|++|.+........+.+.+|+.+++++. ||||+++++++. .....
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~~~~ 77 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHK-ETGLFAAAKIIQIESEEELEDFMVEIDILSECK-HPNIVGLYEAYF----YENKL 77 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEc-CCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCC-CCceeEEEEEEe----cCCeE
Confidence 357899999999999999999985 468899999998777777888999999999995 999999999865 34678
Q ss_pred EEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 78 WILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred EEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 999999976 5555554433 45999999999999999999999999 9999999999999999999999999875432
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhh--hhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC----
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDL--FRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY---- 256 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~--~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~---- 256 (690)
.... ......+++.|+|||++.. .....++.++|||||||++|+|++|+.||........+....
T Consensus 155 ~~~~---------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 225 (280)
T cd06611 155 STLQ---------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP 225 (280)
T ss_pred cccc---------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCC
Confidence 2111 1112357899999997431 123457889999999999999999999998766544332211
Q ss_pred -CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 257 -RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 257 -~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
....+..++..+.++|.+||+.+|.+||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 122344688999999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=313.11 Aligned_cols=257 Identities=19% Similarity=0.293 Sum_probs=201.0
Q ss_pred EEEEEEeeecCceEEEEEEEccc--CCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec--CCC
Q 005577 27 IHVRNVIAEGGFSCVYSARDAIH--MSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL--GRT 100 (690)
Q Consensus 27 y~v~~~LG~GgFG~VylA~d~~~--~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~--~~~ 100 (690)
|++.+.||+|+||.||+|.+... ....||||.+... .......+.+|+.+|+.+ +||||+++++++.... ...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccC
Confidence 56789999999999999987432 3478999988643 344567889999999999 4999999998865332 122
Q ss_pred ceEEEEEecCC-CcHHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeecc
Q 005577 101 KEALLVMECCD-KSLVNVLENR----GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDF 175 (690)
Q Consensus 101 ~~~~LVmEy~~-gsLl~~L~~~----~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DF 175 (690)
...++||||+. |+|...+... ....+++..++.++.||+.||.|||.++ |+||||||+|||++.++.+||+||
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCc
Confidence 35789999996 5676666443 2235899999999999999999999999 999999999999999999999999
Q ss_pred CCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHh-
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQILN- 253 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il~- 253 (690)
|+++........ .......++..|+|||+ +.+..++.++|||||||++|||++ |..||.+....+++.
T Consensus 158 g~~~~~~~~~~~-------~~~~~~~~~~~~~~pe~---~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~ 227 (273)
T cd05035 158 GLSKKIYSGDYY-------RQGRIAKMPVKWIAIES---LADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY 227 (273)
T ss_pred cceeeccccccc-------cccccccCCccccCHhh---cccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 998754322110 01111234678999996 456778999999999999999999 899998766544432
Q ss_pred --ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhh
Q 005577 254 --GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 254 --~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~ 296 (690)
.......+..++..+.++|.+||+.||.+||++.+++..+.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 228 LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2233344567899999999999999999999999998887653
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.62 Aligned_cols=250 Identities=22% Similarity=0.277 Sum_probs=193.2
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
++|++.+.||+|+||.||++++. ..++.||+|++... .......+.+|+.++..+ +|+||+++++++. ..+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~----~~~ 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMK-HTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQ----DEN 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEE----cCC
Confidence 47899999999999999999985 57889999998642 223345577888999888 4999999998864 457
Q ss_pred eEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
..||||||+. |+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++..
T Consensus 75 ~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~ 151 (331)
T cd05624 75 YLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLK 151 (331)
T ss_pred EEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceee
Confidence 8999999995 56777776533 35899999999999999999999999 99999999999999999999999999865
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhh--cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc----
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFR--RELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG---- 254 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~--~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~---- 254 (690)
...... ......+||+.|||||++.... .+.++.++|||||||+||+|++|+.||......+....
T Consensus 152 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~ 223 (331)
T cd05624 152 MNQDGT--------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223 (331)
T ss_pred ccCCCc--------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC
Confidence 322110 0112246899999999743211 14578899999999999999999999987665443322
Q ss_pred cCCCCC---CCCCCHHHHHHHHHHhhhCCCC--CCCHHHHHH
Q 005577 255 NYRIPE---SPKYSSSVTDLIRDMLQASPDD--RPDITQVWF 291 (690)
Q Consensus 255 ~~~~~~---~~~~s~~l~~LI~~~L~~dP~~--RPt~~eil~ 291 (690)
..+.+. ...++..+.+||.+||..++.+ |+++.+++.
T Consensus 224 ~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 224 EERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 112221 2356899999999999876544 457777743
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=317.40 Aligned_cols=261 Identities=22% Similarity=0.298 Sum_probs=204.4
Q ss_pred EeecCceEEEEEEeeecCceEEEEEEEcc----cCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEE
Q 005577 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAI----HMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTI 94 (690)
Q Consensus 20 iei~~~ry~v~~~LG~GgFG~VylA~d~~----~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~ 94 (690)
|++...+|++.+.||+|+||.||+|.+.. ..+..||+|.+.... ......+.+|+.+++.+. ||||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT-CHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEc
Confidence 46778899999999999999999997531 234579999875432 334456788999999995 999999998854
Q ss_pred eecCCCceEEEEEecCC-CcHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeC
Q 005577 95 LDLGRTKEALLVMECCD-KSLVNVLENRG--------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLG 165 (690)
Q Consensus 95 ~~~~~~~~~~LVmEy~~-gsLl~~L~~~~--------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd 165 (690)
.....|+||||+. |+|.+++.... ...+....++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 80 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~ 153 (288)
T cd05061 80 ----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVA 153 (288)
T ss_pred ----CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEc
Confidence 3457899999995 67888876532 123567788999999999999999999 99999999999999
Q ss_pred CCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 005577 166 SDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFD 244 (690)
Q Consensus 166 ~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~ 244 (690)
.++.++|+|||+++....... ........++..|+|||+ +.+..++.++|||||||++|||++ |..||.
T Consensus 154 ~~~~~~L~Dfg~~~~~~~~~~-------~~~~~~~~~~~~y~~pE~---~~~~~~~~~~DvwslG~~l~el~~~~~~p~~ 223 (288)
T cd05061 154 HDFTVKIGDFGMTRDIYETDY-------YRKGGKGLLPVRWMAPES---LKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ 223 (288)
T ss_pred CCCcEEECcCCcccccccccc-------ccccCCCcccccccCHHH---hccCCCChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999875432111 011122345778999996 456678999999999999999998 788998
Q ss_pred CchHHHHHhc---cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 245 GESKLQILNG---NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 245 ~~~~~~il~~---~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
+....++... ......+..++..+.++|.+||+.||++||++.+++..+...+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 224 GLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 7665554332 2222334467899999999999999999999999988777654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.93 Aligned_cols=248 Identities=22% Similarity=0.349 Sum_probs=196.9
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
..+|++.+.||+|+||.||+|.+. ....||+|.+.... ...+.+.+|+.+++.+. ||||+++++++. .....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~--~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~~~~ 74 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLS-HEKLVQLYGVCT----KQRPI 74 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec--CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCC-CCCeeeEEEEEc----cCCCc
Confidence 457899999999999999999873 45569999876433 22466889999999995 999999999864 34568
Q ss_pred EEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
|+||||+. |+|.+++.... ..+++..++.++.||+.||.|||+.+ |+|+||||.|||++.++.+||+|||+++...
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVL 151 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecC
Confidence 99999996 56777766543 35899999999999999999999999 9999999999999999999999999886543
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---HhccCCC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LNGNYRI 258 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i---l~~~~~~ 258 (690)
.... .......++..|++||+ ..+..++.++|||||||++|+|++ |..||.......+ +....+.
T Consensus 152 ~~~~--------~~~~~~~~~~~y~~pe~---~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~ 220 (256)
T cd05113 152 DDEY--------TSSVGSKFPVRWSPPEV---LLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL 220 (256)
T ss_pred CCce--------eecCCCccChhhCCHHH---HhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC
Confidence 2110 00111235678999996 445668999999999999999998 9999976554332 2233333
Q ss_pred CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
..+...+..+.++|.+||..+|.+||++.+++..+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 34456789999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=319.37 Aligned_cols=255 Identities=18% Similarity=0.283 Sum_probs=200.4
Q ss_pred cCceEEEEEEeeecCceEEEEEEEccc---------------CCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCc
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIH---------------MSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNV 86 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~---------------~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNI 86 (690)
...+|++.+.||+|+||.||+|.+... ....||+|.+... .....+.+.+|+++|..+. ||||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLS-DPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcC-CCCE
Confidence 456899999999999999999986421 2356899988654 3455678899999999995 9999
Q ss_pred eEEEEEEEeecCCCceEEEEEecCC-CcHHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCC
Q 005577 87 VTLYAHTILDLGRTKEALLVMECCD-KSLVNVLENRG---------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRD 156 (690)
Q Consensus 87 VkL~~~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~---------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRD 156 (690)
+++++++.. ....++||||+. ++|.+++.... ...+++..++.++.||+.||.|||+++ |+|||
T Consensus 82 ~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~d 155 (296)
T cd05051 82 ARLLGVCTV----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRD 155 (296)
T ss_pred eEEEEEEec----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccc
Confidence 999998753 367899999995 57777776543 124899999999999999999999999 99999
Q ss_pred CCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHH
Q 005577 157 LKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI 236 (690)
Q Consensus 157 LKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyEL 236 (690)
|||+|||++.++.++|+|||+++....... ........+++.|||||+ +.+..++.++|||||||++|+|
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~slG~~l~el 225 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDY-------YRVQGRAPLPIRWMAWES---VLLGKFTTKSDVWAFGVTLWEI 225 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcc-------eeecCcCCCCceecCHHH---hhcCCCCccchhhhhHHHHHHH
Confidence 999999999999999999998865422110 011123356789999996 4456789999999999999999
Q ss_pred Hh--CCCCCCCchHHHHHhcc----------CCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 237 CY--FKNAFDGESKLQILNGN----------YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 237 lt--G~~PF~~~~~~~il~~~----------~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
++ +..||.......++... ...+.+..++.++.+||.+||+.||.+||++.+|+..+.
T Consensus 226 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 226 LTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 98 67888765544432211 112334567899999999999999999999999977654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=319.78 Aligned_cols=253 Identities=27% Similarity=0.402 Sum_probs=198.5
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecC-CCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLG-RTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~-~~~ 101 (690)
.+|++.+.||+|+||.||+|.+. ..++.||||.+.... ......+.+|+.+++.+.+||||+++++++..... ...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDK-NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEEC-CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 36899999999999999999985 578899999875432 22345678899999999767999999988765422 122
Q ss_pred eEEEEEecCCCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCC-CCCeeeeccCC
Q 005577 102 EALLVMECCDKSLVNVLENRGA---GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS-DGLWKLCDFGS 177 (690)
Q Consensus 102 ~~~LVmEy~~gsLl~~L~~~~~---~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~-dg~vKL~DFGl 177 (690)
..|+||||++++|.+++..... ..+++..++.++.||+.||.|||.++ |+||||||+|||++. ++.+||+|||+
T Consensus 80 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 80 SLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred eEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeeccc
Confidence 4799999999999888875432 35899999999999999999999999 999999999999998 88999999998
Q ss_pred CCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCC
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYR 257 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~ 257 (690)
++....... ......+++.|+|||++ .....++.++|||||||++|+|++|..||.+......+.....
T Consensus 158 ~~~~~~~~~---------~~~~~~~~~~~~aPE~~--~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 226 (295)
T cd07837 158 GRAFSIPVK---------SYTHEIVTLWYRAPEVL--LGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226 (295)
T ss_pred ceecCCCcc---------ccCCcccccCCCChHHh--hCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 865422111 01112468899999973 2345678999999999999999999999987654332211000
Q ss_pred ---------------------CC---------CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 ---------------------IP---------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 ---------------------~~---------~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.+ ..+.++..+.+||.+||..||.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 01457899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=325.72 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=195.2
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|++.++||+|+||.||++++. ..++.||+|++... .......+.+|+.++..+ +|+||+++++++. ...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~----~~~ 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQ----DEN 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEe----cCC
Confidence 36899999999999999999985 56889999998542 222344577889999998 4999999998764 457
Q ss_pred eEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
.+||||||+. |+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++..
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~ 151 (332)
T cd05623 75 NLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLK 151 (332)
T ss_pred EEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchhee
Confidence 8999999995 67777776533 35899999999999999999999999 99999999999999999999999998864
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhh--hcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc---
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLF--RRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN--- 255 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~--~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~--- 255 (690)
+..... ......+||+.|||||++... ....++.++|||||||+||||++|+.||...+........
T Consensus 152 ~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~ 223 (332)
T cd05623 152 LMEDGT--------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223 (332)
T ss_pred cccCCc--------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Confidence 321110 011224689999999975322 1346889999999999999999999999887655443222
Q ss_pred -CCC--CC-CCCCCHHHHHHHHHHhhhCCCC--CCCHHHHHHH
Q 005577 256 -YRI--PE-SPKYSSSVTDLIRDMLQASPDD--RPDITQVWFR 292 (690)
Q Consensus 256 -~~~--~~-~~~~s~~l~~LI~~~L~~dP~~--RPt~~eil~~ 292 (690)
.+. +. ...++..+.+||.+||..++.+ |+++.+++.+
T Consensus 224 ~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 224 KERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 111 21 2357999999999999765544 6788888543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.37 Aligned_cols=256 Identities=22% Similarity=0.375 Sum_probs=202.1
Q ss_pred cCceEEEEEEeeecCceEEEEEEEccc--CCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIH--MSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~--~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
...+|++.+.||+|+||.||+|.+... ....+|+|.+... .....+.+.+|+.+++.+. ||||+++++++. .
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~ 76 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVT----K 76 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEe----c
Confidence 346789999999999999999987422 2347899988643 3445678889999999995 999999998864 3
Q ss_pred CceEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 100 TKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
.+..|+||||+.+ +|.+++.... +.+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLS 153 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCcc
Confidence 4678999999965 6766665543 45899999999999999999999999 999999999999999999999999998
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---Hhc
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LNG 254 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i---l~~ 254 (690)
........... ......++..|+|||+ +.+..++.++|||||||++|++++ |..||......+. +..
T Consensus 154 ~~~~~~~~~~~------~~~~~~~~~~y~~pe~---~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~ 224 (267)
T cd05066 154 RVLEDDPEAAY------TTRGGKIPIRWTAPEA---IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE 224 (267)
T ss_pred cccccccceee------ecCCCccceeecCHhH---hccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC
Confidence 75432111000 0111223568999996 455678999999999999999886 9999976554332 333
Q ss_pred cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhh
Q 005577 255 NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 255 ~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~ 295 (690)
.++.+....++..+.+++.+||+++|.+||++.+++..+..
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 225 GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 44555566789999999999999999999999999887664
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=323.53 Aligned_cols=247 Identities=24% Similarity=0.389 Sum_probs=186.3
Q ss_pred EEEeeecCceEEEEEEEcc-cCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEe
Q 005577 30 RNVIAEGGFSCVYSARDAI-HMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVME 108 (690)
Q Consensus 30 ~~~LG~GgFG~VylA~d~~-~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmE 108 (690)
..+||+|+||.||+|++.. ..++.||+|.+.... ....+.+|+.+|+.+. |||||++++++... ....+|+|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELK-HPNVIALQKVFLSH--SDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCC-CCCeeeEEEEEecc--CCCeEEEEEe
Confidence 4689999999999998642 345789999885432 2245678999999995 99999999987532 4567899999
Q ss_pred cCCCcHHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEe----CCCCCeeeeccCC
Q 005577 109 CCDKSLVNVLENRG-------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLL----GSDGLWKLCDFGS 177 (690)
Q Consensus 109 y~~gsLl~~L~~~~-------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILL----d~dg~vKL~DFGl 177 (690)
|++++|++.+.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 81 YAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 99999988875321 224889999999999999999999999 9999999999999 4567899999999
Q ss_pred CCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--------
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL-------- 249 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~-------- 249 (690)
++......... .......||+.|+|||++ .....++.++|||||||++|||++|+.||......
T Consensus 159 a~~~~~~~~~~------~~~~~~~~t~~y~aPE~~--~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~ 230 (317)
T cd07867 159 ARLFNSPLKPL------ADLDPVVVTFWYRAPELL--LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFH 230 (317)
T ss_pred eeccCCCcccc------cccCcceecccccCcHHh--cCCCccCcHHHHHhHHHHHHHHHhCCCCccccccccccccccc
Confidence 97643321111 111234679999999973 23356889999999999999999999999643210
Q ss_pred -----HHHh-----------------------ccCCC-------------CCCCCCCHHHHHHHHHHhhhCCCCCCCHHH
Q 005577 250 -----QILN-----------------------GNYRI-------------PESPKYSSSVTDLIRDMLQASPDDRPDITQ 288 (690)
Q Consensus 250 -----~il~-----------------------~~~~~-------------~~~~~~s~~l~~LI~~~L~~dP~~RPt~~e 288 (690)
.+.. ..+.. ......+..+.+||.+||..||.+|||+.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e 310 (317)
T cd07867 231 HDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQ 310 (317)
T ss_pred HHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHH
Confidence 0000 00000 001123567889999999999999999999
Q ss_pred HHH
Q 005577 289 VWF 291 (690)
Q Consensus 289 il~ 291 (690)
++.
T Consensus 311 ~l~ 313 (317)
T cd07867 311 ALQ 313 (317)
T ss_pred Hhc
Confidence 874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.34 Aligned_cols=239 Identities=22% Similarity=0.340 Sum_probs=192.9
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
+|++.++||+|+||.||+|.+. ..++.||+|++... .......+.+|+.+|+++ +||||+++++++.. .+..+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~~~~ 75 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHL-LTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFV----ENRIS 75 (279)
T ss_pred cchheeeeccCCCeEEEEEEEc-CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEE----CCEEE
Confidence 6788999999999999999985 57889999998654 344556788999999999 59999999998764 36789
Q ss_pred EEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccccc
Q 005577 105 LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKR 184 (690)
Q Consensus 105 LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~ 184 (690)
+||||+.++.+... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 76 lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 76 ICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred EEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 99999987655433 23788999999999999999999999 999999999999999999999999998654221
Q ss_pred chhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-------HHHHh----
Q 005577 185 FEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK-------LQILN---- 253 (690)
Q Consensus 185 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~-------~~il~---- 253 (690)
.....+|+..|+|||+ +.+..++.++|||||||++|+|++|+.||..... .....
T Consensus 149 -----------~~~~~~~~~~y~aPE~---~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 214 (279)
T cd06619 149 -----------IAKTYVGTNAYMAPER---ISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD 214 (279)
T ss_pred -----------cccCCCCChhhcCcee---ecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc
Confidence 1122468999999997 4456789999999999999999999999964221 11111
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 254 GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 254 ~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
..........++..+.++|.+||+.+|++||++.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 215 EDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 11111122357889999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=319.02 Aligned_cols=238 Identities=23% Similarity=0.337 Sum_probs=188.0
Q ss_pred eeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEec
Q 005577 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMEC 109 (690)
Q Consensus 33 LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy 109 (690)
||+|+||.||++++. ..++.||+|++.... ......+..|+.+|+.+ +||||+++++++. ....+|+||||
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~----~~~~~~lv~e~ 74 (277)
T cd05607 1 LGKGGFGEVCAVQVK-NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFE----SKTHLCLVMSL 74 (277)
T ss_pred CCCCCceEEEEEEEc-cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEe----cCCeEEEEEec
Confidence 799999999999985 568999999985422 12234456799999999 5999999988754 34689999999
Q ss_pred CC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhh
Q 005577 110 CD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL 188 (690)
Q Consensus 110 ~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~ 188 (690)
+. ++|...+.......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 75 ~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--- 149 (277)
T cd05607 75 MNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--- 149 (277)
T ss_pred CCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---
Confidence 95 56766766555445899999999999999999999999 9999999999999999999999999886532211
Q ss_pred hhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch----HHHHHhccCCC---CCC
Q 005577 189 EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES----KLQILNGNYRI---PES 261 (690)
Q Consensus 189 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~----~~~il~~~~~~---~~~ 261 (690)
......|++.|+|||+ +.+..++.++|||||||++|+|++|+.||.... ...+....... ...
T Consensus 150 -------~~~~~~~~~~y~aPE~---~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (277)
T cd05607 150 -------TITQRAGTNGYMAPEI---LKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEH 219 (277)
T ss_pred -------eeeccCCCCCccCHHH---HccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccccc
Confidence 1112468999999996 445669999999999999999999999997532 12222222111 112
Q ss_pred CCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 262 PKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 262 ~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
..++.++.+||.+||++||++||++.+++.
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 468999999999999999999999977653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=335.33 Aligned_cols=264 Identities=20% Similarity=0.317 Sum_probs=209.6
Q ss_pred ceEeecCceEEEEEEeeecCceEEEEEEEc----ccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEE
Q 005577 18 RSIDVGNLKIHVRNVIAEGGFSCVYSARDA----IHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAH 92 (690)
Q Consensus 18 ~~iei~~~ry~v~~~LG~GgFG~VylA~d~----~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~ 92 (690)
..+++...+|.+.++||+|+||.||+|++. ....+.||||++... .....+.+++|+.+|.+|..|||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 347788889999999999999999999863 134568999999654 233456788999999999559999999998
Q ss_pred EEeecCCCceEEEEEecCC-CcHHHHHHHhCC------------------------------------------------
Q 005577 93 TILDLGRTKEALLVMECCD-KSLVNVLENRGA------------------------------------------------ 123 (690)
Q Consensus 93 ~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~------------------------------------------------ 123 (690)
+.. ....|||||||. |+|.+++.....
T Consensus 110 ~~~----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (401)
T cd05107 110 CTK----GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDE 185 (401)
T ss_pred Ecc----CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcc
Confidence 753 367899999995 688887764321
Q ss_pred ------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccC
Q 005577 124 ------------------------------------------------GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHR 155 (690)
Q Consensus 124 ------------------------------------------------~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHR 155 (690)
..+++..++.|+.||+.||.|||..+ |+||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHr 263 (401)
T cd05107 186 SADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHR 263 (401)
T ss_pred ccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcc
Confidence 13677788999999999999999999 9999
Q ss_pred CCCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHH
Q 005577 156 DLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFR 235 (690)
Q Consensus 156 DLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyE 235 (690)
||||+|||++.++.+||+|||+++........ .......+++.|||||+ +.+..++.++|||||||++||
T Consensus 264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~-------~~~~~~~~~~~y~aPE~---~~~~~~~~~~DvwslGvil~e 333 (401)
T cd05107 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNY-------ISKGSTFLPLKWMAPES---IFNNLYTTLSDVWSFGILLWE 333 (401)
T ss_pred cCCcceEEEeCCCEEEEEecCcceeccccccc-------ccCCCcCCCCceeChHH---hcCCCCCcHhHHHHHHHHHHH
Confidence 99999999999999999999998653221110 01112356889999996 455678999999999999999
Q ss_pred HHh-CCCCCCCchHH----HHHhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 236 ICY-FKNAFDGESKL----QILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 236 Llt-G~~PF~~~~~~----~il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
|++ |..||...... ..+....+...+..++..+.+||.+||..+|.+||++.+|+..+...+
T Consensus 334 ~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 334 IFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 998 88999764332 233444455556678999999999999999999999999998877653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.35 Aligned_cols=245 Identities=21% Similarity=0.324 Sum_probs=195.4
Q ss_pred EeeecCceEEEEEEEc-ccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEe
Q 005577 32 VIAEGGFSCVYSARDA-IHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVME 108 (690)
Q Consensus 32 ~LG~GgFG~VylA~d~-~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmE 108 (690)
.||+|+||.||+|.+. ...++.||+|++... +....+.+.+|+.+++.+ +||||+++++++. ....++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICE-----AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEc-----CCCcEEEEe
Confidence 5899999999999753 245788999988543 344567888999999999 5999999998753 346789999
Q ss_pred cCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchh
Q 005577 109 CCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEK 187 (690)
Q Consensus 109 y~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~ 187 (690)
|+. ++|.+++.... .+++..++.++.||+.||.|||++| |+||||||.|||++.++.+||+|||+++........
T Consensus 76 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 76 LAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 997 56777775543 4899999999999999999999999 999999999999999999999999998764322111
Q ss_pred hhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH---HHhccCCCCCCCC
Q 005577 188 LEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQ---ILNGNYRIPESPK 263 (690)
Q Consensus 188 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~---il~~~~~~~~~~~ 263 (690)
. .......+++.|+|||+ +....++.++|||||||++|||++ |..||....... .+......+.+..
T Consensus 152 ~------~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 222 (257)
T cd05116 152 Y------KAKTHGKWPVKWYAPEC---MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQR 222 (257)
T ss_pred e------eecCCCCCCccccCHhH---hccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Confidence 0 00111234678999996 445678889999999999999997 999998765433 3333334455567
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhh
Q 005577 264 YSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 264 ~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~ 295 (690)
++..+.+||.+||+.||++||++.+|...+..
T Consensus 223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 223 CPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 89999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=310.85 Aligned_cols=253 Identities=20% Similarity=0.343 Sum_probs=205.3
Q ss_pred EeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 20 iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
|++...+|++.+.||+|+||.||+|.+. .+..+++|.+... ....+.+.+|+.+++.+. |+||+++++++. .
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~--~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~----~ 72 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQ-HDKLVKLHAVVT----K 72 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEec--CCccEEEEecCCC-hhHHHHHHHHHHHHHhcC-CCCcceEEEEEc----C
Confidence 4577889999999999999999999863 5567999987643 334577889999999995 999999988753 2
Q ss_pred CceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 100 TKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
...|+||||++ ++|.+++.......+++..++.++.||+.||.|||..+ ++||||||+||+++.++.+||+|||++
T Consensus 73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~ 149 (260)
T cd05073 73 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLA 149 (260)
T ss_pred -CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcce
Confidence 56899999995 68888887654455888999999999999999999999 999999999999999999999999988
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH---hc
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQIL---NG 254 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il---~~ 254 (690)
........ .......++..|+|||+ +....++.++|||||||++|+|++ |+.||.+.+...+. ..
T Consensus 150 ~~~~~~~~--------~~~~~~~~~~~y~~PE~---~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~ 218 (260)
T cd05073 150 RVIEDNEY--------TAREGAKFPIKWTAPEA---INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 218 (260)
T ss_pred eeccCCCc--------ccccCCcccccccCHhH---hccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Confidence 65422110 00111235678999996 445678999999999999999998 99999876554433 34
Q ss_pred cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 255 NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 255 ~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
.+..+....++..+.+++.+||..+|++||++.++...++
T Consensus 219 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~ 258 (260)
T cd05073 219 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258 (260)
T ss_pred CCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 4555556678999999999999999999999999987665
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=325.44 Aligned_cols=265 Identities=20% Similarity=0.322 Sum_probs=210.4
Q ss_pred CceEeecCceEEEEEEeeecCceEEEEEEEcc------cCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEE
Q 005577 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAI------HMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTL 89 (690)
Q Consensus 17 g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~------~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL 89 (690)
...+++...+|++.+.||+|+||.||+|++.. .....||+|.+... .......+.+|+.+++++.+||||+++
T Consensus 4 ~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 4 DPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred CcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 36778888999999999999999999998631 12236899987653 344567889999999999669999999
Q ss_pred EEEEEeecCCCceEEEEEecCC-CcHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCccc
Q 005577 90 YAHTILDLGRTKEALLVMECCD-KSLVNVLENRGA--------------GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAH 154 (690)
Q Consensus 90 ~~~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~--------------~~lse~~~~~i~~qIa~aL~yLHs~g~~IVH 154 (690)
++++. ....+|+||||+. |+|.+++..+.. ..++..+++.++.||+.||.|||.+| |+|
T Consensus 84 ~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH 157 (334)
T cd05100 84 LGACT----QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIH 157 (334)
T ss_pred eEEEc----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eec
Confidence 99865 3467899999995 578887765421 23778889999999999999999999 999
Q ss_pred CCCCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHH
Q 005577 155 RDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLF 234 (690)
Q Consensus 155 RDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLy 234 (690)
|||||+|||++.++.+||+|||+++........ .......++..|||||+ +.+..++.++|||||||++|
T Consensus 158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~il~ 227 (334)
T cd05100 158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYY-------KKTTNGRLPVKWMAPEA---LFDRVYTHQSDVWSFGVLLW 227 (334)
T ss_pred cccccceEEEcCCCcEEECCcccceeccccccc-------ccccCCCcCceEcCHHH---hccCCcCchhhhHHHHHHHH
Confidence 999999999999999999999998654321100 01111234578999996 45667899999999999999
Q ss_pred HHHh-CCCCCCCchHHHHH---hccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 235 RICY-FKNAFDGESKLQIL---NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 235 ELlt-G~~PF~~~~~~~il---~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
+|++ |..||.+....++. ........+..++..+.+||.+||+.+|.+||++.+++..+....
T Consensus 228 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 228 EIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 9998 88999876654433 333444455678899999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=320.99 Aligned_cols=263 Identities=20% Similarity=0.316 Sum_probs=207.5
Q ss_pred eEeecCceEEEEEEeeecCceEEEEEEEc------ccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEE
Q 005577 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDA------IHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYA 91 (690)
Q Consensus 19 ~iei~~~ry~v~~~LG~GgFG~VylA~d~------~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~ 91 (690)
.+++...+|.+.+.||+|+||.||+|.+. ......||+|++... .......+.+|+.+++.+.+|||||++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 34566789999999999999999999752 123457899987643 34456778899999999966999999999
Q ss_pred EEEeecCCCceEEEEEecCC-CcHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCC
Q 005577 92 HTILDLGRTKEALLVMECCD-KSLVNVLENRG--------------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRD 156 (690)
Q Consensus 92 ~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~--------------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRD 156 (690)
++. ....+|+||||+. |+|.+++..+. ...+++.+++.++.||+.||.|||++| |+|||
T Consensus 86 ~~~----~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~d 159 (314)
T cd05099 86 VCT----QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRD 159 (314)
T ss_pred EEc----cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecc
Confidence 864 3467899999995 57877776532 134888999999999999999999999 99999
Q ss_pred CCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHH
Q 005577 157 LKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI 236 (690)
Q Consensus 157 LKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyEL 236 (690)
|||+|||++.++.+||+|||+++........ .......+++.|||||+ +.+..++.++|||||||++|+|
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~---~~~~~~~~~~DiwslG~~l~el 229 (314)
T cd05099 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYY-------KKTSNGRLPVKWMAPEA---LFDRVYTHQSDVWSFGILMWEI 229 (314)
T ss_pred ccceeEEEcCCCcEEEccccccccccccccc-------cccccCCCCccccCHHH---HccCCcCccchhhHHHHHHHHH
Confidence 9999999999999999999998754321100 00111234568999996 4567789999999999999999
Q ss_pred Hh-CCCCCCCchHHHHH---hccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 237 CY-FKNAFDGESKLQIL---NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 237 lt-G~~PF~~~~~~~il---~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
++ |..||.+.....+. ........+..++..+.+||.+||..+|++||++.+++..+....
T Consensus 230 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 230 FTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 98 89999876554332 333333445678899999999999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.60 Aligned_cols=248 Identities=24% Similarity=0.391 Sum_probs=198.2
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
..+|++.+.||+|+||.||+|.+. ....+++|++..... ....+.+|+.+++.+. ||||+++++++. .....
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~~~----~~~~~ 74 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR--GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLS-HPNLVQLYGVCT----KQRPI 74 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec--CCccEEEEEeccCCC-CHHHHHHHHHHHHhCC-CCCEEEEEEEEc----CCCce
Confidence 357889999999999999999874 566899998754322 2356788999999995 999999998754 34678
Q ss_pred EEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
|+||||+. ++|.+++..+. +.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVL 151 (256)
T ss_pred EEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceecc
Confidence 99999995 57777776544 35899999999999999999999999 9999999999999999999999999886542
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---HhccCCC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LNGNYRI 258 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i---l~~~~~~ 258 (690)
.... .......++..|+|||+ +.+..++.++|||||||++|+|++ |+.||......+. +....+.
T Consensus 152 ~~~~--------~~~~~~~~~~~y~~Pe~---~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~ 220 (256)
T cd05059 152 DDQY--------TSSQGTKFPVKWAPPEV---FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL 220 (256)
T ss_pred cccc--------cccCCCCCCccccCHHH---hccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC
Confidence 2110 00011123567999996 445678999999999999999998 8999976654433 2333444
Q ss_pred CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
..+..++..+.+++.+||..+|++||++.+++..+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 55567899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=312.30 Aligned_cols=258 Identities=21% Similarity=0.307 Sum_probs=206.4
Q ss_pred EeecCceEEEEEEeeecCceEEEEEEEccc--CCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEee
Q 005577 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIH--MSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 20 iei~~~ry~v~~~LG~GgFG~VylA~d~~~--~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~ 96 (690)
+++...+|.+.+.||+|+||.||+|.+... ....|+||...... ....+.+.+|+.+++.+. ||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~-- 77 (270)
T cd05056 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD-HPHIVKLIGVIT-- 77 (270)
T ss_pred CeechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCC-CCchhceeEEEc--
Confidence 467788999999999999999999987422 23468999876554 556778999999999995 999999998764
Q ss_pred cCCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeecc
Q 005577 97 LGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDF 175 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DF 175 (690)
....|+||||+. ++|.+++.... ..+++..++.++.+|+.||.|||+.+ ++||||||+|||++.++.+||+||
T Consensus 78 ---~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~ 151 (270)
T cd05056 78 ---ENPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDF 151 (270)
T ss_pred ---CCCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccC
Confidence 245789999995 57777776543 35899999999999999999999999 999999999999999999999999
Q ss_pred CCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI--- 251 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i--- 251 (690)
|+++........ ......++..|+|||+ +....++.++|||||||++|+|++ |..||.+......
T Consensus 152 g~~~~~~~~~~~--------~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~ 220 (270)
T cd05056 152 GLSRYLEDESYY--------KASKGKLPIKWMAPES---INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR 220 (270)
T ss_pred ceeeecccccce--------ecCCCCccccccChhh---hccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 988654322100 0011234568999996 445678999999999999999986 9999987654433
Q ss_pred HhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 252 LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 252 l~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
+....+.+.+..++..+.++|.+||..+|.+||++.+++..+....
T Consensus 221 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 221 IENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2333344556788999999999999999999999999988877643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=309.72 Aligned_cols=247 Identities=21% Similarity=0.338 Sum_probs=198.1
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-----HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-----EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-----~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
.|.+.+.||+|+||.||+|.+. ..++.|++|.+.... ......+.+|+.+++++ +||||+++++++. ..
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~-~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~----~~ 76 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDV-DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLR----DD 76 (263)
T ss_pred cccccceecCCCceEEEEEEEc-CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEc----cC
Confidence 5888999999999999999985 578899999886432 22345788899999999 4999999999865 34
Q ss_pred ceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 101 KEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 101 ~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
..+|+||||+. ++|.+.+.... .+++..+..++.||+.||.|||..+ |+||||+|+|||++.++.++|+|||+++
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~ 152 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASK 152 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccce
Confidence 58999999996 56777776554 4899999999999999999999999 9999999999999999999999999986
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH----hcc
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL----NGN 255 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il----~~~ 255 (690)
........ ........|+..|+|||+ +.+..++.++|||||||++|+|++|+.||......... ...
T Consensus 153 ~~~~~~~~------~~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 223 (263)
T cd06625 153 RLQTICSS------GTGMKSVTGTPYWMSPEV---ISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP 223 (263)
T ss_pred eccccccc------cccccCCCcCccccCcce---eccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC
Confidence 54221100 000122457889999997 44566899999999999999999999999765443322 222
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 256 YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 256 ~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.....+..++..+.++|.+||..+|.+||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 224 TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 233334578999999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.24 Aligned_cols=259 Identities=24% Similarity=0.359 Sum_probs=221.5
Q ss_pred ceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec
Q 005577 18 RSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97 (690)
Q Consensus 18 ~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~ 97 (690)
..|+....++++.++||-|.||.||.|.++ +..-.||||.+.. +...++.|+.|+.+|+.|+ |||+|+|+++|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWK-kyslTvAVKtLKE-DtMeveEFLkEAAvMKeik-HpNLVqLLGVCT~E- 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTHE- 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeee-ccceeeehhhhhh-cchhHHHHHHHHHHHHhhc-CccHHHHhhhhccC-
Confidence 567788899999999999999999999996 5567899998754 4455899999999999996 99999999998754
Q ss_pred CCCceEEEEEecC-CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccC
Q 005577 98 GRTKEALLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176 (690)
Q Consensus 98 ~~~~~~~LVmEy~-~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFG 176 (690)
..+|||+||| .|+|+++|+......++.-.++.++.||..|++||..++ +|||||...|||+..+..|||+|||
T Consensus 336 ---pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 336 ---PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred ---CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccc
Confidence 6789999999 699999999988777888888999999999999999999 9999999999999999999999999
Q ss_pred CCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH---HHHH
Q 005577 177 STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESK---LQIL 252 (690)
Q Consensus 177 lA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~---~~il 252 (690)
|++.+..+..... .| ..-.+.|.|||- +....++-++|||+|||+|||+.| |-.||.+.+. +.++
T Consensus 411 LsRlMtgDTYTAH-AG-------AKFPIKWTAPEs---LAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL 479 (1157)
T KOG4278|consen 411 LSRLMTGDTYTAH-AG-------AKFPIKWTAPES---LAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL 479 (1157)
T ss_pred hhhhhcCCceecc-cC-------ccCcccccCccc---ccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH
Confidence 9987543221100 00 112678999995 445568899999999999999987 8899998765 4567
Q ss_pred hccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhh
Q 005577 253 NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 253 ~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~ 296 (690)
+..|++..+..|++.+++||+.||+.+|.+||+++++-+.++.+
T Consensus 480 EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 480 EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 89999999999999999999999999999999999996655443
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=308.18 Aligned_cols=247 Identities=26% Similarity=0.445 Sum_probs=199.9
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
.|++.+.||+|+||.||++.+. ..++.|++|.+... .....+.+.+|+.+++.+. |+||+++++.+.. ....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~---~~~~~ 75 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHR-TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK-HPNIVAYRESWEG---EDGLL 75 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEc-CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecC---CCCEE
Confidence 4899999999999999999985 56788999998643 3344567888999999995 9999999876531 23468
Q ss_pred EEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
|+||||+. ++|.+.+.......+++.+++.++.+|+.||.|||++| |+||||||+|||++.++.++|+|||++....
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~ 153 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE 153 (257)
T ss_pred EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEec
Confidence 99999996 57777777654456899999999999999999999999 9999999999999999999999999886542
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh---ccCCCC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN---GNYRIP 259 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~---~~~~~~ 259 (690)
... .......+++.|+|||+ ..+..++.++|||||||++|+|++|+.||.......+.. ......
T Consensus 154 ~~~---------~~~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
T cd08223 154 NQC---------DMASTLIGTPYYMSPEL---FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP 221 (257)
T ss_pred ccC---------CccccccCCcCccChhH---hcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 211 01123467899999996 456678899999999999999999999998765444322 122223
Q ss_pred CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 260 ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 260 ~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.+..++..+.++|.+||+.+|++||++.+++.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 34568899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=343.17 Aligned_cols=244 Identities=22% Similarity=0.320 Sum_probs=191.4
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
+..|.+.+.||+|+||.||+|.+. ..++.||||... ...+.+|+++|++|. |+|||++++++.. ....
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~-~~~~~vavK~~~------~~~~~~E~~iL~~L~-HpnIv~l~~~~~~----~~~~ 235 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHP-DYPQRVVVKAGW------YASSVHEARLLRRLS-HPAVLALLDVRVV----GGLT 235 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEEC-CCCCEEEEeccc------ccCHHHHHHHHHHCC-CCCCCcEEEEEEE----CCEE
Confidence 557999999999999999999985 567889999642 234568999999995 9999999998653 4678
Q ss_pred EEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 104 LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
||||||+.++|+.++..+. ..+++.+++.|+.||+.||.|||.+| ||||||||+||||+.++.+||+|||+++....
T Consensus 236 ~lv~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 236 CLVLPKYRSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred EEEEEccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 9999999999998887643 35999999999999999999999999 99999999999999999999999999875432
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCC-CCc-------h---HHHHH
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAF-DGE-------S---KLQIL 252 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF-~~~-------~---~~~il 252 (690)
.... .......||+.|||||+ +.+..++.++||||||||||||++|..++ ... . ...++
T Consensus 313 ~~~~-------~~~~~~~GT~~Y~APE~---~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i 382 (461)
T PHA03211 313 SWST-------PFHYGIAGTVDTNAPEV---LAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRII 382 (461)
T ss_pred cccc-------ccccccCCCcCCcCHHH---HcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHH
Confidence 1110 01123468999999996 45667999999999999999999877543 211 0 11111
Q ss_pred hc-cCCCC--------------------------------CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 253 NG-NYRIP--------------------------------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 253 ~~-~~~~~--------------------------------~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
.. .+... ....++..+.+||.+||+.||.+||++.|++.+
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 383 RQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11 00000 001345688999999999999999999999754
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=309.80 Aligned_cols=251 Identities=29% Similarity=0.470 Sum_probs=199.1
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeec---CCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC---NDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~---~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|++.+.||+|+||.||+|++. ..++.||||.+.. .+......+.+|+.+++.+. ||||+++++++.. .+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----~~ 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCL-LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIE----DN 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEe-CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEE----CC
Confidence 47899999999999999999985 5788999998754 23455667889999999995 9999999988653 46
Q ss_pred eEEEEEecCCC-cHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 102 EALLVMECCDK-SLVNVLENR--GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 102 ~~~LVmEy~~g-sLl~~L~~~--~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
..++||||+.+ +|.+++... ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~ 153 (267)
T cd08228 76 ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccc
Confidence 78999999975 666666432 2345899999999999999999999999 999999999999999999999999988
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHh---
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES--KLQILN--- 253 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~--~~~il~--- 253 (690)
........ ......|++.|+|||+ +.+..++.++|||||||++|+|++|+.||.... ...+..
T Consensus 154 ~~~~~~~~---------~~~~~~~~~~~~aPE~---~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 221 (267)
T cd08228 154 RFFSSKTT---------AAHSLVGTPYYMSPER---IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE 221 (267)
T ss_pred eeccchhH---------HHhcCCCCccccChhh---hccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHh
Confidence 65432211 0112357889999996 445668899999999999999999999996542 122221
Q ss_pred c-cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhh
Q 005577 254 G-NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 254 ~-~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~ 295 (690)
. .+.......++..+.++|.+||..+|++||++.+++..+..
T Consensus 222 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~ 264 (267)
T cd08228 222 QCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264 (267)
T ss_pred cCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence 1 11111123577899999999999999999999999887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.30 Aligned_cols=258 Identities=24% Similarity=0.324 Sum_probs=202.5
Q ss_pred eecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec--C
Q 005577 21 DVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL--G 98 (690)
Q Consensus 21 ei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~--~ 98 (690)
.....+|++.+.||.|+||.||+|.+. ..++.||+|++..... ....+..|+.+++++.+|+||+++++++.... +
T Consensus 12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 12 RDPAGIFELVEVVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred cChhhhhhhheeeccCCCeEEEEEEEc-CCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 344578999999999999999999985 5788999998865533 34567889999999977999999999875321 2
Q ss_pred CCceEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCC
Q 005577 99 RTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS 177 (690)
Q Consensus 99 ~~~~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGl 177 (690)
....+|+||||+.+ +|.+++.......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcc
Confidence 34678999999965 7777776554455889999999999999999999999 99999999999999999999999998
Q ss_pred CCcccccchhhhhccccccccccCCCCcccCccchhhh--hcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLF--RRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN 255 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~--~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~ 255 (690)
+....... .......|++.|+|||++... .+..++.++|||||||++|+|++|..||........+...
T Consensus 168 ~~~~~~~~---------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~ 238 (282)
T cd06636 168 SAQLDRTV---------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238 (282)
T ss_pred hhhhhccc---------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence 86432111 011234689999999974211 1345788999999999999999999999765443322211
Q ss_pred ----CCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 256 ----YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 256 ----~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
........++..+.+||.+||..||.+||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 111122357899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=315.49 Aligned_cols=248 Identities=28% Similarity=0.425 Sum_probs=199.2
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
+|++.+.||+|+||.||+|.+. ..++.|++|++.... ......+.+|+.+++.+. ||||+++++++.. ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~----~~~~ 74 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDR-ETGETVALKKVALRRLEGGIPNQALREIKALQACQ-HPYVVKLLDVFPH----GSGF 74 (286)
T ss_pred CceEEeecccCCCcEEEEEEEC-CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC-CCCCcceeeEEec----CCee
Confidence 5899999999999999999985 568899999986543 344577889999999995 9999999998653 5788
Q ss_pred EEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 104 LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
|+||||++++|.+.+.... ..+++.+++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 75 ~~v~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 75 VLVMEYMPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSE 151 (286)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence 9999999888888876544 45999999999999999999999999 99999999999999999999999998865432
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC-------
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY------- 256 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~------- 256 (690)
... .......|+..|+|||++ .....++.++|||||||++|+|++|..+|.+......+....
T Consensus 152 ~~~--------~~~~~~~~~~~y~aPE~~--~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~ 221 (286)
T cd07832 152 EEP--------RLYSHQVATRWYRAPELL--YGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPN 221 (286)
T ss_pred CCC--------CccccccCcccccCceee--eccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCC
Confidence 211 011224679999999973 334557899999999999999999998887655432211100
Q ss_pred ----------------CCC---------CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 257 ----------------RIP---------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 257 ----------------~~~---------~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
..+ ..+.++..+.+||.+||..+|.+||++.+++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 222 EETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 013567899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=318.08 Aligned_cols=245 Identities=28% Similarity=0.424 Sum_probs=200.0
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
..+|++.+.||.|+||.||+|.+. ..++.|++|.+........+.+.+|+.+++.+. ||||+++++++. ....+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~----~~~~~ 91 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDV-ATGQEVAIKQINLQKQPKKELIINEILVMKELK-NPNIVNFLDSFL----VGDEL 91 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEc-CCCcEEEEEEEecccCchHHHHHHHHHHHHhcC-CCceeeeeeeEe----cCceE
Confidence 357999999999999999999985 678899999987665555677889999999995 999999999865 34689
Q ss_pred EEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
|+||||+.+ +|..++. .. .+++.+++.++.+|+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 92 ~lv~e~~~~~~L~~~~~-~~--~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 92 FVVMEYLAGGSLTDVVT-ET--CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EEEEEecCCCcHHHHHH-hc--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 999999965 5555553 32 4899999999999999999999999 9999999999999999999999999886532
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh-----ccCC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN-----GNYR 257 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~-----~~~~ 257 (690)
.... ......+++.|+|||+ +.+..++.++|||||||++|+|++|+.||.+......+. ....
T Consensus 167 ~~~~---------~~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T cd06655 167 PEQS---------KRSTMVGTPYWMAPEV---VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE 234 (296)
T ss_pred cccc---------cCCCcCCCccccCcch---hcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc
Confidence 2110 1122457899999996 455668899999999999999999999998766543221 1112
Q ss_pred CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
...+..++..+.+||.+||..||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 2334568899999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.12 Aligned_cols=245 Identities=24% Similarity=0.337 Sum_probs=195.2
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.|++.++||+|+||.||++.+. ..++.||+|.+.... ......+.+|+.+|+.+ +|+||+.+++.+. ....
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~----~~~~ 74 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYE----TKDA 74 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEc-CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEe----cCCE
Confidence 3778899999999999999985 578899999886432 23345677899999999 4999999988864 3468
Q ss_pred EEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
+|+||||+. ++|.+.+.......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 75 ~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05630 75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHV 152 (285)
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence 999999996 56777776555446999999999999999999999999 999999999999999999999999988543
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH---HHHHh---cc
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK---LQILN---GN 255 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~---~~il~---~~ 255 (690)
.... ......|++.|+|||+ +.+..++.++|||||||++|+|++|+.||..... ..... ..
T Consensus 153 ~~~~----------~~~~~~g~~~y~aPE~---~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~ 219 (285)
T cd05630 153 PEGQ----------TIKGRVGTVGYMAPEV---VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 219 (285)
T ss_pred CCCc----------cccCCCCCccccChHH---HcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh
Confidence 2110 1112368999999996 4556789999999999999999999999986421 11111 11
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhCCCCCCC-----HHHHHH
Q 005577 256 YRIPESPKYSSSVTDLIRDMLQASPDDRPD-----ITQVWF 291 (690)
Q Consensus 256 ~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt-----~~eil~ 291 (690)
........+++.+.+||.+||+.||.+||+ +.+++.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 220 VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 122234568899999999999999999999 777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=318.31 Aligned_cols=243 Identities=22% Similarity=0.298 Sum_probs=194.7
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
+|++.+.||+|+||.||++.+. .++..|++|.+... .......+.+|+++++++ +||||+++++++.. .+.+|
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~~~~ 75 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHR-PSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYS----DGEIS 75 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEc-CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee----CCEEE
Confidence 6899999999999999999985 56788999988654 344566788999999999 49999999998753 47899
Q ss_pred EEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 105 LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS-QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 105 LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs-~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
+||||++| +|.+++... +.+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||++....
T Consensus 76 lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred EEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 99999965 677777654 348999999999999999999998 47 9999999999999999999999999886432
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh---ccCC--
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN---GNYR-- 257 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~---~~~~-- 257 (690)
.. ......|++.|+|||+ +.+..++.++|||||||++|+|++|+.||.......... ....
T Consensus 152 ~~-----------~~~~~~~~~~~~aPE~---~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 217 (308)
T cd06615 152 DS-----------MANSFVGTRSYMSPER---LQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEG 217 (308)
T ss_pred cc-----------ccccCCCCcCccChhH---hcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccc
Confidence 21 1123467999999996 445678899999999999999999999997544322110 0000
Q ss_pred ---------------------------------CC--CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 258 ---------------------------------IP--ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 258 ---------------------------------~~--~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
.+ ....++.++.+||.+||..+|++||++.+++..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 218 EAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 011367889999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=314.38 Aligned_cols=255 Identities=16% Similarity=0.230 Sum_probs=199.6
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCe----EEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSK----QYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k----~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~ 97 (690)
...+|++.+.||+|+||+||+|.+. ..+. .|++|.+.... ......+..|+.+++.+ +|||||++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~--- 79 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWI-PEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICP--- 79 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEc-CCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEEC---
Confidence 3468889999999999999999874 2333 47777764332 33456777888899999 5999999999753
Q ss_pred CCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccC
Q 005577 98 GRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176 (690)
Q Consensus 98 ~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFG 176 (690)
....++||||+. |+|.+++.... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 80 --~~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg 154 (279)
T cd05111 80 --GASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFG 154 (279)
T ss_pred --CCccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCc
Confidence 345778999985 78888876543 35899999999999999999999999 9999999999999999999999999
Q ss_pred CCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH---HHH
Q 005577 177 STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKL---QIL 252 (690)
Q Consensus 177 lA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~---~il 252 (690)
+++........ .......++..|+|||+ +.+..++.++|||||||++|||++ |..||.+.... +++
T Consensus 155 ~~~~~~~~~~~-------~~~~~~~~~~~y~~pE~---~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~ 224 (279)
T cd05111 155 VADLLYPDDKK-------YFYSEHKTPIKWMALES---ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224 (279)
T ss_pred cceeccCCCcc-------cccCCCCCcccccCHHH---hccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 98654321110 01112346788999996 445678999999999999999998 99999876543 334
Q ss_pred hccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 253 NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 253 ~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
......+.+..++..+.+++.+||..||.+||++.+++..+....
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 225 EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred HCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 433444444567889999999999999999999999987666543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.69 Aligned_cols=247 Identities=26% Similarity=0.422 Sum_probs=196.8
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
.|++.+.||.|+||.||+|++. ..++.|+||++.... ......+.+|+++++++. ||||+++++++. .....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~----~~~~~ 74 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIH----TENKL 74 (284)
T ss_pred CceeeeeecCCCceEEEEEEEC-CCCCEEEEEEccccccccccchHHHHHHHHHHhcC-CCCCcchhhhcc----cCCcE
Confidence 3788999999999999999985 578899999885432 233457889999999995 999999998854 45688
Q ss_pred EEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 104 LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
|+||||+.++|..++.......+++..++.++.||+.||.|||..+ |+||||+|+|||++.++.+||+|||++.....
T Consensus 75 ~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~ 152 (284)
T cd07860 75 YLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152 (284)
T ss_pred EEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999989888887655556999999999999999999999999 99999999999999999999999998865422
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC-------
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY------- 256 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~------- 256 (690)
... ......+++.|+|||++ .....++.++|||||||++|+|++|+.||.+......+....
T Consensus 153 ~~~---------~~~~~~~~~~y~aPE~~--~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 221 (284)
T cd07860 153 PVR---------TYTHEVVTLWYRAPEIL--LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 221 (284)
T ss_pred Ccc---------ccccccccccccCCeEE--ecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 111 01123468899999973 223446889999999999999999999997765432211100
Q ss_pred ---------------CC---------CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 ---------------RI---------PESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 ---------------~~---------~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.. ...+.++..+.++|.+||+.||.+||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 222 EVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00 002357889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=314.64 Aligned_cols=246 Identities=30% Similarity=0.450 Sum_probs=195.4
Q ss_pred EEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEE
Q 005577 27 IHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALL 105 (690)
Q Consensus 27 y~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~L 105 (690)
|++.+.||+|+||.||+|.+. ..++.||+|++.... .......++|+.+++++.+|+||+++++++... ..+.+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSR-KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR--KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEc-CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC--CCCcEEE
Confidence 678999999999999999985 568899999886531 222234567999999997799999999987532 3367899
Q ss_pred EEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccc
Q 005577 106 VMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185 (690)
Q Consensus 106 VmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~ 185 (690)
||||+++++++.+..+. ..+++..++.++.||+.||.|||..+ |+||||||+|||++. +.+||+|||+++......
T Consensus 78 v~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 78 VFELMDMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 99999999999887643 35899999999999999999999999 999999999999999 999999999986543211
Q ss_pred hhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc----------
Q 005577 186 EKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN---------- 255 (690)
Q Consensus 186 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~---------- 255 (690)
......+++.|+|||++ ..+..++.++|||||||++|+|++|..||.+.+..+.+...
T Consensus 154 ----------~~~~~~~~~~y~aPE~~--~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
T cd07831 154 ----------PYTEYISTRWYRAPECL--LTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAE 221 (282)
T ss_pred ----------CcCCCCCCcccCChhHh--hcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 11123578899999963 33456788999999999999999999999876543321110
Q ss_pred ------------CCCCC---------CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 256 ------------YRIPE---------SPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 256 ------------~~~~~---------~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
+..+. .+.++..+.+||.+||.++|++||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000 1356899999999999999999999999865
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=316.79 Aligned_cols=264 Identities=17% Similarity=0.225 Sum_probs=192.8
Q ss_pred eEeecCceEEEEEEeeecCceEEEEEEEcccC---CeEEEEEEeecCCHHH-H----------HHHHHHHHHHHhhcCCC
Q 005577 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDAIHM---SKQYAMKHMICNDEES-L----------ESAMKEISVMKSLKGHP 84 (690)
Q Consensus 19 ~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~---~k~vAvK~i~~~~~e~-~----------e~~~~Ei~iL~~L~~HP 84 (690)
-+++.+.+|++.++||+|+||.||+|.+. .. .+.+++|+........ . .....++..+..+ +|+
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~-~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~ 83 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCA-SDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHL 83 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEc-CCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCC
Confidence 35677889999999999999999999874 33 4567777643322111 0 1122333444555 599
Q ss_pred CceEEEEEEEeecCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEe
Q 005577 85 NVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLL 164 (690)
Q Consensus 85 NIVkL~~~~~~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILL 164 (690)
||+++++++..........+++|+++..++.+.+.... .+++..++.|+.||+.||.|||+++ |+||||||+|||+
T Consensus 84 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill 159 (294)
T PHA02882 84 GIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMV 159 (294)
T ss_pred CCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE
Confidence 99999987665433333557899999888777665543 3678889999999999999999999 9999999999999
Q ss_pred CCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005577 165 GSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFD 244 (690)
Q Consensus 165 d~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~ 244 (690)
+.++.++|+|||+++........... .........||+.|+|||+ ..+..++.++|||||||+||||++|..||.
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~--~~~~~~~~~gt~~y~ape~---~~~~~~~~~~DiwSlG~~l~el~~g~~P~~ 234 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEY--SKEQKDLHRGTLYYAGLDA---HNGACVTRRGDLESLGYCMLKWAGIKLPWK 234 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCccccc--ccccccccCCCccccCHHH---hCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999998764322111100 0111122468999999996 556779999999999999999999999997
Q ss_pred CchH-H--------HHHhccCC-CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 245 GESK-L--------QILNGNYR-IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 245 ~~~~-~--------~il~~~~~-~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
+... . +.+..... ....+.++..+.+++..||..+|++||++.++...+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 235 GFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred ccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 6521 1 11111111 112346789999999999999999999999987643
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.15 Aligned_cols=258 Identities=22% Similarity=0.290 Sum_probs=200.0
Q ss_pred CceEEEEEEeeecCceEEEEEEEc---ccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDA---IHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~---~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
+.-|++.+.||+|+||.||+|... ...++.|++|.+... .......+.+|+.+|+.+. ||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~ 79 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HENIVKYKGICTED--G 79 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecC--C
Confidence 445788999999999999999742 245788999998644 3445678899999999995 99999999886532 3
Q ss_pred CceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 100 TKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
....++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCccc
Confidence 456899999995 56766665433 35899999999999999999999999 999999999999999999999999998
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch-----------
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES----------- 247 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~----------- 247 (690)
+.+....... .......++..|+|||+ +.+..++.++|||||||++|+|++++.|+....
T Consensus 157 ~~~~~~~~~~------~~~~~~~~~~~y~apE~---~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd05079 157 KAIETDKEYY------TVKDDLDSPVFWYAPEC---LIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTH 227 (284)
T ss_pred cccccCccce------eecCCCCCCccccCHHH---hccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccc
Confidence 7643221110 01112346778999996 445678999999999999999999876542210
Q ss_pred -------HHHHHhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhh
Q 005577 248 -------KLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 248 -------~~~il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~ 296 (690)
....+......+....++..+.+||.+||+.+|++||++.+++..+...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 228 GQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0111222333444567899999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=312.92 Aligned_cols=238 Identities=17% Similarity=0.269 Sum_probs=184.7
Q ss_pred EeeecCceEEEEEEEcc-----------cCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 32 VIAEGGFSCVYSARDAI-----------HMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 32 ~LG~GgFG~VylA~d~~-----------~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
.||+|+||.||+|.... .....|++|.+..........+.+|+.++..+. |||||++++++.. .
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~----~ 76 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS-HKHIVLLYGVCVR----D 76 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCC-CCCEeeEEEEEec----C
Confidence 68999999999997421 123358888876555555667888999999995 9999999998753 3
Q ss_pred ceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCC-------eeee
Q 005577 101 KEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGL-------WKLC 173 (690)
Q Consensus 101 ~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~-------vKL~ 173 (690)
...++||||++++.++.+.......+++..++.++.||+.||.|||+++ |+||||||+||||+.++. ++|+
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 5678999999865555544444456999999999999999999999999 999999999999987664 8999
Q ss_pred ccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHH-hCCCCCCCchHHHHH
Q 005577 174 DFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC-YFKNAFDGESKLQIL 252 (690)
Q Consensus 174 DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELl-tG~~PF~~~~~~~il 252 (690)
|||++...... ....++..|||||++ ..+..++.++|||||||++|+|+ +|..||......+..
T Consensus 155 d~g~~~~~~~~-------------~~~~~~~~y~aPE~~--~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~ 219 (262)
T cd05077 155 DPGIPITVLSR-------------QECVERIPWIAPECV--EDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE 219 (262)
T ss_pred CCCCCccccCc-------------ccccccccccChhhh--cCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH
Confidence 99988543211 123568899999963 23466889999999999999997 588888765443321
Q ss_pred ---hccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 253 ---NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 253 ---~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
.... ......+..+.+||.+||+.||.+||++.+|+..+
T Consensus 220 ~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 220 RFYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 2222 12234568899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=315.30 Aligned_cols=240 Identities=23% Similarity=0.325 Sum_probs=192.2
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.|++.+.||+|+||+||+|.+. ..++.||+|++.... ......+.+|+.+|+.+. |+||+.+++++. ..+.
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~----~~~~ 74 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVR-ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYE----TKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEC-CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEe----cCCE
Confidence 3778899999999999999985 578899999986432 233456788999999995 999999988764 3467
Q ss_pred EEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
.|+||||+.+ +|...+.......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05632 75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKI 152 (285)
T ss_pred EEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceec
Confidence 8999999965 5666665554446999999999999999999999999 999999999999999999999999988543
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH----HHhccC-
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNY- 256 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~----il~~~~- 256 (690)
... .......|++.|+|||+ +.+..++.++|||||||++|+|++|..||.+..... +.....
T Consensus 153 ~~~----------~~~~~~~g~~~~~aPE~---~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~ 219 (285)
T cd05632 153 PEG----------ESIRGRVGTVGYMAPEV---LNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE 219 (285)
T ss_pred CCC----------CcccCCCCCcCccChHH---hcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhc
Confidence 211 01122468999999996 455678999999999999999999999998654322 111111
Q ss_pred -CCCCCCCCCHHHHHHHHHHhhhCCCCCCCH
Q 005577 257 -RIPESPKYSSSVTDLIRDMLQASPDDRPDI 286 (690)
Q Consensus 257 -~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~ 286 (690)
.......++..+.+||..||+.||++||++
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05632 220 TEEVYSAKFSEEAKSICKMLLTKDPKQRLGC 250 (285)
T ss_pred cccccCccCCHHHHHHHHHHccCCHhHcCCC
Confidence 122345688999999999999999999993
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=309.11 Aligned_cols=246 Identities=19% Similarity=0.306 Sum_probs=193.6
Q ss_pred EeeecCceEEEEEEEcc-cCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEec
Q 005577 32 VIAEGGFSCVYSARDAI-HMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMEC 109 (690)
Q Consensus 32 ~LG~GgFG~VylA~d~~-~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy 109 (690)
.||+|+||.||+|.+.. ..+..||+|++.... ....+.+.+|+.+++.+. ||||+++++++. ....++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~-----~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE-----AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc-----CCCeEEEEEe
Confidence 38999999999998742 235579999886543 344567889999999995 999999998753 3468999999
Q ss_pred CC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhh
Q 005577 110 CD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL 188 (690)
Q Consensus 110 ~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~ 188 (690)
+. ++|.+++..+ ...+++..++.++.||+.||.|||.++ |+||||||+|||++.++.+||+|||++..........
T Consensus 76 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 76 ASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 96 5666666543 345899999999999999999999999 9999999999999999999999999986542211100
Q ss_pred hhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---HhccCCCCCCCCC
Q 005577 189 EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LNGNYRIPESPKY 264 (690)
Q Consensus 189 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i---l~~~~~~~~~~~~ 264 (690)
.......+++.|+|||+ +.+..++.++|||||||++|+|++ |..||.......+ +....+...+..+
T Consensus 153 ------~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (257)
T cd05115 153 ------KARSAGKWPLKWYAPEC---INFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAEC 223 (257)
T ss_pred ------eccCCCCCCcccCCHHH---HccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCC
Confidence 00011123578999996 445668999999999999999996 9999987654433 3334444555678
Q ss_pred CHHHHHHHHHHhhhCCCCCCCHHHHHHHHhh
Q 005577 265 SSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 265 s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~ 295 (690)
++++.++|.+||..+|++||++.+|...+..
T Consensus 224 ~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 224 PPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 9999999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=308.46 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=198.9
Q ss_pred EEeeecCceEEEEEEEcccCCe--EEEEEEeecCCH-HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHMSK--QYAMKHMICNDE-ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k--~vAvK~i~~~~~-e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
++||+|+||.||+|.+....++ .||||.+..... ...+.+.+|+.+++++. |||||++++++. . ..+++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~----~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD-HENLIRLYGVVL----T-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcC-CCCccceeEEEc----C-CeEEEEE
Confidence 3689999999999988532333 689999876655 66788999999999995 999999998864 2 6789999
Q ss_pred ecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccch
Q 005577 108 ECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 108 Ey~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~ 186 (690)
||+. ++|.+.+.......+++..++.++.||+.||.|||.++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEecccccccccccccc
Confidence 9995 68888887655346899999999999999999999999 99999999999999999999999999876533211
Q ss_pred hhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHh----ccCCCCCC
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQILN----GNYRIPES 261 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il~----~~~~~~~~ 261 (690)
.. .......++..|+|||+ +.+..++.++|||||||++|+|++ |+.||......+++. .......+
T Consensus 153 ~~------~~~~~~~~~~~y~~pE~---~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (257)
T cd05040 153 HY------VMEEHLKVPFAWCAPES---LRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERP 223 (257)
T ss_pred ce------ecccCCCCCceecCHHH---hcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCC
Confidence 10 01112356789999996 556678999999999999999998 999997665554432 22233334
Q ss_pred CCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 262 PKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 262 ~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
..++..+.+++.+||..+|.+||++.+++..+.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 567899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=318.27 Aligned_cols=245 Identities=28% Similarity=0.395 Sum_probs=199.6
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
..+|++.+.||+|+||.||+|.+. ..++.||+|.+........+.+.+|+.+++.+ +||||+++++++. .....
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~----~~~~~ 91 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDI-ATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYL----VGDEL 91 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEEC-CCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEEe----cCCEE
Confidence 468999999999999999999985 57889999999766555567788999999999 4999999999875 34688
Q ss_pred EEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
|+||||+++ +|.+++.. . .+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~--~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-T--CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred EEeecccCCCCHHHHHHh-C--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 999999965 56666543 2 3899999999999999999999999 9999999999999999999999999886432
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc-----cCC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG-----NYR 257 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~-----~~~ 257 (690)
.... ......+++.|+|||. +.+..++.++|||||||++|+|++|..||.+......+.. ...
T Consensus 167 ~~~~---------~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 234 (297)
T cd06656 167 PEQS---------KRSTMVGTPYWMAPEV---VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE 234 (297)
T ss_pred CCcc---------CcCcccCCccccCHHH---HcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCC
Confidence 2110 0112357899999996 4566788999999999999999999999987654332211 112
Q ss_pred CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
...+..++..+.+||.+||..+|++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2234467889999999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=338.75 Aligned_cols=243 Identities=23% Similarity=0.382 Sum_probs=200.0
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEecC
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECC 110 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy~ 110 (690)
-+||+|.||+||-|+|. .+...+|||.+...+....+-+..||.+.+.|+ |.|||+++|.+ .+++.+-|+||-+
T Consensus 581 vVLGKGTYG~VYA~RD~-~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~----senGf~kIFMEqV 654 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDM-DTQVRIAIKEIPEKDSREVQPLHEEIALHSTLR-HKNIVRYLGSV----SENGFFKIFMEQV 654 (1226)
T ss_pred EEeecCceeEEEeeccc-cceeEEEeeecccccchhhccHHHHHHHHHHHh-hHhHHHHhhcc----CCCCeEEEEeecC
Confidence 47999999999999996 677889999998888888888999999999997 99999999984 3567788999999
Q ss_pred CCcHHHHHHHhCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeC-CCCCeeeeccCCCCcccccchh
Q 005577 111 DKSLVNVLENRGAGYF--EEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLG-SDGLWKLCDFGSTSTNHKRFEK 187 (690)
Q Consensus 111 ~gsLl~~L~~~~~~~l--se~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd-~dg~vKL~DFGlA~~~~~~~~~ 187 (690)
+|+.+..|.+..-|+| .|..+-.+.+||+.||.|||.+. |||||||-+||||+ -.|.+||+|||-++.+
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRL------ 726 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRL------ 726 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhh------
Confidence 7655555555555667 78888899999999999999999 99999999999995 5689999999977543
Q ss_pred hhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHH-hccC--CCCCCC
Q 005577 188 LEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK--LQIL-NGNY--RIPESP 262 (690)
Q Consensus 188 ~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~--~~il-~~~~--~~~~~~ 262 (690)
.+++.-..++.||..|||||+++... ..|+.++|||||||++.||.||++||..... ..+. -+.+ ..+.+.
T Consensus 727 ---AginP~TETFTGTLQYMAPEvIDqG~-RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPe 802 (1226)
T KOG4279|consen 727 ---AGINPCTETFTGTLQYMAPEVIDQGP-RGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPE 802 (1226)
T ss_pred ---ccCCccccccccchhhhChHhhccCC-cCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcH
Confidence 23444455678999999999987543 4599999999999999999999999964322 2222 2223 334455
Q ss_pred CCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 263 KYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 263 ~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.++.+.+.+|.+|+..||.+||++.+++.
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 77889999999999999999999999864
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=317.92 Aligned_cols=256 Identities=26% Similarity=0.358 Sum_probs=202.2
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH---HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE---ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~---e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|++.+.||+|+||.||+|.+. ..++.||||.+..... .....+..|+.+|+.+. ||||+++++++. ...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~----~~~ 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLK-GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQ----TET 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEc-CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeee----cCC
Confidence 37899999999999999999985 5688999999875432 35667889999999995 999999998864 346
Q ss_pred eEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
..|+||||+. ++|.+++.......+++..++.++.||+.||.|||..+ |+||||||+||||+.++.++|+|||++..
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 152 (316)
T cd05574 75 YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQ 152 (316)
T ss_pred EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhc
Confidence 8899999995 57777776544456999999999999999999999999 99999999999999999999999998865
Q ss_pred ccccchhhhh--------------------ccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCC
Q 005577 181 NHKRFEKLEE--------------------MGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK 240 (690)
Q Consensus 181 ~~~~~~~~~~--------------------~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~ 240 (690)
.......... ...........||..|+|||+ +.+..++.++|||||||++|+|++|+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~---~~~~~~~~~~Di~slG~ll~~l~~g~ 229 (316)
T cd05574 153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV---ISGDGHGSAVDWWTLGILLYEMLYGT 229 (316)
T ss_pred ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHH---HcCCCCCchHHHHHHHHHHHHHhhCC
Confidence 4322110000 000011123468999999996 44667899999999999999999999
Q ss_pred CCCCCchHHHH----HhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCC----HHHHHH
Q 005577 241 NAFDGESKLQI----LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPD----ITQVWF 291 (690)
Q Consensus 241 ~PF~~~~~~~i----l~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt----~~eil~ 291 (690)
.||.+...... .......+....++..+.++|.+||+.||++||+ +.+++.
T Consensus 230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 230 TPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 99987654433 2233334444447999999999999999999999 666643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=313.53 Aligned_cols=247 Identities=30% Similarity=0.454 Sum_probs=196.2
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
++|++.+.||+|+||.||+|.+. ..++.||+|++.... ....+.+.+|+.+++.+. ||||+++++++. ....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~----~~~~ 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNR-ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK-HPNLVNLIEVFR----RKRK 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEEC-CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCC-CCCEeeeeeEEe----eCCE
Confidence 47999999999999999999985 568899999886432 223356788999999995 999999998865 3468
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
+++||||+++++++.+.... ..+++..++.++.||+.||.|||..+ |+||||||+|||++.++.++|+|||++....
T Consensus 75 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 75 LHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILT 151 (286)
T ss_pred EEEEEeccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecC
Confidence 89999999988877765543 24899999999999999999999999 9999999999999999999999999986543
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc--------
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG-------- 254 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~-------- 254 (690)
.... ......++..|+|||++ .....++.++|||||||++|+|++|..||.+....+.+..
T Consensus 152 ~~~~---------~~~~~~~~~~~~aPE~~--~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 220 (286)
T cd07847 152 GPGD---------DYTDYVATRWYRAPELL--VGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDL 220 (286)
T ss_pred CCcc---------cccCcccccccCCHHHH--hCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 2111 11123568899999973 2335678899999999999999999999987554322110
Q ss_pred ---------------cCCCCC----------CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 255 ---------------NYRIPE----------SPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 255 ---------------~~~~~~----------~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
....+. .+.++..+.+||.+||+.+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 221 IPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000111 1356788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=326.98 Aligned_cols=245 Identities=25% Similarity=0.410 Sum_probs=204.6
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
.-|.|+.+||+|+||.||+|.++ ..|..+|||.+... ..++.+++|+.||.++. .|+||++|+.++ .+..++
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~-EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~-S~yVVKYYGSYF----K~sDLW 104 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHR-ESGHVLAIKKVPVD--TDLQEIIKEISIMQQCK-SKYVVKYYGSYF----KHSDLW 104 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHh-ccCcEEEEEecCcc--chHHHHHHHHHHHHHcC-Cchhhhhhhhhc----cCCceE
Confidence 35778899999999999999986 78999999988654 35788999999999995 999999999754 457899
Q ss_pred EEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 105 LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 105 LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
||||||+ |+..+.++.+ ++.|+++++..+++..+.||+|||... -||||||..||||+.+|..||+|||.|-.+.+
T Consensus 105 IVMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred eehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 9999997 5666666554 457999999999999999999999998 89999999999999999999999999866543
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCCCCC---
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPE--- 260 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~~~~--- 260 (690)
... ...+..|||.||||||++ .-.|+.++||||||++..||..|++||....+...+..+...|.
T Consensus 182 TMA---------KRNTVIGTPFWMAPEVI~---EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF 249 (502)
T KOG0574|consen 182 TMA---------KRNTVIGTPFWMAPEVIE---EIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTF 249 (502)
T ss_pred hHH---------hhCccccCcccccHHHHH---HhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCC
Confidence 322 223468999999999854 45699999999999999999999999988777655443333222
Q ss_pred --CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 261 --SPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 261 --~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
+...+.++.++|+.||-+.|++|-|+.+++.+
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 23568899999999999999999999988654
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=315.46 Aligned_cols=255 Identities=18% Similarity=0.263 Sum_probs=199.0
Q ss_pred cCceEEEEEEeeecCceEEEEEEEc---------------ccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCc
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDA---------------IHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNV 86 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~---------------~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNI 86 (690)
...+|++.+.||+|+||.||++.+. ......||+|++... .......+.+|+.+|+.+. |+||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i 81 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLK-DPNI 81 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCc
Confidence 4568999999999999999998642 113457899988654 4445678899999999995 9999
Q ss_pred eEEEEEEEeecCCCceEEEEEecCC-CcHHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCC
Q 005577 87 VTLYAHTILDLGRTKEALLVMECCD-KSLVNVLENRGA---------GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRD 156 (690)
Q Consensus 87 VkL~~~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~---------~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRD 156 (690)
+++++++.. ....|+||||+. ++|.+++..... ..+++..++.++.||+.||.|||+.+ |+|||
T Consensus 82 ~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~d 155 (296)
T cd05095 82 IRLLAVCIT----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRD 155 (296)
T ss_pred ceEEEEEec----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eeccc
Confidence 999998653 356899999995 577777765431 23677889999999999999999999 99999
Q ss_pred CCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHH
Q 005577 157 LKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI 236 (690)
Q Consensus 157 LKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyEL 236 (690)
|||+|||++.++.++|+|||+++.+..... .....+..+++.|++||+ ..++.++.++|||||||++|||
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~pe~---~~~~~~~~~~DiwSlG~~l~el 225 (296)
T cd05095 156 LATRNCLVGKNYTIKIADFGMSRNLYSGDY-------YRIQGRAVLPIRWMSWES---ILLGKFTTASDVWAFGVTLWEI 225 (296)
T ss_pred CChheEEEcCCCCEEeccCcccccccCCcc-------eeccCcCcCccccCCHHH---HhcCCccchhhhhHHHHHHHHH
Confidence 999999999999999999999865422110 001112234678999996 3456789999999999999999
Q ss_pred Hh--CCCCCCCchHHHHHhc----------cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 237 CY--FKNAFDGESKLQILNG----------NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 237 lt--G~~PF~~~~~~~il~~----------~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
++ |..||......+++.. ....+.+..++..+.+||.+||+.||.+||++.+|...+.
T Consensus 226 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 226 LTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 98 7788876554443321 1123344568899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=305.43 Aligned_cols=245 Identities=26% Similarity=0.411 Sum_probs=199.8
Q ss_pred EEeeecCceEEEEEEEcccC---CeEEEEEEeecCCHH-HHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHM---SKQYAMKHMICNDEE-SLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLV 106 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~---~k~vAvK~i~~~~~e-~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LV 106 (690)
+.||+|+||.||+|.+. .. +..|++|.+...... ..+.+.+|++++..+. |+||+++++++.. ...+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~-~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~----~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLK-GKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVVRLLGVCTE----EEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEe-cCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcC-CCChheeeeeecC----CCceEEE
Confidence 36899999999999985 33 788999998665333 4678899999999996 9999999988653 5678999
Q ss_pred EecC-CCcHHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 107 MECC-DKSLVNVLENRG-------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 107 mEy~-~gsLl~~L~~~~-------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
|||+ +++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEcccccc
Confidence 9999 678888877641 245999999999999999999999999 999999999999999999999999998
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH---hc
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQIL---NG 254 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il---~~ 254 (690)
........ ........+++.|+|||+ +....++.++|||||||++|+|++ |..||.......+. ..
T Consensus 153 ~~~~~~~~-------~~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 222 (262)
T cd00192 153 RDVYDDDY-------YRKKTGGKLPIRWMAPES---LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK 222 (262)
T ss_pred cccccccc-------cccccCCCcCccccCHHH---hccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 76433211 011223456889999996 444578999999999999999998 69999877654433 23
Q ss_pred cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 255 NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 255 ~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
......+..++..+.++|.+||..+|.+||++.+++..+
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 334455667899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=316.56 Aligned_cols=256 Identities=19% Similarity=0.261 Sum_probs=198.4
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcc-------------cCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCce
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAI-------------HMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVV 87 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~-------------~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIV 87 (690)
+...+|++.+.||+|+||.||++++.. .....||+|.+... .....+.+.+|+++|+++. ||||+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~ 80 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLK-NPNII 80 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCcC
Confidence 446789999999999999999997631 11235899988654 3445677899999999995 99999
Q ss_pred EEEEEEEeecCCCceEEEEEecCC-CcHHHHHHHhC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCC
Q 005577 88 TLYAHTILDLGRTKEALLVMECCD-KSLVNVLENRG----------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRD 156 (690)
Q Consensus 88 kL~~~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~----------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRD 156 (690)
++++++. .....|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||+++ |+|||
T Consensus 81 ~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~d 154 (295)
T cd05097 81 RLLGVCV----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRD 154 (295)
T ss_pred eEEEEEc----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccc
Confidence 9999875 3467899999996 57777765432 113688899999999999999999999 99999
Q ss_pred CCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHH
Q 005577 157 LKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI 236 (690)
Q Consensus 157 LKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyEL 236 (690)
|||+|||++.++.+||+|||++........ ........+++.|+|||+ +.+..++.++|||||||++|+|
T Consensus 155 lkp~Nill~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~---~~~~~~~~~~DvwSlG~~l~el 224 (295)
T cd05097 155 LATRNCLVGNHYTIKIADFGMSRNLYSGDY-------YRIQGRAVLPIRWMAWES---ILLGKFTTASDVWAFGVTLWEM 224 (295)
T ss_pred cChhhEEEcCCCcEEecccccccccccCcc-------eeccCcCcCceeecChhh---hccCCcCchhhHHHHHHHHHHH
Confidence 999999999999999999999865422110 001112345778999996 4456789999999999999999
Q ss_pred Hh--CCCCCCCchHHHHHhc----------cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 237 CY--FKNAFDGESKLQILNG----------NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 237 lt--G~~PF~~~~~~~il~~----------~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
++ +..||......+++.. .......+.++..+.+||.+||+.||++||++.+|+..+.
T Consensus 225 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 225 FTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 88 6678876554333211 1112334567899999999999999999999999977654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=325.16 Aligned_cols=254 Identities=22% Similarity=0.385 Sum_probs=198.9
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEee-cCCCc
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILD-LGRTK 101 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~-~~~~~ 101 (690)
+.+|++.+.||+|+||.||+|.+. .+++.||||++... ......++.+|+.+++.++ ||||+++++++... .....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHK-PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEc-CCCCeEEEEEecccccchhHHHHHHHHHHHHhCC-CCCcCchhheeecccccccc
Confidence 368999999999999999999985 57889999998543 3344567889999999996 99999999876533 22335
Q ss_pred eEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 102 EALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 102 ~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
..|+||||+++++.+.+.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~lv~e~~~~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 82 DVYIVQELMETDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred eEEEEehhcccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 6899999999988877753 24899999999999999999999999 999999999999999999999999998654
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc---C--
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN---Y-- 256 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~---~-- 256 (690)
...... . .......|++.|+|||++ .....++.++|||||||++|+|++|+.||.+.......... +
T Consensus 157 ~~~~~~---~---~~~~~~~~~~~y~aPE~~--~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~ 228 (336)
T cd07849 157 DPEHDH---T---GFLTEYVATRWYRAPEIM--LNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228 (336)
T ss_pred cccccc---c---CCcCCcCcCCCccChHHh--hCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 321110 0 011224679999999963 33456889999999999999999999999765432211000 0
Q ss_pred -------------------------CCC---CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 257 -------------------------RIP---ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 257 -------------------------~~~---~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
..+ ..+.++..+.+||.+||+.+|++||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 013567889999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=329.90 Aligned_cols=242 Identities=21% Similarity=0.319 Sum_probs=188.9
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
....|++.+.||+|+||.||+|.+. ..++.||+|+.... ....|+.+|+.+. |||||++++++.. ...
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~valK~~~~~------~~~~E~~~l~~l~-h~~iv~~~~~~~~----~~~ 131 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKP-GQPDPVVLKIGQKG------TTLIEAMLLQNVN-HPSVIRMKDTLVS----GAI 131 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEEC-CCCceEEEEeCCcc------ccHHHHHHHHhCC-CCCCcChhheEEe----CCe
Confidence 3457999999999999999999985 56788999975332 2356999999995 9999999998763 467
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
.|+||||+.++|+.++.... ..+++..++.|+.||+.||.|||.++ ||||||||+||||+.++.+||+|||+++...
T Consensus 132 ~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 132 TCMVLPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred eEEEEEccCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 89999999999999887644 35999999999999999999999999 9999999999999999999999999986422
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCC-CCCchH-------------
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNA-FDGESK------------- 248 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~P-F~~~~~------------- 248 (690)
.. .......||+.|+|||+ +.+..++.++|||||||++|||+++..+ |.....
T Consensus 209 ~~----------~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l 275 (357)
T PHA03209 209 VA----------PAFLGLAGTVETNAPEV---LARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL 275 (357)
T ss_pred cC----------cccccccccccccCCee---cCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHH
Confidence 11 11123468999999997 4556789999999999999999985544 432110
Q ss_pred HHHHhc-cC---CCC----------------------------CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 249 LQILNG-NY---RIP----------------------------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 249 ~~il~~-~~---~~~----------------------------~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
..++.. .. .++ ....++..+.+||.+||+.||.+||++.|++.+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 276 LKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 001100 00 000 012456778889999999999999999998653
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=307.15 Aligned_cols=246 Identities=20% Similarity=0.306 Sum_probs=196.4
Q ss_pred EEeeecCceEEEEEEEcccC--CeEEEEEEeecCCH-HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHM--SKQYAMKHMICNDE-ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~--~k~vAvK~i~~~~~-e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
++||+|+||.||+|.+.... ...|++|.+..... ...+.+.+|+.+|+.+ +|||||++++++. ....++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCK-----GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEc-----CCceEEEE
Confidence 46999999999999875332 36899998865433 3456788999999999 5999999998753 34679999
Q ss_pred ecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccch
Q 005577 108 ECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 108 Ey~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~ 186 (690)
||+. ++|.+++.... .+++..++.++.||+.||.|||..+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 75 ELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred EeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 9995 67888887655 4899999999999999999999999 99999999999999999999999999876432211
Q ss_pred hhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---HhccCCCCCCC
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LNGNYRIPESP 262 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i---l~~~~~~~~~~ 262 (690)
.. .......++..|+|||+ +.+..++.++|||||||++|+|++ |..||......++ +......+.+.
T Consensus 151 ~~------~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
T cd05060 151 YY------RATTAGRWPLKWYAPEC---INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPE 221 (257)
T ss_pred cc------ccccCccccccccCHHH---hcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCC
Confidence 10 00111224568999996 456678999999999999999997 9999977654433 33333445566
Q ss_pred CCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhh
Q 005577 263 KYSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 263 ~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~ 295 (690)
.++..+.++|.+||..+|.+||++.+++..+..
T Consensus 222 ~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~ 254 (257)
T cd05060 222 ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254 (257)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 789999999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=333.67 Aligned_cols=262 Identities=21% Similarity=0.348 Sum_probs=218.0
Q ss_pred CCceEeecCceEEEEEEeeecCceEEEEEEEccc-CCe--EEEEEEeec-CCHHHHHHHHHHHHHHHhhcCCCCceEEEE
Q 005577 16 EGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIH-MSK--QYAMKHMIC-NDEESLESAMKEISVMKSLKGHPNVVTLYA 91 (690)
Q Consensus 16 ~g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~-~~k--~vAvK~i~~-~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~ 91 (690)
.++.+++...++++.++||.|.||.||+|..... .++ -||||.-.. .+.+..+.|+.|+.+|+.+ +|||||+|+|
T Consensus 380 ~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIG 458 (974)
T KOG4257|consen 380 TVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIG 458 (974)
T ss_pred CCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheee
Confidence 4567788888999999999999999999987532 333 477777655 3566689999999999999 5999999999
Q ss_pred EEEeecCCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCe
Q 005577 92 HTILDLGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLW 170 (690)
Q Consensus 92 ~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~v 170 (690)
+|. ....+||||++. |.|..+|..+. ..|+......++.||+.||.|||+.. +|||||...|||+.....|
T Consensus 459 v~~-----e~P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CV 530 (974)
T KOG4257|consen 459 VCV-----EQPMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCV 530 (974)
T ss_pred eee-----ccceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCccee
Confidence 985 357899999996 77888887655 35899999999999999999999999 9999999999999999999
Q ss_pred eeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 005577 171 KLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKL 249 (690)
Q Consensus 171 KL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~ 249 (690)
||+|||+++.+.+...... .+..-.+-|||||- +....++.++|||-|||++||++. |..||.+-...
T Consensus 531 KLaDFGLSR~~ed~~yYka--------S~~kLPIKWmaPES---INfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs 599 (974)
T KOG4257|consen 531 KLADFGLSRYLEDDAYYKA--------SRGKLPIKWMAPES---INFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS 599 (974)
T ss_pred eecccchhhhccccchhhc--------cccccceeecCccc---cchhcccchhhHHHHHHHHHHHHHhcCCcccccccc
Confidence 9999999988755422111 11233778999996 445569999999999999999975 99999886655
Q ss_pred HH---HhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 250 QI---LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 250 ~i---l~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
++ ++..-++|.+++||+.+..|+.+||+.+|.+||.+.+|...+.+.+
T Consensus 600 DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 600 DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 54 4667788999999999999999999999999999999976655443
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=305.43 Aligned_cols=246 Identities=30% Similarity=0.491 Sum_probs=202.8
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
+|++.+.||.|+||.||.+++. ..++.+++|.+... ......++.+|+.+|+++ +|+||+++++++. +...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~----~~~~~ 74 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFM----DDNTL 74 (256)
T ss_pred CceEeeEecccCCceEEEEEEc-CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEe----cCCeE
Confidence 6899999999999999999986 67888999987654 345567788999999999 5999999999875 34678
Q ss_pred EEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
++|||||. ++|.+.+.......+++..+..++.|++.+|.|||+.+ |+||||+|+|||++.++.+||+|||++....
T Consensus 75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILG 152 (256)
T ss_pred EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence 99999996 57888877654456899999999999999999999999 9999999999999999999999999886542
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh----ccCCC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN----GNYRI 258 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~----~~~~~ 258 (690)
.... ......|++.|+|||+ ..+..++.++|||||||++|+|++|..||......+... ..+.
T Consensus 153 ~~~~---------~~~~~~~~~~y~ape~---~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~- 219 (256)
T cd08221 153 SEYS---------MAETVVGTPYYMSPEL---CQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT- 219 (256)
T ss_pred cccc---------cccccCCCccccCHhh---cCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-
Confidence 2110 1123467999999996 445567889999999999999999999998766544332 2222
Q ss_pred CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
+....++..+.++|.+||..+|.+||++.+++.+
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 2335678999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=311.06 Aligned_cols=246 Identities=24% Similarity=0.375 Sum_probs=195.3
Q ss_pred EeeecCceEEEEEEEcccCCe--EEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEe
Q 005577 32 VIAEGGFSCVYSARDAIHMSK--QYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVME 108 (690)
Q Consensus 32 ~LG~GgFG~VylA~d~~~~~k--~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmE 108 (690)
+||+|+||.||+|.+. ..+. .+++|.+... .....+.+.+|+.++.++.+||||+++++++.. ...+|+|||
T Consensus 2 ~lg~g~~g~v~~~~~~-~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIK-KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGYLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEc-CCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec----CCCceEEEE
Confidence 6899999999999985 3343 4688877643 345567888999999999669999999998753 356899999
Q ss_pred cCC-CcHHHHHHHhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeee
Q 005577 109 CCD-KSLVNVLENRG--------------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLC 173 (690)
Q Consensus 109 y~~-gsLl~~L~~~~--------------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~ 173 (690)
|+. |+|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEEC
Confidence 995 68888876542 124789999999999999999999999 9999999999999999999999
Q ss_pred ccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH
Q 005577 174 DFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQIL 252 (690)
Q Consensus 174 DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il 252 (690)
|||++........ ......+..|+|||+ +....++.++|||||||++|+|++ |..||.+.......
T Consensus 155 dfgl~~~~~~~~~----------~~~~~~~~~y~apE~---~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~ 221 (270)
T cd05047 155 DFGLSRGQEVYVK----------KTMGRLPVRWMAIES---LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 221 (270)
T ss_pred CCCCccccchhhh----------ccCCCCccccCChHH---HccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH
Confidence 9998853221100 001123667999996 456678999999999999999996 99999776544332
Q ss_pred ---hccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 253 ---NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 253 ---~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
...+....+..++..+.+|+.+||..+|.+||++.+++..+...+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 222 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 233344445567899999999999999999999999998887653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=308.66 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=197.8
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC---------HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEee
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---------EESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---------~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~ 96 (690)
+|.+...||.|+||.||+|.+. ..++.|++|.+.... ....+.+.+|+.+++.+. ||||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNA-SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLD- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEec-CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEe-
Confidence 4778899999999999999985 567899999885432 123466788999999995 9999999998653
Q ss_pred cCCCceEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeecc
Q 005577 97 LGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDF 175 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DF 175 (690)
....++||||+.+ +|.+++...+ .+++..+..++.||+.||.|||.++ |+||||+|+|||++.++.++|+||
T Consensus 78 ---~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~df 150 (267)
T cd06628 78 ---ADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDF 150 (267)
T ss_pred ---CCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEeccc
Confidence 4678999999965 6767775543 4899999999999999999999999 999999999999999999999999
Q ss_pred CCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh--
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN-- 253 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~-- 253 (690)
|+++........ ...........|++.|+|||+ +.+..++.++|||||||++|+|++|+.||........+.
T Consensus 151 g~~~~~~~~~~~---~~~~~~~~~~~~~~~y~~pe~---~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 224 (267)
T cd06628 151 GISKKLEANSLS---TKTNGARPSLQGSVFWMAPEV---VKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI 224 (267)
T ss_pred CCCccccccccc---CCccccccccCCCcCccChhH---hccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH
Confidence 998765421110 000111123457899999996 455678899999999999999999999998755433322
Q ss_pred -ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 254 -GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 254 -~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.......+..++..+.++|.+||+.||.+||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 225 GENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred hccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 12222334568999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.24 Aligned_cols=252 Identities=29% Similarity=0.466 Sum_probs=201.4
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeec---CCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC---NDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~---~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|++.+.||+|+||.||+|.+. ..++.|++|.+.. .+....+.+.+|+.+++++ +|+||+++++++.. .+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~----~~ 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICL-LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIE----NN 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEc-CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeec----CC
Confidence 47999999999999999999985 5788999998753 2344467888999999999 59999999998753 46
Q ss_pred eEEEEEecCC-CcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 102 EALLVMECCD-KSLVNVLENR--GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~--~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
..++||||+. ++|..++... ....+++.+++.++.+|+.||.|||+.| |+||||||+|||++.++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~ 153 (267)
T cd08224 76 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEecccee
Confidence 7899999996 5777777542 2345899999999999999999999999 999999999999999999999999988
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHh---
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES--KLQILN--- 253 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~--~~~il~--- 253 (690)
....... .......+++.|+|||+ +.+..++.++|||||||++|+|++|+.||.... ..++..
T Consensus 154 ~~~~~~~---------~~~~~~~~~~~y~apE~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 221 (267)
T cd08224 154 RFFSSKT---------TAAHSLVGTPYYMSPER---IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE 221 (267)
T ss_pred eeccCCC---------cccceecCCccccCHHH---hccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh
Confidence 6532211 01112357889999996 456678999999999999999999999996543 122221
Q ss_pred ccCCCCCC-CCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhh
Q 005577 254 GNYRIPES-PKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 254 ~~~~~~~~-~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~ 296 (690)
.....+.+ ..++..+.++|.+||..+|++||++.+|+..+...
T Consensus 222 ~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 222 KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11111222 26788999999999999999999999998877653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=306.78 Aligned_cols=243 Identities=25% Similarity=0.432 Sum_probs=199.4
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
-.+|++.+.||+|+||.||++.. .++.||+|.+.... ..+.+.+|+.+++.+. ||||+++++++.. +..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~---~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~-----~~~ 73 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY---TGQKVAVKNIKCDV--TAQAFLEETAVMTKLH-HKNLVRLLGVILH-----NGL 73 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc---CCCceEEEeecCcc--hHHHHHHHHHHHHhCC-CCCcCeEEEEEcC-----CCc
Confidence 36799999999999999999864 57789999886543 2467889999999995 9999999988642 347
Q ss_pred EEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
|+||||+. ++|.+++.......+++..++.++.||+.||.|||..| ++||||||+|||++.++.+||+|||++....
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 99999996 58888887665556899999999999999999999999 9999999999999999999999999886432
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH---HHhccCCC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQ---ILNGNYRI 258 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~---il~~~~~~ 258 (690)
... .....+..|+|||+ +.+..++.++|||||||++|+|++ |+.||....... .+....+.
T Consensus 152 ~~~------------~~~~~~~~y~~pe~---~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 216 (254)
T cd05083 152 MGV------------DNSKLPVKWTAPEA---LKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM 216 (254)
T ss_pred ccC------------CCCCCCceecCHHH---hccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC
Confidence 110 11233568999996 456678999999999999999997 999998765433 23334445
Q ss_pred CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
.....++..+.++|.+||+.+|++||++.+++..+.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 555678999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=310.14 Aligned_cols=252 Identities=30% Similarity=0.478 Sum_probs=199.5
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|++.+.||.|+||.||+|.+. ..++.|+||.+... +......+.+|+.+++.+. ||||+++++++.. .+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~----~~ 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCL-LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIE----DN 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeec-CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEe----CC
Confidence 36788899999999999999985 56889999987543 3344567889999999995 9999999988753 46
Q ss_pred eEEEEEecCCC-cHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 102 EALLVMECCDK-SLVNVLENR--GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 102 ~~~LVmEy~~g-sLl~~L~~~--~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
..++||||+.+ +|.+++... ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~ 153 (267)
T cd08229 76 ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhh
Confidence 78999999964 677766532 2345899999999999999999999999 999999999999999999999999987
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHhc--
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK--LQILNG-- 254 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~--~~il~~-- 254 (690)
........ ......|+..|+|||+ +.+..++.++|||||||++|+|++|..||.+... ......
T Consensus 154 ~~~~~~~~---------~~~~~~~~~~~~ape~---~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 221 (267)
T cd08229 154 RFFSSKTT---------AAHSLVGTPYYMSPER---IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE 221 (267)
T ss_pred hccccCCc---------ccccccCCcCccCHHH---hcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh
Confidence 65322110 1112457899999996 4556788999999999999999999999975432 222211
Q ss_pred --cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhh
Q 005577 255 --NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 255 --~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~ 296 (690)
.+.......++..+.++|.+||..||++||++.+|+..+.+.
T Consensus 222 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 222 QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred cCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 111112235788999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=320.19 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=199.5
Q ss_pred eEEEEEEeeecCceEEEEEEEcccC--CeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHM--SKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~--~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
+|++.+.||+|+||.||++.+. .. +..||||++... .......+.+|+.+++++.+|||||++++++........
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~-~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNA-ETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeC-CCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 5889999999999999999985 34 778999988542 233456788999999999779999999987654434445
Q ss_pred eEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 102 EALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 102 ~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
.+|++|+|++++|...+.... .+++..++.++.||+.||.|||.+| |+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred cEEEEEecccCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 689999999999988886543 4899999999999999999999999 999999999999999999999999998754
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc------
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN------ 255 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~------ 255 (690)
...... .........|++.|+|||++ .....++.++|||||||++|+|++|..||.+.....++...
T Consensus 156 ~~~~~~-----~~~~~~~~~g~~~y~aPE~~--~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 228 (332)
T cd07857 156 SENPGE-----NAGFMTEYVATRWYRAPEIM--LSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT 228 (332)
T ss_pred cccccc-----ccccccCcccCccccCcHHH--hCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCC
Confidence 322110 01112234689999999963 23356889999999999999999999999865432221100
Q ss_pred ---------------------CCC------CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 256 ---------------------YRI------PESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 256 ---------------------~~~------~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
... ...+.++..+.+||.+||+.||.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 012346789999999999999999999999853
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=303.88 Aligned_cols=242 Identities=21% Similarity=0.355 Sum_probs=193.2
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEec
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMEC 109 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy 109 (690)
++||+|+||.||+|.+ ..+..||+|.+.... ......+.+|+.+++.+ +||||+++++++.. ....++||||
T Consensus 1 ~~ig~g~~g~vy~~~~--~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTL--KDKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQ----RQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEe--cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEec----CCccEEEEEC
Confidence 3689999999999986 357889999876543 34455788999999999 49999999998653 3578999999
Q ss_pred CC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhh
Q 005577 110 CD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL 188 (690)
Q Consensus 110 ~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~ 188 (690)
+. ++|.+++.... ..+++..++.++.+|+.+|.|||.+| ++||||||+|||++.++.+||+|||++.......
T Consensus 74 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--- 147 (250)
T cd05085 74 VPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI--- 147 (250)
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccc---
Confidence 95 56766665433 45899999999999999999999999 9999999999999999999999999886432211
Q ss_pred hhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---HhccCCCCCCCCC
Q 005577 189 EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LNGNYRIPESPKY 264 (690)
Q Consensus 189 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i---l~~~~~~~~~~~~ 264 (690)
........+++.|+|||+ +....++.++|||||||++|+|++ |..||........ +....+...+..+
T Consensus 148 -----~~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (250)
T cd05085 148 -----YSSSGLKQIPIKWTAPEA---LNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKC 219 (250)
T ss_pred -----cccCCCCCCcccccCHHH---hccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 011111234678999996 455678999999999999999998 9999987654433 2233344445678
Q ss_pred CHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 265 SSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 265 s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
+..+.+++.+||..+|++||++.+++..+
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKEL 248 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 99999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=313.46 Aligned_cols=247 Identities=25% Similarity=0.412 Sum_probs=193.2
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH-HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE-ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~-e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
.+|++.+.||.|+||.||+|.+. ..++.|+||.+..... .....+.+|+.+++.+. |+||+++++++. .....
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~----~~~~~ 78 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSK-LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK-HANIVTLHDIIH----TKKTL 78 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEc-CCCcEEEEEEEecccccCCchhHHHHHHHHhhCC-CcceeeEEEEEe----cCCeE
Confidence 57999999999999999999985 5678999999865422 22345678999999995 999999999865 34789
Q ss_pred EEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 104 LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
|+||||+.++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 79 TLVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred EEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 9999999999988877654 36899999999999999999999999 99999999999999999999999998864321
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch-HHHHHhcc-------
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES-KLQILNGN------- 255 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~-~~~il~~~------- 255 (690)
... ......++..|+|||++ .....++.++|||||||++|+|++|+.||.+.. ..+.+...
T Consensus 156 ~~~---------~~~~~~~~~~~~aPE~~--~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 224 (291)
T cd07844 156 PSK---------TYSNEVVTLWYRPPDVL--LGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTP 224 (291)
T ss_pred CCc---------cccccccccccCCcHHh--hcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCC
Confidence 110 01112468899999973 233557899999999999999999999997654 11111000
Q ss_pred ----------------CCCC---------CCCCCC--HHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 256 ----------------YRIP---------ESPKYS--SSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 256 ----------------~~~~---------~~~~~s--~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.... ..+.+. ..+.++|.+||+.+|.+||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 225 TEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 001233 78889999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=325.50 Aligned_cols=247 Identities=25% Similarity=0.361 Sum_probs=197.2
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec--CC
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL--GR 99 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~--~~ 99 (690)
..+|++.+.||+|+||.||+|.+. ..++.||||++... +......+.+|+.+++.+. ||||+++++++.... .+
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDT-VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEEC-CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCCccc
Confidence 468999999999999999999985 57889999988542 3445567888999999995 999999998865331 23
Q ss_pred CceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 100 TKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 100 ~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
...+||||||+.++|.+.+... +++..+..++.||+.||.|||.+| |+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred cCcEEEEEeccCCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCccce
Confidence 3468999999999998887543 899999999999999999999999 9999999999999999999999999986
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc----
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN---- 255 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~---- 255 (690)
...... ......+++.|+|||+ +.+..++.++|||||||++|+|++|+.||...+........
T Consensus 167 ~~~~~~----------~~~~~~~~~~y~aPE~---~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 233 (353)
T cd07850 167 TAGTSF----------MMTPYVVTRYYRAPEV---ILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL 233 (353)
T ss_pred eCCCCC----------CCCCCcccccccCHHH---HhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 543211 1122357899999996 45677899999999999999999999999765432211000
Q ss_pred ----------------------CCC--------------C-----CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 256 ----------------------YRI--------------P-----ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 256 ----------------------~~~--------------~-----~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
... + .....+..+.+||.+||+.||.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred CCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 0 01134667899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.20 Aligned_cols=252 Identities=21% Similarity=0.321 Sum_probs=193.8
Q ss_pred EEeeecCceEEEEEEEcc--cCCeEEEEEEeec-CCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEE
Q 005577 31 NVIAEGGFSCVYSARDAI--HMSKQYAMKHMIC-NDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~--~~~k~vAvK~i~~-~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
+.||+|+||.||+|.+.. .....||+|.+.. .+....+.+.+|+.+++.+ +||||+++++++.. .....|+||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLP---SEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeec---CCCCcEEEE
Confidence 368999999999998642 2345799998754 3445577888999999999 49999999987642 234578999
Q ss_pred ecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccch
Q 005577 108 ECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 108 Ey~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~ 186 (690)
||+. ++|.+++.... ..+.+..++.++.||+.||.|||..+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 77 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 77 PYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 9995 67777776543 34678888999999999999999999 99999999999999999999999999875432110
Q ss_pred hhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHh---ccCCCCCCC
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQILN---GNYRIPESP 262 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il~---~~~~~~~~~ 262 (690)
. . . .......++..|+|||+ +.+..++.++|||||||++|||++ |..||.......+.. .......+.
T Consensus 154 ~--~--~-~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (262)
T cd05058 154 Y--S--V-HNHTGAKLPVKWMALES---LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPE 225 (262)
T ss_pred e--e--e-cccccCcCCccccChhH---hccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 0 0 0 00112345778999996 445678999999999999999999 567787655544332 222233344
Q ss_pred CCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 263 KYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 263 ~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
.++..+.++|..||..+|++||++.+++..+....
T Consensus 226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 226 YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 57899999999999999999999999998887653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=351.44 Aligned_cols=260 Identities=22% Similarity=0.328 Sum_probs=198.7
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|++.++||+|+||.||+|.+. ..++.||||++... .....+++.+|+++++.+. |||||++++++. +.+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~-~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~----d~~ 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDP-VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICS----DGD 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEEC-CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEe----eCC
Confidence 58999999999999999999985 57889999998643 3344577899999999995 999999998865 346
Q ss_pred eEEEEEecCC-CcHHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCee
Q 005577 102 EALLVMECCD-KSLVNVLENRG---------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWK 171 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~---------~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vK 171 (690)
..|+||||++ ++|.+++.... ...++...++.++.||+.||.|||++| |+||||||+||||+.+|.+|
T Consensus 76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEE
Confidence 7899999996 56767665321 123566778999999999999999999 99999999999999999999
Q ss_pred eeccCCCCcccccchhhhhcc---------ccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCC
Q 005577 172 LCDFGSTSTNHKRFEKLEEMG---------IEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNA 242 (690)
Q Consensus 172 L~DFGlA~~~~~~~~~~~~~~---------~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~P 242 (690)
|+|||+++............. ........+||+.|||||+ +.+..++.++|||||||++|||++|..|
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~---l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPER---LLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHH---hcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 999999976521111000000 0011123579999999996 5567789999999999999999999999
Q ss_pred CCCchHHHHHhccC-----CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHH-HHHhh
Q 005577 243 FDGESKLQILNGNY-----RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVW-FRVNE 295 (690)
Q Consensus 243 F~~~~~~~il~~~~-----~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil-~~l~~ 295 (690)
|.......+..... .......+++.+.+++.+||..||++|++..+.+ ..+..
T Consensus 231 F~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 231 YRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred CCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 98755433322111 1112246789999999999999999998765544 33443
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=312.12 Aligned_cols=256 Identities=20% Similarity=0.262 Sum_probs=200.8
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcc----cCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEee
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAI----HMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~----~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~ 96 (690)
+...+|++.+.||+|+||.||+|.+.. ..+..||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~-- 78 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCA-- 78 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEc--
Confidence 456789999999999999999998731 246789999886543 44556788999999999 5999999999865
Q ss_pred cCCCceEEEEEecCC-CcHHHHHHHhCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccC
Q 005577 97 LGRTKEALLVMECCD-KSLVNVLENRGA--------------------GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHR 155 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~-gsLl~~L~~~~~--------------------~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHR 155 (690)
....+|+||||+. |+|.+++..... ..+++.+++.++.||+.||.|||.++ |+||
T Consensus 79 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~ 154 (288)
T cd05050 79 --VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHR 154 (288)
T ss_pred --CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecc
Confidence 3457899999996 578777764321 23788899999999999999999999 9999
Q ss_pred CCCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHH
Q 005577 156 DLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFR 235 (690)
Q Consensus 156 DLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyE 235 (690)
||||+|||++.++.++|+|||++........ ........+++.|+|||+ +.+..++.++|||||||++|+
T Consensus 155 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~slG~il~e 224 (288)
T cd05050 155 DLATRNCLVGENMVVKIADFGLSRNIYSADY-------YKASENDAIPIRWMPPES---IFYNRYTTESDVWAYGVVLWE 224 (288)
T ss_pred cccHhheEecCCCceEECccccceecccCcc-------ccccCCCccChhhcCHHH---HhcCCCCchhHHHHHHHHHHH
Confidence 9999999999999999999998865322110 000111234677999996 455678999999999999999
Q ss_pred HHh-CCCCCCCchHHHHHhc---cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 236 ICY-FKNAFDGESKLQILNG---NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 236 Llt-G~~PF~~~~~~~il~~---~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
|++ |..||.+....+++.. ....+.+..++..+.+||.+||+.+|.+||++.+++..+.
T Consensus 225 l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 225 IFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 997 8889876655443322 2222334568899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.86 Aligned_cols=245 Identities=28% Similarity=0.395 Sum_probs=200.4
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|.+.+.||+|+||.||+|.+. ..++.|++|++... ..+....+.+|+.+++.+. ||||+++++++.. .+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~----~~ 88 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLR----EH 88 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEc-CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEe----CC
Confidence 56999999999999999999985 56889999988543 3345567889999999995 9999999998763 46
Q ss_pred eEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 102 EALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 102 ~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
..|+||||+.|++.+.+.... ..+++..+..++.||+.||.|||..+ |+||||+|+||+++.++.++|+|||++...
T Consensus 89 ~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 89 TAWLVMEYCLGSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred eEEEEHHhhCCCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceec
Confidence 789999999999988876543 35899999999999999999999999 999999999999999999999999987543
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh----ccCC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN----GNYR 257 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~----~~~~ 257 (690)
.. .....+++.|+|||++.......++.++|||||||++|+|++|..||.+........ ....
T Consensus 166 ~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 232 (307)
T cd06607 166 SP-------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP 232 (307)
T ss_pred CC-------------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC
Confidence 21 112357889999997533345668899999999999999999999998765543321 1111
Q ss_pred CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
......++..+.++|.+||..+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 233 TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 1112347889999999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=317.65 Aligned_cols=249 Identities=29% Similarity=0.460 Sum_probs=197.5
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.+|++.+.||+|+||.||+|.+. ..++.||+|++.... ......+.+|+.+++++. |+||+++++++... ....
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~ 82 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDT-TSGEIVALKKVRMDNERDGIPISSLREITLLLNLR-HPNIVELKEVVVGK--HLDS 82 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEEC-CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCC-CCCCcceEEEEecC--CCCe
Confidence 57999999999999999999986 578899999986542 222335668999999995 99999999886522 3356
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
+|+||||++++|.+++.... ..+++.+++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 83 IFLVMEYCEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEEEEecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 89999999999888877543 45899999999999999999999999 9999999999999999999999999986543
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc-------
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN------- 255 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~------- 255 (690)
.... ......+++.|+|||++ .....++.++|||||||++|+|++|+.||.+.+....+...
T Consensus 160 ~~~~---------~~~~~~~~~~y~aPE~~--~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~ 228 (309)
T cd07845 160 LPAK---------PMTPKVVTLWYRAPELL--LGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP 228 (309)
T ss_pred CccC---------CCCcccccccccChhhh--cCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 2110 11112457889999973 23356789999999999999999999999876654432210
Q ss_pred ----------------CCCCC---------CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 256 ----------------YRIPE---------SPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 256 ----------------~~~~~---------~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
+.... ...+++.+.+||.+||+.||++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 0235788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.88 Aligned_cols=241 Identities=29% Similarity=0.408 Sum_probs=199.2
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|++.+.||+|+||.||++.+. ..++.||+|++... .....+.+.+|+.+|+++. ||||+++++++. ...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~~ 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHK-GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQ----DDS 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEc-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEE----cCC
Confidence 36899999999999999999985 56889999998643 2345677889999999995 999999998864 357
Q ss_pred eEEEEEecC-CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~-~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
.+|+||||+ +++|.+.+.... .+++..++.++.||+.||.|||..+ |+||||+|.||||+.++.+||+|||++..
T Consensus 75 ~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~ 150 (290)
T cd05580 75 NLYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKR 150 (290)
T ss_pred eEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence 899999999 678888876654 4999999999999999999999999 99999999999999999999999998865
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc--CCC
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN--YRI 258 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~--~~~ 258 (690)
.... .....|++.|+|||+ +.+..++.++|||||||++|+|++|..||............ ...
T Consensus 151 ~~~~------------~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 215 (290)
T cd05580 151 VKGR------------TYTLCGTPEYLAPEI---ILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV 215 (290)
T ss_pred cCCC------------CCCCCCCccccChhh---hcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc
Confidence 4321 123467999999996 44556889999999999999999999999876644333221 123
Q ss_pred CCCCCCCHHHHHHHHHHhhhCCCCCC-----CHHHHH
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRP-----DITQVW 290 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~~L~~dP~~RP-----t~~eil 290 (690)
..+..++..+.++|.+||..||.+|+ ++.+++
T Consensus 216 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 216 RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 33456789999999999999999999 666664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=319.42 Aligned_cols=252 Identities=21% Similarity=0.267 Sum_probs=190.0
Q ss_pred EEEEeeec--CceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 29 VRNVIAEG--GFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 29 v~~~LG~G--gFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
+.++||+| +|++||++.+. .+++.||||++... .....+.+.+|+.+++.+ +|||||++++++.. .+..|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~----~~~~~ 75 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYK-PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIA----DNELW 75 (327)
T ss_pred hhhhccccccceEEEEEEeec-ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEE----CCEEE
Confidence 46789999 78999999986 67899999998653 334456677899999999 59999999998764 36789
Q ss_pred EEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 105 LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 105 LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
+||||+. |+|.+++..+....+++..++.++.||+.||.|||+++ ||||||||+|||++.++.++|+||+.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~ 153 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMIN 153 (327)
T ss_pred EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence 9999996 56777776554445899999999999999999999999 99999999999999999999999986543321
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH----hccCC--
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL----NGNYR-- 257 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il----~~~~~-- 257 (690)
....... .........++..|+|||++.. ....++.++|||||||++|+|++|+.||......... .....
T Consensus 154 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (327)
T cd08227 154 HGQRLRV--VHDFPKYSVKVLPWLSPEVLQQ-NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 230 (327)
T ss_pred ccccccc--cccccccccceecccChHHhhc-ccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccc
Confidence 1110000 0001112346788999997421 1145889999999999999999999999764332211 00000
Q ss_pred ------------------------------------------CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 ------------------------------------------IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 ------------------------------------------~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.+....+++.+.+||.+||+.||++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0001135678999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=313.33 Aligned_cols=248 Identities=22% Similarity=0.342 Sum_probs=195.4
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
.+|++.+.||+|+||.||+|.+. ..++.||+|.+... +......+.+|+.+++++ +||||+++++.+.. .+.+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~----~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHR-PTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFI----EGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEc-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheec----CCeE
Confidence 36889999999999999999985 57889999988654 445567889999999999 59999999987653 4789
Q ss_pred EEEEecCCC-cHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 104 LLVMECCDK-SLVNVLENRG-AGYFEEKQVLAIFRDVCNAVFAMHS-QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 104 ~LVmEy~~g-sLl~~L~~~~-~~~lse~~~~~i~~qIa~aL~yLHs-~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
|+||||+.| +|..++.... ...+++..+..++.+|+.||.|||. .+ |+||||||+|||++.++.+||+|||++..
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 152 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGN 152 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence 999999976 5555544321 2358999999999999999999997 47 99999999999999999999999998865
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhh---hcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---h-
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLF---RRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL---N- 253 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~---~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il---~- 253 (690)
+... ......+++.|+|||++... ....++.++|||||||++|+|++|+.||......... .
T Consensus 153 ~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 221 (286)
T cd06622 153 LVAS-----------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA 221 (286)
T ss_pred ccCC-----------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH
Confidence 4221 11123578899999974211 1224588999999999999999999999754332211 1
Q ss_pred --ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 254 --GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 254 --~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.......++.++.++.+||.+||..+|++||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 222 IVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 11122334568999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=312.04 Aligned_cols=238 Identities=17% Similarity=0.265 Sum_probs=182.7
Q ss_pred EeeecCceEEEEEEEcc-----------------------cCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceE
Q 005577 32 VIAEGGFSCVYSARDAI-----------------------HMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVT 88 (690)
Q Consensus 32 ~LG~GgFG~VylA~d~~-----------------------~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVk 88 (690)
.||+|+||.||+|.... .....|++|++..........+.+|+.+++.+. |||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~-h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVS-HIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCC-CCCeee
Confidence 58999999999997421 112357888876554455567888999999995 999999
Q ss_pred EEEEEEeecCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCC
Q 005577 89 LYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG 168 (690)
Q Consensus 89 L~~~~~~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg 168 (690)
+++++.. ....||||||++++.++.+.....+.+++..++.++.||+.||.|||+++ |+||||||+||||+.++
T Consensus 81 ~~~~~~~----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 81 VHGVCVR----GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEEe----CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccC
Confidence 9999763 36789999999765554444444456899999999999999999999999 99999999999997654
Q ss_pred -------CeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHH-hCC
Q 005577 169 -------LWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC-YFK 240 (690)
Q Consensus 169 -------~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELl-tG~ 240 (690)
.+||+|||++...... ....++..|+|||++ .....++.++|||||||++|||+ +|.
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-------------~~~~~~~~~~aPe~~--~~~~~~~~~~Dv~slG~~l~el~~~g~ 219 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-------------EERVERIPWIAPECV--PGGNSLSTAADKWSFGTTLLEICFDGE 219 (274)
T ss_pred cccCccceeeecCCccccccccc-------------cccccCCcccCchhh--cCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 3899999987542110 112467889999963 22356899999999999999995 699
Q ss_pred CCCCCchHHHH---HhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 241 NAFDGESKLQI---LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 241 ~PF~~~~~~~i---l~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
.||........ ....... +......+.++|.+||+.+|++||++.+++..+
T Consensus 220 ~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 220 VPLKERTPSEKERFYEKKHRL--PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred CCccccChHHHHHHHHhccCC--CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 99976544322 2222222 234567899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=313.36 Aligned_cols=248 Identities=27% Similarity=0.398 Sum_probs=196.4
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.+|++.+.||+|+||.||+|.+. ..++.|++|.+.... ......+.+|+.+++.+. ||||+++++++. ....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~~~ 75 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDR-VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVH----SEKR 75 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEec-CCCcEEEEEehhhccccccchHHHHHHHHHHHhcc-CCCEeeEEEEEe----cCCe
Confidence 47999999999999999999985 568899999885432 233456788999999995 999999999865 3468
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCC-CCCeeeeccCCCCcc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS-DGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~-dg~vKL~DFGlA~~~ 181 (690)
+|+||||++++|.+.+.......+++..++.++.||+.||.|||.++ |+||||+|+|||++. ++.+||+|||++...
T Consensus 76 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 76 LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred EEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 99999999999988887655445788999999999999999999999 999999999999985 457999999988643
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC-----
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY----- 256 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~----- 256 (690)
..... ......+++.|+|||++ .....++.++|||||||++|+|++|+.||........+....
T Consensus 154 ~~~~~---------~~~~~~~~~~y~~PE~~--~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 222 (294)
T PLN00009 154 GIPVR---------TFTHEVVTLWYRAPEIL--LGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGT 222 (294)
T ss_pred CCCcc---------ccccCceeecccCHHHH--hCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 22110 01123568899999963 233467899999999999999999999997654432221100
Q ss_pred --------------------CCC------CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 --------------------RIP------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 --------------------~~~------~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
... ..+.++..+.++|.+||+.+|++||++.+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 223 PNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred CChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 12457889999999999999999999999864
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.26 Aligned_cols=247 Identities=24% Similarity=0.330 Sum_probs=192.9
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH-HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE-ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~-e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
.+|++.+.||+|+||.||+|.+. ..++.|++|++..... .....+.+|+.+|+.+. |+||+++++++. .....
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~----~~~~~ 78 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISR-INGQLVALKVISMKTEEGVPFTAIREASLLKGLK-HANIVLLHDIIH----TKETL 78 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEc-CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcC-CCCEeEEEEEEe----cCCeE
Confidence 57999999999999999999985 5678999999865432 22345678999999995 999999999864 34678
Q ss_pred EEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 104 LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
|+||||+.++++..+.... ..+.+..+..++.||+.||.|||..+ |+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred EEEEecccCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9999999999988876543 35888999999999999999999999 99999999999999999999999998865322
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH-HHHhcc-------
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL-QILNGN------- 255 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~-~il~~~------- 255 (690)
... ......+++.|+|||++ .....++.++|||||||++|+|++|..||.+.... +.+...
T Consensus 156 ~~~---------~~~~~~~~~~y~aPE~~--~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 224 (291)
T cd07870 156 PSQ---------TYSSEVVTLWYRPPDVL--LGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVP 224 (291)
T ss_pred CCC---------CCCCccccccccCCcee--ecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCC
Confidence 110 11123568999999973 22345788999999999999999999999764321 111100
Q ss_pred ------------------CCCCC---------CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 256 ------------------YRIPE---------SPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 256 ------------------~~~~~---------~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
..... ....+..+.++|.+||..||.+||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 225 TEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000 0123578899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=315.61 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=196.7
Q ss_pred eEEEEEEeeecCceEEEEEEEccc-CCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIH-MSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~-~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
+|++.+.||+|+||.||+|.+... .++.||||.+.... ....+.+.+|+.+++.+. ||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEH--ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCC--CCc
Confidence 588999999999999999998521 67899999987632 344567788999999995 99999999987532 346
Q ss_pred eEEEEEecCCCcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCC----CCCeeeec
Q 005577 102 EALLVMECCDKSLVNVLENRG---AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS----DGLWKLCD 174 (690)
Q Consensus 102 ~~~LVmEy~~gsLl~~L~~~~---~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~----dg~vKL~D 174 (690)
.+|+||||+++++.+.+.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECC
Confidence 799999999999888775432 235899999999999999999999999 999999999999999 89999999
Q ss_pred cCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH----
Q 005577 175 FGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ---- 250 (690)
Q Consensus 175 FGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~---- 250 (690)
||++......... ........+++.|+|||++ .....++.++|||||||++|+|++|+.||.+.....
T Consensus 156 fg~~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~--~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~ 227 (316)
T cd07842 156 LGLARLFNAPLKP------LADLDPVVVTIWYRAPELL--LGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSN 227 (316)
T ss_pred CccccccCCCccc------ccccCCccccccccCHHHH--hCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccc
Confidence 9998764332111 0111224578999999973 233467899999999999999999999997543211
Q ss_pred ---------HHh-----------------------ccCCCCCCC------------CCCHHHHHHHHHHhhhCCCCCCCH
Q 005577 251 ---------ILN-----------------------GNYRIPESP------------KYSSSVTDLIRDMLQASPDDRPDI 286 (690)
Q Consensus 251 ---------il~-----------------------~~~~~~~~~------------~~s~~l~~LI~~~L~~dP~~RPt~ 286 (690)
++. ........+ ..+..+.++|.+||+.||++||++
T Consensus 228 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~ 307 (316)
T cd07842 228 PFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITA 307 (316)
T ss_pred hhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCH
Confidence 000 000000111 466789999999999999999999
Q ss_pred HHHHH
Q 005577 287 TQVWF 291 (690)
Q Consensus 287 ~eil~ 291 (690)
.+++.
T Consensus 308 ~eil~ 312 (316)
T cd07842 308 EEALE 312 (316)
T ss_pred HHHhc
Confidence 99864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=310.77 Aligned_cols=247 Identities=26% Similarity=0.426 Sum_probs=196.9
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
+|++.+.||.|+||.||+|.+. ..++.||||++.... ......+.+|+.+++.+. ||||+++++++.. .+..|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~----~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNR-TTGEIVALKEIHLDAEEGTPSTAIREISLMKELK-HENIVRLHDVIHT----ENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEEC-CCCeEEEEEEecccccccchHHHHHHHHHHHhhc-CCCEeeeeeeEee----CCcEE
Confidence 4889999999999999999985 568899999986543 233466778999999995 9999999998753 36789
Q ss_pred EEEecCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 105 LVMECCDKSLVNVLENRG-AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 105 LVmEy~~gsLl~~L~~~~-~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
|||||+.++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGI 152 (284)
T ss_pred EEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence 999999999988887654 245899999999999999999999999 99999999999999999999999998864322
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC-------
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY------- 256 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~------- 256 (690)
... ......+++.|++||++ .....++.++|||||||++|+|++|+.||.+.+..+.+....
T Consensus 153 ~~~---------~~~~~~~~~~y~~PE~~--~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 221 (284)
T cd07836 153 PVN---------TFSNEVVTLWYRAPDVL--LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPT 221 (284)
T ss_pred Ccc---------ccccccccccccChHHh--cCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Confidence 110 11123568899999973 233457889999999999999999999998655332211100
Q ss_pred -------------C--CC---------CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 -------------R--IP---------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 -------------~--~~---------~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
. .+ ..+.++..+.++|.+||+.||.+||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 222 ESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 00 01245788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.64 Aligned_cols=257 Identities=18% Similarity=0.287 Sum_probs=204.7
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcccC---CeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHM---SKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~~---~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~ 97 (690)
+...+|++.+.||+|+||.||+|.+.... ...|++|.+.... ......+.+|+.+|+.+. ||||+++++++..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD-HPHVVRLLGICLS-- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec--
Confidence 45678999999999999999999874211 2368999876543 445678889999999994 9999999998752
Q ss_pred CCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccC
Q 005577 98 GRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176 (690)
Q Consensus 98 ~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFG 176 (690)
...++||||+. |+|.+.+.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ---~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg 154 (279)
T cd05057 81 ---SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFG 154 (279)
T ss_pred ---CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCc
Confidence 57899999995 67777776543 34899999999999999999999999 9999999999999999999999999
Q ss_pred CCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH---H
Q 005577 177 STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---L 252 (690)
Q Consensus 177 lA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i---l 252 (690)
+++.......... .....++..|+|||+ +....++.++|||||||++|||++ |+.||.+....++ +
T Consensus 155 ~~~~~~~~~~~~~-------~~~~~~~~~y~~PE~---~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 224 (279)
T cd05057 155 LAKLLDVDEKEYH-------AEGGKVPIKWMALES---ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224 (279)
T ss_pred ccccccCccccee-------cCCCcccccccCHHH---hhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9876432211110 011223678999996 445678899999999999999998 9999987665443 3
Q ss_pred hccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 253 NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 253 ~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
......+.+..++..+.++|.+||..+|.+||++.+++..+...+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 225 EKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred hCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 333344555668899999999999999999999999988877654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=304.21 Aligned_cols=245 Identities=25% Similarity=0.426 Sum_probs=199.2
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
..+|++.+.||.|+||.||+|.+. ..++.|++|.+..... .+.+.+|+++++.+ +||||+++++++.. ...+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l-~~~~i~~~~~~~~~----~~~~ 73 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHK-ETGQVVAIKVVPVEED--LQEIIKEISILKQC-DSPYIVKYYGSYFK----NTDL 73 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEc-CCCcEEEEEEeecHHH--HHHHHHHHHHHHhC-CCCcEeeeeeeeec----CCcE
Confidence 367999999999999999999985 4578999998865433 67889999999999 59999999998653 4788
Q ss_pred EEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
|+||||+.+ +|.+.+.... ..+++..++.++.||+.||.|||..+ |+||||+|.||+++.++.++|+|||++....
T Consensus 74 ~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLT 150 (256)
T ss_pred EEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcc
Confidence 999999975 5666664433 45899999999999999999999999 9999999999999999999999999886543
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC-----C
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY-----R 257 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~-----~ 257 (690)
.... ......++..|+|||+ +.+..++.++|||||||++|+|++|+.||............. .
T Consensus 151 ~~~~---------~~~~~~~~~~y~~PE~---~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 218 (256)
T cd06612 151 DTMA---------KRNTVIGTPFWMAPEV---IQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPT 218 (256)
T ss_pred cCcc---------ccccccCCccccCHHH---HhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCC
Confidence 2110 1112357889999996 455678999999999999999999999998765544332211 1
Q ss_pred CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
...+..++..+.++|.+||+.||++||++.+++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1223457889999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.80 Aligned_cols=246 Identities=30% Similarity=0.526 Sum_probs=201.5
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
+|++.+.||+|+||.||++.+. ..++.|++|.+... .......+.+|+.+++.+. ||||+++++++. ..+..
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~----~~~~~ 74 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK-HPNIVQYQESFE----ENGNL 74 (256)
T ss_pred CceEEEEeccCCceEEEEEEEc-CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCC-CCCeeeeEeeec----CCCeE
Confidence 6899999999999999999985 57889999998643 3344567889999999995 999999998854 45789
Q ss_pred EEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
|+||||+. ++|.+.+.......+++.+++.++.||+.||.|||+++ |+|+||+|+|||++.++.++|+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLN 152 (256)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence 99999995 57888776654445899999999999999999999999 9999999999999999999999999886543
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc---cCCCC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG---NYRIP 259 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~---~~~~~ 259 (690)
..... .....|++.|+|||+ ..+..++.++|||||||++|+|++|+.||.......++.. ....+
T Consensus 153 ~~~~~---------~~~~~~~~~~~~pe~---~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 220 (256)
T cd08218 153 STVEL---------ARTCIGTPYYLSPEI---CENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP 220 (256)
T ss_pred cchhh---------hhhccCCccccCHHH---hCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC
Confidence 32111 112357889999996 4456788899999999999999999999987655443322 12223
Q ss_pred CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 260 ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 260 ~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.+..++..+.++|.+||+.+|.+||++.+++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 34578899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=302.44 Aligned_cols=248 Identities=28% Similarity=0.498 Sum_probs=200.3
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
+|++.+.||.|+||.||+|.+. ..++.|++|.+... .....+.+..|+.+++.+. ||||+++++++... ....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~~ 76 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRK-SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDR--SNQTL 76 (265)
T ss_pred CceeeeeeccCCCeEEEEeeec-CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcC-CCccceeeeeeecC--CCCEE
Confidence 5889999999999999999985 57788999988643 3455677889999999995 99999999876532 44678
Q ss_pred EEEEecCC-CcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCcccCCCCCCcEEeCCCCCeeeecc
Q 005577 104 LLVMECCD-KSLVNVLENR--GAGYFEEKQVLAIFRDVCNAVFAMH-----SQSPPIAHRDLKAENLLLGSDGLWKLCDF 175 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~--~~~~lse~~~~~i~~qIa~aL~yLH-----s~g~~IVHRDLKP~NILLd~dg~vKL~DF 175 (690)
|+||||+. ++|.+++... ....+++..++.++.||+.||.||| ..+ |+|+||||+|||++.++.+||+||
T Consensus 77 ~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~ 154 (265)
T cd08217 77 YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDF 154 (265)
T ss_pred EEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEecc
Confidence 99999996 5777777553 2346899999999999999999999 778 999999999999999999999999
Q ss_pred CCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc-
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG- 254 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~- 254 (690)
|++........ ......+++.|+|||+ +....++.++|||||||++|+|++|+.||.......+...
T Consensus 155 g~~~~~~~~~~---------~~~~~~~~~~~~~pE~---~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 222 (265)
T cd08217 155 GLAKILGHDSS---------FAKTYVGTPYYMSPEQ---LNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222 (265)
T ss_pred cccccccCCcc---------cccccccCCCccChhh---hcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHH
Confidence 99876432210 0112357999999996 4456688999999999999999999999987654433221
Q ss_pred --cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 255 --NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 255 --~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
......+..++..+.++|.+||..+|.+||++.+|+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 223 KEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1112234578899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=324.17 Aligned_cols=254 Identities=23% Similarity=0.343 Sum_probs=201.2
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.+|++.+.||.|+||.||+|.+. ..++.|++|++.... ......+.+|+.+|+.+. |||||++++++.........
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDT-RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEc-CCCCEEEEEEeccccccccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCCce
Confidence 78999999999999999999985 568899999986542 234567788999999995 99999999877654445567
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
+|+||||+.++|.+.+.... .+++..++.++.||+.||.|||.++ |+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 83 VYVVMDLMESDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEEehhhhhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 89999999998888876543 3999999999999999999999999 9999999999999999999999999986543
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc--------
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG-------- 254 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~-------- 254 (690)
..... .........|+..|+|||++. ....++.++|||||||++|+|++|+.||.+......+..
T Consensus 159 ~~~~~-----~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~ 231 (334)
T cd07855 159 SSPTE-----HKYFMTEYVATRWYRAPELLL--SLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231 (334)
T ss_pred ccCcC-----CCcccccccccccccChHHhc--CCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCC
Confidence 21110 001112346789999999732 334588999999999999999999999977543221100
Q ss_pred ------------------cCCC--C-----CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 255 ------------------NYRI--P-----ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 255 ------------------~~~~--~-----~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.+.. . ..+.++..+.++|.+||+.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000 0 01456899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=314.44 Aligned_cols=246 Identities=27% Similarity=0.426 Sum_probs=195.2
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-----HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-----EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-----~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
+|++.+.||+|+||.||+|.+. ..++.|+||.+.... ......+..|+.+++.+. |+||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~----~ 74 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDK-ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGH----K 74 (298)
T ss_pred CceeeeeeeeccccEEEEEEEC-CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeec----C
Confidence 5888999999999999999985 468899999986543 223455678999999995 9999999998653 4
Q ss_pred ceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 101 KEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 101 ~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
...|+||||+.++|.+++.... ..+++..++.++.||+.||.|||.++ |+|+||||+|||++.++.++|+|||+++.
T Consensus 75 ~~~~lv~e~~~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~ 151 (298)
T cd07841 75 SNINLVFEFMETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARS 151 (298)
T ss_pred CEEEEEEcccCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeee
Confidence 6889999999888888876544 35999999999999999999999999 99999999999999999999999999865
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCC---
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYR--- 257 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~--- 257 (690)
...... ......+++.|+|||++ .....++.++|||||||++|+|++|..+|.+......+.....
T Consensus 152 ~~~~~~---------~~~~~~~~~~y~aPE~~--~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~ 220 (298)
T cd07841 152 FGSPNR---------KMTHQVVTRWYRAPELL--FGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALG 220 (298)
T ss_pred ccCCCc---------cccccccceeeeCHHHH--hCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcC
Confidence 432111 11123467889999963 2345678999999999999999999888876554322111100
Q ss_pred C----------------------C-----CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 I----------------------P-----ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 ~----------------------~-----~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
. . ....++..+.+||.+||..||++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 221 TPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred CCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0 0 01245788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.73 Aligned_cols=247 Identities=25% Similarity=0.429 Sum_probs=195.6
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
.+|++.+.||+|+||.||+|.+. .+..+++|.+..... ....+.+|+++++.+. ||||+++++++. .....|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~--~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~~~----~~~~~~ 75 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL--EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLS-HPKLVQLYGVCT----ERSPIC 75 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe--CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCC-CCCeeeEEEEEc----cCCceE
Confidence 47888999999999999999873 467899998764322 2356788999999994 999999998854 345789
Q ss_pred EEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 105 LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 105 LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
+||||+.+ +|.+++... .+.+++..++.++.+++.+|.|||+.+ |+||||||+|||++.++.++|+|||+++....
T Consensus 76 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred EEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 99999965 565555543 345899999999999999999999999 99999999999999999999999998864322
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHh---ccCCCC
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQILN---GNYRIP 259 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il~---~~~~~~ 259 (690)
... .......++..|+|||+ +.+..++.++|||||||++|+|++ |..||.......++. ...+..
T Consensus 153 ~~~--------~~~~~~~~~~~~~aPe~---~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 221 (256)
T cd05112 153 DQY--------TSSTGTKFPVKWSSPEV---FSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY 221 (256)
T ss_pred Ccc--------cccCCCccchhhcCHhH---hccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC
Confidence 110 00011234678999996 455678999999999999999998 999998765544332 223333
Q ss_pred CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 260 ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 260 ~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
.+...+..+.+|+.+||+.+|++||++.+++..+
T Consensus 222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 3445789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=304.69 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=195.6
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-----CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-----DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-----~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
..|++.++||+|+||.||+|.+. ..++.|+||.+... .....+.+.+|+.+++.+. ||||+++++++... .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~ 77 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDA-DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDP--M 77 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEc-CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccC--C
Confidence 46889999999999999999985 57889999988542 2334677889999999995 99999999875422 2
Q ss_pred CceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 100 TKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
...+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++
T Consensus 78 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 78 ERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred CceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCccc
Confidence 356889999996 56777776543 3899999999999999999999999 999999999999999999999999988
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc---
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN--- 255 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~--- 255 (690)
+........ ........|+..|+|||+ +.+..++.++|||||||++|+|++|+.||............
T Consensus 154 ~~~~~~~~~------~~~~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 224 (265)
T cd06652 154 KRLQTICLS------GTGMKSVTGTPYWMSPEV---ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ 224 (265)
T ss_pred ccccccccc------ccccccCCCCccccChhh---hcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC
Confidence 754221100 011123457899999996 34566889999999999999999999999765433322211
Q ss_pred -CCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 256 -YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 256 -~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.....+..++..+.++|.+||. +|.+||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 225 PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1222234577889999999994 9999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=310.61 Aligned_cols=246 Identities=27% Similarity=0.411 Sum_probs=196.5
Q ss_pred EEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 27 IHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 27 y~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
|++.+.||.|++|.||+|.+. ..++.|++|++.... ......+.+|+.+++.+. ||||+++++++. .....|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~----~~~~~~ 74 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDK-LTGEIVALKKIRLETEDEGVPSTAIREISLLKELN-HPNIVRLLDVVH----SENKLY 74 (283)
T ss_pred CchheEecCCCCeEEEEEEEc-CCCCEEEEEEeecccccccchhHHHHHHHHHHhcC-CCCccCHhheec----cCCeEE
Confidence 577899999999999999985 578899999886543 223456788999999995 999999998864 347889
Q ss_pred EEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccccc
Q 005577 105 LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKR 184 (690)
Q Consensus 105 LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~ 184 (690)
+||||++++|.+++.......+++..++.++.||+.||.|||.++ ++||||+|+|||++.++.++|+|||++......
T Consensus 75 iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 75 LVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVP 152 (283)
T ss_pred EEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence 999999999988887665345899999999999999999999999 999999999999999999999999998653221
Q ss_pred chhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc---------
Q 005577 185 FEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN--------- 255 (690)
Q Consensus 185 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~--------- 255 (690)
.. ......+++.|+|||++ .....++.++|||||||++|+|++|+.||...+....+...
T Consensus 153 ~~---------~~~~~~~~~~~~aPE~~--~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (283)
T cd07835 153 VR---------TYTHEVVTLWYRAPEIL--LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDE 221 (283)
T ss_pred cc---------ccCccccccCCCCCcee--ecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 11 01122468899999973 23345788999999999999999999999765543211100
Q ss_pred ----------------CCC------CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 256 ----------------YRI------PESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 256 ----------------~~~------~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
... ...+.++..+.++|.+||+.||.+||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 222 DVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 112467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=313.33 Aligned_cols=247 Identities=32% Similarity=0.482 Sum_probs=195.7
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.+|++.++||+|+||.||+|.+. ..++.||+|++.... ....+.+.+|+++|+.+. ||||+++++++. ....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~~~ 74 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHK-ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR-HENLVNLIEVFR----RKKR 74 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEEC-CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcC-CcchhhHHHhcc----cCCe
Confidence 36899999999999999999985 568899999875432 223566788999999995 999999998864 4578
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
.|+||||+.+++++.+.... ..+++.+++.++.||+.||.|||+.+ |+||||+|+||+++.++.++|+|||++....
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLA 151 (286)
T ss_pred EEEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence 99999999887776665443 23899999999999999999999999 9999999999999999999999999886543
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc--------
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG-------- 254 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~-------- 254 (690)
.... ......++..|+|||++ .....++.++|||||||++|+|++|+.||...........
T Consensus 152 ~~~~---------~~~~~~~~~~y~aPE~~--~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 220 (286)
T cd07846 152 APGE---------VYTDYVATRWYRAPELL--VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNL 220 (286)
T ss_pred CCcc---------ccCcccceeeccCcHHh--ccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCC
Confidence 2111 11123578899999973 2334578899999999999999999999976553221100
Q ss_pred ---------------cCCCC----------CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 255 ---------------NYRIP----------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 255 ---------------~~~~~----------~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
....+ ..+.++..+.+||.+||..+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 221 IPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000 12467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=304.82 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=195.9
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC------HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND------EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~------~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
+|++.+.||.|+||.||+|.+ ..++.+|+|.+.... ......+.+|+.+|+.+. |+||+++++++. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~----~ 73 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT--NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCL----D 73 (265)
T ss_pred CccccceEeccCCeEEEEEEE--cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEee----c
Confidence 478899999999999999987 467889999875431 233467888999999995 999999999865 3
Q ss_pred CceEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 100 TKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
....|+||||+.| +|.+++.+.. .+++..+..++.||+.||.|||..+ |+|+||+|+|||++.++.++|+|||++
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~ 149 (265)
T cd06631 74 DNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCA 149 (265)
T ss_pred CCeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhh
Confidence 4788999999965 6666665543 4899999999999999999999999 999999999999999999999999988
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH----hc
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL----NG 254 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il----~~ 254 (690)
........... .........|+..|+|||+ +.+..++.++|||||||++|+|++|..||......... ..
T Consensus 150 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~pe~---~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~ 223 (265)
T cd06631 150 RRLAWVGLHGT---HSNMLKSMHGTPYWMAPEV---INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH 223 (265)
T ss_pred Hhhhhcccccc---ccccccccCCCccccChhh---hcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc
Confidence 64321100000 0111123468999999996 45567889999999999999999999999765433221 11
Q ss_pred -cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 255 -NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 255 -~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
......+..++..+.++|.+||..+|.+||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 224 RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1122334568999999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.42 Aligned_cols=255 Identities=20% Similarity=0.280 Sum_probs=202.1
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcc----cCCeEEEEEEeecCCHH-HHHHHHHHHHHHHhhcCCCCceEEEEEEEee
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAI----HMSKQYAMKHMICNDEE-SLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~----~~~k~vAvK~i~~~~~e-~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~ 96 (690)
+...+|++...||.|+||.||+|++.. ...+.|++|.+...... ..+.+.+|+++|+++. |+||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~-- 78 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS-HKNVVRLLGLCR-- 78 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcC-CcceeeeEEEEC--
Confidence 345789999999999999999998632 23567999988665443 5678899999999995 999999998864
Q ss_pred cCCCceEEEEEecCC-CcHHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCC
Q 005577 97 LGRTKEALLVMECCD-KSLVNVLENRGA-------GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG 168 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~-gsLl~~L~~~~~-------~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg 168 (690)
.....|+||||+. |+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 79 --~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~ 154 (275)
T cd05046 79 --EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQR 154 (275)
T ss_pred --CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCC
Confidence 3467899999996 677777765441 15899999999999999999999999 99999999999999999
Q ss_pred CeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 005577 169 LWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGES 247 (690)
Q Consensus 169 ~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~ 247 (690)
.++|+|||++........ .......++..|+|||+ +.+..++.++|||||||++|+|++ |..||....
T Consensus 155 ~~~l~~~~~~~~~~~~~~--------~~~~~~~~~~~y~~PE~---~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~ 223 (275)
T cd05046 155 EVKVSLLSLSKDVYNSEY--------YKLRNALIPLRWLAPEA---VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223 (275)
T ss_pred cEEEcccccccccCcccc--------cccCCceeEEeecChhh---hccCCCCchhhHHHHHHHHHHHHhCCCCCccccc
Confidence 999999998764321100 01112345778999996 445668899999999999999998 888997654
Q ss_pred HHHHHh----ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 248 KLQILN----GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 248 ~~~il~----~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
...++. .....+....++..+.++|.+||..+|.+||++.+++..+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 224 DEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred hHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 443332 23334445578999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=302.20 Aligned_cols=245 Identities=29% Similarity=0.493 Sum_probs=199.9
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
+|++.+.||+|+||.||+|.+. ..++.++||.+... .......+.+|+.+|+.+. ||||+++++.+. ..+.+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~----~~~~~ 74 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS-HPNIIEYYENFL----EDKAL 74 (256)
T ss_pred CceEEEEecccCceEEEEEEEc-CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCC-CCchhheeeeEe----cCCEE
Confidence 5899999999999999999985 57889999998654 3345678889999999995 999999998764 34678
Q ss_pred EEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCC-CeeeeccCCCCcc
Q 005577 104 LLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG-LWKLCDFGSTSTN 181 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg-~vKL~DFGlA~~~ 181 (690)
++||||+. ++|.+++.......+++..++.++.+++.+|.|||+++ |+|+||||+|||++.++ .+||+|||++...
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 99999996 57888887655455899999999999999999999999 99999999999998654 5899999988654
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc---CCC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN---YRI 258 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~---~~~ 258 (690)
.... ......|+..|+|||+ +.+..++.++|||||||++|+|++|+.||.+.......... ...
T Consensus 153 ~~~~----------~~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (256)
T cd08220 153 SSKS----------KAYTVVGTPCYISPEL---CEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA 219 (256)
T ss_pred CCCc----------cccccccCCcccCchh---ccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC
Confidence 3211 1122457889999996 44566889999999999999999999999876654333221 122
Q ss_pred CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
+.+..++..+.++|.+||..+|.+||++.+++.
T Consensus 220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 334468999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.14 Aligned_cols=254 Identities=18% Similarity=0.284 Sum_probs=201.5
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCe----EEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSK----QYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k----~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~ 97 (690)
...+|++.+.||+|+||.||+|.+. ..+. .||+|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~-- 80 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWV-PEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLS-- 80 (303)
T ss_pred chhhceeccccccCCCccEEEEEEe-cCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcC--
Confidence 4568889999999999999999874 2333 57888776543 33345688999999999 59999999998642
Q ss_pred CCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccC
Q 005577 98 GRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176 (690)
Q Consensus 98 ~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFG 176 (690)
...++|+||+. |+|.+.+.... ..+++..++.++.||+.||.|||.++ |+||||||+|||++.++.+||+|||
T Consensus 81 ---~~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg 154 (303)
T cd05110 81 ---PTIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFG 154 (303)
T ss_pred ---CCceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEcccc
Confidence 34679999996 67887776543 35899999999999999999999999 9999999999999999999999999
Q ss_pred CCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH---HHHH
Q 005577 177 STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESK---LQIL 252 (690)
Q Consensus 177 lA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~---~~il 252 (690)
+++......... ......++..|+|||+ +.+..++.++|||||||++|||++ |..||.+... ..++
T Consensus 155 ~~~~~~~~~~~~-------~~~~~~~~~~y~~PE~---~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~ 224 (303)
T cd05110 155 LARLLEGDEKEY-------NADGGKMPIKWMALEC---IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224 (303)
T ss_pred ccccccCccccc-------ccCCCccccccCCHHH---hccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 987543211110 1112345778999996 456778999999999999999997 8999976543 3344
Q ss_pred hccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhh
Q 005577 253 NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 253 ~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~ 296 (690)
......+.++.++..+.++|.+||..+|++||++.+++..+...
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 225 EKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 44445555667889999999999999999999999998877754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.09 Aligned_cols=255 Identities=25% Similarity=0.411 Sum_probs=195.9
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecC----
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLG---- 98 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~---- 98 (690)
.+|++.+.||+|+||.||+|.+. .+++.||||++.... ......+.+|+.+++++. ||||+++++++.....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHK-KTKQIVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEEC-CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCC-CCCccceEEEEecccccccC
Confidence 47999999999999999999985 578899999886532 222345678999999995 9999999998754321
Q ss_pred CCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 99 RTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 99 ~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
.....|+||||+.++|.+.+.... ..+++.+++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||++
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCCCc
Confidence 124569999999999988876543 35899999999999999999999999 999999999999999999999999998
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh---c-
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN---G- 254 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~---~- 254 (690)
.......... ........++..|+|||++ .....++.++|||||||++|+|++|..||.+......+. .
T Consensus 167 ~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~--~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~ 239 (310)
T cd07865 167 RAFSLSKNSK-----PNRYTNRVVTLWYRPPELL--LGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239 (310)
T ss_pred ccccCCcccC-----CCCccCcccCccccCcHHh--cCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 7543321110 0111224578899999963 223347889999999999999999999998765432211 0
Q ss_pred --cC-----------------CCCC-----------CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 255 --NY-----------------RIPE-----------SPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 255 --~~-----------------~~~~-----------~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.. ..+. ....+..+.+||.+||..||.+||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 0000 0123567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.60 Aligned_cols=244 Identities=25% Similarity=0.401 Sum_probs=198.5
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
.+|++.+.||.|+||.||+|.+. ..++.|++|.+.... ......+.+|+.+++.+. |+||+++++++.. ...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDK-RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLK----GSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEEC-CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEE----CCeE
Confidence 36888999999999999999985 578899999986543 445567889999999996 9999999988653 3688
Q ss_pred EEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
|+|+||+.+ +|.+.+... .+++..++.++.||+.||.|||.++ |+||||+|+|||++.++.++|+|||+++...
T Consensus 75 ~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 149 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLT 149 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeec
Confidence 999999965 676666543 5899999999999999999999999 9999999999999999999999999986653
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc---cCCCC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG---NYRIP 259 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~---~~~~~ 259 (690)
... .......+++.|+|||+ +.+..++.++|||||||++|+|++|..||........... .....
T Consensus 150 ~~~---------~~~~~~~~~~~y~~PE~---~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~ 217 (274)
T cd06609 150 STM---------SKRNTFVGTPFWMAPEV---IKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPS 217 (274)
T ss_pred ccc---------cccccccCCccccChhh---hccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCC
Confidence 221 11123467889999996 4456689999999999999999999999987654443221 11111
Q ss_pred CCC-CCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 260 ESP-KYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 260 ~~~-~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
... .++..+.++|.+||..+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 112 27899999999999999999999999964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=308.53 Aligned_cols=251 Identities=21% Similarity=0.344 Sum_probs=204.4
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
++++.+..||.|.-|.||+++.. .++..+|||.+..+ +.+...+++..++++....++|+||+.||+|+.+ ..+
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~r-s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n----~dV 166 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFR-STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN----TDV 166 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEc-ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC----chH
Confidence 34455778999999999999986 67899999999765 5667889999999998887789999999999865 557
Q ss_pred EEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 104 LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
+|.||.|.--+..++.+ -.++++|..+-.+...++.||.||..+. +|||||+||+|||||..|++||||||++-.+..
T Consensus 167 ~IcMelMs~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 167 FICMELMSTCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHHHHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeecccccceeec
Confidence 88999987555555544 3456999999999999999999999874 399999999999999999999999999855433
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc-hHHHHH----hcc-CC
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGE-SKLQIL----NGN-YR 257 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~-~~~~il----~~~-~~ 257 (690)
.. ...+..|.+.|||||.++.-....|+-++||||||++|+||.||+.||.+- ...+++ +.. ..
T Consensus 245 Sk----------AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~ 314 (391)
T KOG0983|consen 245 SK----------AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPL 314 (391)
T ss_pred cc----------ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCC
Confidence 22 223457899999999877555678999999999999999999999999873 233333 322 22
Q ss_pred CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
++....+++.+.+|+..||.+|+.+||.+.+++.+
T Consensus 315 L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 315 LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 33334689999999999999999999999998653
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=309.23 Aligned_cols=237 Identities=18% Similarity=0.231 Sum_probs=184.7
Q ss_pred EeeecCceEEEEEEEccc------CCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEE
Q 005577 32 VIAEGGFSCVYSARDAIH------MSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALL 105 (690)
Q Consensus 32 ~LG~GgFG~VylA~d~~~------~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~L 105 (690)
.||.|+||.||+|.+... ....|++|.+........+.+.+|+.+|+.+. |||||++++++.. ....++
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~----~~~~~l 76 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLS-HKHLVLNYGVCVC----GDESIM 76 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCC-CCChhheeeEEEe----CCCcEE
Confidence 689999999999987421 13348888876555555678889999999995 9999999998763 356899
Q ss_pred EEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCC--------eeeeccC
Q 005577 106 VMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGL--------WKLCDFG 176 (690)
Q Consensus 106 VmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~--------vKL~DFG 176 (690)
||||+++ +|..++..+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++. ++|+|||
T Consensus 77 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999965 5666665543 35899999999999999999999999 999999999999987764 6999999
Q ss_pred CCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhC-CCCCCCchHHHH---H
Q 005577 177 STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF-KNAFDGESKLQI---L 252 (690)
Q Consensus 177 lA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG-~~PF~~~~~~~i---l 252 (690)
++..... .....+++.|+|||++. ....++.++|||||||++|+|++| ..||........ .
T Consensus 154 ~~~~~~~-------------~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~ 218 (258)
T cd05078 154 ISITVLP-------------KEILLERIPWVPPECIE--NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY 218 (258)
T ss_pred cccccCC-------------chhccccCCccCchhcc--CCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH
Confidence 8754321 11235688999999742 234578899999999999999998 467665444322 2
Q ss_pred hccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 253 NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 253 ~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
.... ..+...+..+.+||.+||+.||++||++.+++..+
T Consensus 219 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 219 EDRH--QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred Hccc--cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 2222 23345678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=310.84 Aligned_cols=248 Identities=21% Similarity=0.304 Sum_probs=197.9
Q ss_pred eecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 21 DVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 21 ei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
++...+|++.+.||+|+||+||++.+. ..++.||+|++.... ......+.+|+.+++.+. ||||+++++++..
T Consensus 1 ~l~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~---- 74 (284)
T cd06620 1 DLRNEDLETISDLGAGNGGSVSKVKHI-PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR-SPYIVSFYGAFLN---- 74 (284)
T ss_pred CccHHHHHHHHHcCCCCCeEEEEEEEc-CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcC-CCCcceEeeeEec----
Confidence 356788999999999999999999985 568899999886543 445678889999999995 9999999998753
Q ss_pred CceEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCcccCCCCCCcEEeCCCCCeeeeccCC
Q 005577 100 TKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS-QSPPIAHRDLKAENLLLGSDGLWKLCDFGS 177 (690)
Q Consensus 100 ~~~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs-~g~~IVHRDLKP~NILLd~dg~vKL~DFGl 177 (690)
...+||||||+.+ +|.+++... +.+++..+..++.+++.+|.|||. .+ |+||||||+|||++.++.++|+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl 150 (284)
T cd06620 75 ENNICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGV 150 (284)
T ss_pred CCEEEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCc
Confidence 3788999999975 555555443 358999999999999999999997 57 99999999999999999999999998
Q ss_pred CCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--------
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL-------- 249 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~-------- 249 (690)
+...... ......|+..|+|||+ +.+..++.++|||||||++|+|++|+.||......
T Consensus 151 ~~~~~~~-----------~~~~~~~~~~~~aPE~---~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~ 216 (284)
T cd06620 151 SGELINS-----------IADTFVGTSTYMSPER---IQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM 216 (284)
T ss_pred ccchhhh-----------ccCccccCcccCCHHH---HccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhh
Confidence 7543111 0113468999999996 44567889999999999999999999999754331
Q ss_pred ---HHHhccCCC----CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 250 ---QILNGNYRI----PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 250 ---~il~~~~~~----~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
..+...... .....++..+.+||.+||..||++||++.+++..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 217 GILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred HHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 122211111 1112378899999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=312.81 Aligned_cols=247 Identities=28% Similarity=0.395 Sum_probs=201.5
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
..|...+.||+|+||.||+|++. ..+..|++|++... ..+....+.+|+++++.+. |||||++++++.. ..
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~----~~ 98 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLR----EH 98 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEc-CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee----CC
Confidence 34788999999999999999985 56889999998643 3345567889999999995 9999999998753 46
Q ss_pred eEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 102 EALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 102 ~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
..||||||+.|++.+.+.... ..+++.++..++.+|+.||.|||.++ |+||||+|+||+++.++.++|+|||++...
T Consensus 99 ~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 99 TAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIA 175 (317)
T ss_pred eEEEEEeCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCcccc
Confidence 789999999999888776543 35899999999999999999999999 999999999999999999999999987542
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH----HhccCC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI----LNGNYR 257 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~i----l~~~~~ 257 (690)
.. .....|++.|+|||++.....+.++.++|||||||++|+|++|+.||........ ......
T Consensus 176 ~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd06635 176 SP-------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 242 (317)
T ss_pred CC-------------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC
Confidence 21 1124678999999974322445688999999999999999999999976554332 222222
Q ss_pred CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
......++..+.+||.+||+.+|.+||++.+++...
T Consensus 243 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 243 TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 333446788999999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.03 Aligned_cols=247 Identities=20% Similarity=0.283 Sum_probs=186.0
Q ss_pred EeeecCceEEEEEEEc-ccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEec
Q 005577 32 VIAEGGFSCVYSARDA-IHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMEC 109 (690)
Q Consensus 32 ~LG~GgFG~VylA~d~-~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy 109 (690)
.||+|+||.||+|... ......+++|.+... .......+++|+.+++.+ +||||+++++++. ....+|+||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~----~~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCI----ESIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEEC----CCCceEEEEEe
Confidence 5899999999999652 123457888877544 334456788999999999 4999999999865 34678999999
Q ss_pred CC-CcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccc
Q 005577 110 CD-KSLVNVLENRGA---GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185 (690)
Q Consensus 110 ~~-gsLl~~L~~~~~---~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~ 185 (690)
+. |+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccch
Confidence 96 577777765432 23567888999999999999999999 9999999999999999999999999886432211
Q ss_pred hhhhhccccccccccCCCCcccCccchhhh----hcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHh-----cc
Q 005577 186 EKLEEMGIEEDNIRKHTTPAYRAPEMWDLF----RRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQILN-----GN 255 (690)
Q Consensus 186 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~----~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il~-----~~ 255 (690)
. ........+++.|+|||++... ....++.++|||||||++|+|++ |..||......+.+. ..
T Consensus 155 ~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 227 (269)
T cd05042 155 Y-------YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD 227 (269)
T ss_pred h-------eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC
Confidence 0 0011123457789999975321 23457889999999999999998 788997765443322 11
Q ss_pred CCCC---CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 256 YRIP---ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 256 ~~~~---~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
..++ ....++..+.+++..|| .||++||++.+|+..+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 228 IKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 1222 12367888999999998 5999999999997654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.09 Aligned_cols=249 Identities=27% Similarity=0.440 Sum_probs=196.7
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
..|++.+.||.|+||.||+|.+. ..++.|++|.+.... ......+.+|+.+++++. ||||+++++++... +...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~--~~~~ 80 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDK-KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ-HPNIVTVKEVVVGS--NLDK 80 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEEC-CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcC-CCCEEEEEEEEEec--CCCc
Confidence 47889999999999999999985 568899999986543 223346678999999996 99999999886532 3378
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
+||||||++++|.+.+.... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++....
T Consensus 81 ~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 81 IYMVMEYVEHDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred EEEEehhcCcCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99999999998888876644 35899999999999999999999999 9999999999999999999999999886543
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC------
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY------ 256 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~------ 256 (690)
.... ......+++.|+|||++. ....++.++|||||||++|+|++|..||........+....
T Consensus 158 ~~~~---------~~~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~ 226 (293)
T cd07843 158 SPLK---------PYTQLVVTLWYRAPELLL--GAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTP 226 (293)
T ss_pred CCcc---------ccccccccccccCchhhc--CCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 2211 111235688999999732 23346889999999999999999999998655433221100
Q ss_pred -------------------CC-------CCCCC--CCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 -------------------RI-------PESPK--YSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 -------------------~~-------~~~~~--~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.. ...+. +++.+.+||.+||+.+|++||++.|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 227 TEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 00111 5888999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=302.59 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=199.2
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
.+|++.+.||.|+||+||+|.+. ..+..+++|++.... ......+.+|+.+|+.+. |+||+++++.+. ..+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~----~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICL-PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN-HPNVVKYYTSFV----VGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEc-CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcC-CCCEEEEEEEEe----eCCEE
Confidence 36899999999999999999875 567889999886432 335678899999999995 999999998765 34788
Q ss_pred EEEEecCCC-cHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 104 LLVMECCDK-SLVNVLENRGA-GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 104 ~LVmEy~~g-sLl~~L~~~~~-~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
|+||||+.| +|.+.+..... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++..+
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~ 152 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASL 152 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence 999999964 66666665432 46899999999999999999999999 999999999999999999999999988654
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCC----
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYR---- 257 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~---- 257 (690)
....... ........|+..|+|||++. ....++.++|||||||++|+|++|+.||........+.....
T Consensus 153 ~~~~~~~-----~~~~~~~~~~~~y~~Pe~~~--~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (267)
T cd06610 153 ADGGDRT-----RKVRKTFVGTPCWMAPEVME--QVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP 225 (267)
T ss_pred ccCcccc-----ccccccccCChhhcChHHHc--cccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCC
Confidence 3221110 01122346899999999732 223688999999999999999999999987655433322111
Q ss_pred -CCC---CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 -IPE---SPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 -~~~---~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
... ...++..+.++|.+||..||++||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111 1367899999999999999999999999865
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=300.23 Aligned_cols=244 Identities=23% Similarity=0.391 Sum_probs=194.6
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecCCH-HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEec
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE-ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMEC 109 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~-e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy 109 (690)
++||+|+||.||+|.+. . ++.|++|++..... .....+.+|+.+++.+. |+||+++++++. .....|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~-~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~----~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK-G-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD-HPNIVKLIGVCV----QKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEe-C-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCeEEEEEEEe----cCCCeEEEEEc
Confidence 36899999999999984 3 89999998865533 35678899999999995 999999998865 34678999999
Q ss_pred CC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhh
Q 005577 110 CD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL 188 (690)
Q Consensus 110 ~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~ 188 (690)
+. ++|.+++.... ..+++..++.++.+++.+|.|||.++ |+||||||+||||+.++.++|+|||++.........
T Consensus 74 ~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~- 149 (251)
T cd05041 74 VPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT- 149 (251)
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcce-
Confidence 95 56777765543 35899999999999999999999999 999999999999999999999999998654311100
Q ss_pred hhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH---HHhccCCCCCCCCC
Q 005577 189 EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQ---ILNGNYRIPESPKY 264 (690)
Q Consensus 189 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~---il~~~~~~~~~~~~ 264 (690)
.......++..|+|||+ +.+..++.++|||||||++|+|++ |..||....... .+......+.+..+
T Consensus 150 ------~~~~~~~~~~~y~~PE~---~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (251)
T cd05041 150 ------VSDGLKQIPIKWTAPEA---LNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLC 220 (251)
T ss_pred ------eccccCcceeccCChHh---hccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccC
Confidence 00011233567999996 445678999999999999999998 889997655433 23333344445578
Q ss_pred CHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 265 SSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 265 s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
+..+.++|.+||..+|.+||++.+++..+.
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 899999999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=311.91 Aligned_cols=250 Identities=22% Similarity=0.302 Sum_probs=194.9
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
.+|...+.||+|+||.||++.+. ..++.||+|.+.... ......+.+|+.++.++.+|+|||++++++.. ....
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~----~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHK-PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR----EGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEEC-CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec----CCcE
Confidence 35667789999999999999985 568899999986542 34556788999999999679999999998653 4678
Q ss_pred EEEEecCCCcHHHHH---HHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 104 LLVMECCDKSLVNVL---ENRGAGYFEEKQVLAIFRDVCNAVFAMHSQ-SPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L---~~~~~~~lse~~~~~i~~qIa~aL~yLHs~-g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
++||||+.+++.++. .......+++..+..++.+++.||.|||.. + |+||||||+|||++.++.+||+|||+++
T Consensus 79 ~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 156 (288)
T cd06616 79 WICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISG 156 (288)
T ss_pred EEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhH
Confidence 899999987765443 223335699999999999999999999975 7 9999999999999999999999999886
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-HHHHhccC--
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK-LQILNGNY-- 256 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~-~~il~~~~-- 256 (690)
...... ......|++.|+|||++....+..++.++|||||||++|+|++|+.||..... ...+....
T Consensus 157 ~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 226 (288)
T cd06616 157 QLVDSI----------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKG 226 (288)
T ss_pred HhccCC----------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCC
Confidence 432211 11223578899999974322123688999999999999999999999976532 12222111
Q ss_pred ---CC--CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 ---RI--PESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 ---~~--~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.. .....++..+.+||.+||+.+|++||++.+|+.
T Consensus 227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 112357899999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=307.07 Aligned_cols=261 Identities=21% Similarity=0.279 Sum_probs=201.5
Q ss_pred ceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec
Q 005577 18 RSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97 (690)
Q Consensus 18 ~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~ 97 (690)
..+.....+|++.+.||+|+||.||+|.+. ..++.+|+|++.... .....+.+|+.++.++.+||||+++++++....
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~-~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNK-KDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEEC-CCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 445555688999999999999999999985 578899999885432 223566789999999967999999999876432
Q ss_pred C-CCceEEEEEecCCC-cHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeee
Q 005577 98 G-RTKEALLVMECCDK-SLVNVLENR--GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLC 173 (690)
Q Consensus 98 ~-~~~~~~LVmEy~~g-sLl~~L~~~--~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~ 173 (690)
. ....+|+||||+.| +|.+++... ....+++..++.++.||+.||.|||..+ |+||||||+|||++.++.+||+
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEe
Confidence 1 23568999999965 666666432 2345899999999999999999999999 9999999999999999999999
Q ss_pred ccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhh--cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 005577 174 DFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFR--RELINEKVDIWALGCLLFRICYFKNAFDGESKLQI 251 (690)
Q Consensus 174 DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~--~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~i 251 (690)
|||++........ ......|+..|+|||++.... ...++.++|||||||++|+|++|+.||........
T Consensus 171 dfg~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~ 241 (291)
T cd06639 171 DFGVSAQLTSTRL---------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241 (291)
T ss_pred ecccchhcccccc---------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH
Confidence 9998865322110 011235789999999743211 12368899999999999999999999987654333
Q ss_pred Hhcc-----CCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 252 LNGN-----YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 252 l~~~-----~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
+... .....+..++..+.+||.+||+.+|++||++.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 242 LFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 2221 122223457788999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.85 Aligned_cols=247 Identities=28% Similarity=0.453 Sum_probs=198.0
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.+|++.+.||+|+||.||+|.+. ..++.|++|++... .....+.+.+|+++|+.+. |+||+++++++.. .+.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~----~~~ 74 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNK-ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR-HENIVNLKEAFRR----KGR 74 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeC-CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC-CCCeeehhheEEE----CCE
Confidence 37999999999999999999985 56889999987543 3344577889999999995 9999999998753 467
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
.|+||||++++++..+..+. ..+++.+++.++.||+.||.|||.++ |+||||+|+||+++.++.+||+|||++....
T Consensus 75 ~~iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 75 LYLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALR 151 (288)
T ss_pred EEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence 89999999998887776554 34899999999999999999999999 9999999999999999999999999987643
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc-------
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRE-LINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG------- 254 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~-~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~------- 254 (690)
.... .......++..|+|||++ .+. .++.++|||||||++|+|++|+.||.+....+.+..
T Consensus 152 ~~~~--------~~~~~~~~~~~~~~PE~~---~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 220 (288)
T cd07833 152 ARPA--------SPLTDYVATRWYRAPELL---VGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGP 220 (288)
T ss_pred CCcc--------ccccCcccccCCcCCchh---cCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 3211 011224578899999973 344 788999999999999999999999976543321100
Q ss_pred -------------cC---CC-----------CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 255 -------------NY---RI-----------PESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 255 -------------~~---~~-----------~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.+ .. ..+..++..+.+||.+||..+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 221 LPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 00 011234889999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=310.48 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=197.0
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.|++.+.||+|+||.||++.+. ..++.|++|.+.... ......+.+|+.+++.+. ||||+++++.+. ....
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~----~~~~ 75 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHK-ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFE----TKRH 75 (305)
T ss_pred CceEeeEeecCCCeeEEEEEEC-CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEe----cCCE
Confidence 6889999999999999999985 567899999886543 234567889999999995 999999998864 3468
Q ss_pred EEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
+|+||||+.| +|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~ 151 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIG 151 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence 8999999965 6666665543 4899999999999999999999999 999999999999999999999999988632
Q ss_pred cccchh-hhh-----ccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc
Q 005577 182 HKRFEK-LEE-----MGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN 255 (690)
Q Consensus 182 ~~~~~~-~~~-----~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~ 255 (690)
...... ... ...........++..|+|||. +.+..++.++|||||||++|+|++|..||.+....+++...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~ 228 (305)
T cd05609 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEV---ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228 (305)
T ss_pred CcCccccccccccccchhhccccCCccCccccCchh---ccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 111000 000 000001112357889999996 44567899999999999999999999999876655443322
Q ss_pred ----CCCCC-CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 256 ----YRIPE-SPKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 256 ----~~~~~-~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
...+. ...++..+.+||.+||+.||++||+...+...+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 229 ISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred HhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 12222 235789999999999999999999965544433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=320.02 Aligned_cols=252 Identities=22% Similarity=0.362 Sum_probs=198.9
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec-CCC
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL-GRT 100 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~-~~~ 100 (690)
..+|.+.+.||+|+||.||+|++. .+++.||||.+... .......+.+|+.+|+.+ +|+||+++++++.... ...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNS-ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEec-CCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheeccccccc
Confidence 358999999999999999999985 67899999988643 233456678899999999 4999999998765321 122
Q ss_pred ceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 101 KEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 101 ~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
..+||||||++++|.+.+.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 82 NDVYIVYELMDTDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred CcEEEEEeCCCCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 4689999999999988886543 4999999999999999999999999 99999999999999999999999999865
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh-------
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN------- 253 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~------- 253 (690)
..... .......++..|+|||++ .....++.++|||||||++|+|++|+.||.+.+......
T Consensus 158 ~~~~~---------~~~~~~~~~~~y~aPE~~--~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 226 (337)
T cd07858 158 TSEKG---------DFMTEYVVTRWYRAPELL--LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLG 226 (337)
T ss_pred cCCCc---------ccccccccccCccChHHH--hcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Confidence 43211 111223578899999973 233458899999999999999999999997654221100
Q ss_pred --------------------ccCCC------CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 254 --------------------GNYRI------PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 254 --------------------~~~~~------~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
..... ...+.++..+.+||.+||+.+|++||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 227 SPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000 0124678999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=306.47 Aligned_cols=257 Identities=24% Similarity=0.376 Sum_probs=202.8
Q ss_pred CceEEEEEEeeecCceEEEEEEEc---ccCCeEEEEEEeecCCHH-HHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDA---IHMSKQYAMKHMICNDEE-SLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~---~~~~k~vAvK~i~~~~~e-~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
..+|++.+.||+|+||.||+|.+. ...++.||||++...... ..+.+.+|+.+++.+. ||||+++++++... .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~--~ 79 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD-HENIVKYKGVCEKP--G 79 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCC-CCChheEEeeeecC--C
Confidence 467888899999999999999863 234788999998765443 5678899999999994 99999999876532 3
Q ss_pred CceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 100 TKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
....++||||+. ++|.+++.... ..+++..++.++.||+.||.|||.++ |+||||||+|||++.++.++|+|||++
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccccc
Confidence 457899999995 57777776544 24899999999999999999999999 999999999999999999999999998
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH----------
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK---------- 248 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~---------- 248 (690)
........... ......++..|++||+ .....++.++|||||||++|+|++|..||.....
T Consensus 157 ~~~~~~~~~~~------~~~~~~~~~~~~~Pe~---~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 227 (284)
T cd05038 157 KVLPEDKDYYY------VKEPGESPIFWYAPEC---LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQ 227 (284)
T ss_pred cccccCCccee------ccCCCCCcccccCcHH---HccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccc
Confidence 76542211100 0011234567999996 4456788999999999999999999998865321
Q ss_pred --------HHHHhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhh
Q 005577 249 --------LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 249 --------~~il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~ 295 (690)
...+....+.+.+..++..+.+||.+||..+|.+||++.+++..+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 228 GQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred ccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 11223333444456778999999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=299.23 Aligned_cols=243 Identities=23% Similarity=0.377 Sum_probs=196.4
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-----HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-----EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-----~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
+|+..+.||+|+||.||+|.+. ..++.|++|.+.... .+..+.+.+|+.+++.+. |+||+++++++. ..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~----~~ 74 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNL-DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTER----EE 74 (258)
T ss_pred CccccceeeecCCceEEEEEEc-CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEe----cC
Confidence 5778899999999999999985 568899999886543 345678889999999994 999999998864 34
Q ss_pred ceEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 101 KEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 101 ~~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
..+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~ 150 (258)
T cd06632 75 DNLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAK 150 (258)
T ss_pred CeEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccce
Confidence 678999999965 6766665543 4899999999999999999999999 9999999999999999999999999876
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc----
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRREL-INEKVDIWALGCLLFRICYFKNAFDGESKLQILNG---- 254 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~-~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~---- 254 (690)
...... ......|++.|++||.+ .... ++.++|||||||++|+|++|+.||...........
T Consensus 151 ~~~~~~----------~~~~~~~~~~y~~pe~~---~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 217 (258)
T cd06632 151 QVVEFS----------FAKSFKGSPYWMAPEVI---AQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS 217 (258)
T ss_pred eccccc----------cccccCCCcceeCHHHh---cCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc
Confidence 532211 11234578999999963 3333 88999999999999999999999976554333221
Q ss_pred cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 255 NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 255 ~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
......+..++..+.++|.+||..+|.+||++.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 218 KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1122234567899999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=315.17 Aligned_cols=245 Identities=28% Similarity=0.405 Sum_probs=196.6
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALL 105 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~L 105 (690)
.|.....||+|+||.||++.+. ..++.||||.+........+.+.+|+.+++.+. ||||+++++.+. ..+..|+
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~----~~~~~~l 96 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEK-HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH-HENVVDMYNSYL----VGDELWV 96 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEEC-CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCC-CCcHHHHHHhee----cCCeEEE
Confidence 4455677999999999999985 568899999987666666778899999999995 999999998865 3478899
Q ss_pred EEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccc
Q 005577 106 VMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185 (690)
Q Consensus 106 VmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~ 185 (690)
||||+.++.+..+.... .+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.......
T Consensus 97 v~e~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 97 VMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred EEeCCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 99999765444443333 3899999999999999999999999 9999999999999999999999999886432211
Q ss_pred hhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc---cC--CCCC
Q 005577 186 EKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG---NY--RIPE 260 (690)
Q Consensus 186 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~---~~--~~~~ 260 (690)
.......|++.|+|||+ +.+..++.++|||||||++|||++|+.||........+.. .. ..+.
T Consensus 173 ---------~~~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T cd06658 173 ---------PKRKSLVGTPYWMAPEV---ISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKD 240 (292)
T ss_pred ---------ccCceeecCccccCHHH---HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcccc
Confidence 11122457899999996 4556788999999999999999999999987665443222 11 1222
Q ss_pred CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 261 SPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 261 ~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
...++..+.++|..||..||.+||++.+++.+
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 34578899999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=303.64 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=194.6
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-----CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-----DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-----~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
..|++.+.||+|+||.||+|.+. ..++.|++|++... .......+.+|+.+++.+. ||||+++++++.. ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~ 77 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDV-DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRD--RA 77 (266)
T ss_pred CCccccceecCCCCEEEEEEEEc-CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEc--CC
Confidence 36888999999999999999985 56889999987543 2234567888999999995 9999999987642 23
Q ss_pred CceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 100 TKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
...+++||||+. ++|.+.+.... .+++..++.++.||+.||.|||..+ |+||||||+|||++.++.+||+|||++
T Consensus 78 ~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 78 EKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 457889999996 57777776544 3899999999999999999999999 999999999999999999999999998
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY-- 256 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~-- 256 (690)
+.+...... ........++..|+|||+ +.+..++.++|||||||++|+|++|+.||........+....
T Consensus 154 ~~~~~~~~~------~~~~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~ 224 (266)
T cd06651 154 KRLQTICMS------GTGIRSVTGTPYWMSPEV---ISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ 224 (266)
T ss_pred ccccccccc------CCccccCCccccccCHHH---hCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC
Confidence 654221100 001112357899999996 445668899999999999999999999998655433222111
Q ss_pred --CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 --RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 --~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
....+..++..+.++| .||..+|++||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 225 PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1122345678888888 688889999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=303.75 Aligned_cols=248 Identities=19% Similarity=0.254 Sum_probs=186.3
Q ss_pred EEeeecCceEEEEEEEcc-cCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEe
Q 005577 31 NVIAEGGFSCVYSARDAI-HMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVME 108 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~-~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmE 108 (690)
+.||+|+||.||+|.+.. .....+++|.+.... ......+.+|+.+++.+. ||||+++++++. +....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~----~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCT----EVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEc----CCCCcEEEEE
Confidence 358999999999997632 245679999886543 334457888999999995 999999998864 3456899999
Q ss_pred cCC-CcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccccc
Q 005577 109 CCD-KSLVNVLENRG---AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKR 184 (690)
Q Consensus 109 y~~-gsLl~~L~~~~---~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~ 184 (690)
|+. |+|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCc
Confidence 996 67777776432 123567788899999999999999999 999999999999999999999999998643221
Q ss_pred chhhhhccccccccccCCCCcccCccchhhhhc----CCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHh-----c
Q 005577 185 FEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRR----ELINEKVDIWALGCLLFRICY-FKNAFDGESKLQILN-----G 254 (690)
Q Consensus 185 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~----~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il~-----~ 254 (690)
.. ........+++.|+|||++..... ..++.++|||||||++|||++ |..||......+... .
T Consensus 154 ~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 226 (269)
T cd05087 154 DY-------YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ 226 (269)
T ss_pred ce-------eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcc
Confidence 11 011122456889999997532211 236789999999999999996 999997655443321 1
Q ss_pred cCCCCC---CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 255 NYRIPE---SPKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 255 ~~~~~~---~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
..+.+. ...++..+.++|.+|| .+|++||++.+|+..+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 227 QLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred cCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 122222 1246788999999998 6899999999998654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=352.78 Aligned_cols=260 Identities=26% Similarity=0.432 Sum_probs=196.3
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecC-----
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLG----- 98 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~----- 98 (690)
.+|+...+||+||||.||+++++ -.|+.||||+|... .......+++|+.+|.+| +|||||++|..++....
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNK-lDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNK-LDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeec-ccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCccccc
Confidence 47888899999999999999997 47899999999655 445567889999999999 59999999832111000
Q ss_pred --------------------------------------------------------------------------------
Q 005577 99 -------------------------------------------------------------------------------- 98 (690)
Q Consensus 99 -------------------------------------------------------------------------------- 98 (690)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred C----------------------C--------ceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 005577 99 R----------------------T--------KEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQ 148 (690)
Q Consensus 99 ~----------------------~--------~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~ 148 (690)
+ . -.+||-||||+.++++.+..++.-.-....+|++|++|+.||.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0 0 246899999999998888776641114788999999999999999999
Q ss_pred CCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc---ccch------hhhhccccccccccCCCCcccCccchhhhhcCC
Q 005577 149 SPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH---KRFE------KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRREL 219 (690)
Q Consensus 149 g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~---~~~~------~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~ 219 (690)
| ||||||||.||+|+.++.|||+|||+|+... .... .........+....+||-.|+|||++.......
T Consensus 717 g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 717 G--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred c--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9 9999999999999999999999999997621 1111 011112222556779999999999865444447
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCc-hHHHHHhccC--CCCCCC----CCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 220 INEKVDIWALGCLLFRICYFKNAFDGE-SKLQILNGNY--RIPESP----KYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 220 ~s~ksDVwSLGviLyELltG~~PF~~~-~~~~il~~~~--~~~~~~----~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
|+.|+|+|||||||+||+. ||... ....++.... .+|.++ .--+.-..+|..||+.||.+|||+.|++.
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 9999999999999999986 57653 3333443322 222221 12345678999999999999999999864
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=319.65 Aligned_cols=255 Identities=27% Similarity=0.374 Sum_probs=199.9
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
..+|++.+.||+|+||.||+|.+. ..++.++||++... +......+.+|+.+++++.+||||+++++++... +..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~--~~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDR-RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE--NDK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEc-CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC--CCc
Confidence 358899999999999999999985 56889999988542 3344566788999999995599999999986532 345
Q ss_pred eEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 102 EALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 102 ~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
.+|+||||++++|...+... .+.+..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++...
T Consensus 83 ~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 83 DIYLVFEYMETDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred eEEEEecccccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 78999999999888877653 4889999999999999999999999 999999999999999999999999998754
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc-------
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG------- 254 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~------- 254 (690)
....... .........|++.|+|||++ .....++.++|||||||++|+|++|+.||.+......+..
T Consensus 158 ~~~~~~~----~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07852 158 SELEENP----ENPVLTDYVATRWYRAPEIL--LGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231 (337)
T ss_pred ccccccc----cCcchhcccccccccCceee--eccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 3321110 00111234679999999973 3345678899999999999999999999976543221110
Q ss_pred --------------------cCC------CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 255 --------------------NYR------IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 255 --------------------~~~------~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
... ....+.++..+.++|.+||+.||.+||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000 01123478999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=299.51 Aligned_cols=248 Identities=23% Similarity=0.397 Sum_probs=198.4
Q ss_pred EEEEEEeeecCceEEEEEEEcccC---CeEEEEEEeecCCH-HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 27 IHVRNVIAEGGFSCVYSARDAIHM---SKQYAMKHMICNDE-ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 27 y~v~~~LG~GgFG~VylA~d~~~~---~k~vAvK~i~~~~~-e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
+++.+.||.|+||.||++.+.... ...||+|++..... .....+..|+.++..+ +|+||+++++++.. .+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTE----EEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcC----CCe
Confidence 356789999999999999985321 38899999865433 2567889999999999 69999999998653 367
Q ss_pred EEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
.|+||||+. ++|.+.+.......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceec
Confidence 899999996 57777776544333899999999999999999999999 999999999999999999999999998654
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH---hccCC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQIL---NGNYR 257 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il---~~~~~ 257 (690)
..... .... ...+++.|+|||. .....++.++|||||||++|+|++ |..||.......+. .....
T Consensus 154 ~~~~~------~~~~--~~~~~~~y~~Pe~---~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 222 (258)
T smart00219 154 YDDDY------YKKK--GGKLPIRWMAPES---LKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR 222 (258)
T ss_pred ccccc------cccc--cCCCcccccChHH---hccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC
Confidence 32200 0000 1236789999996 456778999999999999999998 88999866554432 33334
Q ss_pred CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
...+..++..+.++|.+||..||.+||++.+++..
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 223 LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence 44456689999999999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=299.86 Aligned_cols=251 Identities=27% Similarity=0.469 Sum_probs=196.7
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH--HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE--ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~--e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
+|.+.+.||+|+||.||+|.+. ..++.|++|.+..... .....+.+|+.+++.+. |+||+++++++. ..+.+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~----~~~~~ 74 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNL-DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-HPNLVKYYGVEV----HREKV 74 (264)
T ss_pred CceeeeEeecCCCcEEEEEEEC-CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCC-CCChhheeeeEe----cCCEE
Confidence 6899999999999999999884 5688999999876544 46788999999999995 999999998754 34678
Q ss_pred EEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
++|+||+. ++|.+.+... ..+++..++.|+.+|+.||.|||+.+ |+|+||+|+|||++.++.+||+|||++....
T Consensus 75 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~ 150 (264)
T cd06626 75 YIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLK 150 (264)
T ss_pred EEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccC
Confidence 99999996 5666666543 34889999999999999999999999 9999999999999999999999999886643
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch-HHHHH---hc--cC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES-KLQIL---NG--NY 256 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~-~~~il---~~--~~ 256 (690)
........ ......+++.|+|||++.......++.++|||||||++|+|++|+.||.... ...+. .. ..
T Consensus 151 ~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 225 (264)
T cd06626 151 NNTTTMGE-----EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP 225 (264)
T ss_pred CCCCcccc-----cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCC
Confidence 32111100 0112357889999997432222348899999999999999999999997542 22211 11 11
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 ~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
..+....++..+.++|.+||+.+|.+||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 22333345899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=304.38 Aligned_cols=245 Identities=22% Similarity=0.413 Sum_probs=196.0
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhc--CCCCceEEEEEEEeecCCCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLK--GHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~--~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.|++.+.||.|+||.||+|.+. ..++.|++|.+... .......+.+|+.+++.+. .||||+++++++. ....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~----~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHV-PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL----KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEc-CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee----eCCE
Confidence 4778899999999999999985 57889999988654 3445677889999999995 5999999999865 3467
Q ss_pred EEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
.|+||||+.| +|.+++.. . .+++..++.++.||+.||.|||..+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-~--~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA-G--PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EEEEEecCCCCcHHHHHHc-c--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 8999999965 56555533 3 4899999999999999999999999 999999999999999999999999988654
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCCC--C
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRI--P 259 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~~--~ 259 (690)
.... .......|+..|+|||++ ..+..++.++|||||||++|+|++|..||.+............. +
T Consensus 152 ~~~~---------~~~~~~~~~~~y~aPE~~--~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 220 (277)
T cd06917 152 NQNS---------SKRSTFVGTPYWMAPEVI--TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPP 220 (277)
T ss_pred CCCc---------cccccccCCcceeCHHHh--ccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCC
Confidence 3211 111224688999999973 23445788999999999999999999999877655443221111 1
Q ss_pred C--CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 260 E--SPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 260 ~--~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
. ...++.++.++|.+||..||++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1 1137889999999999999999999999964
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=338.86 Aligned_cols=259 Identities=22% Similarity=0.377 Sum_probs=219.2
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEccc--CCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecC
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIH--MSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLG 98 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~--~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~ 98 (690)
|.-..+.|.++||.|.||+||+|+.+.. ....||||.+... .+....+|+.|+.||-++ +||||++|-|+..
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVT---- 700 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVT---- 700 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEe----
Confidence 3345677899999999999999997632 3457999999776 455678999999999999 5999999999854
Q ss_pred CCceEEEEEecC-CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCC
Q 005577 99 RTKEALLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS 177 (690)
Q Consensus 99 ~~~~~~LVmEy~-~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGl 177 (690)
..+.+.||.||| +|+|..+|+.+. +.|+..+++.+++.|+.|+.||-+++ +|||||...||||+.+-.+||+|||+
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccc
Confidence 457789999999 578888887765 55999999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccchhhhhccccccccccCC--CCcccCccchhhhhcCCCCchhhHHHHHHHHHHHH-hCCCCCCCchHHHH---
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHT--TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC-YFKNAFDGESKLQI--- 251 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~G--T~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELl-tG~~PF~~~~~~~i--- 251 (690)
+|.+.+...... .+.-| .++|.|||. +....++.++|||||||++||.+ .|..||-..+..++
T Consensus 778 SRvledd~~~~y--------tt~GGKIPiRWTAPEA---Ia~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka 846 (996)
T KOG0196|consen 778 SRVLEDDPEAAY--------TTLGGKIPIRWTAPEA---IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA 846 (996)
T ss_pred eeecccCCCccc--------cccCCccceeecChhH---hhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH
Confidence 987654431111 11112 579999995 55677999999999999999976 59999988877666
Q ss_pred HhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhcCc
Q 005577 252 LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPV 299 (690)
Q Consensus 252 l~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l~~ 299 (690)
++..|++|.+.+||..|.+||..||++|-.+||.+.+|+..+..++..
T Consensus 847 Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 847 IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 467899999999999999999999999999999999999998887643
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=301.91 Aligned_cols=247 Identities=23% Similarity=0.342 Sum_probs=192.6
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALL 105 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~L 105 (690)
.......||+|+||.||+|.+. ..+..|++|.+........+.+.+|+.+++.++ |+||+++++++. ..+..++
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~----~~~~~~l 82 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDL-STQVRIAIKEIPERDSRYVQPLHEEIALHSYLK-HRNIVQYLGSDS----ENGFFKI 82 (268)
T ss_pred cCCceEEEecCCceEEEEeEec-CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcC-CCCeeeeeeeec----cCCEEEE
Confidence 3334568999999999999985 567889999987776667788999999999995 999999999865 3467899
Q ss_pred EEecCC-CcHHHHHHHhCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCC-CCCeeeeccCCCCcc
Q 005577 106 VMECCD-KSLVNVLENRGAGYF--EEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS-DGLWKLCDFGSTSTN 181 (690)
Q Consensus 106 VmEy~~-gsLl~~L~~~~~~~l--se~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~-dg~vKL~DFGlA~~~ 181 (690)
||||+. ++|.+++.... ..+ ++..+..++.||+.||.|||.++ |+||||||+|||++. ++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999996 56777776542 235 88889999999999999999999 999999999999976 678999999988643
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHhc---cC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL--QILNG---NY 256 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~--~il~~---~~ 256 (690)
.... .......|++.|+|||++.. ....++.++|||||||++|+|++|+.||...... ..... ..
T Consensus 160 ~~~~---------~~~~~~~~~~~~~aPE~~~~-~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 229 (268)
T cd06624 160 AGIN---------PCTETFTGTLQYMAPEVIDK-GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI 229 (268)
T ss_pred ccCC---------CccccCCCCccccChhhhcc-ccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhcc
Confidence 2110 11112357899999997421 1234788999999999999999999999753321 11111 11
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 ~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
....+..+++.+.+||.+||+.+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 230 HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 12233467899999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.59 Aligned_cols=260 Identities=25% Similarity=0.405 Sum_probs=197.6
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH--HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecC----
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE--ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLG---- 98 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~--e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~---- 98 (690)
.+|++.+.||.|+||.||+|.+. ..++.|+||++..... .....+.+|+.+++.+. ||||+++++++.....
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQI-KTGRVVALKKILMHNEKDGFPITALREIKILKKLK-HPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcC-CCCccchhhheecccccccc
Confidence 68999999999999999999985 5678899998864322 22345678999999995 9999999987654321
Q ss_pred CCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 99 RTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 99 ~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
....+|+||||+.+++...+.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCccc
Confidence 234679999999999888776543 35999999999999999999999999 999999999999999999999999998
Q ss_pred Ccccccchhhhhc--cccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC
Q 005577 179 STNHKRFEKLEEM--GIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY 256 (690)
Q Consensus 179 ~~~~~~~~~~~~~--~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~ 256 (690)
+............ ..........+++.|+|||++ .....++.++|||||||++|+|++|+.||.+..........+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELL--LGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHh--hCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 7543322111100 000111223568899999963 233458899999999999999999999998765433211100
Q ss_pred ---C------------------------CC-----CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 ---R------------------------IP-----ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 ---~------------------------~~-----~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
. .+ ....+...+.++|.+||..||.+||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0 00 01234578899999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.67 Aligned_cols=253 Identities=24% Similarity=0.378 Sum_probs=197.3
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecC-----
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLG----- 98 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~----- 98 (690)
..+|++.+.||.|+||.||+|.+. .+++.|++|++...+....+.+.+|+.+|+.+. ||||+++++++.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~-~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDS-DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEEC-CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcC-CCcchhhHhhhcccccccccc
Confidence 479999999999999999999985 678899999987766666778889999999994 9999999876543211
Q ss_pred -----CCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCC-CCCeee
Q 005577 99 -----RTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS-DGLWKL 172 (690)
Q Consensus 99 -----~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~-dg~vKL 172 (690)
+....|+||||++++|.+.+.. ..+++..++.++.||+.||.|||..| |+||||||+|||++. ++.+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 82 VGSLTELNSVYIVQEYMETDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccceEEEEeecccccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEE
Confidence 1235789999999888777643 24899999999999999999999999 999999999999975 457899
Q ss_pred eccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 005577 173 CDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL 252 (690)
Q Consensus 173 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il 252 (690)
+|||+++......... .......++..|+|||++ .....++.++|||||||++|+|++|+.||.+......+
T Consensus 157 ~dfg~~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~--~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~ 228 (342)
T cd07854 157 GDFGLARIVDPHYSHK------GYLSEGLVTKWYRSPRLL--LSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228 (342)
T ss_pred CCcccceecCCccccc------cccccccccccccCHHHH--hCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999986543211110 011123578899999973 33456888999999999999999999999765433221
Q ss_pred hcc--------------------------CCCC------CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 253 NGN--------------------------YRIP------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 253 ~~~--------------------------~~~~------~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
... .... ..+.++.++.+||.+||..||.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 110 0000 02357889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=301.96 Aligned_cols=248 Identities=25% Similarity=0.424 Sum_probs=195.5
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC------HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND------EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~------~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
.|+..+.||+|+||.||+|.+. .+++.||+|++.... ....+.+.+|+.+|+.++ |+|||++++++. +
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~----~ 74 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDV-KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATC----E 74 (268)
T ss_pred CccccceecCcCceEEEEEEEc-CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceec----c
Confidence 3777899999999999999985 678899999986432 234577889999999995 999999999864 4
Q ss_pred CceEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCC-CeeeeccCC
Q 005577 100 TKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG-LWKLCDFGS 177 (690)
Q Consensus 100 ~~~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg-~vKL~DFGl 177 (690)
.+.+++||||+.| +|.+++.... .+++..++.++.||+.||.|||++| |+||||||+||+++.++ .++|+|||+
T Consensus 75 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~ 150 (268)
T cd06630 75 DSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGA 150 (268)
T ss_pred CCeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccc
Confidence 5788999999965 6666665543 4899999999999999999999999 99999999999998776 599999999
Q ss_pred CCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH---HHHH--
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK---LQIL-- 252 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~---~~il-- 252 (690)
+......... .........|+..|+|||+ +.+..++.++|||||||++|+|++|..||..... ....
T Consensus 151 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~PE~---~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 222 (268)
T cd06630 151 AARLAAKGTG-----AGEFQGQLLGTIAFMAPEV---LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK 222 (268)
T ss_pred cccccccccc-----CCccccccccccceeCHhH---hccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHH
Confidence 8654332110 0011123467899999996 4456788999999999999999999999965332 1111
Q ss_pred --hccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 253 --NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 253 --~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
........+..++..+.++|.+||..+|++||++.+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 112222334467899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=330.13 Aligned_cols=244 Identities=32% Similarity=0.463 Sum_probs=208.0
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
.-.-|.+.+.||+|.|+.|.+|++. .++..||||.+.+. +...++.+.+|+++|+.| +|||||+||.+.. ..
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~-~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~----t~ 127 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHI-LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIE----TE 127 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEec-CCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeee----ec
Confidence 3457888999999999999999996 56889999998654 555667789999999999 5999999998744 34
Q ss_pred ceEEEEEecC-CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 101 KEALLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 101 ~~~~LVmEy~-~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
..+|+||||+ +|.+.+++.+++. +.+..+..++.|+++|++|||+++ |||||||.+||||+.+.++||+|||++.
T Consensus 128 ~~lylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 128 ATLYLVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred ceeEEEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccce
Confidence 7899999999 6789999988765 788999999999999999999999 9999999999999999999999999986
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH----HHHhcc
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL----QILNGN 255 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~----~il~~~ 255 (690)
.+.. ..-..+.+|++.|.|||++.. ....++.+|+||||++||.|+.|..||++.... .++.+.
T Consensus 204 ~~~~----------~~~lqt~cgsppyAaPEl~~g--~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk 271 (596)
T KOG0586|consen 204 FFDY----------GLMLQTFCGSPPYAAPELFNG--KKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK 271 (596)
T ss_pred eecc----------cccccccCCCCCccChHhhcC--cccCCcceehhhhhhhheeeeecccccCCcccccccchheeee
Confidence 5432 122345789999999998543 346678999999999999999999999987654 345556
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHH
Q 005577 256 YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVW 290 (690)
Q Consensus 256 ~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil 290 (690)
++++. .++.++.+||+++|..+|.+|+++.++.
T Consensus 272 ~rIp~--~ms~dce~lLrk~lvl~Pskr~~~dqim 304 (596)
T KOG0586|consen 272 YRIPF--YMSCDCEDLLRKFLVLNPSKRGPCDQIM 304 (596)
T ss_pred ecccc--eeechhHHHHHHhhccCccccCCHHHhh
Confidence 66665 4788999999999999999999999984
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=307.99 Aligned_cols=259 Identities=21% Similarity=0.326 Sum_probs=202.5
Q ss_pred CCCceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEE
Q 005577 15 LEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHT 93 (690)
Q Consensus 15 ~~g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~ 93 (690)
+.|..+.+....|++.+.||+|+||.||+|.+. ..++.||||.+.... ......+.+|+.++..+.+||||+++++++
T Consensus 5 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 83 (296)
T cd06618 5 IDGQKYPADLNDLENLGEIGSGTCGQVYKMRFK-KTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF 83 (296)
T ss_pred ecceeccCCcchheeeeEeeccCCeEEEEEEEC-CCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee
Confidence 345566677788999999999999999999985 458899999986543 334566777888787776799999999987
Q ss_pred EeecCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCcccCCCCCCcEEeCCCCCeee
Q 005577 94 ILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS-QSPPIAHRDLKAENLLLGSDGLWKL 172 (690)
Q Consensus 94 ~~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs-~g~~IVHRDLKP~NILLd~dg~vKL 172 (690)
.. ....|+||||+++.+..++.... ..+++..+..++.||+.||.|||+ .+ |+||||+|+|||++.++.+||
T Consensus 84 ~~----~~~~~~v~e~~~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL 156 (296)
T cd06618 84 IT----DSDVFICMELMSTCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKL 156 (296)
T ss_pred ec----CCeEEEEeeccCcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEE
Confidence 53 46799999999887777765533 368999999999999999999997 57 999999999999999999999
Q ss_pred eccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhh-cCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-HH
Q 005577 173 CDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFR-RELINEKVDIWALGCLLFRICYFKNAFDGESK-LQ 250 (690)
Q Consensus 173 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~-~~~~s~ksDVwSLGviLyELltG~~PF~~~~~-~~ 250 (690)
+|||++..+.... ......+++.|+|||++.... ...++.++|||||||++|+|++|+.||..... .+
T Consensus 157 ~dfg~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 226 (296)
T cd06618 157 CDFGISGRLVDSK----------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE 226 (296)
T ss_pred CccccchhccCCC----------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH
Confidence 9999886532211 111235688999999743211 23478899999999999999999999976322 22
Q ss_pred HH----hcc-CCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 251 IL----NGN-YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 251 il----~~~-~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.+ ... ...+....++.++.+||.+||..||.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 227 VLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22 221 122222357899999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=302.10 Aligned_cols=256 Identities=18% Similarity=0.289 Sum_probs=198.3
Q ss_pred EEEEEEeeecCceEEEEEEEcc--cCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC--
Q 005577 27 IHVRNVIAEGGFSCVYSARDAI--HMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT-- 100 (690)
Q Consensus 27 y~v~~~LG~GgFG~VylA~d~~--~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~-- 100 (690)
|++.++||+|+||.||+|.+.. ..++.||||++... .....+.+.+|+.+|+.+. ||||+++++++.......
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCcc
Confidence 5678899999999999998642 24688999988654 4456778899999999995 999999999876432211
Q ss_pred ceEEEEEecCC-CcHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeecc
Q 005577 101 KEALLVMECCD-KSLVNVLENRG----AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDF 175 (690)
Q Consensus 101 ~~~~LVmEy~~-gsLl~~L~~~~----~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DF 175 (690)
...+++++|+. |+|..++.... ...++...++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECcc
Confidence 23578899995 56666654321 124788999999999999999999999 999999999999999999999999
Q ss_pred CCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHh-
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQILN- 253 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il~- 253 (690)
|+++....... ........+++.|++||. +....++.++|||||||++|+|++ |+.||.+.....+..
T Consensus 158 g~~~~~~~~~~-------~~~~~~~~~~~~~~~pe~---~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~ 227 (273)
T cd05074 158 GLSKKIYSGDY-------YRQGCASKLPVKWLALES---LADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY 227 (273)
T ss_pred cccccccCCcc-------eecCCCccCchhhcCHhH---HhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHH
Confidence 99875422110 001112245678999996 556678899999999999999998 899998766544322
Q ss_pred --ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhh
Q 005577 254 --GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 254 --~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~ 295 (690)
........+.++..+.+++.+||+.+|++||++.+++..+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 228 LIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 222233345688999999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=304.94 Aligned_cols=245 Identities=23% Similarity=0.355 Sum_probs=198.5
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
..|++.+.||.|+||.||+|.+. ..+..||||++.... ......+.+|+.+++.+ +||||+++++++.. ....
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDN-RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK----GTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEc-cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE----CCEE
Confidence 46788899999999999999985 567899999886543 45567888999999999 59999999998753 4689
Q ss_pred EEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
||||||++| +|.+++.. +.+++.++..++.|++.||.|||..+ ++|+||+|+|||++.++.++|+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06640 78 WIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence 999999965 66666643 24899999999999999999999999 9999999999999999999999999986542
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc---CCCC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN---YRIP 259 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~---~~~~ 259 (690)
... .......++..|+|||+ +.+..++.++|||||||++|+|++|..||............ ....
T Consensus 153 ~~~---------~~~~~~~~~~~y~apE~---~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 220 (277)
T cd06640 153 DTQ---------IKRNTFVGTPFWMAPEV---IQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPT 220 (277)
T ss_pred CCc---------cccccccCcccccCHhH---hccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCC
Confidence 211 01112357889999996 44667899999999999999999999999876654433322 1222
Q ss_pred CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 260 ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 260 ~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
....++..+.+||.+||..+|++||++.+++..
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 233578899999999999999999999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=323.80 Aligned_cols=261 Identities=29% Similarity=0.409 Sum_probs=209.8
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-------HHHHHHHHHHHHHHHhhcCCCCceEEEEEEE
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-------EESLESAMKEISVMKSLKGHPNVVTLYAHTI 94 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-------~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~ 94 (690)
..+.||-++++||+|||+.||+|.|- ...+.||+|+-..+. +.......+|.+|.+.| +||.||++|++|.
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl-~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfs 537 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDL-TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFS 537 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhccc-chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeee
Confidence 35778999999999999999999984 678889999865442 22346678999999999 6999999999998
Q ss_pred eecCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCC---CCCee
Q 005577 95 LDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS---DGLWK 171 (690)
Q Consensus 95 ~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~---dg~vK 171 (690)
++ ...+|-|+|||+|+.++++.+.. ..+++++++.|+.||+.||.||....+||||-||||.||||.. -|.+|
T Consensus 538 lD---tdsFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 538 LD---TDSFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred ec---cccceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence 76 56789999999988777776544 3499999999999999999999999999999999999999954 37899
Q ss_pred eeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhh-cCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-H
Q 005577 172 LCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFR-RELINEKVDIWALGCLLFRICYFKNAFDGESK-L 249 (690)
Q Consensus 172 L~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~-~~~~s~ksDVwSLGviLyELltG~~PF~~~~~-~ 249 (690)
|.||||+++++...... ..|+ .......||.+|++||+|-.-. -..++.++||||+|||+|.+++|+.||..... .
T Consensus 614 ITDFGLSKIMdddSy~~-vdGm-eLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ 691 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNS-VDGM-ELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ 691 (775)
T ss_pred eeecchhhhccCCccCc-ccce-eeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH
Confidence 99999998876543221 1111 2233467999999999853211 23578899999999999999999999986543 3
Q ss_pred HHHh-------ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHH
Q 005577 250 QILN-------GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVW 290 (690)
Q Consensus 250 ~il~-------~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil 290 (690)
+++. ....+|..|.++.+..+||++||+..-++|....++.
T Consensus 692 dILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 692 DILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 3332 2345677788999999999999999999998877764
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=303.16 Aligned_cols=247 Identities=21% Similarity=0.349 Sum_probs=193.9
Q ss_pred EEeeecCceEEEEEEEcc-----cCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 31 NVIAEGGFSCVYSARDAI-----HMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~-----~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
+.||+|+||.||+|.+.. ..++.|+||.+.... ......+.+|+.+|+.+. ||||+++++++. .....|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCL----LNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcC-CCCeeeEeeeec----CCCCeE
Confidence 368999999999998741 123679999876543 344677889999999995 999999999865 345789
Q ss_pred EEEecCC-CcHHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCC-----Ceeee
Q 005577 105 LVMECCD-KSLVNVLENRG-----AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG-----LWKLC 173 (690)
Q Consensus 105 LVmEy~~-gsLl~~L~~~~-----~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg-----~vKL~ 173 (690)
+||||+. ++|.+++.... ...+++.+++.++.||+.||.|||+.+ |+|+||||+|||++.++ .++|+
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~ 153 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIG 153 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEEC
Confidence 9999995 67888776532 234788999999999999999999999 99999999999999887 89999
Q ss_pred ccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH
Q 005577 174 DFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQIL 252 (690)
Q Consensus 174 DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il 252 (690)
|||++........ ........++..|+|||+ +.+..++.++|||||||++|+|++ |..||.........
T Consensus 154 dfg~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~ 223 (269)
T cd05044 154 DFGLARDIYKSDY-------YRKEGEGLLPVRWMAPES---LLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223 (269)
T ss_pred Ccccccccccccc-------cccCcccCCCccccCHHH---HccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH
Confidence 9999865422110 001112345788999996 456678999999999999999998 99999766544433
Q ss_pred h---ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 253 N---GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 253 ~---~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
. ..........++..+.+||.+||..+|.+||++.+++..+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 224 QHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 2 22333445678899999999999999999999999987654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.36 Aligned_cols=242 Identities=26% Similarity=0.414 Sum_probs=193.6
Q ss_pred EEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEe
Q 005577 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVME 108 (690)
Q Consensus 29 v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmE 108 (690)
....||+|+||.||+|.+. ..++.|++|.+........+.+.+|+.+++.+. ||||+++++++.. .+..|+|||
T Consensus 25 ~~~~ig~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~----~~~~~iv~e 98 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HQNVVEMYKSYLV----GEELWVLME 98 (297)
T ss_pred hhhhcCCCCceeEEEEEEc-CCCCEEEEEEEEecccchHHHHHHHHHHHHhCC-CCchhhhhhheee----CCeEEEEEe
Confidence 3457999999999999985 568899999986655555677889999999995 9999999988653 478899999
Q ss_pred cCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhh
Q 005577 109 CCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL 188 (690)
Q Consensus 109 y~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~ 188 (690)
|+.+..+..+.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-- 172 (297)
T cd06659 99 FLQGGALTDIVSQT--RLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-- 172 (297)
T ss_pred cCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--
Confidence 99764444343332 4899999999999999999999999 99999999999999999999999998754322111
Q ss_pred hhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC-----CCCCCCC
Q 005577 189 EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY-----RIPESPK 263 (690)
Q Consensus 189 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~-----~~~~~~~ 263 (690)
......|++.|+|||+ +.+..++.++|||||||++|+|++|+.||........+.... .......
T Consensus 173 -------~~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (297)
T cd06659 173 -------KRKSLVGTPYWMAPEV---ISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHK 242 (297)
T ss_pred -------cccceecCccccCHHH---HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCC
Confidence 1112457899999996 455678999999999999999999999997765544332211 1122346
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 264 YSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 264 ~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
++..+.++|.+||+.+|.+||++.+++.+
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 78999999999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.28 Aligned_cols=245 Identities=26% Similarity=0.402 Sum_probs=200.5
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH-HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE-ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~-e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
.|++.+.||.|+||.||+|.+. ..++.|++|++..... .....+.+|+.++.++. |+||+++++++.. .+.++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~-~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~----~~~~~ 75 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHK-PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE-SPYVVKCYGAFYK----EGEIS 75 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEc-CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEcc----CCeEE
Confidence 6888999999999999999986 5689999999876544 45678899999999996 9999999998653 47899
Q ss_pred EEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 105 LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS-QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 105 LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs-~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
+||||++ ++|.+++... ..+++..++.++.||+.||.|||. .+ ++||||+|+||+++.++.++|+|||++....
T Consensus 76 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 76 IVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred EEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999997 6777777655 349999999999999999999999 99 9999999999999999999999999886543
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHhc---cC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES---KLQILNG---NY 256 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~---~~~il~~---~~ 256 (690)
..... .....++..|+|||+ +....++.++||||||+++|+|++|..||.... ..+.+.. ..
T Consensus 152 ~~~~~---------~~~~~~~~~y~~pE~---~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~ 219 (264)
T cd06623 152 NTLDQ---------CNTFVGTVTYMSPER---IQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP 219 (264)
T ss_pred cCCCc---------ccceeecccccCHhh---hCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCC
Confidence 21111 112357889999996 455678899999999999999999999997663 2222222 22
Q ss_pred CCCCCCC-CCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 257 RIPESPK-YSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 257 ~~~~~~~-~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
....... ++..+.++|..||..+|++||++.+++.+
T Consensus 220 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 220 PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 2222334 78999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=332.74 Aligned_cols=260 Identities=23% Similarity=0.371 Sum_probs=219.1
Q ss_pred CCCCceEeecCceEEEEEEeeecCceEEEEEEEcccCCe--EEEEEEeecCCHH-HHHHHHHHHHHHHhhcCCCCceEEE
Q 005577 14 GLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSK--QYAMKHMICNDEE-SLESAMKEISVMKSLKGHPNVVTLY 90 (690)
Q Consensus 14 ~~~g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k--~vAvK~i~~~~~e-~~e~~~~Ei~iL~~L~~HPNIVkL~ 90 (690)
...+-.--|.+.++.+.++||+|.||+|++|.|....++ .||||++...... ...+|++|+.+|.+|. |||||+||
T Consensus 99 p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~-H~hliRLy 177 (1039)
T KOG0199|consen 99 PSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQ-HPHLIRLY 177 (1039)
T ss_pred cCCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhcc-CcceeEEe
Confidence 355556667888999999999999999999998755554 5799998765433 6789999999999995 99999999
Q ss_pred EEEEeecCCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCC
Q 005577 91 AHTILDLGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGL 169 (690)
Q Consensus 91 ~~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~ 169 (690)
|+.. +....+|||++. |+|++.|.+.....|-...+..|+.||+.||.||.+++ +|||||...||||-....
T Consensus 178 GvVl-----~qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprt 250 (1039)
T KOG0199|consen 178 GVVL-----DQPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRT 250 (1039)
T ss_pred eeec-----cchhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccce
Confidence 9854 256789999995 79999998855667888999999999999999999999 999999999999999999
Q ss_pred eeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 005577 170 WKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESK 248 (690)
Q Consensus 170 vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~ 248 (690)
||||||||.+.+......+ .++ ....-...|+|||. ++...++.++|||+|||+||||++ |..||.|-..
T Consensus 251 VKI~DFGLmRaLg~ned~Y-vm~-----p~rkvPfAWCaPEs---Lrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g 321 (1039)
T KOG0199|consen 251 VKICDFGLMRALGENEDMY-VMA-----PQRKVPFAWCAPES---LRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG 321 (1039)
T ss_pred eeeecccceeccCCCCcce-Eec-----CCCcCcccccCHhH---hccccccccchhhhhhhhHHhhhccCCCCCCCCCH
Confidence 9999999998865443322 111 11223678999994 778889999999999999999997 8899998877
Q ss_pred HHHHh---ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHH
Q 005577 249 LQILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVW 290 (690)
Q Consensus 249 ~~il~---~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil 290 (690)
.+|+. ..-+++.+..|++++++++.+||..+|++||++..|.
T Consensus 322 ~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 322 IQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred HHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 77654 4557788889999999999999999999999999985
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=302.77 Aligned_cols=243 Identities=23% Similarity=0.338 Sum_probs=196.3
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
+|++.+.||.|+||.||+|.+. ..++.|++|.+... .......+.+|+.+++.+. ||||+++++.+.. .+.+|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~----~~~~~ 75 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHR-PTGKIMAVKTIRLEINEAIQKQILRELDILHKCN-SPYIVGFYGAFYN----NGDIS 75 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEc-CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCC-CCchhhhheeeec----CCEEE
Confidence 5788899999999999999985 57889999988655 3455677889999999996 9999999988653 37899
Q ss_pred EEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 105 LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS-QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 105 LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs-~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
+||||+. ++|.+++.... ..+++..+..++.||+.||.|||+ .+ |+|+||||+||+++.++.++|+|||++....
T Consensus 76 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 9999998 56777665542 459999999999999999999999 88 9999999999999999999999999875432
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----hHHHHHhcc--
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGE-----SKLQILNGN-- 255 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~-----~~~~il~~~-- 255 (690)
.... ....++..|+|||+ +.+..++.++|||||||++|+|++|..||... .....+...
T Consensus 153 ~~~~-----------~~~~~~~~y~~PE~---~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 218 (265)
T cd06605 153 NSLA-----------KTFVGTSSYMAPER---IQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN 218 (265)
T ss_pred HHHh-----------hcccCChhccCHHH---HcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc
Confidence 1110 11467889999996 45567899999999999999999999999754 222222211
Q ss_pred -CCCCCCCC-CCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 256 -YRIPESPK-YSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 256 -~~~~~~~~-~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.....+.. ++..+.++|.+||..||++||++.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 219 EPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11111222 7889999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=333.52 Aligned_cols=242 Identities=25% Similarity=0.393 Sum_probs=198.2
Q ss_pred EEEEEeeecCceEEEEEEEcccCCeEEEEEEee----cCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMI----CNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 28 ~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~----~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
+...+||+|+|-+||+|.|. ..+..||--.+. ...++.+++|..|+.+|+.|. |||||++|++++.. .....
T Consensus 43 k~~evLGrGafKtVYka~De-~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~--~n~~i 118 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDE-EEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDT--DNKTI 118 (632)
T ss_pred ehhhhcccccceeeeecccc-ccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecC--CCcee
Confidence 44678999999999999995 567777644332 235677899999999999995 99999999987744 34667
Q ss_pred EEEEecC-CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCC-CCeeeeccCCCCcc
Q 005577 104 LLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD-GLWKLCDFGSTSTN 181 (690)
Q Consensus 104 ~LVmEy~-~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~d-g~vKL~DFGlA~~~ 181 (690)
.+|+|++ .|+|..++.+.+. +..+.+..|++||+.||.|||++.+||||||||.+||+|+.+ |.|||+|+|||...
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 8999999 5788888877765 899999999999999999999999999999999999999765 89999999999764
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHhccCCCCC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDG-ESKLQILNGNYRIPE 260 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~-~~~~~il~~~~~~~~ 260 (690)
...+. ...+|||.|||||++ ...|++.+||||||++++||+|+..||.. .+..+|.........
T Consensus 197 r~s~a-----------ksvIGTPEFMAPEmY----EE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK 261 (632)
T KOG0584|consen 197 RKSHA-----------KSVIGTPEFMAPEMY----EENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK 261 (632)
T ss_pred hcccc-----------ceeccCccccChHHH----hhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC
Confidence 33221 225899999999963 37799999999999999999999999964 556666554433322
Q ss_pred CC----CCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 261 SP----KYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 261 ~~----~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
+. --.+++++||.+||.. ..+|+++.|++.
T Consensus 262 P~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 262 PAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 22 1268999999999999 999999999965
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.11 Aligned_cols=251 Identities=23% Similarity=0.345 Sum_probs=200.1
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec-CCCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDL-GRTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~-~~~~~ 102 (690)
+|++.+.||.|+||.||+|++. ..++.|+||++.... ......+.+|+.+++.+. ||||+++++++.... .....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDK-RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeC-CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccc
Confidence 6899999999999999999985 568899999886543 445678889999999995 999999998865432 22347
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
+|+||||++++|.+.+.... .+++..++.++.+|+.||.|||++| |+||||||.|||++.++.++|+|||++....
T Consensus 79 ~~lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELMETDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchhhhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 89999999988888876544 5999999999999999999999999 9999999999999999999999999986543
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCC---C
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRE-LINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYR---I 258 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~-~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~---~ 258 (690)
..... ........+++.|+|||++ .+. .++.++|||||||++|+|++|+.||.+......+..... .
T Consensus 155 ~~~~~------~~~~~~~~~~~~y~aPE~~---~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 225 (330)
T cd07834 155 PDEDE------KGFLTEYVVTRWYRAPELL---LSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT 225 (330)
T ss_pred ccccc------cccccccccccCcCCceee---ecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCC
Confidence 32110 0111224578899999974 334 789999999999999999999999987654332211000 0
Q ss_pred ------------------------------CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 259 ------------------------------PESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 259 ------------------------------~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
...+.++..+.++|.+||+++|.+||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred CChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 001346889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=309.74 Aligned_cols=255 Identities=26% Similarity=0.385 Sum_probs=198.6
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec--
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDL-- 97 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~-- 97 (690)
+.-.+|++.+.||+|+||.||+|.+. ..++.|++|.+.... ......+.+|+.+++.++ ||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDK-DTGELVALKKVRLDNEKEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEEC-CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchh
Confidence 44568999999999999999999985 567899999986542 223456778999999995 999999998865331
Q ss_pred ----CCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeee
Q 005577 98 ----GRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLC 173 (690)
Q Consensus 98 ----~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~ 173 (690)
.....+||||||+++++...+.... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDHDLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred hhccccCCcEEEEEcccCccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEeC
Confidence 1234789999999999888876543 35899999999999999999999999 9999999999999999999999
Q ss_pred ccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh
Q 005577 174 DFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN 253 (690)
Q Consensus 174 DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~ 253 (690)
|||++........ .......++..|+|||++ .....++.++|||||||++|+|++|+.||........+.
T Consensus 159 dfg~~~~~~~~~~--------~~~~~~~~~~~y~~PE~~--~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~ 228 (302)
T cd07864 159 DFGLARLYNSEES--------RPYTNKVITLWYRPPELL--LGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE 228 (302)
T ss_pred cccccccccCCcc--------cccccceeccCccChHHh--cCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 9998865432111 011122457889999973 233457889999999999999999999998655432211
Q ss_pred ---cc--------CC----C-----------------CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 254 ---GN--------YR----I-----------------PESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 254 ---~~--------~~----~-----------------~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.. +. . .....++..+.++|.+||..||.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 229 LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 00 0 012246899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=303.29 Aligned_cols=248 Identities=28% Similarity=0.463 Sum_probs=196.9
Q ss_pred EEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 27 IHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 27 y~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
|++.+.||.|+||.||+|.+. ..++.|++|++... .......+.+|+.+++.+. ||||+++++++... .....|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~~~ 76 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNK-KTGELVALKKIRMENEKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSK--GKGSIY 76 (287)
T ss_pred CeeeEEeccCCCeEEEEEEEC-CCCeEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCeeeheeeEecC--CCCcEE
Confidence 678999999999999999985 56889999999765 3444567889999999995 99999999886532 236799
Q ss_pred EEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccccc
Q 005577 105 LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKR 184 (690)
Q Consensus 105 LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~ 184 (690)
+||||++++|..++.... ..+++..++.++.||+.||.|||..+ ++|+||||+|||++.++.+||+|||++......
T Consensus 77 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 77 MVFEYMDHDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred EEeccccccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 999999998888886653 35899999999999999999999999 999999999999999999999999988654332
Q ss_pred chhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCC-------
Q 005577 185 FEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYR------- 257 (690)
Q Consensus 185 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~------- 257 (690)
.. .......++..|+|||++ .....++.++|||||||++|+|++|+.||........+.....
T Consensus 154 ~~--------~~~~~~~~~~~y~~PE~~--~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (287)
T cd07840 154 NS--------ADYTNRVITLWYRPPELL--LGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD 223 (287)
T ss_pred Cc--------ccccccccccccCCceee--EccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence 11 011123568889999963 2334578999999999999999999999987654332211100
Q ss_pred --CC-----------------------CCCC-CCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 --IP-----------------------ESPK-YSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 --~~-----------------------~~~~-~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.+ .... ++..+.++|.+||..+|.+||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 224 ENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 0012 3889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.29 Aligned_cols=244 Identities=28% Similarity=0.403 Sum_probs=198.8
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.|...+.||+|+||.||+|++. ..++.|++|++... .......+.+|+.+++.+. ||||+++++++.. ...
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~----~~~ 95 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNS-HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLK----EHT 95 (313)
T ss_pred HhhcceeeccCCCeEEEEEEEC-CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEe----CCE
Confidence 4677788999999999999985 57889999998643 3345567889999999995 9999999998753 467
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
.|+||||+.|++.+.+.... ..+++.+++.++.||+.+|.|||.+| |+||||+|+|||++.++.+||+|||++....
T Consensus 96 ~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~ 172 (313)
T cd06633 96 AWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSS 172 (313)
T ss_pred EEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence 89999999999988886544 35899999999999999999999999 9999999999999999999999999875321
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh----ccCCC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN----GNYRI 258 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~----~~~~~ 258 (690)
......|+..|+|||++.......++.++|||||||++|+|++|..||........+. .....
T Consensus 173 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (313)
T cd06633 173 -------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT 239 (313)
T ss_pred -------------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC
Confidence 1113467899999997533345668899999999999999999999997765433222 12222
Q ss_pred CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.....++..+.+||.+||+.+|.+||++.+++.
T Consensus 240 ~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 240 LQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 223457889999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=335.35 Aligned_cols=249 Identities=20% Similarity=0.247 Sum_probs=183.7
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEE--------------Ee---ecCCHHHHHHHHHHHHHHHhhcCCCCce
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMK--------------HM---ICNDEESLESAMKEISVMKSLKGHPNVV 87 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK--------------~i---~~~~~e~~e~~~~Ei~iL~~L~~HPNIV 87 (690)
.+|++.+.||+|+||.||+|.+....+..+++| .+ ..........+.+|+.+|+.|. |||||
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-HpnIv 226 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-HENIL 226 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-CCCcC
Confidence 589999999999999999987642222222222 11 1122334566789999999995 99999
Q ss_pred EEEEEEEeecCCCceEEEEEecCCCcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEe
Q 005577 88 TLYAHTILDLGRTKEALLVMECCDKSLVNVLENRG---AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLL 164 (690)
Q Consensus 88 kL~~~~~~~~~~~~~~~LVmEy~~gsLl~~L~~~~---~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILL 164 (690)
++++++.. ....|+||+++.++|+.++.... .......+++.|+.||+.||.|||++| ||||||||+||||
T Consensus 227 ~l~~~~~~----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl 300 (501)
T PHA03210 227 KIEEILRS----EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFL 300 (501)
T ss_pred cEeEEEEE----CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE
Confidence 99998653 46789999999999988876532 122446778899999999999999999 9999999999999
Q ss_pred CCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCC-C
Q 005577 165 GSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNA-F 243 (690)
Q Consensus 165 d~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~P-F 243 (690)
+.++.+||+|||+++.+..... ......+||+.|+|||+ +.+..++.++||||||||||||++|..+ |
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~--------~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE--------AFDYGWVGTVATNSPEI---LAGDGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc--------cccccccCCcCCCCchh---hcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 9999999999999976432111 11123578999999996 4566799999999999999999998754 4
Q ss_pred CCc--hH-HH---HHhccC----CCC--------------------------CCCCCCHHHHHHHHHHhhhCCCCCCCHH
Q 005577 244 DGE--SK-LQ---ILNGNY----RIP--------------------------ESPKYSSSVTDLIRDMLQASPDDRPDIT 287 (690)
Q Consensus 244 ~~~--~~-~~---il~~~~----~~~--------------------------~~~~~s~~l~~LI~~~L~~dP~~RPt~~ 287 (690)
... .. .+ ++.... .++ ....++..+.++|.+||+.||.+||++.
T Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~ 449 (501)
T PHA03210 370 GDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAA 449 (501)
T ss_pred cCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHH
Confidence 321 11 11 111000 000 0123567788899999999999999999
Q ss_pred HHHH
Q 005577 288 QVWF 291 (690)
Q Consensus 288 eil~ 291 (690)
|++.
T Consensus 450 elL~ 453 (501)
T PHA03210 450 ELLA 453 (501)
T ss_pred HHhh
Confidence 9965
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.54 Aligned_cols=244 Identities=24% Similarity=0.372 Sum_probs=194.9
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
.|++.+.||+|+||.||+|.+. ..++.||+|.+.... ....+.+.+|+.+++.+. ||||+++++++. .....|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~~~~~ 78 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDN-RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYITRYYGSYL----KGTKLW 78 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEc-CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCC-CCccHhhhcccc----cCCceE
Confidence 4566778999999999999885 567889999886443 445677889999999995 999999999865 346789
Q ss_pred EEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 105 LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 105 LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
+||||+++ +|.+.+.. ..+++..++.++.||+.||.|||.++ |+|+||+|+||+++.++.++|+|||++..+..
T Consensus 79 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 79 IIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 99999975 56555532 34899999999999999999999999 99999999999999999999999999865432
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc---cCCCCC
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG---NYRIPE 260 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~---~~~~~~ 260 (690)
... ......|+..|+|||+ +.+..++.++|||||||++|+|++|+.||........... ......
T Consensus 154 ~~~---------~~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 221 (277)
T cd06642 154 TQI---------KRNTFVGTPFWMAPEV---IKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTL 221 (277)
T ss_pred cch---------hhhcccCcccccCHHH---hCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCC
Confidence 110 1112357889999996 4556788999999999999999999999976544333221 111122
Q ss_pred CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 261 SPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 261 ~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
...++..+.++|.+||..+|++||++.+++.+
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 33578899999999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=297.06 Aligned_cols=246 Identities=31% Similarity=0.581 Sum_probs=198.0
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
+|++.+.||.|+||.||+|.+. ..+..||+|.+.... ....+.+.+|+.+++.++ |+||+++++.+. .....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~----~~~~~ 74 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK-HPNIVTFFASFQ----ENGRL 74 (257)
T ss_pred CceEEEEecCCCcceEEEEEEc-CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCC-CCChhhhhheec----cCCeE
Confidence 5889999999999999999985 567889999986532 234567789999999995 999999998764 34688
Q ss_pred EEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCC-CeeeeccCCCCcc
Q 005577 104 LLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG-LWKLCDFGSTSTN 181 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg-~vKL~DFGlA~~~ 181 (690)
|+||||+. ++|.+.+.......+++..++.++.||+.||.|||..+ |+|+||||+|||++.++ .+||+|||++...
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 99999995 57777776654445899999999999999999999999 99999999999998886 4699999988654
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc---CCC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN---YRI 258 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~---~~~ 258 (690)
..... ......|++.|+|||+ ..+..++.++|||||||++|+|++|..||......+.+... ...
T Consensus 153 ~~~~~---------~~~~~~~~~~~~ape~---~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 220 (257)
T cd08225 153 NDSME---------LAYTCVGTPYYLSPEI---CQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA 220 (257)
T ss_pred cCCcc---------cccccCCCccccCHHH---HcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC
Confidence 32111 1112357899999996 44556889999999999999999999999876544333221 122
Q ss_pred CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
+..+.++..+.++|.+||..+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 334567899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=302.60 Aligned_cols=249 Identities=28% Similarity=0.419 Sum_probs=195.4
Q ss_pred EEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhc--CCCCceEEEEEEEeecC-CCc
Q 005577 27 IHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLK--GHPNVVTLYAHTILDLG-RTK 101 (690)
Q Consensus 27 y~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~--~HPNIVkL~~~~~~~~~-~~~ 101 (690)
|++.+.||+|+||.||+|.+. ..++.||+|.+... .......+.+|+.+++.+. +||||+++++++..... ...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDL-NTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEEC-CCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 678999999999999999985 46889999998643 2222345667888887774 59999999998764421 223
Q ss_pred eEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 102 EALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 102 ~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
.+++||||++++|.+++.......+++..++.++.||+.||.|||..+ |+|+||+|+|||++.++.+||+|||++...
T Consensus 80 ~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 80 KLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCcceec
Confidence 489999999999988887655446999999999999999999999999 999999999999999999999999988654
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCC----
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYR---- 257 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~---- 257 (690)
.... ......+++.|+|||+ +.+..++.++|||||||++|+|++|+.||.+....+.+...+.
T Consensus 158 ~~~~----------~~~~~~~~~~~~~PE~---~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd07838 158 SFEM----------ALTSVVVTLWYRAPEV---LLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGL 224 (287)
T ss_pred cCCc----------ccccccccccccChHH---hccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCC
Confidence 2211 1112346889999996 4456788999999999999999999999987665432211100
Q ss_pred ----------------CC---------CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 ----------------IP---------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 ----------------~~---------~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.+ ..+.++..+.++|.+||+.||.+||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 225 PSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 01235678889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=300.27 Aligned_cols=248 Identities=25% Similarity=0.423 Sum_probs=194.0
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC----------HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEe
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND----------EESLESAMKEISVMKSLKGHPNVVTLYAHTIL 95 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~----------~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~ 95 (690)
+|.+.+.||.|+||.||+|.+. ..++.||+|.+.... ....+.+.+|+.+++.+. ||||+++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~- 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNV-TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFET- 78 (272)
T ss_pred ceeecceecccCceEEEEEeec-CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEec-
Confidence 6889999999999999999885 568899999875321 112456778999999995 999999998864
Q ss_pred ecCCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeec
Q 005577 96 DLGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCD 174 (690)
Q Consensus 96 ~~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~D 174 (690)
..+..++||||+. ++|.+.+... +.+++..+..++.||+.||.|||+++ ++||||+|+||+++.++.++|+|
T Consensus 79 ---~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d 151 (272)
T cd06629 79 ---TEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISD 151 (272)
T ss_pred ---cCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEee
Confidence 3467899999995 5677777655 35899999999999999999999999 99999999999999999999999
Q ss_pred cCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh-
Q 005577 175 FGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN- 253 (690)
Q Consensus 175 FGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~- 253 (690)
||+++........ .......|+..|+|||++.. ....++.++|||||||++|+|++|..||........+.
T Consensus 152 ~~~~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 223 (272)
T cd06629 152 FGISKKSDDIYDN-------DQNMSMQGSVFWMAPEVIHS-YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223 (272)
T ss_pred ccccccccccccc-------cccccccCCccccCHHHhcc-ccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHH
Confidence 9998654321110 11123457899999997421 11247889999999999999999999997655433221
Q ss_pred ---ccCCCC----CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 254 ---GNYRIP----ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 254 ---~~~~~~----~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
...... ..+.++..+.++|.+||..+|.+||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 224 LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred hhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111111 12356899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=300.17 Aligned_cols=250 Identities=27% Similarity=0.499 Sum_probs=198.1
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeec----------CCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEe
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC----------NDEESLESAMKEISVMKSLKGHPNVVTLYAHTIL 95 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~----------~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~ 95 (690)
.|++.+.||+|+||.||+|.+....++.+|+|.+.. .......++.+|+.++.+..+||||+++++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 377889999999999999998643678999998753 233455678889998887446999999999865
Q ss_pred ecCCCceEEEEEecCCC-cHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCcccCCCCCCcEEeCCCCCee
Q 005577 96 DLGRTKEALLVMECCDK-SLVNVLEN--RGAGYFEEKQVLAIFRDVCNAVFAMHS-QSPPIAHRDLKAENLLLGSDGLWK 171 (690)
Q Consensus 96 ~~~~~~~~~LVmEy~~g-sLl~~L~~--~~~~~lse~~~~~i~~qIa~aL~yLHs-~g~~IVHRDLKP~NILLd~dg~vK 171 (690)
.....|+||||+.| +|.+.+.. .....+++..++.++.||+.+|.|||. .+ |+|+||+|+|||++.++.++
T Consensus 80 ---~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~ 154 (269)
T cd08528 80 ---ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVT 154 (269)
T ss_pred ---cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEE
Confidence 34789999999964 67666643 123458999999999999999999996 67 99999999999999999999
Q ss_pred eeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 005577 172 LCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI 251 (690)
Q Consensus 172 L~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~i 251 (690)
|+|||++....... ......|+..|++||+ +.+..++.++|||||||++|+|++|+.||........
T Consensus 155 l~dfg~~~~~~~~~----------~~~~~~~~~~~~~Pe~---~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~ 221 (269)
T cd08528 155 ITDFGLAKQKQPES----------KLTSVVGTILYSCPEI---VKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL 221 (269)
T ss_pred Eecccceeeccccc----------ccccccCcccCcChhh---hcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH
Confidence 99999986533211 1123467899999996 4456689999999999999999999999977655433
Q ss_pred H----hccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 252 L----NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 252 l----~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
. ...+.......++..+.++|.+||+.||++||++.++..++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 222 ATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 2 222222222367899999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=300.45 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=195.2
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
++|++.+.||.|+||.||++.+. ..++.||+|.+.... ......+.+|+++++.+. ||||+++++++... ....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLK-NTGMIFALKTITTDPNPDLQKQILRELEINKSCK-SPYIVKYYGAFLDE--SSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEEC-CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEcc--CCCeE
Confidence 36889999999999999999985 578899999886543 345677899999999995 99999999987533 44578
Q ss_pred EEEEecCC-CcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 104 LLVMECCD-KSLVNVLENR--GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~--~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
|+||||++ ++|.+++... ....+++..+..++.||+.||.|||..+ ++|+||+|.||+++.++.++|+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeecccccc
Confidence 99999996 4666655432 2345899999999999999999999999 99999999999999999999999998864
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHHhcc
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES-----KLQILNGN 255 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~-----~~~il~~~ 255 (690)
..... .....++..|+|||+ +.+..++.++|||||||++|+|++|..||.... ..+.....
T Consensus 155 ~~~~~-----------~~~~~~~~~y~~pE~---~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 220 (287)
T cd06621 155 LVNSL-----------AGTFTGTSFYMAPER---IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI 220 (287)
T ss_pred ccccc-----------cccccCCccccCHHH---hcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH
Confidence 32111 112356889999996 456678999999999999999999999997652 12222111
Q ss_pred CC-----CCCC----CCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 256 YR-----IPES----PKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 256 ~~-----~~~~----~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.. ++.. ..+++.+.+||.+||..+|.+||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 221 VNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11 1111 134678999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=309.61 Aligned_cols=247 Identities=28% Similarity=0.390 Sum_probs=200.2
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeec---CCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC---NDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~---~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
..+|.+.+.||+|+||.||+|++. ..++.|++|.+.. .......++.+|+.+++.+. |+||+++++++.. .
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----~ 87 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLR----E 87 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEc-CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEc----C
Confidence 456888899999999999999985 5678899998853 23445667889999999995 9999999998753 4
Q ss_pred ceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 101 KEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 101 ~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
...|+||||+.|++.+.+.... ..+++..++.++.||+.||.|||..+ ++||||||+|||++.++.++|+|||++..
T Consensus 88 ~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 88 HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (308)
T ss_pred CeeEEEEEccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCccccee
Confidence 6789999999999888776543 45899999999999999999999999 99999999999999999999999998854
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH----HhccC
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI----LNGNY 256 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~i----l~~~~ 256 (690)
... .....+++.|+|||++.......++.++|||||||++|+|++|..||........ .....
T Consensus 165 ~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06634 165 MAP-------------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 231 (308)
T ss_pred ecC-------------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC
Confidence 321 1123578899999974323345688899999999999999999999976544322 22222
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 257 RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 257 ~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
.......++..+.+||.+||..+|++||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 222234688999999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=297.18 Aligned_cols=249 Identities=21% Similarity=0.321 Sum_probs=198.2
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-----CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-----DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-----~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
.+|++.+.||+|+||.||+|.+. .+++.|++|.+... .......+.+|+.+++.+. |+||+++++++.. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~--~~ 77 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDA-DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRD--PE 77 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEc-CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEc--CC
Confidence 47899999999999999999985 67889999987432 2345668889999999995 9999999987642 23
Q ss_pred CceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 100 TKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
...+++||||+. ++|.+.+.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 78 ~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 78 EKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECccccc
Confidence 456889999996 46777776544 3899999999999999999999999 999999999999999999999999998
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc---
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN--- 255 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~--- 255 (690)
+........ ........|+..|+|||+ +.+..++.++|||||||++|+|++|+.||........+...
T Consensus 154 ~~~~~~~~~------~~~~~~~~~~~~y~aPE~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 224 (264)
T cd06653 154 KRIQTICMS------GTGIKSVTGTPYWMSPEV---ISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQ 224 (264)
T ss_pred ccccccccc------CccccccCCcccccCHhh---hcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcC
Confidence 754321100 001122457899999996 44566889999999999999999999999876544433222
Q ss_pred -CCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 256 -YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 256 -~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.....+..+++.+.++|.+||. +|..||+..+++.
T Consensus 225 ~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 225 PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 2223355788999999999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=323.70 Aligned_cols=256 Identities=19% Similarity=0.272 Sum_probs=212.2
Q ss_pred eecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH-HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 21 DVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE-ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 21 ei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~-e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
++...++.++++||+|-||+|.++.. .....||+|++..... .....|.+|+++|.+|+ |||||+|+++|+.+
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCev--eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~D--- 607 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEV--EGPLKVAVKILRPDATKNARNDFLKEIKILSRLK-HPNIVELLGVCVQD--- 607 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEe--cCceEEEEeecCcccchhHHHHHHHHHHHHhccC-CCCeeEEEeeeecC---
Confidence 45567889999999999999999986 4568999999976543 34588999999999996 99999999999865
Q ss_pred CceEEEEEecC-CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 100 TKEALLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~-~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
+.+++||||| .|+|.++|..+....+.....++|+.||+.||+||.+.+ +|||||.+.|||++.++++||+|||++
T Consensus 608 -ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 608 -DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred -CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccc
Confidence 7789999999 478889998876444566778899999999999999999 999999999999999999999999999
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHH--hCCCCCCCchHHHHHhccC
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC--YFKNAFDGESKLQILNGNY 256 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELl--tG~~PF~~~~~~~il~~~~ 256 (690)
+.+..... .....+.+-.+.|||+|. +..+.++.++|||+||+++||++ +...||......++++..-
T Consensus 685 R~lysg~y-------y~vqgr~vlpiRwmawEs---illgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~ 754 (807)
T KOG1094|consen 685 RNLYSGDY-------YRVQGRAVLPIRWMAWES---ILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG 754 (807)
T ss_pred cccccCCc-------eeeecceeeeeeehhHHH---HHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh
Confidence 86543211 111223455889999995 45577999999999999999986 4778999888777764321
Q ss_pred ----------CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhh
Q 005577 257 ----------RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 257 ----------~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~ 295 (690)
-+..++-|+..+.++|.+||..|-.+||++.++...+.+
T Consensus 755 ~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 755 EFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred hhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 223456899999999999999999999999999776654
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=306.74 Aligned_cols=246 Identities=28% Similarity=0.409 Sum_probs=198.9
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
..+|.+.+.||+|+||.||++.+. ..++.|++|.+........+.+.+|+.+++.+. ||||+++++++.. .+..
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~----~~~~ 91 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDV-ATGQEVAIKQMNLQQQPKKELIINEILVMRENK-HPNIVNYLDSYLV----GDEL 91 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEc-CCCCEEEEEEeccccchHHHHHHHHHHHHhhcC-CCCeeehhheeee----CCcE
Confidence 368999999999999999999875 467889999986655555678889999999995 9999999988653 4678
Q ss_pred EEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
|+||||+. ++|.+++... .+++.++..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++....
T Consensus 92 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~ 166 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (293)
T ss_pred EEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence 99999996 5666666542 3889999999999999999999999 9999999999999999999999999875432
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc-----CC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN-----YR 257 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~-----~~ 257 (690)
.... ......|++.|++||+ +.+..++.++|||||||++|+|++|+.||........+... ..
T Consensus 167 ~~~~---------~~~~~~~~~~y~~PE~---~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd06647 167 PEQS---------KRSTMVGTPYWMAPEV---VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE 234 (293)
T ss_pred cccc---------ccccccCChhhcCchh---hccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCC
Confidence 2110 1112357889999996 44566889999999999999999999999876554332211 11
Q ss_pred CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
......++..+.++|.+||..+|++||++.+++.+
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22233567889999999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.17 Aligned_cols=240 Identities=25% Similarity=0.375 Sum_probs=198.3
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecC
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLG 98 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~ 98 (690)
|--++|..+++||+|.||.|-+++.+ .+++.||||++.+. ..+.+...+.|-++|...+ ||.+..|.-. ++
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEK-at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYs----FQ 238 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREK-ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYS----FQ 238 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeec-ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhh----hc
Confidence 34457778899999999999999986 68999999998653 3455677888999999996 9999888433 44
Q ss_pred CCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCC
Q 005577 99 RTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS 177 (690)
Q Consensus 99 ~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGl 177 (690)
....+|+||||.+ |.|+-.|.+.. .|+++.++.+...|+.||.|||+++ ||+||||.+|+|||.||++||.|||+
T Consensus 239 t~drlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGL 314 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGL 314 (516)
T ss_pred cCceEEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeeccc
Confidence 5688999999995 56666665433 4999999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH----Hh
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI----LN 253 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~i----l~ 253 (690)
++.-.. ......+.||||.|+|||| +....|+.++|+|.+||++|||++|+.||.+.+...+ +.
T Consensus 315 CKE~I~---------~g~t~kTFCGTPEYLAPEV---leDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ 382 (516)
T KOG0690|consen 315 CKEEIK---------YGDTTKTFCGTPEYLAPEV---LEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM 382 (516)
T ss_pred chhccc---------ccceeccccCChhhcCchh---hccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh
Confidence 864222 1233456899999999998 5577899999999999999999999999987654333 33
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCC
Q 005577 254 GNYRIPESPKYSSSVTDLIRDMLQASPDDRPD 285 (690)
Q Consensus 254 ~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt 285 (690)
..++ .+..++++.+.|+..+|.+||.+|..
T Consensus 383 ed~k--FPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 383 EDLK--FPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred hhcc--CCccCCHHHHHHHHHHhhcChHhhcC
Confidence 3344 34578999999999999999999963
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=290.50 Aligned_cols=244 Identities=30% Similarity=0.477 Sum_probs=198.5
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALL 105 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~L 105 (690)
+|++.+.||+|+||.||++.+. ..++.+++|++..........+.+|+.+++.+. |+||+++++++.. ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~----~~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHK-RTGKEVAIKVIKLESKEKKEKIINEIQILKKCK-HPNIVKYYGSYLK----KDELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEEC-CCCcEEEEEEecccchhHHHHHHHHHHHHHhCC-CCCEeEEEEEEec----CCeEEE
Confidence 4888999999999999999985 468899999987766556788899999999996 9999999998653 367899
Q ss_pred EEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccccc
Q 005577 106 VMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKR 184 (690)
Q Consensus 106 VmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~ 184 (690)
||||++ ++|.+++.... ..+++..+..++.+++.+|.|||.++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 75 ~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 75 VMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred EEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 999998 56666665542 45899999999999999999999999 999999999999999999999999988654321
Q ss_pred chhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---hc--cCCCC
Q 005577 185 FEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL---NG--NYRIP 259 (690)
Q Consensus 185 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il---~~--~~~~~ 259 (690)
.. .....++..|++||+ +.+..++.++|||||||++|+|++|..||...+....+ .. ....+
T Consensus 152 ~~----------~~~~~~~~~~~~PE~---~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 218 (253)
T cd05122 152 KA----------RNTMVGTPYWMAPEV---INGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR 218 (253)
T ss_pred cc----------ccceecCCcccCHHH---HcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcC
Confidence 10 123467899999996 44556889999999999999999999999876332221 11 11222
Q ss_pred CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 260 ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 260 ~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
....++..+.++|.+||..||.+||++.+++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22334899999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=297.48 Aligned_cols=236 Identities=19% Similarity=0.301 Sum_probs=181.1
Q ss_pred EEeeecCceEEEEEEEcccCC----------eEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 31 NVIAEGGFSCVYSARDAIHMS----------KQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~----------k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
+.||+|+||.||+|.+.. .+ ..|++|.+...... ...+.+|+.+|+.+. ||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~-~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRV-QSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLS-HKHLVKLYGVCVR----- 72 (259)
T ss_pred CcccccccceEEEEEEec-cCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCC-CcchhheeeEEec-----
Confidence 368999999999999852 23 35777776544333 678889999999995 9999999998753
Q ss_pred ceEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCC-------Ceee
Q 005577 101 KEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG-------LWKL 172 (690)
Q Consensus 101 ~~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg-------~vKL 172 (690)
...++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEe
Confidence 456899999965 5666665443 25899999999999999999999999 99999999999999888 7999
Q ss_pred eccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHH
Q 005577 173 CDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI 251 (690)
Q Consensus 173 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~i 251 (690)
+|||++..... .....++..|+|||++.. ....++.++|||||||++|+|++ |..||........
T Consensus 150 ~Dfg~a~~~~~-------------~~~~~~~~~y~aPE~~~~-~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~ 215 (259)
T cd05037 150 SDPGIPITVLS-------------REERVERIPWIAPECIRN-GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215 (259)
T ss_pred CCCCccccccc-------------ccccccCCCccChhhhcC-CCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH
Confidence 99999865322 111346778999997321 11368899999999999999999 5778866532221
Q ss_pred ---HhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 252 ---LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 252 ---l~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
.......+ ......+.++|.+||..+|.+||++.+++..+
T Consensus 216 ~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 216 ERFYQDQHRLP--MPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HHHHhcCCCCC--CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11111111 12248899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=309.20 Aligned_cols=249 Identities=26% Similarity=0.431 Sum_probs=206.9
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEecC
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECC 110 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy~ 110 (690)
+.||+|+|+.|--+.. +.+++.||||++.+.......++++|++++..+.+|+||++|+++|. +...+|||||-|
T Consensus 84 e~LGeGAyasVqtcv~-i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE----dd~~FYLVfEKm 158 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVS-IQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE----DDTRFYLVFEKM 158 (463)
T ss_pred HHhcCccceeeeeeee-eccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc----ccceEEEEEecc
Confidence 6799999999998877 57899999999988877778999999999999999999999998854 568899999999
Q ss_pred -CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCC---eeeeccCCCCcccccch
Q 005577 111 -DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGL---WKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 111 -~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~---vKL~DFGlA~~~~~~~~ 186 (690)
+|.|+..|.++. +|++.++..++++|+.||.|||.+| |.||||||+|||...-.. ||||||.+...+.....
T Consensus 159 ~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 159 RGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred cCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 568899888775 4999999999999999999999999 999999999999966553 89999998765332211
Q ss_pred hhhhccccccccccCCCCcccCccchhhhhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCchH----------------
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRR--ELINEKVDIWALGCLLFRICYFKNAFDGESK---------------- 248 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~--~~~s~ksDVwSLGviLyELltG~~PF~~~~~---------------- 248 (690)
- . ........+.+|+..|||||+++.+.+ ..|+.++|+||||||||-||.|.+||.|...
T Consensus 235 ~-s-pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~ 312 (463)
T KOG0607|consen 235 C-S-PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN 312 (463)
T ss_pred C-C-CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence 1 1 223344566789999999999876654 4689999999999999999999999976321
Q ss_pred ---HHHHhccCCCCC--CCCCCHHHHHHHHHHhhhCCCCCCCHHHHH
Q 005577 249 ---LQILNGNYRIPE--SPKYSSSVTDLIRDMLQASPDDRPDITQVW 290 (690)
Q Consensus 249 ---~~il~~~~~~~~--~~~~s~~l~~LI~~~L~~dP~~RPt~~eil 290 (690)
..|-.+.|.+|. ...++.+..+||..+|.+|+.+|.++.+++
T Consensus 313 ~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vl 359 (463)
T KOG0607|consen 313 KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVL 359 (463)
T ss_pred HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhcc
Confidence 123455666654 457899999999999999999998887764
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.79 Aligned_cols=247 Identities=24% Similarity=0.350 Sum_probs=195.1
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecC--C
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLG--R 99 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~--~ 99 (690)
..+|++.+.||+|+||.||+|.+. ..++.||||++... .......+.+|+.+|+.+. ||||+++++++..+.. .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDR-RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEEC-CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCccccc
Confidence 567999999999999999999985 57889999988542 2334567889999999995 9999999988754321 1
Q ss_pred CceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 100 TKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 100 ~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
...+|+||||++++|..++.. ..+++..++.++.||+.||.|||..| |+||||||+|||++.++.++|+|||++.
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 92 FHDFYLVMPFMGTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred cceEEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 235689999998887776653 24899999999999999999999999 9999999999999999999999999986
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc----
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN---- 255 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~---- 255 (690)
..... .....+++.|+|||++ .....++.++|||||||++|+|++|+.||.+......+...
T Consensus 167 ~~~~~------------~~~~~~~~~y~aPE~~--~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07880 167 QTDSE------------MTGYVVTRWYRAPEVI--LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT 232 (343)
T ss_pred ccccC------------ccccccCCcccCHHHH--hCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 53221 1123568899999973 22245788999999999999999999999865432211100
Q ss_pred C-----------------------CC------CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 256 Y-----------------------RI------PESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 256 ~-----------------------~~------~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
. .. ...+.++..+.++|.+||+.||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 00 011357888999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.07 Aligned_cols=238 Identities=24% Similarity=0.353 Sum_probs=181.4
Q ss_pred EeeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhh--cCCCCceEEEEEEEeecCCCceEEEE
Q 005577 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSL--KGHPNVVTLYAHTILDLGRTKEALLV 106 (690)
Q Consensus 32 ~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L--~~HPNIVkL~~~~~~~~~~~~~~~LV 106 (690)
+||+|+||.||++.+. ..++.||+|.+.... ......+.+|..++..+ .+||||+.+++++. ..+..|+|
T Consensus 1 ~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~----~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH----TPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEEC-CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe----cCCeEEEE
Confidence 4899999999999985 568899999885431 12223344454444433 25999999988765 34678999
Q ss_pred EecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccc
Q 005577 107 MECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185 (690)
Q Consensus 107 mEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~ 185 (690)
|||+.| +|...+...+ .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 76 ~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~- 150 (279)
T cd05633 76 LDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 150 (279)
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceecccc-
Confidence 999964 5666665543 4999999999999999999999999 999999999999999999999999988643211
Q ss_pred hhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch---HHHHH--hccCCCCC
Q 005577 186 EKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES---KLQIL--NGNYRIPE 260 (690)
Q Consensus 186 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~---~~~il--~~~~~~~~ 260 (690)
......|++.|+|||++ ..+..++.++|||||||++|+|++|..||.... ...+. ........
T Consensus 151 ----------~~~~~~~~~~y~aPE~~--~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 218 (279)
T cd05633 151 ----------KPHASVGTHGYMAPEVL--QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVEL 218 (279)
T ss_pred ----------CccCcCCCcCccCHHHh--cCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCC
Confidence 01123689999999973 234568899999999999999999999996532 11211 11223333
Q ss_pred CCCCCHHHHHHHHHHhhhCCCCCC-----CHHHHHH
Q 005577 261 SPKYSSSVTDLIRDMLQASPDDRP-----DITQVWF 291 (690)
Q Consensus 261 ~~~~s~~l~~LI~~~L~~dP~~RP-----t~~eil~ 291 (690)
+..++..+.++|.+||..||.+|| ++.+++.
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 457899999999999999999999 5877754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=313.92 Aligned_cols=246 Identities=26% Similarity=0.376 Sum_probs=194.2
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec--CC
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL--GR 99 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~--~~ 99 (690)
..+|.+.+.||+|+||.||+|.+. ..++.||||++... .......+.+|+.+++.+. ||||+++++++.... ..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDK-RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeC-CCCcEEEEEEecCccccccchhHHHHHHHHHHhcC-CCCccchhheecccccCCC
Confidence 458999999999999999999985 56889999988643 2333456789999999995 999999998875331 12
Q ss_pred CceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 100 TKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 100 ~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
...+|+||||+...+...+. ..+++..+..++.||+.||.|||.++ |+||||||+|||++.++.+||+|||+++
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 92 FQDFYLVMPYMQTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred CceEEEEecccccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 34579999999887665541 24899999999999999999999999 9999999999999999999999999986
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC---
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--- 256 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--- 256 (690)
.... ......+++.|+|||++ .....++.++|||||||++|+|++|+.||.+......+....
T Consensus 166 ~~~~------------~~~~~~~~~~y~aPE~~--~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 231 (342)
T cd07879 166 HADA------------EMTGYVVTRWYRAPEVI--LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 231 (342)
T ss_pred CCCC------------CCCCceeeecccChhhh--cCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 5321 11123568899999973 223458899999999999999999999998765433221100
Q ss_pred ------------------------CCC------CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 ------------------------RIP------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 ------------------------~~~------~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
..+ ..+.++..+.+||.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 232 GVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred CCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 01356788999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.68 Aligned_cols=243 Identities=27% Similarity=0.411 Sum_probs=196.2
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALL 105 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~L 105 (690)
.|...+.||+|+||.||++.+. ..++.|++|++........+.+.+|+.+++.+. ||||+++++++. ..+..|+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~----~~~~~~~ 93 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDK-STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYL----VGDELWV 93 (285)
T ss_pred hhhcceEeccCCCeEEEEEEEC-CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcC-CCChheEEEEEE----cCCeEEE
Confidence 4555679999999999999985 567889999987666566677889999999995 999999999865 3467899
Q ss_pred EEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccccc
Q 005577 106 VMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKR 184 (690)
Q Consensus 106 VmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~ 184 (690)
||||+. ++|.+.+.. ..+++..++.++.||+.||.|||+++ |+||||+|+|||++.++.++|+|||++......
T Consensus 94 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 94 VMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred EEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 999995 566666654 24899999999999999999999999 999999999999999999999999987543211
Q ss_pred chhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC-----CCC
Q 005577 185 FEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY-----RIP 259 (690)
Q Consensus 185 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~-----~~~ 259 (690)
. .......|++.|+|||+ ..+..++.++|||||||++|+|++|+.||........+.... ...
T Consensus 169 ~---------~~~~~~~~~~~y~aPE~---~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd06648 169 V---------PRRKSLVGTPYWMAPEV---ISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK 236 (285)
T ss_pred C---------cccccccCCccccCHHH---hcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCc
Confidence 1 01112457899999996 455678999999999999999999999998766544332211 112
Q ss_pred CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 260 ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 260 ~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
....++..+.++|.+||..+|++||++.+++.
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 22347899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=312.96 Aligned_cols=255 Identities=25% Similarity=0.360 Sum_probs=194.6
Q ss_pred ceEE-EEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHH--------------HHHHHHHHHHHHhhcCCCCceEE
Q 005577 25 LKIH-VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEES--------------LESAMKEISVMKSLKGHPNVVTL 89 (690)
Q Consensus 25 ~ry~-v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~--------------~e~~~~Ei~iL~~L~~HPNIVkL 89 (690)
.||. +.+.||.|+||+||+|.+. ..++.||||++....... ...+.+|+.+++.+. ||||+++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~ 85 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDT-LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIMGL 85 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEEC-CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccceeee
Confidence 4554 5688999999999999985 578899999885432111 124678999999995 9999999
Q ss_pred EEEEEeecCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCC
Q 005577 90 YAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGL 169 (690)
Q Consensus 90 ~~~~~~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~ 169 (690)
++++. .....|+||||+.|+|.+.+.... .+++..+..++.||+.||.|||..+ |+||||+|+|||++.++.
T Consensus 86 ~~~~~----~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 86 VDVYV----EGDFINLVMDIMASDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGI 157 (335)
T ss_pred eEEEe----cCCcEEEEEeccccCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCC
Confidence 99865 346889999999999998887644 3899999999999999999999999 999999999999999999
Q ss_pred eeeeccCCCCcccccchhhh----hc-cccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005577 170 WKLCDFGSTSTNHKRFEKLE----EM-GIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFD 244 (690)
Q Consensus 170 vKL~DFGlA~~~~~~~~~~~----~~-~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~ 244 (690)
++|+|||++........... .. ..........+++.|+|||++ .....++.++|||||||++|+|++|+.||.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELL--MGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhc--ccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999998865431110000 00 000111123468899999973 233457899999999999999999999998
Q ss_pred CchHHHHHhccC------C---C----------------C-----CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 245 GESKLQILNGNY------R---I----------------P-----ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 245 ~~~~~~il~~~~------~---~----------------~-----~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
+....+.+.... . + + ....++..+.++|.+||..+|++||++.+++.
T Consensus 236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 236 GENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 766543221100 0 0 0 01245788999999999999999999999964
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=307.47 Aligned_cols=245 Identities=29% Similarity=0.464 Sum_probs=204.9
Q ss_pred eEEEE-EEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 26 KIHVR-NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 26 ry~v~-~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
+|.+. .+||-|--|.|..+.++ .+++.+|+|++... ....+|+++.-....|||||.+++++...+....+++
T Consensus 62 dY~is~qvLG~GinGkV~~C~~k-~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 62 DYSISWQVLGAGINGKVVQCVHK-RTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred hheehhhhhccccCCceEEEEec-cchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 45543 78999999999999886 67889999987432 4456777776666689999999999887777778899
Q ss_pred EEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCC---CCeeeeccCCCCc
Q 005577 105 LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD---GLWKLCDFGSTST 180 (690)
Q Consensus 105 LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~d---g~vKL~DFGlA~~ 180 (690)
||||+|+ |.|+..+..++...|+|.++..|++||+.|+.|||+.+ |.||||||+|+|+... -.+||+|||+|+.
T Consensus 136 iVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccccc
Confidence 9999995 68999999999889999999999999999999999999 9999999999999654 4699999999976
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHH
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES--------KLQIL 252 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~--------~~~il 252 (690)
... .....+.+-||.|.|||+ +....|+..+|+|||||++|-||+|.+||.... ...+.
T Consensus 214 t~~----------~~~L~TPc~TPyYvaPev---lg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~ 280 (400)
T KOG0604|consen 214 TQE----------PGDLMTPCFTPYYVAPEV---LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIR 280 (400)
T ss_pred cCC----------CccccCCcccccccCHHH---hCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhh
Confidence 332 122334577999999997 566779999999999999999999999996543 23455
Q ss_pred hccCCCCC--CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 253 NGNYRIPE--SPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 253 ~~~~~~~~--~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.+.|.+|. ...++++.+++|+.+|..+|.+|.|+.+++.
T Consensus 281 ~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 281 TGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 66666654 4578999999999999999999999999864
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=298.79 Aligned_cols=244 Identities=25% Similarity=0.394 Sum_probs=195.8
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
-|++.+.||.|+||.||+|.+. ..++.||||++.... ......+.+|+.++..+. ||||+++++++. .....|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~----~~~~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYL----KDTKLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEEC-CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCEeEEEEEEE----eCCeEE
Confidence 4778899999999999999884 567899999875433 344567888999999995 999999999865 346789
Q ss_pred EEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 105 LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 105 LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
+||||+++ +|.+.+.. ..+++..+..++.+|+.+|.|||..+ |+|+||||+||+++.++.++|+|||++..+..
T Consensus 79 lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 79 IIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred EEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 99999975 55555543 24899999999999999999999999 99999999999999999999999998865422
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc---cCCCCC
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG---NYRIPE 260 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~---~~~~~~ 260 (690)
.. .......++..|+|||+ +.+..++.++|||||||++|+|++|..||........... ......
T Consensus 154 ~~---------~~~~~~~~~~~y~~PE~---~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 221 (277)
T cd06641 154 TQ---------IKRNTFVGTPFWMAPEV---IKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTL 221 (277)
T ss_pred ch---------hhhccccCCccccChhh---hccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCC
Confidence 11 01112357889999996 4456688899999999999999999999987654443322 112222
Q ss_pred CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 261 SPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 261 ~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
...++..+.++|.+||..+|.+||++.+++.+
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 34678999999999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=297.18 Aligned_cols=247 Identities=21% Similarity=0.262 Sum_probs=184.3
Q ss_pred EeeecCceEEEEEEEcc-cCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEec
Q 005577 32 VIAEGGFSCVYSARDAI-HMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMEC 109 (690)
Q Consensus 32 ~LG~GgFG~VylA~d~~-~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy 109 (690)
.||+|+||.||+|.+.. .....+++|.+.... ....+.+++|+.+++.+ +|||||++++++. .....|+||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~----~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCV----EAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEec----CCCccEEEEec
Confidence 58999999999997532 223456677665443 34567889999999999 5999999999875 34678999999
Q ss_pred CC-CcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccch
Q 005577 110 CD-KSLVNVLENRG--AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 110 ~~-gsLl~~L~~~~--~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~ 186 (690)
+. |+|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchh
Confidence 96 57777776542 234677788899999999999999999 99999999999999999999999998754221100
Q ss_pred hhhhccccccccccCCCCcccCccchhhhh----cCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHh----c-cC
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFR----RELINEKVDIWALGCLLFRICY-FKNAFDGESKLQILN----G-NY 256 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~----~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il~----~-~~ 256 (690)
........++..|+|||++.... ...++.++|||||||++|||++ |..||.......++. . ..
T Consensus 155 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (268)
T cd05086 155 -------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV 227 (268)
T ss_pred -------hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc
Confidence 01112346788999999753211 2245789999999999999996 577887655443322 1 11
Q ss_pred C---CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 257 R---IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 257 ~---~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
. ......+++.+.++|..|| .+|++||++.+|+..+
T Consensus 228 ~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 228 KLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred ccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 1 1223457899999999999 6899999999997654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=298.45 Aligned_cols=242 Identities=26% Similarity=0.367 Sum_probs=197.0
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.|++.+.||.|+||.||+|.+. ..++.|++|++.... ....+.+.+|+.+++++ +||||+++++.+. ....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~----~~~~ 74 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKR-DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQ----DEEN 74 (258)
T ss_pred CceEEEEeccCCCceEEEEEEc-cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhc----CCCe
Confidence 4889999999999999999985 578899999986532 34567889999999999 5999999987743 4578
Q ss_pred EEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 103 ALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
+|+||||+.| +|.+.+... ..+++..+..++.||+.||.|||.++ |+|+||+|+|||++.++.++|+|||++...
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~ 150 (258)
T cd05578 75 MYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKV 150 (258)
T ss_pred EEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence 9999999965 666666554 35899999999999999999999999 999999999999999999999999988654
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHhcc--C
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES---KLQILNGN--Y 256 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~---~~~il~~~--~ 256 (690)
.... ......|+..|+|||+ +....++.++|||||||++|+|++|..||.... ...+.... .
T Consensus 151 ~~~~----------~~~~~~~~~~y~~PE~---~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 217 (258)
T cd05578 151 TPDT----------LTTSTSGTPGYMAPEV---LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA 217 (258)
T ss_pred CCCc----------cccccCCChhhcCHHH---HcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccc
Confidence 3211 1112457889999996 445568999999999999999999999998755 23322211 2
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhCCCCCCCH--HHHH
Q 005577 257 RIPESPKYSSSVTDLIRDMLQASPDDRPDI--TQVW 290 (690)
Q Consensus 257 ~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~--~eil 290 (690)
....+..++..+.++|.+||..||.+||++ .+++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 334456788999999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.65 Aligned_cols=250 Identities=23% Similarity=0.327 Sum_probs=196.4
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec--
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL-- 97 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~-- 97 (690)
....+|.+.+.||+|+||.||+|.+. .+++.||+|++... .....+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL 91 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEc-CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeecccc
Confidence 34578999999999999999999985 57889999998653 2334567888999999995 999999998765321
Q ss_pred CCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCC
Q 005577 98 GRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS 177 (690)
Q Consensus 98 ~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGl 177 (690)
......|+|+++++++|.+.+... .+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~~~~lv~~~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~dfg~ 166 (345)
T cd07877 92 EEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGL 166 (345)
T ss_pred cccccEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEecccc
Confidence 223457899999988887766532 3899999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc--
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN-- 255 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~-- 255 (690)
++..... .....+++.|+|||++ .....++.++|||||||++|+|++|+.||........+...
T Consensus 167 ~~~~~~~------------~~~~~~~~~y~aPE~~--~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (345)
T cd07877 167 ARHTDDE------------MTGYVATRWYRAPEIM--LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232 (345)
T ss_pred ccccccc------------ccccccCCCccCHHHH--hCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 8653211 1123578999999973 22346788999999999999999999999764432211100
Q ss_pred -------------------------CCCCC------CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 256 -------------------------YRIPE------SPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 256 -------------------------~~~~~------~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
...+. ....+..+.+||.+||+.||.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 11357889999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=289.78 Aligned_cols=244 Identities=27% Similarity=0.439 Sum_probs=199.0
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH--HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE--ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~--e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
+|++.+.||+|+||.||++.+. ..++.|++|.+..... .....+.+|++++.++. ||||+++++++. ..+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~----~~~~~ 74 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNL-ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HPNIVKYIGSIE----TSDSL 74 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEc-CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCC-CCCccEEEEEEE----eCCEE
Confidence 5889999999999999999885 5678899999876543 56678999999999995 999999998864 24678
Q ss_pred EEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
|+||||+.+ +|.+.+... ..+++..++.++.|++.+|.|||++| |+||||||+||+++.++.++|+|||++....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 150 (254)
T cd06627 75 YIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLN 150 (254)
T ss_pred EEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecC
Confidence 999999965 666666654 34899999999999999999999999 9999999999999999999999999886543
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh---ccCCCC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN---GNYRIP 259 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~---~~~~~~ 259 (690)
.... ......++..|+|||+ ..+..++.++|||+||+++|+|++|..||.......... ......
T Consensus 151 ~~~~---------~~~~~~~~~~y~~pe~---~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 218 (254)
T cd06627 151 DVSK---------DDASVVGTPYWMAPEV---IEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP 218 (254)
T ss_pred CCcc---------cccccccchhhcCHhh---hcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCC
Confidence 2211 1122457889999996 344558899999999999999999999997654433221 122223
Q ss_pred CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 260 ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 260 ~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.+..++..+.++|.+||..+|++||++.+++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 34568899999999999999999999999863
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=288.68 Aligned_cols=248 Identities=27% Similarity=0.428 Sum_probs=199.6
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
+|++.+.||+|+||.||+|.+. ..++.|++|++.... ....+.+.+|+.+++++. ||||+++++++... ....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~~ 76 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDK-DTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-HPNIVRYYGSERDE--EKNTL 76 (260)
T ss_pred CceeeeEeeecCceEEEEEEEC-CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecC--CCCeE
Confidence 4788999999999999999985 478899999986654 356788899999999995 99999999886532 13678
Q ss_pred EEEEecC-CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~-~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
++||||+ +++|.+++.... .+++..++.++.+++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 77 NIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 9999999 567777776554 5999999999999999999999999 9999999999999999999999999886543
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch-HHHHHhc----cCC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES-KLQILNG----NYR 257 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~-~~~il~~----~~~ 257 (690)
..... .......++..|++||+ ..+..++.++|||||||++|+|++|..||.... ....+.. ...
T Consensus 153 ~~~~~-------~~~~~~~~~~~y~~pE~---~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 222 (260)
T cd06606 153 DIETG-------EGTGSVRGTPYWMAPEV---IRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP 222 (260)
T ss_pred ccccc-------ccccCCCCCccccCHhh---hcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCC
Confidence 32110 00123457899999996 445558999999999999999999999998764 2222111 122
Q ss_pred CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
...+..++..+.++|.+||+.+|.+||++.+++.
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 2334567899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=301.90 Aligned_cols=246 Identities=30% Similarity=0.471 Sum_probs=194.4
Q ss_pred EEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH-HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEE
Q 005577 27 IHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE-ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALL 105 (690)
Q Consensus 27 y~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~-e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~L 105 (690)
|++.+.||+|+||.||+|.+. ..++.|+||.+..... .......+|+..++++.+||||+++++++. .....|+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~----~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNK-ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR----ENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEEC-CCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh----cCCcEEE
Confidence 678899999999999999985 5678899998754322 222345679999999966999999998864 3578899
Q ss_pred EEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccc
Q 005577 106 VMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185 (690)
Q Consensus 106 VmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~ 185 (690)
||||++|+|++.+.......+++.+++.++.||+.+|.|||+++ |+|+||+|+|||++.++.++|+|||++.......
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 76 VFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred EEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 99999999999887765446899999999999999999999999 9999999999999999999999999886542211
Q ss_pred hhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc-----------
Q 005577 186 EKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG----------- 254 (690)
Q Consensus 186 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~----------- 254 (690)
......++..|+|||++ .....++.++|||||||++|+|++|+.||......+.+..
T Consensus 154 ----------~~~~~~~~~~~~aPE~~--~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (283)
T cd07830 154 ----------PYTDYVSTRWYRAPEIL--LRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQ 221 (283)
T ss_pred ----------CcCCCCCcccccCceee--ecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChh
Confidence 11123578899999973 2345578999999999999999999999976543322110
Q ss_pred ----------cC--CCC---------CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 255 ----------NY--RIP---------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 255 ----------~~--~~~---------~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.. ..+ ..+..+..+.++|.+||+.+|++||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 222 DWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00 000 01233688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.35 Aligned_cols=247 Identities=22% Similarity=0.328 Sum_probs=196.4
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec--CC
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL--GR 99 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~--~~ 99 (690)
..+|++.+.||+|+||.||+|++. ..++.||||++... +......+.+|+.+++.+. ||||+++++++..+. ..
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDT-KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPASSLED 91 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEEC-CCCcEEEEEecccccchhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhccccccc
Confidence 457999999999999999999985 56889999988643 3344567788999999995 999999987654321 12
Q ss_pred CceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 100 TKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 100 ~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
....|+|+||++++|.+++.. ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.++|+|||++.
T Consensus 92 ~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 92 FQDVYLVTHLMGADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred cccEEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEccccccc
Confidence 235899999999988887764 34999999999999999999999999 9999999999999999999999999986
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC---
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--- 256 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--- 256 (690)
..... .....++..|+|||++. ....++.++|||||||++|+|++|+.||.+......+....
T Consensus 167 ~~~~~------------~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~ 232 (343)
T cd07851 167 HTDDE------------MTGYVATRWYRAPEIML--NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV 232 (343)
T ss_pred ccccc------------ccCCcccccccCHHHHh--CCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Confidence 54221 11235788999999732 23367899999999999999999999997665433222110
Q ss_pred C------------------------C------CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 R------------------------I------PESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 ~------------------------~------~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
. . .....++..+.++|.+||..||.+||++.+|+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0 0 001246889999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=307.32 Aligned_cols=245 Identities=24% Similarity=0.374 Sum_probs=194.7
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
.+.+|++.+.||.|+||.||+|.+. ..++.||||++... .......+.+|+.+++.+. |||||++++++.. ..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~---~~ 82 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQ-LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR-HENIISLSDIFIS---PL 82 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEEC-CCCCEEEEEEecccccccchhHHHHHHHHHHHhcC-CCCeeeEeeeEec---CC
Confidence 4567999999999999999999985 57889999987542 2334567788999999995 9999999988643 24
Q ss_pred ceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 101 KEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 101 ~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
..+|+||||++++|...+.. ..+++..+..++.||+.||.|||+.+ |+||||+|.|||++.++.++|+|||++..
T Consensus 83 ~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 83 EDIYFVTELLGTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred CcEEEEeehhccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 57899999999888776653 23888999999999999999999999 99999999999999999999999998864
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH---------
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI--------- 251 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~i--------- 251 (690)
... ......+++.|+|||++ ..+..++.++|||||||++|+|++|+.||........
T Consensus 158 ~~~------------~~~~~~~~~~y~aPE~~--~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~ 223 (328)
T cd07856 158 QDP------------QMTGYVSTRYYRAPEIM--LTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG 223 (328)
T ss_pred cCC------------CcCCCcccccccCceee--eccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 321 11123568899999973 2335689999999999999999999999976543110
Q ss_pred ------H------------hcc---CCCC---CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 252 ------L------------NGN---YRIP---ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 252 ------l------------~~~---~~~~---~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
. ... ...+ ..+.++..+.++|.+||+.+|++||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 224 TPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred CCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 000 0000 11357889999999999999999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=289.11 Aligned_cols=246 Identities=33% Similarity=0.574 Sum_probs=202.3
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
+|++.+.||.|+||.||++.+. ..++.|++|++... +......+.+|+++++.++ ||||+++++.+.. ....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~----~~~~ 74 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRK-SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNIIKYYESFEE----KGKL 74 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEc-CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC-CCChhheEEEEec----CCEE
Confidence 5889999999999999999985 56889999998654 3356678889999999995 9999999988653 3788
Q ss_pred EEEEecCCC-cHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 104 LLVMECCDK-SLVNVLENRG--AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 104 ~LVmEy~~g-sLl~~L~~~~--~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
++||||+++ +|.+.+.... ...+++..++.++.+|+.||.|||..+ |+|+||+|+|||++.++.++|+|||++..
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKV 152 (258)
T ss_pred EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceee
Confidence 999999975 7777776643 356999999999999999999999999 99999999999999999999999998865
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc---CC
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN---YR 257 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~---~~ 257 (690)
..... .......|++.|+|||+ ..+..++.++||||||+++|+|++|..||.......+.... ..
T Consensus 153 ~~~~~---------~~~~~~~~~~~y~~pe~---~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~ 220 (258)
T cd08215 153 LSSTV---------DLAKTVVGTPYYLSPEL---CQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY 220 (258)
T ss_pred cccCc---------ceecceeeeecccChhH---hccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC
Confidence 43221 01122467889999996 45566889999999999999999999999877655443322 12
Q ss_pred CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.+.+..++..+.++|.+||..+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2233468899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=355.22 Aligned_cols=254 Identities=24% Similarity=0.394 Sum_probs=204.5
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
.|+.-...||.|.||.||-|.+. .+|...|+|-+...+ ........+|..+|..|. |||||++|++-++ .+.
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~-~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvH----Rek 1308 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNL-DTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVH----REK 1308 (1509)
T ss_pred eeeccccccCCcceeeeEEeecC-CccchhhhhhhhcCccccccCcchHHHHHHHHhcc-CccccccCceeec----HHH
Confidence 36777889999999999999984 789999999885543 334566778999999994 9999999998664 377
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
++|.||||.|+.+..+..+++ -.++.....+..|++.||.|||.+| ||||||||+||||+.+|.+|++|||.|..+.
T Consensus 1309 v~IFMEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEec
Confidence 899999996554444444443 2677777889999999999999999 9999999999999999999999999998776
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc-hHHHHH---hccCCC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGE-SKLQIL---NGNYRI 258 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~-~~~~il---~~~~~~ 258 (690)
..... +.......+||+.|||||++....++.-..+.||||||||+.||+||+.||... +..+++ ......
T Consensus 1386 ~~~~~-----~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1386 NNAQT-----MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP 1460 (1509)
T ss_pred Cchhc-----CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC
Confidence 55322 122334568999999999976666566778999999999999999999999653 333432 233344
Q ss_pred CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
..+..++.+-++||.+||+.||+.|.++.|++..
T Consensus 1461 q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1461 QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 4455699999999999999999999999888764
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=316.97 Aligned_cols=247 Identities=23% Similarity=0.322 Sum_probs=197.9
Q ss_pred EeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEee
Q 005577 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 20 iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~ 96 (690)
+.+..+.|++-++||+||||.||-++.+ .+|+.||.|++.+.. .......++|-.||.++. .+.||.|--.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvr-aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYA---- 253 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVR-ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYA---- 253 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEe-cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeee----
Confidence 3456778899999999999999999875 789999999884432 223345678999999994 8999998322
Q ss_pred cCCCceEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeecc
Q 005577 97 LGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDF 175 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DF 175 (690)
++....+||||..|+| +|.-+|.+.+...|++..++.++.+|+.||++||..+ ||+|||||+|||||+.|+|+|+|+
T Consensus 254 feTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 254 FETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred ecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeecc
Confidence 3356789999999965 5666777777778999999999999999999999999 999999999999999999999999
Q ss_pred CCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH----HHH
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK----LQI 251 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~----~~i 251 (690)
|||..+.... .....+||.+|||||+ +.++.|+...|+|||||+||||+.|+.||..... .++
T Consensus 332 GLAvei~~g~----------~~~~rvGT~GYMAPEv---l~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv 398 (591)
T KOG0986|consen 332 GLAVEIPEGK----------PIRGRVGTVGYMAPEV---LQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV 398 (591)
T ss_pred ceEEecCCCC----------ccccccCcccccCHHH---HcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH
Confidence 9997653321 1112389999999998 4566799999999999999999999999975322 122
Q ss_pred HhccC--CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHH
Q 005577 252 LNGNY--RIPESPKYSSSVTDLIRDMLQASPDDRPDIT 287 (690)
Q Consensus 252 l~~~~--~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~ 287 (690)
-.... ....+..+++++++|.+.+|++||.+|....
T Consensus 399 drr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 399 DRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 11111 2223468999999999999999999996543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=345.89 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=202.3
Q ss_pred eecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec
Q 005577 21 DVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97 (690)
Q Consensus 21 ei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~ 97 (690)
.+...+|.|+++||+|+||.|.+++++ .+++.||+|++.+-+ ......|..|-.||.-- +.+=||.|+-. |
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k-~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyA----F 144 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHK-STEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYA----F 144 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEee-ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHH----h
Confidence 345678999999999999999999986 689999999986521 12234566677777765 58889998643 5
Q ss_pred CCCceEEEEEecC-CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccC
Q 005577 98 GRTKEALLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176 (690)
Q Consensus 98 ~~~~~~~LVmEy~-~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFG 176 (690)
++.+++|+||||| +|+|+.++.+.. .++++.++.|+..|+.||..||+.| +|||||||+|||||..|++||+|||
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccch
Confidence 5789999999999 567888887766 5999999999999999999999999 9999999999999999999999999
Q ss_pred CCCcccccchhhhhccccccccccCCCCcccCccchhhhhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH--
Q 005577 177 STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRR--ELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL-- 252 (690)
Q Consensus 177 lA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~--~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il-- 252 (690)
.+-.+.... .......+|||-|++||+++...+ +.|+..+|+|||||++|||++|.-||..++.....
T Consensus 221 sClkm~~dG--------~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~K 292 (1317)
T KOG0612|consen 221 SCLKMDADG--------TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGK 292 (1317)
T ss_pred hHHhcCCCC--------cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHH
Confidence 764433221 122334689999999999875543 47999999999999999999999999987765432
Q ss_pred --h--ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCC---HHHH
Q 005577 253 --N--GNYRIPESPKYSSSVTDLIRDMLQASPDDRPD---ITQV 289 (690)
Q Consensus 253 --~--~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt---~~ei 289 (690)
+ ..+.+|....+|...++||.+++. +|+.|.. +.++
T Consensus 293 Im~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedi 335 (1317)
T KOG0612|consen 293 IMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDI 335 (1317)
T ss_pred HhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHH
Confidence 2 245566556799999999999875 7788877 7776
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=297.79 Aligned_cols=238 Identities=23% Similarity=0.346 Sum_probs=181.0
Q ss_pred EeeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhh--cCCCCceEEEEEEEeecCCCceEEEE
Q 005577 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSL--KGHPNVVTLYAHTILDLGRTKEALLV 106 (690)
Q Consensus 32 ~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L--~~HPNIVkL~~~~~~~~~~~~~~~LV 106 (690)
+||+|+||.||+|.+. ..++.||+|++.... ......+..|..+++.+ .+||||+++++++. ....+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~----~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH----TPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEe-cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee----cCCEEEEE
Confidence 4899999999999985 568899999886532 11122233444433332 25999999988754 34678999
Q ss_pred EecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccc
Q 005577 107 MECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185 (690)
Q Consensus 107 mEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~ 185 (690)
|||+.| +|...+... +.+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 76 ~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~- 150 (278)
T cd05606 76 LDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 150 (278)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCcc-
Confidence 999965 565555443 35999999999999999999999999 999999999999999999999999988643221
Q ss_pred hhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc---hHHHHHh--ccCCCCC
Q 005577 186 EKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGE---SKLQILN--GNYRIPE 260 (690)
Q Consensus 186 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~---~~~~il~--~~~~~~~ 260 (690)
......|+..|+|||++ ..+..++.++|||||||++|+|++|+.||... ....+.. .......
T Consensus 151 ----------~~~~~~~~~~y~aPE~~--~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 218 (278)
T cd05606 151 ----------KPHASVGTHGYMAPEVL--QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL 218 (278)
T ss_pred ----------CCcCcCCCcCCcCcHHh--cCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCC
Confidence 11124689999999973 23446889999999999999999999999765 2222211 1122333
Q ss_pred CCCCCHHHHHHHHHHhhhCCCCCC-----CHHHHHH
Q 005577 261 SPKYSSSVTDLIRDMLQASPDDRP-----DITQVWF 291 (690)
Q Consensus 261 ~~~~s~~l~~LI~~~L~~dP~~RP-----t~~eil~ 291 (690)
+..++..+.++|.+||..+|.+|| ++.+++.
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 446789999999999999999999 8888853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=293.09 Aligned_cols=232 Identities=26% Similarity=0.389 Sum_probs=183.3
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecCCH---HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEE
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE---ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~---e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
+.||.|+||.||+|.+. ..++.||+|++..... .....+..|..++....+|+||+++++++. ..+.+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~----~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKR-STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ----SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEec-CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE----cCCeEEEEE
Confidence 56899999999999985 5678999999865432 223345556666555547999999998864 346899999
Q ss_pred ecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccch
Q 005577 108 ECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 108 Ey~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~ 186 (690)
||+. ++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||+|.|||++.++.++|+|||++.....
T Consensus 77 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 149 (260)
T cd05611 77 EYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--- 149 (260)
T ss_pred eccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc---
Confidence 9996 46666665443 4899999999999999999999999 99999999999999999999999998864321
Q ss_pred hhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc----cCCC--CC
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG----NYRI--PE 260 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~----~~~~--~~ 260 (690)
.....+++.|++||+ +.+..++.++|||||||++|+|++|..||.......+... .... ..
T Consensus 150 ----------~~~~~~~~~y~~pe~---~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 216 (260)
T cd05611 150 ----------NKKFVGTPDYLAPET---ILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEV 216 (260)
T ss_pred ----------cccCCCCcCccChhh---hcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 112457889999996 4455589999999999999999999999987665543321 2211 22
Q ss_pred CCCCCHHHHHHHHHHhhhCCCCCCCHH
Q 005577 261 SPKYSSSVTDLIRDMLQASPDDRPDIT 287 (690)
Q Consensus 261 ~~~~s~~l~~LI~~~L~~dP~~RPt~~ 287 (690)
...++..+.++|.+||..+|++||++.
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~ 243 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGAN 243 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCC
Confidence 336799999999999999999999664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=296.59 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=201.7
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|.+.+.||.|+||.||+|.+. ..++.|++|++... .......+.+|+.++..+.+||||+++++++. ...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~----~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEK-ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ----DEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEc-CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc----CCc
Confidence 36899999999999999999985 57889999988542 23445677889999999955999999988754 456
Q ss_pred eEEEEEecC-CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~-~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
..++||||+ +++|.+.+.... .+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~ 151 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKV 151 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccc
Confidence 889999999 678888887654 4999999999999999999999999 99999999999999999999999999865
Q ss_pred ccccchhhhh-----------ccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 005577 181 NHKRFEKLEE-----------MGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL 249 (690)
Q Consensus 181 ~~~~~~~~~~-----------~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~ 249 (690)
.......... ...........++..|+|||+ .....++.++|||||||++|+|++|..||......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~---~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (280)
T cd05581 152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPEL---LNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY 228 (280)
T ss_pred cCCccccccCCCCCccccccccccccccccccCCccccCHHH---hCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 4332110000 000011223457899999996 44566889999999999999999999999876654
Q ss_pred HHHhcc--CCCCCCCCCCHHHHHHHHHHhhhCCCCCCCH----HHHHH
Q 005577 250 QILNGN--YRIPESPKYSSSVTDLIRDMLQASPDDRPDI----TQVWF 291 (690)
Q Consensus 250 ~il~~~--~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~----~eil~ 291 (690)
...... .....+..+++.+.+||.+||..+|.+||++ .+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 LTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 433222 2233445779999999999999999999999 77653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=297.82 Aligned_cols=237 Identities=24% Similarity=0.360 Sum_probs=188.2
Q ss_pred eeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEec
Q 005577 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMEC 109 (690)
Q Consensus 33 LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy 109 (690)
||+|+||+||+|.+. ..++.|++|.+.... ......+.+|+.+|+.++ ||||+++++++. ..+..|+||||
T Consensus 1 lg~g~~g~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~----~~~~~~lv~e~ 74 (277)
T cd05577 1 LGKGGFGEVCACQVK-ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFE----TKDDLCLVMTL 74 (277)
T ss_pred CCCCCceeEEEEEEc-CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEe----cCCeEEEEEec
Confidence 699999999999885 578899999886432 233456678999999995 999999988764 34678999999
Q ss_pred CC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhh
Q 005577 110 CD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL 188 (690)
Q Consensus 110 ~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~ 188 (690)
+. ++|.+.+.......+++..++.++.||+.||.|||..+ |+||||+|+|||++.++.++|+|||++......
T Consensus 75 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---- 148 (277)
T cd05577 75 MNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---- 148 (277)
T ss_pred CCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccC----
Confidence 96 57777777665446999999999999999999999999 999999999999999999999999987643211
Q ss_pred hhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH----HHHHhccC--CCCCCC
Q 005577 189 EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK----LQILNGNY--RIPESP 262 (690)
Q Consensus 189 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~----~~il~~~~--~~~~~~ 262 (690)
.......++..|+|||+ +.+..++.++|||||||++|+|++|+.||..... ..+..... ....+.
T Consensus 149 ------~~~~~~~~~~~y~~PE~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (277)
T cd05577 149 ------KKIKGRAGTPGYMAPEV---LQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD 219 (277)
T ss_pred ------CccccccCCCCcCCHHH---hcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCc
Confidence 01112356889999997 3455688999999999999999999999976432 22222221 223345
Q ss_pred CCCHHHHHHHHHHhhhCCCCCC-----CHHHHH
Q 005577 263 KYSSSVTDLIRDMLQASPDDRP-----DITQVW 290 (690)
Q Consensus 263 ~~s~~l~~LI~~~L~~dP~~RP-----t~~eil 290 (690)
.+++.+.++|.+||+.||.+|| ++.+++
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 252 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVR 252 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCcccHHHHH
Confidence 6899999999999999999999 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=300.34 Aligned_cols=245 Identities=29% Similarity=0.432 Sum_probs=196.4
Q ss_pred EEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 27 IHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 27 y~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
|++.+.||.|++|.||+|.+. ..++.+++|.+.... ......+.+|+.+|+.+. |+||+++++++. .....|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~----~~~~~~ 74 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDK-LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN-HPNIIKLLDVFR----HKGDLY 74 (283)
T ss_pred CccceeeecCCCceEEEEEcC-CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc-CCCcchHHHhhc----cCCCEE
Confidence 567889999999999999985 578899999886542 234567888999999995 999999998854 347889
Q ss_pred EEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccccc
Q 005577 105 LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKR 184 (690)
Q Consensus 105 LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~ 184 (690)
+||||+++++.+.+.... ..+++..++.++.||+.||.|||..+ |+|+||||+|||++.++.++|+|||++......
T Consensus 75 ~v~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 75 LVFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred EEEeccCCCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 999999999988887754 45899999999999999999999999 999999999999999999999999988654332
Q ss_pred chhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--------
Q 005577 185 FEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY-------- 256 (690)
Q Consensus 185 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~-------- 256 (690)
.. ......++..|+|||++. ....++.++|||||||++|+|++|+.||...+..+.+....
T Consensus 152 ~~---------~~~~~~~~~~~~~PE~~~--~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (283)
T cd05118 152 VR---------PYTHYVVTRWYRAPELLL--GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDP 220 (283)
T ss_pred cc---------cccCccCcccccCcHHHh--cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCch
Confidence 10 111235788999999732 23368999999999999999999999997755433211100
Q ss_pred ---------------CC---------CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 ---------------RI---------PESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 ---------------~~---------~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.. ...+.++..+.++|.+||..||.+||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 221 EVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred HhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 011346889999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=292.84 Aligned_cols=236 Identities=28% Similarity=0.428 Sum_probs=191.5
Q ss_pred eeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEec
Q 005577 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMEC 109 (690)
Q Consensus 33 LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy 109 (690)
||.|+||.||+|.+. ..++.|++|++.... ....+.+.+|+.+++.+ +||||+++++++. ....+|+||||
T Consensus 1 lg~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~----~~~~~~lv~e~ 74 (262)
T cd05572 1 LGVGGFGRVELVKVK-SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFK----DKKYIYMLMEY 74 (262)
T ss_pred CCCCCceEEEEEEEC-CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEE----cCCccEEEEec
Confidence 799999999999985 568899999986432 23456788999999999 5999999998764 35778999999
Q ss_pred CC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhh
Q 005577 110 CD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL 188 (690)
Q Consensus 110 ~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~ 188 (690)
+. ++|.+.+.... .+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 75 ~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--- 147 (262)
T cd05572 75 CLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--- 147 (262)
T ss_pred CCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---
Confidence 95 57777776543 3899999999999999999999999 9999999999999999999999999886543211
Q ss_pred hhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHhc----cCCCCCCC
Q 005577 189 EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES--KLQILNG----NYRIPESP 262 (690)
Q Consensus 189 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~--~~~il~~----~~~~~~~~ 262 (690)
......|++.|++||+ +.+..++.++|||||||++|+|++|..||.... ...+... ......+.
T Consensus 148 -------~~~~~~~~~~~~~PE~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (262)
T cd05572 148 -------KTWTFCGTPEYVAPEI---ILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN 217 (262)
T ss_pred -------ccccccCCcCccChhH---hcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCc
Confidence 1122457889999996 445668899999999999999999999998765 3333222 23333445
Q ss_pred CCCHHHHHHHHHHhhhCCCCCCC-----HHHHHH
Q 005577 263 KYSSSVTDLIRDMLQASPDDRPD-----ITQVWF 291 (690)
Q Consensus 263 ~~s~~l~~LI~~~L~~dP~~RPt-----~~eil~ 291 (690)
.++..+.++|.+||..+|++||+ +.|++.
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 56899999999999999999999 677653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=297.90 Aligned_cols=246 Identities=30% Similarity=0.443 Sum_probs=200.6
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
...|++.+.||+|+||.||+|.+. ..++.|++|++..... ..+.+.+|+.+++.+. |+||+++++++... ...
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~----~~~ 90 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDR-ATGKEVAIKKMRLRKQ-NKELIINEILIMKDCK-HPNIVDYYDSYLVG----DEL 90 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEc-cCCcEEEEEEEecCch-hHHHHHHHHHHHHHCC-CCCeeEEEEEEEEC----CEE
Confidence 346888899999999999999985 4678899999876554 5677889999999995 99999999987643 788
Q ss_pred EEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
|+||||++ ++|.+++..+. ..+++..++.++.+|+.||.|||..| |+|+||+|+||+++.++.++|+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 99999997 67888877654 35999999999999999999999999 9999999999999999999999999875432
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh----cc-CC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN----GN-YR 257 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~----~~-~~ 257 (690)
.... ......+++.|++||+ +.+..++.++|||||||++|+|++|+.||.......... .. ..
T Consensus 168 ~~~~---------~~~~~~~~~~y~~PE~---~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd06614 168 KEKS---------KRNSVVGTPYWMAPEV---IKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP 235 (286)
T ss_pred cchh---------hhccccCCcccCCHhH---hcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 2110 1122357889999996 445678999999999999999999999998765443221 11 12
Q ss_pred CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
......++..+.++|.+||+.+|.+||++.+++.
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 2223348899999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=297.53 Aligned_cols=248 Identities=24% Similarity=0.343 Sum_probs=192.5
Q ss_pred eEEEEEEeeecCceEEEEEEEcc--cCCeEEEEEEeecCC----HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAI--HMSKQYAMKHMICND----EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~--~~~k~vAvK~i~~~~----~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
.|++.+.||.|+||.||+|.+.. ..++.||+|++.... ....+.+.+|+.+|..+.+|+||+++++++. .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ----T 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee----c
Confidence 37899999999999999998742 367889999986532 2234667889999999977999999987754 3
Q ss_pred CceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 100 TKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
...+|+||||+. ++|.+.+.... .+++..+..++.||+.||.|||..+ |+||||+|+|||++.++.+||+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 77 DTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred CCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccc
Confidence 467899999996 57878776654 4899999999999999999999999 999999999999999999999999988
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch----HHHHHhc
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES----KLQILNG 254 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~----~~~il~~ 254 (690)
........ .......|+..|+|||++.. ....++.++|||||||++|+|++|..||.... ...+...
T Consensus 153 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~-~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~ 223 (290)
T cd05613 153 KEFHEDEV--------ERAYSFCGTIEYMAPDIVRG-GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR 223 (290)
T ss_pred eecccccc--------cccccccCCcccCChhhccC-CCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH
Confidence 65422110 11123467899999997321 12346789999999999999999999996422 1222221
Q ss_pred c--CCCCCCCCCCHHHHHHHHHHhhhCCCCCC-----CHHHHH
Q 005577 255 N--YRIPESPKYSSSVTDLIRDMLQASPDDRP-----DITQVW 290 (690)
Q Consensus 255 ~--~~~~~~~~~s~~l~~LI~~~L~~dP~~RP-----t~~eil 290 (690)
. ...+.+..++..+.++|.+||+.||++|| +..+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 224 ILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred hhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 1 12233456889999999999999999997 555553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=306.32 Aligned_cols=250 Identities=20% Similarity=0.257 Sum_probs=186.5
Q ss_pred EEeeec--CceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEE
Q 005577 31 NVIAEG--GFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLV 106 (690)
Q Consensus 31 ~~LG~G--gFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LV 106 (690)
..||.| +||+||+|.+. ..++.||||++... ..+..+.+.+|+.+++.+. |||||+++++|.. ....|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~----~~~~~~v 77 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHT-PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTT----GSWLWVI 77 (328)
T ss_pred HHhCCcccCceeEEEEEEc-CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcceEeeeEec----CCceEEE
Confidence 456666 99999999985 67899999998643 3445678888999999895 9999999998753 4678999
Q ss_pred EecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccc
Q 005577 107 MECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185 (690)
Q Consensus 107 mEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~ 185 (690)
|||+. +++.+++.......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+||+.+.......
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~ 155 (328)
T cd08226 78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG 155 (328)
T ss_pred EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence 99996 57777776654445899999999999999999999999 9999999999999999999999998543221110
Q ss_pred hhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC---------
Q 005577 186 EKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--------- 256 (690)
Q Consensus 186 ~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~--------- 256 (690)
..... .........++..|||||++.. ....++.++|||||||++|+|++|+.||........+....
T Consensus 156 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd08226 156 QKAKV--VYDFPQFSTSVLPWLSPELLRQ-DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLD 232 (328)
T ss_pred ccccc--cccccccccCccCccChhhhcC-CCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcc
Confidence 00000 0000111234667999997421 11347899999999999999999999997654322211100
Q ss_pred ----------------------------------------CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 ----------------------------------------RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 ----------------------------------------~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
+.+....++..+.+||.+||+.||++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 01112235678999999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.04 Aligned_cols=239 Identities=26% Similarity=0.397 Sum_probs=192.2
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEecC
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECC 110 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy~ 110 (690)
.+||+|+||.||++.+. ..++.||||++..........+.+|+.+++.+. |+||+++++++.. .+..|+||||+
T Consensus 26 ~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~----~~~~~lv~e~~ 99 (292)
T cd06657 26 IKIGEGSTGIVCIATVK-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLV----GDELWVVMEFL 99 (292)
T ss_pred HHcCCCCCeEEEEEEEc-CCCeEEEEEEecccchhHHHHHHHHHHHHHhcC-CcchhheeeEEEe----CCEEEEEEecC
Confidence 57999999999999885 578899999886555555677889999999995 9999999998653 47899999999
Q ss_pred CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhhhh
Q 005577 111 DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEE 190 (690)
Q Consensus 111 ~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~ 190 (690)
.+..+..+.... .+++..++.++.||+.+|.|||+.| |+|+||+|+|||++.++.++|+|||++.......
T Consensus 100 ~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~----- 170 (292)
T cd06657 100 EGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----- 170 (292)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceeccccc-----
Confidence 765444444333 3899999999999999999999999 9999999999999999999999999875432211
Q ss_pred ccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---hccC--CCCCCCCCC
Q 005577 191 MGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL---NGNY--RIPESPKYS 265 (690)
Q Consensus 191 ~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il---~~~~--~~~~~~~~s 265 (690)
.......|++.|+|||+ +.+..++.++|||||||++|+|++|..||.+......+ .... .......++
T Consensus 171 ----~~~~~~~~~~~y~~pE~---~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T cd06657 171 ----PRRKSLVGTPYWMAPEL---ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVS 243 (292)
T ss_pred ----ccccccccCccccCHHH---hcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCC
Confidence 01112357899999996 44566789999999999999999999999876544322 2111 222334678
Q ss_pred HHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 266 SSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 266 ~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
..+.++|.+||..+|.+||++.+++.
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 99999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=287.93 Aligned_cols=244 Identities=29% Similarity=0.512 Sum_probs=198.5
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
+|++.+.||+|+||.||++.+. ..++.+++|.+... .......+.+|+.+++.+. |+||+++++++. .....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~----~~~~~ 74 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRL-SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN-HPNIISYKEAFL----DGNKL 74 (256)
T ss_pred CceEeeeecCCCceeEEEEEEC-CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCC-CCCchhhhhhhc----cCCEE
Confidence 5889999999999999999885 57789999998653 3344567789999999995 999999988764 34788
Q ss_pred EEEEecCC-CcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 104 LLVMECCD-KSLVNVLENRG--AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~~--~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
|+||||+. ++|..++.... ...+++..++.++.+|+.||.|||+.| ++|+||+|.||+++.++.+||+|||++..
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKV 152 (256)
T ss_pred EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhh
Confidence 99999995 46777665522 235899999999999999999999999 99999999999999999999999999866
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc---cCC
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG---NYR 257 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~---~~~ 257 (690)
..... .....+++.|++||. ..+..++.++|+||||+++|+|++|+.||...+...+... ...
T Consensus 153 ~~~~~-----------~~~~~~~~~~~~Pe~---~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~ 218 (256)
T cd08530 153 LKKNM-----------AKTQIGTPHYMAPEV---WKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY 218 (256)
T ss_pred hccCC-----------cccccCCccccCHHH---HCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC
Confidence 43321 111357889999996 4566788899999999999999999999987665433221 111
Q ss_pred CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.+....++.++.++|.+||..+|++||++.+++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 2233468899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.07 Aligned_cols=254 Identities=26% Similarity=0.420 Sum_probs=198.1
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccC---CeEEEEEEeecCCH--HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHM---SKQYAMKHMICNDE--ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~---~k~vAvK~i~~~~~--e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
..|++...||+|.||.||+|.....+ .+.+|||++..... ..-....+|+.+++.|+ |||||.|..+|+. .
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~-h~nvi~Lv~Vfl~---~ 99 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK-HPNVISLVKVFLS---H 99 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc-CCcchhHHHHHhc---c
Confidence 37889999999999999999643222 34799998854421 12356789999999996 9999999887653 2
Q ss_pred CceEEEEEecCCCcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCC----CCeee
Q 005577 100 TKEALLVMECCDKSLVNVLENRG---AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD----GLWKL 172 (690)
Q Consensus 100 ~~~~~LVmEy~~gsLl~~L~~~~---~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~d----g~vKL 172 (690)
...++||+||.+.+|++.|..+. ...++...+..|+.||+.|+.|||++- |+||||||.||||..+ |+|||
T Consensus 100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEe
Confidence 57899999999999999987543 235899999999999999999999999 9999999999999888 89999
Q ss_pred eccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH---
Q 005577 173 CDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL--- 249 (690)
Q Consensus 173 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~--- 249 (690)
+|||+++.+......+... ...+-|.+|.|||. ++....|+.+.|||+.|||+.||++..+.|.+....
T Consensus 178 aDlGlaR~~~~plkpl~s~------d~VVVTiWYRAPEL--LLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~ 249 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASL------DPVVVTIWYRAPEL--LLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKT 249 (438)
T ss_pred ecccHHHHhhccccccccC------CceEEEEEecChHH--hcccccccchhhhHHHHHHHHHHHccCccccchhhhccc
Confidence 9999999877665444221 13456999999997 466778999999999999999999988888654321
Q ss_pred ------HHHhccCC---------C------CCC------------------------CCCCHHHHHHHHHHhhhCCCCCC
Q 005577 250 ------QILNGNYR---------I------PES------------------------PKYSSSVTDLIRDMLQASPDDRP 284 (690)
Q Consensus 250 ------~il~~~~~---------~------~~~------------------------~~~s~~l~~LI~~~L~~dP~~RP 284 (690)
+.+.+++. + |.. ..-++...+|+.+||..||-+|.
T Consensus 250 ~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRI 329 (438)
T KOG0666|consen 250 KNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRI 329 (438)
T ss_pred CCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhc
Confidence 11111110 0 000 01244578899999999999999
Q ss_pred CHHHHHHH
Q 005577 285 DITQVWFR 292 (690)
Q Consensus 285 t~~eil~~ 292 (690)
|+.+.+.+
T Consensus 330 ta~qAleh 337 (438)
T KOG0666|consen 330 TAEQALEH 337 (438)
T ss_pred cHHHHhcc
Confidence 99998754
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=290.03 Aligned_cols=243 Identities=30% Similarity=0.466 Sum_probs=189.8
Q ss_pred eeecCceEEEEEEEcccCCeEEEEEEeecCCH---HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEec
Q 005577 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDE---ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMEC 109 (690)
Q Consensus 33 LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~---e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy 109 (690)
||.|+||.||++.+. ..++.|++|.+..... ...+.+.+|+.+++++. ||||+++++.+. .....|+||||
T Consensus 1 lg~g~~~~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~----~~~~~~lv~e~ 74 (265)
T cd05579 1 ISKGAYGRVFLAKKK-STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQ----GKKNLYLVMEY 74 (265)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHhee----cCcEEEEEEec
Confidence 689999999999985 5688999998865433 45678889999999995 999999987753 45788999999
Q ss_pred CC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhh
Q 005577 110 CD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL 188 (690)
Q Consensus 110 ~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~ 188 (690)
+. ++|.+++...+ .+++..++.++.||+.||.|||..+ |+|+||+|+|||++.++.++|+|||++..........
T Consensus 75 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 150 (265)
T cd05579 75 LPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN 150 (265)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc
Confidence 96 47777776544 4899999999999999999999999 9999999999999999999999999886432211000
Q ss_pred hhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc----cCCCCCCCCC
Q 005577 189 EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG----NYRIPESPKY 264 (690)
Q Consensus 189 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~----~~~~~~~~~~ 264 (690)
. ...........++..|++||+ .....++.++|||||||++|+|++|..||........... ....+....+
T Consensus 151 ~-~~~~~~~~~~~~~~~~~~Pe~---~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (265)
T cd05579 151 L-NDDEKEDKRIVGTPDYIAPEV---ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEV 226 (265)
T ss_pred c-ccccccccCcccCccccCHHH---hcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccC
Confidence 0 000011122457889999996 4455588899999999999999999999987665543322 2333333335
Q ss_pred CHHHHHHHHHHhhhCCCCCCCHHHH
Q 005577 265 SSSVTDLIRDMLQASPDDRPDITQV 289 (690)
Q Consensus 265 s~~l~~LI~~~L~~dP~~RPt~~ei 289 (690)
+..+.++|.+||+.+|.+||++..+
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~~ 251 (265)
T cd05579 227 SDEAIDLISKLLVPDPEKRLGAKSI 251 (265)
T ss_pred CHHHHHHHHHHhcCCHhhcCCCccH
Confidence 8999999999999999999999333
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=293.33 Aligned_cols=236 Identities=22% Similarity=0.359 Sum_probs=182.7
Q ss_pred eEEEEEE--eeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNV--IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~--LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
.|++.+. ||.|+||.||++.+. ..++.+++|.+....... .|+.+...+.+||||+++++++.. .+.+
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~----~~~~ 84 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHK-PTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT----LKGH 84 (267)
T ss_pred hhccccceeecCCCceEEEEEEEc-CCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec----CCee
Confidence 4555555 499999999999985 568889999875432111 133333334469999999988753 3689
Q ss_pred EEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCC-CeeeeccCCCCcc
Q 005577 104 LLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG-LWKLCDFGSTSTN 181 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg-~vKL~DFGlA~~~ 181 (690)
|+||||+. ++|.+++.... .+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++ .++|+|||++...
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 99999995 67888776654 5999999999999999999999999 99999999999999998 9999999988653
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH-----HHHhc-c
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL-----QILNG-N 255 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~-----~il~~-~ 255 (690)
... ....|+..|+|||+ +.+..++.++|||||||++|+|++|..||...... ..... .
T Consensus 161 ~~~-------------~~~~~~~~y~aPE~---~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 224 (267)
T PHA03390 161 GTP-------------SCYDGTLDYFSPEK---IKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ 224 (267)
T ss_pred CCC-------------ccCCCCCcccChhh---hcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc
Confidence 211 12357899999996 45667899999999999999999999999754321 11111 1
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhCCCCCCC-HHHHHH
Q 005577 256 YRIPESPKYSSSVTDLIRDMLQASPDDRPD-ITQVWF 291 (690)
Q Consensus 256 ~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt-~~eil~ 291 (690)
........++..+.+||.+||+.+|.+||+ +.+++.
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 122333468999999999999999999996 587753
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=294.81 Aligned_cols=251 Identities=25% Similarity=0.316 Sum_probs=193.2
Q ss_pred eEEEEEEeeecCceEEEEEEEc--ccCCeEEEEEEeecCC----HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 26 KIHVRNVIAEGGFSCVYSARDA--IHMSKQYAMKHMICND----EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~--~~~~k~vAvK~i~~~~----~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
.|++.+.||+|+||.||++.+. ...++.||||++.... ......+.+|+.++.++.+||||+++++.+. .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~----~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ----T 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee----c
Confidence 4788999999999999999864 2356789999886432 2334667889999999977999999987754 3
Q ss_pred CceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 100 TKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
...+||||||+. ++|.+.+.... .+++..++.++.|++.+|.|||..+ ++||||||.|||++.++.++|+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 77 DTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred CCEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECccc
Confidence 467899999996 57777776543 4899999999999999999999999 999999999999999999999999988
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch----HHHHHhc
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES----KLQILNG 254 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~----~~~il~~ 254 (690)
+....... .......|++.|+|||++.. ....++.++||||||+++|+|++|..||.... ...+...
T Consensus 153 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~-~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 223 (288)
T cd05583 153 KEFLAEEE--------ERAYSFCGTIEYMAPEVIRG-GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR 223 (288)
T ss_pred cccccccc--------cccccccCCccccCHHHhcC-CCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHH
Confidence 65432110 01112357899999996321 11236789999999999999999999995321 1111111
Q ss_pred --cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 255 --NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 255 --~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
....+.+..++..+.++|.+||+.||++||++.++...+
T Consensus 224 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l 264 (288)
T cd05583 224 ILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIK 264 (288)
T ss_pred HHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHh
Confidence 112234456889999999999999999999987664433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=294.40 Aligned_cols=245 Identities=30% Similarity=0.490 Sum_probs=196.1
Q ss_pred EEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 27 IHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 27 y~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
|++.+.||+|+||.||+|.+. ..++.|++|++.... ....+.+..|+.+++.+. |+||+++++++. .....+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~----~~~~~~ 74 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDK-KTGEIVALKKIRLDNEEEGIPSTALREISLLKELK-HPNIVKLLDVIH----TERKLY 74 (282)
T ss_pred CeeehcccccCcceEEEeeec-CCCcEEEEEEeccccccccccHHHHHHHHHHHhcC-CCCHHHHHhhhh----cCCceE
Confidence 567889999999999999985 568899999987642 334567788999999995 999999998754 347899
Q ss_pred EEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccccc
Q 005577 105 LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKR 184 (690)
Q Consensus 105 LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~ 184 (690)
+||||++++|.+++.... ..+++..++.++.+|+.||.|||..+ |+||||+|+||+++.++.++|+|||+++.....
T Consensus 75 ~v~e~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 75 LVFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred EEecCcCcCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 999999999988887653 34999999999999999999999999 999999999999999999999999988654321
Q ss_pred chhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC--------
Q 005577 185 FEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY-------- 256 (690)
Q Consensus 185 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~-------- 256 (690)
.. ......++..|+|||++ .....++.++|||||||++|+|++|+.||.+......+....
T Consensus 152 ~~---------~~~~~~~~~~~~aPE~~--~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (282)
T cd07829 152 LR---------TYTHEVVTLWYRAPEIL--LGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTE 220 (282)
T ss_pred cc---------ccCccccCcCcCChHHh--cCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcH
Confidence 11 11123457889999973 233378899999999999999999999998765433221100
Q ss_pred --------------CC---------CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 --------------RI---------PESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 --------------~~---------~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.. ...+.++..+.++|.+||..||.+||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 221 ESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00 011345789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=297.42 Aligned_cols=244 Identities=23% Similarity=0.284 Sum_probs=182.6
Q ss_pred CceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEecCC-Cc
Q 005577 37 GFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCD-KS 113 (690)
Q Consensus 37 gFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy~~-gs 113 (690)
++|.||++++. ..++.||||++... .......+.+|+.+|+.++ |+||+++++++. ..+..|++|||+. ++
T Consensus 12 ~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~----~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 12 DLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFI----VDSELYVVSPLMAYGS 85 (314)
T ss_pred CCceEEEEEec-CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcC-Ccchhhhhheee----cCCeEEEEEeccCCCC
Confidence 44555655554 47899999998754 4556788999999999995 999999998865 3467899999997 56
Q ss_pred HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccc
Q 005577 114 LVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGI 193 (690)
Q Consensus 114 Ll~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~ 193 (690)
|.+++.......+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||.+........... ..
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~--~~ 161 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR--VV 161 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeecccccccc--cc
Confidence 667776554445899999999999999999999999 99999999999999999999999998865432211100 01
Q ss_pred cccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh----ccCC------------
Q 005577 194 EEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN----GNYR------------ 257 (690)
Q Consensus 194 ~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~----~~~~------------ 257 (690)
........++..|+|||++.. ....++.++|||||||++|+|++|+.||........+. ....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQ-NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred ccccccccccccccCHHHhcC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 111123456889999997431 11357889999999999999999999997654322211 0000
Q ss_pred --------------------CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 258 --------------------IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 258 --------------------~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
......++..+.+||.+||..||++||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0001123467889999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=327.30 Aligned_cols=145 Identities=30% Similarity=0.445 Sum_probs=126.1
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.+|++.++||+|+||.||+|.+. ..++.||||++... +......+.+|+.+++.+. |||||++++++. ...
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~----~~~ 77 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKK-NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQ----SAN 77 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEE----ECC
Confidence 57999999999999999999985 57889999998643 3445577889999999995 999999997754 346
Q ss_pred eEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 102 EALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
.+||||||+. ++|.+++...+ .+++..++.|+.||+.||.|||.++ ||||||||+||||+.++.+||+|||+++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 8999999995 57777775543 4899999999999999999999999 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=305.64 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=205.5
Q ss_pred CCCCCceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHHHHHHHHHHHhhcCCCCceEE
Q 005577 13 TGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTL 89 (690)
Q Consensus 13 ~~~~g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkL 89 (690)
....+..-.|...+|..+.+||+|+||.|.+|..+ .+.+.||||++.+. ..+.++.-+.|-++|+....-|.+|+|
T Consensus 337 ~~~~~~~d~i~~tDFnFl~VlGKGSFGKVlLaerk-gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~ql 415 (683)
T KOG0696|consen 337 FHNSSKRDRIKATDFNFLMVLGKGSFGKVLLAERK-GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQL 415 (683)
T ss_pred CCCCCcccceeecccceEEEeccCccceeeeeccc-CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHH
Confidence 34444444566778889999999999999999765 56789999988543 234466778899999887667899999
Q ss_pred EEEEEeecCCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCC
Q 005577 90 YAHTILDLGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG 168 (690)
Q Consensus 90 ~~~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg 168 (690)
+.+| +....+|+||||+. |+|.-.+.+-+. |.|..++.++.+|+-||-+||++| ||+||||.+||||+.+|
T Consensus 416 HScF----QTmDRLyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eG 487 (683)
T KOG0696|consen 416 HSCF----QTMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEG 487 (683)
T ss_pred HHHh----hhhhheeeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCC
Confidence 8764 34578999999995 566666666554 999999999999999999999999 99999999999999999
Q ss_pred CeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH
Q 005577 169 LWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK 248 (690)
Q Consensus 169 ~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~ 248 (690)
++||+|||+.+..... .....+.+|||.|+|||+ +....|+..+|+||+||+||||+.|++||++++.
T Consensus 488 HiKi~DFGmcKEni~~---------~~TTkTFCGTPdYiAPEI---i~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 488 HIKIADFGMCKENIFD---------GVTTKTFCGTPDYIAPEI---IAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred ceEeeecccccccccC---------CcceeeecCCCcccccce---EEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 9999999998653211 122345799999999997 4457899999999999999999999999999988
Q ss_pred HHHHhccC--CCCCCCCCCHHHHHHHHHHhhhCCCCCCC
Q 005577 249 LQILNGNY--RIPESPKYSSSVTDLIRDMLQASPDDRPD 285 (690)
Q Consensus 249 ~~il~~~~--~~~~~~~~s~~l~~LI~~~L~~dP~~RPt 285 (690)
.++...+. ....+..++.+..+++..+|.+.|.+|..
T Consensus 556 ~elF~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 556 DELFQAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHHHHHHccCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 76654432 22345678999999999999999999954
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=322.94 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=194.4
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec--CCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL--GRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~--~~~~ 101 (690)
+-+...+.||+||||.||+++++ .+|+.||||.+... ....+++..+|+++|++|. |+|||+++++-...+ --..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnk-etG~~vAvK~~~~~~~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNK-ETGRLVAVKTFNKESSLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeeccc-ccccchhHHhhhhhcccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCcccc
Confidence 56777899999999999999986 78999999988543 2345677889999999995 999999988632111 0134
Q ss_pred eEEEEEecCC-CcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeC--CCC--Ceeeecc
Q 005577 102 EALLVMECCD-KSLVNVLENRG-AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLG--SDG--LWKLCDF 175 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~-~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd--~dg--~vKL~DF 175 (690)
..++|||||. |+|...|..-. ..+|++.+++.++.+|+.||.|||.+| ||||||||.|||+- .+| ..||+||
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeecc
Confidence 5689999995 56777765432 235999999999999999999999999 99999999999993 334 4799999
Q ss_pred CCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-------
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK------- 248 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~------- 248 (690)
|.|+.+.+.. .....+||+.|.+||++ -+.+.|+.-+|.|||||++|+++||..||.....
T Consensus 169 G~Arel~d~s----------~~~S~vGT~~YLhPel~--E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~ 236 (732)
T KOG4250|consen 169 GAARELDDNS----------LFTSLVGTEEYLHPELY--ERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEI 236 (732)
T ss_pred cccccCCCCC----------eeeeecCchhhcChHHH--hhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchh
Confidence 9998865532 23456899999999973 2258899999999999999999999999953211
Q ss_pred -HHHHhc-------------------cCCCCCCCCCCH----HHHHHHHHHhhhCCCCCC--CHHHHHHHHhhhcC
Q 005577 249 -LQILNG-------------------NYRIPESPKYSS----SVTDLIRDMLQASPDDRP--DITQVWFRVNEQLP 298 (690)
Q Consensus 249 -~~il~~-------------------~~~~~~~~~~s~----~l~~LI~~~L~~dP~~RP--t~~eil~~l~~~l~ 298 (690)
..++.. ...+|.+..++. .+..++..+|..+|.+|. .+.+.+..+...+.
T Consensus 237 ~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 237 MWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred hhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 111110 112233333333 345678889999999999 77776666555443
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.47 Aligned_cols=239 Identities=24% Similarity=0.391 Sum_probs=200.3
Q ss_pred EEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEE
Q 005577 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 30 ~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
.++||.|.||+||-|+++ ++|+.||||++.+. ....-..+..|+.||..+. ||.||.|-..| +..+.+|+||
T Consensus 569 devLGSGQFG~VYgg~hR-ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~-HPGiV~le~M~----ET~ervFVVM 642 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHR-KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH-HPGIVNLECMF----ETPERVFVVM 642 (888)
T ss_pred HhhccCCcceeeecceec-ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC-CCCeeEEEEee----cCCceEEEEe
Confidence 578999999999999997 89999999998543 1223366788999999996 99999997553 3567899999
Q ss_pred ecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCC---CCeeeeccCCCCccccc
Q 005577 108 ECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD---GLWKLCDFGSTSTNHKR 184 (690)
Q Consensus 108 Ey~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~d---g~vKL~DFGlA~~~~~~ 184 (690)
|-+.|+.++.|.....++|++.....++.||+.||.|||-++ |||+||||+||||... -.+||||||+|+.+...
T Consensus 643 EKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 643 EKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred hhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 999999999999988889999999999999999999999999 9999999999999654 37999999999986532
Q ss_pred chhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-HH-HHhccC--CCCC
Q 005577 185 FEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK-LQ-ILNGNY--RIPE 260 (690)
Q Consensus 185 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~-~~-il~~~~--~~~~ 260 (690)
. +. ...+|||.|+|||+ ++.+.|...-|+||.|||+|.-|.|..||..+.. .+ +-+..+ ....
T Consensus 721 s--FR--------rsVVGTPAYLaPEV---LrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~P 787 (888)
T KOG4236|consen 721 S--FR--------RSVVGTPAYLAPEV---LRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNP 787 (888)
T ss_pred h--hh--------hhhcCCccccCHHH---HhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCc
Confidence 1 11 23589999999997 5678899999999999999999999999976443 23 333333 3333
Q ss_pred CCCCCHHHHHHHHHHhhhCCCCCCCHHHH
Q 005577 261 SPKYSSSVTDLIRDMLQASPDDRPDITQV 289 (690)
Q Consensus 261 ~~~~s~~l~~LI~~~L~~dP~~RPt~~ei 289 (690)
...++....+||..+|+..-.+|.+....
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 45889999999999999999999998764
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=287.53 Aligned_cols=245 Identities=26% Similarity=0.459 Sum_probs=189.0
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeec---C--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC---N--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~---~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
||.+.+.||+|+||.||++.+. ..+..+++|++.. . .......+.+|+.+++.+. ||||+++++++. +.
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~ 74 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDK-KAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFL----ER 74 (260)
T ss_pred CceeeeeecCCCCceEEEEEec-CCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHh----cC
Confidence 6899999999999999999885 3344455555432 1 2223456778999999995 999999998754 34
Q ss_pred ceEEEEEecCCC-cHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCC
Q 005577 101 KEALLVMECCDK-SLVNVLENR--GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS 177 (690)
Q Consensus 101 ~~~~LVmEy~~g-sLl~~L~~~--~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGl 177 (690)
...++||||+.+ +|.+.+... ....+++.+++.++.||+.||.|||+.+ |+|+||||+||+++. +.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~ 151 (260)
T cd08222 75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGV 151 (260)
T ss_pred CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCc
Confidence 678999999964 666666432 2345899999999999999999999999 999999999999975 5699999998
Q ss_pred CCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccC-
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY- 256 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~- 256 (690)
+........ ......|++.|+|||. +.+..++.++||||||+++|+|++|..||.............
T Consensus 152 ~~~~~~~~~---------~~~~~~~~~~~~~pe~---~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~ 219 (260)
T cd08222 152 SRLLMGSCD---------LATTFTGTPYYMSPEA---LKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219 (260)
T ss_pred eeecCCCcc---------cccCCCCCcCccCHHH---HccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc
Confidence 865422111 1122457889999996 445668889999999999999999999998765544333221
Q ss_pred --CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 --RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 --~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
....+..++..+.++|.+||..+|++||++.+++.
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 220 GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11223467899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=296.61 Aligned_cols=255 Identities=24% Similarity=0.304 Sum_probs=202.6
Q ss_pred eEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec
Q 005577 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97 (690)
Q Consensus 19 ~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~ 97 (690)
..++....++-+..||.|+||+|++-.++ ..++.+|||.+..+. +....+++.|.....+-.++||||++||.++.
T Consensus 58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk-~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-- 134 (361)
T KOG1006|consen 58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHK-PSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-- 134 (361)
T ss_pred ccccccchHHHHHHhcCCcchhhhhhhcC-ccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc--
Confidence 34444555666778999999999999886 689999999998764 45677889999888887789999999998653
Q ss_pred CCCceEEEEEecCCCcHHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeec
Q 005577 98 GRTKEALLVMECCDKSLVNVLEN---RGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCD 174 (690)
Q Consensus 98 ~~~~~~~LVmEy~~gsLl~~L~~---~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~D 174 (690)
.+..+|.||+|+-++..+... -....++|..+-.|....+.||.||-..- .||||||||+||||+..|.|||||
T Consensus 135 --EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILldr~G~vKLCD 211 (361)
T KOG1006|consen 135 --EGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLDRHGDVKLCD 211 (361)
T ss_pred --CCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEecCCCEeeec
Confidence 467899999999876554432 23446999999999999999999998763 399999999999999999999999
Q ss_pred cCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-HHHH-
Q 005577 175 FGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK-LQIL- 252 (690)
Q Consensus 175 FGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~-~~il- 252 (690)
||++-.+...+.... -.|...|||||.+.- .+..|+-++||||||++|||+.||+.||.+.+. .+.+
T Consensus 212 FGIcGqLv~SiAkT~----------daGCrpYmAPERi~p-~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~ 280 (361)
T KOG1006|consen 212 FGICGQLVDSIAKTV----------DAGCRPYMAPERIDP-SDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLC 280 (361)
T ss_pred ccchHhHHHHHHhhh----------ccCCccccChhccCC-ccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHH
Confidence 999866544433322 257889999998653 334699999999999999999999999988653 3332
Q ss_pred ---hccCCCC----CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHH
Q 005577 253 ---NGNYRIP----ESPKYSSSVTDLIRDMLQASPDDRPDITQVW 290 (690)
Q Consensus 253 ---~~~~~~~----~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil 290 (690)
.+..... ....++..+..+|.-||.+|-.+||.+.++.
T Consensus 281 ~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk 325 (361)
T KOG1006|consen 281 QVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLK 325 (361)
T ss_pred HHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhh
Confidence 2222211 1235899999999999999999999999884
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=274.64 Aligned_cols=246 Identities=28% Similarity=0.480 Sum_probs=200.7
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH--HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE--ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~--e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
+|.-.++||+|.||+||+|++. .+.+.||+|.+...+. .--...++|+-+|+.|+ |.|||+++++.. ..+.+
T Consensus 3 ~ydkmekigegtygtvfkarn~-~t~eivalkrvrlddddegvpssalreicllkelk-hknivrl~dvlh----sdkkl 76 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLH----SDKKL 76 (292)
T ss_pred chHHHHhhcCCcceeeEecccC-CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh-hcceeehhhhhc----cCcee
Confidence 4555678999999999999986 6789999999876532 23467889999999996 999999998743 35788
Q ss_pred EEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 104 LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
.+|+|||+-.|..+...-+ +.++...+..++.|++.||.++|+++ ++||||||.|+||+.+|.+||+|||+++...-
T Consensus 77 tlvfe~cdqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 77 TLVFEFCDQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred EEeHHHhhHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 9999999999888776543 56999999999999999999999999 99999999999999999999999999987543
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHhccCCC----
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQILNGNYRI---- 258 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il~~~~~~---- 258 (690)
...... ..+-|.+|.+|.+ .+..+.|+...|+||.|||+.|+.. |++.|.+.+..+.+.++++.
T Consensus 154 pvrcys---------aevvtlwyrppdv--lfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p 222 (292)
T KOG0662|consen 154 PVRCYS---------AEVVTLWYRPPDV--LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222 (292)
T ss_pred ceEeee---------ceeeeeeccCcce--eeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCC
Confidence 322111 1245999999998 5677889999999999999999985 88899998877665543321
Q ss_pred -----------CC----------------CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 259 -----------PE----------------SPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 259 -----------~~----------------~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
+. .|.++..-++|+.++|.-+|..|.++...+.
T Consensus 223 ~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 223 TEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 00 1234556788999999999999999887653
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=281.38 Aligned_cols=233 Identities=29% Similarity=0.392 Sum_probs=190.2
Q ss_pred eeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEec
Q 005577 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMEC 109 (690)
Q Consensus 33 LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy 109 (690)
||.|+||.||++.+. ..++.|++|++.... ......+..|+.+++.+. ||||+++++++. .....|+||||
T Consensus 1 lg~G~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----~~~~~~~v~e~ 74 (250)
T cd05123 1 LGKGSFGKVLLVRKK-DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQ----TEEKLYLVLEY 74 (250)
T ss_pred CCCCCceEEEEEEEC-CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHee----cCCeeEEEEec
Confidence 699999999999985 568899999886542 335668889999999995 999999987754 45789999999
Q ss_pred C-CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhh
Q 005577 110 C-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL 188 (690)
Q Consensus 110 ~-~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~ 188 (690)
+ +++|.+++.... .+++..+..++.||+.||.|||..+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 75 ~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--- 147 (250)
T cd05123 75 APGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--- 147 (250)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCC---
Confidence 9 678888876654 4899999999999999999999999 9999999999999999999999999886542211
Q ss_pred hhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc--CCCCCCCCCCH
Q 005577 189 EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN--YRIPESPKYSS 266 (690)
Q Consensus 189 ~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~--~~~~~~~~~s~ 266 (690)
.......++..|++||+ ..+..++.++|+|||||++|+|++|..||............ .....+..++.
T Consensus 148 ------~~~~~~~~~~~~~~Pe~---~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (250)
T cd05123 148 ------SRTNTFCGTPEYLAPEV---LLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSP 218 (250)
T ss_pred ------CcccCCcCCccccChHH---hCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Confidence 01123457889999996 44556888999999999999999999999876644433222 23344456789
Q ss_pred HHHHHHHHHhhhCCCCCCCHH
Q 005577 267 SVTDLIRDMLQASPDDRPDIT 287 (690)
Q Consensus 267 ~l~~LI~~~L~~dP~~RPt~~ 287 (690)
.+.++|.+||..||++||++.
T Consensus 219 ~l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 219 EARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred HHHHHHHHHhcCCHhhCCCcc
Confidence 999999999999999999994
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=315.09 Aligned_cols=239 Identities=26% Similarity=0.319 Sum_probs=196.9
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
...|.+...||.|+|+.|-.+.+. .+++..++|++.... .+..+|+.++....+||||+++++++. +..+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~-~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~----~~~~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESS-PTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYE----DGKEI 391 (612)
T ss_pred chhhccccccCCCCccceeeeecc-ccccchhheeccccc----cccccccchhhhhcCCCcceeecceec----CCcee
Confidence 457888888999999999999886 678899999986552 233468888888889999999998853 56889
Q ss_pred EEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEe-CCCCCeeeeccCCCCcc
Q 005577 104 LLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLL-GSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 104 ~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILL-d~dg~vKL~DFGlA~~~ 181 (690)
|+|||++.| .+++.+.... ....++..|+++|+.||.|||++| ||||||||+|||+ +..|+++|+|||.++..
T Consensus 392 ~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred eeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 999999965 5566665543 233778889999999999999999 9999999999999 68899999999998765
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-HHHHhccCCCCC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK-LQILNGNYRIPE 260 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~-~~il~~~~~~~~ 260 (690)
... ..+.+-|..|.|||++ ....|++++||||||++||+||+|+.||..... .+++......+.
T Consensus 467 ~~~------------~~tp~~t~~y~APEvl---~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~ 531 (612)
T KOG0603|consen 467 ERS------------CDTPALTLQYVAPEVL---AIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF 531 (612)
T ss_pred chh------------hcccchhhcccChhhh---ccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc
Confidence 432 1223458899999984 367799999999999999999999999976443 456666555555
Q ss_pred CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 261 SPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 261 ~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
...++...++||..||+.||.+|+++.++..
T Consensus 532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 532 SECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 6789999999999999999999999999853
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=314.79 Aligned_cols=256 Identities=25% Similarity=0.361 Sum_probs=212.1
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEee-cCCCc
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILD-LGRTK 101 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~-~~~~~ 101 (690)
....+++..+||.|.+|.||++++. +.++..|+|++...... -+.+..|.+||+.+.+|||++.+|+++... -+.+.
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~-~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHV-KTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeee-ecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 3567899999999999999999985 78888999988654332 245667899999999999999999988654 34566
Q ss_pred eEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
.++||||||+| +.-+++..-....+.|..+..|++.+|.||.+||.+. +||||||-.||||+.+|.|||+|||++..
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeeeeeeee
Confidence 89999999975 4455555444556999999999999999999999999 99999999999999999999999999876
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhh--cCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCCC
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFR--RELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRI 258 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~--~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~~ 258 (690)
++... ....+.+|||.|||||++.+.. ...|+.++|+||||++..||.-|.+|+-...+...+-.+.+.
T Consensus 173 ldsT~---------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN 243 (953)
T KOG0587|consen 173 LDSTV---------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 243 (953)
T ss_pred eeccc---------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC
Confidence 54322 2234568999999999975443 345778999999999999999999999999888877766666
Q ss_pred CCC-----CCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 259 PES-----PKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 259 ~~~-----~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
|++ ...+..+.++|..||.+|-++||+..+++.
T Consensus 244 PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 244 PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 554 356789999999999999999999998864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=291.38 Aligned_cols=257 Identities=27% Similarity=0.456 Sum_probs=202.0
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-H-HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecC---
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-E-ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLG--- 98 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-~-e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~--- 98 (690)
...|.-..+||+|.||+||+|+.. +.++.||+|++...+ . ..-...++|+++|..|+ |+||+.|+..|..-..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~-n~~kkvalkkvlmeneKeGfpitalreikiL~~lk-Henv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSK-NTGKKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKATPTN 93 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhc-CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhccCCcc
Confidence 456777889999999999999986 678889998775432 2 23466789999999996 9999999776543221
Q ss_pred -CCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCC
Q 005577 99 -RTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS 177 (690)
Q Consensus 99 -~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGl 177 (690)
....+|+||.+|..+|.-+|.++. ..|+..++..++.+++.||.|+|.+. |+|||+||+|+||+.+|.+||+|||+
T Consensus 94 r~r~t~ylVf~~cehDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEHDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred cccceeeeeHHHhhhhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeecccc
Confidence 223489999999999998887654 34999999999999999999999999 99999999999999999999999999
Q ss_pred CCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh----
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN---- 253 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~---- 253 (690)
++.+..... .........+-|.+|.+||. .+....|+++.|||+.|||+.||+++.+.|.+.+..+.+.
T Consensus 171 ar~fs~~~n-----~~kprytnrvvTLwYrppEl--lLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~ 243 (376)
T KOG0669|consen 171 ARAFSTSKN-----VVKPRYTNRVVTLWYRPPEL--LLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ 243 (376)
T ss_pred ccceecccc-----cCCCCcccceeeeecCCHHH--hhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence 986543221 12222334566999999997 4667789999999999999999999999999887655332
Q ss_pred --ccCC---CCCC--------------C--------------CCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 254 --GNYR---IPES--------------P--------------KYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 254 --~~~~---~~~~--------------~--------------~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
+... +|.. + .-.++..+||..||..||.+|+++.+++.+
T Consensus 244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1110 0000 0 113578899999999999999999998654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=306.98 Aligned_cols=238 Identities=27% Similarity=0.415 Sum_probs=201.4
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeec---CCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC---NDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~---~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.++.++..||-||||.|=++... .....+|+|++.+ .+....+.+..|-+||..++ .|.||+||-.|. +.+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~-~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfr----d~k 493 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVN-SQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFR----DSK 493 (732)
T ss_pred hhhhhhhhcccCccceEEEEEec-ccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhc----cch
Confidence 46677889999999999999864 1222478887743 45667788999999999996 999999997643 568
Q ss_pred eEEEEEecC-CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~-~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
.+|++||-| +|.++..|..++. |++..+..|+..++.|++|||++| ||+|||||+|+||+.+|.+||.|||+|+.
T Consensus 494 yvYmLmEaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKk 569 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKK 569 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHH
Confidence 899999998 7889999987765 999999999999999999999999 99999999999999999999999999976
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH----HhccC
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI----LNGNY 256 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~i----l~~~~ 256 (690)
+.. .....++||||.|.|||+ +..+..+.++|.||||+++|||++|.+||.+.++... +.+.-
T Consensus 570 i~~----------g~KTwTFcGTpEYVAPEI---ILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid 636 (732)
T KOG0614|consen 570 IGS----------GRKTWTFCGTPEYVAPEI---ILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID 636 (732)
T ss_pred hcc----------CCceeeecCCcccccchh---hhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh
Confidence 432 334557899999999997 4456678999999999999999999999999887654 44444
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhCCCCCCC
Q 005577 257 RIPESPKYSSSVTDLIRDMLQASPDDRPD 285 (690)
Q Consensus 257 ~~~~~~~~s~~l~~LI~~~L~~dP~~RPt 285 (690)
.+..+..++....+||+++...+|.+|..
T Consensus 637 ~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 45556788999999999999999999976
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=278.46 Aligned_cols=220 Identities=22% Similarity=0.256 Sum_probs=173.4
Q ss_pred cCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEecCC-CcH
Q 005577 36 GGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCD-KSL 114 (690)
Q Consensus 36 GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy~~-gsL 114 (690)
|.||.||++++. .+++.||+|.+..... +.+|...+... .||||+++++++. .....||||||+. |+|
T Consensus 4 g~~~~v~~~~~~-~~~~~~~~K~i~~~~~-----~~~~~~~~~~~-~~~~i~~~~~~~~----~~~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDT-RTQQTFILKGLRKSSE-----YSRERLTIIPH-CVPNMVCLHKYIV----SEDSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEc-cCCcEEEEEeecchhh-----hhhHHHHHHhc-CCCceeehhhhee----cCCeEEEEEecCCCCCH
Confidence 889999999996 6788999999865432 23344455555 4999999998864 3478899999996 577
Q ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhhhhcccc
Q 005577 115 VNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIE 194 (690)
Q Consensus 115 l~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~ 194 (690)
.+.+.... .+++..+..++.||+.||.|||.++ |+||||||+|||++.++.++|+|||++......
T Consensus 73 ~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---------- 138 (237)
T cd05576 73 WSHISKFL--NIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---------- 138 (237)
T ss_pred HHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccc----------
Confidence 78776654 3899999999999999999999999 999999999999999999999999977543221
Q ss_pred ccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCCCCCCCCCCHHHHHHHHH
Q 005577 195 EDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRD 274 (690)
Q Consensus 195 ~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~~~~~~~~s~~l~~LI~~ 274 (690)
.....++..|+|||+ ..+..++.++|||||||++|+|++|..||...... .........+..++..+.+||.+
T Consensus 139 --~~~~~~~~~y~aPE~---~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~ 211 (237)
T cd05576 139 --CDGEAVENMYCAPEV---GGISEETEACDWWSLGAILFELLTGKTLVECHPSG--INTHTTLNIPEWVSEEARSLLQQ 211 (237)
T ss_pred --cccCCcCccccCCcc---cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--cccccccCCcccCCHHHHHHHHH
Confidence 112345778999996 44566889999999999999999999887643221 11112223345688999999999
Q ss_pred HhhhCCCCCCCHH
Q 005577 275 MLQASPDDRPDIT 287 (690)
Q Consensus 275 ~L~~dP~~RPt~~ 287 (690)
||+.||++||++.
T Consensus 212 ~l~~dp~~R~~~~ 224 (237)
T cd05576 212 LLQFNPTERLGAG 224 (237)
T ss_pred HccCCHHHhcCCC
Confidence 9999999999863
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=302.94 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=193.9
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH---HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE---ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~---e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
...-|..++.||-|+||+|.+++.. .+...||+|.+.+.+. ..+..+..|-.||... +.+-||+||-. |.+
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~Kv-DT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyyS----FQD 700 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKV-DTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYS----FQD 700 (1034)
T ss_pred cccceEEEeeecccccceeEEEeec-chhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEE----ecc
Confidence 3446888999999999999999864 6788999999876543 3445666788999988 69999999855 446
Q ss_pred CceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 100 TKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
...+|+||+|+. |++..+|.+.+- |+|..++.++.+|.+|++++|..| +|||||||+|||||.||++||.||||+
T Consensus 701 kdnLYFVMdYIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 701 KDNLYFVMDYIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred CCceEEEEeccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeecccc
Confidence 789999999995 677888887754 999999999999999999999999 999999999999999999999999987
Q ss_pred Ccccccc-----------------------------hhhhhc----cccccccccCCCCcccCccchhhhhcCCCCchhh
Q 005577 179 STNHKRF-----------------------------EKLEEM----GIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVD 225 (690)
Q Consensus 179 ~~~~~~~-----------------------------~~~~~~----~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksD 225 (690)
.-+.-.. ..+... .........+||+.|+|||| +....|+.-+|
T Consensus 777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapev---l~r~g~~q~cd 853 (1034)
T KOG0608|consen 777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEV---LARTGYTQLCD 853 (1034)
T ss_pred ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHH---hcccCccccch
Confidence 4321100 000000 00111224578999999998 45677999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCchHH----HHHh--ccCCCCCCCCCCHHHHHHHHHHhhhCCCCCC
Q 005577 226 IWALGCLLFRICYFKNAFDGESKL----QILN--GNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284 (690)
Q Consensus 226 VwSLGviLyELltG~~PF~~~~~~----~il~--~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RP 284 (690)
+||.|||||||+.|+.||...... .+++ ..+.++...+++.++.+||.+++ .+++.|.
T Consensus 854 wws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 854 WWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred hhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 999999999999999999765543 3332 33456667789999999998864 5777774
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=310.38 Aligned_cols=264 Identities=22% Similarity=0.352 Sum_probs=215.6
Q ss_pred eEeecCceEEEEEEeeecCceEEEEEEEcc--c----CCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEE
Q 005577 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDAI--H----MSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYA 91 (690)
Q Consensus 19 ~iei~~~ry~v~~~LG~GgFG~VylA~d~~--~----~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~ 91 (690)
.+++......+.+.||+|.||.|++|.-.. . ....||||.+... +....+.+..|+.+|+.+..|+|||.+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 688888888888899999999999997421 1 2457999988643 34567889999999999988999999999
Q ss_pred EEEeecCCCceEEEEEecC-CCcHHHHHHHhC------C--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCC
Q 005577 92 HTILDLGRTKEALLVMECC-DKSLVNVLENRG------A--------GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRD 156 (690)
Q Consensus 92 ~~~~~~~~~~~~~LVmEy~-~gsLl~~L~~~~------~--------~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRD 156 (690)
+|.. .+.+++|+||+ .|+|+.+|..+. . ..|...+++.++.||+.|++||++.. +||||
T Consensus 370 ~~t~----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRD 443 (609)
T KOG0200|consen 370 ACTQ----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRD 443 (609)
T ss_pred eecc----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchh
Confidence 8763 57889999999 588999998765 0 12889999999999999999999999 99999
Q ss_pred CCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHH
Q 005577 157 LKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI 236 (690)
Q Consensus 157 LKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyEL 236 (690)
|...||||..+..+||+|||+++............ ....-...|||||. +....|+.++|||||||+||||
T Consensus 444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~------~~~~LP~kWmApEs---l~~~~ft~kSDVWSfGI~L~Ei 514 (609)
T KOG0200|consen 444 LAARNVLITKNKVIKIADFGLARDHYNKDYYRTKS------SAGTLPVKWMAPES---LFDRVFTSKSDVWSFGILLWEI 514 (609)
T ss_pred hhhhhEEecCCCEEEEccccceeccCCCCceEecC------CCCccceeecCHHH---hccCcccccchhhHHHHHHHHH
Confidence 99999999999999999999998543221110000 00002456999995 5567899999999999999999
Q ss_pred Hh-CCCCCCCch----HHHHHhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 237 CY-FKNAFDGES----KLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 237 lt-G~~PF~~~~----~~~il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
++ |..||.+.. ..+.+...+++..+..++.++.++|+.||..+|++||++.++...+...+
T Consensus 515 fsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 515 FTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred hhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 98 888998732 23456778888888999999999999999999999999999988777643
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-33 Score=291.97 Aligned_cols=255 Identities=23% Similarity=0.333 Sum_probs=199.6
Q ss_pred CCCceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCC-CC----ceEE
Q 005577 15 LEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGH-PN----VVTL 89 (690)
Q Consensus 15 ~~g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~H-PN----IVkL 89 (690)
+..+.-|+...||.+...||+|.||.|-.+.|. ..+..||||++... ....+..+-|+++|.+|..+ |+ +|.+
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~-~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDR-ETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeec-CCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 444556667789999999999999999999997 44889999987433 33456677899999999523 33 6777
Q ss_pred EEEEEeecCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCC--
Q 005577 90 YAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD-- 167 (690)
Q Consensus 90 ~~~~~~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~d-- 167 (690)
.++|- -.++.|||+|.++-+++++|..++-.+|+..+++.|..|||.++.|||+.+ |+|-||||+|||+.+.
T Consensus 157 ~~wFd----yrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~ 230 (415)
T KOG0671|consen 157 RDWFD----YRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEY 230 (415)
T ss_pred ehhhh----ccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccce
Confidence 66543 357899999999999999999988778999999999999999999999999 9999999999999432
Q ss_pred ------------------CCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHH
Q 005577 168 ------------------GLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWAL 229 (690)
Q Consensus 168 ------------------g~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSL 229 (690)
-.|+|+|||.|+..+... ...+.|..|.|||| +.+-.++..+||||+
T Consensus 231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h------------s~iVsTRHYRAPEV---iLgLGwS~pCDvWSi 295 (415)
T KOG0671|consen 231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH------------STIVSTRHYRAPEV---ILGLGWSQPCDVWSI 295 (415)
T ss_pred EEEeccCCccceeccCCCcceEEEecCCcceeccCc------------ceeeeccccCCchh---eeccCcCCccCceee
Confidence 247899999987643321 23467999999998 445668999999999
Q ss_pred HHHHHHHHhCCCCCCCchHHH---HHhccCC----------------------CCC-------------C----------
Q 005577 230 GCLLFRICYFKNAFDGESKLQ---ILNGNYR----------------------IPE-------------S---------- 261 (690)
Q Consensus 230 GviLyELltG~~PF~~~~~~~---il~~~~~----------------------~~~-------------~---------- 261 (690)
||||+||++|...|.+.+..+ +++..+. ++. +
T Consensus 296 GCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~ 375 (415)
T KOG0671|consen 296 GCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQD 375 (415)
T ss_pred eeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccC
Confidence 999999999999998765332 2221111 000 0
Q ss_pred CCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 262 PKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 262 ~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
......|.+||.+||..||.+|+|+.|++.+
T Consensus 376 d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 376 DLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred cHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 0112457899999999999999999998643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=281.06 Aligned_cols=247 Identities=27% Similarity=0.389 Sum_probs=202.4
Q ss_pred CceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeec---CCHHHHHHHHHHHHHHHhhcCCCCceEEEEEE
Q 005577 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC---NDEESLESAMKEISVMKSLKGHPNVVTLYAHT 93 (690)
Q Consensus 17 g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~---~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~ 93 (690)
+.++.++-.+|+++++||+|+|..|.+++.. ++.+.||+|++.+ ++.+.+.-...|-.+..+..+||.+|.|+.+|
T Consensus 242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~-~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf 320 (593)
T KOG0695|consen 242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLK-KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF 320 (593)
T ss_pred ccccccccccceeeeeecCcchhhhhheehc-ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh
Confidence 3566778889999999999999999999985 7889999998854 56677777888999999988999999998775
Q ss_pred EeecCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeee
Q 005577 94 ILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLC 173 (690)
Q Consensus 94 ~~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~ 173 (690)
. ....+++|.||++|+.+-+-..+.+ .|+++.++.+...|+.||.|||++| ||+||||.+|||||..|++||.
T Consensus 321 q----tesrlffvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghiklt 393 (593)
T KOG0695|consen 321 Q----TESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLT 393 (593)
T ss_pred c----ccceEEEEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeec
Confidence 4 4578999999997654433333332 3999999999999999999999999 9999999999999999999999
Q ss_pred ccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCC-------c
Q 005577 174 DFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDG-------E 246 (690)
Q Consensus 174 DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~-------~ 246 (690)
|+|+.+.... ......+.+|||.|+|||+ +++..|+..+|+|+|||+++||+.|+.||+- .
T Consensus 394 dygmcke~l~---------~gd~tstfcgtpnyiapei---lrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ 461 (593)
T KOG0695|consen 394 DYGMCKEGLG---------PGDTTSTFCGTPNYIAPEI---LRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDM 461 (593)
T ss_pred ccchhhcCCC---------CCcccccccCCCcccchhh---hcccccCceehHHHHHHHHHHHHcCCCCcceecCCCccc
Confidence 9998864322 1223456899999999996 7889999999999999999999999999962 1
Q ss_pred hHH----H-HHhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCC
Q 005577 247 SKL----Q-ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPD 285 (690)
Q Consensus 247 ~~~----~-il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt 285 (690)
+.. + ++....++|. .++-....+++..|.+||.+|..
T Consensus 462 ntedylfqvilekqiripr--slsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 462 NTEDYLFQVILEKQIRIPR--SLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred chhHHHHHHHhhhcccccc--eeehhhHHHHHHhhcCCcHHhcC
Confidence 111 2 3444555543 56777888999999999999954
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=285.61 Aligned_cols=139 Identities=25% Similarity=0.312 Sum_probs=124.4
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCC-------CCceEEEEEEEee
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGH-------PNVVTLYAHTILD 96 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~H-------PNIVkL~~~~~~~ 96 (690)
+.||.|.++||.|-|++||+|.|. ...+.||+|+.... ....+..+.||++|++++.+ .+||+|+++|.+.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDt-q~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDT-QNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeec-cCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 479999999999999999999996 67889999987543 33457788999999999743 3799999999999
Q ss_pred cCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeC
Q 005577 97 LGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLG 165 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd 165 (690)
...+.++|||+|+++.+|+.+|....-..++...+..|++||+.||.|||... +|||-||||+||||.
T Consensus 155 GpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeeee
Confidence 88899999999999999999999887677999999999999999999999984 499999999999995
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=264.02 Aligned_cols=226 Identities=22% Similarity=0.360 Sum_probs=182.3
Q ss_pred ceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEee
Q 005577 18 RSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 18 ~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~ 96 (690)
+.++|....+.....||+|+||.|-+-++. .++...|+|.+... +.....+.++|+.+..+..++|.+|++||...
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~-~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~-- 115 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHI-QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF-- 115 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeec-cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh--
Confidence 336677777777889999999999999885 78999999998653 34456788899999988888999999999643
Q ss_pred cCCCceEEEEEecCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeec
Q 005577 97 LGRTKEALLVMECCDKSLVNVLEN--RGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCD 174 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~gsLl~~L~~--~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~D 174 (690)
+...++|.||.|+-+|..+..+ ...+.++|.-+-+|+..++.||.|||++- .|||||+||.||||+.+|+||+||
T Consensus 116 --regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 116 --REGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred --ccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccCCcEEEcc
Confidence 4577999999999888765543 22346999999999999999999999983 399999999999999999999999
Q ss_pred cCCCCcccccchhhhhccccccccccCCCCcccCccchhh-hhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc-hHHHHH
Q 005577 175 FGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDL-FRRELINEKVDIWALGCLLFRICYFKNAFDGE-SKLQIL 252 (690)
Q Consensus 175 FGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~-~~~~~~s~ksDVwSLGviLyELltG~~PF~~~-~~~~il 252 (690)
||++-.+.+....... .|.-.|||||.++. +....|+-++||||||+++.||.+++.||+.. ++.+++
T Consensus 193 FGIsG~L~dSiAkt~d----------aGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qL 262 (282)
T KOG0984|consen 193 FGISGYLVDSIAKTMD----------AGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQL 262 (282)
T ss_pred cccceeehhhhHHHHh----------cCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHH
Confidence 9998766554433222 36778999997642 23347999999999999999999999999864 566666
Q ss_pred hccCCCC
Q 005577 253 NGNYRIP 259 (690)
Q Consensus 253 ~~~~~~~ 259 (690)
.+....+
T Consensus 263 kqvVeep 269 (282)
T KOG0984|consen 263 KQVVEEP 269 (282)
T ss_pred HHHhcCC
Confidence 6655443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=303.84 Aligned_cols=253 Identities=19% Similarity=0.262 Sum_probs=164.0
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccC----CeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEee--
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHM----SKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILD-- 96 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~----~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~-- 96 (690)
...+|.+.++||+|+||.||+|.+. .. +..||||++...... +....| .++... +.+++.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~-~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~-~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLV-NKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRAC-PNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEc-CCccccCcEEEEEEecccchh--HHHHHH--HHHhhc-hhhHHHHHHhhhcccc
Confidence 4568999999999999999999985 45 788999987543211 111111 111111 22333222111110
Q ss_pred cCCCceEEEEEecCCC-cHHHHHHHhCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCC
Q 005577 97 LGRTKEALLVMECCDK-SLVNVLENRGAG------------------YFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDL 157 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~g-sLl~~L~~~~~~------------------~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDL 157 (690)
......++|||||+++ +|.+++...... ...+..+..|+.||+.||.|||+++ ||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDL 281 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDV 281 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcC
Confidence 1245678999999964 676766543211 0123456689999999999999999 999999
Q ss_pred CCCcEEeCC-CCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhh-------------------c
Q 005577 158 KAENLLLGS-DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFR-------------------R 217 (690)
Q Consensus 158 KP~NILLd~-dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~-------------------~ 217 (690)
||+||||+. ++.+||+|||+++.+.... .......++++.|||||++.... .
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~--------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~ 353 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGI--------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 353 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccc--------ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcc
Confidence 999999986 5799999999997543211 11122357899999999642111 1
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHh-ccCC---------CCCC----------CCCCHHHHHHHHHH
Q 005577 218 ELINEKVDIWALGCLLFRICYFKNAFDGESKL--QILN-GNYR---------IPES----------PKYSSSVTDLIRDM 275 (690)
Q Consensus 218 ~~~s~ksDVwSLGviLyELltG~~PF~~~~~~--~il~-~~~~---------~~~~----------~~~s~~l~~LI~~~ 275 (690)
..++.++||||||||||||+++..+++..... .++. ..+. .... ........+||.+|
T Consensus 354 ~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 354 LNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred ccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence 12455679999999999999987766543211 1111 0000 0000 01123455899999
Q ss_pred hhhCCCCCCCHHHHHH
Q 005577 276 LQASPDDRPDITQVWF 291 (690)
Q Consensus 276 L~~dP~~RPt~~eil~ 291 (690)
|++||.+||++.+++.
T Consensus 434 L~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 434 MRFKGRQRISAKAALA 449 (566)
T ss_pred ccCCcccCCCHHHHhC
Confidence 9999999999999864
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=279.53 Aligned_cols=260 Identities=22% Similarity=0.327 Sum_probs=195.6
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhh-cCCCCceEEEEEEEeecCCCce
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSL-KGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L-~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
..++++.+.||+|.||+||+|++ .|+.||||++...++..+ ++|.+|.... -+|+||+.+++....+.+.-..
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w---rGe~VAVKiF~srdE~SW---frEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW---RGEDVAVKIFSSRDERSW---FRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hheeEEEEEecCccccceeeccc---cCCceEEEEecccchhhh---hhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 46899999999999999999998 488999999988776554 5677776652 1599999999887666555568
Q ss_pred EEEEEecC-CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC-----C-CCcccCCCCCCcEEeCCCCCeeeecc
Q 005577 103 ALLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQ-----S-PPIAHRDLKAENLLLGSDGLWKLCDF 175 (690)
Q Consensus 103 ~~LVmEy~-~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~-----g-~~IVHRDLKP~NILLd~dg~vKL~DF 175 (690)
++||.+|. .|+|+++|.+.. ++....++++..++.||++||.. | +.|.|||||..||||..+|.+.|+|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r~t---v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRNT---VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEeeecccCCcHHHHHhhcc---CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 99999999 589999997743 89999999999999999999964 2 45999999999999999999999999
Q ss_pred CCCCcccccchhhhhccccccccccCCCCcccCccchhhhhc-CCC--CchhhHHHHHHHHHHHHh----------CCCC
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRR-ELI--NEKVDIWALGCLLFRICY----------FKNA 242 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~-~~~--s~ksDVwSLGviLyELlt----------G~~P 242 (690)
|||........ .+.......+||-+|||||+++.-.. ..+ -..+||||||+|+||++. -+.|
T Consensus 361 GLAv~h~~~t~-----~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 361 GLAVRHDSDTD-----TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred eeeEEecccCC-----cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 99976543322 23334456799999999999652211 111 135899999999999974 2467
Q ss_pred CCCc-----hHHHHH----hccCCCCCCCCC-----CHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 243 FDGE-----SKLQIL----NGNYRIPESPKY-----SSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 243 F~~~-----~~~~il----~~~~~~~~~~~~-----s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
|.+. +..++. .+.++...+... -..+..||+.||..+|..|.|+-.|-..+.++.
T Consensus 436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred cccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 7542 222221 122332222211 234567899999999999999988876665543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=257.56 Aligned_cols=232 Identities=34% Similarity=0.488 Sum_probs=187.3
Q ss_pred CceEEEEEEEcccCCeEEEEEEeecCCHHH-HHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEecCCC-cH
Q 005577 37 GFSCVYSARDAIHMSKQYAMKHMICNDEES-LESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SL 114 (690)
Q Consensus 37 gFG~VylA~d~~~~~k~vAvK~i~~~~~e~-~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy~~g-sL 114 (690)
+||.||+|.+. ..++.+++|++....... .+.+.+|+++++++ +|+||+++++++.. ....++||||+++ +|
T Consensus 1 ~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~----~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDK-KTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFED----EDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEEC-CCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheee----CCEEEEEEeCCCCCCH
Confidence 68999999985 467899999987654433 67889999999999 59999999988653 3678999999977 78
Q ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhhhhcccc
Q 005577 115 VNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIE 194 (690)
Q Consensus 115 l~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~ 194 (690)
..++..... ++...++.++.+++.+|.|||..+ |+|+||+|.||+++.++.++|+|||++.......
T Consensus 75 ~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------- 141 (244)
T smart00220 75 FDLLKKRGR--LSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--------- 141 (244)
T ss_pred HHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc---------
Confidence 777765443 899999999999999999999999 9999999999999999999999999886543211
Q ss_pred ccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHhcc---CCCCCCCC--CCHHH
Q 005577 195 EDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDG-ESKLQILNGN---YRIPESPK--YSSSV 268 (690)
Q Consensus 195 ~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~-~~~~~il~~~---~~~~~~~~--~s~~l 268 (690)
......++..|++||+ ..+..++.++|||+||+++|+|++|..||.. .....+.... ........ ++..+
T Consensus 142 -~~~~~~~~~~~~~pE~---~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (244)
T smart00220 142 -LLTTFVGTPEYMAPEV---LLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEA 217 (244)
T ss_pred -ccccccCCcCCCCHHH---HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHH
Confidence 1123457889999996 4466788999999999999999999999977 3333332211 11111111 88999
Q ss_pred HHHHHHHhhhCCCCCCCHHHHHH
Q 005577 269 TDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 269 ~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.+++.+||..+|++||++.+++.
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 99999999999999999999874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=318.29 Aligned_cols=238 Identities=23% Similarity=0.284 Sum_probs=179.8
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALL 105 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~L 105 (690)
.|...++||+|+||.||+|++. ..++.||||.+...... ...|+++|++++ |||||+++++|.. ....|+
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~l~~l~-HpnIv~~~~~~~~----~~~~~l 760 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSI-KNGMQFVVKEINDVNSI----PSSEIADMGKLQ-HPNIVKLIGLCRS----EKGAYL 760 (968)
T ss_pred hCCcccEEccCCCeeEEEEEEC-CCCcEEEEEEccCCccc----cHHHHHHHhhCC-CCCcceEEEEEEc----CCCCEE
Confidence 4556778999999999999984 57889999988543221 234688899995 9999999999753 356899
Q ss_pred EEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 106 VMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH---SQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 106 VmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLH---s~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
|||||. |+|.+++.. +++..+..|+.||+.||.||| ..+ |+||||||+|||++.++..+++ ||.....
T Consensus 761 v~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 761 IHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPA--VVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred EEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCC--eecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 999996 567776642 788999999999999999999 446 9999999999999999887775 6654321
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHHhccC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES-----KLQILNGNY 256 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~-----~~~il~~~~ 256 (690)
.. .....||+.|||||+ +.+..++.++|||||||++|||++|+.||+... ........+
T Consensus 833 ~~-------------~~~~~~t~~y~aPE~---~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 896 (968)
T PLN00113 833 CT-------------DTKCFISSAYVAPET---RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCY 896 (968)
T ss_pred cc-------------CCCccccccccCccc---ccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhc
Confidence 11 112357899999996 456779999999999999999999999985421 111110000
Q ss_pred -----------CCC----CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 257 -----------RIP----ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 257 -----------~~~----~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
... .......++.+++.+||+.||++||++.+++..+....
T Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 897 SDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 000 00112235678999999999999999999998887654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=281.79 Aligned_cols=269 Identities=21% Similarity=0.244 Sum_probs=197.3
Q ss_pred CCCCCCceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhc-CCCCceEEE
Q 005577 12 PTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK-GHPNVVTLY 90 (690)
Q Consensus 12 ~~~~~g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~-~HPNIVkL~ 90 (690)
..+-.+.+.-+...-+++..+||+|.||+||+|.. .++.||||++.. +..+.+..|-+|..... .|+||++++
T Consensus 197 d~~~~~sspl~~l~pl~l~eli~~Grfg~V~KaqL---~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi 270 (534)
T KOG3653|consen 197 DSGPAPSSPLLELDPLQLLELIGRGRFGCVWKAQL---DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFI 270 (534)
T ss_pred CCCCCCCcccccCCchhhHHHhhcCccceeehhhc---cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhh
Confidence 45555555666677889999999999999999986 468999999854 34566777777777532 599999999
Q ss_pred EEEEeecCCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------CCcccCCCCCCcE
Q 005577 91 AHTILDLGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS-------PPIAHRDLKAENL 162 (690)
Q Consensus 91 ~~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g-------~~IVHRDLKP~NI 162 (690)
++-.........++||++|.+ |+|.++|..+- +++....+|+..+++||+|||..- ++|+|||||..||
T Consensus 271 ~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNV 347 (534)
T KOG3653|consen 271 GAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNV 347 (534)
T ss_pred chhccCCccccceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccce
Confidence 875544444557899999995 78889988764 899999999999999999999752 4699999999999
Q ss_pred EeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhc---CCCCchhhHHHHHHHHHHHHhC
Q 005577 163 LLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRR---ELINEKVDIWALGCLLFRICYF 239 (690)
Q Consensus 163 LLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~---~~~s~ksDVwSLGviLyELltG 239 (690)
||..|+++.|+|||+|..+..... ..+....+||.+|||||++..... ...-.+.||||+|.|||||++.
T Consensus 348 LvK~DlTccIaDFGLAl~~~p~~~-------~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SR 420 (534)
T KOG3653|consen 348 LVKNDLTCCIADFGLALRLEPGKP-------QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASR 420 (534)
T ss_pred EEccCCcEEeeccceeEEecCCCC-------CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhh
Confidence 999999999999999977543211 223334689999999998642211 1122468999999999999864
Q ss_pred CC------------CCCC-----chHHHH----HhccCCCCCC-----CCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 240 KN------------AFDG-----ESKLQI----LNGNYRIPES-----PKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 240 ~~------------PF~~-----~~~~~i----l~~~~~~~~~-----~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
.. ||.. .+..++ +....|...+ .....-+++.|..||..|++.|.|+.=+..|+
T Consensus 421 C~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~ 500 (534)
T KOG3653|consen 421 CTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERM 500 (534)
T ss_pred cccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence 43 3321 011111 1111111111 12345688899999999999999988777776
Q ss_pred hhh
Q 005577 294 NEQ 296 (690)
Q Consensus 294 ~~~ 296 (690)
.++
T Consensus 501 ~~l 503 (534)
T KOG3653|consen 501 AEL 503 (534)
T ss_pred HHH
Confidence 654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=296.15 Aligned_cols=255 Identities=20% Similarity=0.287 Sum_probs=209.5
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccC---CeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHM---SKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~---~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
....+..++||.|+||+||+|.+-.+. .-.||||++... ..+....++.|+-+|.+| +||||++|++++..+
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s--- 770 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLS--- 770 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccc---
Confidence 334556789999999999999885331 235788887544 445567899999999999 599999999998754
Q ss_pred CceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 100 TKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
.+.||++||+ |.|+++++.+. +.+-.+..+.|..||++||.|||.+. +|||||-..||||..-..+||.|||++
T Consensus 771 --~~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 771 --TLQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred --hHHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchh
Confidence 3779999996 78888887654 45889999999999999999999999 999999999999999999999999999
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCchHHH---HHhc
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQ---ILNG 254 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~---il~~ 254 (690)
+.+......+...+ ....+-|||=|. ++...|+.++|||||||++||++| |..|+++....+ .++.
T Consensus 846 ~ll~~d~~ey~~~~-------gK~pikwmale~---i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ 915 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPG-------GKVPIKWMALES---IRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK 915 (1177)
T ss_pred hccCcccccccccc-------cccCcHHHHHHH---hhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc
Confidence 87654332222111 123678999995 677889999999999999999998 899999876554 4666
Q ss_pred cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 255 NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 255 ~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
..+++.++.++-++..+|.+||..|++.||++.++...+.+.+
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 7788899999999999999999999999999999976665443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=287.16 Aligned_cols=260 Identities=17% Similarity=0.228 Sum_probs=180.4
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEc---------------ccCCeEEEEEEeecCCHHHHHH--------------HHH
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDA---------------IHMSKQYAMKHMICNDEESLES--------------AMK 72 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~---------------~~~~k~vAvK~i~~~~~e~~e~--------------~~~ 72 (690)
+...+|.+.++||+|+||+||+|.+. ...++.||||++........+. ...
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 35779999999999999999999641 1234679999986543332233 334
Q ss_pred HHHHHHhhcCCCC-----ceEEEEEEEeecC----CCceEEEEEecCC-CcHHHHHHHhCC-------------------
Q 005577 73 EISVMKSLKGHPN-----VVTLYAHTILDLG----RTKEALLVMECCD-KSLVNVLENRGA------------------- 123 (690)
Q Consensus 73 Ei~iL~~L~~HPN-----IVkL~~~~~~~~~----~~~~~~LVmEy~~-gsLl~~L~~~~~------------------- 123 (690)
|+.++.+++ |.+ +++++++|..... .....+|||||+. ++|.+++.....
T Consensus 222 E~~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 222 EAYMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 677777775 443 4667776654321 2346799999995 567776653211
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhhhhcccccccccc
Q 005577 124 ---GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRK 200 (690)
Q Consensus 124 ---~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~ 200 (690)
..+++..++.++.||+.+|.|||..+ |+||||||+|||++.++.+||+|||+++...... .......
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~--------~~~~~~g 370 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI--------NFNPLYG 370 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCC--------ccCcccc
Confidence 12456778899999999999999999 9999999999999999999999999986432211 0111112
Q ss_pred CCCCcccCccchhhhhc-------------------CCCCchhhHHHHHHHHHHHHhCCC-CCCCchHH----H------
Q 005577 201 HTTPAYRAPEMWDLFRR-------------------ELINEKVDIWALGCLLFRICYFKN-AFDGESKL----Q------ 250 (690)
Q Consensus 201 ~GT~~YmAPEvl~~~~~-------------------~~~s~ksDVwSLGviLyELltG~~-PF~~~~~~----~------ 250 (690)
.+|+.|+|||++..... .....+.||||+|||+|+|+++.. ||.+.... .
T Consensus 371 ~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~ 450 (507)
T PLN03224 371 MLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDL 450 (507)
T ss_pred CCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchH
Confidence 35889999997421100 011234799999999999999875 66532111 0
Q ss_pred -----HHhccCCCCCCCCCCHHHHHHHHHHhhhCC---CCCCCHHHHHHH
Q 005577 251 -----ILNGNYRIPESPKYSSSVTDLIRDMLQASP---DDRPDITQVWFR 292 (690)
Q Consensus 251 -----il~~~~~~~~~~~~s~~l~~LI~~~L~~dP---~~RPt~~eil~~ 292 (690)
+....+.+.....+++...+||.+||.++| .+|+++.|++.+
T Consensus 451 ~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 451 NRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred HHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 011223344445678999999999999876 689999998753
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=287.61 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=197.9
Q ss_pred eecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhc-----CCCCceEEEEEEEe
Q 005577 21 DVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK-----GHPNVVTLYAHTIL 95 (690)
Q Consensus 21 ei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~-----~HPNIVkL~~~~~~ 95 (690)
++.+.+|.|....|+|=|++|..|.|. ..+..||||+|..+... ...=++|++||++|. +--|+|+||-+|.
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~-~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~- 504 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQ-ARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFK- 504 (752)
T ss_pred hhhcceeEEEeccccceeeeeeecccc-CCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh-
Confidence 556789999999999999999999996 56779999998665432 344568999999996 2358999998865
Q ss_pred ecCCCceEEEEEecCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCC-CCeeee
Q 005577 96 DLGRTKEALLVMECCDKSLVNVLENRGA-GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD-GLWKLC 173 (690)
Q Consensus 96 ~~~~~~~~~LVmEy~~gsLl~~L~~~~~-~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~d-g~vKL~ 173 (690)
..+++|||+|-+.-+|.++|...+. -.|....+..|+.||..||..|-..| |+|.||||+|||++.. ..+|||
T Consensus 505 ---hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 505 ---HKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred ---hcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeec
Confidence 4589999999999999999998763 35899999999999999999999999 9999999999999876 468999
Q ss_pred ccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh
Q 005577 174 DFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN 253 (690)
Q Consensus 174 DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~ 253 (690)
|||.|......- ......+..|.|||+ +.+-.|+...|+||.||+||||.||+..|.|.+.-+++.
T Consensus 580 DfGSA~~~~ene-----------itPYLVSRFYRaPEI---iLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 580 DFGSASFASENE-----------ITPYLVSRFYRAPEI---ILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred cCcccccccccc-----------ccHHHHHHhccCcce---eecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 999885432211 111233678999997 557789999999999999999999999998865543321
Q ss_pred ------cc---------------CCC-------------------------C---------CCCCC-------CHHHHHH
Q 005577 254 ------GN---------------YRI-------------------------P---------ESPKY-------SSSVTDL 271 (690)
Q Consensus 254 ------~~---------------~~~-------------------------~---------~~~~~-------s~~l~~L 271 (690)
+. +.. | ..+.+ -..+.+|
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL 725 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL 725 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence 10 000 0 00012 2468899
Q ss_pred HHHHhhhCCCCCCCHHHHHHH
Q 005577 272 IRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 272 I~~~L~~dP~~RPt~~eil~~ 292 (690)
|..||..||++|.+..+.|.+
T Consensus 726 Ldkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 726 LDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHhccChhhcCCHHHHhcC
Confidence 999999999999999988643
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-32 Score=271.30 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=190.8
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeec--CCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec-CCCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC--NDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL-GRTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~--~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~-~~~~~ 102 (690)
+++-.+.||-|+||+||.+.|. ..++.|++|++.. .+...-.++++|+++|..++ |.||+.+++...-.. .-..+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDP-RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDP-RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred cCCCCCcccccceeEEEeccCC-CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHH
Confidence 4455678999999999999996 7899999999853 23445678999999999996 999998876521000 00134
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
+|+|+|+|..+|...|..-. .|+.+.+.-++.||+.||.|||+.+ |+||||||.|+|++.+..+||||||+++...
T Consensus 132 iYV~TELmQSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 132 LYVLTELMQSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHHHhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccc
Confidence 67889999888887776543 4999999999999999999999999 9999999999999999999999999998754
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh---------
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN--------- 253 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~--------- 253 (690)
.+.... ....+-|-.|.|||+ ++....|+.++||||.|||+.||+..+..|...++.+.+.
T Consensus 208 ~d~~~h--------MTqEVVTQYYRAPEi--LMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTP 277 (449)
T KOG0664|consen 208 QRDRLN--------MTHEVVTQYYRAPEL--LMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTP 277 (449)
T ss_pred hhhhhh--------hHHHHHHHHhccHHH--hhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCC
Confidence 432221 112244889999998 4556679999999999999999999998887665543221
Q ss_pred ------------------ccCCCCCC---------CCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 254 ------------------GNYRIPES---------PKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 254 ------------------~~~~~~~~---------~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
+..+.|.. ..-..+...++..+|..||++|.+..+.+.
T Consensus 278 s~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 278 SQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred cHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 11111111 122345677889999999999998887754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=292.14 Aligned_cols=245 Identities=25% Similarity=0.433 Sum_probs=189.2
Q ss_pred eEEEEEEeeecCce-EEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 26 KIHVRNVIAEGGFS-CVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 26 ry~v~~~LG~GgFG-~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
-|.-.+++|.|.-| .||+|.. .++.||||.+.. +....+.+|+..|..-.+|||||++|+. ..+....|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y---e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~----E~d~qF~Y 579 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY---EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCS----EQDRQFLY 579 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee---CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEee----ccCCceEE
Confidence 44445678999776 6799986 588999998743 3345677999999999899999999876 23557899
Q ss_pred EEEecCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCC---CC--CeeeeccCC
Q 005577 105 LVMECCDKSLVNVLENRGA--GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS---DG--LWKLCDFGS 177 (690)
Q Consensus 105 LVmEy~~gsLl~~L~~~~~--~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~---dg--~vKL~DFGl 177 (690)
|+.|.|..+|.+++..... .....-..+.++.|++.||++||+.+ ||||||||.||||+. ++ +++|+|||+
T Consensus 580 IalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl 657 (903)
T KOG1027|consen 580 IALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGL 657 (903)
T ss_pred EEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccccc
Confidence 9999999999999987411 11111446789999999999999999 999999999999976 34 689999999
Q ss_pred CCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhC-CCCCCCchHH--HHHhc
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF-KNAFDGESKL--QILNG 254 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG-~~PF~~~~~~--~il~~ 254 (690)
++.+......+.+ .....||-+|+|||+ +....-+.++||||||||+|+.++| ..||...... .|+.+
T Consensus 658 sKkl~~~~sS~~r------~s~~sGt~GW~APE~---L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~ 728 (903)
T KOG1027|consen 658 SKKLAGGKSSFSR------LSGGSGTSGWQAPEQ---LREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG 728 (903)
T ss_pred ccccCCCcchhhc------ccCCCCcccccCHHH---HhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC
Confidence 9887655444433 223568999999997 4455556799999999999999885 8999875443 35555
Q ss_pred cCCCCCCC-CCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 255 NYRIPESP-KYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 255 ~~~~~~~~-~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.+.+.... ....+..+||.+||..+|..||++.+|+.
T Consensus 729 ~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 729 NYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 55432211 11128899999999999999999999964
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=255.35 Aligned_cols=244 Identities=20% Similarity=0.355 Sum_probs=191.7
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
..+|++.+++|+|.|++||.|.+. .+.+.++||++... ....+.+|+.||..|++||||++|+++.. .......
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~-~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~--Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINI-TNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVK--DPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhccccc-CCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhc--CccccCc
Confidence 358999999999999999999874 67788999988543 34567899999999999999999998754 2344567
Q ss_pred EEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCC-CeeeeccCCCCccc
Q 005577 104 LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG-LWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg-~vKL~DFGlA~~~~ 182 (690)
.||+||++...+..|... |+.-+++.++.+|+.||.|+|++| |+|||+||.|+|||... .++|+|+|+|...+
T Consensus 111 aLiFE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhHhhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 899999998887777653 788899999999999999999999 99999999999998764 69999999997665
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCC-CCchHHHHH---------
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAF-DGESKLQIL--------- 252 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF-~~~~~~~il--------- 252 (690)
..... .-.+.+..|--||.+ ..-..|+..-|+|||||+|..|+..+.|| .|.+..+.+
T Consensus 185 p~~eY----------nVRVASRyfKGPELL--Vdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt 252 (338)
T KOG0668|consen 185 PGKEY----------NVRVASRYFKGPELL--VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGT 252 (338)
T ss_pred CCcee----------eeeeehhhcCCchhe--eechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhCh
Confidence 43221 123457788999974 34456888999999999999999998887 333222111
Q ss_pred ------hccCCCC-----------------------C-CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 253 ------NGNYRIP-----------------------E-SPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 253 ------~~~~~~~-----------------------~-~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
-..+.+. . ..-.++++.+||.++|..|-.+|+|+.|.+.
T Consensus 253 ~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 253 DELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0011110 0 1134699999999999999999999999854
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=286.95 Aligned_cols=250 Identities=23% Similarity=0.394 Sum_probs=206.6
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
..+|++...+|.|.||.||+|+|. ..++..|+|++...-.+.+.-+.+|+-+++.++ |||||.+|+.+. ....+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~-~s~elaavkvVkLep~dd~~~iqqei~~~~dc~-h~nivay~gsyl----r~dkl 87 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDK-RSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCR-HPNIVAYFGSYL----RRDKL 87 (829)
T ss_pred ccchhheeeecCCcccchhhhccc-ccCchhhheeeeccCCccccccccceeeeecCC-CcChHHHHhhhh----hhcCc
Confidence 468999999999999999999996 789999999998776666777889999999996 999999998865 34678
Q ss_pred EEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 104 LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
+|+||||+|+.++.+.. ..+.+++.++..+++..+.||+|||+.| -+|||||-.|||+++.|.+||+|||.+-.+..
T Consensus 88 wicMEycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EEEEEecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhh
Confidence 99999997655554443 4467999999999999999999999999 89999999999999999999999998755432
Q ss_pred cchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHh----ccC---
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN----GNY--- 256 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~----~~~--- 256 (690)
... ....+.||+.||||||...-+.+.|...+|||++|++..|+.-.++|.-...+.+.+. ..+
T Consensus 165 ti~---------KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp 235 (829)
T KOG0576|consen 165 TIA---------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP 235 (829)
T ss_pred hhh---------hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC
Confidence 221 1234689999999999766677889999999999999999988888866655554432 222
Q ss_pred CCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 ~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
++......++.+.+|++.+|.++|++||++..++.
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 23334567899999999999999999999987753
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=260.19 Aligned_cols=260 Identities=15% Similarity=0.250 Sum_probs=210.5
Q ss_pred eEeecCceEEEEEEeeecCceEEEEEEEcc----cCCeEEEEEEeecC-CHHHHHHHHHHHHHHHhhcCCCCceEEEEEE
Q 005577 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDAI----HMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHT 93 (690)
Q Consensus 19 ~iei~~~ry~v~~~LG~GgFG~VylA~d~~----~~~k~vAvK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~ 93 (690)
.+.+...|+++..++-+|.||.||.|.+.. ...+.|.+|.+... .+-.+..++.|.-.|..+. ||||..+.+++
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~s-H~nll~V~~V~ 356 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGAS-HPNLLSVLGVS 356 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCc-CCCccceeEEE
Confidence 456678899999999999999999997641 23345667766443 4456788899999999996 99999999998
Q ss_pred EeecCCCceEEEEEecCC-CcHHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCC
Q 005577 94 ILDLGRTKEALLVMECCD-KSLVNVLENR------GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS 166 (690)
Q Consensus 94 ~~~~~~~~~~~LVmEy~~-gsLl~~L~~~------~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~ 166 (690)
+.+ ....+.++.+++ |+|..+|... +...++..+++.++.||+.|++|||.++ |||.||...|++|++
T Consensus 357 ie~---~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 357 IED---YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDD 431 (563)
T ss_pred eec---cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehh
Confidence 764 556778888886 7888888732 2234777889999999999999999999 999999999999999
Q ss_pred CCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 005577 167 DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDG 245 (690)
Q Consensus 167 dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF~~ 245 (690)
.-+|||+|=.+++.+-.. .+...+....-...||+||- +....|+.++|||||||+||||+| |+.||..
T Consensus 432 ~LqVkltDsaLSRDLFP~-------DYhcLGDnEnRPvkWMslEa---l~n~~yssasDvWsfGVllWELmtlg~~Pyae 501 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPG-------DYHCLGDNENRPVKWMSLEA---LQNSHYSSASDVWSFGVLLWELMTLGKLPYAE 501 (563)
T ss_pred heeEEeccchhccccCcc-------cccccCCCCCCcccccCHHH---HhhhhhcchhhhHHHHHHHHHHHhcCCCCccc
Confidence 999999999888754221 11111111123678999994 667889999999999999999998 8999987
Q ss_pred chHHH---HHhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 246 ESKLQ---ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 246 ~~~~~---il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
-++.+ .+...+++..+-+||+++..+|.-||+.+|++||++.|+..-+.
T Consensus 502 IDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 502 IDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred cCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 76655 47788999999999999999999999999999999999966544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=259.90 Aligned_cols=247 Identities=27% Similarity=0.401 Sum_probs=193.2
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec--CC
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL--GR 99 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~--~~ 99 (690)
-.||.-+..+|.|.- .|..|.|. -.++.|++|++... +.....+..+|+.++..+ +|+||++++.+|.-.. ..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~-v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQ-VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchh-hccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHH
Confidence 368888899999998 78888886 46788999987543 344467888999999999 4999999998864221 12
Q ss_pred CceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 100 TKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 100 ~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
...+|+|||||+.+|.+.+.-. ++-..+..|+.|++.|+.|||+.| |+||||||+||++..++.+||+|||+|+
T Consensus 93 ~~e~y~v~e~m~~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 93 FQEVYLVMELMDANLCQVILME----LDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHhHHHHHHhhhhHHHHHHHHh----cchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhc
Confidence 2367999999999999888732 566888999999999999999999 9999999999999999999999999998
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhc-----
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG----- 254 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~----- 254 (690)
.....+ .....+.|..|.|||++ + +..|.+.+||||+||++.||++|+..|.|.+..+....
T Consensus 167 ~e~~~~----------~mtpyVvtRyyrapevi--l-~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~l 233 (369)
T KOG0665|consen 167 TEDTDF----------MMTPYVVTRYYRAPEVI--L-GMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQL 233 (369)
T ss_pred ccCccc----------ccCchhheeeccCchhe--e-ccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHh
Confidence 654331 12234678999999983 3 34499999999999999999999999987654332110
Q ss_pred ----------------cC--------------CCCC---------CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 255 ----------------NY--------------RIPE---------SPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 255 ----------------~~--------------~~~~---------~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
.+ .++. .+.-...+++|+.+||..||++|.++.+++.+
T Consensus 234 gtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 234 GTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred cCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 0000 11224567899999999999999999998754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-27 Score=228.39 Aligned_cols=209 Identities=39% Similarity=0.622 Sum_probs=173.7
Q ss_pred eeecCceEEEEEEEcccCCeEEEEEEeecCCHH-HHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEecCC
Q 005577 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEE-SLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCD 111 (690)
Q Consensus 33 LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e-~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy~~ 111 (690)
||+|++|.||++.+. ..++.+++|++...... ....+.+|+.+++.+. |++|+++++++.. ....++||||++
T Consensus 1 l~~g~~~~v~~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~----~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDK-KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVKLYGVFED----ENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEec-CCCcEEEEEEeccccchhHHHHHHHHHHHHHhcC-CCCeeeEeeeeec----CCeEEEEEecCC
Confidence 689999999999984 45889999998765432 4567889999999995 9999999988653 367899999998
Q ss_pred -CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCC-CCCeeeeccCCCCcccccchhhh
Q 005577 112 -KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS-DGLWKLCDFGSTSTNHKRFEKLE 189 (690)
Q Consensus 112 -gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~-dg~vKL~DFGlA~~~~~~~~~~~ 189 (690)
++|.+++.... ..++...++.++.+++.+|.+||..+ ++|+||+|.||+++. ++.++|+|||++........
T Consensus 75 ~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--- 148 (215)
T cd00180 75 GGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--- 148 (215)
T ss_pred CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---
Confidence 67777766542 34899999999999999999999999 999999999999999 89999999998865432211
Q ss_pred hccccccccccCCCCcccCccchhhhhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCCCCCCCCCCHHH
Q 005577 190 EMGIEEDNIRKHTTPAYRAPEMWDLFRRE-LINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESPKYSSSV 268 (690)
Q Consensus 190 ~~~~~~~~~~~~GT~~YmAPEvl~~~~~~-~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~~~~~~~~s~~l 268 (690)
......+...|++||++ ... .++.+.|+|+||+++|+| ..+
T Consensus 149 ------~~~~~~~~~~~~~pe~~---~~~~~~~~~~D~~~lg~~~~~l-----------------------------~~~ 190 (215)
T cd00180 149 ------LLKTIVGTPAYMAPEVL---LGKGYYSEKSDIWSLGVILYEL-----------------------------PEL 190 (215)
T ss_pred ------hhhcccCCCCccChhHh---cccCCCCchhhhHHHHHHHHHH-----------------------------HHH
Confidence 11123468899999963 333 778899999999999998 789
Q ss_pred HHHHHHHhhhCCCCCCCHHHHHH
Q 005577 269 TDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 269 ~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
.+++..||..+|.+||++.+++.
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~ 213 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILE 213 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhh
Confidence 99999999999999999998864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=267.80 Aligned_cols=216 Identities=27% Similarity=0.417 Sum_probs=175.6
Q ss_pred CCccCCCCCCCceEeecCc-eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--------HHHHHHHHHHHHHH
Q 005577 7 FMQKEPTGLEGRSIDVGNL-KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--------EESLESAMKEISVM 77 (690)
Q Consensus 7 ~~~~~~~~~~g~~iei~~~-ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--------~e~~e~~~~Ei~iL 77 (690)
-...++.+..|+.-++.+. +|...+.||.|+||.|++|.++ .+...|+||.+.+.. ...+-.+-.||.||
T Consensus 542 ~~a~e~e~~~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K-~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIl 620 (772)
T KOG1152|consen 542 TKAVEPEGNIGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHK-ENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQIL 620 (772)
T ss_pred ccccCccccccceeeecccccceeeeeccccccceEEEeeec-ccceEEEeeehhhhhhhhhhhhcccccCccchhHHHH
Confidence 3445577888888888776 8999999999999999999997 458889999886532 11112233699999
Q ss_pred Hhhc--CCCCceEEEEEEEeecCCCceEEEEEecCC-C-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcc
Q 005577 78 KSLK--GHPNVVTLYAHTILDLGRTKEALLVMECCD-K-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIA 153 (690)
Q Consensus 78 ~~L~--~HPNIVkL~~~~~~~~~~~~~~~LVmEy~~-g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IV 153 (690)
..|. .|+||++++++|. +.+.+||+||--+ | +|+++|..+.. ++|.++..|++||+-|+++||+.| ||
T Consensus 621 a~l~~~sH~NIlKlLdfFE----ddd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~~--iv 692 (772)
T KOG1152|consen 621 ATLNKHSHENILKLLDFFE----DDDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQG--IV 692 (772)
T ss_pred HHhhhcCccchhhhhheee----cCCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhccccccccC--ce
Confidence 9994 4999999999854 5688999999984 3 67888877654 999999999999999999999999 99
Q ss_pred cCCCCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhc-CCCCchhhHHHHHHH
Q 005577 154 HRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRR-ELINEKVDIWALGCL 232 (690)
Q Consensus 154 HRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~-~~~s~ksDVwSLGvi 232 (690)
|||||-+||+++.+|.+||+|||.+..... | .--..+||..|.|||+ +++ .+.+..-|||+||++
T Consensus 693 hrdikdenvivd~~g~~klidfgsaa~~ks--------g---pfd~f~gtv~~aapev---l~g~~y~gk~qdiwalgil 758 (772)
T KOG1152|consen 693 HRDIKDENVIVDSNGFVKLIDFGSAAYTKS--------G---PFDVFVGTVDYAAPEV---LGGEKYLGKPQDIWALGIL 758 (772)
T ss_pred ecccccccEEEecCCeEEEeeccchhhhcC--------C---Ccceeeeeccccchhh---hCCCccCCCcchhhhhhhe
Confidence 999999999999999999999998754221 1 1224689999999997 444 445677899999999
Q ss_pred HHHHHhCCCCCCC
Q 005577 233 LFRICYFKNAFDG 245 (690)
Q Consensus 233 LyELltG~~PF~~ 245 (690)
||.++....||.+
T Consensus 759 lytivykenpyyn 771 (772)
T KOG1152|consen 759 LYTIVYKENPYYN 771 (772)
T ss_pred eeEEEeccCCCcC
Confidence 9999999999854
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-27 Score=232.38 Aligned_cols=204 Identities=35% Similarity=0.530 Sum_probs=167.3
Q ss_pred EEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHH-HHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEE
Q 005577 27 IHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEE-SLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALL 105 (690)
Q Consensus 27 y~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e-~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~L 105 (690)
|.+.+.||.|+||.||++.+. ..++.+++|.+...... ....+.+|+..++.+ +|+||+++++++.. ....++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~----~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDK-GTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFED----PEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEc-CCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeec----CCceEE
Confidence 567899999999999999985 45789999998765544 677888999999999 49999999988653 367899
Q ss_pred EEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccccc
Q 005577 106 VMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKR 184 (690)
Q Consensus 106 VmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~ 184 (690)
|+||+++ +|.+++..... .+++..++.++.+++.+|.+||..+ ++|+||+|.||+++.++.++|+|||++......
T Consensus 75 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred EEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 9999977 77777765432 2789999999999999999999999 999999999999999999999999988654322
Q ss_pred chhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCC-chHH
Q 005577 185 FEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDG-ESKL 249 (690)
Q Consensus 185 ~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~-~~~~ 249 (690)
.. .......++..|++||++. ....++.++|||+||+++|+|++|+.||.. ....
T Consensus 152 ~~--------~~~~~~~~~~~~~~pe~~~--~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 152 LA--------ALLKTVKGTPFYLAPEVLL--GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred cc--------ccccceeccCCcCCHhHhc--CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence 10 0112245688899999742 556678899999999999999999999977 3433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-28 Score=243.55 Aligned_cols=244 Identities=24% Similarity=0.330 Sum_probs=185.5
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
...|.|.+.||+|.||.+-+++++ .....+++|.+... .....+|.+|...--.|.-|.|||.-|++. ++..+.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr-~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va---Fqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHR-QSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVA---FQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeecc-CCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHH---hhcCceE
Confidence 357889999999999999999996 56778899977543 334678899998777777799999998764 3445678
Q ss_pred EEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeC-CC-CCeeeeccCCCCc
Q 005577 104 LLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLG-SD-GLWKLCDFGSTST 180 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd-~d-g~vKL~DFGlA~~ 180 (690)
+++|||++ |+|..-+... ++.|.....++.|+++|+.|||+++ +||||||.+||||- .| .+|||||||+++.
T Consensus 98 vF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred EEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccc
Confidence 89999996 6666655443 3889999999999999999999999 99999999999993 33 4799999999876
Q ss_pred ccccchhhhhccccccccccCCCCcccCccchhhhhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCchHHH-----HH-
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRE--LINEKVDIWALGCLLFRICYFKNAFDGESKLQ-----IL- 252 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~--~~s~ksDVwSLGviLyELltG~~PF~~~~~~~-----il- 252 (690)
.......+ --+..|.+||+++....+ ...+.+|||.||+|+|.++||+.|+......+ .+
T Consensus 173 ~g~tV~~~------------~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~ 240 (378)
T KOG1345|consen 173 VGTTVKYL------------EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ 240 (378)
T ss_pred cCceehhh------------hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH
Confidence 44332222 125679999986544333 35678999999999999999999997533211 11
Q ss_pred -hcc--CCCCC-CCCCCHHHHHHHHHHhhhCCCCCCCHHHH
Q 005577 253 -NGN--YRIPE-SPKYSSSVTDLIRDMLQASPDDRPDITQV 289 (690)
Q Consensus 253 -~~~--~~~~~-~~~~s~~l~~LI~~~L~~dP~~RPt~~ei 289 (690)
.+. .+.|. ...+++.+..+.++-|..++++|--+.+.
T Consensus 241 w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~ 281 (378)
T KOG1345|consen 241 WLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTA 281 (378)
T ss_pred HhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHH
Confidence 111 11111 23578899999999999999999655554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=280.62 Aligned_cols=203 Identities=22% Similarity=0.255 Sum_probs=140.9
Q ss_pred C-CCceEEEEEEEeec---CCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCC
Q 005577 83 H-PNVVTLYAHTILDL---GRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLK 158 (690)
Q Consensus 83 H-PNIVkL~~~~~~~~---~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLK 158 (690)
| .||++++++|.... .+...++++|||++++|.++|.... ..+++.+++.|+.||+.||.|||++| |||||||
T Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrDlK 107 (793)
T PLN00181 31 HIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQG--IVVHNVR 107 (793)
T ss_pred HHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--eeeccCC
Confidence 5 57888877752221 2234677889999999999986533 45999999999999999999999999 9999999
Q ss_pred CCcEEeCCCC-------------------CeeeeccCCCCcccccc----hhhhh-c--cccccccccCCCCcccCccch
Q 005577 159 AENLLLGSDG-------------------LWKLCDFGSTSTNHKRF----EKLEE-M--GIEEDNIRKHTTPAYRAPEMW 212 (690)
Q Consensus 159 P~NILLd~dg-------------------~vKL~DFGlA~~~~~~~----~~~~~-~--~~~~~~~~~~GT~~YmAPEvl 212 (690)
|+||||+..| .+||+|||+++...... ..... . .........+||+.|||||+
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~- 186 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE- 186 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh-
Confidence 9999996544 45555666554321100 00000 0 00011122468999999996
Q ss_pred hhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-HHHHhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 213 DLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK-LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 213 ~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~-~~il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
+.+..|+.++|||||||+||||++|..|+..... ...+......+...........++..||.++|.+||++.+++.
T Consensus 187 --~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 187 --DNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred --hccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 4566789999999999999999999988864322 1111111111111123456778999999999999999999964
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=245.84 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=191.0
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEccc--CCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIH--MSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~--~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
-....|.++++||+|.|++||+|.+... ..+.||+|.+.... ...++..|+++|..+.++.||+++.+++. .
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~r----n 106 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFR----N 106 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhc----c
Confidence 3456899999999999999999988532 67889999986543 24568899999999999999999988743 4
Q ss_pred CceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCC-CCeeeeccCCC
Q 005577 100 TKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD-GLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~d-g~vKL~DFGlA 178 (690)
+..+++||||++..-...+... ++..++..+++.++.||.++|.+| ||||||||.|+|.+.. ++-.|+|||+|
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhH
Confidence 5788999999987655555433 678899999999999999999999 9999999999999764 67899999998
Q ss_pred Ccccccc------h----h-------------h-h-----------hccccccccccCCCCcccCccchhhhhcCCCCch
Q 005577 179 STNHKRF------E----K-------------L-E-----------EMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEK 223 (690)
Q Consensus 179 ~~~~~~~------~----~-------------~-~-----------~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~k 223 (690)
...+... . . . . ............||++|.|||+ +++-..-+.+
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEv--L~k~~~Qtta 258 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEV--LFRCPRQTTA 258 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHH--HhhccCcCCc
Confidence 6211100 0 0 0 0 0011112234578999999999 4566677889
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCch-----HHHH--------------Hhcc---CC----------------C-------
Q 005577 224 VDIWALGCLLFRICYFKNAFDGES-----KLQI--------------LNGN---YR----------------I------- 258 (690)
Q Consensus 224 sDVwSLGviLyELltG~~PF~~~~-----~~~i--------------l~~~---~~----------------~------- 258 (690)
+||||.|||+.-+++++.||-... ..++ +.+. +. +
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 999999999999999999984211 1110 0011 00 0
Q ss_pred -C--------CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 259 -P--------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 259 -~--------~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
. ....++..+.+|+++||..||.+|.++.+.+.
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0 00124568899999999999999999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=240.08 Aligned_cols=181 Identities=24% Similarity=0.231 Sum_probs=137.4
Q ss_pred CCCCCceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC-----CHHHHHHHHHHHHHHHhhcCCCCce
Q 005577 13 TGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-----DEESLESAMKEISVMKSLKGHPNVV 87 (690)
Q Consensus 13 ~~~~g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~-----~~e~~e~~~~Ei~iL~~L~~HPNIV 87 (690)
-.+.|.-+.+...+|.+.+.||+|+||+||+|++....+..||||++... .....+.+.+|+++|+.|. |+|||
T Consensus 6 ~~~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv 84 (365)
T PRK09188 6 VPLPGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVV 84 (365)
T ss_pred CCCcccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCC
Confidence 45777888888899999999999999999999886446777899987532 2334567889999999995 99988
Q ss_pred E-EEEEEEeecCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCC-CCCcEEeC
Q 005577 88 T-LYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDL-KAENLLLG 165 (690)
Q Consensus 88 k-L~~~~~~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDL-KP~NILLd 165 (690)
. ++++ +..|||||||.|..+..+. . .. ...++.+++.+|.|||++| |+|||| ||+|||++
T Consensus 85 ~~l~~~--------~~~~LVmE~~~G~~L~~~~--~---~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~ 146 (365)
T PRK09188 85 PQLLAT--------GKDGLVRGWTEGVPLHLAR--P---HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMG 146 (365)
T ss_pred cEEEEc--------CCcEEEEEccCCCCHHHhC--c---cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEc
Confidence 4 5432 3579999999876554321 1 11 1468899999999999999 999999 99999999
Q ss_pred CCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchh
Q 005577 166 SDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWD 213 (690)
Q Consensus 166 ~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~ 213 (690)
.++.+||+|||+++.+..... ........+.....+++.|+|||.+.
T Consensus 147 ~~~~ikLiDFGlA~~~~~~~~-~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 147 PDGEAAVIDFQLASVFRRRGA-LYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred CCCCEEEEECccceecccCcc-hhhhhhhhhhhhhhccCccCCcccCC
Confidence 999999999999987644321 11111112223567899999999764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.9e-24 Score=226.63 Aligned_cols=261 Identities=20% Similarity=0.203 Sum_probs=196.1
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcC---CCCceEEEEEEEeecCCCce
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKG---HPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~---HPNIVkL~~~~~~~~~~~~~ 102 (690)
+|.+.+.||+|+||.||++.+.....+.+|+|............+..|+.+|..+.. -.|+..+++.+. .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~---~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR---STEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc---CCCce
Confidence 899999999999999999998533346789998765433222256778999998862 358999887753 23457
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCC-----CCeeeeccCC
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD-----GLWKLCDFGS 177 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~d-----g~vKL~DFGl 177 (690)
.||||+.++.+|.++......+.|+...++.|+.|++.+|.+||+.| +|||||||.|+++... ..++|.|||+
T Consensus 96 ~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 96 NFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred eEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 79999999999999887666567999999999999999999999999 9999999999999765 3589999999
Q ss_pred CCccc--ccchhhhhcccccc-ccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH----HH
Q 005577 178 TSTNH--KRFEKLEEMGIEED-NIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK----LQ 250 (690)
Q Consensus 178 A~~~~--~~~~~~~~~~~~~~-~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~----~~ 250 (690)
++... ...... ...... .....||..|+++.+ ..+...+.+.|+||++.++.+|+.|..|+.+... ..
T Consensus 174 ar~~~~~~~~~~~--~~~~r~~~~~~rGT~ry~S~~~---H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~ 248 (322)
T KOG1164|consen 174 ARRFKYVGDSGGN--LRPPRPQKGLFRGTLRYASINV---HLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK 248 (322)
T ss_pred CccccccCCCCcc--cccCCCCccCCCCccccccHHH---hCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH
Confidence 98322 111110 000111 123459999999995 6778899999999999999999999999966442 11
Q ss_pred HHhc--cCCCC-CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhh
Q 005577 251 ILNG--NYRIP-ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 251 il~~--~~~~~-~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~ 296 (690)
+... ..... .....+..+..++..+-..+...+|....+...+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 249 FEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 1111 11111 2234567888888888889999999999987765544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-22 Score=207.46 Aligned_cols=249 Identities=32% Similarity=0.463 Sum_probs=187.1
Q ss_pred EEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH---HHHHHHHHHHHHHHhhcCCC-CceEEEEEEEeecCCCce
Q 005577 27 IHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE---ESLESAMKEISVMKSLKGHP-NVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 27 y~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~---e~~e~~~~Ei~iL~~L~~HP-NIVkL~~~~~~~~~~~~~ 102 (690)
|++...||.|+||.||++.+. ..+++|.+..... .....+.+|+.++..+. |+ +|+++++++. ....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~----~~~~ 72 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQ----DEGS 72 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec----cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEe----cCCE
Confidence 788999999999999999984 7789998865422 24778899999999996 66 8999998873 2344
Q ss_pred EEEEEecCCCc-HHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCC-CeeeeccCCCC
Q 005577 103 ALLVMECCDKS-LVNVLENRGA-GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG-LWKLCDFGSTS 179 (690)
Q Consensus 103 ~~LVmEy~~gs-Ll~~L~~~~~-~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg-~vKL~DFGlA~ 179 (690)
.+++++|+.+. +.+.+..... ..+.+..+..++.|++.+|.|+|..+ ++||||||+|||++..+ .++++|||+++
T Consensus 73 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~ 150 (384)
T COG0515 73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAK 150 (384)
T ss_pred EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence 79999999754 4534433321 25899999999999999999999999 99999999999999998 79999999987
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhc---CCCCchhhHHHHHHHHHHHHhCCCCCCCchH----HHHH
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRR---ELINEKVDIWALGCLLFRICYFKNAFDGESK----LQIL 252 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~---~~~s~ksDVwSLGviLyELltG~~PF~~~~~----~~il 252 (690)
........... ........||..|++||+ ..+ ..+....|+|++|++++++++|..||..... ....
T Consensus 151 ~~~~~~~~~~~---~~~~~~~~~t~~~~~pe~---~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~ 224 (384)
T COG0515 151 LLPDPGSTSSI---PALPSTSVGTPGYMAPEV---LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL 224 (384)
T ss_pred ecCCCCccccc---cccccccccccccCCHHH---hcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHH
Confidence 43322111000 011234578999999996 333 5788899999999999999999999876652 2222
Q ss_pred h---ccC-C-CC--CCCCC----CHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 253 N---GNY-R-IP--ESPKY----SSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 253 ~---~~~-~-~~--~~~~~----s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
. ... . .. ..... ...+.+++..|+..+|..|.+.......
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 225 KIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1 111 1 11 11111 2578999999999999999998877543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=207.09 Aligned_cols=156 Identities=28% Similarity=0.415 Sum_probs=121.7
Q ss_pred CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhhhhc
Q 005577 112 KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEM 191 (690)
Q Consensus 112 gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~ 191 (690)
|+|.+++..++ ..|++.+++.|+.||+.||.|||.++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-------
Confidence 67888887654 35999999999999999999999986 999999999999999 9988653211
Q ss_pred cccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH-----HHHhccCCC-----CCC
Q 005577 192 GIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL-----QILNGNYRI-----PES 261 (690)
Q Consensus 192 ~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~-----~il~~~~~~-----~~~ 261 (690)
...||+.|||||+ +.+..++.++||||||||+|||++|+.||...... .+....... ...
T Consensus 63 -------~~~g~~~y~aPE~---~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (176)
T smart00750 63 -------QSRVDPYFMAPEV---IQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNL 132 (176)
T ss_pred -------cCCCcccccChHH---hcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccH
Confidence 1257999999996 45677999999999999999999999999764321 111111111 011
Q ss_pred CCCCH--HHHHHHHHHhhhCCCCCCCHHHHHHHHhh
Q 005577 262 PKYSS--SVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 262 ~~~s~--~l~~LI~~~L~~dP~~RPt~~eil~~l~~ 295 (690)
..++. .+.++|.+||..+|.+||++.+++.++..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 12333 69999999999999999999999877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-21 Score=202.52 Aligned_cols=256 Identities=18% Similarity=0.217 Sum_probs=196.3
Q ss_pred eEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecC
Q 005577 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLG 98 (690)
Q Consensus 19 ~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~ 98 (690)
...+-+..|+|.++||+|.||++++|.+- .+++.||||.-.... ..-++..|.+..+.|...++|..+|-+ ..
T Consensus 22 ~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl-~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYF----Gq 94 (449)
T KOG1165|consen 22 GVLMVGPHYRVGKKIGEGSFGVLFLGKNL-YNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYF----GQ 94 (449)
T ss_pred CceEecccceeccccccCcceeeeccccc-ccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeee----cc
Confidence 44567889999999999999999999984 678999999653322 224456688888888888999999854 33
Q ss_pred CCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCC-----Ceeee
Q 005577 99 RTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG-----LWKLC 173 (690)
Q Consensus 99 ~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg-----~vKL~ 173 (690)
++.+-.||||+++-+|.++..-.++ .|+.+.++-++.|++.-++|+|++. +|+|||||+|.||..-+ .+.|+
T Consensus 95 eG~~NiLVidLLGPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 95 EGKYNILVIDLLGPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred ccchhhhhhhhhCcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEE
Confidence 5566789999999999988877664 4999999999999999999999999 99999999999997544 58999
Q ss_pred ccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchH-----
Q 005577 174 DFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK----- 248 (690)
Q Consensus 174 DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~----- 248 (690)
|||+|+.+.+..... .-.........||..||+--. ..+..-+.+.|+=|||-++++.|.|..||.|...
T Consensus 172 DFGmAK~YrDp~Tkq--HIPYrE~KSLsGTARYMSINT---HlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~ 246 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQ--HIPYREHKSLSGTARYMSINT---HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE 246 (449)
T ss_pred eccchhhhcCccccc--cCccccccccccceeeeEeec---cccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH
Confidence 999998765443221 111122234578999998773 5566778899999999999999999999987432
Q ss_pred -HHHHhccCCC----CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHH
Q 005577 249 -LQILNGNYRI----PESPKYSSSVTDLIRDMLQASPDDRPDITQV 289 (690)
Q Consensus 249 -~~il~~~~~~----~~~~~~s~~l~~LI~~~L~~dP~~RPt~~ei 289 (690)
.+-+...-+. ..+.++|.++..-|+-.-..+-.+-|...-+
T Consensus 247 kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl 292 (449)
T KOG1165|consen 247 KYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL 292 (449)
T ss_pred HHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence 1111111111 1135688888888888877788888887655
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=195.06 Aligned_cols=253 Identities=17% Similarity=0.197 Sum_probs=190.1
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
|-..+|+++++||.|+||.+|+|.. +..+..||||+-...- ..-.+..|.++.+.|+....|..++.++. +..
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~-i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~----e~~ 84 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGIS-ITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGT----EKD 84 (341)
T ss_pred eeccceEEEEeecCCchhheeeeee-ccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcc----ccc
Confidence 4567999999999999999999998 4789999999864331 12346678999999986667777765532 456
Q ss_pred eEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCC---CCeeeeccCCC
Q 005577 102 EALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD---GLWKLCDFGST 178 (690)
Q Consensus 102 ~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~d---g~vKL~DFGlA 178 (690)
.-.+||++++-+|.+++.-.. ..|+.+.++-++.|++.-++|+|.++ +|||||||+|.|..-+ ..+.|+|||++
T Consensus 85 ynvlVMdLLGPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 85 YNVLVMDLLGPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred cceeeeeccCccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccch
Confidence 678999999988887765433 34999999999999999999999999 9999999999999654 46899999999
Q ss_pred CcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHH-------HH
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL-------QI 251 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~-------~i 251 (690)
+.+.+..... .-.........||..|.+--. .-+..-+.+.|+=|+|.+|..+..|..||.+.... .+
T Consensus 162 Kky~d~~t~~--HIpyre~r~ltGTaRYASinA---h~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI 236 (341)
T KOG1163|consen 162 KKYRDIRTRQ--HIPYREDRNLTGTARYASINA---HLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI 236 (341)
T ss_pred hhhccccccc--cCccccCCccceeeeehhhhh---hhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence 7654322111 111223334578999987652 33444577899999999999999999999875431 22
Q ss_pred HhccCCCC---CCCCCCHHHHHHHHHHhhhCCCCCCCHHHH
Q 005577 252 LNGNYRIP---ESPKYSSSVTDLIRDMLQASPDDRPDITQV 289 (690)
Q Consensus 252 l~~~~~~~---~~~~~s~~l~~LI~~~L~~dP~~RPt~~ei 289 (690)
.+.....+ .+..+|.++.-.|.-|-..--++-|...-+
T Consensus 237 ~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 237 SEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred HHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 22222222 246789999999999988888888886544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-22 Score=233.59 Aligned_cols=246 Identities=25% Similarity=0.350 Sum_probs=176.3
Q ss_pred EEEEEeeecCceEEEEEEEcccCCeEEEEEEee----c-CCHHHH-HHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMI----C-NDEESL-ESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 28 ~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~----~-~~~e~~-e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
....++|.|++|.|+.+... ...+.++.|... . ...... ..+..|+-+-..|. ||||+....... +..
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~-~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~----~~~ 394 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRR-SDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQ----EID 394 (601)
T ss_pred CccceeeecccCceEEEEec-CCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHh----hcc
Confidence 45678999999988888764 233434444332 1 112222 22556777777885 999877654321 223
Q ss_pred eEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 102 EALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 102 ~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
..+-+||||.++|+.++...+ .+...++..++.||+.||.|||..| |.|||||++|||+..+|.+||+|||.+...
T Consensus 395 ~~~~~mE~~~~Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 395 GILQSMEYCPYDLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred cchhhhhcccHHHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceee
Confidence 334459999888888887653 4899999999999999999999999 999999999999999999999999988765
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCchHHHHH--hccC--
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELIN-EKVDIWALGCLLFRICYFKNAFDGESKLQIL--NGNY-- 256 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s-~ksDVwSLGviLyELltG~~PF~~~~~~~il--~~~~-- 256 (690)
........ ......+|+..|+|||++ .+..|+ ..+||||.|++++.|++|+.||......+.. ...+
T Consensus 471 ~~~~e~~~-----~~~~g~~gS~pY~apE~~---~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~ 542 (601)
T KOG0590|consen 471 RYPWEKNI-----HESSGIVGSDPYLAPEVL---TGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSD 542 (601)
T ss_pred ccCcchhh-----hhhcCcccCCcCcCcccc---cccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccc
Confidence 55444310 112235789999999983 334444 5689999999999999999999654332211 1111
Q ss_pred --CCC-----CCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHH
Q 005577 257 --RIP-----ESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 257 --~~~-----~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~ 291 (690)
... ....++...+.+|.+||+.||.+|.++.+|+.
T Consensus 543 ~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 543 QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 111 11256788899999999999999999999953
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=202.38 Aligned_cols=241 Identities=23% Similarity=0.312 Sum_probs=151.4
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC---HHHHHHHHHHHHHHHhhcC---------CCCceEEEEEE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKG---------HPNVVTLYAHT 93 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~e~~e~~~~Ei~iL~~L~~---------HPNIVkL~~~~ 93 (690)
.+.....||.|+|+.||.+.|. .+++.+|||++.... ...++.+.+|.-....+.. |-.++.-++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~-~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDV-ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred EEEEccccccCCceEEEEEEEc-cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 5677889999999999999995 789999999986543 2245666666544433221 11122222222
Q ss_pred Eee--------cCCCc-----eEEEEEecCCCcHHHHHH---HhCCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCcccC
Q 005577 94 ILD--------LGRTK-----EALLVMECCDKSLVNVLE---NRGAGY--FEEKQVLAIFRDVCNAVFAMHSQSPPIAHR 155 (690)
Q Consensus 94 ~~~--------~~~~~-----~~~LVmEy~~gsLl~~L~---~~~~~~--lse~~~~~i~~qIa~aL~yLHs~g~~IVHR 155 (690)
.+. ..+.. ..+++|.-+.++|..++. ...... +.....+.+..|++..+++||..| |||+
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHg 169 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHG 169 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEES
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEec
Confidence 111 00011 246788888888876644 333211 112223456689999999999999 9999
Q ss_pred CCCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhh-----hcCCCCchhhHHHHH
Q 005577 156 DLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLF-----RRELINEKVDIWALG 230 (690)
Q Consensus 156 DLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~-----~~~~~s~ksDVwSLG 230 (690)
||+|+|+|++.+|.++|+||+........... ...+..|.+||..... ..-.++.+.|.|+||
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~------------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG 237 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC------------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLG 237 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG------------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec------------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHH
Confidence 99999999999999999999866443221110 1235789999974332 123578999999999
Q ss_pred HHHHHHHhCCCCCCCchHHHHHhccCCCCCCCCCCHHHHHHHHHHhhhCCCCC
Q 005577 231 CLLFRICYFKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283 (690)
Q Consensus 231 viLyELltG~~PF~~~~~~~il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~R 283 (690)
+++|.|+++..||+.......... .+..+.++|+.++.||..+|+.||.+|
T Consensus 238 ~~ly~lWC~~lPf~~~~~~~~~~~--~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 238 ITLYSLWCGRLPFGLSSPEADPEW--DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHSS-STCCCGGGSTSGG--GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHccCCCCCCCccccccc--cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999999999999987643322221 334455899999999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-21 Score=196.76 Aligned_cols=175 Identities=15% Similarity=0.165 Sum_probs=128.8
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---CHHHHHH------HHHHHHHHHhhcCCCCceEEEEE
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLES------AMKEISVMKSLKGHPNVVTLYAH 92 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~e~~e~------~~~Ei~iL~~L~~HPNIVkL~~~ 92 (690)
+.+++|++.++||.|+||.||++.+ .+..||||++... .+..... +.+|+..+.+|. |++|+.+.++
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~---~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~ 103 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT---DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDF 103 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec---CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEe
Confidence 3578999999999999999999755 3667999998533 3333344 578999999995 9999999888
Q ss_pred EEeecC----CCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCC
Q 005577 93 TILDLG----RTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG 168 (690)
Q Consensus 93 ~~~~~~----~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg 168 (690)
+..... -....+|||||++|..+..+. .+++ ..+.+|+.+|..||..| |+||||||.|||++.+|
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC
Confidence 654321 124578999999885443331 1333 34669999999999999 99999999999999999
Q ss_pred CeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHH
Q 005577 169 LWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI 236 (690)
Q Consensus 169 ~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyEL 236 (690)
++|+|||......... |-+. ......|+.++|||+||+++..+
T Consensus 173 -i~liDfg~~~~~~e~~----------------------a~d~--~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRK----------------------AKDR--IDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred -EEEEECCCcccccchh----------------------hHHH--HHHHhHhcccccccceeEeehHH
Confidence 9999999775432110 0011 12233466799999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=189.08 Aligned_cols=197 Identities=17% Similarity=0.165 Sum_probs=139.0
Q ss_pred EEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH----HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE----ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 28 ~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~----e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
.+...|++|+||+||++.. .+..++.+.+..... -....+.+|+++|++|.+|++|++++++ +..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~---~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--------~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG---GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--------DGR 73 (218)
T ss_pred ccceeecCCCcceEEEeec---CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--------cCE
Confidence 4578899999999998864 466677666543321 1123578999999999767899999875 346
Q ss_pred EEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCC-CCCcEEeCCCCCeeeeccCCCCccc
Q 005577 104 LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDL-KAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDL-KP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
|+||||+.|..+..... . ....++.|++.+|.+||.+| |||||| ||+|||++.+|.++|+|||++....
T Consensus 74 ~lvmeyI~G~~L~~~~~-------~-~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPP-------R-GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred EEEEeeecCccHHhhhh-------h-hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 89999998765432211 1 12457889999999999999 999999 7999999999999999999997544
Q ss_pred ccchh---hhhccc-cccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 005577 183 KRFEK---LEEMGI-EEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGE 246 (690)
Q Consensus 183 ~~~~~---~~~~~~-~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~ 246 (690)
..... +..... .........++.|+.|+.-..+. ..--.+.++++.|+.+|.++|+..++-++
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~-~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLK-RTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc-cchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 33211 000000 00011123688999998532221 11225679999999999999999887543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.9e-21 Score=188.72 Aligned_cols=137 Identities=21% Similarity=0.192 Sum_probs=104.2
Q ss_pred EEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHH--H------------------------HHHHHHHHHHHHhhcCC
Q 005577 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEE--S------------------------LESAMKEISVMKSLKGH 83 (690)
Q Consensus 30 ~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e--~------------------------~e~~~~Ei~iL~~L~~H 83 (690)
...||+|+||.||+|.+. .++.||||++...... . .....+|+++|..|. +
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~ 78 (190)
T cd05147 2 NGCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-T 78 (190)
T ss_pred CCccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-H
Confidence 467999999999999984 7899999998643110 0 112235999999996 7
Q ss_pred CCceEEEEEEEeecCCCceEEEEEecCCCcHHH-HHHHhCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCcccCCCCCCc
Q 005577 84 PNVVTLYAHTILDLGRTKEALLVMECCDKSLVN-VLENRGAGYFEEKQVLAIFRDVCNAVFAM-HSQSPPIAHRDLKAEN 161 (690)
Q Consensus 84 PNIVkL~~~~~~~~~~~~~~~LVmEy~~gsLl~-~L~~~~~~~lse~~~~~i~~qIa~aL~yL-Hs~g~~IVHRDLKP~N 161 (690)
++|...+.+.. ...+|||||++|+.+. .+... +.+++..+..++.||+.+|.|| |..| |+||||||+|
T Consensus 79 ~~v~~p~~~~~------~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~N 148 (190)
T cd05147 79 AGIPCPEPILL------KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYN 148 (190)
T ss_pred CCCCCCcEEEe------cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHH
Confidence 77644332211 1238999999875443 32222 3589999999999999999999 7999 9999999999
Q ss_pred EEeCCCCCeeeeccCCCCc
Q 005577 162 LLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 162 ILLd~dg~vKL~DFGlA~~ 180 (690)
||++ ++.++|+|||++..
T Consensus 149 Ili~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 149 LLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred EEEE-CCcEEEEEcccccc
Confidence 9998 57899999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.7e-20 Score=182.27 Aligned_cols=138 Identities=22% Similarity=0.215 Sum_probs=106.9
Q ss_pred EEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHH--------------------------HHHHHHHHHHHHHhhcCC
Q 005577 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEE--------------------------SLESAMKEISVMKSLKGH 83 (690)
Q Consensus 30 ~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e--------------------------~~e~~~~Ei~iL~~L~~H 83 (690)
.+.||+|+||.||+|.+. +++.||||++...... ....+.+|+..+.++. |
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~ 78 (190)
T cd05145 2 NGCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-E 78 (190)
T ss_pred CceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-h
Confidence 468999999999999984 7899999998654210 0123457899999996 8
Q ss_pred CCceEEEEEEEeecCCCceEEEEEecCCCc-HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCcccCCCCCCc
Q 005577 84 PNVVTLYAHTILDLGRTKEALLVMECCDKS-LVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS-QSPPIAHRDLKAEN 161 (690)
Q Consensus 84 PNIVkL~~~~~~~~~~~~~~~LVmEy~~gs-Ll~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs-~g~~IVHRDLKP~N 161 (690)
++|.....+.. ...||||||++|. +...+... ..++..++..++.+++.+|.+||. .| |+||||||+|
T Consensus 79 ~~i~~p~~~~~------~~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~N 148 (190)
T cd05145 79 AGVPVPEPILL------KKNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYN 148 (190)
T ss_pred CCCCCceEEEe------cCCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhh
Confidence 88754433221 1248999999875 33332222 247889999999999999999999 99 9999999999
Q ss_pred EEeCCCCCeeeeccCCCCcc
Q 005577 162 LLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 162 ILLd~dg~vKL~DFGlA~~~ 181 (690)
||++ ++.++|+|||++...
T Consensus 149 Ill~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 149 ILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred EEEE-CCCEEEEEcccceec
Confidence 9998 889999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.7e-22 Score=218.72 Aligned_cols=227 Identities=25% Similarity=0.355 Sum_probs=178.3
Q ss_pred EeeecCceEEEEEEEc--ccCCeEEEEEEeecCCHH--HHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEE
Q 005577 32 VIAEGGFSCVYSARDA--IHMSKQYAMKHMICNDEE--SLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 32 ~LG~GgFG~VylA~d~--~~~~k~vAvK~i~~~~~e--~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
++|+|.||.|++++.. ...+..|++|++...... .......|-.++..+.+||.+|++.-.+. ....+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafq----t~~kl~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQ----TDGKLYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeec----cccchhHhh
Confidence 3799999999998632 235678899987543211 11145567888888878999999976643 447789999
Q ss_pred ecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccch
Q 005577 108 ECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186 (690)
Q Consensus 108 Ey~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~ 186 (690)
+|..| .+...+..... +.+..+..+...++.+++++|..+ |+|||+|++||+++.+|++++.|||+.+.....
T Consensus 77 d~~rgg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~-- 150 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE-- 150 (612)
T ss_pred hhcccchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhh--
Confidence 99965 67666655543 888899999999999999999999 999999999999999999999999988653221
Q ss_pred hhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCCCCCCCCCCH
Q 005577 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESPKYSS 266 (690)
Q Consensus 187 ~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~~~~~~~~s~ 266 (690)
...|||..|||||++. ....++|.||||+++++|++|..||.++....++...+ ..+..++.
T Consensus 151 -----------~~~cgt~eymApEI~~-----gh~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~~~~--~~p~~l~~ 212 (612)
T KOG0603|consen 151 -----------KIACGTYEYRAPEIIN-----GHLSAADWWSFGVLAFELLTGTLPFGGDTMKRILKAEL--EMPRELSA 212 (612)
T ss_pred -----------hhcccchhhhhhHhhh-----ccCCcccchhhhhhHHHHhhCCCCCchHHHHHHhhhcc--CCchhhhH
Confidence 0127899999999743 46778999999999999999999999944444444333 33457889
Q ss_pred HHHHHHHHHhhhCCCCCCCH
Q 005577 267 SVTDLIRDMLQASPDDRPDI 286 (690)
Q Consensus 267 ~l~~LI~~~L~~dP~~RPt~ 286 (690)
.+.+++..++.++|.+|...
T Consensus 213 ~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 213 EARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHHHHhhCHHHHhcc
Confidence 99999999999999999654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.4e-21 Score=221.51 Aligned_cols=252 Identities=22% Similarity=0.274 Sum_probs=179.8
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH----HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE----ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~----e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
.|...+.||.+.|=.|.+|++. .|. |+||++.+.++ ....+.++|++ .... +|||++.+.-+ ....+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~--eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~----~~t~k 94 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR--EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKV----LVTDK 94 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC--Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHH----HHhhH
Confidence 6788999999999999999984 444 99999977653 23444455555 3333 69999987543 12345
Q ss_pred eEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 102 EALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 102 ~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
..|||-+|+-.+|++.|..+. .|..-+.+.|+.||+.||..+|..| |+|+|||.+||||+.-+.+.|+||...+..
T Consensus 95 AAylvRqyvkhnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPt 170 (1431)
T KOG1240|consen 95 AAYLVRQYVKHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPT 170 (1431)
T ss_pred HHHHHHHHHhhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCc
Confidence 678999999999999987653 5888899999999999999999999 999999999999999999999999866433
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhh-------cC-CCCchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFR-------RE-LINEKVDIWALGCLLFRICY-FKNAFDGESKLQIL 252 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~-------~~-~~s~ksDVwSLGviLyELlt-G~~PF~~~~~~~il 252 (690)
.-..+......+.-+.. .--..|+|||.|.... .. ..+++.||||+||+++||++ |+++|.-.......
T Consensus 171 YLPeDNPadf~fFFDTS--rRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr 248 (1431)
T KOG1240|consen 171 YLPEDNPADFTFFFDTS--RRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYR 248 (1431)
T ss_pred cCCCCCcccceEEEecC--CceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHh
Confidence 22211111111111111 1134799999763211 11 26789999999999999987 79999644333322
Q ss_pred hccCCCCC---CCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHH
Q 005577 253 NGNYRIPE---SPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 253 ~~~~~~~~---~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~ 292 (690)
.+.-..+. ..--+..++.||..|++.||.+|.++.+.+..
T Consensus 249 ~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 249 SGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 22100000 00123478999999999999999999998765
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6e-21 Score=193.16 Aligned_cols=246 Identities=17% Similarity=0.286 Sum_probs=192.0
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCC--HHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
..+.+..+|.+.-.|+.|+|++ .+..+++|++...+ ...-.+|..|.-.|+-+. ||||+.+++.|- ...+
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrw---qgndivakil~vr~~t~risrdfneefp~lrifs-hpnilpvlgacn----sppn 261 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRW---QGNDIVAKILNVREVTARISRDFNEEFPALRIFS-HPNILPVLGACN----SPPN 261 (448)
T ss_pred hhhhhhhhhccCCCcccccccc---cCcchhhhhhhhhhcchhhcchhhhhCcceeeec-CCchhhhhhhcc----CCCC
Confidence 4555677899999999999998 35667788775543 223456788888898885 999999999874 3467
Q ss_pred EEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeee--ccCCCC
Q 005577 103 ALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLC--DFGSTS 179 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~--DFGlA~ 179 (690)
+.++..||+ |+|+..|.....-.++..++++++.+|+.|+.|||+..+-|.---|....|+||++-+.+|. |--++
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs- 340 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS- 340 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee-
Confidence 889999996 78999887765445777899999999999999999997545555789999999999877764 32211
Q ss_pred cccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHH----HHhcc
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGN 255 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~----il~~~ 255 (690)
+ ... .....|.||+||.++.-.....-.++|+|||+++||||.|...||...++.+ +....
T Consensus 341 -----f---qe~-------gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg 405 (448)
T KOG0195|consen 341 -----F---QEV-------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG 405 (448)
T ss_pred -----e---ecc-------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc
Confidence 1 011 1244899999997653333344568999999999999999999998877654 44566
Q ss_pred CCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHh
Q 005577 256 YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294 (690)
Q Consensus 256 ~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~ 294 (690)
++...+|.++..+..||.-|+..||.+||.+..|+--++
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpile 444 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILE 444 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence 788888999999999999999999999999998865444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-19 Score=189.97 Aligned_cols=198 Identities=26% Similarity=0.360 Sum_probs=147.4
Q ss_pred CCCCceEEEEEEEee-----------------------cCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHH
Q 005577 82 GHPNVVTLYAHTILD-----------------------LGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDV 138 (690)
Q Consensus 82 ~HPNIVkL~~~~~~~-----------------------~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qI 138 (690)
.|||||+++..|... .+++..+|+||.-+..+|..++-.+. .+.....-|+.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~---~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH---RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC---CchHHHHHHHHHH
Confidence 699999998665422 24456789999999999999987765 5667888899999
Q ss_pred HHHHHHHHhCCCCcccCCCCCCcEEe--CCCC--CeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhh
Q 005577 139 CNAVFAMHSQSPPIAHRDLKAENLLL--GSDG--LWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDL 214 (690)
Q Consensus 139 a~aL~yLHs~g~~IVHRDLKP~NILL--d~dg--~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~ 214 (690)
++|+.|||.+| |.|||||.+|||| ++|+ .+.|+|||++-...... ....+..+....-|.-..||||+...
T Consensus 351 LEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hG---lqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 351 LEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHG---LQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccc---cccccccccccCCCcceecchhhhhc
Confidence 99999999999 9999999999999 5555 47899999763322111 11222333444567888999998654
Q ss_pred hhcCC---CCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhccCCC----CCCCCCCHHHHHHHHHHhhhCCCCCCCHH
Q 005577 215 FRREL---INEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRI----PESPKYSSSVTDLIRDMLQASPDDRPDIT 287 (690)
Q Consensus 215 ~~~~~---~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~~~~----~~~~~~s~~l~~LI~~~L~~dP~~RPt~~ 287 (690)
..+.. .-.++|.|+.|.+.||+++...||.+.....+-...|+. .-+..+++.+++|+..+|+.||.+|++..
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 43321 224899999999999999999999874433322222322 22457899999999999999999999854
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=179.64 Aligned_cols=138 Identities=15% Similarity=0.211 Sum_probs=105.0
Q ss_pred EEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhc----CCCCceEEEEEEEeecCCCceEEE
Q 005577 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK----GHPNVVTLYAHTILDLGRTKEALL 105 (690)
Q Consensus 30 ~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~----~HPNIVkL~~~~~~~~~~~~~~~L 105 (690)
..+||+|+||.||. +. .... .+||++........+.+.+|+.+++.|. +||||+++|+++..+.+.+..+.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp-~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HP-EDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cceecCCCceEEEE--CC-CCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 46799999999995 53 3333 3699887654445677899999999994 479999999987655333333448
Q ss_pred EEecCC---CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCcccCCCCCCcEEeCC----CCCeeeeccCC
Q 005577 106 VMECCD---KSLVNVLENRGAGYFEEKQVLAIFRDVCNAV-FAMHSQSPPIAHRDLKAENLLLGS----DGLWKLCDFGS 177 (690)
Q Consensus 106 VmEy~~---gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL-~yLHs~g~~IVHRDLKP~NILLd~----dg~vKL~DFGl 177 (690)
||||++ ++|.+++.+ . .+++. ..++.+++.++ .|||+++ ||||||||+|||++. ++.++|+||+.
T Consensus 83 I~e~~G~~~~tL~~~l~~-~--~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ-C--RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EecCCCCcchhHHHHHHc-c--cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 999964 688888854 2 26666 46688888888 9999999 999999999999974 34799999553
Q ss_pred C
Q 005577 178 T 178 (690)
Q Consensus 178 A 178 (690)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-19 Score=210.74 Aligned_cols=214 Identities=28% Similarity=0.418 Sum_probs=151.2
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
...+|..+++|..|+||.||+.+|+ .+.+.+|+|+- +++ . ||+ ||..+- +.
T Consensus 81 ~e~df~~IklisngAygavylvrh~-~trqrfa~kiN-kq~--l---------ilR------nilt~a----------~n 131 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHK-ETRQRFAMKIN-KQN--L---------ILR------NILTFA----------GN 131 (1205)
T ss_pred CccccceeEeeccCCCCceeeeecc-ccccchhhccc-ccc--h---------hhh------cccccc----------CC
Confidence 4568899999999999999999986 46677888532 211 0 111 122221 11
Q ss_pred EEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
.+.| |+....+...+. ++.+. +.+++|||+.| |+|||+||+|+||..-|++|+.|||+.+...
T Consensus 132 pfvv-----gDc~tllk~~g~--lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 132 PFVV-----GDCATLLKNIGP--LPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred ccee-----chhhhhcccCCC--Ccchh--------hHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhh
Confidence 2222 444444444333 44432 78999999999 9999999999999999999999999875432
Q ss_pred ccchh-hhhccc-----cccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHHHhcc-
Q 005577 183 KRFEK-LEEMGI-----EEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN- 255 (690)
Q Consensus 183 ~~~~~-~~~~~~-----~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~il~~~- 255 (690)
-.... +....+ +-.....+|||.|+|||| +....|+..+|+|++|+|+||.+.|+.||.++...+++...
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV---ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi 271 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV---ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 271 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhh---hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence 21111 111111 112234589999999998 34466999999999999999999999999999876654332
Q ss_pred ----CCCCCCCCCCHHHHHHHHHHhhhCCCCCCC
Q 005577 256 ----YRIPESPKYSSSVTDLIRDMLQASPDDRPD 285 (690)
Q Consensus 256 ----~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt 285 (690)
........+++++.++|.++|+.+|..|--
T Consensus 272 sd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 272 SDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred hhhccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 222335678999999999999999999953
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-18 Score=204.32 Aligned_cols=251 Identities=19% Similarity=0.254 Sum_probs=170.3
Q ss_pred CCCCceEeecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhc--CCCCceEEEE
Q 005577 14 GLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK--GHPNVVTLYA 91 (690)
Q Consensus 14 ~~~g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~--~HPNIVkL~~ 91 (690)
=-.++.+++++.+|.|.+.||+|+||.||+|.+. .++.||||+-.....-. |.--.+++.+|+ --+.|..++.
T Consensus 687 l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~--~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~ 761 (974)
T KOG1166|consen 687 LNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHS--NGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISS 761 (974)
T ss_pred cCccceeeecceeEEEEeeeccccceEEEEeecC--CCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHH
Confidence 3457889999999999999999999999999985 49999999864332110 000112222221 0123444433
Q ss_pred EEEeecCCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCC---
Q 005577 92 HTILDLGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD--- 167 (690)
Q Consensus 92 ~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~d--- 167 (690)
..++ .+..+||+||.+ |+|++++- ..+.+++..++.|..|+|.-|++||..+ |||+||||+|+||...
T Consensus 762 a~~~----~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~ 833 (974)
T KOG1166|consen 762 AHVF----QNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICA 833 (974)
T ss_pred HHcc----CCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCC
Confidence 2221 245689999996 88998886 4456999999999999999999999999 9999999999999432
Q ss_pred ----CCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCC
Q 005577 168 ----GLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAF 243 (690)
Q Consensus 168 ----g~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF 243 (690)
--++|+|||.+..+.-.... ..-...++|-.+-++|+ ..+...++.+|.|.|+.++|-||.|+.-
T Consensus 834 ~~~~~~l~lIDfG~siDm~lfp~~-------~~F~~~~~td~f~C~EM---~~grpWtYq~DyfGlAa~~h~mLFG~y~- 902 (974)
T KOG1166|consen 834 DSDSKGLYLIDFGRSIDMKLFPDG-------TKFKAVWHTDLFDCIEM---REGRPWTYQIDYFGLAATVHVMLFGKYM- 902 (974)
T ss_pred CCcccceEEEecccceeeeEcCCC-------cEEeeeeccccchhHHH---hcCCCCchhhhhHHHHHHHHHHHHHHHH-
Confidence 24899999977543211111 11122466889999996 6688899999999999999999998642
Q ss_pred CCchHHHHHhccCCCCCCCCCC-----HHHHHHHHHHhhhCCCCCCCHHHHHHHHhh
Q 005577 244 DGESKLQILNGNYRIPESPKYS-----SSVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 244 ~~~~~~~il~~~~~~~~~~~~s-----~~l~~LI~~~L~~dP~~RPt~~eil~~l~~ 295 (690)
++.++.... ...+++ +-..+|+..+|..|-..=|...++...+.+
T Consensus 903 ------q~~~g~~~~-~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~ 952 (974)
T KOG1166|consen 903 ------EVKNGSSWM-VKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEE 952 (974)
T ss_pred ------HhcCCccee-ccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHH
Confidence 122221111 111121 334568888888444444556665444443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-19 Score=196.09 Aligned_cols=260 Identities=21% Similarity=0.301 Sum_probs=168.2
Q ss_pred CceEeecCceEEEEEEeeecCceEEEEEEEccc--CCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEE---
Q 005577 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIH--MSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYA--- 91 (690)
Q Consensus 17 g~~iei~~~ry~v~~~LG~GgFG~VylA~d~~~--~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~--- 91 (690)
+.........+.+.+.++..+++.++....... ....+..+....++........+++-.+.....|+..+.. +
T Consensus 236 ~~~~~~~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~-d~~~ 314 (516)
T KOG1033|consen 236 ESSRHEESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILE-DLRP 314 (516)
T ss_pred CcccccccccccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCccccc-CCCC
Confidence 444445556677778888888888876654211 1233333333333323334445566666665434443332 2
Q ss_pred --E--EE-eecCCCceEEEEEecCC-CcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEe
Q 005577 92 --H--TI-LDLGRTKEALLVMECCD-KSLVNVLENRGA-GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLL 164 (690)
Q Consensus 92 --~--~~-~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~-~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILL 164 (690)
. .. .......++||.|++|. ++|.++|..+.. ...+....+.++.|++.|++| ++ .+||||||.||++
T Consensus 315 s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~ 389 (516)
T KOG1033|consen 315 SLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFF 389 (516)
T ss_pred chhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhcccccccc
Confidence 0 00 00111235789999995 677788865442 236677889999999999999 77 9999999999999
Q ss_pred CCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 005577 165 GSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAF 243 (690)
Q Consensus 165 d~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt-G~~PF 243 (690)
..+..+||+|||+........ ............+||.+||+|| ++.+..|+.++||||||+||+||+. ....|
T Consensus 390 ~~d~q~kIgDFgl~ts~~~~~---~~~~~~a~~t~~~gt~~YmsPE---Qi~g~~y~~kvdIyaLGlil~EL~~~f~T~~ 463 (516)
T KOG1033|consen 390 SDDDQLKIGDFGLVTSQDKDE---TVAPAAASHTQQVGTLLYMSPE---QIRGQQYSEKVDIYALGLILAELLIQFSTQF 463 (516)
T ss_pred ccchhhhhhhhhheeecccCC---cccchhhhhhhcccccccCCHH---HHhhhhhhhhcchhhHHHHHHHHHHHhccHH
Confidence 999999999999986554332 1111122344568999999999 5788999999999999999999987 33444
Q ss_pred CCchHH-HHHhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHH
Q 005577 244 DGESKL-QILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289 (690)
Q Consensus 244 ~~~~~~-~il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~ei 289 (690)
...... ++-.+.+......++ +.-..|+..||...|.+||++.+.
T Consensus 464 er~~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 464 ERIATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HHHHhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence 332222 222233321122233 345689999999999999954443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=171.62 Aligned_cols=144 Identities=22% Similarity=0.192 Sum_probs=109.5
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHH------------------------HHHHHHHHHHHHHh
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEE------------------------SLESAMKEISVMKS 79 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e------------------------~~e~~~~Ei~iL~~ 79 (690)
+.-|.+.+.||+|+||.||+|.|....++.||||++...... ....+.+|+.++.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 446888999999999999999833357899999998643210 11235689999999
Q ss_pred hcCC--CCceEEEEEEEeecCCCceEEEEEecCCCcHH-HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCC
Q 005577 80 LKGH--PNVVTLYAHTILDLGRTKEALLVMECCDKSLV-NVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRD 156 (690)
Q Consensus 80 L~~H--PNIVkL~~~~~~~~~~~~~~~LVmEy~~gsLl-~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRD 156 (690)
+. + ..++++++. ...+|||||++|..+ ..+... ..+...++..++.||+.+|.+||..| .|+|||
T Consensus 107 L~-~~~i~~p~~~~~--------~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~D 174 (237)
T smart00090 107 LY-EAGVPVPKPIAW--------RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEG-ELVHGD 174 (237)
T ss_pred HH-hcCCCCCeeeEe--------cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCC
Confidence 95 4 335555543 234899999988544 332222 23667778899999999999999987 499999
Q ss_pred CCCCcEEeCCCCCeeeeccCCCCc
Q 005577 157 LKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 157 LKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
|||+|||++ ++.++|+|||++..
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhc
Confidence 999999999 88999999998854
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=159.69 Aligned_cols=138 Identities=21% Similarity=0.190 Sum_probs=106.1
Q ss_pred CceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH----------------------HHHHHHHHHHHHHHhhc
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE----------------------ESLESAMKEISVMKSLK 81 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~----------------------e~~e~~~~Ei~iL~~L~ 81 (690)
+..|.+.+.||+|+||.||++.+. .++.||||++..... .....+.+|+.++..+.
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcC--CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 345888899999999999999873 689999998754220 01123567899999995
Q ss_pred CCC--CceEEEEEEEeecCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCC
Q 005577 82 GHP--NVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKA 159 (690)
Q Consensus 82 ~HP--NIVkL~~~~~~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP 159 (690)
|+ .++.+++. ...++||||++|..+..+.. ......++.+|+.++.++|..| |+||||||
T Consensus 92 -~~~i~v~~~~~~--------~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p 153 (198)
T cd05144 92 -EEGFPVPKPIDW--------NRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHG--IIHGDLSE 153 (198)
T ss_pred -HcCCCCCceeec--------CCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCC--CCcCCCCc
Confidence 66 45555432 34589999998765543321 1345678999999999999999 99999999
Q ss_pred CcEEeCCCCCeeeeccCCCCcc
Q 005577 160 ENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 160 ~NILLd~dg~vKL~DFGlA~~~ 181 (690)
+||||+.++.++|+|||++...
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred ccEEEcCCCcEEEEECCccccC
Confidence 9999999999999999988554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.5e-16 Score=159.42 Aligned_cols=133 Identities=22% Similarity=0.305 Sum_probs=103.8
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecCC---H-----HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCce
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---E-----ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~-----e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~ 102 (690)
+.||+|++|.||+|.+ .+..|++|+..... . -...++.+|+.++..+. |++|+....++. ....
T Consensus 2 ~~l~~G~~~~vy~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~----~~~~ 73 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF---LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFV----DPEN 73 (211)
T ss_pred cccccCceEEEEEEee---CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEE----eCCC
Confidence 5789999999999986 46678999764321 1 12346778999999996 888766554443 2356
Q ss_pred EEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 103 ALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 103 ~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
.++||||++| +|.+.+.. . .. ....++.+|+.+|.+||..+ |+||||+|.|||++ ++.++|+|||++..
T Consensus 74 ~~lv~e~~~G~~L~~~~~~-~----~~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINS-N----GM-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CEEEEEEeCCcCHHHHHHh-c----cH-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 7899999976 55555543 2 12 78899999999999999999 99999999999999 78899999998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=5e-16 Score=154.35 Aligned_cols=129 Identities=22% Similarity=0.343 Sum_probs=96.9
Q ss_pred EeeecCceEEEEEEEcccCCeEEEEEEeecCC---H-----HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceE
Q 005577 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICND---E-----ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 32 ~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~---~-----e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
.||+|+||.||+|.+ .+..|++|+..... . ....++.+|++++..+. |++|.....++. .....
T Consensus 1 ~ig~G~~~~vy~~~~---~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~----~~~~~ 72 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF---LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDV----DPDNK 72 (199)
T ss_pred CCCCCceEEEEEeec---CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEE----ECCCC
Confidence 489999999999985 46789999864321 1 12356778999999996 765443332322 12456
Q ss_pred EEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 104 LLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 104 ~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
+|||||++| +|.+.+.. .. . .++.+|+.+|.+||..+ |+|+||+|.|||++ ++.++|+|||++..
T Consensus 73 ~lv~e~~~g~~l~~~~~~-~~-----~---~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 73 TIVMEYIEGKPLKDVIEE-GN-----D---ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEEECCccHHHHHhh-cH-----H---HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 899999976 45454432 11 1 78999999999999999 99999999999999 88999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.1e-16 Score=177.54 Aligned_cols=134 Identities=22% Similarity=0.272 Sum_probs=102.5
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--------CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeec
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--------DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--------~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~ 97 (690)
.|...++||+|+||+||+|.+. +..+++|+.... .....+++.+|+++|+.++ |++|+..+.++..
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~---~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~-- 407 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYL---GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDVD-- 407 (535)
T ss_pred ccCccceeccCCcEEEEEEeec---CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEEe--
Confidence 3456789999999999999873 334454443211 1122456889999999996 9998887655442
Q ss_pred CCCceEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccC
Q 005577 98 GRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176 (690)
Q Consensus 98 ~~~~~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFG 176 (690)
....+|||||++| +|.+.+. ....++.+|+.+|.|||..+ |+||||||+|||+ .++.++|+|||
T Consensus 408 --~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 408 --PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred --CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCc
Confidence 2456899999966 5555543 34678999999999999999 9999999999999 67889999999
Q ss_pred CCCc
Q 005577 177 STST 180 (690)
Q Consensus 177 lA~~ 180 (690)
+++.
T Consensus 473 la~~ 476 (535)
T PRK09605 473 LGKY 476 (535)
T ss_pred cccc
Confidence 8854
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=8e-16 Score=151.22 Aligned_cols=135 Identities=20% Similarity=0.191 Sum_probs=96.9
Q ss_pred EEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH--HHHHH----------------------HHHHHHHHHhhcCC-C
Q 005577 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE--ESLES----------------------AMKEISVMKSLKGH-P 84 (690)
Q Consensus 30 ~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~--e~~e~----------------------~~~Ei~iL~~L~~H-P 84 (690)
.+.||+|+||.||+|.+. .++.||||++..... ..... ...|...+..+..+ -
T Consensus 2 ~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 467999999999999874 688999998764321 11111 13566777777422 2
Q ss_pred CceEEEEEEEeecCCCceEEEEEecCCCc-HH-HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCcccCCCCCCc
Q 005577 85 NVVTLYAHTILDLGRTKEALLVMECCDKS-LV-NVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS-QSPPIAHRDLKAEN 161 (690)
Q Consensus 85 NIVkL~~~~~~~~~~~~~~~LVmEy~~gs-Ll-~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs-~g~~IVHRDLKP~N 161 (690)
.+.+++++ ...+|||||++|. +. ..+.... .. .++..++.+++.++.++|. .+ |+||||||+|
T Consensus 80 ~~~~~~~~--------~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~N 145 (187)
T cd05119 80 PVPKPIDL--------NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYN 145 (187)
T ss_pred CCCceEec--------CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhh
Confidence 35555543 2358999999872 11 1111111 11 6678999999999999999 88 9999999999
Q ss_pred EEeCCCCCeeeeccCCCCcc
Q 005577 162 LLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 162 ILLd~dg~vKL~DFGlA~~~ 181 (690)
||++ ++.++|+|||++...
T Consensus 146 ili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 146 ILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred EEEE-CCcEEEEECcccccc
Confidence 9999 889999999988543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.1e-15 Score=152.93 Aligned_cols=138 Identities=20% Similarity=0.306 Sum_probs=102.7
Q ss_pred EEEee-ecCceEEEEEEEcccCCeEEEEEEeecCC-------------HHHHHHHHHHHHHHHhhcCCCCc--eEEEEEE
Q 005577 30 RNVIA-EGGFSCVYSARDAIHMSKQYAMKHMICND-------------EESLESAMKEISVMKSLKGHPNV--VTLYAHT 93 (690)
Q Consensus 30 ~~~LG-~GgFG~VylA~d~~~~~k~vAvK~i~~~~-------------~e~~e~~~~Ei~iL~~L~~HPNI--VkL~~~~ 93 (690)
...|| .||.|+||.+.. .+..++||++.... .....++.+|+.++..|. |++| ++.+++.
T Consensus 36 ~~~lg~~~g~gtv~~v~~---~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~ 111 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT---PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAAR 111 (239)
T ss_pred CceeecCCCCccEEEEEe---CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeee
Confidence 35688 899999999976 36789998774311 123356788999999996 7774 6777664
Q ss_pred EeecCCCceEEEEEecCCC--cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCee
Q 005577 94 ILDLGRTKEALLVMECCDK--SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWK 171 (690)
Q Consensus 94 ~~~~~~~~~~~LVmEy~~g--sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vK 171 (690)
..........+|||||++| +|.+.+.. . .+++. .+.+|+.+|.+||.+| |+||||||.|||++.++.++
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~--~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQE-A--PLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhc-C--CCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEE
Confidence 4332222234699999976 56665543 2 35554 3578999999999999 99999999999999999999
Q ss_pred eeccCCCCc
Q 005577 172 LCDFGSTST 180 (690)
Q Consensus 172 L~DFGlA~~ 180 (690)
|+|||.++.
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999997754
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.9e-15 Score=168.43 Aligned_cols=206 Identities=22% Similarity=0.325 Sum_probs=148.6
Q ss_pred HhhcCCCCceEEEEEEEeecCCCceEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCC
Q 005577 78 KSLKGHPNVVTLYAHTILDLGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRD 156 (690)
Q Consensus 78 ~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRD 156 (690)
+.+ .|.||.++++.++. ....++|.+||. |+|.+.+.... ..++......++++|+.||.|||..-. ..|+.
T Consensus 2 ~~l-~h~n~~~f~g~~~~----~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~ 74 (484)
T KOG1023|consen 2 RQL-DHDNLNKFIGASVD----GPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPI-GYHGA 74 (484)
T ss_pred ccc-chhhhhhheeeEec----CCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcc-eeeee
Confidence 456 49999999999873 378899999995 78888887643 347888889999999999999999862 29999
Q ss_pred CCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcC----CCCchhhHHHHHHH
Q 005577 157 LKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRE----LINEKVDIWALGCL 232 (690)
Q Consensus 157 LKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~----~~s~ksDVwSLGvi 232 (690)
|+..|++++..-.+||.|||+......... ........-...|.|||.+...... ..+.+.||||||++
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~-------~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii 147 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAE-------PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGII 147 (484)
T ss_pred eccccceeeeeEEEEechhhhccccccccc-------ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHH
Confidence 999999999999999999998765422000 0000011124579999974321111 24678999999999
Q ss_pred HHHHHhCCCCCCCc----hHHHHHh---ccCCCCCC------CCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHHhhhc
Q 005577 233 LFRICYFKNAFDGE----SKLQILN---GNYRIPES------PKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 233 LyELltG~~PF~~~----~~~~il~---~~~~~~~~------~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l~~~l 297 (690)
+||+++...||+.. ...+++. .....+.. ..+++++..++.+||..+|.+||++.++...+....
T Consensus 148 ~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 148 MYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred HHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 99999999999752 2122222 11111111 145667999999999999999999999866554433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.3e-15 Score=136.01 Aligned_cols=135 Identities=16% Similarity=0.221 Sum_probs=107.1
Q ss_pred EEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCC-CCceEEEEEEEeecCCCceEEEEE
Q 005577 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGH-PNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 29 v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~H-PNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
+.+.||.|.++.||++.+. ++.+++|.+..... ...+.+|+.+++.|..+ .++++++.++. ..+..++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~---~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~----~~~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK---DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGE----SDGWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEec---CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcC----CCCccEEEE
Confidence 3578999999999999973 37899998755433 45788899999999733 68888877643 235789999
Q ss_pred ecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 108 ECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS-PPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 108 Ey~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g-~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
||+.|..+..+ +......++.+++.+|.+||... .+++|+||+|+|||++..+.++|+|||+++.
T Consensus 73 e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 73 EWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99987644322 44566788999999999999852 1299999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=9.8e-17 Score=185.28 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=190.4
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--CHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
....|.+.+.||+|+|+.|-++.........+|+|.+... ......+...|..+-+.+.+|.|++++++.. ...
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~----~~~ 93 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS----SSP 93 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc----CCC
Confidence 3668888999999999999998875445566777766443 2344555666888888886699999998763 345
Q ss_pred ceEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCcccCCCCCCcEEeCCCC-CeeeeccCC
Q 005577 101 KEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH-SQSPPIAHRDLKAENLLLGSDG-LWKLCDFGS 177 (690)
Q Consensus 101 ~~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLH-s~g~~IVHRDLKP~NILLd~dg-~vKL~DFGl 177 (690)
...+++++|..| ++...+.......++...+-.++.|+..+|.|+| ..+ +.||||||+|.+++..+ .+++.|||+
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGL 171 (601)
T ss_pred cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchh
Confidence 678899999854 5555552222214677788899999999999999 888 99999999999999999 999999999
Q ss_pred CCcccccchhhhhccccccccccCC-CCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCchHHHH-----
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHT-TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI----- 251 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~G-T~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~~~~~i----- 251 (690)
|..+... .+........+| ++.|+|||.+ .......+..|+||+|+++.-+++|..|+........
T Consensus 172 At~~~~~------~g~~~~~~~~~g~s~~y~a~E~~--~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~ 243 (601)
T KOG0590|consen 172 ATAYRNK------NGAERSLKDRCGSSPPYGAPEHL--SGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW 243 (601)
T ss_pred hcccccc------CCcceeeecccCCCCCCCCcccc--cchhhcCCCcccccccccccccccCCCCccccccccccceee
Confidence 9765431 222333344577 9999999973 3334667889999999999999999999875443221
Q ss_pred Hhc--cCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHH
Q 005577 252 LNG--NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289 (690)
Q Consensus 252 l~~--~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~ei 289 (690)
... .........++....+++.++|..+|..|.+..++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 244 KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred cccccccccCccccCChhhhhcccccccCCchhccccccc
Confidence 111 11233445788899999999999999999998876
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.7e-14 Score=159.47 Aligned_cols=262 Identities=19% Similarity=0.190 Sum_probs=194.2
Q ss_pred CCCCCceEeecCceEEEEEEeee--cCceEEEEEEE--cccCCeEEEEEEee--cCCHHHHHHHHHHHHHHHhhcCCCCc
Q 005577 13 TGLEGRSIDVGNLKIHVRNVIAE--GGFSCVYSARD--AIHMSKQYAMKHMI--CNDEESLESAMKEISVMKSLKGHPNV 86 (690)
Q Consensus 13 ~~~~g~~iei~~~ry~v~~~LG~--GgFG~VylA~d--~~~~~k~vAvK~i~--~~~~e~~e~~~~Ei~iL~~L~~HPNI 86 (690)
.+......+.....+.+...+|. |.+|.||.+.. . ..+..+|+|.-. ........+-++|+...+.+..|+|+
T Consensus 102 ~~~~S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~-~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~ 180 (524)
T KOG0601|consen 102 IYGASPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNS-ESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENP 180 (524)
T ss_pred ccCCCCccchhhhhcccccccccCCCCCceeecccCCcc-cCCcccccccccCCCCCccccccccchhhcccccCccccc
Confidence 34445556667788888999999 99999999987 4 567788888732 22223334456788888888889999
Q ss_pred eEEEEEEEeecCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCcccCCCCCCcE
Q 005577 87 VTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCN----AVFAMHSQSPPIAHRDLKAENL 162 (690)
Q Consensus 87 VkL~~~~~~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~----aL~yLHs~g~~IVHRDLKP~NI 162 (690)
|+.+.. +.....+|+-+|+|+.+|..+...... .+++..++.++.+... ||.++|..+ |+|-|+||.||
T Consensus 181 v~~~~~----~e~~~~lfiqtE~~~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i 253 (524)
T KOG0601|consen 181 VRDSPA----WEGSGILFIQTELCGESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANI 253 (524)
T ss_pred cccCcc----cccCCcceeeeccccchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhhe
Confidence 996655 335678899999999998888776543 4889999999999999 999999999 99999999999
Q ss_pred EeCCC-CCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCC
Q 005577 163 LLGSD-GLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKN 241 (690)
Q Consensus 163 LLd~d-g~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~ 241 (690)
++..+ ..++++|||+...+....-. .......+..|...|++||. ..+.++...|||+||.++.+..++..
T Consensus 254 ~~~~~~~s~~~~df~~v~~i~~~~~~----~~~~~~~r~~~~~~Y~~ke~----~~~l~~~~~di~sl~ev~l~~~l~~~ 325 (524)
T KOG0601|consen 254 FTTSDWTSCKLTDFGLVSKISDGNFS----SVFKVSKRPEGDCIYAAKEL----LNGLATFASDIFSLGEVILEAILGSH 325 (524)
T ss_pred ecccccceeecCCcceeEEccCCccc----cceeeeecCCCCceEeChhh----hccccchHhhhcchhhhhHhhHhhcc
Confidence 99999 78999999988765443211 11111133357788999995 45678999999999999999888766
Q ss_pred CCCCc---hHHHHHhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHH
Q 005577 242 AFDGE---SKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVW 290 (690)
Q Consensus 242 PF~~~---~~~~il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil 290 (690)
.+... ...++-............+..+..++..|++.+|-.|++...+.
T Consensus 326 ~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 326 LPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred cccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 55432 22222222222233445677888899999999999998877663
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.1e-13 Score=140.98 Aligned_cols=209 Identities=19% Similarity=0.263 Sum_probs=140.2
Q ss_pred HHHHhhcCCCCceEEEEEEEeec-CCCceEEEEEecC-CCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 005577 75 SVMKSLKGHPNVVTLYAHTILDL-GRTKEALLVMECC-DKSLVNVLENRG--AGYFEEKQVLAIFRDVCNAVFAMHSQSP 150 (690)
Q Consensus 75 ~iL~~L~~HPNIVkL~~~~~~~~-~~~~~~~LVmEy~-~gsLl~~L~~~~--~~~lse~~~~~i~~qIa~aL~yLHs~g~ 150 (690)
.-|..|- |.|||+++.|+...- .+.....++.||| .|++..+|++.. ...+......+|+.||+.||.|||+..+
T Consensus 119 dnllqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 119 DNLLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 3445553 999999987653221 2344677899999 478888886532 3458888889999999999999999999
Q ss_pred CcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHH
Q 005577 151 PIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALG 230 (690)
Q Consensus 151 ~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLG 230 (690)
+|+|+.|..+-|++..+|.+||+--- -...+... ............+-++|.+||. ......+.++|||+||
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~----~~~~~~Ek~~~~~~~g~~a~~s---g~~tn~~~a~dIy~fg 269 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSV----NSTREAEKSVNTSLPGFSAPES---GTTTNTTGASDIYKFG 269 (458)
T ss_pred ccccCCcchhheeecCCceEEecccC-ccccchhh----hhhhHhhhhccccCCccccCCc---Ccccccccchhhhhhh
Confidence 99999999999999999988875321 11111111 1112222233456789999994 4455677899999999
Q ss_pred HHHHHHHhCCCC-CCCchHHHHHhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 231 CLLFRICYFKNA-FDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 231 viLyELltG~~P-F~~~~~~~il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
++..+|..+..- -.+.+....-..+-.... ..-..--+++|..||+..|..||++..++++.
T Consensus 270 mcAlemailEiq~tnseS~~~~ee~ia~~i~-~len~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 270 MCALEMAILEIQSTNSESKVEVEENIANVII-GLENGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHHHHHHHheeccCCCcceeehhhhhhhhee-eccCccccCcCcccccCCCCCCcchhhhhcCc
Confidence 999999876543 222222111111100000 01122235678999999999999999987653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.1e-12 Score=143.40 Aligned_cols=142 Identities=21% Similarity=0.196 Sum_probs=94.0
Q ss_pred EEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHH----------------------------------------HH
Q 005577 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESL----------------------------------------ES 69 (690)
Q Consensus 30 ~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~----------------------------------------e~ 69 (690)
.+.||.|++|.||+|+. ..|+.||||+......+.+ -+
T Consensus 122 ~~plasaSigQVh~A~l--~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eld 199 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL--VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELD 199 (437)
T ss_pred CcceeeeehhheEEEEe--cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHC
Confidence 35799999999999987 4789999999754311110 02
Q ss_pred HHHHHHHHHhhc----CCCCceEEEEEEEeecCCCceEEEEEecCCCcH-HHHHHHhCCCCCCHHHHHHHHHHHHH-HHH
Q 005577 70 AMKEISVMKSLK----GHPNVVTLYAHTILDLGRTKEALLVMECCDKSL-VNVLENRGAGYFEEKQVLAIFRDVCN-AVF 143 (690)
Q Consensus 70 ~~~Ei~iL~~L~----~HPNIVkL~~~~~~~~~~~~~~~LVmEy~~gsL-l~~L~~~~~~~lse~~~~~i~~qIa~-aL~ 143 (690)
+.+|++.+.+++ ++++ |.+-.++. .-....+|||||++|.. .+....... .+. ...++..++. .+.
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~-v~vP~v~~---~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 200 LRREAANASELGENFKNDPG-VYVPEVYW---DRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLN 271 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCC-EEeCCEeh---hhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHH
Confidence 445666666664 2343 22222211 11234689999997744 343322211 122 2345555555 478
Q ss_pred HHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccc
Q 005577 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 144 yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~ 183 (690)
.+|..| ++|+|+||.|||++.+|.++|+|||++..+..
T Consensus 272 ql~~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 272 QVLRDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHhCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 899999 99999999999999999999999999876654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=5e-12 Score=121.84 Aligned_cols=131 Identities=19% Similarity=0.145 Sum_probs=94.4
Q ss_pred EEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEec
Q 005577 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMEC 109 (690)
Q Consensus 30 ~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy 109 (690)
.+.|+.|.++.||++.. .++.|++|+...... ....+.+|+.+++.+.....+++++.++ ....++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~---~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~------~~~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV---ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD------PETGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEE---CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe------CCCCeEEEEe
Confidence 46789999999999986 377899998754322 1234578999999986333455666542 1234799999
Q ss_pred CCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC---CcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 110 CDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSP---PIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 110 ~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~---~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
++|..+... ......++.+++.+|..||..+. .++|+||+|.|||++ ++.++|+|||.+..
T Consensus 73 i~G~~l~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 73 IEGSELLTE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cCCCccccc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 987543221 01123467899999999999871 149999999999999 66799999997743
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=6e-11 Score=118.93 Aligned_cols=138 Identities=18% Similarity=0.217 Sum_probs=99.2
Q ss_pred EEEeeecCceEEEEEEEccc-----CCeEEEEEEeecC-------------CH---------HHHHH----HHHHHHHHH
Q 005577 30 RNVIAEGGFSCVYSARDAIH-----MSKQYAMKHMICN-------------DE---------ESLES----AMKEISVMK 78 (690)
Q Consensus 30 ~~~LG~GgFG~VylA~d~~~-----~~k~vAvK~i~~~-------------~~---------e~~e~----~~~Ei~iL~ 78 (690)
...||.|--+.||.|..... .+..+|||+.... +. ..... ..+|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 35789999999999976311 2478999986321 10 01122 237999999
Q ss_pred hhcCC-CCceEEEEEEEeecCCCceEEEEEecCCCc-HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCcccC
Q 005577 79 SLKGH-PNVVTLYAHTILDLGRTKEALLVMECCDKS-LVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM-HSQSPPIAHR 155 (690)
Q Consensus 79 ~L~~H-PNIVkL~~~~~~~~~~~~~~~LVmEy~~gs-Ll~~L~~~~~~~lse~~~~~i~~qIa~aL~yL-Hs~g~~IVHR 155 (690)
+|... -++++++++ ...+|||||++++ +....... ..+++.++..++.+++.+|..| |..| |||+
T Consensus 82 rl~~~Gv~vP~pi~~--------~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL--------KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe--------cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC--eecC
Confidence 99643 567777754 3458999999764 21111111 1256677788899999999999 8999 9999
Q ss_pred CCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 156 DLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 156 DLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
||++.|||+. ++.++|+|||.+..
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCcee
Confidence 9999999997 46799999997754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.9e-12 Score=141.52 Aligned_cols=245 Identities=20% Similarity=0.241 Sum_probs=173.2
Q ss_pred cCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHH--HHHHHHHHHHHhhcCCCCceEEEEEEEeecCCC
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESL--ESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~--e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~ 100 (690)
...+|.++..||.|.|+.||........+..|++|.+...-.... ..-+.|+-+...|.-|.|+|.++..+. ..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~----~~ 338 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS----QL 338 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc----cc
Confidence 446888899999999999999875446788899998754422222 223457777777767999999876543 34
Q ss_pred ceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCC-CCeeeeccCCCC
Q 005577 101 KEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD-GLWKLCDFGSTS 179 (690)
Q Consensus 101 ~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~d-g~vKL~DFGlA~ 179 (690)
...||=.|||.+....+-. .-...+.+...+.+..|++.++.++|++. ++|+|+||.||++..+ +..++.|||+..
T Consensus 339 r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred ccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccccc
Confidence 5677999999654332222 11234888999999999999999999999 9999999999999886 778999999875
Q ss_pred cccccchhhhhccccccccccCCCCccc-CccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc-hHHHHHhccCC
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYR-APEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGE-SKLQILNGNYR 257 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~Ym-APEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF~~~-~~~~il~~~~~ 257 (690)
.+... .+ .....-+|+ ..|+ ......+..+.|+|+||..+++.+++...-... ....+..+.
T Consensus 416 ~~~~~------~~------~~~~~~r~~p~~~~--~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~~~-- 479 (524)
T KOG0601|consen 416 RLAFS------SG------VFHHIDRLYPIAEI--LLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRSGD-- 479 (524)
T ss_pred cccee------cc------cccccccccccchh--hccccccccccccccccccccccccCcccCcccccceeeeccc--
Confidence 32111 00 112234455 2554 456677889999999999999999987543322 222222221
Q ss_pred CCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHH
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQVW 290 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil 290 (690)
.+..+.....+..+...++..++..||.+.++.
T Consensus 480 ~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~ 512 (524)
T KOG0601|consen 480 TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELS 512 (524)
T ss_pred ccCCCchHHhhhhhhhhhcCCccccchhhhhhc
Confidence 233344557788888999999999999887763
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.9e-11 Score=137.89 Aligned_cols=145 Identities=19% Similarity=0.228 Sum_probs=91.5
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH----------------------------------HHHH---
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE----------------------------------ESLE--- 68 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~----------------------------------e~~e--- 68 (690)
.|.. +.||.|++|.||+|+.. .+|+.||||++...-. +..+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~-~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLK-DNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEEC-CCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 4555 78999999999999985 3489999999854311 1111
Q ss_pred ---HHHHHHHHHHhhc---CCCCceEEEEEEEeecCCCceEEEEEecCCCcHHHH---HHHhCC--CCCCHHHHHHHHHH
Q 005577 69 ---SAMKEISVMKSLK---GHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNV---LENRGA--GYFEEKQVLAIFRD 137 (690)
Q Consensus 69 ---~~~~Ei~iL~~L~---~HPNIVkL~~~~~~~~~~~~~~~LVmEy~~gsLl~~---L~~~~~--~~lse~~~~~i~~q 137 (690)
++.+|+..+.+++ .+.+.|.+-.++. .-....+||||||.|.-+.. +...+. ..+.+..+..++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~---d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYW---DYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeec---ccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 2344555555553 1222233222211 11245689999998754332 222221 01344444455555
Q ss_pred HHHHHHHHHhCCCCcccCCCCCCcEEeCCCC----CeeeeccCCCCccccc
Q 005577 138 VCNAVFAMHSQSPPIAHRDLKAENLLLGSDG----LWKLCDFGSTSTNHKR 184 (690)
Q Consensus 138 Ia~aL~yLHs~g~~IVHRDLKP~NILLd~dg----~vKL~DFGlA~~~~~~ 184 (690)
|+ ..| ++|+|+||.|||++.+| .++++|||++..+...
T Consensus 276 if-------~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 276 VF-------RDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HH-------hCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 54 577 99999999999999988 9999999998766543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=8.1e-10 Score=108.48 Aligned_cols=129 Identities=21% Similarity=0.298 Sum_probs=95.7
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecC---CH-----HHHHHHHHHHHHHHhhcC-CCCceEEEEEEEeecCCCc
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DE-----ESLESAMKEISVMKSLKG-HPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---~~-----e~~e~~~~Ei~iL~~L~~-HPNIVkL~~~~~~~~~~~~ 101 (690)
..|++|+-+.+|++.. .+..+++|.-... .+ -..++..+|+++|.+++. -=+++.+|++ +..
T Consensus 2 ~~i~~GAEa~i~~~~~---~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv------D~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF---LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV------DPD 72 (204)
T ss_pred chhhCCcceeEEeeec---cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE------cCC
Confidence 3578999999999965 3555777754322 11 124567789999999862 2356666665 345
Q ss_pred eEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 102 EALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 102 ~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
...|+|||++|.++....... ...++..|-.-+.-||..| |||+||.++||++..++ +.++||||+.
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCccc
Confidence 678999999998776443332 2467788888899999999 99999999999998776 9999999885
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.4e-09 Score=106.57 Aligned_cols=140 Identities=20% Similarity=0.218 Sum_probs=105.0
Q ss_pred EEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--------CHHHHHHHHHHHHHHHhhcC-CCCceEEEEEEEeecCC
Q 005577 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--------DEESLESAMKEISVMKSLKG-HPNVVTLYAHTILDLGR 99 (690)
Q Consensus 29 v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--------~~e~~e~~~~Ei~iL~~L~~-HPNIVkL~~~~~~~~~~ 99 (690)
...+|-+|+-+.|+++.+ .++.++||.-... ..-...+..+|+++|.+++. -=.++++|.+ +
T Consensus 11 ~l~likQGAEArv~~~~~---~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~------D 81 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF---SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI------D 81 (229)
T ss_pred cceeeeccceeeEeeecc---CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE------e
Confidence 456788999999999986 6888888865322 11234677889999999851 1234455432 3
Q ss_pred CceEEEEEecCCC--cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCC---eeeec
Q 005577 100 TKEALLVMECCDK--SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGL---WKLCD 174 (690)
Q Consensus 100 ~~~~~LVmEy~~g--sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~---vKL~D 174 (690)
...-+|+|||++| ++.+++...............+++.|-..+.-||.++ |||+||..+||||..+|. +.|+|
T Consensus 82 ~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lId 159 (229)
T KOG3087|consen 82 TYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILID 159 (229)
T ss_pred cCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEe
Confidence 4556799999998 7777777665443444445789999999999999999 999999999999977763 58999
Q ss_pred cCCCC
Q 005577 175 FGSTS 179 (690)
Q Consensus 175 FGlA~ 179 (690)
||++.
T Consensus 160 fgls~ 164 (229)
T KOG3087|consen 160 FGLSS 164 (229)
T ss_pred ecchh
Confidence 99874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.5e-11 Score=142.17 Aligned_cols=250 Identities=22% Similarity=0.263 Sum_probs=172.1
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCH---HHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE---ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~---e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
..+.+.+-+-.|.|+.++.+.-. ..+...++|+...... ...+....+-.++-.-+ ||-++..+-. +....
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa-~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-~P~v~~~~~s----~~~rs 877 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPA-GSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR-SPAVVRSFPS----FPCRS 877 (1205)
T ss_pred ccceecccccCCCCcccccCCcc-ccccccchhhhccchhhccccccccCCccCccccCC-CCceecccCC----CCCCC
Confidence 45667778899999999988754 3343444444322110 01122222222222221 4556554322 33456
Q ss_pred eEEEEEecCC-CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 102 EALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
..+|||+|++ +++...|...+ +.++.-+..++..+..+++|||... ++|||++|.|+|+..+|..++.|||....
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCccccccc
Confidence 7899999996 46666666544 4788888889999999999999998 99999999999999999999999984322
Q ss_pred ccccc--h------------hh----hhcccc----ccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHh
Q 005577 181 NHKRF--E------------KL----EEMGIE----EDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY 238 (690)
Q Consensus 181 ~~~~~--~------------~~----~~~~~~----~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELlt 238 (690)
..... . .+ ...... .......||+.|.+||. ..+......+|+|++|++++|.++
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~---~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEI---LLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcc---cccccCCCcchhhhhhhhhhhhhc
Confidence 11100 0 00 000011 12344578999999996 445567788999999999999999
Q ss_pred CCCCCCCchHHHHHhccCCCCC-----CCCCCHHHHHHHHHHhhhCCCCCCCHH
Q 005577 239 FKNAFDGESKLQILNGNYRIPE-----SPKYSSSVTDLIRDMLQASPDDRPDIT 287 (690)
Q Consensus 239 G~~PF~~~~~~~il~~~~~~~~-----~~~~s~~l~~LI~~~L~~dP~~RPt~~ 287 (690)
|..||......++...+..... +...+....+++.++|..+|.+|..+.
T Consensus 1031 g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999998888766554332 235688999999999999999996644
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.02 E-value=8.5e-09 Score=113.89 Aligned_cols=214 Identities=16% Similarity=0.222 Sum_probs=152.2
Q ss_pred ceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEecCCC--cHH
Q 005577 38 FSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK--SLV 115 (690)
Q Consensus 38 FG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy~~g--sLl 115 (690)
-.+.|++... ..|..|++|++..+..........-+++++++. |+|||.+.++|........-++||++|+++ +|+
T Consensus 289 ~~Ttyk~~s~-~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSN-VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeec-cCCceeeeeeeccccccCcccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 4678999875 578889999985443333333345678899995 999999999887554556678999999964 677
Q ss_pred HHHHHhCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCccc
Q 005577 116 NVLENRGA-------------GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 116 ~~L~~~~~-------------~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~ 182 (690)
++...... ..++|..+|.|+.||..||.++|+.| +..+-|.|.+||++.+.+++|.-.|+.-.+.
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 76654221 23778999999999999999999999 8899999999999999899998777553321
Q ss_pred ccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCC-CCCchHHHH-HhccCCCCC
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNA-FDGESKLQI-LNGNYRIPE 260 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~P-F~~~~~~~i-l~~~~~~~~ 260 (690)
.. + .+| ++. -.+-|.=.||.+++.|.||..- ...+..... +...
T Consensus 445 ~d-------------------~--~~~--le~------~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I----- 490 (655)
T KOG3741|consen 445 ED-------------------P--TEP--LES------QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI----- 490 (655)
T ss_pred CC-------------------C--Ccc--hhH------HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-----
Confidence 11 0 111 111 1246899999999999998643 222222221 2221
Q ss_pred CCCCCHHHHHHHHHHhhhCCCCCCCHHHHH
Q 005577 261 SPKYSSSVTDLIRDMLQASPDDRPDITQVW 290 (690)
Q Consensus 261 ~~~~s~~l~~LI~~~L~~dP~~RPt~~eil 290 (690)
...++.+++++|.-+...++.+ -++.+++
T Consensus 491 ~~~yS~D~rn~v~yl~s~~~~~-ksI~~ll 519 (655)
T KOG3741|consen 491 TTTYSTDLRNVVEYLESLNFRE-KSIQDLL 519 (655)
T ss_pred hhhhhHHHHHHHHHHHhcCccc-ccHHHHH
Confidence 2467889999999998888886 4555553
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.8e-09 Score=119.05 Aligned_cols=165 Identities=19% Similarity=0.275 Sum_probs=116.5
Q ss_pred cCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEecCCCcHHHHHHHhCCCCCCH
Q 005577 49 HMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEE 128 (690)
Q Consensus 49 ~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse 128 (690)
..+..|.|........+..+...+-++.|+.|+ ||||+++++.+. .....|||+|-+.- |-..+.+ +..
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e----~~~~~ylvTErV~P-l~~~lk~-----l~~ 103 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLR-HPNILSYLDTTE----EEGTLYLVTERVRP-LETVLKE-----LGK 103 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhcc-Cchhhhhhhhhc----ccCceEEEeecccc-HHHHHHH-----hHH
Confidence 356677777776655555566777888999997 999999998754 34689999999842 2223332 235
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccC
Q 005577 129 KQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRA 208 (690)
Q Consensus 129 ~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmA 208 (690)
..+...+.||+.||.|||..+ .++|++|.-.-|+|+..|.+||++|-++........ ......--..|..
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---------~~~~~~~~~s~~~ 173 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---------PAKSLYLIESFDD 173 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---------ccccchhhhcccC
Confidence 677888999999999998654 399999999999999999999999987654322110 0000111224566
Q ss_pred ccchhhhhcCCCCchhhHHHHHHHHHHHHhC
Q 005577 209 PEMWDLFRRELINEKVDIWALGCLLFRICYF 239 (690)
Q Consensus 209 PEvl~~~~~~~~s~ksDVwSLGviLyELltG 239 (690)
|+.++ .-.-..|.|-|||++++++.|
T Consensus 174 P~~~~-----~s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 174 PEEID-----PSEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhcC-----ccccchhhhhHHHHHHHHhCc
Confidence 66311 111347999999999999988
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.5e-09 Score=108.60 Aligned_cols=145 Identities=17% Similarity=0.202 Sum_probs=101.5
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecCCH-HHHHHHHHHHHHHHhhcCC-CCceEEEEEEEeecCCCceEEEEEe
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE-ESLESAMKEISVMKSLKGH-PNVVTLYAHTILDLGRTKEALLVME 108 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~-e~~e~~~~Ei~iL~~L~~H-PNIVkL~~~~~~~~~~~~~~~LVmE 108 (690)
+.|+.|.++.||++... .++.+++|+...... .....+.+|+.+++.+..+ .++++++.+.... ...+..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~--~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~-~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG--GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP-SVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec--CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC-CccCCceEEEE
Confidence 56899999999999863 357899998754332 1345678899999999632 3467776653211 01135689999
Q ss_pred cCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 005577 109 CCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS--------------------------------------- 149 (690)
Q Consensus 109 y~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g--------------------------------------- 149 (690)
|++|..+...... ..+++.+...++.+++..|.+||+..
T Consensus 81 ~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 81 RVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9987543322111 23677777778888888888887421
Q ss_pred ---------------CCcccCCCCCCcEEeCC--CCCeeeeccCCCCc
Q 005577 150 ---------------PPIAHRDLKAENLLLGS--DGLWKLCDFGSTST 180 (690)
Q Consensus 150 ---------------~~IVHRDLKP~NILLd~--dg~vKL~DFGlA~~ 180 (690)
..+||+|++|.|||++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23799999999999988 56789999997743
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=4.6e-09 Score=104.77 Aligned_cols=125 Identities=22% Similarity=0.251 Sum_probs=83.2
Q ss_pred EEEEEEEcccCCeEEEEEEeecC-------------------------C-HHHHHHHHHHHHHHHhhcCC-CCceEEEEE
Q 005577 40 CVYSARDAIHMSKQYAMKHMICN-------------------------D-EESLESAMKEISVMKSLKGH-PNVVTLYAH 92 (690)
Q Consensus 40 ~VylA~d~~~~~k~vAvK~i~~~-------------------------~-~e~~e~~~~Ei~iL~~L~~H-PNIVkL~~~ 92 (690)
.||.|.. ..+..+|||+.... . ........+|++.|.++... -++++++++
T Consensus 1 ~Vy~~~~--~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~ 78 (188)
T PF01163_consen 1 DVYHAID--PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY 78 (188)
T ss_dssp EEEEEEE--CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred CEEEEEC--CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence 4899987 46889999986321 0 01224566899999999633 367888765
Q ss_pred EEeecCCCceEEEEEecCC--CcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCcccCCCCCCcEEeCCCCC
Q 005577 93 TILDLGRTKEALLVMECCD--KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA-MHSQSPPIAHRDLKAENLLLGSDGL 169 (690)
Q Consensus 93 ~~~~~~~~~~~~LVmEy~~--gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~y-LHs~g~~IVHRDLKP~NILLd~dg~ 169 (690)
...+|||||++ |..+..|.... ++......++.+++..+.. +|..| |||+||.+.|||++.+ .
T Consensus 79 --------~~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 79 --------NRNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp --------ETTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-C
T ss_pred --------eCCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-e
Confidence 23479999998 76555554432 2234567788888885555 57889 9999999999999887 7
Q ss_pred eeeeccCCCCc
Q 005577 170 WKLCDFGSTST 180 (690)
Q Consensus 170 vKL~DFGlA~~ 180 (690)
+.|+|||.+..
T Consensus 145 ~~iIDf~qav~ 155 (188)
T PF01163_consen 145 VYIIDFGQAVD 155 (188)
T ss_dssp EEE--GTTEEE
T ss_pred EEEEecCccee
Confidence 99999997743
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=5e-08 Score=102.65 Aligned_cols=128 Identities=19% Similarity=0.158 Sum_probs=86.7
Q ss_pred CCeEEEEEEeecCCHH-HHH----------HHHHHHHHHHhhcC-CCCceEEEEEEEeec-CCCceEEEEEecCCC--cH
Q 005577 50 MSKQYAMKHMICNDEE-SLE----------SAMKEISVMKSLKG-HPNVVTLYAHTILDL-GRTKEALLVMECCDK--SL 114 (690)
Q Consensus 50 ~~k~vAvK~i~~~~~e-~~e----------~~~~Ei~iL~~L~~-HPNIVkL~~~~~~~~-~~~~~~~LVmEy~~g--sL 114 (690)
.++.|.||........ .+. .+.+|++.+.+|.. .=.++.+.+++.... ......+||||++++ +|
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL 123 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL 123 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence 4667888865332211 111 37789998888841 112223333332111 113457899999987 46
Q ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCC-------CCCeeeeccCCCC
Q 005577 115 VNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS-------DGLWKLCDFGSTS 179 (690)
Q Consensus 115 l~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~-------dg~vKL~DFGlA~ 179 (690)
.+++...............++.+|+..+.-||..| |+|+||++.||||+. ++.+.|+||+.+.
T Consensus 124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 66665432233567778899999999999999999 999999999999975 4579999999764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1e-07 Score=103.20 Aligned_cols=251 Identities=16% Similarity=0.200 Sum_probs=156.8
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEE---EeecC
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHT---ILDLG 98 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~---~~~~~ 98 (690)
+-+.-+...+.||+|+-+.+|-.-. -...+.|+.......... +-+..|....+||-+-.=+.+- .+...
T Consensus 8 ~~ge~i~~gr~LgqGgea~ly~l~e----~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~ 80 (637)
T COG4248 8 VYGEPIPPGRPLGQGGEADLYTLGE----VRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGR 80 (637)
T ss_pred ccCcccCCCccccCCccceeeecch----hhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCC
Confidence 3344556678899999999995432 234566776554433222 2234455555676544311110 01111
Q ss_pred CCceEEEEEecCCC--cHHHHHH---Hh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeee
Q 005577 99 RTKEALLVMECCDK--SLVNVLE---NR-GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKL 172 (690)
Q Consensus 99 ~~~~~~LVmEy~~g--sLl~~L~---~~-~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL 172 (690)
+....-+.|..+.| ....++. ++ .-..+.++-+++..+.|+.+...||..| .+-+|+.++|+|+.+++.|.|
T Consensus 81 ~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~L 158 (637)
T COG4248 81 RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVL 158 (637)
T ss_pred ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEE
Confidence 22235577888755 2222221 11 1224778899999999999999999999 999999999999999999999
Q ss_pred eccCCCCcccccchhhhhccccccccccCCCCcccCccchh--hhhcCCCCchhhHHHHHHHHHHHHhC-CCCCCCch--
Q 005577 173 CDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWD--LFRRELINEKVDIWALGCLLFRICYF-KNAFDGES-- 247 (690)
Q Consensus 173 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~--~~~~~~~s~ksDVwSLGviLyELltG-~~PF~~~~-- 247 (690)
.|=........ + ....-.+|...|.+||.-. .+.+-.-+...|.|.|||+++++|.| +.||.+..
T Consensus 159 VdsDsfqi~~n--------g--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~ 228 (637)
T COG4248 159 VDSDSFQINAN--------G--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI 228 (637)
T ss_pred EcccceeeccC--------C--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc
Confidence 87543221111 0 0111236889999999521 12233456789999999999999886 99997632
Q ss_pred -------HHHHHhccC---------CCC-----CCCCCCHHHHHHHHHHhhhC--CCCCCCHHHHHH
Q 005577 248 -------KLQILNGNY---------RIP-----ESPKYSSSVTDLIRDMLQAS--PDDRPDITQVWF 291 (690)
Q Consensus 248 -------~~~il~~~~---------~~~-----~~~~~s~~l~~LI~~~L~~d--P~~RPt~~eil~ 291 (690)
..+|..+.+ ..+ ....+++++..|..+|+... +.-||+..-.+.
T Consensus 229 ~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~a 295 (637)
T COG4248 229 SDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVA 295 (637)
T ss_pred CCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHH
Confidence 112322221 111 11246889999999998753 568999765433
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.8e-07 Score=93.18 Aligned_cols=110 Identities=19% Similarity=0.237 Sum_probs=81.6
Q ss_pred HHHHHHHHHHHHhhcC-CCCceEEEEEEEeecCCCceEEEEEecCCC--cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHH
Q 005577 67 LESAMKEISVMKSLKG-HPNVVTLYAHTILDLGRTKEALLVMECCDK--SLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143 (690)
Q Consensus 67 ~e~~~~Ei~iL~~L~~-HPNIVkL~~~~~~~~~~~~~~~LVmEy~~g--sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~ 143 (690)
..++.+|...+..|.. .=.+++.+++.....+.....+||+|+++| +|.+++..... ++......++.+++..+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 3467788888887752 122444555544332223456899999987 46666655333 566778899999999999
Q ss_pred HHHhCCCCcccCCCCCCcEEeCCCC---CeeeeccCCCCc
Q 005577 144 AMHSQSPPIAHRDLKAENLLLGSDG---LWKLCDFGSTST 180 (690)
Q Consensus 144 yLHs~g~~IVHRDLKP~NILLd~dg---~vKL~DFGlA~~ 180 (690)
-||.+| |+|+||++.||||+.++ .+.|+||+-++.
T Consensus 133 ~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999 99999999999998887 899999996643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=6.4e-08 Score=100.31 Aligned_cols=134 Identities=22% Similarity=0.205 Sum_probs=98.4
Q ss_pred EEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC--------------------C--HHHHHHHHHHHHHHHhhcCC-
Q 005577 27 IHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--------------------D--EESLESAMKEISVMKSLKGH- 83 (690)
Q Consensus 27 y~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~--------------------~--~e~~e~~~~Ei~iL~~L~~H- 83 (690)
+.+...||-|--+.||.|.+. .+..+|||.-... . .-....+.+|.++|..|..+
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~--~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP--KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HhhccccccCccceEEEEECC--CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 456789999999999999984 7899999964211 0 11234567899999999533
Q ss_pred CCceEEEEEEEeecCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEE
Q 005577 84 PNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLL 163 (690)
Q Consensus 84 PNIVkL~~~~~~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NIL 163 (690)
-.|++-+++ +...+||||++|..+..+. +.....-.++..|+.-+..+-..| |||+||.+-|||
T Consensus 171 ~~VP~P~~~--------nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIl 234 (304)
T COG0478 171 VKVPKPIAW--------NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNIL 234 (304)
T ss_pred CCCCCcccc--------ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEE
Confidence 357777654 5668999999986543332 123444455666666666666778 999999999999
Q ss_pred eCCCCCeeeeccCCC
Q 005577 164 LGSDGLWKLCDFGST 178 (690)
Q Consensus 164 Ld~dg~vKL~DFGlA 178 (690)
++.||.++|+||--+
T Consensus 235 V~~dg~~~vIDwPQ~ 249 (304)
T COG0478 235 VTEDGDIVVIDWPQA 249 (304)
T ss_pred EecCCCEEEEeCccc
Confidence 999999999999743
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.4e-07 Score=92.66 Aligned_cols=142 Identities=18% Similarity=0.197 Sum_probs=102.6
Q ss_pred eecCceEEEEEEEcccCCeEEEEEEeecC------CHHHHHHHHHHHHHHHhhcCC-CCceEEEEEEEeecCCCceEEEE
Q 005577 34 AEGGFSCVYSARDAIHMSKQYAMKHMICN------DEESLESAMKEISVMKSLKGH-PNVVTLYAHTILDLGRTKEALLV 106 (690)
Q Consensus 34 G~GgFG~VylA~d~~~~~k~vAvK~i~~~------~~e~~e~~~~Ei~iL~~L~~H-PNIVkL~~~~~~~~~~~~~~~LV 106 (690)
|+||.+-|+.... .++.|-+|..... -+-....|.+|+..|..|... -.|+++........+..-..+||
T Consensus 27 ~rgG~SgV~r~~~---~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER---NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe---CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 5789999998765 3556888875311 022456788999999988621 12444432222222223356899
Q ss_pred EecCCC--cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCC--eeeeccCCCCc
Q 005577 107 MECCDK--SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGL--WKLCDFGSTST 180 (690)
Q Consensus 107 mEy~~g--sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~--vKL~DFGlA~~ 180 (690)
+|-++| +|.+++........++.+...++.+|+..|.-||..| +.|+|+.+.|||++.+|. ++++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 999984 7777776654445678888899999999999999999 999999999999987777 99999986543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=4.1e-08 Score=111.97 Aligned_cols=150 Identities=17% Similarity=0.260 Sum_probs=101.8
Q ss_pred HHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhh
Q 005577 136 RDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLF 215 (690)
Q Consensus 136 ~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~ 215 (690)
.+++.||.|+|..- .+||+.|.|++|.++..|.+||+.|+++.................-..-..-...|.|||+ +
T Consensus 106 ~~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~---~ 181 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEY---L 181 (700)
T ss_pred hcccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchh---h
Confidence 34459999999873 4999999999999999999999999977544332111000000000000112568999996 4
Q ss_pred hcCCCCchhhHHHHHHHHHHHH-hCCCCCCCchH---HHH---HhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHH
Q 005577 216 RRELINEKVDIWALGCLLFRIC-YFKNAFDGESK---LQI---LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQ 288 (690)
Q Consensus 216 ~~~~~s~ksDVwSLGviLyELl-tG~~PF~~~~~---~~i---l~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~e 288 (690)
.+...+.++|+|||||++|.+. .|+.-+..... ... ..+.-.......++.++++-|.++|..++..||++..
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~ 261 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDL 261 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence 5577889999999999999998 56655544321 111 1111122223578999999999999999999997766
Q ss_pred H
Q 005577 289 V 289 (690)
Q Consensus 289 i 289 (690)
+
T Consensus 262 l 262 (700)
T KOG2137|consen 262 L 262 (700)
T ss_pred h
Confidence 5
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.7e-06 Score=86.83 Aligned_cols=79 Identities=19% Similarity=0.157 Sum_probs=54.8
Q ss_pred EEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCC-CCceEEEEEEEeecCCCceEEEEEe
Q 005577 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGH-PNVVTLYAHTILDLGRTKEALLVME 108 (690)
Q Consensus 30 ~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~H-PNIVkL~~~~~~~~~~~~~~~LVmE 108 (690)
++.|+.|..+.||+.... . ..+++|..... .....+.+|+.+++.|..+ ..|.+++.++. ........+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~--~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~-~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD--D-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDT-SDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEET--T-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEE-ETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEEC--C-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecc-cccccccceEEEE
Confidence 467999999999999873 3 58999986443 4566778899999988644 23667776442 2222345789999
Q ss_pred cCCCcH
Q 005577 109 CCDKSL 114 (690)
Q Consensus 109 y~~gsL 114 (690)
+++|..
T Consensus 76 ~i~g~~ 81 (239)
T PF01636_consen 76 YIPGRP 81 (239)
T ss_dssp EESSEE
T ss_pred Eecccc
Confidence 998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.9e-06 Score=98.15 Aligned_cols=143 Identities=20% Similarity=0.235 Sum_probs=90.8
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecCC------------------------------HHHHH----------HH
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICND------------------------------EESLE----------SA 70 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~------------------------------~e~~e----------~~ 70 (690)
..|+.++-|.||+|+. ..|+.||||+...+- .+.++ ++
T Consensus 131 ~PiAsASIaQVH~A~L--~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy 208 (517)
T COG0661 131 EPIASASIAQVHRAVL--KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY 208 (517)
T ss_pred CchhhhhHhhheeEEe--cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence 5789999999999997 469999999863221 00011 23
Q ss_pred HHHHHHHHhhc----CCCC--ceEEEEEEEeecCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Q 005577 71 MKEISVMKSLK----GHPN--VVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144 (690)
Q Consensus 71 ~~Ei~iL~~L~----~HPN--IVkL~~~~~~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~y 144 (690)
.+|+..+.+++ +.++ |.++| .+-...-+|+|||++|.-...+.......++.+.+...+.++.- ..
T Consensus 209 ~~EA~n~~~~~~nf~~~~~v~VP~V~------we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~--~q 280 (517)
T COG0661 209 RREAANAERFRENFKDDPDVYVPKVY------WEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFL--RQ 280 (517)
T ss_pred HHHHHHHHHHHHHcCCCCCeEeceee------hhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHH--HH
Confidence 45777666664 3343 33333 11124567999999984333322211123565554443333322 22
Q ss_pred HHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccc
Q 005577 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185 (690)
Q Consensus 145 LHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~ 185 (690)
+-..| +.|.|..|.||+++.+|++.+.|||+...+....
T Consensus 281 ~~~dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~~ 319 (517)
T COG0661 281 LLRDG--FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPKF 319 (517)
T ss_pred HHhcC--ccccCCCccceEEecCCcEEEEcCcceecCCHHH
Confidence 22356 9999999999999999999999999987765554
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.1e-05 Score=82.23 Aligned_cols=143 Identities=16% Similarity=0.222 Sum_probs=91.3
Q ss_pred ecCceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHH---------HHHHHHHHHhhc--CCCCceEEE
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLES---------AMKEISVMKSLK--GHPNVVTLY 90 (690)
Q Consensus 22 i~~~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~---------~~~Ei~iL~~L~--~HPNIVkL~ 90 (690)
+.+..|.+.+++-.....-|.+..- .++.+++|..........+. ..+++..+.+++ +.-.+..+|
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei---~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI---DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE---CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 3467899999999988888888764 57889999875443221111 123444444443 123333333
Q ss_pred EEEEee-cCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCC
Q 005577 91 AHTILD-LGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGL 169 (690)
Q Consensus 91 ~~~~~~-~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~ 169 (690)
.+..-- +.-....+|||||++|--+..+.. +++ .+...|..++.-||..| ++|+|+.|.|+++..++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECCc-
Confidence 222111 111234568999998854322211 232 24456778899999999 99999999999998666
Q ss_pred eeeeccCCCC
Q 005577 170 WKLCDFGSTS 179 (690)
Q Consensus 170 vKL~DFGlA~ 179 (690)
++++||+..+
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 9999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.27 E-value=8.2e-06 Score=84.09 Aligned_cols=137 Identities=23% Similarity=0.220 Sum_probs=95.0
Q ss_pred EEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHH----------------------H--HHHHHHHHHHHHhhc-CC
Q 005577 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEE----------------------S--LESAMKEISVMKSLK-GH 83 (690)
Q Consensus 29 v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e----------------------~--~e~~~~Ei~iL~~L~-~H 83 (690)
+...|..|--+.||+|.. ..+..+|+|+....... . ..-..+|++.|+++. .+
T Consensus 52 ~~g~istGKEA~Vy~a~~--~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAG 129 (268)
T COG1718 52 LVGCISTGKEANVYLAET--GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAG 129 (268)
T ss_pred eEeeecCCcceEEEeecc--CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcC
Confidence 345788899999999976 46789999987432110 0 011346888888775 23
Q ss_pred CCceEEEEEEEeecCCCceEEEEEecCCCcH--HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCcccCCCCCC
Q 005577 84 PNVVTLYAHTILDLGRTKEALLVMECCDKSL--VNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS-QSPPIAHRDLKAE 160 (690)
Q Consensus 84 PNIVkL~~~~~~~~~~~~~~~LVmEy~~gsL--l~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs-~g~~IVHRDLKP~ 160 (690)
=.+.+-+.+ ....|||||++... .-.|.. -.+...++..+..+++..+.-|-. .+ +||+||..=
T Consensus 130 VrvP~Pi~~--------~~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEy 196 (268)
T COG1718 130 VRVPEPIAF--------RNNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEY 196 (268)
T ss_pred CCCCCceee--------cCCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhh
Confidence 345555544 23479999996431 111111 124444788899999999998877 67 999999999
Q ss_pred cEEeCCCCCeeeeccCCCCcc
Q 005577 161 NLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 161 NILLd~dg~vKL~DFGlA~~~ 181 (690)
|||+. ++.+.|+|||-|...
T Consensus 197 NiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 197 NILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred heEEE-CCeEEEEECcccccc
Confidence 99999 888999999977544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.4e-05 Score=82.21 Aligned_cols=138 Identities=13% Similarity=0.096 Sum_probs=79.1
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCC-CceEEEEEEEeecCCCceEEEEEec
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHP-NVVTLYAHTILDLGRTKEALLVMEC 109 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HP-NIVkL~~~~~~~~~~~~~~~LVmEy 109 (690)
..||.|.-+.||+. .+..+++|...... ......+|.++|+.+.... .+.+++.++. ..+...+|||+
T Consensus 7 ~~i~~G~t~~~y~~-----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~----~~~~~glv~e~ 75 (226)
T TIGR02172 7 TQTGEGGNGESYTH-----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVE----DGGRLGLIYEL 75 (226)
T ss_pred eeecCCCCcceeEe-----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEe----cCCeeeeeeee
Confidence 56899999999973 13457888765432 2345678999999886332 2466665532 23456789999
Q ss_pred CCCcH-H---------------HHHHH-----hC--CCCCCHHHH-HHHHH----------HHHHH-HHHH--HhCCCCc
Q 005577 110 CDKSL-V---------------NVLEN-----RG--AGYFEEKQV-LAIFR----------DVCNA-VFAM--HSQSPPI 152 (690)
Q Consensus 110 ~~gsL-l---------------~~L~~-----~~--~~~lse~~~-~~i~~----------qIa~a-L~yL--Hs~g~~I 152 (690)
++|.. . ..+.. +. ......... ..+.. .+... ..+| +.....+
T Consensus 76 i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 76 IVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred cCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 98841 1 11111 00 000111110 00100 00111 1122 1222347
Q ss_pred ccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 153 AHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 153 VHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
+|+|+.|.|||++.++ +.|+||+.+..
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 8999999999999888 99999997743
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.6e-05 Score=81.77 Aligned_cols=73 Identities=15% Similarity=0.074 Sum_probs=49.1
Q ss_pred EeeecCc-eEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEecC
Q 005577 32 VIAEGGF-SCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECC 110 (690)
Q Consensus 32 ~LG~GgF-G~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy~ 110 (690)
.|-.|.. ..||+... .+..+.||+..... ...+.+|+++++.|.++--++++++++.. .+..+||||++
T Consensus 5 ~~~~g~~~~~v~~~~~---~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~----~~~~~lv~e~i 74 (244)
T cd05150 5 RVTEGQSGATVYRLDG---KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSD----DGRAWLLTSAV 74 (244)
T ss_pred ecCCCCCcCeEEEEcC---CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEec----CCccEEEEEee
Confidence 3445555 88999865 23578888764432 34567899999999766456677765432 24578999999
Q ss_pred CCcH
Q 005577 111 DKSL 114 (690)
Q Consensus 111 ~gsL 114 (690)
+|..
T Consensus 75 ~G~~ 78 (244)
T cd05150 75 PGVP 78 (244)
T ss_pred CCcc
Confidence 8743
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.2e-05 Score=78.90 Aligned_cols=131 Identities=22% Similarity=0.267 Sum_probs=89.2
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~ 104 (690)
+..++.+.|++|.+|.||++.++ +..+|+|+-..++ ....+..|+++|..+..----.++|.|. .-+
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~~---~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg--------~~~ 88 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEWR---GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG--------EDF 88 (201)
T ss_pred hhhhhhhhhhcccccEEEEeecc---CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec--------hhh
Confidence 45566789999999999999984 6688999764433 3466788999999886444456677662 345
Q ss_pred EEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCC-CCcEEeCCCCCeeeeccCCCC
Q 005577 105 LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLK-AENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 105 LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLK-P~NILLd~dg~vKL~DFGlA~ 179 (690)
++|||++| .|.... ... +.++ +..++..-.-|-..| |-|..|. |..++|..++.+.|+||..|+
T Consensus 89 i~me~i~G~~L~~~~-~~~----~rk~----l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 89 IRMEYIDGRPLGKLE-IGG----DRKH----LLRVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhhcCcchhhhh-hcc----cHHH----HHHHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 77999988 444332 211 2233 334555555666677 8898886 444444455589999999775
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.02 E-value=0.00011 Score=74.17 Aligned_cols=132 Identities=20% Similarity=0.234 Sum_probs=94.0
Q ss_pred cCceEEEEEEeeecCc-eEEEEEEEcccCCeEEEEEEeec---C-----------CH-------HHHHHHHHHHHHHHhh
Q 005577 23 GNLKIHVRNVIAEGGF-SCVYSARDAIHMSKQYAMKHMIC---N-----------DE-------ESLESAMKEISVMKSL 80 (690)
Q Consensus 23 ~~~ry~v~~~LG~GgF-G~VylA~d~~~~~k~vAvK~i~~---~-----------~~-------e~~e~~~~Ei~iL~~L 80 (690)
.+.+|+..+.||.|.- |.||+++. .++.||||++.. . .. .....|..|.+...+|
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv~I---~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRL 111 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKVEI---DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRL 111 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEEEE---CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHH
Confidence 4478899999999999 99999986 578999999321 0 00 1234567788888777
Q ss_pred c--CCCCc--eEEEEEEEeec-C-------------CCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHH
Q 005577 81 K--GHPNV--VTLYAHTILDL-G-------------RTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAV 142 (690)
Q Consensus 81 ~--~HPNI--VkL~~~~~~~~-~-------------~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL 142 (690)
. ++.++ |++||+...+. . .....-||.||+...- .+... -+.+|++-|
T Consensus 112 ke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl 177 (207)
T PF13095_consen 112 KEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDL 177 (207)
T ss_pred HhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHH
Confidence 5 34566 99999986652 1 1112358888885432 12333 345677778
Q ss_pred HHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 143 FAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 143 ~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
..+|..| |+-+|+++.|.. +| ||+|||.+
T Consensus 178 ~~~~k~g--I~~~Dv~~~ny~---~G--~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKLG--IVPRDVKPRNYR---GG--KLVDFSSS 206 (207)
T ss_pred HHHHHCC--eeeccCcccccc---CC--EEEecccC
Confidence 8999999 999999999987 33 89999953
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.99 E-value=5.3e-05 Score=86.51 Aligned_cols=141 Identities=19% Similarity=0.218 Sum_probs=90.4
Q ss_pred EEEeeecCceEEEEEEEcccCCeEEEEEEeecCC-------------------------------HHHHH------HHHH
Q 005577 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-------------------------------EESLE------SAMK 72 (690)
Q Consensus 30 ~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~-------------------------------~e~~e------~~~~ 72 (690)
.+.||.-+.|.||+|+.. .++.||||+-...- ++..+ +|.+
T Consensus 166 ~~piaaASlaQVhrA~L~--~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~ 243 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLK--NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTK 243 (538)
T ss_pred cchhhhcchhheEEEEec--CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHH
Confidence 367899999999999974 69999999853210 01111 2445
Q ss_pred HHHHHHhhc---CCCC------ceEEEEEEEeecCCCceEEEEEecCCC---cHHHHHHHhCCCCCCHHHHHHHHHHHHH
Q 005577 73 EISVMKSLK---GHPN------VVTLYAHTILDLGRTKEALLVMECCDK---SLVNVLENRGAGYFEEKQVLAIFRDVCN 140 (690)
Q Consensus 73 Ei~iL~~L~---~HPN------IVkL~~~~~~~~~~~~~~~LVmEy~~g---sLl~~L~~~~~~~lse~~~~~i~~qIa~ 140 (690)
|++...+++ .|-+ |+++|-. -...-+|+||||+| +.++.|.+++ ++...+...+.++.
T Consensus 244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~------~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~- 313 (538)
T KOG1235|consen 244 EAKNAERFRENFKDFSLLTYVLVPKVYWD------LSTKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAY- 313 (538)
T ss_pred HHHhHHHHHHHHHhcccccceeCCeehhh------cCcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHH-
Confidence 555444432 2444 5555432 12456899999987 4456666654 56654444333322
Q ss_pred HHHHHHhCCCCcccCCCCCCcEEeCC----CCCeeeeccCCCCcccccc
Q 005577 141 AVFAMHSQSPPIAHRDLKAENLLLGS----DGLWKLCDFGSTSTNHKRF 185 (690)
Q Consensus 141 aL~yLHs~g~~IVHRDLKP~NILLd~----dg~vKL~DFGlA~~~~~~~ 185 (690)
+.-|-..| ++|+|=.|.||+++. ++.+.|.|||+...+....
T Consensus 314 -~~qIf~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~~ 359 (538)
T KOG1235|consen 314 -LEQIFKTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHKT 359 (538)
T ss_pred -HHHHHhcC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccHHH
Confidence 22233456 999999999999984 5689999999987665443
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.92 E-value=9.4e-05 Score=89.75 Aligned_cols=83 Identities=16% Similarity=0.183 Sum_probs=54.8
Q ss_pred EEEeeecCceEEEEEEEcccC-CeEEEEEEeecCC-HHHHHHHHHHHHHHHhhcCCCCc--eEEEEEEEeecCCCceEEE
Q 005577 30 RNVIAEGGFSCVYSARDAIHM-SKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNV--VTLYAHTILDLGRTKEALL 105 (690)
Q Consensus 30 ~~~LG~GgFG~VylA~d~~~~-~k~vAvK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNI--VkL~~~~~~~~~~~~~~~L 105 (690)
...|+.|.+..+|+....... ...+++|+..... ......+.+|+++|+.|.+|.+| +++|.+|... ...+..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~-~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA-SVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC-CcCCCceE
Confidence 567899999999998763111 1467777653322 12234677999999999656654 7777665321 12245789
Q ss_pred EEecCCCc
Q 005577 106 VMECCDKS 113 (690)
Q Consensus 106 VmEy~~gs 113 (690)
||||++|.
T Consensus 122 VME~v~G~ 129 (822)
T PLN02876 122 IMEYLEGR 129 (822)
T ss_pred EEEecCCc
Confidence 99999874
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00039 Score=77.24 Aligned_cols=76 Identities=21% Similarity=0.219 Sum_probs=54.7
Q ss_pred EEEeeecCceEEEEEEEcccCCeEEEEEEeec----C-C--HHHHHHHHHHHHHHHhhcCC--CCceEEEEEEEeecCCC
Q 005577 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC----N-D--EESLESAMKEISVMKSLKGH--PNVVTLYAHTILDLGRT 100 (690)
Q Consensus 30 ~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~----~-~--~e~~e~~~~Ei~iL~~L~~H--PNIVkL~~~~~~~~~~~ 100 (690)
.+.||.|.+..||++.+. ..++.|+||.-.. . + .-..+++..|.+.|..+..+ .+|+++|.+ +.
T Consensus 31 ~~elggGn~N~VyrV~~~-~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~------D~ 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDT-EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY------DE 103 (401)
T ss_pred eeEcCCCceEEEEEEEeC-CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE------CC
Confidence 367899999999999884 2235899997531 1 1 22457778899999887533 568888876 23
Q ss_pred ceEEEEEecCCC
Q 005577 101 KEALLVMECCDK 112 (690)
Q Consensus 101 ~~~~LVmEy~~g 112 (690)
...++||||+++
T Consensus 104 ~~~~lVME~L~~ 115 (401)
T PRK09550 104 ELAVTVMEDLSD 115 (401)
T ss_pred CCCEEEEecCCC
Confidence 557899999964
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.81 E-value=3.8e-06 Score=95.34 Aligned_cols=186 Identities=18% Similarity=0.143 Sum_probs=126.7
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCC-ceEEEEEEEeecCCCceE
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPN-VVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPN-IVkL~~~~~~~~~~~~~~ 103 (690)
..|..-+-+++|+++.+|+.+.. ..+....+.+... ....-++++|.++ +||| +|..++- .+.....
T Consensus 242 kws~~fh~fvK~altknpKkRpt--aeklL~h~fvs~~-----l~~rl~~eLLdK~-n~P~~~v~~~~d----~~~E~~~ 309 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPT--AEKLLQHPFVSQT-----LSRRLAIELLDKV-NNPNPVVRYLED----YDGEDYL 309 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCC--hhhheeceeeccc-----hhhHHHHHHHHHc-cCCCCccccccc----CCccccc
Confidence 35555666889999999999874 3344446655443 2334578899999 5999 5544332 3334567
Q ss_pred EEEEecCCCc--HHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 104 LLVMECCDKS--LVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 104 ~LVmEy~~gs--Ll~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
.++|+|+++. ..... ......|.+-+...+++.-+.+|++||+.- =+||| |||... +..++.||+....+
T Consensus 310 ~i~~~i~s~~rs~~~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEM-TVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred chhhhhhcCCccccccC-ChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCccc
Confidence 8999999654 11111 111112455566677888889999999985 59999 887755 66999999987654
Q ss_pred cccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHHHHHHHHHHHHhCCCCC
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAF 243 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVwSLGviLyELltG~~PF 243 (690)
.... ......+|+.|+|||+ .....+....|+|++|+-..+|.-|-+|-
T Consensus 382 ~~~~----------~~~t~~~~~~~~~pev---~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 382 TRTM----------KPRTAIGTPEPLAPEV---IQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred Cccc----------ccccCCCCCCCCCchh---hcccccccCCCccCCCcchhhcCCCCCCC
Confidence 3321 1223568999999997 45677889999999998777776666554
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00012 Score=76.24 Aligned_cols=137 Identities=14% Similarity=0.130 Sum_probs=76.1
Q ss_pred eeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEecCCC
Q 005577 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK 112 (690)
Q Consensus 33 LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy~~g 112 (690)
|..|-...+|+... .++.+++|..........-...+|..+++.+..+--..+++.++ .-++||||++|
T Consensus 4 ~~~G~tn~~y~~~~---~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--------~~~~v~e~i~G 72 (256)
T TIGR02721 4 LSGGLTNRSWRIEH---PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--------EHWLLVEWLEG 72 (256)
T ss_pred CCCcCcCCeEEEEe---CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--------CCEEEEEeccC
Confidence 45677778998863 46678888754332221123567999999986443345554432 12689999977
Q ss_pred cHHH---------------HHHHhCC-----CCCCHH-HHHHHHHHH---------HHHHHHHHhC------CCCcccCC
Q 005577 113 SLVN---------------VLENRGA-----GYFEEK-QVLAIFRDV---------CNAVFAMHSQ------SPPIAHRD 156 (690)
Q Consensus 113 sLl~---------------~L~~~~~-----~~lse~-~~~~i~~qI---------a~aL~yLHs~------g~~IVHRD 156 (690)
.... .+.+-.. ..+... .+..+..++ ...+..+-.. ...++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 3221 1111110 112211 111221111 1112222111 12389999
Q ss_pred CCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 157 LKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 157 LKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
+.|.|||++.++ +.|+||..+...
T Consensus 153 l~~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 153 VHAYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred CCcCcEEEeCCC-CEEEeccccCcC
Confidence 999999999887 789999987553
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00034 Score=71.41 Aligned_cols=74 Identities=15% Similarity=0.062 Sum_probs=47.3
Q ss_pred EEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEec
Q 005577 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMEC 109 (690)
Q Consensus 30 ~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy 109 (690)
.+.|..|-...||+.......++.|++|+...... ......+|+.+++.+..+--++++++.+. -.+||||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--------~~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ--------NGLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC--------CcEEEEe
Confidence 35677788889999865210256788997643322 12234578999999865555666665421 1379999
Q ss_pred CCC
Q 005577 110 CDK 112 (690)
Q Consensus 110 ~~g 112 (690)
++|
T Consensus 74 i~G 76 (235)
T cd05157 74 IPG 76 (235)
T ss_pred eCC
Confidence 976
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00026 Score=85.49 Aligned_cols=201 Identities=17% Similarity=0.244 Sum_probs=129.6
Q ss_pred HHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEecCCC-cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 005577 69 SAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147 (690)
Q Consensus 69 ~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy~~g-sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs 147 (690)
...-|+..+.++. |+|++.++.|.......+-...+..+||.+ ++...+..-+ .++...++.+..+++.||.|+|+
T Consensus 228 ~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHH
Confidence 3445777788885 999999998876554444233344567754 5555555444 37888999999999999999999
Q ss_pred CCCCcccCCCCCC---cEEeCCCCCeeee--ccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCc
Q 005577 148 QSPPIAHRDLKAE---NLLLGSDGLWKLC--DFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINE 222 (690)
Q Consensus 148 ~g~~IVHRDLKP~---NILLd~dg~vKL~--DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ 222 (690)
.. +.|.-|... +-..+.++.+.+. ||+....+....... ....+..|.++|... ........
T Consensus 305 ~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~----------~~~~~~~~~~~e~~~-~~~~~~~r 371 (1351)
T KOG1035|consen 305 LS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF----------SDLLAEIRNADEDLK-ENTAKKSR 371 (1351)
T ss_pred hc--cceeEEecccccccccCccceeecchhhhcccccCCCcccch----------hhcCccccccccccc-cccchhhh
Confidence 97 777766665 4445566666666 888765543322111 112355677888532 11122333
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCch-HHHHHhccCCCCCCCCCCHHHHHHHHHHhhhCCCCCCCHHHHHHHH
Q 005577 223 KVDIWALGCLLFRICYFKNAFDGES-KLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRV 293 (690)
Q Consensus 223 ksDVwSLGviLyELltG~~PF~~~~-~~~il~~~~~~~~~~~~s~~l~~LI~~~L~~dP~~RPt~~eil~~l 293 (690)
..|+|.+|..+..+..|..+-.... ...++. ........+++..|+..+.++|+...+++...
T Consensus 372 ~~dL~~lgll~~~~~~~~~i~~~~~~~~~~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 372 LTDLWCLGLLLLQLSQGEDISEKSAVPVSLLD--------VLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhHHHHHHHHHhhhhhcCcccccccchhhhhc--------cccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 4799999999998877654432111 111110 11222678889999999999999999886543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00052 Score=73.45 Aligned_cols=82 Identities=13% Similarity=0.106 Sum_probs=56.8
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCC--CCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGH--PNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~H--PNIVkL~~~~~~~~~~~~~~ 103 (690)
.+.-.+.||.|..+.||+..+. .+ .+.+|...... ....+..|+..|+.|..+ -.|+++++++... ...+..
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~--~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~-~~~g~~ 88 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDS--QG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE-QSPGPD 88 (297)
T ss_pred hhheeeecCCccceeEEEEEcC--CC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccC-CcCCCe
Confidence 5556788999999999998652 23 46777643211 224678899999999654 3688888776432 123558
Q ss_pred EEEEecCCCc
Q 005577 104 LLVMECCDKS 113 (690)
Q Consensus 104 ~LVmEy~~gs 113 (690)
+||||+++|.
T Consensus 89 ~LVmE~i~G~ 98 (297)
T PRK10593 89 VLLLERLRGV 98 (297)
T ss_pred EEEEeccCCE
Confidence 9999999763
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00024 Score=72.97 Aligned_cols=73 Identities=11% Similarity=0.031 Sum_probs=43.7
Q ss_pred EEeeecCce-EEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCC--CCceEEEEEEEeecCCCceEEEEE
Q 005577 31 NVIAEGGFS-CVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGH--PNVVTLYAHTILDLGRTKEALLVM 107 (690)
Q Consensus 31 ~~LG~GgFG-~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~H--PNIVkL~~~~~~~~~~~~~~~LVm 107 (690)
..|+.||.. .||+.. ..+++|..... .....+.+|+++|..|..+ --+.++++..... +.....|+||
T Consensus 3 ~~~~~gG~~n~vy~~~------~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~-~~~~~~~~l~ 73 (235)
T cd05155 3 EPVDSGGTDNATFRLG------DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPG-EGYPWPWSVY 73 (235)
T ss_pred eeccCCCcccceEEcC------CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCc-cCCCcceEEE
Confidence 467877776 588652 24777765432 2245788899999988643 1345554432211 1112357899
Q ss_pred ecCCC
Q 005577 108 ECCDK 112 (690)
Q Consensus 108 Ey~~g 112 (690)
++++|
T Consensus 74 ~~i~G 78 (235)
T cd05155 74 RWLEG 78 (235)
T ss_pred EeecC
Confidence 99876
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00083 Score=67.80 Aligned_cols=130 Identities=21% Similarity=0.284 Sum_probs=85.4
Q ss_pred EEeeecCceEEEEEEEcccCCeEEEEEEeecCC----------------HHHHHHHHHHHHHHHhhc-----CCCCceEE
Q 005577 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICND----------------EESLESAMKEISVMKSLK-----GHPNVVTL 89 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~----------------~e~~e~~~~Ei~iL~~L~-----~HPNIVkL 89 (690)
..||+|+.-.||.-- .....+||++.... ........+|+.....+. .+.+|.++
T Consensus 7 ~~i~~G~~R~cy~HP----~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP----DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred cccccCCCceEEECC----CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 469999999999542 34567888886544 122455666776666553 37889999
Q ss_pred EEEEEeecCCCceEEEEEecC---CC----cHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcE
Q 005577 90 YAHTILDLGRTKEALLVMECC---DK----SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENL 162 (690)
Q Consensus 90 ~~~~~~~~~~~~~~~LVmEy~---~g----sLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NI 162 (690)
||+...+ ..+-+|+|.+ +| +|.+++... .+++ .+...+.+ -..||-..+ |+.+||+|.||
T Consensus 83 ~G~veT~----~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~~---f~~~l~~~~--Iv~~dl~~~NI 149 (199)
T PF10707_consen 83 YGFVETN----LGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALDE---FKRYLLDHH--IVIRDLNPHNI 149 (199)
T ss_pred eEEEecC----CceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHHH---HHHHHHHcC--CeecCCCcccE
Confidence 9986544 3345777766 23 566666332 2665 44444444 445666777 99999999999
Q ss_pred EeCCC--C--Ceeeec-cCC
Q 005577 163 LLGSD--G--LWKLCD-FGS 177 (690)
Q Consensus 163 LLd~d--g--~vKL~D-FGl 177 (690)
++... + .+.|+| ||.
T Consensus 150 v~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 150 VVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred EEEecCCCceEEEEEeCCCC
Confidence 99543 2 578888 563
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.47 E-value=9.3e-05 Score=78.83 Aligned_cols=132 Identities=21% Similarity=0.241 Sum_probs=95.0
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecC---------CH---------H----HHHHHHHHHHHHHhhcCC
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---------DE---------E----SLESAMKEISVMKSLKGH 83 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~---------~~---------e----~~e~~~~Ei~iL~~L~~H 83 (690)
-+.+.+.||-|--+.||.+-+ ..++..++|.-... .. . ..-...+|+..|+.|..|
T Consensus 93 v~svGnqIGVGKESDIY~v~d--~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD--EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred hhhhccccccccccceEEEec--CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 456788999999999999988 46888999853110 00 0 112356799999999755
Q ss_pred CC-ceEEEEEEEeecCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcE
Q 005577 84 PN-VVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENL 162 (690)
Q Consensus 84 PN-IVkL~~~~~~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NI 162 (690)
-. |++.+++ +..++|||++.|-.+..+..-. .+-.+...+..-+.-|..+| +||+|..-=||
T Consensus 171 gfpVPkpiD~--------~RH~Vvmelv~g~Pl~~v~~v~-------d~~~ly~~lm~~Iv~la~~G--lIHgDFNEFNi 233 (465)
T KOG2268|consen 171 GFPVPKPIDH--------NRHCVVMELVDGYPLRQVRHVE-------DPPTLYDDLMGLIVRLANHG--LIHGDFNEFNI 233 (465)
T ss_pred CCCCCCcccc--------cceeeHHHhhcccceeeeeecC-------ChHHHHHHHHHHHHHHHHcC--ceecccchhee
Confidence 43 5555544 5678999999886554433221 22345555566667778889 99999999999
Q ss_pred EeCCCCCeeeeccC
Q 005577 163 LLGSDGLWKLCDFG 176 (690)
Q Consensus 163 LLd~dg~vKL~DFG 176 (690)
||+.++.++++||-
T Consensus 234 mv~dd~~i~vIDFP 247 (465)
T KOG2268|consen 234 MVKDDDKIVVIDFP 247 (465)
T ss_pred EEecCCCEEEeech
Confidence 99999999999996
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00055 Score=68.43 Aligned_cols=100 Identities=18% Similarity=0.150 Sum_probs=76.9
Q ss_pred HHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEecCCC-cHHHH---HHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 005577 72 KEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNV---LENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147 (690)
Q Consensus 72 ~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy~~g-sLl~~---L~~~~~~~lse~~~~~i~~qIa~aL~yLHs 147 (690)
.|.-+|..|.+.+++++++|+| + .++|.||++. +++.. +.... .-++.....|+.+++..+.+|+.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C-------G-~~~v~E~~~~~~~~~~~~~l~~~~--~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC-------G-RFYVVEYVGAGSLYGIYRPLSQFL--QSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC-------C-CEEEEEeecCcccccccccccccc--ccCHHHHHHHHHHHHHHHHHHhc
Confidence 5888899997557999999986 2 2578999974 44321 11111 15788999999999999999988
Q ss_pred CCC-CcccCCCCCCcEEeCCCCCeeeeccCCCCcc
Q 005577 148 QSP-PIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 148 ~g~-~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~ 181 (690)
.-. .+.-.|++++|+-|+.+|++|++|...+...
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 421 2888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0022 Score=68.16 Aligned_cols=73 Identities=16% Similarity=0.063 Sum_probs=44.9
Q ss_pred EEeeecCceEEEEEEEcc-----cCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEE
Q 005577 31 NVIAEGGFSCVYSARDAI-----HMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALL 105 (690)
Q Consensus 31 ~~LG~GgFG~VylA~d~~-----~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~L 105 (690)
+.|..|--..||+..... ..++.|++|+..... .......+|++++..|..+--..+++.++. + .+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-----~---~~ 74 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-----N---GR 74 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-----C---Cc
Confidence 445556666888886421 124788999865432 233456789999998864444456655431 1 25
Q ss_pred EEecCCC
Q 005577 106 VMECCDK 112 (690)
Q Consensus 106 VmEy~~g 112 (690)
||||++|
T Consensus 75 v~e~i~G 81 (302)
T cd05156 75 IEEFIPS 81 (302)
T ss_pred hhheeCC
Confidence 7888865
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0035 Score=68.68 Aligned_cols=74 Identities=22% Similarity=0.284 Sum_probs=52.0
Q ss_pred EeeecCceEEEEEEEcccCCeEEEEEEee----cC--C-HHHHHHHHHHHHHHHhhcCC-C-CceEEEEEEEeecCCCce
Q 005577 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMI----CN--D-EESLESAMKEISVMKSLKGH-P-NVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 32 ~LG~GgFG~VylA~d~~~~~k~vAvK~i~----~~--~-~e~~e~~~~Ei~iL~~L~~H-P-NIVkL~~~~~~~~~~~~~ 102 (690)
.||.|-...||++.+. ..++.|+||.-. +. + +-..++...|..+|+.+..+ | +|+++|.+ +...
T Consensus 2 EigdGnlN~VfrV~~~-~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~------D~e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQ-EGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF------DTEM 74 (370)
T ss_pred cCCCCceEEEEEEEcC-CCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE------cccc
Confidence 4799999999999873 333689999752 11 1 33456777888888877533 3 68888866 3456
Q ss_pred EEEEEecCCC
Q 005577 103 ALLVMECCDK 112 (690)
Q Consensus 103 ~~LVmEy~~g 112 (690)
..+|||+++.
T Consensus 75 ~~~vMEdL~~ 84 (370)
T TIGR01767 75 AVTVMEDLSH 84 (370)
T ss_pred ceehHhhCcc
Confidence 6799999953
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0032 Score=66.59 Aligned_cols=142 Identities=15% Similarity=0.066 Sum_probs=80.1
Q ss_pred EEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCC-CceEEEEEE----EeecCCCceEE
Q 005577 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHP-NVVTLYAHT----ILDLGRTKEAL 104 (690)
Q Consensus 30 ~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HP-NIVkL~~~~----~~~~~~~~~~~ 104 (690)
.+.|..|.-..+|+... .+..+++|+.... ....+..|++++..|..+- .+++++... ... ..+..+
T Consensus 19 i~~i~~G~~n~~y~v~~---~~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~--~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT---DSGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE--LAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe---CCCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee--eCCceE
Confidence 45677787789998864 3457899987542 2345667888888885331 255554320 111 124568
Q ss_pred EEEecCCCcHH------------H---HHHHhCCC---------CCCHHHH----------HHHHHHHHHHHHHHHh---
Q 005577 105 LVMECCDKSLV------------N---VLENRGAG---------YFEEKQV----------LAIFRDVCNAVFAMHS--- 147 (690)
Q Consensus 105 LVmEy~~gsLl------------~---~L~~~~~~---------~lse~~~----------~~i~~qIa~aL~yLHs--- 147 (690)
+||+|++|... + .++....+ ...+... ......+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 99999976321 1 11111100 0000000 0011122333444443
Q ss_pred --CCCCcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 148 --QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 148 --~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
....+||+|+.|.|||++.++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 11239999999999999988777899999664
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0059 Score=68.03 Aligned_cols=75 Identities=20% Similarity=0.294 Sum_probs=52.6
Q ss_pred EEEEeeecCceEEEEEEEcccCCeEEEEEEee----cCCH---HHHHHHHHHHHHHHhhcCC--CCceEEEEEEEeecCC
Q 005577 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMI----CNDE---ESLESAMKEISVMKSLKGH--PNVVTLYAHTILDLGR 99 (690)
Q Consensus 29 v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~----~~~~---e~~e~~~~Ei~iL~~L~~H--PNIVkL~~~~~~~~~~ 99 (690)
..+.||.|....||+..+ .++.|+||.-. +... -...+...|++.|+.+..+ .+|+++|.++.
T Consensus 36 ~~~eiggGn~N~VyrV~~---~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de----- 107 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS---SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR----- 107 (418)
T ss_pred eEEEcCCCceeeEEEEEc---CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-----
Confidence 367889999999999886 24568999753 1111 2456666778888776422 47889987742
Q ss_pred CceEEEEEecCCC
Q 005577 100 TKEALLVMECCDK 112 (690)
Q Consensus 100 ~~~~~LVmEy~~g 112 (690)
...+|||||+++
T Consensus 108 -d~~vlvME~L~~ 119 (418)
T PLN02756 108 -TMALIGMRYLEP 119 (418)
T ss_pred -CCCEEEEeecCC
Confidence 456889999966
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0067 Score=64.86 Aligned_cols=145 Identities=14% Similarity=0.053 Sum_probs=78.7
Q ss_pred EEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCC-CCceEEEEEEE--eecCCCceEEE
Q 005577 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGH-PNVVTLYAHTI--LDLGRTKEALL 105 (690)
Q Consensus 29 v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~H-PNIVkL~~~~~--~~~~~~~~~~L 105 (690)
-.+.|+.|--..||+... .+..+++|+...... .+....|++++..|.++ -.|++++.... ......+..++
T Consensus 26 ~i~~~~~G~~n~~y~v~t---~~~~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~ 100 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT---DVGRYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC 100 (307)
T ss_pred eccccCCccccceEEEEe---CCCcEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence 356677777789998864 244688887644321 23345677777777422 12455443210 00011345789
Q ss_pred EEecCCCcH-----H----------HHHHHhCCCC-------CCHHH---H-H-----------HHHHHHHHHHHHHHh-
Q 005577 106 VMECCDKSL-----V----------NVLENRGAGY-------FEEKQ---V-L-----------AIFRDVCNAVFAMHS- 147 (690)
Q Consensus 106 VmEy~~gsL-----l----------~~L~~~~~~~-------lse~~---~-~-----------~i~~qIa~aL~yLHs- 147 (690)
||+|++|.. . ..+.....+. +.... . . .....+...++++..
T Consensus 101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 999997621 1 1111111110 00000 0 0 011223344555532
Q ss_pred ----CCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 148 ----QSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 148 ----~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
....+||+|+.+.||+++.++.+.|+||+.+
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 1123999999999999998887789999966
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0043 Score=68.79 Aligned_cols=76 Identities=18% Similarity=0.179 Sum_probs=54.4
Q ss_pred EEEeeecCceEEEEEEEcccCCeEEEEEEee----cC-C-HHHHHHHHHHHHHHHhhcCC-C-CceEEEEEEEeecCCCc
Q 005577 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHMI----CN-D-EESLESAMKEISVMKSLKGH-P-NVVTLYAHTILDLGRTK 101 (690)
Q Consensus 30 ~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~----~~-~-~e~~e~~~~Ei~iL~~L~~H-P-NIVkL~~~~~~~~~~~~ 101 (690)
.+.||.|--..||++.+. ..++.|+||.-. .. + +-..++..-|.++|+.+..+ | +|+++|.+ +..
T Consensus 34 ~~eigdGnlN~VfrV~~~-~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~------D~e 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDE-QKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF------DSV 106 (409)
T ss_pred eeEcCCCceEEEEEEeeC-CCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE------CcH
Confidence 577899999999999873 235679999752 11 1 23467778888888877532 3 68888866 345
Q ss_pred eEEEEEecCCC
Q 005577 102 EALLVMECCDK 112 (690)
Q Consensus 102 ~~~LVmEy~~g 112 (690)
...+|||+++.
T Consensus 107 ~~~~vMEdL~~ 117 (409)
T PRK12396 107 MNCCVMEDLSD 117 (409)
T ss_pred HhhHHHHhCcc
Confidence 66799999953
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.017 Score=61.92 Aligned_cols=30 Identities=30% Similarity=0.391 Sum_probs=25.5
Q ss_pred CcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 151 PIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 151 ~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
.+||+|+.|.|||++.+...-|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 399999999999998766568999997743
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.00085 Score=82.86 Aligned_cols=203 Identities=11% Similarity=-0.041 Sum_probs=126.6
Q ss_pred HHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEecCC-CcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh
Q 005577 71 MKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCD-KSLVNVLENRGA--GYFEEKQVLAIFRDVCNAVFAMHS 147 (690)
Q Consensus 71 ~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~--~~lse~~~~~i~~qIa~aL~yLHs 147 (690)
+.|...++... |++++..+.- .........|++++|+. |.+...|.+.-. .++.+.-+.....+.+.+..-+|+
T Consensus 1277 l~e~de~~~~~-h~~~~~~p~r--I~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1277 LSERDELREAK-HYLTEVDPLR--IPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred hhhhhhhhhhh-ceeeeccccc--CCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 34444555564 9998887643 22233456789999994 677777765322 234444444444444677776665
Q ss_pred C---CCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchh
Q 005577 148 Q---SPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKV 224 (690)
Q Consensus 148 ~---g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ks 224 (690)
. |.-.+|++||+-|.+|..+..+|++++|+.+........ ....++++.|+.+++ ...-.++.++
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf---------~Gl~l~sp~~v~qli---~N~ik~t~rs 1421 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF---------FGLELCSPIYVLQLI---KNEIKFTKRS 1421 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCchHhh---------hhhhhCCHHHHHHHH---HHHHhhhhHH
Confidence 4 224799999999999999999999999999833222111 112467889999996 3445577889
Q ss_pred hHHHHHHHHHHHHhCCCCCCCchHHHHHhccCCC----CCCCCCCHHHHHHHHHHhhhCCCCCCCHHHH
Q 005577 225 DIWALGCLLFRICYFKNAFDGESKLQILNGNYRI----PESPKYSSSVTDLIRDMLQASPDDRPDITQV 289 (690)
Q Consensus 225 DVwSLGviLyELltG~~PF~~~~~~~il~~~~~~----~~~~~~s~~l~~LI~~~L~~dP~~RPt~~ei 289 (690)
|+|.+|+.+|++..|..+|-..... ++.+..+. ...-..|.+...+...+|-..-..||.-..+
T Consensus 1422 dilr~s~~ly~rs~~n~~fi~flq~-~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~is 1489 (2724)
T KOG1826|consen 1422 DILRRSLSLYLRSDGNAYFIFFLQP-ALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYIS 1489 (2724)
T ss_pred HHHHHHHHHHHHhcccHHHHHHHHH-HHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhh
Confidence 9999999999999888777432221 12222111 1111223444444555555555667665444
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0089 Score=65.12 Aligned_cols=137 Identities=21% Similarity=0.312 Sum_probs=92.8
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeec-----C-------------------CHHH--HHHHHHHHHHHHh
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC-----N-------------------DEES--LESAMKEISVMKS 79 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~-----~-------------------~~e~--~e~~~~Ei~iL~~ 79 (690)
--.|..+|..|--+-||.|.. ..|..+|||+... . ++.. .--...|++-|++
T Consensus 145 i~~inGCiSTGKEANVYHat~--~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkR 222 (520)
T KOG2270|consen 145 IVEINGCISTGKEANVYHATE--EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKR 222 (520)
T ss_pred eeecccccccCccceeEeeec--CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHH
Confidence 345667899999999999986 4788899997621 1 1111 1123468888888
Q ss_pred hcC----CCCceEEEEEEEeecCCCceEEEEEecCCCcHH--HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcc
Q 005577 80 LKG----HPNVVTLYAHTILDLGRTKEALLVMECCDKSLV--NVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIA 153 (690)
Q Consensus 80 L~~----HPNIVkL~~~~~~~~~~~~~~~LVmEy~~gsLl--~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IV 153 (690)
|.+ +|-.+-| ...+|||+|+++.-+ -.|.. ..|+...+..+..+++.-+.-|-... ++|
T Consensus 223 l~~aGIP~PePIlL-----------k~hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c-~LV 287 (520)
T KOG2270|consen 223 LNNAGIPCPEPILL-----------KNHVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKC-RLV 287 (520)
T ss_pred HHhcCCCCCCceee-----------ecceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHh-cee
Confidence 851 2222222 234699999975322 22221 23777888888888888888776553 399
Q ss_pred cCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 154 HRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 154 HRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
|-||.-=|+|+- +|.++|+|-+-+..
T Consensus 288 HADLSEfN~Lyh-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 288 HADLSEFNLLYH-DGKLYIIDVSQSVE 313 (520)
T ss_pred ccchhhhhheEE-CCEEEEEEcccccc
Confidence 999999999984 67799999885543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.013 Score=62.64 Aligned_cols=77 Identities=21% Similarity=0.208 Sum_probs=46.6
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhc--CCCCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK--GHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~--~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
.++-.+.|+-|....+|+.. ..++.+.||+-. ......|..|++-|+.|. .--.|++++++.... ...
T Consensus 18 ~i~~~~~v~GG~i~~a~~~~---~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~----~~~ 87 (288)
T PF03881_consen 18 KITSIEPVSGGDINEAYRLD---TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD----DDA 87 (288)
T ss_dssp ---EEEEE--SSSSEEEEEE---TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S----SCC
T ss_pred ceeeeEecCCCChhheEEEE---CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec----CCc
Confidence 45667889999999999987 367889999875 223355677888888883 234577888776533 345
Q ss_pred EEEEecCCC
Q 005577 104 LLVMECCDK 112 (690)
Q Consensus 104 ~LVmEy~~g 112 (690)
||||||++.
T Consensus 88 fLlle~l~~ 96 (288)
T PF03881_consen 88 FLLLEFLEM 96 (288)
T ss_dssp EEEEE----
T ss_pred eEEEEeecC
Confidence 999999853
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.014 Score=63.86 Aligned_cols=148 Identities=12% Similarity=0.127 Sum_probs=80.5
Q ss_pred ceEEEEEEeeecCceEEEEEEEcc---cCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAI---HMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~---~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
..+.+. .|-.|---.+|++.... ..++.|++|+........+ ...+|+.+++.+.++---.++++++. +.
T Consensus 37 ~~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~-----~g 109 (344)
T PLN02236 37 EALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFP-----NG 109 (344)
T ss_pred CcEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEEC-----Cc
Confidence 344444 44457778999986421 1246788987755433222 33679999998875544556665531 11
Q ss_pred eEEEEEecCCCcHHH-----------H----HHH---hC-CC---CCCHHHHHHHHHHH-----------------HHHH
Q 005577 102 EALLVMECCDKSLVN-----------V----LEN---RG-AG---YFEEKQVLAIFRDV-----------------CNAV 142 (690)
Q Consensus 102 ~~~LVmEy~~gsLl~-----------~----L~~---~~-~~---~lse~~~~~i~~qI-----------------a~aL 142 (690)
.|++|++|..+. . +.+ .. .. .....++..++.++ ...+
T Consensus 110 ---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~ 186 (344)
T PLN02236 110 ---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEI 186 (344)
T ss_pred ---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHH
Confidence 578888652211 1 111 00 00 11122222332111 1111
Q ss_pred HHH----HhC--CCCcccCCCCCCcEEeCC-CCCeeeeccCCCCccc
Q 005577 143 FAM----HSQ--SPPIAHRDLKAENLLLGS-DGLWKLCDFGSTSTNH 182 (690)
Q Consensus 143 ~yL----Hs~--g~~IVHRDLKP~NILLd~-dg~vKL~DFGlA~~~~ 182 (690)
..| ... ...++|+||++.|||++. ++.++|+||..+....
T Consensus 187 ~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~ 233 (344)
T PLN02236 187 NLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP 233 (344)
T ss_pred HHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence 111 111 113899999999999976 4689999999876543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.019 Score=60.82 Aligned_cols=30 Identities=23% Similarity=0.395 Sum_probs=24.9
Q ss_pred CcccCCCCCCcEEeCCCCC-eeeeccCCCCc
Q 005577 151 PIAHRDLKAENLLLGSDGL-WKLCDFGSTST 180 (690)
Q Consensus 151 ~IVHRDLKP~NILLd~dg~-vKL~DFGlA~~ 180 (690)
.+||+|++|.|||++.++. +-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999987565 46999997743
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.017 Score=62.41 Aligned_cols=138 Identities=16% Similarity=0.196 Sum_probs=78.3
Q ss_pred EEEeeecCceEEEEEEEcccCCeEEEEEEee--cCCHHHHHHHHHHHHHHHhhcCC-CCceEEEEEEEeecCCCceEEEE
Q 005577 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHMI--CNDEESLESAMKEISVMKSLKGH-PNVVTLYAHTILDLGRTKEALLV 106 (690)
Q Consensus 30 ~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~--~~~~e~~e~~~~Ei~iL~~L~~H-PNIVkL~~~~~~~~~~~~~~~LV 106 (690)
...+-.|---.+|...+ .++.+++. .. ...........+|..+|+.+... --+...+++|..+. -...|.|
T Consensus 30 v~~~~~G~sn~t~~~~~---~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~--~g~pf~v 103 (321)
T COG3173 30 VEEISGGWSNDTFRLGD---TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY--LGTPFYV 103 (321)
T ss_pred eeeccCCcccceEEEec---CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC--CCCceEE
Confidence 34443343334555544 26677777 32 23344566777899999988421 12344455554332 3467999
Q ss_pred EecCCCc-HHHHHHHhCCCCCCHHHHHHHH-HHHHHHHHHHH--------------------------------------
Q 005577 107 MECCDKS-LVNVLENRGAGYFEEKQVLAIF-RDVCNAVFAMH-------------------------------------- 146 (690)
Q Consensus 107 mEy~~gs-Ll~~L~~~~~~~lse~~~~~i~-~qIa~aL~yLH-------------------------------------- 146 (690)
|+|+.|. ....+. .......++ ..+...|..||
T Consensus 104 ~~~veGe~~~~~~~-------~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~ 176 (321)
T COG3173 104 MEWVEGEVVWSALP-------PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR 176 (321)
T ss_pred EEEecceeccCcCC-------cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence 9999872 111000 000001111 13333333333
Q ss_pred ------------hCC------CCcccCCCCCCcEEeCCCCCeeeeccCCCCc
Q 005577 147 ------------SQS------PPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 147 ------------s~g------~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~ 180 (690)
.+- ..++|+|+.+.||||+.++-+=|.||+++..
T Consensus 177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 221 2499999999999999998899999998854
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.031 Score=60.72 Aligned_cols=151 Identities=13% Similarity=0.110 Sum_probs=79.8
Q ss_pred CceEEEEEEeeecCceEEEEEEEccc--CCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCc
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIH--MSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 24 ~~ry~v~~~LG~GgFG~VylA~d~~~--~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~ 101 (690)
...+++..+.| |---.+|+...... ....|++++...... ..-...+|..+++.+..+---+++++++. ++
T Consensus 14 ~~~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-----~G 86 (330)
T PLN02421 14 DSDFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-----NG 86 (330)
T ss_pred cCceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-----Cc
Confidence 34555555443 66678888864311 123788887754432 23334578999998864433355554431 11
Q ss_pred eEEEEEecCCCcHH-----------HHH----HHhCCCC------C-CHHHHHHHHHHH---------------------
Q 005577 102 EALLVMECCDKSLV-----------NVL----ENRGAGY------F-EEKQVLAIFRDV--------------------- 138 (690)
Q Consensus 102 ~~~LVmEy~~gsLl-----------~~L----~~~~~~~------l-se~~~~~i~~qI--------------------- 138 (690)
+|.+|++|..+ ..+ .+-.... + -...+..++.++
T Consensus 87 ---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (330)
T PLN02421 87 ---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEE 163 (330)
T ss_pred ---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHH
Confidence 47888765321 111 1111100 1 112222222221
Q ss_pred -HHHHH---HHH-hCC--CCcccCCCCCCcEEeCC-CCCeeeeccCCCCccccc
Q 005577 139 -CNAVF---AMH-SQS--PPIAHRDLKAENLLLGS-DGLWKLCDFGSTSTNHKR 184 (690)
Q Consensus 139 -a~aL~---yLH-s~g--~~IVHRDLKP~NILLd~-dg~vKL~DFGlA~~~~~~ 184 (690)
..-+. .+. ..+ .-++|.||.+.|||++. ++.++|+||..|...+..
T Consensus 164 l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd~~ 217 (330)
T PLN02421 164 LRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSYRG 217 (330)
T ss_pred HHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCccH
Confidence 11111 111 111 13799999999999975 578999999988654443
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.015 Score=59.48 Aligned_cols=88 Identities=17% Similarity=0.225 Sum_probs=62.2
Q ss_pred HHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 005577 68 ESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147 (690)
Q Consensus 68 e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs 147 (690)
..+..+.++++++. .|++|.. + .+-.+-+++|+|-.-- .....++.--+.+|...|+
T Consensus 103 ~~y~nky~v~Armh---GilrL~N----D--n~~~yGvIlE~Cy~~~--------------i~~~N~i~agi~~L~~fH~ 159 (308)
T PF07387_consen 103 ALYFNKYRVFARMH---GILRLKN----D--NNYKYGVILERCYKIK--------------INFSNFITAGIKDLMDFHS 159 (308)
T ss_pred hhhhhhhhHHHHhh---heeEeec----C--CCceeEEEEeeccCcc--------------cchhHHHHHhHHHHHHhhc
Confidence 44577899999884 5888852 1 2334558899984211 0112233333577888997
Q ss_pred CCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 148 ~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
.....+|+|..|+|||-|..|.+||.|=+..
T Consensus 160 ~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 160 ENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred cCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 7667999999999999999999999997743
|
The function of this family is unknown. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.0098 Score=59.97 Aligned_cols=29 Identities=38% Similarity=0.585 Sum_probs=20.7
Q ss_pred cccCCCCCCcEEe-CCCCCeeeeccCCCCc
Q 005577 152 IAHRDLKAENLLL-GSDGLWKLCDFGSTST 180 (690)
Q Consensus 152 IVHRDLKP~NILL-d~dg~vKL~DFGlA~~ 180 (690)
++|.||.+.|||+ +.++.++|+||..+..
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 8999999999999 8889999999997754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.062 Score=57.58 Aligned_cols=29 Identities=17% Similarity=0.208 Sum_probs=26.4
Q ss_pred CcccCCCCCCcEEeCCCCCeeeeccCCCC
Q 005577 151 PIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 151 ~IVHRDLKP~NILLd~dg~vKL~DFGlA~ 179 (690)
.+||+|+.++|||++.++.+.|+||..++
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 39999999999999999999999998664
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.012 Score=63.97 Aligned_cols=79 Identities=19% Similarity=0.286 Sum_probs=61.5
Q ss_pred EeecCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCcccCCCCCCcEEeCCCCCeeee
Q 005577 94 ILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLC 173 (690)
Q Consensus 94 ~~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs~g~~IVHRDLKP~NILLd~dg~vKL~ 173 (690)
++...++...|++|++-++.+...- .-...+++.|+.+.+..++-+..+- ++=||||.-.||||+ +|.|-|+
T Consensus 292 vv~~de~~y~yl~~kdhgt~is~ik------~~~~~e~lsff~s~~sil~~lekkf-~fehrnlt~~niLId-~GnvtLI 363 (488)
T COG5072 292 VVSLDETLYLYLHFKDHGTPISIIK------ADRSEEELSFFWSCISILDILEKKF-PFEHRNLTLDNILID-EGNVTLI 363 (488)
T ss_pred EEecCCceEEEEEEecCCceeeeee------cccHHHHHHHHHHHHHHHhhhhhcC-Ccccccccccceeee-cCceEEE
Confidence 3333456678899999877654321 1345788999999888887777664 589999999999999 9999999
Q ss_pred ccCCCCc
Q 005577 174 DFGSTST 180 (690)
Q Consensus 174 DFGlA~~ 180 (690)
||-++|.
T Consensus 364 DfklsRl 370 (488)
T COG5072 364 DFKLSRL 370 (488)
T ss_pred Eeeeeec
Confidence 9999874
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.028 Score=63.65 Aligned_cols=151 Identities=21% Similarity=0.315 Sum_probs=92.1
Q ss_pred HHHHHHHHHHHhhcCCCCceEEEEEEEeecCCCceEEEEEecCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 005577 68 ESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147 (690)
Q Consensus 68 e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~lse~~~~~i~~qIa~aL~yLHs 147 (690)
..++-.+.+++.+. |+|+..+.++- -+......+|||+++-+|.+.+..+... ..... .
T Consensus 27 ~~ilgr~~~lktl~-~~~l~~yl~~~---r~~~~r~IVV~e~~~~Sled~~~~~~l~---~~s~~--------------~ 85 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQ-HDNLCQYLDFS---RGKHERVIVVMEHYTMSLEDILKTGNLK---DESLL--------------A 85 (725)
T ss_pred HHHhhhhHHHHhhc-CccceeeEeee---cCccceEEEEehhhccchHHHHHhcccc---hhhhc--------------c
Confidence 45566788999996 99999887653 2234458899999999999988765421 11100 2
Q ss_pred CCCCcccCCCCCCcEEeCCCCCeeeeccCCCCcccccchhhhhccccccccccCCCCcccCccchhhhhcCCCCchhhHH
Q 005577 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIW 227 (690)
Q Consensus 148 ~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPEvl~~~~~~~~s~ksDVw 227 (690)
++ +.|- || ++++| -++ | .| |-. ..+++|||
T Consensus 86 ~~--~~~~-----~~-------~~~td-~~~------------------------t-~~--~~~--------~~pKsdVw 115 (725)
T KOG1093|consen 86 HG--VLHL-----NI-------IYITD-HFL------------------------T-KY--PSP--------IGPKSDVW 115 (725)
T ss_pred cc--ccee-----hh-------hhccc-ccc------------------------c-cC--CCC--------CCcchhhh
Confidence 22 3332 22 33344 110 0 01 111 12589999
Q ss_pred HHHHHHHHHHhCCCCCCCchHHHHHhcc---CCCCC-----------CCCCCHHHHHHHHHHhhhCCCCCCCHHHH
Q 005577 228 ALGCLLFRICYFKNAFDGESKLQILNGN---YRIPE-----------SPKYSSSVTDLIRDMLQASPDDRPDITQV 289 (690)
Q Consensus 228 SLGviLyELltG~~PF~~~~~~~il~~~---~~~~~-----------~~~~s~~l~~LI~~~L~~dP~~RPt~~ei 289 (690)
++|.|+.+++.|...+......+.+... +..+. ...++..+.++...|+-..|..||...++
T Consensus 116 sl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 116 SLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred hHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 9999999999887766544333322211 11111 12356777888899999999999976665
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.078 Score=54.67 Aligned_cols=76 Identities=21% Similarity=0.267 Sum_probs=52.2
Q ss_pred eEEEEEEeeecCceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhc--CCCCceEEEEEEEeecCCCceE
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK--GHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 26 ry~v~~~LG~GgFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~--~HPNIVkL~~~~~~~~~~~~~~ 103 (690)
+++..+.+.-|..-..|...+ ....+-||+ +..+.+..|..|+.-|+.|. +.-.|.+++++. ....+.
T Consensus 17 ~i~er~~v~gG~inea~~v~d---g~~~~FvK~---n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G----~~~~~s 86 (286)
T COG3001 17 EIKEREEVSGGDINEAWRLRD---GTDPFFVKC---NQREQLSMFTAEADGLELLARSNTITVPKVIAVG----ASRDHS 86 (286)
T ss_pred hhhcccccCCccccceeEeec---CCcceEEEe---cchhhHHHHHHHHHHHHHHHhcCCccccceEEec----CCCCee
Confidence 445566676677667776665 456788886 44455667778888777774 234577777764 356789
Q ss_pred EEEEecCC
Q 005577 104 LLVMECCD 111 (690)
Q Consensus 104 ~LVmEy~~ 111 (690)
||||||++
T Consensus 87 ylVle~L~ 94 (286)
T COG3001 87 YLVLEYLP 94 (286)
T ss_pred EEEEeecc
Confidence 99999984
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.062 Score=58.53 Aligned_cols=138 Identities=14% Similarity=0.114 Sum_probs=76.7
Q ss_pred CceEEEEEEEcccCCeEEEEEEeecCCHHHHHHHHHHHHHHHhhcCCC--C---ceEEEEEEEeecCCCceEEEEEecCC
Q 005577 37 GFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHP--N---VVTLYAHTILDLGRTKEALLVMECCD 111 (690)
Q Consensus 37 gFG~VylA~d~~~~~k~vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HP--N---IVkL~~~~~~~~~~~~~~~LVmEy~~ 111 (690)
.-..||+... .+..+++|+.... .....+..|+..|..|..+. - |..+=|-.+.........+-|++|++
T Consensus 37 ~eN~~f~~~~---~~g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~ 111 (331)
T COG2334 37 EENSNFRVQT---EDGRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLP 111 (331)
T ss_pred ccCceEEEEe---cCCCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecC
Confidence 5567888876 2344588877654 33455566777888775332 1 22221211111111136678899998
Q ss_pred CcHHHH----------------HHHhCCC----------CCCHH----H---------HHHHHHHHHHHHHHHHhCC---
Q 005577 112 KSLVNV----------------LENRGAG----------YFEEK----Q---------VLAIFRDVCNAVFAMHSQS--- 149 (690)
Q Consensus 112 gsLl~~----------------L~~~~~~----------~lse~----~---------~~~i~~qIa~aL~yLHs~g--- 149 (690)
|..... |.....+ ...+. . -.....++...+..+...-
T Consensus 112 G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~ 191 (331)
T COG2334 112 GRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAH 191 (331)
T ss_pred CcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhh
Confidence 754431 1111110 11111 0 0123444555555555431
Q ss_pred ---CC--cccCCCCCCcEEeCCCCC-eeeeccCCCC
Q 005577 150 ---PP--IAHRDLKAENLLLGSDGL-WKLCDFGSTS 179 (690)
Q Consensus 150 ---~~--IVHRDLKP~NILLd~dg~-vKL~DFGlA~ 179 (690)
.+ |||.|+.|.|||++.+.. +.++|||-++
T Consensus 192 lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 192 LPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred CCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 12 899999999999998874 8899999664
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.1 Score=58.03 Aligned_cols=79 Identities=11% Similarity=0.034 Sum_probs=45.8
Q ss_pred ceEEEEEEeeecCceEEEEEEEcccCCeE-----EEEEEeecCCHHHHHHHHHHHHHHHhhcCCCCceEEEEEEEeecCC
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQ-----YAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 25 ~ry~v~~~LG~GgFG~VylA~d~~~~~k~-----vAvK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkL~~~~~~~~~~ 99 (690)
..+.+. .|..|--..+|++......+.. |.+... ....+..-...+|+.+++.|..+-.-.++++.+.
T Consensus 51 ~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~-g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----- 123 (383)
T PTZ00384 51 EFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS-STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----- 123 (383)
T ss_pred ccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEec-cCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC-----
Confidence 345544 4445777899988643111122 333322 1222222334578999999976666777777642
Q ss_pred CceEEEEEecCCCc
Q 005577 100 TKEALLVMECCDKS 113 (690)
Q Consensus 100 ~~~~~LVmEy~~gs 113 (690)
-++|.||++|.
T Consensus 124 ---~g~l~efIeGr 134 (383)
T PTZ00384 124 ---DFTIQEWVEGN 134 (383)
T ss_pred ---CEEEEEEeccc
Confidence 25899999763
|
|
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.08 Score=59.46 Aligned_cols=29 Identities=28% Similarity=0.424 Sum_probs=22.7
Q ss_pred CcccCCCCCCcEEeCCCC-----CeeeeccCCCC
Q 005577 151 PIAHRDLKAENLLLGSDG-----LWKLCDFGSTS 179 (690)
Q Consensus 151 ~IVHRDLKP~NILLd~dg-----~vKL~DFGlA~ 179 (690)
-++|+||...|||++.++ ...|+||-++.
T Consensus 269 VL~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh 302 (414)
T PF07914_consen 269 VLVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVH 302 (414)
T ss_pred ceecCCccHHheeeecCCchhHHHHHHHHHHHhh
Confidence 389999999999998743 24688987653
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=94.61 E-value=0.18 Score=53.26 Aligned_cols=28 Identities=32% Similarity=0.448 Sum_probs=23.7
Q ss_pred cccCCCCCCcEEeCCC--C---CeeeeccCCCC
Q 005577 152 IAHRDLKAENLLLGSD--G---LWKLCDFGSTS 179 (690)
Q Consensus 152 IVHRDLKP~NILLd~d--g---~vKL~DFGlA~ 179 (690)
|+|+|++..|||+..+ | .+++.||-+++
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeecccccc
Confidence 8999999999999655 3 58999998664
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.28 E-value=0.44 Score=59.52 Aligned_cols=29 Identities=31% Similarity=0.523 Sum_probs=24.9
Q ss_pred cccCCCCCCcEEeCCCC--Cee-eeccCCCCc
Q 005577 152 IAHRDLKAENLLLGSDG--LWK-LCDFGSTST 180 (690)
Q Consensus 152 IVHRDLKP~NILLd~dg--~vK-L~DFGlA~~ 180 (690)
+||.|+.+.|||++.++ .+. |+|||.+..
T Consensus 205 vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 205 VIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred eECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 99999999999998875 555 999997754
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=93.74 E-value=0.077 Score=57.12 Aligned_cols=135 Identities=20% Similarity=0.247 Sum_probs=86.8
Q ss_pred EEEEEeeecCceEEEEEEE---------cccCCeEEEEEEeecC------------------------CHHHHHHH--HH
Q 005577 28 HVRNVIAEGGFSCVYSARD---------AIHMSKQYAMKHMICN------------------------DEESLESA--MK 72 (690)
Q Consensus 28 ~v~~~LG~GgFG~VylA~d---------~~~~~k~vAvK~i~~~------------------------~~e~~e~~--~~ 72 (690)
.|..+|..|.-++|+.|.- ..-....||||++... +...+-.+ .+
T Consensus 255 ~i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEk 334 (531)
T KOG2269|consen 255 SIDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEK 334 (531)
T ss_pred hhhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHH
Confidence 3456788999999998832 1112356899876311 11111111 23
Q ss_pred HHHHHHhhc----CCCCceEEEEEEEeecCCCceEEEEEecCCCc-H-HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 005577 73 EISVMKSLK----GHPNVVTLYAHTILDLGRTKEALLVMECCDKS-L-VNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH 146 (690)
Q Consensus 73 Ei~iL~~L~----~HPNIVkL~~~~~~~~~~~~~~~LVmEy~~gs-L-l~~L~~~~~~~lse~~~~~i~~qIa~aL~yLH 146 (690)
|..-|.++. .+|-||.|. ..+|||-|++.. + .-.|.. -.|+.++......|+...+.-|-
T Consensus 335 EmhNL~RMq~~GlpcP~vV~lk-----------khvLVMsFiGd~~~aAPkLK~---v~l~d~E~~~aY~q~~~~M~~lY 400 (531)
T KOG2269|consen 335 EMHNLSRMQKHGLPCPQVVKLK-----------KHVLVMSFIGDQGLAAPKLKN---VELTDDERRNAYDQVQSIMCRLY 400 (531)
T ss_pred HHHHHHHHHhcCCCCCceeeee-----------cceEEEEeecCCCCCCccccc---cccChHHHHHHHHHHHHHHHHHH
Confidence 444444443 467888774 346999999642 2 122221 12888888888899999888775
Q ss_pred hCCCCcccCCCCCCcEEeCCCCCeeeeccCCC
Q 005577 147 SQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 147 s~g~~IVHRDLKP~NILLd~dg~vKL~DFGlA 178 (690)
... .+||-||.--|||+..+ .|.++|..-+
T Consensus 401 ~Ec-~LVHADlSEyN~Lw~~g-Kvw~IDVsQs 430 (531)
T KOG2269|consen 401 KEC-LLVHADLSEYNLLWTPG-KVWVIDVSQS 430 (531)
T ss_pred Hhh-heeecchhhhhheecCC-ceEEEechhc
Confidence 443 29999999999999876 7899997644
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 690 | ||||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-56 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-31 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-22 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-19 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-18 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-17 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-17 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-14 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-14 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-14 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 8e-14 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-14 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-13 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-13 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-13 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-13 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-13 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-13 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-13 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-13 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-13 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-12 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-11 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-10 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-08 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 9e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 7e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-04 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-04 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-04 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-04 |
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 387 bits (995), Expect = e-130
Identities = 119/329 (36%), Positives = 181/329 (55%), Gaps = 12/329 (3%)
Query: 10 KEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLES 69
++ + G+++++G L++ VR V+AEGGF+ VY A+D + ++YA+K ++ N+EE +
Sbjct: 13 RDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQD-VGSGREYALKRLLSNEEEKNRA 71
Query: 70 AMKEISVMKSLKGHPNVVTLYAHTILDL----GRTKEALLVMECCDKSLVNVLENRGA-G 124
++E+ MK L GHPN+V + + E LL+ E C LV L+ + G
Sbjct: 72 IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG 131
Query: 125 YFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKR 184
VL IF C AV MH Q PPI HRDLK ENLLL + G KLCDFGS +T
Sbjct: 132 PLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191
Query: 185 FEKL---EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKN 241
+ + + E+ I ++TTP YR PE+ DL+ I EK DIWALGC+L+ +C+ ++
Sbjct: 192 PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
Query: 242 AFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGL 301
F+ +KL+I+NG Y IP + LIR MLQ +P++R I +V ++ E
Sbjct: 252 PFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA-- 309
Query: 302 QKSLPDRPPETQSAVANEGMSKPMNRSPP 330
+++ + P T+ N G P
Sbjct: 310 -RNVNPKSPITELLEQNGGYGSATLSRGP 337
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 358 bits (921), Expect = e-119
Identities = 84/309 (27%), Positives = 151/309 (48%), Gaps = 17/309 (5%)
Query: 10 KEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLES 69
+E +G + + N + EGGFS V +H YA+K ++C++++ E
Sbjct: 14 RENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREE 72
Query: 70 AMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENR--GAGYF 126
A +E + + HPN++ L A+ + + G EA L++ + +L N +E +
Sbjct: 73 AQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFL 131
Query: 127 EEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186
E Q+L + +C + A+H+ AHRDLK N+LLG +G L D GS + E
Sbjct: 132 TEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189
Query: 187 KLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFD-- 244
+ +D + T +YRAPE++ + +I+E+ D+W+LGC+L+ + + + +D
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV 249
Query: 245 ---GESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGL 301
G+S + IP+SP++SS++ L+ M+ P RP I + ++ L
Sbjct: 250 FQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA-----L 304
Query: 302 QKSLPDRPP 310
Q P +
Sbjct: 305 QPPAPGQHT 313
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 7e-58
Identities = 82/345 (23%), Positives = 146/345 (42%), Gaps = 44/345 (12%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPN 85
I EG F + +QY +K + + + E + +E++V+ ++K HPN
Sbjct: 27 VRLQKIGEGSFGKAILVKS-TEDGRQYVIKEINISRMSSKEREESRREVAVLANMK-HPN 84
Query: 86 VVTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143
+V +L +VM+ C+ L + + F+E Q+L F +C A+
Sbjct: 85 IVQYRESFE-----ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK 139
Query: 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT- 202
+H + I HRD+K++N+ L DG +L DFG +
Sbjct: 140 HVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARV------------LNSTVELARAC 185
Query: 203 --TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNY 256
TP Y +PE+ + N K DIWALGC+L+ +C K+AF+ S I++G++
Sbjct: 186 IGTPYYLSPEIC---ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF 242
Query: 257 RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGLQKSLPDRPPETQSAV 316
P S YS + L+ + + +P DRP + + + + K + A
Sbjct: 243 P-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI-----LEKGF-IAKRIEKFLSPQLIAE 295
Query: 317 ANEGMSKPMNRSPPMPQRSPPPPPSSVD--PTRNISQPSTTPAVS 359
+ S P+P + P +S+ P + I++P+ +
Sbjct: 296 EFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIP 340
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-57
Identities = 68/290 (23%), Positives = 120/290 (41%), Gaps = 35/290 (12%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLY- 90
V+ +G F V AR+ S+ YA+K I + EE L + + E+ ++ SL H VV Y
Sbjct: 13 VLGQGAFGQVVKARN-ALDSRYYAIK-KIRHTEEKLSTILSEVMLLASLN-HQYVVRYYA 69
Query: 91 -------AHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNA 141
+ + K L + ME C+ +L +++ + + + +FR + A
Sbjct: 70 AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEA 128
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGIEEDNIRK 200
+ +HSQ I HRDLK N+ + K+ DFG + + + + +
Sbjct: 129 LSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 201 HT----TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL----QIL 252
T T Y A E+ L NEK+D+++LG + F + Y G ++ ++
Sbjct: 187 LTSAIGTAMYVATEV--LDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKLR 242
Query: 253 NGNYRIPE--SPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQ 296
+ + P +IR ++ P+ RP + W V Q
Sbjct: 243 SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-57
Identities = 72/273 (26%), Positives = 112/273 (41%), Gaps = 35/273 (12%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTL 89
I G + R K K + E + + E+++++ LK HPN+V
Sbjct: 13 TIGTGSYGRCQKIRR-KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRY 70
Query: 90 YAHTILDLGRTKEALLVMECCDK-SLVNVLEN--RGAGYFEEKQVLAIFRDVCNAVFAMH 146
Y I +VME C+ L +V+ + Y +E+ VL + + A+ H
Sbjct: 71 YDRIIDR--TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 147 SQSPP---IAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT- 202
+S + HRDLK N+ L KL DFG ++ + D T
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG--------LARI----LNHDTSFAKTF 176
Query: 203 --TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNY 256
TP Y +PE R NEK DIW+LGCLL+ +C F S+ + I G +
Sbjct: 177 VGTPYYMSPEQM---NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233
Query: 257 RIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
R +YS + ++I ML RP + ++
Sbjct: 234 R-RIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 7e-57
Identities = 65/279 (23%), Positives = 112/279 (40%), Gaps = 44/279 (15%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVV 87
+I GGF V+ A+ K Y +K + N+E+ A +E+ + L H N+V
Sbjct: 14 KEIELIGSGGFGQVFKAKH-RIDGKTYVIKRVKYNNEK----AEREVKALAKLD-HVNIV 67
Query: 88 TLYAH-----------TILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAI 134
+ + L + ME CDK +L +E R ++ L +
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 135 FRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGI 193
F + V +HS+ + +RDLK N+ L K+ DFG TS +
Sbjct: 128 FEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN----------- 174
Query: 194 EEDNIRKHT--TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQ 250
D R + T Y +PE + ++VD++ALG +L + + AF+
Sbjct: 175 --DGKRTRSKGTLRYMSPEQI---SSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT 229
Query: 251 ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
L S + L++ +L P+DRP+ +++
Sbjct: 230 DLR---DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 3e-55
Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 22/273 (8%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLESAMKEISVMKSLKGHPNVVTLY 90
+ GGF V+ A++ YA+K + + N E + E M+E+ + L+ HP +V +
Sbjct: 12 CLGRGGFGVVFEAKN-KVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYF 69
Query: 91 AHTILDLGRTKEAL--------LVMECCDK-SLVNVLENR-GAGYFEEKQVLAIFRDVCN 140
+ K + M+ C K +L + + R E L IF +
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGIEEDNIR 199
AV +HS+ + HRDLK N+ D + K+ DFG T+ + E+ +
Sbjct: 130 AVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 200 KHT--TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQILNGNY 256
T Y +PE + KVDI++LG +LF + Y F + L +
Sbjct: 188 TGQVGTKLYMSPEQI---HGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLK 244
Query: 257 RIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
P + +++DML SP +RP+ +
Sbjct: 245 FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-52
Identities = 77/280 (27%), Positives = 121/280 (43%), Gaps = 44/280 (15%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHP 84
+ I G FS VY A + A+K + D ++ +KEI ++K L HP
Sbjct: 35 RIEKKIGRGQFSEVYRAAC-LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HP 92
Query: 85 NVVTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGA--GYFEEKQVLAIFRDVCN 140
NV+ YA I L +V+E D L ++++ E+ V F +C+
Sbjct: 93 NVIKYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGIEEDNIR 199
A+ MHS+ + HRD+K N+ + + G+ KL D G + K
Sbjct: 148 ALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-------------TTA 192
Query: 200 KHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK------LQ 250
H+ TP Y +PE N K DIW+LGCLL+ + ++ F G+ +
Sbjct: 193 AHSLVGTPYYMSPERI---HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 249
Query: 251 ILNGNY-RIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
I +Y +P S YS + L+ + P+ RPD+T V
Sbjct: 250 IEQCDYPPLP-SDHYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 4e-50
Identities = 71/304 (23%), Positives = 133/304 (43%), Gaps = 48/304 (15%)
Query: 18 RSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC---NDEESLESAMKEI 74
+S+ V + I GG S V+ + + YA+K + D ++L+S EI
Sbjct: 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEK--KQIYAIK-YVNLEEADNQTLDSYRNEI 77
Query: 75 SVMKSLKGH-PNVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVL 132
+ + L+ H ++ LY D T + + +VMEC + L + L+ + + + +
Sbjct: 78 AYLNKLQQHSDKIIRLY-----DYEITDQYIYMVMECGNIDLNSWLKKKKS--IDPWERK 130
Query: 133 AIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMG 192
+ ++++ AV +H I H DLK N L+ DG+ KL DFG + M
Sbjct: 131 SYWKNMLEAVHTIHQHG--IVHSDLKPANFLI-VDGMLKLIDFG-IANQ---------MQ 177
Query: 193 IEEDNIRKHT---TPAYRAPEM--------WDLFRRELINEKVDIWALGCLLFRICY--- 238
+ ++ K + T Y PE + + I+ K D+W+LGC+L+ + Y
Sbjct: 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
Query: 239 -FKNAFDGESKLQ-ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFR 292
F+ + SKL I++ N+ I + D+++ L+ P R I ++ + +
Sbjct: 238 PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297
Query: 293 VNEQ 296
+
Sbjct: 298 IQTH 301
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 4e-50
Identities = 75/363 (20%), Positives = 142/363 (39%), Gaps = 50/363 (13%)
Query: 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQ-YAMKHMIC---NDEESLESAMKEIS 75
I V + I GG S V+ + KQ YA+K + D ++L+S EI+
Sbjct: 4 ISVKGRIYSILKQIGSGGSSKVFQVL---NEKKQIYAIK-YVNLEEADNQTLDSYRNEIA 59
Query: 76 VMKSLKGH-PNVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLA 133
+ L+ H ++ LY D T + + +VMEC + L + L+ + + + + +
Sbjct: 60 YLNKLQQHSDKIIRLY-----DYEITDQYIYMVMECGNIDLNSWLKKKKS--IDPWERKS 112
Query: 134 IFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGI 193
++++ AV +H I H DLK N L+ DG+ KL DFG + M
Sbjct: 113 YWKNMLEAVHTIHQHG--IVHSDLKPANFLI-VDGMLKLIDFGIANQ----------MQP 159
Query: 194 EEDNIRKHT---TPAYRAPEM--------WDLFRRELINEKVDIWALGCLLFRICY---- 238
+ ++ K + T Y PE + + I+ K D+W+LGC+L+ + Y
Sbjct: 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
Query: 239 FKNAFDGESKLQ-ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRV 293
F+ + SKL I++ N+ I + D+++ L+ P R I ++ + ++
Sbjct: 220 FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279
Query: 294 NEQLPVGLQKSLPDRPPETQSAVANEGMSKPMNRSPPMPQRSPPPPPSSVDPTRNISQPS 353
+ K + + + ++ S + +
Sbjct: 280 QTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKK 339
Query: 354 TTP 356
Sbjct: 340 RGK 342
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 6e-50
Identities = 62/267 (23%), Positives = 96/267 (35%), Gaps = 29/267 (10%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEES--LESAMKEISVMKSLKGHPN 85
+ + G + V+ R + YA+K + + E+ + + HP
Sbjct: 60 QRLSRLGHGSYGEVFKVRS-KEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 86 VVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
V L L L E C SL E GA E QV RD A+
Sbjct: 119 CVRLEQAWE-----EGGILYLQTELCGPSLQQHCEAWGA-SLPEAQVWGYLRDTLLALAH 172
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGIEEDNIRKHTT 203
+HSQ + H D+K N+ LG G KL DFG +++E G
Sbjct: 173 LHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-G----------D 219
Query: 204 PAYRAPEMWDLFRRELINEKVDIWALGCLLFRI-CYFKNAFDGESKLQILNGNYRIPESP 262
P Y APE+ + D+++LG + + C + GE Q+ G +
Sbjct: 220 PRYMAPELL----QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTA 275
Query: 263 KYSSSVTDLIRDMLQASPDDRPDITQV 289
SS + ++ ML+ P R +
Sbjct: 276 GLSSELRSVLVMMLEPDPKLRATAEAL 302
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 3e-48
Identities = 76/296 (25%), Positives = 123/296 (41%), Gaps = 49/296 (16%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMK-----EISVMKSLKGHPNVV 87
+ +GGF+ + D + +A K I L+ + EIS+ +SL H +VV
Sbjct: 23 LGKGGFAKCFEISD-ADTKEVFAGK--IVPKSLLLKPHQREKMSMEISIHRSLA-HQHVV 78
Query: 88 TLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH 146
+ D +V+E C + SL+ + + R A E + R + +H
Sbjct: 79 GFH-GFFED---NDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLH 132
Query: 147 SQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGIEEDNIRKHT--- 202
+ HRDLK NL L D K+ DFG +T +E D RK
Sbjct: 133 RNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATK-------------VEYDGERKKVLCG 177
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNYRI 258
TP Y APE+ ++ + +VD+W++GC+++ + K F+ + I Y I
Sbjct: 178 TPNYIAPEV---LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI 234
Query: 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLPDRPP 310
P+ + LI+ MLQ P RP I ++ +F +P L + PP
Sbjct: 235 PKH--INPVAASLIQKMLQTDPTARPTINELLNDEFFTSG-YIPARLPITCLTIPP 287
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-47
Identities = 80/317 (25%), Positives = 127/317 (40%), Gaps = 52/317 (16%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMK-----EISVMKSLKGHPNVV 87
+ +GGF+ + D + +A K I L+ + EIS+ +SL H +VV
Sbjct: 49 LGKGGFAKCFEISD-ADTKEVFAGK--IVPKSLLLKPHQREKMSMEISIHRSLA-HQHVV 104
Query: 88 TLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH 146
+ D +V+E C + SL+ + + R A E + R + +H
Sbjct: 105 GFHGF-FED---NDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLH 158
Query: 147 SQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGIEEDNIRKHT--- 202
+ HRDLK NL L D K+ DFG +T +E D RK
Sbjct: 159 RNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATK-------------VEYDGERKKVLCG 203
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNYRI 258
TP Y APE+ ++ + +VD+W++GC+++ + K F+ + I Y I
Sbjct: 204 TPNYIAPEV---LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI 260
Query: 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLPDRPPETQS 314
P+ + LI+ MLQ P RP I ++ +F +P L + PP
Sbjct: 261 PKH--INPVAASLIQKMLQTDPTARPTINELLNDEFFTSG-YIPARLPITCLTIPPRFSI 317
Query: 315 AVANEGMSKPMNRSPPM 331
P NR P
Sbjct: 318 ---APSSLDPSNRKPLT 331
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 5e-47
Identities = 69/278 (24%), Positives = 121/278 (43%), Gaps = 47/278 (16%)
Query: 35 EGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMK-----EISVMKSLKGHPNVVTL 89
+G F+ VY A IH + A+K + + + ++ M E+ + LK HP+++ L
Sbjct: 21 KGSFAGVYRAES-IHTGLEVAIK--MIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILEL 76
Query: 90 YAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQ 148
Y + D + LV+E C + L+NR F E + + + +HS
Sbjct: 77 YNY-FED---SNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSH 131
Query: 149 SPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGIEEDNIRKHT---TP 204
I HRDL NLLL + K+ DFG +T ++ + + +T TP
Sbjct: 132 G--ILHRDLTLSNLLLTRNMNIKIADFGLATQ-------------LKMPHEKHYTLCGTP 176
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNYRIPE 260
Y +PE+ R + D+W+LGC+ + + + FD ++ ++ +Y +P
Sbjct: 177 NYISPEI---ATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS 233
Query: 261 SPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVN 294
S DLI +L+ +P DR ++ V + N
Sbjct: 234 F--LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-45
Identities = 59/310 (19%), Positives = 118/310 (38%), Gaps = 39/310 (12%)
Query: 5 KPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE 64
P ++++ E + VG + ++V+ G + + ++ A+K +
Sbjct: 4 SPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYR--GMFDNRDVAVKRI---LP 58
Query: 65 ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGA 123
E A +E+ +++ HPNV+ + + ++ + +E C +L +E +
Sbjct: 59 ECFSFADREVQLLRESDEHPNVIRYF-----CTEKDRQFQYIAIELCAATLQEYVEQKDF 113
Query: 124 GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGL-----WKLCDFGST 178
+ + + + + + + +HS + I HRDLK N+L+ + DFG
Sbjct: 114 AH-LGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFG-- 168
Query: 179 STNHKRFEKLEEMGIEEDNIRKHT--TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI 236
K +G + R T + APEM +E VDI++ GC+ + +
Sbjct: 169 ------LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
Query: 237 -CYFKNAFDG--ESKLQILNGNYRIP---ESPKYSSSVTDLIRDMLQASPDDRPDITQV- 289
+ F + + IL G + +LI M+ P RP V
Sbjct: 223 ISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282
Query: 290 ---WFRVNEQ 296
+F E+
Sbjct: 283 KHPFFWSLEK 292
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-45
Identities = 74/362 (20%), Positives = 140/362 (38%), Gaps = 50/362 (13%)
Query: 18 RSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQ-YAMKHMIC---NDEESLESAMKE 73
I V + I GG S V+ + KQ YA+K + D ++L+S E
Sbjct: 49 ECISVKGRIYSILKQIGSGGSSKVFQVL---NEKKQIYAIK-YVNLEEADNQTLDSYRNE 104
Query: 74 ISVMKSLKGH-PNVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQV 131
I+ + L+ H ++ LY D T + + +VMEC + L + L+ + + +
Sbjct: 105 IAYLNKLQQHSDKIIRLY-----DYEITDQYIYMVMECGNIDLNSWLKKKK--SIDPWER 157
Query: 132 LAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEM 191
+ ++++ AV +H I H DLK N L+ DG+ KL DFG + M
Sbjct: 158 KSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI-VDGMLKLIDFGIANQ----------M 204
Query: 192 GIEEDNIRKHT---TPAYRAPEM--------WDLFRRELINEKVDIWALGCLLFRICY-- 238
+ ++ K + Y PE + + I+ K D+W+LGC+L+ + Y
Sbjct: 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
Query: 239 --FKNAFDGESKLQ-ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV----WF 291
F+ + SKL I++ N+ I + D+++ L+ P R I ++ +
Sbjct: 265 TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324
Query: 292 RVNEQLPVGLQKSLPDRPPETQSAVANEGMSKPMNRSPPMPQRSPPPPPSSVDPTRNISQ 351
++ + K + + + ++ S + +
Sbjct: 325 QIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFE 384
Query: 352 PS 353
Sbjct: 385 KK 386
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-43
Identities = 71/290 (24%), Positives = 119/290 (41%), Gaps = 48/290 (16%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMK-----EISVMKSLKGHPN 85
+ +G F VY AR+ A+K + + ++ ++ E+ + L+ HPN
Sbjct: 15 RPLGKGKFGNVYLARE-KQSKFILALK--VLFKAQLEKAGVEHQLRREVEIQSHLR-HPN 70
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
++ LY D L++E ++ L + F+E++ ++ NA+
Sbjct: 71 ILRLY-GYFHD---ATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 124
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT-- 202
HS+ + HRD+K ENLLLGS G K+ DFG + + R+
Sbjct: 125 CHSKR--VIHRDIKPENLLLGSAGELKIADFG--------------WSVHAPSSRRTDLC 168
Query: 203 -TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNYR 257
T Y PEM + +EKVD+W+LG L + K F+ + + I +
Sbjct: 169 GTLDYLPPEM---IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 225
Query: 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQK 303
P + DLI +L+ +P RP + +V W N P Q
Sbjct: 226 FP--DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 273
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 3e-42
Identities = 74/301 (24%), Positives = 126/301 (41%), Gaps = 56/301 (18%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAM-----KEISVMKSLKGHPNV 86
+ +G F VY AR+ A+K + + + + +EI + L+ HPN+
Sbjct: 21 PLGKGKFGNVYLARE-KQNKFIMALK--VLFKSQLEKEGVEHQLRREIEIQSHLR-HPNI 76
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
+ +Y + ++ + L++E + L L+ G F+E++ ++ +A+
Sbjct: 77 LRMYNYF-----HDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHY 129
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT-- 202
H + + HRD+K ENLL+G G K+ DFG + ++R+ T
Sbjct: 130 CHERK--VIHRDIKPENLLMGYKGELKIADFG--------------WSVHAPSLRRRTMC 173
Query: 203 -TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNYR 257
T Y PEM + +EKVD+W G L + FD S + I+N + +
Sbjct: 174 GTLDYLPPEM---IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK 230
Query: 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLPDRPPETQ 313
P P S DLI +L+ P R + V W + N ++ LP TQ
Sbjct: 231 FP--PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN------SRRVLPPVYQSTQ 282
Query: 314 S 314
S
Sbjct: 283 S 283
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 3e-42
Identities = 66/325 (20%), Positives = 126/325 (38%), Gaps = 68/325 (20%)
Query: 18 RSIDVGNLKIHVRN------VIAEGGFSCVYSARDAIHMS--KQYAMKHMICNDEESLES 69
R ++ N + ++N ++ G V + A+K M + +
Sbjct: 2 RIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQ----GSFQGRPVAVKRM---LIDFCDI 54
Query: 70 AMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRG-----A 123
A+ EI ++ HPNV+ Y T L + +E C+ +L +++E++
Sbjct: 55 ALMEIKLLTESDDHPNVIRYY-----CSETTDRFLYIALELCNLNLQDLVESKNVSDENL 109
Query: 124 GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLW------------- 170
+E +++ R + + V +HS I HRDLK +N+L+ + +
Sbjct: 110 KLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167
Query: 171 KLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---TPAYRAPEM----WDLFRRELINEK 223
+ DFG K + G + T +RAPE+ +L + +
Sbjct: 168 LISDFG--------LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS 219
Query: 224 VDIWALGCLLFRI-CYFKNAFDGES--KLQILNGNYRIPES-----PKYSSSVTDLIRDM 275
+DI+++GC+ + I K+ F + + I+ G + + E + TDLI M
Sbjct: 220 IDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQM 279
Query: 276 LQASPDDRPDITQV----WFRVNEQ 296
+ P RP +V F +
Sbjct: 280 IDHDPLKRPTAMKVLRHPLFWPKSK 304
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 66/315 (20%), Positives = 124/315 (39%), Gaps = 47/315 (14%)
Query: 33 IAEGGFSCVYSARD-------AIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPN 85
+ G F V++A D + K+ + ++ L EI+++ ++ H N
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HAN 90
Query: 86 VVTLYAHTILDLGRTKEAL-LVMECCDKS--LVNVLENRGAGYFEEKQVLAIFRDVCNAV 142
++ + D+ + LVME L ++ +E IFR + +AV
Sbjct: 91 IIKVL-----DIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAV 143
Query: 143 FAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT 202
+ + I HRD+K EN+++ D KL DFGS + +R + +T
Sbjct: 144 GYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGS-AAYLERGKLF------------YT 188
Query: 203 ---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIP 259
T Y APE+ L ++++W+LG L+ + + +N F + + P
Sbjct: 189 FCGTIEYCAPEV--LMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--TVEAAIHPP 244
Query: 260 ESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLPDRPPETQSA 315
S + L+ +LQ P+ R + ++ W L + + R + +S
Sbjct: 245 --YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVF-RVNKPESG 301
Query: 316 VANEGMSKPMNRSPP 330
V + + NRS
Sbjct: 302 VLSAASLEMGNRSLS 316
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 62/326 (19%), Positives = 119/326 (36%), Gaps = 69/326 (21%)
Query: 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE---ESLESAMKEISVMK 78
N + +++ +G + V+ R +A+K + N+ ++ M+E V+K
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRH-KKTGDLFAIK--VFNNISFLRPVDVQMREFEVLK 62
Query: 79 SLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRG-AGYFEEKQVLAIFR 136
L H N+V L+A I + T+ +L+ME C SL VLE A E + L + R
Sbjct: 63 KLN-HKNIVKLFA--IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLLGS----DGLWKLCDFGSTSTNHKRFEKLEEM- 191
DV + + I HR++K N++ ++KL DFG + + E+ +
Sbjct: 120 DVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFG-AARELEDDEQFVSLY 176
Query: 192 GIEEDNIRKHTTPAYRAPEMWDLFRRELI-----NEKVDIWALGCLLFRICY----FKNA 242
G T Y P+M++ VD+W++G + F+
Sbjct: 177 G----------TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226
Query: 243 FDGESKLQILN-----------------------GNYRIPESPKYSSSV----TDLIRDM 275
+++ + +P S S + T ++ ++
Sbjct: 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286
Query: 276 LQASPDDRPDITQV----WFRVNEQL 297
L+A + Q ++
Sbjct: 287 LEADQEKCWGFDQFFAETSDILHRGN 312
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 55/278 (19%), Positives = 103/278 (37%), Gaps = 30/278 (10%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKH--MICNDEESLESAMKEISVMKSLKGHPN 85
H I G F V+ YA+K ++A++E+ L H +
Sbjct: 14 HELEKIGSGEFGSVFKCVK-RLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 86 VVTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLE--NRGAGYFEEKQVLAIFRDVCNA 141
VV ++ D + + + E C+ SL + + R YF+E ++ + V
Sbjct: 73 VVRYFSAWAED-----DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS---TNHKRFEKLEEMGIEEDNI 198
+ +HS S + H D+K N+ + + ++K K+ ++G
Sbjct: 128 LRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 199 RKHT---TPAYRAPEMWDLFRRELI--NEKVDIWALGCLLFRICYFKNAF-DGESKLQIL 252
+ A E+ +E K DI+AL + + +G+ +I
Sbjct: 186 SPQVEEGDSRFLANEVL----QENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR 241
Query: 253 NGNY-RIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
G RIP+ S T+L++ M+ P+ RP +
Sbjct: 242 QGRLPRIPQ--VLSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 84/308 (27%), Positives = 136/308 (44%), Gaps = 49/308 (15%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICN----DEESLESAMKEISVMKSLKGHPNVVT 88
I +G F+ V AR I ++ A+K I + + SL+ +E+ +MK L HPN+V
Sbjct: 23 IGKGNFAKVKLARH-ILTGREVAIK--IIDKTQLNPTSLQKLFREVRIMKILN-HPNIVK 78
Query: 89 LYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH 146
L+ ++ T++ L L+ME + + L G +EK+ + FR + +AV H
Sbjct: 79 LF-----EVIETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCH 131
Query: 147 SQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---T 203
+ I HRDLKAENLLL +D K+ DFG S KL
Sbjct: 132 QKR--IVHRDLKAENLLLDADMNIKIADFGF-SNEFTVGGKL------------DAFCGA 176
Query: 204 PAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES----KLQILNGNYRIP 259
P Y APE+ ++ +VD+W+LG +L+ + FDG++ + ++L G YRIP
Sbjct: 177 PPYAAPEL--FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP 234
Query: 260 ESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLPDRPPETQSA 315
S+ +L++ L +P R + Q+ W K + +
Sbjct: 235 --FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG--HEEDELKPFVEPELDISDQ 290
Query: 316 VANEGMSK 323
+ M
Sbjct: 291 KRIDIMVG 298
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 76/315 (24%), Positives = 126/315 (40%), Gaps = 64/315 (20%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYA 91
+ EG FS ++ +A+K +I + + KEI+ +K +GHPN+V L+
Sbjct: 18 PLGEGSFSICRKCVH-KKSNQAFAVK-II--SKRMEANTQKEITALKLCEGHPNIVKLH- 72
Query: 92 HTILDLGRTKEAL-LVMECC------DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
++ + LVME ++ ++ + +F E + I R + +AV
Sbjct: 73 ----EVFHDQLHTFLVMELLNGGELFER-----IKKK--KHFSETEASYIMRKLVSAVSH 121
Query: 145 MHSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH 201
MH + HRDLK ENLL + K+ DFG F +L DN
Sbjct: 122 MHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFG--------FARL----KPPDNQPLK 167
Query: 202 T---TPAYRAPEMWDLFRRELINEKVDIWALGCLL---------FRICYFKNAFDGESKL 249
T T Y APE L + +E D+W+LG +L F+ ++
Sbjct: 168 TPCFTLHYAAPE---LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI 224
Query: 250 --QILNGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGL 301
+I G++ S DLI+ +L P+ R ++ + W + QL
Sbjct: 225 MKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP 284
Query: 302 QKSLPDRPPETQSAV 316
+ PD + +AV
Sbjct: 285 LMT-PDILGSSGAAV 298
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 72/297 (24%), Positives = 117/297 (39%), Gaps = 57/297 (19%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMK--------------------------HMICNDEES 66
I +G + V A + + + YAMK
Sbjct: 21 IGKGSYGVVKLAYN-ENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 67 LESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGY 125
+E +EI+++K L HPNVV L +LD +V E ++ ++ V
Sbjct: 80 IEQVYQEIAILKKLD-HPNVVKLV--EVLDDPNEDHLYMVFELVNQGPVMEVPTL---KP 133
Query: 126 FEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185
E Q F+D+ + +H Q I HRD+K NLL+G DG K+ DFG
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFG--------- 182
Query: 186 EKLEEMGIEEDNIRKHT--TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAF 243
+ D + +T TPA+ APE R+ + +D+WA+G L+ + + F
Sbjct: 183 --VSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240
Query: 244 DGESKLQ----ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFR 292
E + I + P+ P + + DLI ML +P+ R + ++ W
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 74/334 (22%), Positives = 129/334 (38%), Gaps = 72/334 (21%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVT 88
V+ I G +S + ++A+K +I ++S +EI ++ HPN++T
Sbjct: 26 VKEDIGVGSYSVCKRCIH-KATNMEFAVK-II---DKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 89 LYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRG---------AGYFEEKQVLAIFRDV 138
L D+ + + +V E +G +F E++ A+ +
Sbjct: 81 LK-----DVYDDGKYVYVVTELM----------KGGELLDKILRQKFFSEREASAVLFTI 125
Query: 139 CNAVFAMHSQSPPIAHRDLKAENLLLGSDG----LWKLCDFGSTSTNHKRFEKLEEMGIE 194
V +H+Q + HRDLK N+L + ++CDFG F K +
Sbjct: 126 TKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFG--------FAKQ----LR 171
Query: 195 EDNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC------YFKNAFDG 245
+N T T + APE+ R+ + DIW+LG LL+ + D
Sbjct: 172 AENGLLMTPCYTANFVAPEV---LERQGYDAACDIWSLGVLLY-TMLTGYTPFANGPDDT 227
Query: 246 ESKL--QILNGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQL 297
++ +I +G + + S + DL+ ML P R V W +QL
Sbjct: 228 PEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQL 287
Query: 298 PVGLQKSLPDRPPETQSAVANEGMSKPMNRSPPM 331
P Q + D P + A+A + +NR+
Sbjct: 288 P-QYQLNRQDAPHLVKGAMAATYSA--LNRNQSP 318
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-39
Identities = 73/325 (22%), Positives = 118/325 (36%), Gaps = 53/325 (16%)
Query: 6 PFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHM------ 59
P P G + R ++ ++ +GGF V++ + Q A+K +
Sbjct: 14 PGTPTPPPGGKDREAFEAEYRLG--PLLGKGGFGTVFAGHR-LTDRLQVAIKVIPRNRVL 70
Query: 60 ICNDEESLESAMKEISVMKSL---KGHPNVVTLYAHTILDLGRTKEAL-LVMECCDKS-- 113
+ + E++++ + GHP V+ L D T+E LV+E +
Sbjct: 71 GWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL-----DWFETQEGFMLVLERPLPAQD 125
Query: 114 LVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD-GLWKL 172
L + + +G E F V A+ HS+ + HRD+K EN+L+ G KL
Sbjct: 126 LFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKL 181
Query: 173 CDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWAL 229
DFG S E T Y PE + R + +W+L
Sbjct: 182 IDFG--SGALLHDEPY------------TDFDGTRVYSPPEW--ISRHQYHALPATVWSL 225
Query: 230 GCLLFRICYFKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
G LL+ + F+ + + IL P S LIR L P RP + ++
Sbjct: 226 GILLYDMVCGDIPFERDQE--ILEAELHFP--AHVSPDCCALIRRCLAPKPSSRPSLEEI 281
Query: 290 ----WFRVNEQLPVGLQKSLPDRPP 310
W + + V L S P
Sbjct: 282 LLDPWMQTPAE-DVPLNPSKGGPAP 305
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 75/305 (24%), Positives = 118/305 (38%), Gaps = 62/305 (20%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMK---------HMICNDEESLESAMKEISVMK 78
+ ++ G S V K+YA+K +E E+ +KE+ +++
Sbjct: 20 EPKEILGRGVSSVVRRCIH-KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 79 SLKGHPNVVTLYAHTILDLGRTKEAL-LVMECC------DKSLVNVLENRGAGYFEEKQV 131
+ GHPN++ L D T LV + D + E EK+
Sbjct: 79 KVSGHPNIIQLK-----DTYETNTFFFLVFDLMKKGELFDY----LTEK---VTLSEKET 126
Query: 132 LAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEM 191
I R + + A+H + I HRDLK EN+LL D KL DFG S EKL E+
Sbjct: 127 RKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFG-FSCQLDPGEKLREV 183
Query: 192 -GIEEDNIRKHTTPAYRAPEM---WDLFRRELINEKVDIWALGCLLFRIC---YFKNAFD 244
G TP+Y APE+ ++VD+W+ G +++ F
Sbjct: 184 CG----------TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY-TLLAGSP--PFW 230
Query: 245 GESKL----QILNGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVN 294
++ I++GNY+ YS +V DL+ L P R + +F+
Sbjct: 231 HRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290
Query: 295 EQLPV 299
V
Sbjct: 291 VVEEV 295
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 73/292 (25%), Positives = 119/292 (40%), Gaps = 50/292 (17%)
Query: 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTL 89
+ V+ G V ++ A+K + D +E+ G P++V +
Sbjct: 34 KQVLGLGVNGKVLECFH-RRTGQKCALK--LLYDSPKAR---QEVDHHWQASGGPHIVCI 87
Query: 90 YAHTILDLGRTKEAL-LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
++ K L ++MEC + L + ++ RG F E++ I RD+ A+ +HS
Sbjct: 88 LD-VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 148 QSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT-- 202
+ IAHRD+K ENLL S D + KL DFG + + + T
Sbjct: 147 HN--IAHRDVKPENLLYTSKEKDAVLKLTDFG-FA----KETTQNAL---------QTPC 190
Query: 203 -TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC-------YFKNAFDGESKL--QIL 252
TP Y APE+ E ++ D+W+LG +++ I Y + +I
Sbjct: 191 YTPYYVAPEV---LGPEKYDKSCDMWSLGVIMY-ILLCGFPPFYSNTGQAISPGMKRRIR 246
Query: 253 NGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLP 298
G Y P + S LIR +L+ P +R ITQ W + +P
Sbjct: 247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-38
Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 43/287 (14%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYA 91
V+ G V + +++A+K + D +E+ + P++V +
Sbjct: 69 VLGLGINGKVLQIFN-KRTQEKFALK--MLQDCPKAR---REVELHWRASQCPHIVRIVD 122
Query: 92 HTILDLGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSP 150
K L+VMEC D L + +++RG F E++ I + + A+ +HS +
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN- 181
Query: 151 PIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEM-GIEEDNIRKHTTPAY 206
IAHRD+K ENLL S + + KL DFG + L TP Y
Sbjct: 182 -IAHRDVKPENLLYTSKRPNAILKLTDFG-FAKETTSHNSLTTPCY----------TPYY 229
Query: 207 RAPEMWDLFRRELINEKVDIWALGCLLFRI--C-----YFKNAFDGESKL--QILNGNYR 257
APE + E ++ D+W+LG +++ I C Y + + +I G Y
Sbjct: 230 VAPE---VLGPEKYDKSCDMWSLGVIMY-ILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285
Query: 258 IPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLP 298
P + S V LIR++L+ P R IT+ W + ++P
Sbjct: 286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 332
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-38
Identities = 66/322 (20%), Positives = 123/322 (38%), Gaps = 65/322 (20%)
Query: 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE---ESLESAMKEISVMK 78
N + +++ +G + V+ R +A+K + N+ ++ M+E V+K
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKT-GDLFAIK--VFNNISFLRPVDVQMREFEVLK 62
Query: 79 SLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRG-AGYFEEKQVLAIFR 136
L H N+V L+A I + T+ +L+ME C SL VLE A E + L + R
Sbjct: 63 KLN-HKNIVKLFA--IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLLGS----DGLWKLCDFGSTSTNHKRFEKLEEM- 191
DV + + I HR++K N++ ++KL DFG + + E+ +
Sbjct: 120 DVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFG-AARELEDDEQFVSLY 176
Query: 192 GIEEDNIRKHTTPAYRAPEMWDLFRRELI-----NEKVDIWALGCLLF------------ 234
G T Y P+M++ VD+W++G +
Sbjct: 177 G----------TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226
Query: 235 -----------RICYFKNAFDGESKLQILNG----NYRIPESPKYSSS----VTDLIRDM 275
+I K + + NG + +P S S +T ++ ++
Sbjct: 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286
Query: 276 LQASPDDRPDITQVWFRVNEQL 297
L+A + Q + ++ L
Sbjct: 287 LEADQEKCWGFDQFFAETSDIL 308
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 77/335 (22%), Positives = 131/335 (39%), Gaps = 68/335 (20%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK----HMICNDEESLESAMKEISVMKSLKGHPNVV 87
++ EG + V D+ + A+K + + KEI +++ L+ H NV+
Sbjct: 12 LLGEGSYGKVKEVLDSET-LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVI 69
Query: 88 TLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
L +L ++ +VME C + +L++ F Q F + + + +HS
Sbjct: 70 QLV--DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS 127
Query: 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGIEEDNIRKHT---T 203
Q I H+D+K NLLL + G K+ G + + + + T +
Sbjct: 128 QG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT-----------CRTSQGS 174
Query: 204 PAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES--KL--QILNGNYRIP 259
PA++ PE+ KVDIW+ G L+ I F+G++ KL I G+Y IP
Sbjct: 175 PAFQPPEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP 233
Query: 260 ESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLPDRPPETQSA 315
++DL++ ML+ P R I Q+ WF +K P
Sbjct: 234 GD--CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF----------RKKHP--------- 272
Query: 316 VANEGMSKPMNRSPPMPQRSPPPPPSSVDPTRNIS 350
P PP P + D R+++
Sbjct: 273 -------------PAEAPVPIPPSPDTKDRWRSMT 294
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 67/321 (20%), Positives = 109/321 (33%), Gaps = 78/321 (24%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHPNV 86
I +G + V A + A+K + + + +E E+ +MK L HPN+
Sbjct: 33 AIGQGSYGVVRVAIE-NQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNI 90
Query: 87 VTLYAHTILDLGRTKEAL-LVMECC----------------------------------- 110
LY ++ ++ + LVME C
Sbjct: 91 ARLY-----EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 111 ----DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS 166
++ EK + I R + +A+ +H+Q I HRD+K EN L +
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFST 203
Query: 167 DGLW--KLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---TPAYRAPEMWDLFRRELIN 221
+ + KL DFG K + T TP + APE+ +
Sbjct: 204 NKSFEIKLVDFG--------LSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES-YG 254
Query: 222 EKVDIWALGCLLFRICYFKNAFDGESKL----QILNGNYRIPESP--KYSSSVTDLIRDM 275
K D W+ G LL + F G + Q+LN S DL+ ++
Sbjct: 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNL 314
Query: 276 LQASPDDRPDITQV----WFR 292
L + D+R D + W
Sbjct: 315 LNRNVDERFDAMRALQHPWIS 335
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 6e-38
Identities = 59/269 (21%), Positives = 102/269 (37%), Gaps = 20/269 (7%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVT 88
VR A + + + + +++ +I M V
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 89 LYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYF-EEKQVLAIFRDVCNAVFAMH 146
L + + M+ C K +L + + R + E L IF + AV +H
Sbjct: 127 LQPSS-----PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181
Query: 147 SQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---- 202
S+ + HRDLK N+ D + K+ DFG T + E+ + + HT
Sbjct: 182 SKG--LMHRDLKPSNIFFTMDDVVKVGDFG-LVTAMDQDEEEQTVLTPMPAYATHTGQVG 238
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQILNGNYRIPES 261
T Y +PE + KVDI++LG +LF + Y F + + + N + P
Sbjct: 239 TKLYMSPEQI---HGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVR-NLKFPLL 294
Query: 262 P-KYSSSVTDLIRDMLQASPDDRPDITQV 289
+ +++DML SP +RP+ T +
Sbjct: 295 FTQKYPQEHMMVQDMLSPSPTERPEATDI 323
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 17/60 (28%), Positives = 31/60 (51%), Gaps = 3/60 (5%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLESAMKEISVMKSLKGHPNVVTLY 90
+ GGF V+ A++ + YA+K + + N E + E M+E+ + L HP +V +
Sbjct: 13 CMGRGGFGVVFEAKNKV-DDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYF 70
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 66/298 (22%), Positives = 110/298 (36%), Gaps = 48/298 (16%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMI------CNDEESLESAMKEISVMKSLK-GHP 84
++ GGF VYS + + A+KH+ + + E+ ++K + G
Sbjct: 50 LLGSGGFGSVYSGIR-VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 85 NVVTLYAHTILDLGRTKEAL-LVMECCDKS--LVNVLENRGAGYFEEKQVLAIFRDVCNA 141
V+ L D ++ L++E + L + + RGA +E+ + F V A
Sbjct: 109 GVIRLL-----DWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 161
Query: 142 VFAMHSQSPPIAHRDLKAENLLL-GSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRK 200
V H+ + HRD+K EN+L+ + G KL DFG S +
Sbjct: 162 VRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVY------------ 205
Query: 201 HT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYR 257
T Y PE + +W+LG LL+ + F+ + + I+ G
Sbjct: 206 TDFDGTRVYSPPEW--IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--IIRGQVF 261
Query: 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLPDRPPE 311
+ SS LIR L P DRP ++ W + + L P
Sbjct: 262 FR--QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 317
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 67/298 (22%), Positives = 117/298 (39%), Gaps = 50/298 (16%)
Query: 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTL 89
+V+ EG + V + + + S++YA+K + +E+ ++ +GH NV+ L
Sbjct: 18 EDVLGEGAHARVQTCIN-LITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 90 YAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
+ ++ LV E S+++ + R +F E + + +DV +A+ +H+
Sbjct: 77 I-----EFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHN 129
Query: 148 QSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT-- 202
+ IAHRDLK EN+L K+CDF KL T
Sbjct: 130 KG--IAHRDLKPENILCEHPNQVSPVKICDFD-LG----SGIKLNGDCSPISTPELLTPC 182
Query: 203 -TPAYRAPEMWDLFRRELIN--EKVDIWALGCLLF-----------------RICYFKNA 242
+ Y APE+ + F E ++ D+W+LG +L+ +
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 243 FDGESKL--QILNGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFR 292
++ L I G Y P+ S + DLI +L R QV W +
Sbjct: 243 PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 66/291 (22%), Positives = 104/291 (35%), Gaps = 64/291 (21%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHPNV 86
+ G F+ V ++YA K + + EI+V++ K P V
Sbjct: 36 ELGRGKFAVVRQCIS-KSTGQEYAAKFLKKRRRGQDCRAEIL---HEIAVLELAKSCPRV 91
Query: 87 VTLYAHTILDLGRTKEAL-LVMECC------DKSLVNVLENRGAGYFEEKQVLAIFRDVC 139
+ L+ ++ + L++E A E V+ + + +
Sbjct: 92 INLH-----EVYENTSEIILILEYAAGGEIFSL-----CLPELAEMVSENDVIRLIKQIL 141
Query: 140 NAVFAMHSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEM-GIEE 195
V+ +H + I H DLK +N+LL S G K+ DFG S +L E+ G
Sbjct: 142 EGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFG-MSRKIGHACELREIMG--- 195
Query: 196 DNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF----KNAFDGESK--- 248
TP Y APE + + I D+W +G I Y + F GE
Sbjct: 196 -------TPEYLAPE---ILNYDPITTATDMWNIGI----IAYMLLTHTSPFVGEDNQET 241
Query: 249 -LQILNGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFR 292
L I N E S TD I+ +L +P+ RP W +
Sbjct: 242 YLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ 292
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 44/347 (12%), Positives = 76/347 (21%), Gaps = 72/347 (20%)
Query: 5 KPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC--- 61
R + + + G S V+ RD + + +A+K
Sbjct: 49 AETTVDSLLSQGERKLKLVE-------PLRVGDRSVVFLVRD-VERLEDFALKVFTMGAE 100
Query: 62 NDEESLESAMKEISVMKSLKGHPNVVTLYAH----TILDLGRT----------------- 100
N LE + L + D
Sbjct: 101 NSRSELERLHEATFAAARLL-GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYA 159
Query: 101 -KEALLVMECCDKSLVNVLE-----NRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAH 154
LL+M L + G + + + + S+ + H
Sbjct: 160 VANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVH 217
Query: 155 RDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDL 214
+NL + DG L D + K + Y E +
Sbjct: 218 GHFTPDNLFIMPDGRLMLGDVSAL---WKVGTRGPASS---------VPVTYAPREFLNA 265
Query: 215 FRRELINEKVDIWALGCLLFRICYFKNAFDGESK-----------LQILNGNYRIPESPK 263
++ W LG ++R+ F + +
Sbjct: 266 -STATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTP 324
Query: 264 YSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLP 306
V LI L R + F QL + SL
Sbjct: 325 LPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL---QLQNEISSSLS 368
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-37
Identities = 73/290 (25%), Positives = 121/290 (41%), Gaps = 50/290 (17%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKG 82
++ ++ +G F V +D ++YA+K D ++ E+ ++K L
Sbjct: 25 NIVCMLGKGSFGEVLKCKD-RITQQEYAVKVINKASAKNKDTSTILR---EVELLKKL-D 79
Query: 83 HPNVVTLYAHTILDLGRTKEAL-LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCN 140
HPN++ L+ ++ + +V E L + + R F E I + V +
Sbjct: 80 HPNIMKLF-----EILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFS 132
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEM-GIEED 196
+ MH + I HRDLK EN+LL S D K+ DFG ST ++ K+++ G
Sbjct: 133 GITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFG-LSTCFQQNTKMKDRIG---- 185
Query: 197 NIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI-C-Y--FKNAFDGESKLQIL 252
T Y APE+ R +EK D+W+ G +L+ + F + + ++
Sbjct: 186 ------TAYYIAPEV---LRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235
Query: 253 NGNYR--IPESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQ 296
G Y +P+ S DLIR ML P R TQ W +
Sbjct: 236 TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 69/289 (23%), Positives = 109/289 (37%), Gaps = 62/289 (21%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK----HMICNDEESLESAMKEISVMKSLKGHPNVV 87
+ G F V+ + + +K E +E+ EI V+KSL HPN++
Sbjct: 29 KLGSGAFGDVHLVEE-RSSGLERVIKTINKDRSQVPMEQIEA---EIEVLKSL-DHPNII 83
Query: 88 TLYAHTILDLGRTKEAL-LVMECC------DKSLVNVLENRGAGYFEEKQVLAIFRDVCN 140
++ ++ + +VME C ++ V E V + + + N
Sbjct: 84 KIF-----EVFEDYHNMYIVMETCEGGELLERI---VSAQARGKALSEGYVAELMKQMMN 135
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEM-GIEED 196
A+ HSQ + H+DLK EN+L K+ DFG + K E G
Sbjct: 136 ALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFG-LAELFKSDEHSTNAAG---- 188
Query: 197 NIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF----KNAFDGESKL--- 249
T Y APE+ F+R++ K DIW+ G + YF F G S
Sbjct: 189 ------TALYMAPEV---FKRDV-TFKCDIWSAGV----VMYFLLTGCLPFTGTSLEEVQ 234
Query: 250 -QILNGNYRIPESPKY-SSSVTDLIRDMLQASPDDRPDITQV----WFR 292
+ + + DL++ ML P+ RP QV WF+
Sbjct: 235 QKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-37
Identities = 79/298 (26%), Positives = 124/298 (41%), Gaps = 47/298 (15%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMI----CNDEESLESAMKEISVMKSLKGHPNV 86
V+ +G F V +D ++ A+K +I + ES ++E+ ++K L HPN+
Sbjct: 32 RVLGKGSFGEVILCKD-KITGQECAVK-VISKRQVKQKTDKESLLREVQLLKQL-DHPNI 88
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
+ LY + K LV E L + + +R F E I R V + +
Sbjct: 89 MKLY-----EFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITY 141
Query: 145 MHSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEM-GIEEDNIRK 200
MH I HRDLK ENLLL S D ++ DFG ST+ + +K+++ G
Sbjct: 142 MHKNK--IVHRDLKPENLLLESKSKDANIRIIDFG-LSTHFEASKKMKDKIG-------- 190
Query: 201 HTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK----LQILNGNY 256
T Y APE+ +EK D+W+ G +L+ + F+G ++ ++ G Y
Sbjct: 191 --TAYYIAPEV---LHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY 244
Query: 257 RIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLPDR 308
K S S DLIR ML P R W + + + + D
Sbjct: 245 TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDN 302
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 56/324 (17%), Positives = 106/324 (32%), Gaps = 83/324 (25%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK------------HMICNDEESLESAM-----KEI 74
+ +G F+ + +K YA+K N+++ + E+
Sbjct: 38 TLNQGKFNKIILCE---KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 75 SVMKSLKGHPNVVTLYAHTILDLGRTKEAL-LVMECCDK-------SLVNVLENRGAGYF 126
++ +K + +T I+ + + ++ E + VL+ +
Sbjct: 95 QIITDIK-NEYCLTCE--GIIT---NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 127 EEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFE 186
+ + I + V N+ +H++ I HRD+K N+L+ +G KL DFG
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKNGRVKLSDFG---------- 197
Query: 187 KLEEMGIEEDNIRKHT---TPAYRAPEMWDLFRRELI--NEKVDIWALGCLLFRICYFKN 241
+ + T + PE F E KVDIW+LG L+ + Y
Sbjct: 198 ----ESEYMVDKKIKGSRGTYEFMPPEF---FSNESSYNGAKVDIWSLGICLYVMFYNVV 250
Query: 242 AFDGESKLQ-----ILNGNYRIPESPKY-----------------SSSVTDLIRDMLQAS 279
F + L I N P + S+ D ++ L+ +
Sbjct: 251 PFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKN 310
Query: 280 PDDRPDITQV----WFRVNEQLPV 299
P +R W +
Sbjct: 311 PAERITSEDALKHEWLADTNIEDL 334
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-37
Identities = 71/299 (23%), Positives = 107/299 (35%), Gaps = 66/299 (22%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMS--KQYAMKH--------MICNDEESLESAMKEISVM 77
+ + G V A K+ A++ + + + EI ++
Sbjct: 138 IMSKTLGSGACGEVKLA---FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 78 KSLKGHPNVVTLYAHTILDLGRTKEALLVMECC------DKSLVNVLENRGAGYFEEKQV 131
K L HP ++ + + ++ +V+E DK V+ N +E
Sbjct: 195 KKLN-HPCIIKIK-----NFFDAEDYYIVLELMEGGELFDK----VVGN---KRLKEATC 241
Query: 132 LAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKL 188
F + AV +H I HRDLK EN+LL S D L K+ DFG S +
Sbjct: 242 KLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG-HSKILGETSLM 298
Query: 189 EEM-GIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC---YFKNAFD 244
+ G TP Y APE+ N VD W+LG +LF IC Y F
Sbjct: 299 RTLCG----------TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPP--FS 345
Query: 245 GES-----KLQILNGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFR 292
K QI +G Y + S DL++ +L P R + W +
Sbjct: 346 EHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-37
Identities = 82/292 (28%), Positives = 120/292 (41%), Gaps = 50/292 (17%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKG 82
+ G + V RD + A+K + + L E++V+K L
Sbjct: 40 QRVKKLGSGAYGEVLLCRD-KVTHVERAIKIIRKTSVSTSSNSKLLE---EVAVLKLL-D 94
Query: 83 HPNVVTLYAHTILDLGRTKEAL-LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCN 140
HPN++ LY D K LVMEC L + + +R F E I + V +
Sbjct: 95 HPNIMKLY-----DFFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLS 147
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEM-GIEED 196
V +H + I HRDLK ENLLL S D L K+ DFG S + +K++E G
Sbjct: 148 GVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFG-LSAVFENQKKMKERLG---- 200
Query: 197 NIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES----KLQIL 252
T Y APE+ R++ +EK D+W++G +LF + F G++ ++
Sbjct: 201 ------TAYYIAPEV---LRKK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE 250
Query: 253 NGNY--RIPESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLP 298
G Y PE S DLI+ MLQ R Q W +
Sbjct: 251 KGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKK 302
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 76/341 (22%), Positives = 116/341 (34%), Gaps = 79/341 (23%)
Query: 32 VIAEGGFSCVYSARDAIHMS--KQYAMK--------HMICNDEESLESAMKEISVMKSLK 81
+ G V A K+ A+K + + + EI ++K L
Sbjct: 17 TLGSGACGEVKLA---FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 82 GHPNVVTLYAHTILDLGRTKEALLVMECC------DKSLVNVLENRGAGYFEEKQVLAIF 135
HP ++ + + ++ +V+E DK V+ N +E F
Sbjct: 74 -HPCIIKIK-----NFFDAEDYYIVLELMEGGELFDK----VVGN---KRLKEATCKLYF 120
Query: 136 RDVCNAVFAMHSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEMG 192
+ AV +H I HRDLK EN+LL S D L K+ DFG S K + M
Sbjct: 121 YQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG-HS---KILGETSLM- 173
Query: 193 IEEDNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC---YFKNAFDGE 246
T TP Y APE+ N VD W+LG +LF IC Y F
Sbjct: 174 --------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYP--PFSEH 222
Query: 247 SKL-----QILNGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNE 295
QI +G Y + S DL++ +L P R + W +
Sbjct: 223 RTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ--- 279
Query: 296 QLPVGLQKSLPDRPPETQSAVANEGMSKPMNRSPPMPQRSP 336
+ + + + S + P ++ P
Sbjct: 280 ------DEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRP 314
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 65/291 (22%), Positives = 111/291 (38%), Gaps = 72/291 (24%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYA 91
V+ G V + +++A+K + D +E+ + P++V +
Sbjct: 25 VLGLGINGKVLQIFN-KRTQEKFALK--MLQDCPKAR---REVELHWRASQCPHIVRIVD 78
Query: 92 HTILDLGRTKEALLVMECC------DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
K L+VMEC + +++RG F E++ I + + A+ +
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSR-----IQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 146 HSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT 202
HS + IAHRD+K ENLL S + + KL DFG
Sbjct: 134 HSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG-------------------------- 165
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI--C-----YFKNAFDGESKL--QILN 253
A E E ++ D+W+LG +++ I C Y + + +I
Sbjct: 166 ----FAKET----TGEKYDKSCDMWSLGVIMY-ILLCGYPPFYSNHGLAISPGMKTRIRM 216
Query: 254 GNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLP 298
G Y P + S V LIR++L+ P R IT+ W + ++P
Sbjct: 217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 6e-37
Identities = 73/294 (24%), Positives = 111/294 (37%), Gaps = 55/294 (18%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGH 83
V+ + +G FS V ++A K + D + LE E + + L+ H
Sbjct: 10 VKEELGKGAFSVVRRCVH-KTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQ-H 64
Query: 84 PNVVTLYAHTILDLGRTKEAL-LVMECCDKS-LVNVLENRGAGYFEEKQVLAIFRDVCNA 141
PN+V L+ D + + LV + L + R ++ E + + +
Sbjct: 65 PNIVRLH-----DSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILES 117
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEM-GIEEDN 197
+ HS I HR+LK ENLLL S KL DFG + E G
Sbjct: 118 IAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFG-LAIEVNDSEAWHGFAG----- 169
Query: 198 IRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC---YFKNAFDGESKL----Q 250
TP Y +PE + +++ ++ VDIWA G +L+ I Y F E + Q
Sbjct: 170 -----TPGYLSPE---VLKKDPYSKPVDIWACGVILY-ILLVGYP--PFWDEDQHRLYAQ 218
Query: 251 ILNGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLP 298
I G Y P + LI ML +P R Q W E++
Sbjct: 219 IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 272
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 7e-37
Identities = 43/342 (12%), Positives = 92/342 (26%), Gaps = 72/342 (21%)
Query: 5 KPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE 64
+PF + G R++ G V+ + A D + + + +
Sbjct: 60 QPFRVESELGERPRTLVRGT-------VLGQEDPYAYLEATD-QETGESFEVHVPYFTER 111
Query: 65 ES---LESAMKEISVMKSLK------------------------GHPNVVTLYAHTILDL 97
++ +E+ ++ L+ ++ +
Sbjct: 112 PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD--ERD 169
Query: 98 GRTKEALLVMECCDKSLVNVLEN-----RGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPI 152
+ +L E L + V + ++H +
Sbjct: 170 MWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--L 227
Query: 153 AHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEM- 211
H L+ +++L G L F + R + + PE+
Sbjct: 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSS-------------VSRGFEPPELE 274
Query: 212 -------WDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESPKY 264
+ RR L+ D WALG +++ I ++ L +R
Sbjct: 275 ARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSC--KNI 332
Query: 265 SSSVTDLIRDMLQASPDDRPDITQV----WFR-VNEQLPVGL 301
V L+ L+ +DR Q + + +L L
Sbjct: 333 PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAAL 374
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 71/295 (24%), Positives = 114/295 (38%), Gaps = 56/295 (18%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHPNV 86
VI +G FS V + +Q+A+K + S E +E S+ LK HP++
Sbjct: 31 VIGKGPFSVVRRCIN-RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHI 88
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCDKS-LVNVLENRG--AGYFEEKQVLAIFRDVCNAV 142
V L + + L +V E D + L + R + E R + A+
Sbjct: 89 VELL-----ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 143 FAMHSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIR 199
H + I HRD+K +LL S KL FG + + E +
Sbjct: 144 RYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFG-VAIQ-----------LGESGLV 189
Query: 200 KHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC---Y--FKNAFDGESKL-- 249
TP + APE+ +RE + VD+W G +LF I F + + +L
Sbjct: 190 AGGRVGTPHFMAPEV---VKREPYGKPVDVWGCGVILF-ILLSGCLPF---YGTKERLFE 242
Query: 250 QILNGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLP 298
I+ G Y++ S S DL+R ML P +R + + W + ++
Sbjct: 243 GIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYA 297
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 72/298 (24%), Positives = 110/298 (36%), Gaps = 64/298 (21%)
Query: 33 IAEGGFSCVYSARDAIHMSKQY-AMK----HMICNDEESLESAMKEISVMKSLKGHPNVV 87
+ EG + V A + + +++ A+K + E+++ KEI + K L H NVV
Sbjct: 15 LGEGAYGEVQLAVNRV--TEEAVAVKIVDMKRAVDCPENIK---KEICINKMLN-HENVV 68
Query: 88 TLYAHTILDLGRTKEAL-LVMECCDKS-LVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
Y R L +E C L + +E E F + V +
Sbjct: 69 KFY-----GHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYL 121
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGIEEDNIRKHT-- 202
H I HRD+K ENLLL K+ DFG +T + E+L +
Sbjct: 122 HGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-----------LNKMC 168
Query: 203 -TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNA-------FDGESKL----- 249
T Y APE+ L RRE E VD+W+ G +L A +D S
Sbjct: 169 GTLPYVAPEL--LKRREFHAEPVDVWSCGIVLT-------AMLAGELPWDQPSDSCQEYS 219
Query: 250 QILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQK 303
+ K S+ L+ +L +P R I + W+ L G ++
Sbjct: 220 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP--LKKGAKR 275
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-36
Identities = 70/313 (22%), Positives = 118/313 (37%), Gaps = 63/313 (20%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMK-------------HMICNDEESLESAMKEI 74
+ G + V ++ + + A+K N E+ E EI
Sbjct: 39 FKVRKLGSGAYGEVLLCKE-KNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 75 SVMKSLKGHPNVVTLYAHTILDLGRTKEAL-LVMECCD-KSLVNVLENRGAGYFEEKQVL 132
S++KSL HPN++ L+ D+ K+ LV E + L + NR F+E
Sbjct: 98 SLLKSL-DHPNIIKLF-----DVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAA 149
Query: 133 AIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLE 189
I + + + + +H + I HRD+K EN+LL + K+ DFG S+ + KL
Sbjct: 150 NIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFG-LSSFFSKDYKLR 206
Query: 190 EM-GIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF----KNAFD 244
+ G T Y APE+ +++ NEK D+W+ G I Y F
Sbjct: 207 DRLG----------TAYYIAPEV---LKKK-YNEKCDVWSCGV----IMYILLCGYPPFG 248
Query: 245 GES----KLQILNGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVN 294
G++ ++ G Y + S +LI+ ML + R + W +
Sbjct: 249 GQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308
Query: 295 EQLPVGLQKSLPD 307
+
Sbjct: 309 ANNINKSDQKTLC 321
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-36
Identities = 70/296 (23%), Positives = 116/296 (39%), Gaps = 66/296 (22%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHM------ICNDEESLESAMKEISVMKSLKG 82
+ + G F+ V R K+YA K + S E +E+++++ ++
Sbjct: 9 MGEELGSGQFAIVRKCRQ-KGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR- 66
Query: 83 HPNVVTLYAHTILDLGRTKEAL-LVMECC------DKSLVNVLENRGAGYFEEKQVLAIF 135
HPN++TL+ D+ K + L++E D + E E +
Sbjct: 67 HPNIITLH-----DIFENKTDVVLILELVSGGELFDF----LAEK---ESLTEDEATQFL 114
Query: 136 RDVCNAVFAMHSQSPPIAHRDLKAENLLLGS----DGLWKLCDFGSTSTNHKRFEKLEEM 191
+ + + V +HS+ IAH DLK EN++L + KL DFG + + + + +
Sbjct: 115 KQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFG-IAHKIEAGNEFKNI 171
Query: 192 -GIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF----KNAFDGE 246
G TP + APE + E + + D+W++G I Y + F GE
Sbjct: 172 FG----------TPEFVAPE---IVNYEPLGLEADMWSIGV----ITYILLSGASPFLGE 214
Query: 247 SK----LQILNGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFR 292
+K I NY E S D IR +L P R I Q W +
Sbjct: 215 TKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-36
Identities = 77/295 (26%), Positives = 120/295 (40%), Gaps = 61/295 (20%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMK--------HMICNDEESLESAMKEISVMKSL 80
++VI G S V ++A+K EE E+ +E +++ +
Sbjct: 98 PKDVIGRGVSSVVRRCVH-RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 81 KGHPNVVTLYAHTILDLGRTKEAL-LVMECC------DKSLVNVLENRGAGYFEEKQVLA 133
GHP+++TL D + + LV + D + E EK+ +
Sbjct: 157 AGHPHIITLI-----DSYESSSFMFLVFDLMRKGELFDY----LTEK---VALSEKETRS 204
Query: 134 IFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEM-G 192
I R + AV +H+ + I HRDLK EN+LL + +L DFG S + + EKL E+ G
Sbjct: 205 IMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFG-FSCHLEPGEKLRELCG 261
Query: 193 IEEDNIRKHTTPAYRAPEM---WDLFRRELINEKVDIWALGCLLFRIC---YFKNAFDGE 246
TP Y APE+ ++VD+WA G +LF F
Sbjct: 262 ----------TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF-TLLAGSP--PFWHR 308
Query: 247 SKL----QILNGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WF 291
++ I+ G Y+ SS+V DLI +LQ P+ R Q +F
Sbjct: 309 RQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 67/274 (24%), Positives = 117/274 (42%), Gaps = 32/274 (11%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMI--CNDEESLESAMKEISVMKSLKGH 83
++++ I G F V+ A A+K ++ E + ++E+++MK L+ H
Sbjct: 38 DLNIKEKIGAGSFGTVHRA---EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-H 93
Query: 84 PNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAG-YFEEKQVLAIFRDVCNA 141
PN+V + +V E + SL +L GA +E++ L++ DV
Sbjct: 94 PNIVLFMGAVT----QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGIEEDNIRK 200
+ +H+++PPI HR+LK+ NLL+ K+CDFG S G
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG-------- 201
Query: 201 HTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI----LNGNY 256
TP + APE+ R E NEK D+++ G +L+ + + + + Q+
Sbjct: 202 --TPEWMAPEV---LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK 256
Query: 257 RIPESPKY-SSSVTDLIRDMLQASPDDRPDITQV 289
R E P+ + V +I P RP +
Sbjct: 257 R-LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATI 289
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 75/294 (25%), Positives = 109/294 (37%), Gaps = 64/294 (21%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMI----CNDEESLESAMKEISVMKSLKGHPNVV 87
I G + V A + A K I D + + EI +MKSL HPN++
Sbjct: 16 TIGRGSWGEVKIAVQ-KGTRIRRAAK-KIPKYFVEDVDRFKQ---EIEIMKSLD-HPNII 69
Query: 88 TLYAHTILDLGRTKEAL-LVMECC------DKSLVNVLENRGAGYFEEKQVLAIFRDVCN 140
LY + + LVME C ++ V+ F E I +DV +
Sbjct: 70 RLY-----ETFEDNTDIYLVMELCTGGELFER----VVHK---RVFRESDAARIMKDVLS 117
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEM-GIEED 196
AV H + +AHRDLK EN L + D KL DFG + K + + G
Sbjct: 118 AVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFG-LAARFKPGKMMRTKVG---- 170
Query: 197 NIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI--CYFKNAFDGESKL----Q 250
TP Y +P++ L + D W+ G +++ + C + F + +
Sbjct: 171 ------TPYYVSPQV--LEGL--YGPECDEWSAGVMMY-VLLCGYP-PFSAPTDSEVMLK 218
Query: 251 ILNGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLP 298
I G + PE S LIR +L SP R Q WF
Sbjct: 219 IREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 68/303 (22%), Positives = 115/303 (37%), Gaps = 66/303 (21%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHM------ICNDEESLESAMKEISVMKSLKG 82
+ G F+ V R+ QYA K + S E +E+S++K ++
Sbjct: 15 TGEELGSGQFAVVKKCRE-KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ- 72
Query: 83 HPNVVTLYAHTILDLGRTKEAL-LVMECC------DKSLVNVLENRGAGYFEEKQVLAIF 135
HPNV+TL+ ++ K + L++E D + E E++
Sbjct: 73 HPNVITLH-----EVYENKTDVILILELVAGGELFDF----LAEK---ESLTEEEATEFL 120
Query: 136 RDVCNAVFAMHSQSPPIAHRDLKAENLLLGS----DGLWKLCDFGSTSTNHKRFEKLEEM 191
+ + N V+ +HS IAH DLK EN++L K+ DFG + + + +
Sbjct: 121 KQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFG-LAHKIDFGNEFKNI 177
Query: 192 -GIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF----KNAFDGE 246
G TP + APE + E + + D+W++G I Y + F G+
Sbjct: 178 FG----------TPEFVAPE---IVNYEPLGLEADMWSIGV----ITYILLSGASPFLGD 220
Query: 247 SK----LQILNGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQ 296
+K + NY + S+ D IR +L P R I W + +
Sbjct: 221 TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280
Query: 297 LPV 299
Sbjct: 281 QQA 283
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 81/307 (26%), Positives = 127/307 (41%), Gaps = 70/307 (22%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMI----CNDEESLESAMKEISVMKSLKGHPNVV 87
V+ G FS V+ + K +A+K I + SLE+ EI+V+K +K H N+V
Sbjct: 16 VLGSGAFSEVFLVKQ-RLTGKLFALK-CIKKSPAFRDSSLEN---EIAVLKKIK-HENIV 69
Query: 88 TLYAHTILDLGRTKEAL-LVMECC------DKSLVNVLENRGAGYFEEKQVLAIFRDVCN 140
TL D+ + LVM+ D+ +LE G + EK + + V +
Sbjct: 70 TLE-----DIYESTTHYYLVMQLVSGGELFDR----ILER---GVYTEKDASLVIQQVLS 117
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDN 197
AV +H I HRDLK ENLL + + + DFG S + E+ M
Sbjct: 118 AVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFG-LS----KMEQNGIM------ 164
Query: 198 IRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC---YFKNAFDGESKL-- 249
T TP Y APE + ++ ++ VD W++G + + I Y F E++
Sbjct: 165 ---STACGTPGYVAPE---VLAQKPYSKAVDCWSIGVITY-ILLCGYP--PFYEETESKL 215
Query: 250 --QILNGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGL 301
+I G Y S S D I +L+ P++R + W N L +
Sbjct: 216 FEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDI 275
Query: 302 QKSLPDR 308
S+ +
Sbjct: 276 YPSVSLQ 282
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 71/290 (24%), Positives = 110/290 (37%), Gaps = 53/290 (18%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHPNV 86
+ +G FS V ++A K + D + LE +E + + L+ HPN+
Sbjct: 36 ELGKGAFSVVRRCVH-KTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQ-HPNI 90
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCDKS-LVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
V L+ D + + LV + L + R ++ E + + ++
Sbjct: 91 VRLH-----DSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAY 143
Query: 145 MHSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEM-GIEEDNIRK 200
HS I HR+LK ENLLL S KL DFG + E G
Sbjct: 144 CHSNG--IVHRNLKPENLLLASKAKGAAVKLADFG-LAIEVNDSEAWHGFAG-------- 192
Query: 201 HTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI--CYFKNAFDGESKL----QILNG 254
TP Y +PE+ +++ ++ VDIWA G +L+ I + F E + QI G
Sbjct: 193 --TPGYLSPEV---LKKDPYSKPVDIWACGVILY-ILLVGYP-PFWDEDQHRLYAQIKAG 245
Query: 255 NYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLP 298
Y P + LI ML +P R Q W E++
Sbjct: 246 AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 295
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 66/297 (22%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGH 83
+ ++ +G F V +D ++YA+K D ++ E+ ++K L H
Sbjct: 26 IVCMLGKGSFGEVLKCKD-RITQQEYAVKVINKASAKNKDTSTILR---EVELLKKLD-H 80
Query: 84 PNVVTLYAHTILDLGRTKEAL-LVMECC------DKSLVNVLENRGAGYFEEKQVLAIFR 136
PN++ L+ ++ + +V E D+ +++ F E I +
Sbjct: 81 PNIMKLF-----EILEDSSSFYIVGELYTGGELFDE----IIKR---KRFSEHDAARIIK 128
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEM-G 192
V + + MH + I HRDLK EN+LL S D K+ DFG ST ++ K+++ G
Sbjct: 129 QVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFG-LSTCFQQNTKMKDRIG 185
Query: 193 IEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC---YFKNAFDGESKL 249
T Y APE+ L +EK D+W+ G +L+ I F G+++
Sbjct: 186 ----------TAYYIAPEV--LRGT--YDEKCDVWSAGVILY-ILLSGTP--PFYGKNEY 228
Query: 250 ----QILNGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQ 296
++ G Y S DLIR ML P R TQ W +
Sbjct: 229 DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 75/332 (22%), Positives = 118/332 (35%), Gaps = 62/332 (18%)
Query: 33 IAEGGFSCVYSARDAIHMSKQY-AMKHMICNDEESLESAMK---EISVMKSLKGHPNVVT 88
+ EG + V A + + +++ A+K I + + +++ EI + K L H NVV
Sbjct: 15 LGEGAYGEVQLAVNRV--TEEAVAVK--IVDMKRAVDCPENIKKEICINKMLN-HENVVK 69
Query: 89 LYAHTILDLGRTKEAL-LVMECCDKS-LVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH 146
Y R L +E C L + +E E F + V +H
Sbjct: 70 FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH 122
Query: 147 SQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGIEEDNIRKHT--- 202
I HRD+K ENLLL K+ DFG +T + E+L +
Sbjct: 123 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-----------LNKMCG 169
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNA-------FDGESKL-----Q 250
T Y APE+ L RRE E VD+W+ G +L A +D S
Sbjct: 170 TLPYVAPEL--LKRREFHAEPVDVWSCGIVLT-------AMLAGELPWDQPSDSCQEYSD 220
Query: 251 ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLP 306
+ K S+ L+ +L +P R I + W+ L G ++
Sbjct: 221 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP--LKKGAKRPRV 278
Query: 307 DRPPETQSAVANEGMSKPMNRSPPMPQRSPPP 338
++S + P+ S P
Sbjct: 279 TSGGVSESPSGFSKHIQSNLDFSPVNSASRTP 310
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 4e-35
Identities = 46/340 (13%), Positives = 91/340 (26%), Gaps = 58/340 (17%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMI---CNDEESLESAMKEISVMKSLKGHPNVVT 88
V+ + A D + + + +++ +E+ ++ L+G N
Sbjct: 85 VLGQEDPYAYLEATD-QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 89 LYAH----------------TILDLGRTKE------ALLVMECCDKSLVNVLE-----NR 121
H ++ + + + +L E +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 122 GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181
L + V + ++H + H L+ +++L G L F +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEM--WDLFRRELINEKVDIWALGCLLFRICYF 239
G P A M + L+ D W LG ++ I
Sbjct: 262 GASAVSPIGRGF--------APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 240 KNAFDGESKL----QILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV----WF 291
++ L I IP+ V L+ L+ +DR Q +
Sbjct: 314 DLPNTDDAALGGSEWIFRSCKNIPQ------PVRALLEGFLRYPKEDRLLPLQAMETPEY 367
Query: 292 R-VNEQLPVGLQKSLPDRPPETQSAVANEGMSKPMNRSPP 330
+ +L L D P + G S+P
Sbjct: 368 EQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGAA 407
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 68/274 (24%), Positives = 110/274 (40%), Gaps = 38/274 (13%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPN 85
+I V V+ G F V A +K A+K + E ++ + E+ + + HPN
Sbjct: 9 EIEVEEVVGRGAFGVVCKA---KWRAKDVAIKQI--ESESERKAFIVELRQLSRVN-HPN 62
Query: 86 VVTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVL-ENRGAGYFEEKQVLAIFRDVCNAV 142
+V LY G + LVME + SL NVL Y+ ++ V
Sbjct: 63 IVKLY-------GACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 143 FAMHSQSP-PIAHRDLKAENLLLGSDGLW-KLCDFGSTSTNHKRFEKLEEMGIEEDNIRK 200
+HS P + HRDLK NLLL + G K+CDFG T+ + + G
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG-TACD-IQTHMTNNKG-------- 165
Query: 201 HTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI-----LNGN 255
+ A+ APE+ F +EK D+++ G +L+ + + FD ++
Sbjct: 166 --SAAWMAPEV---FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG 220
Query: 256 YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
R P + L+ P RP + ++
Sbjct: 221 TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEI 254
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 78/319 (24%), Positives = 121/319 (37%), Gaps = 60/319 (18%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMK-EISVMKSLKGHPNVVTLYA 91
I G F RD + A+K +++ ++ EI +SL+ HPN+V
Sbjct: 28 IGSGNFGVARLMRD-KLTKELVAVK--YIERGAAIDENVQREIINHRSLR-HPNIVRFK- 82
Query: 92 HTILDLGRTKEAL-LVMECC------DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
++ T L ++ME ++ + N AG F E + F+ + + V
Sbjct: 83 ----EVILTPTHLAIIMEYASGGELYER-ICN------AGRFSEDEARFFFQQLLSGVSY 131
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLW--KLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT 202
HS I HRDLK EN LL K+CDFG S + + +
Sbjct: 132 CHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFG-YSKSSVLHSQP------------KS 176
Query: 203 ---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES--------KLQI 251
TPAY APE+ L R+E + D+W+ G L+ + F+ +I
Sbjct: 177 TVGTPAYIAPEV--LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI 234
Query: 252 LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLPD 307
L+ Y IP+ + S LI + A P R I ++ WF N LP L
Sbjct: 235 LSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN--LPADLMNESNT 292
Query: 308 RPPETQSAVANEGMSKPMN 326
+ + + M
Sbjct: 293 GSQFQEPEQPMQSLDTIMQ 311
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-35
Identities = 70/292 (23%), Positives = 107/292 (36%), Gaps = 56/292 (19%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHPNV 86
+ +G FS V + ++YA + D + LE E + + LK HPN+
Sbjct: 18 ELGKGAFSVVRRCVK-VLAGQEYAAMIINTKKLSARDHQKLER---EARICRLLK-HPNI 72
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCDKS-LVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
V L+ D + L+ + L + R Y+ E + + AV
Sbjct: 73 VRLH-----DSISEEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLH 125
Query: 145 MHSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH 201
H + HR+LK ENLLL S KL DFG + +E +
Sbjct: 126 CHQMG--VVHRNLKPENLLLASKLKGAAVKLADFG-LAIE-----------VEGEQQAWF 171
Query: 202 T---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI--CYFKNAFDGESKL----QIL 252
TP Y +PE+ R++ + VD+WA G +L+ I + F E + QI
Sbjct: 172 GFAGTPGYLSPEV---LRKDPYGKPVDLWACGVILY-ILLVGYP-PFWDEDQHRLYQQIK 226
Query: 253 NGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLP 298
G Y P + DLI ML +P R + W +
Sbjct: 227 AGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVA 278
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-35
Identities = 74/280 (26%), Positives = 115/280 (41%), Gaps = 48/280 (17%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAM-----KEISVMKSLKGHPNVV 87
+ G F V + + A+K I N ++ + +EI +K + HP+++
Sbjct: 19 LGVGTFGKVKIGEHQL-TGHKVAVK--ILNRQKIRSLDVVGKIKREIQNLKLFR-HPHII 74
Query: 88 TLYAHTILDLGRTKEAL-LVMECCDKS-LVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
LY + T +VME L + + G EE + +F+ + +AV
Sbjct: 75 KLY-----QVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYC 127
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT--- 202
H + HRDLK EN+LL + K+ DFG S E L T
Sbjct: 128 HRHM--VVHRDLKPENVLLDAHMNAKIADFG-LSNMMSDGEFL------------RTSCG 172
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES--KL--QILNGNYRI 258
+P Y APE+ + R +VDIW+ G +L+ + FD E L +I G + I
Sbjct: 173 SPNYAAPEV--ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI 230
Query: 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVN 294
P + SV L+ MLQ P R I + WF+ +
Sbjct: 231 P--EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-34
Identities = 58/289 (20%), Positives = 103/289 (35%), Gaps = 45/289 (15%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVV 87
+ + G F V+ + + + K + + EIS+M L HP ++
Sbjct: 54 DILEELGSGAFGVVHRCVE-KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKLI 111
Query: 88 TLYAHTILDLGRTKEAL-LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
L+ D K + L++E L + + E +V+ R C + M
Sbjct: 112 NLH-----DAFEDKYEMVLILEFLSGGELFDRIAAEDYKM-SEAEVINYMRQACEGLKHM 165
Query: 146 HSQSPPIAHRDLKAENLLLGS--DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTT 203
H S I H D+K EN++ + K+ DFG + + E + + T
Sbjct: 166 HEHS--IVHLDIKPENIMCETKKASSVKIIDFG-LA---TKLNPDEIVKV------TTAT 213
Query: 204 PAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF----KNAFDGESK----LQILNGN 255
+ APE + RE + D+WA+G + Y + F GE + +
Sbjct: 214 AEFAAPE---IVDREPVGFYTDMWAIGV----LGYVLLSGLSPFAGEDDLETLQNVKRCD 266
Query: 256 YRIPES--PKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLP 298
+ E S D I+++LQ P R + W + +
Sbjct: 267 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 315
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 66/285 (23%), Positives = 106/285 (37%), Gaps = 45/285 (15%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-------EESLESAMKEISVMK 78
+I I +GGF V+ R A+K +I D E + +E+ +M
Sbjct: 20 EIEYEKQIGKGGFGLVHKGRLVKD-KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 79 SLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRD 137
+L HPN+V LY +VME L + L ++ + L + D
Sbjct: 79 NLN-HPNIVKLYGLM------HNPPRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLD 130
Query: 138 VCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLW-----KLCDFGSTSTNHKRFEKLEEMG 192
+ + M +Q+PPI HRDL++ N+ L S K+ DFG S + + +
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG-LSQ-----QSVHSVS 184
Query: 193 IEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI- 251
+ APE E EK D ++ +L+ I + FD S +I
Sbjct: 185 GLLG------NFQWMAPETIG-AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 252 -----LNGNYR--IPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
R IPE + ++I P RP + +
Sbjct: 238 FINMIREEGLRPTIPED--CPPRLRNVIELCWSGDPKKRPHFSYI 280
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 46/283 (16%), Positives = 86/283 (30%), Gaps = 41/283 (14%)
Query: 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQY-----AMK--HMICNDEESLESAMK 72
ID L + E ++ R + +K + +
Sbjct: 7 IDFKQLNFL--TKLNENHSGELWKGR--------WQGNDIVVKVLKVRDWSTRKSRDFNE 56
Query: 73 EISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQV 131
E ++ HPNV+ + L+ SL NVL ++ Q
Sbjct: 57 ECPRLRIFS-HPNVLPVLGACQSPPAPH--PTLITHWMPYGSLYNVLHEGTNFVVDQSQA 113
Query: 132 LAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEE 190
+ D+ + +H+ P I L + ++++ D ++ S
Sbjct: 114 VKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-----GR 168
Query: 191 MGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ 250
M PA+ APE + D+W+ LL+ + + F S ++
Sbjct: 169 MY----------APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME 218
Query: 251 I----LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
I R P S V+ L++ + P RP +
Sbjct: 219 IGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMI 261
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 53/288 (18%), Positives = 108/288 (37%), Gaps = 56/288 (19%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVV 87
+ + G F V+ + K Y K + KEIS++ H N++
Sbjct: 8 MIAEDLGRGEFGIVHRCVE-TSSKKTYMAK-FVKVKGTDQVLVKKEISILNIA-RHRNIL 64
Query: 88 TLYAHTILDLGRTKEAL-LVMECC------DKSLVNVLENRGAGYFEEKQVLAIFRDVCN 140
L+ + + E L ++ E ++ + E+++++ VC
Sbjct: 65 HLH-----ESFESMEELVMIFEFISGLDIFER----INT-SA-FELNEREIVSYVHQVCE 113
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGS--DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNI 198
A+ +HS + I H D++ EN++ + K+ +FG + ++ + + +
Sbjct: 114 ALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFG-QA---RQLKPGDNFRL----- 162
Query: 199 RKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF----KNAFDGESK----LQ 250
T P Y APE + + ++++ D+W+LG + Y N F E+
Sbjct: 163 -LFTAPEYYAPE---VHQHDVVSTATDMWSLGT----LVYVLLSGINPFLAETNQQIIEN 214
Query: 251 ILNGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFR 292
I+N Y E + S D + +L R ++ W +
Sbjct: 215 IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 62/312 (19%), Positives = 115/312 (36%), Gaps = 66/312 (21%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHM------ICNDEESLESAMKEISVMKSLKG 82
+ + G F+ V R+ +YA K + S E +E+S+++ +
Sbjct: 16 IGEELGSGQFAIVKKCRE-KSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL- 73
Query: 83 HPNVVTLYAHTILDLGRTKEAL-LVMECC------DKSLVNVLENRGAGYFEEKQVLAIF 135
H NV+TL+ D+ + + L++E D + + E++ +
Sbjct: 74 HHNVITLH-----DVYENRTDVVLILELVSGGELFDF----LAQK---ESLSEEEATSFI 121
Query: 136 RDVCNAVFAMHSQSPPIAHRDLKAENLLLGS----DGLWKLCDFGSTSTNHKRFEKLEEM 191
+ + + V +H++ IAH DLK EN++L KL DFG + + + + +
Sbjct: 122 KQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFG-LAHEIEDGVEFKNI 178
Query: 192 -GIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY--------FKNA 242
G TP + APE + E + + D+W++G I Y F
Sbjct: 179 FG----------TPEFVAPE---IVNYEPLGLEADMWSIGV----ITYILLSGASPFLGD 221
Query: 243 FDGESKLQILNGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQ 296
E+ I + +Y E S D IR +L R I + W +
Sbjct: 222 TKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281
Query: 297 LPVGLQKSLPDR 308
+++
Sbjct: 282 QQAMVRRESVVN 293
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-34
Identities = 65/310 (20%), Positives = 103/310 (33%), Gaps = 61/310 (19%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHP 84
++ + GGF V +Q A+K C ++ E EI +MK L HP
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDT-GEQVAIK--QCRQELSPKNRERWCLEIQIMKKLN-HP 72
Query: 85 NVVTLYA--HTILDLGRTKEALLVMECCDK-SLVNVLENRG-AGYFEEKQVLAIFRDVCN 140
NVV+ + L LL ME C+ L L +E + + D+ +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDG---LWKLCDFGSTSTNHKRFEKLEEM-GIEED 196
A+ +H I HRDLK EN++L + K+ D G + + E E G
Sbjct: 133 ALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLG-YAKELDQGELCTEFVG---- 185
Query: 197 NIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLF------------------RICY 238
T Y APE+ ++ VD W+ G L F
Sbjct: 186 ------TLQYLAPEL---LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236
Query: 239 FKNAFDGESKLQILNGNYRIPE--------SPKYSSSVTDLIRDMLQASPDDRPDITQV- 289
+ + + L G + S + + ++ ML R Q
Sbjct: 237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296
Query: 290 ---WFRVNEQ 296
F+ +
Sbjct: 297 NVGCFQALDS 306
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 77/314 (24%), Positives = 128/314 (40%), Gaps = 52/314 (16%)
Query: 33 IAEGGFSCVYSARDAIHMSKQY-AMKHMICNDEESLESAMK-----EISVMKSLKGHPNV 86
+ EG F V A ++Q A+K + + +S M EIS +K L+ HP++
Sbjct: 17 LGEGSFGKVKLATHYK--TQQKVALK--FISRQLLKKSDMHMRVEREISYLKLLR-HPHI 71
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
+ LY D+ T + +V+E L + + + E + F+ + A+
Sbjct: 72 IKLY-----DVITTPTDIVMVIEYAGGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYC 124
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT--- 202
H I HRDLK ENLLL + K+ DFG S L T
Sbjct: 125 HRHK--IVHRDLKPENLLLDDNLNVKIADFG-LSNIMTDGNFL------------KTSCG 169
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES--KL--QILNGNYRI 258
+P Y APE+ + + +VD+W+ G +L+ + + FD E L ++ + Y +
Sbjct: 170 SPNYAAPEV--INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVM 227
Query: 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLPDRPPETQS 314
P+ S LIR M+ A P R I ++ WF VN + + + +
Sbjct: 228 PDF--LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYL---RPMEEVQGSYAD 282
Query: 315 AVANEGMSKPMNRS 328
+ + + M S
Sbjct: 283 SRIVSKLGEAMGFS 296
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 61/285 (21%), Positives = 108/285 (37%), Gaps = 45/285 (15%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPN 85
+ ++ G F V+ + + A K + + E EISVM L H N
Sbjct: 90 TVSKTEILGGGRFGQVHKCEE-TATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD-HAN 147
Query: 86 VVTLYAHTILDLGRTKEAL-LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143
++ LY D +K + LVME D L + + + E + + +C +
Sbjct: 148 LIQLY-----DAFESKNDIVLVMEYVDGGELFDRIIDESYNL-TELDTILFMKQICEGIR 201
Query: 144 AMHSQSPPIAHRDLKAENLLLGS--DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH 201
MH I H DLK EN+L + K+ DFG + +R++ E++ +
Sbjct: 202 HMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFG-LA---RRYKPREKLKV------NF 249
Query: 202 TTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF----KNAFDGESK----LQILN 253
TP + APE + + ++ D+W++G I Y + F G++ IL
Sbjct: 250 GTPEFLAPE---VVNYDFVSFPTDMWSVGV----IAYMLLSGLSPFLGDNDAETLNNILA 302
Query: 254 GNYRIPES--PKYSSSVTDLIRDMLQASPDDRPDITQV----WFR 292
+ + + S + I +L R ++ W
Sbjct: 303 CRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 62/309 (20%), Positives = 118/309 (38%), Gaps = 66/309 (21%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC------NDEESLESAMKEISVMKSLKG 82
+ + G F+ V R+ +YA K + E +E+S+++ +
Sbjct: 16 IGEELGSGQFAIVKKCRE-KSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL- 73
Query: 83 HPNVVTLYAHTILDLGRTKEAL-LVMECC------DKSLVNVLENRGAGYFEEKQVLAIF 135
HPN++TL+ D+ + + L++E D + + E++ +
Sbjct: 74 HPNIITLH-----DVYENRTDVVLILELVSGGELFDF----LAQK---ESLSEEEATSFI 121
Query: 136 RDVCNAVFAMHSQSPPIAHRDLKAENLLLGS----DGLWKLCDFGSTSTNHKRFEKLEEM 191
+ + + V +H++ IAH DLK EN++L KL DFG + + + + +
Sbjct: 122 KQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFG-LAHEIEDGVEFKNI 178
Query: 192 -GIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF----KNAFDGE 246
G TP + APE + E + + D+W++G I Y + F G+
Sbjct: 179 FG----------TPEFVAPE---IVNYEPLGLEADMWSIGV----ITYILLSGASPFLGD 221
Query: 247 SK----LQILNGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQ 296
+K I +Y E + S D IR +L R I + W +
Sbjct: 222 TKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT 281
Query: 297 LPVGLQKSL 305
+++
Sbjct: 282 QQAMVRRES 290
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-33
Identities = 61/288 (21%), Positives = 106/288 (36%), Gaps = 55/288 (19%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVV 87
+ + G F V+ + +A K ++ E E+ KEI M L+ HP +V
Sbjct: 160 DIHEELGTGAFGVVHRVTE-RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLV 217
Query: 88 TLYAHTILDLGRTKEAL-LVMECC------DKSLVNVLENRGAGYFEEKQVLAIFRDVCN 140
L+ D + ++ E +K E+ E + + R VC
Sbjct: 218 NLH-----DAFEDDNEMVMIYEFMSGGELFEK---VADEH---NKMSEDEAVEYMRQVCK 266
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGS--DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNI 198
+ MH + H DLK EN++ + KL DFG T + + + +
Sbjct: 267 GLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLT----AHLDPKQSVKV----- 315
Query: 199 RKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF----KNAFDGESK----LQ 250
T + APE+ + + D+W++G + Y + F GE+
Sbjct: 316 -TTGTAEFAAPEV---AEGKPVGYYTDMWSVGV----LSYILLSGLSPFGGENDDETLRN 367
Query: 251 ILNGNYRIPES--PKYSSSVTDLIRDMLQASPDDRPDITQV----WFR 292
+ + ++ + +S S D IR +L A P+ R I Q W
Sbjct: 368 VKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 74/279 (26%), Positives = 116/279 (41%), Gaps = 56/279 (20%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMI-CNDEESLESAMKEISVMKSLKGHPNVVTLY 90
+ G S VY + K YA+K + D++ + + EI V+ L HPN++ L
Sbjct: 60 ELGRGATSIVYRCKQ-KGTQKPYALKVLKKTVDKKIVRT---EIGVLLRLS-HPNIIKLK 114
Query: 91 AHTILDLGRTKEAL-LVMECC------DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143
++ T + LV+E D+ ++E GY+ E+ + + AV
Sbjct: 115 -----EIFETPTEISLVLELVTGGELFDR----IVEK---GYYSERDAADAVKQILEAVA 162
Query: 144 AMHSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEM-GIEEDNIR 199
+H I HRDLK ENLL + D K+ DFG S + ++ + G
Sbjct: 163 YLHENG--IVHRDLKPENLLYATPAPDAPLKIADFG-LSKIVEHQVLMKTVCG------- 212
Query: 200 KHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI--CYFKNAFDGESKLQ-----IL 252
TP Y APE+ R +VD+W++G + + I C F+ F E Q IL
Sbjct: 213 ---TPGYCAPEI---LRGCAYGPEVDMWSVGIITY-ILLCGFE-PFYDERGDQFMFRRIL 264
Query: 253 NGNYRIPESP--KYSSSVTDLIRDMLQASPDDRPDITQV 289
N Y + S + DL+R ++ P R Q
Sbjct: 265 NCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 65/302 (21%), Positives = 112/302 (37%), Gaps = 30/302 (9%)
Query: 27 IHVRNVIAEGGFSCVYSAR---DAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGH 83
+ V+ +G F M MK +I DEE+ + +KE+ VM+ L+ H
Sbjct: 12 LIHGEVLGKGCFGQAIKVTHRETGEVM----VMKELIRFDEETQRTFLKEVKVMRCLE-H 66
Query: 84 PNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAV 142
PNV+ + K + E +L ++++ + Q ++ +D+ + +
Sbjct: 67 PNVLKFIGVLY----KDKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGM 121
Query: 143 FAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG---STSTNHKRFEKLEEMGIEEDNIR 199
+HS + I HRDL + N L+ + + DFG + E L + + R
Sbjct: 122 AYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 200 KHTTPAYR--APEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI-----L 252
APEM +EKVD+++ G +L I NA + +
Sbjct: 180 YTVVGNPYWMAPEM---INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV 236
Query: 253 NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGLQKSLPDRPPET 312
G P S + P+ RP ++ + E L + L LP P
Sbjct: 237 RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL-ETLRMHLAGHLPLGPQLE 295
Query: 313 QS 314
Q
Sbjct: 296 QL 297
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 63/289 (21%), Positives = 105/289 (36%), Gaps = 57/289 (19%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQY-----AMKHMICNDEESLESAM----KEISV 76
++ + +I GGF VY A + A+K + +E + + +E +
Sbjct: 8 ELTLEEIIGIGGFGKVYRAF--------WIGDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 77 MKSLKGHPNVVTLYAHTILDLGRTKEALL--VMECCDK-SLVNVLENRGAGYFEEKQVLA 133
LK HPN++ L KE L VME L VL + ++
Sbjct: 60 FAMLK-HPNIIALRGVC------LKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVN 109
Query: 134 IFRDVCNAVFAMHSQSP-PIAHRDLKAENLLLGSDGLW--------KLCDFGSTSTNHKR 184
+ + +H ++ PI HRDLK+ N+L+ K+ DFG + R
Sbjct: 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG-LAREWHR 168
Query: 185 FEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFD 244
K+ G A+ APE+ R + ++ D+W+ G LL+ + + F
Sbjct: 169 TTKMSAAG----------AYAWMAPEV---IRASMFSKGSDVWSYGVLLWELLTGEVPFR 215
Query: 245 GESKLQI----LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
G L + +P L+ D P RP T +
Sbjct: 216 GIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNI 264
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-31
Identities = 72/315 (22%), Positives = 124/315 (39%), Gaps = 52/315 (16%)
Query: 33 IAEGGFSCVYSARDAIHMSKQY-AMKHMICNDEESLESAMK-----EISVMKSLKGHPNV 86
+ G F V + + + A+K I N ++ + EI +K + HP++
Sbjct: 24 LGVGTFGKVKVGKHEL--TGHKVAVK--ILNRQKIRSLDVVGKIRREIQNLKLFR-HPHI 78
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCDKS-LVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
+ LY + T + +VME L + + G +EK+ +F+ + + V
Sbjct: 79 IKLY-----QVISTPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDY 131
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT-- 202
H + HRDLK EN+LL + K+ DFG S E L T
Sbjct: 132 CHRHM--VVHRDLKPENVLLDAHMNAKIADFG-LSNMMSDGEFL------------RTSC 176
Query: 203 -TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES----KLQILNGNYR 257
+P Y APE+ + R +VDIW+ G +L+ + FD + +I +G +
Sbjct: 177 GSPNYAAPEV--ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY 234
Query: 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLPDRPPETQ 313
P+ + SV L++ MLQ P R I + WF+ + + +
Sbjct: 235 TPQY--LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDD 292
Query: 314 SAVANEGMSKPMNRS 328
A+ + + S
Sbjct: 293 EALKE--VCEKFECS 305
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 48/283 (16%), Positives = 112/283 (39%), Gaps = 42/283 (14%)
Query: 26 KIHVRNVIAEGGFSCVYSAR---D-AIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK 81
++ + +I +G F VY R + AI + ++ +E+ L++ +E+ + +
Sbjct: 34 QLEIGELIGKGRFGQVYHGRWHGEVAI---RLIDIERD---NEDQLKAFKREVMAYRQTR 87
Query: 82 GHPNVVTLYAHTILDLGRTKEALL--VMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDV 138
H NVV L + C +L +V+ + + + I +++
Sbjct: 88 -HENVVLFMGAC------MSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEI 139
Query: 139 CNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNI 198
+ +H++ I H+DLK++N+ + + + DFG + + G ED +
Sbjct: 140 VKGMGYLHAK--GILHKDLKSKNVFYDNGKV-VITDFG-LF----SISGVLQAGRREDKL 191
Query: 199 RKHT-TPAYRAPEMWDLFRRELI------NEKVDIWALGCLLFRICYFKNAFDGESKLQI 251
R + APE+ + ++ D++ALG + + + + F + I
Sbjct: 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI 251
Query: 252 LNG---NYRIPESPKYS--SSVTDLIRDMLQASPDDRPDITQV 289
+ + P + ++D++ ++RP T++
Sbjct: 252 IWQMGTGMK-PNLSQIGMGKEISDILLFCWAFEQEERPTFTKL 293
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 62/269 (23%), Positives = 108/269 (40%), Gaps = 34/269 (12%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTL 89
I G F VY D + + A + + + +E ++K L+ HPN+V
Sbjct: 33 EIGRGSFKTVYKGLDTET-TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRF 90
Query: 90 YAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQ 148
Y + K +LV E +L L+ + K + + R + + +H++
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTR 148
Query: 149 SPPIAHRDLKAENLLL-GSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYR 207
+PPI HRDLK +N+ + G G K+ D G + F K +G TP +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIG----------TPEFM 197
Query: 208 APEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRI------PES 261
APEM++ E +E VD++A G + + + + + YR P S
Sbjct: 198 APEMYE----EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---YRRVTSGVKPAS 250
Query: 262 P--KYSSSVTDLIRDMLQASPDDRPDITQ 288
V ++I ++ + D+R I
Sbjct: 251 FDKVAIPEVKEIIEGCIRQNKDERYSIKD 279
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 73/269 (27%), Positives = 116/269 (43%), Gaps = 49/269 (18%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAH 92
I +G VY+A D + ++ A++ M + E + EI VM+ K +PN+V
Sbjct: 28 IGQGASGTVYTAMD-VATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDS 85
Query: 93 TILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPP 151
++ E +VME SL +V+ +E Q+ A+ R+ A+ +HS
Sbjct: 86 YLVG----DELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 152 IAHRDLKAENLLLGSDGLWKLCDFGS----TSTNHKRFEKLEEMGIEEDNIRKHT---TP 204
+ HRD+K++N+LLG DG KL DFG T KR T TP
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR----------------STMVGTP 180
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESP-- 262
+ APE + R+ KVDIW+LG + + + + E+ L+ L Y I +
Sbjct: 181 YWMAPE---VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL---YLIATNGTP 234
Query: 263 ------KYSSSVTDLIRDMLQASPDDRPD 285
K S+ D + L+ + R
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGS 263
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-31
Identities = 60/278 (21%), Positives = 117/278 (42%), Gaps = 37/278 (13%)
Query: 26 KIHVRNVIAEGGFSCVYSAR---D-AIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK 81
+I V I G F VY + D A+ K + + L++ E+ V++ +
Sbjct: 25 QITVGQRIGSGSFGTVYKGKWHGDVAV---KMLNVTAP---TPQQLQAFKNEVGVLRKTR 78
Query: 82 GHPNVVTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVC 139
H N++ ++ T L +V + C+ SL + L FE K+++ I R
Sbjct: 79 -HVNILLFMGYS------TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTA 130
Query: 140 NAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIR 199
+ +H++ I HRDLK+ N+ L D K+ DFG +T R+ +
Sbjct: 131 RGMDYLHAK--SIIHRDLKSNNIFLHEDNTVKIGDFG-LATEKSRWSGSHQFEQLSG--- 184
Query: 200 KHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDG-ESKLQILNG---N 255
+ + APE+ + + + D++A G +L+ + + + ++ QI+
Sbjct: 185 ---SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG 241
Query: 256 YRIPESPKYSSS----VTDLIRDMLQASPDDRPDITQV 289
P+ K S+ + L+ + L+ D+RP ++
Sbjct: 242 SLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRI 279
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 67/276 (24%), Positives = 114/276 (41%), Gaps = 46/276 (16%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLY 90
+ +G F VY A++ A K + EE LE + EI ++ + HP +V L
Sbjct: 25 GELGDGAFGKVYKAKN-KETGALAAAKVIETKSEEELEDYIVEIEILATCD-HPYIVKLL 82
Query: 91 AHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS 149
D + +++E C ++ ++ E Q+ + R + A+ +HS+
Sbjct: 83 GAYYHD----GKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 150 PPIAHRDLKAENLLLGSDGLWKLCDFGS----TSTNHKRFEKLEEMGIEEDNIRKHT--- 202
I HRDLKA N+L+ +G +L DFG T KR +
Sbjct: 138 --IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR----------------DSFIG 179
Query: 203 TPAYRAPE--MWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPE 260
TP + APE M + + + K DIW+LG L + + + +++L +I +
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL---LKIAK 236
Query: 261 SP--------KYSSSVTDLIRDMLQASPDDRPDITQ 288
S K+S D ++ L +P+ RP Q
Sbjct: 237 SDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQ 272
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 66/279 (23%), Positives = 110/279 (39%), Gaps = 48/279 (17%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYA 91
++ G + VY R + + A+K M + E +EI+++K H N+ T Y
Sbjct: 31 LVGNGTYGQVYKGRH-VKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 92 HTILDLGRTKEALL--VMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQ 148
I + L VME C S+ ++++N +E+ + I R++ + +H
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148
Query: 149 SPPIAHRDLKAENLLLGSDGLWKLCDFGS----TSTNHKRFEKLEEMGIEEDNIRKHT-- 202
+ HRD+K +N+LL + KL DFG T +R +T
Sbjct: 149 K--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR----------------NTFI 190
Query: 203 -TPAYRAPE--MWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGE---SKLQILNGNY 256
TP + APE D + K D+W+LG I + A +G + + +
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLG-----ITAIEMA-EGAPPLCDMHPMRALF 244
Query: 257 RIPESP-------KYSSSVTDLIRDMLQASPDDRPDITQ 288
IP +P K+S I L + RP Q
Sbjct: 245 LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQ 283
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 69/269 (25%), Positives = 119/269 (44%), Gaps = 49/269 (18%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAH 92
I EG V AR+ H +Q A+K M ++ E E+ +M+ + H NVV +Y
Sbjct: 53 IGEGSTGIVCLARE-KHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HFNVVEMYKS 110
Query: 93 TILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPP 151
++ +E ++ME +L +++ E+Q+ + V A+ +H+Q
Sbjct: 111 YLVG----EELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQG-- 161
Query: 152 IAHRDLKAENLLLGSDGLWKLCDFGS----TSTNHKRFEKLEEMGIEEDNIRKHT---TP 204
+ HRD+K++++LL DG KL DFG + KR + TP
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR----------------KSLVGTP 205
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESP-- 262
+ APE + R L +VDIW+LG ++ + + + +S +Q + R+ +SP
Sbjct: 206 YWMAPE---VISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KRLRDSPPP 259
Query: 263 ------KYSSSVTDLIRDMLQASPDDRPD 285
K S + D + ML P +R
Sbjct: 260 KLKNSHKVSPVLRDFLERMLVRDPQERAT 288
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 56/300 (18%), Positives = 108/300 (36%), Gaps = 53/300 (17%)
Query: 27 IHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNV 86
I + + +G + V+ + A+K DE+S E+ L+ H N+
Sbjct: 10 ITLLECVGKGRYGEVWRGS---WQGENVAVKIFSSRDEKS-WFRETELYNTVMLR-HENI 64
Query: 87 VTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
+ A + + + L+ + SL + L+ + L I + + + +
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHL 121
Query: 146 HSQS------PPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIR 199
H + P IAHRDLK++N+L+ +G + D G + + ++
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG--------LAVMHSQSTNQLDVG 173
Query: 200 KHT---TPAYRAPEMWD---LFRRELINEKVDIWALGCLLFRIC----------YFKNAF 243
+ T Y APE+ D ++VDIWA G +L+ + +K F
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233
Query: 244 DGESKLQ---------ILNGNYR--IPE---SPKYSSSVTDLIRDMLQASPDDRPDITQV 289
+ R IP S +S+ L+++ +P R ++
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 72/271 (26%), Positives = 110/271 (40%), Gaps = 41/271 (15%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHM---ICNDEESLESAMKEISVMKSLKGHPNVV 87
I G F VY ARD + S+ A+K M E + +KE+ ++ L+ HPN +
Sbjct: 60 REIGHGSFGAVYFARD-VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTI 117
Query: 88 TLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
+ + A LVME C S ++LE +E ++ A+ + +HS
Sbjct: 118 QYRGCYLRE----HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS 172
Query: 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---TP 204
+ + HRD+KA N+LL GL KL DFGS S ++ TP
Sbjct: 173 HN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----------------NSFVGTP 214
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIP----- 259
+ APE+ + KVD+W+LG + K + + L Y I
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIAQNESP 271
Query: 260 --ESPKYSSSVTDLIRDMLQASPDDRPDITQ 288
+S +S + + LQ P DRP
Sbjct: 272 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV 302
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 76/323 (23%), Positives = 130/323 (40%), Gaps = 72/323 (22%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLES-AMKEISVMKSLKGHPNVVT 88
++ EG + V R+ + A+K +D++ ++ AM+EI ++K L+ H N+V
Sbjct: 31 GLVGEGSYGMVMKCRN-KDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR-HENLVN 88
Query: 89 LYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
L L++ + K+ LV E D ++++ LE G + + V + N + HS
Sbjct: 89 L-----LEVCKKKKRWYLVFEFVDHTILDDLELFPNG-LDYQVVQKYLFQIINGIGFCHS 142
Query: 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL-EEMGIEEDNIRKHT---- 202
+ I HRD+K EN+L+ G+ KLCDFG + +
Sbjct: 143 HN--IIHRDIKPENILVSQSGVVKLCDFG-----------FARTLAAP---GEVYDDEVA 186
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL-------QIL--- 252
T YRAPE+ L + VD+WA+GCL+ + + F G+S + L
Sbjct: 187 TRWYRAPEL--LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNL 244
Query: 253 ----------NGNYRIPESPKY-------------SSSVTDLIRDMLQASPDDRPDITQV 289
N + P+ S V DL + L PD RP ++
Sbjct: 245 IPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL 304
Query: 290 ----WFRVNEQLPVGLQKSLPDR 308
+F+ + + L +
Sbjct: 305 LHHDFFQ-MDGFAERFSQELQLK 326
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 70/274 (25%), Positives = 113/274 (41%), Gaps = 49/274 (17%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLY 90
+ EG + VY A + A+K + E L+ +KEIS+M+ P+VV Y
Sbjct: 35 EKLGEGSYGSVYKAIH-KETGQIVAIKQV--PVESDLQEIIKEISIMQQCD-SPHVVKYY 90
Query: 91 AHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS 149
+ + +VME C S+ +++ R E ++ I + + +H
Sbjct: 91 GSYFKN----TDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 150 PPIAHRDLKAENLLLGSDGLWKLCDFGS----TSTNHKRFEKLEEMGIEEDNIRKHT--- 202
HRD+KA N+LL ++G KL DFG T T KR +T
Sbjct: 146 --KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR----------------NTVIG 187
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESP 262
TP + APE + + N DIW+LG + K + ++ + + IP +P
Sbjct: 188 TPFWMAPE---VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI---FMIPTNP 241
Query: 263 --------KYSSSVTDLIRDMLQASPDDRPDITQ 288
+S + TD ++ L SP+ R TQ
Sbjct: 242 PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQ 275
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 52/301 (17%), Positives = 105/301 (34%), Gaps = 53/301 (17%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPN 85
+I + I +G + V+ + ++ A+K +E S EI ++ H N
Sbjct: 38 QIQMVKQIGKGRYGEVWMGK---WRGEKVAVKVFFTTEEAS-WFRETEIYQTVLMR-HEN 92
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
++ A I G + L+ + + SL + L++ + K +L + + +
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCH 149
Query: 145 MHSQS------PPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNI 198
+H++ P IAHRDLK++N+L+ +G + D G E +I
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG--------LAVKFISDTNEVDI 201
Query: 199 RKHT---TPAYRAPEMWD---LFRRELINEKVDIWALGCLLFRIC----------YFKNA 242
+T T Y PE+ D D+++ G +L+ + ++
Sbjct: 202 PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261
Query: 243 FDGESKLQ---------ILNGNYR--IPESPKYSS---SVTDLIRDMLQASPDDRPDITQ 288
+ + R P + L+ + +P R +
Sbjct: 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
Query: 289 V 289
V
Sbjct: 322 V 322
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 71/300 (23%), Positives = 117/300 (39%), Gaps = 69/300 (23%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQY-AMKHMICNDEESLE--SAMKEISVMKSLKGHPNVV 87
I EG + V+ R+ + Q A+K + ++++ + A++EI ++K LK HPN+V
Sbjct: 9 GKIGEGSYGVVFKCRN--RDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-HPNLV 65
Query: 88 TLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH 146
L L++ R K L LV E CD ++++ L+ G E V +I AV H
Sbjct: 66 NL-----LEVFRRKRRLHLVFEYCDHTVLHELDRYQRG-VPEHLVKSITWQTLQAVNFCH 119
Query: 147 SQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL-EEMGIEEDNIRKHT--- 202
+ HRD+K EN+L+ + KLCDFG + +
Sbjct: 120 KHN--CIHRDVKPENILITKHSVIKLCDFG-----------FARLLTGP---SDYYDDEV 163
Query: 203 -TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL-------QIL-- 252
T YR+PE+ L VD+WA+GC+ + + G+S + + L
Sbjct: 164 ATRWYRSPEL--LVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGD 221
Query: 253 -----------NGNYRIPESPKYSSSVT-------------DLIRDMLQASPDDRPDITQ 288
N + + P L++ L P +R Q
Sbjct: 222 LIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQ 281
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 67/268 (25%), Positives = 111/268 (41%), Gaps = 48/268 (17%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLESAMKEISVMKSLKGHPNVVTLY 90
I +G F V+ D K A+K + + E+ +E +EI+V+ P V Y
Sbjct: 29 KIGKGSFGEVFKGID-NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYY 86
Query: 91 AHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS 149
+ D + ++ME S +++LE +E Q+ I R++ + +HS+
Sbjct: 87 GSYLKD----TKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEK 139
Query: 150 PPIAHRDLKAENLLLGSDGLWKLCDFGS----TSTNHKRFEKLEEMGIEEDNIRKHT--- 202
HRD+KA N+LL G KL DFG T T KR +T
Sbjct: 140 --KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR----------------NTFVG 181
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESP 262
TP + APE + ++ + K DIW+LG + + +++L + IP++
Sbjct: 182 TPFWMAPE---VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---FLIPKNN 235
Query: 263 ------KYSSSVTDLIRDMLQASPDDRP 284
YS + + + L P RP
Sbjct: 236 PPTLEGNYSKPLKEFVEACLNKEPSFRP 263
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 68/284 (23%), Positives = 114/284 (40%), Gaps = 56/284 (19%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLESAMKEISVMKSLKGHPNVVTLY 90
VI G + V +A ++ A+K + + + S++ +KEI M HPN+V+ Y
Sbjct: 22 VIGSGATAVVQAAYC-APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH-HPNIVSYY 79
Query: 91 AHTILDLGRTKEAL-LVMECCDK-SLVNVLE------NRGAGYFEEKQVLAIFRDVCNAV 142
++ + L LVM+ S++++++ +G +E + I R+V +
Sbjct: 80 TSFVVK-----DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 143 FAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT 202
+H HRD+KA N+LLG DG ++ DFG ++ L G N + T
Sbjct: 135 EYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSA-------FLATGGDITRNKVRKT 185
Query: 203 ---TPAYRAPEMWDLFRRELINEKVDIWALGCL-------------------LFRICYFK 240
TP + APE+ + + + K DIW+ G L
Sbjct: 186 FVGTPCWMAPEV--MEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT---- 239
Query: 241 NAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
+ L+ G KY S +I LQ P+ RP
Sbjct: 240 -LQNDPPSLE--TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 63/312 (20%), Positives = 108/312 (34%), Gaps = 52/312 (16%)
Query: 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMK 78
S+D+ NLK+ +I G + VY + A+K + ++ + K I +
Sbjct: 9 SLDLDNLKLL--ELIGRGRYGAVYKGS---LDERPVAVKVFSFANRQNFINE-KNIYRVP 62
Query: 79 SLKGHPNVVTLYAH-TILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFR 136
++ H N+ + E LLVME SL L + +
Sbjct: 63 LME-HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAH 118
Query: 137 DVCNAVFAMHSQS-------PPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLE 189
V + +H++ P I+HRDL + N+L+ +DG + DFG S +
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG-LSMRLTGNRLVR 177
Query: 190 EMGIEEDNIRKHTTPAYRAPEM----WDLFRRELINEKVDIWALGCLL---FRICYFKNA 242
+ I + T Y APE+ +L E ++VD++ALG + F C
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 243 FDGESKLQI-------------------LNGNYR--IPES----PKYSSSVTDLIRDMLQ 277
+ + Q+ R PE+ S+ + I D
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297
Query: 278 ASPDDRPDITQV 289
+ R
Sbjct: 298 QDAEARLTAQXA 309
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 79/346 (22%), Positives = 129/346 (37%), Gaps = 74/346 (21%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLES-AMKEISVMKSLKGHPNVVTL 89
+ + EG ++ VY + A+K + EE A++E+S++K LK H N+VTL
Sbjct: 8 DKLGEGTYATVYKGKS-KLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTL 65
Query: 90 YAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQ 148
D+ T+++L LV E DK L L++ G V + + H Q
Sbjct: 66 -----HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNI-INMHNVKLFLFQLLRGLAYCHRQ 119
Query: 149 SPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL-EEMGIEEDNIRKHT----T 203
+ HRDLK +NLL+ G KL DFG L I + + T
Sbjct: 120 K--VLHRDLKPQNLLINERGELKLADFG-----------LARAKSIP---TKTYDNEVVT 163
Query: 204 PAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN------G--- 254
YR P++ L + ++D+W +GC+ + + + F G + + L+ G
Sbjct: 164 LWYRPPDI--LLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT 221
Query: 255 -----------NYRIPESPKY------------SSSVTDLIRDMLQASPDDRPDITQV-- 289
++ PKY S DL+ +LQ +R
Sbjct: 222 EETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281
Query: 290 --WFRVNEQLPVGLQKSLPDRPPETQSAVANEGMSKPMNRSPPMPQ 333
+F L + K LPD + + + RS
Sbjct: 282 HPFFL---SLGERIHK-LPD-TTSIFALKEIQLQKEASLRSAHHHH 322
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 73/328 (22%), Positives = 117/328 (35%), Gaps = 76/328 (23%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLES-AMKEISVMKSLKG--HPNV 86
I EG + V+ ARD + + A+K + + EE + ++E++V++ L+ HPNV
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 87 VTLY--AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
V L+ TK LV E D+ L L+ + + + + +
Sbjct: 77 VRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL-EEMGIEEDNIRKHT- 202
+HS + HRDLK +N+L+ S G KL DFG L + T
Sbjct: 136 LHSHR--VVHRDLKPQNILVTSSGQIKLADFG-----------LARIYSFQ----MALTS 178
Query: 203 ---TPAYRAPEMWDLFRRELINEK----VDIWALGCLLFRICYFKNAFDGESKLQILN-- 253
T YRAPE+ L+ VD+W++GC+ + K F G S + L
Sbjct: 179 VVVTLWYRAPEV-------LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 231
Query: 254 -------------GNYRIPES--------------PKYSSSVTDLIRDMLQASPDDRPDI 286
+ +P DL+ L +P R
Sbjct: 232 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 291
Query: 287 TQV----WFRVNEQLPVGLQKSLPDRPP 310
+F+ L + PP
Sbjct: 292 YSALSHPYFQ---DLERCKENLDSHLPP 316
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 40/310 (12%), Positives = 93/310 (30%), Gaps = 50/310 (16%)
Query: 4 FKPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARD----AIHMSKQYAMKHM 59
+ K P +G+ ++V +++ EG F+ VY A +++ +K
Sbjct: 44 TFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ 103
Query: 60 ICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK----SLV 115
+ + + +K + Y+ + ++LV E + +
Sbjct: 104 KPANPWEFYIGTQLMERLKPSM-QHMFMKFYSAHLFQ----NGSVLVGELYSYGTLLNAI 158
Query: 116 NVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLW----- 170
N+ +N + V++ + + +H I H D+K +N +LG+ L
Sbjct: 159 NLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDED 216
Query: 171 ------KLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---TPAYRAPEMWDLFRRELIN 221
L D G + +M + T ++ EM + N
Sbjct: 217 DLSAGLALIDLGQSI----------DMKLFPKGTIFTAKCETSGFQCVEML---SNKPWN 263
Query: 222 EKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESPKY---SSSVTDLIRDMLQA 278
++D + + ++ + + G + + + ML
Sbjct: 264 YQIDYFGVAATVYCMLFGTYMKVKNE-----GGECKPEGLFRRLPHLDMWNEFFHVMLNI 318
Query: 279 SPDDRPDITQ 288
Sbjct: 319 PDCHHLPSLD 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 53/301 (17%), Positives = 106/301 (35%), Gaps = 53/301 (17%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPN 85
I ++ I +G F V+ + ++ A+K +E S EI L+ H N
Sbjct: 43 TIVLQESIGKGRFGEVWRGK---WRGEEVAVKIFSSREERSWFRE-AEIYQTVMLR-HEN 97
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
++ A D G + LV + + SL + L + ++ + + +
Sbjct: 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAH 154
Query: 145 MHSQS------PPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNI 198
+H + P IAHRDLK++N+L+ +G + D G + + +I
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG--------LAVRHDSATDTIDI 206
Query: 199 RKHT---TPAYRAPEMWD---LFRRELINEKVDIWALGCLL----------FRICYFKNA 242
+ T Y APE+ D + ++ DI+A+G + ++
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266
Query: 243 FDGESKLQ---------ILNGNYR--IPESPK---YSSSVTDLIRDMLQASPDDRPDITQ 288
+ + R IP + + ++R+ A+ R +
Sbjct: 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 326
Query: 289 V 289
+
Sbjct: 327 I 327
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 57/313 (18%), Positives = 111/313 (35%), Gaps = 55/313 (17%)
Query: 14 GLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKE 73
G E L++ V A G F CV+ A+ +++ A+K D++S + E
Sbjct: 15 GTENLYFQSMPLQLL--EVKARGRFGCVWKAQ---LLNEYVAVKIFPIQDKQSWQ-NEYE 68
Query: 74 ISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVL 132
+ + +K H N++ + L+ +K SL + L+ ++
Sbjct: 69 VYSLPGMK-HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELC 124
Query: 133 AIFRDVCNAVFAMHSQS--------PPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKR 184
I + + +H P I+HRD+K++N+LL ++ + DFG
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG-------- 176
Query: 185 FEKLEEMGIEEDNIRKHT-TPAYRAPEMWD--LFRRELINEKVDIWALGCLLFRICYFKN 241
E G + T Y APE+ + + + ++D++A+G +L+ +
Sbjct: 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236
Query: 242 AFDGESKLQILNGNYRIPESPKYS-------------------------SSVTDLIRDML 276
A DG +L I + P + + + I +
Sbjct: 237 AADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296
Query: 277 QASPDDRPDITQV 289
+ R V
Sbjct: 297 DHDAEARLSAGCV 309
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 73/324 (22%), Positives = 115/324 (35%), Gaps = 87/324 (26%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLE----SAMKEISVMKSLKG--H 83
I G + VY ARD H A+K + + N S ++E+++++ L+ H
Sbjct: 15 AEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEH 73
Query: 84 PNVVTLY--AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNA 141
PNVV L T K LV E D+ L L+ + + + R
Sbjct: 74 PNVVRLMDVCATSRTDREIK-VTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH 201
+ +H+ I HRDLK EN+L+ S G KL DFG + R +
Sbjct: 133 LDFLHANC--IVHRDLKPENILVTSGGTVKLADFG--------------LA------RIY 170
Query: 202 TTPA----------YRAPEMWDLFRRELINEK----VDIWALGCLLFRICYFKNAFDGES 247
+ YRAPE+ L+ VD+W++GC+ + K F G S
Sbjct: 171 SYQMALTPVVVTLWYRAPEV-------LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 223
Query: 248 KLQILN---------------GNYRIPES--------------PKYSSSVTDLIRDMLQA 278
+ L + +P P+ S L+ +ML
Sbjct: 224 EADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTF 283
Query: 279 SPDDRPDITQV----WFRVNEQLP 298
+P R + + +E P
Sbjct: 284 NPHKRISAFRALQHSYLHKDEGNP 307
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 80/295 (27%), Positives = 124/295 (42%), Gaps = 70/295 (23%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLE----SAMKEISVMKSLKGHPNV 86
I EG + VY A++ + +A+K + E+ E + ++EIS++K LK H N+
Sbjct: 8 EKIGEGTYGVVYKAQNNYG--ETFALKKIRLEKED--EGIPSTTIREISILKELK-HSNI 62
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
V LY D+ TK+ L LV E D+ L +L+ G E + + N +
Sbjct: 63 VKLY-----DVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYC 116
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL-EEMGIEEDNIRKHT-- 202
H + + HRDLK +NLL+ +G K+ DFG L GI +RK+T
Sbjct: 117 HDRR--VLHRDLKPQNLLINREGELKIADFG-----------LARAFGIP---VRKYTHE 160
Query: 203 --TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRI-- 258
T YRAP++ L + + +DIW++GC+ + F G S+ L +RI
Sbjct: 161 IVTLWYRAPDV--LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218
Query: 259 -----------------PESPKY------------SSSVTDLIRDMLQASPDDRP 284
P Y S DL+ ML+ P+ R
Sbjct: 219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI 273
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-27
Identities = 64/349 (18%), Positives = 118/349 (33%), Gaps = 58/349 (16%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMI-CNDEESLESAMKEISVMKSLKGHPNVV 87
V+ IA GG +Y A D + +K ++ D E+ AM E + + HP++V
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV-HPSIV 142
Query: 88 TLYAHTILDLGRTKEAL------LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCN 140
++ + + +VME +SL + + +A ++
Sbjct: 143 QIF-----NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILP 193
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS----TSTNHKRFEKLEEMGIEED 196
A+ +HS + + DLK EN++L + L KL D G+ S + G
Sbjct: 194 ALSYLHSI--GLVYNDLKPENIMLTEEQL-KLIDLGAVSRINSFGYL-------YG---- 239
Query: 197 NIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY 256
TP ++APE+ R DI+ +G L + +G ++G
Sbjct: 240 ------TPGFQAPEI----VRTGPTVATDIYTVGRTLAALTLDLPTRNGRY----VDGLP 285
Query: 257 RIPESPKYSSSVTDLIRDMLQASPDDRP--------DITQVWFRVNEQLPVGLQKSLPDR 308
K S L+R + P R +T V V Q + L
Sbjct: 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTI 345
Query: 309 PPETQSAVANEGMSKPMNRSPPMPQRSPPPPPSSVDPTRNISQPSTTPA 357
++S + + + + + + ++ T
Sbjct: 346 FSPSRSTFGVDLLVAHTDVYLDGQVHAEKLTANEIVTALSVPLVDPTDV 394
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 71/273 (26%), Positives = 114/273 (41%), Gaps = 56/273 (20%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHPNV 86
++ EG FS V AR+ + S++YA+K H+I ++ + +E VM L HP
Sbjct: 37 ILGEGSFSTVVLARE-LATSREYAIKILEKRHIIKENK--VPYVTRERDVMSRLD-HPFF 92
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIF--RDVCNAV 142
V LY + E L + L+ + R G F+E F ++ +A+
Sbjct: 93 VKLYFTF-----QDDEKLYFGLSYAKNGELLKYI--RKIGSFDETC--TRFYTAEIVSAL 143
Query: 143 FAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT 202
+H + I HRDLK EN+LL D ++ DFG K + E R ++
Sbjct: 144 EYLHGKG--IIHRDLKPENILLNEDMHIQITDFG--------TAK--VLSPESKQARANS 191
Query: 203 ---TPAYRAPEMWDLFRRELINEK-----VDIWALGCLLFRICYFKNAFDGESKLQ---- 250
T Y +P EL+ EK D+WALGC+++++ F ++
Sbjct: 192 FVGTAQYVSP--------ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK 243
Query: 251 ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
I+ Y P K+ DL+ +L R
Sbjct: 244 IIKLEYDFP--EKFFPKARDLVEKLLVLDATKR 274
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 85/359 (23%), Positives = 139/359 (38%), Gaps = 83/359 (23%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLE----SAMKEISVMKSLKGHPN 85
+ + EG F+ VY ARD + ++ A+K + + + E+ + +A++EI +++ L HPN
Sbjct: 16 DFLGEGQFATVYKARD-KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPN 73
Query: 86 VVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
++ L D K + LV + + L ++++ + A +
Sbjct: 74 IIGLL-----DAFGHKSNISLVFDFMETDLEVIIKDNSLV-LTPSHIKAYMLMTLQGLEY 127
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL-EEMGIEEDNIRKHT- 202
+H I HRDLK NLLL +G+ KL DFG L + G R +T
Sbjct: 128 LHQHW--ILHRDLKPNNLLLDENGVLKLADFG-----------LAKSFGSP---NRAYTH 171
Query: 203 ---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRI- 258
T YRAPE+ LF + VD+WA+GC+L + G+S L L +
Sbjct: 172 QVVTRWYRAPEL--LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 229
Query: 259 --------------PES---------------PKYSSSVTDLIRDMLQASPDDRPDITQV 289
P+ + DLI+ + +P R TQ
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 289
Query: 290 ----WFRVN------EQLPVGLQKSLPDRPPETQSAVANEGMSKPMNRSPPMPQRSPPP 338
+F QLP P+ P ET +N ++ R+ + Q P
Sbjct: 290 LKMKYFSNRPGPTPGCQLP------RPNCPVETLKEQSNPALAIKRKRTEALEQGGLPK 342
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 74/313 (23%), Positives = 110/313 (35%), Gaps = 76/313 (24%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLES-AMKEISVMKSLKGHPNVVTL 89
+ G ++ VY + A+K + + EE S A++EIS+MK LK H N+V L
Sbjct: 11 EKLGNGTYATVYKGLN-KTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK-HENIVRL 68
Query: 90 YAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGA----GYFEEKQVLAIFRDVCNAVFA 144
D+ T+ L LV E D L +++R E V + +
Sbjct: 69 -----YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT-- 202
H I HRDLK +NLL+ G KL DFG R GI + +
Sbjct: 124 CHENK--ILHRDLKPQNLLINKRGQLKLGDFGLA-----RA-----FGIP---VNTFSSE 168
Query: 203 --TPAYRAPEMWDLFRRELINEKVDIWALGCLL----------------------FRIC- 237
T YRAP++ L + +DIW+ GC+L F I
Sbjct: 169 VVTLWYRAPDV--LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMG 226
Query: 238 --------------YFKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
+ + L + ++ D + +LQ +PD R
Sbjct: 227 TPNESLWPSVTKLPKYNPNIQQRPP-RDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMR 285
Query: 284 PDITQV----WFR 292
Q WF
Sbjct: 286 LSAKQALHHPWFA 298
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 61/228 (26%), Positives = 106/228 (46%), Gaps = 39/228 (17%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLE----SAMKEISVMKSLKGHPNV 86
I EG + V+ A++ + A+K + +D++ E SA++EI ++K LK H N+
Sbjct: 8 EKIGEGTYGTVFKAKN-RETHEIVALKRVRLDDDD--EGVPSSALREICLLKELK-HKNI 63
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
V L D+ + + L LV E CD+ L ++ + + V + + +
Sbjct: 64 VRL-----HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFC 117
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL-EEMGIEEDNIRKHT-- 202
HS++ + HRDLK +NLL+ +G KL +FG L GI +R ++
Sbjct: 118 HSRN--VLHRDLKPQNLLINRNGELKLANFG-----------LARAFGIP---VRCYSAE 161
Query: 203 --TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNA-FDGES 247
T YR P++ LF +L + +D+W+ GC+ + F G
Sbjct: 162 VVTLWYRPPDV--LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 79/296 (26%), Positives = 124/296 (41%), Gaps = 71/296 (23%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLE----SAMKEISVMKSLKGHPNV 86
+ EG + VY A+D+ + A+K + + E+ E +A++EIS++K L HPN+
Sbjct: 27 EKVGEGTYGVVYKAKDS--QGRIVALKRIRLDAED--EGIPSTAIREISLLKELH-HPNI 81
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
V+L +D+ ++ L LV E +K L VL+ G ++ Q+ + V
Sbjct: 82 VSL-----IDVIHSERCLTLVFEFMEKDLKKVLDENKTG-LQDSQIKIYLYQLLRGVAHC 135
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL-EEMGIEEDNIRKHT-- 202
H I HRDLK +NLL+ SDG KL DFG L GI +R +T
Sbjct: 136 HQHR--ILHRDLKPQNLLINSDGALKLADFG-----------LARAFGIP---VRSYTHE 179
Query: 203 --TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN------G 254
T YRAP++ L + + VDIW++GC+ + K F G + L G
Sbjct: 180 VVTLWYRAPDV--LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILG 237
Query: 255 --------------NYRIPESPKY------------SSSVTDLIRDMLQASPDDRP 284
++ + DL+ +ML P+ R
Sbjct: 238 TPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI 293
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 58/270 (21%), Positives = 103/270 (38%), Gaps = 45/270 (16%)
Query: 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESA-MKEISVMKSLKGHPNVVT 88
+ + G F V+ +D Q A+K + LE ++E+ L P +V
Sbjct: 63 QPRVGRGSFGEVHRMKDK-QTGFQCAVKKV------RLEVFRVEELVACAGLS-SPRIVP 114
Query: 89 LYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH 146
LY R + + ME + SL +++ G E + L + +H
Sbjct: 115 LYGAV-----REGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLH 167
Query: 147 SQSPPIAHRDLKAENLLLGSDGLW-KLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT--- 202
++ I H D+KA+N+LL SDG LCDFG L+ G+ + +
Sbjct: 168 TRR--ILHGDVKADNVLLSSDGSRAALCDFGHAL-------CLQPDGLGKSLLTGDYIPG 218
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESP 262
T + APE+ + + KVDIW+ C++ + + + + + +I P
Sbjct: 219 TETHMAPEV---VMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---LKIASEP 272
Query: 263 K--------YSSSVTDLIRDMLQASPDDRP 284
+ I++ L+ P R
Sbjct: 273 PPIREIPPSCAPLTAQAIQEGLRKEPVHRA 302
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 62/327 (18%), Positives = 112/327 (34%), Gaps = 49/327 (14%)
Query: 15 LEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKE 73
+ G+ + + G V+ R A+K M + ++E + + +
Sbjct: 15 IGGQRYQAEINDLENLGEMGSGTCGQVWKMRF-RKTGHVIAVKQMRRSGNKEENKRILMD 73
Query: 74 ISVMKSLKGHPNVVTLYAHTILDLGRTKEALL--VMECCDKSLVNVLENRGAGYFEEKQV 131
+ V+ P +V + I + ME + + G E+ +
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFI------TNTDVFIAMELMGTCAEKLKKRMQ-GPIPERIL 126
Query: 132 LAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEE 190
+ + A++ + + I HRD+K N+LL G KLCDFG S
Sbjct: 127 GKMTVAIVKALYYLKEKHGVI-HRDVKPSNILLDERGQIKLCDFGIS------------- 172
Query: 191 MGIEEDNIRKHT---TPAYRAPE--MWDLFRRELINEKVDIWALGCLL-------FRICY 238
G D+ K AY APE + + + D+W+LG L F
Sbjct: 173 -GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231
Query: 239 FKNAFDGESKLQILNGNY-RIPESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRV 293
K F E ++L +P +S ++D L RP ++ + +
Sbjct: 232 CKTDF--EVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289
Query: 294 NEQLPVGLQ---KSLPDRPPETQSAVA 317
E L V + K + + +S +
Sbjct: 290 YETLEVDVASWFKDVMAKTESPRSGPS 316
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 61/277 (22%), Positives = 115/277 (41%), Gaps = 52/277 (18%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHM---ICNDEESLESAMKEISVMKSLKGHPN 85
+ + + GG S VY A D I ++ + A+K + EE+L+ +E+ L H N
Sbjct: 15 IVDKLGGGGMSTVYLAEDTI-LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQN 72
Query: 86 VVTLYAHTILDLGRTKE-ALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143
+V++ D+ + LVME + +L +E+ G + + + +
Sbjct: 73 IVSMI-----DVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIK 125
Query: 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG---------STSTNHKRFEKLEEMGIE 194
H I HRD+K +N+L+ S+ K+ DFG T TNH +G
Sbjct: 126 HAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHV-------LG-- 174
Query: 195 EDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI--- 251
T Y +PE + E +E DI+++G +L+ + + F+GE+ + I
Sbjct: 175 --------TVQYFSPE---QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK 223
Query: 252 -LNGNYRIPES---PKYSSSVTDLIRDMLQASPDDRP 284
+ + + S++++I + +R
Sbjct: 224 HIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRY 260
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 60/302 (19%), Positives = 111/302 (36%), Gaps = 37/302 (12%)
Query: 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVM 77
S++V + + G + V R + + A+K + + + + + ++ +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRH-VPSGQIMAVKRIRATVNSQEQKRLLMDLDIS 59
Query: 78 KSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLEN--RGAGYFEEKQVLAIF 135
P VT Y R + + ME D SL + E + I
Sbjct: 60 MRTVDCPFTVTFYGALF----REGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIA 115
Query: 136 RDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGIE 194
+ A+ +HS+ I HRD+K N+L+ + G K+CDFG S G
Sbjct: 116 VSIVKALEHLHSKLSVI-HRDVKPSNVLINALGQVKMCDFGIS--------------GYL 160
Query: 195 EDNIRKHT---TPAYRAPEMWDLFRRELI-NEKVDIWALG-----CLLFRICYFKNAFDG 245
D++ K Y APE + + + K DIW+LG + R Y
Sbjct: 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF 220
Query: 246 ESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGL 301
+ Q++ + K+S+ D L+ + +RP ++ +F ++E +
Sbjct: 221 QQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDV 280
Query: 302 QK 303
Sbjct: 281 AS 282
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 71/330 (21%), Positives = 122/330 (36%), Gaps = 70/330 (21%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMIC-NDEESLES-AMKEISVMKSLKGHPNVVT 88
I +G F V+ AR ++ A+K ++ N++E A++EI +++ LK H NVV
Sbjct: 23 AKIGQGTFGEVFKARH-RKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVN 80
Query: 89 LY---AHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
L R K ++ LV + C+ L +L N F ++ + + + N ++
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYY 139
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL-EEMGIEEDNIRKHTT 203
+H I HRD+KA N+L+ DG+ KL DFG L + +++ T
Sbjct: 140 IHRNK--ILHRDMKAANVLITRDGVLKLADFG-----------LARAFSLAKNSQPNRYT 186
Query: 204 PA-----YRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN----- 253
YR PE+ L +D+W GC++ + G ++ L
Sbjct: 187 NRVVTLWYRPPEL--LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244
Query: 254 ------------------GNYRIPESPK-----------YSSSVTDLIRDMLQASPDDRP 284
+ + K DLI +L P R
Sbjct: 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304
Query: 285 DITQV----WFRVNEQLPVGLQKSLPDRPP 310
D +F ++ +P L K +
Sbjct: 305 DSDDALNHDFFW-SDPMPSDL-KGMLSTHL 332
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 65/336 (19%), Positives = 126/336 (37%), Gaps = 67/336 (19%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHM---ICNDEESLESAMKEISVMKSLKGHPN 85
+ ++ GG S V+ ARD + A+K + + D +E +L HP
Sbjct: 16 LGEILGFGGMSEVHLARDLR-DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPA 73
Query: 86 VVTLYAHTILDLGRTKEAL-----LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVC 139
+V +Y D G + +VME D +L +++ G K+ + + D C
Sbjct: 74 IVAVY-----DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADAC 126
Query: 140 NAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-----------STSTNHKRFEKL 188
A+ H I HRD+K N+++ + K+ DFG T T
Sbjct: 127 QALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV----- 179
Query: 189 EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK 248
+G T Y +PE R + ++ + D+++LGC+L+ + + F G+S
Sbjct: 180 --IG----------TAQYLSPE---QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
Query: 249 LQI----LNGNYRIPES--PKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGLQ 302
+ + + + P + S+ + ++ L +P++R ++ L
Sbjct: 225 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTA-------AEMRADLV 277
Query: 303 KSLPDRPPETQSAVANEGMSKPMNRSPPMPQRSPPP 338
+ PPE + + + + P
Sbjct: 278 RVHNGEPPEAPKVLTDAERTSLL---SSAAGNLSGP 310
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 73/399 (18%), Positives = 128/399 (32%), Gaps = 104/399 (26%)
Query: 33 IAEGGFSCVYSARDA-IHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYA 91
+ G + VY A+ K YA+K + SA +EI++++ LK HPNV++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTGISMSACREIALLRELK-HPNVISL-- 83
Query: 92 HTILDLGRTKEAL-LVMECCDKSLVNVLE-------NRGAGYFEEKQVLAIFRDVCNAVF 143
+ L + L+ + + L ++++ N+ V ++ + + +
Sbjct: 84 QKVF-LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 144 AMHSQSPPIAHRDLKAENLLLGSD----GLWKLCDFG---STSTNHKRFEKLEEMGIEED 196
+H+ + HRDLK N+L+ + G K+ D G ++ K
Sbjct: 143 YLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL----------- 189
Query: 197 NIRKHTTPA-----YRAPEMWDLFRRELINEKVDIWALGCLL------------------ 233
P YRAPE+ L + +DIWA+GC+
Sbjct: 190 ---ADLDPVVVTFWYRAPEL--LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 244
Query: 234 -------------FRIC------------------YFKNAFDGESKLQILNGNYRIPESP 262
F + F + Y
Sbjct: 245 TSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 304
Query: 263 KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLP-----VGLQKSLPDRPPETQ 313
K S L++ +L P R Q +F + LP G Q P R T+
Sbjct: 305 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL-EDPLPTSDVFAGCQIPYPKREFLTE 363
Query: 314 SAVANEGMSKPMNRSPPMPQRSPPPPPSSVDPTRNISQP 352
++G K + + P + D + P
Sbjct: 364 EEPDDKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGPP 402
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 62/308 (20%), Positives = 106/308 (34%), Gaps = 44/308 (14%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLESAMKEISVMKSLKGHPNVVTLY 90
I G + V + A+K + DE+ + + ++ V+ P +V Y
Sbjct: 29 EIGRGAYGSVNKMVH-KPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 91 AHTILDLGRTKEALLVMECCDKSLVNVL---ENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
+ G + + ME S + E+ + I A+ +
Sbjct: 88 -GALFREG---DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFG-S---TSTNHKRFEKLEEMGIEEDNIRKHTT 203
I HRD+K N+LL G KLCDFG S + K + G
Sbjct: 144 NLK-IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR----DAG----------C 188
Query: 204 PAYRAPEMWDLFRRELI-NEKVDIWALG-----CLLFRICYFKNAFDGESKLQILNGN-- 255
Y APE D + + D+W+LG R Y K + Q++ G+
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP 248
Query: 256 -YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQ---KSLPD 307
E ++S S + + L RP ++ + + E+ V + + D
Sbjct: 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILD 308
Query: 308 RPPETQSA 315
+ P T S+
Sbjct: 309 QMPATPSS 316
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 43/213 (20%), Positives = 78/213 (36%), Gaps = 30/213 (14%)
Query: 31 NVIAEG--GFSCVYSARDAIHMSKQYAMKHM---ICNDEESLESAMKEISVMKSLKGHPN 85
VI +G V AR + ++ + C++E + E+ V K HPN
Sbjct: 31 TVIGKGFEDLMTVNLARY-KPTGEYVTVRRINLEACSNEM-VTFLQGELHVSKLFN-HPN 87
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
+V A I D E +V S +++ E + I + V A+
Sbjct: 88 IVPYRATFIAD----NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS----TSTNHKRFEKLEEMGIEEDNIRK 200
+H HR +KA ++L+ DG L S S ++ + +
Sbjct: 144 IHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ------RVVHDFPKYS 195
Query: 201 HTTPAYRAPEMWDLFRRELI--NEKVDIWALGC 231
+ +PE + ++ L + K DI+++G
Sbjct: 196 VKVLPWLSPE---VLQQNLQGYDAKSDIYSVGI 225
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 75/313 (23%), Positives = 123/313 (39%), Gaps = 73/313 (23%)
Query: 16 EGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEIS 75
+G++ + + VI G F V+ A+ S + A+K ++ + +E+
Sbjct: 31 DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVE--SDEVAIKKVLQDKRFKN----RELQ 84
Query: 76 VMKSLKGHPNVVTLYA--HTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLA 133
+M+ +K HPNVV L A ++ D LV+E +++ + Y + KQ +
Sbjct: 85 IMRIVK-HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRH----YAKLKQTMP 139
Query: 134 ----------IFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD-GLWKLCDFGSTSTNH 182
+ R ++ +HS I HRD+K +NLLL G+ KL DFGS
Sbjct: 140 MLLIKLYMYQLLR----SLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSA---- 189
Query: 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNA 242
K E + R YRAPE+ +F +DIW+ GC++ + +
Sbjct: 190 KILIAGEPN-VSYICSRY-----YRAPEL--IFGATNYTTNIDIWSTGCVMAELMQGQPL 241
Query: 243 FDGESKLQIL------------------NGNYRIPESPKY-------------SSSVTDL 271
F GES + L N NY + P+ DL
Sbjct: 242 FPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDL 301
Query: 272 IRDMLQASPDDRP 284
I +L+ +P R
Sbjct: 302 ISRLLEYTPSARL 314
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 65/297 (21%), Positives = 107/297 (36%), Gaps = 56/297 (18%)
Query: 8 MQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHM---ICNDE 64
M EG +R ++ GG VY A D + A+K M + +D
Sbjct: 21 MDGTAESREGTQFG----PYRLRRLVGRGGMGDVYEAED-TVRERIVALKLMSETLSSDP 75
Query: 65 ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL-LVMECCD-KSLVNVLENRG 122
+E L+ P+VV ++ D G L + M + L +L +G
Sbjct: 76 VFRTRMQREARTAGRLQ-EPHVVPIH-----DFGEIDGQLYVDMRLINGVDLAAMLRRQG 129
Query: 123 AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG------ 176
+ +AI R + +A+ A H+ HRD+K EN+L+ +D L DFG
Sbjct: 130 P--LAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATT 185
Query: 177 ---STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLL 233
T + +G T Y APE F + DI+AL C+L
Sbjct: 186 DEKLTQLGNT-------VG----------TLYYMAPE---RFSESHATYRADIYALTCVL 225
Query: 234 FRICYFKNAFDGESKLQILNGNYRIP------ESPKYSSSVTDLIRDMLQASPDDRP 284
+ + G+ L ++ + P + +I + +P+DR
Sbjct: 226 YECLTGSPPYQGDQ-LSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRY 281
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 68/299 (22%), Positives = 114/299 (38%), Gaps = 72/299 (24%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLES-AMKEISVMKSLKGHPNVVT 88
+ EG + VY A D ++ A+K + + ++EE + A++E+S++K L+ H N++
Sbjct: 40 TKLGEGTYGEVYKAID-TVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ-HRNIIE 97
Query: 89 LYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
L + L L+ E + L ++ + + + + N V HS
Sbjct: 98 L-----KSVIHHNHRLHLIFEYAENDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHS 150
Query: 148 QSPPIAHRDLKAENLLL-----GSDGLWKLCDFGSTSTNHKRFEKL-EEMGIEEDNIRKH 201
+ HRDLK +NLLL + K+ DFG L GI IR+
Sbjct: 151 RR--CLHRDLKPQNLLLSVSDASETPVLKIGDFG-----------LARAFGIP---IRQF 194
Query: 202 T----TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYR 257
T T YR PE+ L + VDIW++ C+ + F G+S++ L +
Sbjct: 195 THEIITLWYRPPEI--LLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFE 252
Query: 258 I-------------------PESPKY-------------SSSVTDLIRDMLQASPDDRP 284
+ PK+ DL+ ML+ P R
Sbjct: 253 VLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI 311
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 66/283 (23%), Positives = 108/283 (38%), Gaps = 66/283 (23%)
Query: 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTL 89
R V+ +G + VY+ RD + A+K + D + +EI++ K LK H N+V
Sbjct: 27 RVVLGKGTYGIVYAGRDL-SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK-HKNIVQY 84
Query: 90 YAHTILDLGRTKEAL-LVMECCDK-SLVNVLENR-GAGYFEEKQVLAIFRDVCNAVFAMH 146
+ + ME SL +L ++ G E+ + + + + +H
Sbjct: 85 LGSF-----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 147 SQSPPIAHRDLKAENLLLGS-DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT--- 202
I HRD+K +N+L+ + G+ K+ DFG++ KR + N T
Sbjct: 140 DNQ--IVHRDIKGDNVLINTYSGVLKISDFGTS----KR--------LAGINPCTETFTG 185
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCL--------------------LFRICYFKNA 242
T Y APE+ D R + DIW+LGC +F++ FK
Sbjct: 186 TLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH 244
Query: 243 FDGESKLQILNGNYRIPESPK-YSSSVTDLIRDMLQASPDDRP 284
PE P+ S+ I + PD R
Sbjct: 245 ----------------PEIPESMSAEAKAFILKCFEPDPDKRA 271
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 69/273 (25%), Positives = 106/273 (38%), Gaps = 61/273 (22%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHPNV 86
+ G F V + YAMK ++ + +E + E +++++ P +
Sbjct: 48 TLGTGSFGRVMLVKH-KESGNHYAMKILDKQKVVKLKQ--IEHTLNEKRILQAVN-FPFL 103
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCD-KSLVNVLENRGAGYFEEKQVLAIF--RDVCNAV 142
V L + L +VME + + L R G F E A F +
Sbjct: 104 VKLEFSF-----KDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPH--ARFYAAQIVLTF 154
Query: 143 FAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT 202
+HS + +RDLK ENLL+ G ++ DFG F K R T
Sbjct: 155 EYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFG--------FAK-------RVKGRTWT 197
Query: 203 ---TPAYRAPEMWDLFRRELINEK-----VDIWALGCLLFRICYFKNAFDGESKLQ---- 250
TP APE+ I K VD WALG L++ + F + +Q
Sbjct: 198 LCGTPEALAPEI--------ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 251 ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
I++G R P +SS + DL+R++LQ R
Sbjct: 250 IVSGKVRFP--SHFSSDLKDLLRNLLQVDLTKR 280
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 70/309 (22%), Positives = 114/309 (36%), Gaps = 68/309 (22%)
Query: 3 RFKPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMK----- 57
F F+Q + LE + + V+ GGF V++ + K YA K
Sbjct: 167 YFLRFLQWKW--LEAQPMGEDWFLDF--RVLGRGGFGEVFACQMK-ATGKLYACKKLNKK 221
Query: 58 HMICNDEESLESAMKEISVMKSLKGHPNVVTL-YAHTILDLGRTKEAL-LVMECCDKSLV 115
+ + AM E ++ + +V+L YA TK L LVM ++
Sbjct: 222 RLKKRKGY--QGAMVEKKILAKVH-SRFIVSLAYAF------ETKTDLCLVMT-----IM 267
Query: 116 N--------VLENRGAGYFEEKQVLAIF--RDVCNAVFAMHSQSPPIAHRDLKAENLLLG 165
N + F+E + AIF + + + +H ++ I +RDLK EN+LL
Sbjct: 268 NGGDIRYHIYNVDEDNPGFQEPR--AIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD 323
Query: 166 SDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT---TPAYRAPEMWDLFRRELINE 222
DG ++ D G L + TP + APE+ E +
Sbjct: 324 DDGNVRISDLG-----------LAVELKAGQT-KTKGYAGTPGFMAPEL---LLGEEYDF 368
Query: 223 KVDIWALGCLLFRICYFKNAFDGESKLQ--------ILNGNYRIPESPKYSSSVTDLIRD 274
VD +ALG L+ + + F + +L P K+S + D
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--DKFSPASKDFCEA 426
Query: 275 MLQASPDDR 283
+LQ P+ R
Sbjct: 427 LLQKDPEKR 435
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 6e-21
Identities = 85/392 (21%), Positives = 141/392 (35%), Gaps = 94/392 (23%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYA 91
VI G F VY A+ + A+K ++ + +E+ +M+ L H N+V L
Sbjct: 61 VIGNGSFGVVYQAKL-CDSGELVAIKKVLQDKRFKN----RELQIMRKLD-HCNIVRLR- 113
Query: 92 HTILDLGRTKEAL---LVMECCDKSLVNVLENRGAGYFEEKQVLA----------IFRDV 138
+ G K+ + LV++ +++ V + Y KQ L +FR
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTLPVIYVKLYMYQLFR-- 167
Query: 139 CNAVFAMHSQSPPIAHRDLKAENLLLGSD-GLWKLCDFGSTSTNHKRFEKLEEMGIEEDN 197
++ +HS I HRD+K +NLLL D + KLCDFGS K+ + E +
Sbjct: 168 --SLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSA----KQLVRGEPN-VSYIC 218
Query: 198 IRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL----- 252
R YRAPE+ +F +D+W+ GC+L + + F G+S + L
Sbjct: 219 SRY-----YRAPEL--IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271
Query: 253 -------------NGNYRIPESPKY-------------SSSVTDLIRDMLQASPDDRPDI 286
N NY + P+ L +L+ +P R
Sbjct: 272 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 331
Query: 287 TQV--------WFRVNEQLPVGLQKSLPDRPP----ETQSAVANEGMSK---PMNRSPPM 331
+ N +LP G D P TQ +N ++ P +
Sbjct: 332 LEACAHSFFDELRDPNVKLPNG-----RDTPALFNFTTQELSSNPPLATILIPPHARIQA 386
Query: 332 PQRSPPPPPSSVDPTRNISQPSTTPAVSGGGG 363
+P ++ D + A +
Sbjct: 387 AASTPTNATAASDANTGDRGQTNNAASASASN 418
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 7e-21
Identities = 54/292 (18%), Positives = 97/292 (33%), Gaps = 49/292 (16%)
Query: 16 EGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLESAMKEI 74
+ + ++ + + + G V+ A K + + ++E+
Sbjct: 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSH-KPSGLVMARKLIHLEIKPAIRNQIIREL 82
Query: 75 SVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLA 133
V+ P +V Y G E + ME D SL VL + AG E+ +
Sbjct: 83 QVLHECN-SPYIVGFY-GAFYSDG---EISICMEHMDGGSLDQVL--KKAGRIPEQILGK 135
Query: 134 IFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGI 193
+ V + + + I HRD+K N+L+ S G KLCDFG + G
Sbjct: 136 VSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS-------------GQ 181
Query: 194 EEDNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLL----------------- 233
D++ + T +Y +PE + + + DIW++G L
Sbjct: 182 LIDSMAN-SFVGTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237
Query: 234 -FRICYFKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
+ + D R S I ++L ++ P
Sbjct: 238 LELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP 289
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 7e-21
Identities = 69/293 (23%), Positives = 113/293 (38%), Gaps = 71/293 (24%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHPNV 86
++ +G F V R+ + YAMK +I DE + + E V+++ + HP +
Sbjct: 12 LLGKGTFGKVILVRE-KATGRYYAMKILRKEVIIAKDE--VAHTVTESRVLQNTR-HPFL 67
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRG--------AGYFEEKQVLAIF-- 135
L +T + L VME N G F E++ A F
Sbjct: 68 TALKYAF-----QTHDRLCFVMEYA---------NGGELFFHLSRERVFTEER--ARFYG 111
Query: 136 RDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEE 195
++ +A+ +HS+ + +RD+K ENL+L DG K+ DFG L + GI +
Sbjct: 112 AEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFG-----------LCKEGISD 158
Query: 196 DNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ-- 250
T TP Y APE+ VD W LG +++ + + F + +
Sbjct: 159 GA-TMKTFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214
Query: 251 --ILNGNYRIPESPKYSSSVTDLIRDMLQ--------ASPDDRPDI-TQVWFR 292
IL R P S L+ +L+ P D ++ +F
Sbjct: 215 ELILMEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 8e-21
Identities = 60/270 (22%), Positives = 102/270 (37%), Gaps = 47/270 (17%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHPNV 86
+I GGF VY R A K YAMK + E+L + + + S P +
Sbjct: 196 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 87 VTL-YAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143
V + YA T + L +++ + L L G F E + ++ +
Sbjct: 255 VCMSYAF------HTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLE 306
Query: 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT- 202
MH++ + +RDLK N+LL G ++ D G + + + H
Sbjct: 307 HMHNRF--VVYRDLKPANILLDEHGHVRISDLG--------------LACDFSKKKPHAS 350
Query: 203 --TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL-------QILN 253
T Y APE+ L + + D ++LGC+LF++ + F L
Sbjct: 351 VGTHGYMAPEV--LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 408
Query: 254 GNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
+P +S + L+ +LQ + R
Sbjct: 409 MAVELP--DSFSPELRSLLEGLLQRDVNRR 436
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 69/303 (22%), Positives = 119/303 (39%), Gaps = 75/303 (24%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK--GHPNVVTL 89
+ +G F V ++ A+K +I + +E+ +M+ L HPN+V L
Sbjct: 30 MAGQGTFGTVQLGKE-KSTGMSVAIKKVI----QDPRFRNRELQIMQDLAVLHHPNIVQL 84
Query: 90 YAHTILDLGRTKEAL---LVMECCDKSLVNVLENRGAGYFEEKQVLA----------IFR 136
++ R + + +VME +L N Y+ + + R
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRN----YYRRQVAPPPILIKVFLFQLIR 140
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLL-GSDGLWKLCDFGSTSTNHKRFEKLEEMGIEE 195
++ +H S + HRD+K N+L+ +DG KLCDFGS K+ E +
Sbjct: 141 ----SIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA----KKLSPSEPN-VAY 191
Query: 196 DNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES-------- 247
I + YRAPE+ +F + VDIW++GC+ + + F G++
Sbjct: 192 --I---CSRYYRAPEL--IFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244
Query: 248 ----------KLQILNGNY---------RIPESPKYSSSVT-------DLIRDMLQASPD 281
L+ LN ++ IP S +S DL+ +LQ P+
Sbjct: 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPE 304
Query: 282 DRP 284
+R
Sbjct: 305 ERM 307
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-20
Identities = 67/287 (23%), Positives = 114/287 (39%), Gaps = 62/287 (21%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHPNV 86
++ +G F V+ A ++ +A+K ++ +D+ +E M E V+ HP +
Sbjct: 24 MLGKGSFGKVFLAEF-KKTNQFFAIKALKKDVVLMDDD--VECTMVEKRVLSLAWEHPFL 80
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRG--------AGYFEEKQVLAIFRD 137
++ +TKE L VME N G F+ + +
Sbjct: 81 THMFCTF-----QTKENLFFVMEYL---------NGGDLMYHIQSCHKFDLSRATFYAAE 126
Query: 138 VCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDN 197
+ + +HS+ I +RDLK +N+LL DG K+ DFG + + + D
Sbjct: 127 IILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFG-----------MCKENMLGDA 173
Query: 198 IRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ---- 250
+ +T TP Y APE + + N VD W+ G LL+ + ++ F G+ + +
Sbjct: 174 -KTNTFCGTPDYIAPE---ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS 229
Query: 251 ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR----PDI-TQVWFR 292
I N P DL+ + P+ R DI FR
Sbjct: 230 IRMDNPFYP--RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 69/303 (22%), Positives = 117/303 (38%), Gaps = 59/303 (19%)
Query: 3 RFKPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMK----- 57
F F+Q + LE + + + + V+ +GGF V + + K YA K
Sbjct: 166 YFNRFLQWKW--LERQPVTKNTFRQY--RVLGKGGFGEVCACQVR-ATGKMYACKKLEKK 220
Query: 58 HMICNDEESLESAMKEISVMKSLKGHPNVVTL-YAHTILDLGRTKEAL-LVMECCDK-SL 114
+ E A+ E +++ + VV+L YA+ TK+AL LV+ + L
Sbjct: 221 RIKKRKGE--AMALNEKQILEKVN-SRFVVSLAYAY------ETKDALCLVLTLMNGGDL 271
Query: 115 VNVLENRGAGYFEEKQVLAIF--RDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKL 172
+ + G F E + A+F ++C + +H + I +RDLK EN+LL G ++
Sbjct: 272 KFHIYHMGQAGFPEAR--AVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRI 327
Query: 173 CDFGSTSTNHKRFEKLEEMGIE-EDNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWA 228
D G + + + T Y APE+ + E D WA
Sbjct: 328 SDLG--------------LAVHVPEGQTIKGRVGTVGYMAPEV---VKNERYTFSPDWWA 370
Query: 229 LGCLLFRICYFKNAFDGESKLQ--------ILNGNYRIPESPKYSSSVTDLIRDMLQASP 280
LGCLL+ + ++ F K + ++S L +L P
Sbjct: 371 LGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQARSLCSQLLCKDP 428
Query: 281 DDR 283
+R
Sbjct: 429 AER 431
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 59/274 (21%), Positives = 99/274 (36%), Gaps = 47/274 (17%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHPNV 86
VI G FS V + + YAMK M+ E + +E V+ + +
Sbjct: 68 VIGRGAFSEVAVVKM-KQTGQVYAMKIMNKWDMLKRGE--VSCFREERDVLVNGD-RRWI 123
Query: 87 VTL-YAHTILDLGRTKEAL-LVME-CCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143
L +A + + L LVME L+ +L G + ++ A+
Sbjct: 124 TQLHFAF------QDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAID 176
Query: 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT- 202
++H HRD+K +N+LL G +L DFGS + + +R
Sbjct: 177 SVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSC----LK-------LRADGTVRSLVA 223
Query: 203 --TPAYRAPE----MWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----IL 252
TP Y +PE + + D WALG + + Y + F +S + I+
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283
Query: 253 NGNYRIP---ESPKYSSSVTDLIRDMLQASPDDR 283
+ + D I+ +L P+ R
Sbjct: 284 HYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETR 316
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 3e-20
Identities = 64/273 (23%), Positives = 113/273 (41%), Gaps = 61/273 (22%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHPNV 86
+ G F V+ R H + YAMK ++ + +E E ++ + HP +
Sbjct: 13 TLGTGSFGRVHLIRS-RHNGRYYAMKVLKKEIVVRLKQ--VEHTNDERLMLSIVT-HPFI 68
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCD-KSLVNVLENRGAGYFEEKQVLAIF--RDVCNAV 142
+ ++ + + + ++M+ + L ++L R + F A F +VC A+
Sbjct: 69 IRMWGTF-----QDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPV--AKFYAAEVCLAL 119
Query: 143 FAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT 202
+HS+ I +RDLK EN+LL +G K+ DFG F K +T
Sbjct: 120 EYLHSKD--IIYRDLKPENILLDKNGHIKITDFG--------FAK-------YVPDVTYT 162
Query: 203 ---TPAYRAPEMWDLFRRELINEK-----VDIWALGCLLFRICYFKNAFDGESKLQ---- 250
TP Y AP E+++ K +D W+ G L++ + F + ++
Sbjct: 163 LCGTPDYIAP--------EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK 214
Query: 251 ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
ILN R P P ++ V DL+ ++ R
Sbjct: 215 ILNAELRFP--PFFNEDVKDLLSRLITRDLSQR 245
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 73/278 (26%), Positives = 116/278 (41%), Gaps = 64/278 (23%)
Query: 32 VIAEGGFSCVYSARDAI--HMSKQYAMK----HMICNDEESLESAMKEISVMKSLKGHPN 85
V+ +GG+ V+ R + K +AMK MI + + E ++++ +K HP
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPF 82
Query: 86 VVTL-YAHTILDLGRTKEAL-LVMECCDKSLVNVLENRG--------AGYFEEKQV---L 132
+V L YA +T L L++E + G G F E L
Sbjct: 83 IVDLIYAF------QTGGKLYLILEYL---------SGGELFMQLEREGIFMEDTACFYL 127
Query: 133 AIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMG 192
A ++ A+ +H + I +RDLK EN++L G KL DFG L +
Sbjct: 128 A---EISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFG-----------LCKES 171
Query: 193 IEEDNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL 249
I + HT T Y APE+ R N VD W+LG L++ + F GE++
Sbjct: 172 IHDGT-VTHTFCGTIEYMAPEI---LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK 227
Query: 250 Q----ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
+ IL +P P + DL++ +L+ + R
Sbjct: 228 KTIDKILKCKLNLP--PYLTQEARDLLKKLLKRNAASR 263
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 48/242 (19%), Positives = 93/242 (38%), Gaps = 46/242 (19%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQY-AMKHMICNDEESLESAMKEISVMKSLK----- 81
+ + G FS V+ A+D ++ + AMK ++ D+ E+A EI +++ +
Sbjct: 22 ILVRKLGWGHFSTVWLAKD--MVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 82 -----GHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFR 136
G +++ L H ++V E ++L+ +++ V I +
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLL------GSDGLWKLCDFGSTSTNHKRFEKLEE 190
+ + MH + I H D+K EN+L+ + K+ D G+ + +
Sbjct: 139 QLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS-- 195
Query: 191 MGIEEDNIRKHTTPAYRAPE-----MWDLFRRELINEKVDIWALGCLLFRICYFKNAFDG 245
I+ T YR+PE W DIW+ CL+F + F+
Sbjct: 196 --IQ--------TREYRSPEVLLGAPWG--------CGADIWSTACLIFELITGDFLFEP 237
Query: 246 ES 247
+
Sbjct: 238 DE 239
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 5e-20
Identities = 74/271 (27%), Positives = 105/271 (38%), Gaps = 52/271 (19%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKG 82
V VI G F V R K YAMK MI + +E +M
Sbjct: 72 EVVKVIGRGAFGEVQLVRH-KSTRKVYAMKLLSKFEMIKRSD--SAFFWEERDIMAFAN- 127
Query: 83 HPNVVTL-YAHTILDLGRTKEAL-LVME-CCDKSLVNVLENRGAGYFEEKQVLAIF--RD 137
P VV L YA + L +VME LVN++ N EK A F +
Sbjct: 128 SPWVVQLFYAF------QDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKW--ARFYTAE 176
Query: 138 VCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDN 197
V A+ A+HS HRD+K +N+LL G KL DFG+ + +E
Sbjct: 177 VVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTC----MK-------MNKEGM 223
Query: 198 IRKHT---TPAYRAPEMWDLFRRELI---NEKVDIWALGCLLFRICYFKNAFDGESKLQ- 250
+R T TP Y +PE+ L + + D W++G L+ + F +S +
Sbjct: 224 VRCDTAVGTPDYISPEV--LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 281
Query: 251 ---ILNG--NYRIPESPKYSSSVTDLIRDML 276
I+N + P+ S +LI L
Sbjct: 282 YSKIMNHKNSLTFPDDNDISKEAKNLICAFL 312
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 6e-20
Identities = 64/290 (22%), Positives = 114/290 (39%), Gaps = 56/290 (19%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHPNV 86
VI G F V + + K +AMK M+ E +E V+ + +
Sbjct: 81 VIGRGAFGEVAVVKL-KNADKVFAMKILNKWEMLKRAE--TACFREERDVLVNGD-SKWI 136
Query: 87 VTL-YAHTILDLGRTKEAL-LVME-CCDKSLVNVLENRGAGYFEEKQV---LAIFRDVCN 140
TL YA + L LVM+ L+ +L + E+ LA ++
Sbjct: 137 TTLHYAF------QDDNNLYLVMDYYVGGDLLTLLS-KFEDRLPEEMARFYLA---EMVI 186
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRK 200
A+ ++H HRD+K +N+L+ +G +L DFGS + +E+ ++
Sbjct: 187 AIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSC----LK-------LMEDGTVQS 233
Query: 201 HT---TPAYRAPEM--WDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----I 251
TP Y +PE+ + + D W+LG ++ + Y + F ES ++ I
Sbjct: 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293
Query: 252 LNGNYRIP---ESPKYSSSVTDLIRDMLQASP-----DDRPDITQ-VWFR 292
+N R + S + DLIR ++ + + D + +F
Sbjct: 294 MNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS 343
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 67/275 (24%), Positives = 113/275 (41%), Gaps = 50/275 (18%)
Query: 32 VIAEGGFSCVYSARDAI--HMSKQYAM----KHMICNDEESLESAMKEISVMKSLKGHPN 85
V+ G + V+ R K YAM K I ++ E E V++ ++ P
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 86 VVTL-YAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQV---LAIFRDVC 139
+VTL YA +T+ L L+++ + L L R F E +V + ++
Sbjct: 121 LVTLHYAF------QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVG---EIV 169
Query: 140 NAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIR 199
A+ +H I +RD+K EN+LL S+G L DFG L + + ++ R
Sbjct: 170 LALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFG-----------LSKEFVADETER 216
Query: 200 KHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ------ 250
+ T Y AP++ ++ VD W+LG L++ + + F + +
Sbjct: 217 AYDFCGTIEYMAPDIV-RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 275
Query: 251 --ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
IL P + S+ DLI+ +L P R
Sbjct: 276 RRILKSEPPYP--QEMSALAKDLIQRLLMKDPKKR 308
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 72/283 (25%), Positives = 112/283 (39%), Gaps = 68/283 (24%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK----HMICNDEESLESAMKEISVMKSLKGHPNVV 87
VI G ++ V R + YAMK ++ +DE+ ++ E V + HP +V
Sbjct: 16 VIGRGSYAKVLLVRL-KKTDRIYAMKVVKKELVNDDED-IDWVQTEKHVFEQASNHPFLV 73
Query: 88 TLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRG--------AGYFEEKQVLAIF--R 136
L++ +T+ L V+E N G E+ A F
Sbjct: 74 GLHSCF-----QTESRLFFVIEYV---------NGGDLMFHMQRQRKLPEEH--ARFYSA 117
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEED 196
++ A+ +H + I +RDLK +N+LL S+G KL D+G + + G+
Sbjct: 118 EISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYG-----------MCKEGLRPG 164
Query: 197 NIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLL---------FRICYFKNAFD 244
+ T TP Y APE+ R E VD WALG L+ F I + D
Sbjct: 165 D-TTSTFCGTPNYIAPEI---LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220
Query: 245 GESKLQ----ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
++ IL RIP S S +++ L P +R
Sbjct: 221 QNTEDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKER 261
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 62/287 (21%), Positives = 112/287 (39%), Gaps = 58/287 (20%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHM---ICNDEESLESAMKEISVMKSLKGHPNVVT 88
I +G F V + K YAMK+M C + + + KE+ +M+ L+ HP +V
Sbjct: 22 AIGKGSFGKVCIVQK-NDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVN 79
Query: 89 L-YAHTILDLGRTKEAL-LVMECC---DKSLVNVLENRGAGYFEEKQV---LAIFRDVCN 140
L Y+ + +E + +V++ D L L+ F+E+ V + ++
Sbjct: 80 LWYSF------QDEEDMFMVVDLLLGGD--LRYHLQQNVH--FKEETVKLFIC---ELVM 126
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRK 200
A+ + +Q I HRD+K +N+LL G + DF + +
Sbjct: 127 ALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFN--------IAA--ML---PRETQI 171
Query: 201 HT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK-------LQ 250
T T Y APEM+ + + VD W+LG + + + + S
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT 231
Query: 251 ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR----PDITQV-WFR 292
P +S + L++ +L+ +PD R D+ +
Sbjct: 232 FETTVVTYP--SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 68/291 (23%), Positives = 116/291 (39%), Gaps = 66/291 (22%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHPNV 86
V+ +G F V + + YA+K +I +D+ +E M E V+ P +
Sbjct: 27 VLGKGSFGKVMLSER-KGTDELYAVKILKKDVVIQDDD--VECTMVEKRVLALPGKPPFL 83
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRG--------AGYFEEKQVLAIFRD 137
L++ +T + L VME N G G F+E + +
Sbjct: 84 TQLHSCF-----QTMDRLYFVMEYV---------NGGDLMYHIQQVGRFKEPHAVFYAAE 129
Query: 138 VCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDN 197
+ +F + S+ I +RDLK +N++L S+G K+ DFG + + I +
Sbjct: 130 IAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFG-----------MCKENIWDGV 176
Query: 198 IRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ---- 250
T TP Y APE + + + VD WA G LL+ + + F+GE + +
Sbjct: 177 -TTKTFCGTPDYIAPE---IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 232
Query: 251 ILNGNYRIPESPKYSSSVTDLIRDMLQ--------ASPDDRPDI-TQVWFR 292
I+ N P+S S + + ++ P+ DI +FR
Sbjct: 233 IMEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 67/273 (24%), Positives = 110/273 (40%), Gaps = 57/273 (20%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHPNV 86
V+ +G F V AR YA+K ++ +D+ +E M E ++ + HP +
Sbjct: 30 VLGKGSFGKVMLARV-KETGDLYAVKVLKKDVILQDDD--VECTMTEKRILSLARNHPFL 86
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRG--------AGYFEEKQVLAIFRD 137
L+ +T + L VME N G + F+E + +
Sbjct: 87 TQLFC-----CFQTPDRLFFVMEFV---------NGGDLMFHIQKSRRFDEARARFYAAE 132
Query: 138 VCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDN 197
+ +A+ +H + I +RDLK +N+LL +G KL DFG + + GI
Sbjct: 133 IISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFG-----------MCKEGICNGV 179
Query: 198 IRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ---- 250
T TP Y APE + + L VD WA+G LL+ + F+ E++
Sbjct: 180 -TTATFCGTPDYIAPE---ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA 235
Query: 251 ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
ILN P T +++ + +P R
Sbjct: 236 ILNDEVVYPTW--LHEDATGILKSFMTKNPTMR 266
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 6e-19
Identities = 68/291 (23%), Positives = 116/291 (39%), Gaps = 66/291 (22%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHPNV 86
V+ +G F V + + YA+K +I +D+ +E M E V+ P +
Sbjct: 348 VLGKGSFGKVMLSERK-GTDELYAVKILKKDVVIQDDD--VECTMVEKRVLALPGKPPFL 404
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRG--------AGYFEEKQVLAIFRD 137
L++ +T + L VME N G G F+E + +
Sbjct: 405 TQLHSCF-----QTMDRLYFVMEYV---------NGGDLMYHIQQVGRFKEPHAVFYAAE 450
Query: 138 VCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDN 197
+ +F + S+ I +RDLK +N++L S+G K+ DFG + + I +
Sbjct: 451 IAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFG-----------MCKENIWDGV 497
Query: 198 IRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ---- 250
T TP Y APE + + + VD WA G LL+ + + F+GE + +
Sbjct: 498 -TTKTFCGTPDYIAPE---IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 553
Query: 251 ILNGNYRIPESPKYSSSVTDLIRDMLQ--------ASPDDRPDI-TQVWFR 292
I+ N P+S S + + ++ P+ DI +FR
Sbjct: 554 IMEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 73/274 (26%), Positives = 112/274 (40%), Gaps = 59/274 (21%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK----HMICNDEESLESAMKEISVMKSLKGHPNVV 87
VI +G F V AR YA+K I +E + M E +V+ HP +V
Sbjct: 45 VIGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKKE-EKHIMSERNVLLKNVKHPFLV 102
Query: 88 TLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRG--------AGYFEEKQVLAIF--R 136
L+ +T + L V++ N G F E + A F
Sbjct: 103 GLHFSF-----QTADKLYFVLDYI---------NGGELFYHLQRERCFLEPR--ARFYAA 146
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEED 196
++ +A+ +HS + I +RDLK EN+LL S G L DFG L + IE +
Sbjct: 147 EIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFG-----------LCKENIEHN 193
Query: 197 NIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ--- 250
+ T TP Y APE+ ++ + VD W LG +L+ + Y F + +
Sbjct: 194 S-TTSTFCGTPEYLAPEV---LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249
Query: 251 -ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
ILN ++ P ++S L+ +LQ R
Sbjct: 250 NILNKPLQLK--PNITNSARHLLEGLLQKDRTKR 281
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 7e-19
Identities = 55/247 (22%), Positives = 100/247 (40%), Gaps = 58/247 (23%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQY-AMKHMICNDEESLESAMKEISVMKSLKGHP-- 84
+ ++I +G F V A D + +++ A+K +I N + L A E+ +++ + H
Sbjct: 57 EIDSLIGKGSFGQVVKAYD--RVEQEWVAIK-IIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 85 ---NVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCN 140
+V L H + + L LV E +L ++L N + +C
Sbjct: 114 MKYYIVHLKRHFMF-----RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDG--LWKLCDFGSTSTNHK--------RFEKLEE 190
A+ + + I H DLK EN+LL + K+ DFGS+ + RF
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF----- 223
Query: 191 MGIEEDNIRKHTTPAYRAPEM-----WDLFRRELINEKVDIWALGCLLFRICYFKNAFDG 245
YR+PE+ +D +D+W+LGC+L + + F G
Sbjct: 224 ---------------YRSPEVLLGMPYD--------LAIDMWSLGCILVEMHTGEPLFSG 260
Query: 246 ESKLQIL 252
+++ +
Sbjct: 261 ANEVDQM 267
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 9e-19
Identities = 66/275 (24%), Positives = 109/275 (39%), Gaps = 61/275 (22%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHPNV 86
++ +G F V ++ + YAMK ++ DE + + E V+++ + HP +
Sbjct: 155 LLGKGTFGKVILVKE-KATGRYYAMKILKKEVIVAKDE--VAHTLTENRVLQNSR-HPFL 210
Query: 87 VTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRG--------AGYFEEKQVLAIF-- 135
L +T + L VME N G F E + A F
Sbjct: 211 TALKYSF-----QTHDRLCFVMEYA---------NGGELFFHLSRERVFSEDR--ARFYG 254
Query: 136 RDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEE 195
++ +A+ +HS+ + +RDLK ENL+L DG K+ DFG L + GI++
Sbjct: 255 AEIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFG-----------LCKEGIKD 302
Query: 196 DNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ-- 250
T TP Y APE+ VD W LG +++ + + F + +
Sbjct: 303 GA-TMKTFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358
Query: 251 --ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
IL R P + L+ +L+ P R
Sbjct: 359 ELILMEEIRFPRT--LGPEAKSLLSGLLKKDPKQR 391
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 71/283 (25%), Positives = 112/283 (39%), Gaps = 68/283 (24%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMK----HMICNDEESLESAMKEISVMKSLKGHPNVV 87
VI G ++ V R + YAM+ ++ +DE+ ++ E V + HP +V
Sbjct: 59 VIGRGSYAKVLLVRL-KKTDRIYAMRVVKKELVNDDED-IDWVQTEKHVFEQASNHPFLV 116
Query: 88 TLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRG--------AGYFEEKQVLAIF--R 136
L++ +T+ L V+E N G E+ A F
Sbjct: 117 GLHSCF-----QTESRLFFVIEYV---------NGGDLMFHMQRQRKLPEEH--ARFYSA 160
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEED 196
++ A+ +H + I +RDLK +N+LL S+G KL D+G + + G+
Sbjct: 161 EISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYG-----------MCKEGLRPG 207
Query: 197 NIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLL---------FRICYFKNAFD 244
+ T TP Y APE + R E VD WALG L+ F I + D
Sbjct: 208 D-TTSTFCGTPNYIAPE---ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
Query: 245 GESKLQ----ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
++ IL RIP S S +++ L P +R
Sbjct: 264 QNTEDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKER 304
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 6e-18
Identities = 66/279 (23%), Positives = 109/279 (39%), Gaps = 68/279 (24%)
Query: 32 VIAEGGFSCVYSAR--DAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHP 84
V+ +G F V+ + + YAMK + D E ++ + HP
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR---TKMERDILVEVN-HP 86
Query: 85 NVVTL-YAHTILDLGRTKEAL-LVMECCDKSLVNVLENRG--------AGYFEEKQV--- 131
+V L YA +T+ L L+++ G F E+ V
Sbjct: 87 FIVKLHYAF------QTEGKLYLILDFL---------RGGDLFTRLSKEVMFTEEDVKFY 131
Query: 132 LAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEM 191
LA ++ A+ +HS I +RDLK EN+LL +G KL DFG L +
Sbjct: 132 LA---ELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFG-----------LSKE 175
Query: 192 GIEEDNIRKHT---TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK 248
I+ + + ++ T Y APE+ R + D W+ G L+F + F G+ +
Sbjct: 176 SIDHEK-KAYSFCGTVEYMAPEV---VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR 231
Query: 249 LQ----ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
+ IL +P S L+R + + +P +R
Sbjct: 232 KETMTMILKAKLGMP--QFLSPEAQSLLRMLFKRNPANR 268
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 73/367 (19%), Positives = 124/367 (33%), Gaps = 119/367 (32%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTL-- 89
+ G F V D + +A+K + D +E+ +MK L H N++ L
Sbjct: 14 TLGTGSFGIVCEVFDIESGKR-FALK-KVLQDPRY---KNRELDIMKVLD-HVNIIKLVD 67
Query: 90 --YAHTILDLGRTKEAL------------------------------LVMECCDKSLVNV 117
Y + + ++ME +L V
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKV 127
Query: 118 LENRGAGYFEEKQVLA----------IFRDVCNAVFAMHSQSPPIAHRDLKAENLLL-GS 166
L++ + + + +FR AV +HS I HRD+K +NLL+
Sbjct: 128 LKS----FIRSGRSIPMNLISIYIYQLFR----AVGFIHSLG--ICHRDIKPQNLLVNSK 177
Query: 167 DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDI 226
D KLCDFGS K+ E + I + YRAPE+ + +D+
Sbjct: 178 DNTLKLCDFGSA----KKLIPSEPS-VAY--I---CSRFYRAPEL--MLGATEYTPSIDL 225
Query: 227 WALGCLLFRICYFKNAFDGES------------------KLQILNGNY---RIPESPKYS 265
W++GC+ + K F GE+ ++ +N +Y R P
Sbjct: 226 WSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKD 285
Query: 266 ----------SSVTDLIRDMLQASPDDRP---------------DITQVWFRVNEQLPVG 300
S DL+ +L+ PD R + + + N P G
Sbjct: 286 WRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHG 345
Query: 301 LQKSLPD 307
+ +++P
Sbjct: 346 VNQNIPQ 352
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 50/221 (22%), Positives = 89/221 (40%), Gaps = 26/221 (11%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESA---MKEISVMKSLKGHP 84
+ + +G + V+ + D + A+K I + ++ A +EI ++ L GH
Sbjct: 12 ELVKKLGKGAYGIVWKSID-RRTGEVVAVK-KIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 85 NVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
N+V L +L ++ LV + + L V+ A E + + +
Sbjct: 70 NIVNLL--NVLRADNDRDVYLVFDYMETDLHAVIR---ANILEPVHKQYVVYQLIKVIKY 124
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG---STSTNHKRFEKLEEMGIEEDNIRKH 201
+HS + HRD+K N+LL ++ K+ DFG S + + E
Sbjct: 125 LHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 202 TTPA---------YRAPEMWDLFRRELINEKVDIWALGCLL 233
P YRAPE+ L + +D+W+LGC+L
Sbjct: 183 DQPILTDYVATRWYRAPEI--LLGSTKYTKGIDMWSLGCIL 221
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 64/268 (23%), Positives = 108/268 (40%), Gaps = 33/268 (12%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPN 85
I +++ + G + VY S A+K + D +E +KE +VMK +K HPN
Sbjct: 221 DITMKHKLGGGQYGEVYEGV-WKKYSLTVAVK-TLKEDTMEVEEFLKEAAVMKEIK-HPN 277
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
+V L R ++ E +L++ L +L + + +A+
Sbjct: 278 LVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEED--NIRKHT 202
+ ++ HR+L A N L+G + L K+ DFG + R + D
Sbjct: 334 LEKKN--FIHRNLAARNCLVGENHLVKVADFGLS-----RL-------MTGDTYTAHAGA 379
Query: 203 TPAYR--APEMWDLFRRELINEKVDIWALGCLLFRIC-YFKNAFDGESK---LQILNGNY 256
+ APE + K D+WA G LL+ I Y + + G ++L +Y
Sbjct: 380 KFPIKWTAPES---LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 436
Query: 257 RIPESPKYSSSVTDLIRDMLQASPDDRP 284
R+ V +L+R Q +P DRP
Sbjct: 437 RMERPEGCPEKVYELMRACWQWNPSDRP 464
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 55/300 (18%), Positives = 111/300 (37%), Gaps = 75/300 (25%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAH 92
+ G +S V+ A + I +++ +K ++ ++ + +EI ++++L+G PN++TL
Sbjct: 44 LGRGKYSEVFEAIN-ITNNEKVVVK-ILKPVKK--KKIKREIKILENLRGGPNIITLA-D 98
Query: 93 TILDLGRTKEALLVMEC--CD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS 149
+ D AL+ D K L L + ++ ++ A+ HS
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFY--------MYEILKALDYCHSMG 150
Query: 150 PPIAHRDLKAENLLL-GSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH-TTPAYR 207
I HRD+K N+++ +L D+G L E + ++
Sbjct: 151 --IMHRDVKPHNVMIDHEHRKLRLIDWG-----------LAEFYHPGQEYNVRVASRYFK 197
Query: 208 APEMWDLFRRELINEKVDIWALGCLLFRICYFKNA-FDGESKLQILN------------- 253
PE+ L ++ + +D+W+LGC+L + + K F G L
Sbjct: 198 GPEL--LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255
Query: 254 --GNYRIPESPKYSSSVT------------------------DLIRDMLQASPDDRPDIT 287
Y I P+++ + D + +L+ R +T
Sbjct: 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR--LT 313
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 36/307 (11%), Positives = 72/307 (23%), Gaps = 76/307 (24%)
Query: 29 VRNVIAEGGFSCVYSARD-------AIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK 81
+ + A D A+ + ++ L+ + + +
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTF-----VDPQGVLPDDVLQETLSRTLRLSRI- 88
Query: 82 GHPNVVTLYAHTILDLGRTKE-ALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVC 139
P V + D+ T+ L+V E SL V + + + +
Sbjct: 89 DKPGVARVL-----DVVHTRAGGLVVAEWIRGGSLQEVADTSP----SPVGAIRAMQSLA 139
Query: 140 NAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIR 199
A A H +A + + DG L
Sbjct: 140 AAADAAHRA--GVALSIDHPSRVRVSIDGDVVL--------------------------- 170
Query: 200 KHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIP 259
PA N + DI +G L+ + + L R
Sbjct: 171 --AYPATMPDA----------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT 218
Query: 260 ES---------PKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGLQKSLPDRPP 310
++ + +Q R T + + +Q ++ P
Sbjct: 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL--NLMQQATAVADRTEVLGPI 276
Query: 311 ETQSAVA 317
+ A
Sbjct: 277 DEAPVSA 283
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 1e-16
Identities = 68/320 (21%), Positives = 119/320 (37%), Gaps = 53/320 (16%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESA---MKEISVMKSLKGHP 84
+R++I G + V A D + A+K I E L ++EI+++ L H
Sbjct: 56 EIRHLIGTGSYGHVCEAYD-KLEKRVVAIK-KILRVFEDLIDCKRILREIAILNRLN-HD 112
Query: 85 NVVTLYAHTIL--DLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAV 142
+VV + ++ D+ + E +V+E D + R Y E + + ++ V
Sbjct: 113 HVVKVL-DIVIPKDVEKFDELYVVLEIADSDFKKLF--RTPVYLTELHIKTLLYNLLVGV 169
Query: 143 FAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG---STSTNHKRFEKLEEMGIEEDNIR 199
+HS I HRDLK N L+ D K+CDFG + +L E+D
Sbjct: 170 KYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 200 KHTTPA---------------YRAPEMWDLFRRELINEKVDIWALGC----LLFRICYFK 240
YRAPE+ + +E E +D+W++GC LL I
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPEL--ILLQENYTEAIDVWSIGCIFAELLNMIKENV 285
Query: 241 NA-------FDGESKLQILNGNYRIPESPKYSSSVTD---LIRDMLQASPDDRPDITQVW 290
F G S + + ++ D +I ++L +P + +
Sbjct: 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNIL-GTPSE-----EDI 339
Query: 291 FRVNEQLPVGLQKSLPDRPP 310
+ ++ + P R
Sbjct: 340 EALEKEDAKRYIRIFPKREG 359
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 57/262 (21%), Positives = 96/262 (36%), Gaps = 70/262 (26%)
Query: 23 GNLKIHVRNVIA----------EGGFSCVYSARDAIHMSKQY-AMKHMICNDEESLESAM 71
G+ + +A +G F V A D H Q+ A+K M+ N++ A
Sbjct: 85 GSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYD--HKVHQHVALK-MVRNEKRFHRQAA 141
Query: 72 KEISVMKSLKGHP-----NVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGY 125
+EI +++ L+ NV+ + + + + + E +L +++
Sbjct: 142 EEIRILEHLRKQDKDNTMNVIHMLENFTF-----RNHICMTFELLSMNLYELIKKNKFQG 196
Query: 126 FEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG--LWKLCDFGSTSTNHK 183
F V + + A+H I H DLK EN+LL G K+ DFGS+ H+
Sbjct: 197 FSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254
Query: 184 --------RFEKLEEMGIEEDNIRKHTTPAYRAPEM-----WDLFRRELINEKVDIWALG 230
RF YRAPE+ + +D+W+LG
Sbjct: 255 RVYTYIQSRF--------------------YRAPEVILGARYG--------MPIDMWSLG 286
Query: 231 CLLFRICYFKNAFDGESKLQIL 252
C+L + GE + L
Sbjct: 287 CILAELLTGYPLLPGEDEGDQL 308
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 26/222 (11%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESA---MKEISVMKSLKGHPN 85
++++I G + VY A D + K A+K + E L ++EI+++ LK
Sbjct: 30 IKHLIGRGSYGYVYLAYD-KNTEKNVAIK-KVNRMFEDLIDCKRILREITILNRLK-SDY 86
Query: 86 VVTLY-AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
++ LY DL + E +V+E D L + + + E+ + I ++
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF--KTPIFLTEEHIKTILYNLLLGENF 144
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG---STSTNHKRFEKLEEMGIEEDNIRKH 201
+H I HRDLK N LL D K+CDFG + ++ + EE
Sbjct: 145 IHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 202 TTPA----------YRAPEMWDLFRRELINEKVDIWALGCLL 233
YRAPE+ + +E + +DIW+ GC+
Sbjct: 203 NLKKQLTSHVVTRWYRAPEL--ILLQENYTKSIDIWSTGCIF 242
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 61/267 (22%), Positives = 113/267 (42%), Gaps = 33/267 (12%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPN 85
+ + + +G F V+ + + + A+K + S E+ ++E VMK L+ H
Sbjct: 185 SLRLEVKLGQGCFGEVWMGT--WNGTTRVAIK-TLKPGTMSPEAFLQEAQVMKKLR-HEK 240
Query: 86 VVTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143
+V LYA ++E + +V E K SL++ L+ Y Q++ + + + +
Sbjct: 241 LVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTT 203
+ + HRDL+A N+L+G + + K+ DFG + E R+
Sbjct: 295 YVERMN--YVHRDLRAANILVGENLVCKVADFGLA----------RLIEDNEYTARQGAK 342
Query: 204 PAYR--APEMWDLFRRELINEKVDIWALGCLLFRIC-YFKNAFDGESK---LQILNGNYR 257
+ APE K D+W+ G LL + + + G L + YR
Sbjct: 343 FPIKWTAPEA---ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 399
Query: 258 IPESPKYSSSVTDLIRDMLQASPDDRP 284
+P P+ S+ DL+ + P++RP
Sbjct: 400 MPCPPECPESLHDLMCQCWRKEPEERP 426
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 66/304 (21%), Positives = 112/304 (36%), Gaps = 66/304 (21%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLY- 90
+ GG V+SA D K+ A+K ++ D +S++ A++EI +++ L H N+V ++
Sbjct: 18 PLGCGGNGLVFSAVDN-DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD-HDNIVKVFE 75
Query: 91 ---------AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNA 141
+ L +V E + L NVLE G E+ +
Sbjct: 76 ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE---QGPLLEEHARLFMYQLLRG 132
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGS-DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRK 200
+ +HS + + HRDLK NL + + D + K+ DFG + +
Sbjct: 133 LKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL--------- 181
Query: 201 HT----TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ------ 250
+ T YR+P + L + +D+WA GC+ + K F G +L+
Sbjct: 182 -SEGLVTKWYRSPRL--LLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238
Query: 251 ---------------------ILNGNYRIPES-----PKYSSSVTDLIRDMLQASPDDRP 284
I N + P S D + +L SP DR
Sbjct: 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL 298
Query: 285 DITQ 288
+
Sbjct: 299 TAEE 302
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 54/280 (19%), Positives = 93/280 (33%), Gaps = 55/280 (19%)
Query: 26 KIHVRNVIAEGGFSCVYSARD-------AIHMSKQYAMKHMICNDEESLESAMKEISVMK 78
+ + I G F V+S R A+ ++ + ++E ++K
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK-------AKFLQEARILK 167
Query: 79 SLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRD 137
HPN+V L + + +VME + L G K +L + D
Sbjct: 168 QYS-HPNIVRLIGVCT----QKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGD 221
Query: 138 VCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDN 197
+ + S+ HRDL A N L+ + K+ DFG + R +
Sbjct: 222 AAAGMEYLESK--CCIHRDLAARNCLVTEKNVLKISDFGMS-----RE-------EADGV 267
Query: 198 IRKHTTPA---YR--APEMWDLFRRELINEKVDIWALGCLLFRIC------Y--FKNAFD 244
+ APE + R + D+W+ G LL+ Y N
Sbjct: 268 YAASGGLRQVPVKWTAPEAL-NYGRYSS--ESDVWSFGILLWETFSLGASPYPNLSNQ-- 322
Query: 245 GESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
+++ + G R+P +V L+ P RP
Sbjct: 323 -QTREFVEKG-GRLPCPELCPDAVFRLMEQCWAYEPGQRP 360
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 62/303 (20%), Positives = 112/303 (36%), Gaps = 65/303 (21%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESA---MKEISVMKSLKG 82
+ G + V SA D ++ A+K + +S A +E+ ++K ++
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDK-RSGEKVAIK-KLSRPFQSEIFAKRAYRELLLLKHMQ- 81
Query: 83 HPNVVTLYAHTILDLGRT---KEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVC 139
H NV+ L + LVM L ++ + F E+++ + +
Sbjct: 82 HENVIGLL-DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK----FSEEKIQYLVYQML 136
Query: 140 NAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGIEEDNI 198
+ +HS + HRDLK NL + D K+ DFG + + + +
Sbjct: 137 KGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV---------- 184
Query: 199 RKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ-------- 250
T YRAPE+ + N+ VDIW++GC++ + K F G+ L
Sbjct: 185 ---VTRWYRAPEV--ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239
Query: 251 -----------ILNGNYR-----IPESPKY---------SSSVTDLIRDMLQASPDDRPD 285
+ + + +P++P+ S DL+ ML+ D R
Sbjct: 240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 299
Query: 286 ITQ 288
Q
Sbjct: 300 AAQ 302
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 48/245 (19%), Positives = 82/245 (33%), Gaps = 74/245 (30%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK-----G 82
+ + + EG F V D + A+K ++ N + E+A EI V++ L
Sbjct: 17 EIVDTLGEGAFGKVVECIDHKAGGRHVAVK-IVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 83 HPNVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNA 141
V + + +V E S + ++ G F + + +C +
Sbjct: 76 TFRCVQMLEWFEH-----HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGSDGLW-------------------KLCDFGSTSTNH 182
V +HS + H DLK EN+L K+ DFGS + +
Sbjct: 131 VNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 183 K--------RFEKLEEMGIEEDNIRKHTTPAYRAPEM-----WDLFRRELINEKVDIWAL 229
+ R YRAPE+ W + D+W++
Sbjct: 189 EHHSTLVSTRH--------------------YRAPEVILALGWS--------QPCDVWSI 220
Query: 230 GCLLF 234
GC+L
Sbjct: 221 GCILI 225
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 65/301 (21%), Positives = 114/301 (37%), Gaps = 60/301 (19%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESA---MKEISVMKSLKGHP 84
+ I EG + V SA D + A+K + + E ++EI ++ + H
Sbjct: 30 TNLSYIGEGAYGMVCSAYDN-LNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFR-HE 85
Query: 85 NVVTLY-AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143
N++ + + + K+ +V + + L +L+ + + + +
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLK 142
Query: 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG---STSTNHKRFEKLEEMGIEEDNIRK 200
+HS + + HRDLK NLLL + K+CDFG +H L E
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY--------- 191
Query: 201 HTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ---------- 250
T YRAPE+ + + + +DIW++GC+L + + F G+ L
Sbjct: 192 VATRWYRAPEI--MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249
Query: 251 ---------ILNGNYR-----IPESPKY---------SSSVTDLIRDMLQASPDDRPDIT 287
I+N R +P K S DL+ ML +P R ++
Sbjct: 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 309
Query: 288 Q 288
Q
Sbjct: 310 Q 310
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 4e-15
Identities = 61/267 (22%), Positives = 113/267 (42%), Gaps = 33/267 (12%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPN 85
+ + + +G F V+ + + + A+K + S E+ ++E VMK L+ H
Sbjct: 268 SLRLEVKLGQGCFGEVWMGT--WNGTTRVAIK-TLKPGTMSPEAFLQEAQVMKKLR-HEK 323
Query: 86 VVTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143
+V LYA ++E + +V E K SL++ L+ Y Q++ + + + +
Sbjct: 324 LVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 377
Query: 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTT 203
+ + HRDL+A N+L+G + + K+ DFG + E R+
Sbjct: 378 YVERMN--YVHRDLRAANILVGENLVCKVADFGLA----------RLIEDNEYTARQGAK 425
Query: 204 PAYR--APEMWDLFRRELINEKVDIWALGCLLFRIC-YFKNAFDGESK---LQILNGNYR 257
+ APE K D+W+ G LL + + + G L + YR
Sbjct: 426 FPIKWTAPEA---ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 482
Query: 258 IPESPKYSSSVTDLIRDMLQASPDDRP 284
+P P+ S+ DL+ + P++RP
Sbjct: 483 MPCPPECPESLHDLMCQCWRKEPEERP 509
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 51/263 (19%), Positives = 86/263 (32%), Gaps = 74/263 (28%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK-----G 82
+ + EG F V D Q A+K +I N + E+A EI+V+K +K
Sbjct: 22 EIVGNLGEGTFGKVVECLDHARGKSQVALK-IIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 83 HPNVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNA 141
V + + + E K+ L+ + V + +C+A
Sbjct: 81 KFLCVLMSDWFNF-----HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGSDGLW-------------------KLCDFGSTSTNH 182
+ +H + H DLK EN+L + ++ DFGS + +H
Sbjct: 136 LRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 183 K--------RFEKLEEMGIEEDNIRKHTTPAYRAPEM-----WDLFRRELINEKVDIWAL 229
+ R YR PE+ W + D+W++
Sbjct: 194 EHHTTIVATRH--------------------YRPPEVILELGWA--------QPCDVWSI 225
Query: 230 GCLLFRICYFKNAFDGESKLQIL 252
GC+LF F + L
Sbjct: 226 GCILFEYYRGFTLFQTHENREHL 248
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 63/302 (20%), Positives = 107/302 (35%), Gaps = 72/302 (23%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESA---MKEISVMKSLKGHPNVV 87
+ + G + V +A D + A+K + +S+ A +E+ ++K +K H NV+
Sbjct: 35 SPVGSGAYGSVCAAFDTKT-GLRVAVK-KLSRPFQSIIHAKRTYRELRLLKHMK-HENVI 91
Query: 88 TLY--AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
L L + LV L N+++ + + V + + + +
Sbjct: 92 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKYI 148
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFG------STSTNHKRFEKLEEMGIEEDNIR 199
HS I HRDLK NL + D K+ DFG T +
Sbjct: 149 HSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY----------------- 189
Query: 200 KHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ--------- 250
T YRAPE+ + N+ VDIW++GC++ + + F G +
Sbjct: 190 -VATRWYRAPEI--MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246
Query: 251 ----------ILNGNYR-----IPESPKY---------SSSVTDLIRDMLQASPDDRPDI 286
I + + R + + PK + DL+ ML D R
Sbjct: 247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 306
Query: 287 TQ 288
Q
Sbjct: 307 AQ 308
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 50/255 (19%), Positives = 80/255 (31%), Gaps = 90/255 (35%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHP--- 84
V + +G F V + I K YA+K ++ N ++ SA E ++K ++
Sbjct: 38 LVIRKMGDGTFGRVLLCQH-IDNKKYYAVK-VVRNIKKYTRSAKIEADILKKIQNDDINN 95
Query: 85 -NVVTLYA------HTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRD 137
N+V + H L + E SL ++ F + + +
Sbjct: 96 NNIVKYHGKFMYYDHMCL----------IFEPLGPSLYEIITRNNYNGFHIEDIKLYCIE 145
Query: 138 VCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLW-------------------------KL 172
+ A+ + S + H DLK EN+LL KL
Sbjct: 146 ILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 173 CDFGSTSTNHK--------RFEKLEEMGIEEDNIRKHTTPAYRAPEM-----WDLFRREL 219
DFG + R YRAPE+ WD
Sbjct: 204 IDFGCATFKSDYHGSIINTRQ--------------------YRAPEVILNLGWD------ 237
Query: 220 INEKVDIWALGCLLF 234
D+W+ GC+L
Sbjct: 238 --VSSDMWSFGCVLA 250
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 42/213 (19%), Positives = 75/213 (35%), Gaps = 28/213 (13%)
Query: 32 VIAEGGFSCVYSARD------AIHMSKQYAMKHMICNDEESLESA---MKEISVMKSLKG 82
I+ G + V + D AI N ++EI ++
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH- 87
Query: 83 HPNVVTLY-AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNA 141
HPN++ L + + LV E L V+ + + + +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVI-HDQRIVISPQHIQYFMYHILLG 146
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH 201
+ +H + HRDL N+LL + +CDF L + N +
Sbjct: 147 LHVLHEAG--VVHRDLHPGNILLADNNDITICDFN-----------LAREDTADANKTHY 193
Query: 202 -TTPAYRAPEMWDLFRRELINEKVDIWALGCLL 233
T YRAPE+ + + + + VD+W+ GC++
Sbjct: 194 VTHRWYRAPEL--VMQFKGFTKLVDMWSAGCVM 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 59/273 (21%), Positives = 107/273 (39%), Gaps = 49/273 (17%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPN 85
++ + I +G F V + + A+K ++ + ++ + E SVM L+ H N
Sbjct: 22 ELKLLQTIGKGEFGDVMLGD---YRGNKVAVK--CIKNDATAQAFLAEASVMTQLR-HSN 75
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
+V L + + G +V E K SLV+ L +RG +L DVC A+
Sbjct: 76 LVQLLGVIVEEKGGL---YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG------STSTNHK---RFEKLEEMGIEE 195
+ + HRDL A N+L+ D + K+ DFG ST K ++ E
Sbjct: 133 LEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKW-----TAPEA 185
Query: 196 DNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC-YFKNAFDGESK---LQI 251
+K +T K D+W+ G LL+ I + + + +
Sbjct: 186 LREKKFST-------------------KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 226
Query: 252 LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
+ Y++ +V +++++ RP
Sbjct: 227 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRP 259
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 62/297 (20%), Positives = 106/297 (35%), Gaps = 62/297 (20%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESA---MKEISVMKSLKGHPNVV 87
+ G + V SA D + A+K + +S A +E+ ++K ++ H NV+
Sbjct: 31 QPVGSGAYGAVCSAVDG-RTGAKVAIK-KLYRPFQSELFAKRAYRELRLLKHMR-HENVI 87
Query: 88 TLY--AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
L L + LVM L ++++ E ++ + + + +
Sbjct: 88 GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK---LGEDRIQFLVYQMLKGLRYI 144
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGIEEDNIRKHTTP 204
H+ I HRDLK NL + D K+ DFG + + + + T
Sbjct: 145 HAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV-------------VTR 189
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG---------- 254
YRAPE+ + + VDIW++GC++ + K F G L L
Sbjct: 190 WYRAPEV--ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 247
Query: 255 ------------NY--RIPESPKY---------SSSVTDLIRDMLQASPDDRPDITQ 288
NY +PE K S +L+ ML + R +
Sbjct: 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 304
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 68/272 (25%), Positives = 110/272 (40%), Gaps = 41/272 (15%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPN 85
I +++ + G + VY S A+K + D +E +KE +VMK +K HPN
Sbjct: 14 DITMKHKLGGGQYGEVYEGV-WKKYSLTVAVK-TLKEDTMEVEEFLKEAAVMKEIK-HPN 70
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
+V L R ++ E +L++ L +L + + +A+
Sbjct: 71 LVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT-- 202
+ ++ HRDL A N L+G + L K+ DFG + R + D H
Sbjct: 127 LEKKN--FIHRDLAARNCLVGENHLVKVADFGLS-----RL-------MTGDTYTAHAGA 172
Query: 203 ------TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC-YFKNAFDGESKLQILN-- 253
T APE + + I K D+WA G LL+ I Y + + G Q+
Sbjct: 173 KFPIKWT----APESL-AYNKFSI--KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
Query: 254 -GNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
+YR+ V +L+R Q +P DRP
Sbjct: 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRP 257
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 61/371 (16%), Positives = 104/371 (28%), Gaps = 106/371 (28%)
Query: 21 DVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC-NDEESLESAMKEISVMKS 79
D+ N + HV + G FS V+ + D I K AMK + + E E+A+ EI ++KS
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWD-IQGKKFVAMK--VVKSAEHYTETALDEIRLLKS 89
Query: 80 LK-------GHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVL 132
++ VV L + +V E L+ + V
Sbjct: 90 VRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK 149
Query: 133 AIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD--------------GLWKLCDFGST 178
I + V + +H++ I H D+K EN+LL + +
Sbjct: 150 KIIQQVLQGLDYLHTKCR-IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 179 STNHKRFEKLEEMGIEEDNIRKH-----------------------TTPAYRAPEMWDLF 215
+ + + + T YR+ E+ L
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEV--LI 266
Query: 216 RRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL----------------------- 252
N DIW+ C+ F + F+ S +
Sbjct: 267 GSGY-NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVA 325
Query: 253 ----------NGNYRIPESPKYSSS-----------------VTDLIRDMLQASPDDRPD 285
G+ + K TD + ML+ P+ R
Sbjct: 326 GKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT 385
Query: 286 ITQV----WFR 292
+ W
Sbjct: 386 AAECLRHPWLN 396
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 61/269 (22%), Positives = 116/269 (43%), Gaps = 37/269 (13%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPN 85
+ + + G F V+ A + + A+K + S+E+ + E +VMK+L+ H
Sbjct: 189 SLKLEKKLGAGQFGEVWMATY--NKHTKVAVK-TMKPGSMSVEAFLAEANVMKTLQ-HDK 244
Query: 86 VVTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143
+V L+A TKE + ++ E K SL++ L++ +++ + +
Sbjct: 245 LVKLHAVV------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDN--IRKH 201
+ ++ HRDL+A N+L+ + + K+ DFG R IE++ R+
Sbjct: 299 FIEQRN--YIHRDLRAANILVSASLVCKIADFGLA-----RV-------IEDNEYTAREG 344
Query: 202 TTPAYR--APEMWDLFRRELINEKVDIWALGCLLFRIC-YFKNAFDGESK---LQILNGN 255
+ APE F K D+W+ G LL I Y + + G S ++ L
Sbjct: 345 AKFPIKWTAPEAI-NFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 401
Query: 256 YRIPESPKYSSSVTDLIRDMLQASPDDRP 284
YR+P + +++ + P++RP
Sbjct: 402 YRMPRPENCPEELYNIMMRCWKNRPEERP 430
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 47/205 (22%), Positives = 86/205 (41%), Gaps = 12/205 (5%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLESAMKEISVMKSLKGHPNVVTLY 90
++ EG + V SA + A+K + + ++EI ++K K H N++T++
Sbjct: 18 LLGEGAYGVVCSATHK-PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK-HENIITIF 75
Query: 91 -AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS 149
E ++ E L V+ + + + AV +H +
Sbjct: 76 NIQRPDSFENFNEVYIIQELMQTDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSN 132
Query: 150 PPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH-TTPAYRA 208
+ HRDLK NLL+ S+ K+CDFG + E ++ + + T YRA
Sbjct: 133 --VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRA 190
Query: 209 PEMWDLFRRELINEKVDIWALGCLL 233
PE+ + + +D+W+ GC+L
Sbjct: 191 PEV--MLTSAKYSRAMDVWSCGCIL 213
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 62/275 (22%), Positives = 110/275 (40%), Gaps = 49/275 (17%)
Query: 26 KIHVRNVIAEGGFSCVYSARD------AIHMSKQYAMKHMICNDEESLESAMKEISVMKS 79
+ + + G F V+ A+ KQ +M S ++ + E ++MK
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---------SPDAFLAEANLMKQ 64
Query: 80 LKGHPNVVTLYAHTILDLGRTKE-ALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRD 137
L+ H +V LYA T+E ++ E + SLV+ L+ ++L +
Sbjct: 65 LQ-HQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 138 VCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDN 197
+ + + ++ HRDL+A N+L+ K+ DFG R IE++
Sbjct: 118 IAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLA-----RL-------IEDNE 163
Query: 198 --IRKHTTPAYR--APEMWDLFRRELINEKVDIWALGCLLFRIC-YFKNAFDGESK---L 249
R+ + APE + I K D+W+ G LL I + + + G + +
Sbjct: 164 YTAREGAKFPIKWTAPEAI-NYGTFTI--KSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
Query: 250 QILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
Q L YR+ + L+R + P+DRP
Sbjct: 221 QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 255
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 59/267 (22%), Positives = 109/267 (40%), Gaps = 37/267 (13%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPN 85
++ + I +G F V + + A+K ++ + ++ + E SVM L+ H N
Sbjct: 194 ELKLLQTIGKGEFGDVMLGD---YRGNKVAVK--CIKNDATAQAFLAEASVMTQLR-HSN 247
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
+V L + + G +V E K SLV+ L +RG +L DVC A+
Sbjct: 248 LVQLLGVIVEEKGGL---YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTP 204
+ + HRDL A N+L+ D + K+ DFG + E + +
Sbjct: 305 LEGNN--FVHRDLAARNVLVSEDNVAKVSDFG--------------LTKEASSTQDTGKL 348
Query: 205 AYR--APEMWDLFRRELINEKVDIWALGCLLFRIC-YFKNAFDG----ESKLQILNGNYR 257
+ APE ++ K D+W+ G LL+ I + + + + ++ G Y+
Sbjct: 349 PVKWTAPEAL-REKKFST--KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YK 404
Query: 258 IPESPKYSSSVTDLIRDMLQASPDDRP 284
+ +V D++++ RP
Sbjct: 405 MDAPDGCPPAVYDVMKNCWHLDAATRP 431
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 5e-14
Identities = 80/425 (18%), Positives = 131/425 (30%), Gaps = 119/425 (28%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESA---MKEISVMKSLKG 82
+ I G V +A DA + + A+K + ++ A +E+ +MK +
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVN- 119
Query: 83 HPNVVTLY--AHTILDLGRTKEALLVMECCDKSLVNV----LENRGAGYFEEKQVLAIFR 136
H N+++L L ++ LVME D +L V L++ Y + +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL----LYQMLC 175
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG---STSTNHKRFEKLEEMGI 193
+ +HS I HRDLK N+++ SD K+ DFG + T+ +
Sbjct: 176 ----GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV----- 224
Query: 194 EEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDG-------- 245
T YRAPE+ E VDIW++GC++ + K F G
Sbjct: 225 --------VTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 273
Query: 246 ----------ESKLQILNGNYR-----IPESPKYS---------------------SSVT 269
++ L R P+ + S
Sbjct: 274 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQAR 333
Query: 270 DLIRDMLQASPDDRPDITQ--------VWFRVNEQLPVGLQKSLPD-------------- 307
DL+ ML P R + VW+ E Q
Sbjct: 334 DLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKEL 393
Query: 308 ------------RPPETQSAVANEGMSKPMNRSPPMPQRSPPPPPSSVDPTRNISQPSTT 355
+ + + G + + S P S D T S+
Sbjct: 394 IYKEVMNSEEKTKNGVVKGQPSPSGAAVNSSESLPPSSSVNDISSMSTDQTLASDTDSSL 453
Query: 356 PAVSG 360
A +G
Sbjct: 454 EASAG 458
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 70/348 (20%), Positives = 125/348 (35%), Gaps = 69/348 (19%)
Query: 20 IDVGNLKIHVRNVIAEGGFSCVYSARD----------AIHMSKQYAMKHMICNDEESLES 69
+D N+ I V+ G F V S R AI K E+
Sbjct: 42 LDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-------EKQRRD 92
Query: 70 AMKEISVMKSLKGHPNVVTLYA-HTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFE 127
+ E S+M HPN++ L T ++K ++V E + SL + L F
Sbjct: 93 FLGEASIMGQFD-HPNIIRLEGVVT-----KSKPVMIVTEYMENGSLDSFLRKHD-AQFT 145
Query: 128 EKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEK 187
Q++ + R + + + + HRDL A N+L+ S+ + K+ DFG R
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLG-----RV-- 196
Query: 188 LEEMGIEEDNIRKHTTPAYRAPEMWD-----LFRRELINEKVDIWALGCLLFRIC-YFKN 241
+E+D +TT + P W +R+ D+W+ G +L+ + Y +
Sbjct: 197 -----LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS--ASDVWSYGIVLWEVMSYGER 249
Query: 242 AFDGESKLQILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLP 298
+ S ++ YR+P +++ L+ D Q ++RP Q
Sbjct: 250 PYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ---------- 299
Query: 299 VGLQKSLPD--RPPETQSAVANEGMSKPMNRSPPMPQRSPPPPPSSVD 344
+ L R P + + + ++P N +
Sbjct: 300 --IVSILDKLIRNPGSLKIITSAA-ARPSNL-LLDQSNVDITTFRTTG 343
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 61/269 (22%), Positives = 104/269 (38%), Gaps = 45/269 (16%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESA---MKEISVMKSLKGHPNVV 87
I G V +A DA + + A+K + ++ A +E+ +MK + H N++
Sbjct: 31 KPIGSGAQGIVCAAYDA-ILERNVAIK-KLSRPFQNQTHAKRAYRELVLMKCVN-HKNII 87
Query: 88 TLYAHTIL---DLGRTKEALLVMECCDKSLVNV----LENRGAGYFEEKQVLAIFRDVCN 140
L + L ++ +VME D +L V L++ Y + +
Sbjct: 88 GLL-NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL----LYQMLC---- 138
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRK 200
+ +HS I HRDLK N+++ SD K+ DFG R M
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLA-----RTAGTSFMMTPY----- 186
Query: 201 HTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPE 260
T YRAPE+ E VDIW++GC++ + F G + N ++ E
Sbjct: 187 VVTRYYRAPEVILGMG---YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN---KVIE 240
Query: 261 -----SPKYSSSVTDLIRDMLQASPDDRP 284
P++ + +R ++ P
Sbjct: 241 QLGTPCPEFMKKLQPTVRTYVENRPKYAG 269
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 9e-13
Identities = 60/279 (21%), Positives = 105/279 (37%), Gaps = 57/279 (20%)
Query: 26 KIHVRNVIAEGGFSCVYSARD------AIHMSKQYAMKHMICNDEESLESAMKEISVMKS 79
+I + + G F V + A+ M K+ +M E+ +E M
Sbjct: 9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM------SEDEF---FQEAQTMMK 59
Query: 80 LKGHPNVVTLYA-HTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRD 137
L HP +V Y + + +V E L+N L + G E Q+L + D
Sbjct: 60 LS-HPKLVKFYGVCS-----KEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYD 112
Query: 138 VCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDN 197
VC + + S HRDL A N L+ D K+ DFG T R+ + +D
Sbjct: 113 VCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMT-----RY-------VLDDQ 158
Query: 198 IRKHT--------TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC-YFKNAFDGESK 248
+ APE++ + + K D+WA G L++ + K +D +
Sbjct: 159 YVSSVGTKFPVKWS----APEVF-HYFKYSS--KSDVWAFGILMWEVFSLGKMPYDLYTN 211
Query: 249 ---LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
+ ++ +R+ S ++ ++ P+ RP
Sbjct: 212 SEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRP 250
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 65/277 (23%), Positives = 110/277 (39%), Gaps = 55/277 (19%)
Query: 27 IHVRNVIAEGGFSCVYSARD------AIHMSKQYAMKHMICNDEESLESAMKEISVMKSL 80
+ I G F V+ AI ++ AM EE ++E VM L
Sbjct: 10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------SEEDF---IEEAEVMMKL 60
Query: 81 KGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVC 139
HP +V LY + LV E + L + L + G F + +L + DVC
Sbjct: 61 S-HPKLVQLYGVCL----EQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVC 114
Query: 140 NAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIR 199
+ + + HRDL A N L+G + + K+ DFG T RF + +D
Sbjct: 115 EGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMT-----RF-------VLDDQYT 160
Query: 200 KHT--------TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI-CYFKNAFDGESK-- 248
T +PE++ F R K D+W+ G L++ + K ++ S
Sbjct: 161 SSTGTKFPVKWA----SPEVF-SFSRYSS--KSDVWSFGVLMWEVFSEGKIPYENRSNSE 213
Query: 249 -LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
++ ++ +R+ + S+ V ++ + P+DRP
Sbjct: 214 VVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRP 250
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 59/272 (21%), Positives = 104/272 (38%), Gaps = 43/272 (15%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPN 85
+ + G F V + A+K MI S + ++E VM +L H
Sbjct: 25 DLTFLKELGTGQFGVVKYGK--WRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLS-HEK 80
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
+V LY + + ++ E L+N L F+ +Q+L + +DVC A+
Sbjct: 81 LVQLYGVCT----KQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEY 135
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT-- 202
+ S+ HRDL A N L+ G+ K+ DFG + R+ + +D
Sbjct: 136 LESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLS-----RY-------VLDDEYTSSVGS 181
Query: 203 ------TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI-CYFKNAFDGESKLQILN-- 253
+ PE+ ++ + + K DIWA G L++ I K ++ + +
Sbjct: 182 KFPVRWS----PPEVL-MYSK--FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234
Query: 254 -GNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
R+ S V ++ D+RP
Sbjct: 235 AQGLRLYRPHLASEKVYTIMYSCWHEKADERP 266
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 64/284 (22%), Positives = 108/284 (38%), Gaps = 51/284 (17%)
Query: 27 IHVRNVIAEGGFSCVYSARD----------AIHMSKQYAMKHMICNDEESLESAMKEISV 76
IH+ +I G V R AI K E + E S+
Sbjct: 51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT-------ERQRRDFLSEASI 103
Query: 77 MKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIF 135
M HPN++ L ++ GR A++V E + SL L G F Q++ +
Sbjct: 104 MGQFD-HPNIIRLEG--VVTRGRL--AMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGML 157
Query: 136 RDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEE 195
R V + + HRDL A N+L+ S+ + K+ DFG + R +E+
Sbjct: 158 RGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLS-----RV-------LED 203
Query: 196 DNIRKHTTPAYR------APEMWDLFRRELINEKVDIWALGCLLFRIC-YFKNAFDGESK 248
D +TT + APE FR D+W+ G +++ + Y + + +
Sbjct: 204 DPDAAYTTTGGKIPIRWTAPEAI-AFRTFSS--ASDVWSFGVVMWEVLAYGERPYWNMTN 260
Query: 249 LQILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
+++ YR+P ++ L+ D RP +Q+
Sbjct: 261 RDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQI 304
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 52/291 (17%), Positives = 104/291 (35%), Gaps = 56/291 (19%)
Query: 26 KIHVRNVIAEGGFSCVYSAR---DAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKG 82
+ + +G F V R + + A+K + + EE L +EI ++KSL+
Sbjct: 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ- 69
Query: 83 HPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNA 141
H N+V + + L+ME SL + L+ + ++L +C
Sbjct: 70 HDNIVKYKG--VCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKG 126
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH 201
+ + ++ HRDL N+L+ ++ K+ DFG T + + +D
Sbjct: 127 MEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT-----KV-------LPQDK---- 168
Query: 202 TTPAYRAPEMWDLFRR----ELINE-----KVDIWALGCLL---FRICYFKNAFDGESK- 248
++ E + E + E D+W+ G +L F + E
Sbjct: 169 --EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 226
Query: 249 ---------------LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
+++L N R+P + ++ + + + RP
Sbjct: 227 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 277
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 8e-12
Identities = 44/177 (24%), Positives = 66/177 (37%), Gaps = 18/177 (10%)
Query: 5 KPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQY---AMKHM-I 60
KP + +PT E R + + EG F V R A+K +
Sbjct: 8 KPATEVDPTHFEKRFL-------KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP 60
Query: 61 CNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLE 119
+ + KEI ++++L H N+V I L+ME SL L
Sbjct: 61 ESGGNHIADLKKEIEILRNLY-HENIVKYKG--ICTEDGGNGIKLIMEFLPSGSLKEYLP 117
Query: 120 NRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176
KQ L +C + + S+ HRDL A N+L+ S+ K+ DFG
Sbjct: 118 KNK-NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFG 171
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 60/333 (18%), Positives = 116/333 (34%), Gaps = 66/333 (19%)
Query: 26 KIHVRNVIAEGGFSCVYSARD-----------AIHMSKQYAMKHMICNDEESLESAMKEI 74
+ + VI G F VY AI K E+ + E
Sbjct: 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-------EKQRVDFLGEA 97
Query: 75 SVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLA 133
+M H N++ L ++ + +++ E + +L L + G F Q++
Sbjct: 98 GIMGQFS-HHNIIRLEG--VISKYKP--MMIITEYMENGALDKFLREKD-GEFSVLQLVG 151
Query: 134 IFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGI 193
+ R + + + + + HRDL A N+L+ S+ + K+ DFG + ++ E
Sbjct: 152 MLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLS--------RVLEDDP 201
Query: 194 EEDNIRKHTTPAYR--APEMWDLFRRELINEKVDIWALGCLLFRIC-YFKNAFDGESKLQ 250
E R APE +R+ D+W+ G +++ + Y + + S +
Sbjct: 202 EATYTTSGGKIPIRWTAPEAI-SYRKFTS--ASDVWSFGIVMWEVMTYGERPYWELSNHE 258
Query: 251 ILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGLQKSLPD 307
++ +R+P S++ L+ Q RP + L
Sbjct: 259 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD------------IVSILDK 306
Query: 308 --RPPETQSAVANEGMSKPMNRSPPMPQRSPPP 338
R P++ +A+ P + R P
Sbjct: 307 LIRAPDSLKTLADF--------DPRVSIRLPST 331
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 54/337 (16%), Positives = 110/337 (32%), Gaps = 52/337 (15%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQY---AMKHM-ICNDEESLESAMKEISVMKSLK 81
++ V+ G F V+ +K + + +S ++ + + SL
Sbjct: 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 82 GHPNVVTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVC 139
H ++V L +L LV + SL++ + G + +L +
Sbjct: 74 -HAHIVRLLGLC------PGSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIA 125
Query: 140 NAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIR 199
++ + + HR+L A N+LL S ++ DFG + D+ +
Sbjct: 126 KGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVA-----DL-------LPPDDKQ 171
Query: 200 KHTTPA-----YRAPEMWDLFRRELINEKVDIWALGCLLFRICYF-KNAFDGESKLQI-- 251
+ A + A E F + + D+W+ G ++ + F + G ++
Sbjct: 172 LLYSEAKTPIKWMALESI-HFGKYTH--QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD 228
Query: 252 -LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGLQKSLPDRPP 310
L R+ + + V ++ + RP F ++L + R P
Sbjct: 229 LLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPT-----F---KELANEFTRMA--RDP 278
Query: 311 ETQSAVANEGMSKPMNRSPPMPQRSPPPPPSSVDPTR 347
+ E S P P P V+
Sbjct: 279 PRYLVIKRE--SGPGIAPGPEPHGLTNKKLEEVELEP 313
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 58/291 (19%), Positives = 95/291 (32%), Gaps = 49/291 (16%)
Query: 20 IDVGNLKIHVRNVIAEGGFSCVYSA--RDAIHMSKQYAMKHMICNDEESLESA---MKEI 74
I +L +H VI G F CVY D A+K N + + E
Sbjct: 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK--SLNRITDIGEVSQFLTEG 77
Query: 75 SVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLA 133
+MK HPNV++L L + L+V+ L N + N K ++
Sbjct: 78 IIMKDFS-HPNVLSLLG-ICLRSEGS--PLVVLPYMKHGDLRNFIRNET-HNPTVKDLIG 132
Query: 134 IFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGI 193
V + + S+ HRDL A N +L K+ DFG R +
Sbjct: 133 FGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLA-----RD-------M 178
Query: 194 EEDNI-RKHTTPAYR------APE--MWDLFRRELINEKVDIWALGCLLFRIC------Y 238
+ H + A E F K D+W+ G LL+ + Y
Sbjct: 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKF-----TTKSDVWSFGVLLWELMTRGAPPY 233
Query: 239 FKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
+ L R+ + + +++ + RP +++
Sbjct: 234 P--DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 282
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 67/318 (21%), Positives = 103/318 (32%), Gaps = 81/318 (25%)
Query: 26 KIHVRNVIAEGGFSCVYSARD------------AIHMSKQYAMKHMICNDEESLESAMKE 73
++ + G F V A A+ M K A E+ M E
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-------LTEREALMSE 76
Query: 74 ISVMKSLKGHPNVVTLYAH-TILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQV 131
+ V+ L H N+V L T L++ E C L+N L + + K
Sbjct: 77 LKVLSYLGNHMNIVNLLGACT-----IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 132 LAIFRDVCNAV-----FAMHSQSPPIA------------HRDLKAENLLLGSDGLWKLCD 174
AI D A+ + Q +A HRDL A N+LL + K+CD
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQ---VAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 175 FGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYR----APEMWDLFRRELINEKV-----D 225
FG L + N AP E I V D
Sbjct: 189 FG-----------LARDIKNDSNYVVKGNARLPVKWMAP--------ESIFNCVYTFESD 229
Query: 226 IWALGCLLFRIC------YFKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQAS 279
+W+ G L+ + Y D + I G +R+ + + D+++ A
Sbjct: 230 VWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG-FRMLSPEHAPAEMYDIMKTCWDAD 288
Query: 280 PDDRPDITQVWFRVNEQL 297
P RP Q+ + +Q+
Sbjct: 289 PLKRPTFKQIVQLIEKQI 306
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 2e-11
Identities = 89/645 (13%), Positives = 169/645 (26%), Gaps = 248/645 (38%)
Query: 42 YSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100
Y +D + + + + + C D ++ +S + + + + + V+ + +
Sbjct: 16 YQYKDILSVFEDAFVDNFDCKDVQDMPKSILSK-EEIDHIIMSKDAVS-GTLRLFWTLLS 73
Query: 101 KEALLV--------------------MECCDKSL--------VNVLEN-----------R 121
K+ +V E S+ + L N R
Sbjct: 74 KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSR 133
Query: 122 --------------------------GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHR 155
G+G K +A+ DVC
Sbjct: 134 LQPYLKLRQALLELRPAKNVLIDGVLGSG----KTWVAL--DVC---------------L 172
Query: 156 DLKAENLLLGSDGL-WKLCDFGSTSTNHKRFEKLEEMGIEED---NIRKHTTPAYRAP-E 210
K + + + W + + ++ E L+++ + D R + +
Sbjct: 173 SYKVQCKM--DFKIFW--LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH 228
Query: 211 MWDLFRRELINEKV---------DIWALGCLLFRICYFKNAFDGESKL----------QI 251
R L+ K ++ NAF+ K+
Sbjct: 229 SIQAELRRLLKSKPYENCLLVLLNVQNAKAW--------NAFNLSCKILLTTRFKQVTDF 280
Query: 252 LNGNYRI-------------PES----PKY-SSSVTDLIRDMLQASP----------DDR 283
L+ E KY DL R++L +P D
Sbjct: 281 LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDG 340
Query: 284 PDITQVWFRVN-EQLPVGLQKSLPD-RPPETQS-----AVANEGMSKPMNRSPPMPQRSP 336
W VN ++L ++ SL P E + +V
Sbjct: 341 LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF------------------- 381
Query: 337 PPPPSSVDPTRNISQPSTTPAVSGGGGVLGAFWS-----------TQHAKDSIVAEDQSR 385
P S +I P+ +L W + K S+V +
Sbjct: 382 ---PPSA----HI--PT---------ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE 423
Query: 386 SKFYEEPSIYSTSGHSRSQSDNHPVNPSTVEEENIQNHAIRRNV--HGKSHKPEDG---- 439
S I S + + +N + + ++ I + D
Sbjct: 424 STIS----IPSIYLELKVKLENEY----ALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYS 475
Query: 440 --------PSKDIKMNFFQKD-TDTR-IERPKTLKTESTATFQDEAFNSFVAEFDTNKLN 489
+M F+ D R +E+ K ++ +STA + + + + K
Sbjct: 476 HIGHHLKNIEHPERMTLFRMVFLDFRFLEQ-K-IRHDSTAWNASGSILNTLQQLKFYK-- 531
Query: 490 SAISSNKSEKEEALQNEVERLKGQLKQTNLEKAE---ITSKFEKL 531
I N + ERL + L K E I SK+ L
Sbjct: 532 PYICDND--------PKYERLVNAIL-DFLPKIEENLICSKYTDL 567
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 4e-08
Identities = 46/337 (13%), Positives = 98/337 (29%), Gaps = 114/337 (33%)
Query: 5 KPFMQKEPTGLEGR--SIDVGNL-----KIH--VRNVIAEGGFSCVYSARDAIHMSKQY- 54
E L + +L + ++IAE S RD + +
Sbjct: 296 MTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAE-------SIRDGLATWDNWK 348
Query: 55 -----AMKHMICNDEESLESA-MKE----ISVMKSLKGHPNV-VTLYAHTIL--DLGRTK 101
+ +I + LE A ++ +SV P+ + +++ D+ ++
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP-----PSAHIPTILLSLIWFDVIKSD 403
Query: 102 EALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAEN 161
++V + SLV + + ++ S + +LK +
Sbjct: 404 VMVVVNKLHKYSLVE-------------------KQPKESTISIPSI-----YLELKVKL 439
Query: 162 LLLGSDGLWKLCDFGSTSTNHKR----------FEKLEEMGIEEDN-----IRKHTTPAY 206
+ + L H+ F+ + + D I H
Sbjct: 440 -----ENEYAL---------HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIE 485
Query: 207 RAPEMWDLFRRELINEKVDIWALGCLLF---RICYFKNAFDGESK----LQILNGNYR-- 257
E LFR ++ F +I + A++ LQ L Y+
Sbjct: 486 HP-ERMTLFRMVFLD----------FRFLEQKIRHDSTAWNASGSILNTLQQLK-FYKPY 533
Query: 258 -IPESPKYSSSVTDLIRDMLQASPD----DRPDITQV 289
PKY V ++ + + + D+ ++
Sbjct: 534 ICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRI 570
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 54/293 (18%), Positives = 104/293 (35%), Gaps = 63/293 (21%)
Query: 27 IHVRNVIAEGGFSCVYSAR---DAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGH 83
+ + + +G F V R + A+K + + + +EI ++K+L
Sbjct: 25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH-S 83
Query: 84 PNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAV 142
+V + + LVME L + L+ + ++L +C +
Sbjct: 84 DFIVKYRG--VSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGM 140
Query: 143 FAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT 202
+ S+ HRDL A N+L+ S+ K+ DFG + + +++D
Sbjct: 141 EYLGSRR--CVHRDLAARNILVESEAHVKIADFGLA-----KL-----LPLDKDYYVVRE 188
Query: 203 --------TPAYRAPEMWDLFRRELINE-----KVDIWALGCLLFRI-------CYFKNA 242
APE +++ + D+W+ G +L+ + C
Sbjct: 189 PGQSPIFWY----APES--------LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236
Query: 243 FDGESK-----------LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
F L++L R+P P + V +L++ SP DRP
Sbjct: 237 FLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRP 289
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 53/291 (18%), Positives = 104/291 (35%), Gaps = 56/291 (19%)
Query: 26 KIHVRNVIAEGGFSCVYSAR---DAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKG 82
+ + +G F V R + + A+K + + EE L +EI ++KSL+
Sbjct: 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ- 100
Query: 83 HPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNA 141
H N+V + + L+ME SL + L+ + ++L +C
Sbjct: 101 HDNIVKYKG--VCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKG 157
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH 201
+ + ++ HRDL N+L+ ++ K+ DFG T + + +D
Sbjct: 158 MEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT-----KV-------LPQDK---- 199
Query: 202 TTPAYRAPEMWDLFRR----ELINE-----KVDIWALGCLL---FRICYFKNAFDGESK- 248
Y+ E + E + E D+W+ G +L F + E
Sbjct: 200 --EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 257
Query: 249 ---------------LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
+++L N R+P + ++ + + + RP
Sbjct: 258 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 308
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 34/148 (22%), Positives = 60/148 (40%), Gaps = 15/148 (10%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAH 92
I G F +Y D I ++ A+K + E + K ++G + T+
Sbjct: 17 IGSGSFGDIYLGTD-IAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQGGVGIPTIRWC 73
Query: 93 TILDLGRTKEA-LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPP 151
G + ++VME SL ++ F K VL + + + + +HS++
Sbjct: 74 -----GAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN-- 125
Query: 152 IAHRDLKAENLLLGSDGLWK---LCDFG 176
HRD+K +N L+G + DFG
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFG 153
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 74/308 (24%), Positives = 108/308 (35%), Gaps = 86/308 (27%)
Query: 26 KIHVRNVIAEGGFSCVYSARD---------AIHMSKQYAMKHMICNDEESLESAMKEISV 76
I ++VI EG F V AR AI K+YA K +D E+ V
Sbjct: 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK----DDHRDF---AGELEV 78
Query: 77 MKSLKGHPNVVTLYAHTILDLG---RTKEALLVMECCDK-SLVNVL-------------- 118
+ L HPN++ L LG L +E +L++ L
Sbjct: 79 LCKLGHHPNIINL-------LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131
Query: 119 ENRGAGYFEEKQVLAIFRDVCNAVFAM-HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS 177
N A +Q+L DV M + HRDL A N+L+G + + K+ DFG
Sbjct: 132 ANSTASTLSSQQLLHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKIADFG- 187
Query: 178 TSTNHKRFEKLEEMGIEEDNIRKHTT---PAYR--APEMWDLFRRELINEKV-----DIW 227
+ ++ K T P R A E +N V D+W
Sbjct: 188 -------------LSRGQEVYVKKTMGRLP-VRWMAIES--------LNYSVYTTNSDVW 225
Query: 228 ALGCLLFRIC------YFKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPD 281
+ G LL+ I Y + L YR+ + V DL+R + P
Sbjct: 226 SYGVLLWEIVSLGGTPYC--GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPY 283
Query: 282 DRPDITQV 289
+RP Q+
Sbjct: 284 ERPSFAQI 291
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 36/156 (23%), Positives = 63/156 (40%), Gaps = 11/156 (7%)
Query: 25 LKIHVRNVIAEGGFSCVY--SARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLK 81
+ H VI +G F VY D Q A+K + + + +E+ ++E +M+ L
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 82 GHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCN 140
HPNV+ L + G +++ L+ + + K +++ V
Sbjct: 81 -HPNVLALIGIMLPPEGLP---HVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVAR 135
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176
+ + Q HRDL A N +L K+ DFG
Sbjct: 136 GMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFG 169
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 59/283 (20%), Positives = 99/283 (34%), Gaps = 60/283 (21%)
Query: 26 KIHVRNVIAEGGFSCVYSARD----------AIHMSKQYAMKHMICNDEESLESAMKEIS 75
+I + I EG F V+ AI K + E ++E
Sbjct: 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-------DSVREKFLQEAL 68
Query: 76 VMKSLKGHPNVVTLYAHTILDLGRTKE-ALLVMECCDK-SLVNVLENRGAGYFEEKQVLA 133
M+ HP++V L T+ ++ME C L + L+ R + ++
Sbjct: 69 TMRQFD-HPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRK-YSLDLASLIL 120
Query: 134 IFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGI 193
+ A+ + S+ HRD+ A N+L+ S+ KL DFG + R+ +
Sbjct: 121 YAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLS-----RY-------M 166
Query: 194 EEDNIRKHT--------TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC-YFKNAFD 244
E+ K + APE FRR D+W G ++ I + F
Sbjct: 167 EDSTYYKASKGKLPIKWM----APESI-NFRRFTS--ASDVWMFGVCMWEILMHGVKPFQ 219
Query: 245 GESKLQILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
G ++ R+P P ++ L+ P RP
Sbjct: 220 GVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRP 262
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 9e-11
Identities = 60/279 (21%), Positives = 101/279 (36%), Gaps = 52/279 (18%)
Query: 26 KIHVRNVIAEGGFSCVYSARD----------AIHMSKQYAMKHMICNDEESLESAMKEIS 75
+I + I EG F V+ AI K + E ++E
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-------DSVREKFLQEAL 443
Query: 76 VMKSLKGHPNVVTLYAHTILDLGRTKE-ALLVMECCDK-SLVNVLENRGAGYFEEKQVLA 133
M+ HP++V L T+ ++ME C L + L+ R + ++
Sbjct: 444 TMRQFD-HPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRK-FSLDLASLIL 495
Query: 134 IFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGI 193
+ A+ + S+ HRD+ A N+L+ S+ KL DFG + R+ +
Sbjct: 496 YAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLS-----RY-------M 541
Query: 194 EEDNIRKHTT---PA-YRAPEMWDLFRRELINEKVDIWALGCLLFRIC-YFKNAFDGESK 248
E+ K + P + APE FRR D+W G ++ I + F G
Sbjct: 542 EDSTYYKASKGKLPIKWMAPESI-NFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKN 598
Query: 249 LQILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
++ R+P P ++ L+ P RP
Sbjct: 599 NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRP 637
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 56/302 (18%), Positives = 103/302 (34%), Gaps = 62/302 (20%)
Query: 8 MQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARD---------AIHMSKQYAMKH 58
M E + +D L + + + G F V A+ + K A
Sbjct: 1 MALEEIRPKEVYLDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-- 57
Query: 59 MICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL-LVMECCDK-SLVN 116
D + + E +VM+ L +P +V + E+ LVME + L
Sbjct: 58 ----DPALKDELLAEANVMQQLD-NPYIVRMIGIC------EAESWMLVMEMAELGPLNK 106
Query: 117 VLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176
L + + ++K ++ + V + + + HRDL A N+LL + K+ DFG
Sbjct: 107 YL--QQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFG 162
Query: 177 STSTNHKRFEKLEEMGIEEDNIRKHT--------TPAYRAPEMWDLFRRELINEKVDIWA 228
+ + + +E+ + T APE + + K D+W+
Sbjct: 163 LS-----KA-----LRADENYYKAQTHGKWPVKWY----APECI-NYYKFSS--KSDVWS 205
Query: 229 LGCLLFRIC------YFKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDD 282
G L++ Y G +L R+ + DL+ ++
Sbjct: 206 FGVLMWEAFSYGQKPYRG--MKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVEN 263
Query: 283 RP 284
RP
Sbjct: 264 RP 265
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 65/304 (21%), Positives = 111/304 (36%), Gaps = 41/304 (13%)
Query: 11 EPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQY-----AMKHMICNDEE 65
P I +L++ + +G F V K +K + + E
Sbjct: 6 GPLQSLTCLIGEKDLRL--LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE 63
Query: 66 SLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGA 123
+++ ++E++ M SL H N++ LY + +V E SL++ L
Sbjct: 64 AMDDFIREVNAMHSLD-HRNLIRLYGVV------LTPPMKMVTELAPLGSLLDRLRKHQ- 115
Query: 124 GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183
G+F + V + + S+ HRDL A NLLL + L K+ DFG
Sbjct: 116 GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLM----- 168
Query: 184 RFEKLEEMGIEEDNIRKHT---TP-AYRAPEMWDLFRRELINEKVDIWALGCLLFRIC-Y 238
R + +D+ P A+ APE R D W G L+ + Y
Sbjct: 169 RA-----LPQNDDHYVMQEHRKVPFAWCAPESL-KTRTFSH--ASDTWMFGVTLWEMFTY 220
Query: 239 FKNAFDGESKLQILN----GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVN 294
+ + G + QIL+ R+P + +++ P+DRP + +
Sbjct: 221 GQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280
Query: 295 EQLP 298
E P
Sbjct: 281 EAQP 284
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 63/317 (19%), Positives = 103/317 (32%), Gaps = 83/317 (26%)
Query: 26 KIHVRNVIAEGGFSCVYSARD------------AIHMSKQYAMKHMICNDEESLESAMKE 73
+ + G F V A A+ M K A + E+ M E
Sbjct: 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH-------ADEKEALMSE 99
Query: 74 ISVMKSLKGHPNVVTLYAHTILDLG---RTKEALLVMECCDK-SLVNVL-ENRGAGYFEE 128
+ +M L H N+V L LG L++ E C L+N L +
Sbjct: 100 LKIMSHLGQHENIVNL-------LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 129 KQVLAIFRDVCNAVFAMHSQSPPIA------------HRDLKAENLLLGSDGLWKLCDFG 176
+A + SQ +A HRD+ A N+LL + + K+ DFG
Sbjct: 153 AFAIANSTASTRDLLHFSSQ---VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFG 209
Query: 177 STSTNHKRFEKLEEMGIEEDNIRKHTTPAYR----APEMWDLFRRELINEKV-----DIW 227
L + + N APE I + V D+W
Sbjct: 210 -----------LARDIMNDSNYIVKGNARLPVKWMAPES--------IFDCVYTVQSDVW 250
Query: 228 ALGCLLFRIC------YFKNAFDGESKLQILNGNYRIPESPKY-SSSVTDLIRDMLQASP 280
+ G LL+ I Y + + + +G Y++ P + ++ +++ P
Sbjct: 251 SYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG-YQM-AQPAFAPKNIYSIMQACWALEP 308
Query: 281 DDRPDITQVWFRVNEQL 297
RP Q+ + EQ
Sbjct: 309 THRPTFQQICSFLQEQA 325
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 58/306 (18%), Positives = 102/306 (33%), Gaps = 74/306 (24%)
Query: 26 KIHVRNVIAEGGFSCVYSARD------------AIHMSKQYAMKHMICNDEESLESAMKE 73
++ + + G F V A A+ M K+ A + M E
Sbjct: 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------HSEHRALMSE 80
Query: 74 ISVMKSLKGHPNVVTLYAH-TILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQV 131
+ ++ + H NVV L T ++++E C +L L ++ + K
Sbjct: 81 LKILIHIGHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 132 LAIFRDVCNAVFAMHSQSPPIA------------HRDLKAENLLLGSDGLWKLCDFGSTS 179
+ + S +A HRDL A N+LL + K+CDFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG--- 193
Query: 180 TNHKRFEKLEEMGIEEDNIRKHTT---PAYR--APEMWDLFRRELINEKV-----DIWAL 229
L ++ + + P + APE I ++V D+W+
Sbjct: 194 --------LARDIYKDPDYVRKGDARLPL-KWMAPET--------IFDRVYTIQSDVWSF 236
Query: 230 GCLLFRIC------YFKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDR 283
G LL+ I Y D E ++ G R+ + + + D P R
Sbjct: 237 GVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-TRMRAPDYTTPEMYQTMLDCWHGEPSQR 295
Query: 284 PDITQV 289
P +++
Sbjct: 296 PTFSEL 301
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 34/150 (22%), Positives = 62/150 (41%), Gaps = 17/150 (11%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAH 92
I EG F ++ + + ++Q A+K + E K L G + +Y
Sbjct: 18 IGEGSFGVIFEGTN-LLNNQQVAIKFEPRRSDAP--QLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 93 TILDLGRTKE-ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPP 151
G+ +LV++ SL ++L+ G F K V + + V ++H +S
Sbjct: 75 -----GQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS-- 126
Query: 152 IAHRDLKAENLLLGSDGLWK-----LCDFG 176
+ +RD+K +N L+G + DFG
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 37/156 (23%), Positives = 62/156 (39%), Gaps = 13/156 (8%)
Query: 26 KIHVRNVIAEGGFSCVYSAR---DAIHMSKQYAMKHM-ICNDEESLESAMKEISVMKSLK 81
+ + EG F V + A+K + + +EI ++++L
Sbjct: 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY 91
Query: 82 GHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCN 140
H +++ + LVME SL + L G Q+L + +C
Sbjct: 92 -HEHIIKYKG--CCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGL---AQLLLFAQQICE 145
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176
+ +H+Q HRDL A N+LL +D L K+ DFG
Sbjct: 146 GMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFG 179
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 61/315 (19%), Positives = 104/315 (33%), Gaps = 86/315 (27%)
Query: 26 KIHVRNVIAEGGFSCVYSARD------------AIHMSKQYAMKHMICNDEESLESAMKE 73
+ V+ G F V +A A+ M K+ A E+ M E
Sbjct: 46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-------SSEREALMSE 98
Query: 74 ISVMKSLKGHPNVVTLYAHTILDLG---RTKEALLVMECCDK-SLVNVLENRGAGYFEEK 129
+ +M L H N+V L LG + L+ E C L+N L ++ + E++
Sbjct: 99 LKMMTQLGSHENIVNL-------LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 151
Query: 130 QVLAIFRDVCNAVFA-------MHSQSPPIA------------HRDLKAENLLLGSDGLW 170
+ + + + +A HRDL A N+L+ +
Sbjct: 152 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVV 211
Query: 171 KLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYR----APEMWDLFRRELINEKV-- 224
K+CDFG L + + N AP E + E +
Sbjct: 212 KICDFG-----------LARDIMSDSNYVVRGNARLPVKWMAP--------ESLFEGIYT 252
Query: 225 ---DIWALGCLLFRIC------YFKNAFDGESKLQILNGNYRIPESPKY-SSSVTDLIRD 274
D+W+ G LL+ I Y D I NG +++ + P Y + + +++
Sbjct: 253 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG-FKM-DQPFYATEEIYIIMQS 310
Query: 275 MLQASPDDRPDITQV 289
RP +
Sbjct: 311 CWAFDSRKRPSFPNL 325
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 32/161 (19%), Positives = 63/161 (39%), Gaps = 13/161 (8%)
Query: 26 KIHVRNVIAEGGFSCVYSA--RDAIHMSKQYAMK--HMICNDEESLESAMKEISVMKSLK 81
+ + ++ EG F V + S + A+K + + + +E + E + MK
Sbjct: 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS 94
Query: 82 GHPNVVTLYAH-TILDLGRTKEALLVMECCDK-SLVNVLENR----GAGYFEEKQVLAIF 135
HPNV+ L + + ++++ L L G + + +L
Sbjct: 95 -HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 136 RDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176
D+ + + +++ HRDL A N +L D + DFG
Sbjct: 154 VDIALGMEYLSNRN--FLHRDLAARNCMLRDDMTVCVADFG 192
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 59/292 (20%), Positives = 97/292 (33%), Gaps = 51/292 (17%)
Query: 20 IDVGNLKIHVRNVIAEGGFSCVYSA--RDAIHMSKQYAMK--HMICNDEESLESAMKEIS 75
I +L +H VI G F CVY D A+K + I + E + + E
Sbjct: 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGI 142
Query: 76 VMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAI 134
+MK HPNV++L L + L+V+ L N + N K ++
Sbjct: 143 IMKDFS-HPNVLSLLG-ICLRSEGS--PLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGF 197
Query: 135 FRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST----STNHKRFEKLEE 190
V + + S+ HRDL A N +L K+ DFG
Sbjct: 198 GLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 255
Query: 191 -------MGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC------ 237
M +E +K TT K D+W+ G LL+ +
Sbjct: 256 AKLPVKWMALESLQTQKFTT-------------------KSDVWSFGVLLWELMTRGAPP 296
Query: 238 YFKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
Y + L R+ + + +++ + RP +++
Sbjct: 297 YP--DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 346
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 34/161 (21%), Positives = 61/161 (37%), Gaps = 18/161 (11%)
Query: 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK 81
VG V I G F + ++ ++ ++ A+K E K L
Sbjct: 7 VGP-NFRVGKKIGCGNFGELRLGKN-LYTNEYVAIKLEPMKSRAP--QLHLEYRFYKQLG 62
Query: 82 GHPNVVTLYAHTILDLGRTKE-ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCN 140
+ +Y G + +V+E SL ++ + F K VL I + +
Sbjct: 63 SGDGIPQVYYF-----GPCGKYNAMVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLIS 116
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDGLWK-----LCDFG 176
+ +HS++ + +RD+K EN L+G G + DF
Sbjct: 117 RMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 56/281 (19%), Positives = 97/281 (34%), Gaps = 44/281 (15%)
Query: 20 IDVGNLKIHVRNVIAEGGFSCVYSAR-DAIHMSKQYAMKHM-ICNDEESLESAMKEISVM 77
+ NL I + G F V A+K + ++ E M+E +M
Sbjct: 6 LKRDNLLI-ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM 64
Query: 78 KSLKGHPNVVTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIF 135
L +P +V L EAL LVME L L + V +
Sbjct: 65 HQLD-NPYIVRLIGVC------QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELL 116
Query: 136 RDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEE 195
V + + ++ HRDL A N+LL + K+ DFG + + +G ++
Sbjct: 117 HQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLS-----KA-----LGADD 164
Query: 196 DNIRKHT--------TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC-YFKNAFDGE 246
+ APE FR+ + D+W+ G ++ Y + +
Sbjct: 165 SYYTARSAGKWPLKWY----APECI-NFRKFSS--RSDVWSYGVTMWEALSYGQKPYKKM 217
Query: 247 SKLQILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
+++ R+ P+ + L+ D +DRP
Sbjct: 218 KGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRP 258
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 7e-10
Identities = 53/278 (19%), Positives = 99/278 (35%), Gaps = 45/278 (16%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQY---AMKHM-ICNDEESLESAMKEISVMKSLKGHP 84
+ G F V M K+ A+K + ++ E M+E +M L +P
Sbjct: 340 ADIELGCGNFGSVRQGV--YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NP 396
Query: 85 NVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143
+V L + + + +LVME L L + V + V +
Sbjct: 397 YIVRLIG-----VCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMK 450
Query: 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT- 202
+ ++ HR+L A N+LL + K+ DFG + + +G ++ +
Sbjct: 451 YLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLS-----KA-----LGADDSYYTARSA 498
Query: 203 -------TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC-YFKNAFDGESKLQIL-- 252
APE FR+ + D+W+ G ++ Y + + +++
Sbjct: 499 GKWPLKWY----APECI-NFRKFSS--RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 551
Query: 253 -NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
R+ P+ + L+ D +DRPD V
Sbjct: 552 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV 589
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 53/288 (18%), Positives = 97/288 (33%), Gaps = 46/288 (15%)
Query: 26 KIHVRNVIAEGGFSCVY--SARDAIHMSKQYAMK--HMICNDEESLESAMKEISVMKSLK 81
+ + ++ +G F V + + A+K +E ++E + MK
Sbjct: 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 82 GHPNVVTLYAHTILDLGRTKEA--LLVMECCDK-SLVNVL----ENRGAGYFEEKQVLAI 134
HP+V L ++ + + ++++ L L + ++
Sbjct: 84 -HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 135 FRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIE 194
D+ + + S++ HRDL A N +L D + DFG L
Sbjct: 143 MVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFG-----------LSRKIYS 189
Query: 195 EDNIRKHTT---PAYR--APE--MWDLFRRELINEKVDIWALGCLLFRIC------YFKN 241
D R+ P + A E +L+ D+WA G ++ I Y
Sbjct: 190 GDYYRQGCASKLP-VKWLALESLADNLY-----TVHSDVWAFGVTMWEIMTRGQTPYA-- 241
Query: 242 AFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
+ L G R+ + P+ V DL+ A P RP T +
Sbjct: 242 GIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCL 289
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 7e-10
Identities = 38/158 (24%), Positives = 66/158 (41%), Gaps = 19/158 (12%)
Query: 26 KIHVRNVIAEGGFSCVYSA--RDAIHMSKQYAMKHMICNDEESLESA---MKEISVMKSL 80
+ + ++ EG F VY + A+K C + +L++ M E +MK+L
Sbjct: 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVK--TCKKDCTLDNKEKFMSEAVIMKNL 70
Query: 81 KGHPNVVTLYAHTILDLGRTKE-ALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDV 138
HP++V L +E ++ME L + LE + ++ +
Sbjct: 71 D-HPHIVKLIGII------EEEPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQI 122
Query: 139 CNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176
C A+ + S + HRD+ N+L+ S KL DFG
Sbjct: 123 CKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFG 158
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 8e-10
Identities = 51/275 (18%), Positives = 94/275 (34%), Gaps = 44/275 (16%)
Query: 27 IHVRNVIAEGGFSCVYSARDAIHMSKQY---AMKHMICNDEESLESA---MKEISVMKSL 80
V+ G F VY K A+K + S ++ + E VM S+
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASV 74
Query: 81 KGHPNVVTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDV 138
+P+V L + L+ + L++ + + +L +
Sbjct: 75 D-NPHVCRLLGIC------LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQI 126
Query: 139 CNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNI 198
+ + + + HRDL A N+L+ + K+ DFG + + +
Sbjct: 127 AKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLA-----KL-------LGAEEK 172
Query: 199 RKHTTPA-----YRAPEMWDLFRRELINEKVDIWALGCLLFRICYF-KNAFDGESKLQI- 251
H + A E L R + D+W+ G ++ + F +DG +I
Sbjct: 173 EYHAEGGKVPIKWMALESI-LHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229
Query: 252 --LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
L R+P+ P + V ++R D RP
Sbjct: 230 SILEKGERLPQPPICTIDVYMIMRKCWMIDADSRP 264
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 55/287 (19%), Positives = 99/287 (34%), Gaps = 62/287 (21%)
Query: 26 KIHVRNVIAEGGFSCVYSAR------DAIHMSKQYAMKHMICNDEESLESAMKEISVMKS 79
+ + +G F+ ++ + +K + ES + S+M
Sbjct: 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK 68
Query: 80 LKGHPNVVTLYA-HTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRD 137
L H ++V Y E +LV E SL L+ L + +
Sbjct: 69 LS-HKHLVLNYGVCV-----CGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQ 121
Query: 138 VCNAVFAMH---SQSPPIAHRDLKAENLLLGSDGLW--------KLCDFGSTSTNHKRFE 186
+ A MH + + H ++ A+N+LL + KL D G +
Sbjct: 122 LAAA---MHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-----IT- 170
Query: 187 KLEEMGIEEDNIRKHTTPAYRAPEMW-----DLFRRELINEKVDIWALGCLLFRICYFKN 241
+ +I + W + L N D W+ G L+ IC +
Sbjct: 171 ------VLPKDI-------LQERIPWVPPECIENPKNL-NLATDKWSFGTTLWEICSGGD 216
Query: 242 ----AFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
A D + KLQ +++P +PK ++ + +LI + + PD RP
Sbjct: 217 KPLSALDSQRKLQFYEDRHQLP-APK-AAELANLINNCMDYEPDHRP 261
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 63/307 (20%), Positives = 111/307 (36%), Gaps = 76/307 (24%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC--------NDEESLESAMKEISVM 77
K+ + + EG F V A A+ + K + + E+ L + E+ +M
Sbjct: 36 KLTLGKPLGEGAFGQVVMAE-AVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 78 KSLKGHPNVVTLYAHTILDLG---RTKEALLVMECCDK-SLVNVLENRGAGYFEE----- 128
K + H N++ L LG + +++E K +L L R E
Sbjct: 95 KMIGKHKNIINL-------LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 129 ---------KQVLAIFRDVCNAVFAM-HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178
K +++ + M + S HRDL A N+L+ + + K+ DFG
Sbjct: 148 RVPEEQMTFKDLVSCTYQLAR---GMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYR-----APEMWDLFRRELINEKV-----DIWA 228
R I + K TT APE + ++V D+W+
Sbjct: 205 -----RD-------INNIDYYKKTTNGRLPVKWMAPEA--------LFDRVYTHQSDVWS 244
Query: 229 LGCLLFRIC------YFKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDD 282
G L++ I Y E ++L +R+ + ++ + ++RD A P
Sbjct: 245 FGVLMWEIFTLGGSPYP--GIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQ 302
Query: 283 RPDITQV 289
RP Q+
Sbjct: 303 RPTFKQL 309
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 66/313 (21%), Positives = 112/313 (35%), Gaps = 88/313 (28%)
Query: 26 KIHVRNVIAEGGFSCVYSARD--------------AIHMSKQYAMKHMICNDEESLESAM 71
++ + + EG F V A A+ M K A E+ L +
Sbjct: 70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-------EKDLSDLI 122
Query: 72 KEISVMKSLKGHPNVVTLYAHTILDLG---RTKEALLVMECCDK-SLVNVLENRGAGYFE 127
E+ +MK + H N++ L LG + +++E K +L L+ R E
Sbjct: 123 SEMEMMKMIGKHKNIINL-------LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 175
Query: 128 E--------------KQVLAIFRDVCNAVFAM-HSQSPPIAHRDLKAENLLLGSDGLWKL 172
K +++ V M + S HRDL A N+L+ D + K+
Sbjct: 176 YSYNPSHNPEEQLSSKDLVSCAYQVAR---GMEYLASKKCIHRDLAARNVLVTEDNVMKI 232
Query: 173 CDFGSTSTNHKRFEKLEEMGIEEDNIRKHTT---PAYR--APEMWDLFRRELINEKV--- 224
DFG L D +K T P + APE + +++
Sbjct: 233 ADFG-----------LARDIHHIDYYKKTTNGRLP-VKWMAPEA--------LFDRIYTH 272
Query: 225 --DIWALGCLLFRIC------YFKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDML 276
D+W+ G LL+ I Y E ++L +R+ + ++ + ++RD
Sbjct: 273 QSDVWSFGVLLWEIFTLGGSPYP--GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCW 330
Query: 277 QASPDDRPDITQV 289
A P RP Q+
Sbjct: 331 HAVPSQRPTFKQL 343
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 5e-09
Identities = 60/324 (18%), Positives = 99/324 (30%), Gaps = 89/324 (27%)
Query: 26 KIHVRNVIAEGGFSCVYSARD------------AIHMSKQYAMKHMICNDEESLESAMKE 73
+ + + EG F V A A+ M K+ A L + E
Sbjct: 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-------PSELRDLLSE 76
Query: 74 ISVMKSLKGHPNVVTLYAHTILDLG---RTKEALLVMECCDK-SLVNVLENRGAGYFEEK 129
+V+K + HP+V+ L G + LL++E SL L
Sbjct: 77 FNVLKQV-NHPHVIKL-------YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 130 QVLAIFRDVCNAVFAMHSQSPP--------IA------------HRDLKAENLLLGSDGL 169
+ + I+ HRDL A N+L+
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
Query: 170 WKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTT---PAYR--APEMWDLFRRELINEKV 224
K+ DFG L EED+ K + P + A E + + +
Sbjct: 189 MKISDFG-----------LSRDVYEEDSYVKRSQGRIP-VKWMAIES--------LFDHI 228
Query: 225 -----DIWALGCLLFRIC------YFKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIR 273
D+W+ G LL+ I Y E +L +R+ S + L+
Sbjct: 229 YTTQSDVWSFGVLLWEIVTLGGNPYP--GIPPERLFNLLKTGHRMERPDNCSEEMYRLML 286
Query: 274 DMLQASPDDRPDITQVWFRVNEQL 297
+ PD RP + + + +
Sbjct: 287 QCWKQEPDKRPVFADISKDLEKMM 310
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 5e-09
Identities = 31/186 (16%), Positives = 51/186 (27%), Gaps = 48/186 (25%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEE--------SLESAMKEISVMKSLKG-- 82
I EG F V+ A+K + + + E + EI + K L
Sbjct: 28 IGEGVFGEVFQTI---ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLS 84
Query: 83 ------HPNVVTLYAHTI--------------------------LDLGRTKEALLVMECC 110
+ L + D + + +V+E
Sbjct: 85 GEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFE 144
Query: 111 DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLW 170
+ LE +I + ++ A+ S HRDL N+LL L
Sbjct: 145 FGGID--LEQMRTKLSSLATAKSILHQLTASL-AVAEASLRFEHRDLHWGNVLLKKTSLK 201
Query: 171 KLCDFG 176
KL
Sbjct: 202 KLHYTL 207
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 54/337 (16%), Positives = 105/337 (31%), Gaps = 58/337 (17%)
Query: 27 IHVRNVIAEGGFSCVYSARDAIHMSKQY---AMKHMICND---EESLESAMKEISVMKSL 80
V+ G F VY K A+K + ++ + + E VM S+
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASV 74
Query: 81 KGHPNVVTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDV 138
+P+V L + L+ + L++ + + +L +
Sbjct: 75 D-NPHVCRLLGIC------LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQI 126
Query: 139 CNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNI 198
+ + + + HRDL A N+L+ + K+ DFG + + +
Sbjct: 127 AKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLA-----KL-------LGAEEK 172
Query: 199 RKHTTPA-----YRAPEMWDLFRRELINEKVDIWALGCLLFRICYF-KNAFDGESKLQI- 251
H + A E L R + D+W+ G ++ + F +DG +I
Sbjct: 173 EYHAEGGKVPIKWMALESI-LHRIYTH--QSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229
Query: 252 --LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGLQKSLPD-- 307
L R+P+ P + V ++ D RP + L
Sbjct: 230 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRE------------LIIEFSKMA 277
Query: 308 RPPETQSAVANEGMSKPMNRSPPMPQRSPPPPPSSVD 344
R P+ + + + + R+ D
Sbjct: 278 RDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDD 314
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 64/315 (20%), Positives = 115/315 (36%), Gaps = 76/315 (24%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC--------NDEESLESAMKEISVM 77
K+ + + EG F V A A+ + K + + E+ L + E+ +M
Sbjct: 82 KLTLGKPLGEGCFGQVVMAE-AVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 78 KSLKGHPNVVTLYAHTILDLG---RTKEALLVMECCDK-SLVNVLENRGAGYFEE----- 128
K + H N++ L LG + +++E K +L L R E
Sbjct: 141 KMIGKHKNIINL-------LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193
Query: 129 ---------KQVLAIFRDVCNAVFAM-HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178
K +++ + M + S HRDL A N+L+ + + K+ DFG
Sbjct: 194 RVPEEQMTFKDLVSCTYQLAR---GMEYLASQKCIHRDLAARNVLVTENNVMKIADFG-- 248
Query: 179 STNHKRFEKLEEMGIEEDNIRKHTT---PAYR--APEMWDLFRRELINEKV-----DIWA 228
L D +K T P + APE + ++V D+W+
Sbjct: 249 ---------LARDINNIDYYKKTTNGRLPV-KWMAPEA--------LFDRVYTHQSDVWS 290
Query: 229 LGCLLFRIC------YFKNAFDGESKLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDD 282
G L++ I Y E ++L +R+ + ++ + ++RD A P
Sbjct: 291 FGVLMWEIFTLGGSPYP--GIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQ 348
Query: 283 RPDITQVWFRVNEQL 297
RP Q+ ++ L
Sbjct: 349 RPTFKQLVEDLDRIL 363
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 34/150 (22%), Positives = 60/150 (40%), Gaps = 15/150 (10%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAH 92
I G F +Y + I +++ A+K + + E + + L+G + +
Sbjct: 15 IGSGSFGEIYLGTN-IQTNEEVAIKLENVKTKHP--QLLYESKIYRILQGGTGIPNVRWF 71
Query: 93 TILDLGRTKE-ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPP 151
G + +LVM+ SL ++ K VL + + N V +HS+S
Sbjct: 72 -----GVEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS-- 123
Query: 152 IAHRDLKAENLLLGSDGLWK---LCDFGST 178
HRD+K +N L+G + DFG
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 26/164 (15%), Positives = 61/164 (37%), Gaps = 27/164 (16%)
Query: 33 IAEGGFSCVYSARDAIHMS-------KQYAMK-----HMICNDEESLESAMK--EISVMK 78
+Y A ++ +++++K + N++ + A K +++ K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 79 SLKG--HPNVVTLYAHTILDLGRTKEA--LLVMECCDKSLVNVLENRGAGYFEEKQVLAI 134
L + T G ++ LV+ +SL + L+ E+ VL +
Sbjct: 110 KLYSTPLLAIPTCMGF-----GVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQV 164
Query: 135 FRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWK--LCDFG 176
+ +A+ +H H ++ AEN+ + + + L +G
Sbjct: 165 ACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYG 206
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 33/160 (20%), Positives = 57/160 (35%), Gaps = 22/160 (13%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAH 92
I GGF +Y A + +H++ + + E+ + + +
Sbjct: 45 IGSGGFGLIYLAFPTN--KPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 93 TILDL---------GRTKEA-----LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDV 138
LD G T+ +VME L + G F++ VL + +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT--FKKSTVLQLGIRM 160
Query: 139 CNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWK--LCDFG 176
+ + +H H D+KA NLLLG + L D+G
Sbjct: 161 LDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYG 198
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 38/170 (22%), Positives = 70/170 (41%), Gaps = 31/170 (18%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSK-----QYAMK--HMICNDEESLESAMKEISVMK 78
KI + + +G F VY A + K + A+K + + E +E + E SVMK
Sbjct: 26 KITMSRELGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMK 83
Query: 79 SLKGHPNVVTLYAHTILDLG---RTKEALLVMECCDK-SLVNVLENRGAGYFEE------ 128
+VV L LG + + L++ME + L + L +
Sbjct: 84 EF-NCHHVVRL-------LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135
Query: 129 --KQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176
+++ + ++ + + +++ HRDL A N ++ D K+ DFG
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFG 183
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 38/187 (20%), Positives = 56/187 (29%), Gaps = 51/187 (27%)
Query: 26 KIHVRNVIAEGGFSCVYSARD------------AIHMSKQYAMKHMICNDEESLESAMKE 73
I I EG F V+ AR A+ M K+ A + +E
Sbjct: 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-------ADMQADFQRE 100
Query: 74 ISVMKSLKGHPNVVTLYAHTILDLG---RTKEALLVMECCDK-SLVNVLENRGAGYFEEK 129
++M +PN+V L LG K L+ E L L +
Sbjct: 101 AALMAEFD-NPNIVKL-------LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 152
Query: 130 QVLAIFRDVCNAVFAMHSQSPP--------IA------------HRDLKAENLLLGSDGL 169
+ + S +A HRDL N L+G + +
Sbjct: 153 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV 212
Query: 170 WKLCDFG 176
K+ DFG
Sbjct: 213 VKIADFG 219
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 6e-07
Identities = 33/178 (18%), Positives = 44/178 (24%), Gaps = 41/178 (23%)
Query: 26 KIHVRNVIAEGGFSCVYSARD------------AIHMSKQYAMKHMICNDEESLESAMKE 73
+ + E F VY AI K A E E
Sbjct: 10 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-------GPLREEFRHE 62
Query: 74 ISVMKSLKGHPNVVTLYAHTILDLGRTKE--ALLVMECCDK-SLVNVLENRGAGYFEEKQ 130
+ L+ HPNVV L TK+ ++ C L L R
Sbjct: 63 AMLRARLQ-HPNVVCLLGVV------TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGST 115
Query: 131 VLAIFRDVCNAVFAMHSQSPPIA------------HRDLKAENLLLGSDGLWKLCDFG 176
IA H+DL N+L+ K+ D G
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLG 173
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 36/173 (20%), Positives = 63/173 (36%), Gaps = 33/173 (19%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQY-----AMKHMICNDEESLESAMKEISVMKSL 80
I ++ + EG F V+ A ++ + A+K + E + + +E ++ L
Sbjct: 42 DIVLKWELGEGAFGKVFLAE-CHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 81 KGHPNVVTLYAHTILDLG---RTKEALLVMECCDK-SLVNVL-------------ENRGA 123
+ H ++V G + L+V E L L E+
Sbjct: 101 Q-HQHIVRF-------FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 124 GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176
G Q+LA+ V + + HRDL N L+G + K+ DFG
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFG 203
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 29/160 (18%), Positives = 51/160 (31%), Gaps = 19/160 (11%)
Query: 33 IAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVV----- 87
I +GGF C+Y A S ++ + E+ + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 88 ---------TLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDV 138
+ + D ++M+ L + E F K VL + +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA-KRFSRKTVLQLSLRI 161
Query: 139 CNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWK--LCDFG 176
+ + +H H D+KA NLLL + L D+G
Sbjct: 162 LDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYG 199
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 34/171 (19%), Positives = 59/171 (34%), Gaps = 28/171 (16%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQY-----AMKHMICNDEESLESAMKEISVMKSL 80
I ++ + EG F V+ A ++S A+K + + + +E ++ +L
Sbjct: 16 DIVLKRELGEGAFGKVFLAE-CYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 81 KGHPNVVTLYAHTILDLGRTKE--ALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRD 137
+ H ++V Y ++V E L L G
Sbjct: 75 Q-HEHIVKFYGVC------GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127
Query: 138 VCNAVFAMHSQSPPIA------------HRDLKAENLLLGSDGLWKLCDFG 176
+ M + IA HRDL N L+G++ L K+ DFG
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFG 178
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 18/103 (17%), Positives = 37/103 (35%), Gaps = 11/103 (10%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN------DEESLESAMKEISVMKS 79
++ + + G F V A A + K + + + M E+ ++
Sbjct: 23 RLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 80 LKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENR 121
+ H NVV L G ++++E C +L L ++
Sbjct: 82 IGHHLNVVNLLGACTKPGGPL---MVIVEFCKFGNLSTYLRSK 121
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 70/346 (20%), Positives = 117/346 (33%), Gaps = 123/346 (35%)
Query: 16 EGRSIDVGNLKI-------------HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN 62
E + +G LK +N++ GGF VY R + A+K +
Sbjct: 8 EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGR--LADGTLVAVKRL--- 62
Query: 63 DEESLESAMKEISV---MKSLKGHPNVVTLYAHTILDLGRTKEALLV---MECCDKSLVN 116
EE + + M S+ H N++ L + R LLV M + S+ +
Sbjct: 63 KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER----LLVYPYMA--NGSVAS 116
Query: 117 VL--ENRGAGYFEEKQVLAIFRDVCNAVFA------MHSQS-PPIAHRDLKAENLLLGSD 167
L + + I A+ + +H P I HRD+KA N+LL +
Sbjct: 117 CLRERPESQPPLDWPKRQRI------ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170
Query: 168 --------GLWKLCDFGST--STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPE--MWDLF 215
GL KL D+ T +T G T + APE
Sbjct: 171 FEAVVGDFGLAKLMDYKDTHVTT---AV-----RG----------TIGHIAPEYLSTG-- 210
Query: 216 RRELINEKVDIWALGCLLFRICYFKNAFD-----GESKLQI------------------- 251
+EK D++ G +L + + AFD + + +
Sbjct: 211 ---KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDV 267
Query: 252 -LNGNYRIPESPKYSSSVTDLIRDML-------QASPDDRPDITQV 289
L GNY ++ + ++ Q+SP +RP +++V
Sbjct: 268 DLQGNY----------KDEEVEQ-LIQVALLCTQSSPMERPKMSEV 302
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 34/170 (20%), Positives = 62/170 (36%), Gaps = 31/170 (18%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQY-----AMKHM--ICNDEESLESAMKEISVMK 78
I + + G F VY + M A+K + +C++++ L+ + E ++
Sbjct: 31 NITLIRGLGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIIS 88
Query: 79 SLKGHPNVVTLYAHTILDLG---RTKEALLVMECCDK-SLVNVLENRG-----AGYFEEK 129
H N+V +G ++ ++ME L + L
Sbjct: 89 KFN-HQNIVRC-------IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML 140
Query: 130 QVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLL---GSDGLWKLCDFG 176
+L + RD+ + HRD+ A N LL G + K+ DFG
Sbjct: 141 DLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFG 188
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 51/302 (16%), Positives = 90/302 (29%), Gaps = 75/302 (24%)
Query: 26 KIHVRNVIAEGGFSCVYSARD------------AIHMSKQYAMKHMICNDEESLESAMKE 73
I + + G F VY + A+ + E+ + E
Sbjct: 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-------EQDELDFLME 124
Query: 74 ISVMKSLKGHPNVVTLYAHTILDLG---RTKEALLVMECCDK-SLVNVLENRGAGYFEE- 128
++ H N+V +G ++ +++E L + L +
Sbjct: 125 ALIISKFN-HQNIVRC-------IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 176
Query: 129 ----KQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLL---GSDGLWKLCDFGSTSTN 181
+L + RD+ + HRD+ A N LL G + K+ DFG
Sbjct: 177 SLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMA--- 231
Query: 182 HKRFEKLEEMGIEEDNIRKHTTPAYR-----APEMWDLFRRELINEKV-----DIWALGC 231
R I + A PE E + D W+ G
Sbjct: 232 --R-------DIYRAGYYRKGGCAMLPVKWMPPEA--------FMEGIFTSKTDTWSFGV 274
Query: 232 LLFRIC-YFKNAFDGESKLQILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDIT 287
LL+ I + +S ++L R+ V ++ Q P+DRP+
Sbjct: 275 LLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 334
Query: 288 QV 289
+
Sbjct: 335 II 336
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 7e-05
Identities = 50/219 (22%), Positives = 86/219 (39%), Gaps = 46/219 (21%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLY 90
+I G F VY + + + A+K + +E EI + + HP++V+L
Sbjct: 45 FLIGHGVFGKVY--KGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR-HPHLVSLI 101
Query: 91 AHTILDLGRTKEALLVMECCDK-SLVNVL--ENRGAGYFEEKQVLAIFRDVCNAVFA--- 144
E +L+ + + +L L + +Q L I + A
Sbjct: 102 GFCDER----NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI------CIGAARG 151
Query: 145 ---MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH 201
+H+ I HRD+K+ N+LL + + K+ DFG + + G E D H
Sbjct: 152 LHYLHT--RAIIHRDVKSINILLDENFVPKITDFG-----------ISKKGTELDQ--TH 196
Query: 202 T------TPAYRAPEMWDLFRRELINEKVDIWALGCLLF 234
T Y PE F + + EK D+++ G +LF
Sbjct: 197 LSTVVKGTLGYIDPEY---FIKGRLTEKSDVYSFGVVLF 232
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 5e-04
Identities = 67/295 (22%), Positives = 103/295 (34%), Gaps = 70/295 (23%)
Query: 31 NVIAEGGFSCVYSAR-DAIHMSKQYAMKHMICNDEESLESAMK----EISVMKSLKGHPN 85
N + EGGF VY + + A+K + + + E + EI VM + H N
Sbjct: 37 NKMGEGGFGVVYKGYVN----NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HEN 91
Query: 86 VVTLYAHTILDLGRTKEALLV---MECCDKSLVNVLENRGAGYFEEKQVL------AIFR 136
+V L + + LV M + SL++ L + L I +
Sbjct: 92 LVELLGFSSDG----DDLCLVYVYMP--NGSLLDRLSCL-----DGTPPLSWHMRCKIAQ 140
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEED 196
N + +H HRD+K+ N+LL K+ DFG L +
Sbjct: 141 GAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFG-----------LARASEKFA 187
Query: 197 NIRKHT----TPAYRAPE-MWDLFRRELINEKVDIWALGCLLFRICYFKNAFD---GESK 248
+ T AY APE + R I K DI++ G +L I A D
Sbjct: 188 QTVMTSRIVGTTAYMAPEAL-----RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242
Query: 249 L-----QILNGNYRIPE--SPKYSS-SVTDLIRDM------LQASPDDRPDITQV 289
L +I + I + K + T + L + RPDI +V
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 690 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-51 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-50 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-50 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-47 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-41 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-41 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-41 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-41 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-39 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-37 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-34 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-31 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-31 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-19 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 3e-54
Identities = 68/283 (24%), Positives = 124/283 (43%), Gaps = 30/283 (10%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVT 88
+ + +G F VY A++ S A K + EE LE M EI ++ S HPN+V
Sbjct: 16 IIGELGDGAFGKVYKAQN-KETSVLAAAKVIDTKSEEELEDYMVEIDILASCD-HPNIVK 73
Query: 89 LYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
L D + L +++E C V+ + E Q+ + + +A+ +H
Sbjct: 74 LL-----DAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYR 207
I HRDLKA N+L DG KL DFG ++ N + ++ + TP +
Sbjct: 129 NK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF---------IGTPYWM 177
Query: 208 APEMW--DLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL-----NGNYRIPE 260
APE+ + + + K D+W+LG L + + + +++L + + +
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 237
Query: 261 SPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPV 299
++SS+ D ++ L+ + D R +Q+ + V+ P+
Sbjct: 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 6e-51
Identities = 64/288 (22%), Positives = 113/288 (39%), Gaps = 32/288 (11%)
Query: 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEI 74
G S D LK I G F VY D + + A + + + +E
Sbjct: 3 GMSNDGRFLKFD--IEIGRGSFKTVYKGLD-TETTVEVAWCELQDRKLTKSERQRFKEEA 59
Query: 75 SVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAI 134
++K L+ HPN+V Y + K +LV E + R + K + +
Sbjct: 60 EMLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSW 117
Query: 135 FRDVCNAVFAMHSQSPPIAHRDLKAENLLL-GSDGLWKLCDFGSTSTNHKRFEKLEEMGI 193
R + + +H+++PPI HRDLK +N+ + G G K+ D G + F K +G
Sbjct: 118 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIG- 175
Query: 194 EEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL---- 249
TP + APEM+ E +E VD++A G + + + +
Sbjct: 176 ---------TPEFMAPEMY----EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 222
Query: 250 -QILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFR 292
++ +G V ++I ++ + D+R I + +F+
Sbjct: 223 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 4e-50
Identities = 74/275 (26%), Positives = 112/275 (40%), Gaps = 31/275 (11%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPN 85
V I G + R K K + E + + E+++++ LK HPN
Sbjct: 7 EVLYTIGTGSYGRCQKIRR-KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPN 64
Query: 86 VVTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGA--GYFEEKQVLAIFRDVCNA 141
+V Y I RT L +VME C+ L +V+ Y +E+ VL + + A
Sbjct: 65 IVRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 142 VFAMHSQS---PPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNI 198
+ H +S + HRDLK N+ L KL DFG + +
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF------- 174
Query: 199 RKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNG 254
TP Y +PE R NEK DIW+LGCLL+ +C F S+ + I G
Sbjct: 175 --VGTPYYMSPEQM---NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG 229
Query: 255 NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
+R +YS + ++I ML RP + ++
Sbjct: 230 KFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 8e-50
Identities = 74/300 (24%), Positives = 123/300 (41%), Gaps = 38/300 (12%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPN 85
K I +G VY+A D + ++ A++ M + E + EI VM+ K +PN
Sbjct: 21 KYTRFEKIGQGASGTVYTAMD-VATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPN 78
Query: 86 VVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
+V D + L +VME + + +E Q+ A+ R+ A+
Sbjct: 79 IVNYL-----DSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEF 131
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTP 204
+HS + HRD+K++N+LLG DG KL DFG + K M TP
Sbjct: 132 LHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---------VGTP 180
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL-----NGNYRIP 259
+ APE+ R+ KVDIW+LG + + + + E+ L+ L NG +
Sbjct: 181 YWMAPEVV---TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ 237
Query: 260 ESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLPDRPPETQSA 315
K S+ D + L + R ++ + ++ + L SL + A
Sbjct: 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS-----SLTPLIAAAKEA 292
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 9e-50
Identities = 60/298 (20%), Positives = 121/298 (40%), Gaps = 38/298 (12%)
Query: 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMK--HMICNDEESLESAMKEISVM 77
I G + + I G F VY + A+K ++ + L++ E+ V+
Sbjct: 5 IPDGQITVG--QRIGSGSFGTVYKGK----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 58
Query: 78 KSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFR 136
+ + H N++ + +V + C+ SL + L FE +++ I R
Sbjct: 59 RKTR-HVNILLFM-----GYSTAPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIAR 111
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEED 196
+ +H++ I HRDLK+ N+ L D K+ DFG +T R+ +
Sbjct: 112 QTAQGMDYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFG-LATVKSRWSGSHQFE---- 164
Query: 197 NIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK----LQIL 252
+ + + APE+ + + + + D++A G +L+ + + + + + ++
Sbjct: 165 --QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222
Query: 253 NGNYRIPESPKYSSSVT----DLIRDMLQASPDDRPDITQVWFRVNEQLPVGLQKSLP 306
Y P+ K S+ L+ + L+ D+RP Q+ + L +SLP
Sbjct: 223 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL-----LARSLP 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 171 bits (435), Expect = 3e-49
Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 42/288 (14%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHM---------ICNDEESLESAMKEISVMK 78
+ ++ G S V K+YA+K + +E E+ +KE+ +++
Sbjct: 6 EPKEILGRGVSSVVRRCIH-KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 79 SLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRD 137
+ GHPN++ L + LV + K L + L + EK+ I R
Sbjct: 65 KVSGHPNIIQLKDTYETN----TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRA 118
Query: 138 VCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDN 197
+ + A+H I HRDLK EN+LL D KL DFG + + E G
Sbjct: 119 LLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCG----- 171
Query: 198 IRKHTTPAYRAPEMW---DLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ---- 250
TP+Y APE+ ++VD+W+ G +++ + F ++
Sbjct: 172 -----TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 226
Query: 251 ILNGNYRI--PESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFR 292
I++GNY+ PE YS +V DL+ L P R + +F+
Sbjct: 227 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (435), Expect = 7e-49
Identities = 76/297 (25%), Positives = 117/297 (39%), Gaps = 38/297 (12%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHM---ICNDEESLESAMKEISVMKSLKGHPNVV 87
I G F VY ARD + S+ A+K M E + +KE+ ++ L+ HPN +
Sbjct: 21 REIGHGSFGAVYFARD-VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTI 78
Query: 88 TLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
+ + A LVME C S ++LE +E ++ A+ + +HS
Sbjct: 79 QYRGCYLRE----HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS 133
Query: 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYR 207
+ + HRD+KA N+LL GL KL DFGS S TP +
Sbjct: 134 HN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------------ANSFVGTPYWM 178
Query: 208 APEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNYRIPESPK 263
APE+ + KVD+W+LG + K + + I +S
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
Query: 264 YSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLPDRPPETQSAV 316
+S + + LQ P DRP + + E+ P + D T+ AV
Sbjct: 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL-RERPP----TVIMDLIQRTKDAV 290
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 170 bits (432), Expect = 5e-48
Identities = 70/366 (19%), Positives = 131/366 (35%), Gaps = 47/366 (12%)
Query: 4 FKPFMQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND 63
F + Q P +E + V + + + G F V+ + +A K ++
Sbjct: 6 FDIWKQYYPQPVEIKHDHVLD-HYDIHEELGTGAFGVVHRVTE-RATGNNFAAKFVMTPH 63
Query: 64 EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRG 122
E E+ KEI M L+ HP +V L+ D + ++ E +
Sbjct: 64 ESDKETVRKEIQTMSVLR-HPTLVNLH-----DAFEDDNEMVMIYEFMSGGELFEKVADE 117
Query: 123 AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD--GLWKLCDFGSTST 180
E + + R VC + MH + H DLK EN++ + KL DFG T+
Sbjct: 118 HNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTA- 174
Query: 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK 240
+ ++ T + APE+ + + D+W++G L + +
Sbjct: 175 ---------HLDPKQSVKVTTGTAEFAAPEV---AEGKPVGYYTDMWSVGVLSYILLSGL 222
Query: 241 NAFDGESKLQ----ILNGNYRIPES--PKYSSSVTDLIRDMLQASPDDRPDITQV----W 290
+ F GE+ + + + ++ + +S S D IR +L A P+ R I Q W
Sbjct: 223 SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282
Query: 291 FRVNEQLPVGLQKSLPDRPPETQSAVANEGMSKPMNRSPPMPQRSPPPPPSSVDPTRNIS 350
+ P R + S+ + + ++ P PP + ++
Sbjct: 283 LT---------PGNAPGRDSQIPSSRYTK--IRDSIKTKYDAWPEPLPPLGRISNYSSLR 331
Query: 351 QPSTTP 356
+
Sbjct: 332 KHRPQE 337
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-47
Identities = 67/279 (24%), Positives = 108/279 (38%), Gaps = 38/279 (13%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHM---ICNDEESLESAMKEISVMKSLKGHP 84
+ + +G F VY AR+ A+K + +E+ + L+ HP
Sbjct: 9 EIGRPLGKGKFGNVYLARE-KQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 66
Query: 85 NVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143
N++ LY + L++E V + F+E++ ++ NA+
Sbjct: 67 NILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALS 120
Query: 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTT 203
HS+ + HRD+K ENLLLGS G K+ DFG T
Sbjct: 121 YCHSK--RVIHRDIKPENLLLGSAGELKIADFG-----------WSVHAPSSRRTTLCGT 167
Query: 204 PAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNYRIP 259
Y PEM + +EKVD+W+LG L + K F+ + + I + P
Sbjct: 168 LDYLPPEM---IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP 224
Query: 260 ESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVN 294
+ DLI +L+ +P RP + +V W N
Sbjct: 225 --DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 261
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-47
Identities = 60/269 (22%), Positives = 107/269 (39%), Gaps = 31/269 (11%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPN 85
++ + I +G F V + + A+K + ++ + ++ + E SVM L+ H N
Sbjct: 8 ELKLLQTIGKGEFGDVMLGD---YRGNKVAVKCI--KNDATAQAFLAEASVMTQLR-HSN 61
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
+V L + + G +V E K SLV+ L +RG +L DVC A+
Sbjct: 62 LVQLLGVIVEEKGGL---YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTP 204
+ HRDL A N+L+ D + K+ DFG T
Sbjct: 119 LEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKE------------ASSTQDTGKLPV 164
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF-KNAFDGESKLQILN---GNYRIPE 260
+ APE R + + K D+W+ G LL+ I F + + ++ Y++
Sbjct: 165 KWTAPEA---LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA 221
Query: 261 SPKYSSSVTDLIRDMLQASPDDRPDITQV 289
+V +++++ RP Q+
Sbjct: 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQL 250
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 4e-47
Identities = 69/284 (24%), Positives = 105/284 (36%), Gaps = 32/284 (11%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLESAMKEISVMKSLKGHPNV 86
+ + EG + V A + + A+K + + + E+ KEI + K L H NV
Sbjct: 8 DLVQTLGEGAYGEVQLAVN-RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENV 65
Query: 87 VTLYAHTILDLGRTKEALLVMECCDKSLV-NVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
V Y H L +E C + + +E E F + V +
Sbjct: 66 VKFYGHRREG----NIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYL 119
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPA 205
H I HRD+K ENLLL K+ DFG + E + T
Sbjct: 120 HGIG--ITHRDIKPENLLLDERDNLKISDFGLAT-------VFRYNNRERLLNKMCGTLP 170
Query: 206 YRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK-----LQILNGNYRIPE 260
Y APE+ L RRE E VD+W+ G +L + + +D S +
Sbjct: 171 YVAPEL--LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 228
Query: 261 SPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVG 300
K S+ L+ +L +P R I + W+ N+ L G
Sbjct: 229 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY--NKPLKKG 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-46
Identities = 72/288 (25%), Positives = 119/288 (41%), Gaps = 39/288 (13%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVT 88
V+ G V + +++A+K + + A +E+ + P++V
Sbjct: 16 TSQVLGLGINGKVLQIFN-KRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVR 69
Query: 89 LYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
+ K L+VMEC D L + +++RG F E++ I + + A+ +HS
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 148 QSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTP 204
+ IAHRD+K ENLL S + + KL DFG +E TP
Sbjct: 130 IN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA----------KETTSHNSLTTPCYTP 177
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ--------ILNGNY 256
Y APE+ E ++ D+W+LG +++ + F L I G Y
Sbjct: 178 YYVAPEV---LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234
Query: 257 RIP--ESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLP 298
P E + S V LIR++L+ P R IT+ W + ++P
Sbjct: 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 162 bits (411), Expect = 4e-45
Identities = 69/334 (20%), Positives = 122/334 (36%), Gaps = 45/334 (13%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVT 88
+ + G F V+ + + + K + + EIS+M L HP ++
Sbjct: 33 ILEELGSGAFGVVHRCVE-KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKLIN 90
Query: 89 LYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMH 146
L+ D K + L++E L + + E +V+ R C + MH
Sbjct: 91 LH-----DAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH 144
Query: 147 SQSPPIAHRDLKAENLLL--GSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTP 204
S I H D+K EN++ K+ DFG + ++ +E T
Sbjct: 145 EHS--IVHLDIKPENIMCETKKASSVKIIDFGLAT----------KLNPDEIVKVTTATA 192
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNYRIPE 260
+ APE+ RE + D+WA+G L + + + F GE L+ + ++ E
Sbjct: 193 EFAAPEI---VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE 249
Query: 261 S--PKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLPDRPPETQ- 313
S D I+++LQ P R + W + G +L R P ++
Sbjct: 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK-------GDHSNLTSRIPSSRY 302
Query: 314 SAVANEGMSKPMNRSPPMPQRSPPPPPSSVDPTR 347
+ + + K + P P SS+ R
Sbjct: 303 NKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHR 336
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 9e-45
Identities = 59/329 (17%), Positives = 121/329 (36%), Gaps = 43/329 (13%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVV 87
+ + G F V+ + K Y K + KEIS++ + H N++
Sbjct: 8 MIAEDLGRGEFGIVHRCVE-TSSKKTYMAK-FVKVKGTDQVLVKKEISILNIAR-HRNIL 64
Query: 88 TLYAHTILDLGRTKEAL-LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
L+ + + E L ++ E + + E+++++ VC A+ +
Sbjct: 65 HLH-----ESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFL 118
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLW--KLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTT 203
HS I H D++ EN++ + K+ +FG ++ ++ T
Sbjct: 119 HSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQAR----------QLKPGDNFRLLFTA 166
Query: 204 PAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNYRIP 259
P Y APE+ + ++++ D+W+LG L++ + N F E+ Q I+N Y
Sbjct: 167 PEYYAPEVH---QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223
Query: 260 ES--PKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLPDRPPETQ 313
E + S D + +L R ++ W + +++ K +
Sbjct: 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK--QKIERVSTKVIRTLKHRRY 281
Query: 314 SAVANEGMSKPMNRSPPMPQRSPPPPPSS 342
+ + K +N + S S
Sbjct: 282 Y---HTLIKKDLNMVVSAARISCGGAIRS 307
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-44
Identities = 63/271 (23%), Positives = 107/271 (39%), Gaps = 32/271 (11%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHM---ICNDEESLESAMKEISVMKSLKGHP 84
++ EG FS V AR+ + S++YA+K + E + +E VM L HP
Sbjct: 11 KFGKILGEGSFSTVVLARE-LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 68
Query: 85 NVVTLYAHTILDLGRTKEAL-LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAV 142
V LY + E L + L+ + G F+E ++ +A+
Sbjct: 69 FFVKLY-----FTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSAL 121
Query: 143 FAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT 202
+H I HRDLK EN+LL D ++ DFG+ ++
Sbjct: 122 EYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF-------VG 172
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNYRI 258
T Y +PE+ + + D+WALGC+++++ F ++ I+ Y
Sbjct: 173 TAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 229
Query: 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
PE K+ DL+ +L R ++
Sbjct: 230 PE--KFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 7e-44
Identities = 54/269 (20%), Positives = 102/269 (37%), Gaps = 27/269 (10%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPN 85
+ + + G F V+ + + A+K + S ++ + E ++MK L+ H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYY--NGHTKVAVK-SLKQGSMSPDAFLAEANLMKQLQ-HQR 69
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
+V LY + + ++ E + SLV+ L+ ++L + + +
Sbjct: 70 LVRLY-----AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTP 204
+ + HRDL+A N+L+ K+ DFG +L E
Sbjct: 125 IEER--NYIHRDLRAANILVSDTLSCKIADFG--------LARLIEDNEYTAREGAKFPI 174
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRI-CYFKNAFDGESK---LQILNGNYRIPE 260
+ APE K D+W+ G LL I + + + G + +Q L YR+
Sbjct: 175 KWTAPEAI---NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 261 SPKYSSSVTDLIRDMLQASPDDRPDITQV 289
+ L+R + P+DRP +
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYL 260
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 155 bits (393), Expect = 4e-43
Identities = 59/294 (20%), Positives = 115/294 (39%), Gaps = 26/294 (8%)
Query: 6 PFMQKEP---TGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQ--YAMKHMI 60
PF ++P + ID+ +KI VI G F V S + ++ A+K +
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIE--QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 61 CN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLE 119
E+ + E S+M HPNV+ L +++ E + ++
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKS----TPVMIITEFMENGSLDSFL 118
Query: 120 NRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179
+ G F Q++ + R + + + HRDL A N+L+ S+ + K+ DFG +
Sbjct: 119 RQNDGQFTVIQLVGMLRGIAAGMKYLADM--NYVHRDLAARNILVNSNLVCKVSDFGLS- 175
Query: 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF 239
+ E + + APE + D+W+ G +++ + +
Sbjct: 176 ---RFLEDDTSDPTYTSALGGKIPIRWTAPEAI---QYRKFTSASDVWSYGIVMWEVMSY 229
Query: 240 -KNAFDGESKLQILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
+ + + ++N +YR+P S++ L+ D Q + RP Q+
Sbjct: 230 GERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-42
Identities = 55/278 (19%), Positives = 107/278 (38%), Gaps = 27/278 (9%)
Query: 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSK--QYAMKHM---ICNDEESLESAMKEISV 76
+G + + + +G F V K A+K + + + E+++ ++E++
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 77 MKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFR 136
M SL H N++ LY + T +V E + + G+F +
Sbjct: 65 MHSLD-HRNLIRLY-----GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 118
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEED 196
V + + S+ HRDL A NLLL + L K+ DFG + + ++ + ++
Sbjct: 119 QVAEGMGYLESK--RFIHRDLAARNLLLATRDLVKIGDFGLM----RALPQNDDHYVMQE 172
Query: 197 NIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFR-ICYFKNAFDGESKLQ----I 251
+ + A+ APE + + D W G L+ Y + + G + Q I
Sbjct: 173 HRK--VPFAWCAPES---LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227
Query: 252 LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
R+P + +++ P+DRP +
Sbjct: 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 6e-42
Identities = 77/296 (26%), Positives = 121/296 (40%), Gaps = 40/296 (13%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLESAMKEISVMKSLKGHPNVV 87
R+V+ G FS V A D K A+K + E S EI+V+ +K HPN+V
Sbjct: 13 FRDVLGTGAFSEVILAED-KRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPNIV 70
Query: 88 TLYAHTILDLGRTKEAL-LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
L D+ + L L+M+ L + + +G ++ E+ + V +AV +
Sbjct: 71 ALD-----DIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYL 123
Query: 146 HSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT 202
H I HRDLK ENLL S D + DFG + G
Sbjct: 124 HDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG---------- 171
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL----QILNGNYRI 258
TP Y APE+ ++ ++ VD W++G + + + F E+ QIL Y
Sbjct: 172 TPGYVAPEVL---AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF 228
Query: 259 --PESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLPDR 308
P S S D IR +++ P+ R Q W + L + +S+ ++
Sbjct: 229 DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQ 284
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 151 bits (381), Expect = 8e-42
Identities = 55/265 (20%), Positives = 109/265 (41%), Gaps = 23/265 (8%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHM---ICNDEESLESAMKEISVMKSLKGHPN 85
+ ++ GG S V+ ARD + + + A+K + + D +E +L HP
Sbjct: 11 LGEILGFGGMSEVHLARD-LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPA 68
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
+V +Y + +VME D + + + G K+ + + D C A+
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFS 127
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPA 205
H I HRD+K N+++ + K+ DFG + + T
Sbjct: 128 HQN--GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA------AVIGTAQ 179
Query: 206 YRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK----LQILNGNYRIPES 261
Y +PE R + ++ + D+++LGC+L+ + + F G+S Q + + P +
Sbjct: 180 YLSPEQA---RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA 236
Query: 262 --PKYSSSVTDLIRDMLQASPDDRP 284
S+ + ++ L +P++R
Sbjct: 237 RHEGLSADLDAVVLKALAKNPENRY 261
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-41
Identities = 53/277 (19%), Positives = 96/277 (34%), Gaps = 21/277 (7%)
Query: 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQ--YAMKHM-ICNDEESLESAMKEISV 76
I +L +H VI G F CVY + K+ A+K + D + + E +
Sbjct: 22 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 81
Query: 77 MKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFR 136
MK HPNV++L + G L+V+ + K ++
Sbjct: 82 MKDFS-HPNVLSLLGICLRSEGSP---LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 137
Query: 137 DVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEED 196
V + + S+ HRDL A N +L K+ DFG R +E +
Sbjct: 138 QVAKGMKFLASK--KFVHRDLAARNCMLDEKFTVKVADFG-----LARDMYDKEFDSVHN 190
Query: 197 NIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI-CYFKNAFDGESKLQILN-- 253
+ A E + + K D+W+ G LL+ + + + I
Sbjct: 191 KTGAKLPVKWMALES---LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 247
Query: 254 -GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
R+ + + +++ + RP +++
Sbjct: 248 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 284
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-41
Identities = 51/327 (15%), Positives = 98/327 (29%), Gaps = 75/327 (22%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLESAMKEISVMKSLKGHPNVVTL 89
+ + G V+ A K + + ++E+ V+ P +V
Sbjct: 12 SELGAGNGGVVFKVSH-KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGF 69
Query: 90 YAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQ 148
Y + + + ME D ++ + + G E+ + + V + + +
Sbjct: 70 Y-----GAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK 123
Query: 149 SPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRA 208
I HRD+K N+L+ S G KLCDFG + T +Y +
Sbjct: 124 -HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-----------SFVGTRSYMS 171
Query: 209 PEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES--------------------- 247
PE + + + DIW++G L + +
Sbjct: 172 PER---LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228
Query: 248 -------------------------KLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDD 282
I+N S +S D + L +P +
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288
Query: 283 RPDITQV----WFRVNEQLPVGLQKSL 305
R D+ Q+ + + ++ V L
Sbjct: 289 RADLKQLMVHAFIKRSDAEEVDFAGWL 315
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-41
Identities = 59/269 (21%), Positives = 111/269 (41%), Gaps = 27/269 (10%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPN 85
+ + + +G F V+ + + + A+K + S E+ ++E VMK L+ H
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTW--NGTTRVAIK-TLKPGTMSPEAFLQEAQVMKKLR-HEK 73
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
+V LY + + +V E K SL++ L+ Y Q++ + + + +
Sbjct: 74 LVQLY-----AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTP 204
+ HRDL+A N+L+G + + K+ DFG +L E
Sbjct: 129 VERM--NYVHRDLRAANILVGENLVCKVADFGLA--------RLIEDNEYTARQGAKFPI 178
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRI-CYFKNAFDGESKLQILN---GNYRIPE 260
+ APE K D+W+ G LL + + + G ++L+ YR+P
Sbjct: 179 KWTAPEA---ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 235
Query: 261 SPKYSSSVTDLIRDMLQASPDDRPDITQV 289
P+ S+ DL+ + P++RP +
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYL 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 3e-41
Identities = 51/268 (19%), Positives = 95/268 (35%), Gaps = 29/268 (10%)
Query: 31 NVIAEGGFSCVYSARDAI-HMSKQYAMK--HMICNDEESLESAMKEISVMKSLKGHPNVV 87
+ G F V + + K A+K ND + + E +VM+ L +P +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIV 71
Query: 88 TLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
+ + + +LVME + +N + + ++K ++ + V + +
Sbjct: 72 RMI-----GICEAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEE 125
Query: 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH--TTPA 205
HRDL A N+LL + K+ DFG K + H
Sbjct: 126 S--NFVHRDLAARNVLLVTQHYAKISDFG--------LSKALRADENYYKAQTHGKWPVK 175
Query: 206 YRAPEMWDLFRRELINEKVDIWALGCLLFRI-CYFKNAFDGESKLQILN---GNYRIPES 261
+ APE + K D+W+ G L++ Y + + G ++ R+
Sbjct: 176 WYAPEC---INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 232
Query: 262 PKYSSSVTDLIRDMLQASPDDRPDITQV 289
+ DL+ ++RP V
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAV 260
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 6e-41
Identities = 55/296 (18%), Positives = 98/296 (33%), Gaps = 48/296 (16%)
Query: 26 KIHVRNVIAEGGFSCVYSARDA----IHMSKQYAMKHMICN-DEESLESAMKEISVMKSL 80
+ V+ G F V +A +S Q A+K + D E+ M E+ +M L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 81 KGHPNVVTLYAHTILDLGRTKEALLVME-CCDKSLVNVLENRG----------------- 122
H N+V L L L+ E CC L+N L ++
Sbjct: 98 GSHENIVNLLGACTLS----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 123 ----AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178
+ +L V + + + HRDL A N+L+ + K+CDFG
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY 238
+ + APE + K D+W+ G LL+ I
Sbjct: 212 -------RDIMSDSNYVVRGNARLPVKWMAPES---LFEGIYTIKSDVWSYGILLWEIFS 261
Query: 239 F-KNAFDGESK----LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
N + G +++ +++ + + + +++ RP +
Sbjct: 262 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 6e-41
Identities = 57/274 (20%), Positives = 104/274 (37%), Gaps = 27/274 (9%)
Query: 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKS 79
ID L I G F V+ + A+K I S E ++E VM
Sbjct: 2 IDPSELTFV--QEIGSGQFGLVHLGYW--LNKDKVAIK-TIREGAMSEEDFIEEAEVMMK 56
Query: 80 LKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVC 139
L HP +V LY + LV E + ++ G F + +L + DVC
Sbjct: 57 LS-HPKLVQLYGVCLEQ----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 111
Query: 140 NAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIR 199
+ + + + HRDL A N L+G + + K+ DFG + +
Sbjct: 112 EGM--AYLEEACVIHRDLAARNCLVGENQVIKVSDFG--------MTRFVLDDQYTSSTG 161
Query: 200 KHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC----YFKNAFDGESKLQILNGN 255
+ +PE+ F + K D+W+ G L++ + ++ ++
Sbjct: 162 TKFPVKWASPEV---FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 218
Query: 256 YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
+R+ + S+ V ++ + P+DRP +++
Sbjct: 219 FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRL 252
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 8e-41
Identities = 57/274 (20%), Positives = 99/274 (36%), Gaps = 27/274 (9%)
Query: 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKS 79
ID +L + G F V + A+K MI S + ++E VM +
Sbjct: 1 IDPKDLTFL--KELGTGQFGVVKYGKW--RGQYDVAIK-MIKEGSMSEDEFIEEAKVMMN 55
Query: 80 LKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVC 139
L H +V LY + ++ E + F+ +Q+L + +DVC
Sbjct: 56 LS-HEKLVQLYGVCTKQ----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 110
Query: 140 NAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIR 199
A+ + S+ HRDL A N L+ G+ K+ DFG + + ++
Sbjct: 111 EAMEYLESK--QFLHRDLAARNCLVNDQGVVKVSDFGLS--------RYVLDDEYTSSVG 160
Query: 200 KHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF-KNAFDGESKLQILN---GN 255
+ PE+ + K DIWA G L++ I K ++ + +
Sbjct: 161 SKFPVRWSPPEVL---MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 217
Query: 256 YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
R+ S V ++ D+RP +
Sbjct: 218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKIL 251
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 145 bits (367), Expect = 9e-40
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 27/270 (10%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPN 85
I +++ + G + VY S A+K + D +E +KE +VMK +K HPN
Sbjct: 18 DITMKHKLGGGQYGEVYEGVW-KKYSLTVAVK-TLKEDTMEVEEFLKEAAVMKEIK-HPN 74
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
+V L + ++ E +L++ L +L + + +A+
Sbjct: 75 LVQLLGVCTRE----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTP 204
+ HRDL A N L+G + L K+ DFG + + D H
Sbjct: 131 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRL------------MTGDTYTAHAGA 176
Query: 205 AYRAPEM-WDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL----QILNGNYRIP 259
+ + + K D+WA G LL+ I + + L ++L +YR+
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236
Query: 260 ESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
V +L+R Q +P DRP ++
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEI 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-39
Identities = 53/273 (19%), Positives = 96/273 (35%), Gaps = 26/273 (9%)
Query: 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQ-YAMKHM-ICNDEESLESAMKEISVMKSLK 81
NL I + G F V + + A+K + ++ E M+E +M L
Sbjct: 9 NLLI-ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 67
Query: 82 GHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCN 140
+P +V L + + + +LVME L L + V + V
Sbjct: 68 -NPYIVRLI-----GVCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSM 120
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRK 200
+ + + HRDL A N+LL + K+ DFG + K + +
Sbjct: 121 GMKYLEEK--NFVHRDLAARNVLLVNRHYAKISDFGLS----KALGADDSYYTARSAGK- 173
Query: 201 HTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI-CYFKNAFDGESKLQILN---GNY 256
+ APE + + D+W+ G ++ Y + + +++
Sbjct: 174 -WPLKWYAPEC---INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 229
Query: 257 RIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
R+ P+ + L+ D +DRPD V
Sbjct: 230 RMECPPECPPELYALMSDCWIYKWEDRPDFLTV 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 61/291 (20%), Positives = 103/291 (35%), Gaps = 42/291 (14%)
Query: 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQ-YAMKHM-ICNDEESLESAMKEISVM 77
+D ++K +VI EG F V AR + A+K M ++ E+ V+
Sbjct: 7 LDWNDIKFQ--DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 64
Query: 78 KSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENR--------------G 122
L HPN++ L L +E +L++ L
Sbjct: 65 CKLGHHPNIINLLGACEHR----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120
Query: 123 AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182
A +Q+L DV + + HRDL A N+L+G + + K+ DFG +
Sbjct: 121 ASTLSSQQLLHFAADVARGM--DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 178
Query: 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNA 242
+K + A E + D+W+ G LL+ I
Sbjct: 179 VYVKKTMGRL----------PVRWMAIES---LNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
Query: 243 -FDGESKLQILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
+ G + ++ YR+ + V DL+R + P +RP Q+
Sbjct: 226 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 276
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 5e-39
Identities = 69/307 (22%), Positives = 119/307 (38%), Gaps = 51/307 (16%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHM------ICNDEESLESAMKEISVMKSLK 81
+ G F+ V R+ QYA K + S E +E+S++K ++
Sbjct: 13 DTGEELGSGQFAVVKKCRE-KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 82 GHPNVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCN 140
HPNV+TL+ ++ K + L++E + E++ + + N
Sbjct: 72 -HPNVITLH-----EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILN 124
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDGL----WKLCDFGSTSTNHKRFEKLEEMGIEED 196
V+ +HS IAH DLK EN++L + K+ DFG E G
Sbjct: 125 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG---- 178
Query: 197 NIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----IL 252
TP + APE+ E + + D+W++G + + + + F G++K + +
Sbjct: 179 ------TPEFVAPEI---VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229
Query: 253 NGNYRIPES--PKYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLP 306
NY + S+ D IR +L P R I W + P Q++L
Sbjct: 230 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK-----PKDTQQALS 284
Query: 307 DR--PPE 311
P+
Sbjct: 285 SAWSHPQ 291
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-39
Identities = 49/271 (18%), Positives = 95/271 (35%), Gaps = 24/271 (8%)
Query: 27 IHVRNVIAEGGFSCVYSARDAIHMSKQ---YAMKHM-ICNDEESLESAMKEISVMKSLKG 82
+ + VI G F VY K+ A+K + E+ + E +M
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS- 67
Query: 83 HPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAV 142
H N++ L K +++ E + ++ G F Q++ + R + +
Sbjct: 68 HHNIIRLEGVISKY----KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 143 FAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT 202
+ + HRDL A N+L+ S+ + K+ DFG + E
Sbjct: 124 KYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT------SGGKI 175
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK----LQILNGNYRI 258
+ APE D+W+ G +++ + + E ++ +N +R+
Sbjct: 176 PIRWTAPEA---ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232
Query: 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
P S++ L+ Q RP +
Sbjct: 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADI 263
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-38
Identities = 69/330 (20%), Positives = 127/330 (38%), Gaps = 38/330 (11%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHM---ICNDEESLESAMKEISVMKSLKGHPN 85
+ ++ +G F V+ A ++ +A+K + + ++ +E M E V+ HP
Sbjct: 6 LHKMLGKGSFGKVFLAEF-KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 86 VVTLYAHTILDLGRTKEAL-LVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143
+ ++ +TKE L VME + L+ +++ F+ + ++ +
Sbjct: 65 LTHMF-----CTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQ 117
Query: 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTT 203
+HS+ I +RDLK +N+LL DG K+ DFG N K T
Sbjct: 118 FLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF---------CGT 166
Query: 204 PAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL----NGNYRIP 259
P Y APE+ + N VD W+ G LL+ + ++ F G+ + ++ N P
Sbjct: 167 PDYIAPEIL---LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP 223
Query: 260 ESPKYSSSVTDLIRDMLQASPDDRPDITQV-----WFRVNEQLPVGLQKSLPDRPPETQS 314
DL+ + P+ R + FR + ++ P P+ +S
Sbjct: 224 RW--LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKS 281
Query: 315 AVANEGMSKPMNRSPPMPQRSPPPPPSSVD 344
K P + +S+D
Sbjct: 282 PFDCSNFDKEFLNEKPRLSFADRALINSMD 311
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 66/302 (21%), Positives = 110/302 (36%), Gaps = 53/302 (17%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMK--HMICNDEESLESAMKEISVMKSLKG--HP 84
I EG + V+ ARD + + A+K + +E S ++E++V++ L+ HP
Sbjct: 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 70
Query: 85 NVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVF 143
NVV L+ + + L LV E D+ L L+ + + + + +
Sbjct: 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 130
Query: 144 AMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTT 203
+HS + HRDLK +N+L+ S G KL DFG + + T
Sbjct: 131 FLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV----------T 178
Query: 204 PAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESP- 262
YRAPE+ + VD+W++GC+ + K F G S + L + P
Sbjct: 179 LWYRAPEV---LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 263 ----------------------------KYSSSVTDLIRDMLQASPDDRPDITQV----W 290
DL+ L +P R +
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295
Query: 291 FR 292
F+
Sbjct: 296 FQ 297
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-38
Identities = 62/277 (22%), Positives = 102/277 (36%), Gaps = 36/277 (12%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHM------ICNDEESLESAMKEISVMKSLK 81
V ++ GGF VYS + + A+KH+ + + E+ ++K +
Sbjct: 7 QVGPLLGSGGFGSVYSGIR-VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 82 -GHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCN 140
G V+ L R +L++E + G +E+ + F V
Sbjct: 66 SGFSGVIRLLDWFE----RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 141 AVFAMHSQSPPIAHRDLKAENLLL-GSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIR 199
AV H+ + HRD+K EN+L+ + G KL DFGS +
Sbjct: 122 AVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-----------D 168
Query: 200 KHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIP 259
T Y PE + +W+LG LL+ + F+ + +I+ G
Sbjct: 169 FDGTRVYSPPEW--IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRGQVFFR 224
Query: 260 ESPKYSSSVTDLIRDMLQASPDDRPDITQV----WFR 292
+ SS LIR L P DRP ++ W +
Sbjct: 225 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 54/301 (17%), Positives = 108/301 (35%), Gaps = 53/301 (17%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPN 85
I ++ I +G F V+ + ++ A+K + + EE EI L+ H N
Sbjct: 4 TIVLQESIGKGRFGEVWRGK---WRGEEVAVK-IFSSREERSWFREAEIYQTVMLR-HEN 58
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
++ A D G + LV + + SL + L + ++ + + +
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAH 115
Query: 145 MHSQ------SPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNI 198
+H + P IAHRDLK++N+L+ +G + D G + + +I
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG--------LAVRHDSATDTIDI 167
Query: 199 RKHT---TPAYRAPEMWD---LFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ-- 250
+ T Y APE+ D + ++ DI+A+G + + I + Q
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227
Query: 251 -----------------ILNGNYRIPESPKYSSS-----VTDLIRDMLQASPDDRPDITQ 288
+ R ++ S + ++R+ A+ R +
Sbjct: 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
Query: 289 V 289
+
Sbjct: 288 I 288
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-37
Identities = 68/336 (20%), Positives = 120/336 (35%), Gaps = 58/336 (17%)
Query: 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHM-ICNDEESLESAMKEIS 75
G+ DVG + + I EG + V SA D + A+K + + + ++EI
Sbjct: 1 GQVFDVGP-RYTNLSYIGEGAYGMVCSAYD-NVNKVRVAIKKISPFEHQTYCQRTLREIK 58
Query: 76 VMKSLKGHPNVVTLY-AHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAI 134
++ + H N++ + + + K+ LV L +L+ + +
Sbjct: 59 ILLRFR-HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYF 114
Query: 135 FRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIE 194
+ + +HS + HRDLK NLLL + K+CDFG + +
Sbjct: 115 LYQILRGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-- 170
Query: 195 EDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG 254
T YRAPE+ + + + +DIW++GC+L + + F G+ L LN
Sbjct: 171 ----EYVATRWYRAPEI--MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH 224
Query: 255 NYRIPESP---------------------------------KYSSSVTDLIRDMLQASPD 281
I SP S DL+ ML +P
Sbjct: 225 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH 284
Query: 282 DRPDITQV----WFRVNEQLPVGLQKSLPDRPPETQ 313
R ++ Q + Q + + + P +
Sbjct: 285 KRIEVEQALAHPYLE---QYYDPSDEPIAEAPFKFD 317
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 48/294 (16%), Positives = 99/294 (33%), Gaps = 29/294 (9%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMI-----CNDEESLESAMKEISVMKSLKGHPN 85
V+ G F VY I ++ + I ++ + + E VM S+ +P+
Sbjct: 15 KVLGSGAFGTVYKGLW-IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPH 72
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
V L + + L+ L++ + + +L + + +
Sbjct: 73 VCRLLGICL----TSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYL 127
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPA 205
+ + HRDL A N+L+ + K+ DFG ++ G
Sbjct: 128 EDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-------KVPIK 178
Query: 206 YRAPEMWDLFRRELINEKVDIWALGCLLFRI-CYFKNAFDGESK---LQILNGNYRIPES 261
+ A E + + D+W+ G ++ + + +DG IL R+P+
Sbjct: 179 WMALES---ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 235
Query: 262 PKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGLQKSLPDRPPETQSA 315
P + V ++ D RP ++ ++ Q+ L + E
Sbjct: 236 PICTIDVYMIMVKCWMIDADSRPKFREL-IIEFSKMARDPQRYLVIQGDERMHL 288
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-37
Identities = 54/290 (18%), Positives = 106/290 (36%), Gaps = 42/290 (14%)
Query: 26 KIHVRNVIAEGGFSCVYSARD------AIHMSKQYAMKHMICN-DEESLESAMKEISVMK 78
++ + + EG F V A + + A+K + + E+ L + E+ +MK
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 79 SLKGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRG--------------A 123
+ H N++ L D +++E K +L L+ R
Sbjct: 74 MIGKHKNIINLLGACTQD----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 124 GYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183
K +++ V + + S HRDL A N+L+ D + K+ DF
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADF-------G 180
Query: 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI-CYFKNA 242
+ + + + APE + + D+W+ G LL+ I +
Sbjct: 181 LARDIHHIDYYKKTTNGRLPVKWMAPEA---LFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237
Query: 243 FDGESK---LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
+ G ++L +R+ + ++ + ++RD A P RP Q+
Sbjct: 238 YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-37
Identities = 51/271 (18%), Positives = 93/271 (34%), Gaps = 26/271 (9%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAI--HMSKQYAMKHM-ICNDEESLESAMKEISVMKSLKG 82
+I + I EG F V+ + + A+K C + E ++E M+
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD- 66
Query: 83 HPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAV 142
HP++V L + ++ME C + + ++ + A+
Sbjct: 67 HPHIVKLI-----GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121
Query: 143 FAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHT 202
+ S+ HRD+ A N+L+ S+ KL DFG + E +
Sbjct: 122 AYLESK--RFVHRDIAARNVLVSSNDCVKLGDFG--------LSRYMEDSTYYKASKGKL 171
Query: 203 TPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI-CYFKNAFDGESKLQILN---GNYRI 258
+ APE D+W G ++ I + F G ++ R+
Sbjct: 172 PIKWMAPES---INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 228
Query: 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
P P ++ L+ P RP T++
Sbjct: 229 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 259
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-37
Identities = 52/299 (17%), Positives = 104/299 (34%), Gaps = 43/299 (14%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHM----SKQYAMKHM-ICNDEESLESAMKEISVMKSL 80
++ + G F V A + + A+K + E+ M E+ V+ L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 81 KGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRGAGY-------------- 125
H N+V L + L++ E C L+N L + +
Sbjct: 84 GNHMNIVNLLGACTIG----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 126 --FEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183
+ + +L+ V + + S+ HRDL A N+LL + K+CDFG
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRITKICDFG------- 190
Query: 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAF 243
++ + APE + + D+W+ G L+ + ++
Sbjct: 191 LARDIKNDSNYVVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWELFSLGSSP 247
Query: 244 DGESK-----LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297
+++ +R+ + + D+++ A P RP Q+ + +Q+
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 4e-37
Identities = 70/307 (22%), Positives = 111/307 (36%), Gaps = 60/307 (19%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMK-----HMICNDEESLESAMKEISVMKSLKGHPN 85
+ + EG F+ VY ARD + ++ A+K H + +A++EI +++ L HPN
Sbjct: 4 DFLGEGQFATVYKARD-KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPN 61
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
++ L LV + + L ++++ + A + +
Sbjct: 62 IIGLLDAFGHK----SNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYL 116
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPA 205
H I HRDLK NLLL +G+ KL DFG + T
Sbjct: 117 HQH--WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV---------VTRW 165
Query: 206 YRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL----QILNGNYRIPES 261
YRAPE+ LF + VD+WA+GC+L + G+S L +I E
Sbjct: 166 YRAPEL--LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 223
Query: 262 --------------------------PKYSSSVTDLIRDMLQASPDDRPDITQV----WF 291
+ DLI+ + +P R TQ +F
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283
Query: 292 RVNEQLP 298
N P
Sbjct: 284 S-NRPGP 289
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 138 bits (348), Expect = 5e-37
Identities = 53/284 (18%), Positives = 92/284 (32%), Gaps = 33/284 (11%)
Query: 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK 81
VG V I EG F ++ + + ++Q A+K E K L
Sbjct: 3 VGV-HYKVGRRIGEGSFGVIFEGTN-LLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLA 58
Query: 82 GHPNVVTLYAHTILDLGRTKEAL-LVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCN 140
G + +Y G+ LV++ SL ++L+ G F K V + +
Sbjct: 59 GCTGIPNVY-----YFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLA 112
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGS-----DGLWKLCDFGSTSTNHKRFEKLEEMGIEE 195
V ++H +S + +RD+K +N L+G + + DFG K E+
Sbjct: 113 RVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 196 DNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN 255
N+ T Y + + + D+ ALG + + G
Sbjct: 171 KNLS--GTARYMSINT---HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225
Query: 256 YRIPE----------SPKYSSSVTDLIRDMLQASPDDRPDITQV 289
RI E + + + D PD +
Sbjct: 226 ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 137 bits (347), Expect = 1e-36
Identities = 58/268 (21%), Positives = 105/268 (39%), Gaps = 33/268 (12%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHM---ICNDEESLESAMKEISVMKSLKGHP 84
+ + G F V+ R H + YAMK + I + +E E ++ + HP
Sbjct: 7 QILRTLGTGSFGRVHLIRS-RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HP 64
Query: 85 NVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
++ ++ + + + ++ + R + F +VC A+
Sbjct: 65 FIIRMW-----GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTP 204
+HS+ I +RDLK EN+LL +G K+ DFG + + TP
Sbjct: 120 LHSK--DIIYRDLKPENILLDKNGHIKITDFGFAKY------------VPDVTYTLCGTP 165
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNYRIPE 260
Y APE+ + N+ +D W+ G L++ + F + ++ ILN R P
Sbjct: 166 DYIAPEV---VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP- 221
Query: 261 SPKYSSSVTDLIRDMLQASPDDRPDITQ 288
P ++ V DL+ ++ R Q
Sbjct: 222 -PFFNEDVKDLLSRLITRDLSQRLGNLQ 248
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 6e-36
Identities = 68/306 (22%), Positives = 112/306 (36%), Gaps = 57/306 (18%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMK--HMICNDEESLESAMKEISVMKSLKGHPNVVT 88
I EG + VY AR+ + A+K + E +A++EIS++K L HPN+V
Sbjct: 8 EKIGEGTYGVVYKARN-KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVK 65
Query: 89 LYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQ 148
L + + LV E + L ++ + + + +
Sbjct: 66 LLDVIHTE----NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL--AFCH 119
Query: 149 SPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRA 208
S + HRDLK +NLL+ ++G KL DFG + T YRA
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---------VRTYTHEVVTLWYRA 170
Query: 209 PEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESP------ 262
PE+ L + + VDIW+LGC+ + + F G+S++ L +R +P
Sbjct: 171 PEI--LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228
Query: 263 -------------------------KYSSSVTDLIRDMLQASPDDRPDITQV----WFR- 292
L+ ML P+ R +F+
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 293 VNEQLP 298
V + +P
Sbjct: 289 VTKPVP 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 131 bits (331), Expect = 6e-35
Identities = 74/302 (24%), Positives = 118/302 (39%), Gaps = 58/302 (19%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMK--HMICNDEESLESAMKEISVMKSLKGHPN 85
H I EG + VY A++ + + +A+K + DE + ++EIS++K LK H N
Sbjct: 5 HGLEKIGEGTYGVVYKAQN--NYGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSN 61
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
+V LY K +LV E D+ L +L+ G E + + N +
Sbjct: 62 IVKLYDVIHTK----KRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYC 116
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPA 205
H + + HRDLK +NLL+ +G K+ DFG K T
Sbjct: 117 HDR--RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE---------IVTLW 165
Query: 206 YRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYRIPESP--- 262
YRAP++ L + + +DIW++GC+ + F G S+ L +RI +P
Sbjct: 166 YRAPDV--LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223
Query: 263 ----------------------------KYSSSVTDLIRDMLQASPDDRPDITQV----W 290
S DL+ ML+ P+ R Q +
Sbjct: 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
Query: 291 FR 292
F+
Sbjct: 284 FK 285
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 6e-35
Identities = 67/340 (19%), Positives = 120/340 (35%), Gaps = 41/340 (12%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHM---ICNDEESLESAMKEISVMKSLKGHP 84
++ +G F V R+ + YAMK + + ++ + + E V+++ + HP
Sbjct: 8 DYLKLLGKGTFGKVILVRE-KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HP 65
Query: 85 NVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFA 144
+ L VME + + +R F E++ ++ +A+
Sbjct: 66 FLTALKYAFQTH----DRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEY 120
Query: 145 MHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTP 204
+HS+ + +RD+K ENL+L DG K+ DFG ++ TP
Sbjct: 121 LHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF---------CGTP 169
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNYRIPE 260
Y A ++ VD W LG +++ + + F + + IL R P
Sbjct: 170 EYLA---PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP- 225
Query: 261 SPKYSSSVTDLIRDMLQASPDDRP-----DITQV----WFRVNEQLPVGLQKSLPDRPPE 311
S L+ +L+ P R D +V +F V +K LP P+
Sbjct: 226 -RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQ 284
Query: 312 TQSAVANEGMSKPMNRSPPMPQRSPPPPPSSVDPTRNISQ 351
S V +PP S+ +
Sbjct: 285 VTSEVDTRYFDDEFTAQS--ITITPPDRYDSLGLLELDQR 322
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 131 bits (330), Expect = 1e-34
Identities = 55/281 (19%), Positives = 96/281 (34%), Gaps = 29/281 (10%)
Query: 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK 81
VGN + + I G F +Y D I ++ A+K + + E + K ++
Sbjct: 5 VGN-RYRLGRKIGSGSFGDIYLGTD-IAAGEEVAIK--LECVKTKHPQLHIESKIYKMMQ 60
Query: 82 GHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNA 141
G + T+ ++VME SL + L N + F K VL + + +
Sbjct: 61 GGVGIPTIRWCGAEG----DYNVMVMELLGPSLED-LFNFCSRKFSLKTVLLLADQMISR 115
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGSDGLWKLC---DFGSTSTNHKRFEKLEEMGIEEDNI 198
+ +HS++ HRD+K +N L+G L DFG R + + +N
Sbjct: 116 IEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA--KKYRDARTHQHIPYRENK 171
Query: 199 RKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL------ 252
T Y + + + D+ +LG +L + G
Sbjct: 172 NLTGTARYASINT---HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228
Query: 253 -NGNYRIPES---PKYSSSVTDLIRDMLQASPDDRPDITQV 289
P Y S + DD+PD + +
Sbjct: 229 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL 269
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-34
Identities = 68/325 (20%), Positives = 113/325 (34%), Gaps = 61/325 (18%)
Query: 18 RSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC--NDEESLESAMKEIS 75
+ K I +G F V+ AR ++ A+K ++ E +A++EI
Sbjct: 7 DEVS----KYEKLAKIGQGTFGEVFKARH-RKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 76 VMKSLKGHPNVVTLYAHTILDLGRTKEA----LLVMECCDKSLVNVLENRGAGYFEEKQV 131
+++ LK H NVV L LV + C+ L +L N F ++
Sbjct: 62 ILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEI 119
Query: 132 LAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEM 191
+ + + N ++ +H I HRD+KA N+L+ DG+ KL DFG R L +
Sbjct: 120 KRVMQMLLNGLYYIHRN--KILHRDMKAANVLITRDGVLKLADFGLA-----RAFSLAKN 172
Query: 192 GIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ- 250
+ T YR PE+ L +D+W GC++ + G ++
Sbjct: 173 SQPNRYTNRVVTLWYRPPEL--LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 230
Query: 251 ---ILNGNYRIPE------------------------------SPKYSSSVTDLIRDMLQ 277
I I + DLI +L
Sbjct: 231 LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLV 290
Query: 278 ASPDDRPDITQV----WFRVNEQLP 298
P R D +F ++ +P
Sbjct: 291 LDPAQRIDSDDALNHDFFW-SDPMP 314
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 130 bits (328), Expect = 3e-34
Identities = 52/296 (17%), Positives = 91/296 (30%), Gaps = 49/296 (16%)
Query: 26 KIHVRNVIAEGGFSCVYSARD----AIHMSKQYAMKHM-ICNDEESLESAMKEISVMKSL 80
I I EG F V+ AR A+K + + +E ++M
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 81 KGHPNVVTLYAHTILDLGRTKEALLVMECCD-KSLVNVLENRG----------------- 122
+PN+V L + K L+ E L L +
Sbjct: 74 D-NPNIVKLLGVCAVG----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 123 -----AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS 177
+ L I R V + + + HRDL N L+G + + K+ DFG
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI- 236
+ + + + + PE + D+WA G +L+ I
Sbjct: 187 SR-------NIYSADYYKADGNDAIPIRWMPPES---IFYNRYTTESDVWAYGVVLWEIF 236
Query: 237 CYFKNAFDGESKLQILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
Y + G + +++ + + +L+R P DRP +
Sbjct: 237 SYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 131 bits (330), Expect = 6e-34
Identities = 57/286 (19%), Positives = 103/286 (36%), Gaps = 44/286 (15%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHM---ICNDEESLESAMKEISVMKSLK--G 82
V +I GGF VY R K YAMK + ++ A+ E ++ +
Sbjct: 7 SVHRIIGRGGFGEVYGCRK-ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 83 HPNVVTLYAHTILDLGRTKEAL-LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCN 140
P +V + T + L +++ + L L G F E + ++
Sbjct: 66 CPFIVCMS-----YAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIIL 118
Query: 141 AVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRK 200
+ MH++ + +RDLK N+LL G ++ D G K +
Sbjct: 119 GLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSK-----------KKPHAS 165
Query: 201 HTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES-----KLQILNGN 255
T Y APE+ L + + D ++LGC+LF++ + F ++ +
Sbjct: 166 VGTHGYMAPEV--LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223
Query: 256 YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV---------WFR 292
+ +S + L+ +LQ + R +FR
Sbjct: 224 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 6e-34
Identities = 71/349 (20%), Positives = 129/349 (36%), Gaps = 69/349 (19%)
Query: 31 NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLY 90
VI G F VY A+ + A+K ++ + +E+ +M+ L H N+V L
Sbjct: 26 KVIGNGSFGVVYQAKL-CDSGELVAIKKVLQDKRF----KNRELQIMRKLD-HCNIVRLR 79
Query: 91 AHTILDLGRTKEAL---LVMECCDKSLVNVLEN--RGAGYFEEKQVLAIFRDVCNAVFAM 145
+ G K+ + LV++ +++ V + R V + ++ +
Sbjct: 80 -YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 146 HSQSPPIAHRDLKAENLLLGSDG-LWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTP 204
HS I HRD+K +NLLL D + KLCDFGS +++ E N+ +
Sbjct: 139 HSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSA----------KQLVRGEPNVSYICSR 186
Query: 205 AYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN----------- 253
YRAP +F +D+W+ GC+L + + F G+S + L
Sbjct: 187 YYRAP--ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244
Query: 254 ----------GNYRIPE----------SPKYSSSVTDLIRDMLQASPDDRPDITQV---- 289
++ P+ P+ L +L+ +P R +
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304
Query: 290 WFRVNEQLPVGLQKSLPDRPPETQSAVANEGMSKPMNRSPPMPQRSPPP 338
+F L+ P + ++ ++ +PP+ PP
Sbjct: 305 FFD-------ELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPP 346
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 3e-32
Identities = 66/288 (22%), Positives = 109/288 (37%), Gaps = 28/288 (9%)
Query: 9 QKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMS--KQYAMKHM----ICN 62
+ L G + VG + V+ G + V+ R K YAMK + I
Sbjct: 8 ELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ 67
Query: 63 DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRG 122
++ E E V++ ++ P +VTL+ + TK L++ L L R
Sbjct: 68 KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE---TKLHLILDYINGGELFTHLSQRE 124
Query: 123 AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182
F E +V ++ A+ +H I +RD+K EN+LL S+G L DFG +
Sbjct: 125 --RFTEHEVQIYVGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180
Query: 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNA 242
E T Y AP++ ++ VD W+LG L++ + +
Sbjct: 181 ADE--------TERAYDFCGTIEYMAPDIV-RGGDSGHDKAVDWWSLGVLMYELLTGASP 231
Query: 243 FDGESKLQILN------GNYRIPESPKYSSSVTDLIRDMLQASPDDRP 284
F + + P + S+ DLI+ +L P R
Sbjct: 232 FTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRL 279
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 8e-32
Identities = 68/303 (22%), Positives = 121/303 (39%), Gaps = 58/303 (19%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHM--ICNDEESLESAMKEISVMKSLKGHPN 85
I EG + V+ A++ + A+K + +DE SA++EI ++K LK H N
Sbjct: 5 EKLEKIGEGTYGTVFKAKN-RETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKN 62
Query: 86 VVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAM 145
+V L+ D K+ LV E CD+ L ++ G + + V + + +
Sbjct: 63 IVRLHDVLHSD----KKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFC 117
Query: 146 HSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPA 205
HS+ + HRDLK +NLL+ +G KL +FG + T
Sbjct: 118 HSR--NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV---------TLW 166
Query: 206 YRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNA-FDGESKLQILNGNYRIPESP-- 262
YR P++ LF +L + +D+W+ GC+ + F G L +R+ +P
Sbjct: 167 YRPPDV--LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224
Query: 263 -----------------------------KYSSSVTDLIRDMLQASPDDRPDITQV---- 289
K +++ DL++++L+ +P R +
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284
Query: 290 WFR 292
+F
Sbjct: 285 YFS 287
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (311), Expect = 1e-31
Identities = 59/260 (22%), Positives = 97/260 (37%), Gaps = 33/260 (12%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHM---ICNDEESLESAMKEISVMKSLKGHPNVVT 88
+ G F V + YAMK + + +E + E +++++ P +V
Sbjct: 48 TLGTGSFGRVMLVKH-KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVK 105
Query: 89 LYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQ 148
L + ++ + + L G F E + +HS
Sbjct: 106 LEFSFKDNSNLYM---VMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 149 SPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRA 208
+ +RDLK ENLL+ G ++ DFG R L TP A
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL------------CGTPEALA 206
Query: 209 PEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL----NGNYRIPESPKY 264
PE+ + N+ VD WALG L++ + F + +QI +G R P +
Sbjct: 207 PEI---ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP--SHF 261
Query: 265 SSSVTDLIRDMLQASPDDRP 284
SS + DL+R++LQ R
Sbjct: 262 SSDLKDLLRNLLQVDLTKRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-31
Identities = 59/302 (19%), Positives = 101/302 (33%), Gaps = 62/302 (20%)
Query: 32 VIAEGGFSCVYSARDAIHMSKQYAMKHMI--CNDEESLESAMKEISVMKSLKGHPNVVTL 89
+ G + V SA D + A+K + E + A +E+ ++K ++ H NV+ L
Sbjct: 25 PVGSGAYGAVCSAVD-GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGL 82
Query: 90 YAHTILD--LGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
D L + LVM L ++++ E ++ + + + +H+
Sbjct: 83 LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 148 QSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYR 207
HRDLK NL + D K+ DFG T YR
Sbjct: 140 AGII--HRDLKPGNLAVNEDCELKILDFGLARQADSEMTG------------YVVTRWYR 185
Query: 208 APEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL----QILNGNYRIPES-- 261
APE+ + + VDIW++GC++ + K F G L +I+ P
Sbjct: 186 APEV--ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243
Query: 262 ---------------------------PKYSSSVTDLIRDMLQASPDDRPDITQV----W 290
S +L+ ML + R + +
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303
Query: 291 FR 292
F
Sbjct: 304 FE 305
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 6e-31
Identities = 52/296 (17%), Positives = 106/296 (35%), Gaps = 35/296 (11%)
Query: 26 KIHVRNVIAEGGFSCVYSARD----AIHMSKQYAMKHM-ICNDEESLESAMKEISVMKSL 80
KI + + +G F VY + A+K + + E SVMK
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 81 KGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRG--------AGYFEEKQV 131
+VV L + L++ME + L + L + ++
Sbjct: 81 N-CHHVVRLLGVVSQG----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 132 LAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEM 191
+ + ++ + + +++ HRDL A N ++ D K+ DFG + E
Sbjct: 136 IQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFG-------MTRDIYET 186
Query: 192 GIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI-CYFKNAFDGESKLQ 250
+ + +PE + + D+W+ G +L+ I + + G S Q
Sbjct: 187 DYYRKGGKGLLPVRWMSPES---LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243
Query: 251 ILNG---NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGLQK 303
+L + + + +L+R Q +P RP ++ + E++ G ++
Sbjct: 244 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-30
Identities = 47/289 (16%), Positives = 97/289 (33%), Gaps = 40/289 (13%)
Query: 26 KIHVRNVIAEGGFSCVYSARDA----IHMSKQYAMKHM-ICNDEESLESAMKEISVMKSL 80
++ + + G F V A + A+K + + M E+ ++ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 81 KGHPNVVTLYAHTILDLGRTKEALLVMECCDK-SLVNVLENRG--------------AGY 125
H NVV L ++++E C +L L ++ +
Sbjct: 74 GHHLNVVNLLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 126 FEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRF 185
+ ++ V + + S+ HRDL A N+LL + K+CDFG +K
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 186 EKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRI-CYFKNAFD 244
+ + + + A + + + D+W+ G LL+ I + +
Sbjct: 189 DYVRKGDA-------RLPLKWMA---PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238
Query: 245 GESK----LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQV 289
G + L R+ + + + D P RP +++
Sbjct: 239 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 287
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 116 bits (291), Expect = 4e-29
Identities = 53/310 (17%), Positives = 110/310 (35%), Gaps = 69/310 (22%)
Query: 28 HVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVV 87
+ + G +S V+ A + I +++ +K + + +EI ++++L+G PN++
Sbjct: 38 QLVRKLGRGKYSEVFEAIN-ITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNII 93
Query: 88 TLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS 147
TL + RT LV E + + L + + ++ A+ HS
Sbjct: 94 TLADIVKDPVSRTPA--LVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHS 147
Query: 148 QSPPIAHRDLKAENLLLGSDGLW-KLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAY 206
I HRD+K N+++ + +L D+G E ++ + + +
Sbjct: 148 M--GIMHRDVKPHNVMIDHEHRKLRLIDWGLA----------EFYHPGQEYNVRVASRYF 195
Query: 207 RAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFD----------------GESKLQ 250
+ PE+ ++ + +D+W+LGC+L + + K F G L
Sbjct: 196 KGPELL--VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
Query: 251 ILNGNYRIPESPKY------------------------SSSVTDLIRDMLQASPDDRPDI 286
Y I P++ S D + +L+ R
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
Query: 287 TQV----WFR 292
+ +F
Sbjct: 314 REAMEHPYFY 323
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-28
Identities = 63/326 (19%), Positives = 105/326 (32%), Gaps = 71/326 (21%)
Query: 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMK--HMICNDEESLESAMKEISVMKSLKGH 83
+ + + G + V +A D + A+K + +E+ ++K +K H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFD-TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-H 76
Query: 84 PNVVTLYA--HTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNA 141
NV+ L L + LV L N+++ + + V + +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRG 133
Query: 142 VFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKH 201
+ +HS I HRDLK NL + D K+ DFG +++
Sbjct: 134 LKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA------------RHTDDEMTGYV 179
Query: 202 TTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ----ILNGNYR 257
T YRAPE+ + N+ VDIW++GC++ + + F G + IL
Sbjct: 180 ATRWYRAPEI--MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237
Query: 258 IPES-----------------------------PKYSSSVTDLIRDMLQASPDDRPDITQ 288
+ DL+ ML D R Q
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297
Query: 289 V----WFRVNEQLPVGLQKSLPDRPP 310
+F Q PD P
Sbjct: 298 ALAHAYFA---------QYHDPDDEP 314
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 2e-26
Identities = 71/355 (20%), Positives = 130/355 (36%), Gaps = 48/355 (13%)
Query: 19 SIDVGNLKIHVRN------VIAEGGFSCVYSARDAIHMSKQYAMK--HMICNDEESLESA 70
S++VG+ V I G V +A D + + A+K ++ + A
Sbjct: 5 SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYD-AVLDRNVAIKKLSRPFQNQTHAKRA 63
Query: 71 MKEISVMKSLKGHPNVVTLYA--HTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEE 128
+E+ +MK + H N+++L L ++ LVME D +L V++ +
Sbjct: 64 YRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDH 118
Query: 129 KQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKL 188
+++ + + + +HS I HRDLK N+++ SD K+ DFG T F
Sbjct: 119 ERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 176
Query: 189 EEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK 248
+ T YRAPE+ E VDIW++GC++ + K F G
Sbjct: 177 PYVV----------TRYYRAPEVI---LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223
Query: 249 LQILN--GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPVGLQKSLP 306
+ N P++ + +R+ ++ P F + L +
Sbjct: 224 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP--DSLFPADSEHNK 281
Query: 307 DRPPETQSAV-------------ANEGMSKPMNRSPPMPQRSPPPPPSSVDPTRN 348
+ + + + ++ + P P PPP D +
Sbjct: 282 LKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLD 336
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (263), Expect = 2e-25
Identities = 61/351 (17%), Positives = 115/351 (32%), Gaps = 81/351 (23%)
Query: 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK-- 81
+ + + + G FS V+ A+D + + AMK ++ D+ E+A EI +++ +
Sbjct: 12 DARYILVRKLGWGHFSTVWLAKD-MVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDA 69
Query: 82 --------GHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLA 133
G +++ L H ++V E ++L+ +++ V
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 134 IFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLW-KLCDFGSTSTNHKRFEKLEEMG 192
I + + + MH + I H D+K EN+L+ L K +
Sbjct: 130 ISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQI-------KIADLGNACW 181
Query: 193 IEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK---- 248
+E T YR+PE+ DIW+ CL+F + F+ +
Sbjct: 182 YDEHYTNSIQTREYRSPEVL---LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238
Query: 249 ------LQILNGNYRIPE----------------------------------------SP 262
QI+ +P S
Sbjct: 239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 298
Query: 263 KYSSSVTDLIRDMLQASPDDRPDITQV----WFRVNEQLPVGLQKSLPDRP 309
+ ++D + MLQ P R D + W + + + +PDR
Sbjct: 299 DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME---EIRVPDRE 346
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 83.3 bits (205), Expect = 5e-19
Identities = 26/200 (13%), Positives = 66/200 (33%), Gaps = 26/200 (13%)
Query: 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMK---------HMICNDEESLESAMKEISVMKS 79
+ ++ EG S V++ + +K + + + +++ +
Sbjct: 4 IGKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 80 LKGHPNVVTLYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVC 139
+ L + + + ++ME D + + + +
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWEGNAVLMELID--------AKELYRVRVENPDEVLDMIL 113
Query: 140 NAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG-STSTNHKRFEKLEEMGIEEDNI 198
V + + I H DL N+L+ +G+ + DF S + + ++ E + NI
Sbjct: 114 EEVAKFYHR--GIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVR--NI 168
Query: 199 RKHTTPAYRAP-EMWDLFRR 217
+ + YR ++ R
Sbjct: 169 ITYFSRTYRTEKDINSAIDR 188
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 690 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.64 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.41 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.03 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.36 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.99 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.62 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.03 Aligned_cols=247 Identities=27% Similarity=0.403 Sum_probs=206.1
Q ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCCEE
Q ss_conf 82299999850059569999998356890899999512898889999999999996108999008888987624887608
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~~~ 103 (690)
..+|++.+.||+|+||.||+|.+. .+++.||+|++...+....+.+.+|+.+++.+. |||||++++++.. .+.+
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~----~~~~ 92 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYLV----GDEL 92 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBT-TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEE----TTEE
T ss_pred CCCCEEEEEEECCCCCEEEEEEEC-CCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEE----CCEE
T ss_conf 105388789812858299999998-999899999984301727999999999998679-9988058577988----9998
Q ss_pred EEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf 99995379858999997189999999999999999999999982999900379998828967999813531588776553
Q 005577 104 LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGlA~~~~~ 183 (690)
|||||||.|+.+..+..... +++..+..|+.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.+..
T Consensus 93 ~ivmEy~~gg~L~~~~~~~~--l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 93 WVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp EEEEECCTTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEECCCCCHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEECCCCCEEECCCHHHEEECC
T ss_conf 99997037980898864159--999999999999999999999879--72267768886887899686425156413213
Q ss_pred CCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH-----HCCCCC
Q ss_conf 101333115433445567998634864111121079993146999999999997379999993099997-----246778
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL-----NGNYRI 258 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il-----~~~~~~ 258 (690)
.. ......+||+.|||||+ +.+..++.++|||||||++|+|++|+.||.+......+ ......
T Consensus 169 ~~---------~~~~~~~gt~~Y~aPE~---~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~ 236 (293)
T d1yhwa1 169 EQ---------SKRSTMVGTPYWMAPEV---VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 236 (293)
T ss_dssp TT---------CCBCCCCSCGGGCCHHH---HSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC
T ss_pred CC---------CCCCCCCCCCCCCCHHH---HCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC
T ss_conf 66---------64444444777368266---4479988012031372999998048899899799999999985799988
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf 9999999899999999842099999998999999
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
..+..+++.+.+||.+||..||.+||++.+++.+
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8855379999999999866996689099999649
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=370.37 Aligned_cols=246 Identities=28% Similarity=0.398 Sum_probs=206.6
Q ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECC---CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCC
Q ss_conf 22999998500595699999983568908999995128---988899999999999961089990088889876248876
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~ 101 (690)
.+|++.+.||+|+||.||+|++. .+++.||||++... +....+.+.+|+.+|+.|+ |||||++++++.. .+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~----~~ 88 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLR----EH 88 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEE----TT
T ss_pred HHCEEEEEEECCCCEEEEEEEEC-CCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEE----CC
T ss_conf 85676279701888099999998-999399999984444358899999999999999778-9998238999998----99
Q ss_pred EEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCCCCCC
Q ss_conf 08999953798589999971899999999999999999999999829999003799988289679998135315887765
Q 005577 102 EALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 102 ~~~LVmEy~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGlA~~~ 181 (690)
.+|||||||.++++..+.... +.+++..++.|+.||+.||.|||++| ||||||||+||||+.++.+||+|||+++..
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCCCEEEECCCCCEEEEECCCCCCC
T ss_conf 889999806999457899737-99999999999999999999998689--766678842179879997898443653346
Q ss_pred CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH----HCCCC
Q ss_conf 53101333115433445567998634864111121079993146999999999997379999993099997----24677
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL----NGNYR 257 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il----~~~~~ 257 (690)
.. .....||+.|||||++.......|+.++|||||||++|+|++|+.||.+....+.+ .....
T Consensus 166 ~~-------------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~ 232 (309)
T d1u5ra_ 166 AP-------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232 (309)
T ss_dssp SS-------------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred CC-------------CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 77-------------87313476636889983467888672145455899999998788999997999999999828999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf 89999999899999999842099999998999999
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
......+++.+.+||.+||..||.+||++.+++.+
T Consensus 233 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 88878889999999999773796579189999719
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=368.32 Aligned_cols=264 Identities=19% Similarity=0.347 Sum_probs=213.3
Q ss_pred EECCCEEEEEEEEEECCCEEEEEEEECCCC--CEEEEEEEEECC-CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC
Q ss_conf 532822999998500595699999983568--908999995128-98889999999999996108999008888987624
Q 005577 21 DVGNLKIHVRNVIAEGGFSCVYSARDAIHM--SKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97 (690)
Q Consensus 21 ~i~~~ry~i~~~LG~GgfG~Vyla~d~~~~--~k~vAIK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~ 97 (690)
++...+|++.++||+|+||.||+|.+.... ...||+|.+... .....+.+.+|+.+|++|+ |||||++++++.
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~--- 97 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVT--- 97 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC---
T ss_pred HHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCCCCEEEEEE---
T ss_conf 2080042785698027882999999957997889999999784459899999999999998579-988861899996---
Q ss_pred CCCCEEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCC
Q ss_conf 88760899995379858999997189999999999999999999999982999900379998828967999813531588
Q 005577 98 GRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS 177 (690)
Q Consensus 98 ~~~~~~~LVmEy~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGl 177 (690)
....+|+|||||.++.+..+.....+.+++.+++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 98 -~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 98 -KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGL 174 (299)
T ss_dssp -SSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred -ECCEEEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEECCCCCEEECCCCC
T ss_conf -288779999722798530021045679999999999999999889885279--83576150448988999199888443
Q ss_pred CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHH---HH
Q ss_conf 7765531013331154334455679986348641111210799931469999999999973-7999999309999---72
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LN 253 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLlt-Gk~Pf~~~~~~~i---l~ 253 (690)
++.......... ........||+.|||||+ +.++.++.++|||||||++|||+| |+.||.+....++ +.
T Consensus 175 a~~~~~~~~~~~----~~~~~~~~~t~~y~aPE~---~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~ 247 (299)
T d1jpaa_ 175 SRFLEDDTSDPT----YTSALGGKIPIRWTAPEA---IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 247 (299)
T ss_dssp -------------------------CGGGSCHHH---HHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred CEECCCCCCCCE----EEECCCCCCCCCCCCHHH---HHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHH
T ss_conf 157567777653----650256668830038788---8369978612144535789999867999999999999999997
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHCC
Q ss_conf 467789999999899999999842099999998999999953167
Q 005577 254 GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLP 298 (690)
Q Consensus 254 ~~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~l~ 298 (690)
...+.+.+..++..+.+||.+||+.||.+||++.+++..+..++.
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 248 QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf 378899974226999999999758797689299999999999841
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.91 Aligned_cols=251 Identities=25% Similarity=0.384 Sum_probs=206.8
Q ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCCEE
Q ss_conf 82299999850059569999998356890899999512898889999999999996108999008888987624887608
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~~~ 103 (690)
...|++.+.||+|+||.||+|++. .+++.||+|++........+.+.+|+.+|+.|. |||||++++++.. .+.+
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~----~~~~ 84 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNK-ETSVLAAAKVIDTKSEEELEDYMVEIDILASCD-HPNIVKLLDAFYY----ENNL 84 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEE----TTEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEEC-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEE----CCEE
T ss_conf 037598479930778199999999-999399999987289999999999999998679-9998849889800----9958
Q ss_pred EEEEECCCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf 999953798-5899999718999999999999999999999998299990037999882896799981353158877655
Q 005577 104 LLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~g-sLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGlA~~~~ 182 (690)
|||||||.+ +|..++.... +.+++..+..|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~ 161 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 161 (288)
T ss_dssp EEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECH
T ss_pred EEEEECCCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEEEECCHHHEEECCCCCEEEEECHHHHCCC
T ss_conf 99996279981889998628-99999999999999999999999889--8871407003148789998997161230357
Q ss_pred CCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHH--HCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHH----HHCCC
Q ss_conf 310133311543344556799863486411112--107999314699999999999737999999309999----72467
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLF--RRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI----LNGNY 256 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~--~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~i----l~~~~ 256 (690)
.... ......||+.|||||++... .+..|+.++|||||||++|+|++|+.||.+....++ .....
T Consensus 162 ~~~~---------~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~ 232 (288)
T d2jfla1 162 RTIQ---------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP 232 (288)
T ss_dssp HHHH---------HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC
T ss_pred CCCC---------CCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC
T ss_conf 7864---------1001025626479999832025788888066578789999998208899999899999999970799
Q ss_pred -CCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf -789999999899999999842099999998999999
Q 005577 257 -RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 257 -~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
....+..+++.+.+||.+||+.||.+||++.+++.+
T Consensus 233 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 233 PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8777656699999999999766996689199999629
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.96 Aligned_cols=248 Identities=21% Similarity=0.299 Sum_probs=203.3
Q ss_pred EECCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECC-CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCC
Q ss_conf 532822999998500595699999983568908999995128-9888999999999999610899900888898762488
Q 005577 21 DVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 21 ~i~~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~ 99 (690)
++.+++|++.+.||+|+||.||+|++. .+++.||+|++... +....+.+.+|+.+|+.++ |||||++++++. .
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~----~ 75 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFY----S 75 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEET-TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEE----C
T ss_pred CCCCCCCEEEEEEECCCCEEEEEEEEC-CCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCC-CCCCCCEEEEEE----E
T ss_conf 787568889789712778099999998-9996999999875409789999999999998679-999994999999----8
Q ss_pred CCEEEEEEECCCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCEEECCCCCEEEECCCC
Q ss_conf 7608999953798-589999971899999999999999999999999829-99900379998828967999813531588
Q 005577 100 TKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQ-SPPIAHRDLKAENLLLGSDGLWKLCDFGS 177 (690)
Q Consensus 100 ~~~~~LVmEy~~g-sLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~-g~~IVHRDLKP~NILLd~~g~vKL~DFGl 177 (690)
...+|||||||.| +|.+++...+. +++..+..++.||+.||.|||++ + |+||||||+||||+.++.+||+|||+
T Consensus 76 ~~~~~iVmEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGl 151 (322)
T d1s9ja_ 76 DGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGV 151 (322)
T ss_dssp SSEEEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEECCCCCEEEEECCC
T ss_conf 9999999976799868998742499--9999999999999999999998599--97144577994687899899954877
Q ss_pred CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHH--HHH--
Q ss_conf 7765531013331154334455679986348641111210799931469999999999973799999930999--972--
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ--ILN-- 253 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~--il~-- 253 (690)
|+..... .....+||+.|||||+ +.+..|+.++|||||||++|||++|+.||.+.+... ...
T Consensus 152 a~~~~~~-----------~~~~~~GT~~Y~APEv---l~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~ 217 (322)
T d1s9ja_ 152 SGQLIDS-----------MANSFVGTRSYMSPER---LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 217 (322)
T ss_dssp CHHHHHH-----------TC---CCSSCCCCHHH---HHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--
T ss_pred CCCCCCC-----------CCCCCCCCCCCCCCHH---HCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
T ss_conf 6256788-----------6211137714119468---7589989488899899999999988899899887899999988
Q ss_pred ------------------------------------------CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHH
Q ss_conf ------------------------------------------46778999999989999999984209999999899999
Q 005577 254 ------------------------------------------GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 254 ------------------------------------------~~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~ 291 (690)
..........++..+.+||.+||..||.+||++.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 218 QVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ----------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 75177545774212333221111222354134778876650268766764448999999999986899467908999960
Q ss_pred H
Q ss_conf 9
Q 005577 292 R 292 (690)
Q Consensus 292 ~ 292 (690)
+
T Consensus 298 H 298 (322)
T d1s9ja_ 298 H 298 (322)
T ss_dssp S
T ss_pred C
T ss_conf 9
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=368.82 Aligned_cols=246 Identities=24% Similarity=0.394 Sum_probs=207.4
Q ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCCEEE
Q ss_conf 22999998500595699999983568908999995128988899999999999961089990088889876248876089
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 25 ~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~~~~ 104 (690)
.+|++.+.||+|+||.||+|++. .+++.||+|++........+.+.+|+.+|+.|+ |||||++++++. +.+.+|
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~-~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~----~~~~~~ 99 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLVNLHDAFE----DDNEMV 99 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEE----ETTEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEEC-CCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCC-CCCCCCEEEEEE----ECCEEE
T ss_conf 57589889840768199999988-999899999984524316999999999998679-979992999999----899999
Q ss_pred EEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECC--CCCEEEECCCCCCCC
Q ss_conf 9995379-8589999971899999999999999999999999829999003799988289679--998135315887765
Q 005577 105 LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS--DGLWKLCDFGSTSTN 181 (690)
Q Consensus 105 LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~--~g~vKL~DFGlA~~~ 181 (690)
||||||. |+|.+.+.... +.+++..++.|+.||+.||.|||++| ||||||||+|||++. ++.+||+|||+++.+
T Consensus 100 ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp EEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CEEEEECHHHEEECCCCCCEEEEEECCHHEEC
T ss_conf 9998579988999997623-78999999999999999999997569--76000154673641688986999545210442
Q ss_pred CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHH----CCCC
Q ss_conf 531013331154334455679986348641111210799931469999999999973799999930999972----4677
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN----GNYR 257 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il~----~~~~ 257 (690)
.... ......||+.|||||+ +.+..++.++|||||||++|+|++|+.||.+.+..+++. ..+.
T Consensus 177 ~~~~----------~~~~~~gT~~Y~aPEv---~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 243 (350)
T d1koaa2 177 DPKQ----------SVKVTTGTAEFAAPEV---AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN 243 (350)
T ss_dssp CTTS----------CEEEECSCTTTCCHHH---HHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred CCCC----------CCCEECCCCCCCCHHH---HCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 5654----------3200068624218899---75899872676554659999998598998997999999999847889
Q ss_pred CCC--CCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf 899--99999899999999842099999998999999
Q 005577 258 IPE--SPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 258 ~~~--~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
.+. .+.+++.+.+||.+||..||.+||++.+++.+
T Consensus 244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8942235899999999999756896679089998629
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.77 Aligned_cols=261 Identities=21% Similarity=0.305 Sum_probs=213.9
Q ss_pred EEECCCEEEEEEEEEECCCEEEEEEEECCC----CCEEEEEEEEECC-CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEE
Q ss_conf 753282299999850059569999998356----8908999995128-98889999999999996108999008888987
Q 005577 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIH----MSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTI 94 (690)
Q Consensus 20 i~i~~~ry~i~~~LG~GgfG~Vyla~d~~~----~~k~vAIK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~ 94 (690)
|++...+|++.++||+|+||+||+|++... ....||+|.+... +......+.+|+.+|.++.+|||||++++++.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 65778993970198307881999999857885542049999996633587899999999999997158996868778886
Q ss_pred EECCCCCEEEEEEECCC-CCHHHHHHHHCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 62488760899995379-858999997189---------------------99999999999999999999998299990
Q 005577 95 LDLGRTKEALLVMECCD-KSLVNVLENRGA---------------------GYFEEKQVLAIFRDVCNAVFAMHSQSPPI 152 (690)
Q Consensus 95 ~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~---------------------~~Lse~~v~~i~~qIl~aL~yLHs~g~~I 152 (690)
..+.+|||||||+ |+|.+++..+.. ..+++..++.|+.||+.||.|||+++ |
T Consensus 112 ----~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--I 185 (325)
T d1rjba_ 112 ----LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--C 185 (325)
T ss_dssp ----SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred ----ECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--E
T ss_conf ----2995899997279995999998625777510221000012220012577899999999999999999997399--0
Q ss_pred CCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHH
Q ss_conf 03799988289679998135315887765531013331154334455679986348641111210799931469999999
Q 005577 153 AHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCL 232 (690)
Q Consensus 153 VHRDLKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGvi 232 (690)
|||||||+|||++.++.+||+|||+|+........ .......||+.|||||+ +.+..++.++|||||||+
T Consensus 186 iHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-------~~~~~~~gt~~y~aPE~---l~~~~~~~~~DiwS~Gvi 255 (325)
T d1rjba_ 186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY-------VVRGNARLPVKWMAPES---LFEGIYTIKSDVWSYGIL 255 (325)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS-------EEETTEEECGGGCCHHH---HHHCCCCHHHHHHHHHHH
T ss_pred EECCCCHHCCCCCCCCEEEEEECCCCCCCCCCCCE-------EEECCCCCCCCCCCHHH---HCCCCCCCCEECCCHHHH
T ss_conf 50527032144345982898514222204577861-------56234357876578388---727999963303000399
Q ss_pred HHHHHH-CCCCCCCCH----HHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
Q ss_conf 999973-799999930----9999724677899999998999999998420999999989999999531
Q 005577 233 LFRICY-FKNAFDGES----KLQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 233 LyeLlt-Gk~Pf~~~~----~~~il~~~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~ 296 (690)
+|||++ |+.||.+.. ...++...++.+.+..+++.+.+||.+||+.||++||++.+|+.+|.-+
T Consensus 256 l~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~~ 324 (325)
T d1rjba_ 256 LWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 324 (325)
T ss_dssp HHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf 999983899999998989999999856998998876789999999997588966893999999997488
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.35 Aligned_cols=244 Identities=26% Similarity=0.425 Sum_probs=206.2
Q ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCC---HHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCC
Q ss_conf 229999985005956999999835689089999951289---88899999999999961089990088889876248876
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~ 101 (690)
.+|++.+.||+|+||.||+|++. .+++.||+|++.... ....+.+.+|+.+++.+. |||||++++++. +.+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~----~~~ 79 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFH----DAT 79 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEE----CSS
T ss_pred HHEEEEEEEECCCCCEEEEEEEC-CCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEE----ECC
T ss_conf 37699889851778589999998-999499999981688567689999999999998568-888885999999----899
Q ss_pred EEEEEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf 0899995379-858999997189999999999999999999999982999900379998828967999813531588776
Q 005577 102 EALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGlA~~ 180 (690)
.+|||||||+ |+|.+.+..... +++..+..|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~~~~--l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~ 155 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVH 155 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred EEEEEEEECCCCCHHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHHCC--EEEEEECCCCCEECCCCCEEECCCCEEEE
T ss_conf 98999850479858988750489--999999999999999999999889--46522023441466899871155563354
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHCCC--CC
Q ss_conf 5531013331154334455679986348641111210799931469999999999973799999930999972467--78
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RI 258 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il~~~~--~~ 258 (690)
.... ......||+.|||||+ +.+..++.++|||||||++|+|++|+.||.+.+..++..... ..
T Consensus 156 ~~~~-----------~~~~~~Gt~~Y~APE~---~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 221 (263)
T d2j4za1 156 APSS-----------RRTTLCGTLDYLPPEM---IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 221 (263)
T ss_dssp CCCC-----------CCEETTEEGGGCCHHH---HTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC
T ss_pred CCCC-----------CCCCCCCCCCCCCHHH---HCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
T ss_conf 4888-----------5235578876349999---7589989314404675999998329999888999999999971899
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf 9999999899999999842099999998999999
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
..+..+++.+.+||.+||..||.+||++.+++.+
T Consensus 222 ~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 222 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 9986689999999999764797689099999719
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=367.23 Aligned_cols=259 Identities=24% Similarity=0.376 Sum_probs=215.6
Q ss_pred EEEECCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
Q ss_conf 37532822999998500595699999983568908999995128988899999999999961089990088889876248
Q 005577 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLG 98 (690)
Q Consensus 19 ~i~i~~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~ 98 (690)
.|+|...+|++.+.||+|+||+||+|.+. ..++.||||++.... ...+.+++|+.+|++|+ |||||++|+++.
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~-HpnIv~~~~~~~---- 83 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIK-HPNLVQLLGVCT---- 83 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEG-GGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC----
T ss_pred CCEECHHHEEEEEEEEECCCEEEEEEEEC-CCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCC-CCCEECCCCCEE----
T ss_conf 51745799398659820888089999999-999699999977761-03999999999998679-998826775274----
Q ss_pred CCCEEEEEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCC
Q ss_conf 8760899995379-858999997189999999999999999999999982999900379998828967999813531588
Q 005577 99 RTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS 177 (690)
Q Consensus 99 ~~~~~~LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGl 177 (690)
+.+..|||||||. |+|...+.......+++..++.|+.||+.||.|||.++ |+||||||+||||+.++.+||+|||+
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred ECCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEECCCCCEEECCCCC
T ss_conf 5785478763146760677753035541579999999999999788898789--30576045768998999289832445
Q ss_pred CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCC-CCCCHHH---HHHH
Q ss_conf 77655310133311543344556799863486411112107999314699999999999737999-9993099---9972
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNA-FDGESKL---QILN 253 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~P-f~~~~~~---~il~ 253 (690)
++........ ......|++.|||||+ +.+..|+.++|||||||++|||+++..| |.+.... ..+.
T Consensus 162 a~~~~~~~~~--------~~~~~~g~~~y~aPE~---~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~ 230 (287)
T d1opja_ 162 SRLMTGDTYT--------AHAGAKFPIKWTAPES---LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 230 (287)
T ss_dssp TTTCCSSSSE--------EETTEEECGGGCCHHH---HHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred EEECCCCCCE--------EECCCCCCCCCCCHHH---HCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
T ss_conf 4653788722--------1035566546669278---7279998104302178999999867998877425999999985
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHC
Q ss_conf 46778999999989999999984209999999899999995316
Q 005577 254 GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 254 ~~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~l 297 (690)
..++.+.+..+++.+.+||.+||+.||.+||++.+++..+....
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 58888887433099999999975779768939999999999998
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.46 Aligned_cols=259 Identities=20% Similarity=0.335 Sum_probs=209.1
Q ss_pred EEEECCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECC--CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE
Q ss_conf 37532822999998500595699999983568908999995128--9888999999999999610899900888898762
Q 005577 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 19 ~i~i~~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~ 96 (690)
+|+|...+|++.+.||+|+||.||+|+. ...||||++... +....+.+.+|+.+|.+++ |||||++++++.
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~-- 74 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKW----HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-- 74 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEES----SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEC--
T ss_pred CCCCCCCCEEEEEEEEECCCCEEEEEEE----CCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEE--
T ss_conf 7131545189988983078858999999----998999999734699899999999999998479-987864567971--
Q ss_pred CCCCCEEEEEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECC
Q ss_conf 488760899995379-8589999971899999999999999999999999829999003799988289679998135315
Q 005577 97 LGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDF 175 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DF 175 (690)
...++||||||+ |+|.+++.... ..+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+||
T Consensus 75 ---~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DF 148 (276)
T d1uwha_ 75 ---APQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDF 148 (276)
T ss_dssp ---SSSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCC
T ss_pred ---CCEEEEEEECCCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHCCC--EECCCCCHHHEEECCCCCEEECCC
T ss_conf ---558999996589988899985235-78999999999999999988875099--951614789979818997887500
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHH----HH
Q ss_conf 88776553101333115433445567998634864111121079993146999999999997379999993099----99
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKL----QI 251 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~----~i 251 (690)
|+++........ .......||+.|||||++.......|+.++|||||||++|||+||+.||.+.... ..
T Consensus 149 Gla~~~~~~~~~-------~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~ 221 (276)
T d1uwha_ 149 GLATVKSRWSGS-------HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM 221 (276)
T ss_dssp CCSCC-------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH
T ss_pred CCEEECCCCCCC-------CCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
T ss_conf 221333556776-------3125665574317999995056899995315163599999999788998998969999999
Q ss_pred HHCCCCCC----CCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHC
Q ss_conf 72467789----99999989999999984209999999899999995316
Q 005577 252 LNGNYRIP----ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 252 l~~~~~~~----~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~l 297 (690)
+......+ ....+++.+.+||.+||..||.+||++.+++..+..+.
T Consensus 222 ~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 222 VGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp HHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHCCCCCCCCHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 96588898600036555499999999975889768929999999999999
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=366.42 Aligned_cols=246 Identities=23% Similarity=0.366 Sum_probs=207.2
Q ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCCEEE
Q ss_conf 22999998500595699999983568908999995128988899999999999961089990088889876248876089
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 25 ~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~~~~ 104 (690)
.+|++.+.||+|+||.||+|++. .+++.||+|++..........+.+|+.+|+.|. |||||++++++. +...+|
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~----~~~~~~ 102 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKLINLHDAFE----DKYEMV 102 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC-STTBCCEEEEEE----CSSEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEEC-CCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCC-CCCCCCEEEEEE----ECCEEE
T ss_conf 03599899931778299999998-999799999988726467999999999998679-979891999999----899999
Q ss_pred EEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEC--CCCCEEEECCCCCCCC
Q ss_conf 9995379-858999997189999999999999999999999982999900379998828967--9998135315887765
Q 005577 105 LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLG--SDGLWKLCDFGSTSTN 181 (690)
Q Consensus 105 LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd--~~g~vKL~DFGlA~~~ 181 (690)
||||||+ |+|.+.+.... ..|++.+++.|+.||+.||.|||++| ||||||||+||||+ .++.+||+|||+|+.+
T Consensus 103 ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEECCCCCHHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCCCCCCCCCCCEEEEEECCCCEEC
T ss_conf 9998289980888898638-99899999999999999999999779--26513144553113467884899525630343
Q ss_pred CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH----HCCCC
Q ss_conf 53101333115433445567998634864111121079993146999999999997379999993099997----24677
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL----NGNYR 257 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il----~~~~~ 257 (690)
... .......||+.|||||+ +.+..++.++|||||||++|+|++|+.||.+....+++ ...+.
T Consensus 180 ~~~----------~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 246 (352)
T d1koba_ 180 NPD----------EIVKVTTATAEFAAPEI---VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE 246 (352)
T ss_dssp CTT----------SCEEEECSSGGGCCHHH---HTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC
T ss_pred CCC----------CCEEECCCCCCCCCHHH---HCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 788----------72010047645348999---74799897633389899999999688998997999999999847889
Q ss_pred CC--CCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf 89--999999899999999842099999998999999
Q 005577 258 IP--ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 258 ~~--~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
.+ ....+++.+.+||.+||+.||.+||++.+++.+
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8930024799999999999756996689189999609
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.76 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=205.6
Q ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECC---CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCC
Q ss_conf 822999998500595699999983568908999995128---98889999999999996108999008888987624887
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 24 ~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~ 100 (690)
-.+|++.+.||+|+||.||+|++. .+++.||+|++... .....+.+.+|+.+|+.+. |||||++++++. +.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~----~~ 77 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQ----TH 77 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEE----CS
T ss_pred HHHCEEEEEEECCCCEEEEEEEEC-CCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEC----CC
T ss_conf 474289889831768499999998-999899999981565449799999999999998679-998877876403----56
Q ss_pred CEEEEEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf 60899995379-85899999718999999999999999999999998299990037999882896799981353158877
Q 005577 101 KEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 101 ~~~~LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGlA~ 179 (690)
..+|+|||||. |+|...+...+. +++..++.++.||+.||.|||++| ||||||||+|||++.+|.+||+|||+|+
T Consensus 78 ~~~~iv~ey~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~ 153 (337)
T d1o6la_ 78 DRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCK 153 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred CCCCCCEECCCCCCHHHHHHCCCC--CCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEECCCCCEEEEECCCCC
T ss_conf 421110003579860555532567--759999999999965211343159--6224647778476589988882056520
Q ss_pred CCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHCCC--C
Q ss_conf 65531013331154334455679986348641111210799931469999999999973799999930999972467--7
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--R 257 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il~~~~--~ 257 (690)
...... ......+||+.|||||+ +.+..|+.++|||||||++|||++|+.||.+.+...+..... .
T Consensus 154 ~~~~~~---------~~~~~~~GT~~Y~aPE~---~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~ 221 (337)
T d1o6la_ 154 EGISDG---------ATMKTFCGTPEYLAPEV---LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221 (337)
T ss_dssp CSCCTT---------CCBCCCEECGGGCCGGG---GSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred CCCCCC---------CCCCCCEECHHHHHHHH---CCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC
T ss_conf 035678---------62055100889966665---048988833310223067889987899999969999999985289
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCC-----HHHHHH
Q ss_conf 8999999989999999984209999999-----899999
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPD-----ITQVWF 291 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~lL~~dP~~RPt-----~~eil~ 291 (690)
...+..+++.+.+||.+||++||.+|++ +.+++.
T Consensus 222 ~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf 989866899999999866638934422565234999972
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.24 Aligned_cols=247 Identities=23% Similarity=0.354 Sum_probs=201.6
Q ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECC--CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCCEEE
Q ss_conf 999998500595699999983568908999995128--988899999999999961089990088889876248876089
Q 005577 27 IHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEAL 104 (690)
Q Consensus 27 y~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~~~~ 104 (690)
|++.++||+|+||+||+|.+. .++..||+|.+... .....+.+.+|+.+|++|+ |||||++|+++.........+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~-~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEEE
T ss_pred EEEEEEEECCCCCEEEEEEEC-CCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEECCCCCCEEE
T ss_conf 885169700828499999999-99959999998512279899999999999998579-9985069999840334588899
Q ss_pred EEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEC-CCCCEEEECCCCCCCCC
Q ss_conf 9995379-858999997189999999999999999999999982999900379998828967-99981353158877655
Q 005577 105 LVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLG-SDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 105 LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd-~~g~vKL~DFGlA~~~~ 182 (690)
||||||+ |+|.+++..... +++..++.|+.||+.||.|||+++.+|+||||||+|||++ .++.+||+|||+++...
T Consensus 89 ivmE~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEECCCCCCHHHHHHCCCC--CCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCCCEEEEECCCCEECC
T ss_conf 99957898948999751355--4699999999999999999997899799687674351166799988980057654236
Q ss_pred CCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHH-HHHHH----CCCC
Q ss_conf 310133311543344556799863486411112107999314699999999999737999999309-99972----4677
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK-LQILN----GNYR 257 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~-~~il~----~~~~ 257 (690)
.. .....+||+.|||||++ . +.++.++|||||||++|+|++|+.||.+... ..+.. ....
T Consensus 167 ~~-----------~~~~~~GT~~Y~aPE~~---~-~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~ 231 (270)
T d1t4ha_ 167 AS-----------FAKAVIGTPEFMAPEMY---E-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 231 (270)
T ss_dssp TT-----------SBEESCSSCCCCCGGGG---G-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC
T ss_pred CC-----------CCCCCCCCCCCCCHHHH---C-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
T ss_conf 87-----------66775538130089884---7-899986711007999999987889998765599999999738998
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf 89999999899999999842099999998999999
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
......+++.+.+||.+||..||++||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 65675578999999999763797589299999677
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.71 Aligned_cols=247 Identities=23% Similarity=0.376 Sum_probs=206.4
Q ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCC---HHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCC
Q ss_conf 229999985005956999999835689089999951289---88899999999999961089990088889876248876
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~---~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~ 101 (690)
.+|++.+.||+|+||.||+|++. .+++.||||++.... ....+.+.+|+.+|++|. |||||++++++. +.+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~----~~~ 81 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQ----DDE 81 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEE----CSS
T ss_pred CCCEEEEEEEECCCEEEEEEEEC-CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEE----ECC
T ss_conf 87789889850879099999998-999799999986577557778999999999998768-888617999999----899
Q ss_pred EEEEEEECCCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf 08999953798-58999997189999999999999999999999982999900379998828967999813531588776
Q 005577 102 EALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~g-sLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGlA~~ 180 (690)
.+|||||||.| +|.+++...+. +++..++.++.|++.||.|||+.+ ||||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~~ivmEy~~gg~L~~~~~~~~~--l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~ 157 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKV 157 (288)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEECCCCCCHHHHHHCCCC--CCHHHHHHHHHHHHHHHHHHCCCC--EECCCCCCCCCCCCCCCEEEECCCCCCEE
T ss_conf 88999970489877776531599--999999999999999997621650--88476774123668885388603210242
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHCCC--CC
Q ss_conf 5531013331154334455679986348641111210799931469999999999973799999930999972467--78
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RI 258 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il~~~~--~~ 258 (690)
+...... ......+||+.|||||+ +.+..++.++|||||||++|+|++|+.||.+.+...+..... ..
T Consensus 158 ~~~~~~~-------~~~~~~~GT~~Y~APE~---~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~ 227 (288)
T d1uu3a_ 158 LSPESKQ-------ARANSFVGTAQYVSPEL---LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY 227 (288)
T ss_dssp CC-----------------CCCCGGGCCHHH---HHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC
T ss_pred CCCCCCC-------CCCCCCCCCCCCCCCEE---ECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC
T ss_conf 2567764-------33355567755258440---0268989666230456999998038899899599999999971899
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHH
Q ss_conf 999999989999999984209999999899999
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQVWF 291 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~ 291 (690)
..+..+++.+.+||.+||..||.+||++.|++.
T Consensus 228 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCC
T ss_conf 998547999999999985579768919789737
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.26 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=207.3
Q ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECC--CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCCE
Q ss_conf 22999998500595699999983568908999995128--9888999999999999610899900888898762488760
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~~ 102 (690)
.+|++.+.||+|+||.||+|++. .+++.||+|.+... +....+.+.+|+.+++++. |||||++++++... ..+.
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~--~~~~ 79 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDR--TNTT 79 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC------C
T ss_pred HHCEEEEEEECCCCEEEEEEEEC-CCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEEC--CCCE
T ss_conf 33799679830889199999999-99979999998746579799999999999999778-99982489999917--8998
Q ss_pred EEEEEECCC-CCHHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCEEECCCCCEEEECCC
Q ss_conf 899995379-8589999971--8999999999999999999999998299---990037999882896799981353158
Q 005577 103 ALLVMECCD-KSLVNVLENR--GAGYFEEKQVLAIFRDVCNAVFAMHSQS---PPIAHRDLKAENLLLGSDGLWKLCDFG 176 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~--~~~~Lse~~v~~i~~qIl~aL~yLHs~g---~~IVHRDLKP~NILLd~~g~vKL~DFG 176 (690)
+|||||||+ |+|.+++... ..+.+++..++.++.||+.||.|||+++ .+||||||||+||||+.++.+||+|||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECC
T ss_conf 99999568999389999851545789999999999999999999999716778878858676542574788857980010
Q ss_pred CCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHCC-
Q ss_conf 8776553101333115433445567998634864111121079993146999999999997379999993099997246-
Q 005577 177 STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN- 255 (690)
Q Consensus 177 lA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il~~~- 255 (690)
+++....... ......||+.|||||+ +.+..|+.++|||||||++|+|++|+.||.+.+..++....
T Consensus 160 ~a~~~~~~~~---------~~~~~~gt~~Y~APE~---l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~ 227 (269)
T d2java1 160 LARILNHDTS---------FAKAFVGTPYYMSPEQ---MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 227 (269)
T ss_dssp HHHHC--------------------CCCSCCCHHH---HTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CEEECCCCCC---------CCCCCCCCCCCCCHHH---HCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf 0032245777---------5566778823279999---839999938988752789999801889989989999999997
Q ss_pred --CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf --7789999999899999999842099999998999999
Q 005577 256 --YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 256 --~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
.....+..+++.+.+||.+||+.||.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 228 EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 189988974359999999999767995579189999729
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.39 Aligned_cols=248 Identities=25% Similarity=0.324 Sum_probs=201.8
Q ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCC-HHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCCEE
Q ss_conf 229999985005956999999835689089999951289-8889999999999996108999008888987624887608
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 25 ~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~~~ 103 (690)
.+|++.+.||+|+||.||+|++. .+++.||+|++.... .+..+.+.+|+.+|+.+. |||||++++++. +.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~----~~~~~ 78 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRR----EGNIQ 78 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC-------CHHHHHHHHHTCC-CTTBCCEEEEEE----ETTEE
T ss_pred CCEEEEEEEECCCCEEEEEEEEC-CCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCC-CCCEEEEEEEEC----CCCEE
T ss_conf 46089989721748099999999-9997999999845664127999999999998579-988846965404----67436
Q ss_pred EEEEECCCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf 999953798-5899999718999999999999999999999998299990037999882896799981353158877655
Q 005577 104 LLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~g-sLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGlA~~~~ 182 (690)
|||||||.| +|.+.+..+. .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+...
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEEECCCCCCHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEECCCCCEEECCCHHHEEEC
T ss_conf 79886458980899975379--9999999999999999999999759--8357546899788789987983231422404
Q ss_pred CCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCHH----H-HHHHCCC
Q ss_conf 3101333115433445567998634864111121079-99314699999999999737999999309----9-9972467
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRREL-INEKVDIWALGCLLFRICYFKNAFDGESK----L-QILNGNY 256 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~-~s~ksDVwSLGviLyeLltGk~Pf~~~~~----~-~il~~~~ 256 (690)
... ........+||+.|||||+ +.+.. ++.++|||||||++|+|++|+.||..... . .......
T Consensus 155 ~~~-------~~~~~~~~~GT~~Y~APE~---~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~ 224 (271)
T d1nvra_ 155 YNN-------RERLLNKMCGTLPYVAPEL---LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 224 (271)
T ss_dssp ETT-------EECCBCCCCSCGGGSCTHH---HHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT
T ss_pred CCC-------CCCCCCCEEECCCCCCHHH---HCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 688-------6531113255747428728---618999997101617379999998299788889859999999863888
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf 789999999899999999842099999998999999
Q 005577 257 RIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 257 ~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
.......+++.+.+||.+||+.||.+||++.+++.+
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 788644699999999999767996689099999619
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.60 Aligned_cols=260 Identities=19% Similarity=0.267 Sum_probs=210.5
Q ss_pred EEECCCEEEEEEE-EEECCCEEEEEEEECC-CCCEEEEEEEEECC-CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE
Q ss_conf 7532822999998-5005956999999835-68908999995128-9888999999999999610899900888898762
Q 005577 20 IDVGNLKIHVRNV-IAEGGFSCVYSARDAI-HMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 20 i~i~~~ry~i~~~-LG~GgfG~Vyla~d~~-~~~k~vAIK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~ 96 (690)
+-+...+|.+.+. ||+|+||.||+|.+.. ..+..||||.+... +....+.+++|+.+|.+|+ |||||++++++.
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~-- 79 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQ-- 79 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--
T ss_pred EEECCCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEC--
T ss_conf 26544471887848730608099999996089768999999882039789999999999998679-988806865603--
Q ss_pred CCCCCEEEEEEECCCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECC
Q ss_conf 4887608999953798-589999971899999999999999999999999829999003799988289679998135315
Q 005577 97 LGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDF 175 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~g-sLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DF 175 (690)
.+.+|||||||++ +|.+++.. ....+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 80 ---~~~~~lvmE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DF 153 (285)
T d1u59a_ 80 ---AEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDF 153 (285)
T ss_dssp ---SSSEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCC
T ss_pred ---CCEEEEEEEECCCCCHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEECCCCCEEECCC
T ss_conf ---6807999980789968997521-2569999999999999999878998688--105767646604546885420331
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHH---H
Q ss_conf 887765531013331154334455679986348641111210799931469999999999973-799999930999---9
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQ---I 251 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLlt-Gk~Pf~~~~~~~---i 251 (690)
|+++.+...... ........||+.|||||+ +.++.++.++|||||||++|||+| |+.||.+....+ .
T Consensus 154 Gla~~~~~~~~~------~~~~~~~~gt~~y~aPE~---~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~ 224 (285)
T d1u59a_ 154 GLSKALGADDSY------YTARSAGKWPLKWYAPEC---INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 224 (285)
T ss_dssp TTCEECTTCSCE------ECCCCSSCCCGGGCCHHH---HHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH
T ss_pred HHHHCCCCCCCC------CCCCCCCCCCCCCCCHHH---HHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 342115543432------113562113743358688---72799995412322017899999389999999799999999
Q ss_pred HHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHC
Q ss_conf 7246778999999989999999984209999999899999995316
Q 005577 252 LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 252 l~~~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~l 297 (690)
+....+.+.++.+++.+.+||.+||..||++||++.++...+....
T Consensus 225 i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 225 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 9818999999767899999999975779768909999999999999
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=362.78 Aligned_cols=242 Identities=24% Similarity=0.353 Sum_probs=204.9
Q ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECC---CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCC
Q ss_conf 22999998500595699999983568908999995128---988899999999999961089990088889876248876
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~ 101 (690)
.+|++.+.||+|+||.||+|++. .+++.||||++... +....+.+++|+.+|+.+. |||||++++++. ...
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~-~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~----~~~ 114 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFK----DNS 114 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEE----CSS
T ss_pred CCEEEEEEEECCCCCEEEEEEEC-CCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCC-CCCEEECCCCCC----CCC
T ss_conf 37089889611768089999998-999899999982677458899999999999999748-772740344443----222
Q ss_pred EEEEEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf 0899995379-858999997189999999999999999999999982999900379998828967999813531588776
Q 005577 102 EALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGlA~~ 180 (690)
.+|+||||+. |+|...+...+. +++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 115 ~~~~v~e~~~~g~l~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~ 190 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCCCCCCCCCCHHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHCCCCCCCCEEEEECEEEEE
T ss_conf 22322223346622666751589--899999999999999899998599--86176799993607789788610103332
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHCCC--CC
Q ss_conf 5531013331154334455679986348641111210799931469999999999973799999930999972467--78
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RI 258 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il~~~~--~~ 258 (690)
+... .....||+.|||||+ +.+..++.++|||||||++|+|++|+.||.+.+...++.... ..
T Consensus 191 ~~~~------------~~~~~Gt~~Y~APE~---~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~ 255 (350)
T d1rdqe_ 191 VKGR------------TWTLCGTPEALAPEI---ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255 (350)
T ss_dssp CSSC------------BCCCEECGGGCCHHH---HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred CCCC------------CCCCCCCCCCCCHHH---HCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC
T ss_conf 2566------------643367635678899---7179988533114500789999758899899599999999861798
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCC-----CHHHHHH
Q ss_conf 99999998999999998420999999-----9899999
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRP-----DITQVWF 291 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~lL~~dP~~RP-----t~~eil~ 291 (690)
..+..+++.+.+||.+||..||.+|+ ++.+++.
T Consensus 256 ~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf 89766899999999998340998606553454999971
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=360.21 Aligned_cols=243 Identities=22% Similarity=0.372 Sum_probs=203.0
Q ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECC---CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCC
Q ss_conf 22999998500595699999983568908999995128---988899999999999961089990088889876248876
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~ 101 (690)
.+|++.+.||+|+||.||+|++. .+++.||||++... .....+.+.+|+.+++.++ |||||++++++. ...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~----~~~ 77 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQ----DAQ 77 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEE----CSS
T ss_pred HHEEEEEEEECCCCCEEEEEEEC-CCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCC-CCCHHHEEEEEE----ECC
T ss_conf 47088889720768089999998-999799999984577548899999999999998636-967533035685----288
Q ss_pred EEEEEEECCCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf 08999953798-58999997189999999999999999999999982999900379998828967999813531588776
Q 005577 102 EALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~g-sLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGlA~~ 180 (690)
.+|+|||||.| ++...+..... +++..+..++.||+.||.|||++| |+||||||+||||+.+|.+||+|||+|+.
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~ 153 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKY 153 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEEEEECCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHCCCC--EECCCCCCHHEEECCCCCEEEECCCCCEE
T ss_conf 00567650378632234322221--110079999999987655412476--77055681050386899889831752167
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHCCC--CC
Q ss_conf 5531013331154334455679986348641111210799931469999999999973799999930999972467--78
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RI 258 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il~~~~--~~ 258 (690)
.... ....+||+.|||||+ +.+..|+.++|||||||++|+|++|+.||.+.+..++..... ..
T Consensus 154 ~~~~------------~~~~~Gt~~Y~APE~---l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~ 218 (316)
T d1fota_ 154 VPDV------------TYTLCGTPDYIAPEV---VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL 218 (316)
T ss_dssp CSSC------------BCCCCSCTTTCCHHH---HTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC
T ss_pred ECCC------------CCCCCCCCCCCCHHH---HCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC
T ss_conf 1245------------643457634359999---8389998043046533368999759899999699999999970898
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCC-----CHHHHHHH
Q ss_conf 99999998999999998420999999-----98999999
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRP-----DITQVWFR 292 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~lL~~dP~~RP-----t~~eil~~ 292 (690)
..++.+++.+.++|.+||.+||.+|+ ++.+++.+
T Consensus 219 ~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf 899778999999999995449976664310219999819
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.39 Aligned_cols=258 Identities=21% Similarity=0.329 Sum_probs=208.9
Q ss_pred CEEEECCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC
Q ss_conf 63753282299999850059569999998356890899999512898889999999999996108999008888987624
Q 005577 18 RSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97 (690)
Q Consensus 18 ~~i~i~~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~ 97 (690)
..|+|...+|++.+.||+|+||.||+|.+. .+..||||++.... ...+.+.+|+.++.+++ |||||++++++.
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~--- 78 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQ-HQRLVRLYAVVT--- 78 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC---
T ss_pred CCEECCHHHEEEEEEEECCCCCEEEEEEEC--CCCEEEEEEECCCC-CCHHHHHHHHHHHHHCC-CCCEEEEEEEEC---
T ss_conf 770038899388679810798289999999--99999999986476-88899999999998679-998857873104---
Q ss_pred CCCCEEEEEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCC
Q ss_conf 88760899995379-85899999718999999999999999999999998299990037999882896799981353158
Q 005577 98 GRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176 (690)
Q Consensus 98 ~~~~~~~LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFG 176 (690)
.+.+|||||||. |+|.+.+.......+++..++.|+.||+.||.|||.++ |+||||||+||||+.++.+||+|||
T Consensus 79 --~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG 154 (272)
T d1qpca_ 79 --QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFG 154 (272)
T ss_dssp --SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCT
T ss_pred --CCCEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEEECCCCEEECCCC
T ss_conf --597699999578982888875147898878899999999999999997489--5467564225156202440423410
Q ss_pred CCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCHHHHH---H
Q ss_conf 877655310133311543344556799863486411112107999314699999999999737-999999309999---7
Q 005577 177 STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYF-KNAFDGESKLQI---L 252 (690)
Q Consensus 177 lA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltG-k~Pf~~~~~~~i---l 252 (690)
+++....... .......|++.|||||+ +.++.++.++|||||||++|||+|| .+||......++ +
T Consensus 155 la~~~~~~~~--------~~~~~~~gt~~y~APE~---~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i 223 (272)
T d1qpca_ 155 LARLIEDNEY--------TAREGAKFPIKWTAPEA---INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223 (272)
T ss_dssp TCEECSSSCE--------ECCTTCCCCTTTSCHHH---HHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred CEEECCCCCC--------CCCCCCCCCCCCCCHHH---HHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf 1477358864--------42035677444458289---837999824564525799999996898888888999999999
Q ss_pred HCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHC
Q ss_conf 246778999999989999999984209999999899999995316
Q 005577 253 NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 253 ~~~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~l 297 (690)
....+...+..+++.+.+||.+||+.||++||++.+++..+.+..
T Consensus 224 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 224 ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 706888896557199999999975889768939999999861132
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.97 Aligned_cols=262 Identities=18% Similarity=0.320 Sum_probs=210.4
Q ss_pred EEECCCEEEEEEEEEECCCEEEEEEEECCCC---CEEEEEEEEECC-CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE
Q ss_conf 7532822999998500595699999983568---908999995128-988899999999999961089990088889876
Q 005577 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIHM---SKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTIL 95 (690)
Q Consensus 20 i~i~~~ry~i~~~LG~GgfG~Vyla~d~~~~---~k~vAIK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~ 95 (690)
-+|.-..|.+.++||+|+||.||+|.+.... ...||||.+... .......+++|+.++.+|+ |||||++++++.
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~- 79 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVIS- 79 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-
T ss_pred CCCCHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEE-
T ss_conf 857889968615981177909999999689987879999999884459689999999999998568-987832367783-
Q ss_pred ECCCCCEEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECC
Q ss_conf 24887608999953798589999971899999999999999999999999829999003799988289679998135315
Q 005577 96 DLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDF 175 (690)
Q Consensus 96 ~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DF 175 (690)
.....++|||||.++++..+.......+++.+++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 80 ---~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DF 154 (283)
T d1mqba_ 80 ---KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDF 154 (283)
T ss_dssp ---SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC
T ss_pred ---CCCCEEEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCC--CCCCCCCCCEEEECCCCEEEECCC
T ss_conf ---388038999721357402221023454208999999999998541212123--425765644278889984998455
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCCHHH---HH
Q ss_conf 88776553101333115433445567998634864111121079993146999999999997379-999993099---99
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK-NAFDGESKL---QI 251 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk-~Pf~~~~~~---~i 251 (690)
|+++......... .......||+.|||||+ +.++.++.++|||||||++|||+++. .++...... ..
T Consensus 155 Gla~~~~~~~~~~------~~~~~~~gt~~Y~APE~---l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~ 225 (283)
T d1mqba_ 155 GLSRVLEDDPEAT------YTTSGGKIPIRWTAPEA---ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA 225 (283)
T ss_dssp CC-----------------------CCCGGGSCHHH---HHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred CHHHCCCCCCCCC------EEECCCCCCCCCCCHHH---HCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 1030035787652------67426777734348888---70499997355634489899999679886556899999999
Q ss_pred HHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHC
Q ss_conf 7246778999999989999999984209999999899999995316
Q 005577 252 LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 252 l~~~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~l 297 (690)
+....+.+.+..++..+.+||.+||..||++||++.+++..+..++
T Consensus 226 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 8635789985045799999999977679768939999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=362.21 Aligned_cols=246 Identities=28% Similarity=0.415 Sum_probs=205.3
Q ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCC-HHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCCE
Q ss_conf 8229999985005956999999835689089999951289-888999999999999610899900888898762488760
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND-EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 24 ~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~-~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~~ 102 (690)
..+|++.+.||+|+||.||+|++. .+++.||+|.+.... ......+.+|+.+|+.|. |||||++++++. +.+.
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~----~~~~ 81 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDK-RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPNIVALDDIYE----SGGH 81 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEET-TTCCEEEEEEEEC----------CHHHHHHHTCC-CTTBCCEEEEEE----CSSE
T ss_pred CCCEEEEEEEEECCCEEEEEEEEC-CCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCC-CCCCCCEEEEEE----ECCE
T ss_conf 666699889940658399999999-9998999999815773128999999999998679-989991989999----8998
Q ss_pred EEEEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEC---CCCCEEEECCCCC
Q ss_conf 899995379-858999997189999999999999999999999982999900379998828967---9998135315887
Q 005577 103 ALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLG---SDGLWKLCDFGST 178 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd---~~g~vKL~DFGlA 178 (690)
+|||||||+ |+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||+. .++.+||+|||++
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EEEEEECCCCCCHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHCE--EEEEEECCCCEEECCCCCCCEEEEECCCEE
T ss_conf 889885268984888653036--7887899999999999987524130--556870463001104688824998315435
Q ss_pred CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHH----HHC
Q ss_conf 7655310133311543344556799863486411112107999314699999999999737999999309999----724
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI----LNG 254 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~i----l~~ 254 (690)
+..... ......+||+.|||||+ +.+..|+.++|||||||++|+|++|+.||.+....++ ...
T Consensus 158 ~~~~~~----------~~~~~~~GT~~y~APE~---~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~ 224 (307)
T d1a06a_ 158 KMEDPG----------SVLSTACGTPGYVAPEV---LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA 224 (307)
T ss_dssp -------------------------CTTSCHHH---HTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT
T ss_pred EECCCC----------CEEEEEEECCCCCCCHH---HCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC
T ss_conf 872589----------70440032842259188---73799980787345159999998597999998999999998616
Q ss_pred CCCC--CCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf 6778--9999999899999999842099999998999999
Q 005577 255 NYRI--PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 255 ~~~~--~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
.+.. +..+.+++.+.+||.+||.+||.+||++.+++.+
T Consensus 225 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 225 EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8777876666789999999999760897579189998629
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=354.79 Aligned_cols=259 Identities=21% Similarity=0.356 Sum_probs=212.8
Q ss_pred ECCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECC---CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
Q ss_conf 32822999998500595699999983568908999995128---988899999999999961089990088889876248
Q 005577 22 VGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLG 98 (690)
Q Consensus 22 i~~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~ 98 (690)
...++|++.+.||+|+||.||+|.+. ..++.||+|++... +......+.+|+.+++.+. |||||++++++..+..
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDL-RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETP 81 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECS
T ss_pred CCCCEEEEEEEEEECCCEEEEEEEEC-CCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCC-CCCCCCCCCEEEECCC
T ss_conf 70620698689960899299999999-999899999985566469899999999999998569-9988731143543268
Q ss_pred CCCEEEEEEECCCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCC
Q ss_conf 87608999953798-58999997189999999999999999999999982999900379998828967999813531588
Q 005577 99 RTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS 177 (690)
Q Consensus 99 ~~~~~~LVmEy~~g-sLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGl 177 (690)
....+|||||||+| +|...+...+. +++.+++.|+.||+.||.|||++| |+||||||+|||++.++..+|+|||.
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~~~--l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTT
T ss_pred CCCEEEEEEECCCCCEEHHHHCCCCC--CCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCCCCCCCEEEHHHH
T ss_conf 87669999977889871011203589--999999999999999999998579--52763467556657543201003444
Q ss_pred CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHH----
Q ss_conf 7765531013331154334455679986348641111210799931469999999999973799999930999972----
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN---- 253 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il~---- 253 (690)
+......... .......+||+.|||||+ +.+..++.++|||||||++|+|+||+.||.+.+..+++.
T Consensus 158 ~~~~~~~~~~------~~~~~~~~Gt~~Y~aPE~---~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~ 228 (277)
T d1o6ya_ 158 ARAIADSGNS------VTQTAAVIGTAQYLSPEQ---ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228 (277)
T ss_dssp CEECC----------------------TTCCHHH---HTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred HHHHCCCCCC------CCCCCCCCCCCCCCCHHH---HCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHH
T ss_conf 3221235443------333464257624369999---8399999663202652899999769799899699999999984
Q ss_pred CCCCC--CCCCCCCHHHHHHHHHHHHHCCCCCC-CHHHHHHHHHH
Q ss_conf 46778--99999998999999998420999999-98999999953
Q 005577 254 GNYRI--PESPKYSSSVTDLIRDMLQASPDDRP-DITQVWFRVNE 295 (690)
Q Consensus 254 ~~~~~--~~~~~~s~~l~~LI~~lL~~dP~~RP-t~~eil~~l~~ 295 (690)
..... ...+.+++.+.+||.+||.+||.+|| ++.+++..+..
T Consensus 229 ~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 229 EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHH
T ss_conf 699997100347899999999998667976777399999999999
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=354.48 Aligned_cols=244 Identities=23% Similarity=0.351 Sum_probs=195.2
Q ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCC---HHHHHHHHHH---HHHHHHHCCCCCCEEEEEEEEEECC
Q ss_conf 229999985005956999999835689089999951289---8889999999---9999961089990088889876248
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---EESLESAMKE---ISVMKSLKGHPNVVTLYAHTILDLG 98 (690)
Q Consensus 25 ~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~---~e~~e~~~~E---i~iL~~L~~HPNIVkl~~~~~~~~~ 98 (690)
.+|++.++||+|+||.||+|++. .+++.||+|++.... ......+.+| +.+++.+ +|||||++++++.
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~-~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~---- 77 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFH---- 77 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEE----
T ss_pred HHCEEEEEEECCCCEEEEEEEEC-CCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEE----
T ss_conf 76851018842889099999999-99979999998458754266799999999999998508-9985889999999----
Q ss_pred CCCEEEEEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCC
Q ss_conf 8760899995379-858999997189999999999999999999999982999900379998828967999813531588
Q 005577 99 RTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS 177 (690)
Q Consensus 99 ~~~~~~LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGl 177 (690)
..+.+|||||||. |+|.+++..... +++..++.|+.||+.||.|||.++ ||||||||+||||+.+|.+||+|||+
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGl 153 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGL 153 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTT
T ss_pred ECCEEEEEEEECCCCCHHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCEEEECCCCCEEEEEECE
T ss_conf 89988999991489838999873255--327899999999999999999779--62204442216785889679822010
Q ss_pred CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCH---HHHHHHC
Q ss_conf 7765531013331154334455679986348641111210799931469999999999973799999930---9999724
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES---KLQILNG 254 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~---~~~il~~ 254 (690)
|+..... .....+||+.|||||++ ..+..|+.++|||||||++|+|++|+.||.+.. ...+...
T Consensus 154 a~~~~~~-----------~~~~~~GT~~y~APE~~--~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 220 (364)
T d1omwa3 154 ACDFSKK-----------KPHASVGTHGYMAPEVL--QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 220 (364)
T ss_dssp CEECSSS-----------CCCSCCSCGGGCCHHHH--STTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH
T ss_pred EEECCCC-----------CCCCCCCCCCCCHHHHH--HCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
T ss_conf 2333788-----------64331134554216876--0389998441046778999999859998888998999999986
Q ss_pred CC--CCCCCCCCCHHHHHHHHHHHHHCCCCCCC-----HHHHHH
Q ss_conf 67--78999999989999999984209999999-----899999
Q 005577 255 NY--RIPESPKYSSSVTDLIRDMLQASPDDRPD-----ITQVWF 291 (690)
Q Consensus 255 ~~--~~~~~~~~s~~l~~LI~~lL~~dP~~RPt-----~~eil~ 291 (690)
.. ....+..+++.+.+||.+||.+||.+||+ +.+++.
T Consensus 221 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 221 TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf 04688878877899999999998566988808874357999974
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.87 Aligned_cols=253 Identities=23% Similarity=0.391 Sum_probs=207.9
Q ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCCE
Q ss_conf 28229999985005956999999835689089999951289888999999999999610899900888898762488760
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 23 ~~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~~ 102 (690)
.-.+|++.+.||+|+||.||+|++. .+..||||++.... ...+.+.+|+.++++++ |||||++++++. ..+.
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~----~~~~ 74 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLS-HPKLVQLYGVCL----EQAP 74 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET--TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCC-CTTBCCEEEEEC----SSSS
T ss_pred CHHHCEEEEEEEECCCEEEEEEEEC--CCCEEEEEEECCCC-CCHHHHHHHHHHHHHCC-CCCCCCCCCEEC----CCCC
T ss_conf 9699588889820888299999988--99999999987886-76899999999999668-997565352431----5993
Q ss_pred EEEEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCCCCCC
Q ss_conf 899995379-8589999971899999999999999999999999829999003799988289679998135315887765
Q 005577 103 ALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTN 181 (690)
Q Consensus 103 ~~LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGlA~~~ 181 (690)
+|||||||. |+|.+++.... ..+++..++.|+.||+.||.|||.++ |+||||||+|||++.++.+||+|||+++..
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 151 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV 151 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred EEEEEEECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHCCC--EEECCCCHHHEEECCCCCEEECCCCHHEEC
T ss_conf 379998369991899752013-47889999999999999877653164--310443153266668877686553210023
Q ss_pred CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHH---HHCCCC
Q ss_conf 531013331154334455679986348641111210799931469999999999973-7999999309999---724677
Q 005577 182 HKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LNGNYR 257 (690)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLlt-Gk~Pf~~~~~~~i---l~~~~~ 257 (690)
...... ......||+.|||||+ +.+..++.++|||||||++|||+| |+.||......++ +....+
T Consensus 152 ~~~~~~--------~~~~~~gt~~y~aPE~---l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~ 220 (263)
T d1sm2a_ 152 LDDQYT--------SSTGTKFPVKWASPEV---FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR 220 (263)
T ss_dssp ---------------------CTTSCCHHH---HTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC
T ss_pred CCCCCE--------EECCEECCCCCCCHHH---HCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 688733--------5043001766678578---60799984033210599999998789888778999999999980688
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHC
Q ss_conf 8999999989999999984209999999899999995316
Q 005577 258 IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 258 ~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~l 297 (690)
...+..+++.+.+||.+||+.||.+||++.+++.++..++
T Consensus 221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 8995436799999999976579768919999999999998
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.27 Aligned_cols=263 Identities=22% Similarity=0.362 Sum_probs=215.1
Q ss_pred CCCCCCEEEECCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEE
Q ss_conf 99999637532822999998500595699999983568908999995128988899999999999961089990088889
Q 005577 13 TGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAH 92 (690)
Q Consensus 13 ~~~~g~~i~i~~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~ 92 (690)
.|+....|+|...+|++.+.||+|+||.||+|++. ....||||++.... ...+.+.+|+.++.+++ |||||++|++
T Consensus 5 ~~~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~--~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~g~ 80 (285)
T d1fmka3 5 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLR-HEKLVQLYAV 80 (285)
T ss_dssp SSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred CCCCCCCEECCHHHEEEEEEEEECCCEEEEEEEEC--CCCEEEEEEECCCC-CCHHHHHHHHHHHHHCC-CCCEEEEEEE
T ss_conf 99887560747799798469930798099999999--99999999988044-88899999999998666-6788689999
Q ss_pred EEEECCCCCEEEEEEECCCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEE
Q ss_conf 87624887608999953798-58999997189999999999999999999999982999900379998828967999813
Q 005577 93 TILDLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWK 171 (690)
Q Consensus 93 ~~~~~~~~~~~~LVmEy~~g-sLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vK 171 (690)
+. .+..|+|||||.+ ++...+.......+++.+++.|+.+|+.||.|||.++ |+||||||+||||+.++.+|
T Consensus 81 ~~-----~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~k 153 (285)
T d1fmka3 81 VS-----EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCK 153 (285)
T ss_dssp EC-----SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEE
T ss_pred EE-----CCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHH--EECCCCCCEEEEECCCCCEE
T ss_conf 82-----397599999447994354200003553059999999999999999875411--43353123079998999299
Q ss_pred EECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCC-CCCCCHHHH
Q ss_conf 5315887765531013331154334455679986348641111210799931469999999999973799-999930999
Q 005577 172 LCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKN-AFDGESKLQ 250 (690)
Q Consensus 172 L~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~-Pf~~~~~~~ 250 (690)
|+|||+++........ ......||+.|+|||+ +..+.++.++|||||||++|||++|.. ++.+....+
T Consensus 154 l~DfGla~~~~~~~~~--------~~~~~~gt~~y~aPE~---~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~ 222 (285)
T d1fmka3 154 VADFGLARLIEDNEYT--------ARQGAKFPIKWTAPEA---ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 222 (285)
T ss_dssp ECCCCTTC----------------------CCGGGSCHHH---HHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred ECCCCHHHHCCCCCCE--------EECCCCCCCCCCCHHH---HHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHH
T ss_conf 8442555425688733--------5245455665458089---8379989177413235899999868999998888999
Q ss_pred ---HHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHC
Q ss_conf ---97246778999999989999999984209999999899999995316
Q 005577 251 ---ILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 251 ---il~~~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~l 297 (690)
.+....+.+.+..++..+.+||.+||+.||++||++.+|+..+....
T Consensus 223 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 223 VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred HHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 99999826899998323799999999975669758919999999876662
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.18 Aligned_cols=254 Identities=20% Similarity=0.309 Sum_probs=204.4
Q ss_pred CCEEEEE-EEEEECCCEEEEEEEECC-CCCEEEEEEEEECC--CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCC
Q ss_conf 8229999-985005956999999835-68908999995128--9888999999999999610899900888898762488
Q 005577 24 NLKIHVR-NVIAEGGFSCVYSARDAI-HMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 24 ~~ry~i~-~~LG~GgfG~Vyla~d~~-~~~k~vAIK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~ 99 (690)
...+.+. ++||+|+||.||+|.+.. ..++.||||++... +....+.+++|+.+|++|+ |||||+++++|.
T Consensus 5 ~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~----- 78 (277)
T d1xbba_ 5 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICE----- 78 (277)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE-----
T ss_pred HHHCEECCCCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEC-----
T ss_conf 25370018783458782999999816973859999998801089899999999999998679-989852777750-----
Q ss_pred CCEEEEEEECCCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCCC
Q ss_conf 7608999953798-589999971899999999999999999999999829999003799988289679998135315887
Q 005577 100 TKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~g-sLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGlA 178 (690)
.+..|||||||++ +|.+++..... +++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||++
T Consensus 79 ~~~~~lvmE~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla 154 (277)
T d1xbba_ 79 AESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLS 154 (277)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCCEEEEEECCCCCCHHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCHHHCCCCCCCCCCCCHHHH
T ss_conf 5977999974788968999752257--899999999999999976687479--556777611310235675123413453
Q ss_pred CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHH---HHC
Q ss_conf 765531013331154334455679986348641111210799931469999999999973-7999999309999---724
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LNG 254 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLlt-Gk~Pf~~~~~~~i---l~~ 254 (690)
+........ ........||+.|||||+ +.+..++.++|||||||++|||++ |+.||.+....++ +..
T Consensus 155 ~~~~~~~~~------~~~~~~~~gt~~y~APE~---l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~ 225 (277)
T d1xbba_ 155 KALRADENY------YKAQTHGKWPVKWYAPEC---INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225 (277)
T ss_dssp EECCTTCSE------EEC----CCCGGGCCHHH---HHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred HHCCCCCCC------CCCCCCCCCCCEECCCHH---HCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHC
T ss_conf 313432344------322445677842039166---53799984344303403132896589999999899999999982
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
Q ss_conf 677899999998999999998420999999989999999531
Q 005577 255 NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 255 ~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~ 296 (690)
..+.+.+..++..+.+||.+||+.||.+||++.++...+...
T Consensus 226 ~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCH
T ss_conf 899999865679999999997588976890989999985288
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.10 Aligned_cols=246 Identities=26% Similarity=0.416 Sum_probs=205.6
Q ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCC------HHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC
Q ss_conf 8229999985005956999999835689089999951289------8889999999999996108999008888987624
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND------EESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97 (690)
Q Consensus 24 ~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~------~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~ 97 (690)
+.+|++.+.||+|+||.||+|++. .+++.||+|++.... ....+.+.+|+.+|+.|. |||||++++++.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~--- 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYE--- 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE---
T ss_pred CCCEEEEEEEECCCCEEEEEEEEC-CCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCC-CCCCCCEEEEEE---
T ss_conf 567798279811789599999999-999899999987566321340689999999999998679-989993889999---
Q ss_pred CCCCEEEEEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCC----CEEE
Q ss_conf 88760899995379-858999997189999999999999999999999982999900379998828967999----8135
Q 005577 98 GRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG----LWKL 172 (690)
Q Consensus 98 ~~~~~~~LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g----~vKL 172 (690)
+...+|||||||. |+|.+++...+. +++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||
T Consensus 84 -~~~~~~iv~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl 158 (293)
T d1jksa_ 84 -NKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKI 158 (293)
T ss_dssp -CSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEE
T ss_pred -ECCEEEEEEECCCCCCCCCHHCCCCC--CCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCEEEEECCCCCCCCEEE
T ss_conf -79989999986778643100103564--215578999999999987666254--2211333012798258986664696
Q ss_pred ECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 31588776553101333115433445567998634864111121079993146999999999997379999993099997
Q 005577 173 CDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL 252 (690)
Q Consensus 173 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il 252 (690)
+|||++...... .......||+.|+|||+ +.+..++.++|||||||++|+|++|+.||.+.+..+.+
T Consensus 159 ~DfG~a~~~~~~----------~~~~~~~~t~~y~APE~---~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~ 225 (293)
T d1jksa_ 159 IDFGLAHKIDFG----------NEFKNIFGTPEFVAPEI---VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 225 (293)
T ss_dssp CCCTTCEECTTS----------CBCSCCCCCGGGCCHHH---HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCHHHHHHCCCC----------CCCCCCCCCCCCCCHHH---HCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf 433442105777----------63122477774309999---81899997665221409999997088998899999999
Q ss_pred HC----CCCCC--CCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf 24----67789--999999899999999842099999998999999
Q 005577 253 NG----NYRIP--ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 253 ~~----~~~~~--~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
.. .+..+ ..+.++..+.+||.+||..||.+||++.+++.+
T Consensus 226 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 226 ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 9998168888701047889999999999863896689199999619
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.01 Aligned_cols=259 Identities=20% Similarity=0.317 Sum_probs=211.4
Q ss_pred EEEECCCEEEEEEEEEECCCEEEEEEEECCC--CCEEEEEEEEEC-CCHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE
Q ss_conf 3753282299999850059569999998356--890899999512-8988899999999999961089990088889876
Q 005577 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDAIH--MSKQYAMKHMIC-NDEESLESAMKEISVMKSLKGHPNVVTLYAHTIL 95 (690)
Q Consensus 19 ~i~i~~~ry~i~~~LG~GgfG~Vyla~d~~~--~~k~vAIK~i~~-~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~ 95 (690)
.|+|...+|++.+.||+|+||.||+|.+... ....||+|.+.. ......+.+.+|+.++++++ |||||++++++.
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT- 78 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-
T ss_pred CCCCCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEE-
T ss_conf 997688996987799307882999999936996449999999365668799999999999998689-999856988995-
Q ss_pred ECCCCCEEEEEEECCCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEEC
Q ss_conf 24887608999953798-58999997189999999999999999999999982999900379998828967999813531
Q 005577 96 DLGRTKEALLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCD 174 (690)
Q Consensus 96 ~~~~~~~~~LVmEy~~g-sLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~D 174 (690)
.+.+|+|||||.+ ++..++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 79 ----~~~~~iv~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~D 151 (273)
T d1mp8a_ 79 ----ENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGD 151 (273)
T ss_dssp ----SSSCEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC
T ss_pred ----CCEEEEEEEECCCCCHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHCCCC--EECCCCCHHHEEECCCCCEEECC
T ss_conf ----3747999984069807765422-4789999999999999987752302267--44141026553206789678765
Q ss_pred CCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHH--
Q ss_conf 5887765531013331154334455679986348641111210799931469999999999973-7999999309999--
Q 005577 175 FGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI-- 251 (690)
Q Consensus 175 FGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLlt-Gk~Pf~~~~~~~i-- 251 (690)
||+++....... .......||+.|+|||+ +.+..++.++|||||||++|||++ |..||.+....++
T Consensus 152 fG~a~~~~~~~~--------~~~~~~~gt~~y~apE~---l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~ 220 (273)
T d1mp8a_ 152 FGLSRYMEDSTY--------YKASKGKLPIKWMAPES---INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 220 (273)
T ss_dssp ---------------------------CCGGGCCHHH---HHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred CHHHEECCCCCC--------EECCCEECCCCCCHHHH---HCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf 034213367762--------33054005831032667---5169988745244424789999826999988899999999
Q ss_pred -HHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHC
Q ss_conf -7246778999999989999999984209999999899999995316
Q 005577 252 -LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 252 -l~~~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~l 297 (690)
+....+.+.++.+++.+.+||.+||..||.+||++.+++..+...+
T Consensus 221 ~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 221 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 99818999898777999999999976879768929999999999997
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.31 Aligned_cols=247 Identities=28% Similarity=0.410 Sum_probs=199.6
Q ss_pred CEEEEE-EEEEECCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCCEE
Q ss_conf 229999-9850059569999998356890899999512898889999999999996108999008888987624887608
Q 005577 25 LKIHVR-NVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 25 ~ry~i~-~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~~~ 103 (690)
.+|.+. ++||+|+||.||+|++. .+++.||||++... ..+.+|+.++.++.+|||||++++++.........+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNK-RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEEC-CCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 487981079654548699999988-99989999998974-----779999999998669999782989995034689789
Q ss_pred EEEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECC---CCCEEEECCCCCC
Q ss_conf 99995379-8589999971899999999999999999999999829999003799988289679---9981353158877
Q 005577 104 LLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTS 179 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~---~g~vKL~DFGlA~ 179 (690)
|||||||+ |+|.+++..++...|++.++..|+.||+.||.|||++| |+||||||+|||++. .+.+||+|||+++
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEE
T ss_conf 99997789984999998627877579999999999999999999769--8644410022011355556631135455123
Q ss_pred CCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHH----HHC-
Q ss_conf 655310133311543344556799863486411112107999314699999999999737999999309999----724-
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQI----LNG- 254 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~i----l~~- 254 (690)
..... ......+||+.|||||+ +.+..|+.++|||||||++|+|++|+.||.+...... ...
T Consensus 163 ~~~~~----------~~~~~~~gt~~y~aPE~---~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i 229 (335)
T d2ozaa1 163 ETTSH----------NSLTTPCYTPYYVAPEV---LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 229 (335)
T ss_dssp ECCCC----------CCCCCCSCCCSSCCCCC---CCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC
T ss_pred ECCCC----------CCCCCCCCCCCCCCCHH---HCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
T ss_conf 33688----------86432267756379277---748988888888764516778865889988988778899999998
Q ss_pred ---CCCCCC--CCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf ---677899--99999899999999842099999998999999
Q 005577 255 ---NYRIPE--SPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 255 ---~~~~~~--~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
.+..+. ...+++.+.+||.+||..||.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 5388888985434699999999999756996579099999709
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.31 Aligned_cols=265 Identities=19% Similarity=0.313 Sum_probs=214.2
Q ss_pred CEEEECCCEEEEEEEEEECCCEEEEEEEECC----CCCEEEEEEEEECC-CHHHHHHHHHHHHHHHHHCCCCCCEEEEEE
Q ss_conf 6375328229999985005956999999835----68908999995128-988899999999999961089990088889
Q 005577 18 RSIDVGNLKIHVRNVIAEGGFSCVYSARDAI----HMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAH 92 (690)
Q Consensus 18 ~~i~i~~~ry~i~~~LG~GgfG~Vyla~d~~----~~~k~vAIK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~ 92 (690)
.-|+|...+|++.++||+|+||.||+|.+.. ..++.||+|++... .....+.+.+|+.++.++..|+|||.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEE
T ss_conf 25261679979844984167839999998677755578399999986001717899999999998861499849974115
Q ss_pred EEEECCCCCEEEEEEECCC-CCHHHHHHHHC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 8762488760899995379-85899999718--------------99999999999999999999999829999003799
Q 005577 93 TILDLGRTKEALLVMECCD-KSLVNVLENRG--------------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDL 157 (690)
Q Consensus 93 ~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~--------------~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDL 157 (690)
+. .....+++|||||+ |+|.+++..+. ...+++..++.++.||+.||.|||+++ ||||||
T Consensus 86 ~~---~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDl 160 (299)
T d1ywna1 86 CT---KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 160 (299)
T ss_dssp EC---STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EC---CCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCC
T ss_conf 40---4797579999845899299999853666665322202332146899999999999999999887379--717867
Q ss_pred CCCCEEECCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 98828967999813531588776553101333115433445567998634864111121079993146999999999997
Q 005577 158 KAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRIC 237 (690)
Q Consensus 158 KP~NILLd~~g~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLl 237 (690)
||+||||+.++.+||+|||+++........ .......||+.|||||+ +.+..++.++|||||||++|||+
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~-------~~~~~~~gt~~y~APE~---l~~~~~~~~sDiwS~Gvil~ell 230 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDY-------VRKGDARLPLKWMAPET---IFDRVYTIQSDVWSFGVLLWEIF 230 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTS-------CCTTSCCCGGGGCCHHH---HHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCCEEECCCCCEEECCCCCHHHCCCCCCC-------CCCCCEEECCCCCCHHH---HHCCCCCCCCCEEEHHHHHHHHH
T ss_conf 731065779982898457520011356652-------22475166721020368---64688996632213678999998
Q ss_pred HC-CCCCCCCHH----HHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHC
Q ss_conf 37-999999309----9997246778999999989999999984209999999899999995316
Q 005577 238 YF-KNAFDGESK----LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 238 tG-k~Pf~~~~~----~~il~~~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~l 297 (690)
++ ..||.+... ...+....+.+.+..+++.+.++|.+||+.||.+||++.+++.++..++
T Consensus 231 t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 231 SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp TTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 68899998999899999999638988888657899999999976779667919999999997998
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.86 Aligned_cols=255 Identities=17% Similarity=0.274 Sum_probs=207.3
Q ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCE----EEEEEEEECC-CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC
Q ss_conf 282299999850059569999998356890----8999995128-98889999999999996108999008888987624
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSK----QYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97 (690)
Q Consensus 23 ~~~ry~i~~~LG~GgfG~Vyla~d~~~~~k----~vAIK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~ 97 (690)
...+|++.++||+|+||.||+|.+. ..++ .||+|.+... +....+.+++|+.++++++ |||||+++++|..
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~-- 82 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWI-PEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLT-- 82 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEEC-C----CCEEEEEEEECC----CTHHHHHHHHHHHHHCC-CTTBCCEEEEEES--
T ss_pred CHHHCEEEEEEECCCCEEEEEEEEC-CCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEC--
T ss_conf 8899978319820899299999995-89988989999999651349799999999999998679-9888158999961--
Q ss_pred CCCCEEEEEEECC-CCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCC
Q ss_conf 8876089999537-985899999718999999999999999999999998299990037999882896799981353158
Q 005577 98 GRTKEALLVMECC-DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176 (690)
Q Consensus 98 ~~~~~~~LVmEy~-~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFG 176 (690)
...++|++|+ .++|++.+.... ..+++..++.|+.||+.||.|||.++ ||||||||+||||+.++.+||+|||
T Consensus 83 ---~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFG 156 (317)
T d1xkka_ 83 ---STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFG 156 (317)
T ss_dssp ---SSEEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCS
T ss_pred ---CCEEEEEEECCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCHHHCCEECCCCCEEEECCC
T ss_conf ---98369998426874010111334-57999999999999999999998769--5047621203116799875860255
Q ss_pred CCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHH---HHHH
Q ss_conf 87765531013331154334455679986348641111210799931469999999999973-7999999309---9997
Q 005577 177 STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESK---LQIL 252 (690)
Q Consensus 177 lA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLlt-Gk~Pf~~~~~---~~il 252 (690)
+++........ .......||+.|||||+ +.++.++.++|||||||++|||+| |..||.+... ...+
T Consensus 157 la~~~~~~~~~-------~~~~~~~gt~~y~APE~---l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i 226 (317)
T d1xkka_ 157 LAKLLGAEEKE-------YHAEGGKVPIKWMALES---ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226 (317)
T ss_dssp HHHHTTTTCC---------------CCTTTSCHHH---HHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH
T ss_pred CCEECCCCCCC-------CCCCCCCCCCCCCCHHH---HHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf 22233544453-------22365105864467088---746999835654407999999997799999999989999999
Q ss_pred HCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHC
Q ss_conf 246778999999989999999984209999999899999995316
Q 005577 253 NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 253 ~~~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~l 297 (690)
....+.+.+..+++.+.+||.+||..||.+||++.+++.++....
T Consensus 227 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 759989998556899999999847899346919999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.11 Aligned_cols=245 Identities=22% Similarity=0.354 Sum_probs=201.6
Q ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECC---CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCC
Q ss_conf 22999998500595699999983568908999995128---988899999999999961089990088889876248876
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTK 101 (690)
Q Consensus 25 ~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~ 101 (690)
.+|++.+.||+|+||+||+|.+. .+++.||+|++... .....+.+..|..++....+|||||++++++. +.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~-~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~----~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ----TKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE----CSS
T ss_pred CCEEEEEEEECCCCCEEEEEEEC-CCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEC----CCC
T ss_conf 97188658940878289999999-9998999999805553384899999999999998479996878988970----498
Q ss_pred EEEEEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf 0899995379-858999997189999999999999999999999982999900379998828967999813531588776
Q 005577 102 EALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 102 ~~~LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGlA~~ 180 (690)
.+|||||||. |+|.+++..... +++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CEEEEEEECCCCCHHHHHHCCCC--CCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCCEEECCCCCEECCCCCHHHH
T ss_conf 31677750379808998640478--999999999999999999998689--34034765404444899630155530232
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHCCC--CC
Q ss_conf 5531013331154334455679986348641111210799931469999999999973799999930999972467--78
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--RI 258 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il~~~~--~~ 258 (690)
..... .......||+.|+|||+ +.+..++.++|||||||++|+|++|+.||.+.+..++..... ..
T Consensus 153 ~~~~~---------~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~ 220 (320)
T d1xjda_ 153 NMLGD---------AKTNTFCGTPDYIAPEI---LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 220 (320)
T ss_dssp CCCTT---------CCBCCCCSCGGGCCHHH---HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred CCCCC---------CCCCCCCCCCCCCCHHH---HCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC
T ss_conf 35665---------33454578777689999---8279988323201122789898738899999899999999971899
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCHH-HHH
Q ss_conf 99999998999999998420999999989-999
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRPDIT-QVW 290 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~lL~~dP~~RPt~~-eil 290 (690)
..+..+++.+.+||.+||..||.+||++. +++
T Consensus 221 ~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 221 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf 897567999999999965448987838899998
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.95 Aligned_cols=246 Identities=21% Similarity=0.376 Sum_probs=203.6
Q ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCCEE
Q ss_conf 82299999850059569999998356890899999512898889999999999996108999008888987624887608
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~~~ 103 (690)
.++|++.+.||+|+||.||+|.+. .+++.||+|.+.....+ ...+.+|+.+|+.++ |||||++++++. +.+.+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~-~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~-HpnIv~~~~~~~----~~~~~ 76 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVKGTD-QVLVKKEISILNIAR-HRNILHLHESFE----SMEEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSC-CTTBCCEEEEEE----ETTEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEEC-CCCCEEEEEEECCCCCC-HHHHHHHHHHHHHCC-CCCCCEEEEEEE----ECCEE
T ss_conf 010588789831778399999998-99969999997578665-999999999998579-979890989998----89988
Q ss_pred EEEEECCCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCC--CCEEEECCCCCCC
Q ss_conf 999953798-5899999718999999999999999999999998299990037999882896799--9813531588776
Q 005577 104 LLVMECCDK-SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD--GLWKLCDFGSTST 180 (690)
Q Consensus 104 ~LVmEy~~g-sLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~--g~vKL~DFGlA~~ 180 (690)
|||||||.| +|.+.+..++ ..+++.+++.|+.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++.
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEECCCCCEEEEECCCCHHHC
T ss_conf 99995389980889987538-99999999999999999999998769--9751355444344378851899764411100
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHH----CCC
Q ss_conf 5531013331154334455679986348641111210799931469999999999973799999930999972----467
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILN----GNY 256 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il~----~~~ 256 (690)
.... .......+++.|+|||+ ..+..++.++|||||||++|+|++|+.||.+....+++. ..+
T Consensus 154 ~~~~----------~~~~~~~~t~~y~ape~---~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~ 220 (321)
T d1tkia_ 154 LKPG----------DNFRLLFTAPEYYAPEV---HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220 (321)
T ss_dssp CCTT----------CEEEEEESCGGGSCHHH---HTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC
T ss_pred CCCC----------CCCCCCCCCCCCCCCHH---CCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 3467----------75321223322234021---0487778401130279999999828999999899999999983899
Q ss_pred CCCC--CCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf 7899--99999899999999842099999998999999
Q 005577 257 RIPE--SPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 257 ~~~~--~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
..+. .+.+++.+.+||.+||..||.+||++.+++.+
T Consensus 221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 221 TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 98802236789999999999866996689099999639
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.54 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=205.7
Q ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECC--CHHHHHHHHHHHHHHHHHC--CCCCCEEEEEEEEEEC-
Q ss_conf 2822999998500595699999983568908999995128--9888999999999999610--8999008888987624-
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLK--GHPNVVTLYAHTILDL- 97 (690)
Q Consensus 23 ~~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~--~~e~~e~~~~Ei~iL~~L~--~HPNIVkl~~~~~~~~- 97 (690)
.+.+|++.+.||+|+||+||+|++....++.||||++... .......+.+|+.+|+.|. +|||||++++++....
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf 75897988899215586999999988899899999980232451679999999999998742589880236632214666
Q ss_pred CCCCEEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCC
Q ss_conf 88760899995379858999997189999999999999999999999982999900379998828967999813531588
Q 005577 98 GRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGS 177 (690)
Q Consensus 98 ~~~~~~~LVmEy~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGl 177 (690)
......|++||||+++++..........+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCEEEECCCCCEEECCHHH
T ss_conf 6674699999740587144444303789998999999999999999997588--98357986278985899754210001
Q ss_pred CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHCCCC
Q ss_conf 77655310133311543344556799863486411112107999314699999999999737999999309999724677
Q 005577 178 TSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYR 257 (690)
Q Consensus 178 A~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il~~~~~ 257 (690)
++..... .......||+.|||||+ +.+..|+.++|||||||++|||++|+.||.+.+..+.+.....
T Consensus 163 ~~~~~~~----------~~~~~~~gT~~Y~APE~---~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 229 (305)
T d1blxa_ 163 ARIYSFQ----------MALTSVVVTLWYRAPEV---LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229 (305)
T ss_dssp CCCCCGG----------GGGCCCCCCCTTCCHHH---HTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred HHHHCCC----------CCCCCCCCCHHHCCCCH---HCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
T ss_conf 0110023----------45777654851148310---0179888111000328999999878799899898999999998
Q ss_pred -----------------------------CCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf -----------------------------89999999899999999842099999998999999
Q 005577 258 -----------------------------IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 258 -----------------------------~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
......+++.+.+||.+||+.||.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 4079961105321111033302234564544044589999999999874896679189999669
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=344.71 Aligned_cols=250 Identities=27% Similarity=0.434 Sum_probs=207.9
Q ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCC---------HHHHHHHHHHHHHHHHHCCCCCCEEEEEEEE
Q ss_conf 8229999985005956999999835689089999951289---------8889999999999996108999008888987
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND---------EESLESAMKEISVMKSLKGHPNVVTLYAHTI 94 (690)
Q Consensus 24 ~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~---------~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~ 94 (690)
..+|++.+.||+|+||.||+|++. .+++.||||++.... ....+.+++|+.++++|..|||||++++++.
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CCCCEECEEEECCCCEEEEEEEEC-CCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECC
T ss_conf 663888528841768499999999-9998999999962446411478889999999999999998507997479976214
Q ss_pred EECCCCCEEEEEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEE
Q ss_conf 62488760899995379-85899999718999999999999999999999998299990037999882896799981353
Q 005577 95 LDLGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLC 173 (690)
Q Consensus 95 ~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~ 173 (690)
+.+.+|||||||+ |+|.+++..++. +++..++.++.||+.||.|||.+| |+||||||+|||++.++.+||+
T Consensus 81 ----~~~~~~ivmE~~~~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~ 152 (277)
T d1phka_ 81 ----TNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLT 152 (277)
T ss_dssp ----CSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEEC
T ss_pred ----CCCCEEEEEECCCCCHHHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEECCCCCEEEC
T ss_conf ----67605999976898668999986599--999999999999999999998759--9432346254898689983871
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHH---HCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHH
Q ss_conf 158877655310133311543344556799863486411112---10799931469999999999973799999930999
Q 005577 174 DFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLF---RRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ 250 (690)
Q Consensus 174 DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~---~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~ 250 (690)
|||+++.+... .......||+.|+|||++... ....++.++||||+||++|+|++|+.||.+.....
T Consensus 153 DFG~a~~~~~~----------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~ 222 (277)
T d1phka_ 153 DFGFSCQLDPG----------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222 (277)
T ss_dssp CCTTCEECCTT----------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCHHEEECCCC----------CCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHH
T ss_conf 24031672688----------72134524678889888605344567889923318565602310322888988999999
Q ss_pred H----HHCCCCC--CCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf 9----7246778--9999999899999999842099999998999999
Q 005577 251 I----LNGNYRI--PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 251 i----l~~~~~~--~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
+ ....+.. +....+++.+.+||.+||..||.+||++.+++.+
T Consensus 223 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 223 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 999998189888985434689999999999765896689199999739
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.03 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=207.8
Q ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCCEE
Q ss_conf 82299999850059569999998356890899999512898889999999999996108999008888987624887608
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~~~ 103 (690)
-.+|++.++||+|+||+||+|++ +.+..||||.+..... ..+.+++|+.++.+++ |||||++++++. +.+.+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~--~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~----~~~~~ 74 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKW--RGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLS-HEKLVQLYGVCT----KQRPI 74 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEE--TTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCC-CTTBCCEEEEEC----CSSSE
T ss_pred HHHCEEEEEEECCCCEEEEEEEE--CCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCC-CCCEEEEEEEEE----ECCCE
T ss_conf 69979968982078839999998--8998999999874757-7899999999999668-986015889985----07816
Q ss_pred EEEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf 99995379-85899999718999999999999999999999998299990037999882896799981353158877655
Q 005577 104 LLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGlA~~~~ 182 (690)
++||||+. |++..++.... ..+++..++.|+.|++.||.|||..+ |+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 75 FIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp EEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred EEEEECCCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCEEEEECCCCCEEECCCHHHEECC
T ss_conf 99997048993888641024-67768999999999999999875468--4346654135887699847988614420235
Q ss_pred CCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHH---HHCCCCC
Q ss_conf 31013331154334455679986348641111210799931469999999999973-7999999309999---7246778
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI---LNGNYRI 258 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLlt-Gk~Pf~~~~~~~i---l~~~~~~ 258 (690)
.... .......||+.|+|||+ +.+..++.++|||||||++|||+| |+.||.+....++ +....+.
T Consensus 152 ~~~~--------~~~~~~~~t~~y~aPE~---~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 220 (258)
T d1k2pa_ 152 DDEY--------TSSVGSKFPVRWSPPEV---LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 220 (258)
T ss_dssp SSSC--------CCCCCSCCCGGGCCHHH---HHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred CCCC--------EEECCCCCCCCCCCCHH---HCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 7872--------25246578877578078---637998852103364324673975599998899999999999807978
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHH
Q ss_conf 9999999899999999842099999998999999953
Q 005577 259 PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNE 295 (690)
Q Consensus 259 ~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~ 295 (690)
+.+..++..+.+||.+||+.||++||++.+++.++.+
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 9965465999999999766897689399999987418
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.16 Aligned_cols=267 Identities=21% Similarity=0.341 Sum_probs=219.4
Q ss_pred CCCCEEEECCCEEEEEEEEEECCCEEEEEEEECC------CCCEEEEEEEEECC-CHHHHHHHHHHHHHHHHHCCCCCCE
Q ss_conf 9996375328229999985005956999999835------68908999995128-9888999999999999610899900
Q 005577 15 LEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAI------HMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVV 87 (690)
Q Consensus 15 ~~g~~i~i~~~ry~i~~~LG~GgfG~Vyla~d~~------~~~k~vAIK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIV 87 (690)
++.+ |+|...+|++.+.||+|+||.||+|++.. ..+..||||++... .......+.+|+..+.++.+|||||
T Consensus 4 ~~~~-~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv 82 (299)
T d1fgka_ 4 EDPR-WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNII 82 (299)
T ss_dssp CCTT-TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCC-CCCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEE
T ss_conf 5976-722589969700985167828999998578755566754999999881128688999999999999813999697
Q ss_pred EEEEEEEEECCCCCEEEEEEECCC-CCHHHHHHHHC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 888898762488760899995379-85899999718--------------999999999999999999999998299990
Q 005577 88 TLYAHTILDLGRTKEALLVMECCD-KSLVNVLENRG--------------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPI 152 (690)
Q Consensus 88 kl~~~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~--------------~~~Lse~~v~~i~~qIl~aL~yLHs~g~~I 152 (690)
+++++|. +....|+|||||. |+|.+++..+. ...+++..++.++.||+.||.|||+.+ |
T Consensus 83 ~~~~~~~----~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--i 156 (299)
T d1fgka_ 83 NLLGACT----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--C 156 (299)
T ss_dssp CEEEEEC----SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred ECCCCCC----CCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--E
T ss_conf 3465220----188689999736999099999860677643222334574346799999999999999998766379--7
Q ss_pred CCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHH
Q ss_conf 03799988289679998135315887765531013331154334455679986348641111210799931469999999
Q 005577 153 AHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCL 232 (690)
Q Consensus 153 VHRDLKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGvi 232 (690)
|||||||+|||++.++.+||+|||+++...... .........|++.|+|||+ +.++.|+.++|||||||+
T Consensus 157 vHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~~~~y~aPE~---l~~~~y~~k~DiwS~Gvv 226 (299)
T d1fgka_ 157 IHRDLAARNVLVTEDNVMKIADFGLARDIHHID-------YYKKTTNGRLPVKWMAPEA---LFDRIYTHQSDVWSFGVL 226 (299)
T ss_dssp CCSCCSGGGEEECTTCCEEECSTTCCCCGGGCC-------TTCCCTTSCCGGGGSCHHH---HHHCCCCHHHHHHHHHHH
T ss_pred EEEEECCCCEEECCCCCEEECCCHHHCCCCCCC-------CCCCCCCCCCCHHHHHHHH---HCCCCCCCHHHHHHHHHH
T ss_conf 863022102245478976762211101135555-------5431466788846632667---517988825554775888
Q ss_pred HHHHHH-CCCCCCCCHHHHH---HHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHCC
Q ss_conf 999973-7999999309999---72467789999999899999999842099999998999999953167
Q 005577 233 LFRICY-FKNAFDGESKLQI---LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLP 298 (690)
Q Consensus 233 LyeLlt-Gk~Pf~~~~~~~i---l~~~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~l~ 298 (690)
+|||++ |..||.+....++ +....+.+.+..+++.+.+||.+||+.||.+||++.+++..+..++.
T Consensus 227 l~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 227 LWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 8874017989899999999999997288889874352999999999766797679399999999988860
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.48 Aligned_cols=249 Identities=26% Similarity=0.421 Sum_probs=205.2
Q ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCC--HHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCCE
Q ss_conf 229999985005956999999835689089999951289--888999999999999610899900888898762488760
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~~ 102 (690)
.+|++.+.||+|+||.||+|.+. ..++.||+|++.... ....+.+.+|+.+|+.+. |||||++++++. ....
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~----~~~~ 75 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIH----TENK 75 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEC-------CCHHHHHHHHHHTTCC-CTTBCCEEEEEE----ETTE
T ss_pred CCCEECCEEECCCCEEEEEEEEC-CCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCC-CCCEEEECCCCC----CCCC
T ss_conf 99776517723768099999999-99979999998022257589999999999998679-983887445332----2432
Q ss_pred EEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf 89999537985899999718999999999999999999999998299990037999882896799981353158877655
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGlA~~~~ 182 (690)
+|+|||||.++++..+.......+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+++...
T Consensus 76 ~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 76 LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp EEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred EEEEEEECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EECCCCCCHHEEECCCCCCEECCCCCCEECC
T ss_conf 03788623774455544202568888999999999999999865288--9921357114011346762103578613436
Q ss_pred CCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHCCC----C-
Q ss_conf 31013331154334455679986348641111210799931469999999999973799999930999972467----7-
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY----R- 257 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il~~~~----~- 257 (690)
.. ........||+.|+|||++ .....++.++|||||||++|+|++|+.||.+.+....+...+ .
T Consensus 154 ~~---------~~~~~~~~gt~~y~apE~~--~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~ 222 (298)
T d1gz8a_ 154 VP---------VRTYTHEVVTLWYRAPEIL--LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 222 (298)
T ss_dssp CC---------SBCTTCCBCCCTTCCHHHH--TTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred CC---------CCCCEEECCCCEEEEHHHH--CCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCC
T ss_conf 88---------6410010365215411221--366577742210333313427966879989889999999999832898
Q ss_pred ----------C-------C---------CCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf ----------8-------9---------999999899999999842099999998999999
Q 005577 258 ----------I-------P---------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 258 ----------~-------~---------~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
. + ..+.++..+.+||.+||..||.+||++.+++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 223 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 3331444222421243454322220444166789999999999763995579189999678
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.64 Aligned_cols=266 Identities=19% Similarity=0.262 Sum_probs=209.7
Q ss_pred EEECCCEEEEEEEEEECCCEEEEEEEECCCCC--EEEEEEEEEC-CCHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE
Q ss_conf 75328229999985005956999999835689--0899999512-89888999999999999610899900888898762
Q 005577 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIHMS--KQYAMKHMIC-NDEESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 20 i~i~~~ry~i~~~LG~GgfG~Vyla~d~~~~~--k~vAIK~i~~-~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~ 96 (690)
+......+...++||+|+||+||+|.+....+ ..||||.+.. .+....+++++|+.+|.+|+ |||||++++++..
T Consensus 22 ~~~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~- 99 (311)
T d1r0pa_ 22 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLR- 99 (311)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEE-
T ss_pred ECHHHCEECCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEE-
T ss_conf 68688155266698136880999999977998799999999884369789999999999998678-9998678678980-
Q ss_pred CCCCCEEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCC
Q ss_conf 48876089999537985899999718999999999999999999999998299990037999882896799981353158
Q 005577 97 LGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFG 176 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFG 176 (690)
..+.+++|||||.++++..+.......+++..++.++.|++.||.|+|..+ |+||||||+||||+.++.+||+|||
T Consensus 100 --~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG 175 (311)
T d1r0pa_ 100 --SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFG 175 (311)
T ss_dssp --TTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSG
T ss_pred --CCCCEEEEEEEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCC--CCCCCCCHHHEEECCCCCEEEECCC
T ss_conf --699438999874067414421013454048999999999887652003367--6257766875767799988991065
Q ss_pred CCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCH-H---HHHH
Q ss_conf 87765531013331154334455679986348641111210799931469999999999973799999930-9---9997
Q 005577 177 STSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES-K---LQIL 252 (690)
Q Consensus 177 lA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~-~---~~il 252 (690)
+++........ .........||+.|+|||+ .....++.++||||||+++|||++|..||.... . ...+
T Consensus 176 ~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~---~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i 247 (311)
T d1r0pa_ 176 LARDMYDKEFD-----SVHNKTGAKLPVKWMALES---LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 247 (311)
T ss_dssp GGCCTTTTTCC-----CTTCTTCSSCCGGGSCHHH---HHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH
T ss_pred CHHHCCCCCCC-----CCEECCCCCCCCCCCCHHH---HHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf 23225566555-----3100256555645567688---743799974574661999999997899998889999999999
Q ss_pred HCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 24677899999998999999998420999999989999999531675
Q 005577 253 NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLPV 299 (690)
Q Consensus 253 ~~~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~l~~ 299 (690)
....+...+..+++.+.+||.+||..||++||++.+++.++...+..
T Consensus 248 ~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 248 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 80898899644759999999997688976893999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.57 Aligned_cols=244 Identities=27% Similarity=0.418 Sum_probs=198.0
Q ss_pred EEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCCH-----HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCCEE
Q ss_conf 999850059569999998356890899999512898-----889999999999996108999008888987624887608
Q 005577 29 VRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDE-----ESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 29 i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~-----e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~~~ 103 (690)
..++||+|+||+||+|++. ..++.||||++..... .....+.+|+.+++.+. |||||++++++. ..+.+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~----~~~~~ 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFG----HKSNI 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECS-SCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEEC----CTTCC
T ss_pred CCEEECCCCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEC----CCCCE
T ss_conf 5638512728299999999-99969999998420212456799999999999998679-999868985422----58740
Q ss_pred EEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf 99995379858999997189999999999999999999999982999900379998828967999813531588776553
Q 005577 104 LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHK 183 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGlA~~~~~ 183 (690)
|||||||.++++..+.... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~ivmE~~~~~~~~~~~~~~-~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~ 152 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 152 (299)
T ss_dssp EEEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEHHHHHCCHHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHCCC--EECCCCCCCEEEECCCCCCCCCCCCCCCCCCC
T ss_conf 2204553450776554126-67789999999999999998863163--55035776258853778411465761000578
Q ss_pred CCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHCCCC------
Q ss_conf 10133311543344556799863486411112107999314699999999999737999999309999724677------
Q 005577 184 RFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYR------ 257 (690)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il~~~~~------ 257 (690)
.. ......+||+.|+|||++ ..+..|+.++|||||||++|+|++|+.||.+.+..+.+.....
T Consensus 153 ~~---------~~~~~~~gt~~y~aPE~~--~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~ 221 (299)
T d1ua2a_ 153 PN---------RAYTHQVVTRWYRAPELL--FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT 221 (299)
T ss_dssp CC---------CCCCCSCCCCTTCCHHHH--TTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred CC---------CCCCCEECCHHHCCHHHH--CCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCC
T ss_conf 75---------543302047333639997--2677888056436304289999859699999999999999998518997
Q ss_pred ------------------CCC------CCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf ------------------899------99999899999999842099999998999999
Q 005577 258 ------------------IPE------SPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 258 ------------------~~~------~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
.+. .+.+++.+.+||.+||+.||.+||++.|++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 222 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHCCCHHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 25452100021344303478988678565689999999999763894569089999679
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=341.51 Aligned_cols=262 Identities=20% Similarity=0.280 Sum_probs=211.9
Q ss_pred EEEECCCEEEEEEEEEECCCEEEEEEEECC----CCCEEEEEEEEECC-CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEE
Q ss_conf 375328229999985005956999999835----68908999995128-9888999999999999610899900888898
Q 005577 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDAI----HMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHT 93 (690)
Q Consensus 19 ~i~i~~~ry~i~~~LG~GgfG~Vyla~d~~----~~~k~vAIK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~ 93 (690)
.+++...+|++.+.||+|+||.||+|++.. ..++.||||++... .....+++.+|+.+++.++ ||||+++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred HCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCC-CCCCCCCEEEE
T ss_conf 11389889388679820788399999988876577882999999882108579999999999999668-99765524666
Q ss_pred EEECCCCCEEEEEEECCC-CCHHHHHHHHC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q ss_conf 762488760899995379-85899999718----------------------9999999999999999999999982999
Q 005577 94 ILDLGRTKEALLVMECCD-KSLVNVLENRG----------------------AGYFEEKQVLAIFRDVCNAVFAMHSQSP 150 (690)
Q Consensus 94 ~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~----------------------~~~Lse~~v~~i~~qIl~aL~yLHs~g~ 150 (690)
. .....++||||+. |+|.+++.... ...+++..++.|+.||+.||.|||+++
T Consensus 86 ~----~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~- 160 (301)
T d1lufa_ 86 A----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK- 160 (301)
T ss_dssp C----SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred C----CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC-
T ss_conf 0----59803899981589929999985275542100001110012103467889899999999999999855413578-
Q ss_pred CCCCCCCCCCCEEECCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHH
Q ss_conf 90037999882896799981353158877655310133311543344556799863486411112107999314699999
Q 005577 151 PIAHRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALG 230 (690)
Q Consensus 151 ~IVHRDLKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLG 230 (690)
||||||||+||||+.++.+||+|||+++...... .........|++.|+|||+ +.+..|+.++||||||
T Consensus 161 -ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~-------~~~~~~~~~~~~~y~aPE~---~~~~~~t~ksDVwS~G 229 (301)
T d1lufa_ 161 -FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD-------YYKADGNDAIPIRWMPPES---IFYNRYTTESDVWAYG 229 (301)
T ss_dssp -CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG-------CBC----CCBCGGGCCHHH---HHHCCCCHHHHHHHHH
T ss_pred -EEEEEECCCCEEECCCCCEEECCCHHHEECCCCC-------CCCCCCCCCCCCCCCCHHH---HCCCCCCHHHHHCCCH
T ss_conf -6854884011689899928983314421136776-------4111577776767679899---7268898056302523
Q ss_pred HHHHHHHHCC-CCCCCCHHHHHHH---CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHC
Q ss_conf 9999997379-9999930999972---46778999999989999999984209999999899999995316
Q 005577 231 CLLFRICYFK-NAFDGESKLQILN---GNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 231 viLyeLltGk-~Pf~~~~~~~il~---~~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~l 297 (690)
|++|||+++. .||.+....+++. .....+.+..+++.+.+||.+||+.+|.+||++.+|...+..+.
T Consensus 230 vvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 230 VVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 62999980689999998999999999739978887325299999999974889657939999999999842
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.04 Aligned_cols=260 Identities=22% Similarity=0.330 Sum_probs=211.1
Q ss_pred EEEECCCEEEEEEEEEECCCEEEEEEEECCCCC--EEEEEEEEECC---CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEE
Q ss_conf 375328229999985005956999999835689--08999995128---9888999999999999610899900888898
Q 005577 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMS--KQYAMKHMICN---DEESLESAMKEISVMKSLKGHPNVVTLYAHT 93 (690)
Q Consensus 19 ~i~i~~~ry~i~~~LG~GgfG~Vyla~d~~~~~--k~vAIK~i~~~---~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~ 93 (690)
|.-|+..+|++.+.||+|+||.||+|+.....+ ..||||++... +.+..+.+.+|+.+|+.++ |||||++|+++
T Consensus 2 t~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~ 80 (273)
T d1u46a_ 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVV 80 (273)
T ss_dssp CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred CEEECHHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEE
T ss_conf 14886489199789803888399999998899907999999998355579899999999999998689-99987898777
Q ss_pred EEECCCCCEEEEEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEE
Q ss_conf 762488760899995379-8589999971899999999999999999999999829999003799988289679998135
Q 005577 94 ILDLGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKL 172 (690)
Q Consensus 94 ~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL 172 (690)
. ....++|||||. +++.+.+..+. +.+++..++.++.||+.||.|||.++ |+||||||+||||+.++.+||
T Consensus 81 ~-----~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl 152 (273)
T d1u46a_ 81 L-----TPPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKI 152 (273)
T ss_dssp C-----SSSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEE
T ss_pred E-----ECCHHEEEEEECCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEEEEECHHHHCCCCCCCEEE
T ss_conf 4-----010011465423861254442126-89999999999999999998752178--752056688815655654332
Q ss_pred ECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHH
Q ss_conf 315887765531013331154334455679986348641111210799931469999999999973-7999999309999
Q 005577 173 CDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKLQI 251 (690)
Q Consensus 173 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLlt-Gk~Pf~~~~~~~i 251 (690)
+|||+++......... .......|+..|+|||+ +.+..++.++|||||||++|||++ |+.||.+.+..++
T Consensus 153 ~DfGl~~~~~~~~~~~------~~~~~~~~~~~~~aPE~---~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~ 223 (273)
T d1u46a_ 153 GDFGLMRALPQNDDHY------VMQEHRKVPFAWCAPES---LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 223 (273)
T ss_dssp CCCTTCEECCC-CCEE------EC-----CCGGGCCHHH---HHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred CCCHHHHHCCCCCCCC------EECCCCCCCCCCCCHHH---HHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
T ss_conf 5611555303588752------65476325731079999---83799994215661489999999689999999699999
Q ss_pred ----HHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
Q ss_conf ----724677899999998999999998420999999989999999531
Q 005577 252 ----LNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 252 ----l~~~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~ 296 (690)
.....+.+.+..++..+.+||.+||..||++||++.++...+.+.
T Consensus 224 ~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf 9999847999998544539999999997688966792999999999964
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.43 Aligned_cols=266 Identities=20% Similarity=0.320 Sum_probs=216.5
Q ss_pred CCEEEECCCEEEEEEEEEECCCEEEEEEEEC----CCCCEEEEEEEEECC-CHHHHHHHHHHHHHHHHHCCCCCCEEEEE
Q ss_conf 9637532822999998500595699999983----568908999995128-98889999999999996108999008888
Q 005577 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDA----IHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYA 91 (690)
Q Consensus 17 g~~i~i~~~ry~i~~~LG~GgfG~Vyla~d~----~~~~k~vAIK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~ 91 (690)
..-|++...+|++.++||+|+||.||+|.+. ...++.||||++... .......+.+|+.++..+.+|||||++++
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCCCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEE
T ss_conf 40263778996985498206882999999806644778869999998742487799999999999876269998878998
Q ss_pred EEEEECCCCCEEEEEEECCC-CCHHHHHHHHC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 98762488760899995379-85899999718----------------99999999999999999999999829999003
Q 005577 92 HTILDLGRTKEALLVMECCD-KSLVNVLENRG----------------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAH 154 (690)
Q Consensus 92 ~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~----------------~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVH 154 (690)
++. ....+|||||||+ |+|.+++.... ...+++..++.|+.||+.||.|||.++ +||
T Consensus 95 ~~~----~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivH 168 (311)
T d1t46a_ 95 ACT----IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIH 168 (311)
T ss_dssp EEC----SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred EEE----ECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEE
T ss_conf 983----19978999973799879999985356654444453322233458899999999999999999887579--266
Q ss_pred CCCCCCCEEECCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHH
Q ss_conf 79998828967999813531588776553101333115433445567998634864111121079993146999999999
Q 005577 155 RDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLF 234 (690)
Q Consensus 155 RDLKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLy 234 (690)
|||||+|||++.++.+||+|||+++........ .......||+.|+|||+ +.+..++.++|||||||++|
T Consensus 169 rDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~---~~~~~~~~~~DIwS~G~~l~ 238 (311)
T d1t46a_ 169 RDLAARNILLTHGRITKICDFGLARDIKNDSNY-------VVKGNARLPVKWMAPES---IFNCVYTFESDVWSYGIFLW 238 (311)
T ss_dssp SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTS-------EECSSSEECGGGCCHHH---HHHCCCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCCHHEECCCCCCC-------EEEEECCCCHHHCCHHH---HCCCCCCCCCCCCCHHHHHH
T ss_conf 624102100002575210234010233678861-------58620135968767788---61799997400102589999
Q ss_pred HHHH-CCCCCCCCHH----HHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHCC
Q ss_conf 9973-7999999309----99972467789999999899999999842099999998999999953167
Q 005577 235 RICY-FKNAFDGESK----LQILNGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLP 298 (690)
Q Consensus 235 eLlt-Gk~Pf~~~~~----~~il~~~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~l~ 298 (690)
||+| |.++|.+... ..++....+...+..++..+.+||.+||+.||.+||++.+++..+...+.
T Consensus 239 ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf 998589988778998999999986689889854365999999999757796579299999999987653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.10 Aligned_cols=260 Identities=25% Similarity=0.400 Sum_probs=206.6
Q ss_pred CCEEEECCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECC-CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE
Q ss_conf 9637532822999998500595699999983568908999995128-988899999999999961089990088889876
Q 005577 17 GRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTIL 95 (690)
Q Consensus 17 g~~i~i~~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~ 95 (690)
|..++|+. +|++.+.||+|+||.||+|.+. .+++.||||++... .....+++++|+.+|+.|. |||||++++++..
T Consensus 1 ~~~~~i~~-rY~~~~~LG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~ 77 (345)
T d1pmea_ 1 GQVFDVGP-RYTNLSYIGEGAYGMVCSAYDN-VNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIRA 77 (345)
T ss_dssp CCCCCCCT-TEEEEEECC---CCCEEEEEET-TTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECC
T ss_pred CCCCCCCC-CEEEEEEEEECCCEEEEEEEEC-CCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCC-CCCCCCEEEEEEE
T ss_conf 99337389-8599789940648099999999-9994999999803109589999999999999768-9898858889950
Q ss_pred ECC-CCCEEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEEC
Q ss_conf 248-8760899995379858999997189999999999999999999999982999900379998828967999813531
Q 005577 96 DLG-RTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCD 174 (690)
Q Consensus 96 ~~~-~~~~~~LVmEy~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~D 174 (690)
+.. ....+|+++++++++|.+++..+ .+++..++.++.||+.||.|||++| ||||||||+||||+.++.+||+|
T Consensus 78 ~~~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~D 152 (345)
T d1pmea_ 78 PTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICD 152 (345)
T ss_dssp SSTTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECC
T ss_pred CCCCCCCEEEEEEEECCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEECCCCCEEECC
T ss_conf 564554149999962598656644058---9999999999999999999999789--86777876437887999778754
Q ss_pred CCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHC
Q ss_conf 58877655310133311543344556799863486411112107999314699999999999737999999309999724
Q 005577 175 FGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG 254 (690)
Q Consensus 175 FGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il~~ 254 (690)
||++......... .......+||+.|+|||++ .....++.++||||+||++|+|++|+.||.+.........
T Consensus 153 fG~a~~~~~~~~~------~~~~~~~~gt~~y~aPE~l--~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~ 224 (345)
T d1pmea_ 153 FGLARVADPDHDH------TGFLTEYVATRWYRAPEIM--LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH 224 (345)
T ss_dssp CTTCEECCGGGCB------CCTTCCCCSCGGGCCGGGT--TTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CCCEEECCCCCCC------CEEECCCCCCCEECHHHHH--HCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHH
T ss_conf 5705650477764------1010110265200038786--0478887410100467013377669799788888999998
Q ss_pred CC------------------------CCC---------CCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf 67------------------------789---------999999899999999842099999998999999
Q 005577 255 NY------------------------RIP---------ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 255 ~~------------------------~~~---------~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
.. ..+ ..+.+++.+.+||.+||..||.+||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 225 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 76520699756642343322220244677557787778378999999999999764895679089998619
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.54 Aligned_cols=248 Identities=25% Similarity=0.379 Sum_probs=199.1
Q ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC--CCCE
Q ss_conf 22999998500595699999983568908999995128988899999999999961089990088889876248--8760
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLG--RTKE 102 (690)
Q Consensus 25 ~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~--~~~~ 102 (690)
.+|+..++||+|+||+||+|++. ..++.||||++..... ...+|+.+|+.|+ |||||++++++..... ....
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDKR----FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSS----SCCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSCCE
T ss_pred CCCEEEEEEEECCCEEEEEEEEC-CCCCEEEEEEECCCCH----HHHHHHHHHHHCC-CCCCCCEEEEEEECCCCCCCEE
T ss_conf 77675169821768399999999-9997999999881606----8999999998668-9898738789974476577318
Q ss_pred EEEEEECCCCCHHHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCC-CEEEECCCCCC
Q ss_conf 899995379858999997--189999999999999999999999982999900379998828967999-81353158877
Q 005577 103 ALLVMECCDKSLVNVLEN--RGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG-LWKLCDFGSTS 179 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~--~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g-~vKL~DFGlA~ 179 (690)
+|||||||++++...+.. .....+++..+..|+.||+.||.|||++| |+||||||+||||+.++ .+||+|||+++
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCEEEEECCCCCEEEECCCCHH
T ss_conf 9999841688607888863103689999999999999999999998668--76457886037873589711673366054
Q ss_pred CCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHCCC---
Q ss_conf 65531013331154334455679986348641111210799931469999999999973799999930999972467---
Q 005577 180 TNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNY--- 256 (690)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il~~~~--- 256 (690)
..... .......|++.|+|||++ .....++.++|||||||++|||++|+.||...+..+.+....
T Consensus 172 ~~~~~----------~~~~~~~gt~~y~aPE~~--~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~ 239 (350)
T d1q5ka_ 172 QLVRG----------EPNVSYICSRYYRAPELI--FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239 (350)
T ss_dssp ECCTT----------SCCCSCCSCTTSCCHHHH--TTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred HCCCC----------CCCCCCCCCCCCCCHHHH--HCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHH
T ss_conf 40477----------653200255555682776--404688821000246527785502879989879999999999974
Q ss_pred ------------------CC----------CCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf ------------------78----------9999999899999999842099999998999999
Q 005577 257 ------------------RI----------PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 257 ------------------~~----------~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
.. ...+.+++.+.+||.+||..||.+||++.|++.+
T Consensus 240 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8981776543062101103554456744443156899999999999765895579299999669
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.75 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=204.5
Q ss_pred EEEECCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECC--CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE
Q ss_conf 37532822999998500595699999983568908999995128--9888999999999999610899900888898762
Q 005577 19 SIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 19 ~i~i~~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~ 96 (690)
.+++ ..+|++.+.||+|+||.||+|.+. .+++.||||++... +....+.+.+|+.+|+.+. |||||++++++...
T Consensus 13 ~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~ 89 (346)
T d1cm8a_ 13 AWEV-RAVYRDLQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPD 89 (346)
T ss_dssp EECC-BSSEEEEEEC------CEEEEEET-TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSC
T ss_pred EEEC-CCCEEEEEEEECCCCEEEEEEEEC-CCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEECCC
T ss_conf 3344-771899889801778199999999-99989999998522259699999999999998668-98754799986357
Q ss_pred C--CCCCEEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEEC
Q ss_conf 4--88760899995379858999997189999999999999999999999982999900379998828967999813531
Q 005577 97 L--GRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCD 174 (690)
Q Consensus 97 ~--~~~~~~~LVmEy~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~D 174 (690)
. .....+|||||||+..+...+. +.. |++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|
T Consensus 90 ~~~~~~~~~~lv~e~~~~~l~~~~~-~~~--l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~D 164 (346)
T d1cm8a_ 90 ETLDDFTDFYLVMPFMGTDLGKLMK-HEK--LGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILD 164 (346)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHH-HCC--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECC
T ss_pred CCCCCCCEEEEEEECCCCCHHHHHH-HCC--CCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCHHHCCCCCCCCCCC
T ss_conf 6555541599998405521899987-402--269999999999999999987378--76456685111121001221134
Q ss_pred CCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHC
Q ss_conf 58877655310133311543344556799863486411112107999314699999999999737999999309999724
Q 005577 175 FGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNG 254 (690)
Q Consensus 175 FGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il~~ 254 (690)
||+++..... .....||+.|+|||++ .....++.++|||||||++|+|++|+.||.+.+....+..
T Consensus 165 fg~a~~~~~~------------~~~~~~t~~y~aPE~~--~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~ 230 (346)
T d1cm8a_ 165 FGLARQADSE------------MTGYVVTRWYRAPEVI--LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 230 (346)
T ss_dssp CTTCEECCSS------------CCSSCSCGGGCCTHHH--HTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCCEECCCCC------------CCCCCCCCCCCCHHHH--CCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHH
T ss_conf 3102206876------------3102455333588998--1787899650103003899999978699888976899999
Q ss_pred CC---------------------------CC------CCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf 67---------------------------78------9999999899999999842099999998999999
Q 005577 255 NY---------------------------RI------PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 255 ~~---------------------------~~------~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
.. .. .....+++.+.+||.+||..||.+|||+.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHCCCCCCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 98503788488886530003443311578666556677556899999999999772995579299999639
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.54 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=209.0
Q ss_pred EEECCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCC
Q ss_conf 75328229999985005956999999835689089999951289888999999999999610899900888898762488
Q 005577 20 IDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGR 99 (690)
Q Consensus 20 i~i~~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~ 99 (690)
|+|.-.+|++.++||+|+||.||+|.+ .++.||||++... ...+.+.+|+.++++++ |||||++++++.. .
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~---~ 72 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKND--ATAQAFLAEASVMTQLR-HSNLVQLLGVIVE---E 72 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCCC--C--HHHHHTHHHHTTCC-CTTBCCEEEEECC---C
T ss_pred CCCCHHHEEEEEEEECCCCEEEEEEEE---CCEEEEEEEECCH--HHHHHHHHHHHHHHHCC-CCCEEEEEEEEEE---C
T ss_conf 955789948857982079808999999---9909999998857--77999999999998678-9898549878872---3
Q ss_pred CCEEEEEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCCC
Q ss_conf 760899995379-8589999971899999999999999999999999829999003799988289679998135315887
Q 005577 100 TKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 100 ~~~~~LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGlA 178 (690)
.+.+|+||||+. |+|.+++..+....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s 150 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLT 150 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred CCCEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCC--EECCCCCHHHHEECCCCCEEECCCCCC
T ss_conf 892899996369998999987457888899999999999985232113376--553666567601468997763245600
Q ss_pred CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHH---HHHHC
Q ss_conf 765531013331154334455679986348641111210799931469999999999973-79999993099---99724
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICY-FKNAFDGESKL---QILNG 254 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLlt-Gk~Pf~~~~~~---~il~~ 254 (690)
+..... .....+++.|+|||+ +.+..++.++|||||||++|||++ |+.||...... ..+..
T Consensus 151 ~~~~~~------------~~~~~~~~~y~aPE~---l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~ 215 (262)
T d1byga_ 151 KEASST------------QDTGKLPVKWTAPEA---LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 215 (262)
T ss_dssp -----------------------CCTTTSCHHH---HHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT
T ss_pred EECCCC------------CCCCCCCCCCCCHHH---HHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC
T ss_conf 344787------------765566646778178---72798885887775799999999789999999999999999980
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHC
Q ss_conf 6778999999989999999984209999999899999995316
Q 005577 255 NYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 255 ~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~l 297 (690)
..+.+.+..+++.+.+||.+||..||.+||++.+++..+....
T Consensus 216 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 8999997657999999999975669768939999999999998
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.55 Aligned_cols=257 Identities=24% Similarity=0.370 Sum_probs=211.3
Q ss_pred EECCCEEEEEEEEEECCCEEEEEEEECCCCCE--EEEEEEEECC-CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC
Q ss_conf 53282299999850059569999998356890--8999995128-98889999999999996108999008888987624
Q 005577 21 DVGNLKIHVRNVIAEGGFSCVYSARDAIHMSK--QYAMKHMICN-DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL 97 (690)
Q Consensus 21 ~i~~~ry~i~~~LG~GgfG~Vyla~d~~~~~k--~vAIK~i~~~-~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~ 97 (690)
.|.-.+|++.++||+|+||.||+|.+. ..+. .||||.+... ..+..+.+.+|+.+|.++.+|||||++|+++..
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-- 82 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIK-KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-- 82 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEE-ETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--
T ss_pred CCCHHHCEEEEEEEECCCCEEEEEEEC-CCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC--
T ss_conf 668799688779820788289999998-99969999999978233857999999999999862289988367888841--
Q ss_pred CCCCEEEEEEECCC-CCHHHHHHHH--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCE
Q ss_conf 88760899995379-8589999971--------------89999999999999999999999982999900379998828
Q 005577 98 GRTKEALLVMECCD-KSLVNVLENR--------------GAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENL 162 (690)
Q Consensus 98 ~~~~~~~LVmEy~~-gsLl~~L~~~--------------~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NI 162 (690)
.+.+|+||||++ |+|.+++..+ ....|++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 83 --~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NI 158 (309)
T d1fvra_ 83 --RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNI 158 (309)
T ss_dssp --TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred --CCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--CCCCCCCCCEE
T ss_conf --87369999802898699998640355555123101234578999999999999999987663089--54555052048
Q ss_pred EECCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCC-C
Q ss_conf 967999813531588776553101333115433445567998634864111121079993146999999999997379-9
Q 005577 163 LLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFK-N 241 (690)
Q Consensus 163 LLd~~g~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk-~ 241 (690)
|++.++.+||+|||+++....... .....||..|+|||+ +.++.++.++|||||||++|||++|. .
T Consensus 159 L~~~~~~~kl~DfG~a~~~~~~~~----------~~~~~gt~~y~aPE~---l~~~~~~~~sDvwSfGvil~ell~~~~~ 225 (309)
T d1fvra_ 159 LVGENYVAKIADFGLSRGQEVYVK----------KTMGRLPVRWMAIES---LNYSVYTTNSDVWSYGVLLWEIVSLGGT 225 (309)
T ss_dssp EECGGGCEEECCTTCEESSCEECC----------C----CCTTTCCHHH---HHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred EECCCCCEEECCCCCCCCCCCCCC----------CCCEECCCCCCCHHH---HCCCCCCCCCEEEHHHHHHHHHHHCCCC
T ss_conf 986887638743443224442234----------553013775555387---5269999622153138899999836899
Q ss_pred CCCCCHHHHHH---HCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHC
Q ss_conf 99993099997---246778999999989999999984209999999899999995316
Q 005577 242 AFDGESKLQIL---NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 242 Pf~~~~~~~il---~~~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~l 297 (690)
||.+.+..++. ....+.+.+..+++.+.+||.+||..||++||++.+++..+...+
T Consensus 226 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 226 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp TTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 99999999999999826888887667899999999976789668949999999999998
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.44 Aligned_cols=273 Identities=19% Similarity=0.279 Sum_probs=217.4
Q ss_pred CCCCCCCCCCCEEEECCCEEEEEEEEEECCCEEEEEEEECC----CCCEEEEEEEEECC-CHHHHHHHHHHHHHHHHHCC
Q ss_conf 76699999996375328229999985005956999999835----68908999995128-98889999999999996108
Q 005577 8 MQKEPTGLEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAI----HMSKQYAMKHMICN-DEESLESAMKEISVMKSLKG 82 (690)
Q Consensus 8 ~~~~~~~~~g~~i~i~~~ry~i~~~LG~GgfG~Vyla~d~~----~~~k~vAIK~i~~~-~~e~~e~~~~Ei~iL~~L~~ 82 (690)
.+.....+.- .|+|...+|++.+.||+|+||+||+|.+.. ..+..||||++... .......+++|+.+++++.
T Consensus 4 ~~~~~~~~~~-~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~- 81 (308)
T d1p4oa_ 4 FSAADVYVPD-EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN- 81 (308)
T ss_dssp SBCCSCCCCC-TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC-
T ss_pred CCCCCCCCCC-CEEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-
T ss_conf 4703376861-00426899188359820788189999987864477896899999870128689999999999999769-
Q ss_pred CCCCEEEEEEEEEECCCCCEEEEEEECCC-CCHHHHHHHHC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 99900888898762488760899995379-85899999718--------9999999999999999999999982999900
Q 005577 83 HPNVVTLYAHTILDLGRTKEALLVMECCD-KSLVNVLENRG--------AGYFEEKQVLAIFRDVCNAVFAMHSQSPPIA 153 (690)
Q Consensus 83 HPNIVkl~~~~~~~~~~~~~~~LVmEy~~-gsLl~~L~~~~--------~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IV 153 (690)
|||||++++++. .....++|||||. |+|.+++.... ...+++..++.++.+++.||.|||.++ |+
T Consensus 82 h~nIv~~~~~~~----~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--iv 155 (308)
T d1p4oa_ 82 CHHVVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FV 155 (308)
T ss_dssp CTTBCCEEEEEC----SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CB
T ss_pred CCCEEEEEEEEE----CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EE
T ss_conf 998841254784----288106777604899889998750332113444688799999999999999999876479--65
Q ss_pred CCCCCCCCEEECCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHH
Q ss_conf 37999882896799981353158877655310133311543344556799863486411112107999314699999999
Q 005577 154 HRDLKAENLLLGSDGLWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLL 233 (690)
Q Consensus 154 HRDLKP~NILLd~~g~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviL 233 (690)
||||||+|||++.++.+||+|||+++....... ........|++.|+|||+ +.+..++.++|||||||++
T Consensus 156 HrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~-------~~~~~~~~~t~~y~aPe~---l~~~~~~~~~Dv~S~G~il 225 (308)
T d1p4oa_ 156 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-------YRKGGKGLLPVRWMSPES---LKDGVFTTYSDVWSFGVVL 225 (308)
T ss_dssp CSCCSGGGEEECTTCCEEECCTTCCCGGGGGGC-------EEGGGSSEECGGGCCHHH---HHHCCCCHHHHHHHHHHHH
T ss_pred ECEECCCCEEECCCCEEEEEECCCCEECCCCCC-------EEECCCEECCCCCCCHHH---HCCCCCCCCCCCCCHHHHH
T ss_conf 432867754035996499942454202357763-------031340231632378888---7369988333444378999
Q ss_pred HHHHHC-CCCCCCCHHHHHH---HCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHCC
Q ss_conf 999737-9999993099997---2467789999999899999999842099999998999999953167
Q 005577 234 FRICYF-KNAFDGESKLQIL---NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQLP 298 (690)
Q Consensus 234 yeLltG-k~Pf~~~~~~~il---~~~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~l~ 298 (690)
|||++| +.||.+....+++ ......+.+..+++.+.++|.+||+.+|.+||++.+++..+...+.
T Consensus 226 ~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 226 WEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf 999968999999989999999998088888863353999999999757796589399999999787617
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.17 Aligned_cols=242 Identities=27% Similarity=0.409 Sum_probs=197.3
Q ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCC------HHHHHHHHHHHHHHHHHC-CCCCCEEEEEEEEEE
Q ss_conf 8229999985005956999999835689089999951289------888999999999999610-899900888898762
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND------EESLESAMKEISVMKSLK-GHPNVVTLYAHTILD 96 (690)
Q Consensus 24 ~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~------~e~~e~~~~Ei~iL~~L~-~HPNIVkl~~~~~~~ 96 (690)
+.+|++.++||+|+||.||+|++. .+++.||+|++.... .....++.+|+.+++++. .|||||++++++.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~-- 79 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE-- 79 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--
T ss_pred CCEEEEEEEEEECCCEEEEEEEEC-CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--
T ss_conf 883799679840878399999999-99979999998568844334556799999999999974358988127999983--
Q ss_pred CCCCCEEEEEEECCCC--CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCC-CCEEEE
Q ss_conf 4887608999953798--5899999718999999999999999999999998299990037999882896799-981353
Q 005577 97 LGRTKEALLVMECCDK--SLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSD-GLWKLC 173 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~g--sLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~-g~vKL~ 173 (690)
..+..|+||||+.+ .+.+.+..+.. +++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+
T Consensus 80 --~~~~~~lv~e~~~~~~~l~~~~~~~~~--l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~ 153 (273)
T d1xwsa_ 80 --RPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLI 153 (273)
T ss_dssp --CSSEEEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEEC
T ss_pred --ECCEEEEEEEECCCCCHHHHHHHCCCC--CCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEEECCCCEEEEC
T ss_conf --099689999833686228999861589--999999999999999999998779--75566761114774478848977
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 158877655310133311543344556799863486411112107-9993146999999999997379999993099997
Q 005577 174 DFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRE-LINEKVDIWALGCLLFRICYFKNAFDGESKLQIL 252 (690)
Q Consensus 174 DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~-~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il 252 (690)
|||+++..... ......||+.|+|||++ .+. .++.++|||||||++|+|++|+.||.+.. .+.
T Consensus 154 DFG~a~~~~~~-----------~~~~~~GT~~y~aPE~~---~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~i~ 217 (273)
T d1xwsa_ 154 DFGSGALLKDT-----------VYTDFDGTRVYSPPEWI---RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EII 217 (273)
T ss_dssp CCTTCEECCSS-----------CBCCCCSCGGGSCHHHH---HHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHH
T ss_pred CCCCCEECCCC-----------CCCCCCCCCCCCCHHHH---CCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH--HHH
T ss_conf 54653532444-----------55665658774799998---489978865332554034536756889988736--776
Q ss_pred HCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf 2467789999999899999999842099999998999999
Q 005577 253 NGNYRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 253 ~~~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
..... .+..+++.+.+||.+||..||.+||++.+++.+
T Consensus 218 ~~~~~--~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 218 RGQVF--FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HCCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HCCCC--CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 15447--787799999999999760897589399998539
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=337.60 Aligned_cols=247 Identities=28% Similarity=0.434 Sum_probs=202.9
Q ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCC--HHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCCE
Q ss_conf 229999985005956999999835689089999951289--888999999999999610899900888898762488760
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND--EESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~--~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~~ 102 (690)
++|++.++||+|+||.||+|++. .++.||+|++.... ....+++.+|+.+|+++. |||||++++++. ..+.
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~----~~~~ 74 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIH----TKKR 74 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEE----CSSC
T ss_pred CCCEECCEEECCCCCEEEEEEEC--CCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEECC----CCCC
T ss_conf 99634318722778189999968--9999999998123268589999999999998679-986876601204----6773
Q ss_pred EEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf 89999537985899999718999999999999999999999998299990037999882896799981353158877655
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGlA~~~~ 182 (690)
.|+||+|+.++++..+.... +.+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||++....
T Consensus 75 ~~i~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~ 151 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFG 151 (286)
T ss_dssp EEEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred EEEEEEEEHHHHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHCCCC--EEECCCCCCEEEECCCCCEEECCCCCCEECC
T ss_conf 15899740045678998604-77514456899999999999860574--8826787750568689978732366430114
Q ss_pred CCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHCCCC-----
Q ss_conf 310133311543344556799863486411112107999314699999999999737999999309999724677-----
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGNYR----- 257 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il~~~~~----- 257 (690)
... .......|++.|+|||++ .....++.++|||||||++|+|++|+.||.+.+..+.+.....
T Consensus 152 ~~~---------~~~~~~~~~~~y~~pE~~--~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~ 220 (286)
T d1ob3a_ 152 IPV---------RKYTHEIVTLWYRAPDVL--MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP 220 (286)
T ss_dssp C------------------CCCTTCCHHHH--TTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred CCC---------CCCCEECCCCHHHHHHHH--HCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCC
T ss_conf 676---------541010243110137887--178888841002111758999977979989889899999999863899
Q ss_pred --------------------------CCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf --------------------------89999999899999999842099999998999999
Q 005577 258 --------------------------IPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 258 --------------------------~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
......+++.+.+||.+||+.||++||++.|++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHHHCCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 7110421233322143333356764666512589999999999866896689099998569
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.60 Aligned_cols=256 Identities=24% Similarity=0.357 Sum_probs=202.1
Q ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECC--CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC----C
Q ss_conf 22999998500595699999983568908999995128--98889999999999996108999008888987624----8
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL----G 98 (690)
Q Consensus 25 ~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~----~ 98 (690)
.+|++.+.||+|+||+||+|++. ..++.||||++... ......++.+|+.+|+.++ ||||+++++++.... .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC-------
T ss_pred CCEEEEEEEECCCCEEEEEEEEC-CCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHC-CCCCCCEEEEEECCCCCCCC
T ss_conf 79889999722748299999998-99979999998422246378999999999999835-99966067654024654444
Q ss_pred CCCEEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCCC
Q ss_conf 87608999953798589999971899999999999999999999999829999003799988289679998135315887
Q 005577 99 RTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 99 ~~~~~~LVmEy~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGlA 178 (690)
.....|+|||||.++++..+.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~-~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCCEEEEEEECCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHHCCCC--EEECCCCCHHEEECCCCCEEEEECCEE
T ss_conf 576389998535787410122203-44330899999999999998852299--885676722203668996876313500
Q ss_pred CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHCC---
Q ss_conf 76553101333115433445567998634864111121079993146999999999997379999993099997246---
Q 005577 179 STNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN--- 255 (690)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il~~~--- 255 (690)
+........ ........+||+.|+|||++ .....++.++|||||||++|+|++|+.||.+......+...
T Consensus 165 ~~~~~~~~~-----~~~~~~~~~gT~~Y~aPE~~--~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~ 237 (318)
T d3blha1 165 RAFSLAKNS-----QPNRYTNRVVTLWYRPPELL--LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237 (318)
T ss_dssp EECCC----------CCCCCSCCSCGGGCCHHHH--TTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EECCCCCCC-----CCCCCCCEECCHHHHHHHHH--CCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHH
T ss_conf 223554443-----21135660249787428997--07999891787006786466174487998998999999999984
Q ss_pred ---CCCCCC----------------------------CCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf ---778999----------------------------9999899999999842099999998999999
Q 005577 256 ---YRIPES----------------------------PKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 256 ---~~~~~~----------------------------~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
...... ...++.+.+||.+||..||++||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 18998255344320344433201334455503340444599899999999873896589099999749
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=327.20 Aligned_cols=258 Identities=18% Similarity=0.189 Sum_probs=198.7
Q ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCCEE
Q ss_conf 82299999850059569999998356890899999512898889999999999996108999008888987624887608
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~~~ 103 (690)
+++|++.+.||+|+||.||+|++. ..++.||||.+..... ...+.+|+.+++.+. |+|+|.++..+.. .....
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~-~~~~i~~~~~~~~---~~~~~ 78 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQ-GGVGIPTIRWCGA---EGDYN 78 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEESCTT--SCCHHHHHHHHHHST-TSTTCCCEEEEEE---ETTEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEEC-CCCCEEEEEEECHHCC--CHHHHHHHHHHHHCC-CCCCCCEEEEEEE---CCCEE
T ss_conf 888999689850788099999998-8998999999721005--888999999999703-8996017999995---19877
Q ss_pred EEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECC---CCCEEEECCCCCCC
Q ss_conf 999953798589999971899999999999999999999999829999003799988289679---99813531588776
Q 005577 104 LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS---DGLWKLCDFGSTST 180 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~---~g~vKL~DFGlA~~ 180 (690)
++||||+++++...+.... ..+++..++.++.|++.||.|||+++ ||||||||+|||++. +..++|+|||+|+.
T Consensus 79 ~ivme~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 79 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEEECCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCHHHCCCCCCCCCCEEEEECCCCCEE
T ss_conf 8999873871333244306-88768999999999999999999799--44266787660643357776156504675134
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH-------H
Q ss_conf 553101333115433445567998634864111121079993146999999999997379999993099997-------2
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQIL-------N 253 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il-------~ 253 (690)
+...... ............||+.|||||+ ..+..++.++|||||||++|||++|+.||......... .
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 230 (299)
T d1ckia_ 156 YRDARTH--QHIPYRENKNLTGTARYASINT---HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230 (299)
T ss_dssp CBCTTTC--CBCCCCBCCSCCCCSSSCCHHH---HTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred CCCCCCC--CCEECCCCCCCCCCCCCCCHHH---HHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHC
T ss_conf 2554455--4100013577678735329999---9189989832188617789999849876655305779999998523
Q ss_pred CCCCCC---CCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
Q ss_conf 467789---9999998999999998420999999989999999531
Q 005577 254 GNYRIP---ESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQ 296 (690)
Q Consensus 254 ~~~~~~---~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~ 296 (690)
.....+ ....+++.+.++|..||..+|.+||++.++...+...
T Consensus 231 ~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 231 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred CCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 5678983575347889999999998439955791999999999999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.60 Aligned_cols=256 Identities=23% Similarity=0.330 Sum_probs=203.5
Q ss_pred CCCCEEEECCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECC--CHHHHHHHHHHHHHHHHHCCCCCCEEEEEE
Q ss_conf 999637532822999998500595699999983568908999995128--988899999999999961089990088889
Q 005577 15 LEGRSIDVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAH 92 (690)
Q Consensus 15 ~~g~~i~i~~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~ 92 (690)
+.+..+++. .||++.++||+|+||+||+|++. ..++.||||++... +....+++.+|+.+|+.|. |||||+++++
T Consensus 9 ~~~~~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~ 85 (348)
T d2gfsa1 9 LNKTIWEVP-ERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDV 85 (348)
T ss_dssp CSSSEEEEE-TTEEEEEECGGGTTSSEEEEEET-TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEE
T ss_pred CCCCCCCCC-CCEEEEEEEECCCCEEEEEEEEC-CCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEE
T ss_conf 377554589-87188889831788399999999-99979999998820028689999999999998668-9874259999
Q ss_pred EEEEC--CCCCEEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCE
Q ss_conf 87624--8876089999537985899999718999999999999999999999998299990037999882896799981
Q 005577 93 TILDL--GRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLW 170 (690)
Q Consensus 93 ~~~~~--~~~~~~~LVmEy~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~v 170 (690)
+.... .+....|+++++++++|.+++.. + .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~--~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~ 160 (348)
T d2gfsa1 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKC-Q--KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCEL 160 (348)
T ss_dssp ECSCSSTTTCCCCEEEEECCSEEHHHHHTT-C--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCE
T ss_pred EEECCCCCCCCEEEEEEEECCCCHHHHCCC-C--CCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCCCCCCC
T ss_conf 963464566864999996258862320022-4--5309999999999999999997388--7651667763345543220
Q ss_pred EEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHH
Q ss_conf 35315887765531013331154334455679986348641111210799931469999999999973799999930999
Q 005577 171 KLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQ 250 (690)
Q Consensus 171 KL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~ 250 (690)
|++|||++...... .....|++.|+|||++ .....++.++|||||||++|+|++|+.||.+.+...
T Consensus 161 kl~dfg~a~~~~~~------------~~~~~g~~~y~apE~~--~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~ 226 (348)
T d2gfsa1 161 KILDFGLARHTDDE------------MTGYVATRWYRAPEIM--LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 226 (348)
T ss_dssp EECCC----CCTGG------------GSSSCHHHHTSCHHHH--TTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred CCCCCCHHCCCCCC------------CCCCCCCCCCCCCHHH--CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH
T ss_conf 01321000125754------------4443454355583553--377567855124320589999976889978898899
Q ss_pred HHHCC---------------------------CCCCC------CCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf 97246---------------------------77899------99999899999999842099999998999999
Q 005577 251 ILNGN---------------------------YRIPE------SPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 251 il~~~---------------------------~~~~~------~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
..... ...+. ...+++.+.+||.+||..||.+||++.+++.+
T Consensus 227 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 227 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 999999730799757732001024454443035578755566267899999999999775883459389998559
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=322.72 Aligned_cols=262 Identities=19% Similarity=0.214 Sum_probs=205.5
Q ss_pred EECCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCC
Q ss_conf 53282299999850059569999998356890899999512898889999999999996108999008888987624887
Q 005577 21 DVGNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRT 100 (690)
Q Consensus 21 ~i~~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~ 100 (690)
+|-+.+|++.++||+|+||+||+|++. .+++.||+|.+..... ...+.+|+++++.|..|+||+.+++++. ..
T Consensus 1 ~vig~~Y~i~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~----~~ 73 (293)
T d1csna_ 1 NVVGVHYKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQ----EG 73 (293)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEE----ET
T ss_pred CCCCCCEEEEEEEECCCCEEEEEEEEC-CCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEE----CC
T ss_conf 978980699799841788299999998-8997999999750258--2999999999999648999877999960----18
Q ss_pred CEEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECC-----CCCEEEECC
Q ss_conf 608999953798589999971899999999999999999999999829999003799988289679-----998135315
Q 005577 101 KEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGS-----DGLWKLCDF 175 (690)
Q Consensus 101 ~~~~LVmEy~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~-----~g~vKL~DF 175 (690)
...|+||||++++|.+.+...+ ..+++..+..++.|++.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 74 ~~~~~vme~~~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DF 150 (293)
T d1csna_ 74 LHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDF 150 (293)
T ss_dssp TEEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred CCCEEEEEECCCCHHHHHHHHC-CCHHHHHHHHHHHHHHHHHHHHHHCC--CEECCCCCCCEEECCCCCCCCCCEEECCC
T ss_conf 8117999964888799997520-31106899999999999999999779--66266771315234754344795687236
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCH---HHH--
Q ss_conf 887765531013331154334455679986348641111210799931469999999999973799999930---999--
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES---KLQ-- 250 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~---~~~-- 250 (690)
|+++......... ..........+||+.|||||+ +.+..++.++|||||||++|+|++|+.||.+.. ...
T Consensus 151 G~a~~~~~~~~~~--~~~~~~~~~~~GT~~y~aPE~---~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~ 225 (293)
T d1csna_ 151 GMVKFYRDPVTKQ--HIPYREKKNLSGTARYMSINT---HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225 (293)
T ss_dssp TTCEESBCTTTCC--BCCCCCCCCCCSCTTTCCHHH---HTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred CEEEECCCCCCCC--CEEECCCCCEEECHHHCCHHH---HCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 6057714676654--111024676277510267989---64888886999898319999998698767885302199999
Q ss_pred --HHHCCCCC---CCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHC
Q ss_conf --97246778---999999989999999984209999999899999995316
Q 005577 251 --ILNGNYRI---PESPKYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 251 --il~~~~~~---~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~l 297 (690)
+....... .....+|+.+.+++..|+..+|++||++..+...+.+.+
T Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 226 ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
T ss_conf 9997056799958965799899999999984399300859999999999999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.36 Aligned_cols=247 Identities=26% Similarity=0.375 Sum_probs=201.1
Q ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECC--CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC--CCC
Q ss_conf 22999998500595699999983568908999995128--98889999999999996108999008888987624--887
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDL--GRT 100 (690)
Q Consensus 25 ~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~--~~~ 100 (690)
.+|++.++||+|+||+||+|++. .+++.||||++... +.....++.+|+.+++.+. |||||++++++.... +..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~-~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEET-TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTTTC
T ss_pred CCEEEEEEEECCCCEEEEEEEEC-CCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEEECCCCCCCC
T ss_conf 77599889621758599999999-99989999998823369799999999999998648-98764899897025643457
Q ss_pred CEEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf 60899995379858999997189999999999999999999999982999900379998828967999813531588776
Q 005577 101 KEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTST 180 (690)
Q Consensus 101 ~~~~LVmEy~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGlA~~ 180 (690)
..+|+|||||.++++..+. ..+++..++.++.||+.||.|||.+| |+||||||+|||++.++.++++|||+++.
T Consensus 95 ~~~~iv~Ey~~~~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp CEEEEEEECCSEEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CEEEEEEECCCHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCCCCCCCCCEEEECHHHHHC
T ss_conf 6269998414467787650----38999999999999999998865221--12456776321136544313201023211
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHCC-----
Q ss_conf 553101333115433445567998634864111121079993146999999999997379999993099997246-----
Q 005577 181 NHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESKLQILNGN----- 255 (690)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~~~il~~~----- 255 (690)
..... .....++|+.|+|||+ +.+..++.++||||+||++|+|++|+.||.+.+........
T Consensus 169 ~~~~~----------~~~~~~~t~~y~aPE~---l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~ 235 (355)
T d2b1pa1 169 AGTSF----------MMTPYVVTRYYRAPEV---ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_dssp ----------------------CCTTCCHHH---HTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred CCCCC----------CCCCCCCCCCCCCHHH---HCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCC
T ss_conf 46665----------5332214655558133---1477778774333566257898659899888977889999997205
Q ss_pred ---------------------CCCCC------------------CCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf ---------------------77899------------------99999899999999842099999998999999
Q 005577 256 ---------------------YRIPE------------------SPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 256 ---------------------~~~~~------------------~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
..... ....++.+.+||.+||..||++||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8987999876566777764175435666421264333543210133379999999999876994579089999669
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=327.14 Aligned_cols=245 Identities=19% Similarity=0.312 Sum_probs=193.9
Q ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCCEE
Q ss_conf 82299999850059569999998356890899999512898889999999999996108999008888987624887608
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~~~ 103 (690)
..+|++.++||+|+||+||+|++. ..++.||||++.... ..++.+|+.+|+.+.+||||+++++++.. .....+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~--~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINI-TNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD--PVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC--TTTCSE
T ss_pred CCCEEEEEEEECCCCEEEEEEEEC-CCCCEEEEEEECHHH---HHHHHHHHHHHHHCCCCCCCCEEEEEEEE--CCCCCE
T ss_conf 867189789831748199999988-999799999988899---99999999999851579987679999981--687712
Q ss_pred EEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCC-CEEEECCCCCCCCC
Q ss_conf 99995379858999997189999999999999999999999982999900379998828967999-81353158877655
Q 005577 104 LLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG-LWKLCDFGSTSTNH 182 (690)
Q Consensus 104 ~LVmEy~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g-~vKL~DFGlA~~~~ 182 (690)
++|||||.++++..+ .+.|++..+..++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+++...
T Consensus 108 ~~v~e~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 108 ALVFEHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EEEEECCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EEEEEECCCCCHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEECCCCCEEEECCCCCCEECC
T ss_conf 688863179858997----468999999999999999998876433--44345644123774899836641565426646
Q ss_pred CCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCH-HHHH-------H--
Q ss_conf 31013331154334455679986348641111210799931469999999999973799999930-9999-------7--
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGES-KLQI-------L-- 252 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~-~~~i-------l-- 252 (690)
.. ......++|+.|+|||++ .....++.++|||||||++|+|++|+.||.... .... +
T Consensus 182 ~~----------~~~~~~~~t~~y~aPE~~--~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~ 249 (328)
T d3bqca1 182 PG----------QEYNVRVASRYFKGPELL--VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 249 (328)
T ss_dssp TT----------CCCCSCCSCGGGCCHHHH--TTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred CC----------CCCCCCCCCCCCCCCCCC--CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCC
T ss_conf 88----------744432248642476102--688888845232335455587604889998876018999999998788
Q ss_pred --------HCC----------------------CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf --------246----------------------7789999999899999999842099999998999999
Q 005577 253 --------NGN----------------------YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 253 --------~~~----------------------~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
... ........+++.+.+||.+||..||.+|||+.+++.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 4155555422544474300000333433112115521124489999999999866995689089999649
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.61 Aligned_cols=259 Identities=19% Similarity=0.224 Sum_probs=191.4
Q ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCCEE
Q ss_conf 82299999850059569999998356890899999512898889999999999996108999008888987624887608
Q 005577 24 NLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEA 103 (690)
Q Consensus 24 ~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~~~ 103 (690)
..+|.+.+.||+|+||.||+|++ .++.||||++...... ......|+..+..++ |||||++++++..+......+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~---~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSREER-SWFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE---TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEE---CCEEEEEEEECCCCHH-HHHHHHHHHHHHHCC-CCCCCCEEEEEEECCCCCEEE
T ss_conf 86899988982078819999999---9989999998720046-799999999996279-986832688998379860489
Q ss_pred EEEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCCCCCCCCCCCCEEECCCCCEEEEC
Q ss_conf 99995379-858999997189999999999999999999999982--------999900379998828967999813531
Q 005577 104 LLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS--------QSPPIAHRDLKAENLLLGSDGLWKLCD 174 (690)
Q Consensus 104 ~LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs--------~g~~IVHRDLKP~NILLd~~g~vKL~D 174 (690)
|+|||||. |+|..++... . +++..++.++.+++.||.|+|. ++ ||||||||+||||+.++.+||+|
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~--IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-T--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-C--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEECCCCCCHHHHHHCC-C--CCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCC--EECCCCCCCCEEECCCCCEEEEE
T ss_conf 9999646698989998658-9--99899999999999999998876652046898--66153173135786887768876
Q ss_pred CCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHH---CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCH----
Q ss_conf 588776553101333115433445567998634864111121---0799931469999999999973799999930----
Q 005577 175 FGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFR---RELINEKVDIWALGCLLFRICYFKNAFDGES---- 247 (690)
Q Consensus 175 FGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~---~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~---- 247 (690)
||+++........ .........||+.|||||++.... ...++.++|||||||+||||+||..||....
T Consensus 152 FGl~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~ 226 (303)
T d1vjya_ 152 LGLAVRHDSATDT-----IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp CTTCEEEETTTTE-----ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred CCCCCCCCCCCCC-----EECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 3866234677762-----00135525035476782210565454677767501220159999999628998876631124
Q ss_pred -----------HHHH----HHCCCCCCCCC-----CCCHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHC
Q ss_conf -----------9999----72467789999-----99989999999984209999999899999995316
Q 005577 248 -----------KLQI----LNGNYRIPESP-----KYSSSVTDLIRDMLQASPDDRPDITQVWFRVNEQL 297 (690)
Q Consensus 248 -----------~~~i----l~~~~~~~~~~-----~~s~~l~~LI~~lL~~dP~~RPt~~eil~~l~~~l 297 (690)
...+ .....+...+. .....+.+|+.+||+.||.+||++.+++..+..+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 1012255643099999987502468887765577689999999999976069858959999999999888
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=324.35 Aligned_cols=252 Identities=24% Similarity=0.325 Sum_probs=200.1
Q ss_pred CCCEEEEEEEEEECCCEEEEEEEECC--CCCEEEEEEEEECC----CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE
Q ss_conf 28229999985005956999999835--68908999995128----9888999999999999610899900888898762
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAI--HMSKQYAMKHMICN----DEESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 23 ~~~ry~i~~~LG~GgfG~Vyla~d~~--~~~k~vAIK~i~~~----~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~ 96 (690)
.-.+|++.+.||+|+||.||+|++.. ..++.||+|.+... +....+.+.+|+.++++++.||||+++++++.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~-- 99 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ-- 99 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE--
T ss_pred CHHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC--
T ss_conf 510259998983287839999998765887948999998367721016899999999999986467983999620002--
Q ss_pred CCCCCEEEEEEECCC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECC
Q ss_conf 488760899995379-8589999971899999999999999999999999829999003799988289679998135315
Q 005577 97 LGRTKEALLVMECCD-KSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDF 175 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~-gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DF 175 (690)
+...+++||||+. ++|.+.+...+. +++..++.++.||+.||.|+|+++ |+||||||+||||+.++.+||+||
T Consensus 100 --~~~~~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DF 173 (322)
T d1vzoa_ 100 --TETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDF 173 (322)
T ss_dssp --ETTEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCS
T ss_pred --CCCCEEEEEECCCCCHHHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHCCC--EEECCCCCCCEEECCCCCEEEEEC
T ss_conf --48730012312341179999873045--437888888999999998851499--896547732012469998887413
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHH----HHH
Q ss_conf 8877655310133311543344556799863486411112107999314699999999999737999999309----999
Q 005577 176 GSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAFDGESK----LQI 251 (690)
Q Consensus 176 GlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf~~~~~----~~i 251 (690)
|+++........ ......|++.|++||++. .....++.++|||||||+||+|++|+.||.+... ..+
T Consensus 174 G~a~~~~~~~~~--------~~~~~~g~~~~~~pe~~~-~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i 244 (322)
T d1vzoa_ 174 GLSKEFVADETE--------RAYDFCGTIEYMAPDIVR-GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244 (322)
T ss_dssp SEEEECCGGGGG--------GGCGGGSCCTTCCHHHHT-TCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH
T ss_pred CCHHHHCCCCCC--------CCCCCCCCCCCCHHHHHH-CCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
T ss_conf 202220344443--------221222333331068760-57768871325177779999997689998888777799999
Q ss_pred HHC--CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC-----HHHHHH
Q ss_conf 724--6778999999989999999984209999999-----899999
Q 005577 252 LNG--NYRIPESPKYSSSVTDLIRDMLQASPDDRPD-----ITQVWF 291 (690)
Q Consensus 252 l~~--~~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt-----~~eil~ 291 (690)
... ....+.+..+++.+.+||.+||..||.+||+ +.|++.
T Consensus 245 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 245 SRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf 98335689988654799999999997445898819997450999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=317.28 Aligned_cols=248 Identities=26% Similarity=0.423 Sum_probs=198.6
Q ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECC--CHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCCE
Q ss_conf 22999998500595699999983568908999995128--9888999999999999610899900888898762488760
Q 005577 25 LKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICN--DEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKE 102 (690)
Q Consensus 25 ~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~--~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~~ 102 (690)
.+|++.+.||+|+||+||+|++. .+++.||+|++... ......++.+|+.+++.++ |||||++++++. ....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~----~~~~ 75 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLH----SDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEE----CSSE
T ss_pred CCCEEEEEEECCCCEEEEEEEEC-CCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCC-CCCEEEECCCCC----CCCC
T ss_conf 99786269712868199999999-99969999998032178689999999999998567-578882135444----4431
Q ss_pred EEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf 89999537985899999718999999999999999999999998299990037999882896799981353158877655
Q 005577 103 ALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDGLWKLCDFGSTSTNH 182 (690)
Q Consensus 103 ~~LVmEy~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g~vKL~DFGlA~~~~ 182 (690)
.++|++++.+.++..+.... +.+++..+..++.|++.||.|||.++ |+||||||+|||++.++.+||+|||.++...
T Consensus 76 ~~iv~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 76 LTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEECCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHHHHCCC--EEEECCCCCCCCCCCCCCEEEEECCHHHCCC
T ss_conf 15886302332221121235-65403678999999999987743399--8600146761211337826652046011046
Q ss_pred CCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCC-CCCHHHHHHHC------C
Q ss_conf 3101333115433445567998634864111121079993146999999999997379999-99309999724------6
Q 005577 183 KRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAF-DGESKLQILNG------N 255 (690)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf-~~~~~~~il~~------~ 255 (690)
.... ......+++.|+|||++ .....++.++|||||||++|+|++|+.|| .+.+..+.+.. .
T Consensus 153 ~~~~---------~~~~~~~~~~~~~pe~~--~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 221 (292)
T d1unla_ 153 IPVR---------CYSAEVVTLWYRPPDVL--FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221 (292)
T ss_dssp SCCS---------CCCSCCSCGGGCCHHHH--TTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred CCCC---------CCEEECCCCCHHHHHHH--CCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCC
T ss_conf 8875---------10010344310146675--069888804440265418899851899998899999999999861189
Q ss_pred -------------------------CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCHHHHHHH
Q ss_conf -------------------------7789999999899999999842099999998999999
Q 005577 256 -------------------------YRIPESPKYSSSVTDLIRDMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 256 -------------------------~~~~~~~~~s~~l~~LI~~lL~~dP~~RPt~~eil~~ 292 (690)
......+.+++.+.+||.+||+.||.+||++.|++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 97355134432221133444544310433065689999999999864996689099999649
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.1e-43 Score=299.14 Aligned_cols=249 Identities=23% Similarity=0.307 Sum_probs=189.6
Q ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHC----------CCCCCEEEEEE
Q ss_conf 28229999985005956999999835689089999951289888999999999999610----------89990088889
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLK----------GHPNVVTLYAH 92 (690)
Q Consensus 23 ~~~ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~----------~HPNIVkl~~~ 92 (690)
.+.||++.++||+|+||+||+|++. .+++.||||++... ....+.+.+|+.+++.+. +|+|||+++++
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~-~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEEC-CCCCEEEEEEEECC-CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEE
T ss_conf 4785799899750778189999999-99979999998343-133689999999999840145555542276764789987
Q ss_pred EEEECCCCCEEEEEEECC--CCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCEEECCCC-
Q ss_conf 876248876089999537--9858999997189999999999999999999999982-999900379998828967999-
Q 005577 93 TILDLGRTKEALLVMECC--DKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHS-QSPPIAHRDLKAENLLLGSDG- 168 (690)
Q Consensus 93 ~~~~~~~~~~~~LVmEy~--~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs-~g~~IVHRDLKP~NILLd~~g- 168 (690)
+.... ....++||.++ .+.............+++..+..++.||+.||.|||. .| |+||||||+||||+.++
T Consensus 89 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 89 FNHKG--PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp EEEEE--TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEET
T ss_pred EEECC--CCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHEEEECCCC
T ss_conf 63125--65202343200035420000012234678689999999999999888764058--646567705705630576
Q ss_pred -----CEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCC
Q ss_conf -----813531588776553101333115433445567998634864111121079993146999999999997379999
Q 005577 169 -----LWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAPEMWDLFRRELINEKVDIWALGCLLFRICYFKNAF 243 (690)
Q Consensus 169 -----~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~s~ksDVwSLGviLyeLltGk~Pf 243 (690)
.++|+|||.+..... .....+||+.|+|||+ .....++.++||||+||++++|++|+.||
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~------------~~~~~~gt~~y~aPE~---~~~~~~~~~~DiwSlG~il~el~~g~~pF 229 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDE------------HYTNSIQTREYRSPEV---LLGAPWGCGADIWSTACLIFELITGDFLF 229 (362)
T ss_dssp TTTEEEEEECCCTTCEETTB------------CCCSCCSCGGGCCHHH---HHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred CCCCCEEEEEECCCCCCCCC------------CCCCCCCCCCCCCHHH---CCCCCCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf 56443056753144212344------------5422366521057132---14667776432012378999998788998
Q ss_pred CCCHHH----------HHHH--C----------C-----------C-CC----------------CCCCCCCHHHHHHHH
Q ss_conf 993099----------9972--4----------6-----------7-78----------------999999989999999
Q 005577 244 DGESKL----------QILN--G----------N-----------Y-RI----------------PESPKYSSSVTDLIR 273 (690)
Q Consensus 244 ~~~~~~----------~il~--~----------~-----------~-~~----------------~~~~~~s~~l~~LI~ 273 (690)
...... ..+. + . . .. ......++.+.+||.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 309 (362)
T d1q8ya_ 230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309 (362)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred CCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHH
T ss_conf 98755432102689999999837998788624532200013201220243235776444210001567435899999999
Q ss_pred HHHHHCCCCCCCHHHHHHH
Q ss_conf 9842099999998999999
Q 005577 274 DMLQASPDDRPDITQVWFR 292 (690)
Q Consensus 274 ~lL~~dP~~RPt~~eil~~ 292 (690)
+||..||.+|||+.|++.+
T Consensus 310 ~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 310 PMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp GGGCSSTTTCBCHHHHHTC
T ss_pred HHCCCCHHHCCCHHHHHCC
T ss_conf 9877994579089999669
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=6.3e-24 Score=173.21 Aligned_cols=168 Identities=16% Similarity=0.144 Sum_probs=119.7
Q ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCC------------------HHHHHHHHHHHHHHHHHCCCCCCEE
Q ss_conf 9999985005956999999835689089999951289------------------8889999999999996108999008
Q 005577 27 IHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICND------------------EESLESAMKEISVMKSLKGHPNVVT 88 (690)
Q Consensus 27 y~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~------------------~e~~e~~~~Ei~iL~~L~~HPNIVk 88 (690)
+.++++||+|+||+||+|.+. .++.||+|.+.... ........+|+..+.++. |.+++.
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~--~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~ 78 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPK 78 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET--TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCC
T ss_pred CHHCCEEEECCCEEEEEEECC--CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCC-CCCCCE
T ss_conf 022778024856599999979--99999999986044346665565630008889999997789999999816-999144
Q ss_pred EEEEEEEECCCCCEEEEEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEECCCC
Q ss_conf 88898762488760899995379858999997189999999999999999999999982999900379998828967999
Q 005577 89 LYAHTILDLGRTKEALLVMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQSPPIAHRDLKAENLLLGSDG 168 (690)
Q Consensus 89 l~~~~~~~~~~~~~~~LVmEy~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g~~IVHRDLKP~NILLd~~g 168 (690)
.+++. ..++||||+++..... ++...+..++.|++.+|.|||..| |+||||||+|||++.++
T Consensus 79 ~~~~~--------~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~~ 140 (191)
T d1zara2 79 VYAWE--------GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEEG 140 (191)
T ss_dssp EEEEE--------TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETTE
T ss_pred EEEEC--------CCEEEEEEECCCCCCC--------HHHHHHHHHHHHHHHHHHHHHHCC--EEECCCCHHHEEEECCC
T ss_conf 99862--------8889999504565420--------015789999999999999982688--89836890361142898
Q ss_pred CEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCC--CCHHHHHCCCCCCHHHHHHHHHHH
Q ss_conf 81353158877655310133311543344556799863486--411112107999314699999999
Q 005577 169 LWKLCDFGSTSTNHKRFEKLEEMGIEEDNIRKHTTPAYRAP--EMWDLFRRELINEKVDIWALGCLL 233 (690)
Q Consensus 169 ~vKL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP--Evl~~~~~~~~s~ksDVwSLGviL 233 (690)
++|+|||+|+........ .|... +.+..+....|+..+|+||+.--+
T Consensus 141 -~~liDFG~a~~~~~~~~~-----------------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 141 -IWIIDFPQSVEVGEEGWR-----------------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp -EEECCCTTCEETTSTTHH-----------------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred -EEEEECCCCCCCCCCCCH-----------------HHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
T ss_conf -999877884308998709-----------------9998779999999757899844689999987
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.64 E-value=1.1e-07 Score=65.58 Aligned_cols=141 Identities=16% Similarity=0.124 Sum_probs=91.6
Q ss_pred EEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCCCEEEE
Q ss_conf 29999985005956999999835689089999951289888999999999999610899900888898762488760899
Q 005577 26 KIHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILDLGRTKEALL 105 (690)
Q Consensus 26 ry~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~~~~~~~~~L 105 (690)
.|++.+..+-+....||+... .+..+++|+...........+.+|...+..|..+--+.+++.++. ..+..|+
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~---~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~----~~~~~~l 87 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER----HDGWSNL 87 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEEC---SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE----ETTEEEE
T ss_pred CEEEEECCCCCCCCCEEEEEE---CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEE----CCCCEEE
T ss_conf 527997678998771899990---898699998488765325569999999998760699872899975----0896499
Q ss_pred EEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------------
Q ss_conf 99537985899999718999999999999999999999998299------------------------------------
Q 005577 106 VMECCDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS------------------------------------ 149 (690)
Q Consensus 106 VmEy~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g------------------------------------ 149 (690)
||++++|..+..... +......++.++...|..||...
T Consensus 88 v~~~l~G~~~~~~~~------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 88 LMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEECCSSEEHHHHTT------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEEECCCCCCCCCCC------CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 998604334354334------40269999998999999985568421435764465655577899877655554303323
Q ss_pred ---------------------CCCCCCCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf ---------------------990037999882896799981353158877
Q 005577 150 ---------------------PPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 150 ---------------------~~IVHRDLKP~NILLd~~g~vKL~DFGlA~ 179 (690)
..++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCC
T ss_conf 200579999999984498678178986004764236499659996023144
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.41 E-value=1.7e-06 Score=57.75 Aligned_cols=76 Identities=20% Similarity=0.207 Sum_probs=50.9
Q ss_pred EEEEEECCCEEEEEEEECCCCCEEEEEEEEEC----C---CHHHHHHHHHHHHHHHHHCCC--CCCEEEEEEEEEECCCC
Q ss_conf 99850059569999998356890899999512----8---988899999999999961089--99008888987624887
Q 005577 30 RNVIAEGGFSCVYSARDAIHMSKQYAMKHMIC----N---DEESLESAMKEISVMKSLKGH--PNVVTLYAHTILDLGRT 100 (690)
Q Consensus 30 ~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~----~---~~e~~e~~~~Ei~iL~~L~~H--PNIVkl~~~~~~~~~~~ 100 (690)
.+.||.|....||++.+. ..++.+++|.... . -.....+...|+..|+.+..+ ..++++|.++ .
T Consensus 31 ~~eig~G~~N~vfrV~~~-~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d------~ 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQ-EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD------T 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC-----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE------T
T ss_pred EEEECCCCEEEEEEEEEC-CCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEC------C
T ss_conf 998079852768999957-998489996177130346777888778999999999986505798855289985------9
Q ss_pred CEEEEEEECCCC
Q ss_conf 608999953798
Q 005577 101 KEALLVMECCDK 112 (690)
Q Consensus 101 ~~~~LVmEy~~g 112 (690)
...++|||++++
T Consensus 104 ~~~~lvmE~L~~ 115 (392)
T d2pula1 104 EMAVTVMEDLSH 115 (392)
T ss_dssp TTTEEEECCCTT
T ss_pred CCCEEEEECCCC
T ss_conf 887798713577
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.03 E-value=1.9e-05 Score=50.91 Aligned_cols=129 Identities=11% Similarity=0.078 Sum_probs=77.1
Q ss_pred EEEECC-CEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCC-CCCEEEEEEEEEECCCCCEEEEEEEC
Q ss_conf 850059-5699999983568908999995128988899999999999961089-99008888987624887608999953
Q 005577 32 VIAEGG-FSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGH-PNVVTLYAHTILDLGRTKEALLVMEC 109 (690)
Q Consensus 32 ~LG~Gg-fG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~H-PNIVkl~~~~~~~~~~~~~~~LVmEy 109 (690)
.+..|. -..||+... ..+..+++|...... ...+..|+..++.|..+ -.+++++.++. +.+..++||++
T Consensus 17 ~~~~G~s~~~v~r~~~--~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~----~~~~~~~v~~~ 87 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA--QGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVT----EAGRDWLLLGE 87 (255)
T ss_dssp ECSCTTSSCEEEEEEC--TTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEE----CSSCEEEEEEC
T ss_pred ECCCCCCCCEEEEEEE--CCCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEECC----CCCCEEEEEEE
T ss_conf 7678654775899993--898789999589667---76899999999999865999886132224----56615999874
Q ss_pred CCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC----------------------------------------
Q ss_conf 7985899999718999999999999999999999998299----------------------------------------
Q 005577 110 CDKSLVNVLENRGAGYFEEKQVLAIFRDVCNAVFAMHSQS---------------------------------------- 149 (690)
Q Consensus 110 ~~gsLl~~L~~~~~~~Lse~~v~~i~~qIl~aL~yLHs~g---------------------------------------- 149 (690)
++|..+.. ..+... .++.++...|..||...
T Consensus 88 i~G~~~~~------~~~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (255)
T d1nd4a_ 88 VPGQDLLS------SHLAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 158 (255)
T ss_dssp CSSEETTT------SCCCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred EECCCCCC------CCCCHH---HHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHH
T ss_conf 41355432------212689---999999999998736885448875541246889999998754110113401121379
Q ss_pred ----------------CCCCCCCCCCCCEEECCCCCEEEECCCCC
Q ss_conf ----------------99003799988289679998135315887
Q 005577 150 ----------------PPIAHRDLKAENLLLGSDGLWKLCDFGST 178 (690)
Q Consensus 150 ----------------~~IVHRDLKP~NILLd~~g~vKL~DFGlA 178 (690)
..++|+|+.|.|||++.+..+.|+||+.+
T Consensus 159 ~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~ 203 (255)
T d1nd4a_ 159 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 203 (255)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred HHHHHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHC
T ss_conf 999999987187657956786788876357737965899985332
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.36 E-value=0.00064 Score=40.73 Aligned_cols=79 Identities=13% Similarity=0.065 Sum_probs=50.2
Q ss_pred CCCEEEEEEEEEECCCEEEEEEEECC------CCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE
Q ss_conf 28229999985005956999999835------689089999951289888999999999999610899900888898762
Q 005577 23 GNLKIHVRNVIAEGGFSCVYSARDAI------HMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHPNVVTLYAHTILD 96 (690)
Q Consensus 23 ~~~ry~i~~~LG~GgfG~Vyla~d~~------~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~HPNIVkl~~~~~~~ 96 (690)
....+++ ..|+.|---.+|++.... ...+.+.+++.- ... ......+|..+++.+..+.-.+++++++.
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~-- 115 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFS-- 115 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEET--
T ss_pred CCCCEEE-EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-CCC-HHHHHHHHHHHHHHHHHCCCCCEEEEECC--
T ss_conf 9301699-991785334348999688775445789817999659-961-16589999999999975799980899818--
Q ss_pred CCCCCEEEEEEECCCC
Q ss_conf 4887608999953798
Q 005577 97 LGRTKEALLVMECCDK 112 (690)
Q Consensus 97 ~~~~~~~~LVmEy~~g 112 (690)
-.+|++|++|
T Consensus 116 ------~g~I~efi~g 125 (395)
T d1nw1a_ 116 ------GGRLEEYIPS 125 (395)
T ss_dssp ------TEEEECCCCE
T ss_pred ------CCEEEEEECC
T ss_conf ------9569997345
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.99 E-value=0.0014 Score=38.49 Aligned_cols=137 Identities=16% Similarity=0.144 Sum_probs=70.6
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCCCC-CCEEEE---EEEEEECCCCCEEEEEEECCC
Q ss_conf 5956999999835689089999951289888999999999999610899-900888---898762488760899995379
Q 005577 36 GGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKGHP-NVVTLY---AHTILDLGRTKEALLVMECCD 111 (690)
Q Consensus 36 GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~HP-NIVkl~---~~~~~~~~~~~~~~LVmEy~~ 111 (690)
+---.||++.. ..+..|++|...... ...+.+..|...+..|..+. -++... +-... ......+.|+++++
T Consensus 33 s~EN~vy~v~~--~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~--~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 33 SYENRVYQFQD--EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLL--NHQGFYFAVFPSVG 107 (325)
T ss_dssp CSSSEEEEECC--TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCE--EETTEEEEEEECCC
T ss_pred CCCCEEEEEEC--CCCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEE--EEEEEEEEEEEECC
T ss_conf 61202699983--899979999847877-88999999999999998559987875206898056--65347999986527
Q ss_pred CCHH-----H----------HHHHHC-------CCCCCH----------------------HHHHHHHHHHHHHHHHHHH
Q ss_conf 8589-----9----------999718-------999999----------------------9999999999999999982
Q 005577 112 KSLV-----N----------VLENRG-------AGYFEE----------------------KQVLAIFRDVCNAVFAMHS 147 (690)
Q Consensus 112 gsLl-----~----------~L~~~~-------~~~Lse----------------------~~v~~i~~qIl~aL~yLHs 147 (690)
|... + .+.... ...+.. .....++..+...+...-.
T Consensus 108 G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~ 187 (325)
T d1zyla1 108 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 187 (325)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 76889999999999899999988630357865567789788766568999874769988989999999999999998454
Q ss_pred CC--CCCCCCCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf 99--990037999882896799981353158877
Q 005577 148 QS--PPIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 148 ~g--~~IVHRDLKP~NILLd~~g~vKL~DFGlA~ 179 (690)
.. ..+||+|+.+.|||+++ + ..++||+-++
T Consensus 188 ~~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 188 EDFTVLRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp SCSCCEECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred CCCCCEEECCCCCCCCEEEEC-C-CEEEECHHCC
T ss_conf 568712024788804287838-9-3588652014
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.62 E-value=0.0063 Score=34.18 Aligned_cols=146 Identities=14% Similarity=0.095 Sum_probs=70.8
Q ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEECCCHHHHHHHHHHHHHHHHHCC----CCCCEEEE-EEEEEECCCCC
Q ss_conf 99999850059569999998356890899999512898889999999999996108----99900888-89876248876
Q 005577 27 IHVRNVIAEGGFSCVYSARDAIHMSKQYAMKHMICNDEESLESAMKEISVMKSLKG----HPNVVTLY-AHTILDLGRTK 101 (690)
Q Consensus 27 y~i~~~LG~GgfG~Vyla~d~~~~~k~vAIK~i~~~~~e~~e~~~~Ei~iL~~L~~----HPNIVkl~-~~~~~~~~~~~ 101 (690)
+.-...|..|---+.|+.... ...|++|+..... ..+.+..|+.++..|.. .|..+... +..+.. -..
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t~---~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~--~~~ 92 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHTT---KDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE--LSG 92 (316)
T ss_dssp EEEEEEECC---EEEEEEEES---SCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE--ETT
T ss_pred CEEEECCCCCCCCCEEEEEEC---CCCEEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEE--EEC
T ss_conf 568523788852673899978---9728999807899--988999999998754302555455641048976213--412
Q ss_pred EEEEEEECCCCC---------------HHHHHHHHCCC-------CCCH------------------HHHHHHHHHHHHH
Q ss_conf 089999537985---------------89999971899-------9999------------------9999999999999
Q 005577 102 EALLVMECCDKS---------------LVNVLENRGAG-------YFEE------------------KQVLAIFRDVCNA 141 (690)
Q Consensus 102 ~~~LVmEy~~gs---------------Ll~~L~~~~~~-------~Lse------------------~~v~~i~~qIl~a 141 (690)
....++.++.+. .+..+...... .... ......+..+...
T Consensus 93 ~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 172 (316)
T d2ppqa1 93 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 172 (316)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred CCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_conf 55024531146553332046788888998764544432024531011101200245677776531141279999999876
Q ss_pred HHHHHHCCC--CCCCCCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf 999982999--90037999882896799981353158877
Q 005577 142 VFAMHSQSP--PIAHRDLKAENLLLGSDGLWKLCDFGSTS 179 (690)
Q Consensus 142 L~yLHs~g~--~IVHRDLKP~NILLd~~g~vKL~DFGlA~ 179 (690)
+...+..+. ++||+|+.+.|||++.+...-|+||+.+.
T Consensus 173 ~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 173 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 4204855454503337863656402045412674222123
|